PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	HWANG, KC; GRAY, CD; SIVASUBRAMANIAN, N; IM, MJ				HWANG, KC; GRAY, CD; SIVASUBRAMANIAN, N; IM, MJ			INTERACTION SITE OF GTP-BINDING G(H) (TRANSGLUTAMINASE-II) WITH PHOSPHOLIPASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIG LIVER TRANSGLUTAMINASE; GS-ALPHA; TISSUE TRANSGLUTAMINASE; SIGNAL MEDIATOR; PROTEIN; IDENTIFICATION; PURIFICATION; RECEPTOR; ALPHA(1)-ADRENOCEPTOR; RECONSTITUTION	The GTP binding G alpha(h) (transglutaminase II) mediates the alpha(1B)-adrenoreceptor signal to a 69-kDa phospholipase C (PLC). Thus, G alpha(h) possesses both GTPase and transglutaminase activities with a signal transfer role. The recognition sites of this unique GTP binding protein for either the receptor or the effector are completely unknown. A site on human heart G alpha(h) (hhG alpha(h)) has been identified that interacts with and stimulates PLC. Expressed mutants of hhG alpha(h) with deleted C-terminal regions lost the response to (-)-epinephrine and GTP and failed to coimmunoprecipitate PLC by the specific G(h7 alpha) antibody. The interaction regions were further defined by studies with synthetic peptides of hhG alpha(h) and a chimera in which residues VaL(665)-Lys(672) of hhG alpha(h) were substituted with Ile(707)-Ser(714) residues of human coagulation factor XIIIa. Thus, eight amino acid residues near the C terminus of hhG alpha(h) are critical for recognition and stimulation of PLC.	CLEVELAND CLIN FDN,RES INST,DEPT MOLEC CARDIOL FFB37,CLEVELAND,OH 44195	Cleveland Clinic Foundation					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045985] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM45985] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901; BAEK KJ, 1993, J BIOL CHEM, V268, P27390; BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; BIRCKBICHLER PJ, 1981, P NATL ACAD SCI-BIOL, V78, P5005, DOI 10.1073/pnas.78.8.5005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CORDELLAMIELE E, 1990, J BIOL CHEM, V265, P17180; COUPRY I, 1992, J BIOL CHEM, V267, P9852; DAS T, 1993, J BIOL CHEM, V268, P27398; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; GENTILE V, 1991, J BIOL CHEM, V266, P478; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; ICHINOSE A, 1990, J BIOL CHEM, V265, P13411; IM MJ, 1990, J BIOL CHEM, V265, P18944; IM MJ, 1992, J BIOL CHEM, V267, P8887; ITOH H, 1991, J BIOL CHEM, V266, P16226; LEE KN, 1989, BIOCHEM BIOPH RES CO, V162, P1370, DOI 10.1016/0006-291X(89)90825-5; MASTERS SB, 1988, SCIENCE, V241, P448, DOI 10.1126/science.2899356; MAY DC, 1988, BIOCHEMISTRY-US, V27, P4888, DOI 10.1021/bi00413a045; MURTAUGH MP, 1983, J BIOL CHEM, V258, P1074; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; PIACENTINI M, 1991, CELL TISSUE RES, V263, P227, DOI 10.1007/BF00318764; RARICK HM, 1992, SCIENCE, V256, P1031, DOI 10.1126/science.1317058; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766	23	74	75	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27058	27062		10.1074/jbc.270.45.27058	http://dx.doi.org/10.1074/jbc.270.45.27058			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592956	hybrid			2022-12-27	WOS:A1995TE58300056
J	JIANG, Y; YAN, M; GRALLA, JD				JIANG, Y; YAN, M; GRALLA, JD			ABORTIVE INITIATION AND FIRST BOND FORMATION AT AN ACTIVATED ADENOVIRUS E4 PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CARBOXYL-TERMINAL DOMAIN; MAJOR LATE PROMOTER; TRANSCRIPTION INITIATION; NONPHOSPHORYLATED FORM; BASAL TRANSCRIPTION; ATP REQUIREMENT; INVITRO; PHOSPHORYLATION; HELICASE	Abortive initiation at the adenovirus E4 promoter was studied by following the production of RNA formed from the initiating nucleotides UpA and CTP. Formation of a specific short RNA via a reaction with appropriate alpha-amanitin sensitivity required promoter, activator, and ATP, In the absence of any of these, an alpha-amanitin-resistant reaction led to lower levels of a product of unknown origin. The alpha-amanitin-sensitive reaction required open promoter complexes, as assayed directly by permanganate probing. This reaction was not blocked by the inhibition of polymerase C-terminal domain kinase activity or by the lack of DNA supercoiling. Thus, formation of the initial bond of the mRNA appears to require activator and ATP to open the DNA but not phosphorylation of the polymerase C-terminal domain, In addition, the abortive initiation reaction was strongly suppressed when all elongation substrates were present, suggesting that cycling to produce high amounts of abortive product is strongly disfavored during productive initiation at this promoter.	UNIV CALIF LOS ANGELES,DEPT CHEM & BIOCHEM,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90095	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049048] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM49048] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUNICK D, 1982, CELL, V29, P877, DOI 10.1016/0092-8674(82)90449-4; CADENA DL, 1987, J BIOL CHEM, V262, P12468; CAREY M, 1990, SCIENCE, V247, P710, DOI 10.1126/science.2405489; CAREY MF, 1986, J BIOL CHEM, V261, P4309; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; CHANG CH, 1993, J BIOL CHEM, V268, P20482; CONAWAY RC, 1988, J BIOL CHEM, V263, P2962; CORDEN JL, 1990, TRENDS BIOCHEM SCI, V15, P383, DOI 10.1016/0968-0004(90)90236-5; DEMERCOYROL L, 1989, BIOCHEM J, V258, P165, DOI 10.1042/bj2580165; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DRAPKIN R, 1994, TRENDS BIOCHEM SCI, V19, P504, DOI 10.1016/0968-0004(94)90139-2; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; JACOB GA, 1994, J BIOL CHEM, V269, P3655; JACOB GA, 1991, J BIOL CHEM, V266, P22537; JIANG Y, 1993, MOL CELL BIOL, V13, P4572, DOI 10.1128/MCB.13.8.4572; JIANG Y, 1994, J BIOL CHEM, V269, P5505; JIANG Y, 1995, J BIOL CHEM, V270, P1277, DOI 10.1074/jbc.270.3.1277; JIANG Y, 1994, NUCLEIC ACIDS RES, V22, P4958, DOI 10.1093/nar/22.23.4958; JIANG Y, 1993, J BIOL CHEM, V268, P6535; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; LAYBOURN PJ, 1989, J BIOL CHEM, V264, P6693; LAYBOURN PJ, 1990, J BIOL CHEM, V265, P13165; LEE G, 1994, MOL CELL BIOL, V14, P4579, DOI 10.1128/MCB.14.7.4579; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; LUSE DS, 1987, J BIOL CHEM, V262, P14990; MCCLURE WR, 1978, J BIOL CHEM, V253, P8941; NARAYAN S, 1994, J BIOL CHEM, V269, P12755; PARADA CA, 1995, J BIOL CHEM, V270, P2274, DOI 10.1074/jbc.270.5.2274; PARVIN JD, 1992, CELL, V68, P1135, DOI 10.1016/0092-8674(92)90084-P; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; SAWADOGO M, 1984, J BIOL CHEM, V259, P5321; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SERIZAWA H, 1993, J BIOL CHEM, V268, P17300; SERIZAWA H, 1993, NATURE, V363, P371, DOI 10.1038/363371a0; SVEJSTRUP JQ, 1995, CELL, V80, P21, DOI 10.1016/0092-8674(95)90447-6; TIMMERS HTM, 1994, EMBO J, V13, P391, DOI 10.1002/j.1460-2075.1994.tb06273.x; USHEVA A, 1992, CELL, V69, P871, DOI 10.1016/0092-8674(92)90297-P; WANG WD, 1992, SCIENCE, V255, P450, DOI 10.1126/science.1310361; WANG WD, 1992, GENE DEV, V6, P1716, DOI 10.1101/gad.6.9.1716; YANKULOV K, 1994, CELL, V77, P749, DOI 10.1016/0092-8674(94)90058-2; YOUNG RA, 1991, ANNU REV BIOCHEM, V60, P689, DOI 10.1146/annurev.biochem.60.1.689	44	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27332	27338		10.1074/jbc.270.45.27332	http://dx.doi.org/10.1074/jbc.270.45.27332			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592996	hybrid			2022-12-27	WOS:A1995TE58300096
J	LEE, NG; SUNSHINE, MG; ENGSTROM, JJ; GIBSON, BW; APICELLA, MA				LEE, NG; SUNSHINE, MG; ENGSTROM, JJ; GIBSON, BW; APICELLA, MA			MUTATION OF THE HTRB LOCUS OF HAEMOPHILUS-INFLUENZAE NONTYPABLE STRAIN-2019 IS ASSOCIATED WITH MODIFICATIONS OF LIPID-A AND PHOSPHORYLATION OF THE LIPO-OLIGOSACCHARIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE LIPOOLIGOSACCHARIDES; ESCHERICHIA-COLI; NULL MUTATIONS; MULTICOPY SUPPRESSOR; POLYACRYLAMIDE GELS; GENE; LIPOPOLYSACCHARIDES; PLASMIDS; MEDIA	The HtrB protein was first identified in Escherichia coli as a protein required for cell viability at high temperature, but its expression was not regulated by temperature. We isolated an htrB homologue from nontypable Haemophilus influenzae strain (NTHi) 2019, which was able to functionally complement the E, coli htrB mutation, The promoter for the NTHi 2019 htrB gene overlaps the promoter for the rfaE gene, and the two genes are divergently transcribed. The deduced amino acid sequence of NTHi 2019 HtrB had 56% homology to E, coli HtrB, In vitro transcription-translation analysis confirmed production of a protein with an apparent molecular mass of 32-33 kDa, Primer extension analysis revealed that htrB was transcribed from a sigma(70)-dependent consensus promoter and its expression was not affected by temperature, The expression of htrB and rfaE was 2.5-4 times higher in the NTHi htrB mutant B29 than in the parental strain, In order to study the function of the HtrB protein in Haemophilus, we generated two isogenic htrB mutants by shuttle mutagenesis using a mini-Tn3, The htrB mutants initially showed temperature sensitivity, but they lost the sensitivity after a few passages at 30 degrees C and were able to grow at 37 degrees C, They also showed hypersensitivity to deoxycholate and kanamycin, which persisted on passage, SDS-polyacrylamide gel electrophoresis analysis revealed that the lipo-oligosaccharide (LOS) isolated from these mutants migrated faster than the wild type LDS and its color changed from black to brown as has been described for E. coli htrB mutants. Immunoblotting analysis also showed that the LOS from the htrB mutants lost reactivity to a monoclonal antibody, 6E4, which binds to the wild type NTHi 2019 LOS. Electrospray ionization-mass spectrometry analysis of the O-deacylated LOS oligosaccharide indicated a modification of the core structure characterized in part by a net loss in phosphoethanolamine. Mass spectrometric analysis of the lipid A of the htrB mutant indicated a loss of one or both myristic acid substitutions. These data suggest that HtrB is a multifunctional protein and may play a controlling role in regulating cell responses to various environmental changes.	UNIV IOWA, DEPT MICROBIOL, IOWA CITY, IA 52242 USA; UNIV CALIF SAN FRANCISCO, SCH PHARM, DEPT PHARMACEUT CHEM, SAN FRANCISCO, CA 94143 USA	University of Iowa; University of California System; University of California San Francisco					NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024616, R01AI024616] Funding Source: NIH RePORTER; NCRR NIH HHS [NCRR BRTP 01614] Funding Source: Medline; NIAID NIH HHS [AI 24616] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABUKWAIK Y, 1991, MOL MICROBIOL, V5, P2475, DOI 10.1111/j.1365-2958.1991.tb02092.x; BEGG KJ, 1985, J BACTERIOL, V163, P615, DOI 10.1128/JB.163.2.615-622.1985; CHANDLER MS, 1991, PLASMID, V25, P221, DOI 10.1016/0147-619X(91)90016-P; CLEMENTZ T, 1995, 1995 ANN M AM SOC BI, V9, P1311; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; GIBSON BW, 1993, J BACTERIOL, V175, P2702, DOI 10.1128/JB.175.9.2702-2712.1993; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HELANDER IM, 1992, EUR J BIOCHEM, V185, P541; HERRIOTT RM, 1970, J BACTERIOL, V101, P517, DOI 10.1128/JB.101.2.517-524.1970; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; KAROW M, 1992, J BACTERIOL, V174, P702, DOI 10.1128/jb.174.3.702-710.1992; KAROW M, 1993, MOL MICROBIOL, V7, P69, DOI 10.1111/j.1365-2958.1993.tb01098.x; KAROW M, 1991, MOL MICROBIOL, V5, P2285, DOI 10.1111/j.1365-2958.1991.tb02159.x; KAROW M, 1991, J BACTERIOL, V173, P741, DOI 10.1128/jb.173.2.741-750.1991; KAROW M, 1992, J BACTERIOL, V174, P7407, DOI 10.1128/jb.174.22.7407-7418.1992; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE NG, 1995, INFECT IMMUN, V63, P818, DOI 10.1128/IAI.63.3.818-824.1995; MANDRELL RE, 1993, IMMUNOBIOLOGY, V187, P382, DOI 10.1016/S0171-2985(11)80352-9; MELAUGH W, 1992, J BIOL CHEM, V267, P13434; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; PARKER CT, 1992, J BACTERIOL, V174, P2525, DOI 10.1128/jb.174.8.2525-2538.1992; PHILLIPS NJ, 1990, BIOMED ENVIRON MASS, V19, P731, DOI 10.1002/bms.1200191112; PHILLIPS NJ, 1992, BIOCHEMISTRY-US, V31, P4515, DOI 10.1021/bi00133a019; RAY MK, 1994, J BACTERIOL, V176, P4243, DOI 10.1128/jb.176.14.4243-4249.1994; Sambrook J, 1989, MOL CLONING LABORATO; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; SEIFERT HS, 1986, P NATL ACAD SCI USA, V83, P735, DOI 10.1073/pnas.83.3.735; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; WILLIAM JD, 1988, NUCLEIC ACIDS RES, V16, P6127	30	55	66	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27151	27159		10.1074/jbc.270.45.27151	http://dx.doi.org/10.1074/jbc.270.45.27151			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592970	hybrid			2022-12-27	WOS:A1995TE58300070
J	SCHMIDT, KN; TRAENCKNER, EBM; MEIER, B; BAEUERLE, PA				SCHMIDT, KN; TRAENCKNER, EBM; MEIER, B; BAEUERLE, PA			INDUCTION OF OXIDATIVE STRESS BY OKADAIC ACID IS REQUIRED FOR ACTIVATION OF TRANSCRIPTION FACTOR NF-KAPPA-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; PROTEIN-KINASE-C; INTACT-CELLS; FACTOR-ALPHA; PHORBOL ESTER; CALYCULIN-A; PHOSPHORYLATION; INTERLEUKIN-1; TRANSLOCATION; INHIBITORS	The widely used phosphatase 1 and 2A inhibitor okadaic acid is one of the many stimuli activating transcription factor NF-kappa B in cultured cells. Phosphorylation of I kappa B-alpha, one of NF-kappa B's inhibitory subunits, is a prerequisite for I kappa B degradation and the subsequent liberation of transcriptionally active NF-kappa B. This observation suggested that the phosphorylation status of IlcB is influenced by an okadaic acid-sensitive phosphatase. In this study, we provide evidence that the effect of okadaic acid on NF-kappa B activation is indirect and dependent on the production of reactive oxygen intermediates rather than the inhibition of an I kappa B-alpha phosphatase. Okadaic acid was found to be a strong inducer of cellular H2O2 and superoxide production in two distinct cell lines. The structurally unrelated phosphatase inhibitor calyculin A also induced oxidative stress. The delayed onset of reactive oxygen production in response to okadaic acid correlated with the delayed activation of NF-kappa B. Moreover, NF-kappa B induction was optimal at the same okadaic acid concentration that caused optimal H2O2 production. Both reactive oxygen intermediates production and NF-kappa B activation were inhibited by the antioxidant pyrrolidine dithiocarbamate and 8-(diethylamino)octyl-3,4,5-trimethyoxybenzoate, a Ca2+ chelator. Future experiments using phosphatase inhibitors in intact cells must consider that the compounds can act as strong inducers of oxidative stress, which provides one explanation for their tumor-promoting activity.	UNIV FREIBURG, INST BIOCHEM, D-79104 FREIBURG, GERMANY; HANNOVER SCH VET MED, INST CHEM, D-30173 HANNOVER, GERMANY	University of Freiburg; University of Veterinary Medicine Hannover, Foundation								AONUMA S, 1991, MUTAT RES, V250, P375, DOI 10.1016/0027-5107(91)90194-S; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; BOISSY RE, 1989, CYTOMETRY, V10, P779, DOI 10.1002/cyto.990100616; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; CHRISTIANSEN NO, 1986, BIOCHIM BIOPHYS ACTA, V882, P57, DOI 10.1016/0304-4165(86)90055-3; GOPALAKRISHNA R, 1992, BIOCHEM BIOPH RES CO, V189, P950, DOI 10.1016/0006-291X(92)92296-A; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; HARDIE DG, 1991, METHOD ENZYMOL, V201, P469; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; ISHIDA Y, 1992, J CELL PHYSIOL, V150, P484, DOI 10.1002/jcp.1041500308; ISHIHARA H, 1989, J PHARMACOL EXP THER, V250, P388; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; MACKINTOSH C, 1994, TRENDS BIOCHEM SCI, V19, P444, DOI 10.1016/0968-0004(94)90127-9; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MEIER B, 1989, BIOCHEM J, V263, P539, DOI 10.1042/bj2630539; MEIER B, 1990, BIOL CHEM H-S, V371, P1021, DOI 10.1515/bchm3.1990.371.2.1021; MENON SD, 1993, J BIOL CHEM, V268, P26805; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; MEYER M, 1993, OXIDATIVE STRESS CEL, P217; MEYER R, 1991, P NATL ACAD SCI USA, V88, P966, DOI 10.1073/pnas.88.3.966; MUROI M, 1994, J BIOL CHEM, V269, P30561; PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; RIECKMANN P, 1992, BIOCHEM BIOPH RES CO, V187, P51, DOI 10.1016/S0006-291X(05)81457-3; SAKAI R, 1989, P NATL ACAD SCI USA, V86, P9946, DOI 10.1073/pnas.86.24.9946; SCHMIDT KN, 1995, CHEM BIOL, V2, P13, DOI 10.1016/1074-5521(95)90076-4; SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Schreck R, 1991, Trends Cell Biol, V1, P39, DOI 10.1016/0962-8924(91)90072-H; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHULZEOSTHOFF K, 1993, EMBO J, V12, P3095, DOI 10.1002/j.1460-2075.1993.tb05978.x; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; SUZUKI YJ, 1993, FREE RADICAL RES COM, V18, P115, DOI 10.3109/10715769309147348; SUZUKI YJ, 1994, J IMMUNOL, V153, P5008; THEVENIN C, 1990, New Biologist, V2, P793; TRAENCKNER BM, 1995, IN PRESS J CELL SCI; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x	47	165	170	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27136	27142		10.1074/jbc.270.45.27136	http://dx.doi.org/10.1074/jbc.270.45.27136			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592968	hybrid			2022-12-27	WOS:A1995TE58300068
J	JUGEAUBRY, CE; GORLABAJSZCZAK, A; PERNIN, A; LEMBERGER, T; WAHLI, W; BURGER, AG; MEIER, CA				JUGEAUBRY, CE; GORLABAJSZCZAK, A; PERNIN, A; LEMBERGER, T; WAHLI, W; BURGER, AG; MEIER, CA			PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR MEDIATES CROSS-TALK WITH THYROID-HORMONE RECEPTOR BY COMPETITION FOR RETINOID-X RECEPTOR - POSSIBLE ROLE OF A LEUCINE ZIPPER-LIKE HEPTAD REPEAT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING; RESISTANCE; DIMERIZATION; EXPRESSION; ISOFORMS; ELEMENT; GENE; DNA	The peroxisome proliferator-activated receptors (PPAR) and thyroid hormone receptors (TR) are members of the nuclear receptor superfamily, which regulate lipid metabolism and tissue differentiation. In order to bind to DNA and activate transcription, PPAR requires the formation of heterodimers with the retinoid X receptor (RXR). In addition to activating transcription through its own response elements, PPAR is able to selectively down-regulate the transcriptional activity of TR, but not vitamin D receptor. The molecular basis of this functional interaction has not been fully elucidated. By means of site-directed mutagenesis of hPPAR alpha we mapped its inhibitory action on TR to a leucine zipper-like motif in the ligand binding domain of PPAR, which is highly conserved among all subtypes of this receptor and mediates heterodimerization with RXR. Replacement of a single leucine by arginine at position 433 of hPPAR alpha (L433R) abolished heterodimerization of PPAR with RXR and consequently its trans-activating capacity. However, a similar mutation of a leucine residue to arginine at position 422 showed no alteration of heterodimerization, DNA binding, or transcriptional activation. The dimerization deficient mutant L433R was no longer able to inhibit TR action, demonstrating that the selective inhibitory effect of PPAR results from the competition for RXR as well as possibly for other TR-auxiliary proteins. In contrast, abolition of DNA binding by a mutation in the P-box of PPAR (C122S) did not eliminate the inhibition of TR trans-activation, indicating that competition for DNA binding is not involved. Additionally, no evidence for the formation of PPAR:TR heterodimers was found in co-immunoprecipitation experiments. In summary, we have demonstrated that PPAR selectively inhibits the transcriptional activity of TRs by competition for RXR and possibly non-RXR TR-auxiliary proteins. In contrast, this functional interaction is independent of the formation of PPAR:TR heterodimers or competition for DNA binding.	UNIV HOSP GENEVA,DIV ENDOCRINOL,THYROID UNIT,CH-1211 GENEVA,SWITZERLAND; UNIV LAUSANNE,INST BIOL ANIM,CH-1015 LAUSANNE,SWITZERLAND; GLAXO INST MOLEC BIOL SA,CH-1228 PLAN LES OVATES,SWITZERLAND; UNIV HOSP GENEVA,DEPT MED,MED CLIN 2,CH-1211 GENEVA,SWITZERLAND	University of Geneva; University of Lausanne; GlaxoSmithKline; University of Geneva			Lemberger, Thomas/A-7301-2008; Wahli, Walter/I-3194-2019; Wahli, Walter/B-1398-2009	Lemberger, Thomas/0000-0002-2499-4025; Wahli, Walter/0000-0002-5966-9089				AUFLIEGNER M, MOL CELL BIOL, V13, P5725; BARDOT O, 1993, BIOCHEM BIOPH RES CO, V192, P37, DOI 10.1006/bbrc.1993.1378; BOGAZZI F, 1994, J BIOL CHEM, V269, P11683; CARLBERG C, 1993, NATURE, V361, P657, DOI 10.1038/361657a0; DARLING DS, 1993, J BIOL CHEM, V268, P10221; FALCONE M, 1994, EUR J ENDOCRINOL, V130, P97, DOI 10.1530/eje.0.1300097; FALCONE M, 1992, ENDOCRINOLOGY, V131, P2419, DOI 10.1210/en.131.5.2419; FLUG F, 1987, J BIOL CHEM, V262, P6373; FORMAN BM, 1989, MOL ENDOCRINOL, V3, P1610, DOI 10.1210/mend-3-10-1610; GREEN S, 1994, MOL CELL ENDOCRINOL, V100, P149, DOI 10.1016/0303-7207(94)90294-1; KREY G, 1993, J STEROID BIOCHEM, V47, P65, DOI 10.1016/0960-0760(93)90058-5; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEMBERGER T, 1994, J BIOL CHEM, V269, P24527; MEIER CA, 1992, MOL ENDOCRINOL, V6, P248, DOI 10.1210/me.6.2.248; MEIER CA, 1983, J CLIN INVEST, V92, P1986; MEIERHEUSLER SC, 1995, MOL CELL ENDOCRINOL, V107, P55, DOI 10.1016/0303-7207(94)03422-P; NAGAYA T, 1993, J BIOL CHEM, V268, P15766; REFETOFF S, 1993, ENDOCR REV, V14, P348, DOI 10.1210/er.14.3.348; SCHWARTZ HL, 1992, J BIOL CHEM, V267, P11794; SHER T, 1993, BIOCHEMISTRY-US, V32, P8898; STEINFELDER HJ, 1991, P NATL ACAD SCI USA, V88, P3130, DOI 10.1073/pnas.88.8.3130; YAMADA J, 1994, ARCH BIOCHEM BIOPHYS, V315, P555, DOI 10.1006/abbi.1994.1536; YEN PM, 1992, J BIOL CHEM, V267, P3565	23	134	145	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18117	18122		10.1074/jbc.270.30.18117	http://dx.doi.org/10.1074/jbc.270.30.18117			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629123	hybrid			2022-12-27	WOS:A1995RM26600074
J	KOLAKOWSKI, LF; LU, B; GERARD, C; GERARD, NP				KOLAKOWSKI, LF; LU, B; GERARD, C; GERARD, NP			PROBING THE MESSAGE-ADDRESS SITES FOR CHEMOATTRACTANT BINDING TO THE C5A RECEPTOR - MUTAGENESIS OF HYDROPHILIC AND PROLINE RESIDUES WITHIN THE TRANSMEMBRANE SEGMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ADRENERGIC-RECEPTOR; LIGAND-BINDING; INTERLEUKIN-8 RECEPTOR; CYSTEINE RESIDUE-110; SUBTYPE SPECIFICITY; BOVINE RHODOPSIN; AMINO TERMINUS; ANAPHYLATOXIN; IDENTIFICATION	The C5a anaphylatoxin ligand receptor interaction on polymorphonuclear granulocytes stimulates chemotaxis, degranulation, and the oxidative burst. The receptor is a member of the large G-protein-coupled family. The ligand is a cationic peptide of 72 amino acids derived from the C5 component of complement and has been shown to have a number of structural requirements for interaction with the receptor. In order to probe the potential interaction sites between ligand and receptor, we constructed a series of mutated receptor molecules, targeting cysteines, prolines, and additional amino acids of interest because of combinations of charge or hydrophobicity and putative location with respect to the membrane. Transfected mutant receptors were analyzed for cell surface expression, ligand binding, and ligand-activated phospholipase C activity. The receptors created can be placed generally in four distinct classes: those which bind and signal like the natural receptor; those which bind but fail to transduce signals; those which are expressed but neither bind nor transduce signal; and those which are not expressed at the cell surface.	CHILDRENS HOSP,INA SUE PERLMUTTER LAB,BOSTON,MA 02115; CHILDRENS HOSP,DEPT PEDIAT,BOSTON,MA 02115; BETH ISRAEL HOSP,DEPT MED,BOSTON,MA; BRIGHAM & WOMENS HOSP,DEPT MED,BOSTON,MA; HARVARD UNIV,CTR BLOOD RES,SCH MED,BOSTON,MA 02115; HARVARD UNIV,SCH MED,THORNDIKE LAB,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036162, R37HL036162] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL71910, HL36162] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMATRUDA TT, 1993, J BIOL CHEM, V268, P10139; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BAYRAMASHVILI DI, 1984, EUR J BIOCHEM, V142, P583, DOI 10.1111/j.1432-1033.1984.tb08326.x; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BUHL AM, 1994, P NATL ACAD SCI USA, V91, P9190, DOI 10.1073/pnas.91.19.9190; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; DAVIDSON FF, 1994, P NATL ACAD SCI USA, V91, P4029, DOI 10.1073/pnas.91.9.4029; DEMARTINO JA, 1994, J BIOL CHEM, V269, P14446; DIXON RAF, 1987, EMBO J, V6, P3269, DOI 10.1002/j.1460-2075.1987.tb02645.x; GAYLE RB, 1993, J BIOL CHEM, V268, P7283; GERARD C, 1985, J BIOL CHEM, V260, P2613; GERARD C, 1992, J IMMUNOL, V149, P2600; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; GERARD G, 1979, J RETICULOENDOTHEL S, V26, P711; GERARD NP, 1990, BIOCHEMISTRY-US, V29, P9274, DOI 10.1021/bi00491a024; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; HENDERSON R, 1990, PHILOS T ROY SOC B, V326, P379, DOI 10.1098/rstb.1990.0019; HUUANG HV, 1988, BIOTECHNOLOGY, V10, P269; KARNIK SS, 1990, J BIOL CHEM, V265, P17520; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; KAWAI M, 1991, J MED CHEM, V34, P2068, DOI 10.1021/jm00111a022; KUNZ D, 1992, J BIOL CHEM, V267, P9101; LAROSA GJ, 1992, J BIOL CHEM, V267, P25402; LEONG SR, 1994, J BIOL CHEM, V269, P19343; MERY L, 1994, J BIOL CHEM, V269, P3457; MOLLISON KW, 1989, P NATL ACAD SCI USA, V86, P292, DOI 10.1073/pnas.86.1.292; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NAKAYAMA TA, 1990, J BIOL CHEM, V265, P15762; NATHANS J, 1992, BIOCHEMISTRY-US, V31, P4923, DOI 10.1021/bi00136a001; OPPERMANN M, 1993, J IMMUNOL, V151, P3785; ROLLINS TE, 1991, P NATL ACAD SCI USA, V88, P971, DOI 10.1073/pnas.88.3.971; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAVARESE TM, 1992, BIOCHEM J, V283, P1; SCHWYZER R, 1980, PROC R SOC SER B-BIO, V210, P5, DOI 10.1098/rspb.1980.0115; Schwyzer R, 1977, Ann N Y Acad Sci, V297, P3, DOI 10.1111/j.1749-6632.1977.tb41843.x; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; SICILIANO SJ, 1994, P NATL ACAD SCI USA, V91, P1214, DOI 10.1073/pnas.91.4.1214; STRADER CD, 1988, J BIOL CHEM, V263, P10267; SURYANARAYANA S, 1992, J BIOL CHEM, V267, P21991; TOTA MR, 1990, J BIOL CHEM, V265, P16891; VALOVE FM, 1994, ENDOCRINOLOGY, V135, P2657, DOI 10.1210/en.135.6.2657; VOGT W, 1986, Complement, V3, P177; WESS J, 1993, EMBO J, V12, P331, DOI 10.1002/j.1460-2075.1993.tb05661.x; YANCEY KB, 1989, J INVEST DERMATOL, V92, P184, DOI 10.1111/1523-1747.ep12276710; YOKOTA Y, 1992, EMBO J, V11, P3585, DOI 10.1002/j.1460-2075.1992.tb05442.x	46	48	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18077	18082		10.1074/jbc.270.30.18077	http://dx.doi.org/10.1074/jbc.270.30.18077			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629117	hybrid			2022-12-27	WOS:A1995RM26600068
J	LAIDLER, V; CHADDOCK, AM; KNOTT, TG; WALKER, D; ROBINSON, C				LAIDLER, V; CHADDOCK, AM; KNOTT, TG; WALKER, D; ROBINSON, C			A SECY HOMOLOG IN ARABIDOPSIS-THALIANA - SEQUENCE OF A FULL-LENGTH CDNA CLONE AND IMPORT OF THE PRECURSOR PROTEIN INTO CHLOROPLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ESCHERICHIA-COLI; MEMBRANE-PROTEINS; PLASTID GENOME; EXPORT GENE; MATURATION; PEPTIDES; OPERON; MUTANT; LUMEN	Proteins are translocated across the thylakoid membrane by two distinct pathways in higher plant chloroplasts, one of which is related to prokaryotic Sec-dependent translocation mechanisms. SecY is an essential, hydrophobic component of the membrane-bound translocase complex in bacteria, and we report here the nucleotide sequence of a full-length cDNA encoding a homolog of SecY from Arabidopsis thaliana. The predicted protein of 551 residues includes an amino-terminal extension of approximately 120 residues when compared with other SecY proteins. The deduced sequence of the mature protein, cpSecY, is 41% identical with SecY from Synechococcus and 33% identical with the Escherichia coli protein. The extension serves to target the protein into chloroplasts; transcription-translation of the cDNA yields a 58-kDa precursor protein which is imported into pea chloroplasts, processed to a product of 46 kDa, and targeted into the thylakoid membrane.	UNIV WARWICK,DEPT BIOL SCI,COVENTRY CV4 7AL,W MIDLANDS,ENGLAND	University of Warwick				Walker, Denise/0000-0003-1534-1679				AKIYAMA Y, 1985, EMBO J, V4, P3351, DOI 10.1002/j.1460-2075.1985.tb04088.x; BIEKER KL, 1990, J BIOENERG BIOMEMBR, V22, P291, DOI 10.1007/BF00763169; CERRETTI DP, 1983, NUCLEIC ACIDS RES, V11, P2599, DOI 10.1093/nar/11.9.2599; DOUGLAS SE, 1992, FEBS LETT, V298, P93, DOI 10.1016/0014-5793(92)80029-G; EMR SD, 1981, CELL, V23, P79, DOI 10.1016/0092-8674(81)90272-5; FLACHMANN R, 1993, J BIOL CHEM, V268, P7514; FLUGGE UI, 1989, EMBO J, V8, P39, DOI 10.1002/j.1460-2075.1989.tb03346.x; GARDEL C, 1990, EMBO J, V9, P3209, DOI 10.1002/j.1460-2075.1990.tb07519.x; GAVEL Y, 1990, FEBS LETT, V261, P455, DOI 10.1016/0014-5793(90)80614-O; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; HAGEMAN J, 1990, PLANT CELL, V2, P479, DOI 10.1105/tpc.2.5.479; HAGEMAN J, 1986, NATURE, V324, P567, DOI 10.1038/324567a0; ITO K, 1983, CELL, V32, P789, DOI 10.1016/0092-8674(83)90065-X; JAMES HE, 1989, J BIOL CHEM, V264, P19573; KO K, 1989, EMBO J, V8, P3187, DOI 10.1002/j.1460-2075.1989.tb08477.x; NAKAI M, 1994, J BIOL CHEM, V269, P31338; NAKAI M, 1992, BIOCHIM BIOPHYS ACTA, V1171, P113, DOI 10.1016/0167-4781(92)90150-X; ROBINSON C, 1994, PLANT MOL BIOL, V26, P15, DOI 10.1007/BF00039516; SCHATZ PJ, 1989, GENE DEV, V3, P1035, DOI 10.1101/gad.3.7.1035; SHIBA K, 1984, EMBO J, V3, P631, DOI 10.1002/j.1460-2075.1984.tb01859.x; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; WATANABE M, 1989, P NATL ACAD SCI USA, V86, P1895, DOI 10.1073/pnas.86.6.1895; YUAN JG, 1994, SCIENCE, V266, P796, DOI 10.1126/science.7973633	23	85	88	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17664	17667		10.1074/jbc.270.30.17664	http://dx.doi.org/10.1074/jbc.270.30.17664			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629062	hybrid			2022-12-27	WOS:A1995RM26600007
J	RANA, B; XIE, YH; MISCHOULON, D; BUCHER, NLR; FARMER, SR				RANA, B; XIE, YH; MISCHOULON, D; BUCHER, NLR; FARMER, SR			THE DNA-BINDING ACTIVITY OF C/EBP TRANSCRIPTION FACTORS IS REGULATED IN THE G(1) PHASE OF THE HEPATOCYTE CELL-CYCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-REGENERATION; GENE-EXPRESSION; PHOSPHOENOLPYRUVATE CARBOXYKINASE; 3T3-L1 PREADIPOCYTES; INDUCTION-PATTERNS; ACTIVATOR PROTEIN; DIFFERENTIATION; FAMILY; ISOFORMS; PROMOTER	We have isolated the promoter of the rat C/EBP alpha gene and find a high degree of homology with the mouse gene, particularly in putative regulatory domains. Transactivation of this promoter by ectopic expression of rat C/EBP beta occurs through a C/EBP regulatory domain at position -170 to -195. An oligonucleotide corresponding to this domain binds to complexes expressed in rat liver that comprise C/EBP alpha-C/EBP beta heterodimers (alpha beta) as well as C/EBP beta complexed with itself and/or other unidentified nuclear factors (beta 1, beta 2, and beta 3). The DNA binding activity of these complexes changes both qualitatively and quantitatively following partial hepatectomy. Within 2-5 h postsurgery, the binding activity of the alpha beta complexes drops severalfold, reaching a nadir by 20 h. During the ensuing 3-8 days, as regeneration nears completion, this activity slowly returns to normal quiescent liver levels. Western blot analysis shows 3 major C/EBP alpha polypeptide species (42, 40, and 30 kDa), whose abundance in general parallels the decrease and recovery in DNA binding activity. In contrast to C/EBP alpha behavior, the DNA binding activity of the beta complexes is transiently induced severalfold during the early G(1) period between 2 and 6 h posthepatectomy. The major C/EBP beta polypeptide is the 32-kDa LAP protein, whereas the LIP protein (21 kDa) is weakly expressed. Both remain essentially constant throughout the course of regeneration, suggesting that changes in DNA binding activity may reflect changes in the complexed proteins rather than the C/EBP beta polypeptides themselves. In primary hepatocyte cultures, under growth supporting conditions, in the absence of growth factors proliferation is negligible; C/EBP alpha is abundantly expressed at the outset, but is then extensively down-regulated. Epidermal growth factor causes further decay of C/EBP alpha polypeptides and DNA binding activity, and down-regulates C/EBP beta DNA binding activity as well. Addition of transforming growth factor beta completely antagonizes the effects of epidermal growth factor on C/EBP beta activity, and partially overcomes the effect on C/EBP alpha. These results demonstrate that the DNA binding activity of C/EBP alpha and C/EBP beta complexes is regulated in the regenerating liver, and in hepatocyte cultures responding to growth factors that regulate their proliferation.	BOSTON UNIV,SCH MED,DEPT BIOCHEM,BOSTON,MA 02118; BOSTON UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02118	Boston University; Boston University				Farmer, Stephen/0000-0003-2483-2795	NATIONAL CANCER INSTITUTE [R01CA039099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045048] Funding Source: NIH RePORTER; NCI NIH HHS [CA39099] Funding Source: Medline; NIDDK NIH HHS [DK45048] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALAM T, 1992, J BIOL CHEM, V267, P5021; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; BUCHER NLR, 1991, J GASTROEN HEPATOL, V6, P615, DOI 10.1111/j.1440-1746.1991.tb00921.x; BUCHER NLR, 1978, CIBA F S, V55, P95; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; CRESCENZI M, 1990, P NATL ACAD SCI USA, V87, P8442, DOI 10.1073/pnas.87.21.8442; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; DIEHL AM, 1994, HEPATOLOGY, V19, P447; FAUSTO N, 1989, HEPATOLOGY, P49; FLODBY P, 1993, EXP CELL RES, V208, P248, DOI 10.1006/excr.1993.1244; FREYTAG SO, 1992, SCIENCE, V256, P379, DOI 10.1126/science.256.5055.379; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; FRIEDMAN AD, 1989, GENE DEV, V3, P1314, DOI 10.1101/gad.3.9.1314; FRIEDMAN JM, 1984, J MOL BIOL, V179, P37, DOI 10.1016/0022-2836(84)90305-X; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; HABER BA, 1993, J CLIN INVEST, V91, P1319, DOI 10.1172/JCI116332; Higgins GM, 1931, ARCH PATHOL, V12, P186; HSU W, 1994, MOL CELL BIOL, V14, P268, DOI 10.1128/MCB.14.1.268; KAESTNER KH, 1990, P NATL ACAD SCI USA, V87, P251, DOI 10.1073/pnas.87.1.251; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533; MCGOWAN JA, 1981, J CELL PHYSIOL, V108, P353, DOI 10.1002/jcp.1041080309; MCKNIGHT SL, 1989, GENE DEV, V3, P2021, DOI 10.1101/gad.3.12b.2021; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819; MISCHOULON D, 1992, MOL CELL BIOL, V12, P2553, DOI 10.1128/MCB.12.6.2553; MOHN KL, 1990, J BIOL CHEM, V265, P21914; PARK EA, 1990, MOL CELL BIOL, V10, P6264, DOI 10.1128/MCB.10.12.6264; RANA B, 1994, MOL CELL BIOL, V14, P5858, DOI 10.1128/MCB.14.9.5858; ROMAN C, 1990, GENE DEV, V4, P1404, DOI 10.1101/gad.4.8.1404; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SORRENTINO V, 1990, NATURE, V345, P813, DOI 10.1038/345813a0; STEIN B, 1993, MOL CELL BIOL, V13, P3964, DOI 10.1128/MCB.13.7.3964; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; VASSEURCOGNET M, 1993, CURR OPIN GENET DEV, V3, P238, DOI 10.1016/0959-437X(93)90029-O; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; XANTHOPOULOS KG, 1989, P NATL ACAD SCI USA, V86, P4117, DOI 10.1073/pnas.86.11.4117	45	78	78	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18123	18132		10.1074/jbc.270.30.18123	http://dx.doi.org/10.1074/jbc.270.30.18123			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629124	hybrid			2022-12-27	WOS:A1995RM26600075
J	ALLEVATO, G; BILLESTRUP, N; GOUJON, L; GALSGAARD, ED; NORSTEDT, G; POSTELVINAY, MC; KELLY, PA; NIELSEN, JH				ALLEVATO, G; BILLESTRUP, N; GOUJON, L; GALSGAARD, ED; NORSTEDT, G; POSTELVINAY, MC; KELLY, PA; NIELSEN, JH			IDENTIFICATION OF PHENYLALANINE-346 IN THE RAT GROWTH-HORMONE RECEPTOR AS BEING CRITICAL FOR LIGAND-MEDIATED INTERNALIZATION AND DOWN-REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; SIGNAL-TRANSDUCTION; MUTATIONAL ANALYSIS; INSULINOMA CELLS; BINDING-PROTEIN; SEQUENCE; ADIPOCYTES; JAK2; PHOSPHORYLATION; MUTAGENESIS	The functional significance of growth hormone (GH) receptor (GHR) internalization is unknown; therefore, we have analyzed domains and individual amino acids in the cytoplasmic region of the rat GHR required for ligand-mediated receptor internalization, receptor down-regulation, and transcriptional signaling, When various mutated GHR cDNAs were transfected stably into Chinese hamster ovary cells or transiently into monkey kidney (COS-7) cells, internalization of the GHR was found to be dependent upon a domain located between amino acids 318 and 380, Mutational analysis of aromatic residues in this domain revealed that phenylalanine 346 is required for internalization. Receptor down-regulation in transiently transfected COS-7 cells was also dependent upon the phenylalanine 346 residue of the GHR, since no GH-induced down-regulation was observed in cells expressing the F346A GHR mutant. in contrast, the ability to stimulate transcription of the serine protease inhibitor 2.1 promoter by the GHR was not affected by the phenylalanine 346 to alanine mutation, These results demonstrate that phenylalanine 346 is essential for GHR internalization and down-regulation but not for transcriptional signaling, suggesting that ligand-mediated endocytosis is not a prerequisite for GH-induced gene transcription.	HAGEDORN RES INST, DK-2820 GENTOFTE, DENMARK; FAC MED NECKER ENFANTS MALAD, UNITE 344, F-75730 PARIS 15, FRANCE; NOVUM, KAROLINSKA INST, CTR BIOTECHNOL, S-14157 HUDDINGE, SWEDEN	Novo Nordisk; Hagedorn Research Institute; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet			Kelly, Paul/A-7951-2008	Billestrup, Nils/0000-0002-4968-8067; Nielsen, Jens Hoiriis/0000-0001-8252-3048				ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; BACKER JM, 1990, J BIOL CHEM, V265, P16450; BANSAL A, 1991, CELL, V67, P1195, DOI 10.1016/0092-8674(91)90295-A; BASS SH, 1991, P NATL ACAD SCI USA, V88, P4498, DOI 10.1073/pnas.88.10.4498; BILLESTRUP N, 1990, P NATL ACAD SCI USA, V87, P7210, DOI 10.1073/pnas.87.18.7210; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; COLOSI P, 1993, J BIOL CHEM, V268, P12617; COSMAN D, 1990, TRENDS BIOCHEM SCI, V15, P265, DOI 10.1016/0968-0004(90)90051-C; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; EBERLE W, 1991, CELL, V67, P1203, DOI 10.1016/0092-8674(91)90296-B; ESHET R, 1984, ACTA ENDOCRINOL-COP, V107, P9, DOI 10.1530/acta.0.1070009; FOSTER CM, 1988, BIOCHEMISTRY-US, V27, P326, DOI 10.1021/bi00401a049; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; GOUJON L, 1994, P NATL ACAD SCI USA, V91, P957, DOI 10.1073/pnas.91.3.957; HERLITZE S, 1990, GENE, V91, P143, DOI 10.1016/0378-1119(90)90177-S; JIN L, 1992, J MOL BIOL, V226, P851, DOI 10.1016/0022-2836(92)90636-X; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; LOBIE PE, 1991, J BIOL CHEM, V266, P22645; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MCCUTCHAN JH, 1968, JNCI-J NATL CANCER I, V41, P351; MOLDRUP A, 1991, J BIOL CHEM, V266, P17441; MOLLER C, 1992, J BIOL CHEM, V267, P23403; PAQUEREAU L, 1992, EUR J BIOCHEM, V209, P1053, DOI 10.1111/j.1432-1033.1992.tb17381.x; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; ROUPAS P, 1986, MOL CELL ENDOCRINOL, V47, P81, DOI 10.1016/0303-7207(86)90018-3; ROUPAS P, 1988, MOL CELL ENDOCRINOL, V57, P93, DOI 10.1016/0303-7207(88)90037-8; SAVION N, 1981, J BIOL CHEM, V256, P1149; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; Trowbridge IS, 1991, CURR OPIN CELL BIOL, V3, P1062, DOI 10.1016/0955-0674(91)90130-Q; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANDERKUUR JA, 1994, J BIOL CHEM, V269, P21709; WAKSHULL EM, 1985, P NATL ACAD SCI USA, V82, P8513, DOI 10.1073/pnas.82.24.8513; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; YANKNER BA, 1982, ANNU REV BIOCHEM, V51, P845, DOI 10.1146/annurev.bi.51.070182.004213; YOON JB, 1990, J BIOL CHEM, V265, P19947	39	81	84	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17210	17214		10.1074/jbc.270.29.17210	http://dx.doi.org/10.1074/jbc.270.29.17210			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615519	hybrid			2022-12-27	WOS:A1995RK68900026
J	HIGAZI, AA; COHEN, RL; HENKIN, J; KNISS, D; SCHWARTZ, BS; CINES, DB				HIGAZI, AA; COHEN, RL; HENKIN, J; KNISS, D; SCHWARTZ, BS; CINES, DB			ENHANCEMENT OF THE ENZYMATIC-ACTIVITY OF SINGLE-CHAIN UROKINASE PLASMINOGEN-ACTIVATOR BY SOLUBLE UROKINASE RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOUND UROKINASE; PRO-UROKINASE; POTENTIATION; INHIBITION; MONOCYTES; CELLS; MODEL	Single-chain urokinase (scuPA), the unique form of urokinase secreted by cells, is converted to an active two-chain molecule through the cleavage of a single peptide bond by plasmin and other specific proteinases. Although scuPA may express limited enzymatic activity, its contribution to plasminogen activation on cell surfaces remains uncertain. Further, although it is well known that scuPA binds to a specific extracellular urokinase type plasminogen activator receptor, the effect of this interaction on the enzymatic activity of scuPA has not been described. In the present paper we report that the binding of scuPA to cellular and to recombinant soluble urokinase-type plasminogen activator receptors (suPAR) increases its catalytic activity as measured by the cleavage of a urokinase-specific chromogenic substrate. suPAR increased the V-max of scuPA 5-fold with little change in its K-m. suPAR also stimulated the plasminogen activator activity of scuPA by decreasing its K-m for Glu-plasminogen from 1.15 mu M to 0.022 mu M and by increasing the k(cat) of this reaction from 0.0015 to 0.022 s(-1). Preincubation of scuPA with suPAR also enhances its susceptibility to inhibition by plasminogen activator inhibitor type 1, consistent with exposure of its catalytic site. The activity of scuPA bound to suPAR is not accompanied by cleavage of scuPA, which continues to migrate as a single band in SDS-polyacrylamide gel electrophoresis under reducing conditions. Moreover, suPAR increases the plasminogen activator activity of a plasmin-insensitive variant, scuPA (scuPA-Glu(158)), as well. Enhancement of scuPA activity by suPAR is both prevented and reversed by its aminoterminal fragment (amino acids 1-135), which competes for receptor binding, suggesting that continued binding to the receptor is required for expression of scuPA's enzymatic activity. Thus, our data suggest that scuPA may undergo a reversible transformation between a la tent and an active state. The urokinase receptor may induce or stabilize scuPA in its active conformation, thereby contributing to the initiation of plasminogen activation on cell surfaces.	GENENTECH INC,S SAN FRANCISCO,CA 94080; ABBOTT LABS,ABBOTT PK,IL 60064; OHIO STATE UNIV,DEPT OBSTET & GYNECOL,COLUMBUS,OH 43210; UNIV WISCONSIN,DEPT MED,MADISON,WI 53706	Roche Holding; Genentech; Abbott Laboratories; University System of Ohio; Ohio State University; University of Wisconsin System; University of Wisconsin Madison	HIGAZI, AA (corresponding author), HOSP UNIV PENN,DEPT PATHOL & LAB MED,3400 SPRUCE ST,PHILADELPHIA,PA 19104, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049517, P01HL040387] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL40387, HL50970, HL49517] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARNATHAN ES, 1990, J BIOL CHEM, V265, P2865; CROWLEY CW, 1993, P NATL ACAD SCI USA, V90, P5021, DOI 10.1073/pnas.90.11.5021; DISS EM, 1992, AM J OBSTET GYNECOL, V167, P1046, DOI 10.1016/S0002-9378(12)80036-6; ELLIS V, 1991, J BIOL CHEM, V266, P12752; ELLIS V, 1993, J BIOL CHEM, V268, P4806; ELLIS V, 1987, J BIOL CHEM, V262, P14998; ELLIS V, 1990, J BIOL CHEM, V265, P9904; ELLIS V, 1989, J BIOL CHEM, V264, P2185; HARVEY SR, 1988, CLIN EXP METASTAS, V6, P431, DOI 10.1007/BF01784375; HIGAZI AA, 1992, BIOCHEM J, V282, P863, DOI 10.1042/bj2820863; KASAI S, 1985, J BIOL CHEM, V260, P2382; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE SW, 1994, J BIOL CHEM, V269, P2411; LIU JN, 1992, J BIOL CHEM, V267, P15289; MANCHANDA N, 1991, J BIOL CHEM, V266, P14580; MIZUKAMI IF, 1994, CLIN IMMUNOL IMMUNOP, V71, P96, DOI 10.1006/clin.1994.1057; NELLES L, 1987, J BIOL CHEM, V262, P5682; PANNELL R, 1987, BLOOD, V69, P22; PETERSEN LC, 1988, J BIOL CHEM, V263, P11189; ROBBINS KC, 1967, J BIOL CHEM, V242, P2333	20	81	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17375	17380		10.1074/jbc.270.29.17375	http://dx.doi.org/10.1074/jbc.270.29.17375			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615542	hybrid			2022-12-27	WOS:A1995RK68900053
J	THOMSON, RB; IGARASHI, P; BIEMESDERFER, D; KIM, R; ABUALFA, A; SOLEIMANI, M; ARONSON, PS				THOMSON, RB; IGARASHI, P; BIEMESDERFER, D; KIM, R; ABUALFA, A; SOLEIMANI, M; ARONSON, PS			ISOLATION AND CDNA CLONING OF KSP-CADHERIN, A NOVEL KIDNEY-SPECIFIC MEMBER OF THE CADHERIN MULTIGENE FAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; PHENOL-CHLOROFORM EXTRACTION; SINGLE-STEP METHOD; L-CAM; POLYACRYLAMIDE GELS; CYTOPLASMIC DOMAIN; SEQUENCE-ANALYSIS; NERVOUS-SYSTEM; RNA ISOLATION; T-CADHERIN	Cadherins are recognized as the principal mediators of homotypic cellular recognition and, play a demonstrated role in the morphogenic direction of tissue development. We report here the identification of a structurally unique, kidney-specific member of the cadherin multigene family (Ksp-cadherin). cDNA cloning and molecular analysis of the 130-kDa protein confirmed that it was novel and indicated that it most closely resembled members of the LI-cadherin/HPT-1 cadherin subgroup. The predicted protein possesses the definitive cadherin-specific sequence motifs LDRE, DXND, and DXD in well conserved sequential arrangement, and the characteristic cysteine residues found in the last ectodomains of almost all known cadherins. Like LI-cadherin and HPT-1, Ksp-cadherin lacks the prosequence and HAV adhesion recognition sequence typical of most classical cadherins, and possesses a truncated cytoplasmic domain (18-22 amino acids). When expressed in a transient Vaccinia/T7 expression system, Ksp-cadherin displayed the classic calcium sensitivity to trypsin proteolysis that is observed in all cadherins. Immunolocalization studies and Northern analysis indicated that expression of Ksp-cadherin was kidney-specific and limited to the basolateral membranes of renal tubular epithelial cells. In summary, we have identified and cloned a novel, kidney-specific member of the cadherin multigene family that we propose be designated Ksp-cadherin.	YALE UNIV,SCH MED,DEPT INTERNAL MED,NEPHROL SECT,NEW HAVEN,CT 06510	Yale University				Igarashi, Peter/0000-0001-8698-1185; soleimani, m/0000-0002-3446-8870	NIDDK NIH HHS [DK 17433] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017433] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AOTA S, 1988, NUCLEIC ACIDS RES, V16, P315; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BERNDORFF D, 1994, J CELL BIOL, V125, P1353, DOI 10.1083/jcb.125.6.1353; BIEMESDERFER D, 1992, AM J PHYSIOL, V263, pF833, DOI 10.1152/ajprenal.1992.263.5.F833; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEVELAND DW, 1983, METHOD ENZYMOL, V96, P222; DANTZIG AH, 1994, SCIENCE, V264, P430, DOI 10.1126/science.8153632; FUJIMORI T, 1993, MOL BIOL CELL, V4, P37, DOI 10.1091/mbc.4.1.37; GALLIN WJ, 1987, P NATL ACAD SCI USA, V84, P2808, DOI 10.1073/pnas.84.9.2808; GEIGER B, 1992, ANNU REV CELL BIOL, V8, P307, DOI 10.1146/annurev.cb.08.110192.001515; GRASSL SM, 1986, J BIOL CHEM, V261, P8778; Grunwald GB, 1993, CURR OPIN CELL BIOL, V5, P797, DOI 10.1016/0955-0674(93)90028-O; HARTMANN KKP, 1990, ENDOCRINOLOGY, V127, P2038, DOI 10.1210/endo-127-4-2038; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; HILDEBRANDT F, 1991, BIOCHIM BIOPHYS ACTA, V1129, P105, DOI 10.1016/0167-4781(91)90221-7; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P227; HYAFIL F, 1981, CELL, V26, P446; IGARASHI P, 1991, BIOCHEM J, V280, P71, DOI 10.1042/bj2800071; KASHGARIAN M, 1985, KIDNEY INT, V28, P899, DOI 10.1038/ki.1985.216; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LIAW CW, 1990, EMBO J, V9, P2701, DOI 10.1002/j.1460-2075.1990.tb07456.x; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; MCNEILL H, 1990, CELL, V62, P309, DOI 10.1016/0092-8674(90)90368-O; MOSS B, 1990, NATURE, V348, P91, DOI 10.1038/348091a0; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; NAGAFUCHI A, 1989, CELL REGUL, V1, P37, DOI 10.1091/mbc.1.1.37; NOSE A, 1987, EMBO J, V6, P3655, DOI 10.1002/j.1460-2075.1987.tb02698.x; NOSE A, 1986, J CELL BIOL, V103, P2649, DOI 10.1083/jcb.103.6.2649; NOUWEN EJ, 1993, KIDNEY INT, V44, P147, DOI 10.1038/ki.1993.225; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; PUISSANT C, 1990, BIOTECHNIQUES, V8, P148; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P560; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; SOLEIMANI M, 1989, KIDNEY INT, V35, P464; SORKIN BC, 1988, P NATL ACAD SCI USA, V85, P7617, DOI 10.1073/pnas.85.20.7617; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UCHIDA T, 1984, J BIOL CHEM, V259, P2311; VESTAL DJ, 1992, J CELL BIOL, V119, P451, DOI 10.1083/jcb.119.2.451; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; VOLLER A, 1979, GUIDE ABSTRACTS MICR, P1; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WHEELOCK MJ, 1992, J CELL BIOL, V117, P415, DOI 10.1083/jcb.117.2.415; XIANG YY, 1994, CANCER RES, V54, P3034	54	89	93	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17594	17601		10.1074/jbc.270.29.17594	http://dx.doi.org/10.1074/jbc.270.29.17594			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615566	hybrid			2022-12-27	WOS:A1995RK68900083
J	LUTTRELL, LM; VANBIESEN, T; HAWES, BE; KOCH, WJ; TOUHARA, K; LEFKOWITZ, RJ				LUTTRELL, LM; VANBIESEN, T; HAWES, BE; KOCH, WJ; TOUHARA, K; LEFKOWITZ, RJ			G(BETA-GAMMA) SUBUNITS MEDIATE MITOGEN-ACTIVATED PROTEIN-KINASE ACTIVATION BY THE TYROSINE KINASE INSULIN-LIKE GROWTH-FACTOR-1 RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							BC3H-1 MURINE MYOCYTES; PERTUSSIS TOXIN; GTP-BINDING; FIBROBLASTS; CELLS; INVOLVEMENT; P21(RAS); PATHWAY	The receptors for insulin-like growth factor 1 (IGF1) and insulin are related heterotetrameric proteins which, like the epidermal growth factor (EGF) receptor, possess intrinsic ligand-stimulated tyrosine protein kinase activity, In Rat 1 fibroblasts, stimulation of mitogen-activated protein (MAP) kinase via the IGF1 receptor and the G(i)-coupled receptor for lysophosphatidic acid (LPA), but not via the EGF receptor, is sensitive both to pertussis toxin treatment and to cellular expression of a specific G(beta gamma) subunit-binding peptide, The IGF1, LPA, and EGF receptor-mediated signals are all sensitive to inhibitors of tyrosine protein kinases, require p21(ras) activation, and are independent of protein kinase C. These data suggest that some tyrosine kinase growth factor receptors (e.g. IGF1 receptor) and classical G protein-coupled receptors (e.g. LPA receptor) employ a similar mechanism for mitogenic signaling that involves both tyrosine phosphorylation and G(beta gamma) subunits derived from pertussis toxin-sensitive G proteins.	DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT BIOCHEM,DURHAM,NC 27710	Duke University; Howard Hughes Medical Institute; Duke University; Duke University			Lefkowitz, Robert/AAW-2649-2021	Luttrell, Louis/0000-0003-2805-6949	NHLBI NIH HHS [HL 16037] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBLAS J, 1993, J BIOL CHEM, V268, P22235; CAZAUBON SM, 1994, J BIOL CHEM, V269, P24805; CHEN YH, 1994, J BIOL CHEM, V269, P27372; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; DUBLER RE, 1985, ARCH BIOCHEM BIOPHYS, V236, P119, DOI 10.1016/0003-9861(85)90611-3; FAURE M, 1994, J BIOL CHEM, V269, P7851; FEIG LA, 1991, MOL CELL BIOL, V8, P4822; GOREN HJ, 1985, CAN J PHYSIOL PHARM, V63, P1017, DOI 10.1139/y85-167; HEYWORTH CM, 1986, BIOCHEM J, V235, P145, DOI 10.1042/bj2350145; HORDIJK PL, 1994, J BIOL CHEM, V269, P645; HOWE LR, 1993, J BIOL CHEM, V268, P20717; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; KELLERER M, 1991, BIOCHEM J, V276, P103, DOI 10.1042/bj2760103; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; KRUPINSKI J, 1988, J BIOL CHEM, V263, P12333; LUTTRELL L, 1990, J BIOL CHEM, V265, P16873; LUTTRELL LM, 1988, J BIOL CHEM, V263, P6134; LUTTRELL LM, 1995, J BIOL CHEM, V270, P12984, DOI 10.1074/jbc.270.22.12984; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; MEDEMA RH, 1993, CRIT REV ONCOGENESIS, V4, P615; MELOCHE S, 1992, MOL BIOL CELL, V3, P63, DOI 10.1091/mbc.3.1.63; MORGAN DO, 1987, NATURE, V329, P301, DOI 10.1038/329301a0; OKAMOTO T, 1990, CELL, V62, P709, DOI 10.1016/0092-8674(90)90116-V; OKAMOTO T, 1993, FEBS LETT, V334, P143, DOI 10.1016/0014-5793(93)81700-A; OMICHI M, 1994, J BIOL CHEM, V269, P3783; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; ROTHENBERG PL, 1988, J BIOL CHEM, V263, P15546; SASAOKA T, 1994, J BIOL CHEM, V269, P10734; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SHAW G, 1993, BIOCHEM BIOPH RES CO, V195, P1145, DOI 10.1006/bbrc.1993.2164; SPANDIDOS DA, 1984, NATURE, V310, P469, DOI 10.1038/310469a0; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; TSUKADA S, 1994, P NATL ACAD SCI USA, V91, P11256, DOI 10.1073/pnas.91.23.11256; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; VANOBBERGHENSCH.E, 1983, EXP CELL RES, V147, P369; VILA MD, 1990, BIOCHEMISTRY-US, V29, P8735, DOI 10.1021/bi00489a033; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; WHITE MF, 1994, J BIOL CHEM, V269, P1; WINITZ S, 1993, J BIOL CHEM, V268, P19196	41	192	192	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16495	16498		10.1074/jbc.270.28.16495	http://dx.doi.org/10.1074/jbc.270.28.16495			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622449	hybrid			2022-12-27	WOS:A1995RJ34700004
J	NORRIS, FA; AUETHAVEKIAT, V; MAJERUS, PW				NORRIS, FA; AUETHAVEKIAT, V; MAJERUS, PW			THE ISOLATION AND CHARACTERIZATION OF CDNA-ENCODING HUMAN AND RAT-BRAIN INOSITOL POLYPHOSPHATE 4-PHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; SIGNAL TRANSDUCTION; KINASE; 1-PHOSPHATASE; 3-KINASE; PROTEINS	Inositol polyphosphate 4-phosphatase, an enzyme of the inositol phosphate signaling pathway, catalyzes the hydrolysis of the 4-position phosphate of inositol 3,4-bisphosphate. inositol 1,3,4-trisphosphate, and phosphatidylinositol 3,4-bisphosphate. The amino acid sequences of tryptic and CNBr peptides of the enzyme isolated from rat brain were determined. Degenerate oligonucleotide primers based on this sequence were used to amplify a 74-base pair polymerase chain reaction product, This product was used to isolate a 5607-base pair composite cDNA, which had an open reading frame encoding a protein with 939 amino acids with a predicted molecular mass of 105,588 Da. The rat brain polymerase chain reaction product was used as a probe to isolate a human brain cDNA that predicts a protein with 938 amino acids and a molecular mass of 105,710 Da. Remarkably, the human and rat proteins were 97% identical, Recombinant rat protein expressed in Escherichia coli catalyzed the hydrolysis of all three substrates of the 4-phosphatase. Northern blot hybridization indicates that the 4-phosphatase is widely expressed in rat tissues with the highest levels of expression occurring in brain, heart, and skeletal muscle. Polyclonal antiserum directed against the carboxyl terminus of the 4-phosphatase immunoprecipitated >95% of the 4 phosphatase activity in crude homogenates of rat brain, heart, skeletal muscle, and spleen, suggesting that this enzyme accounts for the 4-phosphate activity present in rat tissues. This antiserum also immuno-precipitated the 4-phosphatase from human platelet sonicates.	WASHINGTON UNIV,SCH MED,DEPT BIOL CHEM,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOPHYS,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)	NORRIS, FA (corresponding author), WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,DIV HEMATOL ONCOL,ST LOUIS,MO 63110, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016634, R37HL016634, P50HL014147] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 16634, HL 14147] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; BANSAL VS, 1990, J BIOL CHEM, V265, P1806; BERNATOWICZ MS, 1986, ANAL BIOCHEM, V155, P95, DOI 10.1016/0003-2697(86)90231-9; BRAWERMAN G, 1989, CELL, V57, P9, DOI 10.1016/0092-8674(89)90166-9; CALDWELL KK, 1991, J BIOL CHEM, V266, P18378; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; COUGHLIN SR, 1989, SCIENCE, V243, P1191; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; HOPE HMR, 1994, J BIOL CHEM, V269, P23648; INHORN RC, 1988, J BIOL CHEM, V263, P14559; KANAI F, 1993, BIOCHEM BIOPH RES CO, V195, P762, DOI 10.1006/bbrc.1993.2111; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KOZAK M, 1987, NUCLEIC ACIDS RES, V20, P8125; LIPPS DL, 1989, J BIOL CHEM, V264, P8759; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NORRIS FA, 1994, J BIOL CHEM, V269, P8716; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; SERUNIAN LA, 1989, J BIOL CHEM, V264, P17809; TOKER A, 1994, J BIOL CHEM, V269, P32358; WANG KKW, 1989, BIOCHEM J, V262, P693, DOI 10.1042/bj2620693; YORK JD, 1990, P NATL ACAD SCI USA, V87, P9548, DOI 10.1073/pnas.87.24.9548	23	71	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16128	16133		10.1074/jbc.270.27.16128	http://dx.doi.org/10.1074/jbc.270.27.16128			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608176	hybrid			2022-12-27	WOS:A1995RH22600039
J	STOCKERT, RJ; POTVIN, B; TAO, L; STANLEY, P; WOLKOFF, AW				STOCKERT, RJ; POTVIN, B; TAO, L; STANLEY, P; WOLKOFF, AW			HUMAN HEPATOMA-CELL MUTANT DEFECTIVE IN CELL-SURFACE PROTEIN TRAFFICKING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED RAT HEPATOCYTES; LOW-DENSITY-LIPOPROTEIN; HAMSTER OVARY CELLS; RECEPTOR-MEDIATED ENDOCYTOSIS; HUMAN ASIALOGLYCOPROTEIN RECEPTOR; SEMLIKI FOREST VIRUS; GALACTOSYL RECEPTORS; GOLGI-COMPLEX; END4 MUTANT; TEMPERATURE	To isolate a mutant liver cell defective in the endocytic pathway, a selection strategy using toxic ligands for two distinct membrane receptors was devised, Ovalbumin-gelonin and asialoorosomucoid (ASOR)-gelonin were incubated with mutagenized HuH-7 cells, and a rare survivor termed trafficking mutant 1 (Trf1) was isolated, Trf1 cells were stably 3-fold more resistant than the parental HuH-7 to both toxic conjugates, The anterograde steps of intracellular endocytic processing of ASOR, including internalization, endosomal acidification, and ligand degradation, were unaltered in Trf1 cells, In contrast, retrograde diacytosis of asialoglycoprotein receptor (ASGR). ASOR complex back to the cell surface was enhanced by about 250%, Selective labeling revealed an approximately 46% reduction in cell surface-associated ASGR in Trf1 cells, although their total cellular ASGR content was essentially equivalent to that in HuH-7. Similar results were obtained with the transferrin receptor. Binding of I-125-ASOR and I-125-transferrin was reduced in Trf1 cells to 49 +/- 2.5% and 30 +/- 2%, respectively, of HuH-7 cells. The methionine transporter was also reduced in Trf1 cells, as revealed by a 2-fold reduction in V-max with no change in apparent K-m. Pretreatment with monensin, sodium azide, or colchicine reduced surface binding of I-125-ASOR;, HuH-7 cells by 50% but had no effect on binding to Trf1 cells. This result is predicted for a cell that expresses only State 1 ASGRs, which are resistant to modulation by metabolic and cytoskeletal inhibitors in contrast to State 2, which are responsive to these agents (Weigel, P. H., and Oka, J. A. (1984) J. Biol. Chem. 259, 1150-1154), The Trf1 mutant, having lost the ability to express State 2 receptors, provides genetic evidence for the existence of these two receptor subpopulations and an approach to identifying the biochemical mechanism by which they are generated.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT CELL BIOL,BRONX,NY 10461	Yeshiva University; Albert Einstein College of Medicine	STOCKERT, RJ (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED,MARION BESSIN LIVER RES CTR,1300 MORRIS PK AVE,ULLMANN 517,BRONX,NY 10461, USA.			Stanley, Pamela/0000-0001-5704-3747	NIDDK NIH HHS [DK41918, DK41296] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK041918, P30DK041296] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BUCCI M, 1994, SOMAT CELL MOLEC GEN, V20, P47, DOI 10.1007/BF02257485; CAIN CC, 1991, J BIOL CHEM, V266, P11746; CARLSSON J, 1978, BIOCHEM J, V173, P723, DOI 10.1042/bj1730723; CLARKE BL, 1987, BIOCHEM J, V262, P277; COLBAUGH PA, 1993, ADV CELL MOL BIOL M, V1, P169; EALEY PA, 1988, J MOL ENDOCRINOL, V1, pR1, DOI 10.1677/jme.0.001R001; GEUZE HJ, 1983, CELL, V32, P277, DOI 10.1016/0092-8674(83)90518-4; GEUZE HJ, 1984, EMBO J, V3, P2677, DOI 10.1002/j.1460-2075.1984.tb02193.x; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HARFORD J, 1988, J CELL BIOL, V96, P1824; HAYNES PA, 1994, J BIOL CHEM, V269, P33152; KAO CY, 1992, J CELL BIOL, V117, P701, DOI 10.1083/jcb.117.4.701; KIELIAN M, 1990, J VIROL, V64, P4614, DOI 10.1128/JVI.64.10.4614-4624.1990; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; KRIEGER M, 1983, P NATL ACAD SCI-BIOL, V80, P5607, DOI 10.1073/pnas.80.18.5607; LAMBERT JM, 1985, J BIOL CHEM, V260, P2035; LEHRMAN MA, 1985, CELL, V41, P735, DOI 10.1016/S0092-8674(85)80054-4; MALMSTROM K, 1991, J BIOL CHEM, V266, P24025; MARNELL MH, 1984, J CELL BIOL, V99, P1907, DOI 10.1083/jcb.99.6.1907; MCABEE DD, 1988, BIOCHEMISTRY-US, V27, P2061, DOI 10.1021/bi00406a037; MCABEE DD, 1990, J BIOL CHEM, V265, P629; MCGRAW TE, 1993, J CELL PHYSIOL, V155, P579, DOI 10.1002/jcp.1041550316; MCGRAW TE, 1991, HDB EXPT PHARM, V100, P11; NOVAK DA, 1994, BIOCHEM J, V301, P671, DOI 10.1042/bj3010671; OKA JA, 1983, J BIOL CHEM, V258, P253; PARK JE, 1991, SOMAT CELL MOLEC GEN, V17, P137, DOI 10.1007/BF01232971; PHALEN T, 1991, J CELL BIOL, V112, P615, DOI 10.1083/jcb.112.4.615; RAY B, 1982, MOL CELL BIOL, V2, P535, DOI 10.1128/MCB.2.5.535; ROBBINS AR, 1984, J CELL BIOL, V99, P1296, DOI 10.1083/jcb.99.4.1296; ROFF CF, 1986, J CELL BIOL, V103, P2283, DOI 10.1083/jcb.103.6.2283; SCHWARTZ AL, 1983, J BIOL CHEM, V258, P1249; SEGE RD, 1984, NATURE, V307, P742, DOI 10.1038/307742a0; STANLEY P, 1985, MOL CELL BIOL, V5, P923, DOI 10.1128/MCB.5.5.923; STOCKERT RJ, 1980, LAB INVEST, V43, P556; STOCKERT RJ, 1980, J BIOL CHEM, V255, P9028; STOCKERT RJ, 1993, J BIOL CHEM, V268, P19540; STOCKERT RJ, 1990, J BIOL CHEM, V265, P1841; WALL DA, 1980, CELL, V21, P79, DOI 10.1016/0092-8674(80)90116-6; WANG RH, 1990, J BIOL CHEM, V265, P20179; WEIGEL PH, 1980, J BIOL CHEM, V255, P6111; WEIGEL PH, 1984, J BIOL CHEM, V259, P1150; WEIGEL PH, 1993, J BIOL CHEM, V268, P27186; WEIGEL PH, 1993, ENDOCYTIC COMPONENTS, P125; WEIGEL PH, 1992, GLYCOCONJUGATES COMP, P421; WEISS P, 1994, HEPATOLOGY, V19, P432; WELLNER RB, 1984, J BIOL CHEM, V259, P2788; WILSON RB, 1993, J BIOL CHEM, V268, P25357; WOLKOFF AW, 1984, J CELL BIOL, V98, P375, DOI 10.1083/jcb.98.2.375	49	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16107	16113		10.1074/jbc.270.27.16107	http://dx.doi.org/10.1074/jbc.270.27.16107			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608173	hybrid			2022-12-27	WOS:A1995RH22600036
J	SUN, JR; ROSE, JB; BIRD, P				SUN, JR; ROSE, JB; BIRD, P			GENE STRUCTURE, CHROMOSOMAL LOCALIZATION, AND EXPRESSION OF THE MURINE HOMOLOG OF HUMAN PROTEINASE-INHIBITOR-6 (PI-6) SUGGESTS DIVERGENCE OF PI-6 FROM THE OVALBUMIN SERPINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-2; MAMMALIAN HOMOLOG; FAMILY; CELLS; SECRETION; REGION; MOUSE	Human proteinase inhibitor 6 (PI-6) is a recently described protein belonging to the serine proteinase inhibitor (serpin) superfamily. Sequence similarity suggests that PI-6 most resembles the ovalbumin (ov) serpins which include plasminogen activator inhibitor-2, the squamous cell carcinoma antigen, monocyte/neutrophil elastase inhibitor, and maspin, Although these proteins are associated with carcinomas and inflammation, they appear to have diverse functions and little is known of their physiological roles, In this study we have characterized cDNA and genomic clones encoding mouse PI-6 in order to analyze the localization, structure, and expression of the gene. The reactive center residues (Arg-Cys) are conserved in the mouse molecule, and recombinant mouse PI-6 was shown to bind thrombin, indicating that it has similar inhibitory properties to its human counterpart, Using reverse transcriptase-polymerase chain reaction assays on RNA isolated from 15-day-old embryos and adult mice, we have shown that mouse PI-6 expression is developmentally regulated, and that, unlike human PI-6, it is absent from the placenta, The mouse homologue of the human PI-6 gene has been designated Spi3 and was mapped to chromosome 13 between the Pl1 and ctla2 alpha genes. It spans 20 kilobases, consists of 7 exons and 6 introns, and contains a TATA motif 24 nucleotides upstream of the transcriptional start site. A 680-base pair DNA fragment containing this motif and 31 nucleotides of the 5'-untranslated region of the structural gene directed transcription of a bacterial cat gene, demonstrating the presence of a functional promoter, The PI-6 gene lacks an intron present in the ovalbumin and PAI-2 genes; otherwise it is identical in terms of the numbers, position, and phasing of the intron/exon boundaries. These results suggest that PI-6 and the ov serpin genes have diverged and do not belong to the same subgroup.	BOX HILL HOSP,CLIVE WARD CTR,MONASH MED SCH,DEPT MED,BOX HILL,VIC 3128,AUSTRALIA; UNIV MELBOURNE,DEPT ANAT & CELL BIOL,PARKVILLE,VIC 3052,AUSTRALIA	Box Hill Hospital; Monash University; University of Melbourne				Bird, Phillip/0000-0002-6695-606X				BELIN D, 1993, THROMB HAEMOSTASIS, V70, P144; BILLINGSLEY GD, 1993, AM J HUM GENET, V52, P343; BIRD P, 1987, J CELL BIOL, V105, P2905, DOI 10.1083/jcb.105.6.2905; BORRIELLO F, 1991, P NATL ACAD SCI USA, V88, P9417, DOI 10.1073/pnas.88.21.9417; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; COUGHLIN P, 1993, P NATL ACAD SCI USA, V90, P9417, DOI 10.1073/pnas.90.20.9417; COUGHLIN P, 1995, GENOMICS, V26, P431, DOI 10.1016/0888-7543(95)80240-M; COUGHLIN PB, 1993, J BIOL CHEM, V268, P9541; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; INGLIS JD, 1991, EMBO J, V10, P255, DOI 10.1002/j.1460-2075.1991.tb07945.x; Lane D A, 1989, Baillieres Clin Haematol, V2, P961, DOI 10.1016/S0950-3536(89)80054-X; MADISON EL, 1992, GENE, V121, P179, DOI 10.1016/0378-1119(92)90179-S; MANLY KF, 1993, MAMM GENOME, V4, P303, DOI 10.1007/BF00357089; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; MORGENSTERN KA, 1993, J BIOL CHEM, V268, P21560; NIFORAS P, 1993, BIOCHIM BIOPHYS ACTA, V1173, P179, DOI 10.1016/0167-4781(93)90179-H; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; REMOLDODONNELL E, 1993, FEBS LETT, V315, P105, DOI 10.1016/0014-5793(93)81143-N; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; Sambrook J, 1989, MOL CLONING LABORATO; STRANDBERG L, 1988, EUR J BIOCHEM, V176, P609, DOI 10.1111/j.1432-1033.1988.tb14320.x; SUMINAMI Y, 1991, BIOCHEM BIOPH RES CO, V181, P51, DOI 10.1016/S0006-291X(05)81380-4; TROUTT AB, 1992, P NATL ACAD SCI USA, V89, P9823, DOI 10.1073/pnas.89.20.9823; YE RD, 1989, J BIOL CHEM, V264, P5495; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	27	37	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16089	16096		10.1074/jbc.270.27.16089	http://dx.doi.org/10.1074/jbc.270.27.16089			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608171	hybrid			2022-12-27	WOS:A1995RH22600034
J	BARD, JA; WALKER, MW; BRANCHEK, TA; WEINSHANK, RL				BARD, JA; WALKER, MW; BRANCHEK, TA; WEINSHANK, RL			CLONING AND FUNCTIONAL EXPRESSION OF A HUMAN Y4 SUBTYPE RECEPTOR FOR PANCREATIC-POLYPEPTIDE, NEUROPEPTIDE-Y, AND PEPTIDE YY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							FEEDING-BEHAVIOR; RATS; CHAIN; PP	The pancreatic polypeptide family includes pancreatic polypeptide (PP), neuropeptide Y (NPY), and peptide YY (PYY). Members of the PP family regulate numerous physiological processes, including appetite, gastrointestinal transit, anxiety, and blood pressure. Of the multiple Y-type receptors proposed for PP family members, only the Y1 subtype has been cloned previously. We now report the cloning of an additional Y-type receptor, designated Y4, by homology screening of a human placental genomic library with transmembrane (TM) probes derived from the rat Y1 gene. The Y4 genomic clone encodes a predicted protein of 375 amino acids that is most homologous to Y1 receptors from human, rat, and mouse (42% overall; 55% in TM). I-125-PYY binding to transiently expressed Y4 receptors was saturable (pK(d) = 9.89) and displaceable by human PP family derivatives: PP (pK(i) = 10.25) similar to PP2-36 (pK(i) = 10.06) > PYY (pK(i) = 9.06) similar to [Leu(31),pro(34)]NPY (pK(i) = 8.95) > NPY (PKi = 8.68) > PP13-36 (pK(i) = 7.13) > PP31-36 (pK(i) = 6.46) > PP31-36 free acid (pK(i) < 5). Human PP decreased [cAMP] and increased intracellular [Ca2+] in Y4-transfected LMTK(-) cells, Y4 mRNA was detected by reverse transcriptase-polymerase chain reaction in human brain, coronary artery, and ileum, suggesting potential roles for Y4 receptors in central nervous system, cardiovascular, and gastrointestinal function.			BARD, JA (corresponding author), SYNAPT PHARMACEUT CORP,215 COLL RD,PARAMUS,NJ 07652, USA.							ANDREIS PG, 1993, LIFE SCI, V58, P1353; BANKS WA, 1995, PHARMACOL BIOCHEM BE, V51, P139, DOI 10.1016/0091-3057(94)00412-C; Bhattacharya S., 1994, Society for Neuroscience Abstracts, V20, P861; BLOMQVIST AG, 1995, BBA-GENE STRUCT EXPR, V1261, P439, DOI 10.1016/0167-4781(95)00051-H; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; CLARK JT, 1985, ENDOCRINOLOGY, V117, P2435, DOI 10.1210/endo-117-6-2435; EVA C, 1992, FEBS LETT, V314, P285, DOI 10.1016/0014-5793(92)81490-D; EVA C, 1990, FEBS LETT, V271, P8084; FOUCART S, 1993, J PHARMACOL EXP THER, V265, P903; GATES RJ, 1977, HORM RES, V8, P189, DOI 10.1159/000178800; GERALD C, 1995, J BIOL CHEM, V270, P26758, DOI 10.1074/jbc.270.45.26758; GILBERT WR, 1988, P NATL ACAD SCI USA, V85, P4745, DOI 10.1073/pnas.85.13.4745; HERZOG H, 1992, P NATL ACAD SCI USA, V89, P5794, DOI 10.1073/pnas.89.13.5794; JORGENSEN JC, 1990, EUR J PHARMACOL, V186, P105, DOI 10.1016/0014-2999(90)94065-6; KRAUSE J, 1992, MOL PHARMACOL, V41, P817; LARHAMMAR D, 1992, J BIOL CHEM, V267, P10935; LARSSON LI, 1977, LAB INVEST, V36, P593; LASSMANN V, 1980, DIABETES, V29, P428, DOI 10.2337/diabetes.29.6.428; MCTIGUE DM, 1993, AM J PHYSIOL, V265, pG1169, DOI 10.1152/ajpgi.1993.265.6.G1169; MILLER J, 1986, J EXP MED, V164, P1478, DOI 10.1084/jem.164.5.1478; NATA K, 1990, BIOCHEM BIOPH RES CO, V171, P330, DOI 10.1016/0006-291X(90)91397-B; NGUYEN TD, 1995, AM J PHYSIOL-GASTR L, V268, pG215, DOI 10.1152/ajpgi.1995.268.2.G215; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARTZ TW, 1987, FEBS LETT, V225, P209, DOI 10.1016/0014-5793(87)81159-6; SCHWARTZ TW, 1983, GASTROENTEROLOGY, V85, P1411; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; UHE AM, 1992, AM J CLIN NUTR, V55, P28, DOI 10.1093/ajcn/55.1.28; WAGERPAGE SA, 1992, PEPTIDES, V13, P807, DOI 10.1016/0196-9781(92)90191-5; WAHLESTEDT C, 1993, ANN REV PHARM TOXICO, V32, P309; WEINSHANK RL, 1990, MOL PHARMACOL, V38, P681; WHITCOMB DC, 1992, AM J PHYSIOL, V262, pG532, DOI 10.1152/ajpgi.1992.262.3.G532; WOLLMUTH LP, 1995, J NEUROPHYSIOL, V73, P1323, DOI 10.1152/jn.1995.73.3.1323; ZGOMBICK JM, 1993, MOL PHARMACOL, V44, P575	35	338	356	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26762	26765		10.1074/jbc.270.45.26762	http://dx.doi.org/10.1074/jbc.270.45.26762			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592911	hybrid			2022-12-27	WOS:A1995TE58300011
J	KUIPERS, OP; BEERTHUYZEN, MM; DERUYTER, PGGA; LUESINK, EJ; DEVOS, WM				KUIPERS, OP; BEERTHUYZEN, MM; DERUYTER, PGGA; LUESINK, EJ; DEVOS, WM			AUTOREGULATION OF NISIN BIOSYNTHESIS IN LACTOCOCCUS-LACTIS BY SIGNAL-TRANSDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE ANTIBIOTIC NISIN; LANTIBIOTIC SUBTILIN; BACILLUS-SUBTILIS; GENE; PROTEIN; CLONING; EXPRESSION; PRECURSOR; ORGANIZATION; PURIFICATION	The post-translationally modified, antimicrobial peptide nisin is secreted by strains of Lactococcus lactis that contain the chromosomally located nisin biosynthetic gene cluster nisABTCIPRKFEG. When a 4-base pair deletion is introduced into the structural nisA gene (Delta nisA), transcription of Delta nisA is abolished. Transcription of the Delta nisA gene is restored by adding subinhibitory amounts of nisin, nisin mutants, or nisin analogs to the culture medium, but not by the unmodified precursor peptide or by several other antimicrobial peptides, Upon disruption of the nisK gene, which encodes a putative sensor protein that belongs to the class of two-component regulators, transcription of Delta nisA was no longer inducible by nisin, Fusion of a nisA promoter fragment to the promoterless reporter gene gusA resulted in expression of gusA in L, lactis NZ9800 (Delta nisA) only upon induction with nisin species, The expression level of gusA was directly related to the amount of inducer that was added extracellularly, These results provide insight into a new mechanism of autoregulation through signal transduction in prokaryotes and demonstrate that antimicrobial peptides can exert a second function as signaling molecules.			KUIPERS, OP (corresponding author), NETHERLANDS INST DAIRY RES, DEPT BIOPHYS CHEM, POB 20, 6710 BA EDE, NETHERLANDS.		Kuipers, Oscar/B-6752-2009	Kuipers, Oscar/0000-0001-5596-7735				BUCHMAN GW, 1988, J BIOL CHEM, V263, P16260; CASADABAN MJ, 1980, J BACTERIOL, V143, P971, DOI 10.1128/JB.143.2.971-980.1980; DEVOS WM, 1993, APPL ENVIRON MICROB, V59, P213, DOI 10.1128/AEM.59.1.213-218.1993; DeVos WM, 1995, DEV BIOLOGICALS, V85, P617; ENGELKE G, 1994, APPL ENVIRON MICROB, V60, P814, DOI 10.1128/AEM.60.3.814-825.1994; ENGELKE G, 1992, APPL ENVIRON MICROB, V58, P3730, DOI 10.1128/AEM.58.11.3730-3743.1992; FUKASE K, 1992, B CHEM SOC JPN, V65, P2227, DOI 10.1246/bcsj.65.2227; GALLO RL, 1994, P NATL ACAD SCI USA, V91, P11035, DOI 10.1073/pnas.91.23.11035; GAO FH, 1991, APPL ENVIRON MICROB, V57, P2164, DOI 10.1128/AEM.57.8.2164-2170.1991; GASSON MJ, 1983, J BACTERIOL, V154, P1; Goodman M, 1991, NISIN NOVEL LANTIBIO, P59; GROSS E, 1971, J AM CHEM SOC, V93, P4634, DOI 10.1021/ja00747a073; GROSS E, 1973, H-S Z PHYSIOL CHEM, V354, P799; GUTOWSKIECKEL Z, 1994, APPL ENVIRON MICROB, V60, P1; HOLO H, 1991, J BACTERIOL, V173, P3879, DOI 10.1128/JB.173.12.3879-3887.1991; HORINOUCHI S, 1982, J BACTERIOL, V150, P804, DOI 10.1128/JB.150.2.804-814.1982; Hurst A., 1981, ADV APPL MICROBIOL, V27, P85, DOI [10.1016/s0065-2164(08)70342-3, DOI 10.1016/S0065-2164(08)70342-3, 10.1016/S0065-2164(08)70342-3]; KALETTA C, 1989, J BACTERIOL, V171, P1597, DOI 10.1128/jb.171.3.1597-1601.1989; KLEIN C, 1993, APPL ENVIRON MICROB, V59, P296, DOI 10.1128/AEM.59.1.296-303.1993; KUIPERS OP, 1992, J BIOL CHEM, V267, P24340; KUIPERS OP, 1993, FEBS LETT, V330, P23, DOI 10.1016/0014-5793(93)80911-D; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; Mattick ATR, 1944, NATURE, V154, P551, DOI 10.1038/154551a0; MULDERS JWM, 1991, EUR J BIOCHEM, V201, P581, DOI 10.1111/j.1432-1033.1991.tb16317.x; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; PESCHEL A, 1993, MOL MICROBIOL, V9, P31, DOI 10.1111/j.1365-2958.1993.tb01666.x; PIARD JC, 1992, APPL ENVIRON MICROB, V58, P279, DOI 10.1128/AEM.58.1.279-284.1992; PIARD JC, 1993, J BIOL CHEM, V268, P16361; PLATTEEUW C, 1994, APPL ENVIRON MICROB, V60, P587, DOI 10.1128/AEM.60.2.587-593.1994; RAUCH PJG, 1992, J BACTERIOL, V174, P1280, DOI 10.1128/jb.174.4.1280-1287.1992; Sahl H. G., 1991, NISIN NOVEL LANTIBIO, P347; SAHL HG, 1981, J GEN MICROBIOL, V127, P377; SAHL HG, 1987, ARCH MICROBIOL, V149, P120, DOI 10.1007/BF00425076; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; SIEGERS K, 1995, APPL ENVIRON MICROB, V61, P1082, DOI 10.1128/AEM.61.3.1082-1089.1995; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; TANAKA T, 1988, J BACTERIOL, V170, P3593, DOI 10.1128/jb.170.8.3593-3600.1988; VANDERMEER JR, 1993, J BACTERIOL, V175, P2578, DOI 10.1128/JB.175.9.2578-2588.1993; WAKAMIYA T, 1985, TETRAHEDRON LETT, V26, P665, DOI 10.1016/S0040-4039(00)89174-1; WAKAMIYA T, 1991, NISIN NOVEL LANTIBIO, P189; WAKAMIYA T, 1990, PEPTIDES CHEM STRUCT, P60; WANNER BL, 1992, J BACTERIOL, V174, P2053, DOI 10.1128/JB.174.7.2053-2058.1992; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	44	397	424	5	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27299	27304		10.1074/jbc.270.45.27299	http://dx.doi.org/10.1074/jbc.270.45.27299			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592991	Green Published, hybrid			2022-12-27	WOS:A1995TE58300091
J	SANFORD, JC; YU, JM; PAN, JY; WESSLINGRESNICK, M				SANFORD, JC; YU, JM; PAN, JY; WESSLINGRESNICK, M			GDP DISSOCIATION INHIBITOR SERVES AS A CYTOSOLIC ACCEPTOR FOR NEWLY SYNTHESIZED AND PRENYLATED RAB5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING-PROTEINS; GERANYLGERANYL TRANSFERASE; SMG P25A; VESICULAR TRANSPORT; FUSION INVITRO; COMPONENT-A; COMPARTMENTS; MEMBRANES; CYS	In vitro synthesis and post-translational prenylation of Rab5 is accomplished using reticulocyte lysate supplemented with prenyl precursors (Sanford, J. C., Pan, Y., and Wessling-Resnick, M. (1993) J. Biol. Chem, 268, 23773-23776), When Rab5 is translated in the presence of biotin-lysine-tRNA, it incorporates biotin-lysine into its peptide backbone and is efficiently prenylated; since this modification is dependent on guanine nucleotide binding, biotin-Rab5's functional integrity must be maintained, Prenylated biotin-Rab5 associates with a 45-kDa reticulocyte GDP dissociation inhibitor (GDI), sedimenting as a similar to 70-kDa particle on 5-20% sucrose density gradients, The GDI-Rab5 complex can be captured using streptavidin-linked agarose beads, Only Rab5 peptides that are substrates for prenylation are found to cosediment with the lysate GDI on sucrose gradients, Post-translational association of Rab5 and GDI is a novel finding, since previous reports suggested Rab5 remains associated with Rab escort protein (REP) after prenylation (Alexandrov, K., Horiuchi, H., Steele-Mortimer, O., Seabra, M. C., and Zerial, M. (1994) EMBO J. 13, 5262-5273), Since post-translational prenylation is catalytically mediated by REP, our study suggests that a complex between Rab5 and this factor is transient in nature, Thus, newly synthesized and prenylated Rab5 is most likely escorted to its target membrane by a GDI acceptor molecule. Biotin-Rab5 provides a novel tool for future efforts to capture and characterize additional accessory factors required for Rab protein function in vesicle transport.	HARVARD UNIV,SCH PUBL HLTH,DEPT NUTR,BOSTON,MA 02115	Harvard University; Harvard T.H. Chan School of Public Health								ALEXANDROV K, 1994, EMBO J, V13, P5262, DOI 10.1002/j.1460-2075.1994.tb06860.x; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; ARAKI S, 1991, MOL CELL BIOL, V11, P1438, DOI 10.1128/MCB.11.3.1438; ARAKI S, 1990, J BIOL CHEM, V265, P13007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BURSTEIN ES, 1991, J BIOL CHEM, V266, P2689; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; DIRACSVEJSTRUP AB, 1994, J BIOL CHEM, V269, P15427; FARNSWORTH CC, 1994, P NATL ACAD SCI USA, V91, P11963, DOI 10.1073/pnas.91.25.11963; FARNSWORTH CC, 1991, P NATL ACAD SCI USA, V88, P6196, DOI 10.1073/pnas.88.14.6196; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; HOFFENBERG S, 1995, J BIOL CHEM, V270, P5048, DOI 10.1074/jbc.270.10.5048; HORIUCHI H, 1995, J BIOL CHEM, V270, P11257, DOI 10.1074/jbc.270.19.11257; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; JANOUEIXLEROSEY I, 1995, J BIOL CHEM, V270, P14801, DOI 10.1074/jbc.270.24.14801; KINSELLA BT, 1991, J BIOL CHEM, V266, P8540; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KURZCHALIA TV, 1992, J BIOL CHEM, V267, P18419; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI GP, 1993, J BIOL CHEM, V268, P24475; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; NISHIMURA N, 1994, J BIOL CHEM, V269, P14191; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; REGAZZI R, 1992, J BIOL CHEM, V267, P17512; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; SANFORD JC, 1993, J BIOL CHEM, V268, P23773; SANFORD JC, 1995, ANAL BIOCHEM, V224, P547, DOI 10.1006/abio.1995.1086; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; SEABRA MC, 1991, CELL, V65, P429, DOI 10.1016/0092-8674(91)90460-G; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; SHIRATAKI H, 1992, J BIOL CHEM, V267, P10946; SHISHEVA A, 1994, MOL CELL BIOL, V14, P3459, DOI 10.1128/MCB.14.5.3459; SOLDATI T, 1994, NATURE, V369, P76, DOI 10.1038/369076a0; SOLDATI T, 1993, MOL BIOL CELL, V4, P425, DOI 10.1091/mbc.4.4.425; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; WESSLINGRESNICK M, 1990, J BIOL CHEM, V265, P16751; YANG CZ, 1994, J BIOL CHEM, V269, P31891	41	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26904	26909		10.1074/jbc.270.45.26904	http://dx.doi.org/10.1074/jbc.270.45.26904			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592935	hybrid			2022-12-27	WOS:A1995TE58300035
J	DENISON, MS; WHITLOCK, JP				DENISON, MS; WHITLOCK, JP			XENOBIOTIC-INDUCIBLE TRANSCRIPTION OF CYTOCHROME-P450 GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACYL-COA OXIDASE; PEROXISOME PROLIFERATORS; PHENOBARBITAL INDUCTION; AROMATIC-HYDROCARBONS; RAT HEPATOCYTES; AH-RECEPTOR; ENZYMES; BINDING; SUPERFAMILY; MECHANISMS		STANFORD UNIV, SCH MED, DEPT MOLEC PHARMACOL, STANFORD, CA 94305 USA	Stanford University	DENISON, MS (corresponding author), UNIV CALIF DAVIS, DEPT ENVIRONM TOXICOL, DAVIS, CA 95616 USA.							ANDERSEN JF, 1994, BIOCHEMISTRY-US, V33, P2171, DOI 10.1021/bi00174a025; BARS RG, 1989, BIOCHEM J, V262, P151, DOI 10.1042/bj2620151; BELL DR, 1991, BIOCHEM J, V280, P249, DOI 10.1042/bj2800249; BURGER HJ, 1992, P NATL ACAD SCI USA, V89, P2145, DOI 10.1073/pnas.89.6.2145; CHAN WK, 1994, J BIOL CHEM, V269, P26464; CONNEY AH, 1982, CANCER RES, V42, P4875; ELFERINK CJ, 1994, RECEPTOR, V4, P157; ENGLISH N, 1994, J BIOL CHEM, V269, P26836; FOURNIER T, 1994, J BIOL CHEM, V269, P27175; FULCO AJ, 1991, ANNU REV PHARMACOL, V31, P177; GEARING KL, 1994, J NUTR, V124, pS1284, DOI 10.1093/jn/124.suppl_8.1284S; GONZALEZ FJ, 1988, PHARMACOL REV, V40, P243; GONZALEZ FJ, 1990, TRENDS GENET, V6, P182, DOI 10.1016/0168-9525(90)90174-5; GUENGERICH FP, 1991, J BIOL CHEM, V266, P10019; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; HE JS, 1991, J BIOL CHEM, V266, P7864; HENRY EC, 1994, MOL PHARMACOL, V46, P1022; JAIN S, 1994, J BIOL CHEM, V269, P31518; KAIKAUS RM, 1993, J BIOL CHEM, V268, P9593; KELLER H, 1993, TRENDS ENDOCRIN MET, V4, P291, DOI 10.1016/1043-2760(93)90048-J; KOCAREK TA, 1994, BIOCHEM PHARMACOL, V48, P1815, DOI 10.1016/0006-2952(94)90468-5; LI H, 1994, J BIOL CHEM, V269, P28098; LIANG QW, 1995, J BIOL CHEM, V270, P4438, DOI 10.1074/jbc.270.9.4438; LOCK EA, 1989, ANNU REV PHARMACOL, V29, P145; MASON GGF, 1994, J BIOL CHEM, V269, P4438; MOTOJIMA K, 1993, CELL STRUCT FUNCT, V18, P267, DOI 10.1247/csf.18.267; NEBERT DW, 1991, MOL ENDOCRINOL, V5, P1203, DOI 10.1210/mend-5-9-1203; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; OKEY AB, 1994, TRENDS PHARMACOL SCI, V15, P226, DOI 10.1016/0165-6147(94)90316-6; OKEY AB, 1990, PHARMACOL THERAPEUT, V45, P241, DOI 10.1016/0163-7258(90)90030-6; Ortiz de Montellano P.R., 2015, CYTOCHROME P450 STRU, P912; PALMER CNA, 1994, J BIOL CHEM, V269, P18083; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; PORTER TD, 1991, J BIOL CHEM, V266, P13469; QUATTROCHI LC, 1994, J BIOL CHEM, V269, P6949; RAM PA, 1994, BIOCHEM J, V301, P753, DOI 10.1042/bj3010753; RAMSDEN R, 1993, J BIOL CHEM, V268, P21722; REISZPORSZASZ S, 1994, MOL CELL BIOL, V14, P6075, DOI 10.1128/MCB.14.9.6075; SAVAS U, 1994, J BIOL CHEM, V269, P14905; SAVAS U, 1994, MOL PHARMACOL, V45, P1153; SCHUETZ EG, 1993, HEPATOLOGY, V18, P1254; SELYE H, 1971, J PHARM SCI, V60, P1, DOI 10.1002/jps.2600600102; SHAW PM, 1993, MOL PHARMACOL, V44, P775; SHEPHARD EA, 1994, DNA CELL BIOL, V13, P793, DOI 10.1089/dna.1994.13.793; SUTTER TR, 1994, J BIOL CHEM, V269, P13092; SWANSON HI, 1993, PHARMACOGENETICS, V3, P213, DOI 10.1097/00008571-199310000-00001; SWANSON HI, 1993, BIOCHEMISTRY-US, V32, P12841, DOI 10.1021/bi00210a037; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; WAXMAN DJ, 1992, BIOCHEM J, V281, P577, DOI 10.1042/bj2810577; WHITLOCK JP, 1993, CHEM RES TOXICOL, V6, P754, DOI 10.1021/tx00036a003	50	312	327	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18175	18178		10.1074/jbc.270.31.18175	http://dx.doi.org/10.1074/jbc.270.31.18175			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629130	hybrid			2022-12-27	WOS:A1995RM64200001
J	VANDENBERG, RJ; ARRIZA, JL; AMARA, SG; KAVANAUGH, MP				VANDENBERG, RJ; ARRIZA, JL; AMARA, SG; KAVANAUGH, MP			CONSTITUTIVE ION FLUXES AND SUBSTRATE-BINDING DOMAINS OF HUMAN GLUTAMATE TRANSPORTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RAT-BRAIN; XENOPUS-OOCYTES; GLIAL-CELL; EXPRESSION; CARRIER; CLONING; SODIUM; ACID	Application of L-glutamate activates ionic currents in voltage clamped Xenopus oocytes expressing cloned human excitatory amino acid transporters (EAATs). However, even in the absence of L-glutamate, the membrane conductance of oocytes expressing EAAT1 was significantly increased relative to oocytes expressing EAAT2 or control oocytes. Whereas transport mediated by EAAT2 is blocked by the non-transported competitive glutamate analog kainate (K-i = 14 mu M), EAAT1 is relatively insensitive K-i > 3 mM). Substitution of a block of 76 residues from EAAT2 into EAAT1, in which 18 residues varied from EAAT1, conferred high affinity kainate binding to EAAT1, and application of kainate to oocytes expressing the chimeric transporter blocked a pre-existing monovalent cation conductance that displayed a permeability sequence K+ > Na+ > Li+ >> choline(+). The results identify a structural domain of glutamate transporters that influences kainate binding and demonstrate the presence of a constitutive ion-selective pore in the transporter.	OREGON HLTH SCI UNIV,VOLLUM INST,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,HOWARD HUGHES MED INST,PORTLAND,OR 97201	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University			Vandenberg, Robert John/E-6018-2016	Vandenberg, Robert John/0000-0003-1523-4814; Amara, Susan/0000-0001-8914-1106	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033273, R01NS033270] Funding Source: NIH RePORTER; NINDS NIH HHS [NS33273, NS33270] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARRIZA JL, 1994, J NEUROSCI, V14, P5559; BOUVIER M, 1992, NATURE, V360, P471, DOI 10.1038/360471a0; BOUVIER M, 1994, SEMIN NEUROSCI, V6, P117; BUCK KJ, 1994, P NATL ACAD SCI USA, V91, P12584, DOI 10.1073/pnas.91.26.12584; CAMMACK JN, 1994, NEURON, V13, P946; ERECINSKA M, 1983, J BIOL CHEM, V258, P9069; FAIRMAN WA, 1995, IN PRESS NAUTRE; FRANCIOLINI F, 1987, J GEN PHYSIOL, V90, P453, DOI 10.1085/jgp.90.4.453; JOHNSTON GAR, 1979, J NEUROCHEM, V32, P121, DOI 10.1111/j.1471-4159.1979.tb04518.x; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KAVANAUGH MP, 1992, J BIOL CHEM, V267, P22007; LAUGER P, 1980, J MEMBRANE BIOL, V57, P63; LESTER HA, 1994, ANNU REV PHARMACOL, V34, P219; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; SCHWARTZ EA, 1990, J PHYSIOL-LONDON, V426, P43, DOI 10.1113/jphysiol.1990.sp018126; Sonders M. S., 1994, Society for Neuroscience Abstracts, V20, P627; STALLCUP WB, 1979, J NEUROCHEM, V32, P57, DOI 10.1111/j.1471-4159.1979.tb04509.x; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; UMBACH JA, 1990, BIOPHYS J, V57, P1217, DOI 10.1016/S0006-3495(90)82640-0; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; WADICHE JI, 1995, IN PRESS NEURON; WALLACE B, 1990, J BACTERIOL, V172, P3214, DOI 10.1128/jb.172.6.3214-3220.1990	24	88	88	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17668	17671		10.1074/jbc.270.30.17668	http://dx.doi.org/10.1074/jbc.270.30.17668			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629063	Green Published, hybrid			2022-12-27	WOS:A1995RM26600008
J	KENDREW, SG; HARDING, SE; HOPWOOD, DA; MARSH, ENG				KENDREW, SG; HARDING, SE; HOPWOOD, DA; MARSH, ENG			IDENTIFICATION OF A FLAVIN-NADH OXIDOREDUCTASE INVOLVED IN THE BIOSYNTHESIS OF ACTINORHODIN - PURIFICATION AND CHARACTERIZATION OF THE RECOMBINANT ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-T7 RNA-POLYMERASE; STREPTOMYCES-COELICOLOR; ANTIBIOTIC ACTINORHODIN; POLYKETIDE SYNTHASE; HYBRID ANTIBIOTICS; GENES; EXPRESSION	The biosynthesis of the polyketide antibiotic actinorhodin by Streptomyces coelicolor involves the oxidative dimerization and hydroxylation of a precursor, most likely dihydrokalafungin, as the final steps in its formation. Mutations in the actVB gene block these last steps, and the mutants secrete kalafungin as a shunt product. To investigate the role of the actVB gene in these transformations, we have overexpressed the gene in Escherichia coli and purified and characterized the recombinant protein. ActVB was shown to catalyze the reduction of FMN by NADH to give NAD and FMNH(2), which, unusually, is released into solution. The protein contains no chromogenic cofactors and exhibits no requirements for added metal ions. The reaction obeys simple kinetics and proceeds through the formation of a ternary complex; K-m values for FMN and NADH are 1.5 and 7.3 mu M, respectively, and k(cat) is about 5 s(-1). FAD and riboflavin are also substrates for the enzyme, although they have much higher K-m values. The subunit structure of the enzyme was investigated by analytical ultracentrifugation, which showed the protein to exist in rapid equilibrium between monomer and dimer forms. The possible role of this oxidoreductase in the oxidative chemistry of actinorhodin biosynthesis is discussed.	UNIV CAMBRIDGE,DEPT BIOCHEM,CAMBRIDGE CB2 1QW,ENGLAND; UNIV CAMBRIDGE,CAMBRIDGE CTR MOLEC RECOGNIT,CAMBRIDGE CB2 1QW,ENGLAND; UNIV NOTTINGHAM,DEPT APPL BIOCHEM & FOOD SCI,SUTTON LE12 5RD,LEICS,ENGLAND; JOHN INNES CTR PLANT SCI RES,DEPT GENET,NORWICH NR4 7UH,NORFOLK,ENGLAND	University of Cambridge; University of Cambridge; University of Nottingham; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center			Marsh, Neil/G-7553-2016	Marsh, Neil/0000-0003-1713-1683; Harding, Stephen E./0000-0002-7798-9692	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BLANC V, 1994, Patent No. 08014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COLE SP, 1987, J ANTIBIOT, V40, P340, DOI 10.7164/antibiotics.40.340; FERNANDEZMORENO MA, 1992, J BIOL CHEM, V267, P19278; FUJII I, 1987, J BIOCHEM, V101, P11, DOI 10.1093/oxfordjournals.jbchem.a121881; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; GORSTALLMAN CP, 1981, J ORG CHEM, V46, P455, DOI 10.1021/jo00315a046; GRAMAJO HC, 1991, J BACTERIOL, V173, P6475, DOI 10.1128/jb.173.20.6475-6483.1991; GROSJEAN H, 1982, GENE, V18, P199, DOI 10.1016/0378-1119(82)90157-3; HOPWOOD DA, 1985, NATURE, V314, P642, DOI 10.1038/314642a0; HOPWOOD DA, 1990, ANNU REV GENET, V24, P37, DOI 10.1146/annurev.ge.24.120190.000345; KATZ L, 1993, ANNU REV MICROBIOL, V47, P875, DOI 10.1146/annurev.mi.47.100193.004303; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEI BF, 1994, J BACTERIOL, V176, P3552, DOI 10.1128/JB.176.12.3552-3558.1994; Mann J., 1987, SECONDARY METABOLISM; MARSDEN AFA, 1994, SCIENCE, V263, P378, DOI 10.1126/science.8278811; MARSH EN, 1993, BIOCHEM J, V290, P551, DOI 10.1042/bj2900551; MCDANIEL R, 1993, SCIENCE, V262, P1546, DOI 10.1126/science.8248802; MORRISON PT, 1989, J BACTERIOL, V171, P3641, DOI 10.1128/jb.171.7.3641-3649.1989; OHagan D., 1991, POLYKETIDE METABOLIT; PRIETO MA, 1994, J BIOL CHEM, V269, P22823; Sambrook J, 1989, MOL CLONING LABORATO; SHEN B, 1993, SCIENCE, V262, P1535, DOI 10.1126/science.8248801; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; WILSON K, 1994, PRINCIPLES TECHNIQUE, P223; ZENNO S, 1994, J BACTERIOL, V176, P3536, DOI 10.1128/JB.176.12.3536-3543.1994	27	68	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17339	17343		10.1074/jbc.270.29.17339	http://dx.doi.org/10.1074/jbc.270.29.17339			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615536	hybrid			2022-12-27	WOS:A1995RK68900047
J	YANG, W; JACKOWSKI, S				YANG, W; JACKOWSKI, S			LIPID ACTIVATION OF CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE IS REGULATED BY THE PHOSPHORYLATED CARBOXYL-TERMINAL DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CHINESE-HAMSTER OVARY; PHOSPHOLIPASE-C TREATMENT; CULTURED RAT HEPATOCYTES; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; HELA-CELLS; ENDOPLASMIC-RETICULUM; FEEDBACK-REGULATION; INDUCED INHIBITION; MAMMALIAN-CELLS; FATTY-ACIDS	The role of the phosphorylated carboxyl-terminal domain of CTP:phosphocholine cytidylyltransferase (CT) in the regulation of enzyme activity was investigated by comparing the catalytic properties of wild-type CT to two mutant proteins with altered carboxyl-terminal phosphorylation domains. CT isolated from a baculovirus expression system was extensively phosphorylated at multiple sites in the carboxyl terminal domain, The CT[S315A] mutant lacked a major CT phosphorylation site, and the carboxyl-terminal deletion mutant, CT[Delta 312-367], was not phosphorylated, The higher activities of CT[Delta 312-367] and CT[S315A] relative to CT were attributed to differences in the sensitivities of the enzymes to lipid activators. The rank order of the apparent K-m values for activation by either phosphatidylcholine/oleic acid or phosphatidylcholine/diacylglycerol was CT > CT[S315A] > CT[Delta 312-367]. In addition, CT exhibited negative cooperativity in its activation by phosphatidylcholine/oleic acid (n(H) = 0.64) and phosphatidylcholine/diacylglycerol (n(H) = 0.74) vesicles, whereas CT[Delta 312-367] and CT[S315A] did not. These data support the concept that the phosphorylation of the CT carboxyl-terminal domain interferes with the activation of CT by lipid regulators.	ST JUDE CHILDRENS RES HOSP, DEPT BIOCHEM, MEMPHIS, TN 38105 USA; UNIV TENNESSEE, DEPT BIOCHEM, MEMPHIS, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center			Jackowski, Suzanne/N-8168-2018	Jackowski, Suzanne/0000-0002-6855-1429	NCI NIH HHS [T32 CA09346, CA 21765] Funding Source: Medline; NIGMS NIH HHS [GM45737] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765, T32CA009346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045737] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOGGS KP, 1995, J BIOL CHEM, V270, P7757, DOI 10.1074/jbc.270.13.7757; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CORNELL R, 1987, BIOCHIM BIOPHYS ACTA, V919, P37, DOI 10.1016/0005-2760(87)90215-3; CORNELL RB, 1991, BIOCHEMISTRY-US, V30, P5881, DOI 10.1021/bi00238a011; CORNELL RB, 1991, BIOCHEMISTRY-US, V30, P5873, DOI 10.1021/bi00238a010; CRAIG L, 1994, J BIOL CHEM, V269, P3311; Dixon M., 1979, ENZYMES, Vthird; HATCH GM, 1992, J BIOL CHEM, V267, P15751; HOUWELING M, 1994, J BIOL CHEM, V269, P7544; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; JAMIL H, 1993, BIOCHEM J, V291, P419, DOI 10.1042/bj2910419; JAMIL H, 1990, J BIOL CHEM, V265, P4332; JAMIL H, 1992, J BIOL CHEM, V267, P1752; JAMIL H, 1990, BIOCHEM J, V270, P749, DOI 10.1042/bj2700749; KALMAR GB, 1990, P NATL ACAD SCI USA, V87, P6029, DOI 10.1073/pnas.87.16.6029; KENT C, 1990, PROG LIPID RES, V29, P87, DOI 10.1016/0163-7827(90)90010-I; LIANG P, 1994, CURRENT PROTOCOLS MO; LUCHE MM, 1993, ARCH BIOCHEM BIOPHYS, V301, P114, DOI 10.1006/abbi.1993.1122; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; PADDON HB, 1980, BIOCHIM BIOPHYS ACTA, V620, P636, DOI 10.1016/0005-2760(80)90156-3; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V795, P433, DOI 10.1016/0005-2760(84)90169-3; PELECH SL, 1982, J BIOL CHEM, V257, P4198; PELECH SL, 1983, J BIOL CHEM, V258, P6782; PELECH SL, 1981, J BIOL CHEM, V256, P8283; RUTHERFORD MS, 1993, GENOMICS, V18, P698, DOI 10.1016/S0888-7543(05)80377-5; SANGHERA JS, 1989, J BIOL CHEM, V264, P1215; SLEIGHT R, 1983, J BIOL CHEM, V258, P831; SLEIGHT R, 1983, J BIOL CHEM, V258, P836; SOHAL PS, 1990, J BIOL CHEM, V265, P11746; SWEITZER TD, 1994, ARCH BIOCHEM BIOPHYS, V311, P107, DOI 10.1006/abbi.1994.1215; TRONCHERE H, 1994, BBA-LIPID LIPID MET, V1212, P137, DOI 10.1016/0005-2760(94)90248-8; UTAL AK, 1991, J BIOL CHEM, V266, P24084; VANCE DE, 1989, PHOSPHATIDYLCHOLINE, P225; WANG YL, 1993, J BIOL CHEM, V268, P5512; WATKINS JD, 1992, ARCH BIOCHEM BIOPHYS, V292, P360, DOI 10.1016/0003-9861(92)90003-F; WATKINS JD, 1991, J BIOL CHEM, V266, P21113; WATKINS JD, 1990, J BIOL CHEM, V265, P2190; WIEDER T, 1994, FEBS LETT, V345, P207, DOI 10.1016/0014-5793(94)00433-1; WRIGHT PS, 1985, J BIOL CHEM, V260, P7919; YAO ZM, 1990, J BIOL CHEM, V265, P4326	40	71	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16503	16506		10.1074/jbc.270.28.16503	http://dx.doi.org/10.1074/jbc.270.28.16503			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622451	hybrid			2022-12-27	WOS:A1995RJ34700006
J	BHALERAO, J; TYLZANOWSKI, P; FILIE, JD; KOZAK, CA; MERREGAERT, J				BHALERAO, J; TYLZANOWSKI, P; FILIE, JD; KOZAK, CA; MERREGAERT, J			MOLECULAR-CLONING, CHARACTERIZATION, AND GENETIC-MAPPING OF THE CDNA CODING FOR A NOVEL SECRETORY PROTEIN OF MOUSE - DEMONSTRATION OF ALTERNATIVE SPLICING IN SKIN AND CARTILAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-SERUM-ALBUMIN; CALCIUM-BINDING PROTEINS; EXTRACELLULAR-MATRIX; MESSENGER-RNA; SEQUENCE; EXPRESSION; DIFFERENTIATION; CHROMOSOME-3; PROFILAGGRIN; INVOLUCRIN	A novel 85-kDa protein secreted by the mouse stromal osteogenic cell line MN7 was identified using two-dimensional polyacrylamide gel electrophoresis (Mathieu, E., Meheus, L., Raymackers, J., and Merregaert, J. (1994) J. Bone Miner. Res. 9, 903-913). Degenerate primers were used to isolate the cDNA coding for this protein, The full-length cDNA clone is 1.9 kilobases (kb) and codes for a protein of 559 amino acid residues, The DNA and deduced amino acid sequences have no counterparts in public data bases, but a structural similarity involving typical cysteine doublets can be observed to serum albumin family proteins and to Endo16 (a calcium-binding protein of sea urchin), Northern blot analysis revealed the presence of a 1.9-kb transcript in various tissues, and a shorter transcript of 1.5 kb, derived by alternative splicing in tail, front paw and skin of embryonic mice. The gene for the p85 protein, termed Ecm1 (for extracellular matrix protein 1), is a single-copy gene, which was localized to the region on mouse chromosome 3 known to contain at least one locus associated with developmental disorders of the skin, soft coat (soc), Alternative splicing may serve as a mechanism for generating functional diversity in the Ecm1 gene.	UNIV ANTWERP, DEPT BIOCHEM, MOLEC BIOTECHNOL LAB, B-2610 Antwerp, BELGIUM; NIAID, BETHESDA, MD 20892 USA	University of Antwerp; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)			Tylzanowski, Przemko/G-8881-2013	Tylzanowski, Przemko/0000-0003-0769-559X				ADAMS JC, 1993, DEVELOPMENT, V117, P1183; ADAMSON MC, 1991, VIROLOGY, V183, P778, DOI 10.1016/0042-6822(91)91010-E; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AOKI K, 1986, FEBS LETT, V205, P313, DOI 10.1016/0014-5793(86)80919-X; APPEL RD, 1993, ELECTROPHORESIS, V14, P1232, DOI 10.1002/elps.11501401185; Ayad S, 1994, EXTRACELLULAR MATRIX; BACKENDORF C, 1992, NAT GENET, V2, P91, DOI 10.1038/ng1092-91; BRANDEN C, 1991, INTRO PROTEIN STRUCT, P259; BROWN JR, 1976, FED PROC, V35, P2141; BURR DB, 1989, AM J ANAT, V186, P186, DOI 10.1002/aja.1001860208; CARTER DC, 1989, SCIENCE, V244, P1195, DOI 10.1126/science.2727704; DARLINGTON GJ, 1986, MOL CELL BIOL, V6, P969, DOI 10.1128/MCB.6.4.969; Dickson Ian R., 1993, P249; DOOLEY TP, 1992, GENOMICS, V13, P866, DOI 10.1016/0888-7543(92)90171-N; DORIN JR, 1990, GENOMICS, V8, P420, DOI 10.1016/0888-7543(90)90027-R; DUGAICZYK A, 1982, P NATL ACAD SCI-BIOL, V79, P71, DOI 10.1073/pnas.79.1.71; FERRARI S, 1987, J BIOL CHEM, V262, P8325; GANG A, 1992, AM J RESP CELL MOL, V7, P104, DOI 10.1165/ajrcmb/7.1.104; GATES RE, 1982, BIOCHEM BIOPH RES CO, V105, P57, DOI 10.1016/S0006-291X(82)80010-7; Green EL, 1981, GENETICS PROBABILITY, P77; GREEN MC, 1989, GENETIC VARIANTS STR, P212; HARDER T, 1992, GENE, V113, P269, DOI 10.1016/0378-1119(92)90406-F; HEGYI H, 1993, COMPUT APPL BIOSCI, V9, P371; HEINEGARD D, 1989, FASEB J, V3, P2042, DOI 10.1096/fasebj.3.9.2663581; Heinegard Dick, 1993, P189; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; JOKINEN M, 1981, EUR J BIOCHEM, V114, P393, DOI 10.1111/j.1432-1033.1981.tb05159.x; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; KARTASOVA T, 1988, MOL CELL BIOL, V8, P2195, DOI 10.1128/MCB.8.5.2195; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; KOZAK CA, 1990, GENOMICS, V8, P519, DOI 10.1016/0888-7543(90)90039-W; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KRAGHHANSEN U, 1990, DAN MED BULL, V37, P57; LEE SC, 1993, J INVEST DERMATOL, V100, P65, DOI 10.1111/1523-1747.ep12354504; MALLEINGERIN F, 1993, P NATL ACAD SCI USA, V90, P3289, DOI 10.1073/pnas.90.8.3289; MARKOVA NG, 1993, MOL CELL BIOL, V13, P613, DOI 10.1128/MCB.13.1.613; MATHIEU E, 1994, J BONE MINER RES, V9, P903; MATHIEU E, 1992, CALCIFIED TISSUE INT, V50, P362, DOI 10.1007/BF00301635; MATHIEU E, 1994, J BONE MINER RES, V9, P183; MATHIEU E, 1993, THESIS U ANTWERP BEL; MCKINLEYGRANT LJ, 1989, P NATL ACAD SCI USA, V86, P4848, DOI 10.1073/pnas.86.13.4848; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Murphy Gillian, 1993, P287; NAKISA RC, 1993, DOTPLOT PROGRAM GRAP; NASH JHE, 1993, COMPUT APPL BIOSCI, V9, P469; OBRIEN SJ, 1991, CYTOGENET CELL GENET, V58, P1124, DOI 10.1159/000133725; OSMAN N, 1992, J IMMUNOL, V148, P1570; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PONGOR S, 1993, NUCLEIC ACIDS RES, V21, P3111, DOI 10.1093/nar/21.13.3111; PRESLAND RB, 1992, J BIOL CHEM, V267, P23772; Putnam E., 1975, 3 SERUM ALBUMIN, VSecond, P133, DOI [10.1016/B978-0-12-568401-9.50010-4, DOI 10.1016/B978-0-12-568401-9.50010-4]; Rigoutsos I., 1994, IEEE Computational Science and Engineering, V1, P60, DOI 10.1109/99.326666; ROSENTHAL DS, 1992, J INVEST DERMATOL, V98, P343, DOI 10.1111/1523-1747.ep12499802; ROTHNAGEL JA, 1994, GENOMICS, V23, P450, DOI 10.1006/geno.1994.1522; SABATH DE, 1990, GENE, V91, P185, DOI 10.1016/0378-1119(90)90087-8; SAMBROOK J, 1969, MOL CLONING LABORATO; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; Schubert D, 1992, Trends Cell Biol, V2, P63, DOI 10.1016/0962-8924(92)90057-T; SELDIN MF, 1993, MAMM GENOME, V4, pS47, DOI 10.1007/BF00360829; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; SIMON M, 1989, AM J HUM GENET, V45, P910; SOLTYSIKESPANOLA M, 1994, DEV BIOL, V165, P73, DOI 10.1006/dbio.1994.1235; SONNHAMMER ELL, 1994, PROTEIN SCI, V3, P482; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; STEINERT PM, 1991, INT J BIOL MACROMOL, V13, P130, DOI 10.1016/0141-8130(91)90037-U; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; VOGELAAR NJ, 1991, J MOL BIOL, V220, P545, DOI 10.1016/0022-2836(91)90097-P; VOLZ A, 1993, GENOMICS, V18, P92, DOI 10.1006/geno.1993.1430; Von Der Mark Klaus, 1993, P211; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WAHLE E, 1992, ANNU REV BIOCHEM, V61, P419; Yamada Yoshihiko, 1992, Current Opinion in Cell Biology, V4, P819, DOI 10.1016/0955-0674(92)90105-L; YANG F, 1985, P NATL ACAD SCI USA, V82, P7994, DOI 10.1073/pnas.82.23.7994; YONEDA K, 1992, J BIOL CHEM, V267, P18060; ZABEL BU, 1985, P NATL ACAD SCI USA, V82, P469, DOI 10.1073/pnas.82.2.469	76	40	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16385	16394		10.1074/jbc.270.27.16385	http://dx.doi.org/10.1074/jbc.270.27.16385			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608209	hybrid			2022-12-27	WOS:A1995RH22600076
J	ISHII, K; GERSZTEN, R; ZHENG, YW; WELSH, JB; TURCK, CW; COUGHLIN, SR				ISHII, K; GERSZTEN, R; ZHENG, YW; WELSH, JB; TURCK, CW; COUGHLIN, SR			DETERMINANTS OF THROMBIN RECEPTOR CLEAVAGE - RECEPTOR DOMAINS INVOLVED, SPECIFICITY, AND ROLE OF THE P3 ASPARTATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED PLATELET ACTIVATION; ALPHA-THROMBIN; MECHANISM; PEPTIDES; CLONING; HIRUDIN; COMPLEX; ALTERS; DNA	Thrombin receptor cleavage at the Arg(41)-down arrow-Ser(42) peptide bond in the receptor's amino terminal exodomain is necessary and sufficient for receptor activation. The rate of receptor cleavage at this site is a critical determinant of the magnitude of the cellular response to thrombin. These observations underscore the importance of defining the molecular basis for thrombin-receptor interaction and cleavage. We report that chimeric proteins bearing only thrombin receptor aminoterminal exodomain residues 36-60 are cleaved at rates similar to the wild-type thrombin receptor when expressed on the cell surface. A soluble amino-terminal exodomain protein was also cleaved efficiently by thrombin with a K-m of 1530 mu M and k(cat) of approximately 50 s(-1), with cleavage occurring only at the Arg(41)- down arrow-Ser(42) peptide bond. In the context of previous studies, these data suggest that the receptor's LDPR cleavage recognition sequence and DKYEPF hirudin-like domain account for thrombin-receptor interaction. Because a P3 aspartate in protein C's cleavage site inhibits cleavage by free thrombin, we investigated the role of the P3 aspartate in the receptor's LDPR sequence. Studies with mutant receptors revealed an inhibitory role for this residue only in the absence of the receptor's hirudin-like domain. These and other data suggest that the receptor's hirudin-like domain causes a conformational change in thrombin's active center to accommodate the LDPR sequence and promote efficient receptor cleavage. Taken together, these studies imply that the thrombin receptor's amino-terminal exodomain contains all the machinery needed for efficient recognition and cleavage by thrombin. Thrombin appears to bind and cleave this domain independently of the rest of the receptor, with one thrombin molecule probably activating multiple receptors.	UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DAIICHI RES CTR,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco					NHLBI NIH HHS [HL44907] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044907] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CHEN J, 1994, J BIOL CHEM, V269, P16041; COUGHLIN SR, 1994, P NATL ACAD SCI USA, V91, P9200, DOI 10.1073/pnas.91.20.9200; EHRLICH HJ, 1990, EMBO J, V9, P2367, DOI 10.1002/j.1460-2075.1990.tb07411.x; ESMON CT, 1987, SCIENCE, V235, P1348, DOI 10.1126/science.3029867; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; FORSAYETH JR, 1994, BIOTECHNIQUES, V17, P354; HOXIE JA, 1993, J BIOL CHEM, V268, P13756; HUNG DT, 1992, J CLIN INVEST, V89, P1350, DOI 10.1172/JCI115721; HUNG DT, 1992, J CLIN INVEST, V89, P444, DOI 10.1172/JCI115604; ISHII K, 1993, J BIOL CHEM, V268, P9780; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEBONNIEC BF, 1991, P NATL ACAD SCI USA, V88, P7371, DOI 10.1073/pnas.88.16.7371; LITTMAN DR, 1985, CELL, V40, P237, DOI 10.1016/0092-8674(85)90138-2; LIU LW, 1991, J BIOL CHEM, V266, P16977; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P3266, DOI 10.1021/bi00177a018; RASMUSSEN UB, 1991, FEBS LETT, V288, P123, DOI 10.1016/0014-5793(91)81017-3; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAMBROOK J, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCARBOROUGH RM, 1992, J BIOL CHEM, V267, P13146; SKRZYPCZAKJANKUN E, 1991, J MOL BIOL, V221, P1379; VASSALLO RR, 1992, J BIOL CHEM, V267, P6081; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; WAGNER SL, 1989, J BIOL CHEM, V264, P611	27	63	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16435	16440		10.1074/jbc.270.27.16435	http://dx.doi.org/10.1074/jbc.270.27.16435			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608215	hybrid			2022-12-27	WOS:A1995RH22600083
J	TSEN, GS; NAPIER, A; HALFTER, W; COLE, GJ				TSEN, GS; NAPIER, A; HALFTER, W; COLE, GJ			IDENTIFICATION OF A NOVEL ALTERNATIVELY SPLICED AGRIN MESSENGER-RNA THAT IS PREFERENTIALLY EXPRESSED IN NONNEURONAL CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ACETYLCHOLINE-RECEPTOR; EXTRACELLULAR-MATRIX; ORGANIZING PROTEIN; CULTURED MYOTUBES; AGGREGATION; RNA; COMPONENTS; MOLECULES; MUSCLE; GENE	A novel agrin isoform was identified based on the isolation of an agrin cDNA from E9 chick brain that lacked 21 base pairs (bp) in the NH2-terminal encoding region of the agrin mRNA. Reverse transcription-polymerase chain reaction (RT-PGR) of E9 chick brain mRNA confirmed the existence of this agrin isoform in brain, although the novel splice variant represents a minor fraction of agrin mRNA in brain. However, upon analysis of chick brain astrocyte mRNA, smooth muscle mRNA, and cardiac muscle mRNA by RT-PCR, we show that this novel agrin isoform is the predominant agrin isoform in these non-neuronal cell populations. We extended our analyses to examine the expression of this agrin mRNA isoform during chick development and show that the agrin mRNA lacking this 21-bp exon is up-regulated with brain development, consistent with the increase in glial number during brain development, while the agrin isoform that does not undergo splicing and thus contains the 21-bp exon is down-regulated in brain development. Because the 21-bp exon is inserted in the region of chick agrin which encodes the putative signal sequence of agrin, with the signal peptidase site immediately preceding the putative first amino acid of the mature protein being deleted as a result of splicing, these data raise the interesting possibility that the presence or absence of this alternatively spliced exon may differentially regulate processing of the agrin protein in neuronal and non-neuronal cells, respectively.	OHIO STATE UNIV,CTR NEUROBIOTECHNOL,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT CELL BIOL NEUROBIOL & ANAT,COLUMBUS,OH 43210; UNIV PITTSBURGH,DEPT NEUROBIOL,PITTSBURGH,PA 15261	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh								BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; BURG MA, 1995, J NEUROSCI RES, V41, P49, DOI 10.1002/jnr.490410107; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; GODFREY EW, 1991, EXP CELL RES, V195, P99, DOI 10.1016/0014-4827(91)90504-N; GORDON H, 1993, J NEUROSCI, V13, P586; HOCH W, 1994, J CELL BIOL, V126, P1, DOI 10.1083/jcb.126.1.1; KELLY MM, 1995, DEV BRAIN RES, V85, P31, DOI 10.1016/0165-3806(94)00185-3; MA E, 1994, J NEUROSCI, V14, P2943; MAGILLSOLC C, 1988, J CELL BIOL, V107, P1825, DOI 10.1083/jcb.107.5.1825; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; NITKIN RM, 1990, J CELL BIOL, V111, P1161, DOI 10.1083/jcb.111.3.1161; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1992, J NEUROSCI, V12, P3535; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMITH MA, 1994, NEURON, V12, P795, DOI 10.1016/0896-6273(94)90332-8; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; THOMAS WS, 1993, DEV BIOL, V158, P523, DOI 10.1006/dbio.1993.1210; TSEN G, 1995, J BIOL CHEM, V270, P3392, DOI 10.1074/jbc.270.7.3392; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; WALLACE BG, 1990, J NEUROSCI, V10, P3576; WALLACE BG, 1989, J NEUROSCI, V9, P1294	30	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15934	15937		10.1074/jbc.270.27.15934	http://dx.doi.org/10.1074/jbc.270.27.15934			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608145	hybrid			2022-12-27	WOS:A1995RH22600006
J	RIBONI, L; PRINETTI, A; BASSI, R; CAMINITI, A; TETTAMANTI, G				RIBONI, L; PRINETTI, A; BASSI, R; CAMINITI, A; TETTAMANTI, G			A MEDIATOR ROLE OF CERAMIDE IN THE REGULATION OF NEUROBLASTOMA NEURO2A CELL-DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE CELLS; BLASTOMA CELLS; SPHINGOLIPID SYNTHESIS; EXOGENOUS GANGLIOSIDE; PLASMA-MEMBRANE; RETINOIC ACID; SPHINGOSINE; INHIBITION; SPHINGOMYELIN; CULTURE	Current studies indicate that ceramide is involved in the regulation of important cell functions, namely cell growth, differentiation, and apoptosis, In the present study, the possible role of ceramide in the differentiation of neuroblastoma Neuro2a cells was investigated, The following results were obtained, (a) Ceramide content of Neuro2a cells, induced to differentiate by retinoic acid (RA) treatment rapidly increased after addition of RA, was maintained at high levels in RA differentiated cells and returned to the starting levels with removal of RA and reversal of differentiation; under the same conditions, the sphingosine content remained unchanged, (b) After a short pulse with [H-3]sphingomyelin or [H-3]sphingosine or L-[H-3]serine, the metabolic formation of ceramide was markedly higher and more rapid in RA-differentiated than undifferentiated cells, (c) Inhibitors of ceramide biosynthesis (Fumonisin B1, beta-chloroalanine and L-cycloserine) diminished the extent of the differentiating effect of RA and concomitantly Cer content decreased, (d) The activity of neutral sphingomyelinase increased after addition of RA, maintained high levels in RA-differentiated cells, and returned to the initial levels with removal of RA, (e) Experimental conditions that cause an elevation of ceramide content (treatment with sphingosine or ceramide or C-2-ceramide or bacterial sphingomyelinase) inhibited cell proliferation and stimulated neurite outgrowth; dihydro analogues of sphingosine, ceramide, and C-2-ceramide had no effect on differentiation. (f) treatment with Fumonisin B1 completely inhibited sphingosine-induced differentiation. These data suggest a specific bioregulatory function of ceramide in the control of Neuro2a cell growth and differentiation and pose the general hypothesis of a mediator role of ceramide in the differentiation of cells of neural origin.	UNIV MILAN,DEPT MED CHEM & BIOCHEM,STUDY CTR FUNCT BIOCHEM BRAIN LIPIDS,I-20133 MILAN,ITALY	University of Milan			Prinetti, Alessandro/R-4206-2017; Riboni, Laura/R-4281-2017; Sonnino, Sandro/R-4154-2017	Prinetti, Alessandro/0000-0003-0252-2593; Riboni, Laura/0000-0002-4149-8226; Sonnino, Sandro/0000-0001-8180-5908; BASSI, ROSARIA/0000-0001-7409-4730				BARTLETT GR, 1959, J BIOL CHEM, V234, P466; COLIGAN JE, 1991, CURRENT PROTOCOLS IM, V1, P152; DAS DVM, 1984, BIOCHIM BIOPHYS ACTA, V777, P339; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; DODGE JT, 1967, J LIPID RES, V8, P667; GATT S, 1976, BIOCHEM BIOPH RES CO, V68, P235, DOI 10.1016/0006-291X(76)90034-6; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; HANNUN YA, 1993, ADV LIPID RES, V25, P27; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HANNUN YA, 1993, BIOCHIM BIOPHYS ACTA, V1154, P223, DOI 10.1016/0304-4157(93)90001-5; HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6; HAREL R, 1993, J BIOL CHEM, V268, P14476; HARRIS G, 1954, CHEM IND, V39, P249; IWAMORI M, 1975, J LIPID RES, V16, P332; JI L, 1995, FEBS LETT, V358, P211, DOI 10.1016/0014-5793(94)01428-4; KADOWAKI H, 1990, J NEUROCHEM, V54, P2125, DOI 10.1111/j.1471-4159.1990.tb04919.x; KALEN A, 1992, BIOCHIM BIOPHYS ACTA, V1125, P90, DOI 10.1016/0005-2760(92)90160-W; KOJIMA N, 1994, J BIOL CHEM, V269, P30451; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; KOLESNICK R, 1994, MOL CHEM NEUROPATHOL, V21, P287, DOI 10.1007/BF02815356; Kolesnick Richard, 1992, Trends in Cell Biology, V2, P232, DOI 10.1016/0962-8924(92)90310-J; LEDEEN RW, 1973, J NEUROCHEM, V21, P829, DOI 10.1111/j.1471-4159.1973.tb07527.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEDLOCK KA, 1988, BIOCHEMISTRY-US, V27, P7079, DOI 10.1021/bi00418a061; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; MERRILL AH, 1994, CURR TOP MEMBR, V40, P361, DOI 10.1016/S0070-2161(08)60988-0; MOOIBROEK MJ, 1985, J NEUROCHEM, V44, P1551, DOI 10.1111/j.1471-4159.1985.tb08794.x; OHTA H, 1994, FEBS LETT, V355, P267, DOI 10.1016/0014-5793(94)01218-0; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; PARTRIDGE SM, 1948, BIOCHEM J, V42, P238, DOI 10.1042/bj0420238; PREISS J, 1986, J BIOL CHEM, V261, P8597; RIBONI L, 1992, FEBS LETT, V300, P188, DOI 10.1016/0014-5793(92)80193-K; RIBONI L, 1994, FEBS LETT, V352, P323, DOI 10.1016/0014-5793(94)00984-8; RIBONI L, 1991, J NEUROCHEM, V57, P1931, DOI 10.1111/j.1471-4159.1991.tb06406.x; RIBONI L, 1995, J NEUROCHEM, V64, P451; RIBONI L, 1990, NEUROCHEM RES, V15, P1176; SCHWARZ A, 1995, J BIOL CHEM, V270, P10990, DOI 10.1074/jbc.270.18.10990; SHEA TB, 1985, DEV BRAIN RES, V21, P307, DOI 10.1016/0165-3806(85)90220-2; SPENCE MW, 1978, J NEUROCHEM, V30, P917, DOI 10.1111/j.1471-4159.1978.tb10804.x; SPENCE MW, 1982, BIOCHIM BIOPHYS ACTA, V719, P162, DOI 10.1016/0304-4165(82)90321-X; SUGIYAMA E, 1993, J BIOCHEM-TOKYO, V113, P467, DOI 10.1093/oxfordjournals.jbchem.a124068; SUNDARAM KS, 1984, J NEUROCHEM, V42, P577, DOI 10.1111/j.1471-4159.1984.tb02716.x; Svennerholm L, 1980, Adv Exp Med Biol, V125, P11; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; TAKETOMI T, 1970, J BIOCHEM-TOKYO, V68, P475, DOI 10.1093/oxfordjournals.jbchem.a129378; TETTAMANTI G, 1994, PROG BRAIN RES, V101, P77; TSUJI S, 1988, J NEUROCHEM, V50, P414, DOI 10.1111/j.1471-4159.1988.tb02928.x; UEMURA K, 1993, J BIOCHEM-TOKYO, V114, P610, DOI 10.1093/oxfordjournals.jbchem.a124225; VANCE DE, 1967, J LIPID RES, V8, P621	50	158	158	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26868	26875		10.1074/jbc.270.45.26868	http://dx.doi.org/10.1074/jbc.270.45.26868			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592930	hybrid			2022-12-27	WOS:A1995TE58300030
J	RIEWALD, M; SCHLEEF, RR				RIEWALD, M; SCHLEEF, RR			MOLECULAR-CLONING OF BOMAPIN (PROTEASE-INHIBITOR-10), A NOVEL HUMAN SERPIN THAT IS EXPRESSED SPECIFICALLY IN THE BONE-MARROW	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							OVALBUMIN; SEQUENCE	Serine proteinase inhibitors or serpins are a superfamily of homologous proteins that are for the most part involved in the regulation of proteolytic processes in a variety of biological systems. Utilizing a polymerase chain reaction-based strategy we have cloned a novel member of the ovalbumin family of serpins from a human bone marrow cDNA library. The new gene encodes a 397-amino acid protein, designated bomapin, with a calculated molecular mass of 45 kDa and 48% amino acid identity with plasminogen activator inhibitor-2, human leukocyte elastase inhibitor, and cytoplasmic antiproteinase. A single 2.3-kilobase bomapin transcript is highly expressed in human bone marrow cells but was undetectable in all other analyzed human tissues. lie vitro transcription and translation of the bomapin cDNA revealed the synthesis of an appropriately sized protein that was able to form SDS-stable complexes with thrombin and trypsin. The restricted expression of bomapin to the bone marrow raises the possibility that this serpin may play a role in the regulation of protease activities during hematopoiesis.	Scripps Res Inst, RES INST, DEPT VASC BIOL VB1, LA JOLLA, CA 92037 USA	Scripps Research Institute					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049563, R01HL045954] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL49563, HL45954] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; COUGHLIN P, 1993, P NATL ACAD SCI USA, V90, P9417, DOI 10.1073/pnas.90.20.9417; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; HOPKINS PCR, 1994, SCIENCE, V265, P1893; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; HUNT LT, 1980, BIOCHEM BIOPH RES CO, V95, P864, DOI 10.1016/0006-291X(80)90867-0; KAMENS J, 1995, J BIOL CHEM, V270, P15250, DOI 10.1074/jbc.270.25.15250; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KUMAR S, 1995, TRENDS BIOCHEM SCI, V20, P198, DOI 10.1016/S0968-0004(00)89007-6; KUMAR S, 1991, J BIOL CHEM, V266, P20960; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; MORGENSTERN KA, 1994, BIOCHEMISTRY-US, V33, P3432, DOI 10.1021/bi00177a037; PEMBERTON PA, 1995, J BIOL CHEM, V270, P15832, DOI 10.1074/jbc.270.26.15832; POTEMPA J, 1988, SCIENCE, V241, P699, DOI 10.1126/science.2456616; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; REMOLDODONNELL E, 1992, P NATL ACAD SCI USA, V89, P5635, DOI 10.1073/pnas.89.12.5635; REMOLDODONNELL E, 1993, FEBS LETT, V315, P105, DOI 10.1016/0014-5793(93)81143-N; Sambrook J, 1989, MOL CLONING LABORATO; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; STEIN PE, 1991, J MOL BIOL, V221, P941, DOI 10.1016/0022-2836(91)80185-W; SUMINAMI Y, 1991, BIOCHEM BIOPH RES CO, V181, P51, DOI 10.1016/S0006-291X(05)81380-4; SUN JR, 1995, J BIOL CHEM, V270, P16089, DOI 10.1074/jbc.270.27.16089; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; WANG XD, 1995, J BIOL CHEM, V270, P18044, DOI 10.1074/jbc.270.30.18044; YE RD, 1987, J BIOL CHEM, V262, P3718; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	27	46	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26754	26757		10.1074/jbc.270.45.26754	http://dx.doi.org/10.1074/jbc.270.45.26754			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592909	hybrid			2022-12-27	WOS:A1995TE58300009
J	SCRIPTURE, JB; HUBER, PW				SCRIPTURE, JB; HUBER, PW			ANALYSIS OF THE BINDING OF XENOPUS RIBOSOMAL-PROTEIN L5 TO OOCYTE 5-S-RIBOSOMAL-RNA - THE MAJOR DETERMINANTS OF RECOGNITION ARE LOCATED IN HELIX-III-LOOP-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-IIIA; ESCHERICHIA-COLI; LAEVIS OOCYTES; RIBONUCLEIC-ACID; FINGER PROTEIN; ALPHA-SARCIN; RNA GENE; COMPLEX; DNA; TFIIIA	Xenopus ribosomal protein L5 was expressed in Escherichia:coli and exhibits high affinity (K-d = 2 nM) and specificity for oocyte 5 S rRNA. The pH dependence of the association constant for the complex reveals an ionization with a pK(a) value of 10.1, indicating that tyrosine and/or lysine residues are important for specific binding of L5 to the RNA. Formation of the L5 5 S rRNA complex is remarkably insensitive to ionic strength, providing evidence that nonelectrostatic interactions make significant contributions to binding, Together, these results suggest that one or more tyrosine residues may form critical contacts through stacking interactions with bases in the RNA, In order to locate recognition elements within 5 S rRNA, we measured binding of L5 to a collection of site-specific mutants, Mutations in the RNA that affected the interaction are confined to the hairpin structure comprised of helix III and loop C, Earlier experiments with a rhodium structural probe had shown that the two nucleotide bulge in helix III and the intrinsic structure of loop C create sites in the major groove that are opened and accessible to stacking interactions with the metal complex, In the present studies, we detect a correlation between the intercalative binding of the rhodium complex to mutants in the hairpin and binding of L5, supporting the proposal that binding of the protein is mediated, in some part, by stacking interactions. Furthermore, the results from mutagenesis establish;that, despite overlapping binding sites on 5 S rRNA, L5 and transcription factor IIIA utilize distinct structural elements for recognition.	UNIV NOTRE DAME,DEPT CHEM & BIOCHEM,NOTRE DAME,IN 46556	University of Notre Dame					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038200] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON LA, 1991, DEV BIOL, V144, P129, DOI 10.1016/0012-1606(91)90485-L; ALLISON LA, 1995, DEV BIOL, V168, P284, DOI 10.1006/dbio.1995.1080; AOYAMA K, 1984, J BIOCHEM-TOKYO, V95, P1179, DOI 10.1093/oxfordjournals.jbchem.a134707; BAUDIN F, 1991, J MOL BIOL, V218, P679; BHATTACHARYYA A, 1990, NATURE, V343, P484, DOI 10.1038/343484a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROW DA, 1987, J BIOL CHEM, V262, P13959; BRUNEL C, 1990, J MOL BIOL, V215, P103, DOI 10.1016/S0022-2836(05)80099-3; CHAN YL, 1987, J BIOL CHEM, V262, P12879; CHOW CS, 1992, BIOCHEMISTRY-US, V31, P3534, DOI 10.1021/bi00128a030; CHOW CS, 1992, BIOCHEMISTRY-US, V31, P972, DOI 10.1021/bi00119a005; CLEMENS KR, 1993, SCIENCE, V260, P530, DOI 10.1126/science.8475383; DARSILLO P, 1991, J BIOL CHEM, V266, P21075; DIGUAN C, 1988, GENE, V67, P21, DOI 10.1016/0378-1119(88)90004-2; DIXON M, 1953, BIOCHEM J, V55, P161, DOI 10.1042/bj0550161; DRAPER DE, 1995, ANNU REV BIOCHEM, V64, P593, DOI 10.1146/annurev.bi.64.070195.003113; GABBAY EJ, 1973, BIOCHEMISTRY-US, V12, P4021, DOI 10.1021/bi00745a001; GROSS B, 1985, NUCLEIC ACIDS RES, V13, P2325, DOI 10.1093/nar/13.7.2325; GUDDAT U, 1990, CELL, V60, P619, DOI 10.1016/0092-8674(90)90665-2; HEUS HA, 1991, SCIENCE, V253, P191, DOI 10.1126/science.1712983; HUBER PW, 1986, J BIOL CHEM, V261, P3002; HUBER PW, 1984, P NATL ACAD SCI-BIOL, V81, P322, DOI 10.1073/pnas.81.2.322; HUBER PW, 1991, J BIOL CHEM, V266, P3278; JOHO KE, 1990, CELL, V61, P293, DOI 10.1016/0092-8674(90)90809-S; LI SJ, 1987, BIOCHEMISTRY-US, V26, P1578, DOI 10.1021/bi00380a014; MCBRYANT SJ, 1995, J MOL BIOL, V248, P44, DOI 10.1006/jmbi.1995.0201; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; NAZAR RN, 1979, J BIOL CHEM, V254, P7724; NAZAR RN, 1983, NUCLEIC ACIDS RES, V11, P3155, DOI 10.1093/nar/11.10.3155; PELHAM HRB, 1980, P NATL ACAD SCI-BIOL, V77, P4170, DOI 10.1073/pnas.77.7.4170; PERRELLA FW, 1988, ANAL BIOCHEM, V174, P437, DOI 10.1016/0003-2697(88)90042-5; PICARD B, 1980, EUR J BIOCHEM, V109, P359, DOI 10.1111/j.1432-1033.1980.tb04802.x; ROMANIUK PJ, 1985, NUCLEIC ACIDS RES, V13, P5369, DOI 10.1093/nar/13.14.5369; ROMBY P, 1990, BIOCHIMIE, V72, P437, DOI 10.1016/0300-9084(90)90068-R; SCHULTE C, 1974, BIOCHEMISTRY-US, V13, P1032, DOI 10.1021/bi00702a031; STEITZ JA, 1988, J CELL BIOL, V106, P545, DOI 10.1083/jcb.106.3.545; TERAO K, 1982, BIOCHIM BIOPHYS ACTA, V697, P20, DOI 10.1016/0167-4781(82)90040-9; THEUNISSEN O, 1992, CELL, V71, P679, DOI 10.1016/0092-8674(92)90601-8; VARANI G, 1991, BIOCHEMISTRY-US, V30, P3280, DOI 10.1021/bi00227a016; WEEKS KM, 1993, SCIENCE, V261, P1574, DOI 10.1126/science.7690496; WIMBERLY B, 1993, BIOCHEMISTRY-US, V32, P1078, DOI 10.1021/bi00055a013; WORMINGTON WM, 1989, MOL CELL BIOL, V9, P5281, DOI 10.1128/MCB.9.12.5281; YEH LCC, 1988, J BIOL CHEM, V263, P17412; YOU QM, 1991, BIOCHEMISTRY-US, V30, P2495, DOI 10.1021/bi00223a028; ZANG WQ, 1995, J MOL BIOL, V245, P549, DOI 10.1006/jmbi.1994.0045	45	34	37	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27358	27365		10.1074/jbc.270.45.27358	http://dx.doi.org/10.1074/jbc.270.45.27358			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592999	hybrid			2022-12-27	WOS:A1995TE58300099
J	VANSEUNINGEN, I; OSTROWSKI, J; BUSTELO, XR; SLEATH, PR; BOMSZTYK, K				VANSEUNINGEN, I; OSTROWSKI, J; BUSTELO, XR; SLEATH, PR; BOMSZTYK, K			THE K-PROTEIN DOMAIN THAT RECRUITS THE INTERLEUKIN 1-RESPONSIVE K-PROTEIN-KINASE LIES ADJACENT TO A CLUSTER OF C-SRC AND VAV SH3-BINDING SITES - IMPLICATIONS THAT K-PROTEIN ACTS AS A DOCKING PLATFORM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; T-CELLS; BINDING; RNA; DNA; EXPRESSION; IDENTIFICATION; PURIFICATION; ACTIVATION; AFFINITY	The heterogeneous ribonucleoprotein particle (hnRNP) K protein interacts with multiple molecular partners including DNA, RNA, serine/threonine, and tyrosine kinases and the product of the proto-oncogene, Vav. The K protein is phosphorylated in vivo and in vitro on serine/threonine residues by an interleukin 1 (IL-1)-responsive kinase with which it forms a complex. In this study we set out to map the K protein domains that bind kinases. We demonstrate that the K protein contains a cluster of at least three SH3-binding sites (P1, PPGRGGRPMPPSRR, amino acids 265-278; P2, PRRGPPPPPPGRG, 285-297; and P3, RARNLPLPPPPPPRGG, 303-318) and that each one of these sites is capable of selectively engaging c-Src and Vav SH3 domains but not SH3 domains of Abl, p85 phosphatidylinositol 3-kinase, Grb-2, and Csk. We demonstrate that the K protein domain that recruits and is phosphorylated in an RNA-dependent manner by the IL-1-responsive kinase, designated KPK for K protein kinase, is contained within the 338-425-amino acid stretch and thus is contiguous but does not include the cluster of the SH3-binding sites. K protein and KPK co-immunoprecipitate from cell extracts with either c-Src or Vav, suggesting that K protein-KPK-c-Src and K protein-KPK-Vav complexes exist in vivo. Furthermore, in the context of K protein, c-Src can reactivate KPK in vitro. The succession of kinase-binding sites contained within the K protein that allow it to form multienzyme complexes and facilitate kinase cross-talk suggest that K protein may serve as a docking platform that promotes molecular interactions occurring during signal transduction.	UNIV WASHINGTON, DEPT MED, SEATTLE, WA 98195 USA; IMMUNEX RES & DEV CORP, SEATTLE, WA 98101 USA; BRISTOL MYERS SQUIBB PHARMACEUT RES INST, PRINCETON, NJ 08543 USA; CTR CANC, MED CTR POSTGRAD EDUC, DEPT GASTROENTEROL, PL-02781 WARSAW, POLAND	University of Washington; University of Washington Seattle; Bristol-Myers Squibb; Centre of Postgraduate Medical Education - Poland			Bustelo, Xose R./A-9526-2010; VAN SEUNINGEN, Isabelle/N-6176-2016	Bustelo, Xose R./0000-0001-9398-6072; VAN SEUNINGEN, Isabelle/0000-0002-3131-2694; Ostrowski, Jerzy/0000-0003-1363-3766	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM042508, R01GM045134] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM42508, GM45134] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUSTELO XR, 1995, MOL CELL BIOL, V15, P1324; CHOI KY, 1994, CELL, V78, P499; CLEMENS KR, 1993, SCIENCE, V260, P530, DOI 10.1126/science.8475383; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DEJGAARD K, 1994, J MOL BIOL, V236, P33, DOI 10.1006/jmbi.1994.1116; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; GAILLARD C, 1994, NUCLEIC ACIDS RES, V22, P4183, DOI 10.1093/nar/22.20.4183; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GALLO KA, 1994, J BIOL CHEM, V269, P15092; HAKES DJ, 1992, ANAL BIOCHEM, V202, P293, DOI 10.1016/0003-2697(92)90108-J; HALL A, 1992, CELL, V69, P389, DOI 10.1016/0092-8674(92)90441-E; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; HOBERT O, 1994, J BIOL CHEM, V269, P20225; IWASAKI T, 1992, FEBS LETT, V298, P240, DOI 10.1016/0014-5793(92)80067-Q; JOSHIBARVE SS, 1993, J BIOL CHEM, V268, P18018; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; LIU Q, 1995, MOL CELL BIOL, V15, P2800; LOWENTHAL JW, 1986, J EXP MED, V164, P1060, DOI 10.1084/jem.164.4.1060; MATUNIS MJ, 1992, MOL CELL BIOL, V12, P164, DOI 10.1128/MCB.12.1.164; MUNOZ E, 1992, EUR J IMMUNOL, V22, P1391, DOI 10.1002/eji.1830220610; OSTROWSKI J, 1994, J BIOL CHEM, V269, P17626; OSTROWSKI J, 1991, J BIOL CHEM, V266, P12722; OSTROWSKI J, 1993, NUCLEIC ACIDS RES, V21, P1045, DOI 10.1093/nar/21.4.1045; RACHIE NA, 1993, J BIOL CHEM, V268, P22143; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RICHARD S, 1995, MOL CELL BIOL, V15, P186, DOI 10.1128/MCB.15.1.186; SALTIEL AR, 1994, FASEB J, V8, P1034, DOI 10.1096/fasebj.8.13.7926368; SEGEL IH, 1993, ENZYME KINETICS, P106; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; THEUNISSEN O, 1992, CELL, V71, P679, DOI 10.1016/0092-8674(92)90601-8; VANSEUNINGEN I, 1995, BIOCHEMISTRY-US, V34, P5644, DOI 10.1021/bi00016a040; WANG LL, 1995, J BIOL CHEM, V270, P2010, DOI 10.1074/jbc.270.5.2010; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; WONG G, 1992, CELL, V69, P551, DOI 10.1016/0092-8674(92)90455-L; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	46	99	99	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26976	26985		10.1074/jbc.270.45.26976	http://dx.doi.org/10.1074/jbc.270.45.26976			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592945	hybrid			2022-12-27	WOS:A1995TE58300045
J	JUSTICE, JM; MURTAGH, JJ; MOSS, J; VAUGHAN, M				JUSTICE, JM; MURTAGH, JJ; MOSS, J; VAUGHAN, M			HYDROPHOBICITY AND SUBUNIT INTERACTIONS OF ROD OUTER SEGMENT PROTEINS INVESTIGATED USING TRITON X-114 PHASE PARTITIONING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSDUCIN-ALPHA-SUBUNIT; CYCLIC-GMP PHOSPHODIESTERASE; GTP-BINDING PROTEIN; INTEGRAL MEMBRANE-PROTEINS; CGMP-PHOSPHODIESTERASE; ADP-RIBOSYLATION; PERTUSSIS TOXIN; GAMMA-SUBUNIT; BETA-GAMMA; TERMINAL DOMAIN	Triton X-114 phase partitioning, a procedure used for purifying integral membrane proteins, was used to study protein components of the mammalian visual transduction cascade. An integral membrane protein, rhodopsin, and two isoprenylated protein complexes, cyclic GMP phosphodiesterase and G(t beta gamma), partitioned into the detergent-rich phase. Arrestin, a soluble protein, accumulated in the aqueous phase. G(t alpha) distributed about equally between phases whether G;DP (G(t alpha). GDP) or GTP (G(t alpha). GTP) was bound. G(t beta gamma) increased recovery of G(t alpha). GDP but not G(t alpha). GTP in the detergent phase. Trypsin-treated G(t alpha), which lacks the fatty acylated amino-terminal 2-kDa region, accumulated to a greater extent in the aqueous phase than did intact G(t alpha). Trypsinized cGMP phosphodiesterase, which lacks the isoprenyl group, partitioned into the aqueous phase. A carboxyl-terminal truncated mutant (Val-331 stop) of G(t alpha) accumulated more in the aqueous phase then did recombinant full-length G(t alpha), supporting the role of the carboxyl terminus in increasing its hydrophobicity. N-Myristoylated recombinant G(o alpha) was more hydrophobic than recombinant G(o alpha) without myristate. ADP-ribosylation of G(t alpha) catalyzed by NAD:arginine ADP-ribosyltransferase, but not by pertussis toxin, increased hydrophilicity. Triton X-114 phase partitioning can thus semiquantify the hydrophobic nature of proteins and protein domains. It may aid in evaluating changes associated with post-translational protein modification and protein-protein interactions in a defined system.			JUSTICE, JM (corresponding author), NHLBI,PULM CRIT CARE MED BRANCH,10 CTR DR,MSC 1434,BLDG 10,RM 5N-307,BETHESDA,MD 20892, USA.							ANANT JS, 1992, J BIOL CHEM, V267, P687; AUDIGIER Y, 1990, J CELL BIOL, V111, P1427, DOI 10.1083/jcb.111.4.1427; BAEHR W, 1979, J BIOL CHEM, V254, P1669; BIANCHI R, 1992, FEBS LETT, V296, P158, DOI 10.1016/0014-5793(92)80369-R; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BUSS JE, 1987, P NATL ACAD SCI USA, V84, P7493, DOI 10.1073/pnas.84.21.7493; CATTY P, 1991, EUR J BIOCHEM, V199, P263, DOI 10.1111/j.1432-1033.1991.tb16119.x; CATTY P, 1992, J BIOL CHEM, V267, P19489; CERIONE RA, 1988, J BIOL CHEM, V263, P9345; CLERC A, 1992, J BIOL CHEM, V267, P19948; CLERC A, 1992, J BIOL CHEM, V267, P6620; COULTER S, 1992, P NATL ACAD SCI USA, V89, P5842, DOI 10.1073/pnas.89.13.5842; DEGTYAREV MY, 1993, BIOCHEMISTRY-US, V32, P8057, DOI 10.1021/bi00083a001; DENKER BM, 1992, J BIOL CHEM, V267, P6272; DENTLER WL, 1988, J CELL BIOL, V107, P2679, DOI 10.1083/jcb.107.6.2679; DENTLER WL, 1992, J PROTOZOOL, V39, P368, DOI 10.1111/j.1550-7408.1992.tb01466.x; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; EDERCOLLI L, 1992, BRAIN RES, V573, P284, DOI 10.1016/0006-8993(92)90774-4; EIDE B, 1987, BIOCHEM BIOPH RES CO, V148, P1398, DOI 10.1016/S0006-291X(87)80287-5; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; FUNG BKK, 1989, BIOCHEMISTRY-US, V28, P3133, DOI 10.1021/bi00434a003; FUNG BKK, 1983, J BIOL CHEM, V258, P503; FUNG BKK, 1983, J BIOL CHEM, V258, P495; GRAF R, 1992, J BIOL CHEM, V267, P24307; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; HAUN RS, 1993, J BIOL CHEM, V268, P7064; HONG JX, 1994, J BIOL CHEM, V269, P9743; HONG K, 1973, BIOCHEMISTRY-US, V12, P4517, DOI 10.1021/bi00746a033; HSIA JA, 1984, J BIOL CHEM, V259, P1086; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; HURLEY JB, 1984, SCIENCE, V226, P860, DOI 10.1126/science.6436980; JONES TLZ, 1990, P NATL ACAD SCI USA, V87, P568, DOI 10.1073/pnas.87.2.568; JOURNOT L, 1991, P NATL ACAD SCI USA, V88, P10054, DOI 10.1073/pnas.88.22.10054; JUSTICE JM, 1995, J BIOL CHEM, V270, P6436, DOI 10.1074/jbc.270.12.6436; KANAHO Y, 1984, J BIOL CHEM, V259, P7378; KOKAME K, 1992, NATURE, V359, P749, DOI 10.1038/359749a0; KRUEGER JG, 1983, CURR TOP MICROBIOL I, V107, P52; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; KUROSE H, 1983, J BIOL CHEM, V258, P4870; LAI RK, 1990, P NATL ACAD SCI USA, V87, P7673, DOI 10.1073/pnas.87.19.7673; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; LINDER ME, 1991, J BIOL CHEM, V266, P4654; MASTERS SB, 1988, SCIENCE, V241, P448, DOI 10.1126/science.2899356; MILLER JD, 1995, J CELL BIOL, V128, P273, DOI 10.1083/jcb.128.3.273; MORRISON DF, 1989, J BIOL CHEM, V264, P11671; MOSS J, 1980, J BIOL CHEM, V255, P5838; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P5873, DOI 10.1073/pnas.87.15.5873; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; NAVON SE, 1987, J BIOL CHEM, V262, P15746; NEUBERT TA, 1992, J BIOL CHEM, V267, P18274; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; NYSTROM S, 1991, BIOCHIM BIOPHYS ACTA, V1107, P39; PELLMAN D, 1985, NATURE, V314, P374, DOI 10.1038/314374a0; PHILLIPS WJ, 1992, J BIOL CHEM, V267, P17040; RANDERATH K, 1967, METHODS ENZYMOLOGY A, V12, P323; REED SL, 1992, INFECT IMMUN, V60, P542, DOI 10.1128/IAI.60.2.542-549.1992; SCHULTZ AM, 1987, BIOCHEM BIOPH RES CO, V146, P1234, DOI 10.1016/0006-291X(87)90780-7; SHINOZAWA T, 1980, P NATL ACAD SCI-BIOL, V77, P1408, DOI 10.1073/pnas.77.3.1408; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; STERNWEIS PC, 1986, J BIOL CHEM, V261, P631; TSAI SC, 1987, BIOCHEMISTRY-US, V26, P4728, DOI 10.1021/bi00389a020; VAILLANCOURT RR, 1990, P NATL ACAD SCI USA, V87, P3645, DOI 10.1073/pnas.87.10.3645; WATKINS PA, 1985, J BIOL CHEM, V260, P3478; WENSEL TG, 1990, BIOCHEMISTRY-US, V29, P2155, DOI 10.1021/bi00460a028; WEST RE, 1985, J BIOL CHEM, V260, P4428; YAMAMOTO T, 1983, J BIOL CHEM, V258, P2526; YAMANE HK, 1990, P NATL ACAD SCI USA, V87, P5868, DOI 10.1073/pnas.87.15.5868	68	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17970	17976		10.1074/jbc.270.30.17970	http://dx.doi.org/10.1074/jbc.270.30.17970			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629104	hybrid			2022-12-27	WOS:A1995RM26600054
J	WAKADE, AR; PRZYWARA, DA; PALMER, KC; KULKARNI, JS; WAKADE, TD				WAKADE, AR; PRZYWARA, DA; PALMER, KC; KULKARNI, JS; WAKADE, TD			DEOXYNUCLEOSIDE INDUCES NEURONAL APOPTOSIS INDEPENDENT OF NEUROTROPHIC FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; ADENOSINE-DEAMINASE DEFICIENCY; SYMPATHETIC NEURONS; FACTOR DEPRIVATION; HUMAN-LYMPHOCYTES; CHICK-EMBRYO; CELL-DEATH; CYCLIC-AMP; DEOXYADENOSINE; TOXICITY	Postmitotic sympathetic neurons are known to undergo a programmed cell death (apoptosis) when they are deprived of nerve growth factor (NGF) or treated with arabinofuranosyl nucleoside antimetabolites. Here we report the existence of a biochemical mechanism for the induction of neuronal death by an endogenous nucleoside in the presence of NGF. In support of such a mechanism we show that 2-deoxyadenosine (dAdo) induces apoptosis in chick embryonic sympathetic neurons supported in culture by NGF, excess K+, phorbol 12,13-dibutyrate, or forskolin. Neuronal death was related to a dramatic increase in the dATP content of sympathetic neurons exposed to dAdo (34.96 +/- 5.98 versus 0.75 +/- 0.16 pmol/mu g protein in untreated controls, n = 9), implicating dATP in the toxicity. Supportive evidence for a central role of dATP was gained by inhibition of kinases necessary for phosphorylation of dAdo. 5'-Iodotubercidin in nanomolar concentrations completely and dose-dependently inhibited formation of dATP and also protected against toxicity of submillimolar lar concentrations of dAdo in sympathetic neurons. Although some of these actions of dAdo were remarkably similar to those reported for human lymphoid cells, several were uniquely different. For example, [H-3]dAdo was not transported into neurons by the nucleoside transporter, and therefore inhibition of the transporter (dilazep, nitrobenzylthioinosine) did not prevent neurotoxicity by dAdo. Precursors of pyrimidine synthesis (2'-deoxycytidine, uridine) or NAD(+) synthesis (nicotinamide) were ineffective in protecting sympathetic neurons against dAdo toxicity. Finally, inhibition of adenosine deaminase by deoxycoformycin or erythro-9-(2-hydroxy-3-nonyl) adenine did not potentiate the toxic effects of dAdo. Our results provide evidence for the first time that neuronal cells are as susceptible to nucleoside lethality as human lymphocytes are, and provide a new model to study the salvage pathway of deoxyribonucleosides in controlling neuronal populations through programmed cell death.	WAYNE STATE UNIV,SCH MED,DEPT PHARMACOL,DETROIT,MI 48201; WAYNE STATE UNIV,SCH MED,DEPT PATHOL,DETROIT,MI 48201	Wayne State University; Wayne State University								AGARWAL RP, 1982, PHARMACOL THERAPEUT, V17, P399, DOI 10.1016/0163-7258(82)90023-7; BAGNARA AS, 1982, P NATL ACAD SCI-BIOL, V79, P2673, DOI 10.1073/pnas.79.8.2673; BALT JA, 1993, ADV ENZYME REGUL, V33, P285; BHAVE SV, 1995, IN PRESS J NEUROCHEM; CARSON DA, 1977, P NATL ACAD SCI USA, V74, P5677, DOI 10.1073/pnas.74.12.5677; COHEN A, 1978, P NATL ACAD SCI USA, V75, P472, DOI 10.1073/pnas.75.1.472; COLEMAN MS, 1978, J BIOL CHEM, V253, P1619; CRAWFORD CR, 1990, J BIOL CHEM, V265, P13730; DECKWERTH TL, 1994, DEV BIOL, V165, P63, DOI 10.1006/dbio.1994.1234; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; EDWARDS SN, 1994, J CELL BIOL, V124, P537, DOI 10.1083/jcb.124.4.537; EDWARDS SN, 1991, J NEUROCHEM, V57, P2140, DOI 10.1111/j.1471-4159.1991.tb06434.x; GIBLETT ER, 1972, LANCET, V2, P1067; HENDERSON JF, 1980, PHARMACOL THERAPEUT, V8, P573; HERSHFIELD MS, 1979, J CLIN INVEST, V63, P807, DOI 10.1172/JCI109367; HIRSCHHORN R, 1980, NEW ENGL J MED, V303, P377, DOI 10.1056/NEJM198008143030706; HIRSCHHORN R, 1980, J CLIN INVEST, V65, P768, DOI 10.1172/JCI109725; HURLEY MC, 1988, ADV EXP MED BIOL, V195, P141; JOHNSTON JM, 1979, J IMMUNOL, V123, P97; KAUKEL E, 1972, BIOCHEM BIOPH RES CO, V48, P1516, DOI 10.1016/0006-291X(72)90886-8; KESLER JA, 1993, NEURON, V11, P1123; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; MARTIN DP, 1990, J NEUROSCI, V10, P184; MITCHELL BS, 1978, P NATL ACAD SCI USA, V75, P5011, DOI 10.1073/pnas.75.10.5011; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PISONI RL, 1989, J BIOL CHEM, V264, P4850; PLAGEMANN PGW, 1990, BIOCHIM BIOPHYS ACTA, V1022, P103, DOI 10.1016/0005-2736(90)90405-D; PLAGEMANN PGW, 1985, CANCER RES, V45, P6418; POLMAR SH, 1976, NEW ENGL J MED, V295, P13437; ROHER AE, 1991, BIOCHEM BIOPH RES CO, V174, P572, DOI 10.1016/0006-291X(91)91455-L; SCHACTERLE GR, 1973, ANAL BIOCHEM, V51, P654, DOI 10.1016/0003-2697(73)90523-X; SETO S, 1985, J CLIN INVEST, V75, P377, DOI 10.1172/JCI111710; SNYDER FF, 1976, J CLIN INVEST, V58, P654, DOI 10.1172/JCI108512; SOLTER AW, 1969, BIOCHIM BIOPHYS ACTA, V174, P585, DOI 10.1016/0005-2787(69)90288-3; TATTERSALL MHN, 1975, BIOCHEM PHARMACOL, V24, P1495, DOI 10.1016/0006-2952(75)90025-8; TOMKINS CE, 1994, J CELL SCI, V107, P1499; ULLMAN B, 1976, CELL, V9, P205, DOI 10.1016/0092-8674(76)90111-2; ULLMAN B, 1978, CELL, V14, P365, DOI 10.1016/0092-8674(78)90122-8; WAKADE AR, 1990, J NEUROCHEM, V54, P1281, DOI 10.1111/j.1471-4159.1990.tb01960.x; WAKADE AR, 1983, EXP CELL RES, V144, P377, DOI 10.1016/0014-4827(83)90417-2; WAKADE AR, 1988, J NEUROCHEM, V57, P975; YU AL, 1981, CANCER RES, V41, P2677	42	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17986	17992		10.1074/jbc.270.30.17986	http://dx.doi.org/10.1074/jbc.270.30.17986			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629106	hybrid			2022-12-27	WOS:A1995RM26600056
J	YAMAUCHI, K; RIBON, V; SALTIEL, AR; PESSIN, JE				YAMAUCHI, K; RIBON, V; SALTIEL, AR; PESSIN, JE			IDENTIFICATION OF THE MAJOR SHPTP2-BINDING PROTEIN THAT IS TYROSINE-PHOSPHORYLATED IN RESPONSE TO INSULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SH2-CONTAINING PHOSPHOTYROSINE PHOSPHATASE; CELL ANTIGEN RECEPTOR; SIGNAL TRANSDUCTION; SH2 DOMAINS; DROSOPHILA; KINASE; TORSO; ACTIVATION; CORKSCREW; HOMOLOG	Immunoprecipitation of the cytosolic Src homology 2 domain-containing protein-tyrosine phosphatase, SHPTP2, from insulin-stimulated 3T3L1 adipocytes or Chinese hamster ovary cells expressing the human insulin receptor resulted in the coimmunoprecipitation of a diffuse tyrosine-phosphorylated band in the 115-kDa protein region on SDS-polyacrylamide gels. Although platelet-derived growth factor induced the tyrosine phosphorylation of the platelet-derived growth factor receptor and SHPTP2, there was no significant increase in the coimmunoprecipitation of tyrosine-phosphorylated pp115 with SHPTP2. SHPTP2 was also associated with tyrosine-phosphorylated insulin receptor substrate-1, but this only accounted for <2% of the total immunoreactive SHPTP2 protein. Similarly, only a small fraction of the total amount of tyrosine-phosphorylated insulin receptor substrate-1 (<4%) was associated with SHPTP2. Expression and immunoprecipitation of a Myc epitope-tagged wild-type SHPTP2 (Myc-WT-SHPTP2) and a catalytically inactive point mutant of SHPTP2 (Myc-C/S-SHPTP2) also demonstrated an insulin-dependent association of SHPTP2 with tyrosine-phosphorylated pp115. Furthermore, expression of the catalytically inactive SHPTP2 mutant resulted in a marked enhancement in the amount of coimmunoprecipitated tyrosine-phosphorylated pp115 compared with the expression of wild-type SHPTP2. These data indicate that the insulin-stimulated tyrosine-phosphorylated 115-kDa protein is the predominant in vivo SHPTP2-binding protein and that pp115 may function as a physiological substrate for the SHPTP2 protein-tyrosine phosphatase.	UNIV IOWA,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242; UNIV MICHIGAN,SCH MED,DEPT PHYSIOL,ANN ARBOR,MI 48104; WARNER LAMBERT PARKE DAVIS,PARKE DAVIS PHARMACEUT RES,DEPT SIGNAL TRANSDUCT,ANN ARBOR,MI 48105	University of Iowa; University of Michigan System; University of Michigan; Pfizer			Saltiel, Alan/L-3632-2019	Saltiel, Alan/0000-0002-9726-9828	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033823, P30DK025295, R37DK033823] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK33823, DK25295] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADACHI M, 1992, FEBS LETT, V314, P336; AHMAD S, 1993, P NATL ACAD SCI USA, V90, P2197, DOI 10.1073/pnas.90.6.2197; AMBROSIO L, 1989, NATURE, V342, P288, DOI 10.1038/342288a0; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; BIFFEN M, 1994, EMBO J, V13, P1920, DOI 10.1002/j.1460-2075.1994.tb06461.x; CASANOVA J, 1989, GENE DEV, V3, P2025, DOI 10.1101/gad.3.12b.2025; DECHERT U, 1994, J BIOL CHEM, V269, P5602; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; FRATTALI AL, 1991, J BIOL CHEM, V266, P9829; FREEMAN RM, 1992, P NATL ACAD SCI USA, V89, P11239, DOI 10.1073/pnas.89.23.11239; HIRAGA A, 1992, EUR J BIOCHEM, V209, P195, DOI 10.1111/j.1432-1033.1992.tb17277.x; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; KAZLAUSKAS A, 1993, P NATL ACAD SCI USA, V90, P6939, DOI 10.1073/pnas.90.15.6939; Keller Susanne R., 1994, Trends in Cell Biology, V4, P115, DOI 10.1016/0962-8924(94)90065-5; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; KORETZKY GA, 1991, P NATL ACAD SCI USA, V88, P2037, DOI 10.1073/pnas.88.6.2037; KUHNE MR, 1993, J BIOL CHEM, V268, P11479; KUHNE MR, 1994, J BIOL CHEM, V269, P15833; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P13434; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; MILARSKI KL, 1994, J BIOL CHEM, V269, P21239; MYERS MG, 1993, DIABETES, V42, P643, DOI 10.2337/diabetes.42.5.643; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; PRONK GJ, 1993, J BIOL CHEM, V268, P5748; RUBIN CS, 1977, J BIOL CHEM, V252, P3554; SASAOKA T, 1994, J BIOL CHEM, V269, P10734; SAWASDIKOSOL S, 1995, J BIOL CHEM, V270, P2893, DOI 10.1074/jbc.270.7.2893; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; SPRENGER F, 1989, NATURE, V338, P478, DOI 10.1038/338478a0; SUGIMOTO S, 1994, J BIOL CHEM, V269, P13614; SUGIMOTO S, 1993, J BIOL CHEM, V268, P22771; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; WHITE MF, 1994, J BIOL CHEM, V269, P1; XIAO S, 1994, J BIOL CHEM, V269, P21244; YAMAUCHI K, 1994, J BIOL CHEM, V269, P31107; YAMAUCHI K, 1995, P NATL ACAD SCI USA, V92, P664, DOI 10.1073/pnas.92.3.664; YAMAUCHI K, 1994, MOL CELL BIOL, V14, P4427, DOI 10.1128/MCB.14.7.4427; ZHAO ZZ, 1994, J BIOL CHEM, V269, P8780; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	47	49	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17716	17722		10.1074/jbc.270.30.17716	http://dx.doi.org/10.1074/jbc.270.30.17716			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629070	hybrid			2022-12-27	WOS:A1995RM26600016
J	DUGUAY, SJ; JIE, LZ; STEINER, DF				DUGUAY, SJ; JIE, LZ; STEINER, DF			MUTATIONAL ANALYSIS OF THE INSULIN-LIKE GROWTH-FACTOR-I PROHORMONE PROCESSING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS EXOTOXIN-A; MESSENGER-RNAS; MOUSE FURIN; CELLS; PRECURSOR; PC2; ENDOPROTEASE; RECEPTOR; CLEAVAGE; PROOPIOMELANOCORTIN	Insulin-like growth factor I (IGF-I) is a mitogenic peptide that is produced in most tissues and cell lines and plays an important role in embryonic development and postnatal growth. IGF-I is initially synthesized as a prohormone precursor that is converted to mature IGF-I by endoproteolytic removal of the carboxyl-terminal E-domain. Regulation of the conversion of proIGF-I to mature IGF-I is a potential mechanism by which the biological activity of this growth factor might be modulated. Endoproteolysis of the IGF-I prohormone occurs at the unique pentabasic motif Lys-X-X-Lys-X-X-Arg(71)-X-X-Arg-X-X-Arg. Recently, a family of enzymes which cleave prohormone precursors at sites containing multiple basic residues has been discovered. The goals of this study were 1) to determine which basic residues in the pentabasic proIGF-I processing site were necessary for proper cleavage and 2) to examine the role that subtilisin-related proprotein convertase 1 (SPC1/furin) might play in proIGF-I processing. We have shown that an expression vector coding for an epitope-tagged proIGF-I directs synthesis and secretion of mature IGF-I-(1-70), extended IGF-I-(1-76), proIGF-I, and N-glycosylated proIGF-I in human embryonic kidney 293 cells. Extended IGF-I-(1-76) is produced by cleavage at Arg(77) and requires both Arg(74) (P4) and Arg(77) (P1). Cleavage at Arg(77) does not occur in the SPC1-dedcient cell lines RPE.40 and LoVo, suggesting that processing at this site is mediated by SPC1. Mature IGF-I-(1-70) is produced by cleavage at Arg(71) and requires both Lys(68) (P4) and Arg(71) (P1). Lys(65) in the P7 position is important for efficient cleavage. SPC1 is not required for processing at Arg(71) since this cleavage occurs in RPE.40 and LoVo cells. These data suggest the existence of a processing enzyme which is specific for the Lys-X-X-Arg motif of proIGF-I.	UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,CHICAGO,IL 60637	University of Chicago	DUGUAY, SJ (corresponding author), UNIV CHICAGO,HOWARD HUGHES MED INST,5841 S MARYLAND AVE,MC 1028,CHICAGO,IL 60637, USA.				NIDDK NIH HHS [DK13914] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013914, R37DK013914] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel FM, 1988, MOL REPROD DEV; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; CREEMERS JWM, 1993, FEBS LETT, V336, P65, DOI 10.1016/0014-5793(93)81610-C; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; DAVIDSON HW, 1988, NATURE, V333, P93, DOI 10.1038/333093a0; GOTOH B, 1992, J VIROL, V66, P6391, DOI 10.1128/JVI.66.11.6391-6397.1992; HALBAN PA, 1994, BIOCHEM J, V299, P1; HATSUZAWA K, 1992, J BIOL CHEM, V267, P16094; Higuchi R., 1990, PCR PROTOCOLS GUIDE; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; MOEHRING JM, 1983, INFECT IMMUN, V41, P998, DOI 10.1128/IAI.41.3.998-1009.1983; MOEHRING JM, 1993, J BIOL CHEM, V268, P2590; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; MONDINO A, 1991, MOL CELL BIOL, V11, P6084, DOI 10.1128/MCB.11.12.6084; OHUCHI R, 1991, J VIROL, V65, P3530, DOI 10.1128/JVI.65.7.3530-3537.1991; PIEROTTI AR, 1994, P NATL ACAD SCI USA, V91, P6078, DOI 10.1073/pnas.91.13.6078; REHEMTULLA A, 1993, BIOCHEMISTRY-US, V32, P11586, DOI 10.1021/bi00094a015; ROBERTSON BJ, 1993, J BIOL CHEM, V268, P24274; ROTWEIN P, 1986, P NATL ACAD SCI USA, V83, P77, DOI 10.1073/pnas.83.1.77; ROUILLE Y, 1994, P NATL ACAD SCI USA, V91, P3242, DOI 10.1073/pnas.91.8.3242; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SIMMONS JG, 1993, GROWTH FACTORS, V9, P205, DOI 10.3109/08977199309010833; SMEEKENS SP, 1992, P NATL ACAD SCI USA, V89, P8822, DOI 10.1073/pnas.89.18.8822; STEINER DF, 1992, J BIOL CHEM, V267, P23435; STEINER DF, 1990, HDB EXPT PHARM, V92, P67; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; THOMAS L, 1991, P NATL ACAD SCI USA, V88, P5297, DOI 10.1073/pnas.88.12.5297; WALKER JA, 1994, J VIROL, V68, P1213, DOI 10.1128/JVI.68.2.1213-1218.1994; YANG YWH, 1985, J BIOL CHEM, V260, P2570; ZHOU A, 1993, J BIOL CHEM, V268, P1763	32	55	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17566	17574		10.1074/jbc.270.29.17566	http://dx.doi.org/10.1074/jbc.270.29.17566			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615562	hybrid			2022-12-27	WOS:A1995RK68900079
J	MAYER, B; SCHRAMMEL, A; KLATT, P; KOESLING, D; SCHMIDT, K				MAYER, B; SCHRAMMEL, A; KLATT, P; KOESLING, D; SCHMIDT, K			PEROXYNITRITE-INDUCED ACCUMULATION OF CYCLIC-GMP IN ENDOTHELIAL-CELLS AND STIMULATION OF PURIFIED SOLUBLE GUANYLYL CYCLASE - DEPENDENCE ON GLUTATHIONE AND POSSIBLE ROLE OF S-NITROSATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHESIS; RELAXING FACTOR; BOVINE LUNG; SUPEROXIDE; NO; OXIDATION; INVITRO; ACTIVATION; RELEASE; MEDIA	Peroxynitrite (ONOO-) is widely recognized as mediator of NO toxicity, but recent studies have indicated that this compound may also have physiological activity and induce vascular relaxation as well as inhibition of platelet aggregation. We found that ONOO- induced a pronounced increase in endothelial cyclic GMP levels, and that this effect was significantly attenuated by pretreatment of the cells with GSH depleting agents. In the presence of 2 mM GSH, ONOO- stimulated purified soluble guanylyl cyclase with a half maximally effective concentration of about 20 mu M. In contrast to the NO donor 2,2-Diethyl-1-nitroso-oxyhydrazine sodium salt (DEA/NO), ONOO- was completely inactive in the absence of GSH, indicating that thiol-mediated bioactivation of ONOO- is involved in enzyme stimulation. Studies on the reaction between ONOO- and GSH revealed that about 1% of ONOO- was non-enzymatically converted to S-nitrosoglutathione. The authentic nitrosothiol was found to be stable in solution, but slowly decomposed in the presence of GSH. GSH-induced decomposition of S-nitrosoglutathione was apparently catalyzed by trace metals and was accompanied by a sustained release of NO and a 40-100-fold increase in its potency to stimulate purified soluble guanylyl cyclase. Our data suggest that the biologic activity of ONOO- involves S-nitrosation of cellular thiols resulting in NO-mediated cyclic GMP accumulation.	FREE UNIV BERLIN,INST PHARMAKOL,D-14195 BERLIN,GERMANY	Free University of Berlin	MAYER, B (corresponding author), KARL FRANZENS UNIV GRAZ,INST PHARMAKOL & TOXIKOL,UNIV PL 2,A-8010 GRAZ,AUSTRIA.		Mayer, Bernd/B-9391-2008	Mayer, Bernd/0000-0002-2921-3494				BAYDOUN AR, 1990, BIOCHEM BIOPH RES CO, V173, P940, DOI 10.1016/S0006-291X(05)80876-9; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; CASTRO L, 1994, J BIOL CHEM, V269, P29409; CRAVEN PA, 1978, BIOCHIM BIOPHYS ACTA, V524, P231, DOI 10.1016/0005-2744(78)90121-3; CROW JP, 1994, FREE RADICAL BIO MED, V16, P331, DOI 10.1016/0891-5849(94)90034-5; GARTHWAITE J, 1993, SEMIN NEUROSCI, V5, P171, DOI 10.1016/S1044-5765(05)80050-8; GERZER R, 1981, FEBS LETT, V132, P71, DOI 10.1016/0014-5793(81)80429-2; GHIGO D, 1993, AM J PHYSIOL, V265, pC728, DOI 10.1152/ajpcell.1993.265.3.C728; GORDGE MP, 1995, BRIT J PHARMACOL, V114, P1083, DOI 10.1111/j.1476-5381.1995.tb13317.x; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; HECKER M, 1992, AM J PHYSIOL, V262, pH888, DOI 10.1152/ajpheart.1992.262.3.H888; HENRY Y, 1993, FASEB J, V7, P1124, DOI 10.1096/fasebj.7.12.8397130; HOGG N, 1992, BIOCHEM J, V281, P419, DOI 10.1042/bj2810419; HUGHES MN, 1968, J CHEM SOC A, P450, DOI 10.1039/j19680000450; HUMBERT P, 1990, EUR J BIOCHEM, V190, P273, DOI 10.1111/j.1432-1033.1990.tb15572.x; IGNARRO LJ, 1991, BLOOD VESSELS, V28, P67; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; KHARITONOV VG, 1994, J BIOL CHEM, V269, P5881; KOOY NW, 1994, ARCH BIOCHEM BIOPHYS, V310, P352, DOI 10.1006/abbi.1994.1178; KOWALUK EA, 1990, J PHARMACOL EXP THER, V255, P1256; LIU S, 1994, J PHARMACOL EXP THER, V268, P1114; MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013; MAROZIN N, 1993, AM J PHYSIOL, V265, pL220; MAYER B, 1995, J BIOL CHEM, V270, P655, DOI 10.1074/jbc.270.2.655; MAYER B, 1993, BIOCHEM PHARMACOL, V45, P367, DOI 10.1016/0006-2952(93)90072-5; MAYER B, 1993, SEMIN NEUROSCI, V5, P197, DOI 10.1016/S1044-5765(05)80053-3; MCANINLY J, 1993, J CHEM SOC CHEM COMM, P1758, DOI 10.1039/c39930001758; MEISTER A, 1983, SCIENCE, V220, P472, DOI 10.1126/science.6836290; MEYER DJ, 1994, FEBS LETT, V345, P177, DOI 10.1016/0014-5793(94)00429-3; MILLER DM, 1990, FREE RADICAL BIO MED, V8, P95, DOI 10.1016/0891-5849(90)90148-C; MOHR S, 1994, FEBS LETT, V348, P223, DOI 10.1016/0014-5793(94)00596-6; MONCADA S, 1991, PHARMACOL REV, V43, P109; MORO MA, 1994, P NATL ACAD SCI USA, V91, P6702, DOI 10.1073/pnas.91.14.6702; MURPHY ME, 1991, J BIOL CHEM, V266, P19378; NGUYEN T, 1992, P NATL ACAD SCI USA, V89, P3030, DOI 10.1073/pnas.89.7.3030; NIROOMAND F, 1991, BIOCHEM PHARMACOL, V41, P1777, DOI 10.1016/0006-2952(91)90185-8; PAPEE HM, 1964, NATURE, V204, P142, DOI 10.1038/204142a0; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; RADI R, 1991, J BIOL CHEM, V266, P4244; RADOMSKI MW, 1992, BRIT J PHARMACOL, V107, P745, DOI 10.1111/j.1476-5381.1992.tb14517.x; RUBBO H, 1994, J BIOL CHEM, V269, P26066; SCHARFSTEIN JS, 1994, J CLIN INVEST, V94, P1432, DOI 10.1172/JCI117480; SCHMIDT K, 1994, BIOCHEM J, V301, P645, DOI 10.1042/bj3010645; SCHMIDT K, 1989, EUR J PHARMACOL, V170, P157, DOI 10.1016/0014-2999(89)90536-0; SCHULTZ G, 1984, METHOD ENZYMAT AN, V4, P379; SPARROW CP, 1993, J LIPID RES, V34, P1219; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; STONE JR, 1994, BIOCHEMISTRY-US, V83, P5636; TRAYLOR TG, 1992, BIOCHEMISTRY-US, V31, P2847, DOI 10.1021/bi00126a001; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; WINK DA, 1993, CHEM RES TOXICOL, V6, P23, DOI 10.1021/tx00031a003; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; WINK DA, 1994, CHEM RES TOXICOL, V7, P519, DOI 10.1021/tx00040a007; WU MD, 1994, AM J PHYSIOL, V266, pH2108, DOI 10.1152/ajpheart.1994.266.5.H2108; YU AE, 1994, J AM CHEM SOC, V116, P4117, DOI 10.1021/ja00088a073	58	184	184	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17355	17360		10.1074/jbc.270.29.17355	http://dx.doi.org/10.1074/jbc.270.29.17355			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615539	hybrid			2022-12-27	WOS:A1995RK68900050
J	NAKAMURA, J; TAJIMA, G				NAKAMURA, J; TAJIMA, G			NEGATIVE OR POSITIVE COOPERATION IN CALCIUM-BINDING TO DETERGENT-SOLUBILIZED ATPASE OF THE SARCOPLASMIC-RETICULUM - ITS MODULATION BY A HIGH-CONCENTRATION OF ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE-TRIPHOSPHATASE; PUMP PROTEIN; CA-2+-ATPASE; CA2+-ATPASE; KINETICS; SITE; TRANSPORT; MEMBRANES; MUSCLE; STATE	Two different conformations of chemically equivalent Ca2+-ATPase molecules in the sarcoplasmic reticulum have been shown to non- and positive cooperatively bind two calcium ions, respectively (Nakamura, J. (1994) J. Biol. Chem. 269, 30822-30827). At pH 7.40, these ATPase molecules split into E(1) (high affinity state for calcium) and E(2) (low affinity state for calcium), respectively, before calcium binding. At this pH, calcium binding to the monomeric ATPase, solubilized with dodecyloctaethylenglycol monoether, was studied by examining Ca-45(2+) binding to the ATPase and calcium dependences of its phosphorylation, fluorescence intensity, ATP-hydrolysis at a low (5 mu M) concentration of ATP, and acetyl phosphate hydrolysis. The results suggest that the solubilized ATPase molecules predominantly preexist in E(2) and negative cooperatively (the Hill value (n(H)) = 0.5-0.6) bind 2 mol of calcium/mol of the ATPase with an apparent calcium affinity (K-0.5) of 3-5 mu M. The nonequivalences of calcium bindings at the membranous ATPase molecules seem to result from the intermolecular interaction of the molecules. A high concentration (5 mm) of ATP modulated the binding manner so that it became positively cooperative (n(H) similar to 2) and increased the K-0.5 to 0.1 mu M.			NAKAMURA, J (corresponding author), TOHOKU UNIV, FAC SCI, INST BIOL, AOBA KU, SENDAI, MIYAGI 98077, JAPAN.							ALBERS RW, 1968, MOL PHARMACOL, V4, P324; ANDERSEN JP, 1982, J BIOL CHEM, V257, P8300; ANDERSEN JP, 1981, BIOCHEMISTRY-US, V20, P4928, DOI 10.1021/bi00520a019; ANDERSEN JP, 1986, BIOCHEMISTRY-US, V25, P6439, DOI 10.1021/bi00369a015; ANDERSEN JP, 1985, J BIOL CHEM, V260, P371; BONTING SL, 1961, ARCH BIOCHEM BIOPHYS, V95, P416, DOI 10.1016/0003-9861(61)90170-9; De Meis L., 1982, MEMBRANE TRANSPORT C, P141; DEMEIS L, 1969, BIOCHIM BIOPHYS ACTA, V172, P343; DUPONT Y, 1985, J BIOL CHEM, V260, P7241; DUPONT Y, 1977, EUR J BIOCHEM, V72, P185, DOI 10.1111/j.1432-1033.1977.tb11238.x; GORNALL AG, 1949, J BIOL CHEM, V177, P751; HARAFUJI H, 1980, J BIOCHEM, V87, P1305, DOI 10.1093/oxfordjournals.jbchem.a132868; HEEGAARD CW, 1990, J BIOL CHEM, V265, P12020; IKEMOTO N, 1982, ANNU REV PHYSIOL, V44, P297, DOI 10.1146/annurev.ph.44.030182.001501; LEMAIRE M, 1978, J BIOL CHEM, V253, P7051; LEMAIRE M, 1976, BIOCHEMISTRY-US, V15, P2336, DOI 10.1021/bi00656a014; LIPMANN F, 1945, J BIOL CHEM, V159, P21; MACINTOSH DB, 1988, J BIOL CHEM, V263, P12220; MAURER A, 1979, J BIOL CHEM, V254, P9209; MCINTOSH DB, 1983, BIOCHEMISTRY-US, V22, P2867, DOI 10.1021/bi00281a015; MEISSNER G, 1973, BIOCHIM BIOPHYS ACTA, V298, P906, DOI 10.1016/0005-2736(73)90395-7; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; MOLLER JV, 1988, METHOD ENZYMOL, V157, P261; MURPHY AJ, 1982, J BIOL CHEM, V257, P3551; NAKAMURA J, 1994, J BIOL CHEM, V269, P30818; NAKAMURA J, 1983, BIOCHIM BIOPHYS ACTA, V723, P182, DOI 10.1016/0005-2728(83)90118-4; NAKAMURA J, 1994, J BIOL CHEM, V269, P30822; NAKAMURA J, 1977, BIOCHIM BIOPHYS ACTA, V18, P108; PUCELL A, 1971, J BIOL CHEM, V246, P3389; SCOFANO HM, 1979, J BIOL CHEM, V254, P227; SILVA JL, 1983, BIOCHEMISTRY-US, V22, P707, DOI 10.1021/bi00272a028; SUZUKI H, 1990, BIOCHEMISTRY-US, V29, P7040, DOI 10.1021/bi00482a013; TADA M, 1978, PHYSIOL REV, V56, P1; TAYLOR JS, 1979, J BIOL CHEM, V254, P4402; TAYLOR KA, 1986, J MOL BIOL, V187, P417, DOI 10.1016/0022-2836(86)90442-0; TOYOSHIMA C, 1993, NATURE, V362, P469, DOI 10.1038/362469a0; VANDERKOOI JM, 1977, BIOCHEMISTRY-US, V16, P1262, DOI 10.1021/bi00626a003; VERJOVSKIALMEIDA S, 1981, J BIOL CHEM, V256, P2940	38	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17350	17354		10.1074/jbc.270.29.17350	http://dx.doi.org/10.1074/jbc.270.29.17350			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615538	hybrid			2022-12-27	WOS:A1995RK68900049
J	SPANJAARD, RA; SUGAWARA, A; IKEDA, M; CHIN, WW				SPANJAARD, RA; SUGAWARA, A; IKEDA, M; CHIN, WW			EVIDENCE THAT RETINOID-X RECEPTORS MEDIATE RETINOID-DEPENDENT TRANSCRIPTIONAL ACTIVATION OF THE RETINOIC ACID RECEPTOR-BETA GENE IN S91 MELANOMA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE; NUCLEAR RECEPTORS; RESPONSE ELEMENTS; DIFFERENTIAL PATTERN; AUXILIARY PROTEIN; BINDING-PROTEINS; DIRECT REPEATS; RXR-ALPHA; TRANSACTIVATION; EXPRESSION	S91 melanoma cells are growth arrested and differentiate when treated with retinoids. These processes correlate with expression of the retinoic acid receptor (RAR)beta gene, which is induced through a retinoic acid response element (beta RARE). We wished to determine which endogenous retinoid receptors (RARs and retinoid X receptors, RXRs) mediate induction of the RAR beta gene. We show that RXR alpha and RXR beta are constitutively expressed. Electrophoretic mobility shift assays with nuclear extracts show specific binding to the beta RARE (Complex I) in untreated cells, which can be supershifted by antibodies against RXRs but not by anti-RAR antibodies. After 48 h of treatment with retinoic acid, Complex I is replaced by a faster migrating Complex II, which can be supershifted by anti-RAR beta and anti-RXR alpha antibodies. This suggests that induction of the RAR beta gene is largely mediated by RXRs only. Accordingly, we also find that 9-cis RA, which activates both RAR and RXR, is a more potent inducer of the RAR beta gene than RA, which only activates RAR. After 48 h, all RXRs appear to be titrated by the newly synthesized RAR beta into an RAR beta . RXR heterodimer complex. Thus, it appears that the beta RARE is sequentially occupied by RXR dimers and RAR . RXR heterodimers.	HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Harvard Medical School	SPANJAARD, RA (corresponding author), BRIGHAM & WOMENS HOSP,HOWARD HUGHES MED INST,DEPT MED,DIV GENET,20 SHATTUCK ST,BOSTON,MA 02115, USA.			Sugawara, Akira/0000-0003-4511-8101				AMOS B, 1990, METHOD ENZYMOL, V189, P100; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BERKENSTAM A, 1992, CELL, V69, P401, DOI 10.1016/0092-8674(92)90443-G; BOYLAN JF, 1993, P NATL ACAD SCI USA, V9, P9601; BUGGE TH, 1992, EMBO J, V11, P1409, DOI 10.1002/j.1460-2075.1992.tb05186.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLIFFORD JL, 1990, MOL ENDOCRINOL, V4, P1546, DOI 10.1210/mend-4-10-1546; DE LUCA LM, 1991, FASEB J, V5, P2924; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DOLLE P, 1990, DEVELOPMENT, V110, P1133; DURAND B, 1992, CELL, V71, P73, DOI 10.1016/0092-8674(92)90267-G; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FISHER GJ, 1994, J BIOL CHEM, V269, P20629; GLASS CK, 1991, DNA CELL BIOL, V10, P623, DOI 10.1089/dna.1991.10.623; GOLDSTEIN AM, 1993, CURR OPIN ONCOL, V3, P358; GUDAS LJ, 1992, CELL GROWTH DIFFER, V3, P655; HALL BL, 1993, P NATL ACAD SCI USA, V90, P6929, DOI 10.1073/pnas.90.15.6929; HEERY DM, 1993, P NATL ACAD SCI USA, V90, P4281, DOI 10.1073/pnas.90.9.4281; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; HOFFMANN B, 1990, MOL ENDOCRINOL, V4, P1727, DOI 10.1210/mend-4-11-1727; IKEDA M, 1995, ENDOCRINOLOGY, V135, P1628; IMPERIALE MJ, 1984, MOL CELL BIOL, V4, P867, DOI 10.1128/MCB.4.5.867; KASTNER P, 1990, P NATL ACAD SCI USA, V87, P2700, DOI 10.1073/pnas.87.7.2700; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; LATHANGUE NB, 1987, CELL, V49, P507, DOI 10.1016/0092-8674(87)90453-3; LEHMANN JM, 1992, SCIENCE, V258, P1944, DOI 10.1126/science.1335166; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; LOTAN R, 1978, J NATL CANCER I, V60, P1035, DOI 10.1093/jnci/60.5.1035; LOTAN R, 1981, J CELL PHYSIOL, V106, P179, DOI 10.1002/jcp.1041060203; MADER S, 1993, EMBO J, V12, P5029, DOI 10.1002/j.1460-2075.1993.tb06196.x; MADER S, 1993, J BIOL CHEM, V268, P591; MANGELSDORF DJ, 1991, CELL, V66, P555, DOI 10.1016/0092-8674(81)90018-0; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; MARKS MS, 1992, EMBO J, V11, P1419, DOI 10.1002/j.1460-2075.1992.tb05187.x; MINUCCI S, 1994, MOL CELL BIOL, V14, P360, DOI 10.1128/MCB.14.1.360; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; PRATT MAC, 1990, MOL CELL BIOL, V10, P6445, DOI 10.1128/MCB.10.12.6445; REDFERN CPF, 1990, FEBS LETT, V273, P19, DOI 10.1016/0014-5793(90)81041-L; RUBERTE E, 1990, DEVELOPMENT, V108, P213; RUBERTE E, 1991, DEVELOPMENT, V111, P45; Sambrook J, 1989, MOL CLONING LABORATO; SCHRADER M, 1993, NUCLEIC ACIDS RES, V21, P1231, DOI 10.1093/nar/21.5.1231; STUNNENBERG HG, 1993, BIOESSAYS, V15, P309, DOI 10.1002/bies.950150504; SUCOV HM, 1990, P NATL ACAD SCI USA, V87, P5392, DOI 10.1073/pnas.87.14.5392; SUGAWARA A, 1995, ENDOCRINOLOGY, V136, P1766, DOI 10.1210/en.136.4.1766; TABIN CJ, 1991, CELL, V66, P199, DOI 10.1016/0092-8674(91)90612-3; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; YEN PM, 1992, J BIOL CHEM, V267, P3565; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0	55	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17429	17436		10.1074/jbc.270.29.17429	http://dx.doi.org/10.1074/jbc.270.29.17429			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615548	hybrid			2022-12-27	WOS:A1995RK68900061
J	SNIJDER, EJ; WASSENAAR, ALM; SPAAN, WJM; GORBALENYA, AE				SNIJDER, EJ; WASSENAAR, ALM; SPAAN, WJM; GORBALENYA, AE			THE ARTERIVIRUS NSP2 PROTEASE - AN UNUSUAL CYSTEINE PROTEASE WITH PRIMARY STRUCTURE SIMILARITIES TO BOTH PAPAIN-LIKE AND CHYMOTRYPSIN-LIKE PROTEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EQUINE ARTERITIS VIRUS; STRAND RNA VIRUSES; SERINE PROTEASES; SEQUENCE; PROTEINASE; SITE; FLAVIVIRUSES; PESTIVIRUSES; SUPERFAMILY; TRANSLATION	The replicase ORF1a polyprotein of equine arteritis virus, a positive stranded RNA virus, is proteolytically processed into (at least) six nonstructural proteins (Nsp). A papain-like Cys protease in Nsp1 and a chymotrypsin-like Ser protease in Nsp4 are involved in this process. In this paper we demonstrate that the Nsp2/3 junction is not cleaved by either of these previously described proteases. Comparative sequence analysis suggested that an additional Cys protease resided in the N-terminal Nsp2 domain. For equine arteritis virus, this domain was shown to induce Nsp2/3 cleavage in a trans-cleavage assay. Processing was abolished when the putative active site residues, Cys-270 and His-332, were replaced. Other Nsp2 domains and three other conserved Cys residues were also shown to be essential. The Nsp2 Cys protease displays sequence similarity with viral papain-like proteases. However, the presumed catalytic Cys-270 is followed by a conserved Gly rather than the characteristic Trp. Replacement of Gly-271 by Trp abolished the Nsp2/3 cleavage. Conservation of a Cys-Gly dipeptide is a hallmark of viral chymotrypsin-like Cys proteases. Thus, the arterivirus Nsp2 protease is an unusual Cys protease with amino acid sequence similarities to both papain-like and chymotrypsin-like proteases.	RUSSIAN ACAD MED SCI,INST POLIOMYELITIS & VIRAL ENCEPHALITIS,MOSCOW 142782,RUSSIA; PURDUE UNIV,DEPT BIOL SCI,W LAFAYETTE,IN 47907	Russian Academy of Medical Sciences; Purdue University System; Purdue University; Purdue University West Lafayette Campus	SNIJDER, EJ (corresponding author), LEIDEN UNIV,FAC MED,INST MED MICROBIOL,DEPT VIROL,POSTBUS 320,2300 AH LEIDEN,NETHERLANDS.		Gorbalenya, Alexander E/J-4818-2012; Snijder, Eric J./E-6073-2018	Gorbalenya, Alexander E/0000-0002-4967-7341; Snijder, Eric J./0000-0003-3297-2309				ALLAIRE M, 1994, NATURE, V369, P72, DOI 10.1038/369072a0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BAZAN JF, 1989, VIROLOGY, V171, P637, DOI 10.1016/0042-6822(89)90639-9; BAZAN JF, 1988, P NATL ACAD SCI USA, V85, P7872, DOI 10.1073/pnas.85.21.7872; BONIOTTI B, 1994, J VIROL, V68, P6487, DOI 10.1128/JVI.68.10.6487-6495.1994; BRENNER S, 1988, NATURE, V334, P528, DOI 10.1038/334528a0; CHOI HK, 1991, NATURE, V354, P37, DOI 10.1038/354037a0; Dayhoff M, 1978, ATLAS PROTEIN SEQ ST, P345; DENBOON JA, 1991, J VIROL, V65, P2910, DOI 10.1128/JVI.65.6.2910-2920.1991; DENBOON JA, 1995, IN PRESS J VIROL, V69; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOUGHERTY WG, 1993, MICROBIOL REV, V57, P781, DOI 10.1128/MMBR.57.4.781-822.1993; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GARAVITO RM, 1977, BIOCHEMISTRY-US, V16, P5065, DOI 10.1021/bi00642a019; GODENY EK, 1993, VIROLOGY, V194, P585, DOI 10.1006/viro.1993.1298; Gorbalenya A.E., 1993, SOV SCI REV D, V11, P1; GORBALENYA AE, 1989, J MOL EVOL, V28, P256, DOI 10.1007/BF02102483; GORBALENYA AE, 1991, FEBS LETT, V288, P201, DOI 10.1016/0014-5793(91)81034-6; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P3889, DOI 10.1093/nar/17.10.3889; GORBALENYA AE, 1989, FEBS LETT, V243, P103, DOI 10.1016/0014-5793(89)80109-7; GORBALENYA AE, 1986, FEBS LETT, V194, P253, DOI 10.1016/0014-5793(86)80095-3; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; KAMINSKI A, 1990, EMBO J, V9, P3753, DOI 10.1002/j.1460-2075.1990.tb07588.x; KRAUSSLICH HG, 1988, ANNU REV BIOCHEM, V57, P701, DOI 10.1146/annurev.bi.57.070188.003413; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEONTOVICH AM, 1993, BIOSYSTEMS, V30, P57, DOI 10.1016/0303-2647(93)90062-H; LIN C, 1993, J VIROL, V67, P2327, DOI 10.1128/JVI.67.4.2327-2335.1993; MATTHEWS DA, 1994, CELL, V77, P761, DOI 10.1016/0092-8674(94)90059-0; MEULENBERG JJM, 1993, VIROLOGY, V192, P62, DOI 10.1006/viro.1993.1008; PLAGEMANN PGW, 1991, ADV VIRUS RES, V41, P99; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; SNIJDER EJ, 1992, J VIROL, V66, P7040, DOI 10.1128/JVI.66.12.7040-7048.1992; SNIJDER EJ, 1994, J VIROL, V68, P5755, DOI 10.1128/JVI.68.9.5755-5764.1994; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Strauss JH, 1990, SEMIN VIROL, V1, P347; STRAUSS JH, 1990, SEMIN VIROL, V1, P307; STURROCK SS, 1993, MPSRCH VERSION 1 3; THOMPSON JD, 1994, COMPUT APPL BIOSCI, V10, P19; YU SYF, 1992, VIROLOGY, V186, P725, DOI 10.1016/0042-6822(92)90039-R	42	119	133	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16671	16676		10.1074/jbc.270.28.16671	http://dx.doi.org/10.1074/jbc.270.28.16671			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622476	hybrid			2022-12-27	WOS:A1995RJ34700035
J	BARRETT, JF; LEWIS, BC; HOANG, AT; ALVAREZ, RJ; DANG, CV				BARRETT, JF; LEWIS, BC; HOANG, AT; ALVAREZ, RJ; DANG, CV			CYCLIN-A LINKS C-MYC TO ADHESION-INDEPENDENT CELL-PROLIFERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							DNA-REPLICATION; TRANSFORMATION; PROGRESSION; FIBROBLASTS; EXPRESSION; ONCOGENES	Adhesion-independent growth is a neoplastic phenotype that is inducible in Rat 1a fibroblasts by enforced MYC expression. The c-Myc protein has been well characterized as a transcription factor, yet the molecular basis of c-Myc-induced neoplastic transformation has remained elusive, In this report, we demonstrate a link between ectopic MYC expression, deregulated cyclin A levels, and adhesion-independent growth.	JOHNS HOPKINS UNIV, SCH MED, JOHNS HOPKINS ONCOL CTR, BALTIMORE, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	BARRETT, JF (corresponding author), JOHNS HOPKINS UNIV, SCH MED,DEPT MED,DIV HEMATOL,ROSS RES BLDG, RM 1025, 720 RUTLAND AVE, BALTIMORE, MD 21205 USA.		Dang, Chi/Y-3375-2019	Dang, Chi/0000-0002-4031-2522	NCI NIH HHS [CA57341] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057341] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMATI B, 1993, EMBO J, V12, P5083, DOI 10.1002/j.1460-2075.1993.tb06202.x; Blackwood EM, 1992, CURR OPIN GENET DEV, V2, P227, DOI 10.1016/S0959-437X(05)80278-3; DAKSIS JI, 1994, ONCOGENE, V9, P3635; DEPINHO RA, 1991, ADV CANCER RES, V57, P1; DURSO G, 1990, SCIENCE, V250, P786, DOI 10.1126/science.2173140; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GUADAGNO TM, 1993, SCIENCE, V262, P1572, DOI 10.1126/science.8248807; HANSON KD, 1994, MOL CELL BIOL, V14, P5748, DOI 10.1128/MCB.14.9.5748; HOANG AT, 1994, P NATL ACAD SCI USA, V91, P6875, DOI 10.1073/pnas.91.15.6875; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; JANSENDURR P, 1993, P NATL ACAD SCI USA, V90, P3685, DOI 10.1073/pnas.90.8.3685; KATO GJ, 1992, FASEB J, V6, P3065, DOI 10.1096/fasebj.6.12.1521738; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; SMALL MB, 1987, MOL CELL BIOL, V7, P1638, DOI 10.1128/MCB.7.5.1638; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697	17	48	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15923	15925		10.1074/jbc.270.27.15923	http://dx.doi.org/10.1074/jbc.270.27.15923			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608142	hybrid			2022-12-27	WOS:A1995RH22600003
J	BRANDA, SS; ISAYA, G				BRANDA, SS; ISAYA, G			PREDICTION AND IDENTIFICATION OF NEW NATURAL SUBSTRATES OF THE YEAST MITOCHONDRIAL INTERMEDIATE PEPTIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEHYDROGENASE FLAVOPROTEIN SUBUNIT; SACCHAROMYCES-CEREVISIAE GENE; CYTOCHROME-C-OXIDASE; IRON-SULFUR PROTEIN; NUCLEAR GENE; ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; MALATE-DEHYDROGENASE; RIBOSOMAL-PROTEIN	Most mitochondrial precursor proteins are processed to the mature form in one step by mitochondrial processing peptidase (MPP), while a subset of precursors destined for the matrix or the inner membrane are cleaved sequentially by MPP and mitochondrial intermediate peptidase (MIP), We showed previously that yeast MIP (YMIP) is required for mitochondrial function in Saccharomyces cerevisiae. To further define the role played by two-step processing in mitochondrial biogenesis, we have now characterized the natural substrates of YMIP, A total of 133 known yeast mitochondrial precursors were collected from the literature and analyzed for the presence of the motif RX(down arrow)(F/L/I)XX(T/S/G)XXXX(down arrow), typical of precursors cleaved by MPP and MIP. We found characteristic MIP cleavage sites in two distinct sets of proteins: respiratory components, including subunits of the electron transport chain and tricarboxylic acid cycle enzymes, and components of the mitochondrial genetic machinery, including ribosomal proteins, translation factors, and proteins required for mitochondrial DNA metabolism. Representative precursors from both sets were cleaved to predominantly mature form by mitochondrial matrix or intact mitochondria from wild-type yeast. In contrast, intermediate-size forms were accumulated upon incubation of the precursors with matrix from mip1 Delta yeast or intact mitochondria from mip1(ts) yeast, indicating that YMIP is necessary for maturation of these proteins. Consistent with the fact that some of these substrates are essential for the maintenance of mitochondrial protein synthesis and mitochondrial DNA replication, mip1 Delta yeast undergoes loss of functional mitochondrial genomes.	YALE UNIV, SCH MED, DEPT GENET, NEW HAVEN, CT 06510 USA	Yale University				Branda, Steven/0000-0001-8763-1013	NIGMS NIH HHS [GM48076] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048076] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM PR, 1994, MOL GEN GENET, V242, P708, DOI 10.1007/BF00283426; ASHBY MN, 1992, J BIOL CHEM, V267, P4128; BAKER KP, 1991, NATURE, V349, P205, DOI 10.1038/349205a0; BARRETT AJ, 1995, METHOD ENZYMOL, V248, P529; BECKMANN JD, 1989, J BIOL CHEM, V264, P3716; BOUSQUET I, 1991, EMBO J, V10, P2023, DOI 10.1002/j.1460-2075.1991.tb07732.x; BRANDT U, 1993, J BIOL CHEM, V268, P8387; BROWNING KS, 1988, P NATL ACAD SCI USA, V85, P1831, DOI 10.1073/pnas.85.6.1831; DANG H, 1990, NUCLEIC ACIDS RES, V18, P6895, DOI 10.1093/nar/18.23.6895; DAUM G, 1982, J BIOL CHEM, V257, P3028; DAVIS ES, 1992, P NATL ACAD SCI USA, V89, P11169, DOI 10.1073/pnas.89.23.11169; DECOSTER E, 1993, J MOL BIOL, V232, P79, DOI 10.1006/jmbi.1993.1371; DOWHAN W, 1985, EMBO J, V4, P179, DOI 10.1002/j.1460-2075.1985.tb02334.x; GANGLOFF SP, 1990, MOL CELL BIOL, V10, P3551, DOI 10.1128/MCB.10.7.3551; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GRAHAM LA, 1993, J BIOENERG BIOMEMBR, V25, P245, DOI 10.1007/BF00762586; HAFTER P, 1990, GENETICS, V125, P495; HARRER R, 1993, CURR GENET, V24, P136, DOI 10.1007/BF00324677; HARTL FU, 1986, CELL, V47, P939, DOI 10.1016/0092-8674(86)90809-3; HASELBECK RJ, 1991, J BIOL CHEM, V266, P2339; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; HURT EC, 1985, EMBO J, V4, P2061, DOI 10.1002/j.1460-2075.1985.tb03892.x; ISAYA G, 1991, J CELL BIOL, V113, P65, DOI 10.1083/jcb.113.1.65; ISAYA G, 1994, MOL CELL BIOL, V14, P5603, DOI 10.1128/MCB.14.8.5603; ISAYA G, 1995, GENOMICS, V28, P450, DOI 10.1006/geno.1995.1174; ISAYA G, 1992, J BIOL CHEM, V267, P7904; ISAYA G, 1992, P NATL ACAD SCI USA, V89, P8317, DOI 10.1073/pnas.89.17.8317; ISAYA G, 1994, SIGNAL PEPTIDASES, P87; JENSEN RE, 1988, EMBO J, V7, P3863, DOI 10.1002/j.1460-2075.1988.tb03272.x; KALOUSEK F, 1992, EMBO J, V11, P2803, DOI 10.1002/j.1460-2075.1992.tb05347.x; KITAKAWA M, 1990, NUCLEIC ACIDS RES, V18, P1521, DOI 10.1093/nar/18.6.1521; LABBEBOIS R, 1990, J BIOL CHEM, V267, P7278; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; NAGATA S, 1983, P NATL ACAD SCI-BIOL, V80, P6192, DOI 10.1073/pnas.80.20.6192; OHMEN JD, 1990, MOL CELL BIOL, V10, P3027, DOI 10.1128/MCB.10.6.3027; PAPE LK, 1985, J BIOL CHEM, V260, P5362; PEL HJ, 1992, NUCLEIC ACIDS RES, V20, P6339, DOI 10.1093/nar/20.23.6339; ROBINSON KM, 1991, J BIOL CHEM, V266, P21347; ROBINSON KM, 1992, J BIOL CHEM, V267, P10101; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; SANCAR GB, 1985, NUCLEIC ACIDS RES, V13, P8231, DOI 10.1093/nar/13.22.8231; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; STRICK CA, 1987, MOL CELL BIOL, V7, P2728, DOI 10.1128/MCB.7.8.2728; SZTUL ES, 1988, J BIOL CHEM, V263, P12085; SZTUL ES, 1987, J CELL BIOL, V105, P2631, DOI 10.1083/jcb.105.6.2631; THOMPSON LM, 1988, BIOCHEMISTRY-US, V27, P8393, DOI 10.1021/bi00422a015; TROPSCHUG M, 1988, J BIOL CHEM, V263, P14433; UH M, 1990, J BIOL CHEM, V265, P19047; VAMBUTAS A, 1991, EUR J BIOCHEM, V201, P643, DOI 10.1111/j.1432-1033.1991.tb16325.x; VANDYCK E, 1992, EMBO J, V11, P3421, DOI 10.1002/j.1460-2075.1992.tb05421.x; VASSAROTTI A, 1987, J BIOL CHEM, V262, P411; WIESENBERGER G, 1992, J BIOL CHEM, V267, P6963; WITTE C, 1988, EMBO J, V7, P1439, DOI 10.1002/j.1460-2075.1988.tb02961.x; YAFFE MP, 1991, METHOD ENZYMOL, V194, P627	56	86	93	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27366	27373		10.1074/jbc.270.45.27366	http://dx.doi.org/10.1074/jbc.270.45.27366			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7593000	hybrid			2022-12-27	WOS:A1995TE58300100
J	LEE, JW; ZHANG, YX; WEAVER, CD; SHOMER, NH; LOUIS, CF; ROBERTS, DM				LEE, JW; ZHANG, YX; WEAVER, CD; SHOMER, NH; LOUIS, CF; ROBERTS, DM			PHOSPHORYLATION OF NODULIN-26 ON SERINE-262 AFFECTS ITS VOLTAGE-SENSITIVE CHANNEL ACTIVITY IN PLANAR LIPID BILAYERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; INTRINSIC PROTEIN; PERIBACTEROID MEMBRANE; JUNCTION PROTEIN; SOYBEAN NODULES; LENS; SEQUENCE; ACID; MP26; MIP	Nodulin 26 is an symbiosome membrane protein of soybean nodules that shows ion channel activity in planar lipid bilayers, Serine 262 of nodulin 26 is phosphorylated by calmodulin-like domain protein kinase. To study the effects of phosphorylation, nodulin 26 with Ser, Ala, or Asp at position 262 were expressed in Escherichia coli, The expressed protein possessed a histidine-rich leader sequence for purification by Ni(2+)chelate fast protein liquid chromatography, Upon reconstitution into planar lipid bilayers, the recombinant proteins showed a large single channel conductance (3.1 nanosiemens (nS) in cis(0.2 M)/trans(1.0) and 1.6 nS in cis(0.2 M)/trans(0.2 M KCl)) and weak anion selectivity, similar to native soybean nodulin 26. Nodulin 26 with Ser or Ala-262 occupied the maximal open conductance state greater than 97% of the time (3.1 nS in cis(0.2 M)/ trans(1.0 M KCl)) regardless of applied voltage. However, nodulin 26 with Asp-262 showed increased gating and preferential occupancy of lower subconductance states (1.8 and 0.6 nS in cis(0.2 M)/trans (1.0 M KCl)) at high applied voltages (e.g, 70 mV), In situ phosphorylation of Ser-262 of nodulin 26 by calmodulin-like domain protein kinase also resulted in increased voltage-dependent gating and preferential occupancy of lower subconductance states. These results suggest that phosphorylation of serine 262 of nodulin 26 modulates channel activity by conferring voltage sensitivity.	UNIV TENNESSEE,DEPT BIOCHEM,KNOXVILLE,TN 37996; UNIV TENNESSEE,CTR LEGUME RES,KNOXVILLE,TN 37996; UNIV MINNESOTA,DEPT VET PATHOBIOL & BIOCHEM,ST PAUL,MN 55108	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Minnesota System; University of Minnesota Twin Cities			Lee, Jung Weon/AAC-1146-2020; Lee, Jung Weon/F-9149-2012	Lee, Jung Weon/0000-0003-2722-8200; Roberts, Daniel/0000-0002-0780-7056; Shomer, Nirah/0000-0003-2520-0108				BENZANILLA F, 1994, ANNU REV BIOPH BIOM, V23, P819; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chandy Grischa, 1995, Biophysical Journal, V68, pA353; CHRISPEELS MJ, 1994, TRENDS BIOCHEM SCI, V19, P421, DOI 10.1016/0968-0004(94)90091-4; DAY DA, 1993, SYMBIOSIS, V14, P175; EHRING GR, 1990, J GEN PHYSIOL, V96, P631, DOI 10.1085/jgp.96.3.631; EHRING GR, 1991, J MEMBRANE BIOL, V126, P75; FORTIN MG, 1987, NUCLEIC ACIDS RES, V15, P813, DOI 10.1093/nar/15.2.813; HARPER JF, 1991, SCIENCE, V252, P951, DOI 10.1126/science.1852075; HARPER JF, 1994, BIOCHEMISTRY-US, V33, P7267, DOI 10.1021/bi00189a031; HELLER KB, 1980, J BACTERIOL, V144, P274, DOI 10.1128/JB.144.1.274-278.1980; JAN LY, 1994, SCIENCE, V371, P119; JOHNSON KD, 1992, PLANT PHYSIOL, V100, P1787, DOI 10.1104/pp.100.4.1787; JOHNSON KR, 1986, J CELL BIOL, V102, P1334, DOI 10.1083/jcb.102.4.1334; LABARCA P, 1992, METHOD ENZYMOL, V207, P447; LAMPE PD, 1986, EUR J BIOCHEM, V156, P351, DOI 10.1111/j.1432-1033.1986.tb09590.x; LAMPE PD, 1989, J MEMBRANE BIOL, V107, P145, DOI 10.1007/BF01871720; LAMPE PD, 1990, EUR J BIOCHEM, V194, P541, DOI 10.1111/j.1432-1033.1990.tb15650.x; LEVITAN IB, 1994, ANNU REV PHYSIOL, V56, P193, DOI 10.1146/annurev.ph.56.030194.001205; MULDERS SM, 1995, J BIOL CHEM, V270, P9010, DOI 10.1074/jbc.270.15.9010; REIZER J, 1993, CRIT REV BIOCHEM MOL, V28, P235, DOI 10.3109/10409239309086796; Roberts DM, 1993, CURR OPIN CELL BIOL, V5, P242, DOI 10.1016/0955-0674(93)90110-C; Roth L.E., 1988, MOL GENETICS PLANT M, P220; SHEN L, 1991, J MEMBRANE BIOL, V124, P21, DOI 10.1007/BF01871361; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; UDVARDI MK, 1989, PLANT PHYSIOL, V90, P982, DOI 10.1104/pp.90.3.982; VANDONGEN AMJ, 1992, BIOPHYS J, V61, pA256; VERBAVATZ JM, 1994, J CELL SCI, V107, P1083; WEAVER CD, 1991, PLANT PHYSIOL, V95, P222, DOI 10.1104/pp.95.1.222; WEAVER CD, 1994, J BIOL CHEM, V269, P17858; WEAVER CD, 1992, BIOCHEMISTRY-US, V31, P8954, DOI 10.1021/bi00152a035; YANG LJO, 1991, FEBS LETT, V293, P188; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; ZHANG YX, 1995, MOL BIOL CELL, V6, P109, DOI 10.1091/mbc.6.1.109	35	55	55	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27051	27057		10.1074/jbc.270.45.27051	http://dx.doi.org/10.1074/jbc.270.45.27051			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592955	hybrid			2022-12-27	WOS:A1995TE58300055
J	WISHART, MJ; DENU, JM; WILLIAMS, JA; DIXON, JE				WISHART, MJ; DENU, JM; WILLIAMS, JA; DIXON, JE			A SINGLE MUTATION CONVERTS A NOVEL PHOSPHOTYROSINE BINDING DOMAIN INTO A DUAL-SPECIFICITY PHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MAP KINASE; PROTEIN	Dual-specificity protein-tyrosine phosphatases (dsPTPases) have been implicated in the inactivation of mitogen-activated protein kinases (MAPKs), We have identified a novel. phosphoserine/thhreonine/tyrosine-binding protein (STYX) that is related in amino acid sequence to dsPTPases, except for the substitution of Gly for Cys in the conserved dsPTPase catalytic loop (HCXYGXXR(S/T)), cDNA subcloning and Northern blot analysis in mouse shows poly(A(+)) hybridization bands of 4.6, 2.4, 1.5, and 1.2 kilobases, with highest abundance in skeletal muscle, testis, and heart, Polymerase chain reaction amplification of reverse-transcribed poly(A(+)) RNA revealed an alternatively spliced form of STYX containing a unique carboxyl terminus, Bacterially expressed STYX. is incapable of hydrolyzing Tyr(P)-containing substrates; however, mutation of Gly(120) to Cys (G120C), which structurally mimics the active site of dsPTPases, confers phosphatase activity to this molecule, STYX-G120C mutant hydrolyzes p-nitrophenyl phosphate and dephosphorylates both Tyr(P) and Thr(P) residues of peptide sequences of MAPK homologues. The kinetic parameters of dephosphorylation are similar to human dsPTPase, Vaccinia H1-related, including inhibition by vanadate, We believe this is the first example of a naturally occurring ''dominant negative'' phosphotyrosine/serine/threonine-binding protein which is structurally related to dsPTPases.	UNIV MICHIGAN,SCH MED,DEPT BIOL CHEM,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT PHYSIOL,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan				Williams, John/0000-0002-6063-7615	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018849, R01DK041122, R01DK018024, R37DK041122, R37DK018024] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-18849, DK-41122, DK-18024] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALESSI DR, 1993, ONCOGENE, V8, P2015; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; AROCA P, 1995, J BIOL CHEM, V270, P14229, DOI 10.1074/jbc.270.23.14229; DENU JM, 1995, J BIOL CHEM, V270, P3796, DOI 10.1074/jbc.270.8.3796; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; GUAN KL, 1995, J BIOL CHEM, V270, P7197, DOI 10.1074/jbc.270.13.7197; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; ISHIBASHI T, 1995, P NATL ACAD SCI USA, V89, P12170; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; KEYSE SM, 1995, BBA-MOL CELL RES, V1265, P152, DOI 10.1016/0167-4889(94)00211-V; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KWAK SP, 1995, J BIOL CHEM, V270, P1156, DOI 10.1074/jbc.270.3.1156; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; SCHUBERT HL, 1995, IN PRESS PROTEIN SCI; STONE RL, 1994, J BIOL CHEM, V269, P31323; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; ZHOU GC, 1994, J BIOL CHEM, V269, P28084	20	79	316	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26782	26785		10.1074/jbc.270.45.26782	http://dx.doi.org/10.1074/jbc.270.45.26782			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592916	hybrid			2022-12-27	WOS:A1995TE58300016
J	APRELIKOVA, O; XIONG, Y; LIU, ET				APRELIKOVA, O; XIONG, Y; LIU, ET			BOTH P16 AND P21 FAMILIES OF CYCLIN-DEPENDENT KINASE (CDK) INHIBITORS BLOCK THE PHOSPHORYLATION OF CYCLIN-DEPENDENT KINASES BY THE CDK-ACTIVATING KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN-KINASE; CATALYTIC SUBUNIT; P34(CDC2); P40(MO15)	Phosphorylation of cyclin-dependent kinases (CDKs) by the CDK-activating kinase is required for the activation of CDK enzymes, Members of two families of CDK inhibitors, p16/p18 and p21/p27, become physically associated with and inhibit the activity of CDKs in response to a variety of growth-modulating signals, Here, we show that the representative members of both families of CDK inhibitors, p21(waf1,cip1), p27(kip1), and p18, can prevent the phosphorylation of their CDK partners, CDK2 and CDK6, by CDK-activating kinase. No direct interaction between CDK-activating kinase and the CDK inhibitors could be detected, suggesting that binding of these CDK inhibitors to CDK subunits renders CDK inaccessible to the CDK-activating kinase phosphorylation. These findings suggest that a general mechanism of CDK inhibitor function is to block the phosphorylation of CDK enzymes by CDK-activating kinase.	UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT MED,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599; UNIV N CAROLINA,CURRICULUM GENET & MOLEC BIOL,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill			Liu, Edison/C-4141-2008		NCI NIH HHS [P50-CA-58223] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA058223] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; DESAI D, 1992, MOL BIOL CELL, V3, P571, DOI 10.1091/mbc.3.5.571; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FESQUET D, 1993, EMBO J, V12, P3111, DOI 10.1002/j.1460-2075.1993.tb05980.x; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HARPER JW, 1993, CELL, V75, P805; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; KAMB A, 1994, NAT GENET, V8, P22, DOI 10.1038/ng0994-22; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; LEVEDAKOU EN, 1994, ONCOGENE, V9, P1977; LI Y, 1994, ONCOGENE, V9, P2261; MAKELA TP, 1994, NATURE, V371, P254, DOI 10.1038/371254a0; MORI T, 1994, CANCER RES, V54, P3396; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; POON RYC, 1993, EMBO J, V12, P3123, DOI 10.1002/j.1460-2075.1993.tb05981.x; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHUTTLEWORTH J, 1990, EMBO J, V9, P3233, DOI 10.1002/j.1460-2075.1990.tb07522.x; SOLOMON MJ, 1993, EMBO J, V12, P3133, DOI 10.1002/j.1460-2075.1993.tb05982.x; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; SPRUCK CH, 1994, NATURE, V370, P183, DOI 10.1038/370183a0; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750	30	188	190	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18195	18197		10.1074/jbc.270.31.18195	http://dx.doi.org/10.1074/jbc.270.31.18195			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629134	hybrid, Green Published			2022-12-27	WOS:A1995RM64200006
J	PESTELL, RG; ALBANESE, C; WATANABE, G; JOHNSON, J; EKLUND, N; LASTOWIECKI, P; JAMESON, JL				PESTELL, RG; ALBANESE, C; WATANABE, G; JOHNSON, J; EKLUND, N; LASTOWIECKI, P; JAMESON, JL			EPIDERMAL GROWTH-FACTOR AND C-JUN ACT VIA A COMMON DNA REGULATORY ELEMENT TO STIMULATE TRANSCRIPTION OF THE OVINE P-450 CHOLESTEROL SIDE-CHAIN CLEAVAGE (CYP11A1) PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION; MAP KINASES; RESPONSE ELEMENT; BINDING-PROTEIN; GENE PROMOTER; FOS PROTEINS; CYCLIC-AMP; V-JUN; AP-1	The P-450 side chain cleavage (CYP11A1) gene encodes the enzyme that catalyzes the initial step in steroid biosynthesis, resulting in the conversion of cholesterol to pregnenolone. Expression of the CYP11A1 gene is increased by hormones, such as adrenocorticotropin and luteinizing hormone, as well as by a number of growth factors, suggesting that its promoter may con tain regulatory elements that respond to multiple signal transduction pathways, Using transient expression assays of the ovine CYP11A1 promoter in JEG-3 placental cells, distinct regulatory elements were found to mediate transcriptional stimulation by cAMP and epidermal growth factor (EGF). The cAMP response was mediated through a CC-rich sequence localized between -117 and -92. In contrast, EGF induced CYP11A1 transcription through an adjacent but distinct sequence (-92 to -77 base pairs) that was shown previously to bind nuclear proteins in DNase I footprinting reactions, This EGF-responsive element (EGF-RE) resembles an activator protein-1 (AP-1) site and was also required for transactivation by co-transfected c-Jun, A point mutation within the EGF-RE impaired stimulation by both EGF and c-Jun, suggesting that these pathways converge on a common regulatory element, Transfer of single or multiple copies of the EGF-RE upstream of an heterologous promoter conferred EGF and c-Jun responses, providing further evidence that this element is sufficient for both responses, Transfection studies employing mutant c-Jun proteins confirmed a requirement for its DNA binding, leucine zipper and amino-terminal domains, each of which are required for activation of a classical AP-1 reporter, Gel shift studies demonstrated that protein binding to the CYP11A1 EGF-RE was competed specifically by a canonical AP-1 site, and the addition of an anti JUN antibody confirmed the presence of AP-1 proteins, Consistent with the possibility that EGF may act in part via c-Jun, EGF stimulated the activity of a chimeric GAL4 c-Jun protein, indicating that JUN can serve as a potential target of EGF in JEG-3 cells, EGF also induced mitogen-activated protein kinase activity, and a dominant negative mutant of mitogen-activated protein kinase partially blocked EGF stimulation of GAL4 c-Jun activity, We conclude that EGF stimulates the CYP11A1 promoter through an AP-1 like element and that c-Jun is one of the targets of EGF action.	NORTHWESTERN UNIV,SCH MED,DIV ENDOCRINOL METAB & MOLEC MED,CHICAGO,IL 60611	Northwestern University				Jameson, James/0000-0001-9538-4059	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023519] Funding Source: NIH RePORTER; NCI NIH HHS [KO8 CA 620008 01] Funding Source: Medline; NICHD NIH HHS [HD23519] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AHLGREN R, 1990, J BIOL CHEM, V265, P3313; ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BAICHWAL VR, 1990, CELL, V63, P815, DOI 10.1016/0092-8674(90)90147-7; BAIRD A, 1990, PEPTIDE GROWTH FACTO, V1, P369; BEGEOT M, 1993, J BIOL CHEM, V268, P17317; BERKOWITZ LA, 1990, P NATL ACAD SCI USA, V87, P5258, DOI 10.1073/pnas.87.14.5258; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BOHMANN D, 1989, CELL, V59, P709, DOI 10.1016/0092-8674(89)90017-2; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Bravo R., 1990, GROWTH FACTORS DIFFE, P324; CLEMENS JW, 1994, ENDOCRINOLOGY, V134, P1499, DOI 10.1210/en.134.3.1499; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DRUST DS, 1991, MOL ENDOCRINOL, V5, P1541, DOI 10.1210/mend-5-10-1541; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HUIM DW, 1993, ENDOCRINOLOGY, V132, P546; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; INOUE H, 1991, EUR J BIOCHEM, V195, P563, DOI 10.1111/j.1432-1033.1991.tb15738.x; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; KARIN M, 1989, TRENDS GENET, V5, P65, DOI 10.1016/0168-9525(89)90027-9; KARIN M, 1992, FASEB J, V6, P2581, DOI 10.1096/fasebj.6.8.1317309; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; KOVARY K, 1992, MOL CELL BIOL, V12, P5015, DOI 10.1128/MCB.12.11.5015; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LAU LF, 1991, MOL ASPECTS CELLULAR, V6, P257; LI L, 1992, GENE DEV, V6, P676, DOI 10.1101/gad.6.4.676; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; LOPEZ G, 1993, MOL CELL BIOL, V13, P3042, DOI 10.1128/MCB.13.5.3042; MAURER RA, 1989, J BIOL CHEM, V264, P6870; MAXWELL IH, 1989, BIOTECHNIQUES, V7, P276; MILLER WL, 1988, ENDOCR REV, V9, P295, DOI 10.1210/edrv-9-3-295; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; MOMOI K, 1992, MOL ENDOCRINOL, V6, P1682, DOI 10.1210/me.6.10.1682; MOORE CCD, 1990, MOL CELL BIOL, V10, P6013, DOI 10.1128/MCB.10.11.6013; MOORE CCD, 1992, MOL ENDOCRINOL, V6, P2045, DOI 10.1210/me.6.12.2045; MOROHASHI K, 1993, MOL ENDOCRINOL, V7, P1196, DOI 10.1210/me.7.9.1196; PAGANO M, 1994, GENE DEV, V8, P1627, DOI 10.1101/gad.8.14.1627; PELECH SL, 1992, SCIENCE, V257, P1355, DOI 10.1126/science.1382311; PESTELL RG, 1994, J BIOL CHEM, V269, P31090; PESTELL RG, 1993, J MOL ENDOCRINOL, V10, P297, DOI 10.1677/jme.0.0100297; PESTELL RG, 1994, MOL ENDOCRINOLOGY BA, P774; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; RADLERPOHL A, 1993, EMBO J, V12, P1005, DOI 10.1002/j.1460-2075.1993.tb05741.x; RIABOWOL KT, 1988, MOL CELL BIOL, V8, P1670, DOI 10.1128/MCB.8.4.1670; RICE DA, 1990, J BIOL CHEM, V265, P11713; RYSECK RP, 1991, ONCOGENE, V6, P533; SAMBROOK T, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATOH T, 1992, J BIOL CHEM, V267, P24149; SETH A, 1992, J BIOL CHEM, V267, P24796; SMITH MJ, 1992, BLOOD, V79, P2107; STEIN B, 1993, EMBO J, V12, P3879, DOI 10.1002/j.1460-2075.1993.tb06066.x; URBAN RJ, 1994, J BIOL CHEM, V269, P25761; WATERMAN MR, 1994, J BIOL CHEM, V269, P27783; WILLIAMS NG, 1993, P NATL ACAD SCI USA, V90, P5772, DOI 10.1073/pnas.90.12.5772; WOOD WM, 1989, J BIOL CHEM, V264, P14840	59	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18301	18308		10.1074/jbc.270.31.18301	http://dx.doi.org/10.1074/jbc.270.31.18301			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629150	hybrid			2022-12-27	WOS:A1995RM64200025
J	KURLANDSKY, SB; GAMBLE, MV; RAMAKRISHNAN, R; BLANER, WS				KURLANDSKY, SB; GAMBLE, MV; RAMAKRISHNAN, R; BLANER, WS			PLASMA DELIVERY OF RETINOIC ACID TO TISSUES IN THE RAT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; VITAMIN-A; LIQUID-CHROMATOGRAPHY; METABOLISM; TRANSPORT; CELLS; QUANTIFICATION; DISPOSITION; EXPRESSION; ADIPOCYTES	All-trans-retinoic acid (RA) activates Ligand-dependent transcription factors that regulate retinoid-responsive gene expression. It is assumed that all-trans-RA is formed within cells through in situ oxidation of retinol derived from the circulation. However, the circulation contains low level of all-trans-RA (approximately 0.2-0.7% of that of plasma retinol). Our studies investigated the extent to which plasma all-trans-RA contributes to tissue pools of this retinoid and explored factors responsible for regulating its uptake by tissues and cells. Rats were continuously infused, to steady state, with all-trans-[H-3]RA. From measures of specific activities of all-trans [H-3]RA at steady state, we determined that the preponderance of all-trans-RA in brain and liver was derived from the circulation. For six other tissues, approximately 10-30% of the retinoid was derived from the circulation, but pancreas and testis derived very little from the circulating pool. In other studies, we showed that retinoid nutritional status influences clearance of a bolus dose of all-trans-RA and that neither the rate of cellular all-trans-RA uptake nor its intracellular half-life is influenced by cellular lipid levels. Taken together, our data indicate that plasma all-trans-RA contributes to tissue pools of this retinoid and that specific and physiologically responsive cellular processes mediate its uptake.	COLUMBIA UNIV, DEPT MED, NEW YORK, NY 10032 USA; COLUMBIA UNIV, DEPT PEDIAT, NEW YORK, NY 10032 USA; COLUMBIA UNIV, INST HUMAN NUTR, NEW YORK, NY 10032 USA	Columbia University; Columbia University; Columbia University					NIDDK NIH HHS [DK47389] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047389] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARUA AB, 1989, BIOCHEM J, V263, P403, DOI 10.1042/bj2630403; BLANER WS, 1990, METHOD ENZYMOL, V189, P270; BLANER WS, 1985, J NUTR, V115, P856, DOI 10.1093/jn/115.7.856; BLANER WS, 1994, J BIOL CHEM, V269, P16559; BLANER WS, 1994, RETINOIDS BIOL CHEM, P283; BLOMHOFF R, 1990, SCIENCE, V250, P399, DOI 10.1126/science.2218545; BLOMHOFF R, 1991, PHYSIOL REV, V71, P951, DOI 10.1152/physrev.1991.71.4.951; CASTER WO, 1956, P SOC EXP BIOL MED, V91, P122, DOI 10.3181/00379727-91-22186; CHIEN DS, 1992, DRUG METAB DISPOS, V20, P211; CHYTIL F, 1990, Critical Reviews in Eukaryotic Gene Expression, V1, P61; CULLUM ME, 1985, J BIOL CHEM, V260, P590; DELEENHEER AP, 1982, J LIPID RES, V23, P1362; ECKHOFF C, 1990, J LIPID RES, V31, P1445; GOLDBERG IJ, 1990, J CLIN INVEST, V86, P463, DOI 10.1172/JCI114732; GOODMAN DS, 1984, NEW ENGL J MED, V310, P1023, DOI 10.1056/NEJM198404193101605; GOODMAN DS, 1984, RETINOIDS, V2, P1; GREEN MH, 1987, J NUTR, V117, P694, DOI 10.1093/jn/117.4.694; Gudas Lorraine J., 1994, P443; KALIN JR, 1981, DRUG METAB DISPOS, V9, P196; KALUZNY MA, 1985, J LIPID RES, V26, P135; KATO M, 1985, J BIOL CHEM, V260, P4832; KIERSZENBAUM AL, 1986, BIOL REPROD, V35, P227, DOI 10.1095/biolreprod35.1.227; MAKOVER A, 1988, J BIOL CHEM, V263, P8598; Mangelsdorf David J., 1994, P319; MOORE T, 1957, VITAMIN A, P295; NAPOLI JL, 1986, METHOD ENZYMOL, V123, P112, DOI 10.1016/S0076-6879(86)23015-3; NAPOLI JL, 1985, J LIPID RES, V26, P387; NOY N, 1992, BIOCHIM BIOPHYS ACTA, V1106, P159, DOI 10.1016/0005-2736(92)90234-D; NOY N, 1991, BIOCHEMISTRY-US, V30, P6380, DOI 10.1021/bi00240a005; POSCH KC, 1991, BIOCHEMISTRY-US, V30, P6224, DOI 10.1021/bi00239a021; RIAZULHAQ, 1991, BIOCHEM BIOPH RES CO, V176, P1539, DOI 10.1016/0006-291X(91)90462-G; ROSS AC, 1993, FASEB J, V7, P317, DOI 10.1096/fasebj.7.2.8440409; SAARI JC, 1991, PROGR RETINAL RES, V9, P363; SMITH JE, 1973, BIOCHEM J, V132, P821, DOI 10.1042/bj1320821; Soprano Dianne Robert, 1994, P257; TANG GW, 1990, J LIPID RES, V31, P175; TANG GW, 1991, J NUTR BIOCHEM, V2, P210, DOI 10.1016/0955-2863(91)90018-Z; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; VANBENNEKUM AM, 1993, BIOCHEMISTRY-US, V32, P1727, DOI 10.1021/bi00058a005; VANPELT AMM, 1991, ENDOCRINOLOGY, V128, P697, DOI 10.1210/endo-128-2-697; WANG CC, 1980, DRUG METAB DISPOS, V8, P8; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753; ZOVICH DC, 1992, J BIOL CHEM, V267, P13884	43	203	206	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17850	17857		10.1074/jbc.270.30.17850	http://dx.doi.org/10.1074/jbc.270.30.17850			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629087				2022-12-27	WOS:A1995RM26600035
J	LISTER, J; FORRESTER, WC; BARON, MH				LISTER, J; FORRESTER, WC; BARON, MH			INHIBITION OF AN ERYTHROID-DIFFERENTIATION SWITCH BY THE HELIX-LOOP-HELIX PROTEIN ID1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLOBIN LOCUS; ERYTHROLEUKEMIA CELL-DIFFERENTIATION; DNA-BINDING PROTEINS; C-MYC; TRANSCRIPTION FACTORS; MYOGENIC DIFFERENTIATION; TRANSIENT HETEROKARYONS; REGULATED EXPRESSION; CHROMATIN STRUCTURE; NEGATIVE REGULATOR	The Id proteins function as negative regulators of basic-helix-loop helix transcription factors, which play important roles in determination of cell lineage and in tissue-specific differentiation. Down-regulation of Id1 mRNA is associated with dimethyl sulfoxide-induced terminal differentiation of mouse erythroleukemia cells. To examine the significance of Id1 down-regulation in erythroid differentiation, we generated stable mouse erythroleukemia cell lines that constitutively express a ''marked'' form of the murine Id1 gene. Terminal erythroid differentiation was inhibited in these lines, as indicated by a block in activation of the erythroid-spe cific genes alpha-globin, beta-globin, and band 3 and continued proliferation in the presence of dimethyl sulfoxide. Interestingly, this block, occurred even in the presence of normal levels of the lineage-specific transcription factors GATA-1, NF-E2, and EKLF. Constitutive expression of Id1 did not interfere with DNase I hypersensitivity at site HS2 of the locus control region, expression of the erythropoietin receptor gene, or down-regulation of the endogenous Id1 or c-myc genes. The differentiation block is reversible in these lines and can be rescued by fusion with human erythroleukemia cells. These findings suggest that in vivo, Id1 functions as an antagonist of terminal erythroid differentiation.	HARVARD UNIV, BIOL LABS, DEPT MOLEC & CELLULAR BIOL, CAMBRIDGE, MA 02138 USA; UNIV CALIF SAN FRANCISCO, DEPT MICROBIOL & IMMUNOL, SAN FRANCISCO, CA 94143 USA	Harvard University; University of California System; University of California San Francisco			Lister, James/A-9295-2008		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042413] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 07620, R01 GM42413] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APLAN PD, 1992, EMBO J, V11, P4073, DOI 10.1002/j.1460-2075.1992.tb05500.x; BAER R, 1993, SEMIN CANCER BIOL, V4, P341; Baron MH, 1993, CURR OPIN CELL BIOL, V5, P1050, DOI 10.1016/0955-0674(93)90091-4; BARON MH, 1994, MOL CELL BIOL, V14, P3108, DOI 10.1128/MCB.14.5.3108; BARON MH, 1986, CELL, V46, P591, DOI 10.1016/0092-8674(86)90885-8; BARON MH, 1991, MOL CELL BIOL, V11, P1239, DOI 10.1128/MCB.11.3.1239; BARONE MV, 1994, P NATL ACAD SCI USA, V91, P4985, DOI 10.1073/pnas.91.11.4985; BENEZRA R, 1990, ANN NY ACAD SCI, V599, P1, DOI 10.1111/j.1749-6632.1990.tb42359.x; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BLAU HM, 1992, ANNU REV BIOCHEM, V61, P1213, DOI 10.1146/annurev.bi.61.070192.010025; BRESNICK EH, 1993, J BIOL CHEM, V268, P18824; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DILLON N, 1993, TRENDS GENET, V9, P134, DOI 10.1016/0168-9525(93)90208-Y; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; DUNCAN M, 1992, DEV BIOL, V154, P1, DOI 10.1016/0012-1606(92)90042-F; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; ENGEL JD, 1994, NATURE, V367, P516; FAIRMAN R, 1993, P NATL ACAD SCI USA, V90, P10429, DOI 10.1073/pnas.90.22.10429; FORRESTER WC, 1989, P NATL ACAD SCI USA, V86, P5439, DOI 10.1073/pnas.86.14.5439; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; GREEN AR, 1991, EMBO J, V10, P4153, DOI 10.1002/j.1460-2075.1991.tb04993.x; HARA E, 1994, J BIOL CHEM, V269, P2139; HARLOW E, 1988, ANTIBODIES LABORATOR; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; HOFER E, 1982, CELL, V29, P887, DOI 10.1016/0092-8674(82)90450-0; HSU HL, 1994, P NATL ACAD SCI USA, V91, P3181, DOI 10.1073/pnas.91.8.3181; HSU HL, 1994, P NATL ACAD SCI USA, V91, P5947, DOI 10.1073/pnas.91.13.5947; HU JS, 1992, MOL CELL BIOL, V12, P1031, DOI 10.1128/MCB.12.3.1031; HUG BA, 1992, NUCLEIC ACIDS RES, V20, P5771, DOI 10.1093/nar/20.21.5771; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; KADESCH T, 1993, CELL GROWTH DIFFER, V4, P49; KIRSCH IR, 1986, J CELL BIOCHEM, V32, P11, DOI 10.1002/jcb.240320103; KOPITO RR, 1987, J BIOL CHEM, V262, P8035; KREIDER BL, 1992, SCIENCE, V255, P1700, DOI 10.1126/science.1372755; KUME TU, 1988, J MOL BIOL, V202, P779, DOI 10.1016/0022-2836(88)90558-X; LACHMAN HM, 1985, P NATL ACAD SCI USA, V82, P5323, DOI 10.1073/pnas.82.16.5323; MARKS PA, 1994, P NATL ACAD SCI USA, V91, P10251, DOI 10.1073/pnas.91.22.10251; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; MINER JH, 1991, MOL CELL BIOL, V11, P2842, DOI 10.1128/MCB.11.5.2842; MOON AM, 1990, P NATL ACAD SCI USA, V87, P7693, DOI 10.1073/pnas.87.19.7693; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NIELSEN AL, 1992, MOL CELL BIOL, V12, P3449, DOI 10.1128/MCB.12.8.3449; ORKIN SH, 1992, BLOOD, V80, P575; PESCE S, 1993, MOL CELL BIOL, V13, P7874, DOI 10.1128/MCB.13.12.7874; PETERSON CA, 1990, CELL, V62, P493, DOI 10.1016/0092-8674(90)90014-6; PEVERALI FA, 1994, EMBO J, V13, P4291, DOI 10.1002/j.1460-2075.1994.tb06749.x; PONGUBALA JMR, 1991, MOL CELL BIOL, V11, P1040, DOI 10.1128/MCB.11.2.1040; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; REMMERS EF, 1986, EMBO J, V5, P899, DOI 10.1002/j.1460-2075.1986.tb04301.x; Sambrook J, 1989, MOL CLONING LABORATO; SCHAFER BW, 1990, NATURE, V344, P454, DOI 10.1038/344454a0; SHEFFERY M, 1982, P NATL ACAD SCI-BIOL, V79, P1180, DOI 10.1073/pnas.79.4.1180; SHEHEE WR, 1989, J MOL BIOL, V205, P41, DOI 10.1016/0022-2836(89)90363-X; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; SHOJI W, 1994, J BIOL CHEM, V269, P5078; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SUN XH, 1994, CELL, V79, P893, DOI 10.1016/0092-8674(94)90078-7; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; THAYER MJ, 1990, CELL, V63, P23, DOI 10.1016/0092-8674(90)90285-M; VISVADER J, 1991, ONCOGENE, V6, P187; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; WILSON RB, 1991, MOL CELL BIOL, V11, P6185, DOI 10.1128/MCB.11.12.6185; YOUSSOUFIAN H, 1990, MOL CELL BIOL, V10, P3675, DOI 10.1128/MCB.10.7.3675; ZHUANG Y, 1992, P NATL ACAD SCI USA, V89, P12132, DOI 10.1073/pnas.89.24.12132	69	86	86	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17939	17946		10.1074/jbc.270.30.17939	http://dx.doi.org/10.1074/jbc.270.30.17939			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629100				2022-12-27	WOS:A1995RM26600050
J	BERNASCONI, P; WOODWORTH, AR; ROSEN, BA; SUBRAMANIAN, MV; SIEHL, DL				BERNASCONI, P; WOODWORTH, AR; ROSEN, BA; SUBRAMANIAN, MV; SIEHL, DL			A NATURALLY-OCCURRING POINT MUTATION CONFERS BROAD RANGE TOLERANCE TO HERBICIDES THAT TARGET ACETOLACTATE SYNTHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CROSS-RESISTANCE; MOLECULAR-BASIS; GENES; INHIBITORS; IMAZAQUIN; SEQUENCE; TOBACCO; SITE	Acetolactate synthase (ALS) inhibitors are among the most commonly used herbicides. They fall into four distinct families of compounds: sulfonylureas, imidazolinones, triazolopyrimidine sulfonanilides, and pyrimidinyl oxybenzoates. We have investigated the molecular basis of imidazolinone tolerance of two field isolates of cocklebur (Xanthium sp.) from Mississippi and Missouri. In both cases, tolerance was conferred by a form of ALS that was less sensitive to inhibitors than the wild type. The insensitivity pattern of the Mississippi isolate was similar to that of a commercial mutant of corn generated in the laboratory: ICI 8532 IT. Sequencing revealed that the same residue (Ala(57) --> Thr) was mutated in both Mississippi cocklebur and ICI 8532 IT corn. ALS from the Missouri isolate was highly insensitive to all the ALS herbicide families, similar in this respect to another commercial corn mutant: Pioneer 3180 IR corn, Sequencing of ALS from both plants revealed a common mutation that changed Trp(552) to Leu. The sensitive cocklebur ALS cDNA, fused with a glutathione S-transferase, was functionally expressed in Escherichia coli. The recombinant protein had enzymatic properties similar to those of the plant enzyme. All the possible point mutations affecting Trp(552) were investigated by site-directed mutagenesis. Only the Trp --> Leu mutation yielded an active enzyme. This mutation conferred a dramatically reduced sensitivity toward representatives of all four chemical families, demonstrating its role in herbicide tolerance. This study indicates that mutations conferring herbicide tolerance, obtained in an artificial environment, also occur in nature, where the selection pressure is much lower. Thus, this study validates the use of laboratory models to predict mutations that may develop in natural populations.			BERNASCONI, P (corresponding author), SANDOZ AGRO INC,DIV RES,975 CALIF AVE,PALO ALTO,CA 94304, USA.							Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BABCZINSKI P, 1991, PESTIC SCI, V31, P305, DOI 10.1002/ps.2780310306; BERNASCONI P, 1994, PLANT PHYSIOL, V106, P353, DOI 10.1104/pp.106.1.353; BRYAN JK, 1990, BIOCH PLANTS COMPREH, P161; DURNER J, 1991, PLANT PHYSIOL, V95, P1144, DOI 10.1104/pp.95.4.1144; FANG LY, 1992, PLANT MOL BIOL, V18, P1185, DOI 10.1007/BF00047723; GREAVES JA, 1993, 48TH P ANN CORN SORG, P104; GUTTIERI MJ, 1992, WEED SCI, V40, P670, DOI 10.1017/S0043174500058288; HAUGHN GW, 1988, MOL GEN GENET, V211, P266, DOI 10.1007/BF00330603; KENDIG JA, 1994, WEED SCI SOC AM; KLESCHICK WA, 1992, PESTIC SCI, V29, P341; LEE KY, 1988, EMBO J, V7, P1241, DOI 10.1002/j.1460-2075.1988.tb02937.x; LOS M, 1984, ACS SYM SER, V255, P29; MALLORYSMITH CA, 1990, WEED TECHNOL, V4, P163, DOI 10.1017/S0890037X00025173; MAZUR BJ, 1989, ANNU REV PLANT PHYS, V40, P441, DOI 10.1146/annurev.pp.40.060189.002301; MAZUR BJ, 1987, PLANT PHYSIOL, V85, P1110, DOI 10.1104/pp.85.4.1110; MIFLIN BJ, 1974, PLANT PHYSIOL, V54, P550, DOI 10.1104/pp.54.4.550; Saari L. L., 1994, P83; SATHASIVAN K, 1991, PLANT PHYSIOL, V97, P1044, DOI 10.1104/pp.97.3.1044; SAUERS RF, 1984, ACS SYM SER, V255, P21; SAXENA PK, 1988, PLANT PHYSIOL, V86, P863, DOI 10.1104/pp.86.3.863; SCHLOSS JV, 1988, NATURE, V331, P360, DOI 10.1038/331360a0; SCHMITZER PR, 1993, PLANT PHYSIOL, V103, P281, DOI 10.1104/pp.103.1.281; SIEHL DL, 1995, IN PRESS CROP SCI; SINGH B, 1992, PLANT PHYSIOL, V99, P812, DOI 10.1104/pp.99.3.812; SMITH JK, 1989, P NATL ACAD SCI USA, V86, P4179, DOI 10.1073/pnas.86.11.4179; SUBRAMANIAN MV, 1990, PLANT PHYSIOL, V94, P239, DOI 10.1104/pp.94.1.239; SUBRAMANIAN MV, 1991, PLANT PHYSIOL, V96, P310, DOI 10.1104/pp.96.1.310	28	195	223	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17381	17385		10.1074/jbc.270.29.17381	http://dx.doi.org/10.1074/jbc.270.29.17381			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615543	hybrid			2022-12-27	WOS:A1995RK68900054
J	CHEN, ZG; SPIES, A; HEIN, R; ZHOU, XL; THOMAS, BC; RICHTER, ML; GEGENHEIMER, P				CHEN, ZG; SPIES, A; HEIN, R; ZHOU, XL; THOMAS, BC; RICHTER, ML; GEGENHEIMER, P			A SUBUNIT INTERACTION IN CHLOROPLAST ATP SYNTHASE DETERMINED BY GENETIC COMPLEMENTATION BETWEEN CHLOROPLAST AND BACTERIAL ATP SYNTHASE GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLING FACTOR-I; PROTON-TRANSLOCATING ATPASE; T7 RNA-POLYMERASE; BETA-SUBUNIT; ESCHERICHIA-COLI; ADENOSINE-TRIPHOSPHATASE; NUCLEOTIDE BINDING; EXPRESSION; SITES; RECONSTITUTION	F1F0-ATP synthases utilize protein conformational changes induced by a transmembrane proton gradient to synthesize ATP. The allosteric cooperativity of these multisubunit enzymes presumably requires numerous protein-protein interactions within the enzyme complex. To correlate known in vitro changes in subunit structure with in vivo allosteric interactions, we introduced the beta subunit of spinach chloroplast coupling factor 1 ATP into a bacterial F-1 ATP synthase. A cloned atpB gene, encoding the complete chloroplast beta subunit, complemented a chromosomal deletion of the cognate uncD gene in Escherichia coli and was incorporated into a functional hybrid F-1 ATP synthase. The cysteine residue at position 63 in chloroplast beta is known to be located at the interface between alpha and beta subunits and to be conformationally coupled, in vitro, to the nucleotide binding site >40 Angstrom away. Enlarging the side chain of chloroplast coupling factor 1 beta residue 63 from Cys to Trp blocked ATP synthesis in vivo without significantly impairing ATPase activity or ADP binding in vitro. The in vivo coupling of nucleotide binding at catalytic sites to transmembrane proton movement may thus involve an interaction, via conformational changes, between the amino-terminal domains of the alpha and beta subunits.	UNIV KANSAS, DEPT BIOCHEM, LAWRENCE, KS 66045 USA; UNIV KANSAS, MOLEC GENET PROGRAM, LAWRENCE, KS 66045 USA; UNIV KANSAS, DEPT BOT, LAWRENCE, KS 66045 USA	University of Kansas; University of Kansas; University of Kansas			Gegenheimer, Peter Albert/E-2271-2013	Gegenheimer, Peter Albert/0000-0001-9863-1545				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; AVNI A, 1992, SCIENCE, V257, P1245, DOI 10.1126/science.1387730; BALBAS P, 1988, VECTORS SURVEY MOL C, P5; BOEKEMA EJ, 1992, BIOCHIM BIOPHYS ACTA, V1098, P131, DOI 10.1016/S0005-2728(05)80328-7; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; BURKOVSKI A, 1994, BBA-BIOENERGETICS, V1186, P243, DOI 10.1016/0005-2728(94)90184-8; CHEN ZG, 1992, FEBS LETT, V298, P69, DOI 10.1016/0014-5793(92)80024-B; COLVERT KK, 1992, BIOCHEMISTRY-US, V31, P3930, DOI 10.1021/bi00131a006; ENGELBRECHT S, 1986, EUR J BIOCHEM, V160, P635, DOI 10.1111/j.1432-1033.1986.tb10085.x; GATENBY AA, 1986, GENE, V41, P241, DOI 10.1016/0378-1119(86)90104-6; GIBSON F, 1977, BIOCHEM J, V164, P193, DOI 10.1042/bj1640193; GUNSALUS RP, 1982, P NATL ACAD SCI-BIOL, V79, P320, DOI 10.1073/pnas.79.2.320; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HAWTHORNE CA, 1986, J BIOL CHEM, V261, P5245; HU NM, 1993, J BIOL CHEM, V268, P8536; LEE RSF, 1991, BIOCHEMISTRY-US, V30, P6842, DOI 10.1021/bi00242a006; LILL H, 1993, BIOCHIM BIOPHYS ACTA, V1144, P278, DOI 10.1016/0005-2728(93)90112-S; MIKI J, 1994, ARCH BIOCHEM BIOPHYS, V312, P317, DOI 10.1006/abbi.1994.1315; MIKI J, 1994, J BIOL CHEM, V269, P4227; MILLS DA, 1991, J BIOL CHEM, V266, P7440; MILLS DA, 1995, BIOCHEMISTRY-US, V34, P6100, DOI 10.1021/bi00018a013; MUNN AL, 1991, BIOCHIM BIOPHYS ACTA, V1060, P82, DOI 10.1016/S0005-2728(05)80122-7; MUSIER KM, 1987, BIOCHEMISTRY-US, V26, P5982, DOI 10.1021/bi00393a006; NALIN CM, 1987, CURR TOP BIOENERG, V15, P273; NOUMI T, 1986, J BIOL CHEM, V261, P7070; OLINS PO, 1990, METHOD ENZYMOL, V185, P115; PENEFSKY HS, 1991, ADV ENZYMOL RELAT AR, V64, P173; REZNIKOFF WS, 1986, MAXIMIZING GENE EXPR, P1; RICHARDS FM, 1974, J MOL BIOL, V82, P1, DOI 10.1016/0022-2836(74)90570-1; RICHTER ML, 1986, J BIOL CHEM, V261, P2109; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; ROST B, 1993, P NATL ACAD SCI USA, V90, P7558, DOI 10.1073/pnas.90.16.7558; SCHUMANN J, 1985, J BIOL CHEM, V260, P1817; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SMITH PK, 1987, ANAL BIOCHEM, V163, P279; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; WALKER JE, 1985, J MOL BIOL, V184, P677, DOI 10.1016/0022-2836(85)90313-4; ZURAWSKI G, 1982, P NATL ACAD SCI-BIOL, V79, P6260, DOI 10.1073/pnas.79.20.6260	41	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17124	17132		10.1074/jbc.270.29.17124	http://dx.doi.org/10.1074/jbc.270.29.17124			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615507	hybrid			2022-12-27	WOS:A1995RK68900014
J	KILSDONK, EPC; YANCEY, PG; STOUDT, GW; BANGERTER, FW; JOHNSON, WJ; PHILLIPS, MC; ROTHBLAT, GH				KILSDONK, EPC; YANCEY, PG; STOUDT, GW; BANGERTER, FW; JOHNSON, WJ; PHILLIPS, MC; ROTHBLAT, GH			CELLULAR CHOLESTEROL EFFLUX MEDIATED BY CYCLODEXTRINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY LIPOPROTEIN; APOLIPOPROTEIN-A-I; LYSOSOMAL CHOLESTEROL; HUMAN-ERYTHROCYTES; KINETIC POOLS; CELLS; MEMBRANE; FIBROBLASTS; MACROPHAGES; STEROL	In this study, we compared cholesterol efflux mediated by either high density lipoproteins (HDL(3)) or beta-cyclodextrins, cyclic oligosaccharides that are able to dis solve lipids in their hydrophobic core. beta-Cyclodextrin, 2-hydroxypropyl-beta-cyclodextrin, and methyl-beta-cyclodextrin at 10 mM induced the release of 50-90% of L-cell [H-3]cholesterol after 8 h of incubation, with a major portion of this cholesterol being released in the first 1-2 h of incubation. The cholesterol efflux kinetics are different if cells are incubated with HDL(3), which induces a relatively constant rate of release of cholesterol throughout an 8-h incubation. Cholesterol efflux to cyclodextrins was much greater than phospholipid release. To test the hypothesis that maximal efflux rate constants for a particular cell are independent of the type of acceptor, we estimated the maximal rate constants for efflux (V-max) of cellular cholesterol from L-cells, Fu5AH cells, and GM3468A fibroblasts. The rate constant for HDL(3)-mediated efflux varied among cell lines in the order Fu5AH > L-cells > fibroblasts. However, these differences were not evident when cyclodextrins were used as cholesterol accepters. The estimated V-max values for cyclodextrin-mediated efflux were 3.5-70-fold greater than for HDL(3) for the three cell lines. The very high efficiency of cyclodextrins in stimulating cell cholesterol efflux suggests that these compounds can be used in two general ways for studies of atherosclerosis: 1) as research tools to probe mechanisms of cholesterol transport and aspects of membrane structure or 2) as potential pharmacological agents that could modify in vivo cholesterol metabolism and influence the development of the atherosclerotic plaque.	MED COLL PENN,DEPT BIOCHEM,PHILADELPHIA,PA 19129; HAHNEMANN UNIV,PHILADELPHIA,PA 19129; PFIZER INC,CENT RES,GROTON,CT 06340	Drexel University; Drexel University; Pfizer			Yancey, Patricia/ABB-5856-2021	Phillips, Michael/0000-0002-7147-8007	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633, T32HL007443] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL22633, HL07443] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BELLINI F, 1984, BIOCHIM BIOPHYS ACTA, V777, P209, DOI 10.1016/0005-2736(84)90422-X; BIELICKI JK, 1992, J LIPID RES, V33, P1699; DAVIDSON WS, 1995, J BIOL CHEM, V270, P17106, DOI 10.1074/jbc.270.29.17106; DAVIDSON WS, 1995, J BIOL CHEM, V270, P5882, DOI 10.1074/jbc.270.11.5882; DECAPRIO J, 1992, J LIPID RES, V33, P441; DELALLERAMOYA M, 1994, ARTERIOSCLER THROMB, V14, P1056, DOI 10.1161/01.ATV.14.7.1056; DIEDERICH F, 1994, ANGEW CHEM INT EDIT, V33, P1625; DUCHENE D, 1990, 5TH INT S CYCL; FIELDING CJ, 1995, J LIPID RES, V36, P211; FRIJLINK HW, 1991, PHARMACEUT RES, V8, P9, DOI 10.1023/A:1015861719134; GLOMSET JA, 1968, J LIPID RES, V9, P155; Hatch F T, 1968, Adv Lipid Res, V6, P1; IRIE T, 1982, J PHARMACOBIO-DYNAM, V5, P741; IRIE T, 1992, J PHARM SCI, V81, P521, DOI 10.1002/jps.2600810609; JOHNSON WJ, 1986, J BIOL CHEM, V261, P5766; JOHNSON WJ, 1990, J BIOL CHEM, V265, P5546; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; KILSDONK EPC, 1994, J LIPID RES, V36, P505; MAHLBERG FH, 1991, J BIOL CHEM, V266, P19930; MAHLBERG FH, 1992, J BIOL CHEM, V267, P4541; MAHLBERG FH, 1990, ATHEROSCLEROSIS, V84, P95, DOI 10.1016/0021-9150(90)90078-W; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MAZZONE T, 1992, J LIPID RES, V36, P544; MCCLOSKEY HM, 1987, BIOCHIM BIOPHYS ACTA, V921, P320, DOI 10.1016/0005-2760(87)90033-6; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; ORAM JF, 1983, ARTERIOSCLEROSIS, V3, P420, DOI 10.1161/01.ATV.3.5.420; PHILLIPS MC, 1987, BIOCHIM BIOPHYS ACTA, V906, P223, DOI 10.1016/0304-4157(87)90013-X; PITHA J, 1988, LIFE SCI, V43, P493, DOI 10.1016/0024-3205(88)90150-6; REID VC, 1992, ATHEROSCLEROSIS, V92, P251, DOI 10.1016/0021-9150(92)90285-O; RIOTTOT M, 1993, LIPIDS, V28, P181, DOI 10.1007/BF02536637; Rothblat G H, 1986, Methods Enzymol, V129, P628; ROTHBLAT GH, 1970, SCIENCE, V169, P880, DOI 10.1126/science.169.3948.880; ROTHBLAT GH, 1992, J LIPID RES, V33, P1091; SCHROEDER F, 1991, P SOC EXP BIOL MED, V196, P235; Segel IH, 1976, BIOCH CALCULATIONS; SHIRHATTI V, 1985, ANAL BIOCHEM, V147, P410, DOI 10.1016/0003-2697(85)90290-8; SOKOLOFF L, 1974, P SOC EXP BIOL MED, V146, P1166; STECK TL, 1988, J BIOL CHEM, V263, P13023; Stern WC, 1989, DRUG NEWS PERSPECT, V2, P410; UEKAMA K, 1987, CRIT REV THER DRUG, V3, P1	40	697	709	0	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17250	17256		10.1074/jbc.270.29.17250	http://dx.doi.org/10.1074/jbc.270.29.17250			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615524	hybrid			2022-12-27	WOS:A1995RK68900032
J	PFEFFER, SR; DIRACSVEJSTRUP, AB; SOLDATI, T				PFEFFER, SR; DIRACSVEJSTRUP, AB; SOLDATI, T			RAB-GDP DISSOCIATION INHIBITOR - PUTTING RAB-GTPASES IN THE RIGHT PLACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GTP-BINDING PROTEIN; GDP/GTP EXCHANGE PROTEIN; SMG P25A; GERANYLGERANYL TRANSFERASE; REGULATORY PROTEIN; BOVINE BRAIN; MEMBRANE; SEC4; CYTOSOL; PURIFICATION				PFEFFER, SR (corresponding author), STANFORD UNIV,SCH MED,DEPT BIOCHEM,STANFORD,CA 94305, USA.		SOLDATI, Thierry/U-6494-2019; SOLDATI, Thierry/A-2902-2009	SOLDATI, Thierry/0000-0002-2056-7931; SOLDATI, Thierry/0000-0002-2056-7931				ALEXANDROV K, 1994, EMBO J, V13, P5262, DOI 10.1002/j.1460-2075.1994.tb06860.x; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; ARAKI S, 1991, MOL CELL BIOL, V11, P1438, DOI 10.1128/MCB.11.3.1438; ARAKI S, 1990, J BIOL CHEM, V265, P13007; BERANGER F, 1994, J BIOL CHEM, V269, P13637; BRENNWALD P, 1993, NATURE, V362, P560, DOI 10.1038/362560a0; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; DIRACSVEJSTRUP AB, 1994, J BIOL CHEM, V269, P15427; DUNN B, 1993, NATURE, V362, P563, DOI 10.1038/362563a0; ELAZAR Z, 1994, J BIOL CHEM, V269, P794; GARRETT MD, 1993, FEBS LETT, V331, P233, DOI 10.1016/0014-5793(93)80343-S; GARRETT MD, 1994, EMBO J, V13, P1718, DOI 10.1002/j.1460-2075.1994.tb06436.x; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; HORIUCHI H, 1995, J BIOL CHEM, V270, P11257, DOI 10.1074/jbc.270.19.11257; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; MATSUI Y, 1990, MOL CELL BIOL, V10, P4116, DOI 10.1128/MCB.10.8.4116; MUSHA T, 1992, J BIOL CHEM, V267, P9821; NISHIMURA N, 1994, J BIOL CHEM, V269, P14191; NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9; NUOFFER C, 1994, ANNU REV BIOCHEM, V63, P949, DOI 10.1146/annurev.bi.63.070194.004505; PETER F, 1994, J CELL BIOL, V126, P1393, DOI 10.1083/jcb.126.6.1393; PFEFFER SR, 1994, CURR OPIN CELL BIOL, V6, P522, DOI 10.1016/0955-0674(94)90071-X; REGAZZI R, 1992, J BIOL CHEM, V267, P17512; SASAKI T, 1991, MOL CELL BIOL, V11, P2909, DOI 10.1128/MCB.11.5.2909; SASAKI T, 1990, J BIOL CHEM, V265, P2333; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; SHAPIRO AD, 1995, J BIOL CHEM, V270, P11085, DOI 10.1074/jbc.270.19.11085; SHISHEVA A, 1994, J BIOL CHEM, V269, P23865; SHISHEVA A, 1994, MOL CELL BIOL, V14, P3459, DOI 10.1128/MCB.14.5.3459; SOLDATI T, 1994, NATURE, V369, P76, DOI 10.1038/369076a0; SOLDATI T, 1993, MOL BIOL CELL, V4, P425, DOI 10.1091/mbc.4.4.425; STEELEMORTIMER O, 1993, FEBS LETT, V329, P313, DOI 10.1016/0014-5793(93)80244-O; STENMARK H, 1994, EMBO J, V13, P575, DOI 10.1002/j.1460-2075.1994.tb06295.x; UEDA T, 1991, BIOCHEMISTRY-US, V30, P909, DOI 10.1021/bi00218a005; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; ULLRICH O, 1993, J BIOL CHEM, V268, P18143; YANG CZ, 1994, J BIOL CHEM, V269, P31891; ZAHNER JE, 1993, MOL CELL BIOL, V13, P217, DOI 10.1128/MCB.13.1.217; Zerial M, 1993, CURR OPIN CELL BIOL, V5, P613, DOI 10.1016/0955-0674(93)90130-I	39	201	201	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17057	17059		10.1074/jbc.270.29.17057	http://dx.doi.org/10.1074/jbc.270.29.17057			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615494	hybrid, Green Published			2022-12-27	WOS:A1995RK68900001
J	KUBISESKI, TJ; FLYNN, TG				KUBISESKI, TJ; FLYNN, TG			STUDIES ON HUMAN ALDOSE REDUCTASE - PROBING THE ROLE OF ARGININE-268 BY SITE-DIRECTED MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KM ALDEHYDE REDUCTASE; HUMAN PSOAS MUSCLE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ACTIVE-SITE; PIG BRAIN; BINDING; EXPRESSION; COMPLICATIONS; SUPERFAMILY	Aldose reductase (ALR2) shows a strong specificity for its nucleotide coenzyme, binding NADPH much more tightly than NADH (K-D of <1 mu M versus 1.2 mM respectively). Interactions responsible for this specificity include salt linkages between the highly conserved residues Lys-262 and Arg-268, and the 2'-phosphate of NADP(H). Previous studies show that mutation of Lys-262 results in an increase in the K-m for both coenzyme and aldehyde substrate, as well as in the k(cat) of reduction. The present study shows that mutation of Arg-268 to methionine results in a 36-fold increase in K-m and 205-fold increase in K-D for NADPH, but little change in K-m for DL-glyceraldehyde or in the k(cat) of the reaction. Calculation of free energy changes show that the 2'-phosphate of NADPH contributes 4.7 kcal/mol of binding energy to its interaction with WT-hALR2. For the R268M mutant, the interaction of NADPH was destabilized by 3.2 kcal/mol, indicating that the mutation decreases the binding energy of NADPH by 65%. The effect of removing Arg-268 in the absence of the 2'-phosphate of NADPH was virtually identical to the destabilization of the activation energy in the absence of the 2'-phosphate itself (1.9 versus 2.0 kcal/mol, respectively). Therefore, while the 2'-phosphate of the coenzyme plays a role in both coenzyme binding and transition state stabilization during catalysis, the role of Arg-268 lies strictly in tighter coenzyme binding.	QUEENS UNIV,DEPT BIOCHEM,KINGSTON,ON K7L 3N6,CANADA	Queens University - Canada				Kubiseski, Terrance/0000-0001-9388-8608				AMARA FM, 1994, J BIOL CHEM, V269, P6709; BETTER M, 1988, SCIENCE, V240, P1041, DOI 10.1126/science.3285471; BOHREN KM, 1989, J BIOL CHEM, V264, P9547; BOHREN KM, 1991, J BIOL CHEM, V266, P24031; BOHREN KM, 1994, BIOCHEMISTRY-US, V33, P2021, DOI 10.1021/bi00174a007; BOHREN KM, 1992, J BIOL CHEM, V267, P20965; BORHANI DW, 1992, J BIOL CHEM, V267, P24841; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANLANT G, 1982, EUR J BIOCHEM, V129, P99, DOI 10.1111/j.1432-1033.1982.tb07026.x; CARPER D, 1987, FEBS LETT, V220, P209, DOI 10.1016/0014-5793(87)80905-5; CROMLISH JA, 1983, J BIOL CHEM, V258, P3583; DAVIS GJ, 1994, ARCH BIOCHEM BIOPHYS, V311, P307, DOI 10.1006/abbi.1994.1242; EHRIG T, 1994, BIOCHEMISTRY-US, V33, P7157, DOI 10.1021/bi00189a019; Fersht A., 1985, ENZYME STRUCTURE MEC; FERSHT AR, 1972, J MOL BIOL, V64, P497, DOI 10.1016/0022-2836(72)90513-X; GABBAY KH, 1975, ANNU REV MED, V26, P521, DOI 10.1146/annurev.me.26.020175.002513; GRIMSHAW CE, 1992, BIOCHEMISTRY-US, V31, P10139, DOI 10.1021/bi00157a001; GRIMSHAW CE, 1990, BIOCHEMISTRY-US, V29, P9947, DOI 10.1021/bi00494a027; GRIMSHAW CE, 1989, BIOCHEMISTRY-US, V28, P5343, DOI 10.1021/bi00439a006; GRUNDMANN U, 1990, DNA CELL BIOL, V9, P149, DOI 10.1089/dna.1990.9.149; HARRISON DH, 1994, BIOCHEMISTRY-US, V33, P2011, DOI 10.1021/bi00174a006; KUBISESKI TJ, 1992, J BIOL CHEM, V267, P6510; KUBISESKI TJ, 1994, J BIOL CHEM, V269, P2183; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU SQ, 1992, BIOCHEM PHARMACOL, V44, P2427, DOI 10.1016/0006-2952(92)90693-D; MIERENDORF RC, 1987, METHOD ENZYMOL, V152, P458; MORJANA NA, 1989, J BIOL CHEM, V264, P2906; MORJANA NA, 1989, J BIOL CHEM, V264, P2912; NISHIMURA C, 1990, J BIOL CHEM, V265, P9788; PETRASH JM, 1992, J BIOL CHEM, V267, P24833; QIN KN, 1994, BIOCHEMISTRY-US, V33, P3223, DOI 10.1021/bi00177a012; RONDEAU JM, 1992, NATURE, V355, P469, DOI 10.1038/355469a0; RYLE CM, 1985, BIOCHEM J, V227, P621, DOI 10.1042/bj2270621; Sambrook J, 1989, MOL CLONING LABORATO; SEM DS, 1993, BIOCHEMISTRY-US, V32, P11548, DOI 10.1021/bi00094a011; STINSON RA, 1973, BIOCHEM J, V131, P719, DOI 10.1042/bj1310719; TARLE I, 1993, J BIOL CHEM, V268, P25687; THOMPSON ST, 1975, P NATL ACAD SCI USA, V72, P669, DOI 10.1073/pnas.72.2.669; TOMLINSON DR, 1994, TRENDS PHARMACOL SCI, V15, P298; TSAI MD, 1991, BIOCHEMISTRY-US, V30, P6806, DOI 10.1021/bi00242a002; Turner A J, 1982, Prog Clin Biol Res, V114, P401; TURNER AJ, 1972, BIOCHEM J, V130, P765, DOI 10.1042/bj1300765; VEECH RL, 1987, PYRIDINE NUCLEOTIDE, V2, P79; WARD WHJ, 1993, ADV EXP MED BIOL, V328, P301; WELLS TNC, 1991, BIOCHEMISTRY-US, V30, P5151, DOI 10.1021/bi00235a006; WILSON DK, 1992, SCIENCE, V257, P81, DOI 10.1126/science.1621098; WILSON DK, 1993, P NATL ACAD SCI USA, V90, P9847, DOI 10.1073/pnas.90.21.9847; WINEGRAD AI, 1972, HDB PHYSL, P456; YAMAOKA T, 1992, BIOCHEM BIOPH RES CO, V183, P327, DOI 10.1016/0006-291X(92)91647-9; YANAGIDA N, 1986, J BACTERIOL, V166, P937, DOI 10.1128/jb.166.3.937-944.1986; 1993, PROMEGA PROTEIN GUID	51	40	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16911	16917		10.1074/jbc.270.28.16911	http://dx.doi.org/10.1074/jbc.270.28.16911			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622508	hybrid			2022-12-27	WOS:A1995RJ34700069
J	KAWANO, T; KOYAMA, S; TAKEMATSU, H; KOZUTSUMI, Y; KAWASAKI, H; KAWASHIMA, S; KAWASAKI, T; SUZUKI, A				KAWANO, T; KOYAMA, S; TAKEMATSU, H; KOZUTSUMI, Y; KAWASAKI, H; KAWASHIMA, S; KAWASAKI, T; SUZUKI, A			MOLECULAR-CLONING OF CYTIDINE MONOPHOSPHO-N-ACETYLNEURAMINIC ACID HYDROXYLASE - REGULATION OF SPECIES-SPECIFIC AND TISSUE-SPECIFIC EXPRESSION OF N-GLYCOLYLNEURAMINIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HANGANUTZIU-DEICHER ANTIGEN; MOUSE-LIVER CYTOSOL; GLYCOLOYLNEURAMINIC ACID; GLYCOLYNEURAMINIC ACID; GANGLIOSIDE EXPRESSION; MONOCLONAL-ANTIBODIES; SIALIC ACIDS; BIOSYNTHESIS; RAT; CHROMATOGRAPHY	Cytidine monophospho-N-acetylneuraminic acid (CMP-NeuAc) hydroxylase, which is the key enzyme for the synthesis of N-glycolylneuraminic acid (NeuGc), has been purified from the cytosolic fraction of mouse liver, as described in our previous paper. The amino acid sequences of the purified CMP-NeuAc hydroxylase, and peptides obtained by lysylendopeptidase digestion, were used to synthesize specific oligonucleotide primers. A mouse cDNA clone of the enzyme was obtained by a combination of the polymerase chain reaction and rapid amplification of cDNA ends. The sequence of the clone contained an open reading frame coding for a protein of 577 amino acids with a predicted molecular mass of 66 kDa. The deduced sequence included the amino acid sequences obtained for the purified enzyme and peptides, and a complete match was obtained for 159 residues. The enzyme has neither a signal peptide sequence nor a membrane spanning domain, which is consistent with localization of the enzyme in the cytosol. Transfection of a cDNA construct to COS-1 cells increased the enzyme activity and the amount of NeuGc. Comparison of the sequence with GenBank data indicated that no similar sequence has been reported so far. Northern blot analysis of various mouse tissues with the enzyme cDNA as a probe indicated that expression of NeuGc is related to the level of CMP-NeuAc hydroxylase mRNA. On Southern blot analysis with the same probe, cross-hybridizing bands were detected in the human and fish genomes.	TOKYO METROPOLITAN INST MED SCI,DEPT MEMBRANE BIOCHEM,BUNKYO KU,TOKYO 113,JAPAN; TOKYO METROPOLITAN INST MED SCI,DEPT MOLEC BIOL,BUNKYO KU,TOKYO 113,JAPAN; KYOTO UNIV,FAC PHARMACEUT SCI,DEPT BIOL CHEM,SAKYO KU,KYOTO 606,JAPAN	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Kyoto University			Kawano, Takehiro/A-3080-2016; Kawasaki, Hiroshi/C-3048-2011	Kawasaki, Hiroshi/0000-0002-2517-159X				BOUHOURS D, 1988, J BIOL CHEM, V263, P15540; BUSCHER HP, 1977, EUR J BIOCHEM, V77, P297, DOI 10.1111/j.1432-1033.1977.tb11668.x; DATTA AK, 1995, J BIOL CHEM, V270, P1497, DOI 10.1074/jbc.270.4.1497; FUKUNAGA R, 1984, P NATL ACAD SCI-BIOL, V81, P5086, DOI 10.1073/pnas.81.16.5086; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; HARA S, 1989, ANAL BIOCHEM, V179, P162, DOI 10.1016/0003-2697(89)90218-2; HIDARI K, 1991, J BIOCHEM-TOKYO, V110, P412, DOI 10.1093/oxfordjournals.jbchem.a123595; HIGASHI H, 1985, CANCER RES, V45, P3796; HIGASHI H, 1977, BIOCHEM BIOPH RES CO, V79, P388, DOI 10.1016/0006-291X(77)90169-3; HIGGA HH, 1985, J BIOL CHEM, V260, P8838; HIRABAYASHI Y, 1987, JPN J CANCER RES, V78, P614; IWAMORI M, 1978, BIOCHIM BIOPHYS ACTA, V528, P257; KAWAI T, 1991, CANCER RES, V51, P1242; KAWANO T, 1993, INT J CANCER, V53, P91, DOI 10.1002/ijc.2910530118; KAWANO T, 1993, GLYCOCONJUGATE J, V10, P109, DOI 10.1007/BF00731194; KAWANO T, 1994, J BIOL CHEM, V269, P9024; KAWASHIMA I, 1993, J BIOCHEM-TOKYO, V114, P186, DOI 10.1093/oxfordjournals.jbchem.a124153; KELM S, 1993, GLYCOCONJUGATE J, V10, P330, DOI 10.1007/BF01210145; KITAGAKIOGAWA H, 1990, BIOCHIM BIOPHYS ACTA, V1033, P49, DOI 10.1016/0304-4165(90)90193-Z; KITAJIMA K, 1988, J BIOL CHEM, V263, P18269; KOTANI M, 1993, GLYCOBIOLOGY, V3, P137, DOI 10.1093/glycob/3.2.137; KOZUTSUMI Y, 1991, J BIOCHEM, V110, P429, DOI 10.1093/oxfordjournals.jbchem.a123598; KOZUTSUMI Y, 1990, J BIOCHEM, V108, P704, DOI 10.1093/oxfordjournals.jbchem.a123268; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LEPERS A, 1990, EUR J BIOCHEM, V193, P715, DOI 10.1111/j.1432-1033.1990.tb19391.x; LEPERS A, 1989, FEBS LETT, V250, P245, DOI 10.1016/0014-5793(89)80731-8; MIYAKE M, 1990, CANCER, V65, P499, DOI 10.1002/1097-0142(19900201)65:3<499::AID-CNCR2820650321>3.0.CO;2-P; MUCHMORE EA, 1989, J BIOL CHEM, V264, P20216; NAKAMURA K, 1983, J BIOCHEM-TOKYO, V94, P1359, DOI 10.1093/oxfordjournals.jbchem.a134482; NAKAMURA K, 1988, J BIOCHEM-TOKYO, V103, P201, DOI 10.1093/oxfordjournals.jbchem.a122232; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; ONO E, 1989, INFECT IMMUN, V57, P907, DOI 10.1128/IAI.57.3.907-911.1989; SAITO M, 1992, J NEUROCHEM, V58, P83, DOI 10.1111/j.1471-4159.1992.tb09280.x; Sambrook J, 1989, MOL CLONING LABORATO; SCHAUER R, 1971, H-S Z PHYSIOL CHEM, V352, P1282, DOI 10.1515/bchm2.1971.352.2.1282; SCHAUER R, 1991, CARBOHYD RES, V213, P353, DOI 10.1016/S0008-6215(00)90623-2; Schauer R., 1982, CELL BIOL MONOGRAPHS, V10; SHAW L, 1988, BIOL CHEM H-S, V369, P477, DOI 10.1515/bchm3.1988.369.1.477; SUZUKI Y, 1987, BIOCHIM BIOPHYS ACTA, V903, P417, DOI 10.1016/0005-2736(87)90048-4; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x; TAKEMATSU H, 1993, J BIOCH, V115, P381; TSUJI S, 1988, J BIOCHEM, V104, P498, DOI 10.1093/oxfordjournals.jbchem.a122498; VARKI A, 1992, GLYCOBIOLOGY, V2, P25, DOI 10.1093/glycob/2.1.25; VASKOVSKY VE, 1970, COMP BIOCHEM PHYSIOL, V34, P163, DOI 10.1016/0010-406X(70)90064-2; WAKAMIYA N, 1991, BIOCHEM BIOPH RES CO, V181, P310, DOI 10.1016/S0006-291X(05)81419-6; WAKAMIYA N, 1991, BIOCHEM BIOPH RES CO, V181, P810; White T.J., 1990, PCR PROTOCOLS GUIDE, V18, P315	48	124	133	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16458	16463		10.1074/jbc.270.27.16458	http://dx.doi.org/10.1074/jbc.270.27.16458			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608218	hybrid			2022-12-27	WOS:A1995RH22600086
J	ZHANG, JN; WILKS, JE; BILLADELLO, JJ				ZHANG, JN; WILKS, JE; BILLADELLO, JJ			CHARACTERIZATION OF A NUCLEAR-PROTEIN THAT INTERACTS WITH REGULATORY ELEMENTS IN THE HUMAN B-CREATINE-KINASE GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-ARTERY OCCLUSION; CARDIAC-MUSCLE; DEVELOPMENTAL REGULATION; SKELETAL-MUSCLE; PROMOTER REGION; BINDING PROTEIN; MESSENGER-RNAS; POLYMERASE-III; EXPRESSION; TRANSCRIPTION	The B creatine kinase gene is regulated by an array of positive and negative cis-elements in the 5'-flanking DNA that function in both muscle and nonmuscle cells. In C2C12 myogenic cells M and B creatine kinase mRNAs are coordinately up-regulated in the early stages of myogenesis and then undergo distinct regulatory programs. The B creatine kinase gene is down-regulated in the late stages of myogenesis as M creatine kinase becomes the predominant species in mature myotubes, Sequences between -92 and +80 of the B creatine kinase gene confer a regulated pattern of expression to chimeric plasmids that closely resembles the time course of expression of the endogenous B creatine kinase gene in C2C12 cells undergoing differentiation. We show that sequences within the first exon of the B creatine kinase gene are important for the developmental regulation of the gene in C2C12 cells and that these sequences bind a nuclear protein that shows a similar tissue-specific distribution and developmentally regulated expression to that of the endogenous B creatine kinase gene.	WASHINGTON UNIV,SCH MED,DIV CARDIOVASC,ST LOUIS,MO 63110	Washington University (WUSTL)								AMACHER SL, 1993, MOL CELL BIOL, V13, P2753, DOI 10.1128/MCB.13.5.2753; APPLE FS, 1985, J APPL PHYSIOL, V59, P149, DOI 10.1152/jappl.1985.59.1.149; BAINS W, 1984, MOL CELL BIOL, V4, P1449, DOI 10.1128/MCB.4.8.1449; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BENFIELD PA, 1988, GENE, V63, P227, DOI 10.1016/0378-1119(88)90527-6; BERGSMA D, 1986, MOL BIOL MUSCLE DEV, P531; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; BUSKIN JN, 1989, MOL CELL BIOL, V9, P2627, DOI 10.1128/MCB.9.6.2627; CHANDLER WL, 1984, CLIN CHEM, V30, P1804; CHNG JLC, 1990, SCIENCE, V248, P1003, DOI 10.1126/science.2343304; CHNG JLC, 1994, J BIOL CHEM, V269, P2336; DEPONTIZILLI L, 1988, P NATL ACAD SCI USA, V85, P1389, DOI 10.1073/pnas.85.5.1389; EPPENBERGER HM, 1964, DEV BIOL, V10, P1, DOI 10.1016/0012-1606(64)90002-8; FONTANET HL, 1991, CIRC RES, V68, P1007, DOI 10.1161/01.RES.68.4.1007; FRIEDMAN DL, 1989, EXP EYE RES, V49, P445, DOI 10.1016/0014-4835(89)90053-5; HAWKER KJ, 1993, BIOTECHNIQUES, V14, P764; HEBERLEIN U, 1988, NATURE, V331, P410, DOI 10.1038/331410a0; HOBSON GM, 1990, MOL CELL BIOL, V10, P6533, DOI 10.1128/MCB.10.12.6533; HOBSON GM, 1988, NUCLEIC ACIDS RES, V16, P8925, DOI 10.1093/nar/16.18.8925; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; INGWALL JS, 1993, CIRCULATION, V87, P58; INGWALL JS, 1979, HEART CREATINE KINAS, V1, P9; JOHNSON JE, 1989, MOL CELL BIOL, V9, P3393, DOI 10.1128/MCB.9.8.3393; KADDURAHDAOUK R, 1990, MOL CELL BIOL, V10, P1476, DOI 10.1128/MCB.10.4.1476; KAWAMOTO S, 1994, J BIOL CHEM, V269, P15101; KAYE FJ, 1987, J CLIN INVEST, V79, P1412, DOI 10.1172/JCI112969; KIM SJ, 1992, J BIOL CHEM, V267, P15140; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; LOUGH J, 1977, DEV BIOL, V57, P330, DOI 10.1016/0012-1606(77)90219-6; MARIMAN E, 1991, GENE, V102, P205, DOI 10.1016/0378-1119(91)90079-Q; MARIMAN E C M, 1987, Genomics, V1, P126, DOI 10.1016/0888-7543(87)90004-8; MEDCALF RL, 1990, J BIOL CHEM, V265, P14618; MITCHELL MT, 1992, J BIOL CHEM, V267, P1995; MITCHELL MT, 1990, J BIOL CHEM, V265, P8259; MITCHELL MT, 1993, J BIOL CHEM, V268, P1141; NAKAMURA S, 1993, J BIOL CHEM, V268, P11670; NIKOVITS W, 1990, MOL CELL BIOL, V10, P3468, DOI 10.1128/MCB.10.7.3468; PFEIFFER FE, 1984, ARCH NEUROL-CHICAGO, V41, P1175, DOI 10.1001/archneur.1984.04050220073017; REISS NA, 1981, J BIOL CHEM, V256, P5741; RITCHIE ME, 1991, NUCLEIC ACIDS RES, V19, P6231, DOI 10.1093/nar/19.22.6231; ROSENBERG UB, 1981, EUR J BIOCHEM, V116, P87, DOI 10.1111/j.1432-1033.1981.tb05304.x; SANDLER MA, 1994, J BIOL CHEM, V269, P21500; SARTORELLI V, 1990, GENE DEV, V4, P1811, DOI 10.1101/gad.4.10.1811; SCHULER GD, 1988, CELL, V55, P1115, DOI 10.1016/0092-8674(88)90256-5; Seraydarian M W, 1986, Adv Exp Med Biol, V194, P41; SHAPIRO IM, 1992, J BONE MINER RES, V7, P493; SHARKEY SW, 1989, AM J PHYSIOL, V256, pH508, DOI 10.1152/ajpheart.1989.256.2.H508; SHARKEY SW, 1991, CIRCULATION, V84, P333, DOI 10.1161/01.CIR.84.1.333; SOMJEN D, 1984, BIOCHEM J, V219, P1037; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; TRASK RV, 1990, BIOCHIM BIOPHYS ACTA, V1049, P182, DOI 10.1016/0167-4781(90)90039-5; TRASK RV, 1992, NUCLEIC ACIDS RES, V20, P2313, DOI 10.1093/nar/20.9.2313; VINCENT CK, 1993, MOL CELL BIOL, V13, P1264, DOI 10.1128/MCB.13.2.1264; WEINTRAUB H, 1990, P NATL ACAD SCI USA, V87, P5623, DOI 10.1073/pnas.87.15.5623; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783	57	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16134	16139		10.1074/jbc.270.27.16134	http://dx.doi.org/10.1074/jbc.270.27.16134			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608177	hybrid			2022-12-27	WOS:A1995RH22600040
J	GILL, SS; COWLES, EA; FRANCIS, V				GILL, SS; COWLES, EA; FRANCIS, V			IDENTIFICATION, ISOLATION, AND CLONING OF A BACILLUS-THURINGIENSIS CRYIAC TOXIN-BINDING PROTEIN FROM THE MIDGUT OF THE LEPIDOPTERAN INSECT HELIOTHIS-VIRESCENS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANE; AMINO-ACID SEQUENCE; CATION-SELECTIVE CHANNELS; PLANAR LIPID BILAYERS; DELTA-ENDOTOXIN; AMINOPEPTIDASE-N; MOLECULAR-CLONING; VAR ISRAELENSIS; SPECIFICITY; RESISTANCE	Bacillus thuringiensis toxins are insecticidal to a variety of insect species, The selectivity of the toxins produced by these bacteria is dependent on both the toxin structure and the receptor sites that are present in different insect species, One of these toxins, CryIAc, is highly insecticidal to the noctuid pest Heliothis virescens. Using toxin overlay assay, a 120-kDa glycoprotein was identified as a toxin-binding protein. This protein was partially purified, its N-terminal sequence was determined, and the full-length cDNA encoding this protein was isolated from a H. virescens midgut library, The B. thuringiensis toxin-binding protein, BTBP1, has high homology to aminopeptidase N from eukaryotes and prokaryotes.	UNIV CALIF RIVERSIDE, ENVIRONM TOXICOL GRAD PROGRAM, RIVERSIDE, CA 92521 USA; UNIV CALIF RIVERSIDE, DEPT ENTOMOL, RIVERSIDE, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside					NIEHS NIH HHS [ES03298] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003298] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BULLA LA, 1980, CRC CR REV MICROBIOL, V8, P147, DOI 10.3109/10408418009081124; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHEN XJ, 1993, P NATL ACAD SCI USA, V90, P9041, DOI 10.1073/pnas.90.19.9041; CHOW E, 1989, APPL ENVIRON MICROB, V55, P2779, DOI 10.1128/AEM.55.11.2779-2788.1989; CHRISTENSEN JE, 1995, GENE, V155, P89, DOI 10.1016/0378-1119(94)00924-H; CIOFFI M, 1983, TISSUE CELL, V15, P781, DOI 10.1016/0040-8166(83)90050-2; COWLES EA, 1995, APPL ENVIRON MICROB, V61, P2738, DOI 10.1128/AEM.61.7.2738-2744.1995; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; FERRE J, 1991, P NATL ACAD SCI USA, V88, P5119, DOI 10.1073/pnas.88.12.5119; GARCIAALVAREZ N, 1991, EUR J BIOCHEM, V202, P993, DOI 10.1111/j.1432-1033.1991.tb16461.x; GARCZYNSKI SF, 1995, INSECT BIOCHEM MOLEC, V25, P409, DOI 10.1016/0965-1748(94)00072-7; GARCZYNSKI SF, 1991, APPL ENVIRON MICROB, V57, P2816, DOI 10.1128/AEM.57.10.2816-2820.1991; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GE AZ, 1989, P NATL ACAD SCI USA, V86, P4037, DOI 10.1073/pnas.86.11.4037; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; GILL SS, 1992, ANNU REV ENTOMOL, V37, P615, DOI 10.1146/annurev.en.37.010192.003151; GOULD F, 1992, P NATL ACAD SCI USA, V89, P7986, DOI 10.1073/pnas.89.17.7986; HOFMANN C, 1988, P NATL ACAD SCI USA, V85, P7844, DOI 10.1073/pnas.85.21.7844; HOFTE H, 1989, MICROBIOL REV, V53, P242; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P227; JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; KNIGHT PJK, 1995, J BIOL CHEM, V270, P17765, DOI 10.1074/jbc.270.30.17765; KNOWLES BH, 1989, FEBS LETT, V244, P259, DOI 10.1016/0014-5793(89)80540-X; KNOWLES BH, 1991, P ROY SOC B-BIOL SCI, V245, P31, DOI 10.1098/rspb.1991.0084; KNOWLES BH, 1987, BIOCHIM BIOPHYS ACTA, V924, P509, DOI 10.1016/0304-4165(87)90167-X; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1954, J BIOL CHEM, V207, P19; MANLEY JL, 1985, MOL CELL BIOL, V5, P373, DOI 10.1128/MCB.5.2.373; MBUNGU D, 1995, ARCH BIOCHEM BIOPHYS, V318, P489, DOI 10.1006/abbi.1995.1258; MURPHY GJP, 1991, FEBS LETT, V289, P4, DOI 10.1016/0014-5793(91)80895-A; ODDOU P, 1991, EUR J BIOCHEM, V202, P673, DOI 10.1111/j.1432-1033.1991.tb16422.x; ODDOU P, 1993, EUR J BIOCHEM, V212, P145, DOI 10.1111/j.1432-1033.1993.tb17644.x; OLSEN J, 1988, FEBS LETT, V238, P307, DOI 10.1016/0014-5793(88)80502-7; PERCY J, 1983, J INVERTEBR PATHOL, V41, P86, DOI 10.1016/0022-2011(83)90239-2; SAIKI I, 1993, INT J CANCER, V54, P137, DOI 10.1002/ijc.2910540122; SANGADALA S, 1994, J BIOL CHEM, V269, P10088; SCHWARTZ JL, 1991, BIOCHIM BIOPHYS ACTA, V1065, P250, DOI 10.1016/0005-2736(91)90237-3; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cellbio.2.1.255; SINGH GJP, 1986, PESTIC BIOCHEM PHYS, V26, P36, DOI 10.1016/0048-3575(86)90060-X; SLATIN SL, 1990, BIOCHEM BIOPH RES CO, V169, P765, DOI 10.1016/0006-291X(90)90397-6; TABASHNIK BE, 1994, P NATL ACAD SCI USA, V91, P4120, DOI 10.1073/pnas.91.10.4120; TOMITA M, 1994, INT J BIOCHEM, V26, P977, DOI 10.1016/0020-711X(94)90068-X; TUPPY HANS, 1962, ZEIT PHYSIOL CHEM, V329, P278; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; VADLAMUDI RK, 1995, J BIOL CHEM, V270, P5490, DOI 10.1074/jbc.270.10.5490; VANRIE J, 1990, SCIENCE, V247, P72, DOI 10.1126/science.2294593; VANRIE J, 1989, EUR J BIOCHEM, V186, P239, DOI 10.1111/j.1432-1033.1989.tb15201.x; WALTERS FS, 1994, INSECT BIOCHEM MOLEC, V24, P963, DOI 10.1016/0965-1748(94)90133-3; WATT VM, 1989, J BIOL CHEM, V264, P5480; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; WU D, 1992, J BIOL CHEM, V267, P2311; WU Q, 1990, P NATL ACAD SCI USA, V87, P993, DOI 10.1073/pnas.87.3.993; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0	56	173	206	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27277	27282		10.1074/jbc.270.45.27277	http://dx.doi.org/10.1074/jbc.270.45.27277			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592988	hybrid			2022-12-27	WOS:A1995TE58300088
J	LAIRD, AD; TAYLOR, SJ; OBERST, M; SHALLOWAY, D				LAIRD, AD; TAYLOR, SJ; OBERST, M; SHALLOWAY, D			RAF-1 IS ACTIVATED DURING MITOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN-KINASE; CELL-CYCLE; MAP KINASE; PHOSPHORYLATION; TRANSFORMATION; MATURATION; ARREST; ONCOPROTEIN; REQUIREMENT; RESIDUES	The Raf-1 serine/threonine kinase transmits proliferative and developmental signals to downstream effecters in the mitogen-activated protein kinase cascade, Studies to date have concentrated on its role in growth factor-mediated activation of the cell cycle. We show here that Raf-l kinase activity is also highly stimulated during mitosis, with an attendant distinctive electrophoretic mobility shift due to hyperphosphorylation. These results suggest that Raf-1 may play a role in traversal of at least two distinct phases of the cell cycle.	CORNELL UNIV, BIOCHEM MOLEC & CELL BIOL SECT, ITHACA, NY 14853 USA	Cornell University					NCI NIH HHS [CA 32317] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA032317] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; DAAR I, 1991, SCIENCE, V253, P74, DOI 10.1126/science.1829549; DANOS O, 1988, P NATL ACAD SCI USA, V85, P6460, DOI 10.1073/pnas.85.17.6460; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; FABIAN JR, 1993, J CELL BIOL, V122, P645, DOI 10.1083/jcb.122.3.645; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; FORD JC, 1994, SCIENCE, V265, P533, DOI 10.1126/science.8036497; GALAKTIONOV K, 1995, GENE DEV, V9, P1046, DOI 10.1101/gad.9.9.1046; GARDNER AM, 1994, METHOD ENZYMOL, V238, P258; HACCARD O, 1993, SCIENCE, V262, P1262, DOI 10.1126/science.8235656; HALL A, 1994, SCIENCE, V264, P1413, DOI 10.1126/science.8197454; HEIDER H, 1994, EUR J BIOCHEM, V219, P513, DOI 10.1111/j.1432-1033.1994.tb19966.x; IZUMI T, 1991, J BIOL CHEM, V266, P7933; JAMAL S, 1995, ONCOGENE, V10, P2095; LI SF, 1993, P NATL ACAD SCI USA, V90, P9247, DOI 10.1073/pnas.90.20.9247; MAMON H, 1991, COLD SPRING HARB SYM, V56, P251; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; MORRISON D, 1994, SCIENCE, V266, P56, DOI 10.1126/science.7939645; MORRISON DK, 1995, METHOD ENZYMOL, V255, P301; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; MUSLIN AJ, 1993, MOL CELL BIOL, V13, P4197, DOI 10.1128/MCB.13.7.4197; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; SAMUELS ML, 1993, MOL CELL BIOL, V13, P6241, DOI 10.1128/MCB.13.10.6241; SHALLOWAY D, 1991, ADV CANCER RES, V57, P185; SHENOY S, 1989, CELL, V57, P763, DOI 10.1016/0092-8674(89)90791-5; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; STEWART N, 1995, ONCOGENE, V10, P109; TAMEMOTO H, 1992, J BIOL CHEM, V267, P20293; WANG JYJ, 1994, TRENDS BIOCHEM SCI, V19, P373, DOI 10.1016/0968-0004(94)90114-7; WILLIAMS NG, 1992, P NATL ACAD SCI USA, V89, P2922, DOI 10.1073/pnas.89.7.2922	35	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26742	26745		10.1074/jbc.270.45.26742	http://dx.doi.org/10.1074/jbc.270.45.26742			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592906	hybrid			2022-12-27	WOS:A1995TE58300006
J	LERNER, EC; QIAN, YM; BLASKOVICH, MA; FOSSUM, RD; VOGT, A; SUN, JZ; COX, AD; DER, CJ; HAMILTON, AD; SEBTI, SM				LERNER, EC; QIAN, YM; BLASKOVICH, MA; FOSSUM, RD; VOGT, A; SUN, JZ; COX, AD; DER, CJ; HAMILTON, AD; SEBTI, SM			RAS CAAX PEPTIDOMIMETIC FTI-277 SELECTIVELY BLOCKS ONCOGENIC RAS SIGNALING BY INDUCING CYTOPLASMIC ACCUMULATION OF INACTIVE RAS-RAF COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE ASSOCIATION; PROTEIN; P21RAS; FARNESYLTRANSFERASE; TRANSFORMATION; INHIBITION; FARNESYL; TERMINUS	Ras-induced malignant transformation requires Ras farnesylation, a lipid posttranslational modification catalyzed by farnesyltransferase (FTase). Inhibitors of this enzyme have been shown to block Ras-dependent transformation, but the mechanism by which this occurs remains largely unknown. We have designed FTI-276, a peptide mimetic of the COOH-terminal Cys-Val-Ile-Met of K-Ras4B that inhibited potently FTase in vitro (IC50 = 500 pM) and was highly selective for FTase over geranylgeranyltransferase I (GGTase I) (IC50 = 50 nM). FTI-277, the methyl ester derivative of FTI-276, was extremely potent (IC50 = 100 nM) at inhibiting H-Ras, but not the geranylgeranylated Rap1A processing in whole cells. Treatment of H-Ras oncogene-transformed NIH 3T3 cells with FTI-277 blocked recruitment to the plasma membrane and subsequent activation of the serine/threonine kinase c-Raf-1 in cells transformed by farnesylated Ras (H-RasF), but not geranylgeranylated, Ras (H-RasGG), FTI-277 induced accumulation of cytoplasmic non-farnesylated H-Ras that was able to bind Raf and form cytoplasmic Ras/Raf complexes in which Raf kinase was not activated, Furthermore, FTI-277 blocked constitutive activation of mitogen-activated protein kinase (MAPK) in H-RasF, but not H-RasGG, or Raf-transformed cells, FTI-277 also inhibited oncogenic K-Ras4B processing and constitutive activation of MAPK, but the concentrations required were 100-fold higher than those needed for H-Ras inhibition. The results demonstrate that FTI-277 blocks Ras oncogenic signaling by accumulating inactive Ras/Raf complexes in the cytoplasm, hence preventing constitutive activation of the MAPK cascade.	UNIV PITTSBURGH,SCH MED,DEPT PHARMACOL,PITTSBURGH,PA 15261; UNIV PITTSBURGH,FAC ARTS & SCI,DEPT CHEM,PITTSBURGH,PA 15261; UNIV N CAROLINA,DEPT PHARMACOL,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT RADIAT ONCOL,CHAPEL HILL,NC 27599	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill				Cox, Adrienne D./0000-0002-4901-2454; Der, Channing/0000-0002-7751-2747	NCI NIH HHS [U19-CA6777, CA-61951, CA-55823] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA061951, R01CA055823] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barbacid M, 1986, Important Adv Oncol, P3; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BUSS JE, 1989, SCIENCE, V243, P1600, DOI 10.1126/science.2648572; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; COX AD, 1992, MOL CELL BIOL, V12, P2606, DOI 10.1128/MCB.12.6.2606; COX AD, 1994, J BIOL CHEM, V269, P19203; GARCIA AM, 1993, J BIOL CHEM, V268, P18415; GIBBS JB, 1991, CELL, V65, P1, DOI 10.1016/0092-8674(91)90352-Y; GIBBS JB, 1989, P NATL ACAD SCI USA, V86, P6630, DOI 10.1073/pnas.86.17.6630; GIBBS JB, 1994, CELL, V77, P175, DOI 10.1016/0092-8674(94)90308-5; GRAHAM SL, 1994, J MED CHEM, V37, P725, DOI 10.1021/jm00032a004; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HALLBERG B, 1994, J BIOL CHEM, V269, P3913; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; JACKSON JH, 1990, P NATL ACAD SCI USA, V87, P3042, DOI 10.1073/pnas.87.8.3042; JAMES GL, 1994, J BIOL CHEM, V269, P27705; JAMES GL, 1995, J BIOL CHEM, V270, P6221, DOI 10.1074/jbc.270.11.6221; JAMES GL, 1993, SCIENCE, V260, P193; KATO K, 1992, P NATL ACAD SCI USA, V89, P6403, DOI 10.1073/pnas.89.14.6403; KOHL NE, 1994, P NATL ACAD SCI USA, V91, P9141, DOI 10.1073/pnas.91.19.9141; KOHL NE, 1993, SCIENCE, V260, P1934, DOI 10.1126/science.8316833; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LERNER EC, 1995, J BIOL CHEM, V270, P26770, DOI 10.1074/jbc.270.45.26770; MANNE V, 1990, P NATL ACAD SCI USA, V87, P7541, DOI 10.1073/pnas.87.19.7541; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MCCORMICK F, 1994, CURR OPIN GENET DEV, V4, P71, DOI 10.1016/0959-437X(94)90093-0; MCCORMICK F, 1993, NATURE, V363, P15, DOI 10.1038/363015a0; MOORES SL, 1991, J BIOL CHEM, V266, P14603; NIGAM M, 1993, J BIOL CHEM, V268, P20695; QIAN YM, 1994, BIOORG MED CHEM LETT, V4, P2579, DOI 10.1016/S0960-894X(01)80287-0; QIAN YM, 1994, J BIOL CHEM, V269, P12410; REISS Y, 1991, J BIOL CHEM, V266, P10672; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; SUN JZ, 1995, CANCER RES, V55, P4243; VOGT A, 1995, J BIOL CHEM, V270, P660, DOI 10.1074/jbc.270.2.660; WILLUMSEN BM, 1984, EMBO J, V3, P2581, DOI 10.1002/j.1460-2075.1984.tb02177.x; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0	39	336	348	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26802	26806		10.1074/jbc.270.45.26802	http://dx.doi.org/10.1074/jbc.270.45.26802			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592920	Green Published, hybrid			2022-12-27	WOS:A1995TE58300020
J	MOTTA, A; BREMNES, B; MORELLI, MAC; FRANK, RW; SAVIANO, G; BAKKE, O				MOTTA, A; BREMNES, B; MORELLI, MAC; FRANK, RW; SAVIANO, G; BAKKE, O			STRUCTURE-ACTIVITY RELATIONSHIP OF THE LEUCINE-BASED SORTING MOTIFS IN THE CYTOSOLIC TAIL OF THE MAJOR HISTOCOMPATIBILITY COMPLEX-ASSOCIATED INVARIANT CHAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; IMMUNOGENIC PEPTIDE-FRAGMENTS; HELIX-FORMING TENDENCIES; SECONDARY STRUCTURE; AMINO-ACIDS; INTERNALIZATION SIGNAL; PROTEIN STRUCTURES; CYTOPLASMIC TAIL; WATER SOLUTION; IDENTIFICATION	The cytosolic tail of the major histocompatibility complex-associated invariant chain protein contains two Leu-based motifs that both mediate efficient sorting to the endocytic pathway, Nuclear magnetic resonance data on a peptide of 27 residues corresponding to the cytosolic tail of human invariant chain indicate that in water at pH 7.4 the membrane distal motif Leu(7)-Ile(8) lies within a nascent helix, while the membrane proximal motif Met(16)-Leu(17) is part of a turn. The presence of a small amount of methanol stabilizes an alpha helix from Gln(4) to Leu(17) with a kink on pro(15), Point mutations of the cytosolic tail of the protein suggest that amino-terminal residues located in spatial proximity to the Leu motifs contribute to efficient internalization and targeting to endosomes in transfected COS cells, Residues on the spatially opposite side of the Leu motifs were, on the other hand, mutated with no measurable effect on targeting, Structural and biological data thus suggest that the signals are not continuous but consist of ''signal patches'' formed by the three-dimensional structure of the cytosolic tail of invariant chain.	UNIV OSLO,DEPT BIOL,DIV MOLEC CELL BIOL,N-0316 OSLO,NORWAY; UNIV BASILICATA,DIPARTIMENTO CHIM,I-85100 POTENZA,ITALY; UNIV HEIDELBERG,ZENTRUM MOLEK BIOL,D-69052 HEIDELBERG,GERMANY	University of Oslo; University of Basilicata; Ruprecht Karls University Heidelberg	MOTTA, A (corresponding author), CNR,IST CHIM MOLEC INTERESSE BIOL,I-80072 NAPLES,ITALY.		Saviano, Gabriella/AAZ-5650-2021	Castiglione Morelli, Maria Antonietta/0000-0003-3967-3117; Motta, Andrea/0000-0002-8643-658X; Saviano, Gabriella/0000-0002-1112-2041; Bakke, Oddmund/0000-0003-4843-7626				ARNESON LS, 1995, J CELL BIOL, V129, P1217, DOI 10.1083/jcb.129.5.1217; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BANSAL A, 1991, CELL, V67, P1195, DOI 10.1016/0092-8674(91)90295-A; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BIJLMAKERS MJE, 1994, J EXP MED, V180, P623, DOI 10.1084/jem.180.2.623; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; BREMNES B, 1994, J CELL SCI, V107, P2021; BROOKS CL, 1993, J AM CHEM SOC, V115, P11034, DOI 10.1021/ja00076a089; CARPINO LA, 1972, J ORG CHEM, V37, P3404, DOI 10.1021/jo00795a005; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; COSTE J, 1990, TETRAHEDRON LETT, V31, P205, DOI 10.1016/S0040-4039(00)94371-5; DROBNY G, 1979, FARADAY DIV CHEM SOC, V13, P49; DYSON HJ, 1988, J MOL BIOL, V201, P161, DOI 10.1016/0022-2836(88)90446-9; DYSON HJ, 1988, J MOL BIOL, V201, P201, DOI 10.1016/0022-2836(88)90447-0; EBERLE W, 1991, CELL, V67, P1203, DOI 10.1016/0092-8674(91)90296-B; FOROOD B, 1993, P NATL ACAD SCI USA, V90, P838, DOI 10.1073/pnas.90.3.838; Frank R., 1988, MODERN METHODS PROTE, V3, P41; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; GUNTERT P, 1989, J AM CHEM SOC, V111, P3997; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; HUYLEBROECK D, 1988, GENE, V66, P163, DOI 10.1016/0378-1119(88)90354-X; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MARKS MS, 1990, J CELL BIOL, V111, P839, DOI 10.1083/jcb.111.3.839; NEUHAUS D, 1985, EUR J BIOCHEM, V151, P257, DOI 10.1111/j.1432-1033.1985.tb09096.x; ODORIZZI CG, 1994, J CELL BIOL, V126, P317, DOI 10.1083/jcb.126.2.317; OGATA S, 1994, J BIOL CHEM, V269, P5210; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; PADMANABHAN S, 1990, NATURE, V344, P268, DOI 10.1038/344268a0; PARDI A, 1984, J MOL BIOL, V180, P741, DOI 10.1016/0022-2836(84)90035-4; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; PIELA L, 1987, BIOPOLYMERS, V26, P1587, DOI 10.1002/bip.360260910; PIETERS J, 1993, J CELL SCI, V106, P831; POLINSKY A, 1992, BIOPOLYMERS, V32, P399, DOI 10.1002/bip.360320416; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; ROCHE PA, 1993, P NATL ACAD SCI USA, V84, P2688; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; SANDOVAL IV, 1994, J BIOL CHEM, V269, P6622; SIMONSEN A, 1993, INT IMMUNOL, V5, P903, DOI 10.1093/intimm/5.8.903; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; van Gunsteren W. F., 1987, GRONINGEN MOL SIMULA, P1; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; VANROMPUY L, 1982, J MOL BIOL, V161, P1, DOI 10.1016/0022-2836(82)90274-1; VAUX D, 1992, Trends in Cell Biology, V2, P189, DOI 10.1016/0962-8924(92)90232-C; WAGNER G, 1986, J MOL BIOL, V187, P131, DOI 10.1016/0022-2836(86)90413-4; WAGNER G, 1987, J MOL BIOL, V196, P611, DOI 10.1016/0022-2836(87)90037-4; WILDE A, 1994, J BIOL CHEM, V269, P7131; WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; WUTHRICH K, 1984, J MOL BIOL, V180, P715, DOI 10.1016/0022-2836(84)90034-2; Wuthrich K., 1986, NMR PROTEINS NUCL AC; ZUIDERWEG ERP, 1986, J MAGN RESON, V70, P336, DOI 10.1016/0022-2364(86)90020-X	59	45	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27165	27171		10.1074/jbc.270.45.27165	http://dx.doi.org/10.1074/jbc.270.45.27165			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592972	hybrid, Green Published			2022-12-27	WOS:A1995TE58300072
J	VIDAL, M; HOEKSTRA, D				VIDAL, M; HOEKSTRA, D			IN-VITRO FUSION OF RETICULOCYTE ENDOCYTIC VESICLES WITH LIPOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOSOME-ENDOSOME FUSION; MEMBRANE-FUSION; TRANSFERRIN RECEPTOR; VESICULAR TRANSPORT; SENDAI VIRUS; PROTEIN; REQUIRES; INVITRO; INHIBITORS; EXOCYTOSIS	Since reticulocytes have a high demand for iron, which is required for heme biosynthesis, these cells are highly specialized in the endocytosis of the iron carrier transferrin (Tf). From the resulting endocytic vesicles (EVs), iron is released and the vesicles rapidly return to the cell membrane where they fuse, causing the release of the apotransferrin. Due to a lack of other intracellular compartments, the endocytic vesicles can be readily isolated. In this study, we have investigated the fusogenic properties of EVs, using liposomes as target membranes. Membrane fusion was monitored by a lipid mixing assay based on the relief of fluorescence self-quenching, using octadecylrhodamine B-chloride (R18). Application of this procedure was verified and solidified by analysis of the fusion event by an independent lipid mixing assay, after in situ labeling of EVs, and by determination of the mixing of aqueous contents. We demonstrate that the endocytic vesicles are particularly prone to fuse with target membranes that contain dioleoylphosphatidylethanolamine (DOPE). Relative to DOPE, bilayers composed of phosphatidylserine or phosphatidylcholine show a reduced fusion activity with EV. The specific and strong inhibition of fusion by cyclosporin A and a peptide known to interfere with the propensity of DOPE to adopt the hexagonal HII phase suggests that the mechanism of fusion involves the ability of this lipid to readily adopt non-bilayer phases. ATP, GTP, and/or cytosol are not necessary to obtain fusion. However, trypsin treatment of the endocytic vesicles inhibits fusion, indicating the involvement of (a) protein(s) in the fusion event.	UNIV GRONINGEN,PHYSIOL CHEM LAB,9712 KZ GRONINGEN,NETHERLANDS	University of Groningen	VIDAL, M (corresponding author), UNIV MONTPELLIER 2,CNRS,URA 1856,PL E BATAILLON,CC 107,F-34095 MONTPELLIER,FRANCE.							ADAM M, 1986, J CELL PHYSIOL, V127, P8, DOI 10.1002/jcp.1041270103; ARTS EGJM, 1993, EUR J BIOCHEM, V217, P1001, DOI 10.1111/j.1432-1033.1993.tb18331.x; BARBIERI MA, 1994, J BIOL CHEM, V269, P18720; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BECK KA, 1992, J CELL BIOL, V119, P787, DOI 10.1083/jcb.119.4.787; BECKERS CJM, 1989, NATURE, V339, P397, DOI 10.1038/339397a0; BETTEBOBILLO P, 1995, EUR J BIOCHEM, V228, P199, DOI 10.1111/j.1432-1033.1995.0199o.x; COLOMBO MI, 1991, J BIOL CHEM, V266, P23438; CULLIS PR, 1978, BIOCHIM BIOPHYS ACTA, V513, P31, DOI 10.1016/0005-2736(78)90109-8; DIAZ R, 1989, NATURE, V339, P398, DOI 10.1038/339398a0; EPAND RM, 1993, BIOCHIM BIOPHYS ACTA, V1152, P128, DOI 10.1016/0005-2736(93)90239-V; EPAND RM, 1987, J BIOL CHEM, V262, P1526; GALLI T, 1994, J CELL BIOL, V125, P1015, DOI 10.1083/jcb.125.5.1015; GRASSO JA, 1990, BIOCHEM J, V266, P261, DOI 10.1042/bj2660261; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; HOEKSTRA D, 1982, BIOCHEMISTRY-US, V21, P6097, DOI 10.1021/bi00267a011; HULTSCH T, 1991, P NATL ACAD SCI USA, V88, P6229, DOI 10.1073/pnas.88.14.6229; KAGIWADA S, 1993, J BIOL CHEM, V268, P1430; KELSEY DR, 1990, J BIOL CHEM, V265, P12178; KLAPPE K, 1986, BIOCHEMISTRY-US, V25, P8252, DOI 10.1021/bi00373a019; KOK JW, 1990, EUR J CELL BIOL, V53, P173; KREMER JMH, 1977, BIOCHEMISTRY-US, V16, P3932, DOI 10.1021/bi00636a033; LENHARD JM, 1994, ARCH BIOCHEM BIOPHYS, V312, P474, DOI 10.1006/abbi.1994.1334; MARTIN I, 1992, ADV MEMBRANE FLUIDIT, V6, P365; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; MULLOCK BM, 1994, J CELL BIOL, V126, P1173, DOI 10.1083/jcb.126.5.1173; PITT A, 1991, EUR J CELL BIOL, V55, P328; PLEY U, 1993, CRIT REV BIOCHEM MOL, V28, P431, DOI 10.3109/10409239309078441; RAPOPORT SM, 1991, BLOOD CELL BIOCH ERY, P151; RUTLEDGE EA, 1991, J BIOL CHEM, V266, P21125; SCHEULE RK, 1986, BIOCHEMISTRY-US, V25, P4223, DOI 10.1021/bi00363a009; SIEGEL DP, 1986, BIOPHYS J, V49, P1171, DOI 10.1016/S0006-3495(86)83745-6; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; STECK TL, 1973, J SUPRAMOL STRUCT, V1, P221; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; STROUS GJ, 1988, J BIOL CHEM, V263, P18197; Sztul Elizabeth S., 1992, Trends in Cell Biology, V2, P381, DOI 10.1016/0962-8924(92)90051-N; TAKIZAWA PA, 1993, CELL, V75, P593, DOI 10.1016/0092-8674(93)90477-8; TOURNOIS H, 1987, BIOCHEMISTRY-US, V26, P6613, DOI 10.1021/bi00395a008; VIDAL MJ, 1993, EUR J CELL BIOL, V60, P261; VOGEL SS, 1992, J BIOL CHEM, V267, P25640; WASCHULEWSKI IH, 1993, BRIT J PHARMACOL, V108, P892, DOI 10.1111/j.1476-5381.1993.tb13483.x; YEAGLE PL, 1992, BIOCHEMISTRY-US, V31, P3177, DOI 10.1021/bi00127a019; ZAAL KJM, 1994, EUR J CELL BIOL, V63, P10	44	54	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17823	17829		10.1074/jbc.270.30.17823	http://dx.doi.org/10.1074/jbc.270.30.17823			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629083	hybrid			2022-12-27	WOS:A1995RM26600031
J	AGNEW, BJ; MINAMIDE, LS; BAMBURG, JR				AGNEW, BJ; MINAMIDE, LS; BAMBURG, JR			REACTIVATION OF PHOSPHORYLATED ACTIN DEPOLYMERIZING FACTOR AND IDENTIFICATION OF THE REGULATORY SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION 2-DIMENSIONAL ELECTROPHORESIS; NUCLEAR TRANSPORT; CULTURED-CELLS; PORCINE BRAIN; CHICK BRAIN; COFILIN; PROTEINS; SEQUENCE; MUSCLE; CDNA	Actin depolymerizing factor (ADF) occurs naturally in two forms, one of which contains a phosphorylated Ser and does not bind G-actin or depolymerize F-actin. Removal of this phosphate in vitro by alkaline phosphatase restores full F-actin depolymerizing activity. To identify the phosphorylation site, [P-32]pADF was purified and digested with endoproteinase Lys-C. The digest contained only one P-32-labeled peptide. Further digestion with endoproteinase Asp-N and mass spectrometric analysis showed that this peptide came from the N terminus of ADF. Alkaline phosphatase treatment of one Asp-N peptide (mass 753) converted it to a peptide of mass 673, demonstrating that this peptide contains the phosphate group. Tandem mass spectrometric sequence analysis of this peptide identified the phosphorylated Ser as the encoded Ser(3) (Ser(2) in the processed protein). HeLa cells, transfected with either chick wild-type ADF cDNA or a cDNA mutated to code for Ala in place of Ser(24) or Thr(25), express and phosphorylate the exogenous ADF. Cells also expressed high levels of mutant ADF when Ser(3) was deleted or converted to either Ala or Glu. However, none of these mutants was phosphorylated, confirming that Ser(3) in the encoded ADF is the single in vivo regulatory site.	COLORADO STATE UNIV, DEPT BIOCHEM & MOLEC BIOL, FT COLLINS, CO 80523 USA; COLORADO STATE UNIV, PROGRAM NEURONAL GROWTH & DEV, FT COLLINS, CO 80523 USA	Colorado State University; Colorado State University					FIC NIH HHS [TW01856] Funding Source: Medline; NCRR NIH HHS [RR06217] Funding Source: Medline; NIGMS NIH HHS [GM35126, R01 GM035126] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [F06TW001856] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR006217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035126] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE H, 1990, BIOCHEMISTRY-US, V29, P7420, DOI 10.1021/bi00484a010; ABE H, 1993, EXP CELL RES, V206, P1, DOI 10.1006/excr.1993.1113; ADAMS ME, 1990, BIOCHEMISTRY-US, V29, P7414, DOI 10.1021/bi00484a009; BAMBURG JR, 1987, J CELL BIOL, V105, P2817, DOI 10.1083/jcb.105.6.2817; BAMBURG JR, 1991, METHOD ENZYMOL, V196, P125; BAORTO DM, 1992, J CELL BIOL, V117, P357, DOI 10.1083/jcb.117.2.357; DAVIDSON MML, 1994, BIOCHEM J, V301, P41, DOI 10.1042/bj3010041; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; EDWARDS KA, 1994, P NATL ACAD SCI USA, V91, P4589, DOI 10.1073/pnas.91.10.4589; GIULIANO KA, 1988, BIOCHEMISTRY-US, V27, P8931, DOI 10.1021/bi00425a009; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; HARRIS HE, 1982, ANAL BIOCHEM, V119, P102, DOI 10.1016/0003-2697(82)90672-8; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KIM SR, 1993, PLANT MOL BIOL, V21, P39, DOI 10.1007/BF00039616; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MATSUZAKI F, 1988, J BIOL CHEM, V263, P11564; MCKIM KS, 1994, MOL GEN GENET, V242, P346, DOI 10.1007/BF00280425; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; MOON AL, 1993, J CELL BIOL, V120, P421, DOI 10.1083/jcb.120.2.421; MORGAN TE, 1993, J CELL BIOL, V122, P623, DOI 10.1083/jcb.122.3.623; MORIYAMA K, 1990, J BIOL CHEM, V265, P5771; NELLES LP, 1976, ANAL BIOCHEM, V73, P522, DOI 10.1016/0003-2697(76)90202-5; NISHIDA E, 1984, BIOCHEMISTRY-US, V23, P5307, DOI 10.1021/bi00317a032; NISHIDA E, 1987, P NATL ACAD SCI USA, V84, P5262, DOI 10.1073/pnas.84.15.5262; NISHIZAWA M, 1992, EMBO J, V11, P2433, DOI 10.1002/j.1460-2075.1992.tb05308.x; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; OHTA Y, 1989, J BIOL CHEM, V264, P16143; ONO S, 1993, J MUSCLE RES CELL M, V14, P195, DOI 10.1007/BF00115454; OZOLS J, 1990, METHOD ENZYMOL, V182, P587; PARDEE JD, 1982, METHOD CELL BIOL, V24, P271; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; QUIRK S, 1993, BIOCHEMISTRY-US, V32, P8525, DOI 10.1021/bi00084a019; SAITO T, 1994, EXP CELL RES, V212, P49, DOI 10.1006/excr.1994.1117; Sambrook J, 1989, MOL CLONING LABORATO; SAMSTAG Y, 1994, P NATL ACAD SCI USA, V91, P4494, DOI 10.1073/pnas.91.10.4494; SILVER PA, 1991, CELL, V64, P489, DOI 10.1016/0092-8674(91)90233-O; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUN HQ, 1995, CURR OPIN CELL BIOL, V7, P102, DOI 10.1016/0955-0674(95)80051-4; SWIDERIK KM, 1995, IN PRESS METHODS ENZ; TAKAGI T, 1988, J BIOL CHEM, V263, P3097; WALSH DA, 1991, PHYSIOL REV, V71, P285, DOI 10.1152/physrev.1991.71.1.285; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; YONEZAWA N, 1991, J BIOL CHEM, V266, P17218; YONEZAWA N, 1989, EUR J BIOCHEM, V183, P235, DOI 10.1111/j.1432-1033.1989.tb14918.x; YONEZAWA N, 1985, J BIOL CHEM, V260, P4410	51	308	315	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17582	17587		10.1074/jbc.270.29.17582	http://dx.doi.org/10.1074/jbc.270.29.17582			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615564	hybrid			2022-12-27	WOS:A1995RK68900081
J	SCHAPER, S; MESSER, W				SCHAPER, S; MESSER, W			INTERACTION OF THE INITIATOR PROTEIN DNAA OF ESCHERICHIA-COLI WITH ITS DNA TARGET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION ORIGIN; GEL RETARDATION; AUTO-REGULATION; CHROMOSOME; INVITRO; SEQUENCE; BINDING; SITES; GENE; COMPLEXES	Equilibrium and kinetic rate constants were determined for the binding of the initiator protein DnaA of Escherichia coli to its binding site, the non-palindromic 9-bp DnaA box, using gel retardation techniques. The dissociation constant for specific binding was between 1 and 50 nM for individual DnaA boxes on 21-bp double-stranded oligonucleotides. Only DnaA boxes of the sequence TT(A/T)TNCACA resulted in specific fragment retention. Both the 9-bp consensus sequence and flanking sequences determined the binding efficiency. One DnaA monomer was found to bind to a DnaA box and to induce a bend of about 40 degrees.	MAX PLANCK INST MOLEC GENET,D-14195 BERLIN,GERMANY	Max Planck Society								ATLUNG T, 1985, MOL GEN GENET, V200, P442, DOI 10.1007/BF00425729; BARCELO F, 1991, BIOCHEMISTRY-US, V30, P4863, DOI 10.1021/bi00234a005; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; BRANDEN C, 1991, INTRO PROTEIN STRUCT, P82; BRAUN RE, 1985, CELL, V40, P159, DOI 10.1016/0092-8674(85)90319-8; BUHK HJ, 1983, GENE, V24, P265, DOI 10.1016/0378-1119(83)90087-2; CARAS IW, 1980, J BIOL CHEM, V255, P3575; CAREY J, 1991, METHOD ENZYMOL, V208, P103; CAREY J, 1988, P NATL ACAD SCI USA, V85, P975, DOI 10.1073/pnas.85.4.975; CASTUMA CE, 1993, J BIOL CHEM, V268, P24665; CROOKE E, 1993, J MOL BIOL, V233, P16, DOI 10.1006/jmbi.1993.1481; CROOKE E, 1992, J BIOL CHEM, V267, P16779; DIEDERICH L, 1994, BIOTECHNIQUES, V16, P916; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; FUNNELL BE, 1987, J BIOL CHEM, V262, P10327; GILLE H, 1991, EMBO J, V10, P1579, DOI 10.1002/j.1460-2075.1991.tb07678.x; HANSEN FG, 1991, J BACTERIOL, V173, P5194, DOI 10.1128/jb.173.16.5194-5199.1991; HOLZ A, 1992, MOL GEN GENET, V233, P81, DOI 10.1007/BF00587564; KIM J, 1988, GENE AMST, V85, P15; KOPKA ML, 1985, P NATL ACAD SCI USA, V82, P1376, DOI 10.1073/pnas.82.5.1376; Kornberg A., 1992, DNA REPLICATION; KUBISTA M, 1987, BIOCHEMISTRY-US, V26, P4545, DOI 10.1021/bi00388a057; KUCHERER C, 1986, MOL GEN GENET, V205, P115, DOI 10.1007/BF02428040; LANGER U, 1994, FEMS MICROBIOL LETT, V119, P123; MANZINI G, 1983, NUCLEIC ACIDS RES, V11, P8861, DOI 10.1093/nar/11.24.8861; MASAI H, 1990, J BIOL CHEM, V265, P15134; MATSUI M, 1985, J MOL BIOL, V184, P529, DOI 10.1016/0022-2836(85)90299-2; MESSER W, 1995, ESCHERICHIA COLI SAL; PARADA CA, 1991, J BIOL CHEM, V266, P18895; ROTH A, 1995, EMBO J, V14, P2106, DOI 10.1002/j.1460-2075.1995.tb07202.x; Sambrook J, 1989, MOL CLONING LABORATO; SAMITT CE, 1989, EMBO J, V8, P989, DOI 10.1002/j.1460-2075.1989.tb03462.x; SCHAEFER C, 1991, MOL GEN GENET, V226, P34, DOI 10.1007/BF00273584; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7131; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7124; SEUFERT W, 1987, CELL, V48, P73, DOI 10.1016/0092-8674(87)90357-6; SEUFERT W, 1986, EMBO J, V5, P3401, DOI 10.1002/j.1460-2075.1986.tb04656.x; SKARSTAD K, 1994, BBA-GENE STRUCT EXPR, V1217, P111, DOI 10.1016/0167-4781(94)90025-6; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; WANG QP, 1987, MOL GEN GENET, V209, P518, DOI 10.1007/BF00331158; WOELKER B, 1993, NUCLEIC ACIDS RES, V21, P5025, DOI 10.1093/nar/21.22.5025; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0	43	206	208	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17622	17626		10.1074/jbc.270.29.17622	http://dx.doi.org/10.1074/jbc.270.29.17622			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615570	hybrid			2022-12-27	WOS:A1995RK68900087
J	DEBINSKI, W; OBIRI, NI; PASTAN, I; PURI, RK				DEBINSKI, W; OBIRI, NI; PASTAN, I; PURI, RK			A NOVEL CHIMERIC PROTEIN COMPOSED OF INTERLEUKIN-13 AND PSEUDOMONAS EXOTOXIN IS HIGHLY CYTOTOXIC TO HUMAN CARCINOMA-CELLS EXPRESSING RECEPTORS FOR INTERLEUKIN-13 AND INTERLEUKIN-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CHAIN; FUNCTIONAL COMPONENT; SIGNAL-TRANSDUCTION; INVITRO; DOMAIN	Chimeric proteins provide a unique opportunity to target therapeutic bacterial toxins to a subset of specific cells. We have generated a new recombinant chimeric toxin composed of human interleukin 13 (hIL13) and a Pseudomonas exotoxin A (PE) mutant, PE38QQR. The hIL13-PE38QQR chimera is highly cytotoxic to cell lines derived from several human epithelial carcinomas such as adenocarcinoma of stomach, colon, and skin. The cytotoxic action of hIL13-PE38QQR, which can only occur upon internalization of ligand-receptor complex, is blocked by an excess of hIL13 but not of hIL2. This action is not solely hIL13-specific because an excess of hIL4 also blocks the cytotoxicity of hIL13 toxin. Conversely, hIL13 blocks the cytotoxicity of a hIL4-PE38QQR chimera. Binding studies showed that hIL13 displaces competitively I-126-labeled hIL4-PE38QQR on carcinoma cells. These results indicate that IL4 and IL13 compete for a common binding site on the studied human cell lines. Despite this competition, hIL4 but not hIL13 decreased protein synthesis in malignant cells susceptible to the cytotoxicity of both hIL13- and hIL4-PE38QQR. Our results suggest that a spectrum of human carcinomas express binding sites for IL13. Furthermore, hIL13 and hIL4 compete reciprocally for a form of the receptor that is internalized upon binding a ligand. Thus, cancer cells represent an interesting model fbr studying receptors for these two growth factors. Finally, hIL13-PE38QQR may be a useful agent in the treatment of several malignancies.	PENN STATE UNIV,DEPT MICROBIOL & IMMUNOL,HERSHEY,PA 17033; US FDA,CTR BIOL EVALUAT & RES,DIV CELLULAR & GENE THERAPIES,MOLEC TUMOR BIOL LAB,BETHESDA,MD 20892; NCI,DIV CANC BIOL DIAG & CTR,MOLEC BIOL LAB,BETHESDA,MD 20892	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	DEBINSKI, W (corresponding author), PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT SURG,DIV NEUROSURG,HERSHEY,PA 17033, USA.		pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270				CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; DEBINSKI W, 1993, J BIOL CHEM, V268, P14065; DEBINSKI W, 1992, J CLIN INVEST, V90, P405, DOI 10.1172/JCI115875; DEBINSKI W, 1994, INT J CANCER, V58, P744, DOI 10.1002/ijc.2910580520; DEBINSKI W, 1994, BIOCONJUGATE CHEM, V5, P40, DOI 10.1021/bc00025a006; DEBINSKI W, 1995, IN PRESS CLIN CANCER; HARADA N, 1992, J BIOL CHEM, V267, P22752; IDZERDA RL, 1990, J EXP MED, V171, P861, DOI 10.1084/jem.171.3.861; JACOBSEN SEW, 1994, J EXP MED, V180, P75, DOI 10.1084/jem.180.1.75; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; MORRISON BW, 1992, J BIOL CHEM, V267, P11957; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; OBIRI NI, 1993, J CLIN INVEST, V91, P88, DOI 10.1172/JCI116205; OBIRI NI, 1995, J BIOL CHEM, V270, P8797, DOI 10.1074/jbc.270.15.8797; PASTAN L, 1992, ANNU REV BIOCHEM, V61, P331; PUNNONEN J, 1994, J EXP MED, V179, P135; PURI RK, 1994, CELL IMMUNOL, V154, P369, DOI 10.1006/cimm.1994.1084; RAMANATHAN L, 1993, BIOCHEMISTRY-US, V32, P3549, DOI 10.1021/bi00065a005; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SIEGALL CB, 1992, FASEB J, V3, P2647; SIRONI M, 1994, BLOOD, V84, P1913; WALDMANN TA, 1992, ANN INTERN MED, V116, P148, DOI 10.7326/0003-4819-116-2-148; ZURAWSKI SM, 1993, EMBO J, V12, P2663, DOI 10.1002/j.1460-2075.1993.tb05927.x	25	154	173	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16775	16780		10.1074/jbc.270.28.16775	http://dx.doi.org/10.1074/jbc.270.28.16775			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622490	hybrid			2022-12-27	WOS:A1995RJ34700050
J	JOSEPH, M; NAGARAJ, R				JOSEPH, M; NAGARAJ, R			INTERACTION OF PEPTIDES CORRESPONDING TO FATTY ACYLATION SITES IN PROTEINS WITH MODEL MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-MYRISTOYLTRANSFERASE; INTRACELLULAR RELEASE; PHOSPHOLIPID-VESICLES; MYRISTOYL-COA; BINDING; FLUORESCENCE; TRYPTOPHAN; SEQUENCE; P60SRC; IDENTIFICATION	In recent years, a large number of proteins having covalently linked myristic and palmitic acids have been discovered. It is assumed that fatty acid acylation serves to anchor proteins to membranes. However, it is not clear whether fatty acids modulate orientation of peptide chain in membranes or help in associating hydrophilic segments of peptides with membranes. We have examined the aggregation properties and membrane association of peptides corresponding to myristoylation and palmitoylation regions of proteins by fluorescence spectroscopy. Both acylated and non-acylated peptides were used for investigation. Binding of the peptides to lipid vesicles was assessed by monitoring the fluorescence of tryptophan as well as the quenching of its fluorescence in the presence of quenchers like I- and acrylamide. Our results indicate that in the peptide corresponding to a transmembrane segment, palmitoylation results in a change in the orientation of the peptide chain in the lipid bilayer. In the case of peptides that do not have a hydrophobic segment, acylation with palmitic or myristic acid does not appear to result in increased binding to lipid bilayer, Our results suggest that (i) the primary role of myristoylation may not be an anchor for membrane attachment as assumed, (ii) palmitoylation in the case of proteins having transmembrane segments may serve to realign the transmembrane segment from the normal orientation perpendicular to the bilayer surface, (iii) in the case of proteins where there is no hydrophobic segment, palmitoylation may not serve as a membrane anchor and could be involved in interaction with other membrane bound proteins.	CTR CELLULAR & MOLEC BIOL,HYDERABAD 500007,ANDHRA PRADESH,INDIA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)								ATHERTON E, 1989, SOLID PHASE PEPTIDE, P75; BERGER M, 1986, J BIOL CHEM, V261, P4912; BLUMENTHAL R, 1977, P NATL ACAD SCI USA, V74, P5603, DOI 10.1073/pnas.74.12.5603; CHEN RF, 1965, SCIENCE, V147, P729, DOI 10.1126/science.147.3659.729; CHOW M, 1987, NATURE, V327, P482, DOI 10.1038/327482a0; CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P537; DEKROON AIP, 1990, BIOCHEMISTRY-US, V29, P8229, DOI 10.1021/bi00488a006; DEMPSEY CE, 1990, BIOCHIM BIOPHYS ACTA, V1031, P143, DOI 10.1016/0304-4157(90)90006-X; DEYOUNG LR, 1993, ACCOUNTS CHEM RES, V26, P614, DOI 10.1021/ar00036a002; EFTINK MR, 1976, J PHYS CHEM-US, V80, P486, DOI 10.1021/j100546a014; GLOVER CJ, 1988, BIOCHEM J, V250, P485, DOI 10.1042/bj2500485; GODDARD C, 1989, J BIOL CHEM, V264, P15173; GRAND RJA, 1989, BIOCHEM J, V258, P625, DOI 10.1042/bj2580625; GUY B, 1987, NATURE, V330, P266, DOI 10.1038/330266a0; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; JAMES G, 1990, BIOCHEMISTRY-US, V29, P2623, DOI 10.1021/bi00463a001; JOSEPH M, 1993, BIOORG MED CHEM LETT, V3, P1025, DOI 10.1016/S0960-894X(00)80280-2; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; Lakowicz J.R., 1983, PRINC FLUORESC SPECT, P341, DOI [10.1007/978-1-4615-7658-7_11, DOI 10.1007/978-1-4615-7658-7_11]; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; MATHEW MK, 1982, J BIOL CHEM, V257, P2170; MATSUZAKI K, 1994, BIOCHEMISTRY-US, V33, P3342, DOI 10.1021/bi00177a027; MCKNIGHT CJ, 1991, BIOCHEMISTRY-US, V30, P6241, DOI 10.1021/bi00239a023; MOORE R, 1986, EMBO J, V5, P919, DOI 10.1002/j.1460-2075.1986.tb04304.x; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; RENIL M, 1994, TETRAHEDRON, V50, P6681, DOI 10.1016/S0040-4020(01)89696-4; RESH MD, 1990, NATURE, V346, P84, DOI 10.1038/346084a0; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; RESH MD, 1989, CELL, V58, P281, DOI 10.1016/0092-8674(89)90842-8; ROSE JK, 1981, J VIROL, V39, P519, DOI 10.1128/JVI.39.2.519-528.1981; SABERWAL G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P43, DOI 10.1016/0005-2736(93)90069-C; SCHMIDT MFG, 1989, BIOCHIM BIOPHYS ACTA, V988, P411, DOI 10.1016/0304-4157(89)90013-0; SCHOLTZ JM, 1992, ANNU REV BIOPH BIOM, V21, P95, DOI 10.1146/annurev.bb.21.060192.000523; SCHULTZ AM, 1988, ANNU REV CELL BIOL, V4, P611, DOI 10.1146/annurev.cb.04.110188.003143; SINENSKY M, 1992, BIOESSAYS, V14, P25, DOI 10.1002/bies.950140106; SITARAM N, 1993, BIOCHEMISTRY-US, V32, P3124, DOI 10.1021/bi00063a026; SUREWICZ WK, 1984, BIOCHEMISTRY-US, V23, P6072, DOI 10.1021/bi00320a026; TAPPIN MJ, 1988, BIOCHEMISTRY-US, V27, P1643, DOI 10.1021/bi00405a038; TOWLER DA, 1987, P NATL ACAD SCI USA, V84, P2708, DOI 10.1073/pnas.84.9.2708; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; WEINSTEIN JN, 1977, SCIENCE, V195, P489, DOI 10.1126/science.835007; WILCOX C, 1987, SCIENCE, V238, P1275, DOI 10.1126/science.3685978; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; WOLD F, 1981, ANNU REV BIOCHEM, V50, P783, DOI 10.1146/annurev.bi.50.070181.004031; ZAGORSKI MG, 1991, BIOCHEMISTRY-US, V30, P8009, DOI 10.1021/bi00246a019	45	40	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16749	16755		10.1074/jbc.270.28.16749	http://dx.doi.org/10.1074/jbc.270.28.16749			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622487	hybrid			2022-12-27	WOS:A1995RJ34700047
J	TETI, A; PANICCIA, R; GOLDRING, SR				TETI, A; PANICCIA, R; GOLDRING, SR			CALCITONIN INCREASES CYTOSOLIC-FREE CALCIUM-CONCENTRATION VIA CAPACITATIVE CALCIUM INFLUX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAROTID ACINAR-CELLS; INOSITOL PHOSPHATE; EXTRACELLULAR CALCIUM; RECEPTOR; ENTRY; CA2+; CLONING; OSTEOCLASTS; EXPRESSION; ACTIVATION	The calcitonin receptor has been proposed to function as an extracellular Ca2+ concentration ([Ca2+](o)) sensor (Stroop, S. D., Thompson, D. L., Kuestner, R. E., and Moore, E. E. (1993) J, Biol. Chem, 268, 19927-19930). To test this hypothesis we studied the LLC-PK1 renal tubular cells and the PC, cells, a cell line stably transfected with the cloned porcine calcitonin receptor. [Ca2+](i) was measured by fura-a single cell microfluorometry. Addition to the cells equilibrated in 1.25 mM Ca2+-containing media of 1-10 mM extracellular Ca2+ did not result in a significant increase of [Ca2+](i). Treatment with 10(-7) M salmon calcitonin (sCT) elicited a rapid, persistent elevation of [Ca2+](i). Addition of 1-10 mM extracellular Ca2+ in the presence of sCT induced a significant [Ca2+](i) elevation, about 10-fold that observed in the absence of the hormone. Ca2+ influx was inhibited by lanthanum. The rise of [Ca2+](i) at elevated [Ca2+](o) was not due to a Ca2+ sensing mechanism with release of Ca2+ from intracellular stores, since it was prolonged, and was not abolished by prior depletion of Ca2+ stores with 10(-6) M thapsigargin. On the contrary, this agent potentiated Ca2+ influx after addition of 1-10 mM Ca2+ by 13-fold versus control. Prior stimulation of [Ca2+](i) with 10(-7) M arginine-vasopressin had similar effects, enhancing the subsequent Ca2+ influx. Enhancement of Ca2+ influx by sCT was confirmed by increased Mn2+ quenching of fura-2 fluorescence. In conclusion, arginine-vasopressin or calcitonin enhance Ca2+ influx in LLC-PK1 cells via a Ca2+ release-activated conductance, probably dependent upon capacitative Ca2+ entry. Thus, these effects are not unique to the calcitonin receptor and argue against the receptor functioning as a [Ca2+](o) sensor.	IST DERMOPAT IMMACOLATA,I-00167 ROME,ITALY; UNIV ROMA LA SAPIENZA,INST HISTOL & GEN EMBRYOL,I-00161 ROME,ITALY; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,BOSTON,MA 02129; HARVARD UNIV,NEW ENGLAND DEACONESS HOSP,SCH MED,BOSTON,MA 02129; HARVARD UNIV,BAPTIST MEM HOSP,SCH MED,BOSTON,MA 02129	IRCCS Istituto Dermopatico dell'Immacolata (IDI); Sapienza University Rome; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	TETI, A (corresponding author), UNIV LAQUILA,SCH MED,DEPT EXPTL MED,VIA VETOIO,COPPITO 2,I-67100 LAQUILA,ITALY.			Teti, Anna Maria/0000-0002-5887-4419	NIAMS NIH HHS [AR-03564] Funding Source: Medline; NIDDK NIH HHS [DK-46773] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR003564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046773] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Azria M, 1989, CALCITONINS; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; CASTEELS R, 1981, J PHYSIOL-LONDON, V317, P263, DOI 10.1113/jphysiol.1981.sp013824; CHABRE O, 1992, MOL ENDOCRINOL, V6, P551, DOI 10.1210/me.6.4.551; CHAMBERS TJ, 1986, ENDOCRINOLOGY, V116, P234; FORCE T, 1992, AM J PHYSIOL, V262, pF1110, DOI 10.1152/ajprenal.1992.262.6.F1110; GAMBERUCCI A, 1994, J BIOL CHEM, V269, P23597; GOLDRING SR, 1978, BIOCHEM BIOPH RES CO, V83, P434, DOI 10.1016/0006-291X(78)91009-4; GOLTZMAN D, 1985, SCIENCE, V227, P1343, DOI 10.1126/science.2983422; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P2440; HALLAM TJ, 1989, BIOCHEM J, V259, P125, DOI 10.1042/bj2590125; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; JUPPNER H, 1992, SCIENCE, V254, P1024; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; MALGAROLI A, 1989, J BIOL CHEM, V264, P14342; MENE P, 1994, KIDNEY INT, V46, P122, DOI 10.1038/ki.1994.251; MONTERO M, 1994, J BIOL CHEM, V269, P29451; MURAD F, 1970, Proceedings of the National Academy of Sciences of the United States of America, V65, P446, DOI 10.1073/pnas.65.2.446; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NEMETH EF, 1987, J BIOL CHEM, V262, P5188; NICHOLSON GC, 1986, J CLIN INVEST, V78, P355, DOI 10.1172/JCI112584; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; PAREKH AB, 1993, NATURE, V364, P814, DOI 10.1038/364814a0; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; PUTNEY JW, 1993, ENDOCR REV, V14, P610, DOI 10.1210/er.14.5.610; PUTNEY JW, 1993, CELL, V75, P199, DOI 10.1016/0092-8674(93)80061-I; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; SEXTON PM, 1987, KIDNEY INT, V32, P862, DOI 10.1038/ki.1987.287; STROOP SD, 1993, J BIOL CHEM, V268, P19927; TAKEMURA H, 1989, BIOCHEM J, V258, P409, DOI 10.1042/bj2580409; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; ZAIDI M, 1989, BIOCHEM BIOPH RES CO, V163, P1461, DOI 10.1016/0006-291X(89)91143-1	35	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16666	16670		10.1074/jbc.270.28.16666	http://dx.doi.org/10.1074/jbc.270.28.16666			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622475	hybrid			2022-12-27	WOS:A1995RJ34700034
J	VASU, SK; ROME, LH				VASU, SK; ROME, LH			DICTYOSTELIUM VAULTS - DISRUPTION OF THE MAJOR PROTEINS REVEALS GROWTH AND MORPHOLOGICAL DEFECTS AND UNCOVERS A NEW ASSOCIATED PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEOPROTEIN-PARTICLES; SMALL RNA; CONTAIN	Vaults are large cytoplasmic ribonucleoprotein particles that are highly conserved in both morphology and protein composition. Protein components of vaults isolated from Dictyostelium discoideum migrate on SDS-polyacrylamide gels as two bands, one at 94 kDa (MvpA) and the other at 92 kDa (MvpB). An MvpB cDNA clone was isolated from a Dictyostelium expression library. MvpB shares 60% identity with MvpA at the amino acid level. This cDNA has been used to disrupt the single mvpB gene in both wild-type and mvpA(-) genetic backgrounds. Although the mvp(-) mutant lines are viable, they show that loss of MvpA and/or MvpB interferes with vault function sufficiently to impede growth under conditions of nutritional stress. The resulting mutant cell lines reach stationary phase in suspension culture at one-third of the density of wild-type cells. Ovoid structures isolated from mvp(-) single mutant lines represent what remains of vaults in these cells. Similar ovoid structures isolated from the mvpA(-) mvpB(-) line copurify with a newly identified protein of 92 kDa (MvpC), which lacks cross-reactivity with currently available anti-vault antibodies. Our results indicate that the major vault proteins are necessary for optimal cell growth in Dictyostelium and reveal an unanticipated complexity in vault composition.	UNIV CALIF LOS ANGELES,DEPT BIOL CHEM,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,MENTAL RETARDAT RES CTR,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles			Rome, Leonard H/E-8786-2016	Rome, Leonard H/0000-0002-1236-2063	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038097] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 38097] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHUGANI DC, 1993, J CELL SCI, V106, P23; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; COCUCCI SM, 1970, J CELL BIOL, V45, P399, DOI 10.1083/jcb.45.2.399; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DYNES JL, 1989, P NATL ACAD SCI USA, V86, P7966, DOI 10.1073/pnas.86.20.7966; KEDERSHA NL, 1990, J CELL BIOL, V110, P895, DOI 10.1083/jcb.110.4.895; KEDERSHA NL, 1990, MOL BIOL REP, V14, P121, DOI 10.1007/BF00360441; KEDERSHA NL, 1986, J CELL BIOL, V103, P699, DOI 10.1083/jcb.103.3.699; KICKHOEFER VA, 1994, GENE, V151, P257, DOI 10.1016/0378-1119(94)90667-X; KICKHOEFER VA, 1993, J BIOL CHEM, V268, P7868; Rome L, 1991, Trends Cell Biol, V1, P47, DOI 10.1016/0962-8924(91)90088-Q; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SPUDICH JA, 1987, METHOD CELL BIOL, V28, P3; SUSSMAN M, 1961, J GEN MICROBIOL, V25, P375, DOI 10.1099/00221287-25-3-375; VASU SK, 1993, J BIOL CHEM, V268, P15356	15	43	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16588	16594		10.1074/jbc.270.28.16588	http://dx.doi.org/10.1074/jbc.270.28.16588			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622465	hybrid			2022-12-27	WOS:A1995RJ34700022
J	WU, CL; WHITEWAY, M; THOMAS, DY; LEBERER, E				WU, CL; WHITEWAY, M; THOMAS, DY; LEBERER, E			MOLECULAR CHARACTERIZATION OF STE20P, A POTENTIAL MITOGEN-ACTIVATED PROTEIN OR EXTRACELLULAR SIGNAL-REGULATED KINASE KINASE (MEK) KINASE KINASE FROM SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHEROMONE RESPONSE PATHWAY; MAP KINASE; CONSERVED FEATURES; GAMMA-SUBUNITS; CELL-CYCLE; YEAST; PHOSPHORYLATION; GENE; IDENTIFICATION; TRANSDUCTION	The Ste20p protein kinase was immunopurified from yeast cells and analyzed in an in vitro assay system, Ste20p immune complexes exhibited autophosphorylating activity at serine and threonine residues and specifically phosphorylated a bacterially expressed glutathione S-transferase (GST) fusion of Ste11p (a mitogen-activated protein or extracellular signal-regulated kinase kinase (MEK) kinase homologue) at serine and threonine residues. In contrast, GST fusions either of Ste7p (a MEK homologue) or the beta-subunit of the mating response G-protein and immunoprecipitated Ste5p were not phosphorylated by the Ste20p immune complexes. Myelin basic protein was identified as an excellent in. vitro substrate, whereas histone H1 was only poorly phosphorylated. Evidence was obtained that autophosphorylation might play a regulatory role for the in vitro kinase activity. The in vitro activity was found to be Ca2+-independent. Both the in vivo and in vitro activities were abolished by mutational changes of either the conserved lysine residue 649 within the ATP binding site or threonine 777 between the catalytic subdomains VII and VIII. Wild-type Ste20p and the catalytically inactive T777A mutant were identified as phosphoproteins in vivo. The phosphorylation occurred at serine and threonine residues independent of pheromone stimulation. Based on the genetically determined significance of Ste20p in pheromone signal transduction and on our in vitro studies, we propose the model that Ste20p represents a yeast MEK kinase kinase whose function is to link G-protein-coupled receptors through G(beta gamma) to a mitogen-activated protein kinase module.	NATL RES COUNCIL CANADA, BIOTECHNOL RES INST, EUKARYOT GENET GRP, MONTREAL, PQ H4P 2R2, CANADA	National Research Council Canada			Thomas, David/M-7661-2017	Thomas, David/0000-0002-8854-762X				ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CAIRNS BR, 1992, GENE DEV, V6, P1305, DOI 10.1101/gad.6.7.1305; CHOI KY, 1994, CELL, V78, P499; COURCHESNE WE, 1989, CELL, V58, P1107, DOI 10.1016/0092-8674(89)90509-6; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; ELION EA, 1990, CELL, V60, P649, DOI 10.1016/0092-8674(90)90668-5; ELLEDGE SJ, 1991, EMBO J, V10, P2653, DOI 10.1002/j.1460-2075.1991.tb07808.x; ERREDE B, 1993, NATURE, V362, P261, DOI 10.1038/362261a0; FAURE M, 1994, J BIOL CHEM, V269, P7851; FINEGOLD AA, 1990, SCIENCE, V249, P165, DOI 10.1126/science.1695391; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARLOW E, 1988, ANTIBODIES LABORATOR; HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; IRIE K, 1993, MOL CELL BIOL, V13, P3076, DOI 10.1128/MCB.13.5.3076; JELINEK T, 1993, BIOTECHNIQUES, V15, P628; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LEBERER E, 1993, MOL GEN GENET, V241, P241, DOI 10.1007/BF00284675; LEBERER E, 1992, EMBO J, V11, P4805, DOI 10.1002/j.1460-2075.1992.tb05586.x; LEBERER E, 1992, EMBO J, V11, P4815, DOI 10.1002/j.1460-2075.1992.tb05587.x; Maniatis T., 1982, MOL CLONING; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARCUS S, 1994, P NATL ACAD SCI USA, V91, P7762, DOI 10.1073/pnas.91.16.7762; MARSHALL CJ, 1994, NATURE, V367, P686, DOI 10.1038/367686a0; NEIMAN AM, 1994, P NATL ACAD SCI USA, V91, P3398, DOI 10.1073/pnas.91.8.3398; PAGES G, 1994, EMBO J, V13, P3003, DOI 10.1002/j.1460-2075.1994.tb06599.x; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PELECH SL, 1993, CURR BIOL, V3, P513, DOI 10.1016/0960-9822(93)90043-N; PRINTEN JA, 1994, GENETICS, V138, P609; RAD MR, 1992, MOL GEN GENET, V236, P145; RAMER SW, 1993, P NATL ACAD SCI USA, V90, P452, DOI 10.1073/pnas.90.2.452; RHODES N, 1990, GENE DEV, V4, P1862, DOI 10.1101/gad.4.11.1862; Rose MD., 1990, METHODS YEAST GENETI; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STEVENSON BJ, 1992, GENE DEV, V6, P1293, DOI 10.1101/gad.6.7.1293; SUTHERLAND C, 1993, EUR J BIOCHEM, V212, P581, DOI 10.1111/j.1432-1033.1993.tb17696.x; TALIAN JC, 1983, J CELL BIOL, V97, P1277, DOI 10.1083/jcb.97.4.1277; TEAGUE MA, 1986, P NATL ACAD SCI USA, V83, P7371, DOI 10.1073/pnas.83.19.7371; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WANG Y, 1991, MOL CELL BIOL, V11, P3554, DOI 10.1128/MCB.11.7.3554; WHITEWAY M, 1989, CELL, V56, P467, DOI 10.1016/0092-8674(89)90249-3; WHITEWAY M, 1990, MOL CELL BIOL, V10, P217, DOI 10.1128/MCB.10.1.217; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x; ZHOU ZQ, 1993, MOL CELL BIOL, V13, P2069, DOI 10.1128/MCB.13.4.2069	60	153	159	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15984	15992		10.1074/jbc.270.27.15984	http://dx.doi.org/10.1074/jbc.270.27.15984			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608157	hybrid			2022-12-27	WOS:A1995RH22600018
J	WU, ZN; JOHNSON, KW; CHOI, Y; CIARDELLI, TL				WU, ZN; JOHNSON, KW; CHOI, Y; CIARDELLI, TL			LIGAND-BINDING ANALYSIS OF SOLUBLE INTERLEUKIN-2 RECEPTOR COMPLEXES BY SURFACE-PLASMON RESONANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANALOGS	Knowledge of the kinetic binding characteristics is often critical to the development of ligand/receptor structure-activity relationships, To better understand the contribution of each of the subunits to ligand binding in the multimeric interleukin-2 receptor system, we have previously prepared stable solution complexes of the alpha- and beta subunits. In this study, we have employed surface plasmon resonance biosensor methodology (BLAcore(TM)) to evaluate both the kinetic and equilibrium binding constants for these complexes, The structural nature of the complexes facilitated immobilization on the sensor surfaces in a manner that minimized interference with ligand interactions. The interleukin-2 receptor complex surfaces displayed excellent binding capacity and stability toward regeneration. In all eases where the binding constants were measurable, the values determined for interleukin-2 were in good agreement with those previously determined by other methods, When interleukin-2 analogs with receptor subunit specific mutations were employed, the binding parameters were consistent with the nature of the mutations. The combination of coiled-coil-mediated solution assembly and surface plasmon resonance analysis of ligand binding provides a powerful approach to the study of multimeric cytokine receptor systems.	DARTMOUTH COLL,SCH MED,DEPT PHARMACOL & TOXICOL,HANOVER,NH 03755; VET ADM MED CTR,WHITE RIVER JCT,VT 05009; CHIRON CORP,EMERYVILLE,CA 94608	Dartmouth College; US Department of Veterans Affairs; Veterans Health Administration (VHA); Novartis					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034331] Funding Source: NIH RePORTER; NIAID NIH HHS [AI34331] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BERNDT WG, 1994, BIOCHEMISTRY-US, V33, P6571, DOI 10.1021/bi00187a026; CHANG DZ, 1995, MOL PHARMACOL, V47, P206; COLLINS L, 1988, P NATL ACAD SCI USA, V85, P7709, DOI 10.1073/pnas.85.20.7709; Fisher Robert J., 1994, Current Opinion in Biotechnology, V5, P389, DOI 10.1016/0958-1669(94)90047-7; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; LANDGRAF BE, 1991, PROTEINS, V9, P207, DOI 10.1002/prot.340090306; LANDGRAF BE, 1992, J BIOL CHEM, V267, P18511; LOWMAN HB, 1993, J MOL BIOL, V234, P564, DOI 10.1006/jmbi.1993.1612; MATSUOKA M, 1993, EUR J IMMUNOL, V23, P2472, DOI 10.1002/eji.1830231014; MCPHERSON GA, 1985, J PHARMACOL METHOD, V14, P213, DOI 10.1016/0160-5402(85)90034-8; Morton Thomas A., 1994, Journal of Molecular Recognition, V7, P47, DOI 10.1002/jmr.300070107; NAKARAI T, 1994, J EXP MED, V180, P241, DOI 10.1084/jem.180.1.241; O'Shannessy D J, 1994, Curr Opin Biotechnol, V5, P65, DOI 10.1016/S0958-1669(05)80072-2; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; QU Z, 1995, J BIOL CHEM, V270, P16039; ROSENTHAL HE, 1967, ANAL BIOCHEM, V20, P525, DOI 10.1016/0003-2697(67)90297-7; WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055; WU ZN, 1994, PROTEIN ENG, V7, P1137, DOI 10.1093/protein/7.9.1137	18	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16045	16051		10.1074/jbc.270.27.16045	http://dx.doi.org/10.1074/jbc.270.27.16045			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608166	hybrid			2022-12-27	WOS:A1995RH22600027
J	BALER, R; KLEIN, DC				BALER, R; KLEIN, DC			CIRCADIAN EXPRESSION OF TRANSCRIPTION FACTOR FRA-2 IN THE RAT PINEAL-GLAND	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POST-TRANSLATIONAL MODIFICATION; IMMEDIATE-EARLY GENE; C-FOS; FACTOR AP-1; CROSS-TALK; PROTEINS; JUN; ACTIVATION; IMMUNOREACTIVITY; INDUCTION	Physiological changes in Fos-like immunoreactivity in the rat pineal gland are shown here to be due primarily to changes in a 42/46-kDa Fos-related antigen (Era). Studies are presented that indicate this 42/46-kDa Fra is Fra-2, a poorly understood member of the Fos family of transcription factors. Both Fra-2 mRNA and protein are absent during the day and increase robustly at night on a circadian basis; organ culture studies indicate that regulation is mediated by an adrenergic --> cyclic AMP mechanism. AP-1 binding activity changes in parallel to changes in the level of Fra a protein.	NICHHD,DEV NEUROBIOL LAB,NEUROENDOCRINOL SECT,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)				Klein, David/0000-0002-1792-5806				BALER R, 1992, J CELL BIOL, V117, P1151, DOI 10.1083/jcb.117.6.1151; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; CARTER DA, 1992, MOL BRAIN RES, V16, P111, DOI 10.1016/0169-328X(92)90200-U; CARTER DA, 1990, BIOCHEM BIOPH RES CO, V166, P589, DOI 10.1016/0006-291X(90)90849-I; CARTER DA, 1995, NEUROSCIENCE, V62, P1267; CHATTON B, 1994, ONCOGENE, V9, P375; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; CURRAN T, 1985, MOL CELL BIOL, V5, P167, DOI 10.1128/MCB.5.1.167; CURRAN T, 1987, ONCOGENE, V2, P79; CURRAN T, 1986, P NATL ACAD SCI USA, V83, P8521, DOI 10.1073/pnas.83.22.8521; Curran T, 1988, ONCOGENE HDB, P307; EHRET M, 1991, J NEUROCHEM, V57, P1516, DOI 10.1111/j.1471-4159.1991.tb06346.x; FOLETTA VC, 1994, ONCOGENE, V9, P3305; GRUDA MC, 1994, ONCOGENE, V9, P2537; KAMEDA T, 1993, P NATL ACAD SCI USA, V90, P9369, DOI 10.1073/pnas.90.20.9369; Klein D.C., 1991, SUPRACHIASMATIC NUCL; KLEIN DC, 1970, SCIENCE, V169, P1093, DOI 10.1126/science.169.3950.1093; KLEIN DC, 1985, CIBA F SYMP, V117, P38; KLEIN DC, 1992, P SOC BIOCH, V8, P61; KOISTINAHO J, 1990, HISTOCHEMISTRY, V95, P73, DOI 10.1007/BF00737230; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MASQUILIER D, 1992, J BIOL CHEM, V267, P22460; MATSUI M, 1990, ONCOGENE, V5, P249; MURAKAMI M, 1989, P SOC EXP BIOL MED, V190, P190; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; NISHINA H, 1990, P NATL ACAD SCI USA, V87, P3619, DOI 10.1073/pnas.87.9.3619; PENNYPACKER KR, 1994, J NEUROSCI, V14, P3998; PENNYPACKER KR, 1992, J BIOL CHEM, V267, P20148; QUINN JP, 1989, J VIROL, V63, P1737, DOI 10.1128/JVI.63.4.1737-1742.1989; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; ROSEBOOM PH, 1995, MOL PHARMACOL, V47, P439; RYSECK RP, 1991, ONCOGENE, V6, P533; SASSONECORSI P, 1990, ONCOGENE, V5, P427; SONNENBERG JL, 1989, NEURON, V3, P359, DOI 10.1016/0896-6273(89)90260-2; STEHLE JH, 1993, NATURE, V365, P314, DOI 10.1038/365314a0; SUGDEN AL, 1987, J BIOL CHEM, V262, P741; Sugden D., 1983, METHODS BIOGENIC AMI, P567; SUZUKI T, 1991, NUCLEIC ACIDS RES, V19, P5537, DOI 10.1093/nar/19.20.5537; TUULIVAARA A, 1991, HISTOCHEMISTRY, V96, P401, DOI 10.1007/BF00315997; VANECEK J, 1985, ENDOCRINOLOGY, V116, P2167, DOI 10.1210/endo-116-6-2167; VOISIN P, 1990, BRAIN RES, V517, P25, DOI 10.1016/0006-8993(90)91003-Y; WISDOM R, 1993, MOL CELL BIOL, V13, P7429, DOI 10.1128/MCB.13.12.7429; YOSHIDA T, 1993, NUCLEIC ACIDS RES, V21, P2715, DOI 10.1093/nar/21.11.2715; YOUNG ST, 1991, P NATL ACAD SCI USA, V88, P1291, DOI 10.1073/pnas.88.4.1291; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	47	87	88	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27319	27325		10.1074/jbc.270.45.27319	http://dx.doi.org/10.1074/jbc.270.45.27319			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592994	hybrid			2022-12-27	WOS:A1995TE58300094
J	BELLOSTA, S; NATHAN, BP; ORTH, M; DONG, LM; MAHLEY, RW; PITAS, RE				BELLOSTA, S; NATHAN, BP; ORTH, M; DONG, LM; MAHLEY, RW; PITAS, RE			STABLE EXPRESSION AND SECRETION OF APOLIPOPROTEINS E3 AND E4 IN MOUSE NEUROBLASTOMA-CELLS PRODUCES DIFFERENTIAL-EFFECTS ON NEURITE OUTGROWTH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; SPORADIC ALZHEIMERS-DISEASE; RECEPTOR-RELATED PROTEIN; CENTRAL NERVOUS-SYSTEM; CULTURED-CELLS; CEREBROSPINAL-FLUID; TRANSGENIC MICE; E POLYMORPHISM; TYPE-4 ALLELE; E APOPROTEIN	Previously, we demonstrated in cultured dorsal root ganglion neurons that, in the presence of beta-migrating very low density lipoproteins (beta-VLDL), apolipoprotein (apo) E4, but not apoE3, suppresses neurite outgrowth, In the current studies, murine neuroblastoma cells (Neuro-2a) were stably transfected with human apoE3 or apoE4 eDNA, and the effect on neurite outgrowth was examined, The stably transfected cells secreted nano gram quantities of apoE (44-89 ng/mg of cell protein in 48 h), In the absence of lipoproteins, neurite outgrowth was similar in the apoE3- and apoE4-secreting cells, The apoE4-secreting cells, when incubated with beta-VLDL, VLDL, cerebrospinal fluid lipoproteins (d < 1.21 g/ml), or with triglyceride/phospholipid (2.7:1 (w/w)) emulsions, showed a reduction in the number of neurites/cell, a decrease in neurite branching, and an inhibition of neurite extension, whereas in the apoE3-secreting cells in the presence of a lipid source, neurite extension was increased, Uptake of beta-VLDL occurred to a similar extent in both the apoE3- and apoE4-secreting cells. With low density lipoproteins or with dimyristoylphosphatidylcholine emulsions, either alone or complexed with cholesterol, no differential effect on neurite outgrowth was observed, A slight differential effect was observed with apoE-containing high density lipoproteins. The differential effect of apoE3 and apoE4 in the presence of beta-VLDL was blocked by incubation of the cells with heparinase and chlorate, with lactoferrin, or with receptor-assocciated protein, all of which prevent the uptake of lipoproteins by the low density lipoprotein receptor-related protein (LRP). The data suggest that the secreted and/or cell surface-bound apoE interact with the lipoproteins and facilitate their internalization via the heparan sulfate proteoglycan-LRP pathway, The mechanism by which apoE3 and apoE4 exert differential effects on neurite outgrowth remains speculative, However, the data suggest that apoE4, which has been shown to be associated with late onset familial and sporadic Alzheimer's disease, may inhibit neuronal remodeling and contribute to the progression of the disease.	UNIV CALIF SAN FRANCISCO, GLADSTONE INST CARDIOVASC DIS, SAN FRANCISCO, CA 94141 USA; UNIV CALIF SAN FRANCISCO, CARDIOVASC RES INST, SAN FRANCISCO, CA 94141 USA; UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94141 USA; UNIV CALIF SAN FRANCISCO, DEPT PATHOL, SAN FRANCISCO, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco			Bellosta, Stefano/B-4473-2010; Orth, Matthias/AAF-7094-2019; Orth, Matthias/B-8519-2013	Bellosta, Stefano/0000-0001-5344-7824; Orth, Matthias/0000-0003-2881-8384; Orth, Matthias/0000-0003-2881-8384	NHLBI NIH HHS [HL41633] Funding Source: Medline; NIA NIH HHS [AG13619] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013619] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BOTTENSTEIN JE, 1980, EXP CELL RES, V129, P361, DOI 10.1016/0014-4827(80)90504-2; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; BROUSSEAU T, 1994, NEUROLOGY, V44, P342, DOI 10.1212/WNL.44.2.342; BROWN MS, 1991, CURR OPIN LIPIDOL, V2, P65; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DONG LM, 1994, J BIOL CHEM, V269, P22358; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P203, DOI 10.1073/pnas.82.1.203; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; Goedert M, 1991, Curr Opin Neurobiol, V1, P441, DOI 10.1016/0959-4388(91)90067-H; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; HALLMAN DM, 1991, AM J HUM GENET, V49, P338; HAN SH, 1994, J NEUROPATH EXP NEUR, V53, P535, DOI 10.1097/00005072-199409000-00013; HANDELMANN GE, 1992, J LIPID RES, V33, P1677; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; HUANG DY, 1994, NEUROSCI LETT, V182, P55, DOI 10.1016/0304-3940(94)90204-6; HUMPHRIES DE, 1989, METHOD ENZYMOL, V179, P428; INNERARITY TL, 1983, J BIOL CHEM, V258, P2341; INNERARITY TL, 1979, J BIOL CHEM, V254, P4186; JI ZS, 1994, J BIOL CHEM, V269, P2764; JI ZS, 1994, J BIOL CHEM, V269, P13429; JI ZS, 1993, J BIOL CHEM, V268, P10160; JI ZS, 1994, ARTERIOSCLER THROMB, V14, P2025, DOI 10.1161/01.ATV.14.12.2025; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; KUUSISTO J, 1994, BRIT MED J, V309, P636, DOI 10.1136/bmj.309.6955.636; LINTON MF, 1991, J CLIN INVEST, V88, P270, DOI 10.1172/JCI115288; Mahley Robert W., 1995, Current Opinion in Lipidology, V6, P86, DOI 10.1097/00041433-199504000-00005; MAHLEY RW, 1994, ANN NY ACAD SCI, V737, P39, DOI 10.1111/j.1749-6632.1994.tb44300.x; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAHLEY RW, 1977, AM J PATHOL, V87, P205; MAYEUX R, 1993, ANN NEUROL, V34, P752, DOI 10.1002/ana.410340527; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NATHAN BP, 1995, J BIOL CHEM, V270, P19791, DOI 10.1074/jbc.270.34.19791; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; PEACOCK ML, 1994, NEUROLOGY, V44, P339, DOI 10.1212/WNL.44.2.339; PITAS RE, 1980, J BIOL CHEM, V255, P5454; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; PITAS RE, 1981, ARTERIOSCLEROSIS, V1, P177, DOI 10.1161/01.ATV.1.3.177; PITAS RE, 1987, J BIOL CHEM, V262, P14352; PITAS RE, 1983, ARTERIOSCLEROSIS, V3, P2, DOI 10.1161/01.ATV.3.1.2; PITTMAN RC, 1987, J BIOL CHEM, V262, P2435; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; REBECK GW, 1993, NEURON, V11, P575; ROHEIM PS, 1979, P NATL ACAD SCI USA, V76, P4646, DOI 10.1073/pnas.76.9.4646; Sambrook J, 1989, MOL CLONING LABORATO; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SPOONER PJR, 1988, J BIOL CHEM, V263, P1444; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; STRITTMATTER WJ, 1994, EXP NEUROL, V125, P163, DOI 10.1006/exnr.1994.1019; TSAI MS, 1994, AM J HUM GENET, V54, P643; UEKI A, 1993, NEUROSCI LETT, V163, P166, DOI 10.1016/0304-3940(93)90373-S; WEISGRABER KH, 1994, CURR OPIN STRUC BIOL, V4, P507, DOI 10.1016/S0959-440X(94)90212-7; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; WILLNOW TE, 1992, J BIOL CHEM, V267, P26172; YU CE, 1994, AM J HUM GENET, V54, P631	57	275	280	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27063	27071		10.1074/jbc.270.45.27063	http://dx.doi.org/10.1074/jbc.270.45.27063			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592957	Green Published, hybrid			2022-12-27	WOS:A1995TE58300057
J	BRAUN, C; BRAYER, GD; WITHERS, SG				BRAUN, C; BRAYER, GD; WITHERS, SG			MECHANISM-BASED INHIBITION OF YEAST ALPHA-GLUCOSIDASE AND HUMAN PANCREATIC ALPHA-AMYLASE BY A NEW CLASS OF INHIBITORS - 2-DEOXY-2,2-DIFLUORO-ALPHA-GLYCOSIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							BETA-GLUCOSIDASES; IRREVERSIBLE INHIBITORS; GLYCOSIDASE INHIBITORS; CYCLOPHELLITOL	2-Deoxy-2,2-difluoroglycosides are a new class of mechanism-based inhibitors of alpha-glycosidases, which function via the accumulation of a stable difluoroglycosyl-enzyme intermediate. Two members of this new class of inhibitor have been synthesized and kinetic studies performed with their target glycosidases. Thus 2,4,6-trinitrophenyl 2-deoxy-2,2-difluoro-alpha-glucoside is shown to inactivate yeast a-glucosidase with a second order rate constant of k(i)/K-i = 0.25 min(-1) mM(-1). The equivalent difluoromaltoside inactivates human pancreatic cu-amylase with k(i)/K-i = 0.0073 min(-1) mM(-1). Competitive inhibitors protect the enzyme against inactivation in each case, showing reaction to occur at the active site. A burst of release of one equivalent of trinitrophenolate observed upon inactivation of human pancreatic a-amylase proves the required 1:1 stoichiometry. These are the first mechanism-based inhibitors of this class to be described, and the first mechanism-based inhibitors of any sort for the medically important alpha-amylase. In addition to having potential as therapeutics, compounds of this class should prove useful in subsequent structural and mechanistic studies of these enzymes.	UNIV BRITISH COLUMBIA,DEPT CHEM,VANCOUVER,BC V6T 1Z1,CANADA; UNIV BRITISH COLUMBIA,DEPT BIOCHIM,VANCOUVER,BC V6T 1Z1,CANADA	University of British Columbia; University of British Columbia								ATSUMI S, 1990, J ANTIBIOT, V43, P1579, DOI 10.7164/antibiotics.43.1579; BRIGGS JC, 1992, J CHEM SOC CHEM COMM, P1039, DOI 10.1039/c39920001039; BURK D, 1993, J MOL BIOL, V230, P1084, DOI 10.1006/jmbi.1993.1221; CLAUSEN TP, 1990, TETRAHEDRON LETT, V31, P4537, DOI 10.1016/S0040-4039(00)97668-8; ELBEIN AD, 1984, ARCH BIOCHEM BIOPHYS, V235, P579, DOI 10.1016/0003-9861(84)90232-7; HALAZY S, 1990, BIOORG CHEM, V18, P330, DOI 10.1016/0045-2068(90)90007-R; KEMPTON JB, 1992, BIOCHEMISTRY-US, V31, P9961, DOI 10.1021/bi00156a015; KONSTANTINIDIS A, 1991, BIOCHEM J, V279, P587, DOI 10.1042/bj2790587; LEATHERBARROW RG, 1990, GRAFIT VERSION 2 0; LEGLER G, 1970, H-S Z PHYSIOL CHEM, V351, P25, DOI 10.1515/bchm2.1970.351.1.25; LEGLER G, 1990, ADV CARBOHYD CHEM BI, V48, P319, DOI 10.1016/S0065-2318(08)60034-7; LEGLER G, 1968, Z. Physiol. Chem., V349, P767; MARSHALL PJ, 1970, J CHEM SOC P1, P366; MCCARTER JD, 1993, CARBOHYD RES, V249, P77, DOI 10.1016/0008-6215(93)84061-A; MCCARTER JD, 1994, BIOCHEM J, V301, P343, DOI 10.1042/bj3010343; MOOSER G, 1991, J BIOL CHEM, V266, P8916; Mooser G., 1992, ENZYMES, P187; PRASAD SS, 1987, BIOCHEM BIOPH RES CO, V148, P206; Sinnott M. L., 1987, ENZYME MECHANISMS, P259; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; SINNOTT ML, 1976, J CHEM SOC CHEM COMM, P223, DOI 10.1039/c39760000223; TAO BY, 1989, BIOCHIM BIOPHYS ACTA, V995, P214, DOI 10.1016/0167-4838(89)90038-1; TRUSCHEIT E, 1981, ANGEW CHEM INT EDIT, V20, P744, DOI 10.1002/anie.198107441; WITHERS SG, 1991, BIOCHEM BIOPH RES CO, V177, P532, DOI 10.1016/0006-291X(91)92016-D; WITHERS SG, 1988, J BIOL CHEM, V263, P7929; WITHERS SG, 1990, J AM CHEM SOC, V112, P5887, DOI 10.1021/ja00171a043; WITHERS SG, 1995, PROTEIN SCI, V4, P361; WITHERS SG, 1995, IN PRESS PURE APPL C; WITHERS SG, 1987, J AM CHEM SOC, V109, P7630	29	114	119	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26778	26781		10.1074/jbc.270.45.26778	http://dx.doi.org/10.1074/jbc.270.45.26778			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592915	hybrid			2022-12-27	WOS:A1995TE58300015
J	REGNOUF, F; SAGOT, I; DELOUCHE, B; DEVILLIERS, G; CARTAUD, J; HENRY, JP; PRADEL, LA				REGNOUF, F; SAGOT, I; DELOUCHE, B; DEVILLIERS, G; CARTAUD, J; HENRY, JP; PRADEL, LA			IN-VITRO PHOSPHORYLATION OF ANNEXIN-2 HETEROTETRAMER BY PROTEIN-KINASE-C - COMPARATIVE PROPERTIES OF THE UNPHOSPHORYLATED AND PHOSPHORYLATED ANNEXIN-2 ON THE AGGREGATION AND FUSION OF CHROMAFFIN GRANULE MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALPACTIN-I; BRAIN SPECTRIN; SUBSTRATE; CALCIUM; BINDING; EXOCYTOSIS; CELLS; FORMS	Heterotetrameric annexin 2 phosphorylated ''in vitro'' by rat brain protein kinase C is purified and obtained devoid of unphosphorylated protein; it contains 2 mol of phosphate/mol of heterotetramer. The aggregative and binding properties of the phosphorylated annexin 2 toward purified chromaffin granules are compared with those of the unphosphorylated annexin 2, Annexin 2 binds to chromaffin granules with high affinity, Phosphorylation of annexin 2 decreases the affinity of this binding without affecting the maximum binding capacity, The binding curves are strongly cooperative, It is suggested that a surface oligomerization of the proteins may take place upon binding. Besides, phosphorylation of annexin 2 is followed by a dissociation of the light chains from the heavy chains in the heterotetramer. Whereas annexin 2 induces the aggregation of chromaffin granules at mu M calcium concentration, the phosphorylated annexin 2 does not induce aggregation at any concentration of calcium either at pH 6 or 7, The phosphorylation of annexin 2 by protein kinase C, MgATP, and 12-O-tetradecanoylphorbol-13-acetate on chromaffin fin granules induces a fusion of chromaffin granules membranes observed in electron microscopy. The fusion requires the activation of protein kinase C by 12-O-tetradecanoylphorbol-13-acetate. Given these results and since annexin 2 is phosphorylated by protein kinase C under stimulation of chromaffin cells, it is suggested that phosphorylated annexin 2 may be implicated in the fusion step during exocytosis of chromaffin granules.	UNIV PARIS 07, INST BIOL PHYS CHIM, CTR NATL RECH SCI, UNITE 1112 NEUROBIOL PHYS CHIM, F-75005 PARIS, FRANCE; UNIV PARIS 07, INST JACQUES MONOD, DEPT BIOL SUPRAMOLEC & CELLULAIRE BIOL CELLULAIRE, UMR 9922, F-75005 PARIS, FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite								BENFENATI F, 1989, J CELL BIOL, V108, P1851, DOI 10.1083/jcb.108.5.1851; BLASCHKO H, 1967, BIOCHEM J, V104, P545, DOI 10.1042/bj1040545; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARTY SE, 1980, ANAL BIOCHEM, V106, P438, DOI 10.1016/0003-2697(80)90545-X; CREUTZ CE, 1978, J BIOL CHEM, V253, P2858; DAMER CK, 1994, J BIOL CHEM, V269, P31115; DRUST DS, 1988, NATURE, V331, P88, DOI 10.1038/331088a0; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FRAPPIER T, 1987, EUR J BIOCHEM, V169, P651, DOI 10.1111/j.1432-1033.1987.tb13657.x; GLENNEY J, 1986, P NATL ACAD SCI USA, V83, P4258, DOI 10.1073/pnas.83.12.4258; GOULD KL, 1986, MOL CELL BIOL, V6, P2738, DOI 10.1128/MCB.6.7.2738; JOHNSSON N, 1986, EMBO J, V5, P3455, DOI 10.1002/j.1460-2075.1986.tb04669.x; JOHNSTONE SA, 1992, J BIOL CHEM, V267, P25976; Kitano T, 1986, Methods Enzymol, V124, P349; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAYORGA LS, 1994, J BIOL CHEM, V269, P30927; MONCK JR, 1992, J CELL BIOL, V119, P1395, DOI 10.1083/jcb.119.6.1395; NAKATA T, 1990, J CELL BIOL, V110, P13, DOI 10.1083/jcb.110.1.13; NEWTON AC, 1989, J BIOL CHEM, V264, P14909; PELECH SL, 1986, BIOCHEMISTRY-US, V25, P8348, DOI 10.1021/bi00374a002; PEPINSKY RB, 1989, BIOCHEM J, V263, P97, DOI 10.1042/bj2630097; PHILLIPS JH, 1973, BIOCHEM J, V136, P579, DOI 10.1042/bj1360579; POWELL MA, 1987, BIOCHEM J, V247, P321, DOI 10.1042/bj2470321; PRADEL LA, 1993, FEBS LETT, V327, P41, DOI 10.1016/0014-5793(93)81035-X; REGNOUF F, 1985, EUR J BIOCHEM, V153, P313, DOI 10.1111/j.1432-1033.1985.tb09303.x; REGNOUF F, 1991, J NEUROCHEM, V56, P1985, DOI 10.1111/j.1471-4159.1991.tb03457.x; SARAFIAN T, 1991, J CELL BIOL, V114, P1135, DOI 10.1083/jcb.114.6.1135; SMITH AD, 1967, BIOCHEM J, V103, P480, DOI 10.1042/bj1030480; WEI W, 1992, BIOCHEMISTRY-US, V31, P9934, DOI 10.1021/bi00156a011; WINKLER H, 1976, NEUROSCIENCE, V1, P65, DOI 10.1016/0306-4522(76)90001-4	30	60	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27143	27150		10.1074/jbc.270.45.27143	http://dx.doi.org/10.1074/jbc.270.45.27143			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592969	hybrid			2022-12-27	WOS:A1995TE58300069
J	SETIADI, H; DISDIER, M; GREEN, SA; CANFIELD, WM; MCEVER, RP				SETIADI, H; DISDIER, M; GREEN, SA; CANFIELD, WM; MCEVER, RP			RESIDUES THROUGHOUT THE CYTOPLASMIC DOMAIN AFFECT THE INTERNALIZATION EFFICIENCY OF P-SELECTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRANULE MEMBRANE-PROTEIN; DENSITY-LIPOPROTEIN RECEPTOR; FACTOR-II RECEPTOR; POLYMERIC IMMUNOGLOBULIN RECEPTOR; REGULATED SECRETORY PATHWAY; BASOLATERAL SORTING SIGNAL; LYSOSOMAL ACID-PHOSPHATASE; WEIBEL-PALADE BODIES; COATED PIT FORMATION; PLASMA-MEMBRANE	The cytoplasmic domains of many membrane proteins have short sequences, usually including a tyrosine or a di-leucine, that function as sorting signals, P-selectin is an adhesion receptor for leukocytes that is expressed on activated platelets and endothelial cells, Its 35 residue cytoplasmic domain contains signals for sorting into regulated secretory granules, for endocytosis, and for movement from endosomes to lysosomes, The domain has a membrane-distal sequence, YGVFTNAAF, that resembles some tyrosine-based signals, We studied the effects of deletions and mutations in the cytoplasmic tail of human P-selectin on its internalization in clathrin-coated pits of transfected Chinese hamster ovary cells. Mutations and deletions in the putative tyrosine-based motif did not clearly implicate these residues as critical components of a short internalization signal, Indeed, a construct containing a truncated 18-residue cytoplasmic domain with a single substitution (K761A/H773Stop) was internalized nearly three times as fast as wild-type P-selectin; this construct contained no di-leucine, tyrosine, or other known sorting motif, Substitution of residues throughout the cytoplasmic domain affected the internalization rate of P-selectin, Furthermore, the cytoplasmic domain of P-selectin mediated faster internalization when attached to the extracellular and transmembrane domains of the low density lipoprotein receptor than when attached to the corresponding domains of P-selectin. Thus, we were unable to identify a short internalization signal in the cytoplasmic tail of P-selectin, Residues throughout the cytoplasmic domain, and perhaps the transmembrane sequence to which the domain is attached, affect the efficiency of internalization.	UNIV OKLAHOMA,HLTH SCI CTR,WK WARREN MED RES INST,OKLAHOMA CITY,OK 73104; UNIV OKLAHOMA,HLTH SCI CTR,DEPT BIOCHEM & MOLEC BIOL,OKLAHOMA CITY,OK 73104; OKLAHOMA MED RES FDN,CARDIOVASC BIOL RES PROGRAM,OKLAHOMA CITY,OK 73104; UNIV VIRGINIA,SCH MED,DEPT CELL BIOL,CHARLOTTESVILLE,VA 22908; UNIV OKLAHOMA,HLTH SCI CTR,DEPT MED,OKLAHOMA CITY,OK 73104	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; University of Virginia; University of Oklahoma System; University of Oklahoma Health Sciences Center			Setiadi, Hendra/ACQ-9386-2022	Setiadi, Hendra/0000-0002-0570-1354	NHLBI NIH HHS [HL 34363] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL034363, R01HL034363] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; AUCHAMPACH JA, 1994, GENE, V145, P251, DOI 10.1016/0378-1119(94)90015-9; BANSAL A, 1991, CELL, V67, P1195, DOI 10.1016/0092-8674(91)90295-A; BELTZER JP, 1991, EMBO J, V10, P3735, DOI 10.1002/j.1460-2075.1991.tb04942.x; BERMAN CL, 1986, J CLIN INVEST, V78, P130, DOI 10.1172/JCI112542; BONFANTI R, 1989, BLOOD, V73, P1109; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; CORVERA S, 1994, J CELL BIOL, V126, P979, DOI 10.1083/jcb.126.4.979; DARGEMONT C, 1993, EMBO J, V12, P1713, DOI 10.1002/j.1460-2075.1993.tb05816.x; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; DISDIER M, 1992, MOL BIOL CELL, V3, P309, DOI 10.1091/mbc.3.3.309; EBERLE W, 1991, CELL, V67, P1203, DOI 10.1016/0092-8674(91)90296-B; FUJIMOTO T, 1993, BLOOD, V82, P1758; FUJIMOTO T, 1993, J BIOL CHEM, V268, P11394; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; GLICKMAN JN, 1989, EMBO J, V8, P1041, DOI 10.1002/j.1460-2075.1989.tb03471.x; GREEN SA, 1994, J CELL BIOL, V124, P435, DOI 10.1083/jcb.124.4.435; GUARNIERI FG, 1993, J BIOL CHEM, V268, P1941; HAFT CR, 1994, J BIOL CHEM, V269, P26286; HAMBURGER SA, 1990, BLOOD, V75, P550; HANSEN SH, 1993, J CELL BIOL, V121, P61, DOI 10.1083/jcb.121.1.61; HATTORI R, 1989, J BIOL CHEM, V264, P7768; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; ITIN C, 1995, EMBO J, V14, P2250, DOI 10.1002/j.1460-2075.1995.tb07219.x; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; JADOT M, 1992, J BIOL CHEM, V267, P11069; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; JOHNSON KF, 1992, J BIOL CHEM, V267, P17110; JOHNSTON GI, 1989, J BIOL CHEM, V264, P1816; JOHNSTON GI, 1990, J BIOL CHEM, V265, P21381; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; KAPPELER F, 1994, J BIOL CHEM, V269, P6279; KOEDAM JA, 1992, J CELL BIOL, V116, P617, DOI 10.1083/jcb.116.3.617; KTISTAKIS NT, 1990, J CELL BIOL, V111, P1393, DOI 10.1083/jcb.111.4.1393; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; LAZAROVITS J, 1988, CELL, V53, P743, DOI 10.1016/0092-8674(88)90092-X; LEBIVIC A, 1990, J CELL BIOL, V110, P1533, DOI 10.1083/jcb.110.5.1533; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; LOW SH, 1991, J BIOL CHEM, V266, P13391; MATTER K, 1993, CELL, V74, P1053, DOI 10.1016/0092-8674(93)90727-8; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; MCEVER RP, 1983, J BIOL CHEM, V258, P5269; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445; NI F, 1994, ACCOUNTS CHEM RES, V27, P257, DOI 10.1021/ar00045a001; OKAMOTO CT, 1992, J BIOL CHEM, V267, P9925; PEARSE BMF, 1988, EMBO J, V7, P3331, DOI 10.1002/j.1460-2075.1988.tb03204.x; ROBINSON MS, 1994, CURR OPIN CELL BIOL, V6, P538, DOI 10.1016/0955-0674(94)90074-4; ROTH MG, 1993, ADV CELL MOL BIOL M, V1, P19; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SANDERS WE, 1992, BLOOD, V80, P795; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; SCHMID SL, 1991, J CELL BIOL, V114, P869, DOI 10.1083/jcb.114.5.869; SOSA MA, 1993, J BIOL CHEM, V268, P12537; SRINIVASAN J, 1994, BIOCHEMISTRY-US, V33, P13553, DOI 10.1021/bi00250a007; STENBERG PE, 1985, J CELL BIOL, V101, P880, DOI 10.1083/jcb.101.3.880; STRUBEL NA, 1993, BIOCHEM BIOPH RES CO, V192, P338, DOI 10.1006/bbrc.1993.1420; SUBRAMANIAM M, 1993, MOL BIOL CELL, V4, P791, DOI 10.1091/mbc.4.8.791; TEDDER TF, 1989, J EXP MED, V170, P123, DOI 10.1084/jem.170.1.123; THOMAS DC, 1994, J BIOL CHEM, V269, P15732; THOMAS DC, 1993, J BIOL CHEM, V268, P3313; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; USHIYAMA S, 1993, J BIOL CHEM, V268, P15229; VANDRIEL IR, 1987, J BIOL CHEM, V262, P16127; WILDE A, 1994, J BIOL CHEM, V269, P7131; WONG SH, 1993, J BIOL CHEM, V268, P22853	72	61	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26818	26826		10.1074/jbc.270.45.26818	http://dx.doi.org/10.1074/jbc.270.45.26818			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592923	hybrid			2022-12-27	WOS:A1995TE58300023
J	SPARKS, DL; DAVIDSON, WS; LUNDKATZ, S; PHILLIPS, MC				SPARKS, DL; DAVIDSON, WS; LUNDKATZ, S; PHILLIPS, MC			EFFECTS OF THE NEUTRAL LIPID-CONTENT OF HIGH-DENSITY-LIPOPROTEIN ON APOLIPOPROTEIN-A-I STRUCTURE AND PARTICLE STABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECITHIN-CHOLESTEROL ACYLTRANSFERASE; TRANSFER PROTEIN; SERUM-LIPOPROTEINS; PHASE-BEHAVIOR; HUMAN PLASMA; CONFORMATION; QUANTITATION; METABOLISM; EMULSIONS; TRIOLEIN	Alterations in high density lipoprotein (HDL) composition that occur in dyslipidemic states may modulate a number of events involved in cholesterol homeostasis. To elucidate the details of how HDL-core composition can affect the molecular structure of different kinds of HDL particles, the conformation and stability of apoA-I have been investigated in homogeneous recombinant HDL particles (LpA-I) containing palmitoyloleoyl phosphatidylcholine (POPC), triolein (TG), and/or cholesteryl linoleate (CE). In a discoidal particle containing two molecules of apoA-I and 85 molecules of POPC, apoA-I exhibits an alpha-helix content of 70% and a free energy of stability of its alpha-helical segments (Delta G(D)(0)) of 2.2 kcal/mol. Inclusion of eight molecules of TG into the complex significantly reduces the alpha-helix content and stability of apoA-I, whereas inclusion of four molecules of CE into the complex has an opposite effect in that the alpha-helix content is significantly reduced and the stability of the remaining alpha-helical structure of apoA-I is increased, Neutral lipids have a different effect on apoA-I conformation in spherical LpA-I particles. In a sonicated-spherical LpA-I particle containing two molecules of apoA-I and 70 molecules of POPC, apoA-I exhibits an alpha-helix content of about 60% and a Delta G(D)(0) of 1.2 kcal/mol apoA-I. Inclusion of either 10 molecules of TG or six molecules of CE into such a particle increases both the alpha-helix content and stability of apoA-I. Increasing the CE/TG ratio in LpA-I particles that contain both neutral lipids enhances the stability of the Alpha-helical segments. ApoA-I molecules tend to dissociate and cause particle instability when Delta G(D)(0) for the lipid-bound alpha-helices is less than that for helices in the lipid-free state. The stabilities of both discoidal and spherical LpA-I particles are relatively low when the only neutral lipid present is TG but the particle stability is enhanced by the presence of CE molecules, Such dissociation of apoA-I molecules from LpA-I particles that have a low CE/TG ratio would be promoted in the hypertriglyceridemic state in vivo.	MED COLL PENN,DEPT BIOCHEM,PHILADELPHIA,PA 19129; HAHNEMANN UNIV,PHILADELPHIA,PA 19129	Drexel University; Drexel University	SPARKS, DL (corresponding author), UNIV OTTAWA,INST HEART,LIPOPROT & ATHEROSCLEROSIS GRP,1053 CARLING AVE,OTTAWA,ON K1Y 4E9,CANADA.			Davidson, William/0000-0003-2756-2989; Phillips, Michael/0000-0002-7147-8007	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007443, P01HL022633] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL07443, HL22633] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ATKINSON D, 1986, ANNU REV BIOPHYS BIO, V15, P403; BOLIN DJ, 1994, J BIOL CHEM, V269, P7429; BREWER HB, 1986, METHOD ENZYMOL, V128, P223; CASTRO GR, 1988, BIOCHEMISTRY-US, V27, P25, DOI 10.1021/bi00401a005; CLAY MA, 1991, ARTERIOSCLER THROMB, V11, P415, DOI 10.1161/01.ATV.11.2.415; COLLET X, 1991, J BIOL CHEM, V266, P9145; DOBIASOVA M, 1991, ARTERIOSCLER THROMB, V11, P64, DOI 10.1161/01.ATV.11.1.64; DUVERGER N, 1993, BIOCHEMISTRY-US, V32, P12372, DOI 10.1021/bi00097a014; EISENBERG S, 1984, J LIPID RES, V25, P1017; FORTE TM, 1986, METHOD ENZYMOL, V128, P442; GLOMSET JA, 1970, AM J CLIN NUTR, V23, P1129; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HIRZ R, 1970, BIOCHIM BIOPHYS ACTA, V207, P364, DOI 10.1016/0005-2795(70)90029-2; HOROWITZ BS, 1993, J CLIN INVEST, V91, P1743, DOI 10.1172/JCI116384; ISHIDA BY, 1987, J LIPID RES, V28, P778; JANIAK MJ, 1974, J MOL BIOL, V86, P325, DOI 10.1016/0022-2836(74)90022-9; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; JONAS A, 1991, BIOCHIM BIOPHYS ACTA, V1084, P205, DOI 10.1016/0005-2760(91)90062-M; JONAS A, 1990, J BIOL CHEM, V265, P22123; JONAS A, 1993, J BIOL CHEM, V268, P1596; JONAS A, 1989, J BIOL CHEM, V264, P4818; JONAS A, 1986, METHOD ENZYMOL, V128, P553; KRUSKI AW, 1974, CHEM PHYS LIPIDS, V13, P27, DOI 10.1016/0009-3084(74)90040-1; LUNDKATZ S, 1990, J BIOL CHEM, V265, P12217; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MCCALL MR, 1993, J LIPID RES, V34, P37; MILLER KW, 1982, J COLLOID INTERF SCI, V89, P466, DOI 10.1016/0021-9797(82)90197-7; MILLER KW, 1983, BIOCHEMISTRY-US, V22, P443, DOI 10.1021/bi00271a030; MORTON RE, 1990, EXPERIENTIA, V46, P552, DOI 10.1007/BF01939693; MORTON RE, 1988, J BIOL CHEM, V263, P12235; NEARY RH, 1987, CLIN CHEM, V33, P1163; NICHOLS AV, 1986, METHOD ENZYMOL, V128, P417; RYE KA, 1995, J BIOL CHEM, V270, P189, DOI 10.1074/jbc.270.1.189; SCANU AM, 1971, ANAL BIOCHEM, V44, P576, DOI 10.1016/0003-2697(71)90247-8; SOKOLOFF L, 1974, P SOC EXP BIOL MED, V146, P1166; SPARKS D, 1991, AM HEART J, V122, P601, DOI 10.1016/0002-8703(91)91031-H; SPARKS DL, 1989, ATHEROSCLEROSIS, V77, P183, DOI 10.1016/0021-9150(89)90080-4; SPARKS DL, 1995, J BIOL CHEM, V270, P5151, DOI 10.1074/jbc.270.10.5151; SPARKS DL, 1993, J BIOL CHEM, V268, P23250; SPARKS DL, 1992, J BIOL CHEM, V267, P25839; SPARKS DL, 1989, J LIPID RES, V30, P1491; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; SPARKS DL, 1989, BIOCHEM CELL BIOL, V67, P358, DOI 10.1139/o89-056; SWANEY JB, 1986, METHOD ENZYMOL, V128, P613; TERPSTRA AHM, 1981, ANAL BIOCHEM, V111, P149, DOI 10.1016/0003-2697(81)90243-8; TU AY, 1993, J BIOL CHEM, V268, P23098; WEISWEILER P, 1987, CLIN CHIM ACTA, V169, P249, DOI 10.1016/0009-8981(87)90325-1	47	96	100	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26910	26917		10.1074/jbc.270.45.26910	http://dx.doi.org/10.1074/jbc.270.45.26910			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592936	hybrid			2022-12-27	WOS:A1995TE58300036
J	BOYD, RS; DUGGAN, MJ; SHONE, CC; FOSTER, KA				BOYD, RS; DUGGAN, MJ; SHONE, CC; FOSTER, KA			THE EFFECT OF BOTULINUM NEUROTOXINS ON THE RELEASE OF INSULIN FROM THE INSULINOMA CELL-LINES HIT-15 AND RINM5F	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TETANUS-TOXIN; MEMBRANE-PROTEIN; NEUROTRANSMITTER RELEASE; PROTEOLYTIC CLEAVAGE; NERVE-TERMINALS; PC12 CELLS; SYNAPTOBREVIN; FUSION; NORADRENALINE; PURIFICATION	Western blotting of the insulin-secreting beta-cell lines HIT-15 and RINm5F with anti SNAP-25 (synaptosomal associated protein of 25 kDa), anti-synaptobrevin, and anti-syntaxin 1 antibodies revealed the presence of proteins with the same electrophoretic mobility as found in neural tissue. Permeabilization of both of these insulinoma cell lines to botulinum neurotoxin A by electroporation resulted, after 3 days of culture, in the loss of similar to 90% of SNAP-25 immunoreactivity. A similar permeabilization of these cells with botulinum neurotoxin B resulted in the cleavage of similar to 90% of the synaptobrevin-like immunoreactivities. Botulinum neurotoxin F also cleaved similar to 90% of the synaptobrevin-like immunoreactivity in RINm5F cells. The permeabilization of both insulinoma cells to neurotoxin A resulted in a >90% inhibition of potassium-stimulated, calcium-dependent insulin release. By contrast, permeabilization of the insulinoma cell lines to neurotoxin B resulted in only a similar to 60% inhibition of potassium-stimulated insulin release in HIT-15 cells, and neither neurotoxin B nor F caused inhibition in RINm5F cells. Thus HIT-15 and RINm5F cells contain the components of the putative exocytotic docking complex described in cells derived from the neural crest. In HIT-15 cells both SNAP-25 and synaptobrevin appear to be involved in calcium-dependent insulin secretion, whereas in RINm5F cells SNAP-25 but not synaptobrevin is involved.	PUBL HLTH LAB SERV,CTR APPL MICROBIOL & RES,DIV BIOL,SALISBURY SP4 0JG,WILTS,ENGLAND		BOYD, RS (corresponding author), SPEYWOOD PHARMACEUT LTD,PORTON HOUSE,1 BATH RD,MAIDENHEAD SL4 4UH,BERKS,ENGLAND.							BARTELS F, 1992, INFECT IMMUN, V60, P302, DOI 10.1128/IAI.60.1.302-307.1992; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BLACK JD, 1986, J CELL BIOL, V103, P521, DOI 10.1083/jcb.103.2.521; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BORDIER C, 1981, J BIOL CHEM, V256, P1604; DAGMAR R, 1994, FEBS LETT, V351, P207; DOLLY JO, 1990, J PHYSIOL-PARIS, V84, P237; DOLLY JO, 1984, NATURE, V307, P457, DOI 10.1038/307457a0; DUGGAN MJ, 1991, J BIOL CHEM, V266, P24778; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; FORAN P, 1995, BIOCHEMISTRY-US, V34, P5544; GAISANO HY, 1994, J BIOL CHEM, V269, P17062; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; JACOBSSON G, 1994, P NATL ACAD SCI USA, V91, P12487, DOI 10.1073/pnas.91.26.12487; KOMATSU M, 1993, J BIOL CHEM, V268, P23927; LINK E, 1992, BIOCHEM BIOPH RES CO, V189, P1017, DOI 10.1016/0006-291X(92)92305-H; MCINNES C, 1990, FEBS LETT, V261, P323, DOI 10.1016/0014-5793(90)80582-4; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PENNER R, 1986, NATURE, V324, P76, DOI 10.1038/324076a0; SADOUL K, 1995, J CELL BIOL, V128, P1019, DOI 10.1083/jcb.128.6.1019; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1993, J BIOL CHEM, V268, P11516; SHONE CC, 1993, EUR J BIOCHEM, V217, P965, DOI 10.1111/j.1432-1033.1993.tb18327.x; SHONE CC, 1992, EUR J BIOCHEM, V207, P1009, DOI 10.1111/j.1432-1033.1992.tb17137.x; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SOLLNER T, 1993, NATURE, V364, P318; WADSWORTH JDF, 1990, BIOCHEM J, V268, P123, DOI 10.1042/bj2680123; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925	30	49	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18216	18218		10.1074/jbc.270.31.18216	http://dx.doi.org/10.1074/jbc.270.31.18216			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629139	hybrid			2022-12-27	WOS:A1995RM64200012
J	FAN, JQ; TAKEGAWA, K; IWAHARA, S; KONDO, A; KATO, I; ABEYGUNAWARDANA, C; LEE, YC				FAN, JQ; TAKEGAWA, K; IWAHARA, S; KONDO, A; KATO, I; ABEYGUNAWARDANA, C; LEE, YC			ENHANCED TRANSGLYCOSYLATION ACTIVITY OF ARTHROBACTER-PROTOPHORMIAE ENDO-BETA-N-ACETYLGLUCOSAMINIDASE IN MEDIA CONTAINING ORGANIC-SOLVENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYMATIC-SYNTHESIS; D-GALACTOSIDASE; SIMPLE STRATEGY; SUGAR CHAINS; PURIFICATION; GLYCOPROTEINS; SPECTROSCOPY; OLIGOSACCHARIDES; REGIOSELECTIVITY; DISACCHARIDES	The transglycosylation activity of endo beta-N-acetylglucosaminidase hom Arthrobacter protophormiae (endo-A) was enhanced by inclusion of organic solvents in the reaction mixture. In aqueous solution, the transglycosylation yield relative to starting substrate was 32% using Man(9)GlcNAc(2)Asn as donor and 0.5 M GlcNAc as acceptor. However, in the media containing 30% (v/v) acetone, dioxane, N,N-dimethylformamide, or dimethyl sulfoxide with 0.5 M GlcNAc as acceptor, the transglycosylation attained yields of 89, 13, 28, and 75% respectively, as analyzed by high performance anion exchange chromatography. The enzyme was stable in media containing up to 30% acetone, 30% dimethyl sulfoxide, or 20% N,N-dimethylformamide at 37 degrees C for at least 30 min. The acceptor (GlcNAc) concentration must be greater than 0.2 M for efficient transglycosylation. Electrospray mass spectrometry analysis of the transglycosylation product obtained in 30% acetone with Man(5)GlcNAc(2)Asn as donor and methyl alpha-2-acetamido-2-deoxy-D-glucopyranoside as acceptor showed a mass ion of m/z 1249.4, consistent with the expected molecular weight. Analysis by H-1 NMR of the product revealed that transglycosylation occurred at the C-4 of GlcNAc and the linkage was of the beta-configuration. In the acetone-containing me dium, Glc, Man, a deoxy-Glc, and methyl alpha-D-GlcNAc can serve as a good acceptor as GlcNAc. Less favorable accepters are xylose, fructose, 6-deoxy-Glc, and 3-O-methyl-D-glucose. On the other hand, GalNAc, Gal, allose, and 3-deoxy-Glc could not serve as accepters of the enzyme transglycosylation.	JOHNS HOPKINS UNIV, DEPT BIOL, BALTIMORE, MD 21218 USA; KAGAWA UNIV, FAC AGR, DEPT BIORESOURCE SCI, KAGAWA, JAPAN; TAKARA SHUZO CO LTD, BIOTECHNOL RES LAB, OTSU, SHIGA 52021, JAPAN; JOHNS HOPKINS UNIV, SCH MED, DEPT BIOL CHEM, BALTIMORE, MD 21205 USA	Johns Hopkins University; Kagawa University; Takara Holdings Inc.; Johns Hopkins University								ABEYGUNAWARDANA C, 1991, BIOCHEMISTRY-US, V30, P8568, DOI 10.1021/bi00099a012; AJISAKA K, 1989, CARBOHYD RES, V185, P139, DOI 10.1016/0008-6215(89)84029-7; ASHIDA H, 1993, ARCH BIOCHEM BIOPHYS, V305, P559, DOI 10.1006/abbi.1993.1461; BARDALES RM, 1989, J BIOL CHEM, V264, P19893; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; COHENANISFELD ST, 1993, J AM CHEM SOC, V115, P10531, DOI 10.1021/ja00076a010; DELMOTTE F, 1976, CR ACAD SCI D NAT, V283, P1121; FAN JQ, 1994, ANAL BIOCHEM, V219, P224, DOI 10.1006/abio.1994.1261; FAN JQ, 1995, J BIOL CHEM, V270, P17730, DOI 10.1074/jbc.270.30.17730; HEDBYS L, 1989, CARBOHYD RES, V186, P217, DOI 10.1016/0008-6215(89)84036-4; HITOMI J, 1985, J BIOCHEM-TOKYO, V98, P527, DOI 10.1093/oxfordjournals.jbchem.a135307; ICHIKAWA Y, 1992, ANAL BIOCHEM, V202, P215, DOI 10.1016/0003-2697(92)90099-S; INADA Y, 1986, TRENDS BIOTECHNOL, V4, P190, DOI 10.1016/0167-7799(86)90244-1; ITO K, 1993, J BIOL CHEM, V268, P16074; KADOWAKI S, 1991, J BIOCHEM-TOKYO, V110, P17, DOI 10.1093/oxfordjournals.jbchem.a123536; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V96, P1156, DOI 10.1016/0006-291X(80)90073-X; Lee Y. C., 1994, P3; LI YT, 1991, J BIOL CHEM, V266, P10723; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; MATSUI I, 1994, BIOCHEMISTRY-US, V33, P451, DOI 10.1021/bi00168a009; MOREAU A, 1994, EUR J BIOCHEM, V219, P261, DOI 10.1111/j.1432-1033.1994.tb19937.x; MURAMATS.T, 1971, J BIOL CHEM, V246, P5534; NAKAMURA A, 1994, FEBS LETT, V337, P66, DOI 10.1016/0014-5793(94)80631-4; NILSSON K, 1984, BIOTECHNOL BIOENG, V26, P1146, DOI 10.1002/bit.260261003; Nilsson K. G. I., 1987, In 'Biocatalysis in organic media', edited by Laane, C. et al. Amsterdam, Netherlands; Elsevier Science Publishers BV. ISBN 0-444-42785-6 [see FSTA (1989) 21 8B67]., P369; NILSSON KGI, 1988, CARBOHYD RES, V180, P53, DOI 10.1016/0008-6215(88)80063-6; NILSSON KGI, 1987, CARBOHYD RES, V167, P95, DOI 10.1016/0008-6215(87)80271-9; NISHIGAK.M, 1974, BIOCHEM BIOPH RES CO, V59, P638, DOI 10.1016/S0006-291X(74)80027-6; OGATAARAKAWA M, 1977, J BIOCHEM-TOKYO, V82, P611; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; SAKAI K, 1992, J CARBOHYD CHEM, V11, P553, DOI 10.1080/07328309208016148; SHINOYAMA H, 1988, AGR BIOL CHEM TOKYO, V52, P2375; SHINOYAMA H, 1988, AGR BIOL CHEM TOKYO, V52, P2197; TACHIBANA Y, 1982, ARCH BIOCHEM BIOPHYS, V214, P199, DOI 10.1016/0003-9861(82)90023-6; TAKEGAWA K, 1991, BIOCHEM INT, V24, P849; TAKEGAWA K, 1989, APPL ENVIRON MICROB, V55, P3107, DOI 10.1128/AEM.55.12.3107-3112.1989; TAKEGAWA K, 1995, J BIOL CHEM, V270, P3094, DOI 10.1074/jbc.270.7.3094; TAKEGAWA K, 1991, BIOCHEM INT, V25, P829; TARENTINO AL, 1974, J BIOL CHEM, V249, P811; TOONE EJ, 1989, TETRAHEDRON, V45, P5365, DOI 10.1016/S0040-4020(01)89487-4; TRIMBLE RB, 1986, J BIOL CHEM, V261, P2000; USUI T, 1993, CARBOHYD RES, V244, P315, DOI 10.1016/0008-6215(83)85010-1; USUI T, 1993, CARBOHYD RES, V250, P57, DOI 10.1016/0008-6215(93)84154-X; USUI T, 1988, J BIOCHEM-TOKYO, V103, P969, DOI 10.1093/oxfordjournals.jbchem.a122395; VANHALBEEK H, 1980, FEBS LETT, V121, P65; YAMAMOTO K, 1986, AGR BIOL CHEM TOKYO, V50, P421, DOI 10.1080/00021369.1986.10867399; YET MG, 1988, J BIOL CHEM, V263, P118	48	83	85	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17723	17729		10.1074/jbc.270.30.17723	http://dx.doi.org/10.1074/jbc.270.30.17723			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629071	hybrid			2022-12-27	WOS:A1995RM26600017
J	GARCIARAMIREZ, M; ROCCHINI, C; AUSIO, J				GARCIARAMIREZ, M; ROCCHINI, C; AUSIO, J			MODULATION OF CHROMATIN FOLDING BY HISTONE ACETYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOME CORE PARTICLE; TRANSCRIPTIONALLY ACTIVE CHROMATIN; HYPERACETYLATION; DNA; OLIGONUCLEOSOMES; DYNAMICS; PROTEINS; NUCLEI; TAILS	A homogeneous oligonucleosome complex was prepared by reconstitution of highly hyperacetylated histone octamers onto a linear DNA template consisting of 12 tandemly arranged 208-base pair fragments of the 5 S rRNA gene from the sea urchin Lytechinus variegatus. The ionic strength-dependent folding of this oligonucleosome assembly was monitored by sedimentation velocity and electron microscopy. Both types of analysis indicate that under ionic conditions resembling those found in the physiological range and in the absence of histone H1, the acetylated oligonucleosome complexes remain in an extended conformation in contrast to their nonacetylated counterparts. The implications of this finding in the context of a multistate model of chromatin folding (Hansen, J. C., and Ausio, J. (1992) TIBS 197, 187-191) as well as its biological relevance are discussed.	UNIV VICTORIA,DEPT BIOCHEM & MICROBIOL,VICTORIA,BC V8W 3P6,CANADA; HOSP DURAN REYNALS,INST RECERCA ONCOL,GEN CATALUNYA,E-08907 BARCELONA,SPAIN	University of Victoria; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals				Garcia-Ramirez, Marta/0000-0003-4249-7177				ALLAN J, 1982, J CELL BIOL, V93, P285, DOI 10.1083/jcb.93.2.285; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; AUSIO J, 1992, J CELL SCI, V102, P1; AUSIO J, 1986, BIOCHEMISTRY-US, V25, P1421, DOI 10.1021/bi00354a035; BAUER WR, 1994, J MOL BIOL, V236, P685, DOI 10.1006/jmbi.1994.1180; BERTRAND E, 1984, ARCH BIOCHEM BIOPHYS, V229, P395, DOI 10.1016/0003-9861(84)90167-X; BODE J, 1983, EUR J BIOCHEM, V130, P437, DOI 10.1111/j.1432-1033.1983.tb07170.x; BODE J, 1980, EUR J BIOCHEM, V110, P143, DOI 10.1111/j.1432-1033.1980.tb04849.x; BONNER WM, 1980, EUR J BIOCHEM, V109, P17, DOI 10.1111/j.1432-1033.1980.tb04762.x; Cavalier- Smith T, 1981, SOC GEN MICROBIOL S, V32, P33; CAVALIERSMITH T, 1988, BIOESSAYS, V9, P72, DOI 10.1002/bies.950090209; CSORDAS A, 1990, BIOCHEM J, V265, P23, DOI 10.1042/bj2650023; DAVIE JR, 1994, J CELL BIOCHEM, V55, P98, DOI 10.1002/jcb.240550112; DIMITROV S, 1986, FEBS LETT, V197, P217, DOI 10.1016/0014-5793(86)80329-5; EARNSHAW WC, 1987, J CELL BIOL, V105, P1479, DOI 10.1083/jcb.105.4.1479; GARCIARAMIREZ M, 1992, J BIOL CHEM, V267, P19587; GRIGORYEV SA, 1990, NUCLEIC ACIDS RES, V18, P7397, DOI 10.1093/nar/18.24.7397; GRUNSTEIN M, 1990, ANNU REV CELL BIOL, V6, P643, DOI 10.1146/annurev.cellbio.6.1.643; GRUNSTEIN M, 1990, TRENDS GENET, V6, P395, DOI 10.1016/0168-9525(90)90299-L; HANSEN JC, 1992, TRENDS BIOCHEM SCI, V17, P187, DOI 10.1016/0968-0004(92)90264-A; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; HANSEN JC, 1992, BIOCHEMISTRY-US, V31, P7977, DOI 10.1021/bi00149a032; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; IMAI BS, 1986, J BIOL CHEM, V261, P8784; KIRKWOOD JG, 1954, J POLYM SCI, V12, P1, DOI 10.1002/pol.1954.120120102; LABHART P, 1981, EUR J CELL BIOL, V24, P309; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; LEUBA SH, 1994, P NATL ACAD SCI USA, V91, P11621, DOI 10.1073/pnas.91.24.11621; LIBERTINI LJ, 1988, BIOPHYS J, V53, P477, DOI 10.1016/S0006-3495(88)83126-6; LUTTER LC, 1992, MOL CELL BIOL, V12, P5004, DOI 10.1128/MCB.12.11.5004; Maniatis T., 1982, MOL CLONING; MCGHEE JD, 1983, NUCLEIC ACIDS RES, V11, P4065, DOI 10.1093/nar/11.12.4065; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; OLIVA R, 1990, NUCLEIC ACIDS RES, V18, P2739, DOI 10.1093/nar/18.9.2739; PARANJAPE SM, 1994, ANNU REV BIOCHEM, V63, P265, DOI 10.1146/annurev.biochem.63.1.265; PERRY CA, 1991, EXP CELL RES, V196, P337, DOI 10.1016/0014-4827(91)90269-Z; POGO BGT, 1966, P NATL ACAD SCI USA, V55, P805, DOI 10.1073/pnas.55.4.805; RIDSDALE JA, 1990, J BIOL CHEM, V265, P5150; SIMPSON RT, 1978, CELL, V13, P691, DOI 10.1016/0092-8674(78)90219-2; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; SIMPSON RT, 1979, J BIOL CHEM, V254, P123; TURNER BM, 1991, J CELL SCI, V99, P13; TURNER BM, 1993, CELL, V75, P5, DOI 10.1016/S0092-8674(05)80078-9; WEISCHET WO, 1978, NUCLEIC ACIDS RES, V5, P139, DOI 10.1093/nar/5.1.139; WOLFFE AP, 1992, FASEB J, V6, P3354, DOI 10.1096/fasebj.6.15.1464369; YAO J, 1990, P NATL ACAD SCI USA, V87, P7603, DOI 10.1073/pnas.87.19.7603; ZLANATOVA J, 1992, J CELL SCI, V103, P889	48	274	278	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17923	17928		10.1074/jbc.270.30.17923	http://dx.doi.org/10.1074/jbc.270.30.17923			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629098	hybrid			2022-12-27	WOS:A1995RM26600047
J	REIKERSTORFER, A; HOLZ, H; STUNNENBERG, HG; BUSSLINGER, M				REIKERSTORFER, A; HOLZ, H; STUNNENBERG, HG; BUSSLINGER, M			LOW-AFFINITY BINDING OF INTERLEUKIN-1-BETA AND INTRACELLULAR SIGNALING VIA NF-KAPPA-B IDENTIFY FIT-1 AS A DISTANT MEMBER OF THE INTERLEUKIN-1 RECEPTOR FAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							IL-1 RECEPTOR; SOLUBLE RECEPTOR; VACCINIA VIRUS; PROTEIN; GENE; EXPRESSION; DROSOPHILA; IDENTIFICATION; TRANSFORMATION; PURIFICATION	The fit-1 gene gives rise to two different mRNA isoforms, which code for soluble (Fit-1S) and membrane-bound (Fit-1M) proteins related to the type I interleukin (IL)-1 receptor. To investigate IL-1 binding, we have synthesized and purified histidine-tagged polypeptides corresponding to Fit-1S and the extracellular domain of the type I IL-1 receptor using a vaccinia expression system. Fit-1S is shown to interact with IL-1 beta, but not with IL-1 alpha. However, Fit-1S binds IL-1 beta only with low affinity in contrast to the IL-1 receptor, suggesting that IL-1 beta is not a physiological ligand of Fit-1S. Moreover, expression of the membrane-bound protein Fit-1M in transiently transfected Jurkat cells did not result in activation of the transcription factor NF-kappa B following IL-1 beta treatment. However, a chimeric protein consisting of the extracellular domain of the type I IL-1 receptor and of the transmembrane and intracellular regions of Fit-1M stimulated NF-kappa B-dependent transcription as efficiently as the full-length type I IL-1 receptor. These data indicate that Fit-1M is a signaling molecule belonging to the IL-1 receptor family.	RES INST MOLEC PATHOL,A-1030 VIENNA,AUSTRIA; EUROPEAN MOLEC BIOL LAB,D-69012 HEIDELBERG,GERMANY	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); European Molecular Biology Laboratory (EMBL)			Stunnenberg, Hendrik G./D-6875-2012; Busslinger, Meinrad J./J-1249-2016	Stunnenberg, Hendrik G./0000-0002-0066-1576; Busslinger, Meinrad J./0000-0002-9111-9351				ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; BERGERS G, 1994, EMBO J, V13, P176; BOEHMELT G, 1992, EMBO J, V11, P4641, DOI 10.1002/j.1460-2075.1992.tb05566.x; BRADFORD M, 1906, ANAL BIOCHEM, V72, P248; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; CURTIS BM, 1989, P NATL ACAD SCI USA, V86, P3045, DOI 10.1073/pnas.86.9.3045; DINARELLO CA, 1991, CYTOKINE HDB, P47; DOWER SK, 1989, J IMMUNOL, V142, P4314; EASTGATE JA, 1990, FEBS LETT, V260, P213, DOI 10.1016/0014-5793(90)80106-S; FRESHNEY NWW, 1994, CELL, V78, P103; GIRI JG, 1990, J BIOL CHEM, V265, P17416; HART RP, 1993, J NEUROIMMUNOL, V44, P49, DOI 10.1016/0165-5728(93)90267-3; HEGUY A, 1992, J BIOL CHEM, V267, P2605; HULTMARK D, 1994, BIOCHEM BIOPH RES CO, V199, P144, DOI 10.1006/bbrc.1994.1206; JANKNECHT R, 1991, P NATL ACAD SCI USA, V88, P8972, DOI 10.1073/pnas.88.20.8972; KUNO K, 1993, J BIOL CHEM, V268, P13510; LEUNG KY, 1994, J BIOL CHEM, V269, P1579; MCINTYRE KW, 1991, J EXP MED, V173, P931, DOI 10.1084/jem.173.4.931; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; NISHIDA T, 1988, P73; ROSOFF PM, 1988, CELL, V54, P73, DOI 10.1016/0092-8674(88)90181-X; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; SLACK J, 1993, J BIOL CHEM, V268, P2513; SPRIGGS MK, 1992, CELL, V71, P145, DOI 10.1016/0092-8674(92)90273-F; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; SUPERTIFURGA G, 1991, P NATL ACAD SCI USA, V88, P5114, DOI 10.1073/pnas.88.12.5114; SYMONS J A, 1990, Cytokine, V2, P190, DOI 10.1016/1043-4666(90)90015-L; SYMONS JA, 1991, J EXP MED, V174, P1251, DOI 10.1084/jem.174.5.1251; TOMINAGA S, 1991, BIOCHIM BIOPHYS ACTA, V1090, P1, DOI 10.1016/0167-4781(91)90029-L; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6	33	24	28	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17645	17648		10.1074/jbc.270.30.17645	http://dx.doi.org/10.1074/jbc.270.30.17645			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629057	hybrid, Green Accepted			2022-12-27	WOS:A1995RM26600002
J	WANG, YL; KENT, C				WANG, YL; KENT, C			EFFECTS OF ALTERED PHOSPHORYLATION SITES ON THE PROPERTIES OF CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHINESE-HAMSTER OVARY; CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE; PHOSPHOLIPASE-C TREATMENT; MEMBRANE-ASSOCIATED CTP; HEP G2 CELLS; FATTY-ACIDS; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; HELA-CELLS; MAMMALIAN-CELLS; RAT-LIVER	To investigate the role of phosphorylation and dephosphorylation in modulating the activity and location of CTP:phosphocholine cytidylyltransferase, we used site-directed mutagenesis to construct four mutant forms of cytidylyltransferase. These forms were 5SP --> AP, in which five of the seven Ser-Pro sequences were converted to Ala-Pro; 7SP --> AP, in which all of the seven Ser-Pro sequences converted to Ala-Pro; 16S --> A, in which all sixteen Ser residues that can be phosphorylated in wild type cytidylyltransferase were converted to Ala; and 16S --> E, in which all sixteen Ser residues were converted to Glu. The mutant enzymes were expressed in the strain 58 Chinese hamster ovary cell line, which is temperature-sensitive for growth and cytidylyltransferase activity. All mutant enzyme forms were enzymatically as active as the wild type when assayed under optimal conditions. In untreated cells, more of the Ser --> Ala mutants were membrane-associated than in cells expressing wild type enzyme, consistent with the phosphorylation state of the enzyme affecting its affinity for membranes. About half of the 16S --> A mutant remained soluble, however, indicating that dephosphorylation alone does not trigger membrane association. Although the amount of membrane-associated enzyme in the 16S --> A mutant was about 10-fold greater than that of wild type, phosphatidylcholine synthesis was increased by only about 75%, suggesting that membrane association does not necessarily cause full activation. Ah mutant forms, including the 16S --> E mutant, translocated to the particulate fraction upon oleate treatment, indicating that a high negative charge in the phosphorylation region does not preclude association of cytidylyltransferase with membranes. Ah mutant enzymes were able to support growth of strain 58 at 40 degrees C, and the rate of phosphatidylcholine synthesis was not greatly altered in the cell lines expressing mutant cytidylyltransferase forms, These results are consistent with a role for phosphorylation in the equilibrium distribution of cytidylyltransferase but suggest that changes in enzyme activity and location are not triggered exclusively by changes in the phosphorylation state.	UNIV MICHIGAN,MED CTR,DEPT BIOL CHEM,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan					NATIONAL CANCER INSTITUTE [R01CA064159] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER; NCI NIH HHS [CA64159] Funding Source: Medline; NCRR NIH HHS [M01RR00042] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CRAIG L, 1994, J BIOL CHEM, V269, P3311; ESKO JD, 1980, P NATL ACAD SCI-BIOL, V77, P5192, DOI 10.1073/pnas.77.9.5192; ESKO JD, 1981, J BIOL CHEM, V256, P7388; FELDMAN DA, 1980, BIOCHIM BIOPHYS ACTA, V620, P603, DOI 10.1016/0005-2760(80)90152-6; HOUWELING M, 1994, J BIOL CHEM, V269, P7544; HOUWELING M, 1993, EUR J BIOCHEM, V214, P927, DOI 10.1111/j.1432-1033.1993.tb17996.x; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; JAMIL H, 1993, BIOCHEM J, V291, P419, DOI 10.1042/bj2910419; KALMAR GB, 1990, P NATL ACAD SCI USA, V87, P6029, DOI 10.1073/pnas.87.16.6029; KENT C, 1990, PROG LIPID RES, V29, P87, DOI 10.1016/0163-7827(90)90010-I; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; MORAND JN, 1989, J BIOL CHEM, V264, P13785; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V795, P433, DOI 10.1016/0005-2760(84)90169-3; PELECH SL, 1983, J BIOL CHEM, V258, P6782; SLEIGHT R, 1980, J BIOL CHEM, V255, P644; SLEIGHT R, 1983, J BIOL CHEM, V258, P831; SLEIGHT R, 1983, J BIOL CHEM, V258, P836; SWEITZER TD, 1994, ARCH BIOCHEM BIOPHYS, V311, P107, DOI 10.1006/abbi.1994.1215; TESSNER TG, 1991, J BIOL CHEM, V266, P16261; WANG YL, 1993, J BIOL CHEM, V268, P5512; WANG YL, 1993, J BIOL CHEM, V268, P5899; WATKINS JD, 1991, J BIOL CHEM, V266, P21113; WATKINS JD, 1992, J BIOL CHEM, V267, P5686; WATKINS JD, 1990, J BIOL CHEM, V265, P2190; WEINHOLD PA, 1992, METHOD ENZYMOL, V209, P248; WEINHOLD PA, 1984, J BIOL CHEM, V259, P315; WEINHOLD PA, 1994, BBA-LIPID LIPID MET, V1210, P335, DOI 10.1016/0005-2760(94)90238-0; WEINHOLD PA, 1991, J BIOL CHEM, V266, P6093; WEINHOLD PA, 1989, BIOCHIM BIOPHYS ACTA, V1006, P299, DOI 10.1016/0005-2760(89)90017-9; WHITLON DS, 1985, BIOCHIM BIOPHYS ACTA, V835, P369, DOI 10.1016/0005-2760(85)90293-0	32	68	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17843	17849		10.1074/jbc.270.30.17843	http://dx.doi.org/10.1074/jbc.270.30.17843			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629086	hybrid			2022-12-27	WOS:A1995RM26600034
J	KANTOROW, M; HORWITZ, J; VANBOEKEL, MAM; DEJONG, WW; PIATIGORSKY, J				KANTOROW, M; HORWITZ, J; VANBOEKEL, MAM; DEJONG, WW; PIATIGORSKY, J			CONVERSION FROM OLIGOMERS TO TETRAMERS ENHANCES AUTOPHOSPHORYLATION BY LENS ALPHA-A-CRYSTALLIN - SPECIFICITY BETWEEN ALPHA-A AND ALPHA-B-CRYSTALLIN SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN; CREUTZFELDT-JAKOB DISEASE; NONLENTICULAR TISSUES; PHOSPHORYLATION SITES; BOVINE LENS; EXPRESSION; UBIQUITIN; GENE; CHAPERONES; EVOLUTION	Previously we showed that cu crystallins are autophosphorylated (Kantorow, M., and Piatigorsky, J. (1994) Proc. Natl. Acad. Sci. U.S.A. 91, 3112-3116), Here we report that addition of 1% deoxycholate converted alpha A-crystallin aggregates into 80-kDa tetramers which were 16-fold more active for autophosphorylation, Circular dichroism (CD) spectra of alpha-crystallin revealed little or no change in secondary and tertiary structures in 1% deoxycholate, alpha A2D, a truncated form of bovine alpha A that exists as a tetramer, was as active for autophosphorylation in the absence of deoxycholate as intact alpha A was in the presence of deoxycholate, At least one serine between amino acids 131 and 145 of bovine alpha A was auto phosphorylated in peptide mapping experiments, Chicken alpha A-crystallin, which lacks the Ser-122 cAMP-dependent kinase site of bovine alpha A, was also autophosphorylated in the presence of deoxycholate, In contrast to alpha A crystallin, autophosphorylation by alpha B-crystallin was not activated by deoxycholate despite its conversion to a tetrameric form, and alpha B was also more efficiently phosphorylated by cAMP-dependent kinase than alpha A, These data suggest metabolic differences between the alpha-crystallin subunits that may be related to specific expression of alpha A in the lens and ubiquitous expression of alpha B in numerous normal and diseased tissues.	NEI, MOLEC & DEV BIOL LAB, BETHESDA, MD 20892 USA; UNIV CALIF LOS ANGELES, SCH MED, JULES STEIN EYE INST, LOS ANGELES, CA 90024 USA; UNIV NIJMEGEN, DEPT BIOCHEM, 6525 EK NIJMEGEN, NETHERLANDS	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Radboud University Nijmegen					NATIONAL EYE INSTITUTE [R01EY009683] Funding Source: NIH RePORTER; NEI NIH HHS [EY03879, EYO9683] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AUGUSTEYN RC, 1992, EXP EYE RES, V54, P219, DOI 10.1016/S0014-4835(05)80211-8; BENNDORF R, 1994, J BIOL CHEM, V269, P20780; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; BLOEMENDAL H, 1991, PROG NUCLEIC ACID RE, V41, P259; CARLINO A, 1992, P NATL ACAD SCI USA, V89, P2081, DOI 10.1073/pnas.89.6.2081; CHIESA R, 1987, BIOCHEM BIOPH RES CO, V144, P1340, DOI 10.1016/0006-291X(87)91457-4; CHIESA R, 1988, EXP EYE RES, V46, P199, DOI 10.1016/S0014-4835(88)80077-0; CHIESA R, 1987, J BIOL CHEM, V262, P1438; CHIESA R, 1990, FEBS LETT, V268, P222, DOI 10.1016/0014-5793(90)81013-E; CREWS CM, 1992, CELL GROWTH DIFFER, V3, P135; DASGUPTA S, 1992, EXP EYE RES, V54, P461, DOI 10.1016/0014-4835(92)90058-Z; DEJONG WW, 1993, MOL BIOL EVOL, V10, P103; DUBIN RA, 1989, MOL CELL BIOL, V9, P1083, DOI 10.1128/MCB.9.3.1083; DUGUID JR, 1988, P NATL ACAD SCI USA, V85, P5738, DOI 10.1073/pnas.85.15.5738; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; GROENEN PJTA, 1994, EUR J BIOCHEM, V225, P1, DOI 10.1111/j.1432-1033.1994.00001.x; GROENEN PJTA, 1992, EUR J BIOCHEM, V205, P671, DOI 10.1111/j.1432-1033.1992.tb16827.x; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; IWAKI T, 1991, KIDNEY INT, V40, P52, DOI 10.1038/ki.1991.178; IWAKI T, 1992, AM J PATHOL, V140, P345; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; IWAKI T, 1991, AM J PATHOL, V139, P1303; IWAKI T, 1991, CANCER, V68, P2230, DOI 10.1002/1097-0142(19911115)68:10<2230::AID-CNCR2820681023>3.0.CO;2-7; JAKOB U, 1993, J BIOL CHEM, V268, P1517; KANTOROW M, 1994, P NATL ACAD SCI USA, V91, P3112, DOI 10.1073/pnas.91.8.3112; KATO K, 1994, J BIOL CHEM, V269, P11274; KATO K, 1991, BIOCHIM BIOPHYS ACTA, V1080, P173, DOI 10.1016/0167-4838(91)90146-Q; KATO K, 1992, J BIOL CHEM, V267, P7718; KATO S, 1992, ACTA NEUROPATHOL, V84, P443; KLEIMAN NJ, 1988, J BIOL CHEM, V263, P14978; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; LANDRY J, 1992, J BIOL CHEM, V267, P794; LOWE J, 1992, J PATHOL, V166, P61, DOI 10.1002/path.1711660110; MERCK KB, 1992, BIOCHIM BIOPHYS ACTA, V1130, P267, DOI 10.1016/0167-4781(92)90439-7; MERCK KB, 1993, J BIOL CHEM, V268, P1046; MIESBAUER LR, 1994, J BIOL CHEM, V269, P12494; MULDERS JWM, 1985, EUR J BIOCHEM, V152, P721, DOI 10.1111/j.1432-1033.1985.tb09253.x; MURANO S, 1991, MOL CELL BIOL, V11, P3905, DOI 10.1128/MCB.11.8.3905; PALMISANO DV, 1995, BBA-PROTEIN STRUCT M, V1246, P91, DOI 10.1016/0167-4838(94)00176-H; REDDY MC, 1992, BIOCHEM BIOPH RES CO, V189, P1578, DOI 10.1016/0006-291X(92)90256-K; RENKAWEK K, 1992, ACTA NEUROPATHOL, V83, P324, DOI 10.1007/BF00296796; ROQUEMORE EP, 1992, J BIOL CHEM, V267, P555; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SAX CM, 1993, ADV ENZYMOL RAMB, V69, P155; SCOTTING P, 1991, FEBS LETT, V285, P75, DOI 10.1016/0014-5793(91)80728-L; SMITH JB, 1992, PROTEIN SCI, V1, P601, DOI 10.1002/pro.5560010506; SPECTOR A, 1985, P NATL ACAD SCI USA, V82, P4712, DOI 10.1073/pnas.82.14.4712; SREDY J, 1984, EXP EYE RES, V39, P653, DOI 10.1016/0014-4835(84)90064-2; SRINIVASAN AN, 1992, J BIOL CHEM, V267, P23337; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; STOKOE D, 1992, FEBS LETT, V309, P111; TAWA P, 1994, BIOCHEMISTRY-US, V33, P7917, DOI 10.1021/bi00191a019; TOMOKANE N, 1991, AM J PATHOL, V138, P875; VANHAERINGEN B, 1993, EUR J BIOCHEM, V217, P143; VOORTER CEM, 1989, FEBS LETT, V259, P50; VOORTER CEM, 1986, EUR J BIOCHEM, V160, P203; WISTOW G, 1993, EXP EYE RES, V56, P729, DOI 10.1006/exer.1993.1090; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; ZANTEMA A, 1992, J BIOL CHEM, V267, P12936	60	58	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17215	17220		10.1074/jbc.270.29.17215	http://dx.doi.org/10.1074/jbc.270.29.17215			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615520	hybrid			2022-12-27	WOS:A1995RK68900027
J	MIRZA, UA; CHAIT, BT; LANDER, HM				MIRZA, UA; CHAIT, BT; LANDER, HM			MONITORING REACTIONS OF NITRIC-OXIDE WITH PEPTIDES AND PROTEINS BY ELECTROSPRAY-IONIZATION MASS-SPECTROMETRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEOTIDE REDUCTASE; ACTIVATION; CELLS	Recent studies have demonstrated the biological importance of the interaction of nitric oxide (NO) with proteins, Protein-associated targets of NO include heme, Cys, and Tyr. Electrospray ionization-mass spectrometry was used to monitor the results of exposure of model peptides and an enzyme to NO under different conditions and thus addressed aspects of NO-protein interactions, The molecular mass of a decapeptide containing a single Cys residue increased by 29 Da upon treatment with NO under aerobic and acidic conditions, consistent with the substitution of one NO moiety, The mass of reduced somatostatin, a peptide containing two Cys residues, increased by 58 Da, consistent with the substitution of two NO moieties, These substitutions were prevented by pretreatment of the peptides with N-ethylmaleimide. The strength of the nitrosothiol bond was examined by varying the amount of energy applied to the peptide ions and indicated a labile species, Cys residues were very rapidly nitrosated, while other reactions were observed to occur at much slower rates, These include the further oxidation of nitrosothiol to sulfonic acid and nitration of Tyr, Peptides treated with NO at physiological pH were observed to undergo dimerization as well as nitrosation. These studies were extended to the enzyme p21(ras), whose activity has been postulated to be modulated by nitrosothiol formation, and revealed the formation of a single nitrosothiol on p21(ras) upon NO treatment, These data suggest that electrospray ionization-mass spectrometry allows for quantitation and characterization of nitrosothiol bonds in peptides and proteins.	CORNELL UNIV,COLL MED,DEPT BIOCHEM,NEW YORK,NY 10021; ROCKEFELLER UNIV,NEW YORK,NY 10021	Cornell University; Rockefeller University					NCRR NIH HHS [RR00862] Funding Source: Medline; NIAID NIH HHS [AI37637] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI037637] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHAIT BT, 1992, SCIENCE, V257, P1885, DOI 10.1126/science.1411504; CHOWDHURY SK, 1990, RAPID COMMUN MASS SP, V4, P81, DOI 10.1002/rcm.1290040305; DERUBERTIS FR, 1976, SCIENCE, V193, P897, DOI 10.1126/science.7837; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; HAJJAR DP, 1995, J AM CHEM SOC, V17, P3340; IGNARRO LJ, 1991, BIOCHEM PHARMACOL, V41, P485, DOI 10.1016/0006-2952(91)90618-F; KWON NS, 1991, J EXP MED, V174, P761, DOI 10.1084/jem.174.4.761; LANDER HM, 1995, J BIOL CHEM, V270, P7017, DOI 10.1074/jbc.270.13.7017; LANDER HM, 1993, J IMMUNOL, V151, P7182; LANDER HM, 1993, J IMMUNOL, V150, P1509; LEPOIVRE M, 1991, BIOCHEM BIOPH RES CO, V179, P442, DOI 10.1016/0006-291X(91)91390-X; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; OAE S, 1978, J CHEM SOC PERK T 1, P913, DOI 10.1039/p19780000913; PARTIS MD, 1983, J PROTEIN CHEM, V2, P263, DOI 10.1007/BF01025358; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0	20	100	101	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17185	17188		10.1074/jbc.270.29.17185	http://dx.doi.org/10.1074/jbc.270.29.17185			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615515	hybrid			2022-12-27	WOS:A1995RK68900022
J	MULLINS, C; LU, YQ; CAMPBELL, A; FANG, H; GREEN, N				MULLINS, C; LU, YQ; CAMPBELL, A; FANG, H; GREEN, N			A MUTATION AFFECTING SIGNAL PEPTIDASE INHIBITS DEGRADATION OF AN ABNORMAL MEMBRANE-PROTEIN IN SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SECRETORY PATHWAY; ENDOPLASMIC-RETICULUM; NUCLEOTIDE-SEQUENCE; SEC11 PROTEIN; TRANSLOCATION; TRANSPORT; COMPLEX; GENE; PURIFICATION; INSERTION	Signal peptidase removes amino terminal signal peptides from precursor proteins during or immediately following their translocation to the lumen of the endoplasmic reticulum (ER) and may participate in ER degradation, a poorly defined process whereby abnormal proteins are rapidly degraded early in the secretory pathway. Here, the involvement of signal peptidase in ER degradation is examined through the use of two chimeric membrane proteins that lack amino-terminal signal peptides: A18BinvHD, which contains sequences derived from arginine permease and histidinol dehydrogenase, and AHDK2, containing the ER-resident protein Kar2p fused to the carboxyl terminus of A189invHD, Degradation of approximately 95% of A189invHD is observed in yeast cells expressing enzymatically active signal peptidase, whereas only 60% undergoes rapid degradation in a sec11 mutant bearing a temperature-sensitive mutation in the gene encoding the 18-kDa subunit (Sec11p) of the signal peptidase complex, AHDR2 is proteolyzed in a reaction yielding at least two fragments in wild-type cells and in the sec11 mutant containing a plasmid bearing the SEC11 gene, The proteolytic reaction is catalyzed in a temperature-dependent manner in the sec11 mutant, with AHDK2 remaining stable at the nonpermissive temperature, Using conditional mutants defective in protein translocation into and out of the ER and in vitro protease protection studies, the site of degradation for AHDK2 is localized to the ER lumen, The data therefore indicate (i) A189invHD is degraded through both signal peptidase-dependent and independent processes; (ii) signal peptidase, specifically the Sec11p subunit, is required for the proteolysis of AHDK2; and (iii) the Kar2 fragment at the carboxyl terminus of AHDK2 permits detection of proteolytic intermediates.			MULLINS, C (corresponding author), VANDERBILT UNIV, SCH MED, DEPT MICROBIOL & IMMUNOL, NASHVILLE, TN 37232 USA.				NATIONAL CANCER INSTITUTE [T32CA009385] Funding Source: NIH RePORTER; NCI NIH HHS [2 T32 CA09385-11] Funding Source: Medline; NCRR NIH HHS [RR-05424] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AMARA JF, 1989, J CELL BIOL, V109, P3315, DOI 10.1083/jcb.109.6.3315; BAKER RK, 1987, BIOCHEMISTRY-US, V26, P8561, DOI 10.1021/bi00400a010; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BOHNI PC, 1988, J CELL BIOL, V106, P1035, DOI 10.1083/jcb.106.4.1035; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; DONAHUE TF, 1982, GENE, V18, P47, DOI 10.1016/0378-1119(82)90055-5; DUNN B, 1994, CURRENT PROTOCOLS MO; EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581; FANG H, 1994, MOL BIOL CELL, V5, P933, DOI 10.1091/mbc.5.9.933; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; GREEN GN, 1989, J CELL SCI, P109; GREEN N, 1992, MOL CELL BIOL, V12, P276, DOI 10.1128/MCB.12.1.276; GREEN N, 1992, J CELL BIOL, V116, P597, DOI 10.1083/jcb.116.3.597; GREENBURG G, 1989, J BIOL CHEM, V264, P15762; HOFFMANN W, 1985, J BIOL CHEM, V260, P1831; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; LILJESTROM P, 1991, J VIROL, V65, P147; LIPP J, 1986, CELL, V46, P1103, DOI 10.1016/0092-8674(86)90710-5; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; SCHMID SR, 1988, J BIOL CHEM, V263, P16886; SHELNESS GS, 1990, J BIOL CHEM, V265, P9512; SIKORSKI RS, 1989, GENETICS, V122, P19; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; STOLLER TJ, 1989, J CELL BIOL, V108, P1647, DOI 10.1083/jcb.108.5.1647; STRAUSS AW, 1979, P NATL ACAD SCI USA, V76, P4225, DOI 10.1073/pnas.76.9.4225; TAUSSIG R, 1983, NUCLEIC ACIDS RES, V11, P1943, DOI 10.1093/nar/11.6.1943; WAGNER I, 1994, EMBO J, V13, P5135, DOI 10.1002/j.1460-2075.1994.tb06843.x; WALTER P, 1979, P NATL ACAD SCI USA, V76, P1795, DOI 10.1073/pnas.76.4.1795; YADEAU JT, 1991, P NATL ACAD SCI USA, V88, P517, DOI 10.1073/pnas.88.2.517; YUK MH, 1993, J CELL BIOL, V123, P1735, DOI 10.1083/jcb.123.6.1735	37	31	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17139	17147		10.1074/jbc.270.29.17139	http://dx.doi.org/10.1074/jbc.270.29.17139			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615509	hybrid			2022-12-27	WOS:A1995RK68900016
J	LOMAS, DA; ELLIOTT, PR; SIDHAR, SK; FOREMAN, RC; FINCH, JT; COX, DW; WHISSTOCK, JC; CARRELL, RW				LOMAS, DA; ELLIOTT, PR; SIDHAR, SK; FOREMAN, RC; FINCH, JT; COX, DW; WHISSTOCK, JC; CARRELL, RW			ALPHA(1)-ANTITRYPSIN MMALTON (PHE(52)-DELETED) FORMS LOOP-SHEET POLYMERS IN-VIVO - EVIDENCE FOR THE C-SHEET MECHANISM OF POLYMERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-1-PROTEINASE INHIBITOR; CRYSTAL-STRUCTURE; ALPHA-1-ANTITRYPSIN DEFICIENCY; PROTEINASE-INHIBITORS; PLASMINOGEN-ACTIVATOR; ANTITHROMBIN-III; MOLECULAR-BASIS; REACTIVE SITE; LUNG-DISEASE; RESOLUTION	The Z (Glu(342) --> Lys) and Siiyama (Ser(53) --> Phe) deficiency variants of alpha(1)-antitrypsin result in the retention of protein in the endoplasmic reticulum of the hepatocyte by loop-sheet polymerization in which the reactive center loop of one molecule is inserted into a beta-pleated sheet of a second. We show here that antitrypsin Mmal-ton (Phe(52)-deleted), which is associated with the same liver inclusions, is also retained at an endoglycosidase H-sensitive stage of processing in the Xenopus oocyte and spontaneously forms polymers in vivo. These polymers, obtained from the plasma of an Mmalton/QO (null) bolton heterozygote, were much shorter than other antitrypsin polymers and contained a reactive center loop-cleaved species. Monomeric mutant antitrypsin was also isolated from the plasma. The monomeric component had a normal unfolding transition on transverse urea gradient gel electrophoresis and formed polymers in vitro more readily than M, but less readily than Z, antitrypsin, The A beta-sheet accommodated a reactive center loop peptide much less readily than Z antitrypsin, which in turn was less receptive than native M antitrypsin. The nonreceptive conformation of the A sheet in antitrypsin Mmalton had little effect on kinetic parameters, the formation of SDS-stable complexes, the S to R transition, and the formation of the latent conformation. Comparison of the results with similar findings of short chain polymers associated with the antithrombin variant Rouen VI (Bruce, D., Perry, D., Borg, J.-Y., Carrell, R. W., and Wardell, M. R. (1994) J. Clin. Invest. 94, 2265-2274) suggests that polymerization is more complicated than the mechanism proposed earlier. The Z, Siiyama, and Mmalton mutations favor a conformational change in the antitrypsin molecule to an intermediate between the native and latent forms. This would involve a partial overinsertion of the reactive loop into the A sheet with displacement of strand 1C and consequent loop-C sheet polymerization.	MRC CTR, MOLEC BIOL LAB, CAMBRIDGE CB2 2QH, ENGLAND; UNIV SOUTHAMPTON, DEPT PHYSIOL & PHARMACOL, SOUTHAMPTON SO9 3TU, HANTS, ENGLAND; HOSP SICK CHILDREN, DEPT PEDIAT, TORONTO, ON M5G 1X8, CANADA; HOSP SICK CHILDREN, DEPT GENET, TORONTO, ON M5G 1X8, CANADA	MRC Laboratory Molecular Biology; University of Southampton; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	LOMAS, DA (corresponding author), UNIV CAMBRIDGE, DEPT HEMATOL, HILLS RD, CAMBRIDGE CB2 2QH, ENGLAND.			Whisstock, James/0000-0003-4200-5611	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AULAK KS, 1993, J BIOL CHEM, V268, P18088; BAUMANN U, 1991, J MOL BIOL, V218, P595, DOI 10.1016/0022-2836(91)90704-A; BAUMANN U, 1992, J MOL BIOL, V226, P1207, DOI 10.1016/0022-2836(92)91062-T; BJORK I, 1993, BIOCHEMISTRY-US, V32, P6501; Bode W, 1991, CURR OPIN STRUC BIOL, V1, P45, DOI 10.1016/0959-440X(91)90010-Q; BRUCE D, 1994, J CLIN INVEST, V94, P2265, DOI 10.1172/JCI117589; BRUCH M, 1988, J BIOL CHEM, V263, P16626; CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; Carrell RW, 1992, CURR OPIN STRUC BIOL, V2, P438; CHANG WSW, 1994, BLOOD, V84, pA391; COX DW, 1986, FEBS LETT, V205, P255, DOI 10.1016/0014-5793(86)80908-5; COX DW, 1975, PROTIDES BIOL FLUIDS, V23, P375; CURIEL DT, 1989, J BIOL CHEM, V264, P13938; ELDERING E, 1995, J BIOL CHEM, V270, P2579, DOI 10.1074/jbc.270.6.2579; FABER JP, 1993, J HEPATOL, V18, P313, DOI 10.1016/S0168-8278(05)80275-2; FRAIZER GC, 1989, AM J HUM GENET, V44, P894; FRAIZER GC, 1989, HUM GENET, V83, P377, DOI 10.1007/BF00291385; GETTINS P, 1988, BIOCHEMISTRY-US, V27, P3634, DOI 10.1021/bi00410a017; GRAHAM A, 1989, HUM GENET, V84, P55, DOI 10.1007/BF00210671; GUZDEK A, 1990, FEBS LETT, V272, P125, DOI 10.1016/0014-5793(90)80464-T; JOHNSON D, 1978, J BIOL CHEM, V253, P7142; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LOMAS DA, 1993, BIOCHEMISTRY-US, V32, P500, DOI 10.1021/bi00053a014; LOMAS DA, 1993, J BIOL CHEM, V268, P516; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; LOMAS DA, 1993, J BIOL CHEM, V268, P15333; LOMAS DA, 1995, J BIOL CHEM, V270, P5282, DOI 10.1074/jbc.270.10.5282; LONGSTAFF C, 1991, BIOCHEMISTRY-US, V30, P979, DOI 10.1021/bi00218a014; MAST AE, 1992, BIOCHEMISTRY-US, V31, P2720, DOI 10.1021/bi00125a012; MATHESON NR, 1991, J BIOL CHEM, V266, P13489; MATSUNAGA E, 1990, AM J HUM GENET, V46, P602; MIKUS P, 1993, EUR J BIOCHEM, V218, P1071, DOI 10.1111/j.1432-1033.1993.tb18467.x; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; MOUREY L, 1993, J MOL BIOL, V232, P223, DOI 10.1006/jmbi.1993.1378; OGUSHI F, 1987, J CLIN INVEST, V80, P1366, DOI 10.1172/JCI113214; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; ROBERTS EA, 1984, AM J CLIN PATHOL, V82, P424, DOI 10.1093/ajcp/82.4.424; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; SERGI C, 1994, LAB INVEST, V70, P130; SEYAMA K, 1991, J BIOL CHEM, V266, P12627; SIDHAR SK, 1995, J BIOL CHEM, V270, P8393, DOI 10.1074/jbc.270.15.8393; SKRIVER K, 1991, J BIOL CHEM, V266, P9216; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; STEIN PE, 1991, J MOL BIOL, V221, P941, DOI 10.1016/0022-2836(91)80185-W; STEIN PE, 1990, NATURE, V347, P99, DOI 10.1038/347099a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRAVIS J, 1981, METHOD ENZYMOL, V80, P754; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; WEI AZ, 1994, NAT STRUCT BIOL, V1, P251, DOI 10.1038/nsb0494-251	51	141	144	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16864	16870		10.1074/jbc.270.28.16864	http://dx.doi.org/10.1074/jbc.270.28.16864			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622502	hybrid			2022-12-27	WOS:A1995RJ34700063
J	SEALFON, SC; CHI, L; EBERSOLE, BJ; RODIC, V; ZHANG, D; BALLESTEROS, JA; WEINSTEIN, H				SEALFON, SC; CHI, L; EBERSOLE, BJ; RODIC, V; ZHANG, D; BALLESTEROS, JA; WEINSTEIN, H			RELATED CONTRIBUTION OF SPECIFIC HELIX-2 AND HELIX-7 RESIDUES TO CONFORMATIONAL ACTIVATION OF THE SEROTONIN 5-HT2A RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; BETA-ADRENERGIC RECEPTORS; 2ND TRANSMEMBRANE DOMAIN; LIGAND-BINDING; CONSERVED ASPARTATE; AGONIST BINDING; AMINO-ACIDS; IDENTIFICATION; MUTATION; AFFINITY	A conserved helix 2 Asp is required for the proper function of many G-protein-coupled receptors. To reveal the structural basis for the role of this residue, the additive effects of mutations at this locus and at a conserved helix 7 locus were investigated in the 5-HT2A receptor. All mutant receptors studied retained high affinity agonist and antagonist binding. Whereas an Asp --> Asn mutation in helix 2 eliminated coupling, interchanging the residues at the two positions by a second mutation of Asn --> Asp in helix 7 restored receptor function. These data suggest that these residues are adjacent in space and interact. The loss of function observed with Ala at either position is consistent with each side chain forming hydrogen bonds. Molecular dynamics simulations were performed on three-dimensional computational models of agonist-receptor complexes of both the wild-type receptor and the Asp --> Asn mutant receptor. Consonant with the lack of coupling observed for the mutant construct, introducing the mutation into the computational model produced a conformational change in a direction opposite to that seen from computational simulations of activation of the wild-type receptor model. These results implicate both loci in a common hydrogen-bonding network underlying receptor activation by agonist.	CUNY MT SINAI SCH MED, DEPT NEUROL, NEW YORK, NY 10029 USA; CUNY MT SINAI SCH MED, DEPT ANESTHESIOL, NEW YORK, NY 10029 USA; CUNY MT SINAI SCH MED, DEPT PHARMACOL, NEW YORK, NY 10029 USA; CUNY MT SINAI SCH MED, DEPT PHYSIOL & BIOPHYS, NEW YORK, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	SEALFON, SC (corresponding author), CUNY MT SINAI SCH MED, FISHBERG RES CTR NEUROBIOL, BOX 1065, 1 GUSTAVE LEVY PL, NEW YORK, NY 10029 USA.		WEINSTEIN, HAREL/O-8245-2019	WEINSTEIN, HAREL/0000-0003-3473-9818; SEALFON, Stuart/0000-0001-5791-1217	NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000060, R01DA009083, R01DA009088] Funding Source: NIH RePORTER; NIDA NIH HHS [DA09083, DA09088, KO5 DA00060] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BERG KA, 1994, MOL PHARMACOL, V45, P826; BIHOREAU C, 1993, P NATL ACAD SCI USA, V90, P5133, DOI 10.1073/pnas.90.11.5133; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; CHANDA PK, 1993, MOL PHARMACOL, V43, P516; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHUNG FZ, 1988, J BIOL CHEM, V263, P4052; DONNELLY D, 1994, CURR OPIN STRUC BIOL, V4, P582, DOI 10.1016/S0959-440X(94)90221-6; FRASER CM, 1989, J BIOL CHEM, V264, P9266; FRASER CM, 1989, MOL PHARMACOL, V36, P840; HO BY, 1992, FEBS LETT, V312, P259, DOI 10.1016/0014-5793(92)80948-G; HORSTMAN DA, 1990, J BIOL CHEM, V265, P21590; JI IH, 1991, J BIOL CHEM, V266, P14953; KONG HY, 1993, J BIOL CHEM, V268, P23055; KONG HY, 1993, MOL PHARMACOL, V44, P380; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUO XC, 1994, PROTEIN ENG, V7, P1441, DOI 10.1093/protein/7.12.1441; NEVE KA, 1991, MOL PHARMACOL, V39, P733; NEVE KA, 1991, MOL PHARMACOL, V39, P570; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; QUINTANA J, 1993, MOL ENDOCRINOL, V7, P767, DOI 10.1210/me.7.6.767; SALTZMAN AG, 1991, BIOCHEM BIOPH RES CO, V181, P1469, DOI 10.1016/0006-291X(91)92105-S; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; STRADER CD, 1988, J BIOL CHEM, V263, P10267; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; SURPRENANT A, 1992, SCIENCE, V257, P977, DOI 10.1126/science.1354394; WANG CD, 1993, MOL PHARMACOL, V43, P931; WANG CD, 1991, MOL PHARMACOL, V40, P168; WARD WHJ, 1990, TRENDS PHARMACOL SCI, V11, P280, DOI 10.1016/0165-6147(90)90009-W; ZHANG DQ, 1994, FEBS LETT, V337, P207, DOI 10.1016/0014-5793(94)80274-2; ZHANG DQ, 1993, J MED CHEM, V36, P934, DOI 10.1021/jm00059a021; ZHANG DQ, 1993, MED CHEM RES, V3, P357; ZHOU W, 1994, MOL PHARMACOL, V45, P165	35	191	193	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16683	16688		10.1074/jbc.270.28.16683	http://dx.doi.org/10.1074/jbc.270.28.16683			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622478	hybrid			2022-12-27	WOS:A1995RJ34700037
J	YUAN, CS; BORCHARDT, RT				YUAN, CS; BORCHARDT, RT			PHOTOAFFINITY-LABELING OF HUMAN PLACENTAL S-ADENOSYLHOMOCYSTEINE HYDROLASE WITH [2-H-3]8-AZIDO-ADENOSINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-HOMOCYSTEINE HYDROLASE; AMINO-ACID SEQUENCE; RAT-LIVER; CHEMICAL MODIFICATION; COENZYME BINDING; CDNA SEQUENCE; ACTIVE-SITE; INACTIVATION; MECHANISM; RESIDUES	The potential photoaffinity probe 8-azido-adenosine (8-N-3-Ado) was shown to serve as a substrate for the 3'-oxidative activity of human S-adenosylhomocysteine (AdoHcy) hydrolase (Aiyar, V. N., and Hershfield, M.S. (1985) Biochem. J. 232, 643-650). In this study, we have determined the equilibrium binding properties of 8-N-3-Ado with AdoHcy hydrolase (NAD(+) form) and identified the specific amino acid residues that are covalently modified. After irradiation of the reaction mixture of [2-H-3]8-N-3-Ado and AdoHcy hydrolase (NAD(+) form) and followed by tryptic digestion, peptides specifically photolabeled by [2-H-3]3'-keto-8-N-3-Ado were effectively separated from peptides nonspecifically labeled with [2-H-3]8-N-3-Ado using boronate affinity chromatography. After purification by reverse phase high performance liquid chromatography, two photolabeled peptides were isolated and identified as Val(175)-Lys(186) and Val(319)-Arg(327), in which Ala(177) and Ile(321) were associated with radioactivity, The specificity of the photoaffinity labeling with [2-H-3]3'-keto-8-N-3-Ado was demonstrated by the observation that these photolabeled peptides were not isolated when [2-H-3]8-N-3-Ado was incubated with apo AdoHcy hydrolase and irradiated, The two photolabeled peptides are assumed to be parts of the adenine-binding domain for substrates, They are both within well conserved regions of AdoHcy hydrolases. The peptide Val(175)-Lys(186) is located very close to Cys(195) and Glu(197) Ser(198), both of which were indicated to be located in the active site of the enzyme by chemical modification and limited proteolysis methods. The peptide Val(319)-Arg(327) is adjacent to Leu(330), which is proposed by a computer graphics model to interact with the C-6-NH2 group of Ado.	UNIV KANSAS, DEPT BIOCHEM, LAWRENCE, KS 66045 USA	University of Kansas					NIGMS NIH HHS [GM-29332] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029332] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIYAR VN, 1985, BIOCHEM J, V232, P643, DOI 10.1042/bj2320643; AKSAMIT RR, 1994, J BIOL CHEM, V269, P4084; AULTRICHE DB, 1994, J BIOL CHEM, V269, P31472; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAVAN AJ, 1992, J BIOL CHEM, V267, P14866; COULTERKARIS DE, 1989, ANN HUM GENET, V53, P169, DOI 10.1111/j.1469-1809.1989.tb01781.x; CREEDON KA, 1994, J BIOL CHEM, V269, P16364; DELAHABA G, 1959, J BIOL CHEM, V234, P603; GOMI T, 1986, J BIOL CHEM, V261, P3422; GOMI T, 1989, BIOCHIM BIOPHYS ACTA, V994, P172, DOI 10.1016/0167-4838(89)90157-X; GOMI T, 1982, BIOCHEMISTRY-US, V21, P4171, DOI 10.1021/bi00260a039; GOMI T, 1983, BIOCHEMISTRY-US, V22, P137, DOI 10.1021/bi00270a020; GOMI T, 1990, J BIOL CHEM, V265, P16102; GUPTA RA, 1995, ARCH BIOCHEM BIOPHYS, V319, P365, DOI 10.1006/abbi.1995.1306; HENDERSON DM, 1992, MOL BIOCHEM PARASIT, V53, P169, DOI 10.1016/0166-6851(92)90019-G; KASIR J, 1988, BIOCHEM BIOPH RES CO, V153, P359, DOI 10.1016/S0006-291X(88)81231-2; KAWALLECK P, 1992, P NATL ACAD SCI USA, V89, P4713, DOI 10.1073/pnas.89.10.4713; OGAWA H, 1987, P NATL ACAD SCI USA, V84, P719, DOI 10.1073/pnas.84.3.719; OLCOTT MC, 1994, BIOCHEMISTRY-US, V33, P11935, DOI 10.1021/bi00205a032; PALMER JL, 1979, J BIOL CHEM, V254, P1217; POTTER RL, 1983, METHOD ENZYMOL, V91, P613; PRASAD SS, 1993, GENOME, V36, P57, DOI 10.1139/g93-008; RICHARDS KD, 1993, EMBL L11872 GENB ACC; SCHOTT H, 1973, BIOCHEMISTRY-US, V12, P932, DOI 10.1021/bi00729a022; SCHROEDER G, 1993, EMBL Z26881 GENB ACC; SGANGA MW, 1992, P NATL ACAD SCI USA, V89, P6328, DOI 10.1073/pnas.89.14.6328; TAKATA Y, 1983, J BIOL CHEM, V258, P7374; TAKATA Y, 1985, ARCH BIOCHEM BIOPHYS, V240, P827, DOI 10.1016/0003-9861(85)90092-X; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; YEH JC, 1991, J COMPUT AID MOL DES, V5, P213, DOI 10.1007/BF00124340; YUAN CS, 1993, J BIOL CHEM, V268, P17030; YUAN CS, 1993, BIOCHEMISTRY-US, V32, P10414, DOI 10.1021/bi00090a017; YUAN CS, 1994, BIOCHEMISTRY-US, V33, P12305, DOI 10.1021/bi00206a038	33	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16140	16146		10.1074/jbc.270.27.16140	http://dx.doi.org/10.1074/jbc.270.27.16140			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608178	hybrid			2022-12-27	WOS:A1995RH22600041
J	SCHERER, PE; WILLIAMS, S; FOGLIANO, M; BALDINI, G; LODISH, HF				SCHERER, PE; WILLIAMS, S; FOGLIANO, M; BALDINI, G; LODISH, HF			A NOVEL SERUM-PROTEIN SIMILAR TO C1Q, PRODUCED EXCLUSIVELY IN ADIPOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GLUCOSE-TRANSPORT PROTEIN; PLASMA-MEMBRANE; CELL-LINE; INSULIN; RECEPTORS; REDISTRIBUTION; IDENTIFICATION; EXPRESSION; SEQUENCES; TISSUES	We describe a novel 30-kDa secretory protein, Acrp30 (adipocyte complement-related protein of <(30)under bar> kDa), that is made exclusively in adipocytes and whose mRNA is induced over 100-fold during adipocyte differentiation. Acrp30 is structurally similar to complement factor Clq and to a hibernation-specific protein isolated from the plasma of Siberian chipmunks; it forms large homo-oligomers that undergo a series of post-translational modifications, Like adipsin, secretion of Acrp30 is enhanced by insulin, and Acrp30 is an abundant serum protein. Acrp30 may be a factor that participates in the delicately balanced system of energy homeostasis involving food intake and carbohydrate and lipid catabolism. Our experiments also further corroborate the existence of an insulin regulated secretory pathway in adipocytes.	WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142; PFIZER INC,CENT RES,GROTON,CT 06340; MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT); Whitehead Institute; Pfizer; Massachusetts Institute of Technology (MIT)			Scherer, Philipp E/K-7819-2012	Scherer, Philipp E/0000-0003-0680-3392	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047618, R37DK047618] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 47618] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALDINI G, 1995, P NATL ACAD SCI USA, V92, P4284, DOI 10.1073/pnas.92.10.4284; BALDINI G, 1992, P NATL ACAD SCI USA, V89, P5049, DOI 10.1073/pnas.89.11.5049; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; CIANFLONE K, 1994, BIOCHEMISTRY-US, V33, P9489, DOI 10.1021/bi00198a014; COLLEY KJ, 1987, J BIOL CHEM, V262, P10290; CORVERA S, 1989, J BIOL CHEM, V264, P10133; DAVIS RJ, 1986, J BIOL CHEM, V261, P8708; DEHERREROS AG, 1989, J BIOL CHEM, V264, P9885; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; FLOROS J, 1986, J BIOL CHEM, V261, P9029; FRIEDMAN JM, 1991, GENOMICS, V11, P1054, DOI 10.1016/0888-7543(91)90032-A; GEPPERT M, 1994, NATURE, V369, P498; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; KITAGAWA K, 1989, BIOCHIM BIOPHYS ACTA, V1014, P88; KONDO N, 1992, J BIOL CHEM, V267, P473; MOORE HPH, 1988, NATURE, V302, P434; REICHENBERGER E, 1992, FEBS LETT, V311, P305, DOI 10.1016/0014-5793(92)81126-7; REID KBM, 1982, BIOCHEM J, V203, P559, DOI 10.1042/bj2030559; RESNICK D, 1993, J BIOL CHEM, V268, P3538; SAMBANIS A, 1990, BIOTECHNOL BIOENG, V35, P771, DOI 10.1002/bit.260350804; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; SIMPSON IA, 1986, ANNU REV BIOCHEM, V55, P1059, DOI 10.1146/annurev.biochem.55.1.1059; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; THIEL S, 1989, FEBS LETT, V250, P78, DOI 10.1016/0014-5793(89)80689-1; WALKER PS, 1989, J BIOL CHEM, V264, P6587; WARDZALA LJ, 1984, J BIOL CHEM, V259, P8378; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	30	2485	2732	3	98	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26746	26749		10.1074/jbc.270.45.26746	http://dx.doi.org/10.1074/jbc.270.45.26746			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592907	hybrid			2022-12-27	WOS:A1995TE58300007
J	SILENCE, K; HARTMANN, M; GUHRS, KH; GASE, A; SCHLOTT, B; COLLEN, D; LIJNEN, HR				SILENCE, K; HARTMANN, M; GUHRS, KH; GASE, A; SCHLOTT, B; COLLEN, D; LIJNEN, HR			STRUCTURE-FUNCTION-RELATIONSHIPS IN STAPHYLOKINASE AS REVEALED BY CLUSTERED CHARGE TO ALANINE MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT STAPHYLOKINASE; HUMAN PLASMINOGEN; THROMBOLYTIC PROPERTIES; ACTIVATION; ALPHA-2-ANTIPLASMIN; MECHANISM; FIBRIN; STREPTOKINASE; PURIFICATION; EXPRESSION	Eighteen mutants of recombinant staphylokinase (SakSTAR) in which clusters of two or three charged residues were converted to alanine (''clustered charge-to-alanine scan'') were characterized, Fifteen of these mutants had specific plasminogen-activating activities of >20% of that of wild-type SakSTAR, whereas three mutants, SakSTAR K11A D13A D14A (SakSTAR13), SakSTAR E46A K50A (SakSTAR48), and SakSTAR E65A D69A (SakSTARB67) had specific activities of 3%. SakSTAR13 had an intact affinity for plasminogen and a normal: rate of active site exposure in equimolar mixtures with plasminogen. The plasmin-SakSTAR13 complex had a 14-fold reduced catalytic efficiency for plasminogen activation but was 5-fold more efficient for conversion of plasminogen-SakSTAR13 to plasmin-SakSTAR13, SakSTAR48 and SakSTAR67 had a 10-20-fold reduced affinity for plasminogen and a markedly re reduced active site exposure; their complexes with plasmin had a more than 20-fold reduced catalytic efficiency toward plasminogen. Thus, plasminogen activation by catalytic amounts of SakSTAR is dependent on complex formation between plasmin(ogen) and SakSTAR, which is deficient with SakSTAR48 and SakSTAR67, but also on the induction of a functional active site configuration in the plasmin-SakSTAR complex, which is deficient with all three mutants, These findings support a mechanism for the activation of plasminogen by SakSTAR involving formation of an equimolar complex of SakSTAR with traces of plasmin, which converts plasminogen to plasmin and, more rapidly, inactive plasminogen-SakSTAR to plasmin-SakSTAR.	UNIV LOUVAIN,CTR MOLEC & VASC BIOL,B-3000 LOUVAIN,BELGIUM; INST MOLEC BIOTECHNOL,O-6980 JENA,GERMANY				Lijnen, Roger/AAA-4085-2020					BENNETT WF, 1991, J BIOL CHEM, V266, P5191; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSBY SJ, 1991, J BIOL CHEM, V266, P15286; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; COLLEN D, 1993, CIRCULATION, V87, P996, DOI 10.1161/01.CIR.87.3.996; COLLEN D, 1993, CIRCULATION, V87, P1850, DOI 10.1161/01.CIR.87.6.1850; COLLEN D, 1992, FIBRINOLYSIS, V6, P203, DOI 10.1016/0268-9499(92)90073-Q; COLLEN D, 1993, J BIOL CHEM, V268, P8284; CUNNINGHAM BC, 1989, SCIENCE, V244, P1801; DAMASCHUN G, 1993, BIOCHIM BIOPHYS ACTA, V1161, P244, DOI 10.1016/0167-4838(93)90220-L; DECLERCK PJ, 1994, THROMB HAEMOSTASIS, V12, P185; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; JOHNSON BH, 1994, BIO-TECHNOL, V12, P1357, DOI 10.1038/nbt1294-1357; KOWALSKALOTH B, 1975, ACTA BIOCHIM POL, V22, P327; LACK CH, 1948, NATURE, V161, P559, DOI 10.1038/161559b0; LEWIS JH, 1951, AM J PHYSIOL, V166, P594, DOI 10.1152/ajplegacy.1951.166.3.594; LIJNEN HR, 1991, J BIOL CHEM, V266, P11826; LIJNEN HR, 1992, BIOCHIM BIOPHYS ACTA, V1118, P144, DOI 10.1016/0167-4838(92)90142-Z; LIJNEN HR, 1994, EUR J BIOCHEM, V224, P143, DOI 10.1111/j.1432-1033.1994.tb20005.x; MATSUO O, 1990, BLOOD, V76, P925; MCCLINTOCK DK, 1971, BIOCHEM BIOPH RES CO, V43, P694, DOI 10.1016/0006-291X(71)90670-X; NELLES L, 1978, EUR J BIOCHEM, V87, P143; SAKAI M, 1989, BIOCHEM BIOPH RES CO, V162, P830, DOI 10.1016/0006-291X(89)92385-1; Sambrook J, 1989, MOL CLONING LABORATO; SCHLOTT B, 1994, BIO-TECHNOL, V12, P185, DOI 10.1038/nbt0294-185; SILENCE K, 1993, J BIOL CHEM, V268, P9811; SILENCE K, 1993, BLOOD, V82, P1175, DOI 10.1182/blood.V82.4.1175.bloodjournal8241175; SOTTRUPJENSEN L, 1977, PROGR CHEM FIBRINOLY, V3, P191; STANSSENS P, 1989, NUCLEIC ACIDS RES, V17, P4441, DOI 10.1093/nar/17.12.4441; UESHIMA S, 1994, THROMB HAEMOSTASIS, V71, P134; WIMAN B, 1980, BIOCHEM J, V191, P229, DOI 10.1042/bj1910229	31	37	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27192	27198		10.1074/jbc.270.45.27192	http://dx.doi.org/10.1074/jbc.270.45.27192			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592976	hybrid			2022-12-27	WOS:A1995TE58300076
J	YAN, CYI; FERRARI, G; GREENE, LA				YAN, CYI; FERRARI, G; GREENE, LA			N-ACETYLCYSTEINE-PROMOTED SURVIVAL OF PC12 CELLS IS GLUTATHIONE-INDEPENDENT BUT TRANSCRIPTIONAL-DEPENDENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; SYMPATHETIC NEURONS; FACTOR DEPRIVATION; KAPPA-B; PHEOCHROMOCYTOMA CELLS; STIMULATED HUMAN; BINDING-ACTIVITY; DEATH; 2-MERCAPTOETHANOL; APOPTOSIS	Our prior work established that comparable concentrations of N-acetylcysteine (NAG) both block the proliferation of PC12 cells and prevent death of trophic factor-deprived sympathetic neurons and PC12 cells. The present work addresses several aspects of the mechanisms of these actions, NAC increases intracellular levels of glutathione (GSH) by approximately 10-fold in PC12 cells, However, blockade of this increase by treatment with buthionine sulfoximine did not affect either promotion of survival or inhibition of DNA synthesis. Thus, these actions of NAC are independent of its effects on intracellular GSH, NAC's actions in our system do not appear to be dependent on its anti-oxidant/radical scavenger properties, but may be due to its activity as a reductant, Consistent with this, several other reducing agents, the most effective of which was 2,3-dimercaptopropanol, mimicked NAC in blocking DNA synthesis and suppressing death of PC12 cells and sympathetic neurons, Finally, we observed that in striking contrast to nerve growth factor and a number of other trophic agents, the survival-promoting effects of NAC on PC12 cells are blocked by actinomycin D. This suggests that NAC may act by inducing specific gene expression.	COLUMBIA UNIV COLL PHYS & SURG, CTR NEUROBIOL & BEHAV, NEW YORK, NY 10032 USA	Columbia University	YAN, CYI (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, NEW YORK, NY 10032 USA.		Yan, Chao Yun Irene/B-4700-2011	Yan, Chao Yun Irene/0000-0003-0527-5719				ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; BANDYOPADHYAY S, 1994, J BIOL CHEM, V269, P29949; BATISTATOU A, 1993, J CELL BIOL, V122, P523, DOI 10.1083/jcb.122.3.523; BATISTATOU A, 1991, J CELL BIOL, V115, P461, DOI 10.1083/jcb.115.2.461; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; EDWARDS SN, 1991, J NEUROCHEM, V57, P2140, DOI 10.1111/j.1471-4159.1991.tb06434.x; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FERRARI G, 1993, J NEUROSCI, V13, P1879; FERRARI G, 1994, EMBO J, V13, P5922, DOI 10.1002/j.1460-2075.1994.tb06937.x; FERRARI G, 1995, J NEUROSCI, V15, P2857; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GREENE LA, 1990, J NEUROSCI, V10, P1479; GRIFFITH OW, 1979, J BIOL CHEM, V254, P1205; GRILL RJ, 1993, BRAIN RES, V613, P168, DOI 10.1016/0006-8993(93)90470-8; HEFTI F, 1994, NEUROBIOL AGING, V15, pS193; ISHII K, 1993, NEUROSCI LETT, V163, P159, DOI 10.1016/0304-3940(93)90371-Q; JONES DP, 1995, IMMUNOL LETT, V45, P205, DOI 10.1016/0165-2478(95)00004-O; LEE VM, 1980, NEUROSCIENCE, V5, P2239, DOI 10.1016/0306-4522(80)90140-2; LI WC, 1994, EXP EYE RES, V59, P179, DOI 10.1006/exer.1994.1096; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496; MESNER PW, 1992, J CELL BIOL, V119, P1669, DOI 10.1083/jcb.119.6.1669; MESSINA JP, 1992, INT J IMMUNOPHARMACO, V14, P1221, DOI 10.1016/0192-0561(92)90058-S; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; MIHM S, 1991, AIDS, V5, P497, DOI 10.1097/00002030-199105000-00004; MITOMO K, 1994, GENE, V145, P197; MOLDEUS P, 1994, METHOD ENZYMOL, V234, P482; OISHI T, 1993, J NEURAL TRANSM-PARK, V6, P45, DOI 10.1007/BF02252622; OLSON L, 1994, J NEUROL, V242, pS12, DOI 10.1007/BF00939233; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; RATAN RR, 1994, J NEUROSCI, V14, P4385; ROEDERER M, 1990, P NATL ACAD SCI USA, V87, P4884, DOI 10.1073/pnas.87.12.4884; RUBIN LL, 1993, CURR BIOL, V3, P391, DOI 10.1016/0960-9822(93)90211-6; RUKENSTEIN A, 1991, J NEUROSCI, V11, P2552; SOTO AM, 1985, J STEROID BIOCHEM, V23, P87, DOI 10.1016/0022-4731(85)90265-1; THOR H, 1979, ARCH BIOCHEM BIOPHYS, V192, P405, DOI 10.1016/0003-9861(79)90109-7; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; TOLEDANO MB, 1991, P NATL ACAD SCI USA, V88, P4328, DOI 10.1073/pnas.88.10.4328; TROY CM, 1994, P NATL ACAD SCI USA, V91, P6384, DOI 10.1073/pnas.91.14.6384; WEI S, 1992, TOXICOL APPL PHARM, V112, P32, DOI 10.1016/0041-008X(92)90276-X	44	121	124	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26827	26832		10.1074/jbc.270.45.26827	http://dx.doi.org/10.1074/jbc.270.45.26827			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592924	hybrid			2022-12-27	WOS:A1995TE58300024
J	MAO, QC; SCHUNK, T; GERBER, B; ERNI, B				MAO, QC; SCHUNK, T; GERBER, B; ERNI, B			A STRING OF ENZYMES, PURIFICATION AND CHARACTERIZATION OF A FUSION PROTEIN COMPRISING THE 4 SUBUNITS OF THE GLUCOSE PHOSPHOTRANSFERASE SYSTEM OF ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTIFICIAL BIFUNCTIONAL ENZYME; MITOCHONDRIAL INNER MEMBRANES; ACID CYCLE ENZYMES; SUGAR-TRANSPORT; SALMONELLA-TYPHIMURIUM; CITRATE SYNTHASE; GENE FUSION; MULTIENZYME COMPLEXES; MOLECULAR-CLONING; MANNOSE PERMEASE	A multidomain protein comprising the four subunits of the glucose phosphotransferase system of Escherichia coli was constructed by fusion of the transmembrane subunit IICBGlc and the three cytoplasmic proteins, IIA(Glc), HPr, and enzyme I, The subunits were linked in the above order with Ala-Pro rich linkers; the fusion protein was overexpressed in E. coli and purified by Ni2+ chelate affinity chromatography, Approximately 3 mg of the fusion protein could be purified from 1 liter of culture, The phosphotransferase activity of the purified fusion protein was 3-4 times higher than that of an equimolar mixture of the isolated subunits, The mannose transporter, which also requires enzyme I and HPr, was not an effective competitor in the overall phosphoryltransfer reaction when the fusion protein was used, whereas it was a competitor when an equimolar mixture of the separate subunits was employed, Transphosphorylation activity of the fusion protein was almost indistinguishable from the wild-type IICBGlc. Addition of extra IICBGlc subunit could significantly stimulate the phosphotransferase activity of the fusion protein, addition of extra IIA(Glc) subunit and enzyme I, in contrast, was slightly inhibitory, and HPr had almost no effect, An optimal detergent-lipid ratio is required for maximum activity of the fusion protein, Our results suggest that Ala-Pro-rich linker sequences may be of general use for the construction of catalytically active fusion proteins with novel properties.	UNIV BERN, INST BIOCHEM, CH-3012 BERN, SWITZERLAND; UNIV MARBURG, DEPT BIOL, W-3550 MARBURG, GERMANY	University of Bern; Philipps University Marburg								ALPERT CA, 1985, BIOCHEMISTRY-US, V24, P959, DOI 10.1021/bi00325a023; ARGOS P, 1990, J MOL BIOL, V211, P943, DOI 10.1016/0022-2836(90)90085-Z; BARNES SJ, 1986, FEBS LETT, V201, P267, DOI 10.1016/0014-5793(86)80621-4; BRENT LG, 1987, J BIOL CHEM, V262, P319; BROUWER M, 1982, BIOCHEMISTRY-US, V21, P82, DOI 10.1021/bi00530a015; BUHR A, 1993, J BIOL CHEM, V268, P11599; BUHR A, 1994, J BIOL CHEM, V269, P23437; BULOW L, 1991, TRENDS BIOTECHNOL, V9, P226, DOI 10.1016/0167-7799(91)90075-S; BULOW L, 1987, EUR J BIOCHEM, V163, P443, DOI 10.1111/j.1432-1033.1987.tb10889.x; CURTIS SJ, 1975, J BACTERIOL, V122, P1189, DOI 10.1128/JB.122.3.1189-1199.1975; DATTA A, 1985, J BIOL CHEM, V260, P5008; DSOUZA SF, 1983, J BIOL CHEM, V258, P4706; ERNI B, 1992, INT REV CYTOL, V137A, P127; ERNI B, 1989, FEMS MICROBIOL LETT, V63, P13, DOI 10.1016/0168-6445(89)90004-1; ERNI B, 1982, J BIOL CHEM, V257, P13726; ERNI B, 1986, BIOCHEMISTRY-US, V25, P305, DOI 10.1021/bi00350a004; ERNI B, 1989, J BIOL CHEM, V264, P18733; ERNI B, 1987, J BIOL CHEM, V262, P5238; FISHER CW, 1992, P NATL ACAD SCI USA, V89, P10817, DOI 10.1073/pnas.89.22.10817; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; GEERSE RH, 1989, MOL GEN GENET, V216, P517, DOI 10.1007/BF00334399; GERBER B, 1993, THESIS U BERNE SWITZ; GRDADOLNIK SG, 1994, EUR J BIOCHEM, V219, P945; HAN MK, 1990, J BIOL CHEM, V265, P1996; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; JIA ZC, 1994, J MOL BIOL, V236, P1341, DOI 10.1016/0022-2836(94)90062-0; KUNDIG W, 1971, J BIOL CHEM, V246, P1407; LENGELER JW, 1994, BBA-BIOENERGETICS, V1188, P1, DOI 10.1016/0005-2728(94)90017-5; LICALSI C, 1991, J BIOL CHEM, V266, P19519; LINDBLADH C, 1994, BIOCHEMISTRY-US, V33, P11692, DOI 10.1021/bi00205a004; LJUNGCRANTZ P, 1989, BIOCHEMISTRY-US, V28, P8786, DOI 10.1021/bi00448a016; MA JX, 1993, BIOCHEMISTRY-US, V32, P7692, DOI 10.1021/bi00081a013; MAO QC, 1995, J BIOL CHEM, V270, P5258, DOI 10.1074/jbc.270.10.5258; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; MEINS M, 1988, J BIOL CHEM, V263, P12986; MEINS M, 1993, J BIOL CHEM, V268, P11604; MIKAELIAN I, 1992, NUCLEIC ACIDS RES, V20, P376, DOI 10.1093/nar/20.2.376; MISSET O, 1983, BIOCHEMISTRY-US, V22, P6163, DOI 10.1021/bi00295a019; NEYROZ P, 1987, J BIOL CHEM, V262, P15900; PERHAM RN, 1975, PHILOS T ROY SOC B, V272, P123, DOI 10.1098/rstb.1975.0075; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; PERI KG, 1988, BIOCHEMISTRY-US, V27, P6054, DOI 10.1021/bi00416a034; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; RADFORD SE, 1989, J BIOL CHEM, V264, P767; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; REIZER J, 1992, J BIOL CHEM, V267, P9158; RHIEL E, 1994, BIOL CHEM H-S, V375, P551, DOI 10.1515/bchm3.1994.375.8.551; ROBINSON JB, 1985, J BIOL CHEM, V260, P800; SAFFEN DW, 1987, J BIOL CHEM, V262, P16241; SAIER MH, 1994, MOL MICROBIOL, V13, P755; SAIER MH, 1982, J CELL BIOCHEM, V18, P231, DOI 10.1002/jcb.1982.240180210; Sambrook J, 1989, MOL CLONING LAB MANU, P1; SCHOLTE BJ, 1982, J BACTERIOL, V149, P576, DOI 10.1128/JB.149.2.576-586.1982; SCHUNK T, 1992, DEVEL BIOCH, V29, P87; SCHUNK T, 1992, THESIS U MARBURG GER; SHET MS, 1994, ARCH BIOCHEM BIOPHYS, V311, P402, DOI 10.1006/abbi.1994.1255; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Srere PA, 1985, ORG MULTIENZYME SYST, P1; SRIVASTAVA DK, 1986, CURR TOP CELL REGUL, V28, P1; SRIVASTAVA DK, 1986, SCIENCE, V234, P1081, DOI 10.1126/science.3775377; STANSSENS P, 1989, NUCLEIC ACIDS RES, V17, P4441, DOI 10.1093/nar/17.12.4441; STOLZ B, 1993, J BIOL CHEM, V268, P27094; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VOGLER AP, 1988, MOL MICROBIOL, V2, P719, DOI 10.1111/j.1365-2958.1988.tb00082.x; WAEBER U, 1993, FEBS LETT, V324, P109, DOI 10.1016/0014-5793(93)81542-8; WELCH GR, 1994, TRENDS BIOCHEM SCI, V19, P193; WORTHYLAKE D, 1991, P NATL ACAD SCI USA, V88, P10382, DOI 10.1073/pnas.88.23.10382; WU LF, 1990, J MOL BIOL, V213, P687, DOI 10.1016/S0022-2836(05)80256-6	69	34	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18295	18300		10.1074/jbc.270.31.18295	http://dx.doi.org/10.1074/jbc.270.31.18295			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629149	hybrid			2022-12-27	WOS:A1995RM64200024
J	PETERSON, BZ; CATTERALL, WA				PETERSON, BZ; CATTERALL, WA			CALCIUM-BINDING IN THE PORE OF L-TYPE CALCIUM CHANNELS MODULATES HIGH-AFFINITY DIHYDROPYRIDINE BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SKELETAL-MUSCLE; ALPHA-1 SUBUNIT; CA2+ CHANNELS; ION SELECTIVITY; BRAIN; IDENTIFICATION; DETERMINANTS; LOCALIZATION; PERMEATION; EXPRESSION	The pore forming alpha(1) subunit of L-type voltage-gated Ca2+ channels contains a Ca2+-binding site that is allosterically coupled to the receptor site for dihydropyridine (DHP) Ca2+ antagonists. Site-directed mutations of conserved Phe and Glu residues in the pore-lining SS1/SS2 segments greatly reduced Ca2+ enhancement of DHP binding. Substitution of Phe-1O13 in the alpha(1) subunit from rabbit skeletal muscle (alpha(1S)) with Gly (F1013G) as in DHP-insensitive Ca2+ channels caused a 4-fold decrease in sensitivity to Ca2+. Mutation of the Ca2+-binding residues Glu-1014 in domain III and Glu-1323 in domain IV to Gln (E1014Q and E1323Q) caused 11- and 35-fold decreases in sensitivity to Ca2+, respectively, as well as decreases in the maximal DHP binding affinities attained at optimal concentrations of Ca2+, DHP binding to the charge-reversal mutation, E1014K, had no sensitivity to Ca2+. Our results demonstrate that high affinity Ca2+ binding to the Glu residues in the SS1/SS2 segments of domains III and TV of alpha(1S) stabilizes the DHP receptor site in its high affinity state. We propose a three-state model in which the affinity for DHPs is dependent on the presence of 0, 1, or 2 bound Ca2+ ions at sites in the pore.	UNIV WASHINGTON,SCH MED,DEPT PHARMACOL,SEATTLE,WA 98195	University of Washington; University of Washington Seattle					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312, P01HL044948] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL 44948, T32 HL07312] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALMERS W, 1984, J PHYSIOL-LONDON, V353, P565, DOI 10.1113/jphysiol.1984.sp015351; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; FOSSET M, 1983, J BIOL CHEM, V258, P6086; GLOSSMANN H, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1917; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HESS P, 1984, NATURE, V309, P453, DOI 10.1038/309453a0; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; Hille B., 1992, IONIC CHANNELS EXCIT; KALASZ H, 1993, FEBS LETT, V331, P177, DOI 10.1016/0014-5793(93)80321-K; KIM MS, 1993, FEBS LETT, V318, P145, DOI 10.1016/0014-5793(93)80009-J; KOSTYUK PG, 1983, J MEMBRANE BIOL, V76, P83, DOI 10.1007/BF01871455; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KUO CC, 1993, J PHYSIOL-LONDON, V466, P657; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; NAKAYAMA H, 1991, P NATL ACAD SCI USA, V88, P9203, DOI 10.1073/pnas.88.20.9203; NIIDOME T, 1992, FEBS LETT, V308, P7, DOI 10.1016/0014-5793(92)81038-N; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; Sather William A., 1994, Current Opinion in Neurobiology, V4, P313, DOI 10.1016/0959-4388(94)90091-4; SCHWARTZ LM, 1985, NATURE, V314, P747, DOI 10.1038/314747a0; Smith RM, 1974, CRITICAL STABILITY C, V1-6; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; STRIESSNIG J, 1991, P NATL ACAD SCI USA, V88, P10769, DOI 10.1073/pnas.88.23.10769; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V87, P5478; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANG SQ, 1993, J BIOL CHEM, V268, P13026; TANG SQ, 1993, NEURON, V11, P1013, DOI 10.1016/0896-6273(93)90215-D; WEST JW, 1992, NEURON, V8, P59, DOI 10.1016/0896-6273(92)90108-P; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0	28	74	75	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18201	18204		10.1074/jbc.270.31.18201	http://dx.doi.org/10.1074/jbc.270.31.18201			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629136	hybrid			2022-12-27	WOS:A1995RM64200008
J	QUIROS, LM; SALAS, JA				QUIROS, LM; SALAS, JA			BIOSYNTHESIS OF THE MACROLIDE OLEANDOMYCIN BY STREPTOMYCES-ANTIBIOTICUS - PURIFICATION AND KINETIC CHARACTERIZATION OF AN OLEANDOMYCIN GLUCOSYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							23S RIBOSOMAL-RNA; RESISTANCE DETERMINANT; PRODUCER ORGANISM; METHYLATION; INHIBITORS; POLYMERASE; MECHANISM; FRADIAE; CLONING; GENE	The oleandomycin (OM) producer, Streptomyces antibioticus, possesses a mechanism involving two enzymes for the intracellular inactivation and extracellular reactivation of the antibiotic, Inactivation takes place by transfer of a glucose molecule from a donor (UDP-glucose) to OM, a process catalyzed by an intracellular glucosyltransferase, Glucosyltransferase activity is detectable in cell-free extracts concurrent with biosynthesis of OM, The enzyme has been purified 1,097-fold as a monomer, with a molecular mass of 57.1 kDa by a four-step procedure using three chromatographic columns, The reaction operates via a compulsory-order mechanism, This has been shown by steady state kinetic studies using either ORI or an alternative substrate (rosaramycin) and dead-end inhibitors, and isotopic exchange reactions at equilibrium, OM binds first to the enzyme, followed by UDP-glucose, A ternary complex is thus formed prior to transfer of glucose. UDP is then released, followed by the glycosylated oleandomycin (GS OM).	UNIV OVIEDO,DEPT BIOL FUNC,E-33006 OVIEDO,SPAIN; UNIV OVIEDO,INST UNIV BIOTECNOL ASTURIAS,E-33006 OVIEDO,SPAIN	University of Oviedo; University of Oviedo			Quirós, Luis/T-3822-2017	Quirós, Luis/0000-0003-3505-3762				ARCA P, 1988, ANTIMICROB AGENTS CH, V32, P1552, DOI 10.1128/AAC.32.10.1552; BLANCO MG, 1984, J GEN MICROBIOL, V130, P2883; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; CUNDLIFFE E, 1989, ANNU REV MICROBIOL, V43, P207, DOI 10.1146/annurev.micro.43.1.207; DAZIEL K, 1957, ACTA CHEM SCAND, V11, P1706; GLOCKNER C, 1984, FEMS MICROBIOL LETT, V25, P121, DOI 10.1016/0378-1097(84)90058-2; Hopwood D.A., 1985, GENETIC MANIPULATION; KAWAGUCHI A, 1979, ARCH BIOCHEM BIOPHYS, V197, P30, DOI 10.1016/0003-9861(79)90214-5; LAEMMLI UK, 1971, NATURE, V227, P680; OLANO C, 1995, MOL MICROBIOL, V16, P333, DOI 10.1111/j.1365-2958.1995.tb02305.x; PIENDL W, 1982, ANTIMICROB AGENTS CH, V22, P231, DOI 10.1128/AAC.22.2.231; QUIROS LM, 1994, EUR J BIOCHEM, V222, P129, DOI 10.1111/j.1432-1033.1994.tb18850.x; RODRIGUEZ AM, 1992, MOL MICROBIOL, V8, P571; ROZA J, 1986, J ANTIBIOT, V39, P609, DOI 10.7164/antibiotics.39.609; SKINNER RH, 1982, J GEN MICROBIOL, V128, P2411; THIARA AS, 1988, EMBO J, V7, P2255, DOI 10.1002/j.1460-2075.1988.tb03065.x; VARA J, 1985, BIOCHEMISTRY-US, V24, P8074, DOI 10.1021/bi00348a036; VILCHES C, 1992, J BACTERIOL, V174, P161, DOI 10.1128/jb.174.1.161-165.1992; VILCHES C, 1990, J GEN MICROBIOL, V136, P1447, DOI 10.1099/00221287-136-8-1447; WATANABE S, 1976, BIOCHEM BIOPH RES CO, V72, P522, DOI 10.1016/S0006-291X(76)80072-1; YAMAMOTO H, 1981, BIOCHEM BIOPH RES CO, V100, P1396, DOI 10.1016/0006-291X(81)91979-3; ZALACAIN M, 1989, J BACTERIOL, V171, P4254, DOI 10.1128/JB.171.8.4254-4260.1989; ZALACAIN M, 1990, EUR J BIOCHEM, V189, P67, DOI 10.1111/j.1432-1033.1990.tb15460.x; ZALACAIN M, 1991, GENE, V97, P137, DOI 10.1016/0378-1119(91)90021-3	25	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18234	18239		10.1074/jbc.270.31.18234	http://dx.doi.org/10.1074/jbc.270.31.18234			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629141	hybrid			2022-12-27	WOS:A1995RM64200015
J	HUPP, TR; LANE, DP				HUPP, TR; LANE, DP			2 DISTINCT SIGNALING PATHWAYS ACTIVATE THE LATENT DNA-BINDING FUNCTION OF P53 IN A CASEIN KINASE-II-INDEPENDENT MANNER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILD-TYPE P53; TUMOR-SUPPRESSOR PROTEIN; SERUM RESPONSE FACTOR; GROWTH ARREST; PHOSPHORYLATION SITE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MUTANT P53; CELLS; FORMS	Post-translational modification of a carboxyl-terminal negative regulatory domain in vitro by either casein kinase II or protein kinase C allosterically activates the latent sequence-specific DNA binding function of p53. Reported here is a biochemical approach to determine the types of signaling pathways and enzymes that are involved in p53 activation in cells. Using a novel chromatographic method, we have been able to separate three distinct biochemical forms of p53 that have been synthesized in vivo; two are in an activated state, and one is in a latent state for sequence specific DNA binding. The two activated forms of p53 appear to be controlled individually by either a constitutive or a UV-inducible signaling pathway. p53 lacking the COOH-terminal casein kinase II site (p53 Delta 4) was characterized biochemically and used to determine the affects of deletion of the casein kinase II motif on the production of the two activated forms of p53 in vivo. As observed with full-length p53, the production of two distinct chromatographic forms of activated p53 Delta 4 occurs in vivo, indicating that p53 activation can occur through a casein kinase II-independent pathway and suggesting that two other factors are involved in activation of p53 in vivo.	UNIV DUNDEE,DEPT BIOCHEM,CANC RES CAMPAIGN LABS,DUNDEE DD1 4HN,SCOTLAND	University of Dundee			Lane, David P/C-4920-2008	Lane, David/0000-0003-0551-3545				ACKERMAN P, 1988, J BIOL CHEM, V263, P12653; ADDISON C, 1990, ONCOGENE, V5, P423; ALMON E, 1993, DEV BIOL, V156, P107, DOI 10.1006/dbio.1993.1062; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; BARAK Y, 1992, EMBO J, V11, P2115, DOI 10.1002/j.1460-2075.1992.tb05270.x; BARGONETTI J, 1992, GENE DEV, V6, P1886, DOI 10.1101/gad.6.10.1886; BARNES DM, 1992, LANCET, V340, P259, DOI 10.1016/0140-6736(92)92354-I; BARTEK J, 1991, ONCOGENE, V6, P1699; BAUDIER J, 1992, P NATL ACAD SCI USA, V89, P11627, DOI 10.1073/pnas.89.23.11627; BIRCH JM, 1994, BRIT J CANCER, V70, P1176, DOI 10.1038/bjc.1994.468; BISCHOFF JR, 1990, P NATL ACAD SCI USA, V87, P4766, DOI 10.1073/pnas.87.12.4766; BOUSSET K, 1993, ONCOGENE, V8, P3211; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DAYAMAKIN M, 1994, CANCER RES, V15, P2262; DEGROOT RP, 1993, EMBO J, V12, P3903, DOI 10.1002/j.1460-2075.1993.tb06068.x; DELPHIN C, 1994, J BIOL CHEM, V269, P29579; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FISCELLA M, 1994, ONCOGENE, V9, P3249; FISCELLA M, 1993, ONCOGENE, V8, P1519; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; HAINAUT P, 1993, CANCER RES, V53, P4469; HALAZONETIS TD, 1993, EMBO J, V12, P5057, DOI 10.1002/j.1460-2075.1993.tb06199.x; HALL PA, 1993, ONCOGENE, V8, P203; HALL PA, 1994, J PATHOL, V1172, P1; HARLOW E, 1988, ANTIBODIES LABORATOR; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; HUPP TR, 1994, CURR BIOL, V4, P865, DOI 10.1016/S0960-9822(00)00195-0; HUPP TR, 1993, NUCLEIC ACIDS RES, V21, P3167, DOI 10.1093/nar/21.14.3167; HUPP TR, 1994, COLD SPRING HARB SYM, V59, P195, DOI 10.1101/SQB.1994.059.01.024; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; KOLMAN JL, 1993, P NATL ACAD SCI USA, V90, P10115, DOI 10.1073/pnas.90.21.10115; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; KULESZMARTIN MF, 1994, MOL CELL BIOL, V14, P1698, DOI 10.1128/MCB.14.3.1698; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; LUSCHER B, 1994, EUR J BIOCHEM, V220, P521, DOI 10.1111/j.1432-1033.1994.tb18651.x; MACK DH, 1993, NATURE, V363, P281, DOI 10.1038/363281a0; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; MANAK JR, 1990, GENE DEV, V4, P955, DOI 10.1101/gad.4.6.955; MARAIS RM, 1992, EMBO J, V11, P97, DOI 10.1002/j.1460-2075.1992.tb05032.x; MARTIN DW, 1993, J BIOL CHEM, V268, P13062; MEEK DW, 1990, EMBO J, V9, P3253, DOI 10.1002/j.1460-2075.1990.tb07524.x; MEGGIO F, 1992, EUR J BIOCHEM, V205, P939, DOI 10.1111/j.1432-1033.1992.tb16860.x; MEGGIO F, 1994, BIOCHEMISTRY-US, V33, P4336, DOI 10.1021/bi00180a030; MERRITT AJ, 1994, CANCER RES, V54, P614; MESTRES P, 1994, ACTA ANAT, V149, P13; MIDGLEY CA, 1995, J CELL SCI, V108, P1843; MIDGLEY CA, 1993, J CELL SCI, V101, P183; MILNE DM, 1992, NUCLEIC ACIDS RES, V20, P5565, DOI 10.1093/nar/20.21.5565; MILNE DM, 1995, J BIOL CHEM, V270, P5511, DOI 10.1074/jbc.270.10.5511; MILNE DM, 1992, ONCOGENE, V7, P1361; MILNE DM, 1994, J BIOL CHEM, V269, P9253; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; OSIFCHIN NE, 1994, J BIOL CHEM, V269, P6383; PIETENPOL JA, 1994, P NATL ACAD SCI USA, V91, P1998, DOI 10.1073/pnas.91.6.1998; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; PRIGENT C, 1992, EMBO J, V11, P2925, DOI 10.1002/j.1460-2075.1992.tb05362.x; SCHARER E, 1992, NUCLEIC ACIDS RES, V20, P1539, DOI 10.1093/nar/20.7.1539; SETO E, 1992, P NATL ACAD SCI USA, V89, P12028, DOI 10.1073/pnas.89.24.12028; SKOUV J, 1994, CELL GROWTH DIFFER, V5, P329; SOMMERCORN J, 1987, P NATL ACAD SCI USA, V84, P8834, DOI 10.1073/pnas.84.24.8834; SOUSSI T, 1990, ONCOGENE, V5, P945; STIGARE J, 1983, MOL CELL BIOCHEM, V129, P77; STRAUSFELD UP, 1994, CURR BIOL, V4, P876, DOI 10.1016/S0960-9822(00)00196-2; TAWFIC S, 1994, J BIOL CHEM, V269, P7489; TOKINO T, 1994, HUM MOL GENET, V3, P1537, DOI 10.1093/hmg/3.9.1537; TURMAN MA, 1993, BIOCHEM MED METAB B, V50, P210, DOI 10.1006/bmmb.1993.1063; UEBA T, 1994, P NATL ACAD SCI USA, V91, P9009, DOI 10.1073/pnas.91.19.9009; ULLRICH SJ, 1992, ONCOGENE, V7, P1635; ULLRICH SJ, 1992, J BIOL CHEM, V267, P15259; VANDELFT S, 1993, BIOCHEM BIOPH RES CO, V197, P542, DOI 10.1006/bbrc.1993.2513; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; VOJTESEK B, 1995, ONCOGENE, V10, P389; WADEEVANS A, 1985, EMBO J, V4, P699, DOI 10.1002/j.1460-2075.1985.tb03686.x; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WEINTRAUB H, 1991, P NATL ACAD SCI USA, V88, P4570, DOI 10.1073/pnas.88.11.4570; WU Y, 1994, EMBO J, V13, P4823, DOI 10.1002/j.1460-2075.1994.tb06808.x; YENICE S, 1994, PROSTATE, V24, P11, DOI 10.1002/pros.2990240105; YONISH RE, 1991, NATURE, V353, P345; ZAMBETTI GP, 1992, GENE DEV, V6, P1143, DOI 10.1101/gad.6.7.1143; ZHAN QM, 1993, MOL CELL BIOL, V13, P4242, DOI 10.1128/MCB.13.7.4242; ZHAO JQ, 1994, MOL CELL BIOL, V14, P8483, DOI 10.1128/MCB.14.12.8483	96	123	125	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18165	18174		10.1074/jbc.270.30.18165	http://dx.doi.org/10.1074/jbc.270.30.18165			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629129	hybrid			2022-12-27	WOS:A1995RM26600081
J	KHOO, KH; SARDA, S; XU, XF; CAULFIELD, JP; MCNEIL, MR; HOMANS, SW; MORRIS, HR; DELL, A				KHOO, KH; SARDA, S; XU, XF; CAULFIELD, JP; MCNEIL, MR; HOMANS, SW; MORRIS, HR; DELL, A			A UNIQUE MULTIFUCOSYLATED -3GALNAC-BETA-1-]4GLCNAC-BETA-1-]3GAL-ALPHA-1- MOTIF CONSTITUTES THE REPEATING UNIT OF THE COMPLEX O-GLYCANS DERIVED FROM THE CERCARIAL GLYCOCALYX OF SCHISTOSOMA-MANSONI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; N-ACETYLGALACTOSAMINE; HIGH-RESOLUTION; GLYCOPROTEINS; CARBOHYDRATE; ULTRASTRUCTURE; SYNTHESIZES; ANTIBODIES; ANTIGENS; EPITOPES	The entire surface of the cercarial stage of the human blood fluke Schistosoma mansoni is covered by a 1-mu m thick, highly immunogenic, fucose-rich glycocalyx (GCX). Using strategies based on enzymatic, chemical, and mass spectrometric analysis, we have defined the structures of the major glycans released by reductive elimination from GCX. They comprise a heterogeneous population of multifucosylated complex oligosaccharides with the following nonreducing terminal sequences: +/- Fuc alpha 1 --> 2Fuc alpha 1 --> 3GalNAc beta 1 --> 4GlcNAc beta 1 --> 3Gal alpha 1 --> 3 (up arrow) +/- Fuc alpha 1 --> 2Fuc alpha 1 --> 2Fuc alpha 1 STRUCTURE 1 Our structural data suggest that these tri- to pentafucosylated epitopes are carried on type 1, R-->Gal beta-1-->3GalNAc, and type 2, R-->Gal beta 1-->3(R-->GlcNAc beta-1-->6)GalNAc, core structures via repeat units of (3GalNAc beta 1-->4(Fuc alpha 1-->2Fuc alpha 1-->2Fuc alpha 1--3_GlcNAc beta-1-->3Gal alpha-->)(n)), where it is mainly 0 and 1, and all sugars are in the pyranose form, The proposed structure represents the first instance where an alpha-galactosylated beta-GalNAc(1-->4)-beta-GlcNAc sequence occurs as a repeating unit in a glycoprotein. It is also unique in being substituted with oligofucosyl appendages. The unusual oligosaccharide structures described here, particularly the potentially immunodominant oligofucosyl moieties, are most likely responsible for the known potency of GCX in modulating various immune responses including complement activation, B cell mitogenesis, and delayed type hypersensitivity in schistosomiasis.	UNIV LONDON IMPERIAL COLL SCI & TECHNOL, DEPT BIOCHEM, LONDON SW7 2AY, ENGLAND; SYNTEX INC, DISCOVERY RES, PALO ALTO, CA 94304 USA; COLORADO STATE UNIV, DEPT MICROBIOL, FT COLLINS, CO 80523 USA; UNIV ST ANDREWS, INSTV BIOMOLEC SCI, ST ANDREWS KY16 9ST, FIFE, SCOTLAND	Imperial College London; Syntex Corporation; Colorado State University; University of St Andrews			McNeil, Michael/G-3325-2019; Khoo, Kay-Hooi/E-1989-2019	Khoo, Kay-Hooi/0000-0003-2906-406X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023083, R22AI023083] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-23083] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission)		ALBERSHEIM PETER, 1967, CARBOHYD RES, V5, P340, DOI 10.1016/S0008-6215(00)80510-8; ALMEIDA IC, 1994, BIOCHEM J, V304, P793, DOI 10.1042/bj3040793; CAULFIELD JP, 1987, J PARASITOL, V73, P514, DOI 10.2307/3282129; COUTO AS, 1990, MOL BIOCHEM PARASIT, V39, P100; DALTON JP, 1987, EXP PARASITOL, V63, P215, DOI 10.1016/0014-4894(87)90164-0; DELL A, 1994, METHOD ENZYMOL, V230, P108; DELL A, 1987, ADV CARBOHYD CHEM BI, V45, P19, DOI 10.1016/S0065-2318(08)60136-5; DELL A, 1993, CURR OPIN STRUC BIOL, V3, P687, DOI 10.1016/0959-440X(93)90051-L; DUNNE DW, 1990, PARASITOL TODAY, V6, P45, DOI 10.1016/0169-4758(90)90068-F; GERWIG GJ, 1978, CARBOHYD RES, V62, P349, DOI 10.1016/S0008-6215(00)80881-2; GOWDA DC, 1994, J BIOL CHEM, V269, P20031; GRZYCH JM, 1982, J IMMUNOL, V129, P2739; HARN DA, 1984, J EXP MED, V159, P1371, DOI 10.1084/jem.159.5.1371; KANG S, 1993, J PARASITOL, V79, P815, DOI 10.2307/3283717; KEMP WM, 1970, J PARASITOL, V56, P713, DOI 10.2307/3277718; KO AI, 1990, P NATL ACAD SCI USA, V87, P4159, DOI 10.1073/pnas.87.11.4159; KOSTER B, 1994, PARASITOLOGY, V108, P433, DOI 10.1017/S0031182000075995; LEVERY SB, 1992, J BIOL CHEM, V267, P5542; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; MULDER H, 1995, EUR J BIOCHEM, V227, P175, DOI 10.1111/j.1432-1033.1995.tb20374.x; NANDURI J, 1991, J BIOL CHEM, V266, P1341; NEELEMAN AP, 1994, GLYCOBIOLOGY, V4, P641, DOI 10.1093/glycob/4.5.641; NYAME K, 1989, J BIOL CHEM, V264, P3235; PATEL T, 1993, BIOCHEMISTRY-US, V32, P679, DOI 10.1021/bi00053a037; REASON AJ, 1994, GLYCOBIOLOGY, V4, P593, DOI 10.1093/glycob/4.5.593; SAMUELSON JC, 1985, J CELL BIOL, V100, P1423, DOI 10.1083/jcb.100.5.1423; SEKO A, 1989, J BIOL CHEM, V264, P15922; SIMPSON AJG, 1990, PARASITOL TODAY, V6, P40, DOI 10.1016/0169-4758(90)90067-E; SRIVATSAN J, 1994, J PARASITOL, V80, P884, DOI 10.2307/3283435; SRIVATSAN J, 1992, GLYCOBIOLOGY, V2, P445, DOI 10.1093/glycob/2.5.445; SRIVATSAN J, 1992, J BIOL CHEM, V267, P20196; STANDEN O. D., 1952, JOUR HELMINTHOL, V26, P25, DOI 10.1017/S0022149X00032570; STRECKER G, 1995, GLYCOBIOLOGY, V5, P137, DOI 10.1093/glycob/5.1.137; STRECKER G, 1992, EUR J BIOCHEM, V207, P995, DOI 10.1111/j.1432-1033.1992.tb17135.x; STULTS CLM, 1989, METHOD ENZYMOL, V179, P167; VANDAM GJ, 1994, EUR J BIOCHEM, V225, P467, DOI 10.1111/j.1432-1033.1994.00467.x; VANKUIK JA, 1987, EUR J BIOCHEM, V169, P399; VELUPILLAI P, 1994, P NATL ACAD SCI USA, V91, P18, DOI 10.1073/pnas.91.1.18; VLIEGENTHART JFG, 1983, ADV CARBOHYD CHEM BI, V41, P209, DOI 10.1016/S0065-2318(08)60059-1; WEISS JB, 1986, J IMMUNOL, V136, P4275; WEISS JB, 1985, J IMMUNOL, V135, P1421; Xu X. F., 1993, Molecular Biology of the Cell, V4, p455A; XU XF, 1994, EXP PARASITOL, V79, P399, DOI 10.1006/expr.1994.1102; ZAMZE SE, 1991, J BIOL CHEM, V266, P20244	44	108	110	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17114	17123		10.1074/jbc.270.29.17114	http://dx.doi.org/10.1074/jbc.270.29.17114			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615506	hybrid			2022-12-27	WOS:A1995RK68900013
J	QUAN, H; FAN, GB; WANG, CC				QUAN, H; FAN, GB; WANG, CC			INDEPENDENCE OF THE CHAPERONE ACTIVITY OF PROTEIN DISULFIDE-ISOMERASE FROM ITS THIOREDOXIN-LIKE ACTIVE-SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PEPTIDE BINDING	Protein disulfide isomerase (PDI) alkylated at thiols of the thioredoxin-like -CHC- active sites is devoid of isomerase activity, but its chaperone-like activity to increase the reactivation yield and prevent the aggregation of guanidine hydrochloride-denatured D-glyceraldehyde-3-phospate dehydrogenase upon dilution is unimpaired. A peptide of 28 amino acids markedly inhibits both the enzyme and the chaperone activities of PDI. The above results indicate that the -CGHC- active site is necessary for the isomerase activity but not required for the chaperone activity of PDI, whereas the peptide binding site is essential for both activities.	ACAD SINICA,INST BIOPHYS,NATL LAB BIOMACROMOLECULES,BEIJING 100101,PEOPLES R CHINA	Chinese Academy of Sciences; Institute of Biophysics, CAS								CAI H, 1994, J BIOL CHEM, V269, P24550; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HAWKINS HC, 1991, BIOCHEM J, V275, P349, DOI 10.1042/bj2750349; HAWKINS HC, 1991, BIOCHEM J, V275, P335, DOI 10.1042/bj2750335; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; KATZEN HM, 1966, J BIOL CHEM, V241, P1006; LAMANTIA ML, 1993, CELL, V74, P899, DOI 10.1016/0092-8674(93)90469-7; LAMBERT N, 1983, BIOCHEM J, V213, P225, DOI 10.1042/bj2130225; LILIE H, 1994, J BIOL CHEM, V269, P14290; MARANGOS PJ, 1974, BIOCHEMISTRY-US, V13, P904, DOI 10.1021/bi00702a012; MORJANA NA, 1991, BIOCHEMISTRY-US, V30, P4985, DOI 10.1021/bi00234a021; NIGAM SK, 1994, J BIOL CHEM, V269, P1744; NOIVA R, 1993, J BIOL CHEM, V268, P19210; NOIVA R, 1991, J BIOL CHEM, V266, P19645; NOIVA R, 1994, PROTEIN EXPRES PURIF, V5, P1, DOI 10.1006/prep.1994.1001; OTSU M, 1994, J BIOL CHEM, V269, P6874; PUIG A, 1994, J BIOL CHEM, V269, P7764; PUIG A, 1994, J BIOL CHEM, V269, P19128; SHORTLE D, 1986, J CELL BIOCHEM, V30, P281, DOI 10.1002/jcb.240300402; VUORI K, 1992, J BIOL CHEM, V267, P7211; WANG CC, 1993, FASEB J, V7, P1515, DOI 10.1096/fasebj.7.15.7903263	24	116	120	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17078	17080		10.1074/jbc.270.29.17078	http://dx.doi.org/10.1074/jbc.270.29.17078			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615500	hybrid			2022-12-27	WOS:A1995RK68900007
J	VANDERKLEI, IJ; HILBRANDS, RE; SWAVING, GJ; WATERHAM, HR; VRIELING, EG; TITORENKO, VI; CREGG, JM; HARDER, W; VEENHUIS, M				VANDERKLEI, IJ; HILBRANDS, RE; SWAVING, GJ; WATERHAM, HR; VRIELING, EG; TITORENKO, VI; CREGG, JM; HARDER, W; VEENHUIS, M			THE HANSENULA-POLYMORPHA PER3 GENE IS ESSENTIAL FOR THE IMPORT OF PTS1 PROTEINS INTO THE PEROXISOMAL MATRIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHANOL METABOLISM; TARGETING SIGNAL; DEFICIENT MUTANT; YEAST; BIOGENESIS; MEMBRANE; MICROBODIES; REPLICATION; SYNTHASE; LOCATION	PER genes are essential for the assembly of peroxisomes in Hansenula polymorpha. Here we describe the PER3 gene which was cloned by functional complementation of a H. polymorpha per3 mutant. The complementing PER3 gene encodes a protein of 569 amino acids (Per3p) with a calculated mass of 63.9 kDa; Per3p belongs to the tetratricopeptide repeat protein family and is located in both the cytosol and the peroxisomal matrix. Remarkably, Per3p does not contain a known targeting signal (PTS1 or PTS2). The PER3 gene product shows similarity to the Saccharomyces cerevisiae Pas10p (40% identity) and the Pichia pastoris Pas8p (55% identity). However, their function apparently cannot be interchanged since the P. pastoris PAS8 gene failed to functionally complement a H. polymorpha per3 disruption mutant, The per3 disruption mutant contained normal but small peroxisomes in which PTS2 proteins (both homologous and heterologous) were imported. Other matrix proteins (in particular PTS1 proteins) resided in the cytosol where they were normally assembled and active. We argue that Per3p is a component of the peroxisomal import machinery and most probably shuttles matrix proteins from the cytosol to the organellar matrix.	OREGON GRAD INST SCI & TECHNOL,PORTLAND,OR 97291		VANDERKLEI, IJ (corresponding author), UNIV GRONINGEN,CTR BIOL,GRONINGEN BIOMOLEC SCI & BIOTECHNOL INST,DEPT MICROBIOL,KERKLAAN 30,9751 NN HAREN,NETHERLANDS.		van der Klei, Ida J/D-1919-2012	Van der Klei, Ida J./0000-0001-7165-9679	NIDDK NIH HHS [DK-43698] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043698] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAFLE A, 1990, PEDIATR RES, V27, P304; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROCARD C, 1994, BIOCHEM BIOPH RES CO, V204, P1016, DOI 10.1006/bbrc.1994.2564; BRUINENBERG PG, 1990, YEAST, V6, P245, DOI 10.1002/yea.320060309; DEHOOP MJ, 1992, BIOCHEM J, V286, P657, DOI 10.1042/bj2860657; DOUMA AC, 1990, YEAST, V6, P99, DOI 10.1002/yea.320060203; DOUMA AC, 1985, ARCH MICROBIOL, V143, P237, DOI 10.1007/BF00411242; EVERS ME, 1995, IN PRESS FEBS LETT; FABER KN, 1995, FEBS LETT, V357, P115, DOI 10.1016/0014-5793(94)01317-T; FABER KN, 1992, J GEN MICROBIOL, V138, P2405, DOI 10.1099/00221287-138-11-2405; FABER KN, 1994, CURR GENET, V25, P305, DOI 10.1007/BF00351482; FABER KN, 1994, P NATL ACAD SCI USA, V91, P12985, DOI 10.1073/pnas.91.26.12985; FUJIKI Y, 1982, J CELL BIOL, V93, P103, DOI 10.1083/jcb.93.1.103; GIETL C, 1994, P NATL ACAD SCI USA, V91, P3151, DOI 10.1073/pnas.91.8.3151; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; GOULD SJ, 1990, EMBO J, V9, P85, DOI 10.1002/j.1460-2075.1990.tb08083.x; HARLOW E, 1988, ANTIBODIES LABORATOR, P315; KEIZER I, 1992, FEMS MICROBIOL LETT, V93, P7, DOI 10.1016/0378-1097(92)90481-3; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245; ROGGENKAMP R, 1986, MOL GEN GENET, V202, P302, DOI 10.1007/BF00331655; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; SUBRAMANI S, 1992, J MEMBRANE BIOL, V125, P99; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; SULTER GJ, 1993, EMBO J, V12, P2205, DOI 10.1002/j.1460-2075.1993.tb05868.x; TITORENKO VI, 1993, P NATL ACAD SCI USA, V90, P7470, DOI 10.1073/pnas.90.16.7470; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; VANDERKLEI IJ, 1991, YEAST, V7, P15, DOI 10.1002/yea.320070103; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; VANDIJKEN JP, 1976, ARCH MICROBIOL, V111, P137; VEENHUIS M, 1992, CELL BIOCHEM FUNCT, V10, P175, DOI 10.1002/cbf.290100307; VEENHUIS M, 1989, ARCH MICROBIOL, V151, P105, DOI 10.1007/BF00414422; VEENHUIS M, 1990, YEAST, V6, P511, DOI 10.1002/yea.320060608; VEENHUIS M, 1990, METHOD ENZYMOL, V188, P411; VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I; WALTON PA, 1992, MOL CELL BIOL, V12, P531, DOI 10.1128/MCB.12.2.531; WATERHAM HR, 1992, YEAST, V8, P961, DOI 10.1002/yea.320081106; WATERHAM HR, 1994, J CELL BIOL, V137, P737; ZWART KB, 1983, A VAN LEEUW J MICROB, V49, P369	46	117	118	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17229	17236		10.1074/jbc.270.29.17229	http://dx.doi.org/10.1074/jbc.270.29.17229			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615522	hybrid			2022-12-27	WOS:A1995RK68900029
J	BEAUMONT, A; ODONOHUE, MJ; PAREDES, N; ROUSSELET, N; ASSICOT, M; BOHUON, C; FOURNIEZALUSKI, MC; ROQUES, BP				BEAUMONT, A; ODONOHUE, MJ; PAREDES, N; ROUSSELET, N; ASSICOT, M; BOHUON, C; FOURNIEZALUSKI, MC; ROQUES, BP			THE ROLE OF HISTIDINE-231 IN THERMOLYSIN-LIKE ENZYMES - A SITE-DIRECTED MUTAGENESIS STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRAL ENDOPEPTIDASE 24.11; TRANSITION-STATE ANALOGS; CRYSTALLINE THERMOLYSIN; ZINC PEPTIDASES; RETRO-THIORPHAN; ACTIVE-SITE; COS-1 CELLS; PROTEASE; INHIBITORS; BINDING	In the zinc metallopeptidases produced by the genus Bacillus, an active site histidine has been proposed to either stabilize the transition state in catalysis by donating a hydrogen bond to the hydrated peptide (Matthews, B. W. (1988) Acc. Chem. Res. 21, 333-340) or to polarize a water molecule, which subsequently attacks the peptidyl bond (Mock, W. L., and Aksamawati, M. (1994) Biochem, J. 302, 57-68). Site-directed mutagenesis techniques have been used to change this residue in the zinc endopeptidase from Bacillus stearothermophillus to either phenylalanine or alanine. At pH 7.0, the k(cat)/K-m values of the substrate leucine enkephalin for the phenylalanine and alanine mutants were reduced by factors of 430- and 500-fold, respectively, as compared with the wild-type enzyme, mostly due to changes in k(cat). In addition, the enzymatic activities of the mutant enzymes showed little pH dependence in the alkaline range, unlike the wild-type enzyme. The mutations did not greatly alter the binding affinities of inhibitors containing sulfydryl groups to chelate the active site zinc, while those of inhibitors containing hydroxamate or carboxylate zinc-chelating groups were increased between 80- and 250-fold. The largest change in the binding affinity of an inhibitor (>5 orders of magnitude) was found with the proposed transition state mimic, phosphoramidon. The results are generally in agreement with x-ray crystallography studies and favor the involvement of the active site histidine in transition state binding.	UNIV PARIS 05,FAC PHARM,DEPT PHARMACOCHIM MOLEC & STRUCT,UFR SCI PHARMACEUT & BIOL,CNRS,F-75270 PARIS 06,FRANCE; INST GUSTAVE ROUSSY,DEPT BIOL CLIN,F-94805 VILLEJUIF,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy			O'Donohue, Michael J/E-9183-2013; O'Donohue, Michael/ABD-9239-2021	O'Donohue, Michael J/0000-0003-4246-3938; O'Donohue, Michael/0000-0003-4246-3938				BATEMAN RC, 1990, J BIOL CHEM, V265, P8365; BENCHETRIT T, 1987, BIOCHEM BIOPH RES CO, V147, P1034, DOI 10.1016/S0006-291X(87)80174-2; BODE W, 1992, NATURE, V358, P164, DOI 10.1038/358164a0; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; BOUBOUTOU R, 1984, LIFE SCI, V35, P1023, DOI 10.1016/0024-3205(84)90669-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRON S, 1990, MOL BIOL METHODS BAC, P142; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CORBEIL D, 1993, FEBS LETT, V335, P361, DOI 10.1016/0014-5793(93)80420-Y; DEVAULT A, 1988, J BIOL CHEM, V263, P4033; DION N, 1993, FEBS LETT, V318, P301, DOI 10.1016/0014-5793(93)80533-Z; EIJSINK VGH, 1990, PROTEIN ENG, V4, P99, DOI 10.1093/protein/4.1.99; FEDER J, 1974, BIOCHEMISTRY-US, V9, P2784; FOURNIEZALUSKI MC, 1992, P NATL ACAD SCI USA, V89, P6388, DOI 10.1073/pnas.89.14.6388; GOMEZRUTH FX, 1994, J MOL BIOL, V239, P513; GOMEZRUTH FX, 1993, J MOL BIOL, V229, P945; GOOLEY PR, 1994, NAT STRUCT BIOL, V1, P111, DOI 10.1038/nsb0294-111; HAUSRATH AC, 1994, J BIOL CHEM, V269, P18839; HOLMES MA, 1981, BIOCHEMISTRY-US, V20, P6912, DOI 10.1021/bi00527a026; KITAGISHI K, 1984, J BIOCHEM-TOKYO, V95, P529, DOI 10.1093/oxfordjournals.jbchem.a134635; KUBO M, 1992, APPL ENVIRON MICROB, V58, P3779, DOI 10.1128/AEM.58.11.3779-3783.1992; LOVEJOY B, 1994, BIOCHEMISTRY-US, V33, P8207, DOI 10.1021/bi00193a006; LOVEJOY B, 1994, SCIENCE, V236, P375; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; MOEK WL, 1994, BIOCHEM J, V302, P57; MONZINGO AF, 1982, BIOCHEMISTRY-US, V21, P3390, DOI 10.1021/bi00257a022; MONZINGO AF, 1984, BIOCHEMISTRY-US, V23, P5724, DOI 10.1021/bi00319a010; NICOLETTI VG, 1993, BIOTECHNIQUES, V14, P536; ODONOHUE MJ, 1994, BIOCHEM J, V300, P599, DOI 10.1042/bj3000599; PAUPTIT RA, 1988, J MOL BIOL, V199, P525, DOI 10.1016/0022-2836(88)90623-7; PHILLIPS MA, 1990, J BIOL CHEM, V265, P20692; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; RODERICK SL, 1989, BIOCHEMISTRY-US, V28, P1493, DOI 10.1021/bi00430a011; ROQUES BP, 1980, NATURE, V288, P286, DOI 10.1038/288286a0; ROQUES BP, 1993, PHARMACOL REV, V45, P87; ROQUES BP, 1983, P NATL ACAD SCI-BIOL, V80, P3178, DOI 10.1073/pnas.80.11.3178; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIGNOR G, 1990, EUR J BIOCHEM, V189, P221, DOI 10.1111/j.1432-1033.1990.tb15480.x; SIMONEN M, 1993, MICROBIOL REV, V57, P109, DOI 10.1128/MMBR.57.1.109-137.1993; STANSSENS P, 1989, NUCLEIC ACIDS RES, V17, P4441, DOI 10.1093/nar/17.12.4441; Thorsett E. D., 1987, NEUROPEPTIDES THEIR, P229; TOMA S, 1989, PROTEIN ENG, V2, P359, DOI 10.1093/protein/2.5.359; TRONRUD DE, 1986, EUR J BIOCHEM, V157, P261, DOI 10.1111/j.1432-1033.1986.tb09664.x; TSURU D, 1993, J BIOCHEM-TOKYO, V113, P101, DOI 10.1093/oxfordjournals.jbchem.a123991; VOGEL Z, 1977, FEBS LETT, V80, P332, DOI 10.1016/0014-5793(77)80469-9; VRIEND G, 1993, J COMPUT AID MOL DES, V7, P367, DOI 10.1007/BF02337558	46	64	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16803	16808		10.1074/jbc.270.28.16803	http://dx.doi.org/10.1074/jbc.270.28.16803			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622493	Green Submitted, hybrid			2022-12-27	WOS:A1995RJ34700054
J	ITOH, Y; NAGASE, H				ITOH, Y; NAGASE, H			PREFERENTIAL INACTIVATION OF TISSUE INHIBITOR OF METALLOPROTEINASES-1 THAT IS BOUND TO THE PRECURSOR OF MATRIX METALLOPROTEINASE-9 (PROGELATINASE-B) BY HUMAN NEUTROPHIL ELASTASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							IV COLLAGENASE; ALPHA-1-PROTEINASE INHIBITOR; GELATINASE-B; ALVEOLAR MACROPHAGES; FIBROSARCOMA CELLS; V COLLAGEN; STROMELYSIN; EXPRESSION; PURIFICATION; ACTIVATION	The precursor of matrix metalloproteinase 9 (pro-MMP-9) forms a complex with the tissue inhibitor of metalloproteinases (TIMP)-1 through the C-terminal domain of each molecule, and the N-terminal domain of TIMP-1 in the complex interacts and inhibits active MMPs. We have reported that a catalytic amount of MMP-3 (stromelysin 1) activates pro-MMP-9 (Ogata, Y., Enghild, J. J., and Nagase, H. (1992) J. Biol. Chem. 267, 3581-3584). To activate pro-MMP-9 in the complex, however, an excess molar amount of MMP-3 is required to saturate the TIMP-1 in the complex. The aim of this study was to test the hypothesis that the requirement for excess MMP-3 can be circumvented by specific destruction of TIMP-1 by non-target proteinases. We have tested trypsin, plasmin, cathepsin G, neutrophil elastase, and chymotrypsin as possible inactivators of TIMP-1 and found that neutrophil elastase inactivates TIMP-1 in the complex without significant destruction of pro-MMP-9. Once TIMP-1 is inactivated, pro MMP-9 can be readily activated by a catalytic amount of MMP-3. These results suggest that neutrophil elastase may participate in connective tissue destruction at the inflammatory sites not only by its direct action on matrix macromolecules but also by rendering pro-MMP-9 in the pro-MMP-9 . TIMP-1 complex activable by MMP-3 as well as activating pro MMP-3.	UNIV KANSAS,MED CTR,DEPT BIOCHEM & MOLEC BIOL,KANSAS CITY,KS 66160	University of Kansas; University of Kansas Medical Center				Itoh, Yoshifumi/0000-0002-2128-2823	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994, R01AR039189] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 39189, AR 40994] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; CAWSTON TE, 1979, ANAL BIOCHEM, V99, P340, DOI 10.1016/S0003-2697(79)80017-2; FOSANG AJ, 1992, J BIOL CHEM, V267, P19470; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; HARRIS ED, 1972, BIOCHIM BIOPHYS ACTA, V258, P566, DOI 10.1016/0005-2744(72)90249-5; HIBBS MS, 1987, J CLIN INVEST, V80, P1644, DOI 10.1172/JCI113253; ITO A, 1988, ARCH BIOCHEM BIOPHYS, V267, P211, DOI 10.1016/0003-9861(88)90025-2; JOHNSON DA, 1986, J BIOL CHEM, V261, P4748; LEFEBVRE V, 1991, BIOCHIM BIOPHYS ACTA, V1094, P8, DOI 10.1016/0167-4889(91)90020-X; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; MAINARDI CL, 1984, COLLAGEN REL RES, V4, P479; MAST AE, 1991, J BIOL CHEM, V266, P15810; MOHTAI M, 1993, J CLIN INVEST, V92, P179, DOI 10.1172/JCI116547; MONTGOMERY AMP, 1993, BIOCHIM BIOPHYS ACTA, V1176, P265, DOI 10.1016/0167-4889(93)90054-S; MORIHARA K, 1984, J BIOCHEM, V95, P795, DOI 10.1093/oxfordjournals.jbchem.a134671; MORODOMI T, 1992, BIOCHEM J, V285, P603, DOI 10.1042/bj2850603; MURPHY G, 1989, J CELL SCI, V92, P487; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; NAGASE H, 1990, BIOCHEMISTRY-US, V29, P5783, DOI 10.1021/bi00476a020; NGUYEN Q, 1994, BIOCHEMISTRY-US, V33, P2089, DOI 10.1021/bi00174a015; NGUYEN Q, 1993, BIOCHEM J, V295, P595, DOI 10.1042/bj2950595; OGATA Y, 1992, J BIOL CHEM, V267, P3581; OGATA Y, 1992, EXP CELL RES, V201, P254; OKADA Y, 1992, J BIOL CHEM, V267, P21712; OKADA Y, 1989, ANN RHEUM DIS, V48, P645, DOI 10.1136/ard.48.8.645; OKADA Y, 1989, FEBS LETT, V229, P157; POTEMPA J, 1986, J BIOL CHEM, V261, P14330; REPONEN P, 1994, J CELL BIOL, V124, P1091, DOI 10.1083/jcb.124.6.1091; SHAPIRO SD, 1995, J BIOL CHEM, V270, P6351, DOI 10.1074/jbc.270.11.6351; SIRES UI, 1993, J BIOL CHEM, V268, P2069; SOPATA I, 1974, BIOCHIM BIOPHYS ACTA, V370, P510, DOI 10.1016/0005-2744(74)90112-0; STETLERSTEVENSO.WG, 1993, ANNU REV CELL BIOL, V9, P541; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; TETLOW LC, 1993, RHEUMATOL INT, V13, P53, DOI 10.1007/BF00307734; UNEMORI EN, 1991, J CLIN INVEST, V88, P1656, DOI 10.1172/JCI115480; WELGUS HG, 1990, J CLIN INVEST, V86, P1496, DOI 10.1172/JCI114867; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; ZHOU H, 1993, BIOCHIM BIOPHYS ACTA, V1177, P174, DOI 10.1016/0167-4889(93)90037-P	39	145	149	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16518	16521		10.1074/jbc.270.28.16518	http://dx.doi.org/10.1074/jbc.270.28.16518			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622455	hybrid			2022-12-27	WOS:A1995RJ34700010
J	LEE, SJ; LEE, SD; PARK, JG; KIM, CM; RYU, SH; SUH, PG				LEE, SJ; LEE, SD; PARK, JG; KIM, CM; RYU, SH; SUH, PG			OVEREXPRESSION OF PHOSPHOLIPASE C-GAMMA-1 IN COLORECTAL CARCINOMAS IS ASSOCIATED WITH OVEREXPRESSION OF FACTORS THAT BIND ITS PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; C ISOZYMES; EGF RECEPTOR; BETA-GAMMA; TRANSCRIPTION; PROTEINS; GENE; SP1; EXPRESSION; REGION	The 5'-upstream sequence of the phospholipase C-gamma 1 (PLC-gamma 1) gene contains several transcriptional regulatory regions. We have studied one of the regions (-551 to -480, named GPE1) which exhibits a strong positive regulatory activity, GPE1 stimulated the transcription when fused to heterologous TATA element in an orientation-dependent manner. The region between -536 and -470 was identified as the protein binding site in GPE1 by the DNase I footprinting method, Electrophoretic mobility shift assays with several competitors revealed three protein binding sites in this region, designated as GES1, GES2, and GES3. The binding sites were -535 GGAGGGGGCG -524, -512 TGTCACTCA -504, and -491 CAATCCA -485, respectively. Mutational analyses suggested that GPE1 binding proteins cooperate with each other to activate the transcription of the PLC-gamma 1 gene. Additionally, immunoblot analyses revealed that the level of PLC-gamma 1 expression was considerably higher in 9 of 11 colorectal carcinomas than in adjacent normal colorectal tissues. In 7 of 9 cases of colorectal carcinomas which express higher level of PLC-gamma 1, the DNA binding activities to GES1, GES2, and GES3 sites also increased when compared with normal tissues. These results suggest that the GPE1 binding proteins might be attributed to the elevated expression of PLC-gamma 1 in colorectal carcinomas and may play important roles in proliferation of colorectal carcinoma cells.	POHANG UNIV SCI & TECHNOL,DEPT LIFE SCI,POHANG 790784,SOUTH KOREA; POHANG UNIV SCI & TECHNOL,BASIC SCI RES CTR,POHANG 790784,SOUTH KOREA; SEOUL NATL UNIV,CANC RES INST,CELL BIOL LAB,SEOUL 110799,SOUTH KOREA; KOREA CANC CTR HOSP,DEPT INTERNAL MED,SEOUL 139240,SOUTH KOREA	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); National Cancer Center - Korea (NCC)			Park, Jae-Gahb/J-5494-2012; Suh, Pann-Ghill/F-3610-2010	Ryu, Sung Ho/0000-0003-0913-3048				ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; ARTEAGA CL, 1991, P NATL ACAD SCI USA, V88, P10435, DOI 10.1073/pnas.88.23.10435; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KAGEYAMA R, 1988, J BIOL CHEM, V263, P6329; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KIM SJ, 1989, J BIOL CHEM, V264, P402; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; KITADAI Y, 1992, BIOCHEM BIOPH RES CO, V189, P1342, DOI 10.1016/0006-291X(92)90221-6; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEE SJ, 1993, BIOCHEM BIOPH RES CO, V194, P294, DOI 10.1006/bbrc.1993.1818; LEE SJ, 1995, BIOCHEM BIOPH RES CO, V206, P194, DOI 10.1006/bbrc.1995.1027; LEE YH, 1993, CANCER LETT, V68, P237, DOI 10.1016/0304-3835(93)90152-Y; LEE YH, 1995, FEBS LETT, V358, P105, DOI 10.1016/0014-5793(94)01404-O; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; MAJERUS PW, 1990, CELL, V63, P459, DOI 10.1016/0092-8674(90)90442-H; MITCHELL PJ, 1988, SCIENCE, V245, P371; NANNEY LB, 1992, CELL GROWTH DIFFER, V3, P233; NOH DY, 1994, CANCER, V73, P36, DOI 10.1002/1097-0142(19940101)73:1<36::AID-CNCR2820730108>3.0.CO;2-5; PARK JG, 1994, CANCER RES, V54, P2240; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; RHEE SG, 1992, J BIOL CHEM, V267, P12393; ROESLER WT, 1989, J BIOL CHEM, V263, P9063; Sambrook J, 1989, MOL CLONING LABORATO; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SMITH MR, 1990, SCIENCE, V247, P1074, DOI 10.1126/science.2408147; SMITH MR, 1989, P NATL ACAD SCI USA, V86, P3659, DOI 10.1073/pnas.86.10.3659; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; SUH PG, 1988, J BIOL CHEM, V263, P14497; SUH PG, 1988, P NATL ACAD SCI USA, V85, P5419, DOI 10.1073/pnas.85.15.5419; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; YAMADA M, 1991, DEV BRAIN RES, V59, P7, DOI 10.1016/0165-3806(91)90023-C	39	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16378	16384		10.1074/jbc.270.27.16378	http://dx.doi.org/10.1074/jbc.270.27.16378			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608208	hybrid			2022-12-27	WOS:A1995RH22600075
J	SAITO, K; YOKOYAMA, H; NOJI, M; MURAKOSHI, I				SAITO, K; YOKOYAMA, H; NOJI, M; MURAKOSHI, I			MOLECULAR-CLONING AND CHARACTERIZATION OF A PLANT SERINE ACETYLTRANSFERASE PLAYING A REGULATORY ROLE IN CYSTEINE BIOSYNTHESIS FROM WATERMELON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; CDNA CLONING; SPINACIA-OLERACEA; O-ACETYLSERINE; GENE; SYNTHASE; EXPRESSION; METABOLISM; CYSE	Serine acetyltransferase (SATase; EC 2.3.1.30), which catalyzes the reaction connecting serine and cysteine/methionine metabolism, plays a regulatory role in cysteine biosynthesis in plants. We have isolated a cDNA clone encoding SATase by direct genetic complementation of a Cys(-) mutation in Escherichia coli using an expression library of Citrullus vulgaris (watermelon) cDNA. The cDNA encodes a polypeptide of 294 amino acids (31,536 Da) exhibiting 51% homology with that of E. coli SATase. RNA-blot analysis indicated the presence of a single copy of the SATase gene (sat) in watermelon. RNA hybridization analysis suggested the relatively ubiquitous and preferential expression in the hypocotyls of etiolated seedlings. Immunoblot analysis indicated the accumulation of SATase predominantly in etiolated plants. L-Cysteine, an end product of the cysteine biosynthetic pathway, inhibited the SATase in an allosteric manner, indicating the regulatory function of SATase in this metabolic pathway, whereas beta-(pyrazole-1-yl)-L-alanine, a secondary metabolite formed partly through the cysteine biosynthetic pathway, showed no inhibitory effect. A multi-enzyme complex was formed from recombinant proteins of SATase and cysteine synthase (O-acetylserine(thiol)-lyase) from watermelon, suggesting efficient metabolic channeling from serine to cysteine, preventing the diffusion of intermediary O-acetyl-L-serine.			SAITO, K (corresponding author), CHIBA UNIV,FAC PHARMACEUT SCI,MED RESOURCES RES CTR,MOLEC BIOL & BIOTECHNOL LAB,INAGE KU,CHIBA 263,JAPAN.		Saito, Kazuki/D-2670-2009	Saito, Kazuki/0000-0001-6310-5342				ALLIGNET J, 1993, GENE, V130, P91, DOI 10.1016/0378-1119(93)90350-C; Anderson JW, 1991, MOL ACTIVITIES PLANT; BAECKER PA, 1980, ANAL BIOCHEM, V102, P16, DOI 10.1016/0003-2697(80)90310-3; BAEV N, 1992, PLANT MOL BIOL, V18, P843, DOI 10.1007/BF00020033; BROWN EG, 1990, PHYTOCHEMISTRY, V29, P469, DOI 10.1016/0031-9422(90)85099-2; BROWN HG, 1982, PHYTOCHEMISTRY, V21, P863; BRUNOLD C, 1990, SULFUR NUTRITION AND SULFUR ASSIMILATION IN HIGHER PLANTS, P13; BRUNOLD C, 1982, PLANTA, V155, P321, DOI 10.1007/BF00429459; COOK PF, 1977, ARCH BIOCHEM BIOPHYS, V178, P293, DOI 10.1016/0003-9861(77)90194-1; DENK D, 1987, J GEN MICROBIOL, V133, P515; DUNNILL PM, 1963, BIOCHEM J, V86, P388, DOI 10.1042/bj0860388; EVANS DJ, 1991, J BACTERIOL, V173, P5457, DOI 10.1128/jb.173.17.5457-5469.1991; FOWDEN L, 1964, ANNU REV BIOCHEM, V33, P173, DOI 10.1146/annurev.bi.33.070164.001133; GIOVANELLI J, 1990, SULFUR NUTRITION AND SULFUR ASSIMILATION IN HIGHER PLANTS, P33; HEDIGER MA, 1985, P NATL ACAD SCI USA, V82, P6414, DOI 10.1073/pnas.82.19.6414; IKEGAMI F, 1988, PHYTOCHEMISTRY, V27, P697, DOI 10.1016/0031-9422(88)84078-0; IKEGAMI F, 1994, BIOL PHARM BULL, V18, P360; KLONUS D, 1994, PLANT J, V6, P105, DOI 10.1046/j.1365-313X.1994.6010105.x; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; KREDICH NM, 1987, ESCHERICHIA COLI SAL, V1, P419; LAI CY, 1992, GENE, V119, P113, DOI 10.1016/0378-1119(92)90074-Y; LEUSTEK T, 1994, PLANT PHYSIOL, V105, P897, DOI 10.1104/pp.105.3.897; Luckner M., 1990, SECONDARY METABOLISM; NAKAMURA K, 1988, PLANT CELL PHYSIOL, V29, P689; NAKAMURA K, 1987, PLANT CELL PHYSIOL, V28, P885, DOI 10.1093/oxfordjournals.pcp.a077370; NAKAMURA K, 1990, AGR BIOL CHEM TOKYO, V54, P649, DOI 10.1080/00021369.1990.10870005; NEUENSCHWANDER U, 1991, PLANT PHYSIOL, V97, P253, DOI 10.1104/pp.97.1.253; NOE FF, 1960, BIOCHEM J, V77, P543, DOI 10.1042/bj0770543; NOJI M, 1993, BIOCHEM BIOPH RES CO, V197, P1111, DOI 10.1006/bbrc.1993.2592; NOJI M, 1994, MOL GEN GENET, V244, P57, DOI 10.1007/BF00280187; PARENT R, 1992, J BACTERIOL, V174, P2891, DOI 10.1128/JB.174.9.2891-2897.1992; RENNENBERG H, 1982, PHYTOCHEMISTRY, V21, P2771, DOI 10.1016/0031-9422(80)85045-X; RENNENBERG H, 1983, PLANT PHYSIOL, V73, P560, DOI 10.1104/pp.73.3.560; ROLLAND N, 1993, ARCH BIOCHEM BIOPHYS, V300, P213, DOI 10.1006/abbi.1993.1030; ROMER S, 1992, J BIOL CHEM, V267, P17966; RUFFET ML, 1994, PLANT PHYSIOL, V104, P597, DOI 10.1104/pp.104.2.597; SAITO K, 1993, FEBS LETT, V324, P247, DOI 10.1016/0014-5793(93)80127-G; SAITO K, 1994, PLANT PHYSIOL, V106, P887, DOI 10.1104/pp.106.3.887; SAITO K, 1992, P NATL ACAD SCI USA, V89, P8078, DOI 10.1073/pnas.89.17.8078; SAITO K, 1994, J BIOL CHEM, V269, P28187; Sambrook J, 1989, MOL CLONING LABORATO; Schmidt A., 1986, Progress in Botany, V48, P133; SCHMIDT A, 1992, ANNU REV PLANT PHYS, V43, P325, DOI 10.1146/annurev.pp.43.060192.001545; SIMOENS CR, 1988, GENE, V67, P1, DOI 10.1016/0378-1119(88)90002-9; SIVAPRASAD AV, 1991, EMBL X59594 DAT BANK; SMITH IK, 1971, BIOCHIM BIOPHYS ACTA, V227, P288, DOI 10.1016/0005-2744(71)90061-1; SMITH IK, 1972, PLANT PHYSIOL, V50, P477, DOI 10.1104/pp.50.4.477; STODIER FW, 1990, METHOD ENZYMOL, V185, P60; SURIN BP, 1988, MOL MICROBIOL, V2, P173, DOI 10.1111/j.1365-2958.1988.tb00019.x; TEI H, 1990, BIOCHEM BIOPH RES CO, V167, P948, DOI 10.1016/0006-291X(90)90615-T; TENNIGKEIT J, 1991, GENE, V98, P113, DOI 10.1016/0378-1119(91)90112-O; YOUSSEFIAN S, 1993, PLANT J, V4, P759, DOI 10.1046/j.1365-313X.1993.04050759.x	52	102	111	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16321	16326		10.1074/jbc.270.27.16321	http://dx.doi.org/10.1074/jbc.270.27.16321			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608200	hybrid			2022-12-27	WOS:A1995RH22600067
J	DE FRUTOS, PG; HARDIG, Y; DAHLBACK, B				DE FRUTOS, PG; HARDIG, Y; DAHLBACK, B			SERUM AMYLOID-P COMPONENT BINDING TO C4B-BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-DEPENDENT PROTEIN; C-REACTIVE PROTEIN; HUMAN-COMPLEMENT; S-BINDING; ALPHA-CHAIN; LIGAND; SITE; ASSOCIATION; GALACTOSE; COMPLEXES	Human C4b-binding protein (C4BP), which is a regulator of the classical complement pathway C3 convertase, forms high affinity complexes with anticoagulant protein S and with the pentraxin serum amyloid P component (SAP), SAP is a plasma protein present in all amyloid deposits. Recently, SAP was shown to inhibit the complement regulatory functions of C4BP. In this investigation, we have studied the structural requirements for the C4BP-SAP interaction. C4BP was subjected to chymotrypsin digestion, which yielded two major fragments corresponding to the central core (160 kDa) and to the cleaved-off tentacles (48 kDa). SAP-Sepharose specifically bound the 160-kDa fragment, suggesting that the central core of C4BP contains the binding site for SAP. In a quantitative affinity chromatography assay, the dissociation constants for binding of intact C4BP and of the 160-kDa central core fragment to SAP were found,to be 30 and 70 nM, respectively. Recombinant C4BP composed of only alpha-chains bound SAP with similar affinity (K-d = 22 nM), whereas nonglycosylated recombinant ru-chain C4BP (synthesized in the presence of tunicamycin) bound SAP with lower affinity (K-d = 126 nM). This suggests that the carbohydrate moiety of the central core of C4BP is important for binding of C4BP to SAP in contrast to the C4BP beta-chain, which is not required. EDTA, heparin, and phosphorylethanolamine as well as a peptide comprising amino acids 27-39 of SAP were found to completely displace C4BP from the SAP matrix. Moreover, the immobilized SAP peptide bound C4BP in a reaction that, in contrast to the C4BP-SAP interaction, was not dependent on calcium.	LUND UNIV, MALMO GEN HOSP, DEPT CLIN CHEM, WALLENBERG LAB, S-20502 MALMO, SWEDEN	Lund University			de Frutos, Pablo García/B-8594-2011	de Frutos, Pablo García/0000-0003-1547-1190; Dahlback, Bjorn/0000-0003-1546-0328				BARLOW PN, 1993, J MOL BIOL, V232, P268, DOI 10.1006/jmbi.1993.1381; BREATHNACH SM, 1989, J EXP MED, V170, P1433, DOI 10.1084/jem.170.4.1433; BROWN MR, 1993, J IMMUNOL, V151, P2087; CHRISTNER RB, 1994, ARCH BIOCHEM BIOPHYS, V314, P337, DOI 10.1006/abbi.1994.1451; CHRISTNER RB, 1994, J BIOL CHEM, V269, P9760; CHUNG LP, 1985, BIOCHEM J, V230, P133, DOI 10.1042/bj2300133; DAHLBACK B, 1991, THROMB HAEMOSTASIS, V66, P49; DAHLBACK B, 1983, P NATL ACAD SCI-BIOL, V80, P3461, DOI 10.1073/pnas.80.11.3461; DAHLBACK B, 1981, P NATL ACAD SCI-BIOL, V78, P2512, DOI 10.1073/pnas.78.4.2512; DE FRUTOS PG, 1994, J IMMUNOL, V152, P2430; DE FRUTOS PG, 1994, BLOOD, V84, P815; DE FRUTOS PG, 1995, BBA-GENE STRUCT EXPR, V1261, P285, DOI 10.1016/0167-4781(95)00019-D; DEBEER FC, 1981, J EXP MED, V154, P1134, DOI 10.1084/jem.154.4.1134; DHAWAN S, 1990, BIOCHEM BIOPH RES CO, V171, P1284, DOI 10.1016/0006-291X(90)90825-8; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; HAMAZAKI H, 1987, J BIOL CHEM, V262, P1456; HAMAZAKI H, 1989, BIOCHIM BIOPHYS ACTA, V998, P231, DOI 10.1016/0167-4838(89)90279-3; HARDIG Y, 1995, BIOCHEM J, V308, P795; HESSING M, 1993, FEBS LETT, V317, P228, DOI 10.1016/0014-5793(93)81281-4; HICKS PS, 1992, J IMMUNOL, V149, P3689; HILLARP A, 1987, J BIOL CHEM, V262, P11300; HILLARP A, 1989, FEBS LETT, V259, P53, DOI 10.1016/0014-5793(89)81492-9; HILLARP A, 1990, P NATL ACAD SCI USA, V87, P1183, DOI 10.1073/pnas.87.3.1183; HILLARP A, 1988, J BIOL CHEM, V263, P12759; HILLARP A, 1994, J IMMUNOL, V153, P4190; HOGG PJ, 1987, ANAL BIOCHEM, V163, P331, DOI 10.1016/0003-2697(87)90232-6; KINOSHITA CM, 1992, PROTEIN SCI, V1, P700, DOI 10.1002/pro.5560010602; LANDSMANN P, 1994, EUR J BIOCHEM, V223, P805, DOI 10.1111/j.1432-1033.1994.tb19056.x; LOVELESS RW, 1992, EMBO J, V11, P813, DOI 10.1002/j.1460-2075.1992.tb05118.x; NAGASAWA S, 1982, J BIOCHEM-TOKYO, V125, P578; OGATA RT, 1993, J IMMUNOL, V150, P2273; PAINTER RH, 1982, ANN NY ACAD SCI, V389, P199, DOI 10.1111/j.1749-6632.1982.tb22138.x; PEPYS MB, 1982, ANN NY ACAD SCI, V389, P286, DOI 10.1111/j.1749-6632.1982.tb22144.x; PEPYS MB, 1987, BIOCHEM BIOPH RES CO, V148, P308, DOI 10.1016/0006-291X(87)91111-9; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; PERKINS SJ, 1986, BIOCHEM J, V233, P799, DOI 10.1042/bj2330799; PERSSON E, 1993, J BIOL CHEM, V268, P22531; ROBEY FA, 1981, J BIOL CHEM, V256, P969; RUBIO N, 1993, J BIOCHEM-TOKYO, V113, P277, DOI 10.1093/oxfordjournals.jbchem.a124039; SCHWALBE RA, 1992, BIOCHEMISTRY-US, V31, P4907, DOI 10.1021/bi00135a023; SCHWALBE RA, 1991, J BIOL CHEM, V266, P12896; SCHWALBE RA, 1990, J BIOL CHEM, V265, P21749; SIRIPONT J, 1988, CELL IMMUNOL, V117, P239, DOI 10.1016/0008-8749(88)90115-3; STENFLO J, 1976, J BIOL CHEM, V251, P355	44	63	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26950	26955		10.1074/jbc.270.45.26950	http://dx.doi.org/10.1074/jbc.270.45.26950			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592941	hybrid			2022-12-27	WOS:A1995TE58300041
J	JUNG, D; YANG, B; MEYER, J; CHAMBERLAIN, JS; CAMPBELL, KP				JUNG, D; YANG, B; MEYER, J; CHAMBERLAIN, JS; CAMPBELL, KP			IDENTIFICATION AND CHARACTERIZATION OF THE DYSTROPHIN ANCHORING SITE ON BETA-DYSTROGLYCAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; CYSTEINE-RICH DOMAIN; GLYCOPROTEIN COMPLEX; SKELETAL-MUSCLE; PROTEINS; ORGANIZATION; DEFICIENCY; SARCOLEMMA; LAMININ	Dystrophin, the product of the Duchenne muscular dystrophy gene, is tightly associated with the sarcolemmal membrane to a large glycoprotein complex. One function of the dystrophin-glycoprotein complex is to Link the cytoskeleton to the extracellular matrix in skeletal muscle. However, the molecular interactions of dystrophin with the membrane components of the dystrophin-glycoprotein complex are still elusive, Here, we demonstrate and characterize a specific interaction between beta-dystroglycan and dystrophin. We show that skeletal muscle and brain dystrophin as well as brain dystrophin isoforms specifically bind to beta-dystroglycan, To localize and characterize the dystrophin and beta-dystroglycan interaction domains, we reconstituted the interaction in vitro using dystrophin fusion proteins and in vitro translated beta-dystroglycan. We demonstrated that the 15 C-terminal amino acids of beta-dystroglycan constituted a unique binding site for the second half of the hinge 4 and the cysteine-rich domain of dystrophin (amino acids 3054-3271), This dystrophin binding site is located in a proline-rich environment of beta-dystroglycan within amino acids 880-895, The identification of the interaction sites in dystrophin and beta-dystroglycan provides further insight into the structure and the molecular organization of the dystrophin glycoprotein complex at the sarcolemma membrane and will be helpful for studying the pathogenesis of Duchenne muscular dystrophy.	UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242; UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,CTR HUMAN GENOME,ANN ARBOR,MI 48109	University of Iowa; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	JUNG, D (corresponding author), UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,400 ECKSTEIN MED RES BLDG,IOWA CITY,IA 52242, USA.			Campbell, Kevin/0000-0003-2066-5889; Chamberlain, Jeffrey/0000-0001-5299-0059				AHN AH, 1995, J CELL BIOL, V128, P363, DOI 10.1083/jcb.128.3.363; BIES RD, 1992, J CLIN INVEST, V90, P666, DOI 10.1172/JCI115909; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; CORRADO K, 1994, FEBS LETT, V334, P255; COX GA, 1994, NAT GENET, V8, P333, DOI 10.1038/ng1294-333; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; DSOUZA VN, 1995, HUM MOL GENET, V4, P837, DOI 10.1093/hmg/4.5.837; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FABRIZIO E, 1994, BIOCHEM J, V299, P359; GEE SH, 1993, J BIOL CHEM, V268, P14972; GREENBERG DS, 1994, NAT GENET, V8, P340, DOI 10.1038/ng1294-340; IBRAGHIMOVBESKR.O, 1993, HUM MOL GENET, V2, P1641; IBRAGHINOVBESKR, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; JUNG D, 1993, NEUROMUSCULAR DISORD, V3, P515, DOI 10.1016/0960-8966(93)90107-U; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; OHLENDIECK K, 1993, NEUROLOGY, V43, P795, DOI 10.1212/WNL.43.4.795; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; RAFAEL JA, 1994, HUM MOL GENET, V3, P1725, DOI 10.1093/hmg/3.10.1725; ROBERDS SL, 1993, J BIOL CHEM, V268, P23739; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; SUZUKI A, 1992, FEBS LETT, V308, P154, DOI 10.1016/0014-5793(92)81265-N; SUZUKI A, 1995, J CELL BIOL, V128, P373, DOI 10.1083/jcb.128.3.373; SUZUKI A, 1994, EUR J BIOCHEM, V220, P283, DOI 10.1111/j.1432-1033.1994.tb18624.x; YANG B, 1994, J BIOL CHEM, V269, P6040; YANG B, 1995, J BIOL CHEM, V270, P4975, DOI 10.1074/jbc.270.10.4975; YANG B, 1995, J BIOL CHEM, V270, P11711, DOI 10.1074/jbc.270.20.11711; YOSHIDA M, 1994, EUR J BIOCHEM, V222, P1055, DOI 10.1111/j.1432-1033.1994.tb18958.x; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276; YOSHIOKA K, 1992, J NEUROL SCI, V108, P214, DOI 10.1016/0022-510X(92)90054-O; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	36	271	280	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27305	27310		10.1074/jbc.270.45.27305	http://dx.doi.org/10.1074/jbc.270.45.27305			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592992	hybrid			2022-12-27	WOS:A1995TE58300092
J	RIMON, A; GERCHMAN, Y; OLAMI, Y; SCHULDINER, S; PADAN, E				RIMON, A; GERCHMAN, Y; OLAMI, Y; SCHULDINER, S; PADAN, E			REPLACEMENTS OF HISTIDINE-226 OF NHAA-NA+/H+ ANTIPORTER OF ESCHERICHIA-COLI - CYSTEINE (H226C) OR SERINE (H226S) RETAIN BOTH NORMAL ACTIVITY AND PH SENSITIVITY, ASPARTATE (H226D) SHIFTS THE PH PROFILE TOWARD BASIC PH, AND ALANINE (H226A) INACTIVATES THE CARRIER AT ALL PH VALUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC-PROPERTIES; MEMBRANE-VESICLES; GENE; ANT; EXPRESSION; PROTEINS; GRADIENT	We have previously shown that replacement of His-226 in the NhaA Na+/H+ antiporter of Escherichia coli to Arg (H226R) shifts the pH profile of the antiporter toward acidic pH and as a result a Delta nha Delta nhaB strain bearing this mutation is Na+ sensitive at alkaline pH (Gerchman, Y., Olami, Y., Rimon, A., Taglicht, D., Schuldiner, S. and Padan, E. (1993) Proc. Natl. Acad. Sci, U.S.A. 90, 1212-1216). In the present work the role of His-226 in the response of NhaA to pH has been studied in detail. The Na+ sensitivity of the Delta nhaA Delta nhaB mutant bearing the H226R NhaA plasmid at alkaline pH provided a very powerful tool to isolate revertants and suppressants of H226R growing on high Na+ at alkaline pH, With this approach cysteine (H226C) and serine (H226S) replacements were found to efficiently replace His-226 and yield an antiporter, which like the wild-type protein, is activated by pH between pH 7 and 8. These results imply that polarity and/or hydrogen bonding, the common properties shared by these amino acid residues, are essential at position 226 for pH regulation of NhaA. This suggestion was substantiated by site-directed mutagenesis of His-226 either to alanine (H226A) or aspartate (H226D), Whereas H226A-NhaA shows very low activity which is not activated by pH, H226D-NhaA is active and regulated by pH. The pH profile of H226D is shifted by half a pH unit toward alkaline pH, as opposed to the previously isolated mutant H226R which has a pH profile shift, to the same extent, but toward acidic pH, It is suggested that charge modifies the pH profile but is not essential for the pH regulation of NhaA.	HEBREW UNIV JERUSALEM, INST LIFE SCI, DIV MICROBIAL & MOLEC ECOL, IL-91904 JERUSALEM, ISRAEL	Hebrew University of Jerusalem			Schuldiner, Shimon/F-7628-2012; Gerchman, Yoram/F-5226-2015; Gerchman, Yoram/H-4698-2019	Schuldiner, Shimon/0000-0002-4874-6237; Gerchman, Yoram/0000-0002-8637-9589; 				ANTOSIEWICZ J, 1994, J MOL BIOL, V238, P415, DOI 10.1006/jmbi.1994.1301; ARONSON PS, 1985, ANNU REV PHYSIOL, V47, P545, DOI 10.1146/annurev.ph.47.030185.002553; BASSILANA M, 1984, BIOCHEMISTRY-US, V23, P5288, DOI 10.1021/bi00317a029; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Budowsky E I, 1976, Prog Nucleic Acid Res Mol Biol, V16, P125; CARMEL O, 1994, EMBO J, V13, P1981, DOI 10.1002/j.1460-2075.1994.tb06467.x; Fersht A. R., 1985, ENZYME STRUCTURE MEC, P155; GERCHMAN Y, 1993, P NATL ACAD SCI USA, V90, P1212, DOI 10.1073/pnas.90.4.1212; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KARPEL R, 1988, J BIOL CHEM, V263, P10408; KARPEL R, 1991, J BIOL CHEM, V266, P21753; KING SM, 1985, P NATL ACAD SCI USA, V82, P4717, DOI 10.1073/pnas.82.14.4717; MILLER JH, 1992, LABORATORY MANUAL HD; NOEL J, 1995, AM J PHYSIOL-CELL PH, V268, pC283, DOI 10.1152/ajpcell.1995.268.2.C283; OKAMURA MY, 1992, ANNU REV BIOCHEM, V61, P861; OLSNES S, 1987, BIOCHEMISTRY-US, V26, P2778, DOI 10.1021/bi00384a019; PADAN E, 1993, J BIOENERG BIOMEMBR, V25, P647; PADAN E, 1989, J BIOL CHEM, V264, P20297; PADAN E, 1994, BBA-BIOENERGETICS, V1185, P129, DOI 10.1016/0005-2728(94)90204-6; PADAN E, 1976, EUR J BIOCHEM, V63, P533, DOI 10.1111/j.1432-1033.1976.tb10257.x; PADAN E, 1992, ALKALI CATION TRANSP, P3; PINNER E, 1992, J BIOL CHEM, V267, P11064; PINNER E, 1993, J BIOL CHEM, V268, P1729; PINNER E, 1994, J BIOL CHEM, V269, P26274; RAHAVMANOR O, 1992, J BIOL CHEM, V267, P10433; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; Schuldiner S., 1992, ALKALI CATION TRANSP, P25; SILHAVY TJ, 1984, EXPT GENE FUSIONS, P135; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382	33	44	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26813	26817		10.1074/jbc.270.45.26813	http://dx.doi.org/10.1074/jbc.270.45.26813			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592922	hybrid			2022-12-27	WOS:A1995TE58300022
J	RISINGER, JI; UMAR, A; BARRETT, JC; KUNKEL, TA				RISINGER, JI; UMAR, A; BARRETT, JC; KUNKEL, TA			A HPMS2 MUTANT-CELL LINE IS DEFECTIVE IN STRAND-SPECIFIC MISMATCH REPAIR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							NONPOLYPOSIS COLON-CANCER; SACCHAROMYCES-CEREVISIAE; GENETIC INSTABILITY; COLORECTAL-CANCER; DNA; MUTATIONS; TOLERANT; HOMOLOG	Human cells contain several homologs of the bacterial mutL gene required for mismatch repair, including a gene on chromosome 7 designated hPMS2. We have identified an endometrial carcinoma cell line, HEC-1-A, that has a C --> T mutation in hPMS2 that generates a nonsense codon and yields a protein truncated at the C terminus, No wild-type gene or gene product was detected, The missing amino acids in hPMS2 are highly conserved among PMS homologs, suggesting that they may be critical for function, In support of this, extracts of HEC-1-A cells are defective in repairing a variety of mismatched substrates. Moreover, di-, tri-, and tetranucleotide repeated sequences are highly unstable in single cell clones of HEC-1-A cells, and HEC-1-A cells are resistant to killing by N-methyl-N'-nitro-N-nitrosoguanidine. The results provide strong experimental support for the involvement of the hPMS2 gene product in mismatch repair in human cells and support the concept that a defective hPMS2 gene may lead to predisposition to certain forms of cancer.	NIEHS,MOLEC GENET LAB,RES TRIANGLE PK,NC 27709; NIEHS,MOLEC CARCINOGENESIS LAB,RES TRIANGLE PK,NC 27709; UNIV N CAROLINA,CURRICULUM GENET & MOLEC BIOL,CHAPEL HILL,NC 27599	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill			Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788				AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BHATTACHARYYA NP, 1994, P NATL ACAD SCI USA, V91, P6319, DOI 10.1073/pnas.91.14.6319; BISHOP DK, 1989, P NATL ACAD SCI USA, V86, P3713, DOI 10.1073/pnas.86.10.3713; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; ESHLEMAN JR, 1995, ONCOGENE, V10, P33; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; HAN HJ, 1993, CANCER RES, V53, P5087; HORII A, 1994, BIOCHEM BIOPH RES CO, V204, P1257, DOI 10.1006/bbrc.1994.2598; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; JEYAPRAKASH A, 1994, MUTAT RES LETT, V325, P21, DOI 10.1016/0165-7992(94)90023-X; KARRAN P, 1994, BIOESSAYS, V16, P833, DOI 10.1002/bies.950161110; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; Kimpton C., 1992, Human Molecular Genetics, V1, P287, DOI 10.1093/hmg/1.4.287; KOI M, 1994, CANCER RES, V54, P4308; KOLODNER RD, 1994, GENOMICS, V24, P516, DOI 10.1006/geno.1994.1661; KOLODNER RD, 1995, CANCER RES, V55, P242; KRAMER W, 1989, J BACTERIOL, V171, P5339, DOI 10.1128/jb.171.10.5339-5346.1989; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; LIU B, 1994, CANCER RES, V54, P4590; LOEB LA, 1994, CANCER RES, V54, P5059; MARRA G, 1995, IN PRESS J NATL CANC; MODRICH P, 1994, SCIENCE, V266, P1959, DOI 10.1126/science.7801122; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; PROLLA TA, 1994, SCIENCE, V265, P1091, DOI 10.1126/science.8066446; PROLLA TA, 1994, MOL CELL BIOL, V14, P407, DOI 10.1128/MCB.14.1.407; RISINGER JI, 1993, CANCER RES, V53, P5100; RISINGER JI, 1994, NAT GENET, V7, P98, DOI 10.1038/ng0594-98; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; THOMAS DC, 1995, IN PRESS GENOMETHODS; UMAR A, 1994, J BIOL CHEM, V269, P14367	36	95	96	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18183	18186		10.1074/jbc.270.31.18183	http://dx.doi.org/10.1074/jbc.270.31.18183			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629132	Green Published, hybrid			2022-12-27	WOS:A1995RM64200003
J	KIM, SY; CHUNG, SI; STEINERT, PM				KIM, SY; CHUNG, SI; STEINERT, PM			HIGHLY-ACTIVE SOLUBLE PROCESSED FORMS OF THE TRANSGLUTAMINASE-1 ENZYME IN EPIDERMAL-KERATINOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; FACTOR-XIII; GUINEA-PIG; PROTRANSGLUTAMINASE-E; MEMBRANE ANCHORAGE; SUBUNIT DEFICIENCY; RETINYL ACETATE; HAIR FOLLICLE; CDNA CLONES; EXPRESSION	The transglutaminase 1 (TGase 1) enzyme is required for the formation of a cornified cell envelope in epidermal keratinocytes. We show here that in addition to its membrane-anchored form, soluble forms of it are also important in keratinocytes. Proliferating cells contain soluble full-length enzyme of 106 kDa, but terminally differentiating cells contain a soluble 67-kDa form often complexed with a 33-kDa protein as well. The amino terminus of the 67 kDa form is residue 93 of the TGase 1 protein, corresponding to the site of proteolytic activation of the factor XIIIa TGase. The amino terminus of the 33-kDa protein is residue 573, corresponding to the site of a second proteolytic cleavage site of factor XIIIa, and of the site for proteolytic activation of the TGase 3 enzyme. The specific activity of the 67/33-kDa soluble complex is twice that of the soluble 67-kDa form and 10 times that of full-length TGase 1. The half-lives of the 67/33- and 106-kDa forms are about 7 or 20 h, respectively. Thus the TGase 1 enzyme is complex, since it exists in keratinocytes as multiple soluble forms, either intact or proteolytically processed at conserved sites, and which have varying specific activities and likely functions.	NIAMS, SKIN BIOL BRANCH, BETHESDA, MD 20892 USA; NIDR, CELLULAR DEV & ONCOL LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)								ANDO Y, 1988, ARCH DERMATOL RES, V280, P380, DOI 10.1007/BF00426618; BISHOP PD, 1990, BIOCHEMISTRY-US, V29, P1861, DOI 10.1021/bi00459a028; BOARD P, 1992, BLOOD, V80, P937; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAKRAVARTY R, 1989, J BIOL CHEM, V264, P625; CHANG SK, 1986, J BIOL CHEM, V261, P8112; CHUNG SI, 1972, ANN NY ACAD SCI, V202, P240, DOI 10.1111/j.1749-6632.1972.tb16338.x; CHUNG SI, 1972, P NATL ACAD SCI USA, V69, P303, DOI 10.1073/pnas.69.2.303; CHUNG SI, 1988, ADV POSTTRANSLATIONA, P1; CHUNG SI, 1992, J DENT RES, V71, P466; CLINE PR, 1983, CANCER RES, V43, P3203; CONNELLAN JM, 1971, J BIOL CHEM, V246, P1093; CURTIS CG, 1974, BIOCHEMISTRY-US, V13, P3257, DOI 10.1021/bi00713a012; DUVIC M, 1994, J INVEST DERMATOL, V102, P462, DOI 10.1111/1523-1747.ep12373021; FOLK JE, 1985, METHOD ENZYMOL, V113, P358; FOLK JE, 1973, ADV ENZYMOL RAMB, V38, P109; GENTILE V, 1991, J BIOL CHEM, V266, P478; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; IKURA K, 1988, BIOCHEMISTRY-US, V27, P2898, DOI 10.1021/bi00408a035; JETTEN AM, 1986, J BIOL CHEM, V261, P5097; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; KAMURA T, 1992, J CLIN INVEST, V90, P315, DOI 10.1172/JCI115864; KIM HC, 1990, J BIOL CHEM, V265, P21971; KIM HC, 1991, J BIOL CHEM, V266, P536; KIM IG, 1993, J BIOL CHEM, V268, P12682; KIM IG, 1992, J BIOL CHEM, V267, P7710; KIM SY, 1995, J INVEST DERMATOL, V104, P211, DOI 10.1111/1523-1747.ep12612769; KIM SY, 1994, J BIOL CHEM, V269, P27979; LAZARUS GS, 1991, PHYSL BIOCH MOL BIOL, P464; MICHEL S, 1992, J INVEST DERMATOL, V98, P364, DOI 10.1111/1523-1747.ep12499806; MIKKOLA H, 1994, BLOOD, V84, P517; MUELLEREBERHARD HJ, 1992, INFLAMMATION BASIC P, P63; MULLERTZ S, 1984, SEMIN THROMB HEMOST, V10, P1, DOI 10.1055/s-2007-1004402; NEGI M, 1985, J INVEST DERMATOL, V85, P75, DOI 10.1111/1523-1747.ep12275357; OGAWA H, 1976, J BIOL CHEM, V251, P7281; PARK SC, 1988, J CELL BIOL, V107, P139; PETERSON LL, 1984, MOL CELL BIOCHEM, V58, P99, DOI 10.1007/BF00240609; PHILLIPS MA, 1993, BIOCHEMISTRY-US, V32, P11057, DOI 10.1021/bi00092a015; PHILLIPS MA, 1992, J BIOL CHEM, V267, P2282; PISANO JJ, 1975, PROTEASES BIOL CONTR, P199; Reichert Uwe, 1993, P107; RICE RH, 1977, CELL, V11, P417, DOI 10.1016/0092-8674(77)90059-9; RICE RH, 1990, BIOCHEM J, V265, P351, DOI 10.1042/bj2650351; SCHMIDT R, 1988, J INVEST DERMATOL, V90, P475, DOI 10.1111/1523-1747.ep12460936; SCHROEDER WT, 1992, J INVEST DERMATOL, V99, P27, DOI 10.1111/1523-1747.ep12611394; STANDEN GR, 1993, BRIT J HAEMATOL, V85, P769, DOI 10.1111/j.1365-2141.1993.tb03221.x; STEINERT P, 1976, J INVEST DERMATOL, V66, P276; STEINERT PM, 1994, CHONNAM J MED SCI, V6, P78; TAKAGI T, 1974, BIOCHEMISTRY-US, V13, P750, DOI 10.1021/bi00701a018; TAKAHASHI N, 1986, P NATL ACAD SCI USA, V83, P8019, DOI 10.1073/pnas.83.21.8019; THACHER SM, 1989, J INVEST DERMATOL, V92, P578; THACHER SM, 1985, CELL, V40, P685, DOI 10.1016/0092-8674(85)90217-X; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296; YUSPA SH, 1974, EXP CELL RES, V86, P95, DOI 10.1016/0014-4827(74)90653-3; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207	56	103	105	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18026	18035		10.1074/jbc.270.30.18026	http://dx.doi.org/10.1074/jbc.270.30.18026			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629111	hybrid			2022-12-27	WOS:A1995RM26600062
J	IRRGANG, KD; SHI, LX; FUNK, C; SCHRODER, WP				IRRGANG, KD; SHI, LX; FUNK, C; SCHRODER, WP			A NUCLEAR-ENCODED SUBUNIT OF THE PHOTOSYSTEM-II REACTION-CENTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-MASS PROTEINS; REACTION CENTER COMPLEX; THYLAKOID MEMBRANE-PROTEIN; SPINACH-CHLOROPLASTS; POLYACRYLAMIDE GELS; ELECTRON-TRANSPORT; OXYGEN EVOLUTION; SYNECHOCYSTIS SP; CORE COMPLEX; GENE-PRODUCT	A nuclear encoded polypeptide of 6.1 kDa was identified in isolated photosystem II (PSII) reaction center from Spinacia oleracea. The hydrophobic membrane protein easily escapes staining procedures such as Coomassie R-250 or silver staining, but it is clearly detected by immunodecoration with peptide-directed IgG. This additional subunit was found to be present in PSII reaction centers previously known to contain only the D1/D2/cytb(559) proteins and the psbI gene product. Furthermore, cross-linking experiments using 1-(3-dimethylaminopropyl-)3-ethylcarbodiimide showed that the nearest neighbors were the D1 and D2 proteins and the cytb(559). The 6.1-kDa protein was purified by immune affinity chromatography. N-terminal sequence analysis of the isolated protein confirmed the identity of the 6.1-kDa protein and enabled finding of strong similarities with a randomly obtained cDNA from Arabidopsis thaliana. Using enzyme-linked immunosorbent assay in combination with thylakoid membrane preparations of different orientation, the N terminus off the protein, predicted to span the membrane once, is suggested to be exposed at the lumen side of the membrane. Consequently the 6.1-kDa protein seems to be the only subunit in the PSII reaction center that is nuclear encoded and has its N terminus on the lumen side of the membrane. These findings open for new interesting suggestions concerning the properties of photosystem II reaction center with respect to the photosynthetic activity, regulation and assembly in higher plants.	UNIV STOCKHOLM, ARRHENIUS LABS NAT SCI, DEPT BIOCHEM, S-10691 STOCKHOLM, SWEDEN	Stockholm University			Schröder, Wolfgang/A-8799-2008; Funk, Christiane/AAO-6041-2021	Funk, Christiane/0000-0002-7897-4038; Schroder, Wolfgang/0000-0001-9831-1533				AKERLUND HE, 1976, BIOCHIM BIOPHYS ACTA, V449, P525, DOI 10.1016/0005-2728(76)90161-4; ANDERSSON B, 1976, BIOCHIM BIOPHYS ACTA, V423, P122, DOI 10.1016/0005-2728(76)90106-7; ANDERSSON B., 1991, CURR TOP BIOENERG, V16, P1; ANDERSSON B, 1992, MOL MECHANISMS BIOEN, P121; BARBER J, 1987, FEBS LETT, V220, P67, DOI 10.1016/0014-5793(87)80877-3; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; BOZA MVT, 1993, 41ST HARD C PHOT PHO; BURKE JJ, 1978, ARCH BIOCHEM BIOPHYS, V187, P252, DOI 10.1016/0003-9861(78)90031-0; CRAMER WA, 1977, ANNU REV PLANT PHYS, V28, P133, DOI 10.1146/annurev.pp.28.060177.001025; DEBOER D, 1993, PIGMENT PROTEIN COMP, P311; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; DEVITRY C, 1991, J BIOL CHEM, V266, P16614; GHANOTAKIS DF, 1989, BIOCHIM BIOPHYS ACTA, V974, P44, DOI 10.1016/S0005-2728(89)80164-1; GHANOTAKIS DF, 1986, FEBS LETT, V197, P244, DOI 10.1016/0014-5793(86)80335-0; HAAG E, 1990, EUR J BIOCHEM, V189, P47, DOI 10.1111/j.1432-1033.1990.tb15458.x; HANSSON O, 1990, PHOTOSYNTH RES, V23, P131, DOI 10.1007/BF00035006; HOFTE H, 1993, PLANT J, V4, P1051, DOI 10.1046/j.1365-313X.1993.04061051.x; IKEUCHI M, 1989, FEBS LETT, V242, P263, DOI 10.1016/0014-5793(89)80482-X; IKEUCHI M, 1988, FEBS LETT, V241, P99, DOI 10.1016/0014-5793(88)81039-1; IKEUCHI M, 1991, J BIOL CHEM, V266, P11111; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIND LK, 1993, J BIOL CHEM, V268, P1575; LJUNGBERG U, 1986, BIOCHIM BIOPHYS ACTA, V849, P112, DOI 10.1016/0005-2728(86)90102-7; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MAYES SR, 1993, BIOCHEMISTRY-US, V32, P1454, DOI 10.1021/bi00057a008; MICHEL H, 1988, J BIOL CHEM, V263, P1123; MICHEL H, 1988, BIOCHEMISTRY-US, V27, P1, DOI 10.1021/bi00401a001; MICHEL H, 1986, ENCY PLANT PHYSL PHO, V19, P371; NAGATSUKA T, 1991, BIOCHIM BIOPHYS ACTA, V1057, P223, DOI 10.1016/S0005-2728(05)80105-7; NANBA O, 1987, P NATL ACAD SCI USA, V84, P109, DOI 10.1073/pnas.84.1.109; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; RENGER G, 1993, PHOTOSYNTH RES, V38, P229, DOI 10.1007/BF00046749; ROCHAIX JD, 1984, PLANT MOL BIOL, V3, P363, DOI 10.1007/BF00033383; SAYRE RT, 1986, CELL, V47, P601, DOI 10.1016/0092-8674(86)90624-0; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHRODER WP, 1988, FEBS LETT, V235, P289, DOI 10.1016/0014-5793(88)81281-X; SEIBERT M, 1988, PLANT PHYSIOL, V87, P303, DOI 10.1104/pp.87.2.303; TAE GS, 1994, BIOCHEMISTRY-US, V33, P10060, DOI 10.1021/bi00199a033; TAE GS, 1988, BIOCHEMISTRY-US, V27, P9075, DOI 10.1021/bi00426a002; TANG XS, 1990, FEBS LETT, V273, P257, DOI 10.1016/0014-5793(90)81098-9; TOMO T, 1993, FEBS LETT, V323, P15, DOI 10.1016/0014-5793(93)81438-6; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; WEBBER AN, 1989, FEBS LETT, V242, P259, DOI 10.1016/0014-5793(89)80481-8	46	47	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17588	17593		10.1074/jbc.270.29.17588	http://dx.doi.org/10.1074/jbc.270.29.17588			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615565	hybrid			2022-12-27	WOS:A1995RK68900082
J	BUCHBERGER, A; THEYSSEN, H; SCHRODER, H; MCCARTY, JS; VIRGALLITA, G; MILKEREIT, P; REINSTEIN, J; BUKAU, B				BUCHBERGER, A; THEYSSEN, H; SCHRODER, H; MCCARTY, JS; VIRGALLITA, G; MILKEREIT, P; REINSTEIN, J; BUKAU, B			NUCLEOTIDE-INDUCED CONFORMATIONAL-CHANGES IN THE ATPASE AND SUBSTRATE-BINDING DOMAINS OF THE DNAK CHAPERONE PROVIDE EVIDENCE FOR INTERDOMAIN COMMUNICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; ESCHERICHIA-COLI DNAJ; UNCOATING PROTEIN; PEPTIDE BINDING; GRPE; DISSOCIATION; HYDROLYSIS; FRAGMENT; GENE	Interactions of the DnaK (Hsp70) chaperone from Escherichia coli with substrates are controlled by ATP. Nucleotide-induced changes in DnaK conformation were investigated by monitoring changes in tryptic digestion pattern and tryptophan fluorescence. Using nucleotide-free DnaK preparations, not only the known ATP-induced major changes in kinetics and pattern of proteolysis but also minor ADP-induced changes were detected. Similar ATP-induced conformational changes occurred in the DnaK-T199A mutant protein defective in ATPase activity, demonstrating that they result from binding, not hydrolysis, of ATP. N-terminal sequencing and immunological mapping of tryptic fragments of DnaK identified cleavage sites that, upon ATP addition, appeared within the proposed C-terminal substrate binding region and disappeared in the N-terminal ATPase domain. They hence reflect structural alterations in DnaK correlated to substrate release and indicate ATP-dependent domain interactions. Domain interactions are a prerequisite for efficient tryptic degradation as fragments of DnaK comprising the ATPase and C-terminal domains were highly protease-resistant. Fluorescence analysis of the N-terminally located single tryptophan residue of DnaK revealed that the known ATP-induced alteration of the emission spectrum, proposed to result directly from conformational changes in the ATPase domain, requires the presence of the C-terminal domain and therefore mainly results from altered domain interaction. Analyses of the C-terminally truncated DnaK163 mutant protein revealed that nucleotide-dependent interdomain communication requires a 15-kDa segment assumed to constitute the substrate binding site.	UNIV HEIDELBERG,ZENTRUM MOLEK BIOL,D-69120 HEIDELBERG,GERMANY; MAX PLANCK INST MOLEK PHYSIOL,PHYS BIOCHEM ABT,D-44139 DORTMUND,GERMANY; HOFFMANN LA ROCHE AG,CH-4002 BASEL,SWITZERLAND	Ruprecht Karls University Heidelberg; Max Planck Society; Roche Holding			Buchberger, Alexander/AAF-4728-2019; Buchberger, Alexander/J-4070-2019	Buchberger, Alexander/0000-0002-2836-0820; Buchberger, Alexander/0000-0002-2836-0820; Bukau, Bernd/0000-0003-0521-7199				BANECKI B, 1992, J BIOL CHEM, V267, P25051; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BOLLIGER L, 1994, EMBO J, V13, P1998, DOI 10.1002/j.1460-2075.1994.tb06469.x; BUCHBERGER A, 1994, NAT STRUCT BIOL, V1, P95, DOI 10.1038/nsb0294-95; BUCHBERGER A, 1994, EMBO J, V13, P1687, DOI 10.1002/j.1460-2075.1994.tb06433.x; BUKAU B, 1989, J BACTERIOL, V171, P2337, DOI 10.1128/jb.171.5.2337-2346.1989; BURKHOLDER WF, 1994, J MOL BIOL, V242, P364, DOI 10.1006/jmbi.1994.1587; CAPLAN AJ, 1993, MOL BIOL CELL, V4, P555, DOI 10.1091/mbc.4.6.555; CHAPPELL TG, 1987, J BIOL CHEM, V262, P746; DEMACARIO EC, 1994, J MOL BIOL, V240, P65; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLAHERTY KM, 1994, J BIOL CHEM, V269, P12899; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; GAO BC, 1994, BIOCHEMISTRY-US, V33, P2048, DOI 10.1021/bi00174a010; GAO BC, 1993, J BIOL CHEM, V268, P8507; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes Ken C., 1993, Trends in Cell Biology, V3, P53, DOI 10.1016/0962-8924(93)90161-S; HOLTZMAN DA, 1994, J CELL BIOL, V126, P423, DOI 10.1083/jcb.126.2.423; HONTS JE, 1994, J CELL BIOL, V126, P413, DOI 10.1083/jcb.126.2.413; IKEDA E, 1994, FEBS LETT, V339, P265, DOI 10.1016/0014-5793(94)80428-1; KASSENBROCK CK, 1989, EMBO J, V8, P1461, DOI 10.1002/j.1460-2075.1989.tb03529.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LALORAYA S, 1994, P NATL ACAD SCI USA, V91, P6481, DOI 10.1073/pnas.91.14.6481; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; LIBEREK K, 1991, J BIOL CHEM, V266, P14491; MCCARTY JS, 1991, P NATL ACAD SCI USA, V88, P9513, DOI 10.1073/pnas.88.21.9513; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; MCGOUGH A, 1994, J CELL BIOL, V126, P433, DOI 10.1083/jcb.126.2.433; MILARSKI KL, 1989, J CELL BIOL, V109, P1947, DOI 10.1083/jcb.109.5.1947; MONTGOMERY D, 1993, J MOL BIOL, V232, P680, DOI 10.1006/jmbi.1993.1418; MORIMOTO RI, 1994, BIOL HEAT SHOCK PROT, P1; NARBERHAUS F, 1992, J BACTERIOL, V174, P3290, DOI 10.1128/jb.174.10.3290-3299.1992; PALLEROS DR, 1994, J BIOL CHEM, V269, P13107; PALLEROS DR, 1993, FEBS LETT, V336, P124, DOI 10.1016/0014-5793(93)81624-9; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; PALLEROS DR, 1992, J BIOL CHEM, V267, P5279; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SCHMID SL, 1985, J BIOL CHEM, V260, P10050; SCHONFELD HJ, 1995, J BIOL CHEM, V270, P2183, DOI 10.1074/jbc.270.5.2183; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; WANG TF, 1993, J BIOL CHEM, V268, P26049; WETZSTEIN M, 1992, J BACTERIOL, V174, P3300, DOI 10.1128/jb.174.10.3300-3310.1992; ZYLICZ M, 1985, J BIOL CHEM, V260, P7591	49	215	217	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16903	16910		10.1074/jbc.270.28.16903	http://dx.doi.org/10.1074/jbc.270.28.16903			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622507	hybrid			2022-12-27	WOS:A1995RJ34700068
J	THINAKARAN, G; SLUNT, HH; SISODIA, SS				THINAKARAN, G; SLUNT, HH; SISODIA, SS			NOVEL REGULATION OF CHONDROITIN SULFATE GLYCOSAMINOGLYCAN MODIFICATION OF AMYLOID PRECURSOR PROTEIN AND ITS HOMOLOG, APLP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; MESSENGER-RNA; PROTEOGLYCAN FORM; NEXIN-II; IDENTIFICATION; DOMAIN; CDNA	Alzheimer's disease is characterized by the presence of parenchymal and cerebrovascular deposits of beta-amyloid (A beta). A beta is derived from larger amyloid precursor proteins (APP), a member of a family of related polypeptides that includes amyloid precursor-like proteins, APLP1 and APLP2, APP and APLP2 isoforms are encoded by several alternatively spliced APP and APLP2 transcripts, respectively, We previously reported that the APLP2-751 isoform is modified by the addition of chondroitin sulfate glycosminoglycan (CS GAG) at Ser-614, In this report, we demonstrate that the APLP2-763 isoform, which contains an insertion of 12 amino acids immediately N-terminal to Ser-614, is not modified by CS GAG, Finally, we demonstrate that like APLP2-751, APP isoforms that lack sequences encoded by exon 15 (L-APP) are also modified by CS GAG, whereas APP forms containing exon 15 are not, We suggest that CS GAG modification of a subset of APP and APLP2 isoforms represents a means of generating functional diversity for these polypeptides.	JOHNS HOPKINS UNIV,SCH MED,NEUROPATHOL LAB,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University					NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS020471, P50NS020471] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 20471, NS AG 05146] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; BOURDON MA, 1987, P NATL ACAD SCI USA, V84, P3194, DOI 10.1073/pnas.84.10.3194; CHEN C, 1987, MOL CELL BIOL, V7, P2746; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; HUNG AY, 1994, EMBO J, V13, P534, DOI 10.1002/j.1460-2075.1994.tb06291.x; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; KONIG G, 1992, J BIOL CHEM, V267, P10804; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; OHGAMI T, 1993, J NEUROCHEM, V61, P1553, DOI 10.1111/j.1471-4159.1993.tb13655.x; OHGAMI T, 1993, MOL BRAIN RES, V20, P240, DOI 10.1016/0169-328X(93)90046-R; OLTERSDORF T, 1989, NATURE, V341, P144, DOI 10.1038/341144a0; PETERSEN LC, 1994, FEBS LETT, V338, P53, DOI 10.1016/0014-5793(94)80115-0; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; SANDBRINK R, 1994, J BIOL CHEM, V269, P14227; SANDBRINK R, 1994, J BIOL CHEM, V269, P1510; SHIOI J, 1993, NEUROSCI LETT, V154, P121, DOI 10.1016/0304-3940(93)90186-O; SHIOI J, 1992, J BIOL CHEM, V267, P13819; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; SPRECHER CA, 1993, BIOCHEMISTRY-US, V32, P4481, DOI 10.1021/bi00068a002; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; THINAKARAN G, 1994, J BIOL CHEM, V269, P22099; VANNOSTRAND WE, 1994, BBA-PROTEIN STRUCT M, V1209, P165, DOI 10.1016/0167-4838(94)90180-5; VANNOSTRAND WE, 1989, NATURE, V341, P546; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3	30	43	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16522	16525		10.1074/jbc.270.28.16522	http://dx.doi.org/10.1074/jbc.270.28.16522			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622456	hybrid			2022-12-27	WOS:A1995RJ34700011
J	TSIANG, M; JAIN, AK; DUNN, KE; ROJAS, ME; LEUNG, LLK; GIBBS, CS				TSIANG, M; JAIN, AK; DUNN, KE; ROJAS, ME; LEUNG, LLK; GIBBS, CS			FUNCTIONAL MAPPING OF THE SURFACE RESIDUES OF HUMAN THROMBIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-THROMBIN; THROMBOMODULIN-BINDING SITE; PRO-ARG CHLOROMETHYLKETONE; AMINO-ACID SUBSTITUTIONS; STRANDED-DNA APTAMER; BLOOD-COAGULATION; CRYSTAL-STRUCTURE; ANTITHROMBIN-III; PROTEIN-C; KUNITZ INHIBITORS	Utilizing site directed mutagenesis, 77 charged and polar residues that are highly exposed on the surface of human thrombin were systematically substituted with alanine. Functional assays using thrombin mutants identified residues that were required for the recognition and cleavage of the procoagulant substrate fibrinogen (Lys(21), Trp(50), Lys(52), Asn(53)+Thr(55), Lys(65), His(66), Arg(68), Tyr(71), Arg(73), Lys(77), Lys(106)+Lys(107), Asp(193)+Lys(196), Glu(202), Glu(229), Arg(233), Asp(234)) and the anticoagulant substrate protein C (Lys(21), Trp(50), Lys(65), His(66), Arg(68), Tyr(71), Arg(73), Lys(77), Lys(106)+Lys(107), Glu(229), Arg(233)), interactions with the cofactor thrombomodulin (Gln(24), Arg(70)) and inhibition by the thrombin aptamer, an oligonucleotide-based thrombin inhibitor (Lys(65) , His(66), Arg(7)0, Tyr(71) Arg(73)). Although there is considerable overlap between the functional epitopes, distinct and specific residues with unique functions were identified. When the functional residues were mapped on the surface of thrombin, they were located on a single hemisphere of thrombin that included both the active site cleft and the highly basic exosite 1. No functional residues were located on the opposite face of thrombin. Residues with procoagulant or anticoagulant functions were not spatially separated but interdigitated with residues of opposite or shared function. Thus thrombin utilizes the same general surface for substrate recognition regardless of substrate function although the critical contact residues may vary.			TSIANG, M (corresponding author), GILEAD SCI INC,353 LAKESIDE DR,FOSTER CITY,CA 94404, USA.							ADAMS GA, 1985, MOL CELL BIOL, V5, P1442, DOI 10.1128/MCB.5.6.1442; BANFIELD DK, 1992, P NATL ACAD SCI USA, V89, P2779, DOI 10.1073/pnas.89.7.2779; BINNIE CG, 1993, BLOOD, V81, P3186; BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BODE W, 1993, SEMIN THROMB HEMOST, V19, P321, DOI 10.1055/s-2007-993283; BODE W, 1992, PROTEIN SCI, V1, P426; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; CHURCH FC, 1989, J BIOL CHEM, V264, P18419; DEGEN SJF, 1983, BIOCHEMISTRY-US, V22, P2087, DOI 10.1021/bi00278a008; ESMON CT, 1993, THROMB HAEMOSTASIS, V70, P29; FURIE B, 1982, J BIOL CHEM, V257, P3875; GAILANI D, 1991, SCIENCE, V253, P909, DOI 10.1126/science.1652157; Gibbs C.S., 1991, METHODS COMPANION ME, V3, P165; GRUTTER MG, 1990, EMBO J, V9, P2361, DOI 10.1002/j.1460-2075.1990.tb07410.x; HEDNER U, 1989, METABOLIC BASIS INHE, P2107; HORNE MK, 1983, BLOOD, V63, P188; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; KLAPPER MH, 1977, BIOCHEM BIOPH RES CO, V78, P1018, DOI 10.1016/0006-291X(77)90523-X; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEBONNIEC BF, 1993, J BIOL CHEM, V268, P19055; LEBONNIEC BF, 1992, J BIOL CHEM, V267, P19341; LEBONNIEC BF, 1991, P NATL ACAD SCI USA, V88, P7371, DOI 10.1073/pnas.88.16.7371; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LIU LW, 1994, J BIOL CHEM, V269, P11807; LORAND L, 1992, THROMBIN STRUCTURE F, P257; Mann K.G.R., 1987, HEMOSTASIS THROMBOSI, P148; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MARAGANORE JM, 1989, J BIOL CHEM, V264, P8692; NOE G, 1988, J BIOL CHEM, V263, P11729; PABORSKY LR, 1993, J BIOL CHEM, V268, P20808; PADMANABHAN K, 1993, J BIOL CHEM, V268, P17651; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; ROSENBERG RD, 1987, MOL BASIS BLOOD DISE, P534; RYDEL TJ, 1990, SCIENCE, V249, P277, DOI 10.1126/science.2374926; SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518; SHEEHAN JP, 1993, J BIOL CHEM, V268, P3639; SKRZYPCZAKJANKUN E, 1991, J MOL BIOL, V221, P1379; STUBBS MT, 1993, SEMIN THROMB HEMOST, V19, P344, DOI 10.1055/s-2007-993285; STUBBS MT, 1992, EUR J BIOCHEM, V206, P187, DOI 10.1111/j.1432-1033.1992.tb16916.x; SUZUKI K, 1990, J BIOL CHEM, V265, P13263; SUZUKI K, 1991, J BIOL CHEM, V266, P18498; TSIANG M, 1992, J BIOL CHEM, V267, P6164; TSIANG M, 1990, BIOCHEMISTRY-US, V29, P10602, DOI 10.1021/bi00499a005; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WU QY, 1991, P NATL ACAD SCI USA, V88, P6775, DOI 10.1073/pnas.88.15.6775; WU QY, 1992, J BIOL CHEM, V267, P24408; YE J, 1994, J BIOL CHEM, V269, P17965	49	166	174	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16854	16863		10.1074/jbc.270.28.16854	http://dx.doi.org/10.1074/jbc.270.28.16854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622501	hybrid			2022-12-27	WOS:A1995RJ34700062
J	HERRMANN, JM; KOLL, H; COOK, RA; NEUPERT, W; STUART, RA				HERRMANN, JM; KOLL, H; COOK, RA; NEUPERT, W; STUART, RA			TOPOGENESIS OF CYTOCHROME-OXIDASE SUBUNIT II - MECHANISMS OF PROTEIN EXPORT FROM THE MITOCHONDRIAL MATRIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST NUCLEAR GENE; POSITIVELY CHARGED RESIDUES; C-OXIDASE; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; INTERMEMBRANE SPACE; TRANSLATION; EXPRESSION; COMPLEX; PRODUCT	Cytochrome c oxidase subunit II (COXII) in yeast mitochondria is synthesized as a precursor (preCOXII) and is sorted across the inner membrane, whereby both N and C termini become exposed to the intermembrane space. We describe here how this process can be experimentally dissected into a number of distinct stages. Our results demonstrate that the translation of COXII is not obligatorily coupled to translocation, Insertion into the inner membrane and export of the N and C-terminal domains require an energized inner membrane. The export of COXII is independent of both maturation by the Imp1p protease and assembly into the cytochrome c oxidase complex. When linked to a mitochondrial matrix-targeting sequence, the N terminal portion of preCOXII (fused to mouse dihydrofolate reductase) can be imported into the mitochondrial matrix. Following accumulation in the matrix, this chimeric protein can become exported across the inner membrane, delivering the N terminus into the intermembrane space where it undergoes processing by the Imp1p protease. This export process displays a number of similarities to bacterial protein export and supports the view that the principles of sorting are conserved from prokaryotes to eukaryotic organelles.			HERRMANN, JM (corresponding author), UNIV MUNICH,INST PHYSIOL CHEM,GOETHESTR 33,D-80336 MUNICH,GERMANY.							ACKERMAN SH, 1990, J BIOL CHEM, V265, P9952; ANDRE J., 1965, ARCH BIOL, V76, P277; BARANOWSKA H, 1983, CURR GENET, V7, P225, DOI 10.1007/BF00434894; BAUER M, 1994, MOL GEN GENET, V245, P272, DOI 10.1007/BF00290106; BISSON R, 1982, J BIOL CHEM, V257, P6716; BONNEFOY N, 1994, J MOL BIOL, V239, P201, DOI 10.1006/jmbi.1994.1363; BORST P, 1978, CELL, V15, P705, DOI 10.1016/0092-8674(78)90257-X; BOUSQUET I, 1991, EMBO J, V10, P2023, DOI 10.1002/j.1460-2075.1991.tb07732.x; BOYD D, 1990, CELL, V62, P1031, DOI 10.1016/0092-8674(90)90378-R; CHOMYN A, 1981, NUCLEIC ACIDS RES, V9, P867, DOI 10.1093/nar/9.4.867; CLARKSON GHD, 1989, J BIOL CHEM, V264, P10114; COSTANZO MC, 1990, ANNU REV GENET, V24, P91; COVELLO PS, 1992, EMBO J, V11, P3815, DOI 10.1002/j.1460-2075.1992.tb05473.x; DALBEY RE, 1990, TRENDS BIOCHEM SCI, V15, P253, DOI 10.1016/0968-0004(90)90047-F; DOWHAN W, 1985, EMBO J, V4, P179, DOI 10.1002/j.1460-2075.1985.tb02334.x; FUJIKI Y, 1982, J CELL BIOL, V93, P103, DOI 10.1083/jcb.93.1.103; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; GRUHLER A, 1995, EMBO J, V14, P1349, DOI 10.1002/j.1460-2075.1995.tb07121.x; Herrmann J. M., 1994, CELL BIOL LAB HDB, VI, P538; HERRMANN JM, 1994, J CELL BIOL, V127, P893, DOI 10.1083/jcb.127.4.893; KRAMER W, 1987, METHOD ENZYMOL, V154, P350; KRUMMECK G, 1990, CURR GENET, V18, P13, DOI 10.1007/BF00321109; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACINO G, 1983, J BIOL CHEM, V258, P3230; MASON TL, 1973, J BIOL CHEM, V248, P1355; MCKEE EE, 1984, J BIOL CHEM, V259, P9320; MICHAELIS U, 1991, MOL GEN GENET, V230, P177, DOI 10.1007/BF00290666; NICHOLSON DW, 1987, EUR J BIOCHEM, V164, P147, DOI 10.1111/j.1432-1033.1987.tb11006.x; NOBREGA MP, 1990, J BIOL CHEM, V265, P14220; NUGENT JM, 1991, CELL, V66, P473, DOI 10.1016/0092-8674(81)90011-8; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PAJIC A, 1994, FEBS LETT, V353, P201, DOI 10.1016/0014-5793(94)01046-3; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; PFANNER N, 1987, EUR J BIOCHEM, V169, P289, DOI 10.1111/j.1432-1033.1987.tb13610.x; Poyton Robert O., 1992, Trends in Cell Biology, V2, P369, DOI 10.1016/0962-8924(92)90049-S; PRATJE E, 1983, EMBO J, V2, P1049, DOI 10.1002/j.1460-2075.1983.tb01544.x; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SCHULZE M, 1988, MOL GEN GENET, V211, P492, DOI 10.1007/BF00425706; SCHWARZ E, 1993, EMBO J, V12, P2295, DOI 10.1002/j.1460-2075.1993.tb05883.x; SEVERINO KA, 1980, P NATL ACAD SCI USA, V77, P142; STEFFENS GCM, 1979, H-S Z PHYSIOL CHEM, V360, P1633, DOI 10.1515/bchm2.1979.360.2.1633; TZAGOLOFF A, 1990, EMBO J, V9, P2759, DOI 10.1002/j.1460-2075.1990.tb07463.x; TZAGOLOFF A, 1986, ANNU REV BIOCHEM, V55, P249, DOI 10.1146/annurev.bi.55.070186.001341; VIGNAIS PV, 1969, FEBS LETT, V3, P177, DOI 10.1016/0014-5793(69)80128-6; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WATSON K, 1972, J CELL BIOL, V55, P721, DOI 10.1083/jcb.55.3.721; WHITLEY P, 1994, EMBO J, V13, P4653, DOI 10.1002/j.1460-2075.1994.tb06788.x	47	61	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27079	27086		10.1074/jbc.270.45.27079	http://dx.doi.org/10.1074/jbc.270.45.27079			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592959	hybrid			2022-12-27	WOS:A1995TE58300059
J	PUSHPAREKHA, TR; BURDSALL, AL; OLEKSA, LM; CHISOLM, GM; DRISCOLL, DM				PUSHPAREKHA, TR; BURDSALL, AL; OLEKSA, LM; CHISOLM, GM; DRISCOLL, DM			RAT PHOSPHOLIPID-HYDROPEROXIDE GLUTATHIONE-PEROXIDASE - CDNA CLONING AND IDENTIFICATION OF MULTIPLE TRANSCRIPTION AND TRANSLATION START SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASES; MESSENGER-RNA; CHOLESTEROL HYDROPEROXIDES; SACCHAROMYCES-CEREVISIAE; NEUROSPORA-CRASSA; SIGNAL PEPTIDE; GENE ENCODES; MITOCHONDRIAL; SEQUENCES; TESTIS	Phospholipid-hydroperoxide glutathione peroxidase (PhGPx) is a selenoenzyme that reduces hydroperoxides of phospholipid, cholesterol, and cholesteryl ester, Previous studies suggested that both the mitochondrial and nonmitochondrial forms of PhGPx are similar to 170 amino acids long, In this study, we isolated a full-length cDNA clone encoding rat testis PhGPx, Based on sequence analysis, the cDNA encodes a protein of 197 amino acids, with translation initiating at AUG(61). The additional 27 amino acids at the N terminus contain the features of a mitochondrial targeting sequence. In vitro translation of the full-length PhGPx mRNA initiated predominantly at AUG(61). However, translation initiated at AUG(141) when AUG(61) was deleted, An RNase protection assay was used to map the 5'-ends of PhGPx mRNAs in rat tissues, We identified two major windows of transcription initiation that are tissue specific. Rat testis predominantly expresses larger transcripts that encode the 197-amino acid protein containing the potential mitochondrial targeting signal, The predominant smaller transcripts in somatic tissues lack AUG(61) and encode a 170-amino acid protein, which may represent the nonmitochondrial forms of PhGPx, Our results suggest that the use of alternative transcription and translation start sites determines the subcellular localization of PhGPx in different tissues.	CLEVELAND CLIN FDN,DEPT CELL BIOL,CLEVELAND,OH 44195	Cleveland Clinic Foundation					NHLBI NIH HHS [HL29582] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BELTZER JP, 1988, J BIOL CHEM, V263, P368; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; BRIGELIUS-FLOHE R, 1994, J BIOL CHEM, V269, P7342; CHAMBERS JS, 1995, INT J BIOCHEM, V26, P1279; CHATTON B, 1988, J BIOL CHEM, V263, P52; CHISOLM GM, 1994, P NATL ACAD SCI USA, V91, P11452, DOI 10.1073/pnas.91.24.11452; CHU FF, 1994, CYTOGENET CELL GENET, V66, P96, DOI 10.1159/000133675; COOPER AJ, 1992, GENE, V114, P145; DIHANICH ME, 1987, MOL CELL BIOL, V7, P177, DOI 10.1128/MCB.7.1.177; DRISCOLL DM, 1993, MOL CELL BIOL, V13, P7288, DOI 10.1128/MCB.13.12.7288; ELLIS SR, 1989, MOL CELL BIOL, V9, P1611, DOI 10.1128/MCB.9.4.1611; ESWORTHY RS, 1994, GENE, V144, P317, DOI 10.1016/0378-1119(94)90400-6; FARRES J, 1988, BIOCHEM BIOPH RES CO, V150, P1083, DOI 10.1016/0006-291X(88)90740-1; FLOHE L, 1989, COENZYME COFACTORS; GODEAS C, 1994, BBA-BIOMEMBRANES, V1191, P147, DOI 10.1016/0005-2736(94)90242-9; HAKE LE, 1993, J BIOL CHEM, V268, P4788; HARTL FU, 1987, CELL, V51, P1027, DOI 10.1016/0092-8674(87)90589-7; HOWARD TE, 1990, MOL CELL BIOL, V10, P4294, DOI 10.1128/MCB.10.8.4294; JAEGER JA, 1989, P NATL ACAD SCI USA, V86, P7706, DOI 10.1073/pnas.86.20.7706; KILPATRICK DL, 1990, MOL CELL BIOL, V10, P3717, DOI 10.1128/MCB.10.7.3717; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KOZAK M, 1990, ANN REV CELL BIOL, V8, P197; KUBELIK AR, 1991, MOL CELL BIOL, V11, P4022, DOI 10.1128/MCB.11.8.4022; MAIORINO M, 1991, J BIOL CHEM, V266, P7728; MAIORINO M, 1990, METHOD ENZYMOL, V186, P448; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; ODA T, 1990, J BIOL CHEM, V265, P7513; ROVERI A, 1994, METHOD ENZYMOL, V233, P202; ROVERI A, 1994, BBA-PROTEIN STRUCT M, V1208, P211, DOI 10.1016/0167-4838(94)90106-6; ROVERI A, 1992, J BIOL CHEM, V267, P6142; Sambrook J, 1989, MOL CLONING LABORATO; SCHUCKELT R, 1991, FREE RADICAL RES COM, V14, P343, DOI 10.3109/10715769109093424; SHEN QC, 1993, J BIOL CHEM, V268, P11463; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; SUNDE RA, 1993, BIOCHEM BIOPH RES CO, V193, P905, DOI 10.1006/bbrc.1993.1711; TAHARA SM, 1991, J BIOL CHEM, V266, P3594; TERUYA JH, 1990, MOL CELL BIOL, V10, P2315, DOI 10.1128/MCB.10.5.2315; THOMAS JP, 1990, J BIOL CHEM, V265, P454; THOMAS JP, 1990, BIOCHIM BIOPHYS ACTA, V1045, P252, DOI 10.1016/0005-2760(90)90128-K; TOUSSAINT C, 1994, J BIOL CHEM, V269, P13318; TROPSCHUG M, 1988, J BIOL CHEM, V263, P14433; URSINI F, 1982, BIOCHIM BIOPHYS ACTA, V710, P197, DOI 10.1016/0005-2760(82)90150-3; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V339, P62; VILLASANTE A, 1986, MOL CELL BIOL, V6, P2409, DOI 10.1128/MCB.6.7.2409; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x	46	162	167	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26993	26999		10.1074/jbc.270.45.26993	http://dx.doi.org/10.1074/jbc.270.45.26993			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592947	hybrid			2022-12-27	WOS:A1995TE58300047
J	CUSACK, B; MCCORMICK, DJ; PANG, YP; SOUDER, T; GARCIA, R; FAUQ, A; RICHELSON, E				CUSACK, B; MCCORMICK, DJ; PANG, YP; SOUDER, T; GARCIA, R; FAUQ, A; RICHELSON, E			PHARMACOLOGICAL AND BIOCHEMICAL PROFILES OF UNIQUE NEUROTENSIN-8-13 ANALOGS EXHIBITING SPECIES SELECTIVITY, STEREOSELECTIVITY, AND SUPERAGONISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLASTOMA CLONE N1E-115; HYPOTHALAMIC PEPTIDE; ALZHEIMERS-DISEASE; CYCLIC-GMP; RECEPTOR; BINDING; EXPRESSION; BRAIN	Recently, the rat neurotensin receptor and the two human neurotensin receptor clones (differing by one amino acid residue) have been isolated. We present results with 33 newly synthesized neurotensin analogs. We have evaluated their binding potency at the three neurotensin receptor clones by determining equilibrium dissociation constants and coupling to phosphatidylinositol turnover. Our work focused on position 8 and 9 substitutions as well as position 11 of the neurotensin hexamer NT8-13. The results presented include: 1) the development of a compound that is species selective, with a binding potency at the rat receptor that is 20-fold more potent than at the human receptor; 2) the development of a pair of stereoselective compounds with the L-isomer exhibiting 190-700-fold more potency than the D isomer; and 3) the development of an agonist that has a K-d of 0.3 and 0.2 nM at the human and rat neurotensin receptor, respectively, ranking it as among the most potent tested. Also, we present the first evidence that 1) the effect of pi electrons at position 11 (L-Tyr) are important for binding to the neurotensin receptor, and 2) the length of the side chain on position 9 (L-Arg) changes binding potency.	MAYO CLIN & MAYO FDN,MAYO PROT CARE FACIL,ROCHESTER,MN 55905; MAYO FDN MED EDUC & RES,NEUROCHEM RES,JACKSONVILLE,FL 32224; MAYO FDN MED EDUC & RES,NEUROPSYCHOPHARMACOL,JACKSONVILLE,FL 32224	Mayo Clinic; Mayo Clinic; Mayo Clinic			Cusack, Bernadette/D-4606-2013; Richelson, Elliott/A-9407-2012		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH027692] Funding Source: NIH RePORTER; NIMH NIH HHS [MH27692] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALRHODAN NRF, 1991, BRAIN RES, V557, P227; BENZING WC, 1990, BRAIN RES, V537, P298, DOI 10.1016/0006-8993(90)90372-I; BISSETTE G, 1985, ANN NEUROL, V17, P324, DOI 10.1002/ana.410170403; BISSETTE G, 1976, NATURE, V262, P607, DOI 10.1038/262607a0; CAIN ST, 1992, REGUL PEPTIDES, V39, P55, DOI 10.1016/0167-0115(92)90008-I; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; CARRAWAY R, 1975, PEPTIDES CHEM STRUCT; CLINESCHMIDT BV, 1977, EUR J PHARMACOL, V45, P395; CUSACK B, 1991, EUR J PHARM-MOLEC PH, V206, P339, DOI 10.1016/0922-4106(91)90119-3; CUSACK B, 1993, J RECEPTOR RES, V13, P123, DOI 10.3109/10799899309073650; DELEAN A, 1982, MOL PHARMACOL, V21, P5; DUBUC I, 1994, BRIT J PHARMACOL, V112, P352, DOI 10.1111/j.1476-5381.1994.tb13077.x; FLEMING WW, 1972, J PHARMACOL-PARIS, V181, P339; GILBERT JA, 1989, BIOCHEM PHARMACOL, V38, P3377, DOI 10.1016/0006-2952(89)90637-0; GILBERT JA, 1984, EUR J PHARMACOL, V99, P245, DOI 10.1016/0014-2999(84)90248-6; GOEDERT M, 1984, BRAIN RES, V323, P193, DOI 10.1016/0006-8993(84)90288-9; GULLY D, 1993, P NATL ACAD SCI USA, V90, P65, DOI 10.1073/pnas.90.1.65; JOLICOEUR FB, 1981, PEPTIDES, V2, P171, DOI 10.1016/S0196-9781(81)80031-9; KAO HT, 1992, FEBS LETT, V307, P324, DOI 10.1016/0014-5793(92)80705-L; KITABGI P, 1980, MOL PHARMACOL, V18, P11; LABBEJULLIE C, 1994, J PHARMACOL EXP THER, V268, P328; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MORBECK DE, 1993, METHODS COMPANION ME, V6; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NEMEROFF CB, 1977, BRAIN RES, V128, P485, DOI 10.1016/0006-8993(77)90173-1; NEMEROFF CB, 1979, P NATL ACAD SCI USA, V76, P5368, DOI 10.1073/pnas.76.10.5368; NEMEROFF CB, 1989, REGUL PEPTIDES, V25, P123, DOI 10.1016/0167-0115(89)90254-1; OSBAHR AJ, 1979, EUR J PHARMACOL, V54, P299, DOI 10.1016/0014-2999(79)90090-6; PFENNING MA, 1990, METHODS NEUROTRANSMI; QUIRION R, 1980, EUR J PHARMACOL, V66, P257, DOI 10.1016/0014-2999(80)90457-4; SHI WX, 1992, J NEUROSCI, V12, P2433; SNIDJERS R, 1982, NEUROPHARMACOLOGY, V21, P465; Tallarida RJ, 1986, MANUAL PHARM CALCULA; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; VITA N, 1993, FEBS LETT, V317, P139, DOI 10.1016/0014-5793(93)81509-X; WATSON M, 1993, MAYO CLIN PROC, V68, P1043, DOI 10.1016/S0025-6196(12)60896-9; WIDERLOV E, 1982, AM J PSYCHIAT, V139, P1122	37	45	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18359	18366		10.1074/jbc.270.31.18359	http://dx.doi.org/10.1074/jbc.270.31.18359			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629159	hybrid			2022-12-27	WOS:A1995RM64200035
J	CHOI, SG; ODONNELL, SE; SARKEN, KD; HARDMAN, JK				CHOI, SG; ODONNELL, SE; SARKEN, KD; HARDMAN, JK			TRYPTOPHAN-CONTAINING ALPHA-SUBUNITS OF THE ESCHERICHIA-COLI TRYPTOPHAN SYNTHASE - ENZYMATIC AND UREA STABILITY PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANIDINE-HYDROCHLORIDE; DENATURATION; INTERMEDIATE	Early studies suggested that the Escherichia coli tryptophan synthase alpha-subunit unfolded in a two-step process in which there was a stable intermediate composed of a native alpha-1 folding unit (residues 1-188) and a completely unfolded alpha-2 folding unit (residues 189-268). More recent evidence has indicated that such a structure for the intermediate seems unlikely. In this report, single Trp residues (absent in the wild-type alpha-subunit) are substituted separately for Phe residues at positions 139 (in alpha-1) and 258 (in alpha-2) to produce the F139W, F258W, and F139W/F258W mutant alpha-subunits. The UV absorbance and fluorescence properties of the F139W/F258W double mutant are identical with those of equimolar mixtures of the single mutants, suggesting that the Trp residue at each position can independently report the behavior of its respective folding unit. Each mutant alpha-subunit is wild-type enzymatically, and when UV absorbance is monitored, the urea induced unfolding of the three tryptophan-containing alpha-subunits is virtually identical to the wild-type protein. These wild-type properties make these proteins attractive candidates for a fluorescence examination of the behavior of the individual folding units and the structure of potential intermediate(s) and as host proteins for the insertion of our existing destabilizing and/or stabilizing mutational alterations.	UNIV ALABAMA,DEPT BIOL SCI,CELL & DEV SECT,TUSCALOOSA,AL 35487; UNIV MONTEVALLO,DEPT BIOL & CHEM,MONTEVALLO,AL 35115	University of Alabama System; University of Alabama Tuscaloosa								BEASTY AM, 1986, BIOCHEMISTRY-US, V25, P2965, DOI 10.1021/bi00358a035; BEASTY AM, 1985, BIOCHEMISTRY-US, V24, P3547, DOI 10.1021/bi00335a024; CHEN XW, 1994, BIOCHEMISTRY-US, V33, P6356, DOI 10.1021/bi00186a040; CHRUNYK BA, 1990, BIOCHEMISTRY-US, V29, P2149, DOI 10.1021/bi00460a027; CRISANTI MM, 1981, BIOCHEMISTRY-US, V20, P2700, DOI 10.1021/bi00512a052; CUPO JF, 1983, BIOCHEMISTRY-US, V22, P2654, DOI 10.1021/bi00280a010; FABER GK, 1980, TRENDS BIOCHEM SCI, V15, P228; FAEDER EJ, 1970, BIOCHEMISTRY-US, V9, P4043, DOI 10.1021/bi00823a003; HURLE MR, 1987, BIOCHIM BIOPHYS ACTA, V913, P179, DOI 10.1016/0167-4838(87)90328-1; HURLE MR, 1987, PROTEINS, V2, P54, DOI 10.1002/prot.340020107; HYDE CC, 1988, J BIOL CHEM, V263, P17857; IWAHASHI H, 1983, BIOCHIM BIOPHYS ACTA, V744, P189, DOI 10.1016/0167-4838(83)90089-4; LEGGETTBAILEY J, 1962, TECHNIQUES PROTEIN C, P249; LIM WK, 1991, J BIOL CHEM, V266, P20205; LIM WK, 1992, ARCH BIOCHEM BIOPHYS, V292, P34, DOI 10.1016/0003-9861(92)90047-Z; MATTHEWS CR, 1981, BIOCHEMISTRY-US, V20, P784, DOI 10.1021/bi00507a021; MILES EW, 1982, BIOCHEMISTRY-US, V21, P2586, DOI 10.1021/bi00540a002; MILES EW, 1978, J BIOL CHEM, V253, P6266; MILTON DL, 1986, J BIOL CHEM, V261, P6604; OGASAHARA K, 1994, J MOL BIOL, V236, P1227, DOI 10.1016/0022-2836(94)90023-X; OGASAHARA K, 1993, J MOL BIOL, V234, P1197, DOI 10.1006/jmbi.1993.1670; Pace C N, 1986, Methods Enzymol, V131, P266; PRESS WH, 1986, NUMERICAL RECIPES AR; SAABRINCON G, 1993, BIOCHEMISTRY-US, V32, P13981, DOI 10.1021/bi00213a031; SARKER KD, 1995, PROTEINS, V21, P130, DOI 10.1002/prot.340210207; TSUJI T, 1993, BIOCHEMISTRY-US, V32, P5566, DOI 10.1021/bi00072a011; YUTANI K, 1979, J BIOCHEM-TOKYO, V85, P915, DOI 10.1093/oxfordjournals.jbchem.a132423	27	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17712	17715		10.1074/jbc.270.30.17712	http://dx.doi.org/10.1074/jbc.270.30.17712			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629069	hybrid			2022-12-27	WOS:A1995RM26600015
J	VOLIOVITCH, H; SCHINDLER, DG; HADARI, YR; TAYLOR, SI; ACCILI, D; ZICK, Y				VOLIOVITCH, H; SCHINDLER, DG; HADARI, YR; TAYLOR, SI; ACCILI, D; ZICK, Y			TYROSINE PHOSPHORYLATION OF INSULIN-RECEPTOR SUBSTRATE-1 IN-VIVO DEPENDS UPON THE PRESENCE OF ITS PLECKSTRIN HOMOLOGY REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3'-KINASE; SIGNAL TRANSDUCTION; PROTEIN-KINASE; PH DOMAIN; IRS-1; CELLS; ASSOCIATION; ACTIVATION; ANTIBODIES; EXPRESSION	To characterize the structural basis for the interactions between the insulin receptor (IR) and its major substrate, insulin receptor substrate-1 (IRS-1), a segment of the NH2-terminal region of IRS-1 (Pro(5)-Pro(65)) was deleted. This region contains the first four conserved boxes of a pleckstrin homology (PH) domain, located at the NH2-terminal part of IRS-1. COS-7 cells were then cotransfected with the genes coding for IR and a wild-type (WT) or a mutated form of IRS-1. IRS-1(Delta PH) underwent significantly reduced insulin-dependent tyrosine phosphorylation compared with WT IRS-1. The reduced in. vivo tyrosine phosphorylation of IRS-1(Delta PH) was accompanied by reduced association between IRS-1(Delta PH) and its downstream effector p85 regulatory subunit of phosphatidylinositol-3 kinase. In contrast, both WT IRS-1 and IRS-1(Delta PH) underwent comparable in insulin-dependent tyrosine phosphorylation in vitro when incubated with partially purified insulin receptor ki nase. These findings suggest that the overall structure of IRS-1 is not altered by deletion of its PH domain and that the PR domain is not the main site for protein-protein interactions between the insulin receptor and IRS-1, at least in vitro. In conclusion, the PH region might facilitate in vivo binding of IRS-1 to membrane phospholipids or other cellular constituents in close proximity to the IR, whereas the actual interactions with the IR are presumably mediated through other domains of the IRS-1 molecule. This could account for the fact that partial deletion of the PH domain selectively impairs the in vivo interactions between the insulin receptor and IRS-1, whereas their in vitro interactions remain unaffected.	WEIZMANN INST SCI, DEPT CHEM IMMUNOL, IL-76100 REHOVOT, ISRAEL; NIH, DIABET BRANCH, BETHESDA, MD 20982 USA	Weizmann Institute of Science; National Institutes of Health (NIH) - USA			Zick, Yehiel/K-1479-2012					ARAKI E, 1993, DIABETES, V42, P1041, DOI 10.2337/diabetes.42.7.1041; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BALTENSPERGER K, 1993, SCIENCE, V260, P1950, DOI 10.1126/science.8391166; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; HADARI YR, 1992, J BIOL CHEM, V267, P17483; HADARI YR, 1993, MOL CELL ENDOCRINOL, V97, P9, DOI 10.1016/0303-7207(93)90206-Y; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HASLAM RJ, 1993, NATURE, V363, P309, DOI 10.1038/363309b0; HEFFETZ D, 1991, METHOD ENZYMOL, V201, P44; HEFFETZ D, 1990, J BIOL CHEM, V265, P2896; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MACIAS MJ, 1994, NATURE, V369, P675, DOI 10.1038/369675a0; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; MUSACCHIO A, 1992, NATURE, V359, P851, DOI 10.1038/359851a0; MYERS MG, 1994, TRENDS BIOCHEM SCI, V19, P289, DOI 10.1016/0968-0004(94)90007-8; ONEILL TJ, 1994, MOL CELL BIOL, V14, P6433, DOI 10.1128/MCB.14.10.6433; PRONK GJ, 1993, J BIOL CHEM, V268, P5748; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RUSSELL DS, 1987, J BIOL CHEM, V262, P11833; Sambrook J, 1989, MOL CLONING LABORATO; SHAW G, 1993, BIOCHEM BIOPH RES CO, V195, P1145, DOI 10.1006/bbrc.1993.2164; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; SUN XJ, 1992, J BIOL CHEM, V267, P22662; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; TAVARE JM, 1993, BIOCHIM BIOPHYS ACTA, V1178, P21, DOI 10.1016/0167-4889(93)90106-Y; TAYLOR SI, 1991, INSULIN LIKE GROWTH, P221; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; TYERS M, 1988, NATURE, V333, P470, DOI 10.1038/333470a0; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; WATERS SB, 1993, J BIOL CHEM, V268, P22231; WHITE MF, 1994, CURR OPIN GENET DEV, V4, P47, DOI 10.1016/0959-437X(94)90090-6; WHITE MF, 1994, J BIOL CHEM, V269, P1; WILDEN PA, 1992, J BIOL CHEM, V267, P13719; YOON HS, 1994, NATURE, V369, P672, DOI 10.1038/369672a0; ZICK Y, 1983, J BIOL CHEM, V258, P75; ZICK Y, 1989, CRIT REV BIOCHEM MOL, V24, P217, DOI 10.3109/10409238909082554; ZICK Y, 1983, J BIOL CHEM, V258, P3431	44	87	87	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18083	18087		10.1074/jbc.270.30.18083	http://dx.doi.org/10.1074/jbc.270.30.18083			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629118	hybrid			2022-12-27	WOS:A1995RM26600069
J	WANG, CC; MORIYAMA, R; LOMBARDO, CR; LOW, PS				WANG, CC; MORIYAMA, R; LOMBARDO, CR; LOW, PS			PARTIAL CHARACTERIZATION OF THE CYTOPLASMIC DOMAIN OF HUMAN KIDNEY BAND-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ERYTHROCYTE-MEMBRANE; ANION-TRANSPORT PROTEIN; ANKYRIN-BINDING SITE; RED-CELL MEMBRANE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; INTERCALATED CELLS; COLLECTING DUCT; RAT-KIDNEY; TYROSINE PHOSPHORYLATION; PLASMA-MEMBRANE	The major anion exchanger in type A intercalated cells of the cortical and medullary collecting ducts of the human kidney is a truncated isoform of erythrocyte band 3 (AE1) that lacks the N-terminal 65 residues. Because this missing sequence has been implicated in the binding of ankyrin, protein 4.1, several glycolytic enzymes, hemoglobin, and hemichromes in erythrocytes, we have undertaken examination of the structure and peripheral protein interactions of this kidney isoform. The cytoplasmic domain of kidney band 3, kidney CDB3, was expressed in Escherichia coli and purified to homogeneity. The kidney isoform exhibited a circular dichroism spectrum and Stokes radius similar to its larger erythrocyte counterpart. Kidney CDB3 was also observed to engage in the same conformational equilibrium characteristic of erythrocyte CDB3. In contrast, the tryptophan and cysteine clusters of kidney CDB3 behaved very differently from erythrocyte CDB3 in response to pH changes and oxidizing conditions. Furthermore, kidney CDB3 did not bind ankyrin, protein 4.1, or aldolase, and expression of erythrocyte CDB3 was toxic to its bacterial host, whereas expression of kidney CDB3 was not. Taken together, these data suggest that the absence of the N-terminal 65 amino acids in kidney CDB3 eliminates the major function currently ascribed to CDB3 in erythrocytes, i.e. that of peripheral protein binding. The primary function of residues 66-379 found in kidney CDB3 thus remains to be elucidated.	PURDUE UNIV,DEPT CHEM,W LAFAYETTE,IN 47907	Purdue University System; Purdue University; Purdue University West Lafayette Campus				Low, Philip/0000-0001-9042-5528	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024417, R37GM024417] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24417] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALPER SL, 1991, ANNU REV PHYSIOL, V53, P549, DOI 10.1146/annurev.physiol.53.1.549; ALPER SL, 1989, P NATL ACAD SCI USA, V86, P5429, DOI 10.1073/pnas.86.14.5429; APPELL KC, 1981, J BIOL CHEM, V256, P1104; BENNETT V, 1980, J BIOL CHEM, V255, P6424; BENNETT V, 1979, NATURE, V280, P468, DOI 10.1038/280468a0; BENNETT V, 1992, J BIOL CHEM, V267, P8703; BROSIUS FC, 1989, J BIOL CHEM, V264, P7784; CASEY JR, 1991, J BIOL CHEM, V266, P15726; DANILOV YN, 1990, J BIOL CHEM, V265, P2556; DAVIS L, 1989, J BIOL CHEM, V264, P9665; DING Y, 1995, J BIOL CHEM, V269, P32201; DRENCKHAHN D, 1985, SCIENCE, V230, P1287, DOI 10.1126/science.2933809; DUBENDORFF JW, 1991, J MOL BIOL, V219, P45, DOI 10.1016/0022-2836(91)90856-2; ERCOLANI L, 1992, AM J PHYSIOL, V262, pF892, DOI 10.1152/ajprenal.1992.262.5.F892; HARGREAVES WR, 1980, J BIOL CHEM, V255, P1965; HARRISON ML, 1991, J BIOL CHEM, V266, P4106; IDEGUCHI H, 1992, BRIT J HAEMATOL, V82, P122, DOI 10.1111/j.1365-2141.1992.tb04603.x; JENKINS JD, 1984, J BIOL CHEM, V259, P9374; JONS T, 1992, EMBO J, V11, P2863, DOI 10.1002/j.1460-2075.1992.tb05354.x; KLIMAN HJ, 1980, J BIOL CHEM, V255, P6314; KOLLERTJONS A, 1993, AM J PHYSIOL, V265, pF813, DOI 10.1152/ajprenal.1993.265.6.F813; Kopito R R, 1990, Int Rev Cytol, V123, P177, DOI 10.1016/S0074-7696(08)60674-9; KOPITO RR, 1987, P NATL ACAD SCI USA, V84, P7149, DOI 10.1073/pnas.84.20.7149; KORSGREN C, 1986, J BIOL CHEM, V261, P5536; KUDRYCKI KE, 1990, J BIOL CHEM, V265, P462; KUDRYCKI KE, 1989, J BIOL CHEM, V264, P8185; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOMBARDO CR, 1992, J BIOL CHEM, V267, P9540; LOW PS, 1987, J BIOL CHEM, V262, P4592; LOW PS, 1986, BIOCHIM BIOPHYS ACTA, V864, P145, DOI 10.1016/0304-4157(86)90009-2; LOW PS, 1984, J BIOL CHEM, V259, P3070; LOW PS, 1991, BLOOD, V77, P1581; LOW PS, 1993, J BIOL CHEM, V268, P14627; LUX SE, 1989, P NATL ACAD SCI USA, V86, P9089, DOI 10.1073/pnas.86.23.9089; MADSEN KM, 1992, AM J PHYSIOL, V262, pF1015, DOI 10.1152/ajprenal.1992.262.6.F1015; MURONETZ VI, 1994, ARCH BIOCHEM BIOPHYS, V313, P253, DOI 10.1006/abbi.1994.1385; MURTHY SNP, 1981, J BIOL CHEM, V256, P1203; MURTHY SNP, 1984, H-S Z PHYSIOL CHEM, V365, P9, DOI 10.1515/bchm2.1984.365.1.9; NELSON WJ, 1990, J CELL BIOL, V110, P349, DOI 10.1083/jcb.110.2.349; OSTEDGAARD LS, 1991, P NATL ACAD SCI USA, V88, P981, DOI 10.1073/pnas.88.3.981; REITHMEIER RAF, 1979, J BIOL CHEM, V254, P3054; REITHMEIER RAF, 1979, J BIOL CHEM, V254, P6151; ROGALSKI AA, 1989, J BIOL CHEM, V264, P6438; RYBICKI AC, 1993, BLOOD, V81, P2155; SCHOFIELD AE, 1994, BLOOD, V84, P2000; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TANNER MJA, 1993, SEMIN HEMATOL, V30, P34; TANNER MJA, 1988, BIOCHEM J, V256, P703, DOI 10.1042/bj2560703; THEVENIN BJM, 1990, J BIOL CHEM, V265, P16166; THEVENIN BJM, 1989, J BIOL CHEM, V264, P15886; TSAI IH, 1982, J BIOL CHEM, V257, P1438; VERLANDER JW, 1988, AM J PHYSIOL, V255, pF115, DOI 10.1152/ajprenal.1988.255.1.F115; WAGNER S, 1987, AM J PHYSIOL, V253, pF213, DOI 10.1152/ajprenal.1987.253.2.F213; WALDER JA, 1984, J BIOL CHEM, V259, P238; WANG CC, 1992, PROTEIN SCI, V1, P1206, DOI 10.1002/pro.5560010913; WAUGH SM, 1985, BIOCHEMISTRY-US, V24, P34, DOI 10.1021/bi00322a006; WILLARDSON BM, 1989, J BIOL CHEM, V264, P15893	57	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17892	17897		10.1074/jbc.270.30.17892	http://dx.doi.org/10.1074/jbc.270.30.17892			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629093	hybrid			2022-12-27	WOS:A1995RM26600041
J	ADAM, D; KESSLER, U; KRONKE, M				ADAM, D; KESSLER, U; KRONKE, M			CROSS-LINKING OF THE P55 TUMOR-NECROSIS-FACTOR RECEPTOR CYTOPLASMIC DOMAIN BY A DIMERIC LIGAND INDUCES NUCLEAR FACTOR-KAPPA-B AND MEDIATES CELL-DEATH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; FACTOR TNF RECEPTOR; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; FACTOR-BINDING; FACTOR-ALPHA; EXPRESSION; ACTIVATION; FORM; INTERLEUKIN-2	We have fused the cytoplasmic domain of the p55 tumor necrosis factor (TNF) receptor to the extracellular and transmembrane domain of the mouse platelet-derived growth factor (PDGF) receptor. Mouse mammary gland epithelial (NMuMG;) cells were stably transfected with the PDGFR-TR55 chimeric receptor. These cells lack endogenous PDGF receptor expression and do not respond to PDGF. In the PDGFR-TR55 transfectants, PDGF elicited a cytotoxic response, which is indistinguishable from that induced by the wild type p55 TNF receptor. In addition, PDGF-induced activation of the PDGFR-TR55 chimeric receptor resulted in nuclear translocation of NF-kappa B. The data presented suggest that cross-linking of the p55 TNF receptor cytoplasmic domain by a dimeric ligand such as PDGF is sufficient to generate cellular responses that do not differ from those observed with the trimeric ligand TNF.	TECH UNIV MUNICH,INST MED MIKROBIOL & HYG,TROGERSTR 32,D-81675 MUNICH,GERMANY	Technical University of Munich	ADAM, D (corresponding author), CHRISTIAN ALBRECHTS UNIV KIEL,INST IMMUNOL,BRUNSWIKER STR 4,D-24105 KIEL,GERMANY.		Adam, Dieter/E-9763-2010	Adam, Dieter/0000-0002-5668-5032				ADAM D, 1993, J BIOL CHEM, V268, P19882; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BELKA K, 1995, EMBO J, V14, P1156; BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; BISHAYEE S, 1989, J BIOL CHEM, V264, P11699; BOLDIN MP, 1994, J BIOL CHEM, V2700, P387; BRAKEBUSCH C, 1992, EMBO J, V11, P943, DOI 10.1002/j.1460-2075.1992.tb05133.x; CLEMENT MV, 1994, J EXP MED, V180, P557, DOI 10.1084/jem.180.2.557; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; ECK MJ, 1992, J BIOL CHEM, V267, P2119; ENGELMANN H, 1990, J BIOL CHEM, V265, P14497; ESPEVIK T, 1990, J EXP MED, V171, P415, DOI 10.1084/jem.171.2.415; FIERS W, 1991, FEBS LETT, V285, P199, DOI 10.1016/0014-5793(91)80803-B; GOEDDEL DV, 1986, COLD SPRING HARB SYM, V51, P597, DOI 10.1101/SQB.1986.051.01.072; GOODWIN RG, 1991, MOL CELL BIOL, V11, P3020, DOI 10.1128/MCB.11.6.3020; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HELDIN CH, 1989, TRENDS GENET, V5, P108, DOI 10.1016/0168-9525(89)90040-1; HIMMLER A, 1990, DNA CELL BIOL, V9, P705, DOI 10.1089/dna.1990.9.705; JONES EY, 1989, NATURE, V338, P225, DOI 10.1038/338225a0; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KRUPPA G, 1992, J IMMUNOL, V148, P3152; LEWIS M, 1991, P NATL ACAD SCI USA, V88, P2830, DOI 10.1073/pnas.88.7.2830; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; LOWENTHAL JW, 1989, P NATL ACAD SCI USA, V86, P2331, DOI 10.1073/pnas.86.7.2331; MATHIAS S, 1993, SCIENCE, V259, P519, DOI 10.1126/science.8424175; OLD LJ, 1988, SCI AM, V258, P59, DOI 10.1038/scientificamerican0588-59; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; OWENS RB, 1974, J NATL CANCER I, V53, P261, DOI 10.1093/jnci/53.1.261; PERKINS ND, 1991, P NATL ACAD SCI USA, V89, P1529; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; SMITH RA, 1987, J BIOL CHEM, V262, P6951; TARTAGLIA LA, 1992, J BIOL CHEM, V267, P4304; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; WIEGMANN K, 1992, J BIOL CHEM, V267, P17997; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; WILLIAMS LT, 1984, J BIOL CHEM, V259, P5287	40	23	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17482	17487						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615552				2022-12-27	WOS:A1995RK68900067
J	ALMLOF, T; WRIGHT, APH; GUSTAFSSON, JA				ALMLOF, T; WRIGHT, APH; GUSTAFSSON, JA			ROLE OF ACIDIC AND PHOSPHORYLATED RESIDUES IN GENE ACTIVATION BY THE GLUCOCORTICOID RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; TRANSACTIVATION DOMAIN; YEAST; PROTEINS; SUPERFAMILY; EXPRESSION; BINDING; CELLS; SITES; GAL4	To investigate the role of acidic and phosphorylated amino acids in the function of the major transactivation domain (tau(1)) of the glucocorticoid receptor, we have performed a mutagenesis study. Aspartic and glutamic acid residues were neutralized in clusters of 2 to 4 amino acids throughout the tau(1) domain. The activity of the mutant proteins was determined using transactivation as says in yeast and mammalian cells. Some acidic residues in the core region of tau(1) appear to play a minor role in tau(1) activity, but, generally, individual acidic residues are not critical for activity. Mutagenesis of five serine residues that are phosphorylated in the mouse glucocorticoid receptor and which are conserved in the human receptor did not affect the transactivation activity of the tau(1) domain in yeast. As in mouse cells, these serine residues are the predominant sites of phosphorylation for ectopically expressed receptor in yeast, since the mutant protein lacking all five sites had a severely reduced phosphorylation level. Mutant proteins in which larger numbers of acidic residues are neutralized show a progressive decrease in activity indicating that acidity in general is important for tau(1) function. However, our results are not consistent with the ''acid blob'' theory of transactivator function that has been suggested for some other activator proteins. Other putative roles for the acidity of tau(1) are discussed.	KAROLINSKA INST,NOVUM,CTR BIOTECHNOL,S-14157 HUDDINGE,SWEDEN	Karolinska Institutet			Wright, Anthony/J-8187-2015	Wright, Anthony/0000-0003-1029-9969				ANDERSSON S, 1988, J BIOL CHEM, V264, P8222; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BEGGS JD, 1978, NATURE, V275, P104, DOI 10.1038/275104a0; BODWELL JE, 1991, J BIOL CHEM, V266, P7549; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CRESS WD, 1991, SCIENCE, V251, P87, DOI 10.1126/science.1846049; DAHLMANWRIGHT K, 1995, P NATL ACAD SCI USA, V92, P1699, DOI 10.1073/pnas.92.5.1699; DAHLMANWRIGHT K, 1994, P NATL ACAD SCI USA, V91, P1619, DOI 10.1073/pnas.91.5.1619; DANIELSEN M, 1987, MOL ENDOCRINOL, V1, P816, DOI 10.1210/mend-1-11-816; DONALDSON L, 1992, J BIOL CHEM, V267, P1411; ECKSTEIN F, 1988, NUCLEIC ACIDS RES, V16, P791; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GEISSELSODER MC, 1989, BIOTECHNIQUES, V7, P282; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GODOWSKI PJ, 1988, SCIENCE, V241, P812, DOI 10.1126/science.3043662; HILLIARD GM, 1994, BIOCHEMISTRY-US, V33, P4300, DOI 10.1021/bi00180a026; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; HOPE IA, 1988, NATURE, V333, P635, DOI 10.1038/333635a0; JENSEN EV, 1991, NUCLEAR HORMONE RECE, P1; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEE MG, 1987, NATURE, V327, P31, DOI 10.1038/327031a0; LEUTHER KK, 1993, CELL, V72, P575, DOI 10.1016/0092-8674(93)90076-3; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MARTIN KJ, 1990, NATURE, V346, P147, DOI 10.1038/346147a0; MASON SA, 1993, J BIOL CHEM, V268, P21501; MCEWAN IJ, 1994, J BIOL CHEM, V269, P25629; MCEWAN IJ, 1993, MOL CELL BIOL, V13, P399, DOI 10.1128/MCB.13.1.399; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; OMALLEY B, 1990, MOL ENDOCRINOL, V4, P363, DOI 10.1210/mend-4-3-363; ORTI E, 1989, J STEROID BIOCHEM, V34, P85, DOI 10.1016/0022-4731(89)90069-1; POLETTI A, 1993, BIOCHEMISTRY-US, V32, P9563, DOI 10.1021/bi00088a007; REGIER JL, 1993, P NATL ACAD SCI USA, V90, P883, DOI 10.1073/pnas.90.3.883; Sambrook J, 1989, MOL CLONING LABORATO; SCHMITZ ML, 1994, J BIOL CHEM, V269, P25613; SCHULE R, 1988, SCIENCE, V242, P1418, DOI 10.1126/science.3201230; SIGLER PB, 1988, NATURE, V333, P210, DOI 10.1038/333210a0; TASSET D, 1990, CELL, V62, P1177, DOI 10.1016/0092-8674(90)90394-T; VANHOY M, 1993, CELL, V72, P587, DOI 10.1016/0092-8674(93)90077-4; WAHLI W, 1991, FASEB J, V5, P2243, DOI 10.1096/fasebj.5.9.1860615; WRIGHT APH, 1990, J BIOL CHEM, V265, P14763; WRIGHT APH, 1991, MOL ENDOCRINOL, V5, P1366, DOI 10.1210/mend-5-10-1366; ZILLIACUS J, 1991, J BIOL CHEM, V266, P3101	42	84	84	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17535	17540		10.1074/jbc.270.29.17535	http://dx.doi.org/10.1074/jbc.270.29.17535			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615559	hybrid			2022-12-27	WOS:A1995RK68900075
J	GANGULI, S; WANG, H; MATSUMURA, P; VOLZ, K				GANGULI, S; WANG, H; MATSUMURA, P; VOLZ, K			UNCOUPLED PHOSPHORYLATION AND ACTIVATION IN BACTERIAL CHEMOTAXIS - THE 2.1-ANGSTROM STRUCTURE OF A THREONINE TO ISOLEUCINE MUTANT AT POSITION-87 OF CHEY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOSIGNALING PROTEIN CHEY; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; FLAGELLAR SWITCH; CONSERVED ASPARTATE; RESPONSE REGULATOR; F-19 NMR; BINDING; MUTATIONS	Position 87 of the chemotaxis regulatory protein CheY is a highly conserved threonine/serirle residue in the response regulator superfamily. A threonine 87 to isoleucine mutant in CheY, identified by its in vivo non-chemotactic phenotype, was also found to be phosphorylatable in vitro. These properties indicate that this mutant does not undergo activation upon phosphorylation. The x-ray crystallographic structure of the threonine to isoleucine CheY mutant has been solved and refined at 2.1-Angstrom resolution, to an R factor of 15.6%. Comparison with the wild-type, Mg2+-free CheY structure shows that the active site structure is retained, but there are significant localized differences in the backbone conformation distal from the substitution. The presence of the isoleucine side chain also restricts the rotational conformation of another conserved residue in the molecule. tyrosine at position 106. These results provide further evidence for a signaling surface remote from the phosphorylation site of the CheY molecule and implicate threonine 87 and other residues in the post-phosphorylation signaling events.	UNIV ILLINOIS,DEPT MICROBIOL & IMMUNOL,CHICAGO,IL 60612	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047522] Funding Source: NIH RePORTER; NIAID NIH HHS [AI18985] Funding Source: Medline; NIGMS NIH HHS [GM47522] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARAK R, 1992, BIOCHEMISTRY-US, V31, P1821, DOI 10.1021/bi00121a034; BARAK R, 1992, BIOCHEMISTRY-US, V31, P10099, DOI 10.1021/bi00156a033; BELLSOLELL L, 1994, J MOL BIOL, V238, P489, DOI 10.1006/jmbi.1994.1308; BERG HC, 1988, COLD SPRING HARB SYM, V53, P1, DOI 10.1101/SQB.1988.053.01.003; BOURRET RB, 1990, P NATL ACAD SCI USA, V87, P41, DOI 10.1073/pnas.87.1.41; BOURRET RB, 1993, J BIOL CHEM, V268, P13089; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRISSETTE RE, 1991, J BACTERIOL, V173, P3749, DOI 10.1128/JB.173.12.3749-3755.1991; BUCKLE AM, 1993, J MOL BIOL, V234, P847, DOI 10.1006/jmbi.1993.1630; CLEGG DO, 1984, P NATL ACAD SCI-BIOL, V81, P5056, DOI 10.1073/pnas.81.16.5056; DAILEY FE, 1993, J BACTERIOL, V175, P3236, DOI 10.1128/JB.175.10.3236-3239.1993; DELGADO J, 1993, MOL MICROBIOL, V10, P1037, DOI 10.1111/j.1365-2958.1993.tb00974.x; DRAKE SK, 1993, J BIOL CHEM, V268, P13081; FINZEL BC, 1987, J APPL CRYSTALLOGR, V20, P53, DOI 10.1107/S0021889887087144; FITZGERALD PMD, 1988, J APPL CRYSTALLOGR, V21, P273, DOI 10.1107/S0021889887012299; HALL SR, 1988, XTAL 2 4 USERS MANUA; HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P252; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; HESS JF, 1987, P NATL ACAD SCI USA, V84, P7609, DOI 10.1073/pnas.84.21.7609; HOWARD AJ, 1987, J APPL CRYSTALLOGR, V20, P383, DOI 10.1107/S0021889887086436; HURLEY JH, 1992, J MOL BIOL, V224, P1143, DOI 10.1016/0022-2836(92)90475-Y; JONES TA, 1985, METHOD ENZYMOL, V115, P157; KANAMARU K, 1992, J BIOCHEM-TOKYO, V111, P425, DOI 10.1093/oxfordjournals.jbchem.a123773; KAR L, 1992, BIOCHEM J, V287, P521, DOI 10.1042/bj2870521; KAR L, 1992, BIOCHEM J, V287, P533, DOI 10.1042/bj2870533; LUKAT GS, 1991, J BIOL CHEM, V266, P8348; LUKAT GS, 1990, BIOCHEMISTRY-US, V29, P5436, DOI 10.1021/bi00475a004; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; Macnab R. M., 1987, ESCHERICHIA COLI SAL, V1, P732; MARTINEZOYANEDEL J, 1991, J MOL BIOL, V222, P335, DOI 10.1016/0022-2836(91)90215-R; MATSUMURA P, 1984, J BACTERIOL, V160, P36, DOI 10.1128/JB.160.1.36-41.1984; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; OHLENDORF DH, 1994, ACTA CRYSTALLOGR D, V50, P808, DOI 10.1107/S0907444994002659; OLMEDO G, 1990, J MOL BIOL, V215, P359, DOI 10.1016/S0022-2836(05)80357-2; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; PHILLIPS GN, 1990, PROTEINS, V7, P358, DOI 10.1002/prot.340070407; RAVID S, 1986, P NATL ACAD SCI USA, V83, P7157, DOI 10.1073/pnas.83.19.7157; ROMAN SJ, 1992, J BACTERIOL, V174, P6247, DOI 10.1128/JB.174.19.6247-6255.1992; Rossmann M. G., 1972, MOL REPLACEMENT METH; RUSSO FD, 1993, J MOL BIOL, V231, P261, DOI 10.1006/jmbi.1993.1281; SANDERS DA, 1989, J BIOL CHEM, V264, P21770; SMITH JL, 1986, BIOCHEMISTRY-US, V25, P5018, DOI 10.1021/bi00366a008; SOCKETT H, 1992, J BACTERIOL, V174, P793, DOI 10.1128/jb.174.3.793-806.1992; STEWART RC, 1987, CHEM REV, V87, P997, DOI 10.1021/cr00081a007; STOCK AM, 1993, BIOCHEMISTRY-US, V32, P13375, DOI 10.1021/bi00212a001; VOLZ K, 1991, J BIOL CHEM, V266, P15511; VOLZ K, 1993, BIOCHEMISTRY-US, V32, P11741, DOI 10.1021/bi00095a001; WEINSTEIN M, 1992, MOL MICROBIOL, V6, P2041, DOI 10.1111/j.1365-2958.1992.tb01377.x; WELCH M, 1993, P NATL ACAD SCI USA, V90, P8757; WOLFE AJ, 1987, J BACTERIOL, V169, P1878, DOI 10.1128/jb.169.5.1878-1885.1987; WYLIE D, 1988, BIOCHEM BIOPH RES CO, V151, P891, DOI 10.1016/S0006-291X(88)80365-6	52	57	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17386	17393		10.1074/jbc.270.29.17386	http://dx.doi.org/10.1074/jbc.270.29.17386			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615544	hybrid			2022-12-27	WOS:A1995RK68900055
J	HAWES, BE; VANBIESEN, T; KOCH, WJ; LUTTRELL, LM; LEFKOWITZ, RJ				HAWES, BE; VANBIESEN, T; KOCH, WJ; LUTTRELL, LM; LEFKOWITZ, RJ			DISTINCT PATHWAYS OF G(I)-MEDIATED AND G(Q)-MEDIATED MITOGEN-ACTIVATED PROTEIN-KINASE ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; PHOSPHOLIPASE-C; SIGNAL-TRANSDUCTION; ADENYLYL CYCLASE; TYROSINE KINASES; ALPHA-SUBUNIT; MAP KINASE; SF9 CELLS; RECEPTOR; EXPRESSION	Receptors that couple to the heterotrimeric G proteins, G(1) or G(q), can stimulate phosphoinositide (PI) hydrolysis and mitogen-activated protein kinase (MAPK) activation. PI hydrolysis produces inositol 1,4,5-trisphosphate and diacylglycerol, leading to activation of protein kinase C (PKC), which can stimulate increased MAPK activity. However, the relationship between PI hydrolysis and MAPK activation in G(i) and G(q) signaling has not been clearly defined and is the subject study. The effects of several signaling inhibitors assessed including expression of a peptide derived from the carboxyl terminus of the beta adrenergic receptor kinase 1 (beta ARKct), which specifically blocks signaling mediated by the beta gamma subunits of G proteins (G beta gamma), expression of dominant negative mutants of p21(ras) (RasN17) and p74(raf-1) (N Delta Raf), protein-tyrosine kinase (PTK) inhibitors and cellular depletion of PRC. The G(1)-coupled alpha 2A adrenergic receptor (AR) stimulates MAPK activation which is blocked by expression of beta ARKct, RasN17, or N Delta Raf, or by PTK inhibitors, but unaffected by cellular depletion of PKC. In contrast, MAPK activation stimulated by the G(q) coupled, alpha 1B AR or M1 muscarinic cholinergic receptor is unaffected by expression of beta ARKct or RasN17 expression or by PTK inhibitors, but is blocked by expression of N Delta Raf or by PKC depletion. These data demonstrate that G(i)- and G(q)-coupled receptors stimulate MAPK activation via distinct signaling pathways. G beta gamma is responsible for mediating G(i)-coupled receptor-stimulated MAPK activation through a mechanism utilizing p21ras and p74raf independent of PKC. In contrast, G alpha mediates G(q)-coupled receptor-stimulated MAPK activation using a p21(ras)-independent mechanism employing PKC and p74(raf). To define the role of G beta gamma in G(i)-coupled receptor mediated PI hydrolysis and MAPK activation, direct stimulation with G beta gamma was used. Expression of G beta gamma resulted in MAPK activation that was sensitive to inhibition by expression of beta ARKct, RasN17, or N Delta Raf or by PTK inhibitors, but insensitive to PKC deletion. By comparison, G beta gamma-mediated PI hydrolysis not affected by beta ARKct, RasN17, or N Delta Raf expression or by PTK inhibitors. Together, these results demonstrate that G beta gamma mediates MAPK activation and PI hydrolysis via independent signaling pathways.	DUKE UNIV, MED CTR, DEPT MED CARDIOL, HOWARD HUGHES MED INST, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT BIOCHEM, HOWARD HUGHES MED INST, DURHAM, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute			Lefkowitz, Robert/AAW-2649-2021	Luttrell, Louis/0000-0003-2805-6949	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 16037] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKIYAMA T, 1991, METHOD ENZYMOL, V201, P362; ALBLAS J, 1993, J BIOL CHEM, V268, P22235; ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; BLANK JL, 1992, J BIOL CHEM, V267, P23069; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CARROLL MP, 1994, J BIOL CHEM, V269, P1249; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; DEARRY A, 1990, NATURE, V347, P72, DOI 10.1038/347072a0; FAURE M, 1994, J BIOL CHEM, V269, P7851; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; HONDA Z, 1994, J BIOL CHEM, V269, P2307; HORDIJK PL, 1994, J BIOL CHEM, V269, P645; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; HOWE LR, 1993, J BIOL CHEM, V268, P20717; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; JELSEMA CL, 1987, P NATL ACAD SCI USA, V84, P3623, DOI 10.1073/pnas.84.11.3623; KAZLAUSKAS A, 1988, J CELL BIOL, V106, P1395, DOI 10.1083/jcb.106.4.1395; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; LAMORTE VJ, 1994, J BIOL CHEM, V269, P13490; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MACDONALD SG, 1993, MOL CELL BIOL, V13, P6615, DOI 10.1128/MCB.13.11.6615; MELOCHE S, 1992, MOL BIOL CELL, V3, P63, DOI 10.1091/mbc.3.1.63; NORI M, 1992, MOL CELL BIOL, V12, P936, DOI 10.1128/MCB.12.3.936; PERALTA EG, 1987, EMBO J, V6, P3923, DOI 10.1002/j.1460-2075.1987.tb02733.x; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; PRONIN AN, 1992, P NATL ACAD SCI USA, V89, P6220, DOI 10.1073/pnas.89.13.6220; RAVICHANDRAN KS, 1995, MOL CELL BIOL, V15, P593; SASAOKA T, 1994, J BIOL CHEM, V269, P32621; SCHMIDT CJ, 1992, J BIOL CHEM, V267, P13807; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMITS AMM, 1992, NATURE, V357, P602; SPANDIDOS DA, 1984, NATURE, V310, P469, DOI 10.1038/310469a0; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; TAUSSIG R, 1993, J BIOL CHEM, V268, P9; THOMASON PA, 1994, J BIOL CHEM, V269, P16525; UEDA N, 1994, J BIOL CHEM, V269, P4388; UEHARA Y, 1991, METHOD ENZYMOL, V201, P370; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; VANRENTERGHEM B, 1994, J BIOL CHEM, V269, P24666; WINITZ S, 1993, J BIOL CHEM, V268, P19196; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297	50	419	425	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17148	17153		10.1074/jbc.270.29.17148	http://dx.doi.org/10.1074/jbc.270.29.17148			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615510	hybrid			2022-12-27	WOS:A1995RK68900017
J	MA, JF; SHINADA, T; MATSUDA, C; NOMOTO, K				MA, JF; SHINADA, T; MATSUDA, C; NOMOTO, K			BIOSYNTHESIS OF PHYTOSIDEROPHORES, MUGINEIC ACIDS, ASSOCIATED WITH METHIONINE CYCLING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2'-DEOXYMUGINEIC ACID; HIGHER-PLANTS	The biosynthesis of 2'-deoxymugineic acid, a key phytosiderophore, was examined in association with the putative methionine recycling pathway in the roots of wheat using labeling experiments and structural analysis, Feeding with D-[1-C-13]ribose did not result in C-13 enrichment of 2'-deoxymugineic acid, while D-[2-C-13]ribose resulted in C-13 enrichment at the C-4'', -1, -4' positions, and D-[5-C-13]ribose did in C-1', -4, and -1'' positions of 2'-deoxymugineic acid, respectively. Furthermore, two isotope-labeled intermediates of the methionine recycling pathway, 5-[5-H-2(2)]methylthioribose and 2-[1-C-13]keto-4-methylthiobutyric acid, were synthesized, and their incorporation into 2'-deoxymugineic acids was investigated. Six deuterium atoms at the C-4, -1', and -1'' positions of 2'-deoxymugineic acid were observed after feeding with 5-[5-H-2(2)]methylthioribose. Feeding with 2-[1-C-13]keto-4-methylthiobutyric acid yielded 2'-deoxymugineic acid enriched with C-13 at the C-4', -1, and -4'' positions. These results demonstrated for the first time that the biosynthesis of 2'-deoxymugineic acid is associated with the methionine recycling pathway. This association system functions to recycle methionine required for continued synthesis of mugineic acids in the roots of gramineous plants.	SUNTORY INST BIOORGAN RES,SHIMAMOTO 618,OSAKA,JAPAN	Suntory Holdings Ltd			Feng, Jian/C-7213-2009; Ma, Jianfeng/GZB-0110-2022	Feng, Jian/0000-0003-3411-827X; 				DEVOSS JJ, 1994, J ORG CHEM, V59, P2715, DOI 10.1021/jo00089a013; GIOVANELLI J, 1974, PLANT PHYSIOL, V54, P725, DOI 10.1104/pp.54.5.725; KAWAI S, 1988, TETRAHEDRON LETT, V29, P1053, DOI 10.1016/0040-4039(88)85333-4; MA JF, 1992, CHEM PHARM BULL, V40, P2888, DOI 10.1248/cpb.40.2888; MA JF, 1994, SOIL SCI PLANT NUTR, V40, P311, DOI 10.1080/00380768.1994.10413305; MA JF, 1994, PLANT PHYSIOL, V105, P607, DOI 10.1104/pp.105.2.607; MA JF, 1993, PLANT PHYSIOL, V102, P373, DOI 10.1104/pp.102.2.373; MA JF, 1993, PHYTOCHEMISTRY, V34, P599, DOI 10.1016/0031-9422(93)85323-J; MEISTER A, 1952, J BIOL CHEM, V197, P309; MORI S, 1987, PLANT CELL PHYSIOL, V28, P1081; Nomoto K, 1987, IRON TRANSPORT MICRO; ROMHELD V, 1987, PHYSIOL PLANTARUM, V70, P231, DOI 10.1111/j.1399-3054.1987.tb06137.x; SHOJIMA S, 1990, PLANT PHYSIOL, V93, P1497, DOI 10.1104/pp.93.4.1497; TAKAGI S, 1984, J PLANT NUTR, V7, P469, DOI 10.1080/01904168409363213; TAKAGI SI, 1976, SOIL SCI PLANT NUTR, V22, P423, DOI 10.1080/00380768.1976.10433004; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103	16	103	110	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16549	16554		10.1074/jbc.270.28.16549	http://dx.doi.org/10.1074/jbc.270.28.16549			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622460	hybrid			2022-12-27	WOS:A1995RJ34700016
J	BULLESBACH, EE; SCHWABE, C				BULLESBACH, EE; SCHWABE, C			A NOVEL LEYDIG-CELL CDNA-DERIVED PROTEIN IS A RELAXIN-LIKE FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOLOGICAL-ACTIVITY; INSULIN; BINDING; RECEPTOR; PEPTIDE; SITE	According to Burkhardt et al. (Burkhardt, E., Adham, I.M,, Brosig, B., Gastmann, A., Mattei, M. G., and Engel, W. (1994) Genomics 20, 13-19) Leydig cells contain the message for a protein of the insulin/relaxin family which was named Leydig cell insulin-like protein (LEY I-L), We have synthesized the human LEY I-L according to the amino acid sequence deduced from the published cDNA structure and obtained preliminary results concerning its potential target organs and its biological activity. Leydig cell insulin-like protein binds specifically to crude membrane preparations of mouse uterus and brain and shows cross-reactivity with the relaxin receptor, but not the insulin receptor, On the basis of these observations, together with the results of earlier structure-function considerations, we suggest that the new protein is a relaxin-like factor, By itself the new factor shows no obvious effect, but when given together with relaxin it significantly enhances relaxin-mediated widening of the mouse symphysis pubis.			BULLESBACH, EE (corresponding author), MED UNIV S CAROLINA,DEPT BIOCHEM & MOLEC BIOL,CHARLESTON,SC 29425, USA.				PHS HHS [48829] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADHAM IM, 1993, J BIOL CHEM, V268, P26668; Adler A J, 1973, Methods Enzymol, V27, P675; BULLESBACH EE, 1992, J BIOL CHEM, V267, P22957; BULLESBACH EE, 1991, J BIOL CHEM, V266, P10754; BULLESBACH EE, 1993, BIOCHEM BIOPH RES CO, V196, P311, DOI 10.1006/bbrc.1993.2250; BULLESBACH EE, 1980, H-S Z PHYSIOL CHEM, V361, P865, DOI 10.1515/bchm2.1980.361.1.865; BULLESBACH EE, 1994, J BIOL CHEM, V269, P13124; BULLESBACH EE, 1994, ENDOCRINE, V2, P1115; BURKHARDT E, 1994, GENOMICS, V20, P13, DOI 10.1006/geno.1994.1121; EIGENBROT C, 1991, J MOL BIOL, V221, P15, DOI 10.1016/0022-2836(91)90796-9; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; HOCK RA, 1980, J BIOL CHEM, V255, P731; LINDE S, 1986, J CHROMATOGR, V369, P327, DOI 10.1016/S0021-9673(00)90139-0; OLEFSKY JM, 1982, ANN NY ACAD SCI, V380, P200, DOI 10.1111/j.1749-6632.1982.tb18043.x; REMBIESA B, 1993, ENDOCR J, V1, P263; SCHWABE C, 1978, BIOCHEM BIOPH RES CO, V84, P374, DOI 10.1016/0006-291X(78)90180-8; SCHWABE C, 1994, FASEB J, V8, P1; SIEBER P, 1977, HELV CHIM ACTA, V60, P27, DOI 10.1002/hlca.19770600105; STEINETZ BG, 1960, ENDOCRINOLOGY, V67, P102, DOI 10.1210/endo-67-1-102; TAM JP, 1991, J AM CHEM SOC, V113, P6657, DOI 10.1021/ja00017a044; TASHIMA LS, 1995, J CLIN ENDOCR METAB, V80, P707, DOI 10.1210/jc.80.2.707; YANG S, 1992, ENDOCRINOLOGY, V130, P179, DOI 10.1210/en.130.1.179	22	95	96	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16011	16015		10.1074/jbc.270.27.16011	http://dx.doi.org/10.1074/jbc.270.27.16011			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608161	hybrid			2022-12-27	WOS:A1995RH22600022
J	GRAMMATIKAKIS, N; GRAMMATIKAKIS, A; YONEDA, M; YU, Q; BANERJEE, SD; TOOLE, BP				GRAMMATIKAKIS, N; GRAMMATIKAKIS, A; YONEDA, M; YU, Q; BANERJEE, SD; TOOLE, BP			A NOVEL GLYCOSAMINOGLYCAN-BINDING PROTEIN IS THE VERTEBRATE HOMOLOG OF THE CELL-CYCLE CONTROL PROTEIN, CDC37	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; HYALURONIC-ACID; HEPARAN-SULFATE; MESSENGER-RNA; MOLECULAR-CLONING; 3T3 CELLS; RAT-LIVER; EXPRESSION; BRAIN; DNA	Using a monoclonal antibody, IVd4, that recognizes a novel group of hyaluronan-binding proteins, we have immunoscreened a cDNA library constructed from embryonic chick heart muscle mRNA. One of the cDNAs isolated from the library encodes a 29.3-kDa protein homologous to Cdc37, an essential cell cycle regulatory factor previously characterized genetically in yeast and Drosophila; this the first vertebrate CDC37 gene to be cloned to date. We also present evidence for the existence of a second chick isoform that is identical to the 29.3-kDa protein over the first 175 amino acids but is entirely different at the carbonyl terminus and lacks the IVd4 epitope. The avian Cdc37 binds hyaluronan, chrondroitin sulfate and heparin in vitro, and both isoforms contain glycosaminoglycan-binding motifs previously described in several hyaluronan-binding proteins. These findings suggest a role for glycosaminoglycans in cell division control.	TUFTS UNIV, SCH MED, DEPT ANAT & CELLULAR BIOL, BOSTON, MA 02111 USA	Tufts University					NICHD NIH HHS [HD23681] Funding Source: Medline; NIDCR NIH HHS [DE05838] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD023681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE005838] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BANERJEE SD, 1991, DEV BIOL, V146, P186, DOI 10.1016/0012-1606(91)90459-G; BANERJEE SD, 1992, J CELL BIOL, V119, P643, DOI 10.1083/jcb.119.3.643; BOSCHELLI F, 1993, MOL CELL BIOL, V13, P5112, DOI 10.1128/MCB.13.8.5112; BRECHT M, 1986, BIOCHEM J, V239, P445, DOI 10.1042/bj2390445; BUSCH SJ, 1992, J CELL BIOL, V116, P31, DOI 10.1083/jcb.116.1.31; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CHIROSSO G, 1987, J CELL BIOCHEM, V33, P173, DOI 10.1002/jcb.240330304; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; DALE RMK, 1985, PLASMID, V13, P31, DOI 10.1016/0147-619X(85)90053-8; FEDARKO NS, 1989, J CELL PHYSIOL, V139, P287, DOI 10.1002/jcp.1041390210; FEDARKO NS, 1986, J CELL BIOL, V102, P587, DOI 10.1083/jcb.102.2.587; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERGUSON J, 1986, NUCLEIC ACIDS RES, V14, P6681, DOI 10.1093/nar/14.16.6681; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FURUKAWA K, 1977, BIOCHIM BIOPHYS ACTA, V499, P278, DOI 10.1016/0304-4165(77)90010-1; FURUKAWA T, 1990, J BIOCHEM-TOKYO, V108, P297, DOI 10.1093/oxfordjournals.jbchem.a123197; GOETINCK PF, 1987, J CELL BIOL, V105, P2403, DOI 10.1083/jcb.105.5.2403; GRAMMATIKAKIS N, 1995, IN PRESS BIOCH MOL B; HASCALL VC, 1977, J SUPRAMOL STR CELL, V7, P101, DOI 10.1002/jss.400070110; HISCOCK DRR, 1994, J BIOL CHEM, V269, P4539; ISHIHARA M, 1989, J CELL PHYSIOL, V138, P467, DOI 10.1002/jcp.1041380305; ISHIHARA M, 1986, J BIOL CHEM, V261, P3575; JAWORSKI DM, 1994, J CELL BIOL, V125, P495, DOI 10.1083/jcb.125.2.495; KAWAJIRI K, 1983, J BIOCHEM, V94, P1465; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LEBARON RG, 1992, J BIOL CHEM, V267, P10003; LESLEY J, 1993, EUR J IMMUNOL, V23, P1902, DOI 10.1002/eji.1830230826; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; LOKESHWAR VB, 1991, J BIOL CHEM, V266, P17983; LUSTIGMAN S, 1992, J BIOL CHEM, V267, P17339; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PERIDES G, 1992, J BIOL CHEM, V267, P23883; POUYANI T, 1994, BIOCONJUGATE CHEM, V5, P370, DOI 10.1021/bc00028a015; PRATT CW, 1992, J BIOL CHEM, V267, P8795; PUKAC LA, 1990, CELL REGUL, V1, P435, DOI 10.1091/mbc.1.5.435; QIN Y, 1992, DEV DYNAM, V193, P145, DOI 10.1002/aja.1001930206; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; RAUCH U, 1992, J BIOL CHEM, V267, P19536; REED SI, 1992, ANNU REV CELL BIOL, V8, P529, DOI 10.1146/annurev.cb.08.110192.002525; REED SI, 1980, GENETICS, V95, P561; RIPELLINO JA, 1988, J CELL BIOL, V106, P845, DOI 10.1083/jcb.106.3.845; RIPELLINO JA, 1989, J CELL BIOL, V108, P1899, DOI 10.1083/jcb.108.5.1899; Sambrook J, 1989, MOL CLONING LABORATO; SHERMAN L, 1994, CURR OPIN CELL BIOL, V6, P726, DOI 10.1016/0955-0674(94)90100-7; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; SOBEL M, 1992, J BIOL CHEM, V267, P8857; Toole B. P., 1991, CELL BIOL EXTRACELLU, P305; TOOLE BP, 1993, PROG CLIN BIOL RES, V383, P437; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURLEY EA, 1992, CANCER METAST REV, V11, P21, DOI 10.1007/BF00047600; UNDERHILL C, 1992, J CELL SCI, V103, P293; UNDERHILL CB, 1983, J BIOL CHEM, V258, P8086; UNDERHILL CB, 1979, J CELL BIOL, V82, P475, DOI 10.1083/jcb.82.2.475; YAMAGATA M, 1986, J BIOL CHEM, V261, P3526; YANG BH, 1994, J CELL BIOCHEM, V56, P455, DOI 10.1002/jcb.240560406; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x; YONEDA M, 1988, J CELL SCI, V90, P265; YU Q, 1995, IN PRESS BIOTECHNIQU; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	64	93	101	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16198	16205		10.1074/jbc.270.27.16198	http://dx.doi.org/10.1074/jbc.270.27.16198			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608185	hybrid			2022-12-27	WOS:A1995RH22600049
J	JESSENMARSHALL, AE; PAUL, NJ; BROOKER, RJ				JESSENMARSHALL, AE; PAUL, NJ; BROOKER, RJ			THE CONSERVED MOTIF, GXXX(D/E)(R/K)XG[X](R/K)(R/K), IN HYDROPHILIC LOOP-2/3 OF THE LACTOSE PERMEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-TETRACYCLINE/H+ ANTIPORTER; ESCHERICHIA-COLI; CARRIER PROTEIN; DIRECTED MUTAGENESIS; ACTIVE-TRANSPORT; LAC PERMEASE; PLASMID DNA; PROTON; MEMBRANE; SEQUENCE	A conserved motif, GXXX(D/E)(R/K)XG(R/K)(R/K), has been identified among a large group of evolutionarily related membrane proteins involved in the transport of small molecules across the membrane. To determine the importance of this motif within the lactose permease of Escherichia coli, a total of 28 site-directed mutations at the conserved first, fifth, sixth, eighth, ninth, and tenth positions were analyzed. A dramatic inhibition of activity was observed with all bulky mutations at the first-position glycine. Based on these results, together with sequence comparisons within the superfamily, it seems likely that small side chain volume (and possibly high beta-turn propensity) may be structurally important at this position. The acidic residue at the fifth position was also found to be very important for transport activity and even a conservative glutamate at this location exhibited marginal transport activity, In contrast, many substitutions at the eighth-position glycine, even those with a high side chain volume and/or low beta-turn propensity, still retained high levels of transport activity. Similarly, none of the basic residues within the motif were essential for transport activity when replaced individually by nonbasic residues. However, certain substitutions at the basic residue sites as well as the eighth-position glycine were observed to have moderately reduced levels of active transport of lactose, Taken together, the results of this study confirm the importance of the conserved loop 2/3 motif in transport function. It is suggested that this moth may be important in promoting global conformational changes within the permease.	UNIV MINNESOTA,DEPT GENET & CELL BIOL,ST PAUL,MN 55108; UNIV MINNESOTA,INST ADV STUDIES BIOL PROC TECHNOL,ST PAUL,MN 55108	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053259] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53259] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BROOKER RJ, 1990, RES MICROBIOL, V141, P309, DOI 10.1016/0923-2508(90)90004-A; BROOKER RJ, 1985, P NATL ACAD SCI USA, V82, P3959, DOI 10.1073/pnas.82.12.3959; BUCHEL DE, 1980, NATURE, V283, P541, DOI 10.1038/283541a0; CAIRNS BR, 1989, P NATL ACAD SCI USA, V86, P7682, DOI 10.1073/pnas.86.20.7682; CALAMIA J, 1990, P NATL ACAD SCI USA, V87, P4937, DOI 10.1073/pnas.87.13.4937; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CRANE RK, 1977, REV PHYSIOL BIOCH P, V78, P99, DOI 10.1007/BFb0027722; CRANE RK, 1962, FED PROC, V21, P891; CRANE RK, 1960, PHYSIOL REV, V40, P784; EDDY AA, 1971, BIOCHEM J, V122, P701, DOI 10.1042/bj1220701; FOSTER DL, 1983, J BIOL CHEM, V258, P31; GOSWITZ VC, 1995, PROTEIN SCI, V4, P534; GRIFFITH J K, 1992, Current Opinion in Cell Biology, V4, P684, DOI 10.1016/0955-0674(92)90090-Y; HENDERSON PJF, 1990, J BIOENERG BIOMEMBR, V22, P525, DOI 10.1007/BF00762961; HOFER M, 1978, BIOCHEM J, V172, P15; JUNG K, 1995, BIOCHEMISTRY-US, V34, P1030, DOI 10.1021/bi00003a038; KING SC, 1991, BIOCHIM BIOPHYS ACTA, V1062, P177, DOI 10.1016/0005-2736(91)90390-T; KOMOR E, 1973, FEBS LETT, V38, P16, DOI 10.1016/0014-5793(73)80501-0; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; MANDEL M, 1970, J MOL BIOL, V63, P154; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; MCKENNA E, 1992, P NATL ACAD SCI USA, V89, P11954, DOI 10.1073/pnas.89.24.11954; MILLER J, 1973, EXPT MOL GENETICS, P433; Mitchell P., 1963, BIOCHEM SOC SYMP, V22, P142; RICKENBERG HV, 1956, ANN I PASTEUR PARIS, V91, P829; ROEPE PD, 1990, RES MICROBIOL, V141, P290, DOI 10.1016/0923-2508(90)90003-9; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SLAYMAN CL, 1974, P NATL ACAD SCI USA, V71, P1935, DOI 10.1073/pnas.71.5.1935; TEATHER RM, 1978, MOL GEN GENET, V159, P239, DOI 10.1007/BF00268260; TEATHER RM, 1980, EUR J BIOCHEM, V108, P223, DOI 10.1111/j.1432-1033.1980.tb04715.x; WEST IC, 1970, BIOCHEM BIOPH RES CO, V41, P655, DOI 10.1016/0006-291X(70)90063-X; WILSON TH, 1983, CELL MEMBR METH REV, V1, P1; WRUBEL W, 1990, J BACTERIOL, V172, P5374, DOI 10.1128/jb.172.9.5374-5381.1990; YAMAGUCHI A, 1990, J BIOL CHEM, V265, P15525; YAMAGUCHI A, 1992, J BIOL CHEM, V267, P19155; YAMAGUCHI A, 1994, J BIOCHEM-TOKYO, V115, P958, DOI 10.1093/oxfordjournals.jbchem.a124445; YAMISCHPERRON C, 1985, GENE, V33, P103; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	41	81	83	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16251	16257		10.1074/jbc.270.27.16251	http://dx.doi.org/10.1074/jbc.270.27.16251			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608191	hybrid			2022-12-27	WOS:A1995RH22600057
J	PALMER, CNA; HSU, MH; GRIFFIN, KJ; JOHNSON, EF				PALMER, CNA; HSU, MH; GRIFFIN, KJ; JOHNSON, EF			NOVEL SEQUENCE DETERMINANTS IN PEROXISOME PROLIFERATOR SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE RECEPTOR SUPERFAMILY; COA OXIDASE GENE; RESPONSE ELEMENT; RETINOIC ACID; NUCLEAR RECEPTOR; ORPHAN RECEPTORS; BINDING-PROTEIN; DIRECT REPEAT; FATTY-ACIDS; DNA-BINDING	The gene encoding cytochrome P-450 4A6 (CYP4A6) is transcriptionally activated by peroxisome proliferators, This response is dependent on a strong enhancer element (Z) and weaker elements (X and -27), The peroxisome proliferator response is mediated by the binding of heterodimers containing the peroxisome proliferator-activated receptor cu (PPAR alpha) and the retinoid X receptor alpha (RXR alpha) to these elements, These peroxisome proliferator response elements (PPREs) contain imperfect direct repeats of the nuclear receptor consensus recognition sequence with a spacing of one nucleotide (DR1) (AGGTCA N AGGTCA). This DR1 motif is seen in the binding sites for other nuclear receptor complexes, such as ARP-1, HNF-4, and RXR alpha homodimers. Mutational analysis of the Z element reveals that the DR1 motif is required for the transcriptional activation of the CYP4A6 gene by peroxisome proliferators; however, deletion of sequences immediately upstream of this motif also abolishes this response. Oligonucleotides corresponding to truncated and mutated Z elements were assayed by gel retardation for binding to RXR alpha, PPAR alpha, and ARP-1. Deletions or mutations within six nucleotides 5' of the DR1 motif dramatically diminish PPAR alpha . RXR alpha binding without reducing the binding of either RXR alpha or ARP-1 homodimers, whereas mutation or deletion of the core DR1 sequences abolishes the binding of PPAR alpha . RXR alpha heterodimers and of RXR alpha or ARP-1 homodimers, Thus, the DR1 motif in the Z element is not sufficient to constitute a PPRE. Moreover, the binding of PPAR alpha . RXR alpha to the Z element requires sequences immediately 5' of the DR1, These sequences are conserved in natural PPREs and promote binding of PPAR alpha . RXR alpha heterodimers in preference to potential competitors such as ARP-1 and RXR alpha.	SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, DIV BIOCHEM, LA JOLLA, CA 92037 USA	Scripps Research Institute			Palmer, Colin NA/C-7053-2008	Palmer, Colin NA/0000-0002-6415-6560	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD004445] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD004445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00833] Funding Source: Medline; NICHD NIH HHS [HD04445] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALDRIDGE TC, 1995, BIOCHEM J, V306, P473, DOI 10.1042/bj3060473; BARDOT O, 1993, BIOCHEM BIOPH RES CO, V192, P37, DOI 10.1006/bbrc.1993.1378; BARDOT O, 1995, FEBS LETT, V360, P183, DOI 10.1016/0014-5793(95)00097-S; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; CARLBERG C, 1993, NATURE, V361, P657, DOI 10.1038/361657a0; CARLBERG C, 1993, BIOCHEM BIOPH RES CO, V195, P1345, DOI 10.1006/bbrc.1993.2191; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; FORMAN B M, 1990, New Biologist, V2, P587; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; ISSEMANN I, 1992, BIOCHEM SOC T, V20, P824, DOI 10.1042/bst0200824; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; KLIEWER SA, 1992, P NATL ACAD SCI USA, V89, P1448, DOI 10.1073/pnas.89.4.1448; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; MADER S, 1993, J BIOL CHEM, V268, P591; MANGELSDORF DJ, 1991, CELL, V66, P555, DOI 10.1016/0092-8674(81)90018-0; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; MIYATA KS, 1993, J BIOL CHEM, V268, P19169; MOODY DE, 1991, FUND APPL TOXICOL, V16, P233, DOI 10.1016/0272-0590(91)90108-G; MUERHOFF AS, 1992, J BIOL CHEM, V267, P19051; NAKSHATRI H, 1994, J BIOL CHEM, V269, P890; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V175, P866, DOI 10.1016/0006-291X(91)91645-S; PALMER CNA, 1994, J BIOL CHEM, V269, P18083; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; RAO MS, 1987, CARCINOGENESIS, V8, P631; RODRIGUEZ JC, 1994, J BIOL CHEM, V269, P18767; Sambrook J, 1989, MOL CLONING LABORATO; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794; WILSON TE, 1992, SCIENCE, V256, P107, DOI 10.1126/science.1314418; ZECHEL C, 1994, EMBO J, V13, P1425, DOI 10.1002/j.1460-2075.1994.tb06396.x; ZECHEL C, 1994, EMBO J, V13, P1414, DOI 10.1002/j.1460-2075.1994.tb06395.x; ZHANG BW, 1992, P NATL ACAD SCI USA, V89, P7541, DOI 10.1073/pnas.89.16.7541	38	242	249	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16114	16121		10.1074/jbc.270.27.16114	http://dx.doi.org/10.1074/jbc.270.27.16114			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608174	hybrid			2022-12-27	WOS:A1995RH22600037
J	WIENECKE, R; KONIG, A; DECLUE, JE				WIENECKE, R; KONIG, A; DECLUE, JE			IDENTIFICATION OF TUBERIN, THE TUBEROUS SCLEROSIS-2 PRODUCT - TUBERIN POSSESSES SPECIFIC RAP1GAP ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 NEUROFIBROMATOSIS; RAS SUPERFAMILY; PROTEINS; GENE; GTPASE; CELLS; RAP1/KREV-1; ACTIVATION; REGION; DOMAIN	Tuberous sclerosis (TSC) is a human genetic syndrome characterized by the development of benign tumors in a variety of tissues, as well as rare malignancies. Two different genetic loci have been implicated in TSC; one of these loci, the tuberous sclerosis-2 gene (TSC2), encodes an open reading frame with a putative protein product of 1784 amino acids. The putative TSC2 product (tuberin) contains a region of limited homology to the catalytic domain of Rap1GAP. We have generated antisera against the N-terminal and C-terminal portions of tuberin, and these antisera specifically recognize a 180-kDa protein in immunoprecipitation and immunoblotting analyses. A wide variety of human cell lines express the 180-kDa tuberin protein, and subcellular fractionation revealed that most tuberin is found in a membrane/particulate (100,000 x g) fraction. Immunoprecipitates of native tuberin contain an activity that specifically stimulates the intrinsic GTPase activity of Rap1a. These results were confirmed in assays with a C-terminal fragment of tuberin, expressed in bacteria or Sf9 cells. Tuberin did not stimulate the GTPase activity of Rap2, Ha-Ras, Rac, or Rho. These results suggest that the loss of tuberin leads to constitutive activation of Rap1 in tumors of patients with tuberous sclerosis.	NCI,CELLULAR ONCOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOLLAG G, 1991, ANNU REV CELL BIOL, V7, P601, DOI 10.1146/annurev.cellbio.7.1.601; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; CEN H, 1992, EMBO J, V11, P4007, DOI 10.1002/j.1460-2075.1992.tb05494.x; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; DECLUE JE, 1991, P NATL ACAD SCI USA, V88, P9914, DOI 10.1073/pnas.88.22.9914; DOWNWARD J, 1990, TRENDS BIOCHEM SCI, V15, P469, DOI 10.1016/0968-0004(90)90300-Z; European Chromosome 16 Tuberous Sclerosis C., 1993, CELL, V75, P1305; Frech M, 1990, SCIENCE, V249, P169, DOI 10.1126/science.2164710; Gomez MR, 1988, TUBEROUS SCLEROSIS; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; HARIHARAN IK, 1991, CELL, V67, P717, DOI 10.1016/0092-8674(91)90066-8; HARLOW E, 1988, ANTIBODIES LABORATOR; HATTORI M, 1995, MOL CELL BIOL, V15, P552, DOI 10.1128/MCB.15.1.552; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; JANSSEN B, 1994, HUM GENET, V94, P437, DOI 10.1007/BF00201608; JOHNSON MR, 1994, MOL CELL BIOL, V14, P641, DOI 10.1128/MCB.14.1.641; KIM H, IN PRESS ONCOGENE; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KOBAYASHI T, 1995, NAT GENET, V9, P70, DOI 10.1038/ng0195-70; KWIATKOWSKI DJ, 1993, CYTOGENET CELL GENET, V64, P94; LEROSEY I, 1991, J BIOL CHEM, V266, P4315; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; LUBBERT M, 1991, BLOOD, V77, P909; PIZON V, 1988, NUCLEIC ACIDS RES, V16, P7719, DOI 10.1093/nar/16.15.7719; PIZON V, 1988, ONCOGENE, V3, P201; PIZON V, 1994, J CELL SCI, V107, P1661; POLAKIS PG, 1991, P NATL ACAD SCI USA, V88, P239, DOI 10.1073/pnas.88.1.239; RUBINFELD B, 1991, CELL, V65, P1033, DOI 10.1016/0092-8674(91)90555-D; RUBINFELD B, 1992, MOL CELL BIOL, V12, P4634, DOI 10.1128/MCB.12.10.4634; TUNG JS, 1989, PCR TECHNOLOGY PRINC, P99; YEUNG RS, 1994, P NATL ACAD SCI USA, V91, P11413, DOI 10.1073/pnas.91.24.11413; YOSHIDA Y, 1992, MOL CELL BIOL, V12, P3407, DOI 10.1128/MCB.12.8.3407; ZHANG K, 1991, SCIENCE, V254, P1630, DOI 10.1126/science.1749934; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	37	317	320	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16409	16414		10.1074/jbc.270.27.16409	http://dx.doi.org/10.1074/jbc.270.27.16409			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608212	hybrid			2022-12-27	WOS:A1995RH22600079
J	DAUCH, P; VINCENT, JP; CHECLER, F				DAUCH, P; VINCENT, JP; CHECLER, F			MOLECULAR-CLONING AND EXPRESSION OF RAT-BRAIN ENDOPEPTIDASE-3.4.24.16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-CONVERTING ENZYME; NEUROTENSIN-DEGRADING METALLOENDOPEPTIDASE; MITOCHONDRIAL INTERMEDIATE PEPTIDASE; AMINO-ACID SEQUENCE; SOLUBLE METALLOENDOPEPTIDASE; MICROSOMAL ENDOPEPTIDASE; PROCESSING PROPROTEINS; SUBSTRATE-SPECIFICITY; SYNAPTIC-MEMBRANES; PURIFICATION	We have isolated by immunological screening of a lambda ZAPII cDNA library constructed from rat brain mRNAs a cDNA clone encoding endopeptidase 3.4.24.16. The longest open reading frame encodes a 704-amino acid protein with a theoretical molecular mass of 80,202 daltons and bears the consensus sequence of the zinc metalloprotease family, The sequence exhibits a 60.2% homology with those of another zinc metallopeptidase, endopeptidase 3.4.24.15, Northern blot analysis reveals two mRNA species of about 3 and 5 kilobases in rat brain, ileum, kidney, and testis, We have transiently transfected COS-7 cells with pcDNA(3) containing the cloned cDNA and established the overexpression of a 70-75-kDa immunoreactive protein. This protein hydrolyzes QFS, a quenched fluorimetric substrate of endopeptidase 3.4.24.16, and cleaves neurotensin at a single peptide bond, leading to the formation of neurotensin (1-10) and neurotensin (11-13), QFS and neurotensin hydrolysis are potently inhibited by the selective endopeptidase 3.4.24.16 dipeptide blocker pro-lie and by dithiothreitol, while the enzymatic activity remains unaffected by phosphoramidon and captopril, the specific inhibitors of endopeptidase 3.4.24.11 and angiotensin-converting enzyme, respectively, Altogether, these physicochemical, biochemical, and immunological properties unambiguously identify endopeptidase 3.4.24.16 as the protein encoded by the isolated cDNA clone.	INST PHARMACOL MOLEC & CELLULAIRE,F-06560 VALBONNE,FRANCE				Checler, Frederic/C-1241-2009	Checler, Frederic/0000-0003-2098-1750				BARELLI H, 1993, EUR J BIOCHEM, V211, P79, DOI 10.1111/j.1432-1033.1993.tb19872.x; BARELLI H, 1988, EUR J BIOCHEM, V175, P481, DOI 10.1111/j.1432-1033.1988.tb14220.x; BARELLI H, 1994, BRIT J PHARMACOL, V112, P127, DOI 10.1111/j.1476-5381.1994.tb13041.x; BARELLI H, 1991, NEUROCHEM LIFE SCI A, V10, P115; BERNSTEIN KE, 1988, J BIOL CHEM, V263, P11021; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCHLER M, 1994, EUR J BIOCHEM, V219, P627, DOI 10.1111/j.1432-1033.1994.tb19978.x; CHABRY J, 1990, J NEUROSCI, V10, P3916, DOI 10.1523/JNEUROSCI.10-12-03916.1990; CHECLER F, 1986, J BIOL CHEM, V261, P1274; CHECLER F, 1995, METHOD ENZYMOL, V248, P593; CHECLER F, 1983, J NEUROCHEM, V41, P375, DOI 10.1111/j.1471-4159.1983.tb04753.x; CHECLER F, 1989, BIOCHEM J, V257, P549, DOI 10.1042/bj2570549; CHECLER F, 1988, BIOCHIMIE, V70, P75, DOI 10.1016/0300-9084(88)90161-7; CHECLER F, 1995, METH NEUROSCI, V23, P363; CHU TG, 1985, ENDOCRINOLOGY, V116, P1418, DOI 10.1210/endo-116-4-1418; DAUCH P, 1991, EUR J BIOCHEM, V202, P269, DOI 10.1111/j.1432-1033.1991.tb16372.x; DAUCH P, 1991, BIOCHEM J, V280, P421, DOI 10.1042/bj2800421; DEVAULT A, 1987, EMBO J, V6, P1317, DOI 10.1002/j.1460-2075.1987.tb02370.x; EHLERS MRW, 1989, P NATL ACAD SCI USA, V86, P7741, DOI 10.1073/pnas.86.20.7741; FRICKER LD, 1986, NATURE, V323, P461, DOI 10.1038/323461a0; HENRICH B, 1993, J BACTERIOL, V175, P7290, DOI 10.1128/JB.175.22.7290-7300.1993; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; HOOPER NM, 1988, BIOCHEM J, V250, P865, DOI 10.1042/bj2500865; HRYCYNA CA, 1993, BIOCHEMISTRY-US, V32, P11293, DOI 10.1021/bi00093a005; ISAYA G, 1992, P NATL ACAD SCI USA, V89, P8317, DOI 10.1073/pnas.89.17.8317; JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5; KALOUSEK F, 1992, EMBO J, V11, P2803, DOI 10.1002/j.1460-2075.1992.tb05347.x; KAWABATA S, 1992, J BIOL CHEM, V267, P10331; KAWABATA S, 1993, J BIOL CHEM, V268, P12498; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MALFROY B, 1987, BIOCHEM BIOPH RES CO, V144, P59, DOI 10.1016/S0006-291X(87)80475-8; MILLICAN PE, 1991, BIOCHEM J, V276, P583, DOI 10.1042/bj2760583; MITRA A, 1994, J BIOL CHEM, V269, P19876; ONDETTI MA, 1977, SCIENCE, V196, P441, DOI 10.1126/science.191908; ORLOWSKI M, 1983, EUR J BIOCHEM, V135, P81, DOI 10.1111/j.1432-1033.1983.tb07620.x; PERLMAN JH, 1992, J BIOL CHEM, V267, P24413; PIEROTTI A, 1990, BIOCHEMISTRY-US, V29, P10323, DOI 10.1021/bi00497a006; ROY P, 1993, J BIOL CHEM, V268, P2699; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; SUDA H, 1973, J ANTIBIOT TOKYO, V10, P621; VINCENT B, 1995, BRIT J PHARMACOL, V115, P1053, DOI 10.1111/j.1476-5381.1995.tb15918.x; WOULFE J, 1992, EUR J NEUROSCI, V4, P1309, DOI 10.1111/j.1460-9568.1992.tb00156.x	44	65	69	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27266	27271		10.1074/jbc.270.45.27266	http://dx.doi.org/10.1074/jbc.270.45.27266			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592986	hybrid			2022-12-27	WOS:A1995TE58300086
J	GERALD, C; WALKER, MW; VAYSSE, PJJ; HE, CG; BRANCHEK, TA; WEINSHANK, RL				GERALD, C; WALKER, MW; VAYSSE, PJJ; HE, CG; BRANCHEK, TA; WEINSHANK, RL			EXPRESSION CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF A HUMAN HIPPOCAMPAL NEUROPEPTIDE-Y PEPTIDE YY Y2 RECEPTOR SUBTYPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN-COUPLED RECEPTOR; FUNCTIONAL EXPRESSION; RAT-BRAIN; CDNA; GENE; IDENTIFICATION; TRANSLATION; SYSTEM; PYY	The pancreatic polypeptide family includes neuropeptide Y (NPY), one of the most abundant neuropeptides in the mammalian nervous system, as well as peptide YY (PW) and pancreatic polypeptide (PP). This peptide family is involved in numerous physiological processes such as memory, pain, blood pressure, appetite, anxiety, and circadian rhythm. Of the multiple Y-type receptors proposed for PP family members, only the Y1 subtype was cloned previously. We now report the isolation of a human Y2 (hhY2) receptor cDNA by expression cloning from a human hippocampal cDNA library, using a I-125-PYY binding assay. hhY2 cDNA encodes a predicted protein of 381 amino acids with low amino acid identity to the human Y1 receptor (31% overall; 41% transmembrane). I-125-PYY binding to transiently expressed hY2 receptors was saturable (pK(d) = 10.17) and displaceable by human PP family members in rank order: PW (pK(i) = 9.47) similar to NPY (pK(i) = 9.27) much greater than PP (pK(i) < 6) and by peptide analogs: NPY2-36 (pK(i) = 8.80) similar to NPY13-36 (pK(i) = 8.55)CB-NPY (pK, = 8.54) > NPY,,,, (pK, = 6.51) [Leu(31),Pro(34)]Npy (PKi = 6 23). Human PYY decreased [cAMP] and increased intracellular [Ca2+] in hY2-transfected 293 cells.			GERALD, C (corresponding author), SYNAPT PHARMACEUT CORP, 215 COLL RD, PARAMUS, NJ 07652 USA.							AICHER SA, 1991, NEUROSCI LETT, V130, P32, DOI 10.1016/0304-3940(91)90220-N; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; BALDWIN JM, 1994, CURR OPIN CELL BIOL, V6, P180, DOI 10.1016/0955-0674(94)90134-1; BARD JA, 1995, J BIOL CHEM, V270, P26762, DOI 10.1074/jbc.270.45.26762; Bayer S.A, 1985, RAT NERVOUS SYSTEM, V1, P335; BLEAKMAN D, 1991, BRIT J PHARMACOL, V103, P1781, DOI 10.1111/j.1476-5381.1991.tb09863.x; BLOMQVIST AG, 1995, BBA-GENE STRUCT EXPR, V1261, P439, DOI 10.1016/0167-4781(95)00051-H; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURBACH JPH, 1992, EUR J PHARM-MOLEC PH, V227, P1, DOI 10.1016/0922-4106(92)90136-J; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DUMONT Y, 1990, EUR J PHARMACOL, V191, P501, DOI 10.1016/0014-2999(90)94189-5; DUMONT Y, 1992, PROG NEUROBIOL, V38, P125, DOI 10.1016/0301-0082(92)90038-G; EVA C, 1992, FEBS LETT, V314, P285, DOI 10.1016/0014-5793(92)81490-D; GEARING DP, 1989, EMBO J, V8, P3667, DOI 10.1002/j.1460-2075.1989.tb08541.x; GERARD NP, 1991, BIOCHEMISTRY-US, V30, P10640, DOI 10.1021/bi00108a006; GRANDT D, 1994, REGUL PEPTIDES, V51, P151, DOI 10.1016/0167-0115(94)90204-6; GRUNDEMAR L, 1992, EUR J PHARMACOL, V232, P271; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HARDING RK, 1989, PEPTIDES, V10, P21, DOI 10.1016/0196-9781(89)90069-7; HARRIGAN MT, 1991, MOL ENDOCRINOL, V5, P1331, DOI 10.1210/mend-5-9-1331; HERZOG H, 1992, P NATL ACAD SCI USA, V89, P5794, DOI 10.1073/pnas.89.13.5794; HESS JF, 1992, BIOCHEM BIOPH RES CO, V184, P260, DOI 10.1016/0006-291X(92)91187-U; JORGENSEN JC, 1990, EUR J PHARMACOL, V186, P105, DOI 10.1016/0014-2999(90)94065-6; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; KLUXEN FW, 1992, P NATL ACAD SCI USA, V89, P4618, DOI 10.1073/pnas.89.10.4618; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KRAUSE J, 1992, MOL PHARMACOL, V41, P817; LABURTHE M, 1990, TRENDS ENDOCRIN MET, V1, P168, DOI 10.1016/1043-2760(90)90031-W; LARHAMMAR D, 1992, J BIOL CHEM, V267, P10935; LI W, 1991, BRAIN RES, V553, P167, DOI 10.1016/0006-8993(91)90246-R; LI XJ, 1992, J BIOL CHEM, V267, P9; McCormick M, 1987, Methods Enzymol, V151, P445, DOI 10.1016/S0076-6879(87)51036-9; MCDONALD TJ, 1993, REGUL PEPTIDES, V44, P33, DOI 10.1016/0167-0115(93)90128-U; MCTIGUE DM, 1993, AM J PHYSIOL, V265, pG1169, DOI 10.1152/ajpgi.1993.265.6.G1169; MORLEY JE, 1990, ANN NY ACAD SCI, V611, P226; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Sambrook J, 1989, MOL CLONING LABORATO; SCHWARTZ TW, 1983, GASTROENTEROLOGY, V85, P1141; SCHWARZ H, 1994, J NEUROIMMUNOL, V51, P53, DOI 10.1016/0165-5728(94)90128-7; SHIGERI Y, 1994, J BIOL CHEM, V269, P8842; WAHLESTEDT C, 1993, ANNU REV PHARMACOL, V33, P309, DOI 10.1146/annurev.pa.33.040193.001521; WAHLESTEDT CL, 1987, FERNSTROM F SERIES, V10, P231; WARDEN D, 1968, J GEN VIROL, V3, P371, DOI 10.1099/0022-1317-3-3-371; ZGOMBICK JM, 1993, MOL PHARMACOL, V44, P575	46	239	249	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26758	26761		10.1074/jbc.270.45.26758	http://dx.doi.org/10.1074/jbc.270.45.26758			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592910	hybrid			2022-12-27	WOS:A1995TE58300010
J	SMITH, JB; HERSCHMAN, HR				SMITH, JB; HERSCHMAN, HR			GLUCOCORTICOID-ATTENUATED RESPONSE GENES ENCODE INTERCELLULAR MEDIATORS, INCLUDING A NEW C-X-C CHEMOKINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DEGRADATION; NITRIC-OXIDE SYNTHASE; IMMEDIATE-EARLY GENE; GROWTH-FACTOR-BETA; SWISS 3T3 CELLS; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; IDENTIFICATION; INTERFERON; INDUCTION	A major part of the anti-inflammatory effect of glucocorticoids is attributable to their attenuation of the induction of genes whose products mediate intercellular interactions, e.g. cytokines and the inducible forms of prostaglandin synthase and nitric oxide synthase. We hypothesized that (i) there exists a class of immediate-early/primary response genes whose induction by inflammatory agents, mitogens, and other stimuli is attenuated by glucocorticoids, and (ii) the products of these glucocorticoid-attenuated response genes (GARGs) function predominantly in paracrine cell processes. We constructed a lambda cDNA library from transforming growth factor beta 1-pretreated murine Swiss 3T3 cells stimulated with lipopolysaccharide (LPS) or serum in the presence of cycloheximide, screened 15,000 plaques by differential hybridization, and cloned 12 LPS-induced, dexamethasone-attenuated cDNAs. Seven were previously known. Six of these encode intercellular mediators (thrombospondin-1, MCSF, JE/MCP-1, MARC/fic/MCP-3, crg2/IP-10, and cyr61); one encodes a protein of unknown function (IRG2). Thus, a large majority of these GARG cDNAs encode intercellular mediators, as hypothesized. Of the five GARG cDNAs not previously known, one encodes a novel member of the CXC chemokine family, designated LM (LPS-induced CXC chemokine). The predicted LM protein has a 40-amino acid signal sequence and a 92-amino acid mature peptide with a distinctive COOH-terminal region. Surprisingly, segments of the 3'-untranslated regions of LIX and two other CXC chemokines have substantially greater nucleotide sequence homology than do their coding regions. These segments may perform an unknown regulatory function. The LM message is strongly induced by LPS in fibroblasts, but not in macrophages, suggesting that LM may participate in the recruitment of inflammatory cells by injured or infected tissue.	UNIV CALIF LOS ANGELES,CTR HLTH SCI,SCH MED,DEPT BIOL CHEM,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,DIV NEONATOL,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,SCH MED,DEPT PHARMACOL,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,SCH MED,INST MOLEC BIOL,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,SCH MED,STRUCT BIOL & MOLEC MED LAB,LOS ANGELES,CA 90095	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024797] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24797] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTA JA, 1994, J BIOL CHEM, V269, P4532; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMANO Y, 1993, MOL PHARMACOL, V43, P176; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; BRETZ JD, 1994, P NATL ACAD SCI USA, V91, P7306, DOI 10.1073/pnas.91.15.7306; BRUNNER A, 1991, DNA CELL BIOL, V10, P293, DOI 10.1089/dna.1991.10.293; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARKLEWIS I, 1994, J BIOL CHEM, V269, P16075; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; DELAMARTER JF, 1987, NUCLEIC ACIDS RES, V15, P2389, DOI 10.1093/nar/15.5.2389; DELPHIN S, 1995, J EXP MED, V181, P181, DOI 10.1084/jem.181.1.181; DENG ZW, 1994, BIOCHEM BIOPH RES CO, V203, P1809, DOI 10.1006/bbrc.1994.2397; DEWAAL RMW, 1994, MOL BIOL REP, V19, P81, DOI 10.1007/BF00997151; FARBER JM, 1992, MOL CELL BIOL, V12, P1535, DOI 10.1128/MCB.12.4.1535; FENG L, 1994, AM J PHYSIOL, V266, pF713, DOI 10.1152/ajprenal.1994.266.5.F713; FRETER RR, 1992, MOL CELL BIOL, V12, P5288, DOI 10.1128/MCB.12.12.5288; GILBERT RS, 1993, J CELL PHYSIOL, V157, P128, DOI 10.1002/jcp.1041570117; GILBERT RS, 1993, BIOCHEM BIOPH RES CO, V195, P380, DOI 10.1006/bbrc.1993.2054; GILBERT RS, 1994, J CELL PHYSIOL, V159, P67, DOI 10.1002/jcp.1041590110; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; GODAMBE SA, 1994, J IMMUNOL, V153, P143; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; GOODMAN RB, 1992, BIOCHEMISTRY-US, V31, P10483, DOI 10.1021/bi00158a011; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; HEINRICH JN, 1993, MOL CELL BIOL, V13, P2020, DOI 10.1128/MCB.13.4.2020; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HERSCHMAN HR, 1993, J LIPID MEDIATOR, V6, P89; HOU JZ, 1994, P NATL ACAD SCI USA, V91, P11641, DOI 10.1073/pnas.91.24.11641; JONAT G, 1990, CELL, V62, P1189; KAWAHARA RS, 1991, J BIOL CHEM, V266, P13261; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KUJUBU DA, 1991, J BIOL CHEM, V266, P12866; KUJUBU DA, 1992, J BIOL CHEM, V267, P7991; KULMBURG PA, 1992, J EXP MED, V176, P1773, DOI 10.1084/jem.176.6.1773; LEE CGL, 1994, J IMMUNOL, V152, P5758; LEOF EB, 1986, J CELL PHYSIOL, V127, P83, DOI 10.1002/jcp.1041270111; LIM RW, 1987, ONCOGENE, V1, P263; LUSTER AD, 1993, J EXP MED, V178, P1057, DOI 10.1084/jem.178.3.1057; LUSTINARASIMHAN M, 1995, J BIOL CHEM, V270, P2716, DOI 10.1074/jbc.270.6.2716; MANSFIELD PJ, 1994, J IMMUNOL, V153, P4219; MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17; NICOSIA RF, 1994, J CELL BIOL, V124, P183, DOI 10.1083/jcb.124.1.183; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569; OHMORI Y, 1990, BIOCHEM BIOPH RES CO, V168, P1261, DOI 10.1016/0006-291X(90)91164-N; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; PROOST P, 1993, BIOCHEMISTRY-US, V32, P10170, DOI 10.1021/bi00089a037; RAMEH LE, 1992, MOL CELL BIOL, V12, P4612, DOI 10.1128/MCB.12.10.4612; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; ROLLINS BJ, 1991, CANCER CELL-MON REV, V3, P517; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; THIRION S, 1994, BIOCHEM BIOPH RES CO, V201, P493, DOI 10.1006/bbrc.1994.1729; TUSZYNSKI GP, 1993, J CELL BIOL, V120, P513, DOI 10.1083/jcb.120.2.513; VANGURI P, 1990, J BIOL CHEM, V265, P15049; VICIAN L, 1995, P NATL ACAD SCI USA, V92, P2164, DOI 10.1073/pnas.92.6.2164; VONHEIJNE G, 1984, J MOL BIOL, V173, P243, DOI 10.1016/0022-2836(84)90192-X; WALZ A, 1991, J EXP MED, V174, P1355, DOI 10.1084/jem.174.6.1355; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V	64	77	78	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16756	16765		10.1074/jbc.270.28.16756	http://dx.doi.org/10.1074/jbc.270.28.16756			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622488	hybrid			2022-12-27	WOS:A1995RJ34700048
J	TOUHARA, K; KOCH, WJ; HAWES, BE; LEFKOWITZ, RJ				TOUHARA, K; KOCH, WJ; HAWES, BE; LEFKOWITZ, RJ			MUTATIONAL ANALYSIS OF THE PLECKSTRIN HOMOLOGY DOMAIN OF THE BETA-ADRENERGIC-RECEPTOR KINASE - DIFFERENTIAL-EFFECTS ON G(BETA-GAMMA) AND PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; G-PROTEINS; GAMMA-SUBUNITS; DEPENDENT PHOSPHORYLATION; SIGNALING PROTEINS; PH DOMAIN; ACTIVATION	The beta gamma subunits of heterotrimeric G proteins (G(beta gamma)) play a variety of roles in cellular signaling, one of which is membrane targeting of the beta-adrenergic receptor kinase (beta ARK). This is accomplished via a physical interaction of G(beta gamma) and a domain within the carboxyl terminus of beta ARK which overlaps with a pleckstrin homology (PH) domain. The PH domain of beta ARK not only binds G(beta gamma) but also interacts with phosphatidylinositol 4,5-bisphosphate (PIP2). Based on previous mapping of the G(beta gamma) binding region of beta ARK, and conserved residues within the PH domain, we have constructed a series of mutants in the carboxyl terminus of beta ARK in order to determine important residues involved in G(beta gamma) and PIP2 binding. To examine the effects of mutations on G(beta gamma) binding, we employed three different methodologies: direct G(beta gamma) binding to GST fusion proteins; the ability of GST fusion proteins to inhibit G(beta gamma)-mediated beta ARK translocation to rhodopsin-enriched rod outer segments; and the ability of mutant peptides expressed in cells to inhibit G(beta gamma)-mediated inositol phosphate accumulation. Direct PIP2 binding was also assessed on mutant GST fusion proteins. Ala residue insertion following Trp(643) completely abolished the ability of beta ARK to bind G(beta gamma), suggesting that a proper alpha-helical conformation is necessary for the G(beta gamma).beta ARK interaction. In contrast, this insertional mutation had no effect on PIP2 binding. Both G(beta gamma) binding and PIP2 binding were abolished following Ala replacement of Trp(643), suggesting that this conserved residue within the last subdomain of the PH domain is crucial for both interactions. Other mutations also produced differential effects on the physical interactions of the beta ARK carboxyl terminus with G(beta gamma) and PIP2. These results suggest that the last PH subdomain and its neighboring sequences within the carboxyl terminus of beta ARK, including Trp(643), Leu(647), and residues Lys(663)-Arg(669), are critical for G(beta gamma) binding while Trp(643) and residues Asp(635)-Glu(639) are important for the PH domain to form the correct structure for binding to PIP2.	DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT BIOCHEM,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710	Duke University; Howard Hughes Medical Institute; Duke University; Duke University			Lefkowitz, Robert/AAW-2649-2021		NHLBI NIH HHS [HL16037] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOEKHOFF I, 1994, J BIOL CHEM, V269, P37; CASSILL JA, 1993, P NATL ACAD SCI USA, V88, P11067; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; DAVIS LH, 1994, J BIOL CHEM, V269, P4409; DAYHOFF MO, 1978, ATLAS PROTEIN SEQ S3, V2; FAURE M, 1994, J BIOL CHEM, V269, P7851; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; HAGA K, 1992, J BIOL CHEM, V267, P2222; HAGA K, 1990, FEBS LETT, V268, P43, DOI 10.1016/0014-5793(90)80968-O; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HASLAM RJ, 1993, NATURE, V363, P310; HAWES BE, 1994, J BIOL CHEM, V269, P29825; INGLESE J, 1995, TRENDS BIOCHEM SCI, V20, P151, DOI 10.1016/S0968-0004(00)88992-6; INGLESE J, 1994, P NATL ACAD SCI USA, V91, P3637, DOI 10.1073/pnas.91.9.3637; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; INGLESE J, 1993, J BIOL CHEM, V268, P23735; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; LUTTRELL LM, 1995, J BIOL CHEM, V270, P12984, DOI 10.1074/jbc.270.22.12984; MACIAS MJ, 1994, NATURE, V369, P675, DOI 10.1038/369675a0; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; PARRUTI G, 1993, BIOCHEM BIOPH RES CO, V190, P475, DOI 10.1006/bbrc.1993.1072; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; SHAW G, 1993, BIOCHEM BIOPH RES CO, V195, P1145, DOI 10.1006/bbrc.1993.2164; SIMONDS WF, 1993, TRENDS BIOCHEM SCI, V18, P315; TAKAO K, 1994, NEURON, V13, P747, DOI 10.1016/0896-6273(94)90041-8; TIMM D, 1994, NAT STRUCT BIOL, V1, P782, DOI 10.1038/nsb1194-782; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; TSUKADA S, 1994, P NATL ACAD SCI USA, V91, P11256, DOI 10.1073/pnas.91.23.11256; WANG DS, 1994, BIOCHEM BIOPH RES CO, V203, P29, DOI 10.1006/bbrc.1994.2144; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297; YAO L, 1994, P NATL ACAD SCI USA, V91, P9175, DOI 10.1073/pnas.91.19.9175; YOON HS, 1994, NATURE, V369, P672, DOI 10.1038/369672a0	39	111	112	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					17000	17005		10.1074/jbc.270.28.17000	http://dx.doi.org/10.1074/jbc.270.28.17000			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622521	hybrid			2022-12-27	WOS:A1995RJ34700082
J	HAYSLETT, JP; MACALA, LJ; SMALLWOOD, JI; KALGHATGI, L; GASSALAHERRAIZ, J; ISALES, C				HAYSLETT, JP; MACALA, LJ; SMALLWOOD, JI; KALGHATGI, L; GASSALAHERRAIZ, J; ISALES, C			VASOPRESSIN-STIMULATED ELECTROGENIC SODIUM-TRANSPORT IN A6 CELLS IS LINKED TO A CA2+-MOBILIZING SIGNAL MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CORTICAL COLLECTING TUBULE; ADENYLATE-CYCLASE; CYCLIC-AMP; INTRACELLULAR CALCIUM; NA-TRANSPORT; FORSKOLIN; CAMP; ADENOSINE; DUCT	Vasopressin is known to activate two types of cell surface receptors; V-2, coupled to adenylate cyclase, and V-1, linked to a Ca2+-dependent transduction system. We investigated whether arginine vasopressin (AVP) stimulation of electrogenic sodium transport in A6 cells, derived from Xenopus laevis, is mediated by activation of either one or both types of AVP-specific receptors. AVP caused a rapid increase in electrogenic sodium transport, reflected by the transepithelial potential difference (V-T) and equivalent short circuit current (I-eq) measurements. AVP also rapidly increased intracellular Ca2+ (Ca-i(2+)) and total inositol trisphosphate. The increase in I-eq was dependent on the rise in (Ca-i(2+)), because 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) dose-dependently inhibited the I-eq response. There was no evidence, however, that activation of adenylate cyclase mediated AVP-stimulated I-eq; transport was not inhibited after AVP-induced activation of adenylate cyclase was abolished by 2',5'-dideoxyadenosine or when cAMP-dependent protein kinase (PKA) activity was abolished by the specific PKA inhibitor IP20. Further studies showed that although both forskolin and 8-(4-chlorophenylthio)-cAMP stimulated I-eq, this occurred by mechanisms independent of PKA activation. These results indicate that AVP-stimulated Na+ transport is mediated by a V-1 receptor and a Ca2+-dependent mechanism.	MED COLL GEORGIA,INST MOLEC MED,AUGUSTA,GA 30912	University System of Georgia; Augusta University	HAYSLETT, JP (corresponding author), YALE UNIV,SCH MED,DEPT INTERNAL MED,333 CEDAR ST,LMP 2076,NEW HAVEN,CT 06510, USA.		Isales, Carlos/J-9902-2013	Isales, Carlos/0000-0002-4480-3484	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019813, R37DK019813, R01DK018061] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 19813, DK 18061] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AFTAB DT, 1991, MOL PHARMACOL, V40, P798; ANDO Y, 1988, NEWS PHYSIOL SCI, V3, P235; BREYER MD, 1991, AM J PHYSIOL, V260, pF1, DOI 10.1152/ajprenal.1991.260.1.F1; BREYER MD, 1991, J CLIN INVEST, V88, P1502, DOI 10.1172/JCI115460; BURNATOWSKAHLED.MA, 1989, J CLIN INVEST, V83, P84; BURNATOWSKAHLED.MA, 1991, AM J PHYSIOL, V260, pC143; CHENG HC, 1986, J BIOL CHEM, V261, P989; DEWIT RJW, 1982, EUR J BIOCHEM, V122, P95; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DILLINGHAM MA, 1985, J MEMBRANE BIOL, V88, P277, DOI 10.1007/BF01871091; FELDER CC, 1990, AM J PHYSIOL, V259, pF297, DOI 10.1152/ajprenal.1990.259.2.F297; FLORES JA, 1992, ENDOCRINOLOGY, V130, P1862, DOI 10.1210/en.130.4.1862; HAYS RM, 1987, KIDNEY INT, V31, P530, DOI 10.1038/ki.1987.32; HAYSLETT JP, 1995, KIDNEY INT, V47, P1576, DOI 10.1038/ki.1995.221; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; HIDAKA H, 1981, P NATL ACAD SCI-BIOL, V78, P4354, DOI 10.1073/pnas.78.7.4354; JARD S, 1985, FRONTIERS HORMONE RE, V13, P89; JOOST HG, 1988, MOL PHARMACOL, V33, P449; KEMP BE, 1977, J BIOL CHEM, V252, P4888; LAURENZA A, 1989, TRENDS PHARMACOL SCI, V10, P442, DOI 10.1016/S0165-6147(89)80008-2; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; ORLOFF J, 1962, J CLIN INVEST, V41, P702, DOI 10.1172/JCI104528; PETZEL D, 1992, J CLIN INVEST, V89, P150, DOI 10.1172/JCI115555; RISS TL, 1980, J LIQ CHROMATOGR, V3, P133, DOI 10.1080/01483918008060160; RODRIGUEZCOMMES J, 1994, KIDNEY INT, V46, P666, DOI 10.1038/ki.1994.319; SAGE SO, 1989, BIOCHEM J, V258, P923, DOI 10.1042/bj2580923; SATOH T, 1992, J CLIN INVEST, V89, P1496, DOI 10.1172/JCI115740; SEAMON KB, 1986, ADV CYCLIC NUCL PROT, V20, P1; SEAMON KB, 1984, P NATL ACAD SCI-BIOL, V81, P5081, DOI 10.1073/pnas.81.16.5081; SMOLEN JE, 1981, BIOCHIM BIOPHYS ACTA, V677, P512, DOI 10.1016/0304-4165(81)90267-1; SORBERA LA, 1991, SCIENCE, V253, P1286, DOI 10.1126/science.1653970; TORPHY TJ, 1982, J BIOL CHEM, V257, P1609; WAGONER PK, 1988, SCIENCE, V240, P1655, DOI 10.1126/science.2454507; WHITE MM, 1988, MOL PHARMACOL, V34, P427; WINDHAGER EE, 1983, ANNU REV PHYSIOL, V45, P519, DOI 10.1146/annurev.ph.45.030183.002511; WOLFF J, 1981, ADV CYCL NUCL RES<D>, V14, P199; WONG SME, 1988, AM J PHYSIOL, V255, pF1015	37	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16082	16088		10.1074/jbc.270.27.16082	http://dx.doi.org/10.1074/jbc.270.27.16082			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608170	hybrid			2022-12-27	WOS:A1995RH22600033
J	WU, DQ; KUANG, YN; WU, YP; JIANG, HP				WU, DQ; KUANG, YN; WU, YP; JIANG, HP			SELECTIVE COUPLING OF BETA(2)-ADRENERGIC RECEPTOR TO HEMATOPOIETIC-SPECIFIC G-PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC RECEPTORS; PHOSPHOLIPASE-C BETA; ALPHA-SUBUNITS; SIGNAL-TRANSDUCTION; ACTIVATION; CELLS; ADRENOCEPTOR; LYMPHOCYTES; DENSITY; GAMMA	The coupling of the beta(2)-adrenergic receptor (AR) to the or subunits of the Gq class of G proteins was investigated in a cotransfection system, COS-7 cells cotransfected with the beta(2)-AR cDNA and the G alpha(15) or G alpha(16) cDNA showed marked norepinephrine-induced increases in accumulation of inositol phosphates in a concentration-dependent manner. However, cells cotransfected with the cDNA encoding G alpha q, G alpha(11), or G alpha(14) instead of G alpha(16) gave no ligand-dependent activation of phospholipase C (PLC). The facts that the beta-AR agonist isoprenaline can also induce activation of PLC in cells coexpressing beta(2)-AR and G alpha(16) and that the beta(2)-AR-specific antagonist propranolol can block norepinephrine-induced activation of PLC in these cotransfected cells further indicate that it is the beta(2)-AR that mediates the activation of phospholipase C in these cotransfected cells. To test the possibility of involvement of G beta gamma, a G beta gamma antagonist, G gamma 3 mutant with substitution of a Ser residue for the C-terminal Cys residue, was used because this protein, when expressed in COS-7 cells, can inhibit only G beta gamma-mediated but not G alpha-mediated activation of PLC. The result that the G gamma 3 mutant could not inhibit beta(2)-adrenergic receptor-mediated activation of PLC in cells cotransfected with the G alpha(16) cDNA suggests that G beta gamma is unlikely to be a major mediator of beta(2)-adrenergic receptor-induced activation of PLC. Thus, we conclude that the beta(2)-adrenergic receptor can specifically couple to G alpha(15) and G alpha(16), but not to G alpha g, G alpha(11), or G alpha(14) to activate PLC.	UNIV ROCHESTER,MED CTR,DEPT BIOCHEM,ROCHESTER,NY 14642	University of Rochester	WU, DQ (corresponding author), UNIV ROCHESTER,MED CTR,DEPT PHARMACOL,ROCHESTER,NY 14642, USA.							AMATRUDA TT, 1991, P NATL ACAD SCI USA, V88, P5587, DOI 10.1073/pnas.88.13.5587; AMATRUDA TT, 1993, J BIOL CHEM, V268, P10139; BARTIK MM, 1993, CELL IMMUNOL, V148, P408, DOI 10.1006/cimm.1993.1122; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V90, P163; BISHOPRIC NH, 1980, J ALLERGY CLIN IMMUN, V65, P29, DOI 10.1016/0091-6749(80)90173-6; BLALOCK JE, 1989, PHYSIOL REV, V69, P1, DOI 10.1152/physrev.1989.69.1.1; BRODDE OE, 1986, SCIENCE, V231, P1584, DOI 10.1126/science.3006250; DANTZER R, 1989, LIFE SCI, V44, P1995, DOI 10.1016/0024-3205(89)90345-7; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; FELDMAN RD, 1987, IMMUNOL REV, V100, P225; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRIESE M, 1988, EUR J CLIN INVEST, V18, P213, DOI 10.1111/j.1365-2362.1988.tb02416.x; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; HATFIELD SM, 1986, J PHARMACOL EXP THER, V239, P460; KATZ A, 1992, NATURE, V360, P686, DOI 10.1038/360686a0; KHAN MM, 1986, BIOCHEM PHARMACOL, V35, P1137, DOI 10.1016/0006-2952(86)90150-4; KRAUSE A, 1992, EUR J CLIN INVEST, V22, P47; LEE CH, 1992, J BIOL CHEM, V267, P16044; LEFKOWITZ RJ, 1988, J BIOL CHEM, V263, P4993; LI YS, 1990, IMMUNOLOGY, V69, P367; MEURS H, 1987, J ALLERGY CLIN IMMUN, V80, P326, DOI 10.1016/0091-6749(87)90039-X; PARK D, 1992, J BIOL CHEM, V267, P16048; PLAUT M, 1987, ANNU REV IMMUNOL, V5, P521; POCHET R, 1983, BIOCHEM PHARMACOL, V32, P1651, DOI 10.1016/0006-2952(83)90344-1; ROONEY TA, 1991, J BIOL CHEM, V266, P15068; SEVERN A, 1992, J IMMUNOL, V148, P3441; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; TALMADGE J, 1993, INT J IMMUNOPHARMACO, V15, P219, DOI 10.1016/0192-0561(93)90098-J; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; VAZIRI C, 1992, BIOCHEM J, V284, P917, DOI 10.1042/bj2840917; WILKIE TM, 1991, P NATL ACAD SCI USA, V88, P10049, DOI 10.1073/pnas.88.22.10049; WONG SKF, 1990, J BIOL CHEM, V265, P6219; WONG YH, 1992, SCIENCE, V255, P339, DOI 10.1126/science.1347957; WU D, 1992, J BIOL CHEM, V267, P25793; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297; WU DQ, 1993, J BIOL CHEM, V268, P3704; WU DQ, 1992, J BIOL CHEM, V267, P1811	40	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16008	16010		10.1074/jbc.270.27.16008	http://dx.doi.org/10.1074/jbc.270.27.16008			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608160	hybrid			2022-12-27	WOS:A1995RH22600021
J	HO, MY; CARTER, DA; ANG, HL; MURPHY, D				HO, MY; CARTER, DA; ANG, HL; MURPHY, D			BOVINE OXYTOCIN TRANSGENES IN MICE - HYPOTHALAMIC EXPRESSION, PHYSIOLOGICAL REGULATION, AND INTERACTIONS WITH THE VASOPRESSIN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; RAT; STIMULATION; RESPONSES; PROMOTER; NEURONS; NEUROPHYSIN; SEQUENCE; ELEMENT; SYSTEM	To gain insights into the molecular mechanisms that restrict the expression of the oxytocin gene to anatomically defined groups of neurons in the hypothalamus, we generated transgenic mice bearing bovine oxytocin genomic fragments, Appropriate neuron specific and physiological regulation was observed in mice bearing transgene bOT3.5, which consists of the oxytocin structural gene flanked by 0.6 kilobase pair (kbp) of upstream and 1.9 kbp of downstream sequences, bOT3.5 is expressed in oxytocin magnocellular neurons in the mouse supraoptic nucleus and paraventricular nucleus, but transgene RNAs are excluded from vasopressin neurons, Replacement of the drinking diet of the transgenic mice with 2% (w/v) NaCl for 7 days significantly increased the abundance of bovine oxytocin transcripts in the supraoptic nucleus, but not in the paraventricular nucleus, in parallel with the endogenous mouse oxytocin RNA. Surprisingly, mimicry of the endogenous oxytocin gene expression pattern was lost with larger transgenes, Addition of 0.7 kbp of contiguous downstream sequences (transgene bOT) or linkage to the bovine vasopressin gene (transgene VP-B/bOT3.5) repressed hypothalamic expression, No mice were derived bearing transgene bOT6.4, which consists of the oxytocin structural gene flanked by 3 kbp of upstream and 2.6 kbp of downstream sequences, suggesting that the presence of this DNA is detrimental to normal embryonic development, These data suggest that while bOT3.5 contains sufficient cis-acting sequences to mediate expression to particular subsets of hypothalamic neurons, the overall regulation of the oxytocin gene is governed by multiple interacting enhancers and repressors.	INST MOLEC & CELL BIOL,NEUROPEPTIDE LAB,SINGAPORE 0511,SINGAPORE	Agency for Science Technology & Research (ASTAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)			Carter, David/A-4479-2010; Murphy, David/C-3967-2012	Carter, David/0000-0002-8419-3975; Murphy, David/0000-0003-2946-0353				ADAN RAH, 1991, BIOCHEM BIOPH RES CO, V175, P117, DOI 10.1016/S0006-291X(05)81208-2; ADAN RAH, 1992, J BIOL CHEM, V267, P3771; ANG HL, 1993, EMBO J, V12, P2397, DOI 10.1002/j.1460-2075.1993.tb05894.x; ANG HL, 1994, J ENDOCRINOL, V140, P53, DOI 10.1677/joe.0.1400053; ANG HL, 1991, ENDOCRINOLOGY, V128, P2110, DOI 10.1210/endo-128-4-2110; AXELSON JF, 1990, J NEUROENDOCRINOL, V2, P209, DOI 10.1111/j.1365-2826.1990.tb00852.x; BELENKY M, 1992, BRAIN RES, V583, P279, DOI 10.1016/S0006-8993(10)80034-4; BROWNSTEIN MJ, 1980, SCIENCE, V207, P373, DOI 10.1126/science.6153132; BURBACH JPH, 1984, NEUROENDOCRINOLOGY, V39, P582; BURBACH JPH, 1990, J NEUROENDOCRINOL, V2, P633; DALE HH, 1906, J PHYSIOL-LONDON, V34, P165; Gainer Harold, 1994, P1099; HARA Y, 1990, MOL BRAIN RES, V8, P319, DOI 10.1016/0169-328X(90)90045-F; HERMAN JP, 1991, MOL ENDOCRINOL, V5, P1447, DOI 10.1210/mend-5-10-1447; IVELL R, 1991, J NEUROENDOCRINOL, V3, P583, DOI 10.1111/j.1365-2826.1991.tb00321.x; IVELL R, 1986, EMBO J, V5, P971, DOI 10.1002/j.1460-2075.1986.tb04311.x; KIYAMA H, 1990, J NEUROENDOCRINOL, V2, P257, DOI 10.1111/j.1365-2826.1990.tb00401.x; LEFEBVRE DL, 1994, ENDOCRINOLOGY, V134, P2556, DOI 10.1210/en.134.6.2556; LEFEBVRE DL, 1992, SCIENCE, V256, P1553, DOI 10.1126/science.1598587; LEFEBVRE DL, 1994, ENDOCRINOLOGY, V134, P2562, DOI 10.1210/en.134.6.2562; LIGHTMAN SL, 1987, J PHYSIOL-LONDON, V394, P23, DOI 10.1113/jphysiol.1987.sp016858; MAZEY E, 1991, ENDOCRINOLOGY, V129, P1814; MOHR E, 1988, FEBS LETT, V242, P144, DOI 10.1016/0014-5793(88)81003-2; MURPHY D, 1990, MOL ENDOCRINOL, V4, P1051, DOI 10.1210/mend-4-7-1051; MURPHY D, 1993, ANN NY ACAD SCI, V689, P91, DOI 10.1111/j.1749-6632.1993.tb55540.x; MURPHY D, 1992, Current Opinion in Cell Biology, V4, P274, DOI 10.1016/0955-0674(92)90043-C; MURPHY D, 1993, TRANSGENIC TECHNIQUE; OTT L, 1911, P SOC EXP BIOL MED, V8, P48; RENAUD LP, 1991, PROG NEUROBIOL, V36, P131, DOI 10.1016/0301-0082(91)90020-2; RICHARD S, 1991, J BIOL CHEM, V266, P21428; RICHARD S, 1990, J BIOL CHEM, V265, P6098; RICHARD S, 1991, Molecular and Cellular Neuroscience, V2, P501; RUPPERT S, 1984, NATURE, V308, P554, DOI 10.1038/308554a0; SCHMITZ E, 1991, DNA CELL BIOL, V10, P81, DOI 10.1089/dna.1991.10.81; SHERMAN TG, 1988, J NEUROSCI, V8, P3785; VANTOL HHM, 1987, ENDOCRINOLOGY, V120, P71, DOI 10.1210/endo-120-1-71; VANTOL HHM, 1988, ENDOCRINOLOGY, V122, P945, DOI 10.1210/endo-122-3-945; YOUNG WS, 1990, J NEUROENDOCRINOL, V2, P917, DOI 10.1111/j.1365-2826.1990.tb00660.x; ZENG Q, 1994, J NEUROENDOCRINOL, V6, P469, DOI 10.1111/j.1365-2826.1994.tb00610.x; ZINGG HH, 1986, J BIOL CHEM, V261, P2956	40	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27199	27205		10.1074/jbc.270.45.27199	http://dx.doi.org/10.1074/jbc.270.45.27199			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592977	hybrid			2022-12-27	WOS:A1995TE58300077
J	LIU, PS; ANDERSON, RGW				LIU, PS; ANDERSON, RGW			COMPARTMENTALIZED PRODUCTION OF CERAMIDE AT THE CELL-SURFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; MA104 CELLS; RECEPTOR; CAVEOLAE; PROTEIN; FOLATE; CHOLESTEROL; BINDING; INTERNALIZATION; FIBROBLASTS	Ceramide produced by the hydrolysis of sphingomyelin is an important cellular intermediate in hormone action. Here, we present evidence that interleukin 1 beta (IL-1 beta) binding to normal human fibroblasts initiates a lipid messenger cascade that takes place in a sphingomyelin-rich plasma membrane domain with the characteristics of caveolae. Hormone binding first stimulated the appearance of diacylglycerol (DAG) in a caveolea-rich membrane fraction isolated from whole cells, This was immediately followed by the loss of a resident population of sphingomyelin from the fraction and the concomitant appearance of ceramide. The ceramide produced in response to IL-1 beta blocked platelet-derived growth factor-stimulated DNA synthesis, IL-1 beta stimulated the appearance of DAG in other fractions from the same cell, but this DAG was not coupled to ceramide production. This indicates that ceramide production is highly compartmentalized at the cell surface. Since caveolae are known to be involved in membrane internalization, they may be essential for the delivery of ceramide to a site of action within the cell.	UNIV TEXAS,SW MED CTR,DEPT CELL BIOL & NEUROSCI,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas			Liu, Pingsheng/B-7124-2012		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043169] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 20948] Funding Source: Medline; NIGMS NIH HHS [GM 43169] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOHUSLAV J, 1993, EUR J IMMUNOL, V23, P825, DOI 10.1002/eji.1830230409; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CHANG WJ, 1992, J CELL BIOL, V118, P63, DOI 10.1083/jcb.118.1.63; CHANG WJ, 1994, J CELL BIOL, V126, P127, DOI 10.1083/jcb.126.1.127; CHATTERJEE S, 1993, J BIOL CHEM, V268, P3401; CHATTERJEE S, 1994, J BIOL CHEM, V269, P879; CHUN MY, 1994, P NATL ACAD SCI USA, V91, P11728, DOI 10.1073/pnas.91.24.11728; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; FAN JY, 1983, J CELL SCI, V61, P219; FUJIMOTO T, 1992, J CELL BIOL, V119, P1507, DOI 10.1083/jcb.119.6.1507; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; GO M, 1987, BIOCHEM BIOPH RES CO, V144, P598; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; KAMEN BA, 1989, J CLIN INVEST, V84, P1379, DOI 10.1172/JCI114310; KAMEN BA, 1988, J BIOL CHEM, V263, P13602; KAMEN BA, 1991, J CLIN INVEST, V87, P1442, DOI 10.1172/JCI115150; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; KOLESNICK RN, 1987, J BIOL CHEM, V262, P16759; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; MERRILL AH, 1991, J BIOENERG BIOMEMBR, V23, P83; MONTESANO R, 1982, NATURE, V296, P651, DOI 10.1038/296651a0; MONTESANO R, 1979, NATURE, V280, P328, DOI 10.1038/280328a0; OKAZAKI T, 1994, J BIOL CHEM, V269, P4070; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; PRASAD PD, 1994, BBA-MOL CELL RES, V1222, P309, DOI 10.1016/0167-4889(94)90184-8; ROETTGER BF, 1995, J CELL BIOL, V128, P1029, DOI 10.1083/jcb.128.6.1029; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; ROTHBERG KG, 1990, J CELL BIOL, V110, P637, DOI 10.1083/jcb.110.3.637; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SCHUTZE S, 1994, J LEUKOCYTE BIOL, V56, P533, DOI 10.1002/jlb.56.5.533; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; SIMIONESCU N, 1983, J CELL BIOL, V97, P1592, DOI 10.1083/jcb.97.5.1592; SIMIONESCU N, 1983, PHYSIOL REV, V63, P1536, DOI 10.1152/physrev.1983.63.4.1536; SLOTTE JP, 1988, BIOCHEM J, V250, P653, DOI 10.1042/bj2500653; SMART EJ, 1994, J CELL BIOL, V127, P1185, DOI 10.1083/jcb.127.5.1185; SMART EJ, 1994, J CELL BIOL, V124, P307, DOI 10.1083/jcb.124.3.307; SMART EJ, 1995, IN PRESS J CELL BIOL; SMART EJ, 1995, IN PRESS P NATL ACAD; STAHL A, 1995, J CELL BIOL, V129, P335, DOI 10.1083/jcb.129.2.335; SUCKLING KE, 1985, J LIPID RES, V26, P647; TRIGATTI BL, 1991, J BIOL CHEM, V266, P22621; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5	50	278	284	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27179	27185		10.1074/jbc.270.45.27179	http://dx.doi.org/10.1074/jbc.270.45.27179			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592974	hybrid			2022-12-27	WOS:A1995TE58300074
J	TOLIAS, KF; CANTLEY, LC; CARPENTER, CL				TOLIAS, KF; CANTLEY, LC; CARPENTER, CL			RHO-FAMILY GTPASES BIND TO PHOSPHOINOSITIDE KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLINOSITOL 3-KINASE; CELL POLARITY; PURIFICATION; CDC42	Rho family GTPases appear to play an important role in the regulation of the actin cytoskeleton, but the mechanism of regulation is unknown. Since phosphoinositide 3-kinase and phosphatidylinositol 4,5-bisphosphate have also been implicated in actin reorganization, we investigated the possibility that Rho family members interact with phosphoinositide kinases. We found that both GTP- and GDP-bound Rac1 associate with phosphatidylinositol-4-phosphate 5-kinase in vitro and in vivo. Phosphoinositide 3-kinase also bound to Rac1 and Cdc42Hs, and these interactions were GTP-dependent. Stimulation of Swiss 3T3 cells with platelet-derived growth factor induced the association of PI 3-kinase with Rac in immunoprecipitates. PI 3-kinase activity was also detected in Cdc42 immunoprecipitates from COS7 cells. These results suggest that phosphoinositide kinases are involved in Rho family signal transduction pathways and raise the possibility that the effects of Rho family members on the actin cytoskeleton are mediated in part by phosphoinositide kinases.	HARVARD UNIV,SCH MED,DEPT CELL BIOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; BETH ISRAEL HOSP,DIV SIGNAL TRANSDUCT,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center			Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653; Tolias, Kimberley/0000-0002-2092-920X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036624] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM36624] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; AUGER KR, 1989, J BIOL CHEM, V264, P20181; AUGER KR, 1992, J BIOL CHEM, V267, P5408; BAZENET CE, 1990, J BIOL CHEM, V265, P10812; Bretscher A, 1993, CURR OPIN CELL BIOL, V5, P653, DOI 10.1016/0955-0674(93)90136-E; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; CARPENTER CL, 1993, MOL CELL BIOL, V13, P1657, DOI 10.1128/MCB.13.3.1657; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; DIVECHA N, 1992, BIOCHEM J, V288, P637, DOI 10.1042/bj2880637; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; KAPELLER R, 1994, J BIOL CHEM, V269, P1927; KOTANI K, 1994, EMBO J, V13, P2313, DOI 10.1002/j.1460-2075.1994.tb06515.x; LING LE, 1989, J BIOL CHEM, V264, P5080; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P386; Salmon ED, 1989, CURR OPIN CELL BIOL, V1, P541, DOI 10.1016/0955-0674(89)90018-5; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; WENNSTROM S, 1994, CURR BIOL, V4, P385, DOI 10.1016/S0960-9822(00)00087-7; WENNSTROM S, 1994, ONCOGENE, V9, P651; ZHANG J, 1993, J BIOL CHEM, V268, P22251; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	25	407	409	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17656	17659		10.1074/jbc.270.30.17656	http://dx.doi.org/10.1074/jbc.270.30.17656			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629060	hybrid			2022-12-27	WOS:A1995RM26600005
J	VIGNERON, L; RUYSSCHAERT, JM; GOORMAGHTIGH, E				VIGNERON, L; RUYSSCHAERT, JM; GOORMAGHTIGH, E			FOURIER-TRANSFORM INFRARED-SPECTROSCOPY STUDY OF THE SECONDARY STRUCTURE OF THE RECONSTITUTED NEUROSPORA-CRASSA PLASMA-MEMBRANE H+-ATPASE AND OF ITS MEMBRANE-ASSOCIATED PROTEOLYTIC PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL ELECTROPHORESIS; HYDROGEN-DEUTERIUM EXCHANGE; NEGATIVELY STAINED CRYSTALS; LOW-DENSITY-LIPOPROTEIN; SARCOPLASMIC-RETICULUM; PURPLE MEMBRANE; PROTEIN BACTERIORHODOPSIN; CYTOPLASMIC LOCATION; RESOLUTION; AMINO	We reconstituted purified plasma membrane H+-ATPase from Neurospora crassa into soybean phospholipid vesicles (lipid/ATPase ratio of 5:1 w/w), The proteo-liposomes contained an active ATPase, oriented inside-out. They were subjected to proteolysis by using Pronase, proteinase K, trypsin, and carboxypeptidase Y. Fourier transform infrared attenuated total reflection spectroscopy indicates that the amount of protein remaining after hydrolysis and elimination of the extramembrane domain of ATPase represents about 43% of the intact protein. The secondary structure of intact ATPase and of the membrane-associated domain of ATPase was determined by infrared spectroscopy. The membrane domain shows a typical alpha-helix and beta-sheet absorption. Polarized infrared spectroscopy reveals that the orientation of the helices is about perpendicular to the membrane. Amide hydrogen/deuterium exchange kinetics performed for the intact H+-ATPase and for the membrane-associated domain demonstrate that this part of ATPase shows less accessibility to the solvent than the entire protein but remains much more accessible to the solvent than bacteriorhodopsin membrane segments.			VIGNERON, L (corresponding author), FREE UNIV BRUSSELS,CHIM PHYS MACROMOLEC INTERFACES LAB,CP206-2,CAMPUS PLAINE,B-1050 BRUSSELS,BELGIUM.			Goormaghtigh, Erik/0000-0002-2071-2262				ADDISON R, 1986, J BIOL CHEM, V261, P4896; ALVAREZ J, 1987, J BIOL CHEM, V262, P3502; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CABIAUX V, 1989, J BIOL CHEM, V264, P4928; CHALLOU N, 1994, BIOCHEMISTRY-US, V33, P6902, DOI 10.1021/bi00188a020; CHIRGADZE YN, 1974, BIOPOLYMERS, V13, P1701, DOI 10.1002/bip.1974.360130902; CLARKE DM, 1989, J BIOL CHEM, V264, P11246; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; CORBALANGARCIA S, 1994, BIOCHEMISTRY-US, V33, P8247, DOI 10.1021/bi00193a011; COWAN SW, 1994, SCIENCE, V264, P914, DOI 10.1126/science.8178151; DOWNER NW, 1986, J BIOL CHEM, V261, P3640; DRAHEIM JE, 1991, BIOPHYS J, V60, P89, DOI 10.1016/S0006-3495(91)82033-1; DUMONT ME, 1985, J MEMBRANE BIOL, V88, P233, DOI 10.1007/BF01871088; EARNEST TN, 1990, BIOPHYS J, V58, P1539, DOI 10.1016/S0006-3495(90)82498-X; FIMMEL S, 1989, BIOCHIM BIOPHYS ACTA, V978, P231, DOI 10.1016/0005-2736(89)90120-X; FISCHBARG J, 1993, P NATL ACAD SCI USA, V90, P11658, DOI 10.1073/pnas.90.24.11658; FRINGELI UP, 1981, MEMBRANE SPECTROSCOP, P270; GOORMAGHTIGH E, 1986, ANAL BIOCHEM, V159, P122, DOI 10.1016/0003-2697(86)90316-7; GOORMAGHTIGH E, 1993, BIOCHEMISTRY-US, V32, P6104, DOI 10.1021/bi00074a023; GOORMAGHTIGH E, 1994, SPECTROCHIM ACTA A, V50, P2137; Goormaghtigh E, 1994, Subcell Biochem, V23, P363; Goormaghtigh E, 1994, Subcell Biochem, V23, P405; GOORMAGHTIGH E, 1994, J BIOL CHEM, V269, P27409; GOORMAGHTIGH E, 1986, J BIOL CHEM, V261, P7466; GOORMAGHTIGH E, 1990, EUR J BIOCHEM, V193, P409, DOI 10.1111/j.1432-1033.1990.tb19354.x; Goormaghtigh E, 1994, Subcell Biochem, V23, P329; GOORMAGHTIGH E, 1989, BIOCHIM BIOPHYS ACTA, V1006, P147, DOI 10.1016/0005-2760(89)90338-X; GOORMAGHTIGH E, 1991, EUR J BIOCHEM, V195, P421, DOI 10.1111/j.1432-1033.1991.tb15721.x; GOORMAGHTIGH E, 1990, MOL DESCRIPTION BIOL, P285; GORNETSCHELNOKO.U, 1994, EMBO J, V13, P338; HAGER KM, 1986, P NATL ACAD SCI USA, V83, P7693, DOI 10.1073/pnas.83.20.7693; HARIS PI, 1989, BIOCHIM BIOPHYS ACTA, V995, P160, DOI 10.1016/0167-4838(89)90075-7; Harrick N.J., 1967, INTERNAL REFLECTION; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; HENNESSEY JP, 1989, ANAL BIOCHEM, V176, P284, DOI 10.1016/0003-2697(89)90310-2; HENNESSEY JP, 1990, J BIOL CHEM, V265, P532; HENNESSEY JP, 1988, J BIOL CHEM, V263, P3123; HEYN MP, 1981, BIOCHEMISTRY-US, V20, P840, DOI 10.1021/bi00507a029; HUCHO F, 1994, TRENDS BIOCHEM SCI, V19, P383, DOI 10.1016/0968-0004(94)90116-3; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; KAHN TW, 1992, BIOCHEMISTRY-US, V31, P8829, DOI 10.1021/bi00152a020; KAHN TW, 1992, BIOCHEMISTRY-US, V31, P6144, DOI 10.1021/bi00141a027; KAUPPINEN JK, 1981, APPL OPTICS, V20, P1866, DOI 10.1364/AO.20.001866; LIN J, 1994, J BIOL CHEM, V269, P3887; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANDALA SM, 1989, J BIOL CHEM, V264, P16276; NABEDRYK E, 1988, BIOPHYS J, V53, P671, DOI 10.1016/S0006-3495(88)83148-5; NIELSEN BL, 1984, ANAL BIOCHEM, V141, P311, DOI 10.1016/0003-2697(84)90047-2; PAUL C, 1985, EMBO J, V4, P1593, DOI 10.1002/j.1460-2075.1985.tb03822.x; POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7; RAO US, 1990, J BIOL CHEM, V265, P7227; RAO US, 1991, J BIOL CHEM, V266, P14740; RAO US, 1992, BIOCHIM BIOPHYS ACTA, V1108, P153, DOI 10.1016/0005-2736(92)90020-M; RATH P, 1991, BIOPHYS J, V59, P516, DOI 10.1016/S0006-3495(91)82268-8; ROTHSCHILD KJ, 1984, BIOCHEMISTRY-US, V23, P6103, DOI 10.1021/bi00320a031; ROTHSCHILD KJ, 1979, SCIENCE, V204, P311, DOI 10.1126/science.432645; SAMI M, 1988, FEBS LETT, V240, P211, DOI 10.1016/0014-5793(88)80370-3; SCARBOROUGH GA, 1976, P NATL ACAD SCI USA, V73, P1485, DOI 10.1073/pnas.73.5.1485; SCARBOROUGH GA, 1984, J BIOL CHEM, V259, P9109; SCARBOROUGH GA, 1990, J BIOL CHEM, V265, P16145; SMITH R, 1984, ANAL BIOCHEM, V138, P156, DOI 10.1016/0003-2697(84)90784-X; SONVEAUX N, 1994, J BIOL CHEM, V269, P25637; STOKES DL, 1990, BIOCHEM SOC T, V18, P841, DOI 10.1042/bst0180841; SWEADNER KJ, 1992, ANN NY ACAD SCI, V671, P217, DOI 10.1111/j.1749-6632.1992.tb43798.x; TAYLOR KA, 1986, J MOL BIOL, V187, P417, DOI 10.1016/0022-2836(86)90442-0; TOYOSHIMA C, 1993, NATURE, V362, P469, DOI 10.1038/362469a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; VENYAMINOV SY, 1991, BIOPOLYMERS, V30, P1259; VIGNERON L, 1995, BBA-BIOMEMBRANES, V1236, P95, DOI 10.1016/0005-2736(95)00028-2; WEISS MS, 1991, FEBS LETT, V280, P379, DOI 10.1016/0014-5793(91)80336-2; WILSON CM, 1979, ANAL BIOCHEM, V96, P263, DOI 10.1016/0003-2697(79)90581-5	73	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17685	17696		10.1074/jbc.270.30.17685	http://dx.doi.org/10.1074/jbc.270.30.17685			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629067	hybrid			2022-12-27	WOS:A1995RM26600012
J	CAMACHO, M; GODESSART, N; ANTON, R; GARCIA, M; VILA, L				CAMACHO, M; GODESSART, N; ANTON, R; GARCIA, M; VILA, L			INTERLEUKIN-1 ENHANCES THE ABILITY OF CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS TO OXIDIZE LINOLEIC-ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN ENDOPEROXIDE SYNTHASE; ARACHIDONIC-ACID; 13-HYDROXYOCTADECADIENOIC ACID; 15-HYDROXYEICOSATETRAENOIC ACID; 9-HYDROXYOCTADECADIENOIC ACID; POLYMORPHONUCLEAR LEUKOCYTES; FIBROBLAST CYCLOOXYGENASE; LIPOXYGENASE PATHWAY; OMEGA-6 LIPOXYGENASE; SURFACE EXPRESSION	Human umbilical vein endothelial cells (HUVEC) were treated with recombinant interleukin (IL)-1 beta, and the metabolism of exogenous linoleic acid was studied. High performance liquid chromatography, gas chromatography-mass spectrometry, and chiral analysis revealed that HUVEC enzymatically convert linoleic acid mainly into 13-(S)hydroxy-9(Z),11(E)-octadecadienoic (13-HODE) and 9-(R)hydroxy-10(E),12(Z)-octadecadienoic acids, which may isomerize toward all-trans compounds. IL-1 beta increased the formation of all octadecanoids in a time and dose-dependent manner with similar EC(50) (approximately 1 unit/ml). The apparent K-m values of linoleic acid were 15.59 +/- 8.39 and 152.9 +/- 84 mu M (P < 0.05) in IL-1 beta-treated cells and controls, respectively, indicating a higher substrate affinity in cells stimulated with IL-1 beta. Ratios of S/R enantiomers for the hydroxyoctadecanoids produced by untreated and IL-1 beta-treated cells were similar to those from isolated cyclooxygenases (COXs), whereas isolated 15-lipoxygenase yielded 13-HODE with a strict S configuration. The formation of octadecanoids was inhibited in a dose dependent manner by several COX inhibitors in both controls and IL-1 beta-treated cells, COX2 selective inhibitors being more effective on IL-1 beta-treated cells than on controls. COX1 and COX2 protein levels increased less than 2-fold and 8-fold, respectively, after IL-1 beta treatment. The specificity of COX inhibitors was proven since they did not inhibit 13-HODE formation by human polymorphonuclear leukocytes. Overall, these results indicate that COXs are responsible for the oxidative metabolism of linoleic acid in HUVEC, and IL-1 beta increases it by inducing the expression of new enzyme, mainly COX2.	HOSP SANTA CRUZ & SAN PABLO,INFLAMMAT MEDIATOR LAB,E-08025 BARCELONA,SPAIN				Antón, Rosa/AAO-1350-2021	Antón, Rosa/0000-0003-4261-4150; Camacho, Mercedes/0000-0001-5970-3294; Godessart, Nuria/0000-0003-3546-4924				AGARWAL R, 1991, DRUG METAB DISPOS, V19, P620; ANDERSON KM, 1992, CLIN BIOCHEM, V25, P1, DOI 10.1016/0009-9120(92)80038-I; BAER AN, 1991, BIOCHIM BIOPHYS ACTA, V1085, P45, DOI 10.1016/0005-2760(91)90230-F; BAER AN, 1991, J LIPID RES, V32, P341; BALCONI G, 1986, MED BIOL, V64, P231; BASTIDA E, 1990, J LIPID MEDIATOR, V2, P281; BERTOMEU MC, 1993, CLIN EXP METASTAS, V11, P243, DOI 10.1007/BF00121167; BEVILACQUA MP, 1984, J EXP MED, V160, P618, DOI 10.1084/jem.160.2.618; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREIDER MA, 1993, J AM VET MED ASSOC, V203, P300; BUCHANAN MR, 1993, BLOOD, V81, P3303; BUCHANAN MR, 1985, THROMB HAEMOSTASIS, V53, P306; BUCHANAN MR, 1985, J BIOL CHEM, V260, P6056; CLAEYS M, 1985, BIOCHIM BIOPHYS ACTA, V837, P35, DOI 10.1016/0005-2760(85)90083-9; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; COWLEN MS, 1993, BIOCHIM BIOPHYS ACTA, V1174, P234, DOI 10.1016/0167-4781(93)90192-G; DARET D, 1989, PROSTAGLANDINS, V38, P203, DOI 10.1016/0090-6980(89)90083-X; DeWitt D L, 1993, Am J Med, V95, p40S, DOI 10.1016/0002-9343(93)90396-7; DINARELLO CA, 1991, BLOOD, V77, P1627; FOLCIK VA, 1994, J LIPID RES, V35, P1570; FUNK CD, 1985, J BIOL CHEM, V260, P7481; FUNK CD, 1983, BIOCHIM BIOPHYS ACTA, V754, P57; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; GLASGOW WC, 1992, J BIOL CHEM, V267, P10771; GODESSART N, 1994, J INVEST DERMATOL, V102, P98, DOI 10.1111/1523-1747.ep12371740; HAAS TA, 1990, BIOCHIM BIOPHYS ACTA, V1051, P174, DOI 10.1016/0167-4889(90)90190-O; HAMBERG M, 1980, BIOCHIM BIOPHYS ACTA, V617, P545, DOI 10.1016/0005-2760(80)90022-3; HAMBERG M, 1967, J BIOL CHEM, V242, P5344; HECKER M, 1987, EUR J BIOCHEM, V169, P113, DOI 10.1111/j.1432-1033.1987.tb13587.x; HLA T, 1993, ANN NY ACAD SCI, V696, P197; HOPKINS NK, 1984, J BIOL CHEM, V259, P4048; INGRAM CD, 1988, LIPIDS, V23, P340, DOI 10.1007/BF02537345; IVERSEN L, 1991, AGENTS ACTIONS, V33, P286, DOI 10.1007/BF01986575; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; JONES DA, 1993, J BIOL CHEM, V268, P9049; KADUCE TL, 1989, J BIOL CHEM, V264, P6823; KORN JH, 1989, CLIN IMMUNOL IMMUNOP, V50, P196, DOI 10.1016/0090-1229(89)90128-1; KU G, 1992, J BIOL CHEM, V267, P14183; KUHN H, 1985, PROSTA LEUKOTR MED, V17, P291, DOI 10.1016/0262-1746(85)90118-0; KUHN H, 1986, ADV ENZYMOL RAMB, V58, P273; KUNN H, 1992, EICOSANOIDS, V5, P17; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LONG MW, 1992, EXP HEMATOL, V20, P288; LOPEZ S, 1993, BIOCHIM BIOPHYS ACTA, V1170, P17, DOI 10.1016/0005-2760(93)90170-E; MAIER JAM, 1990, J BIOL CHEM, V265, P10805; MANTOVANI A, 1989, IMMUNOL TODAY, V10, P370, DOI 10.1016/0167-5699(89)90270-3; MATTHEW JA, 1977, LIPIDS, V12, P324, DOI 10.1007/BF02533358; MEADE EA, 1993, J BIOL CHEM, V268, P6610; MONTESANO R, 1985, J CELL PHYSL, V122, P422; MORITA E, 1990, SCAND J IMMUNOL, V32, P497, DOI 10.1111/j.1365-3083.1990.tb03190.x; NUGTEREN DH, 1987, BIOCHIM BIOPHYS ACTA, V921, P135, DOI 10.1016/0005-2760(87)90179-2; PARTHASARATHY S, 1989, P NATL ACAD SCI USA, V86, P1046, DOI 10.1073/pnas.86.3.1046; POBER JS, 1990, PHYSIOL REV, V70, P427, DOI 10.1152/physrev.1990.70.2.427; RAZ A, 1988, J BIOL CHEM, V263, P3022; REINAUD O, 1989, BIOCHEM BIOPH RES CO, V161, P883, DOI 10.1016/0006-291X(89)92682-X; RIMARACHIN JA, 1994, ARTERIOSCLER THROMB, V14, P1021, DOI 10.1161/01.ATV.14.7.1021; SETTY BNY, 1987, BIOCHEM BIOPH RES CO, V148, P528, DOI 10.1016/0006-291X(87)90908-9; SETTY BNY, 1986, J CLIN INVEST, V77, P202, DOI 10.1172/JCI112277; SETTY BNY, 1987, BIOCHEM BIOPH RES CO, V146, P502, DOI 10.1016/0006-291X(87)90557-2; SIGAL E, 1990, J BIOL CHEM, V265, P5113; SIGAL E, 1988, J BIOL CHEM, V263, P5328; SMITH WL, 1992, AM J PHYSIOL, V263, pF181; SOBERMAN RJ, 1985, J BIOL CHEM, V260, P4508; SOLA J, 1991, ARCH DERMATOL RES, V283, P77, DOI 10.1007/BF00371612; TAKAYAMA H, 1987, THROMB RES, V45, P803, DOI 10.1016/0049-3848(87)90090-9; TANG DG, 1993, INT J CANCER, V54, P102, DOI 10.1002/ijc.2910540117; TLOTI MA, 1991, THROMB RES, V62, P305, DOI 10.1016/0049-3848(91)90151-L; TOBIAS LD, 1979, LIPIDS, V14, P181, DOI 10.1007/BF02533870	68	51	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17279	17286		10.1074/jbc.270.29.17279	http://dx.doi.org/10.1074/jbc.270.29.17279			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615528	hybrid			2022-12-27	WOS:A1995RK68900037
J	CURNOW, AW; GARCIA, GA				CURNOW, AW; GARCIA, GA			TRANSFER-RNA-GUANINE TRANSGLYCOSYLASE FROM ESCHERICHIA-COLI - MINIMAL TRANSFER-RNA STRUCTURE AND SEQUENCE REQUIREMENTS FOR RECOGNITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ASPARTIC-ACID; TRANSFER-RNA; PURIFICATION; REFINEMENT; STABILITY; LOOP	Previously, we have demonstrated that the tRNA-guanine transglycosylase (TGT) from Escherichia coli is capable of utilizing an in vitro generated minihelix consisting of the anticodon stem and loop sequence of E. coli tRNA(Tyr) (Curnow, A. W., Kung, F. L., Koch, K. A., and Garcia, G. A. (1993) Biochemistry 32, 5239-5246). This suggests that the tRNA structural motifs necessary for recognition comprise a loop at the end of a short helix. To gain further insight into the structural requirements for TGT recognition, we have investigated the conformation of this minimal substrate. Thermal denaturation studies and kinetic analyses at 20 and 37 degrees C indicate that this minihelix is predominantly melted at 37 degrees C and that the melted conformation is not a substrate for TGT. This is confirmed by the determination that a non-helical analogue of the minihelix is not a substrate for TGT at either temperature. Two additional minihelices designed to be stable at 37 degrees C, ECYMH (a 4-base pair extension of the previous minihelix) and SCDMH (a yeast tRNA(Asp) analogue of ECYMH), were generated and char acterized. Finally, several sequence mutants of SCDMH, focusing on the G(30)U(40) base pair and U(33)G(34)U(35) loop sequence, have been produced, and kinetic parameter determinations have been performed at 37 degrees C. Our results are consistent with a recent report (Nakanishi, S., Ueda, T., Hori, H., Yamazaki, N., Okada, N., and Watanabe, K. (1994) J. Biol. Chem. 269, 32221-32225) indicating that a UGU sequence in a 7-base loop is the minimal requirement for TGT recognition.	UNIV MICHIGAN, COLL PHARM, INTERDEPT PROGRAM MED CHEM, ANN ARBOR, MI 48109 USA	University of Michigan System; University of Michigan					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767, R29GM045968, R55GM045968] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM07767, GM45968] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHONG SR, 1994, BIOTECHNIQUES, V17, P686; CURNOW AW, 1994, BIOCHIMIE, V76, P1183, DOI 10.1016/0300-9084(94)90048-5; CURNOW AW, 1993, BIOCHEMISTRY-US, V32, P5239, DOI 10.1021/bi00070a036; CURNOW AW, 1994, FASEB J, V8, pA1348; DERRICK WB, 1993, NUCLEIC ACIDS RES, V21, P4948, DOI 10.1093/nar/21.21.4948; DUMAS P, 1985, BIOCHIMIE, V67, P597, DOI 10.1016/S0300-9084(85)80199-1; GARCIA GA, 1993, J MOL BIOL, V231, P489, DOI 10.1006/jmbi.1993.1296; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; GROEBE DR, 1989, BIOCHEMISTRY-US, V28, P742, DOI 10.1021/bi00428a049; GROEBE DR, 1988, NUCLEIC ACIDS RES, V16, P11725, DOI 10.1093/nar/16.24.11725; GU XG, 1991, BIOCHEMISTRY-US, V30, P2999, DOI 10.1021/bi00226a003; HARADA F, 1972, BIOCHEMISTRY-US, V11, P301, DOI 10.1021/bi00752a024; NAKANISHI S, 1994, J BIOL CHEM, V269, P32221; OKADA N, 1979, J BIOL CHEM, V254, P3061; PUGLISI JD, 1989, METHOD ENZYMOL, V180, P304; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; TSANG TH, 1983, BIOCHIM BIOPHYS ACTA, V741, P180, DOI 10.1016/0167-4781(83)90058-1; WESTHOF E, 1988, ACTA CRYSTALLOGR A, V44, P112, DOI 10.1107/S010876738700446X; WESTHOF E, 1985, J MOL BIOL, V184, P119, DOI 10.1016/0022-2836(85)90048-8	19	51	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17264	17267		10.1074/jbc.270.29.17264	http://dx.doi.org/10.1074/jbc.270.29.17264			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615526	hybrid			2022-12-27	WOS:A1995RK68900034
J	SAKATSUME, M; IGARASHI, K; WINESTOCK, KD; GAROTTA, G; LARNER, AC; FINBLOOM, DS				SAKATSUME, M; IGARASHI, K; WINESTOCK, KD; GAROTTA, G; LARNER, AC; FINBLOOM, DS			THE JAK KINASES DIFFERENTIALLY ASSOCIATE WITH THE ALPHA AND BETA (ACCESSORY FACTOR) CHAINS OF THE INTERFERON-GAMMA RECEPTOR TO FORM A FUNCTIONAL RECEPTOR UNIT CAPABLE OF ACTIVATING STAT TRANSCRIPTION FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCER; HUMAN-MONOCYTES; DOMAIN; PROMOTER; BINDING; REGION; GENE	Interferon gamma (IFN gamma) induces the expression of early response genes by tyrosine phosphorylation of Jak kinases and transcription factors referred to as STAT proteins. The topology of the IFN gamma receptor is partially understood and the relationship between the alpha chain that binds the ligand and the beta chain that is required for signal transduction is undefined. In a cell line which expresses only the human alpha chain, we show that these cells did not activate Jak kinases or STAT proteins with human IFN gamma, even though Jak1 co-immunoprecipitated with the alpha chain. In cells unexposed to IFN gamma, Jak1 preferentially associated with the alpha chain, while Jak2 associated with the beta chain. There was evidence for Jak1 kinase activity in untreated cells. For Jak2, kinase activity was IFN gamma-dependent. Although the alpha chain was tyrosine-phosphorylated in response to ligand, we found no evidence for tyrosine phosphorylation of the beta chain. These data are consistent with a model of the IFN gamma receptor in which Jak1 associates with the a chain, whereas Jak2 associates with the beta chain, IFN gamma clusters at least two receptor units which results in the tyrosine phosphorylation of Jak1 and Jak2, the activation of Jak2 kinase activity, and the recruitment of STAT1 alpha resulting in its activation by tyrosine phosphorylation.	US FDA,CTR BIOL EVALUAT & RES,DIV CYTOKINE BIOL,BETHESDA,MD 20892; F HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES,NEW TECHNOL,CH-4002 BASEL,SWITZERLAND	US Food & Drug Administration (FDA); Roche Holding								AGUET M, 1988, CELL, V55, P273, DOI 10.1016/0092-8674(88)90050-5; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; FINBLOOM DS, 1991, J BIOL CHEM, V266, P22545; FINBLOOM DS, 1985, J IMMUNOL, V135, P300; FU XY, 1992, CELL, V70, P323, DOI 10.1016/0092-8674(92)90106-M; FUKUNAGA R, 1991, EMBO J, V10, P2855, DOI 10.1002/j.1460-2075.1991.tb07835.x; GAROTTA G, 1990, J BIOL CHEM, V265, P6908; GIBBS VC, 1991, MOL CELL BIOL, V11, P5860, DOI 10.1128/MCB.11.12.5860; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; HEMMI S, 1994, CELL, V76, P803, DOI 10.1016/0092-8674(94)90355-7; HEMMI S, 1992, P NATL ACAD SCI USA, V89, P2737, DOI 10.1073/pnas.89.7.2737; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; IGARASHI K, 1993, MOL CELL BIOL, V13, P3984, DOI 10.1128/MCB.13.7.3984; IGARASHI K, 1994, J BIOL CHEM, V269, P14333; JUNG V, 1987, P NATL ACAD SCI USA, V84, P6934; LARNER AC, 1995, IN PRESS BIOCH BIOPH; LUTTICKEN C, 1994, SCIENCE, V263, P89, DOI 10.1126/science.8272872; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; PEARSE RN, 1991, P NATL ACAD SCI USA, V88, P11305, DOI 10.1073/pnas.88.24.11305; RUSSELL SM, 1994, SCIENCE, V266, P1042, DOI 10.1126/science.7973658; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; SLATE DL, 1978, J VIROL, V25, P319, DOI 10.1128/JVI.25.1.319-325.1978; SOH J, 1994, CELL, V76, P793, DOI 10.1016/0092-8674(94)90354-9; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; TAN YH, 1973, J EXP MED, V137, P317, DOI 10.1084/jem.137.2.317; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; WILKS AF, 1991, MOL CELL BIOL, V11, P2057, DOI 10.1128/MCB.11.4.2057; WILSON KC, 1992, P NATL ACAD SCI USA, V89, P11964, DOI 10.1073/pnas.89.24.11964	31	120	129	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17528	17534		10.1074/jbc.270.29.17528	http://dx.doi.org/10.1074/jbc.270.29.17528			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615558	hybrid			2022-12-27	WOS:A1995RK68900074
J	DEGOMEZPUYOU, MT; SANDOVAL, F; GOMEZPUYOU, A				DEGOMEZPUYOU, MT; SANDOVAL, F; GOMEZPUYOU, A			SYNTHESIS OF MEDIUM PYROPHOSPHATE BY SOLUBLE MITOCHONDRIAL F1 THROUGH DIMETHYL SULFOXIDE-WATER TRANSITIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI F1-ATPASE; ENZYME-BOUND ATP; BEEF-HEART; ADENOSINE-TRIPHOSPHATASE; CATALYTIC PROPERTIES; DIMETHYLSULFOXIDE; SYNTHASE; BINDING; ENERGY; SITES	Soluble F-1 from heart mitochondria incubated in mixtures that have Mg2+, inorganic phosphate, and dimethyl sulfoxide (40% (v/v)) catalyzes the spontaneous synthesis of ATP and pyrophosphate (Tuena de Gomez-Puyou, M., Garcia, J. J,, and Gomez-Puyou, A. (1993) Biochemistry 32, 2213-2218). By filtration techniques, it was determined that synthesized ATP and pyrophosphate are enzyme bound, albeit the affinity for pyrophosphate was lower than that of ATP. After ATP and pyrophosphate were formed in dimethyl sulfoxide mixtures, dilution with aqueous buffer to a dimethyl sulfoxide concentration of 6.0% brought about the partition of pyrophosphate into the media. This was evidenced by filtration experiments as well as by the accessibility of synthesized pyrophosphate to soluble inorganic pyrophosphatase. Release of pyrophosphate induced by dilution occurred in less than 15 s. Under conditions that produce release of pyrophosphate, no release of ATP was observed; instead, ATP underwent hydrolysis. Studies on the effect of arsenate on the synthesis and hydrolysis of ATP and PPi in F-1 showed that hydrolysis of synthesized PPi at its site of synthesis was slower than that of ATP. Thus, the question of whether differences in the rates of hydrolysis accounted for the dilution-induced release of PPi but not of ATP was addressed, Synthesis and hydrolysis of ATP and pyrophosphate were examined in preparations of soluble F-1 in complex with its inhibitor protein; the complex had an ATPase activity about 100 times lower than that of free F-1. In mixtures that contained dimethyl sulfoxide, the complex synthesized ATP and pyrophosphate at nearly the same rates; upon dilution, hydrolysis of both compounds occurred also at similar rates, yet only pyrophosphate was released. The same phenomenon was observed in F-1 that had been depleted of adenine nucleotides. Hence, dilution-induced release of PPi was independent of the overall catalytic properties of the enzyme or its content of adenine nucleotides. Since synthesis of ATP occurs at the expense of the ADP that remains after depletion of adenine nucleotides, it is likely that the failure of ATP to be released is due to the high affinity that F-1 exhibits for the synthesized ATP. Nevertheless, the results illustrate that a complete catalytic cycle that starts with medium P-i and ends with medium pyrophosphate may be reproduced in soluble mitochondrial F-1.			DEGOMEZPUYOU, MT (corresponding author), UNIV NACL AUTONOMA MEXICO, INST FISIOL CELULAR, APARTADO POSTAL 70600, MEXICO CITY 04510, DF, MEXICO.							ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ALSHAWI MK, 1992, BIOCHEMISTRY-US, V31, P886, DOI 10.1021/bi00118a034; ALSHAWI MK, 1988, J BIOL CHEM, V263, P19640; ALSHAWI MK, 1990, J BIOL CHEM, V265, P4402; BALTSCHEFFSKY H, 1966, SCIENCE, V153, P1120, DOI 10.1126/science.153.3740.1120; BEHARRY S, 1992, BIOCHEM BIOPH RES CO, V182, P697, DOI 10.1016/0006-291X(92)91788-R; BEHARRY S, 1991, FEBS LETT, V291, P282, DOI 10.1016/0014-5793(91)81302-O; BEHARRY S, 1991, BIOCHEM CELL BIOL, V69, P291, DOI 10.1139/o91-044; BELTRAN C, 1984, EUR J BIOCHEM, V144, P151, DOI 10.1111/j.1432-1033.1984.tb08443.x; BIANCHET M, 1991, J BIOL CHEM, V266, P21197; BOYER PD, 1973, P NATL ACAD SCI USA, V70, P2837, DOI 10.1073/pnas.70.10.2837; CRANE RK, 1953, J BIOL CHEM, V201, P235; DEGOMEZPUYOU MT, 1993, BIOCHEMISTRY-US, V32, P2213, DOI 10.1021/bi00060a012; DEGOMEZPUYOU MT, 1977, ARCH BIOCHEM BIOPHYS, V90, P147; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1984, J BIOL CHEM, V259, P6090; DEMEIS L, 1989, BIOCHIM BIOPHYS ACTA, V973, P333, DOI 10.1016/S0005-2728(89)80440-2; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; GARBOCZI DN, 1988, J BIOL CHEM, V263, P812; GARRETT NE, 1975, J BIOL CHEM, V250, P6640; GRUBMEYER C, 1982, J BIOL CHEM, V257, P2092; GRUBMEYER C, 1981, J BIOL CHEM, V256, P3718; ISSARTEL JP, 1987, J BIOL CHEM, V262, P13538; KANDPAL RP, 1987, BIOCHEMISTRY-US, V31, P2088; KASAHARA M, 1978, J BIOL CHEM, V253, P4180; LOWRY OH, 1951, J BIOL CHEM, V193, P265; PEINNEQUIN A, 1992, BIOCHEMISTRY-US, V31, P2088, DOI 10.1021/bi00122a028; PENEFSKY HS, 1991, ADV ENZYMOL RAMB, V64, P173; PENEFSKY HS, 1985, J BIOL CHEM, V260, P3728; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; PUYOU AG, 1986, EUR J BIOCHEM, V159, P133, DOI 10.1111/j.1432-1033.1986.tb09843.x; SAKAMOTO J, 1983, J BIOCHEM, V93, P1601, DOI 10.1093/oxfordjournals.jbchem.a134299; SENIOR AE, 1992, ARCH BIOCHEM BIOPHYS, V297, P340, DOI 10.1016/0003-9861(92)90682-M; WOOD JM, 1987, J BIOL CHEM, V262, P2180; YOSHIDA M, 1983, BIOCHEM BIOPH RES CO, V114, P907, DOI 10.1016/0006-291X(83)90646-0	35	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16820	16825		10.1074/jbc.270.28.16820	http://dx.doi.org/10.1074/jbc.270.28.16820			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622496	hybrid			2022-12-27	WOS:A1995RJ34700057
J	GUNTHER, MR; KELMAN, DJ; CORBETT, JT; MASON, RP				GUNTHER, MR; KELMAN, DJ; CORBETT, JT; MASON, RP			SELF-PEROXIDATION OF METMYOGLOBIN RESULTS IN FORMATION OF AN OXYGEN-REACTIVE TRYPTOPHAN-CENTERED RADICAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-SPIN-RESONANCE; SPERM WHALE MYOGLOBIN; CYTOCHROME-C PEROXIDASE; HYDROGEN-PEROXIDE; LIPID-PEROXIDATION; PHOTOLYSIS; TYROSINE; TYR-151; DAMAGE; AGENTS	In the reaction between hydrogen peroxide and metmyoglobin, the heme iron is oxidized to its ferryl-oxo form and the globin to protein radicals, at least one of which reacts with dioxygen to form a peroxyl radical. To identify the residue(s) that forms the oxygen-reactive radical, we utilized electron spin resonance (ESR) spectroscopy and the spin traps 2-methyl-2-nitrosopropane and 3,5-dibromo-4-nitrosobenzenesulfonic acid (DBNBS), Metmyoglobin radical adducts had spectra typical of immobilized nitroxides that provided little structural information, but subsequent nonspecific protease treatment resulted in the detection of isotropic three-line spectra, indicative of a radical adduct centered on a tertiary carbon with no bonds to nitrogen or hydrogen. Similar isotropic three-line ESR spectra were obtained by spin trapping the oxidation product of tryptophan reacting with catalytic metmyoglobin and hydrogen peroxide. High resolution ESR spectra of DBNBS/(.)trp and of the protease-treated DBNBS/(.)metMb were simulated using superhyperfine coupling to a nitrogen and three non equivalent hydrogens, consistent with a radical adduct formed at C-3 of the indole ring. Oxidation of tryptophan by catalytic metMb and hydrogen peroxide resulted in spin trap-inhibitable oxygen consumption, consistent with formation of a peroxyl radical. The above results support self-peroxidation of a tryptophan residue in the reaction between metMb and hydrogen peroxide.			GUNTHER, MR (corresponding author), NIEHS, MOLEC TOXICOL LAB, RES TRIANGLE PK, NC 27709 USA.		Mason, Ronald P/G-5967-2019	Mason, Ronald P/0000-0002-1859-9109				ANTON M, 1991, P INT C MEAT SCI TEC, V37, P320; ARDUINI A, 1992, FREE RADICAL BIO MED, V13, P449, DOI 10.1016/0891-5849(92)90185-J; ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P; BUTLER J, 1982, BIOCHIM BIOPHYS ACTA, V705, P150, DOI 10.1016/0167-4838(82)90173-X; CATALANO CE, 1989, J BIOL CHEM, V264, P10534; CHOE YS, 1994, ARCH BIOCHEM BIOPHYS, V314, P126, DOI 10.1006/abbi.1994.1420; DAVIES MJ, 1991, FREE RADICAL RES COM, V15, P111, DOI 10.3109/10715769109049131; DAVIES MJ, 1990, FREE RADICAL RES COM, V10, P361, DOI 10.3109/10715769009149905; DAVIES MJ, 1991, BIOCHIM BIOPHYS ACTA, V1077, P86, DOI 10.1016/0167-4838(91)90529-9; DEFELIPPIS MR, 1989, BIOCHEMISTRY-US, V28, P4847, DOI 10.1021/bi00437a049; DULING DR, 1994, J MAGN RESON SER B, V104, P105, DOI 10.1006/jmrb.1994.1062; EVANS SV, 1990, J MOL BIOL, V213, P885, DOI 10.1016/S0022-2836(05)80270-0; FERRARI R, 1991, AM J MED, V91, pS95, DOI 10.1016/0002-9343(91)90291-5; GEORGE P, 1955, BIOCHEM J, V60, P596, DOI 10.1042/bj0600596; GEORGE P, 1952, BIOCHEM J, V52, P511, DOI 10.1042/bj0520511; GIBSON JF, 1958, NATURE, V181, P1398, DOI 10.1038/1811398a0; GOODIN DB, 1993, BIOCHEMISTRY-US, V32, P3313, DOI 10.1021/bi00064a014; GRISHAM M B, 1985, Journal of Free Radicals in Biology and Medicine, V1, P227, DOI 10.1016/0748-5514(85)90122-9; HARADA K, 1987, J BIOCHEM, V101, P283, DOI 10.1093/oxfordjournals.jbchem.a121903; HAREL S, 1988, FREE RADICAL RES COM, V5, P21, DOI 10.3109/10715768809068555; HIRAMOTO K, 1994, FREE RADICAL RES, V21, P341, DOI 10.3109/10715769409056586; HOFFMAN BM, 1981, J BIOL CHEM, V256, P6556; HONG S-J, 1989, Korean Biochemical Journal, V22, P196; JANSSEN YMW, 1993, LAB INVEST, V69, P261; JOVANOVIC SV, 1985, FREE RADICAL BIO MED, V1, P125; KANNER J, 1985, ARCH BIOCHEM BIOPHYS, V237, P314, DOI 10.1016/0003-9861(85)90282-6; KAUR H, 1981, J CHEM SOC CHEM COMM, P142, DOI 10.1039/c39810000142; KELMAN DJ, 1992, FREE RADICAL RES COM, V16, P27, DOI 10.3109/10715769209049156; KELMAN DJ, 1994, J BIOL CHEM, V269, P7458; KING NK, 1967, BIOCHIM BIOPHYS ACTA, V133, P65; KING NK, 1963, J BIOL CHEM, V238, P1520; KNECHT KT, 1992, MOL PHARMACOL, V41, P943; LION Y, 1982, PHOTOCHEM PHOTOBIOL, V35, P53, DOI 10.1111/j.1751-1097.1982.tb03810.x; LION Y, 1982, PHOTOCHEM PHOTOBIOL, V35, P43, DOI 10.1111/j.1751-1097.1982.tb03809.x; MIKI H, 1989, ARCH BIOCHEM BIOPHYS, V275, P354, DOI 10.1016/0003-9861(89)90382-2; MURAKAMI J, 1989, PHOTOCHEM PHOTOBIOL, V49, P465, DOI 10.1111/j.1751-1097.1989.tb09196.x; NEWMAN ESR, 1991, BIOCHEM BIOPH RES CO, V179, P1414, DOI 10.1016/0006-291X(91)91730-Z; PAILTHORPE MT, 1971, PHOTOCHEM PHOTOBIOL, V14, P135, DOI 10.1111/j.1751-1097.1971.tb06158.x; PUPPO A, 1988, FREE RADICAL RES COM, V4, P415, DOI 10.3109/10715768809066910; RAO SI, 1993, J BIOL CHEM, V268, P803; ROMERO FJ, 1992, J BIOL CHEM, V267, P1680; SAHLIN M, 1994, J BIOL CHEM, V269, P11699; SHIGA T, 1973, ARCH BIOCHEM BIOPHYS, V154, P540, DOI 10.1016/0003-9861(73)90006-4; SZAJDZINSKAPIETEK E, 1993, J PHOTOCH PHOTOBIO A, V75, P131, DOI 10.1016/1010-6030(93)80194-E; TAJIMA G, 1993, INT J BIOCHEM, V25, P101, DOI 10.1016/0020-711X(93)90495-Z; TASSIN JD, 1980, PHOTOCHEM PHOTOBIOL, V32, P577, DOI 10.1111/j.1751-1097.1980.tb04025.x; TEW D, 1988, J BIOL CHEM, V263, P17880; TURNER JJO, 1991, BIOCHEM J, V277, P833, DOI 10.1042/bj2770833; WILKS A, 1992, J BIOL CHEM, V267, P8827; WOGAN GN, 1989, ENVIRON HEALTH PERSP, V81, P9, DOI 10.2307/3430797; XU Y, 1990, J AGR FOOD CHEM, V38, P1494, DOI 10.1021/jf00097a014	51	103	103	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16075	16081		10.1074/jbc.270.27.16075	http://dx.doi.org/10.1074/jbc.270.27.16075			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608169	hybrid			2022-12-27	WOS:A1995RH22600032
J	LEE, HJJ; MIGNACCA, RC; SAKAMOTO, KM				LEE, HJJ; MIGNACCA, RC; SAKAMOTO, KM			TRANSCRIPTIONAL ACTIVATION OF EGR-1 BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR BUT NOT INTERLEUKIN-3 REQUIRES PHOSPHORYLATION OF CAMP RESPONSE ELEMENT-BINDING PROTEIN (CREB) ON SERINE-133	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE RECEPTOR SUPERFAMILY; TYROSINE PHOSPHORYLATION; KINASE; DIFFERENTIATION; PATHWAY; SITE	Granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin 3 (IL-3) stimulate the proliferation and maturation of myeloid progenitor cells following interaction with heterodimeric receptors that share a common beta subunit required for signal transduction. Our previous studies have demonstrated that GM-CSF and IL-3 activate signaling pathways which converge upon a cAMP response element-binding protein (CREB)-binding site of the human immediate early response gene (early growth response gene-1, egr-1) promoter. Using electromobility supershift assays and antibodies directed against CREB phosphorylated on serine 133, we show that CREB is phosphorylated on serine 133 in response to GM-CSF or IL-3 stimulation. We demonstrate that phosphorylation of CREB on serine 133 substantially contributes to transcriptional activation of egr-1 in response to GM-CSF but not IL-3. These studies suggest that phosphorylation of CREB may play different roles during signal transduction, resulting in unique and overlapping biological functions in myeloid cells.	JONSSON COMPREHENS CANC CTR,LOS ANGELES,CA 90095; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,GWYNNE HAZEN CHERRY MEM LABS,DIV HEMATOL ONCOL,LOS ANGELES,CA 90095	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA					NATIONAL CANCER INSTITUTE [K08CA059463] Funding Source: NIH RePORTER; NCI NIH HHS [CA59463-02, 5TC CA09056] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BOHM M, 1995, CELL GROWTH DIFFER, V6, P291; BORRELLI E, 1992, Critical Reviews in Oncogenesis, V3, P321; CAO XM, 1993, J BIOL CHEM, V268, P16949; CARROLL MP, 1990, J BIOL CHEM, V265, P19812; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; COLEMAN DL, 1989, J IMMUNOL, V143, P4134; COSMAN D, 1990, TRENDS BIOCHEM SCI, V15, P265, DOI 10.1016/0968-0004(90)90051-C; DASH PK, 1991, P NATL ACAD SCI USA, V88, P5061, DOI 10.1073/pnas.88.11.5061; DURONIO V, 1992, J BIOL CHEM, V267, P21856; FRANK D, 1994, BLOOD, V84, pA224; GASSON JC, 1991, BLOOD, V77, P1131, DOI 10.1182/blood.V77.6.1131.1131; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GINTY DD, 1991, J BIOL CHEM, V266, P15325; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HANAZONO Y, 1993, EMBO J, V12, P1641, DOI 10.1002/j.1460-2075.1993.tb05809.x; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; LALLI E, 1994, J BIOL CHEM, V269, P17359; LARNER AC, 1993, SCIENCE, V261, P1730, DOI 10.1126/science.8378773; LEE KAW, 1993, BIOCHIM BIOPHYS ACTA, V1174, P221, DOI 10.1016/0167-4781(93)90191-F; LEIBERMANN DA, 1994, CURR OPIN HEMATOL, V1, P24; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; MIYAJIMA A, 1993, BLOOD, V82, P1960; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; QUINN PG, 1993, J BIOL CHEM, V268, P16999; RONCO LV, 1994, J BIOL CHEM, V269, P277; SAKAMOTO KM, 1994, RECEPTOR CHANNEL, V2, P175; SAKAMOTO KM, 1994, MOL CELL BIOL, V14, P5975, DOI 10.1128/MCB.14.9.5975; SAKAMOTO KM, 1991, INT J CELL CLONING, V9, P531, DOI 10.1002/stem.5530090603; SAKAMOTO KM, 1992, ONCOGENE, V7, P2125; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; YOUNG MR, 1993, INT J CANCER, V53, P667, DOI 10.1002/ijc.2910530424	35	54	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15979	15983		10.1074/jbc.270.27.15979	http://dx.doi.org/10.1074/jbc.270.27.15979			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608156	hybrid			2022-12-27	WOS:A1995RH22600017
J	BILLY, D; WILLEMS, GM; HEMKER, HC; LINDHOUT, T				BILLY, D; WILLEMS, GM; HEMKER, HC; LINDHOUT, T			PROTHROMBIN CONTRIBUTES TO THE ASSEMBLY OF THE FACTOR VA-FACTOR XA COMPLEX AT PHOSPHATIDYLSERINE-CONTAINING PHOSPHOLIPID-MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE FACTOR-V; CATALYZED ACTIVATION; COAGULATION; MEIZOTHROMBIN; VESICLES; BINDING; PROTEIN	The activation of prothrombin is catalyzed by prothrombinase, a complex of factor Xa and factor Va assembled on a negatively charged phospholipid membrane, We used a tubular flow reactor to identify the relative contributions of factor Va, prothrombin, and the negatively charged phosphatidylserine to the assembly of prothrombinase. Perfusion of phospholipid-coated capillaries with a mixture of factor Xa, factor Va, and prothrombin resulted in a steady-state rate of thrombin production that increased with (i) the phosphatidylserine content of the phospholipid bilayer, (ii) the factor Va concentration, and, most interestingly, (iii) the prothrombin concentration of the perfusion solution, Incorporation of 20 mol % phosphatidylethanolamine, a phospholipid with poor ability to promote prothrombinase activity, into a 5 mol % phosphatidylserine membrane also increased the steady-state rate of thrombin production, Direct measurements of the amount of prothrombinase in the flow reactor demonstrated that increased catalytic activities were the result of an increased steady-state amount of membrane associated prothrombinase. Thus, similar turnover numbers of prothrombin activation (3100 min(-1)) were calculated, irrespective of the phosphatidylserine content of the membrane, We established for membranes with low phosphatidylserine content (<10 mol%) a linear relationship between the prothrombinase activity and the arithmetical product of the factor Va concentration in the perfusion solution and the prothrombin concentration near the catalytic surface, Our results indicate that, in addition to factor Va, prothrombin also is essential to the assembly of prothrombinase at macroscopic surfaces with low phosphatidylserine content. The data further suggest that the prothrombin concentration near the surface, controlled by the prothrombinase activity and mass transfer, is an important regulator of the prothrombinase surface density,	UNIV LIMBURG,CARDIOVASC RES INST MAASTRICHT,DEPT BIOCHEM,6200 MD MAASTRICHT,NETHERLANDS	Hasselt University; Maastricht University				Hemker, Coen/0000-0003-1669-2358				BILLY D, 1995, J BIOL CHEM, V270, P1029, DOI 10.1074/jbc.270.3.1029; BLOOM JW, 1979, BIOCHEMISTRY-US, V18, P4419, DOI 10.1021/bi00587a023; BOSKOVIC DS, 1990, J BIOL CHEM, V265, P10497; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; COMFURIUS P, 1994, BIOCHEMISTRY-US, V33, P10319, DOI 10.1021/bi00200a012; ESMON CT, 1974, J BIOL CHEM, V249, P7798; GERADS I, 1990, BIOCHEMISTRY-US, V29, P7967, DOI 10.1021/bi00486a027; GIESEN PLA, 1991, J BIOL CHEM, V266, P18720; GOVERSRIEMSLAG JWP, 1992, BIOCHEMISTRY-US, V31, P10000, DOI 10.1021/bi00156a020; HEMKER HC, 1987, NATURE, V215, P248; HENDRIX H, 1983, J BIOL CHEM, V258, P3637; JACKSON CM, 1974, THROMB DIATH HAEMO, V17, P273; Jesty J, 1988, Thromb Res, V50, P745, DOI 10.1016/0049-3848(88)90333-7; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; KUNG C, 1994, J BIOL CHEM, V269, P25838; Levich VG, 1962, PHYSICOCHEMICAL HYDR, P112; LINDHOUT T, 1978, BIOCHIM BIOPHYS ACTA, V533, P327; LINDHOUT T, 1982, BIOCHEMISTRY-US, V21, P5495; LUCKOW EA, 1989, BIOCHEMISTRY-US, V28, P2348, DOI 10.1021/bi00431a055; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MANN KG, 1992, SEMIN HEMATOL, V29, P213; MERTENS K, 1980, BIOCHEM J, V185, P647, DOI 10.1042/bj1850647; NELSESTUEN GL, 1977, BIOCHEMISTRY-US, V16, P4172, DOI 10.1021/bi00638a006; NEMERSON Y, 1986, BIOCHEMISTRY-US, V25, P4020, DOI 10.1021/bi00362a006; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; PAPAHADJOPOULOS D, 1964, BIOCHIM BIOPHYS ACTA, V90, P436, DOI 10.1016/0304-4165(64)90220-X; PEI G, 1993, J BIOL CHEM, V268, P3226; PUSEY ML, 1982, BIOCHEMISTRY-US, V21, P5262, DOI 10.1021/bi00264a022; ROSING J, 1980, J BIOL CHEM, V255, P274; SCHOEN P, 1990, THROMB HAEMOSTASIS, V64, P542; SMIRNOV MD, 1994, J BIOL CHEM, V269, P816; SMITH RL, 1973, J BIOL CHEM, V248, P2418; TANS G, 1991, J BIOL CHEM, V266, P21864; VANDEWAART P, 1983, BIOCHEMISTRY-US, V22, P2427, DOI 10.1021/bi00279a019; VANDEWAART P, 1984, BIOCHEMISTRY-US, V23, P2838, DOI 10.1021/bi00307a047; VANRIJN JLML, 1984, BIOCHEMISTRY-US, V23, P4557, DOI 10.1021/bi00315a008; WALKER RK, 1994, J BIOL CHEM, V269, P27441; ZWAAL RFA, 1978, BIOCHIM BIOPHYS ACTA, V515, P163, DOI 10.1016/0304-4157(78)90003-5	38	32	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26883	26889		10.1074/jbc.270.45.26883	http://dx.doi.org/10.1074/jbc.270.45.26883			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592932	hybrid			2022-12-27	WOS:A1995TE58300032
J	BUDD, ME; CHOE, WC; CAMPBELL, JL				BUDD, ME; CHOE, WC; CAMPBELL, JL			DNA2 ENCODES A DNA HELICASE ESSENTIAL FOR REPLICATION OF EUKARYOTIC CHROMOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SACCHAROMYCES-CEREVISIAE; REPAIR	Although a number of eukaryotic DNA helicases have been identified biochemically and still more have been inferred from the amino acid sequences of the products of cloned genes, none of the cellular helicases or putative helicases has to date been implicated in eukaryotic chromosomal DNA replication, By the same token, numerous eukaryotic replication proteins have been identified, but none of these is a helicase, We have recently identified and characterized a temperature-sensitive yeast mutant, dna2ts, defective in DNA replication, and have cloned the corresponding gene (Kuo, C.-L., Huang, C.-H., and Campbell, J. L. (1983) Proc. Natl. Acad. Sci. U.S.A. 30, 6465-6469; Budd, M. E., and Campbell, J. L. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 7642-7646). The DNA2 gene is essential and encodes a 172-kDa protein with DNA helicase motifs in its C-terminal half and an N-terminal half with no similarity to any previously described protein (Budd, M. E., and Campbell, J. L. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 7642-7646). Here we show that the helicase domain is required in vivo and that a 3' to 5' DNA helicase activity specific for forked substrates is intrinsic to the Dna2p. The N terminus is also essential for DNA replication, Thus, the structure of this new helicase is different from all previously characterized replicative helicases, which is consistent with the complex organization of eukaryotic replication forks, where the activities of not one but three essential DNA polymerases must be coordinated.	CALTECH,BRAUN LABS,PASADENA,CA 91125	California Institute of Technology								BUDD ME, 1989, MOL CELL BIOL, V9, P365, DOI 10.1128/MCB.9.2.365; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; KUO CL, 1983, P NATL ACAD SCI-BIOL, V80, P6465, DOI 10.1073/pnas.80.21.6465; NAUMOVSKI L, 1986, MOL CELL BIOL, V6, P1218, DOI 10.1128/MCB.6.4.1218; NOTARNICOLA SM, 1993, J BIOL CHEM, V268, P27198; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; SOMMERS CH, 1995, J BIOL CHEM, V270, P4193, DOI 10.1074/jbc.270.9.4193; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0	12	143	144	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26766	26769		10.1074/jbc.270.45.26766	http://dx.doi.org/10.1074/jbc.270.45.26766			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592912	hybrid, Green Accepted			2022-12-27	WOS:A1995TE58300012
J	LEE, TR; TILL, JH; LAWRENCE, DS; MILLER, WT				LEE, TR; TILL, JH; LAWRENCE, DS; MILLER, WT			PRECISION SUBSTRATE TARGETING OF PROTEIN-KINASES V-ABL AND C-SRC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTECTED PEPTIDE-FRAGMENTS; LEUKEMIA-VIRUS GENOME; SOLID-PHASE SYNTHESIS; SPECIFICITY; ACID; PHOSPHORYLATION; COMBINATION; SEQUENCE; ONCOGENE; MOTIFS	The active site substrate specificities of v-Abl and c-Src are compared and contrasted, Both enzymes catalyze the phosphorylation of a broad assortment of peptide-bound aliphatic and aromatic alcohols, such as achiral and simple straight chain residues, In addition, both protein kinases exhibit a ''dual specificity'' with respect to the ability to utilize D- and L-configurational isomers as substrates, However, c-Src and v-Abl are extremely inefficient as catalysts for certain structural arrangements, including secondary alcohols and primary alcohols containing large substituents in close proximity to the hydroxyl moiety. In addition to these similarities, these enzymes also display noteworthy differences in catalytic behavior, Whereas c-Src exhibits a modest preference for aromatic versus aliphatic alcohols, v-Abl does not, Most dramatic is the ability of c-Src to utilize short chain alcohols as substrates, an activity virtually absent from the catalytic repertoire of v-Abl, The implications of these observations are 2-fold. First, because both enzymes are able to accommodate a wide variety of structural variants within their respective active site regions, there exists a substantial degree of flexibility with respect to inhibitor design, Second, because these enzymes exhibit disparate active site specificities, it is possible that other tyrosine-specific protein kinases will display unique substrate specificities as well, Consequently, it may ultimately be possible to exploit these differences to generate inhibitors that precisely target specific protein kinases.	SUNY BUFFALO, DEPT CHEM, BUFFALO, NY 14260 USA; SUNY BUFFALO, DEPT MED CHEM, BUFFALO, NY 14260 USA; SUNY STONY BROOK, SCH MED, DEPT PHYSIOL & BIOPHYS, STONY BROOK, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook					NCI NIH HHS [CA5853001] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA058530, R01CA058530] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BUSS JE, 1985, J VIROL, V53, P7, DOI 10.1128/JVI.53.1.7-12.1985; ELLER M, 1991, BIOCHEM INT, V25, P453; ELLER M, 1993, J BIOCHEM-TOKYO, V114, P177, DOI 10.1093/oxfordjournals.jbchem.a124151; GARCIA P, 1993, J BIOL CHEM, V268, P25146; GEAHLEN RL, 1990, PEPT PROT PHOSPH, P239; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KWON YG, 1993, J AM CHEM SOC, V115, P7527, DOI 10.1021/ja00069a072; KWON YG, 1993, J BIOL CHEM, V268, P16725; KWON YG, 1993, J BIOL CHEM, V268, P10713; KWON YG, 1994, J BIOL CHEM, V269, P4839; LEE TR, 1994, BIOCHEMISTRY-US, V33, P4245, DOI 10.1021/bi00180a019; LEE TR, 1995, J BIOL CHEM, V270, P5375, DOI 10.1074/jbc.270.10.5375; LEE TR, 1993, J AM CHEM SOC, V115, P9888, DOI 10.1021/ja00075a003; Mayer Bruce J., 1993, Trends in Cell Biology, V3, P8, DOI 10.1016/0962-8924(93)90194-6; MENDELOW M, 1993, J BIOL CHEM, V268, P12289; MERGLER M, 1988, TETRAHEDRON LETT, V29, P4009, DOI 10.1016/S0040-4039(00)80406-2; MERGLER M, 1988, TETRAHEDRON LETT, V29, P4005, DOI 10.1016/S0040-4039(00)80405-0; MURRAY A, 1993, CELL CYCLE; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; REDDY EP, 1983, P NATL ACAD SCI-BIOL, V80, P3623, DOI 10.1073/pnas.80.12.3623; RINK H, 1987, TETRAHEDRON LETT, V28, P3787, DOI 10.1016/S0040-4039(00)96384-6; ROSENBERG N, 1988, ADV VIRUS RES, V35, P39; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; TILL JH, 1994, J BIOL CHEM, V269, P7423; VANBEVEREN C, 1986, CURR TOP MICROBIOL, V123, P73; VARMUS H, 1993, GENES BIOL CANCER	31	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27022	27026		10.1074/jbc.270.45.27022	http://dx.doi.org/10.1074/jbc.270.45.27022			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592951	hybrid			2022-12-27	WOS:A1995TE58300051
J	LERNER, EC; QIAN, YM; HAMILTON, AD; SEBTI, SM				LERNER, EC; QIAN, YM; HAMILTON, AD; SEBTI, SM			DISRUPTION OF ONCOGENIC K-RAS4B PROCESSING AND SIGNALING BY A POTENT GERANYLGERANYLTRANSFERASE-I INHIBITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN GERANYLGERANYLTRANSFERASE; RAS PROTEIN; FARNESYLTRANSFERASE; FARNESYL; PEPTIDOMIMETICS; TRANSFORMATION; TRANSFERASE; PRENYLATION; SPECIFICITY; SUBUNIT	Prenylation of the carboxyl-terminal CAAX (C, cysteine; A, aliphatic acid; and X, any amino acid) of Pas is required for its biological activity. We have designed a CAAX peptidomimetic, GGTI-287, which is 10 times more potent toward inhibiting geranylgeranyltransferase I (GGTase I) in vitro (IC50 = 5 nM) than our previously reported farnesyltransferase inhibitor, FTI-276. In whole cells, the methyl ester derivative of GGTI-287, GGTI-286, was 25-fold more potent (IC50 = 2 mu M) than the corresponding methyl ester of FTI-276, FTI-277, toward inhibiting the processing of the geranylgeranylated protein Rap1A. Furthermore, GGTI-286 is highly selective for geranylgeranylation over farnesylation since it inhibited the processing of farnesylated H-Pas only at much higher concentrations (IC50 > 30 mu M), While the processing of H-Pas was very sensitive to inhibition by FTI-277 (IC50 = 100 nM), that of K-Ras4B was highly resistant (IC50 = 10 mu M). In contrast, we found the processing of K-Ras4B to be much more sensitive to GGTI-286 (IC50 = 2 mu M). Furthermore, oncogenic K-Ras4B stim ulation of mitogen-activated protein (MAP) kinase was inhibited potently by GGTI-286 (IC50 = 1 mu M) but weakly by FTI-277 (IC50 = 30 mu M). Significant inhibition of oncogenic K-Ras4B stimulation of MAP kinase by GGTI-286 occurred at concentrations (1-3 mu M) that did not inhibit oncogenic H-Ras stimulation of MAP kinase, The data presented in this study provide the first demonstration of seledtive disruption of oncogenic K-Ras4B processing and signaling by a CAAX peptidomimetic, The higher sensitivity of K-Ras4B toward a GGTase I inhibitor has a tremendous impact on future research directions targeting Pas in anticancer therapy.	UNIV PITTSBURGH,SCH MED,DEPT PHARMACOL,PITTSBURGH,PA 15261; UNIV PITTSBURGH,FAC ARTS & SCI,DEPT CHEM,PITTSBURGH,PA 15261	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					NATIONAL CANCER INSTITUTE [R01CA055823] Funding Source: NIH RePORTER; NCI NIH HHS [CA-55823, U19-CA67701] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barbacid M, 1986, Important Adv Oncol, P3; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CASEY PJ, 1992, J LIPID RES, V33, P1731; COX AD, 1992, MOL CELL BIOL, V12, P2606, DOI 10.1128/MCB.12.6.2606; COX AD, 1994, J BIOL CHEM, V269, P19203; GIBBS JB, 1994, CELL, V77, P175, DOI 10.1016/0092-8674(94)90308-5; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; JACKSON JH, 1990, P NATL ACAD SCI USA, V87, P3042, DOI 10.1073/pnas.87.8.3042; JAMES GL, 1993, SCIENCE, V260, P1937, DOI 10.1126/science.8316834; JAMES GL, 1994, J BIOL CHEM, V269, P27705; JAMES GL, 1995, J BIOL CHEM, V270, P6221, DOI 10.1074/jbc.270.11.6221; KATO K, 1992, P NATL ACAD SCI USA, V89, P6403, DOI 10.1073/pnas.89.14.6403; KAUFFMANN RC, 1995, IN PRESS P NATL ACAD, V92; KOHL NE, 1994, P NATL ACAD SCI USA, V91, P9141, DOI 10.1073/pnas.91.19.9141; KOHL NE, 1993, SCIENCE, V260, P1934, DOI 10.1126/science.8316833; LERNER EC, 1995, J BIOL CHEM, V270, P26802, DOI 10.1074/jbc.270.45.26802; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MCCORMICK F, 1994, CURR OPIN GENET DEV, V4, P71, DOI 10.1016/0959-437X(94)90093-0; MCCORMICK F, 1993, NATURE, V363, P15, DOI 10.1038/363015a0; MOOMAW JF, 1992, J BIOL CHEM, V267, P17438; MOORES SL, 1991, J BIOL CHEM, V266, P14603; NIGAM M, 1993, J BIOL CHEM, V268, P20695; OMER CA, 1993, BIOCHEMISTRY-US, V32, P5167, DOI 10.1021/bi00070a028; QIAN YM, 1994, BIOORG MED CHEM LETT, V4, P2579, DOI 10.1016/S0960-894X(01)80287-0; QIAN YM, 1994, J BIOL CHEM, V269, P12410; REISS Y, 1991, J BIOL CHEM, V266, P10672; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; SEABRA MC, 1991, CELL, V65, P429, DOI 10.1016/0092-8674(91)90460-G; SUN JZ, 1995, CANCER RES, V55, P4243; TRUEBLOOD CE, 1993, MOL CELL BIOL, V13, P4260, DOI 10.1128/MCB.13.7.4260; VOGT A, 1995, J BIOL CHEM, V270, P660, DOI 10.1074/jbc.270.2.660; YOKOYAMA K, 1991, P NATL ACAD SCI USA, V88, P5302, DOI 10.1073/pnas.88.12.5302; ZHANG FL, 1994, J BIOL CHEM, V269, P3175	34	170	182	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26770	26773		10.1074/jbc.270.45.26770	http://dx.doi.org/10.1074/jbc.270.45.26770			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592913	hybrid			2022-12-27	WOS:A1995TE58300013
J	SAOUAF, SJ; KUT, SA; FARGNOLI, J; ROWLEY, RB; BOLEN, JB; MAHAJAN, S				SAOUAF, SJ; KUT, SA; FARGNOLI, J; ROWLEY, RB; BOLEN, JB; MAHAJAN, S			RECONSTITUTION OF THE B-CELL ANTIGEN RECEPTOR SIGNALING COMPONENTS IN COS CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; GROWTH-FACTOR RECEPTORS; MYRISTIC ACID; IG-ALPHA; ASSOCIATION; IMMUNOGLOBULIN; ACTIVATION; COMPLEX; P60SRC; BETA	To elucidate interactions occurring between B cell protein tyrosine kinases and the signaling components of the B cell antigen receptor, we have co transfected into COS cells individual tyrosine kinases together with chimeric cell surface receptors containing the cytoplasmic domains of Iga or Ig beta, Of the tyrosine kinases transfected (Lyn, Blk, Hck, Syk, Fyn), only Blk was able to phosphorylate and subsequently associate with cotransfected Ig alpha and Ig beta chimeras in vivo, Association between Blk and the Ig alpha and Ig beta cytoplasmic domains was shown by mutational analyses to be the result of an SH2-phosphotyrosine interaction, We identified the tyrosine residues of the Ig alpha and Ig beta cytoplasmic domains phosphorylated by Blk. The enzymatic activity and membrane association of Blk were required for the observed phosphorylation of the Ig alpha and Ig beta chimeras, Sequences within the amino-terminal unique domain of Blk are responsible for recognition and subsequent phosphorylation of the Ig alpha chimera since transfer of the unique region of Blk to Fyn results in the chimeric kinase's ability to phosphorylate the cytoplasmic domain of Ig alpha. These findings indicate that the unique domain of Src family kinases may direct recognition of certain substrates leading to their phosphorylation.			SAOUAF, SJ (corresponding author), BRISTOL MYERS SQUIBB PHARMACEUT RES INST, DEPT ONCOL, H24-03, POB 4000, PRINCETON, NJ 08543 USA.							ALLAND L, 1994, J BIOL CHEM, V269, P16701; BURKHARDT AL, 1994, MOL CELL BIOL, V14, P1095, DOI 10.1128/MCB.14.2.1095; BURKHARDT AL, 1991, P NATL ACAD SCI USA, V88, P7410, DOI 10.1073/pnas.88.16.7410; BURKHARDT AL, 1993, CURRENT PROTOCOLS IM, P1; BUSS JE, 1985, J VIROL, V53, P7, DOI 10.1128/JVI.53.1.7-12.1985; BUSS JE, 1986, J VIROL, V58, P468, DOI 10.1128/JVI.58.2.468-474.1986; CAMPBELL KS, 1990, EMBO J, V9, P441, DOI 10.1002/j.1460-2075.1990.tb08129.x; CAMPBELL MA, 1992, MOL CELL BIOL, V12, P2315, DOI 10.1128/MCB.12.5.2315; CHOQUET D, 1994, J BIOL CHEM, V269, P6491; CLARK MR, 1992, SCIENCE, V258, P123, DOI 10.1126/science.1439759; CLARK MR, 1994, EMBO J, V13, P1911, DOI 10.1002/j.1460-2075.1994.tb06460.x; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; DEICHAITE I, 1988, MOL CELL BIOL, V8, P4295, DOI 10.1128/MCB.8.10.4295; DEWEERS M, 1994, J BIOL CHEM, V269, P23857; ESCOBEDO JA, 1988, J BIOL CHEM, V263, P1482; FLASWINKEL H, 1994, EMBO J, V13, P83, DOI 10.1002/j.1460-2075.1994.tb06237.x; GAUEN LKT, 1992, MOL CELL BIOL, V12, P5438, DOI 10.1128/MCB.12.12.5438; GOLD MR, 1991, P NATL ACAD SCI USA, V88, P3436, DOI 10.1073/pnas.88.8.3436; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; HUTCHCROFT JE, 1991, J BIOL CHEM, V266, P14846; ISAKOV N, 1995, J EXP MED, V181, P375, DOI 10.1084/jem.181.1.375; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; KIM KM, 1993, IMMUNOL REV, V132, P125, DOI 10.1111/j.1600-065X.1993.tb00840.x; KINET JP, 1988, P NATL ACAD SCI USA, V85, P6483, DOI 10.1073/pnas.85.17.6483; LAW DA, 1993, CURR BIOL, V3, P645, DOI 10.1016/0960-9822(93)90062-S; MAHAJAN S, 1995, MOL CELL BIOL, V15, P5304; PELLMAN D, 1985, P NATL ACAD SCI USA, V82, P1623, DOI 10.1073/pnas.82.6.1623; PELLMAN D, 1985, NATURE, V314, P374, DOI 10.1038/314374a0; PLEIMAN CM, 1994, P NATL ACAD SCI USA, V91, P4268, DOI 10.1073/pnas.91.10.4268; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; ROWLEY RB, 1995, J BIOL CHEM, V270, P11590, DOI 10.1074/jbc.270.19.11590; SANCHEZ M, 1993, J EXP MED, V178, P1049, DOI 10.1084/jem.178.3.1049; SAOUAF SJ, 1994, P NATL ACAD SCI USA, V91, P9524, DOI 10.1073/pnas.91.20.9524; SILVERMAN L, 1992, J CELL BIOL, V119, P415, DOI 10.1083/jcb.119.2.415; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; TADDIE JA, 1994, J BIOL CHEM, V269, P13529; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; VEILLETTE A, 1988, MOL CELL BIOL, V8, P4353, DOI 10.1128/MCB.8.10.4353; WILLIAMS GT, 1994, P NATL ACAD SCI USA, V91, P474, DOI 10.1073/pnas.91.2.474; YAMADA T, 1993, EUR J BIOCHEM, V213, P455, DOI 10.1111/j.1432-1033.1993.tb17781.x; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; YOUNG-SHARP D, 1990, Technique (Philadelphia), V2, P155	46	22	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27072	27078		10.1074/jbc.270.45.27072	http://dx.doi.org/10.1074/jbc.270.45.27072			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592958	hybrid			2022-12-27	WOS:A1995TE58300058
J	WANG, BQ; BURTON, ZF				WANG, BQ; BURTON, ZF			FUNCTIONAL DOMAINS OF HUMAN RAP74 INCLUDING A MASKED POLYMERASE BINDING DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-IIF; GENERAL INITIATION-FACTOR; ESCHERICHIA-COLI SIGMA-70; PREINITIATION COMPLEX; ACCURATE INITIATION; MINIMAL SET; DNA; SUBUNIT; RAP30; PURIFICATION	RAP74, the large subunit of human transcription factor IIF (TEIIF), has been analyzed by deletion mutagenesis and in vitro assays to map functional domains. Tight binding to the RAP30 subunit involves amino acids between positions 1-172. Amino acids 1-205 are minimally sufficient to stimulate accurate transcription from the adenovirus major late promoter in an extract system, although C-terminal sequences contribute to activity. A partially masked RNA polymerase II binding domain has been mapped to the C-terminal region of the protein (amino acids 363-444), Sequences near the N terminus and within the central portion of RAP74 affect accessibility of this domain. Extending this domain to 363-486 creates a peptide that binds polymerase and DNA and inhibits transcription initiation in vitro from non-promoter DNA sites. This larger C-terminal domain may modify polymerase interaction with template during initiation and/or elongation of RNA chains.	MICHIGAN STATE UNIV,DEPT BIOCHEM,E LANSING,MI 48824	Michigan State University								ASO T, 1992, NATURE, V355, P461, DOI 10.1038/355461a0; BENGAL E, 1991, MOL CELL BIOL, V11, P1195, DOI 10.1128/MCB.11.3.1195; BURTON ZF, 1988, MOL CELL BIOL, V8, P1602, DOI 10.1128/MCB.8.4.1602; CHAMBERS RS, 1995, J BIOL CHEM, V270, P14962, DOI 10.1074/jbc.270.25.14962; CHANG CH, 1993, J BIOL CHEM, V268, P20482; CONAWAY JW, 1989, J BIOL CHEM, V264, P2357; CONAWAY JW, 1990, SCIENCE, V248, P1550, DOI 10.1126/science.2193400; CONAWAY RC, 1991, P NATL ACAD SCI USA, V88, P6205, DOI 10.1073/pnas.88.14.6205; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; COULOMBE B, 1994, J BIOL CHEM, V269, P19962; DAHMUS ME, 1994, TRANSCRIPTION MECHAN, P243; DRAPKIN R, 1994, TRENDS BIOCHEM SCI, V19, P504, DOI 10.1016/0968-0004(94)90139-2; FINKELSTEIN A, 1992, NATURE, V355, P464, DOI 10.1038/355464a0; FLORES O, 1990, J BIOL CHEM, V265, P5629; FLORES O, 1988, J BIOL CHEM, V263, P10812; FLORES O, 1991, P NATL ACAD SCI USA, V88, P9999, DOI 10.1073/pnas.88.22.9999; GARRETT KP, 1992, J BIOL CHEM, V267, P23942; GONG DW, 1992, NUCLEIC ACIDS RES, V20, P6736, DOI 10.1093/nar/20.24.6736; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; HA I, 1993, GENE DEV, V7, P1021, DOI 10.1101/gad.7.6.1021; HENRY NL, 1994, GENE DEV, V8, P2868, DOI 10.1101/gad.8.23.2868; HENRY NL, 1992, J BIOL CHEM, V267, P23388; HODO HG, 1977, BIOCHEMISTRY-US, V16, P2334, DOI 10.1021/bi00630a005; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; JOLIET V, 1995, NATURE, V373, P632, DOI 10.1038/373632a0; KEPHART DD, 1994, J BIOL CHEM, V269, P13536; KEPHART DD, 1993, NUCLEIC ACIDS RES, V21, P1319, DOI 10.1093/nar/21.5.1319; KILLEEN M, 1992, J BIOL CHEM, V267, P9463; KILLEEN MT, 1992, MOL CELL BIOL, V12, P30, DOI 10.1128/MCB.12.1.30; KITAJIMA S, 1994, J BIOL CHEM, V269, P29970; KITAJIMA S, 1990, NUCLEIC ACIDS RES, V18, P4848; LEMESLEVARLOOT L, 1990, BIOCHIMIE, V72, P555, DOI 10.1016/0300-9084(90)90120-6; MAXON ME, 1994, GENE DEV, V8, P515, DOI 10.1101/gad.8.5.515; MCCRACKEN S, 1991, SCIENCE, V253, P900, DOI 10.1126/science.1652156; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; PINTO I, 1992, CELL, V68, P977, DOI 10.1016/0092-8674(92)90040-J; SOPTA M, 1985, J BIOL CHEM, V260, P353; SOPTA M, 1989, NATURE, V341, P410, DOI 10.1038/341410a0; SUN ZW, 1995, P NATL ACAD SCI USA, V92, P3127, DOI 10.1073/pnas.92.8.3127; TAN SY, 1994, J BIOL CHEM, V269, P25684; TAN SY, 1994, P NATL ACAD SCI USA, V91, P9808, DOI 10.1073/pnas.91.21.9808; TIMMERS HTM, 1994, EMBO J, V13, P391, DOI 10.1002/j.1460-2075.1994.tb06273.x; TYREE CM, 1993, GENE DEV, V7, P1254, DOI 10.1101/gad.7.7a.1254; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; WANG BQ, 1994, PROTEIN EXPRES PURIF, V5, P476, DOI 10.1006/prep.1994.1067; WANG BQ, 1993, PROTEIN EXPRES PURIF, V4, P207, DOI 10.1006/prep.1993.1027; YONAHA M, 1993, NUCLEIC ACIDS RES, V21, P273, DOI 10.1093/nar/21.2.273; ZAWEL L, 1993, PROG NUCLEIC ACID RE, V44, P67, DOI 10.1016/S0079-6603(08)60217-2; ZHU H, 1994, J BIOL CHEM, V269, P3489	49	46	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27035	27044		10.1074/jbc.270.45.27035	http://dx.doi.org/10.1074/jbc.270.45.27035			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592953	hybrid			2022-12-27	WOS:A1995TE58300053
J	WEI, XY; PAN, S; LANG, WH; KIM, HY; SCHNEIDER, T; PEREZREYES, E; BIRNBAUMER, L				WEI, XY; PAN, S; LANG, WH; KIM, HY; SCHNEIDER, T; PEREZREYES, E; BIRNBAUMER, L			MOLECULAR DETERMINANTS OF CARDIAC CA2+ CHANNEL PHARMACOLOGY - SUBUNIT REQUIREMENT FOR THE HIGH-AFFINITY AND ALLOSTERIC REGULATION OF DIHYDROPYRIDINE BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE CALCIUM-CHANNEL; SKELETAL-MUSCLE; BETA-SUBUNIT; FUNCTIONAL EXPRESSION; CA-2+ CHANNEL; GAMMA-SUBUNIT; CELL-LINE; RECEPTOR; ALPHA-1-SUBUNIT; BLOCKERS	Cardiac L-type Ca2+ channels are multisubunit complexes composed of alpha(1C), alpha(2) delta, and beta(2) subunits, We tested the roles of these subunits in forming a functional complex by characterizing the effects of subunit composition on dihydropyridine binding, its allosteric regulation, and the ability of dihydropyridines to inhibit channel activity, Transfection of COS.M6 cells with cardiac alpha(1C-a) (alpha(1)) led to the appearance of dihydropyridine ([H-3]PN200-110) binding which was increased by coexpression of cardiac beta(2a) (beta), alpha(2) delta(a) (alpha(2)), and the skeletal muscle gamma. Maximum binding was achieved when cells expressed alpha(1), beta, and alpha(2). Cells transfected with alpha(1) and beta had a binding affinity that was 5-10-fold lower than that observed in cardiac membranes. Coexpression of alpha(2) normalized this affinity, (-)-D600 and diltiazem both partially inhibited PN200-110 binding to cardiac microsomes, but stimulated binding in cells transfected with alpha(1) and beta. Again, coexpression of alpha(2) normalized this allosteric regulation. Therefore coexpression of alpha(1) beta and alpha(2) completely reconstituted high affinity dihydropyridine binding and its allosteric regulation as observed in cardiac membranes, Skeletal muscle gamma was not required for this reconstitution, Expression in Xenopus oocytes demonstrated that coexpression of alpha(2) with alpha(1) beta increased the potency and maximum extent of block of Ca2+ channel currents by nisoldipine, a dihydropyridine Ca2+ channel antagonist. Our results demonstrate that alpha(2) subunits are essential components of the cardiac L-type Ca2+ channel and predict a minimum subunit composition of alpha(1C)beta(2) alpha(2) delta for this channel.	MED COLL GEORGIA, INST MOLEC MED & GENET, AUGUSTA, GA 30912 USA; MED COLL GEORGIA, DEPT PHARMACOL & TOXICOL, AUGUSTA, GA 30912 USA; BAYLOR COLL MED, DEPT CELL BIOL, HOUSTON, TX 77030 USA; UNIV COLOGNE, INST NEUROPHYSIOL, COLOGNE, GERMANY; LOYOLA UNIV, MED CTR, DEPT PHYSIOL, MAYWOOD, IL 60153 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT ANESTHESIOL, LOS ANGELES, CA 90024 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; Baylor College of Medicine; University of Cologne; Loyola University Chicago; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA					NIAMS NIH HHS [AR43411] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043411] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; BOSSE E, 1990, FEBS LETT, V267, P153, DOI 10.1016/0014-5793(90)80312-7; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; CHANG FC, 1988, J BIOL CHEM, V263, P18929; COOPER CL, 1987, J BIOL CHEM, V262, P509; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; GLOSSMANN H, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1917; GLOSSMANN H, 1990, REV PHYSL BIOCH PHAR, V114, P1; HAASE H, 1993, FEBS LETT, V335, P217, DOI 10.1016/0014-5793(93)80733-B; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; JAY SD, 1990, SCIENCE, V248, P490, DOI 10.1126/science.2158672; KIM HS, 1990, J BIOL CHEM, V265, P11858; KUNIYASU A, 1992, J BIOCHEM, V112, P235, DOI 10.1093/oxfordjournals.jbchem.a123883; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MACGREGOR GR, 1987, SOMAT CELL MOLEC GEN, V13, P253, DOI 10.1007/BF01535207; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MITTERDORFER J, 1994, FEBS LETT, V352, P141, DOI 10.1016/0014-5793(94)00938-4; NEELY A, 1994, BIOPHYS J, V66, P1895, DOI 10.1016/S0006-3495(94)80983-X; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; NISHIMURA S, 1993, FEBS LETT, V324, P283, DOI 10.1016/0014-5793(93)80135-H; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; PEREZREYES E, 1994, DRUG DEVELOP RES, V33, P295, DOI 10.1002/ddr.430330311; RAMPE D, 1990, BIOCHEM BIOPH RES CO, V169, P825, DOI 10.1016/0006-291X(90)91967-W; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SATHER WA, 1993, NEURON, V11, P291, DOI 10.1016/0896-6273(93)90185-T; SCHNEIDER T, 1988, EUR J BIOCHEM, V174, P369, DOI 10.1111/j.1432-1033.1988.tb14107.x; SCHNEIDER T, 1991, EUR J BIOCHEM, V200, P245, DOI 10.1111/j.1432-1033.1991.tb21073.x; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; STAUDINGER R, 1991, J BIOL CHEM, V266, P10787; TAGLIALATELA M, 1992, BIOPHYS J, V61, P78, DOI 10.1016/S0006-3495(92)81817-9; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TOKUMARU H, 1992, EUR J PHARM-MOLEC PH, V227, P363, DOI 10.1016/0922-4106(92)90152-L; WEI XY, 1989, MOL PHARMACOL, V35, P541; WEI XY, 1991, J BIOL CHEM, V266, P21943; WEI XY, 1994, BIOPHYS J, V66, pA128; WELLING A, 1993, J PHYSIOL-LONDON, V471, P749, DOI 10.1113/jphysiol.1993.sp019926; WELLING A, 1995, PFLUG ARCH EUR J PHY, V429, P400, DOI 10.1007/BF00374156	41	54	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27106	27111		10.1074/jbc.270.45.27106	http://dx.doi.org/10.1074/jbc.270.45.27106			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592963	hybrid			2022-12-27	WOS:A1995TE58300063
J	CHEN, CK; INGLESE, J; LEFKOWITZ, RJ; HURLEY, JB				CHEN, CK; INGLESE, J; LEFKOWITZ, RJ; HURLEY, JB			CA2+-DEPENDENT INTERACTION OF RECOVERIN WITH RHODOPSIN KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN; ROD OUTER SEGMENTS; CYCLIC-GMP PHOSPHODIESTERASE; GUANYLATE-CYCLASE; NERVOUS-SYSTEM; RETINAL RODS; FATTY-ACIDS; S-MODULIN; CELLS; PHOSPHORYLATION	Recoverin (Rv) is a myristoylated Ca2+-binding protein present primarily in bovine photoreceptors. It represents a newly identified family of neuronal specific Ca2+-binding proteins that includes neurocalcin, hippocalcin, and guanylyl cyclase-activating protein. To investigate the function of Rv in photoreceptors, we identified proteins that bind immobilized Rv in a Ca2+-dependent manner. Rhodopsin kinase (RK), interphotoreceptor retinoid-binding protein, and tubulin interact with Rv in the presence of Ca2+. The importance of the Rv/RK interaction was further characterized. RK, purified using immobilized Rv as an affinity matrix, catalyzed the light-dependent and Ca2+-independent incorporation of phosphates into rhodopsin when reconstituted with urea-stripped rod outer segment membranes. When only a small fraction (0.04%) of rhodopsin was photolyzed, as many as 700 phosphates were incorporated per photolyzed rhodopsin, a phenomenon known as ''high gain'' phosphorylation. When recoverin was added, the activity of RK became sensitive to free Ca2+, with EC(50) = 3 mu M. The N-terminal myristoyl residue of Rv enhances the inhibitory effect of Rv and introduces cooperativity to the Ca2+-dependent inhibition of rhodopsin phosphorylation. Rv neither interacts with other members of the G-protein-coupled receptor kinase family such as beta-adrenergic receptor kinase 1 nor inhibits beta-adrenergic receptor kinase 1 activity. The specific and Ca2+-dependent Rv/RK interaction is necessary for the inhibitory effect of Rv on rhodopsin phosphorylation and may play an important role in photoreceptor light adaptation.	UNIV WASHINGTON,HOWARD HUGHES MED INST,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195; DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DEPT MED & BIOCHEM,DURHAM,NC 27710	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Duke University; Howard Hughes Medical Institute			Lefkowitz, Robert/AAW-2649-2021		NEI NIH HHS [R01 EY006641, EYO6641] Funding Source: Medline; NHLBI NIH HHS [HL16037] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006641] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMES JB, 1995, J BIOL CHEM, V270, P4526, DOI 10.1074/jbc.270.9.4526; BAZAN NG, 1985, J BIOL CHEM, V260, P3677; BENOVIC JL, 1986, NATURE, V322, P869; BINDER BM, 1990, J BIOL CHEM, V265, P15333; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; CHEN CK, 1994, INVEST OPHTH VIS SCI, V35, P1485; DIZHOOR AM, 1992, J BIOL CHEM, V267, P16033; DIZHOOR AM, 1993, SCIENCE, V259, P829, DOI 10.1126/science.8430337; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; GORODOVIKOVA EN, 1993, FEBS LETT, V335, P277, DOI 10.1016/0014-5793(93)80746-H; GRAYKELLER MP, 1993, NEURON, V10, P523, DOI 10.1016/0896-6273(93)90339-S; GRAYKELLER MP, 1994, NEURON, V13, P1; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; HURLEY JB, 1993, SCIENCE, V260, P740, DOI 10.1126/science.8097896; INGLESE J, 1992, J BIOL CHEM, V267, P1422; INGLESE J, 1993, J BIOL CHEM, V268, P23735; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; KAWAMURA S, 1994, BIOCHEM BIOPH RES CO, V203, P121, DOI 10.1006/bbrc.1994.2157; KAWAMURA S, 1993, J BIOL CHEM, V268, P14579; KELLEHER DJ, 1990, J BIOL CHEM, V265, P2632; KLENCHIN VA, 1994, BIOPHYS J, V66, pA48; KOBAYASHI M, 1992, BIOCHEM BIOPH RES CO, V189, P511, DOI 10.1016/0006-291X(92)91587-G; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KWATRA MM, 1993, J BIOL CHEM, V268, P9161; LAGNADO L, 1992, NEURON, V8, P995, DOI 10.1016/0896-6273(92)90122-T; LENZ SE, 1992, MOL BRAIN RES, V15, P133, DOI 10.1016/0169-328X(92)90160-D; MILAM AH, 1993, VISUAL NEUROSCI, V10, P1, DOI 10.1017/S0952523800003175; NEWTON AC, 1993, J BIOL CHEM, V268, P18181; OKAZAKI K, 1992, BIOCHEM BIOPH RES CO, V185, P147, DOI 10.1016/S0006-291X(05)80968-4; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; PALCZEWSKI K, 1993, J BIOL CHEM, V268, P6004; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; POLANS AS, 1991, J CELL BIOL, V112, P981, DOI 10.1083/jcb.112.5.981; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; PREMONT RT, 1994, J BIOL CHEM, V269, P6832; RAY S, 1992, P NATL ACAD SCI USA, V89, P5705, DOI 10.1073/pnas.89.13.5705; SHICHI H, 1978, J BIOL CHEM, V253, P7040; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; YAMAGATA K, 1990, NEURON, V4, P469, DOI 10.1016/0896-6273(90)90059-O; YARFITZ S, 1994, J BIOL CHEM, V269, P14329; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	44	252	255	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18060	18066		10.1074/jbc.270.30.18060	http://dx.doi.org/10.1074/jbc.270.30.18060			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629115	hybrid			2022-12-27	WOS:A1995RM26600066
J	ROSCHE, B; TSHISUAKA, B; FETZNER, S; LINGENS, F				ROSCHE, B; TSHISUAKA, B; FETZNER, S; LINGENS, F			2-OXO-1,2-DIHYDROQUINOLINE 8-MONOOXYGENASE, A 2-COMPONENT ENZYME-SYSTEM FROM PSEUDOMONAS-PUTIDA-86	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-METHOXYBENZOATE O-DEMETHYLASE; BENZOATE 1,2-DIOXYGENASE SYSTEM; COMAMONAS-TESTOSTERONI T-2; IRON SULFUR PROTEINS; RHODOCOCCUS-SPEC B1; SP STRAIN NCIB-9816; MICROBIAL-METABOLISM; OXYGENASE COMPONENT; QUINOLINE OXIDOREDUCTASE; NAPHTHALENE DIOXYGENASE	2-Oxo-1,2-dihydroquinoline 8-monooxygenase, which catalyzes the NADH-dependent oxygenation of 2-oxo-1,2-dihydroquinoline to 8-hydroxy-2-oxo-1,2-dihydroquinoline, is the second enzyme in the quinoline degradation pathway of Pseudomonas putida 86. This enzyme system consists of two inducible protein components, which were purified, characterized, and identified as reductase and oxygenase. The yellow reductase is a monomeric iron-sulfur flavoprotein (M(r), 38,000), containing flavin adenine dinucleotide and plant-type ferredoxin [2Fe-2S]. It transferred electrons from NADH to the oxygenase or to some artificial electron accepters. The red-brown oxygenase (M(r), 330,000) consists of six identical subunits (M(r), 55,000) and was identified as an iron-sulfur protein, possessing about six Rieske-type [2Fe-2S] clusters and additional iron. It was reduced by NADH plus catalytic amounts of reductase. For monooxygenase activity, reductase, oxygenase, NADH, molecular oxygen, and substrate were required. The activity was considerably enhanced by the addition of polyethylene glycol and Fe2+. 2-Oxo-1,2-dihydroquinoline 8-monooxygenase revealed a high substrate specificity toward 2-oxo-1,2-dihydroquinoline, since none of 25 other tested compounds was converted. Based on its physical, chemical, and catalytic properties, we presume 2-oxo-1,2-dihydroquinoline 8-monooxygenase to belong to the class IB multicomponent non-heme iron oxygenases.	UNIV HOHENHEIM,INST MIKROBIOL,D-70593 STUTTGART,GERMANY	University Hohenheim				Fetzner, Susanne/0000-0002-7228-1871				ADRIAN W, 1980, H-S Z PHYSIOL CHEM, V361, P211; ARMSTRONG JM, 1964, BIOCHIM BIOPHYS ACTA, V86, P194; ATKINSON A, 1973, J APPL CHEM BIOTECHN, V23, P517; AXCELL BC, 1975, BIOCHEM J, V146, P173, DOI 10.1042/bj1460173; BABSON AL, 1973, CLIN CHEM, V19, P766; BATIE CJ, 1987, J BIOL CHEM, V262, P1510; BATIE CJ, 1991, CHEM BIOCH FLAVOENZY, P543; BAUDER R, 1990, BIOL CHEM H-S, V371, P1137, DOI 10.1515/bchm3.1990.371.2.1137; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BERGMEYER HU, 1975, Z KLIN CHEM KLIN BIO, V13, P507; BERNHARD.FH, 1973, EUR J BIOCHEM, V35, P126, DOI 10.1111/j.1432-1033.1973.tb02818.x; BERNHARDT FH, 1978, EUR J BIOCHEM, V92, P209, DOI 10.1111/j.1432-1033.1978.tb12739.x; BERNHARDT FH, 1975, EUR J BIOCHEM, V57, P241, DOI 10.1111/j.1432-1033.1975.tb02296.x; BILL E, 1981, EUR J BIOCHEM, V121, P39, DOI 10.1111/j.1432-1033.1981.tb06426.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNEL F, 1988, J BACTERIOL, V170, P4924, DOI 10.1128/jb.170.10.4924-4930.1988; BUNZ PV, 1993, J BACTERIOL, V175, P6467; Cann J R, 1979, Methods Enzymol, V61, P142; ENSLEY BD, 1983, J BACTERIOL, V155, P505, DOI 10.1128/JB.155.2.505-511.1983; ERICKSON BD, 1992, J BACTERIOL, V174, P2903, DOI 10.1128/JB.174.9.2903-2912.1992; FETZNER S, 1993, FEMS MICROBIOL LETT, V112, P151, DOI 10.1111/j.1574-6968.1993.tb06441.x; FETZNER S, 1992, J BACTERIOL, V174, P279, DOI 10.1128/jb.174.1.279-290.1992; FRATER R, 1970, J CHROMATOGR, V50, P469, DOI 10.1016/S0021-9673(00)97974-3; GEARY PJ, 1984, BIOCHEM J, V217, P667, DOI 10.1042/bj2170667; HAAK B, 1995, J BACTERIOL, V177, P667, DOI 10.1128/jb.177.3.667-675.1995; HAIGLER BE, 1990, J BACTERIOL, V172, P457, DOI 10.1128/JB.172.1.457-464.1990; HAIGLER BE, 1990, J BACTERIOL, V172, P465, DOI 10.1128/JB.172.1.465-468.1990; HARAYAMA S, 1986, MOL GEN GENET, V202, P226, DOI 10.1007/BF00331641; HETTRICH D, 1991, BIOL CHEM H-S, V372, P513, DOI 10.1515/bchm3.1991.372.2.513; HOLLAND HL, 1992, ORGANIC SYNTHESIS OX; LOCHER HH, 1991, BIOCHEM J, V274, P833, DOI 10.1042/bj2740833; LOCHER HH, 1991, J BACTERIOL, V173, P3741, DOI 10.1128/JB.173.12.3741-3748.1991; MARKUS A, 1986, J BIOL CHEM, V261, P2883; MASON JR, 1992, ANNU REV MICROBIOL, V46, P277, DOI 10.1146/annurev.mi.46.100192.001425; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; NIELSEN P, 1986, METHOD ENZYMOL, V122, P209, DOI 10.1016/0076-6879(86)22172-2; PESCHKE B, 1991, BIOL CHEM H-S, V372, P1081, DOI 10.1515/bchm3.1991.372.2.1081; POWLOWSKI J, 1990, J BACTERIOL, V172, P6834, DOI 10.1128/jb.172.12.6834-6840.1990; RIBBONS DW, 1970, FEBS LETT, V12, P105, DOI 10.1016/0014-5793(70)80574-9; SARIASLANI FS, 1989, CRIT REV BIOTECHNOL, V9, P170; SAUBER K, 1977, EUR J BIOCHEM, V74, P89, DOI 10.1111/j.1432-1033.1977.tb11370.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHELLENBERG KA, 1958, J BIOL CHEM, V231, P547; SCHICKLE H, SDRE01 PHARM B; SCHWARZ G, 1988, SYST APPL MICROBIOL, V10, P185, DOI 10.1016/S0723-2020(88)80035-3; SCHWARZ G, 1989, BIOL CHEM H-S, V370, P1183, DOI 10.1515/bchm3.1989.370.2.1183; SCHWEIZER D, 1987, J BIOL CHEM, V262, P9340; SHAW JP, 1992, EUR J BIOCHEM, V209, P51, DOI 10.1111/j.1432-1033.1992.tb17260.x; SHUKLA OP, 1986, APPL ENVIRON MICROB, V51, P1332, DOI 10.1128/AEM.51.6.1332-1342.1986; Siegel L M, 1978, Methods Enzymol, V53, P419; SUBRAMANIAN V, 1981, J BIOL CHEM, V256, P2723; SUBRAMANIAN V, 1979, BIOCHEM BIOPH RES CO, V91, P1131, DOI 10.1016/0006-291X(79)91998-3; SUBRAMANIAN V, 1985, J BIOL CHEM, V260, P2355; SUZUKI M, 1991, J BACTERIOL, V173, P1690, DOI 10.1128/jb.173.5.1690-1695.1991; TAKIZAWA N, 1994, J BACTERIOL, V176, P2444, DOI 10.1128/JB.176.8.2444-2449.1994; TSHISUAKA B, 1993, BIOCHEMISTRY-US, V32, P12928, DOI 10.1021/bi00210a047; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; WHITED GM, 1991, J BACTERIOL, V173, P3010, DOI 10.1128/JB.173.9.3010-3016.1991; WHITESTEVENS RH, 1972, J BIOL CHEM, V247, P2358; YAMAGUCHI M, 1980, J BIOL CHEM, V255, P5058; YAMAGUCHI M, 1978, J BIOL CHEM, V253, P8848; YAMAGUCHI M, 1982, J BIOL CHEM, V257, P2497	62	31	33	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17836	17842		10.1074/jbc.270.30.17836	http://dx.doi.org/10.1074/jbc.270.30.17836			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629085	hybrid			2022-12-27	WOS:A1995RM26600033
J	DAVIDSON, WS; RODRIGUEZA, WV; LUNDKATZ, S; JOHNSON, WJ; ROTHBLAT, GH; PHILLIPS, MC				DAVIDSON, WS; RODRIGUEZA, WV; LUNDKATZ, S; JOHNSON, WJ; ROTHBLAT, GH; PHILLIPS, MC			EFFECTS OF ACCEPTOR PARTICLE-SIZE ON THE EFFLUX OF CELLULAR FREE-CHOLESTEROL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; LARGE UNILAMELLAR VESICLES; ENDOTHELIAL SURFACE; PERIPHERAL LYMPH; LPA-I; MEMBRANE; CHROMATOGRAPHY; PERMEABILITY; FIBROBLASTS	Several subspecies of human high density lipoprotein (HDL) have been shown to exist, and particle size is one parameter that can be used to distinguish them, Recently, a small HDL subspecies has been described that may be a particularly efficient acceptor of peripheral cell unesterified (free) cholesterol (FC), To address the effects of particle size on the ability of HDL to remove FC from cells, homogeneous, well defined HDL particles were reconstituted (rHDL) that varied in particle diameter within the size range of human HDL particles (7-13 nm), The abilities of each of these particles to remove cellular FC from mouse L-cells and rat Fu5AH hepatoma cells were compared on the basis of their phospholipid (PL) content as well as on a per particle basis, The effect of particle size was also examined using small unilamellar vesicles (SUV) of 25 nm in diameter and large unilamellar vesicles (LUVs) of 70-180 nn in diameter, The SUV were prepared by sonication, and the LUVs were prepared by extrusion techniques, The FC efflux efficiency of these particles (in order of decreasing efficiency) was: rHDL > SUV > LUV when compared on the basis of acceptor PL content across a range of concentrations (i.e. at a given PL concentration for these three acceptor classes, smaller particles were more efficient), The FC efflux differences between the rHDL and the vesicles were not due to the absence of apolipoprotein in the vesicles, No difference was detected among the rHDL of varying size, nor was a difference detected among the LUVs of varying size when compared on the basis of PL content, When the FC efflux data for rHDL and LUVs were normalized on the basis of the number of acceptor particles present at a given PL concentration, a correlation was found between acceptor particle radius and the ability to accept cellular FC with larger particles being the most efficient, However, the dependence of the rate of FC efflux on acceptor particle size was not quantitatively the same within the rHDL and LUV classes of acceptor particles, The dependence of FC efflux on acceptor particle size may reflect differing abilities of the variously sized acceptor particles to access the region very close to the cell plasma membrane where most of the FC removal is expected to occur.	MED COLL PENN,DEPT BIOCHEM,PHILADELPHIA,PA 19129; HAHNEMANN UNIV,PHILADELPHIA,PA 19129	Drexel University; Drexel University				Davidson, William/0000-0003-2756-2989; Phillips, Michael/0000-0002-7147-8007	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633, T32HL007443] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL22633, HL07443] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGNANI G, 1993, BIOCHEMISTRY-US, V32, P2643, DOI 10.1021/bi00061a024; BARBEE KA, 1994, CIRC RES, V74, P163, DOI 10.1161/01.RES.74.1.163; BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; BARENHOLZ Y, 1984, PHYSL MEMBRANE FLUID, V1, P134; BARRY PH, 1984, PHYSIOL REV, V64, P763, DOI 10.1152/physrev.1984.64.3.763; CASTRO GR, 1988, BIOCHEMISTRY-US, V27, P25, DOI 10.1021/bi00401a005; CHEUNG MC, 1984, J BIOL CHEM, V259, P2201; CHRISTENSEN HN, 1974, ENZYME KINETICS, P50; CLOUGH G, 1991, PROG BIOPHYS MOL BIO, V55, P47, DOI 10.1016/0079-6107(91)90011-G; DAVIDSON WS, 1994, J BIOL CHEM, V269, P22975; DAVIDSON WS, 1995, J BIOL CHEM, V270, P5882, DOI 10.1074/jbc.270.11.5882; DELAMATRE J, 1986, BIOCHIM BIOPHYS ACTA, V875, P419, DOI 10.1016/0005-2760(86)90061-5; FRANCONE OL, 1990, EUR HEART J, V11, P218, DOI 10.1093/eurheartj/11.suppl_E.218; GERRITY RG, 1977, PROG BIOCHEM PHARM, V14, P134; GOROG P, 1982, BRIT J EXP PATHOL, V63, P447; HALDENBY KA, 1994, J VASC RES, V31, P2, DOI 10.1159/000159025; HAVEL RJ, 1955, J CLIN INVEST, V34, P476; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; HUANG CH, 1969, BIOCHEMISTRY-US, V8, P344, DOI 10.1021/bi00829a048; HUANG YD, 1993, ARTERIOSCLER THROMB, V13, P445, DOI 10.1161/01.ATV.13.3.445; HUANG YD, 1994, P NATL ACAD SCI USA, V91, P1834, DOI 10.1073/pnas.91.5.1834; JOHNSON WJ, 1988, J BIOL CHEM, V263, P14099; JOHNSON WJ, 1991, BIOCHIM BIOPHYS ACTA, V1085, P273, DOI 10.1016/0005-2760(91)90132-2; JONAS A, 1989, J BIOL CHEM, V264, P4818; JONAS A, 1994, J LIPID RES, V35, P860; LEFEVRE M, 1988, J LIPID RES, V29, P1139; LETIZIA JY, 1991, BIOCHEMISTRY-US, V30, P866, DOI 10.1021/bi00217a041; LUNDKATZ S, 1986, BIOCHEMISTRY-US, V25, P1562, DOI 10.1021/bi00355a016; MARCEL YL, 1984, EUR J BIOCHEM, V143, P467, DOI 10.1111/j.1432-1033.1984.tb08394.x; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MCLEAN LR, 1984, BIOCHIM BIOPHYS ACTA, V776, P21, DOI 10.1016/0005-2736(84)90246-3; PHILLIPS MC, 1987, BIOCHIM BIOPHYS ACTA, V906, P223, DOI 10.1016/0304-4157(87)90013-X; RADER DJ, 1991, J LIPID RES, V32, P1849; REICHL D, 1990, EUR HEART J, V11, P230, DOI 10.1093/eurheartj/11.suppl_E.230; RODRIGUEZA WV, 1995, BIOCHEMISTRY-US, V34, P6208, DOI 10.1021/bi00018a025; RODRIGUEZA WV, 1993, BIOCHIM BIOPHYS ACTA, V1153, P9, DOI 10.1016/0005-2736(93)90270-A; ROTHBLAT GH, 1992, J LIPID RES, V33, P1091; RYAN US, 1986, FASEB J, V45, P101; SCANU AM, 1971, ANAL BIOCHEM, V44, P576, DOI 10.1016/0003-2697(71)90247-8; SCHROEDER F, 1991, P SOC EXP BIOL MED, V195, P235; SKIPSKI VP, 1972, BLOOD LIPIDS LIPOPRO, P471; SOKOLOFF L, 1974, P SOC EXP BIOL MED, V146, P1166; SPARKS DL, 1992, J LIPID RES, V33, P123; SPARKS DL, 1992, J BIOL CHEM, V267, P25830; SWANEY JB, 1986, METHOD ENZYMOL, V128, P613; THOMAS PD, 1988, BIOCHEM J, V254, P155, DOI 10.1042/bj2540155; WEAST RC, 1983, HDB CHEM PHYSICS, pF40; WEISWEILER P, 1987, CLIN CHIM ACTA, V169, P249, DOI 10.1016/0009-8981(87)90325-1; WESTERGAARD H, 1974, J CLIN INVEST, V54, P718, DOI 10.1172/JCI107810; YOKOYAMA S, 1980, J BIOL CHEM, V255, P7333	50	115	117	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17106	17113		10.1074/jbc.270.29.17106	http://dx.doi.org/10.1074/jbc.270.29.17106			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615505	hybrid			2022-12-27	WOS:A1995RK68900012
J	GRUNEWALD, M; KANNER, B				GRUNEWALD, M; KANNER, B			CONFORMATIONAL-CHANGES MONITORED ON THE GLUTAMATE TRANSPORTER GLT-1 INDICATE THE EXISTENCE OF 2 NEUROTRANSMITTER-BOUND STATES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ANTIGENIC DETERMINANTS; RAT-BRAIN; MEMBRANE-VESICLES; ACID TRANSPORTER; SYNAPTIC CLEFT; HIGH-AFFINITY; AMINO-ACIDS; RECONSTITUTION; EXPRESSION; ASPARTATE	Membrane vesicles from rat brain have been subjected to trypsin treatment in the absence and presence of substrates of the (Na+ + K+)-coupled L-glutamate transporter GLT-1. The fragments of this transporter have been detected upon immunoblotting employing several antibodies raised against sequences from this transporter. At the amino terminus, initially a fragment of an apparent molecular mass of 30 kDa is generated. This fragment is subsequently cleaved to one of 16 kDa. The generation of these bands is greatly inhibited in the presence of lithium. Moreover, lithium abolishes the positive cooperative activation of the transporter by sodium. The generation of the 30- and 16-kDa fragments is accelerated in the presence of L-glutamate and other transportable analogues, provided sodium is present as well. The 30-kDa fragment also contains an epitope from the loop connecting the putative membrane-spanning alpha-helices 3 and 4. This epitope, in contrast with the amino-terminal one, is destroyed with time. The carboxyl-terminal epitope is predominantly located on a 43-kDa fragment which is slowly converted to one of 35 kDa. This conversion is not inhibited by lithium. It is, however, stimulated by L-glutamate and other transportable analogues, but only in sodium-containing media. Potassium also stimulates this conversion regardless of the presence of L-glutamate. The stimulation of generation of amino- and carboxyl-terminal fragments by L-glutamate is not mimicked by the nontransportable analogue dihydrokainate. However, the analogue blocks the stimulation exerted by L-glutamate. In addition to new experimental information on the trans porters topology, our observations provide novel information on the function of the GLT-1 transporter. Although lithium by itself does not sustain transport, it may occupy one of the sodium sites and be transported. Furthermore, the transporter-glutamate complex appears to exist in at least two states. After the initial binding (suggested to be important for the decay of synaptic glutamate), it undergoes a conformational change which represents, or is tightly associated with, the transport step.	HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT BIOCHEM,IL-91120 JERUSALEM,ISRAEL	Hebrew University of Jerusalem								ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; BALCAR VJ, 1972, J NEUROBIOL, V3, P295, DOI 10.1002/neu.480030403; BARBOUR B, 1991, J PHYSIOL-LONDON, V436, P169, DOI 10.1113/jphysiol.1991.sp018545; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; BOUVIER M, 1992, NATURE, V335, P433; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; DANBOLT NC, 1990, BIOCHEMISTRY-US, V29, P6734, DOI 10.1021/bi00480a025; FOLCH J, 1957, J BIOL CHEM, V226, P497; HOPP TP, 1983, MOL IMMUNOL, V20, P483, DOI 10.1016/0161-5890(83)90029-9; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; ISAACSON JS, 1993, J NEUROPHYSIOL, V70, P1287; JIANG J, 1989, J BACTERIOL, V171, P5244, DOI 10.1128/jb.171.10.5244-5253.1989; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; KANAI Y, 1993, TRENDS NEUROSCI, V16, P365, DOI 10.1016/0166-2236(93)90094-3; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KANNER BI, 1993, FEBS LETT, V325, P9599; KARLISH SJD, 1990, P NATL ACAD SCI USA, V87, P4566, DOI 10.1073/pnas.87.12.4566; LIAO MJ, 1984, J BIOL CHEM, V259, P4200; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; POCOCK JM, 1988, J NEUROCHEM, V50, P745, DOI 10.1111/j.1471-4159.1988.tb02977.x; RADIAN R, 1985, J BIOL CHEM, V260, P1859; Reimerdes E H, 1976, Methods Enzymol, V45, P26, DOI 10.1016/S0076-6879(76)45005-X; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; SARANTIS M, 1993, NEURON, V11, P541, DOI 10.1016/0896-6273(93)90158-N; SHAFQAT S, 1993, J BIOL CHEM, V268, P14351; STALLCUP WB, 1979, J NEUROCHEM, V32, P57, DOI 10.1111/j.1471-4159.1979.tb04509.x; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; TAGAKI T, 1991, ADV ELECTROPHORESIS, V4, P391; TOLNER B, 1992, J BACTERIOL, V174, P2391, DOI 10.1128/JB.174.7.2391-2393.1992; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; ZHANG YM, 1994, J BIOL CHEM, V269, P19573	40	68	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					17017	17024		10.1074/jbc.270.28.17017	http://dx.doi.org/10.1074/jbc.270.28.17017			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622523	hybrid			2022-12-27	WOS:A1995RJ34700085
J	PALMER, TM; GETTYS, TW; STILES, GL				PALMER, TM; GETTYS, TW; STILES, GL			DIFFERENTIAL INTERACTION WITH AND REGULATION OF MULTIPLE G-PROTEINS BY THE RAT A(3) ADENOSINE RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY G-PROTEIN; DOWN-REGULATION; MOLECULAR-CLONING; PHOSPHOLIPASE-C; ALPHA-SUBUNITS; ACETYLCHOLINE-RECEPTOR; RBL-2H3 CELLS; CHO CELLS; ACTIVATION; DEGRADATION	Interaction of the rat A(3) adenosine receptor (A(3)AR) with G-proteins has been assessed using a stably transfected Chinese hamster ovary cell system. The non-selective AR agonist 5'-N-ethylcarboxamidoadenosine (NECA) increased the labeling of a 41-kDa membrane protein by 4-azidoanilido-[alpha-P-32] guanosine 5'-triphosphate (AA-[P-32]GTP), a photolabile GTP analogue. Subsequent immunoprecipitation of G(i) alpha-subunits indicated that NECA stimulated incorporation of label into both G(i) alpha-2 and G(i) alpha-3. Additional experiments revealed an A(3)AR stimulation of label into G(q) and/or G(11) alpha-subunits, albeit to a lesser degree than that elicited by endogenous P-2U purinergic receptors. No interaction with G(s) could be detected. Sustained cellular exposure to NECA induced A(3)AR desensitization and specific down-regulation of G(i) alpha-3 and G-protein beta-subunits without changing levels of G(i) alpha-2, G(s) alpha, or G(q+11) alpha-subunits. Therefore the A(3)AR can interact with G(i) alpha-2, G(i) alpha-3, and, to some extent, G(q)-like proteins, but sustained agonist exposure downregulates only one of the G-proteins with which it interacts. This is the first description of the differing specificities of A(3)AR/G-protein coupling versus downregulation in situ and provides a potential mechanism by which the A(3)AR could elicit the heterologous desensitization of signaling events mediated by G(i)3.	DUKE UNIV, MED CTR, DEPT PHARMACOL, DURHAM, NC 27710 USA; MED UNIV S CAROLINA, DEPT MED, CHARLESTON, SC 29425 USA	Duke University; Medical University of South Carolina	PALMER, TM (corresponding author), DUKE UNIV, MED CTR, DEPT MED, BOX 3444, DURHAM, NC 27710 USA.		Palmer, Timothy/E-7290-2013; Palmer, Timothy/C-4975-2009; Gettys, Thomas W/N-1964-2017	Palmer, Timothy/0000-0002-9803-7164; Gettys, Thomas W/0000-0001-7125-7995	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL017670, R01HL035134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK042486] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL35134, P50HL17670] Funding Source: Medline; NIDDK NIH HHS [DK42486] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADIE EJ, 1994, BIOCHEM J, V300, P709, DOI 10.1042/bj3000709; ALI H, 1990, J BIOL CHEM, V265, P745; CHANG FH, 1989, J BIOL CHEM, V264, P5352; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; EASON MG, 1994, MOL PHARMACOL, V45, P696; FIELDS TA, 1994, BIOCHEMISTRY-US, V33, P6877, DOI 10.1021/bi00188a017; GETTYS TW, 1994, BIOCHEMISTRY-US, V33, P4283, DOI 10.1021/bi00180a024; GETTYS TW, 1994, ANAL BIOCHEM, V220, P82, DOI 10.1006/abio.1994.1302; GREEN A, 1992, J BIOL CHEM, V267, P3223; GREEN A, 1990, J BIOL CHEM, V265, P5206; HADCOCK JR, 1990, J BIOL CHEM, V265, P14784; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HAWES BE, 1994, J BIOL CHEM, V269, P15776; HEPLER JR, 1993, J BIOL CHEM, V268, P14367; HIDE M, 1991, MOL PHARMACOL, V40, P473; IREDALE PA, 1993, BRIT J PHARMACOL, V110, P1305, DOI 10.1111/j.1476-5381.1993.tb13960.x; KIM GD, 1994, J BIOL CHEM, V269, P19933; KUROSE H, 1991, BIOCHEMISTRY-US, V30, P3335, DOI 10.1021/bi00227a024; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; LINDEN J, 1993, MOL PHARMACOL, V44, P524; LONGABAUGH JP, 1989, MOL PHARMACOL, V36, P681; MCKENZIE FR, 1990, J BIOL CHEM, V265, P17084; MILLIGAN G, 1993, TRENDS PHARMACOL SCI, V14, P413, DOI 10.1016/0165-6147(93)90064-Q; MILLIGAN G, 1989, BIOCHEM J, V262, P643, DOI 10.1042/bj2620643; MITCHELL FM, 1993, BIOCHEM J, V293, P495, DOI 10.1042/bj2930495; MULLANEY I, 1993, FEBS LETT, V324, P241, DOI 10.1016/0014-5793(93)81401-K; MULLANEY I, 1992, BIOCHEM J, V289, P125; OFFERMANNS S, 1991, METHOD ENZYMOL, V195, P286; OLAH ME, 1994, MOL PHARMACOL, V45, P978; OLSSON RA, 1990, PHYSIOL REV, V70, P761, DOI 10.1152/physrev.1990.70.3.761; Palmer T M, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P83; PALMER TM, 1994, MOL PHARMACOL, V45, P1082; RAMKUMAR V, 1993, J BIOL CHEM, V268, P16887; RAMKUMAR V, 1994, REGULATION CELLULAR, P217; RAYMOND JR, 1993, BIOCHEMISTRY-US, V32, P11064, DOI 10.1021/bi00092a016; SALVATORE CA, 1993, P NATL ACAD SCI USA, V90, P10365, DOI 10.1073/pnas.90.21.10365; SHAH BH, 1994, MOL PHARMACOL, V46, P1; STRATHMANN M, 1989, P NATL ACAD SCI USA, V86, P7407, DOI 10.1073/pnas.86.19.7407; TUCKER AL, 1993, CARDIOVASC RES, V27, P62, DOI 10.1093/cvr/27.1.62; ZHOU QY, 1992, P NATL ACAD SCI USA, V89, P7432, DOI 10.1073/pnas.89.16.7432	40	106	108	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16895	16902		10.1074/jbc.270.28.16895	http://dx.doi.org/10.1074/jbc.270.28.16895			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622506	hybrid			2022-12-27	WOS:A1995RJ34700067
J	SWEITZER, SM; CALVO, S; KRAUS, MH; FINBLOOM, DS; LARNER, AC				SWEITZER, SM; CALVO, S; KRAUS, MH; FINBLOOM, DS; LARNER, AC			CHARACTERIZATION OF A STAT-LIKE DNA-BINDING ACTIVITY IN DROSOPHILA-MELANOGASTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RECEPTOR-TYROSINE KINASES; TRANSCRIPTION FACTOR; INTERFERON-ALPHA; PHOSPHORYLATION; ACTIVATION; PROTEIN; GAMMA; ISGF3	The cytokine signaling pathways that activate the Janus family of tyrosine kinases (Jaks) and the ''signal transducers and activators of transcription'' (Stats) have been well characterized in mammalian systems. Work shown here provides evidence that an analogous signaling pathway exists in Drosophila melanogaster. Because many of the ligand-receptor pairs in Drosophila have not been fully characterized, it was necessary to bypass the receptor stimulation event that normally triggers intracellular Jak/Stat activation, This was done by treating Drosophila Schneider 2 cells with vanadate/peroxide, which has been shown to closely mimic some signaling events triggered by interferon gamma, including the activation of Jak1, Jak2, and the Stat1 alpha protein. Evidence presented here demonstrates that vanadate/peroxide can induce a gamma response region binding complex in Drosophila Schneider 2 cells, This complex contains two phosphoproteins of 100 and 150 kDa, respectively, and shares many features with the vanadate/peroxide-stimulated binding complex in the mammalian system, Southern blot analysis of genomic DNA using the src homology domain 2 (SH2) of Stat1 alpha confirms the presence of a related gene in the Drosophila genome.	US FDA, DIV CYTOKINE BIOL, BETHESDA, MD 20892 USA; NCI, CELLULAR & MOLEC BIOL LAB, BETHESDA, MD 20892 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								BINARI R, 1994, GENE DEV, V8, P300, DOI 10.1101/gad.8.3.300; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVID M, 1993, J BIOL CHEM, V268, P6593; DUFFY JB, 1994, DEV BIOL, V166, P380, DOI 10.1006/dbio.1994.1324; FU XY, 1992, CELL, V70, P323, DOI 10.1016/0092-8674(92)90106-M; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; GUTCH MJ, 1992, P NATL ACAD SCI USA, V89, P11411, DOI 10.1073/pnas.89.23.11411; IGARASHI K, 1993, MOL CELL BIOL, V13, P3984, DOI 10.1128/MCB.13.7.3984; KOTANIDES H, 1993, SCIENCE, V262, P1265, DOI 10.1126/science.7694370; KRAUS MH, 1991, METHOD ENZYMOL, V200, P546; LARNER AC, 1993, SCIENCE, V261, P1730, DOI 10.1126/science.8378773; PERRIMON N, 1993, CELL, V74, P219, DOI 10.1016/0092-8674(93)90412-J; RAZ E, 1991, GENETICS, V129, P191; ROTHMAN P, 1994, IMMUNITY, V1, P457, DOI 10.1016/1074-7613(94)90088-4; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; SHILO BZ, 1992, FASEB J, V6, P2915, DOI 10.1096/fasebj.6.11.1322852; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; WAGNER BJ, 1990, EMBO J, V9, P4477, DOI 10.1002/j.1460-2075.1990.tb07898.x; YAMAMOTO K, 1994, MOL CELL BIOL, V14, P4342, DOI 10.1128/MCB.14.7.4342; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	22	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16510	16513		10.1074/jbc.270.28.16510	http://dx.doi.org/10.1074/jbc.270.28.16510			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622453	hybrid			2022-12-27	WOS:A1995RJ34700008
J	POHLMANN, R; BOEKER, MWC; VONFIGURA, K				POHLMANN, R; BOEKER, MWC; VONFIGURA, K			THE 2 MANNOSE 6-PHOSPHATE RECEPTORS TRANSPORT DISTINCT COMPLEMENTS OF LYSOSOMAL PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-II; TRANSMEMBRANE PROTEIN; TARGETED DISRUPTION; ACID-PHOSPHATASE; BOVINE LIVER; ENZYMES; OLIGOSACCHARIDES; CELLS; PHOSPHORYLATION; PURIFICATION	Mammalian cells express two different mannose g-phosphate receptors (MPR 46 and MPR 300), which both mediate targeting of Man-6-P-containing lysosomal proteins to lysosomes, To assess the contribution of either and both MPRs to the transport of lysosomal proteins, fibroblasts were established from mouse embryos that were homozygous for disrupted alleles of either MPR 46 or MPR 300 or both MPRs, Fibroblasts missing both MPRs secreted most of the newly synthesized lysosomal proteins and were unable to maintain the catabolic function of lysosomes. The intracellular levels of lysosomal proteins decreased to <20%, and undigested material accumulated in the lysosomal compartment. Fibroblasts lacking either MPR exhibited only a partial missorting and maintained, in general, half normal to normal level of lysosomal proteins, The same species of lysosomal proteins were found in secretions of double MPR-deficient fibroblasts as in secretions of single MPR-deficient fibroblasts, but at different ratios, This clearly indicates that neither MPR has an exclusive affinity for one or several lysosomal proteins, Furthermore, neither MPR can substitute in vivo for the loss of the other. It is proposed that the heterogeneity of the Man B-P recognition marker within a lysosomal protein and among different lysosomal proteins has necessitated the evolution of two MPRs with complementary binding properties to ensure an efficient targeting of lysosomal proteins.			POHLMANN, R (corresponding author), UNIV GOTTINGEN,BIOCHEM ABT 2,GOSSLERSTR 12D,D-37073 GOTTINGEN,GERMANY.							BRAUN M, 1989, EMBO J, V8, P3633, DOI 10.1002/j.1460-2075.1989.tb08537.x; CANFIELD WM, 1989, J BIOL CHEM, V264, P7100; CANTOR AB, 1992, J BIOL CHEM, V267, P23349; CANTOR AB, 1992, J BIOL CHEM, V267, P23357; CHAO HHJ, 1990, EMBO J, V9, P3507, DOI 10.1002/j.1460-2075.1990.tb07559.x; CLAIRMONT KB, 1989, J BIOL CHEM, V264, P16390; DISTLER JJ, 1991, J BIOL CHEM, V266, P21687; FILSON AJ, 1993, DEVELOPMENT, V118, P731; GABEL CA, 1983, P NATL ACAD SCI-BIOL, V80, P775, DOI 10.1073/pnas.80.3.775; GIESELMANN V, 1994, HOPPESEYLERS Z PHYSL, V365, P651; HASILIK A, 1992, EXPERIENTIA, V48, P130, DOI 10.1007/BF01923507; HOFLACK B, 1987, J BIOL CHEM, V262, P123; HOFLACK B, 1985, J BIOL CHEM, V260, P2008; HOGAN B, 1986, MANIPULATING MOUSE L; JOHNSON KF, 1992, J BIOL CHEM, V267, P17110; KLUMPERMAN J, 1993, J CELL BIOL, V121, P997, DOI 10.1083/jcb.121.5.997; KORNER C, 1995, J BIOL CHEM, V270, P287, DOI 10.1074/jbc.270.1.287; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KOSTER A, 1994, EUR J BIOCHEM, V224, P685, DOI 10.1111/j.1432-1033.1994.00685.x; KOSTER A, 1993, EMBO J, V12, P5219, DOI 10.1002/j.1460-2075.1993.tb06217.x; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; LUDWIG T, 1993, EMBO J, V12, P5225, DOI 10.1002/j.1460-2075.1993.tb06218.x; LUDWIG T, 1994, EMBO J, V13, P3430, DOI 10.1002/j.1460-2075.1994.tb06648.x; NOLAN CM, 1989, METABOLIC BASIS INHE, P1589; OKAMOTO T, 1990, CELL, V62, P709, DOI 10.1016/0092-8674(90)90116-V; STEIN M, 1987, BIOL CHEM H-S, V368, P927, DOI 10.1515/bchm3.1987.368.2.927; TONG PY, 1989, J BIOL CHEM, V264, P7970; ULLRICH K, 1978, BIOCHEM J, V170, P643, DOI 10.1042/bj1700643; VONFIGURA K, 1985, BIOCHEM J, V225, P543, DOI 10.1042/bj2250543; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; WAHEED A, 1988, EMBO J, V7, P2351, DOI 10.1002/j.1460-2075.1988.tb03079.x; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; WATANABE H, 1990, P NATL ACAD SCI USA, V87, P8036, DOI 10.1073/pnas.87.20.8036; WENK J, 1991, BIOCHEM INT, V23, P723	35	173	176	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27311	27318		10.1074/jbc.270.45.27311	http://dx.doi.org/10.1074/jbc.270.45.27311			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592993	hybrid			2022-12-27	WOS:A1995TE58300093
J	SCHLOSSMANN, J; NEUPERT, W				SCHLOSSMANN, J; NEUPERT, W			ASSEMBLY OF THE PREPROTEIN RECEPTOR MOM72/MAS70 INTO THE PROTEIN IMPORT COMPLEX OF THE OUTER-MEMBRANE OF MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP ATP CARRIER; PRECURSOR PROTEINS; YEAST MITOCHONDRIA; TRANSLOCATION; INSERTION; IDENTIFICATION; RECOGNITION; BINDING; MOM19; MOM22	Membrane integration and assembly of MOM72 from Neurospora crassa and its yeast homolog MAS70 was studied with isolated mitochondria. After synthesis in vitro, the precursors of MOM72/MAS70 are tightly folded and expose only their N-terminal amino acid residues comprising the targeting and the membrane anchor domain. Insertion of the protein into the mitochondrial outer membrane (MOM) occurs in a time- and temperature-dependent manner and is stimulated by ATP. MOM72/MAS70 is then assembled into the outer membrane MOM complex. Whereas membrane insertion occurred independently of the presence of protease-sensitive surface components, the assembly reaction depended on such components. In the MOM complex MOM72 and MAS70 were found in the neighborhood of different components in yeast and N. crassa mitochondria, MOM72 was found in association with MOM22 in N. crassa mitochondria, whereas MAS70 was in proximity to a 37-kDa component in yeast outer mitochondrial membrane. The interaction with the 37-kDa protein is important for integration of MAS70 into the MOM complex. Thus, the 37-kDa protein plays an important role in the biogenesis of MAS70.	UNIV MUNICH,INST PHYSIOL CHEM,D-80336 MUNICH,GERMANY	University of Munich			Schlossmann, Jens/I-7743-2016	Schlossmann, Jens/0000-0002-2550-6839				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7; DAUM G, 1982, J BIOL CHEM, V257, P3028; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; GRATZER S, 1995, J CELL BIOL, V129, P25, DOI 10.1083/jcb.129.1.25; HARKNESS TAA, 1994, J CELL BIOL, V124, P637, DOI 10.1083/jcb.124.5.637; HARKNESS TAA, 1994, GENETICS, V136, P107; HASHIYA N, 1994, EMBO J, V13, P5146; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; KEIL P, 1993, FEBS LETT, V321, P197, DOI 10.1016/0014-5793(93)80107-6; KEIL P, 1993, J BIOL CHEM, V269, P19177; KIEBLER M, 1993, CELL, V74, P483, DOI 10.1016/0092-8674(93)80050-O; KIEBLER M, 1990, NATURE, V348, P610, DOI 10.1038/348610a0; KIEBLER M, 1993, J MEMBRANE BIOL, V135, P191; Kyshe-Andersen J, 1984, J BIOCHEM BIOPH METH, V10, P203; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI JM, 1992, SCIENCE, V256, P1815, DOI 10.1126/science.1615327; LITHGOW T, 1994, P NATL ACAD SCI USA, V91, P11973, DOI 10.1073/pnas.91.25.11973; MAYER A, 1995, CELL, V80, P127, DOI 10.1016/0092-8674(95)90457-3; MAYER A, 1993, J CELL BIOL, V121, P1233, DOI 10.1083/jcb.121.6.1233; MAYER A, 1995, EMBO J, V14, P4204, DOI 10.1002/j.1460-2075.1995.tb00094.x; MCBRIDE HM, 1992, J CELL BIOL, V19, P1451; MILLAR DG, 1994, J BIOL CHEM, V269, P12229; MOCZKO M, 1992, FEBS LETT, V310, P265, DOI 10.1016/0014-5793(92)81345-M; NAKAI M, 1993, J BIOL CHEM, V268, P24262; NAKAI M, 1995, FEBS LETT, V357, P202; NARGANG FE, 1995, EMBO J, V14, P1099, DOI 10.1002/j.1460-2075.1995.tb07093.x; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; PFANNER N, 1987, CELL, V49, P815, DOI 10.1016/0092-8674(87)90619-2; PFANNER N, 1987, J BIOL CHEM, V262, P7528; RIEZMAN H, 1983, EMBO J, V2, P1113, DOI 10.1002/j.1460-2075.1983.tb01554.x; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; SCHLOSSMANN J, 1994, J BIOL CHEM, V269, P11893; SCHNEIDER H, 1991, SCIENCE, V254, P1659, DOI 10.1126/science.1661031; SHORE GC, 1995, EUR J BIOCHEM, V227, P9, DOI 10.1111/j.1432-1033.1995.tb20354.x; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1992, NATURE, V355, P84, DOI 10.1038/355084a0; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; WEISS H, 1970, EUR J BIOCHEM, V14, P75, DOI 10.1111/j.1432-1033.1970.tb00263.x; ZHUANG ZP, 1992, J BIOL CHEM, V267, P591	43	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27116	27121		10.1074/jbc.270.45.27116	http://dx.doi.org/10.1074/jbc.270.45.27116			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592965	hybrid			2022-12-27	WOS:A1995TE58300065
J	UFRETVINCENTY, CA; SHORT, AD; ALFONSO, A; GILL, DL				UFRETVINCENTY, CA; SHORT, AD; ALFONSO, A; GILL, DL			A NOVEL CA2+ ENTRY MECHANISM IS TURNED ON DURING GROWTH ARREST INDUCED BY CA2+ POOL DEPLETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							INOSITOL TRISPHOSPHATE; INTRACELLULAR CALCIUM; SARCOPLASMIC-RETICULUM; CAFFEINE ANALOGS; CELL-GROWTH; RELEASE; THAPSIGARGIN	Ca2+ pool depletion with Ca2+ pump blockers induces growth arrest of rapidly dividing DDT(1)MF-2 smooth muscle cells and causes cells to enter a stable, quiescent G(o)-like growth state (Short, A. D., Bian, J., Ghosh, T. K., Waldron, R. T., Rybak, S. L., and Gill, D. L. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 4986-4990). Here we reveal that induction of this quiescent growth state with the Ca2+ pump blocker, thapsigargin, is correlated with the appearance of a novel caffeine-activated Ca2+ influx mechanism. Ca2+ influx through this mechanism is clearly distinct from and additive with Ca2+ entry through store-operated channels (SOCs). Whereas SOC-mediated entry is activated seconds after Ca2+ pool release, caffeine-sensitive influx requires at least 30 min of pool emptying, Although activated in the 1-10 mM caffeine range, this mechanism has clearly distinct methylxanthine specificity from ryanodine receptors and is not modified by ryanodine. It is also unaffected by the Ca2+ channel blockers SKF96365 or verapamil and is independent of modifiers of cyclic nucleotide levels. Growth arrest by thapsigargin-induced Ca2+ pool depletion can be reversed by treatment with 20% serum (Waldron, R. T., Short, A. D., Meadows, J. J., Ghosh, T. K., and Gill, D. L. (1994) J. Biol. Chem. 269, 11927-11933). The serum-induced return of functional Ca2+ pools and reentry of cells into the cell cycle correlates exactly with the disappearance of the caffeine-sensitive Ca2+ influx mechanism. Therefore, appearance and function of this novel Ca2+ entry mechanism are closely tied to Ca2+ pool function and cell, growth state and may provide an important means for modifying exit from or entry into the cell cycle.	UNIV MARYLAND,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21201	University System of Maryland; University of Maryland Baltimore			Alfonso, Amparo/GLN-2591-2022	Alfonso Rancano, Maria Amparo/0000-0003-1572-9016	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM015407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019304] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM15407] Funding Source: Medline; NINDS NIH HHS [NS19304] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BIAN JH, 1991, J BIOL CHEM, V266, P8801; DALY JW, 1991, PHARMACOLOGY, V42, P309, DOI 10.1159/000138813; ENDO M, 1985, CURR TOP MEMBR TRANS, V25, P181; FURUYA Y, 1994, CANCER RES, V54, P6167; GHOSH TK, 1989, NATURE, V340, P236, DOI 10.1038/340236a0; GHOSH TK, 1991, J BIOL CHEM, V266, P24690; Gill Donald L., 1992, Advances in Second Messenger and Phosphoprotein Research, V26, P265; GRYNKIEWICZ G, 1985, J BIOL CHEM, V261, P3440; GUERRERO A, 1994, J GEN PHYSIOL, V104, P395, DOI 10.1085/jgp.104.2.395; GUERRERO A, 1994, J GEN PHYSIOL, V104, P375, DOI 10.1085/jgp.104.2.375; HOTH M, 1992, J PHYSIOL-LONDON, V465, P359; MISSIAEN L, 1994, J BIOL CHEM, V269, P5817; MISSIAEN L, 1992, J PHYSIOL-LONDON, V455, P623, DOI 10.1113/jphysiol.1992.sp019319; MULLER CE, 1993, BIOCHEM PHARMACOL, V46, P1825, DOI 10.1016/0006-2952(93)90589-O; PARKER I, 1991, J PHYSIOL-LONDON, V433, P229, DOI 10.1113/jphysiol.1991.sp018423; PREMACK BA, 1994, J IMMUNOL, V152, P5226; PUTNEY JW, 1993, ENDOCR REV, V14, P610, DOI 10.1210/er.14.5.610; ROUSSEAU E, 1988, ARCH BIOCHEM BIOPHYS, V267, P75, DOI 10.1016/0003-9861(88)90010-0; SAMBROOK JF, 1990, CELL, V61, P197, DOI 10.1016/0092-8674(90)90798-J; SHORT AD, 1993, J BIOL CHEM, V268, P25887; SHORT AD, 1993, P NATL ACAD SCI USA, V90, P4986, DOI 10.1073/pnas.90.11.4986; WALDRON RT, 1995, J BIOL CHEM, V270, P11955, DOI 10.1074/jbc.270.20.11955; WALDRON RT, 1994, J BIOL CHEM, V269, P11927	24	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26790	26793		10.1074/jbc.270.45.26790	http://dx.doi.org/10.1074/jbc.270.45.26790			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592918	hybrid			2022-12-27	WOS:A1995TE58300018
J	BERDITCHEVSKI, F; BAZZONI, G; HEMLER, ME				BERDITCHEVSKI, F; BAZZONI, G; HEMLER, ME			SPECIFIC ASSOCIATION OF CD63 WITH THE VLA-3 AND VLA-6 INTEGRINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION RECEPTORS; CYTOPLASMIC DOMAIN; MONOCLONAL-ANTIBODIES; ALPHA-SUBUNIT; ONCOGENIC TRANSFORMATION; MEMBRANE GLYCOPROTEIN; EXTRACELLULAR-MATRIX; FIBRONECTIN RECEPTOR; MOLECULAR-CLONING; ENDOTHELIAL-CELLS	We screened monoclonal antibodies to cell surface proteins and selected an antibody, called 6H1, that recognizes a putative integrin-associated protein. The 6H1 monoclonal antibody (mAb) indirectly coprecipitated alpha(3) beta(1) and/or alpha(6) beta(1) but not alpha(2) beta(1), or alpha(5) beta(1) from Brij 96 detergent lysates of multiple cell lines. Large scale purification using the 6H1 mAb yielded a single protein of 45-60 kDa with an amino-terminal sequence that exactly matched CD63. Confirming that the 6H1 mAb recognized the CD63 protein, 6H1 and a known anti-CD63 mAb yielded identical coprecipitation results and identical colocalization into lysosomal granules containing cathepsin D. Furthermore, we used an established anti-CD63 mAb to detect this protein in an alpha(3) beta(1) immunoprecipitate, and also we observed VLA-3 and CD63 colocalization in cellular ''footprints.'' Notably, the cytoplasmic domain of alpha(3) was neither required nor sufficient for CD63 association, suggesting that it occurred elsewhere within the alpha(3) beta(1) complex. Knowledge of these specific CD63-alpha(3) beta(1), and CD63-alpha(6) beta(1) biochemical associations should lead to critical insights into the specialized functions of alpha(3) beta(1), alpha(6) beta(1) and CD63.	HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School					NIGMS NIH HHS [GM46526] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046526] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKIYAMA SK, 1994, J BIOL CHEM, V269, P15961; BALZAC F, 1993, J CELL BIOL, V121, P171, DOI 10.1083/jcb.121.1.171; BARTEK J, 1991, P NATL ACAD SCI USA, V88, P3520, DOI 10.1073/pnas.88.9.3520; BARTFELD NS, 1993, J BIOL CHEM, V268, P17270; BAUER JS, 1993, J CELL BIOL, V122, P209, DOI 10.1083/jcb.122.1.209; BEAULIEU JF, 1992, J CELL SCI, V102, P427; BERDICHEVSKY F, 1994, J CELL SCI, V107, P3557; BERGELSON JM, 1994, CELL ADHES COMMUN, V2, P455, DOI 10.3109/15419069409004455; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; CHAN BM, 1992, CELL, V68, P1051, DOI 10.1016/0092-8674(92)90077-P; CHAN BMC, 1992, J BIOL CHEM, V267, P8366; CHAN BMC, 1993, J CELL BIOL, V120, P537, DOI 10.1083/jcb.120.2.537; CHOY MY, 1990, J PATHOL, V160, P35, DOI 10.1002/path.1711600109; DAMJANOVICH L, 1992, AM J RESP CELL MOL, V6, P197, DOI 10.1165/ajrcmb/6.2.197; DELWEL GO, 1994, MOL BIOL CELL, V5, P203, DOI 10.1091/mbc.5.2.203; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; FRADET Y, 1984, P NATL ACAD SCI-BIOL, V81, P224, DOI 10.1073/pnas.81.1.224; GEHLSEN KR, 1988, SCIENCE, V24, P1228; GIUNTA M, 1991, J EXP MED, V173, P1537, DOI 10.1084/jem.173.6.1537; HEMLER ME, 1983, J IMMUNOL, V131, P334; HOREJSI V, 1991, FEBS LETT, V288, P1, DOI 10.1016/0014-5793(91)80988-F; HOTTA H, 1994, CANCER RES, V48, P2955; HUBBARD AL, 1975, J CELL BIOL, V64, P438, DOI 10.1083/jcb.64.2.438; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IKEYAMA S, 1993, J EXP MED, V177, P1231, DOI 10.1084/jem.177.5.1231; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; KAWAGUCHI S, 1993, J BIOL CHEM, V268, P16279; KIM JP, 1992, J INVEST DERMATOL, V98, P764, DOI 10.1111/1523-1747.ep12499947; KNOL EF, 1991, J ALLERGY CLIN IMMUN, V88, P328, DOI 10.1016/0091-6749(91)90094-5; KORHONEN M, 1990, J CELL BIOL, V111, P1245, DOI 10.1083/jcb.111.3.1245; LAFLAMME SE, 1994, J CELL BIOL, V126, P1287, DOI 10.1083/jcb.126.5.1287; LEE RT, 1995, CIRC RES, V76, P209, DOI 10.1161/01.RES.76.2.209; LEMKE H, 1978, NATURE, V271, P249, DOI 10.1038/271249a0; LINDBERG FP, 1993, J CELL BIOL, V123, P485, DOI 10.1083/jcb.123.2.485; LOBB RR, 1994, J CLIN INVEST, V1269, P8348; MARCANTONIO EE, 1988, J CELL BIOL, V106, P1765, DOI 10.1083/jcb.106.5.1765; MASELLISSMITH A, 1994, J IMMUNOL, V152, P2768; MATSUYAMA T, 1989, J EXP MED, V170, P1133, DOI 10.1084/jem.170.4.1133; METZELAAR MJ, 1991, J BIOL CHEM, V266, P3239; MIYAKE K, 1992, J CELL BIOL, V119, P653, DOI 10.1083/jcb.119.3.653; MIYAMOTO H, 1994, BBA-GENE STRUCT EXPR, V1217, P312, DOI 10.1016/0167-4781(94)90291-7; NAGIRA M, 1994, CELL IMMUNOL, V157, P144, DOI 10.1006/cimm.1994.1212; NIEUWENHUIS HK, 1987, BLOOD, V70, P838; NISHIBORI M, 1993, J CLIN INVEST, V91, P1775, DOI 10.1172/JCI116388; NISHIKATA H, 1992, J IMMUNOL, V149, P862; OREN R, 1994, MOL CELL BIOL, V10, P4007; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; PASQUALINI R, 1993, J CELL SCI, V105, P101; PASQUALINI R, 1994, J CELL BIOL, V125, P447, DOI 10.1083/jcb.125.2.447; PAVALKO FM, 1993, J IMMUNOL, V151, P3795; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; ROMAN J, 1989, J CELL BIOL, V108, P2529, DOI 10.1083/jcb.108.6.2529; RUBINSTEIN E, 1994, EUR J IMMUNOL, V24, P3005, DOI 10.1002/eji.1830241213; SCHWARTZ MA, 1993, CANCER RES, V53, P1503; SHAW LM, 1993, J BIOL CHEM, V268, P11401; SHAW LM, 1994, MOL BIOL CELL, V5, P679, DOI 10.1091/mbc.5.6.679; SIKORA LKJ, 1987, INT J CANCER, V39, P138, DOI 10.1002/ijc.2910390203; SLUPSKY JR, 1989, J BIOL CHEM, V264, P12289; SONNENBERG A, 1988, NATURE, V360, P487; TAKADA Y, 1991, J CELL BIOL, V115, P257, DOI 10.1083/jcb.115.1.257; TAKADA Y, 1989, J CELL BIOL, V109, P397, DOI 10.1083/jcb.109.1.397; TAMURA RN, 1990, J CELL BIOL, V111, P1593, DOI 10.1083/jcb.111.4.1593; TAMURA RN, 1991, P NATL ACAD SCI USA, V88, P10183, DOI 10.1073/pnas.88.22.10183; TOOTHILL VJ, 1990, J IMMUNOL, V145, P283; TSUJI T, 1991, J BIOCHEM-TOKYO, V109, P659, DOI 10.1093/oxfordjournals.jbchem.a123436; VISCHER UM, 1993, BLOOD, V82, P1184, DOI 10.1182/blood.V82.4.1184.1184; VUORI K, 1994, SCIENCE, V266, P1576, DOI 10.1126/science.7527156; WAYNER EA, 1987, J CELL BIOL, V105, P1873, DOI 10.1083/jcb.105.4.1873; WEITZMAN JB, 1993, J BIOL CHEM, V268, P8651; WRIGHT MD, 1994, IMMUNOL TODAY, V15, P588, DOI 10.1016/0167-5699(94)90222-4	72	143	145	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17784	17790		10.1074/jbc.270.30.17784	http://dx.doi.org/10.1074/jbc.270.30.17784			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629079	hybrid			2022-12-27	WOS:A1995RM26600026
J	DECOTTIGNIES, A; LAMBERT, L; CATTY, P; DEGAND, H; EPPING, EA; MOYEROWLEY, WS; BALZI, E; GOFFEAU, A				DECOTTIGNIES, A; LAMBERT, L; CATTY, P; DEGAND, H; EPPING, EA; MOYEROWLEY, WS; BALZI, E; GOFFEAU, A			IDENTIFICATION AND CHARACTERIZATION OF SNQ2, A NEW MULTIDRUG ATP BINDING CASSETTE TRANSPORTER OF THE YEAST PLASMA-MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ADENYLATE KINASE; DRUG-RESISTANCE; P-GLYCOPROTEIN; GENE; CELLS; DNA; EXPRESSION; PROTEINS; MUTATION	The SNQ2 gene of Saccharomyces cerevisiae, which encodes an ATP binding cassette protein responsible for resistance to the mutagen 4-nitroquinoline oxide, is regulated by the DNA-binding proteins PDR1 and PDR3. In a plasma membrane-enriched fraction from a pdr1 mutant, the SNQ2 protein is found in the 160-kDa over-expressed band, together with PDR5. The SNQ2 protein was solubilized with n-dodecyl beta-D-maltoside from the plasma membranes of a PDR5-deleted strain and separated from the PMA1 H+-ATPase by sucrose gradient centrifugation. The enzyme shows a nucleoside triphosphatase activity that differs biochemically from that of PDR5 (Decottignies, A., Kolaczkowski, M., Balzi, E., and Goffeau, A. (1994) J. Biol. Chem. 269, 12797-12803) and is sensitive to vanadate, erythrosine B, and Triton X-100 but not to oligomycin, which inhibits the PDR5 activity only. Disruption of both PDR5 and SNQ2 in a pdr1 mutant decreases the cell growth rate and reveals the presence of at least two other ATP binding cassette proteins in the 160-kDa overexpressed band that have been identified by amino-terminal microsequencing.	UNIV CATHOLIQUE LOUVAIN, UNITE BIOCHIM PHYSIOL, B-1348 LOUVAIN, BELGIUM; UNIV IOWA, DEPT PHYSIOL & BIOPHYS, IOWA CITY, IA 52242 USA	Universite Catholique Louvain; University of Iowa			Moye-Rowley, Scott/AFL-7135-2022	Moye-Rowley, Scott/0000-0002-7163-1120; Epping, Eric/0000-0001-7193-3041	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049825] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM49825] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; BALZI E, 1987, J BIOL CHEM, V262, P16871; BALZI E, 1994, J BIOL CHEM, V269, P2206; BALZI E, 1994, BIOCHIM BIOPHYS ACTA, V1187, P151; BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506; BISSINGER PH, 1994, J BIOL CHEM, V269, P4180; BORSTPAUWELS GWFH, 1977, BIOCHIM BIOPHYS ACTA, V466, P488, DOI 10.1016/0005-2736(77)90341-8; DECOTTIGNIES A, 1994, J BIOL CHEM, V269, P12797; DELAHODDE A, 1995, IN PRESS MOL CELL BI; DELAVEAU T, 1992, YEAST, V8, P761, DOI 10.1002/yea.320080909; DELAVEAU T, 1994, MOL GEN GENET, V244, P501, DOI 10.1007/BF00583901; DEXTER D, 1994, GENETICS, V136, P505; DUFOUR JP, 1980, EUR J BIOCHEM, V105, P145, DOI 10.1111/j.1432-1033.1980.tb04484.x; GOFFEAU A, 1988, METHOD ENZYMOL, V157, P528; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; GUERINEAU M, 1974, BIOCHEM BIOPH RES CO, V61, P462, DOI 10.1016/0006-291X(74)90979-6; HAASE E, 1992, CURR GENET, V21, P319, DOI 10.1007/BF00351689; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HIRATA D, 1994, CURR GENET, V26, P285, DOI 10.1007/BF00310491; HORIO M, 1988, P NATL ACAD SCI USA, V85, P3580, DOI 10.1073/pnas.85.10.3580; KATZMANN DJ, 1994, MOL CELL BIOL, V14, P4653, DOI 10.1128/MCB.14.7.4653; KUCHLER K, 1989, EMBO J, V8, P3973, DOI 10.1002/j.1460-2075.1989.tb08580.x; KUO CL, 1983, MOL CELL BIOL, V3, P1730, DOI 10.1128/MCB.3.10.1730; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEMAIRE M, 1993, ANAL BIOCHEM, V214, P50, DOI 10.1006/abio.1993.1455; LEPPERT G, 1990, GENETICS, V125, P13; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCGRATH JP, 1989, NATURE, V340, P400, DOI 10.1038/340400a0; MEYERS S, 1992, CURR GENET, V21, P431, DOI 10.1007/BF00351651; Miller J.H., 1972, EXPT MOL GENETICS; MOOS M, 1988, J BIOL CHEM, V263, P6005; NASS G, 1976, MOL GEN GENET, V147, P39, DOI 10.1007/BF00337933; PAWAGI AB, 1994, J MOL BIOL, V235, P554, DOI 10.1006/jmbi.1994.1013; PRASAD R, 1995, CURR GENET, V27, P320, DOI 10.1007/BF00352101; RANK GH, 1976, MOL GEN GENET, V144, P281, DOI 10.1007/BF00341726; REINSTEIN J, 1990, BIOCHEMISTRY-US, V29, P7451, DOI 10.1021/bi00484a014; ROMANOS MA, 1992, YEAST, V8, P423, DOI 10.1002/yea.320080602; Sambrook J, 1989, MOL CLONING LABORATO; SARKADI B, 1992, J BIOL CHEM, V267, P4854; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SERVOS J, 1993, MOL GEN GENET, V236, P214, DOI 10.1007/BF00277115; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; THOMAS PJ, 1993, J BIOENERG BIOMEMBR, V25, P11, DOI 10.1007/BF00768063; TIAN G, 1990, BIOCHEMISTRY-US, V29, P4296, DOI 10.1021/bi00470a006; ULAWZEWSKI S, 1987, MOL GEN GENET, V207, P38	46	139	144	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18150	18157		10.1074/jbc.270.30.18150	http://dx.doi.org/10.1074/jbc.270.30.18150			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629127	hybrid			2022-12-27	WOS:A1995RM26600079
J	DOPPLER, W; WELTE, T; PHILIPP, S				DOPPLER, W; WELTE, T; PHILIPP, S			CCAAT/ENHANCER-BINDING PROTEIN ISOFORM-BETA AND ISOFORM-DELTA ARE EXPRESSED IN MAMMARY EPITHELIAL-CELLS AND BIND TO MULTIPLE SITES IN THE BETA-CASEIN GENE PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-1-ACID GLYCOPROTEIN GENE; TRANSCRIPTION FACTOR; NUCLEAR FACTOR; C/EBP FAMILY; GLUCOCORTICOID RECEPTOR; EXTRACELLULAR-MATRIX; MYELOMONOCYTIC CELLS; SIGNAL TRANSDUCTION; HORMONAL INDUCTION; RESPONSE ELEMENTS	Lactogenic hormone-dependent expression of the rat beta-casein gene in mammary epithelial cells is controlled via a complex regulatory region in the promoter. The sequence between -176 and -82 is the minimal region to confer the response to glucocorticoid hormone and prolactin on a heterologous promoter. The response is further enhanced by the region between -282 and -176. DNase I footprinting experiments and electromobility shift assays revealed the presence of four binding sites for CCAAT/enhancer-binding protein (C/EBP) isoforms in the hormone response region between -220 and -132. In nuclear extracts from mammary epithelial cells, the prevalent C/EBP isoform binding to these sites is beta (C/EBP-beta). C/EBP-delta is also present in mammary epithelial cells, whereas C/EBP-alpha is not detectable. The C/EBP sites are located in close proximity to the previously characterized binding sites for the prolactin-inducible mammary gland factor/signal transducer and activator of transcription-5, the nuclear factor YY1, and the glucocorticoid receptor. The importance of the two proximal C/EBP binding sites at the 5' border of the minimal region was tested by mutational analysis. Mutations of each site were found to inhibit strongly both the basal and the lactogenic hormone-induced transcription of a beta-casein gene promoter chloramphenicol acetyltransferase construct. The results implicate C/EBPs as important regulators of beta-casein gene expression in the mammary epithelium.			DOPPLER, W (corresponding author), UNIV INNSBRUCK, INST MED CHEM & BIOCHEM, FRITZ PREGL STR 3, A-6020 INNSBRUCK, AUSTRIA.							AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; ALAM T, 1993, J BIOL CHEM, V268, P15681; ALTIOK S, 1993, MOL CELL BIOL, V13, P7303, DOI 10.1128/MCB.13.12.7303; ALTIOK S, 1994, MOL CELL BIOL, V14, P6004, DOI 10.1128/MCB.14.9.6004; BAUMANN H, 1992, J BIOL CHEM, V267, P19744; BURK O, 1993, EMBO J, V12, P2027, DOI 10.1002/j.1460-2075.1993.tb05852.x; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CEREGHINI S, 1987, CELL, V50, P627, DOI 10.1016/0092-8674(87)90036-5; CHANDRASEKARAN C, 1993, P NATL ACAD SCI USA, V90, P8871, DOI 10.1073/pnas.90.19.8871; CHANG CJ, 1990, MOL CELL BIOL, V10, P6642, DOI 10.1128/MCB.10.12.6642; CHEN HM, 1993, J BIOL CHEM, V268, P25311; DELPHIN S, 1995, J EXP MED, V181, P181, DOI 10.1084/jem.181.1.181; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; DIEHL JA, 1994, MOL CELL BIOL, V14, P6635, DOI 10.1128/MCB.14.10.6635; DOPPLER W, 1991, MOL ENDOCRINOL, V5, P1624, DOI 10.1210/mend-5-11-1624; DOPPLER W, 1990, MOL ENDOCRINOL, V4, P912, DOI 10.1210/mend-4-6-912; DOPPLER W, 1989, P NATL ACAD SCI USA, V86, P104, DOI 10.1073/pnas.86.1.104; GOTOH T, 1994, J BIOCHEM-TOKYO, V115, P778, DOI 10.1093/oxfordjournals.jbchem.a124409; GROENEN MAM, 1992, NUCLEIC ACIDS RES, V20, P4311, DOI 10.1093/nar/20.16.4311; INGRASSIA R, 1994, DNA CELL BIOL, V13, P615, DOI 10.1089/dna.1994.13.615; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KANAI A, 1993, GENE, V126, P195, DOI 10.1016/0378-1119(93)90006-O; KATZ S, 1993, EMBO J, V12, P1321, DOI 10.1002/j.1460-2075.1993.tb05777.x; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; LECAM A, 1994, J BIOL CHEM, V269, P21532; LECLAIR KP, 1992, P NATL ACAD SCI USA, V89, P8145, DOI 10.1073/pnas.89.17.8145; LEE CS, 1992, ENDOCRINOLOGY, V131, P2257, DOI 10.1210/en.131.5.2257; LEE YH, 1994, MOL CELL BIOL, V14, P1383, DOI 10.1128/MCB.14.2.1383; LI S, 1994, J BIOL CHEM, V269, P14235; LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; McKnight SL, 1992, TRANSCRIPTIONAL REGU, P771; MEIER VS, 1994, MOL CELL BIOL, V14, P128, DOI 10.1128/MCB.14.1.128; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; NISHIO Y, 1993, MOL CELL BIOL, V13, P1854, DOI 10.1128/MCB.13.3.1854; PIERRE S, 1994, MOL ENDOCRINOL, V8, P1720, DOI 10.1210/me.8.12.1720; PIONTKEWITZ Y, 1993, ENDOCRINOLOGY, V133, P2327, DOI 10.1210/en.133.5.2327; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; POPE RM, 1994, J CLIN INVEST, V94, P1449, DOI 10.1172/JCI117482; RAUGHT B, 1994, MOL CELL BIOL, V14, P1752, DOI 10.1128/MCB.14.3.1752; RAY A, 1994, MOL CELL BIOL, V14, P4324, DOI 10.1128/MCB.14.6.4324; RAY BK, 1994, GENE, V147, P253, DOI 10.1016/0378-1119(94)90076-0; RAY BK, 1994, EUR J BIOCHEM, V222, P891, DOI 10.1111/j.1432-1033.1994.tb18937.x; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; SCHMIDHAUSER C, 1990, P NATL ACAD SCI USA, V87, P9118, DOI 10.1073/pnas.87.23.9118; SCHMIDHAUSER C, 1992, MOL BIOL CELL, V3, P699, DOI 10.1091/mbc.3.6.699; SCHMITT-NEY M, 1991, MOL CELL BIOL, V11, P3745, DOI 10.1128/MCB.11.7.3745; SCOTT LM, 1992, BLOOD, V80, P1725; SEARS RC, 1994, MOL CELL BIOL, V14, P4855, DOI 10.1128/MCB.14.7.4855; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STANDKE GJR, 1994, MOL ENDOCRINOL, V8, P469, DOI 10.1210/me.8.4.469; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; THEISEN M, 1993, MOL CELL BIOL, V13, P7666, DOI 10.1128/MCB.13.12.7666; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; VALLEJO M, 1993, P NATL ACAD SCI USA, V90, P4679, DOI 10.1073/pnas.90.10.4679; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; WELTE T, 1994, EUR J BIOCHEM, V223, P997, DOI 10.1111/j.1432-1033.1994.tb19078.x; WELTE T, 1994, MOL ENDOCRINOL, V8, P1091, DOI 10.1210/me.8.8.1091; WELTE T, 1993, J STEROID BIOCHEM, V47, P75, DOI 10.1016/0960-0760(93)90059-6; WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; YOSHIMURA M, 1990, P NATL ACAD SCI USA, V87, P3670, DOI 10.1073/pnas.87.10.3670	66	76	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17962	17969		10.1074/jbc.270.30.17962	http://dx.doi.org/10.1074/jbc.270.30.17962			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629103	hybrid			2022-12-27	WOS:A1995RM26600053
J	GOPALAKRISHNAN, L; SCARPULLA, RC				GOPALAKRISHNAN, L; SCARPULLA, RC			STRUCTURE, EXPRESSION, AND CHROMOSOMAL ASSIGNMENT OF THE HUMAN GENE ENCODING NUCLEAR RESPIRATORY FACTOR-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-GENE; SUBUNIT-IV GENE; MITOCHONDRIAL-DNA; RAT; IDENTIFICATION; TRANSCRIPTION; ACTIVATOR; SEQUENCES; FAMILY; NRF-1	Nuclear respiratory factor 1 (NRF-1) is a transcription factor that acts on nuclear genes encoding respiratory subunits and components of the mitochondrial transcription and replication machinery. Here we describe the isolation and characterization of the human gene encoding NRF-1. The human genomic sequences detected with NRF-1 cDNA probes at high stringency are all contained within seven overlapping recombinant lambda clones. The NRF-1 gene encompassed by these recombinants spans similar to 65 kilobases (kb) and has 11 exons and 10 introns that range in size from 0.8 to 15 kb. A rapid amplification of cDNA ends-polymerase chain reaction product containing the 5'-terminus of the NRF-1 cDNA has two exons from the 5'-untranslated region and terminates at a major transcription initiation site identified by S1 nuclease mapping. A genomic fragment containing a portion of the 5'-terminal exon and an additional 1 kb upstream had a functional promoter that was active in transfected COS cells, HeLa cells, and L6 myoblasts. The transcription initiation site utilized by the transfected promoter corresponded to that used by the endogenous gene in vivo. NRF-1 mRNA was expressed at very low levels in rat tissues compared with cytochrome c and, unlike cytochrome c, was most abundantly expressed in lung and testis. The NRF-1 gene was localized to human chromosome 7 by analysis of DNA from a panel of human-hamster cell hybrids with human-specific NRF-1 polymerase chain reaction primers. This assignment was further refined to 7q31 by cohybridization of NRF-1- and chromosome 7-specific probes to human metaphase chromosomes. These analyses should be useful in evaluating the potential role of NRF-1 in mitochondrial diseases resulting from defects in the nuclear control of mitochondrial function.			GOPALAKRISHNAN, L (corresponding author), NORTHWESTERN UNIV,SCH MED,DEPT MOLEC & CELL BIOL,303 E CHICAGO AVE,CHICAGO,IL 60611, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032525, R56GM032525] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32525-12] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRAIDOTTI G, 1993, J BIOL CHEM, V268, P1109; BURKE JF, 1984, GENE, V30, P63, DOI 10.1016/0378-1119(84)90105-7; CHEN CH, 1989, J BIOL CHEM, V264, P11934; CLAYTON DA, 1992, INT REV CYTOL, V141, P317; EVANS MJ, 1988, MOL CELL BIOL, V8, P35, DOI 10.1128/MCB.8.1.35; EVANS MJ, 1989, J BIOL CHEM, V264, P14361; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GOPALAKRISHNAN L, 1994, J BIOL CHEM, V269, P105; GUGNEJA S, 1995, MOL CELL BIOL, V15, P102, DOI 10.1128/MCB.15.1.102; KASLOW DC, 1986, NUCLEIC ACIDS RES, V14, P6767, DOI 10.1093/nar/14.16.6767; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603; MACGREGOR GR, 1987, SOMAT CELL MOLEC GEN, V13, P253, DOI 10.1007/BF01535207; MORAES CT, 1991, AM J HUM GENET, V48, P492; PARISI MA, 1993, MOL CELL BIOL, V13, P1951, DOI 10.1128/MCB.13.3.1951; POULTON J, 1994, HUM MOL GENET, V3, P1763, DOI 10.1093/hmg/3.10.1763; ROSENTHAL N, 1987, METHOD ENZYMOL, V152, P704; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCARPULLA RC, 1981, J BIOL CHEM, V256, P6480; SCARPULLA RC, 1983, CELL, V32, P473, DOI 10.1016/0092-8674(83)90467-1; SCARPULLA RC, 1982, P NATL ACAD SCI-BIOL, V79, P739, DOI 10.1073/pnas.79.3.739; SHADEL GS, 1993, J BIOL CHEM, V268, P16083; TOMINAGA K, 1993, BIOCHEM BIOPH RES CO, V194, P544, DOI 10.1006/bbrc.1993.1854; TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209; VIRBASIUS CMA, 1993, GENE DEV, V7, P2431, DOI 10.1101/gad.7.12a.2431; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; VIRBASIUS JV, 1991, MOL CELL BIOL, V11, P5631, DOI 10.1128/MCB.11.11.5631; VIRBASIUS JV, 1993, GENE DEV, V7, P380, DOI 10.1101/gad.7.3.380; VIRBASIUS JV, 1990, NUCLEIC ACIDS RES, V18, P6581, DOI 10.1093/nar/18.22.6581; VIRBASIUS JV, 1988, J BIOL CHEM, V263, P6791; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523	33	55	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18019	18025		10.1074/jbc.270.30.18019	http://dx.doi.org/10.1074/jbc.270.30.18019			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629110	hybrid			2022-12-27	WOS:A1995RM26600061
J	HEWITT, SM; FRAIZER, GC; SAUNDERS, GF				HEWITT, SM; FRAIZER, GC; SAUNDERS, GF			TRANSCRIPTIONAL SILENCER OF THE WILMS-TUMOR GENE WT1 CONTAINS AN ALU REPEAT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; NEGATIVE REGULATION; REPEATED SEQUENCES; NUCLEAR PROTEINS; KERATIN-18 GENE; TRANSGENIC MICE; PROMOTER REGION; EXPRESSION; BINDING; ENHANCER	Expression of the Wilms' tumor gene WT1 is tightly regulated throughout development. In constrast, the WT1 promoter is promiscuous, functioning in all cell lines tested, We have cloned a transcriptional silencer that is involved in regulation of the WT1 gene. The transcriptional silencer is located in the third intron of the WT1 gene, approximately 12 kilobases from the promoter, and functions to repress transcription from the WT1 promoter in cell lines of non-renal origin. The 460-base pair silencer region is unusual in that it contains a full-length Alu repeat. We have also cloned an enhancer like-element located 1.3 kilobases upstream of the WT1 promoter.	UNIV TEXAS, MD ANDERSON CANC CTR, DEPT BIOCHEM & MOLEC BIOL, HOUSTON, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center				Hewitt, Stephen/0000-0001-8283-1788	NCI NIH HHS [CA34936, CA 16672, T32 CA09299] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA034936, T32CA009299, P30CA016672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUGEREAU P, 1986, EMBO J, V5, P1791, DOI 10.1002/j.1460-2075.1986.tb04428.x; BLESSING M, 1987, EMBO J, V6, P567, DOI 10.1002/j.1460-2075.1987.tb04792.x; BRINI AT, 1993, J BIOL CHEM, V268, P1355; BUCKLER AJ, 1991, MOL CELL BIOL, V11, P1707, DOI 10.1128/MCB.11.3.1707; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CAMPBELL CE, 1994, ONCOGENE, V9, P583; DEY BR, 1994, MOL ENDOCRINOL, V8, P595, DOI 10.1210/me.8.5.595; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; DRUMMOND IA, 1992, SCIENCE, V257, P674, DOI 10.1126/science.1323141; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; FRAIZER GC, 1994, J BIOL CHEM, V269, P8892; FUJITA T, 1987, CELL, V49, P357, DOI 10.1016/0092-8674(87)90288-1; GARVIN AJ, 1993, AM J PATHOL, V142, P375; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GESSLER M, 1993, GENOMICS, V17, P499, DOI 10.1006/geno.1993.1355; GRANGE T, 1991, NUCLEIC ACIDS RES, V19, P131, DOI 10.1093/nar/19.1.131; HAMBOR JE, 1993, MOL CELL BIOL, V13, P7056, DOI 10.1128/MCB.13.11.7056; HARRINGTON MA, 1993, J BIOL CHEM, V268, P21271; HOUCK CM, 1979, J MOL BIOL, V132, P289, DOI 10.1016/0022-2836(79)90261-4; HUANG A, 1990, SCIENCE, V250, P991, DOI 10.1126/science.2173145; HUFF V, 1993, BIOCHIM BIOPHYS ACTA, V1155, P295, DOI 10.1016/0304-419X(93)90011-Z; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JURKA J, 1988, P NATL ACAD SCI USA, V85, P4775, DOI 10.1073/pnas.85.13.4775; KARIYA Y, 1987, GENE, V53, P1, DOI 10.1016/0378-1119(87)90087-4; KIM JH, 1989, NUCLEIC ACIDS RES, V17, P5687, DOI 10.1093/nar/17.14.5687; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LOCKER J, 1990, J DNA SEQUENCING MAP, V1, P3; LUBON H, 1987, NUCLEIC ACIDS RES, V15, P2103, DOI 10.1093/nar/15.5.2103; MADDEN SL, 1991, SCIENCE, V253, P1550, DOI 10.1126/science.1654597; MAOUCHE L, 1994, NUCLEIC ACIDS RES, V22, P338, DOI 10.1093/nar/22.3.338; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MIWA H, 1992, J NATL CANCER I, V84, P181, DOI 10.1093/jnci/84.3.181; MIWA H, 1992, LEUKEMIA, V6, P405; MIYAGI T, 1993, LEUKEMIA, V7, P970; NEZNANOV N, 1993, MOL CELL BIOL, V13, P2214, DOI 10.1128/MCB.13.4.2214; NEZNANOV NS, 1993, MOL CELL BIOL, V13, P1815, DOI 10.1128/MCB.13.3.1815; OKA T, 1991, ONCOGENE, V6, P2077; PARK JH, 1988, MOL CELL BIOL, V8, P2536, DOI 10.1128/MCB.8.6.2536; PARK S, 1993, NAT GENET, V4, P415, DOI 10.1038/ng0893-415; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PERELYGINA LM, 1987, MOL BIOL REP, V12, P111, DOI 10.1007/BF00368878; RICCARDI VM, 1978, PEDIATRICS, V61, P604; RUPPRECHT HD, 1994, J BIOL CHEM, V269, P6198; SHANNON MF, 1988, P NATL ACAD SCI USA, V85, P674, DOI 10.1073/pnas.85.3.674; SHEN MR, 1991, J MOL EVOL, V33, P311; TADOKORO K, 1992, JPN J CANCER RES, V83, P1198, DOI 10.1111/j.1349-7006.1992.tb02745.x; VANWIJNEN AJ, 1988, NUCLEIC ACIDS RES, V16, P571, DOI 10.1093/nar/16.2.571; WALKER C, 1992, CANCER RES, V52, P301; WALL L, 1988, GENE DEV, V2, P1089, DOI 10.1101/gad.2.9.1089; WALSH K, 1987, J BIOL CHEM, V262, P9429; WANG ZY, 1992, J BIOL CHEM, V267, P21999; WERNER H, 1994, J BIOL CHEM, V269, P12577; WU J, 1990, MOL CELL BIOL, V10, P1209, DOI 10.1128/MCB.10.3.1209; WU YJ, 1995, J BIOL CHEM, V270, P5944, DOI 10.1074/jbc.270.11.5944; YOUNG JL, 1975, J PEDIATR-US, V86, P254, DOI 10.1016/S0022-3476(75)80484-7	55	64	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17908	17912		10.1074/jbc.270.30.17908	http://dx.doi.org/10.1074/jbc.270.30.17908			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629096	hybrid			2022-12-27	WOS:A1995RM26600044
J	JAKUBOWSKI, H				JAKUBOWSKI, H			PROOFREADING IN-VIVO - EDITING OF HOMOCYSTEINE BY AMINOACYL-TRANSFER-RNA SYNTHETASES IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TRANSFER-RNA-SYNTHETASE; ASPARAGINYL-TRANSFER-RNA; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; HYDROXY ANALOGS; SEQUENCE; CLONING; GENE; INVIVO; ACIDS	Editing reactions are an essential part of biological information transfer processes that require high accuracy, such as replication, transcription, and translation. The editing in amino acid selection for protein synthesis by an aminoacyl-tRNA synthetase, the first proofreading process discovered in the flow of genetic information, prevents attachment of incorrect amino acids to tRNA. Of numerous editing reactions studied in vitro, only one, editing of homocysteine by methionyl-tRNA synthetase, has also been demonstrated in vivo. It is therefore unclear to what extent editing of errors is physiologically relevant. Here we show that isoleucyl-and leucyl-tRNA synthetases also edit homocysteine by cyclizing it to homocysteine thiolactone in the bacterium Escherichia coli. These and other data also suggest that metabolite compartmentation or channeling governs which synthetase participates in editing in bacterial cells.			JAKUBOWSKI, H (corresponding author), UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT MICROBIOL & MOLEC GENET,NEWARK,NJ 07103, USA.		Jakubowski, Hieronim/AAA-6834-2019; Jakubowski, Hieronim/A-2510-2017	Jakubowski, Hieronim/0000-0001-5845-4409				ANSELME J, 1989, GENE, V84, P481, DOI 10.1016/0378-1119(89)90524-6; BREVET A, 1989, P NATL ACAD SCI USA, V86, P8275, DOI 10.1073/pnas.86.21.8275; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; ENGLISCHPETERS S, 1990, BIOCHEMISTRY-US, V29, P7953, DOI 10.1021/bi00486a025; ERIANI G, 1990, NUCLEIC ACIDS RES, V18, P7109, DOI 10.1093/nar/18.23.7109; ERIANI G, 1989, NUCLEIC ACIDS RES, V17, P5725, DOI 10.1093/nar/17.14.5725; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; ERIANI G, 1991, NUCLEIC ACIDS RES, V19, P265, DOI 10.1093/nar/19.2.265; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P1250, DOI 10.1021/bi00574a021; FERSHT AR, 1986, ACCURACY MOL PROCESS, P67; GAO WW, 1994, BIOCHEMISTRY-US, V33, P11528, DOI 10.1021/bi00204a015; HARTLEIN M, 1987, NUCLEIC ACIDS RES, V15, P1005, DOI 10.1093/nar/15.3.1005; HARTLEIN M, 1987, NUCLEIC ACIDS RES, V15, P10199, DOI 10.1093/nar/15.24.10199; JAKUBOWSKI H, 1993, FEBS LETT, V317, P237, DOI 10.1016/0014-5793(93)81283-6; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; JAKUBOWSKI H, 1991, EMBO J, V10, P593, DOI 10.1002/j.1460-2075.1991.tb07986.x; JAKUBOWSKI H, 1990, P NATL ACAD SCI USA, V87, P4504, DOI 10.1073/pnas.87.12.4504; JAKUBOWSKI H, 1981, NUCLEIC ACIDS RES, V9, P3105, DOI 10.1093/nar/9.13.3105; JAKUBOWSKI H, 1994, ANN NY ACAD SCI, V745, P4; WEBSTER T, 1984, SCIENCE, V226, P1315, DOI 10.1126/science.6390679; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	21	48	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17672	17673		10.1074/jbc.270.30.17672	http://dx.doi.org/10.1074/jbc.270.30.17672			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629064	hybrid			2022-12-27	WOS:A1995RM26600009
J	POTAPOV, AP; TRIANAALONSO, FJ; NIERHAUS, KH				POTAPOV, AP; TRIANAALONSO, FJ; NIERHAUS, KH			RIBOSOMAL DECODING PROCESSES AT CODONS IN THE A-SITE OR P-SITE DEPEND DIFFERENTLY ON 2'-OH GROUPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA BINDING; ESCHERICHIA-COLI RIBOSOMES; SUGAR-PHOSPHATE BACKBONE; ALLOSTERIC 3-SITE MODEL; ANTICODON INTERACTION; ELONGATION CYCLE; MESSENGER-RNA; TRANSLATION; EFFICIENCY; ACCURACY	The importance of 2'-OH groups of codons for binding of cognate tRNAs to ribosomal P and A sites was analyzed applying the following strategy. An mRNA of 41 nucleotides was synthesized with the structure C-16-GAA-UUG-GUC-C-16 coding for glutamic acid (E), phenylalanine (F) and valine (V), respectively, in the middle (EFV-mRNA). A second template, the E(dF)V-mRNA, was identical except that it carried a deoxyribo-codon-dUdUdC- for phenylalanine. tRNA binding to the P site is totally insensitive to the presence or absence of the 2'-OH group of the P-site codon, and tRNA binding to the P site is also not affected if the A-site codon lacks the 2'-OH groups. However, binding is impaired if the deoxy-codon is present at the E site. In sharp contrast, the A-site binding of Ac-aminoacyl-tRNA was severely reduced in the presence of the deoxy-codon at the A-site as well as at the P site. The results demonstrate that the correctness of base pairing is also ''sensed'' via a correct sugar structure of the codon, e.g. positioning of the sugar pucker (2'-OH), during the decoding process at the A site (elongation) but not during the decoding at the P site (initiation).	MAX PLANCK INST MOLEC GENET, AG RIBSOMEN, D-14195 BERLIN, GERMANY	Max Planck Society								BEYER D, 1994, J BIOL CHEM, V269, P30713; BILGIN N, 1992, J MOL BIOL, V224, P1011, DOI 10.1016/0022-2836(92)90466-W; BOUADLOUN F, 1983, EMBO J, V2, P1351, DOI 10.1002/j.1460-2075.1983.tb01591.x; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; GNIRKE A, 1989, J BIOL CHEM, V264, P7291; GROSJEAN HJ, 1978, P NATL ACAD SCI USA, V75, P610, DOI 10.1073/pnas.75.2.610; HALL KB, 1993, CURR OPIN STRUC BIOL, V3, P336, DOI 10.1016/S0959-440X(05)80103-4; HARTZ D, 1990, RIBOSOME, P275; HOPFIELD JJ, 1980, RIBOSOMES STRUCTURE, P585; KANG C, 1985, J MOL BIOL, V181, P241, DOI 10.1016/0022-2836(85)90088-9; KOMINE Y, 1990, J MOL BIOL, V212, P579, DOI 10.1016/0022-2836(90)90224-A; KURLAND CG, 1987, TRENDS BIOCHEM SCI, V12, P126, DOI 10.1016/0968-0004(87)90060-0; LIBBY RT, 1989, EMBO J, V8, P3153, DOI 10.1002/j.1460-2075.1989.tb08469.x; LUHRMANN R, 1979, NATURE, V280, P423, DOI 10.1038/280423a0; MCCARTHY BJ, 1965, P NATL ACAD SCI USA, V54, P880, DOI 10.1073/pnas.54.3.880; MORGAN AR, 1967, J MOL BIOL, V26, P447; NIERHAUS KH, 1990, BIOCHEMISTRY-US, V29, P4997, DOI 10.1021/bi00473a001; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; POTAPOV AP, 1992, BIOCHIMIE, V74, P435, DOI 10.1016/0300-9084(92)90083-Q; POTAPOV AP, 1990, BIOCHIMIE, V72, P345, DOI 10.1016/0300-9084(90)90030-K; POTAPOV AP, 1988, J MOL BIOL, V203, P885, DOI 10.1016/0022-2836(88)90114-3; POTAPOV AP, 1982, FEBS LETT, V146, P5, DOI 10.1016/0014-5793(82)80693-5; POTAPOV AP, 1991, 14TH INT TRNA WORKSH, P202; RAJBHANDARY UL, 1994, J BACTERIOL, V176, P547, DOI 10.1128/jb.176.3.547-552.1994; RHEINBERGER HJ, 1988, METHOD ENZYMOL, V164, P658; RICKER RD, 1991, NUCLEIC ACIDS RES, V19, P6573, DOI 10.1093/nar/19.23.6573; RUUSALA T, 1982, EMBO J, V1, P741, DOI 10.1002/j.1460-2075.1982.tb01240.x; SALAS J, 1968, J BIOL CHEM, V243, P1012; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHILLINGBARTETZKO S, 1992, J BIOL CHEM, V267, P4693; SOLDATKIN KO, 1992, BIOCHIM BIOPHYS ACTA, V1130, P38, DOI 10.1016/0167-4781(92)90458-C; THOMPSON RC, 1977, P NATL ACAD SCI USA, V74, P198, DOI 10.1073/pnas.74.1.198; WEIJLAND A, 1993, SCIENCE, V259, P1311, DOI 10.1126/science.8446899; WURMBACH P, 1979, P NATL ACAD SCI USA, V76, P2143, DOI 10.1073/pnas.76.5.2143; WURMBACH P, 1983, EUR J BIOCHEM, V130, P9	35	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17680	17684		10.1074/jbc.270.30.17680	http://dx.doi.org/10.1074/jbc.270.30.17680			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629066	hybrid			2022-12-27	WOS:A1995RM26600011
J	SCHONEBERG, T; LIU, J; WESS, J				SCHONEBERG, T; LIU, J; WESS, J			PLASMA-MEMBRANE LOCALIZATION AND FUNCTIONAL RESCUE OF TRUNCATED FORMS OF A G-PROTEIN-COUPLED RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENERGIC-RECEPTORS; BINDING; BACTERIORHODOPSIN; LIGAND; COEXPRESSION; FRAGMENTS; GENES	To test the hypothesis that G protein-coupled receptors consist of multiple autonomous folding domains, the rat m3 muscarinic acetylcholine receptor was ''split'' in all three intracellular (i1-i3) and all three extracellular loops (o2-o4). The six resulting polypeptide pairs (N-i1. C-i1, N-o2. C-o2, etc.) were coexpressed in COS-7 cells and studied for their ability to bind muscarinic ligands and to activate G proteins. In addition, immunocytochemical and ELISA studies were carried out to study the expression and subcellular localization of the individual receptor fragments. Interestingly, all N- and C-terminal receptor fragments studied (except N-i1, which contained only the first transmembrane domain) were found to be localized to the plasma membrane, even when expressed alone. Coexpression of three of the six polypeptide pairs, generated by splitting the m3 muscarinic receptor in the i2, o3, or i3 loop, resulted in receptor complexes (N-i2. C-i2, N-o3. C-o3, and N-i3. C-i3, respectively), which were able to bind muscarinic agonists and antagonists with high affinity. The N-o3. C-o3 and N-i3. C-i3 polypeptide combinations, but not the N-i2. C-i2 complex, were also able to stimulate carbachol-dependent phosphatidyl inositol hydrolysis to a similar maximum extent as the wild type m3 muscarinic receptor. These findings strongly suggest that G protein-coupled receptors are composed of several independent folding units and may shed light on the molecular mechanisms governing receptor assembly and membrane insertion.	NIDDKD, BIOORGAN CHEM LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)								BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; DORJE F, 1991, J PHARMACOL EXP THER, V256, P727; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Higuchi R., 1989, PCR TECHNOLOGY, P61; KAHN TW, 1992, BIOCHEMISTRY-US, V31, P6144, DOI 10.1021/bi00141a027; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; LIAO MJ, 1983, J BIOL CHEM, V258, P9949; MAGGIO R, 1993, P NATL ACAD SCI USA, V90, P3103, DOI 10.1073/pnas.90.7.3103; MAGGIO R, 1993, FEBS LETT, V319, P195, DOI 10.1016/0014-5793(93)80066-4; MORO O, 1993, J BIOL CHEM, V268, P22273; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; RAYMOND JR, 1994, AM J PHYSIOL, V266, pF163, DOI 10.1152/ajprenal.1994.266.2.F163; ROSENFELD PJ, 1992, NAT GENET, V1, P85; SAVARESE TM, 1992, BIOCHEM J, V283, P1; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; WESS J, 1993, TRENDS PHARMACOL SCI, V14, P308, DOI 10.1016/0165-6147(93)90049-P; WONG SKF, 1990, J BIOL CHEM, V265, P6219	26	141	146	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18000	18006						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629108				2022-12-27	WOS:A1995RM26600058
J	ZIMMER, G; KLENK, HD; HERRLER, G				ZIMMER, G; KLENK, HD; HERRLER, G			IDENTIFICATION OF A 40-KDA CELL-SURFACE SIALOGLYCOPROTEIN WITH THE CHARACTERISTICS OF A MAJOR INFLUENZA-C VIRUS RECEPTOR IN A MADIN-DARBY CANINE KIDNEY-CELL LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-CONTAINING RECEPTORS; DE-ORTHO-ACETYLATION; HUMAN-MELANOMA CELLS; SIALIC ACIDS; DESTROYING ENZYME; N-ACETYL-9-O-ACETYLNEURAMINIC ACID; LINKED OLIGOSACCHARIDES; POLYACRYLAMIDE GELS; BOVINE CORONAVIRUS; ENDOCYTIC PATHWAY	Infection of cells by influenza C virus is known to be initiated by virus attachment to cell surface glycoconjugates containing N-acetyl-9-O-acetylneuraminic acid. Using an in vitro virus binding assay, we have detected this carbohydrate on several glycoproteins of Madin-Darby canine kidney cells (type I), a polarized epithelial cell line permissive for infection with influenza C virus. Among these proteins, only one was found to be present to a significant extent on the cell surface. This protein, gp40, was characterized as an O-glycosylated (mucin-type) integral membrane protein of 40 kDa, which was predominantly localized on the apical plasma membrane of filter-grown cells. It is a major cell surface sialoglycoprotein in this cell line and was shown to be subject to constitutive and rapid endocytosis. Thus, this glycoprotein can mediate not only the binding of influenza C virus to the cell surface, but also its delivery to endosomes, where penetration occurs by membrane fusion. Other highly sialylated cell surface glycoproteins were also detected but did not mediate influenza C virus binding to a significant extent, indicating that only gp40 contains 9-O-acetylated sialic acids.	UNIV MARBURG, INST VIROL, D-35037 MARBURG, GERMANY	Philipps University Marburg				Zimmer, Gert/0000-0002-2708-2507				BAENZIGER JU, 1979, J BIOL CHEM, V254, P2400; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BRETSCHER MS, 1980, P NATL ACAD SCI-BIOL, V77, P4156, DOI 10.1073/pnas.77.7.4156; CARRAWAY KL, 1992, J CELL SCI, V103, P299; DEH ME, 1985, ANAL BIOCHEM, V150, P166, DOI 10.1016/0003-2697(85)90456-7; DIAZ S, 1989, J BIOL CHEM, V264, P19416; FORMANOWSKI F, 1990, J GEN VIROL, V71, P1181, DOI 10.1099/0022-1317-71-5-1181; GALLAGHER JT, 1985, BIOCHEM J, V231, P115, DOI 10.1042/bj2310115; GOTTSCHALK A, 1949, NATURE, V164, P232, DOI 10.1038/164232a0; Gottschalk A, 1959, VIRUSES, V3, P51; HASELBECK A, 1990, ANAL BIOCHEM, V191, P25, DOI 10.1016/0003-2697(90)90381-I; HERRLER G, 1987, VIROLOGY, V159, P102, DOI 10.1016/0042-6822(87)90352-7; HERRLER G, 1985, EMBO J, V4, P1503, DOI 10.1002/j.1460-2075.1985.tb03809.x; HERRLER G, 1988, J GEN VIROL, V69, P839, DOI 10.1099/0022-1317-69-4-839; HERRLER G, 1991, ADV VIRUS RES, V40, P213; HERRLER G, 1981, VIROLOGY, V113, P439, DOI 10.1016/0042-6822(81)90173-2; HERRLER G, 1992, J BIOL CHEM, V267, P12501; HIGA HH, 1989, J BIOL CHEM, V264, P19427; HIGA HH, 1985, VIROLOGY, V144, P279, DOI 10.1016/0042-6822(85)90325-3; KEEN JH, 1990, ANNU REV BIOCHEM, V59, P415, DOI 10.1146/annurev.biochem.59.1.415; KITAME F, 1982, ARCH VIROL, V73, P357, DOI 10.1007/BF01318090; KOBATA A, 1979, ANAL BIOCHEM, V100, P1, DOI 10.1016/0003-2697(79)90102-7; KORNFELD K, 1981, J BIOL CHEM, V256, P6633; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENTZ TL, 1990, J GEN VIROL, V71, P751, DOI 10.1099/0022-1317-71-4-751; LISANTI MP, 1988, P NATL ACAD SCI USA, V85, P9557, DOI 10.1073/pnas.85.24.9557; MANZI AE, 1990, J BIOL CHEM, V265, P13091; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; MERRIL CR, 1979, P NATL ACAD SCI USA, V76, P4335, DOI 10.1073/pnas.76.9.4335; NORGARD KE, 1993, J BIOL CHEM, V268, P12764; OGATA S, 1975, J BIOCHEM, V78, P687, DOI 10.1093/oxfordjournals.jbchem.a130956; OHUCHI M, 1982, J VIROL, V42, P1076, DOI 10.1128/JVI.42.3.1076-1079.1982; PEARSE BMF, 1990, ANNU REV CELL BIOL, V6, P151, DOI 10.1146/annurev.cb.06.110190.001055; ROGERS GN, 1986, J BIOL CHEM, V261, P5947; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; ROTH MG, 1986, J CELL BIOL, V102, P1271, DOI 10.1083/jcb.102.4.1271; SASTRY MVK, 1986, J BIOL CHEM, V261, P1726; SCHAUER R, 1988, BIOL CHEM H-S, V369, P1121, DOI 10.1515/bchm3.1988.369.2.1121; SCHAUER R, 1982, ADV CARBOHYD CHEM BI, V40, P131, DOI 10.1016/S0065-2318(08)60109-2; SCHULTZE B, 1992, J GEN VIROL, V73, P901, DOI 10.1099/0022-1317-73-4-901; SCHULTZE B, 1990, VIRUS RES, V16, P185, DOI 10.1016/0168-1702(90)90022-4; Segrest JP, 1972, METHOD ENZYMOL, V28, P54, DOI DOI 10.1016/0076-6879(72)28007-7; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331; SJOBERG ER, 1993, J BIOL CHEM, V268, P10185; STROBL B, 1993, VIROLOGY, V192, P679, DOI 10.1006/viro.1993.1087; SUEYOSHI S, 1988, CARBOHYD RES, V178, P213, DOI 10.1016/0008-6215(88)80113-7; SUTHERLAND DR, 1992, J IMMUNOL, V148, P1458; SZEPANSKI S, 1992, VIROLOGY, V188, P85, DOI 10.1016/0042-6822(92)90737-A; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; Trowbridge IS, 1991, CURR OPIN CELL BIOL, V3, P1062, DOI 10.1016/0955-0674(91)90130-Q; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; VARKI A, 1992, GLYCOBIOLOGY, V2, P25, DOI 10.1093/glycob/2.1.25; VLASAK R, 1988, P NATL ACAD SCI USA, V85, P4526, DOI 10.1073/pnas.85.12.4526; WANG WC, 1988, J BIOL CHEM, V263, P4576; WILLOUGHBY RE, 1993, GLYCOBIOLOGY, V3, P437, DOI 10.1093/glycob/3.5.437	57	53	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17815	17822		10.1074/jbc.270.30.17815	http://dx.doi.org/10.1074/jbc.270.30.17815			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629082	hybrid			2022-12-27	WOS:A1995RM26600030
J	BEAUDET, L; GROS, P				BEAUDET, L; GROS, P			FUNCTIONAL DISSECTION OF P-GLYCOPROTEIN NUCLEOTIDE-BINDING DOMAINS IN CHIMERIC AND MUTANT PROTEINS - MODULATION OF DRUG-RESISTANCE PROFILES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; BACTERIAL TRANSPORT PROTEINS; CONFER MULTIDRUG RESISTANCE; CYSTIC-FIBROSIS MUTATIONS; ASCITES TUMOR-CELLS; MDR GENE FAMILY; CLASS-II REGION; ESCHERICHIA-COLI; MOUSE MDR1; SUBSTRATE-SPECIFICITY	We wished to determine if the two nucleotide-binding domains (NBD) of P-glycoprotein are functionally equivalent and interchangeable, and if not, which segments and amino acids are important for proper function of each NBD within the context of the C- or N-terminal P-glycoprotein halves, For this, we constructed and tested the biological activity in yeast and mammalian cells of a series of chimeric mdr3 cDNAs in which discrete domains of the N-terminal NBD (NBD1) were replaced by the homologous segments of the C-terminal NBD (NBD2). Although most NBD1 segments could be replaced without loss of P-glycoprotein function, exchange of small segments near the Walker B motif caused a dramatic reduction in Adriamycin, actinomycin D, and colchicine resistance in LR73 cells, as well as in FK506 resistance and STE6 complementation in yeast, Site-directed mutagenesis identified amino acid positions 522-525 (ERGA --> DKGT) and 578 (Thr --> Cys) as essential for proper function of NBD1 in the context of the N-terminal half P-glycoprotein, In addition, the observed phenotype of the mutants (altered drug resistance profile) suggests that these residues may participate directly or indirectly in substrate interactions and are possibly implicated in signal transduction from NBDs to transmembrane domains, the primary sites of drug binding in P-glycoprotein.	MCGILL UNIV, DEPT BIOCHEM, MONTREAL, PQ H3G 1Y6, CANADA	McGill University								AMES GF, 1992, ADV ENZYMOL RAMB, V65, P1; ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; ARISPE N, 1992, P NATL ACAD SCI USA, V89, P1539, DOI 10.1073/pnas.89.5.1539; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; BAUBICHONCORTAY H, 1994, J BIOL CHEM, V269, P22983; BERKOWER C, 1991, EMBO J, V10, P3777, DOI 10.1002/j.1460-2075.1991.tb04947.x; BUSCHMAN E, 1991, MOL CELL BIOL, V11, P595, DOI 10.1128/MCB.11.2.595; BUSCHMAN E, 1992, J BIOL CHEM, V267, P18093; CHAN HSL, 1994, HEMATOL ONCOL CLIN N, V8, P383, DOI 10.1016/S0889-8588(18)30178-3; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CHOI K, 1988, CELL, V53, P519, DOI 10.1016/0092-8674(88)90568-5; CORNWELL MM, 1987, FASEB J, V1, P51, DOI 10.1096/fasebj.1.1.2886389; DANO K, 1973, BIOCHIM BIOPHYS ACTA, V323, P466, DOI 10.1016/0005-2736(73)90191-0; DEVAULT A, 1990, MOL CELL BIOL, V10, P1652, DOI 10.1128/MCB.10.4.1652; DEVERSON EV, 1990, NATURE, V348, P738, DOI 10.1038/348738a0; DEVINE SE, 1992, P NATL ACAD SCI USA, V89, P4564, DOI 10.1073/pnas.89.10.4564; DHIR R, 1993, BIOCHEMISTRY-US, V32, P9492, DOI 10.1021/bi00087a030; DUDLER R, 1992, J BIOL CHEM, V267, P5882; FELMLEE T, 1985, J BACTERIOL, V163, P94, DOI 10.1128/JB.163.1.94-105.1985; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; FRY DC, 1986, P NATL ACAD SCI USA, V83, P907, DOI 10.1073/pnas.83.4.907; GIBBS TW, 1992, MOL GEN GENET, V234, P121, DOI 10.1007/BF00272353; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; GREENBERGER LM, 1993, J BIOL CHEM, V268, P11417; Gros P, 1993, Int Rev Cytol, V137C, P169; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; GROS P, 1991, P NATL ACAD SCI USA, V88, P7289, DOI 10.1073/pnas.88.16.7289; GROS P, 1988, MOL CELL BIOL, V8, P2770, DOI 10.1128/MCB.8.7.2770; HIGGINS CF, 1994, CELL, V79, P393, DOI 10.1016/0092-8674(94)90248-8; HIGGINS FC, 1992, ANN REV CELL BIOL, V8, P67; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; HOOF T, 1994, J BIOL CHEM, V269, P20575; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KUCHLER K, 1989, EMBO J, V8, P3973, DOI 10.1002/j.1460-2075.1989.tb08580.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINCKE CR, 1991, J BIOL CHEM, V266, P5303; LOO TW, 1993, J BIOL CHEM, V268, P3143; LOO TW, 1994, J BIOL CHEM, V269, P7243; LOO TW, 1994, J BIOL CHEM, V269, P7750; LOO TW, 1993, J BIOL CHEM, V268, P19965; MCGRATH JP, 1989, NATURE, V340, P400, DOI 10.1038/340400a0; MIMURA CS, 1991, P NATL ACAD SCI USA, V88, P84, DOI 10.1073/pnas.88.1.84; MONACO JJ, 1990, SCIENCE, V250, P1723, DOI 10.1126/science.2270487; MORRIS DI, 1991, BIOCHEMISTRY-US, V30, P8371, DOI 10.1021/bi00098a014; PETRONILLI V, 1991, J BIOL CHEM, V266, P16293; POWIS SJ, 1992, NATURE, V357, P211, DOI 10.1038/357211a0; RAVIV Y, 1990, J BIOL CHEM, V265, P3975; RAYMOND M, 1992, SCIENCE, V256, P232, DOI 10.1126/science.1348873; RAYMOND M, 1994, MOL CELL BIOL, V14, P277, DOI 10.1128/MCB.14.1.277; RIORDAN JR, 1989, SCIENCE, V245, P1066; RUETZ S, 1993, P NATL ACAD SCI USA, V90, P11588, DOI 10.1073/pnas.90.24.11588; RUETZ S, 1994, CELL, V77, P1071, DOI 10.1016/0092-8674(94)90446-4; RUETZ S, 1994, J BIOL CHEM, V269, P12277; SAFA AR, 1992, CANCER INVEST, V10, P295, DOI 10.3109/07357909209032754; SCHURR E, 1989, CANCER RES, V49, P2729; SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745; SHEPPARD DN, 1994, CELL, V76, P1091, DOI 10.1016/0092-8674(94)90385-9; Sherman F., 1982, METHODS YEAST GENETI; SHYAMALA V, 1991, J BIOL CHEM, V266, P18714; SIMON SM, 1994, P NATL ACAD SCI USA, V91, P3497, DOI 10.1073/pnas.91.9.3497; SKOVSGAARD T, 1978, CANCER RES, V38, P4722; SMIT LS, 1993, P NATL ACAD SCI USA, V90, P9963, DOI 10.1073/pnas.90.21.9963; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SPEISER DM, 1991, J BACTERIOL, V173, P1444, DOI 10.1128/jb.173.4.1444-1451.1991; SPIES T, 1992, NATURE, V355, P644, DOI 10.1038/355644a0; SPRAGUE GF, 1991, METHOD ENZYMOL, V194, P77; TANGWAI DF, 1993, BIOCHEMISTRY-US, V32, P6470, DOI 10.1021/bi00076a022; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; VANDERBLIEK AM, 1988, GENE, V71, P401, DOI 10.1016/0378-1119(88)90057-1; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; White T.J., 1990, PCR PROTOCOLS GUIDE, V18, P315; WU CT, 1991, MOL CELL BIOL, V11, P3940, DOI 10.1128/MCB.11.8.3940	76	72	75	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17159	17170		10.1074/jbc.270.29.17159	http://dx.doi.org/10.1074/jbc.270.29.17159			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615512	hybrid			2022-12-27	WOS:A1995RK68900019
J	LEROY, D; SCHMID, N; BEHR, JP; FILHOL, O; PARES, S; GARIN, J; BOURGARIT, JJ; CHAMBAZ, EM; COCHET, C				LEROY, D; SCHMID, N; BEHR, JP; FILHOL, O; PARES, S; GARIN, J; BOURGARIT, JJ; CHAMBAZ, EM; COCHET, C			DIRECT IDENTIFICATION OF A POLYAMINE BINDING DOMAIN ON THE REGULATORY SUBUNIT OF THE PROTEIN-KINASE CASEIN KINASE-2 BY PHOTOAFFINITY-LABELING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR SUPPRESSOR PROTEIN; EPIDERMAL GROWTH-FACTOR; LARGE T-ANTIGEN; BETA-SUBUNIT; II ACTIVITY; POLYAMINOBENZENEDIAZONIUM SALTS; CELL-GROWTH; PHOSPHORYLATION; DNA; ACTIVATION	Phosphorylation of many protein substrates by the protein kinase casein kinase 2 (CK2) is stimulated severalfold in the presence of polyamines such as spermine. Previous experiments have shown that CK2 is a polyamine binding protein and that the regulatory beta subunit is required for this binding activity. To delineate the spermine binding site of CK2, we have applied a photoaffinity labeling method using a tritiated photoactivable analog of spermine, [H-3]sperminediazonium. The photoaffinity labeled beta subunit was cleaved with cyanogen bromide, and two labeled peptides were separated by high performance liquid chromatography. The major one was the peptide T(72)EQAAEM(78) and the minor one was a 22-amino acid peptide comprising residues Ile(98) to Met(119). Thr(72) and His(108) were identified as the labeled amino acids of the Thr(72)-Met(78) and Ile(98) Met(119) peptides, respectively. In the same manner, we succeeded in determining the residue Leu(220) as an alpha subunit residue covalently bound to the probe. The photoaffinity labeling method described here enabled the first elucidation, by direct microsequencing, of a polyamine binding site on CK2 for which we propose a provisional structural model. These observations suggest a possible mechanism for CK2 activation by polyamines at the molecular level.	CEN GRENOBLE, DEPT BIOL MOLEC & STRUCT, CEA, INSERM, U244, F-38054 GRENOBLE 9, FRANCE; FAC PHARM ILLKIRCH, CNRS, UNIT 1386, F-67401 ILLKIRCH GRAFFENSTADEN, FRANCE; INST BIOL STRUCT, CRISTALLOG MACROMOLEC LAB, F-38027 GRENOBLE 1, FRANCE	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)			Filhol-Cochet, Odile/I-3962-2016	Cochet, Claude/0000-0002-1772-4270; Filhol, Odile/0000-0003-1964-7958				ACKERMAN P, 1989, J BIOL CHEM, V264, P11958; ALLEN JC, 1983, CELL BIOCHEM FUNCT, V1, P131, DOI 10.1002/cbf.290010302; BARBOSA MS, 1990, EMBO J, V9, P153, DOI 10.1002/j.1460-2075.1990.tb08091.x; BEHR JP, 1989, J CHEM SOC CHEM COMM, P101, DOI 10.1039/c39890000101; BERBERICH SJ, 1992, GENE DEV, V6, P166, DOI 10.1101/gad.6.2.166; BOLDYREFF B, 1994, J BIOL CHEM, V269, P4827; BOLDYREFF B, 1990, ADV MOL GENET, V3, P91; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNGER AT, 1992, X PLOR VERSION 3 1; CARROLL D, 1989, J BIOL CHEM, V264, P7345; CARROLL D, 1988, COLD SPRING HARB SYM, V53, P91, DOI 10.1101/SQB.1988.053.01.014; COCHET C, 1983, MOL CELL ENDOCRINOL, V30, P247, DOI 10.1016/0303-7207(83)90062-X; COCHET C, 1983, J BIOL CHEM, V258, P1403; FILHOL O, 1991, BIOCHEMISTRY-US, V30, P11133, DOI 10.1021/bi00110a016; FILHOL O, 1992, J BIOL CHEM, V267, P20577; FILHOL O, 1990, BIOCHEMISTRY-US, V29, P9928, DOI 10.1021/bi00494a025; FILHOL O, 1991, BIOCHEM BIOPH RES CO, V180, P945, DOI 10.1016/S0006-291X(05)81157-X; FIRZLAFF J M, 1989, New Biologist, V1, P44; GARCIA A, 1990, NUCLEIC ACIDS RES, V18, P89, DOI 10.1093/nar/18.1.89; GOYNS MH, 1982, J THEOR BIOL, V97, P577, DOI 10.1016/0022-5193(82)90359-9; GRASSER FA, 1988, VIROLOGY, V165, P13, DOI 10.1016/0042-6822(88)90653-8; HATHAWAY GM, 1982, CURR TOP CELL REGUL, V21, P101; HEBY O, 1981, DIFFERENTIATION, V19, P1, DOI 10.1111/j.1432-0436.1981.tb01123.x; HOPKINS D, 1982, S AFR J SCI, V78, P25; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLARLUND JK, 1988, J BIOL CHEM, V263, P15872; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT ED; KREBS EG, 1988, COLD SPRING HARB SYM, V53, P77, DOI 10.1101/SQB.1988.053.01.012; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN WJ, 1991, J BIOL CHEM, V266, P5664; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; LUSCHER B, 1990, NATURE, V344, P517, DOI 10.1038/344517a0; MEEK DW, 1990, EMBO J, V9, P3253, DOI 10.1002/j.1460-2075.1990.tb07524.x; MEGGIO F, 1992, EUR J BIOCHEM, V204, P293, DOI 10.1111/j.1432-1033.1992.tb16636.x; MELLGREN RL, 1990, BIOCHIM BIOPHYS ACTA, V1040, P28, DOI 10.1016/0167-4838(90)90142-3; MORENO FJ, 1993, BIOCHEM J, V289, P631, DOI 10.1042/bj2890631; PADMANABHA R, 1987, J BIOL CHEM, V262, P1829; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; POMERANTZ AH, 1975, BIOCHEMISTRY-US, V14, P3858, DOI 10.1021/bi00688a019; POMMIER Y, 1989, BIOCHEMISTRY-US, V28, P995, DOI 10.1021/bi00429a012; SCALABRINO G, 1991, MOL CELL ENDOCRINOL, V77, P1, DOI 10.1016/0303-7207(91)90056-X; SCALABRINO G, 1981, ADV CANCER RES, V35, P151, DOI 10.1016/S0065-230X(08)60911-2; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHMID N, 1991, BIOCHEMISTRY-US, V30, P4357, DOI 10.1021/bi00231a035; SOMMERCORN J, 1987, P NATL ACAD SCI USA, V84, P8834, DOI 10.1073/pnas.84.24.8834; SRIVENUGOPAL KS, 1985, BIOCHEMISTRY-US, V24, P4766, DOI 10.1021/bi00339a009; TABET M, 1993, J AM CHEM SOC, V115, P3866, DOI 10.1021/ja00063a002; TRAUGH JA, 1990, ADV SEC MESS PHOSPH, V24, P224; TUAZON PT, 1991, ADV SEC MESS PHOSPH, V23, P123; TUNG HYL, 1985, EUR J BIOCHEM, V149, P305, DOI 10.1111/j.1432-1033.1985.tb08927.x; VOGEL S, 1986, EUR J BIOCHEM, V154, P253, DOI 10.1111/j.1432-1033.1986.tb09390.x; WOLFF J, 1975, J BIOL CHEM, V250, P6897	52	42	44	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17400	17406		10.1074/jbc.270.29.17400	http://dx.doi.org/10.1074/jbc.270.29.17400			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615545	hybrid			2022-12-27	WOS:A1995RK68900057
J	RODRIGUEZ, H; DROUIN, R; HOLMQUIST, GP; OCONNOR, TR; BOITEUX, S; LAVAL, J; DOROSHOW, JH; AKMAN, SA				RODRIGUEZ, H; DROUIN, R; HOLMQUIST, GP; OCONNOR, TR; BOITEUX, S; LAVAL, J; DOROSHOW, JH; AKMAN, SA			MAPPING OF COPPER HYDROGEN PEROXIDE-INDUCED DNA-DAMAGE AT NUCLEOTIDE RESOLUTION IN HUMAN GENOMIC DNA BY LIGATION-MEDIATED POLYMERASE CHAIN-REACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ENDONUCLEASE-III; SITE-SPECIFIC MUTAGENESIS; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; IONIZING-RADIATION; OXIDATIVE DAMAGE; MAMMALIAN CHROMATIN; OXYGEN RADICALS; ION; 8-HYDROXYGUANINE	The ligation-mediated polymerase chain reaction was used to map the frequency of reactive oxygen species-induced DNA damage at nucleotide resolution in genomic DNA purified from cultured human male fibroblasts, Damaged pyrimidine and purine bases were recognized and cleaved by the Nth and Fpg proteins from Escherichia coli, respectively. Strand breaks and modified bases were induced in vitro by copper ion-mediated reduction of hydrogen peroxide in the presence of ascorbate; reactant concentrations were adjusted to induce lesions at a frequency of 1 per 2-3 kilobases in purified genomic DNA. Glyoxal gel analysis demonstrated that the ratio of induced strand breaks to induced base damage was 0.8/2.7 in DNA dialyzed extensively to remove adventitious transition metal ions. Ligation-mediated polymerase chain reaction analysis of the damage frequency in the promoter region of the transcriptionally active phosphoglycerate kinase (PGK 1) gene revealed that Cu(II)/ascorbate/H2O2 caused DNA base damage by a sequence-dependent mechanism, with the 5' bases of d(pG(n)) and d(pC(n)) being damage hot spots, as were the most internal guanines of d(pGGGCCC) and d(pCCCGGG). Since base damage occurs after formation of a DNA-Cu(I)-H2O2 complex, these data suggest that the local DNA sequence affects formation of DNA-Cu(I)-H2O2 complexes and/or the efficiency of base oxidation during resolution of this complex.	CITY HOPE NATL MED CTR, DEPT MED ONCOL & THERAPEUT RES, DUARTE, CA 91010 USA; CITY HOPE NATL MED CTR, BECKMAN RES INST, DIV BIOL, DUARTE, CA 91010 USA; INST GUSTAVE ROUSSY, CNRS, URA 147, F-94805 VILLEJUIF, FRANCE	City of Hope; City of Hope; Beckman Research Institute of City of Hope; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy				O'Connor, Timothy/0000-0001-5848-3592	NCI NIH HHS [CA-53115] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKMAN SA, 1991, MUTAT RES, V261, P123, DOI 10.1016/0165-1218(91)90058-T; AMES BN, 1991, MUTAT RES, V250, P3, DOI 10.1016/0027-5107(91)90157-J; ARUOMA OI, 1991, BIOCHEM J, V273, P601, DOI 10.1042/bj2730601; BASU AK, 1989, P NATL ACAD SCI USA, V86, P7677, DOI 10.1073/pnas.86.20.7677; BOITEUX S, 1992, BIOCHEMISTRY-US, V31, P106, DOI 10.1021/bi00116a016; BRYAN SE, 1976, BIOCHEMISTRY-US, V15, P1667, DOI 10.1021/bi00653a013; CHEVION M, 1988, FREE RADICAL BIO MED, V5, P27, DOI 10.1016/0891-5849(88)90059-7; DIZDAROGLU M, 1991, ARCH BIOCHEM BIOPHYS, V285, P317, DOI 10.1016/0003-9861(91)90366-Q; DIZDAROGLU M, 1992, MUTAT RES, V275, P331, DOI 10.1016/0921-8734(92)90036-O; DIZDAROGLU M, 1991, ARCH BIOCHEM BIOPHYS, V285, P388, DOI 10.1016/0003-9861(91)90378-V; DIZDAROGLU M, 1991, FREE RADICAL BIO MED, V10, P225, DOI 10.1016/0891-5849(91)90080-M; DIZDAROGLU M, 1993, BIOCHEMISTRY-US, V32, P12105, DOI 10.1021/bi00096a022; DROUIN R, 1993, CHROMOSOMAL ABERRATI, P10; FEIG DI, 1994, P NATL ACAD SCI USA, V91, P6609, DOI 10.1073/pnas.91.14.6609; FLOYD RA, 1986, BIOCHEM BIOPH RES CO, V137, P841, DOI 10.1016/0006-291X(86)91156-3; FLOYD RA, 1988, ARCH BIOCHEM BIOPHYS, V262, P266, DOI 10.1016/0003-9861(88)90188-9; FLOYD RA, 1990, FASEB J, V4, P2587, DOI 10.1096/fasebj.4.9.2189775; GAO SW, 1994, SCIENCE, V263, P1438, DOI 10.1126/science.8128226; GEIERSTANGER BH, 1991, J BIOL CHEM, V266, P20185; GOLDSTEIN S, 1986, Journal of Free Radicals in Biology and Medicine, V2, P3, DOI 10.1016/0748-5514(86)90117-0; GUYTON KZ, 1993, BRIT MED BULL, V49, P523, DOI 10.1093/oxfordjournals.bmb.a072628; HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6; HATAHET Z, 1994, J BIOL CHEM, V269, P18814; IZATT RM, 1971, CHEM REV, V71, P439, DOI 10.1021/cr60273a002; JOHN DCA, 1989, BIOCHEM BIOPH RES CO, V165, P1235, DOI 10.1016/0006-291X(89)92734-4; JOHNSON GRA, 1988, J CHEM SOC FARAD T 1, V84, P501, DOI 10.1039/f19888400501; KAGAWA TF, 1991, J BIOL CHEM, V266, P20175; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; KAZAKOV SA, 1988, NATURE, V335, P186, DOI 10.1038/335186a0; KIM J, 1988, NUCLEIC ACIDS RES, V16, P1135, DOI 10.1093/nar/16.3.1135; KOW YW, 1987, BIOCHEMISTRY-US, V26, P8200, DOI 10.1021/bi00399a027; LEVIN JD, 1988, J BIOL CHEM, V263, P8066; LOEB LA, 1988, P NATL ACAD SCI USA, V85, P3918, DOI 10.1073/pnas.85.11.3918; MACCABEE M, 1994, J MOL BIOL, V236, P514, DOI 10.1006/jmbi.1994.1162; MALINS DC, 1993, CANCER-AM CANCER SOC, V71, P3036, DOI 10.1002/1097-0142(19930515)71:10<3036::AID-CNCR2820711025>3.0.CO;2-P; MASARWA M, 1988, J AM CHEM SOC, V110, P4293, DOI 10.1021/ja00221a031; MCBRIDE TJ, 1991, BIOCHEMISTRY-US, V30, P207, DOI 10.1021/bi00215a030; MILNE L, 1993, ARCH BIOCHEM BIOPHYS, V304, P102, DOI 10.1006/abbi.1993.1327; MINCHENKOVA LE, 1967, BIOPOLYMERS, V5, P615, DOI 10.1002/bip.1967.360050703; MORIYA M, 1991, MUTAT RES, V254, P281, DOI 10.1016/0921-8777(91)90067-Y; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; OCONNOR TR, 1989, P NATL ACAD SCI USA, V86, P5222, DOI 10.1073/pnas.86.14.5222; OGDEN RC, 1987, METHOD ENZYMOL, V152, P61; PEZZANO H, 1980, CHEM REV, V80, P366; Pfeifer G P, 1993, Methods Mol Biol, V23, P169; PFEIFER GP, 1993, MUTAT RES, V288, P39, DOI 10.1016/0027-5107(93)90206-U; PFEIFER GP, 1992, MOL CELL BIOL, V12, P1798, DOI 10.1128/MCB.12.4.1798; PFEIFER GP, 1991, P NATL ACAD SCI USA, V88, P1374, DOI 10.1073/pnas.88.4.1374; PFEIFER GP, 1989, SCIENCE, V246, P810, DOI 10.1126/science.2814502; PRUTZ WA, 1990, INT J RADIAT BIOL, V58, P215, DOI 10.1080/09553009014551581; SAGRIPANTI JL, 1989, J BIOL CHEM, V264, P1729; SCHNEIDER JE, 1990, NUCLEIC ACIDS RES, V18, P631, DOI 10.1093/nar/18.3.631; SINGERSAM J, 1984, GENE, V32, P409, DOI 10.1016/0378-1119(84)90016-7; STOEWE R, 1987, FREE RADICAL BIO MED, V3, P97, DOI 10.1016/S0891-5849(87)80003-5; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; TKESHELASHVILI LK, 1991, J BIOL CHEM, V266, P6401; TORNALETTI S, 1993, ONCOGENE, V8, P2051; TORNALETTI S, 1994, SCIENCE, V263, P1436, DOI 10.1126/science.8128225; WEITZMAN SA, 1990, BLOOD, V76, P655; Willis C E, 1988, Appl Theor Electrophor, V1, P11; WOOD ML, 1990, BIOCHEMISTRY-US, V29, P7024, DOI 10.1021/bi00482a011; YAMAMOTO K, 1989, J BIOL CHEM, V264, P15435; YAMAMOTO K, 1992, CHEM RES TOXICOL, V5, P440, DOI 10.1021/tx00027a019	63	88	93	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17633	17640		10.1074/jbc.270.29.17633	http://dx.doi.org/10.1074/jbc.270.29.17633			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615572	hybrid			2022-12-27	WOS:A1995RK68900089
J	GUO, B; BROWN, FM; PHILLIPS, JD; YU, Y; LEIBOLD, EA				GUO, B; BROWN, FM; PHILLIPS, JD; YU, Y; LEIBOLD, EA			CHARACTERIZATION AND EXPRESSION OF IRON REGULATORY PROTEIN-2 (IRP2) - PRESENCE OF MULTIPLE IRP2, TRANSCRIPTS REGULATED BY INTRACELLULAR IRON LEVELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING-PROTEIN; FERRITIN MESSENGER-RNA; TRANSFERRIN RECEPTOR EXPRESSION; RESPONSIVE ELEMENT; SULFUR CLUSTER; UNTRANSLATED REGION; CYTOSOLIC ACONITASE; PROCESSING FACTOR; PURIFICATION; CLONING	Iron regulatory proteins (IRP1 and IRP2) are RNA-binding proteins that bind to stem-loop structures, termed iron-responsive elements (IREs), present in either the 5'- or 3'-untranslated regions of specific mRNAs. The binding of IRPs to 5'-IREs inhibits translation of mRNA, whereas the binding of IRPs to 3'-IREs stabilizes mRNA. To study the structure and regulation of IRP2, we isolated cDNAs for rat and human IRP2. The derived amino acid sequence of rat IPR2 is 93% identical with that of human IRP2 and is present in lower eukaryotes, indicating that IRP2 is highly conserved, IRP1 and IRP2 share 61% overall amino acid identity, IRP2 is ubiquitously expressed in rat tissues, the highest amounts present in skeletal muscle and heart, IRP2 is encoded by multiple mRNAs of 6.4, 4.0, and 3.7 kilobases, The 3'-untranslated region of rat IRP2 contains multiple polyadenylation signals, two of which could account for the 4.0 kb and 3.7-kb mRNAs, The 3.7-kb mRNA is increased in iron-depleted cells and occurs with a reciprocal decrease in the 6.4-kb transcript, These data suggest that the 3.7-kb mRNA is produced by alternative poly(A) site utilization in iron-depleted cells.	UNIV UTAH,DEPT MED,SALT LAKE CITY,UT 84112; UNIV UTAH,ECCLES PROGRAM HUMAN MOLEC BIOL & GENET,SALT LAKE CITY,UT 84112	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah					NCI NIH HHS [CA4201] Funding Source: Medline; NIGMS NIH HHS [GM45201] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045201] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASILION JP, 1994, P NATL ACAD SCI USA, V91, P574, DOI 10.1073/pnas.91.2.574; BHASKER CR, 1993, J BIOL CHEM, V268, P12699; BINDER R, 1994, EMBO J, V13, P1969, DOI 10.1002/j.1460-2075.1994.tb06466.x; CAIRO G, 1994, J BIOL CHEM, V269, P6405; CAIRO G, 1994, J BIOL CHEM, V270, P700; CASEY JL, 1989, EMBO J, V8, P3693, DOI 10.1002/j.1460-2075.1989.tb08544.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COX LA, 1993, BIOCHEMISTRY-US, V32, P4738, DOI 10.1021/bi00069a007; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GOOSSEN B, 1990, EMBO J, V9, P4127, DOI 10.1002/j.1460-2075.1990.tb07635.x; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; GUO B, 1994, J BIOL CHEM, V269, P24252; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P7536, DOI 10.1073/pnas.89.16.7536; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; HENDERSON BR, 1994, J BIOL CHEM, V268, P27327; KAPTAIN S, 1991, P NATL ACAD SCI USA, V88, P10109, DOI 10.1073/pnas.88.22.10109; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; LEIBOLD EA, 1992, ANNU REV NUTR, V12, P345, DOI 10.1146/annurev.nu.12.070192.002021; MANN KP, 1993, MOL CELL BIOL, V13, P2411, DOI 10.1128/MCB.13.4.2411; MCLAUCHLAN J, 1989, CELL, V59, P1093, DOI 10.1016/0092-8674(89)90765-4; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; NEUPERT B, 1990, NUCLEIC ACIDS RES, V18, P51, DOI 10.1093/nar/18.1.51; PATINO MM, 1992, J BIOL CHEM, V267, P19011; PETERSON ML, 1994, MOL CELL BIOL, V14, P7891, DOI 10.1128/MCB.14.12.7891; PHILPOTT CC, 1994, P NATL ACAD SCI USA, V91, P7321, DOI 10.1073/pnas.91.15.7321; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; ROBBINS AH, 1989, PROTEINS, V5, P289, DOI 10.1002/prot.340050406; ROTHENBERGER S, 1990, NUCLEIC ACIDS RES, V18, P1175, DOI 10.1093/nar/18.5.1175; ROUAULT TA, 1988, SCIENCE, V241, P1207, DOI 10.1126/science.3413484; ROUAULT TA, 1992, BIOMETALS, V5, P131, DOI 10.1007/BF01061319; ROUAULT TA, 1991, CELL, V64, P881, DOI 10.1016/0092-8674(91)90312-M; ROUAULT TA, 1990, P NATL ACAD SCI USA, V87, P7958, DOI 10.1073/pnas.87.20.7958; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; TANG CK, 1992, J BIOL CHEM, V267, P24466; THEIL EC, 1993, BIOFACTORS, V4, P87; WALDEN WE, 1989, J BIOL CHEM, V264, P13765; WICKENS M, 1990, TRENDS BIOCHEM SCI, V15, P277, DOI 10.1016/0968-0004(90)90054-F; YU Y, 1992, J BIOL CHEM, V267, P19005; ZHENG LM, 1992, ARCH BIOCHEM BIOPHYS, V299, P356, DOI 10.1016/0003-9861(92)90287-7; ZHENG LM, 1990, J BIOL CHEM, V265, P2814	43	111	118	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16529	16535		10.1074/jbc.270.28.16529	http://dx.doi.org/10.1074/jbc.270.28.16529			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622457	hybrid			2022-12-27	WOS:A1995RJ34700013
J	SUQUET, C; MITCHELL, DL; SMERDON, MJ				SUQUET, C; MITCHELL, DL; SMERDON, MJ			REPAIR OF UV-INDUCED (6-4) PHOTOPRODUCTS IN NUCLEOSOME CORE DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HUMAN-CELLS; PYRIMIDINE(6-4)PYRIMIDONE PHOTOPRODUCTS; CYCLOBUTANE DIMERS; PYRIMIDINE DIMERS; ESCHERICHIA-COLI; HUMAN CHROMATIN; ULTRAVIOLET; DAMAGE; (6-4)PHOTOPRODUCTS; BINDING	Using radioimmunoassays, we examined rates of removal of UV-induced pyrimidine-pyrimidone (6-4) photoproducts ((6-4)PDs) and cyclobutane pyrimidine dimers (CPDs) from 146-base pair nucleosome core DNA (and 166-base pair chromatosome DNA) of confluent human diploid fibroblasts. Dose-response experiments indicate that the yield of (6-4)PDs in core DNA is about 30% that of CPDs in the UV dose range of 0-200 J/m(2). Repair experiments indicate that, at 40 J/m(2), (6-4)PDs are removed much faster (similar to 75% in 2 h) from nucleosome core (and chromatosome) DNA than CPDs (10-15% in 2 h). A slow rate of removal of CPDs is also observed when the UV dose is reduced to 10 J/m(2) (i.e. even when the level of CPDs is less than that of (6-4)PDs at 40 J/m(2)). These results indicate that (a) the accessibility of repair proteins to (6-4)PDs in nucleosomes is markedly different than their accessibility to CPDs and/or (b) repair enzymes are much more efficient at incising and removing (6-4)PDs than CPDs in human chromatin.	UNIV TEXAS,MD ANDERSON CANC CTR,SMITHVILLE,TX 78957	University of Texas System; UTMD Anderson Cancer Center	SUQUET, C (corresponding author), WASHINGTON STATE UNIV,DEPT BIOCHEM & BIOPHYS,PULLMAN,WA 99164, USA.				NIEHS NIH HHS [ES05914, ES02614] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES002614, R01ES002614] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ARMSTRONG JD, 1992, MUTAT RES, V268, P83, DOI 10.1016/0027-5107(92)90086-H; Bohr VA, 1988, DNA REPAIR LABORATOR, V3, P347; BRASH DE, 1988, PHOTOCHEM PHOTOBIOL, V48, P59; CADET J, 1992, J PHOTOCH PHOTOBIO B, V15, P277, DOI 10.1016/1011-1344(92)85135-H; FRIEDBERG EC, 1994, MUTAT RES, V307, P5, DOI 10.1016/0027-5107(94)90272-0; GALE JM, 1987, P NATL ACAD SCI USA, V84, P6644, DOI 10.1073/pnas.84.19.6644; GALE JM, 1990, PHOTOCHEM PHOTOBIOL, V51, P411, DOI 10.1111/j.1751-1097.1990.tb01732.x; GALE JM, 1988, J MOL BIOL, V204, P949, DOI 10.1016/0022-2836(88)90054-X; HANAWALT P, 1993, CURR BIOL, V3, P67, DOI 10.1016/0960-9822(93)90156-I; Harm W, 1980, BIOL EFFECTS ULTRAVI; HOLBROOK SR, 1988, REV CHEM INTERMED, V10, P71, DOI 10.1007/BF03158339; JENSEN KA, 1990, BIOCHEMISTRY-US, V29, P4773, DOI 10.1021/bi00472a005; LAN SY, 1985, BIOCHEMISTRY-US, V24, P7771, DOI 10.1021/bi00347a041; Marzluff W. F., 1984, TRANSCRIPTION TRANSL, P89; MITCHELL DL, 1990, J INVEST DERMATOL, V95, P55, DOI 10.1111/1523-1747.ep12873312; MITCHELL DL, 1990, NUCLEIC ACIDS RES, V18, P963, DOI 10.1093/nar/18.4.963; MITCHELL DL, 1985, MUTAT RES, V143, P109, DOI 10.1016/S0165-7992(85)80018-X; MITCHELL DL, 1981, BIOCHIM BIOPHYS ACTA, V655, P54, DOI 10.1016/0005-2787(81)90066-6; MITCHELL DL, 1990, J BIOL CHEM, V265, P5353; MITCHELL DL, 1989, PHOTOCHEM PHOTOBIOL, V49, P805, DOI 10.1111/j.1751-1097.1989.tb05578.x; MULLENDERS LHF, 1993, MUTAT RES, V299, P271, DOI 10.1016/0165-1218(93)90103-K; NIGGLI HJ, 1982, BIOCHEM BIOPH RES CO, V105, P1215, DOI 10.1016/0006-291X(82)91098-1; PEHRSON JR, 1992, NUCLEIC ACIDS RES, V20, P1321, DOI 10.1093/nar/20.6.1321; PFEIFER GP, 1992, MOL CELL BIOL, V12, P1798, DOI 10.1128/MCB.12.4.1798; REARDON JT, 1993, J BIOL CHEM, V268, P21301; SIDIK K, 1990, CANCER RES, V50, P1613; SMERDON MJ, 1978, BIOCHEMISTRY-US, V17, P2377, DOI 10.1021/bi00605a020; SMERDON MJ, 1982, J BIOL CHEM, V257, P13441; SMERDON MJ, 1989, DNA REPAIR MECHANISM, V182, P271; SUQUET C, 1993, J BIOL CHEM, V268, P23755; SZYMKOWSKI DE, 1993, P NATL ACAD SCI USA, V90, P9823, DOI 10.1073/pnas.90.21.9823; TAYLOR JS, 1988, BIOCHEMISTRY-US, V27, P7206, DOI 10.1021/bi00419a007; TODO T, 1993, NATURE, V361, P371, DOI 10.1038/361371a0; WANG YC, 1993, MOL CELL BIOL, V13, P4276, DOI 10.1128/MCB.13.7.4276	34	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16507	16509		10.1074/jbc.270.28.16507	http://dx.doi.org/10.1074/jbc.270.28.16507			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622452	hybrid			2022-12-27	WOS:A1995RJ34700007
J	MCCOLLAM, L; BONFINI, L; KARLOVICH, CA; CONWAY, BR; KOZMA, LM; BANERJEE, U; CZECH, MP				MCCOLLAM, L; BONFINI, L; KARLOVICH, CA; CONWAY, BR; KOZMA, LM; BANERJEE, U; CZECH, MP			FUNCTIONAL ROLES FOR THE PLECKSTRIN AND DBL HOMOLOGY REGIONS IN THE RAS EXCHANGE FACTOR SON-OF-SEVENLESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RECEPTOR TYROSINE KINASES; GENE-PRODUCT; SH3 DOMAINS; GRB2; PROTEIN; BINDING; P21(RAS); SOS1	Activation of p21(ras) by receptor tyrosine kinases is thought to result from recruitment of guanine nucleotide exchange factors such as Son-of-sevenless (Sos) to plasma membrane receptor substrates via adaptor proteins such as Grb2. This hypothesis was tested in the present studies by evaluating the ability of truncation and deletion mutants of Drosophila (d)Sos to enhance [P-32]GTP loading of p21(ras) when expressed in P-32-labeled COS or 293 cells, The dSos catalytic domain (residues 758-1125), expressed without the dSos NH2-terminal (residues 1-757) or adaptor-binding, COOH-terminal (residues 1126-1596) regions, exhibits intrinsic exchange activity as evidenced by its rescue of mutant Saccharomyces cerevisiae deficient in endogenous GTP/GDP exchange activity, Here we show that this dSos catalytic domain fails to affect GTP.p21(ras) levels when expressed in cultured mammalian cells unless the NH2-terminal domain is also present, Surprisingly, the COOH-terminal, adaptor binding domain of dSos was not sufficient to confer p21(ras) exchange activity to the Sos catalytic domain in these cells in the absence of the NH2-terminal domain. This function of promoting catalytic domain activity could be localized by mutational analysis to the pleckstrin and Dbl homology sequences located just NH2-terminal to the catalytic domain, The results demonstrate a functional role for these pleckstrin and Dbl domains within the dsos protein, and suggest the presence of unidentified cellular elements that interact with these domains and participate in the regulation of p21(ras).	UNIV MASSACHUSETTS,MED CTR,DEPT BIOCHEM & MOLEC BIOL,WORCESTER,MA 01605; UNIV CALIF LOS ANGELES,DEPT BIOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024	University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	MCCOLLAM, L (corresponding author), UNIV MASSACHUSETTS,MED CTR,PROGRAM MOLEC MED,WORCESTER,MA 01605, USA.				NIDDK NIH HHS [P30DK32520, DK30648] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520, R01DK030648] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; BALTENSPERGER K, 1993, SCIENCE, V260, P1950, DOI 10.1126/science.8391166; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; FARNSWORTH CL, 1991, CELL, V64, P625, DOI 10.1016/0092-8674(91)90246-U; GIBSON TJ, 1994, TRENDS BIOCHEM SCI, V19, P349, DOI 10.1016/0968-0004(94)90108-2; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; JOHNSON GL, 1994, CURR OPIN CELL BIOL, V6, P230, DOI 10.1016/0955-0674(94)90141-4; KARLOVICH CA, 1995, SCIENCE, V268, P576, DOI 10.1126/science.7725106; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; LIU BX, 1993, ONCOGENE, V8, P3081; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MACIAS MJ, 1994, NATURE, V369, P675, DOI 10.1038/369675a0; Mayer Bruce J., 1993, Trends in Cell Biology, V3, P8, DOI 10.1016/0962-8924(93)90194-6; MCCORMICK F, 1994, CURR OPIN GENET DEV, V4, P71, DOI 10.1016/0959-437X(94)90093-0; McCormick Frank, 1994, Trends in Cell Biology, V4, P347, DOI 10.1016/0962-8924(94)90075-2; MEDEMA RH, 1993, CRIT REV ONCOGENESIS, V4, P615; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PORFIRI E, 1994, J BIOL CHEM, V269, P22672; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; SLOAT BF, 1981, J CELL BIOL, V89, P395, DOI 10.1083/jcb.89.3.395; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; WANG W, 1995, IN PRESS NATURE GENE; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; YAO L, 1994, P NATL ACAD SCI USA, V91, P9175, DOI 10.1073/pnas.91.19.9175; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	34	70	72	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15954	15957		10.1074/jbc.270.27.15954	http://dx.doi.org/10.1074/jbc.270.27.15954			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608150	hybrid			2022-12-27	WOS:A1995RH22600011
J	UPTON, T; WILTSHIRE, S; FRANCESCONI, S; EISENBERG, S				UPTON, T; WILTSHIRE, S; FRANCESCONI, S; EISENBERG, S			ABF1 SER-720 IS A PREDOMINANT PHOSPHORYLATION SITE FOR CASEIN KINASE-II OF SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTONOMOUSLY REPLICATING SEQUENCES; SUBSTRATE-SPECIFICITY DETERMINANTS; DNA TOPOISOMERASE-II; CELLULAR-REGULATION; CHROMOSOMAL ORIGIN; MOLECULAR-COMPLEX; PROTEIN-KINASES; BETA-SUBUNIT; YEAST; BINDING	ABF1 is a multifunctional phosphoprotein that binds specifically to yeast origins of replication and to transcriptional regulatory sites of a variety of genes. We isolated a protein kinase from extracts of Saccharomyces cerevisiae on the basis of its ability to specifically phosphorylate the ABF1 protein, physical and biochemical properties of this kinase identify it as casein kinase II (CKII). The purified kinase has a high affinity for the ABF1 substrate as indicated by a relatively low K-m value. Furthermore, when incubated with ABF1 and anti-ABF1 antibodies, the kinase forms an immunocomplex active in the phosphorylation of ABF1. Biochemical and genetic mapping localized a major site for phosphorylation at Ser-720 near the C terminus of the ABF1 protein, This serine is embedded within a domain enriched for acidic amino acid residues. A Ser-720 to Ala mutation abolishes phosphorylation by CKlI in vitro. The same mutation also abolishes phosphorylation of this site in vivo, suggesting that CKII phosphorylates Ser-720 in vivo as well. Although three CKII enzymes, yeast, sea star, and recombinant human, utilize casein as a substrate with similar efficiencies, only the yeast enzyme efficiently phosphorylates the ABF1 protein. This suggests that ABF1 is a specific substrate of the yeast CKII and that this specificity may reside within one of the beta regulatory subunits of the enzyme, Thus, phosphorylation of ABF1 by yeast CKII may prove to be a useful system for studying targeting mechanisms of CKII to a physiological substrate,	UNIV CONNECTICUT,SCH MED,DEPT MICROBIOL,FARMINGTON,CT 06030	University of Connecticut					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046760] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM46760-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOJANOWSKI K, 1993, J BIOL CHEM, V268, P22920; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; BUCHMAN AR, 1990, MOL CELL BIOL, V10, P887, DOI 10.1128/MCB.10.3.887; CARDENAS ME, 1993, J CELL SCI, V104, P219; CARDENAS ME, 1993, J CELL SCI, V104, P533; CARDENAS ME, 1992, EMBO J, V11, P7885; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; DIFFLEY JFX, 1988, P NATL ACAD SCI USA, V85, P2120, DOI 10.1073/pnas.85.7.2120; DORSMAN JC, 1988, NUCLEIC ACIDS RES, V16, P7287, DOI 10.1093/nar/16.15.7287; EISENBERG S, 1988, P NATL ACAD SCI USA, V85, P743, DOI 10.1073/pnas.85.3.743; EISENBERG S, 1979, J BIOL CHEM, V254, P5328; ESTES HG, 1992, P NATL ACAD SCI USA, V89, P11156, DOI 10.1073/pnas.89.23.11156; FEIGE JJ, 1980, FEBS LETT, V121, P139, DOI 10.1016/0014-5793(80)81283-X; FENG L, 1994, MOL CELL BIOL, V14, P5139, DOI 10.1128/MCB.14.8.5139; FILHOL O, 1992, J BIOL CHEM, V267, P20577; FRANCESCONI SC, 1989, MOL CELL BIOL, V9, P2906, DOI 10.1128/MCB.9.7.2906; FRANCESCONI SC, 1991, P NATL ACAD SCI USA, V88, P4089, DOI 10.1073/pnas.88.10.4089; FRANCESCONI SC, 1992, THESIS U CONNECTICUT; GOEL A, 1988, MOL CELL BIOL, V8, P2572, DOI 10.1128/MCB.8.6.2572; GRASSER FA, 1988, VIROLOGY, V165, P13, DOI 10.1016/0042-6822(88)90653-8; HALFTER H, 1989, EMBO J, V8, P3029, DOI 10.1002/j.1460-2075.1989.tb08453.x; HALFTER H, 1989, EMBO J, V8, P4265, DOI 10.1002/j.1460-2075.1989.tb08612.x; HAMIL KG, 1988, MOL CELL BIOL, V8, P4328, DOI 10.1128/MCB.8.10.4328; HATHAWAY GM, 1982, CURR TOP CELL REGUL, V21, P101; ISSINGER OG, 1993, PHARMACOL THERAPEUT, V59, P1, DOI 10.1016/0163-7258(93)90039-G; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KOVARI LZ, 1991, J BACTERIOL, V173, P6332, DOI 10.1128/jb.173.20.6332-6338.1991; KRAAKMAN LS, 1993, MOL GEN GENET, V239, P196, DOI 10.1007/BF00281618; KREK W, 1992, J CELL BIOL, V116, P43, DOI 10.1083/jcb.116.1.43; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; LUSCHER B, 1990, NATURE, V344, P517, DOI 10.1038/344517a0; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; PADMANABHA R, 1987, J BIOL CHEM, V262, P1829; PADMANABHA R, 1990, MOL CELL BIOL, V10, P4089, DOI 10.1128/MCB.10.8.4089; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; PRIGENT C, 1992, EMBO J, V11, P2925, DOI 10.1002/j.1460-2075.1992.tb05362.x; REED JC, 1994, J BIOL CHEM, V269, P18192; RHODE PR, 1992, MOL CELL BIOL, V12, P1064, DOI 10.1128/MCB.12.3.1064; ROUSSOU I, 1994, MOL CELL BIOL, V14, P576, DOI 10.1128/MCB.14.1.576; SAIJO M, 1990, BIOCHEMISTRY-US, V29, P583, DOI 10.1021/bi00454a036; SANDER M, 1984, P NATL ACAD SCI-BIOL, V81, P6938, DOI 10.1073/pnas.81.22.6938; SCHECHTER Y, 1976, BIOCHEMISTRY-US, V15, P5071; SILVE S, 1992, MOL CELL BIOL, V12, P4197, DOI 10.1128/MCB.12.9.4197; Stone K.L., 1992, TECHNIQUES PROTEIN C, P23; SWEDER KS, 1988, J BIOL CHEM, V263, P17270; TAKIO K, 1987, P NATL ACAD SCI USA, V84, P4851, DOI 10.1073/pnas.84.14.4851; TANASIJEVIC MJ, 1993, J BIOL CHEM, V268, P18157; TUAZON PT, 1991, ADV SEC MESS PHOSPH, V23, P124; WALKER SS, 1990, P NATL ACAD SCI USA, V87, P4665, DOI 10.1073/pnas.87.12.4665; WARNER JR, 1973, METHOD ENZYMOL, V194, P423	52	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16153	16159		10.1074/jbc.270.27.16153	http://dx.doi.org/10.1074/jbc.270.27.16153			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608180	hybrid			2022-12-27	WOS:A1995RH22600043
J	WILSON, DM; TAKESHITA, M; GROLLMAN, AP; DEMPLE, B				WILSON, DM; TAKESHITA, M; GROLLMAN, AP; DEMPLE, B			INCISION ACTIVITY OF HUMAN APURINIC ENDONUCLEASE (APE) AT ABASIC SITE ANALOGS IN DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; APYRIMIDINIC ENDONUCLEASE; EXONUCLEASE-III; REPAIR ENZYME; IV; PURIFICATION; EXPRESSION; MECHANISM; CLEAVAGE; APN1	The major apurinic/apyrimidinic (AP) endonuclease of human cells, the Ape protein, incises DNA adjacent to abasic sites to initiate DNA repair and counteract the cytotoxic and mutagenic effects of AP sites. Here we address the determinants of Ape AP endonuclease activity using duplex DNA substrates that contain synthetic analogs of AP sites: tetrahydrofuranyl (F), propanediol (P), ethanediol (E), or 2-(aminobutyl)-1,3-propanediol (Q). The last of these, a branched abasic structure, was a poor substrate for which Ape had k(cat) > 1000-fold lower than for F. In contrast, the specificity constant (k(cat)/K-m) for E or P of Ape purified from HeLa cells was only 5-8-fold lower than for F, Positioning a phosphorothioate ester immediately 5' to F inhibited Ape incision activity 20-fold (Rp isomer) or > 10,000-fold (Sp isomer). Although Ape did not have detectable endonuclease activity toward single-stranded substrates or unmodified double-stranded DNA, the enzyme displayed a low level of 3'-exonuclease activity for duplex DNA (<0.03% of its AP endonuclease activity), which was influenced by the reaction conditions. The base positioned opposite F did not dramatically affect the cleavage efficiency of Ape, but an F:F arrangement was cleaved at approximately one-third of the efficiency of F:C. A 3'-mismatch diminished P and E cleavage only slightly and F not at all. A 5'-mismatch reduced the Ape cleavage rate 4-10-fold for F and similar to 100-fold for P and E. A series of substrates with F at different positions along the oligonucleotide showed that Ape requires greater than or equal to 4 base pairs 5' to the abasic site and greater than or equal to 3 base pairs on the 3'-side. The implications of these results for substrate recognition by Ape are discussed.	HARVARD UNIV,SCH PUBL HLTH,DEPT MOLEC & CELLULAR TOXICOL,BOSTON,MA 02115; SUNY STONY BROOK,DEPT PHARMACOL SCI,STONY BROOK,NY 11794	Harvard University; Harvard T.H. Chan School of Public Health; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook			Wilson, David M/AAK-5409-2021	Wilson, David M/0000-0002-8945-0395	NATIONAL CANCER INSTITUTE [R37CA017395, R01CA017395, P01CA047995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040000] Funding Source: NIH RePORTER; NCI NIH HHS [CA47995, CA17395] Funding Source: Medline; NIGMS NIH HHS [GM40000] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHEN DS, 1991, NUCLEIC ACIDS RES, V19, P5907, DOI 10.1093/nar/19.21.5907; CUNNINGHAM RP, 1986, J BACTERIOL, V168, P1120, DOI 10.1128/jb.168.3.1120-1127.1986; DEMPLE B, 1986, P NATL ACAD SCI USA, V83, P7731, DOI 10.1073/pnas.83.20.7731; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; DEMPLE B, 1991, P NATL ACAD SCI USA, V88, P11450, DOI 10.1073/pnas.88.24.11450; ECKSTEIN F, 1985, ANNU REV BIOCHEM, V54, P367, DOI 10.1146/annurev.bi.54.070185.002055; GILONI L, 1981, J BIOL CHEM, V256, P8608; HARING M, 1994, NUCLEIC ACIDS RES, V22, P2010, DOI 10.1093/nar/22.11.2010; HENNER WD, 1983, J BIOL CHEM, V258, P5198; KANE CM, 1981, J BIOL CHEM, V256, P3405; KUNZ BA, 1994, P NATL ACAD SCI USA, V91, P8165, DOI 10.1073/pnas.91.17.8165; LEVIN JD, 1991, J BIOL CHEM, V266, P22893; LEVIN JD, 1990, NUCLEIC ACIDS RES, V18, P5069, DOI 10.1093/nar/18.17.5069; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; LINDAHL T, 1993, NATURE, V363, P709; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; NES IF, 1980, EUR J BIOCHEM, V112, P161, DOI 10.1111/j.1432-1033.1980.tb04997.x; POPOFF SC, 1990, P NATL ACAD SCI USA, V87, P4193, DOI 10.1073/pnas.87.11.4193; RAMOTAR D, 1991, MOL CELL BIOL, V11, P4537, DOI 10.1128/MCB.11.9.4537; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P5519, DOI 10.1093/nar/19.20.5519; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P1037; Sambrook J, 1989, MOL CLONING LABORATO; SANDER M, 1993, J BIOL CHEM, V268, P2075; SANDERSON BJS, 1989, BIOCHEMISTRY-US, V28, P3894, DOI 10.1021/bi00435a040; SEKI S, 1992, BIOCHIM BIOPHYS ACTA, V1131, P287, DOI 10.1016/0167-4781(92)90027-W; SEKI S, 1993, INT J BIOCHEM, V25, P53; SEKI S, 1991, BIOCHIM BIOPHYS ACTA, V1079, P57, DOI 10.1016/0167-4838(91)90024-T; STEIGHNER RJ, 1990, P NATL ACAD SCI USA, V87, P8350, DOI 10.1073/pnas.87.21.8350; TAKESHITA M, 1987, J BIOL CHEM, V262, P10171; TAKEUCHI M, 1994, J BIOL CHEM, V269, P21907; Von Sonntag C, 1987, CHEM BASIS RAD BIOL; WALLACE SS, 1988, ENVIRON MOL MUTAGEN, V12, P431, DOI 10.1002/em.2860120411; WEISS B, 1976, J BIOL CHEM, V251, P1896; WINTERS TA, 1994, NUCLEIC ACIDS RES, V22, P1866, DOI 10.1093/nar/22.10.1866; WINTERS TA, 1992, NUCLEIC ACIDS RES, V20, P2573, DOI 10.1093/nar/20.10.2573; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x	37	240	248	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16002	16007		10.1074/jbc.270.27.16002	http://dx.doi.org/10.1074/jbc.270.27.16002			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608159	hybrid			2022-12-27	WOS:A1995RH22600020
J	ZHANG, Z; SUMBILLA, C; LEWIS, D; SUMMERS, S; KLEIN, MG; INESI, G				ZHANG, Z; SUMBILLA, C; LEWIS, D; SUMMERS, S; KLEIN, MG; INESI, G			MUTATIONAL ANALYSIS OF THE PEPTIDE SEGMENT LINKING PHOSPHORYLATION AND CA2+-BINDING DOMAINS IN THE SARCOPLASMIC-RETICULUM CA2+-ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; AMINO-ACID-SEQUENCE; FUNCTIONAL CONSEQUENCES; ADENOSINE-TRIPHOSPHATASE; TRANSMEMBRANE DOMAIN; COMPLEMENTARY-DNA; ESCHERICHIA-COLI; CALCIUM-BINDING; CA2+ TRANSPORT; CA-2+-ATPASE	The sarcoplasmic reticulum ATPase segment extending from the phosphorylation site (Asp-351) to the preceding transmembrane helix M4 (which is involved in Ca2+ binding in conjunction with transmembrane helices M5, M6, and M8) retains a marked sequence homology to the corresponding segments of other cation ATPases. We made 26 point mutations in this segment and found that nonconservative mutations of residues that are homologous in various cation ATPases result in strong inhibition of catalytic and transport function, Mutations of nonhomologous residues to match the corresponding residues of other cation ATPases are not inhibitory and, in some cases, produce higher activity, The inhibitory mutations affect the phosphorylated intermediate turnover, which is associated with the vectorial translocation of bound Ca2+, The same mutations do not affect the kinetics of ATPase activation by Ca2+ following enzyme preincubation with EGTA. This suggests that activation of the phosphoryl transfer reaction by Ca2+ binding and vectorial displacement of bound Ca2+ by enzyme phosphorylation do not occur simply as the forward and reverse directions of the same process, but are linked to distinct structural features of the enzyme, The peptide segment extending from the phosphorylation site in the enzyme extramembranous headpiece through the M4 helix in the membrane-bound region sustains a prominent role in transmission of the phosphorylation signal for displacement of bound Ca2+. A critical structural role of this segment is also demonstrated by the interference of specific mutations with membrane assembly of the expressed protein.			ZHANG, Z (corresponding author), UNIV MARYLAND, SCH MED, DEPT BIOL CHEM, BALTIMORE, MD 21201 USA.				NHLBI NIH HHS [HL27867-13] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL027867] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSEN JP, 1992, J BIOL CHEM, V267, P19383; ANDERSEN JP, 1992, J BIOL CHEM, V267, P2767; ANDERSEN JP, 1989, J BIOL CHEM, V264, P21018; ARGUELLO JM, 1991, J BIOL CHEM, V266, P14627; BASTIDE F, 1973, J BIOL CHEM, V248, P8485; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARKE DM, 1989, J BIOL CHEM, V264, P11246; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; CLARKE DM, 1990, J BIOL CHEM, V265, P22223; DEGANI C, 1973, J BIOL CHEM, V248, P8222; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; GREEN NM, 1992, ACTA PHYSIOL SCAND, V146, P59; GUILLAIN F, 1981, J BIOL CHEM, V256, P6140; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; INESI G, 1994, BIOPHYS J, V66, P554, DOI 10.1016/S0006-3495(94)80872-0; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; INESI G, 1992, J BIOENERG BIOMEMBR, V24, P271; INESI G, 1980, J BIOL CHEM, V255, P3025; Inesi G, 1978, Ann N Y Acad Sci, V307, P224, DOI 10.1111/j.1749-6632.1978.tb41947.x; JURNAK F, 1985, SCIENCE, V230, P32, DOI 10.1126/science.3898365; KARIN NJ, 1989, MOL CELL BIOL, V9, P1978, DOI 10.1128/MCB.9.5.1978; LACOUR TFM, 1985, EMBO J, V4, P2385, DOI 10.1002/j.1460-2075.1985.tb03943.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACLENNAN DH, 1990, BIOPHYS J, V58, P1355, DOI 10.1016/S0006-3495(90)82482-6; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MAEDA M, 1988, BIOCHEM BIOPH RES CO, V157, P203, DOI 10.1016/S0006-291X(88)80033-0; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MARUYAMA K, 1989, J BIOL CHEM, V264, P13038; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; PICKART CM, 1984, J BIOL CHEM, V259, P1629; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; SERRANO R, 1988, BIOCHIM BIOPHYS ACTA, V947, P1, DOI 10.1016/0304-4157(88)90017-2; SHAINSKAYA A, 1994, J BIOL CHEM, V269, P10780; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; SUMBILLA C, 1993, J BIOL CHEM, V268, P21185; SUMIDA M, 1978, J BIOL CHEM, V253, P8772; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TANFORD C, 1982, P NATL ACAD SCI-BIOL, V79, P2882, DOI 10.1073/pnas.79.9.2882; TONG L, 1991, J MOL BIOL, V217, P503, DOI 10.1016/0022-2836(91)90753-S; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; VILSEN B, 1991, J BIOL CHEM, V266, P16157; VILSEN B, 1991, J BIOL CHEM, V266, P18839; VILSEN B, 1989, J BIOL CHEM, V264, P21024; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEBER K, 1969, J BIOL CHEM, V244, P4406; YAMAMOTO T, 1968, J BIOCHEM-TOKYO, V64, P137, DOI 10.1093/oxfordjournals.jbchem.a128873; ZHANG ZY, 1993, FEBS LETT, V335, P261, DOI 10.1016/0014-5793(93)80742-D	54	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16283	16290						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608196				2022-12-27	WOS:A1995RH22600062
J	SAWAI, H; OKAZAKI, T; YAMAMOTO, H; OKANO, H; TAKEDA, Y; TASHIMA, M; SAWADA, H; OKUMA, M; ISHIKURA, H; UMEHARA, H; DOMAE, N				SAWAI, H; OKAZAKI, T; YAMAMOTO, H; OKANO, H; TAKEDA, Y; TASHIMA, M; SAWADA, H; OKUMA, M; ISHIKURA, H; UMEHARA, H; DOMAE, N			REQUIREMENT OF AP-1 FOR CERAMIDE-INDUCED APOPTOSIS IN HUMAN LEUKEMIA HL-60 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; ACTIVATED PROTEIN-KINASE; C-JUN PROTOONCOGENE; TRANSCRIPTIONAL REGULATION; SIGNAL-TRANSDUCTION; BINDING-PROTEINS; GENE-EXPRESSION; FREE SYSTEM; KAPPA-B; DIFFERENTIATION	Ceramide has emerged as a novel lipid mediator in cell proliferation, differentiation, and apoptosis. In this work, we demonstrate that the levels of c-jun mRNA, c-Jun protein, and DNA binding activity of a nuclear transcription factor AP-1 to 12-o-tetradecanoylphorbol 13-acetate responsive elements all increased following treatment with the cell-permeable ceramide, N-acetylsphingosine in human leukemia HL-60 cells, N-Acetylsphingosine (1-10 mu M) increased the levels of c-jun mRNA in a dose-dependent manner, and maximal expression was achieved 1 h after treatment. Increase of c-jun expression treated with 5 mu M N-acetyldihydrosphingosine, which could not induce apoptosis, was one third of that with 5 mu M N-acetylsphingosine. Ceramide-induced growth inhibition and DNA fragmentation were both prevented by treatment with curcumin, 1,7-bis[4-hydroxy-3-methoxy-phenyl]-1,6-heptadiene-3,5-dione (an:inhibitor of AP-1 activation), or antisense oligonucleotides for c-jun. These results suggest that the transcription factor AP-1 is critical for apoptosis in HL-60 cells and that an intracellular sphingolipid mediator, ceramide, modulates a signal transduction inducing apoptosis through AP-1 activation.	OSAKA DENT UNIV,DEPT MED,CYUO KU,OSAKA 540,JAPAN; OSAKA DENT UNIV,DEPT ORAL SURG,CYUO KU,OSAKA 540,JAPAN; KYOTO UNIV,FAC MED,DEPT INTERNAL MED,DIV 1,KYOTO 606,JAPAN	Kyoto University								ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BALLOU LR, 1992, J BIOL CHEM, V267, P20044; BIELAWSKA A, 1993, J BIOL CHEM, V268, P26226; BRACH MA, 1993, MOL CELL BIOL, V13, P4284, DOI 10.1128/MCB.13.7.4284; BRACH MA, 1992, BLOOD, V79, P728; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; CIFONE MG, 1994, J EXP MED, V177, P1547; COLOTTA F, 1992, J BIOL CHEM, V267, P18278; DBAIBO GS, 1993, J BIOL CHEM, V268, P17762; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; DOBROWSKY RT, 1994, SCIENCE, V265, P1596, DOI 10.1126/science.8079174; DRESSLER KA, 1992, SCIENCE, V255, P1715, DOI 10.1126/science.1313189; GAYNOR R, 1991, BLOOD, V77, P2618; GOLDSTONE SD, 1994, ONCOGENE, V9, P2305; HANAZAWA S, 1993, J BIOL CHEM, V268, P9526; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292; JARVIS WD, 1994, P NATL ACAD SCI USA, V91, P73, DOI 10.1073/pnas.91.1.73; KHARBANDA SM, 1990, J CLIN INVEST, V86, P1517, DOI 10.1172/JCI114870; KIM MY, 1991, J BIOL CHEM, V266, P484; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LIU J, 1994, J BIOL CHEM, V269, P3047; LORD KA, 1993, MOL CELL BIOL, V13, P841, DOI 10.1128/MCB.13.2.841; MATHIAS S, 1991, P NATL ACAD SCI USA, V88, P10009, DOI 10.1073/pnas.88.22.10009; MATHIAS S, 1993, SCIENCE, V259, P519, DOI 10.1126/science.8424175; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MOLLINEDO F, 1991, EUR J BIOCHEM, V200, P483, DOI 10.1111/j.1432-1033.1991.tb16208.x; MOLLINEDO F, 1993, BIOCHEM J, V294, P137, DOI 10.1042/bj2940137; MUEGGE K, 1989, SCIENCE, V246, P249, DOI 10.1126/science.2799385; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OGAWA K, 1994, EXP HEMATOL, V22, P45; OKAZAKI T, 1994, J BIOL CHEM, V269, P4070; OKAZAKI T, 1990, J BIOL CHEM, V265, P15823; OKAZAKI T, 1989, J BIOL CHEM, V264, P19067; RAINES MA, 1993, J BIOL CHEM, V268, P14572; RUBIN E, 1992, CANCER RES, V52, P878; RUBIN E, 1991, MOL PHARMACOL, V39, P697; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SHERMAN ML, 1990, J BIOL CHEM, V265, P3320; SHERMAN ML, 1990, P NATL ACAD SCI USA, V87, P5663, DOI 10.1073/pnas.87.15.5663; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; SMITH MJ, 1992, BLOOD, V79, P2107; SU Y, 1994, J BIOL CHEM, V269, P16512; UMEHARA H, 1994, INT IMMUNOL, V6, P1071, DOI 10.1093/intimm/6.7.1071; WU BY, 1989, J BIOL CHEM, V264, P9000; YANG Z, 1983, J BIOL CHEM, V268, P20520	55	183	183	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27326	27331		10.1074/jbc.270.45.27326	http://dx.doi.org/10.1074/jbc.270.45.27326			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592995	hybrid			2022-12-27	WOS:A1995TE58300095
J	FORGE, V; MINTZ, E; CANET, D; GUILLAIN, F				FORGE, V; MINTZ, E; CANET, D; GUILLAIN, F			LUMENAL CA2+ DISSOCIATION FROM THE PHOSPHORYLATED CA2+-ATPASE OF THE SARCOPLASMIC-RETICULUM IS SEQUENTIAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING SITES; ADENOSINE-TRIPHOSPHATASE; BOUND CALCIUM; ATPASE; MECHANISM; AFFINITY; PUMP; CA-2+-ATPASE; FLUORESCENCE; TEMPERATURE	Once two radioactive Ca2+ coming from the cytoplasm are bound to the transport sites of the nonphosphorylated ATPase, excess EGTA induces rapid dissociation of both ions, whereas excess nonradioactive Ca2+ only reaches one of the two bound Ca2+. This difference has been explained assuming that the two Ca2+ sites are in a single file channel in which the superficial Ca2+ is freely exchangeable from the cytoplasm, whereas the deeper Ca2+ is exchangeable only when the superficial site is vacant, The same experiment was done using phosphorylated ATPase to determine whether Ca2+ dissociation toward the lumen is sequential as well, Under conditions that allow ADP-sensitive phosphoenzyme to accumulate (leaky vesicles, 5 degrees C, pH 8, 300 mM KCl), we found the same two pools of Ca2+. Excess EGTA induced dissociation of both ions together with dephosphorylation, Excess nonradioactive Ca2+ induced the exchange of half the radioactive Ca2+ without any effect on the phosphoenzyme level, Our results show a close similarity between the transport sites of the nonphosphorylated and the phosphorylated enzymes, although the orientation, affinities, and dissociation rate constants are different.	CTR ETUD SACLAY,DEPT BIOL CELLULAIRE & MOLEC,BIOPHYS PROT & MEMBRANES SECT,CNRS,UNITE RECH 1290,F-91191 GIF SUR YVETTE,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	FORGE, V (corresponding author), CTR ETUD SACLAY,CEA,F-91191 GIF SUR YVETTE,FRANCE.							ANDERSEN JP, 1994, J BIOL CHEM, V269, P15931; ANDERSEN JP, 1995, FEBS LETT, V359, P101, DOI 10.1016/0014-5793(95)00019-6; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; CUENDA A, 1991, FEBS LETT, V283, P273, DOI 10.1016/0014-5793(91)80606-4; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DUPONT Y, 1982, BIOCHIM BIOPHYS ACTA, V688, P75, DOI 10.1016/0005-2736(82)90580-6; DUPONT Y, 1984, ANAL BIOCHEM, V142, P504, DOI 10.1016/0003-2697(84)90496-2; DUPONT Y, 1976, BIOCHEM BIOPH RES CO, V71, P544, DOI 10.1016/0006-291X(76)90821-4; DUPONT Y, 1980, EUR J BIOCHEM, V109, P231, DOI 10.1111/j.1432-1033.1980.tb04788.x; FORGE V, 1993, J BIOL CHEM, V268, P10953; FORGE V, 1993, J BIOL CHEM, V268, P10961; GUILLAIN F, 1980, J BIOL CHEM, V255, P2072; GUIMARAESMOTTA H, 1980, ARCH BIOCHEM BIOPHYS, V203, P395, DOI 10.1016/0003-9861(80)90192-7; HANEL AM, 1991, BIOCHEMISTRY-US, V30, P11320, DOI 10.1021/bi00111a019; IKEMOTO N, 1974, J BIOL CHEM, V249, P649; INESI G, 1994, BIOPHYS J, V66, P554, DOI 10.1016/S0006-3495(94)80872-0; INESI G, 1987, J BIOL CHEM, V262, P16338; INESI G, 1980, J BIOL CHEM, V255, P3025; NAKAMURA J, 1986, BIOCHIM BIOPHYS ACTA, V870, P495, DOI 10.1016/0167-4838(86)90258-X; ORLOWSKI S, 1991, BIOCHEMISTRY-US, V30, P352, DOI 10.1021/bi00216a007; ORLOWSKI S, 1991, BIOCHEMISTRY-US, V30, P11331, DOI 10.1021/bi00111a020; PETITHORY JR, 1988, BIOCHEMISTRY-US, V27, P5553, DOI 10.1021/bi00415a025; PRAGER R, 1979, EUR J BIOCHEM, V97, P239, DOI 10.1111/j.1432-1033.1979.tb13108.x; SHIGEKAWA M, 1979, J BIOL CHEM, V254, P4726; TAKISAWA H, 1981, NATURE, V290, P271, DOI 10.1038/290271a0; VERJOVSKIALMEID.S, 1977, BIOCHEMISTRY-US, V16, P329; VILSEN B, 1992, J BIOL CHEM, V267, P25739; YAMADA S, 1980, J BIOL CHEM, V255, P3108	28	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18271	18276		10.1074/jbc.270.31.18271	http://dx.doi.org/10.1074/jbc.270.31.18271			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629146	hybrid			2022-12-27	WOS:A1995RM64200021
J	YANO, T; YAGI, T; SLED, VD; OHNISHI, T				YANO, T; YAGI, T; SLED, VD; OHNISHI, T			EXPRESSION AND CHARACTERIZATION OF THE 66-KILODALTON (NQO3) IRON-SULFUR SUBUNIT OF THE PROTON-TRANSLOCATING NADH-QUINONE OXIDOREDUCTASE OF PARACOCCUS-DENITRIFICANS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RES; ATP SYNTHASE COMPLEX; UBIQUINONE OXIDOREDUCTASE; AZOTOBACTER-VINELANDII; ESCHERICHIA-COLI; CROSS-LINKING; F0 SUBUNITS; CLUSTERS; DEHYDROGENASE; PROTEIN	The proton translocating NADH-quinone oxidoreductase (NDH-1) of Paracoccus denitrificans is composed of at least 14 dissimilar subunits which are designated NQO1-14 and contains one noncovalently bound FMN and at least five EPR-visible iron-sulfur clusters (N1a, N1b, N2, N3, and N4) as prosthetic groups. Comparison of the deduced primary structures of the subunits with consensus sequences for the cofactor binding sites has predicted that NQO1, NQO2, NQO3, NQO9, and probably NQO6 subunits are cofactor binding subunits. Previously, we have reported that the NQO2 (25 kDa) subunit was overexpressed as a water-soluble protein in Escherichia coli and was found to ligate a single [2Fe-2S] cluster with rhombic symmetry (g(x,y,z) = 1.92, 1.95, and 2.00) (Yano, T., Sled', V. D., Ohnishi, T., and Yagi, T. (1994) Biochemistry 33, 494-499). In the present study, the NQO3 (66 kDa) subunit, which is equivalent to the 75-kDa subunit of bovine heart Complex I, was overexpressed in E. coli. The expressed NQO3 subunit was found predominantly in the cytoplasmic phase and was purified by ammonium sulfate fractionation and anion-exchange chromatography. The chemical analyses and W-visible and EPR spectroscopic studies showed that the expressed NQO3 subunit contains at least two distinct iron-sulfur clusters: a [2Fe-2S] cluster with axial EPR signals (g(perpendicular to,parallel to) = 1.934 and 2.026, and L(perpendicular to,parallel to) = 1.8 and 3.0 millitesla) and a [4Fe-4S] cluster with rhombic symmetry (g(x,y,z) = 1.892, 1.928, and 2.063, and L(x,y,z) = 2.40, 1.55, and 1.75 millitesla). The midpoint redox potentials of [2Fe-2S] and [4Fe-4S] clusters at pH 8.6 are -472 and -391 mV, respectively. The tetranuclear cluster in the isolated NQO3 subunit is sensitive toward oxidants and converts into [3Fe-4S] form. The assignment of these iron-sulfur clusters to those identified in the P. denitrificans NDH-1 enzyme complex and the possible functional role of the NQO3 subunit is discussed.	UNIV PENN, SCH MED, JOHNSON RES FDN, DEPT BIOCHEM & BIOPHYS, PHILADELPHIA, PA 19104 USA	University of Pennsylvania	YANO, T (corresponding author), SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, DIV BIOCHEM, LA JOLLA, CA 92037 USA.				NCRR NIH HHS [M01RR00833] Funding Source: Medline; NIGMS NIH HHS [R01GM33712, R01GM30376] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712, R01GM030376] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AASA R, 1975, J MAGN RESON, V19, P308, DOI 10.1016/0022-2364(75)90045-1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BELL SH, 1982, FEBS LETT, V142, P143, DOI 10.1016/0014-5793(82)80238-X; BLUM H, 1980, BIOCHIM BIOPHYS ACTA, V621, P9, DOI 10.1016/0005-2795(80)90057-4; CAMMACK R, 1992, ADV INORG CHEM, V38, P281, DOI 10.1016/S0898-8838(08)60066-5; CROUSE BR, 1994, J BIOL CHEM, V269, P21030; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOEG KA, 1962, ARCH BIOCHEM BIOPHYS, V97, P37, DOI 10.1016/0003-9861(62)90041-3; Dutton P L, 1978, Methods Enzymol, V54, P411; FECKE W, 1994, EUR J BIOCHEM, V220, P551, DOI 10.1111/j.1432-1033.1994.tb18655.x; FORGO JK, 1949, ANAL BIOCHEM, V21, P732; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; GOLBECK JH, 1992, ANNU REV PLANT PHYS, V43, P293, DOI 10.1146/annurev.pp.43.060192.001453; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GRAY KA, 1995, IN PRESS ANOXYGENIC; GUIGLIARELLI B, 1985, BIOCHIM BIOPHYS ACTA, V810, P319, DOI 10.1016/0005-2728(85)90216-6; HAN AL, 1988, ARCH BIOCHEM BIOPHYS, V267, P490, DOI 10.1016/0003-9861(88)90055-0; HAN AL, 1989, ARCH BIOCHEM BIOPHYS, V275, P166, DOI 10.1016/0003-9861(89)90360-3; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; HEKMAN C, 1991, J BIOL CHEM, V266, P13564; HEKMAN C, 1991, ARCH BIOCHEM BIOPHYS, V284, P90, DOI 10.1016/0003-9861(91)90268-N; JAWOROWSKI A, 1981, BIOCHEMISTRY-US, V20, P2041, DOI 10.1021/bi00510a047; JOHNSON MK, 1994, ENCY INORGANIC CHEM, P1896; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEIF H, 1995, IN PRESS EUR J BIOCH; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASUI R, 1991, J BIOCHEM-TOKYO, V109, P534, DOI 10.1093/oxfordjournals.jbchem.a123416; MATSUBARA H, 1992, ADV INORG CHEM, V38, P223, DOI 10.1016/S0898-8838(08)60065-3; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MEINHARDT SW, 1987, J BIOL CHEM, V262, P9147; MORGAN TV, 1984, FEBS LETT, V167, P137, DOI 10.1016/0014-5793(84)80848-0; OHNISHI T, 1985, J BIOL CHEM, V260, P2782; OHNISHI T, 1981, J BIOL CHEM, V256, P9216; PATEL SD, 1988, BIOCHEM J, V256, P529, DOI 10.1042/bj2560529; PATEL SD, 1988, BIOCHEM J, V256, P521, DOI 10.1042/bj2560521; PRICE MG, 1989, CELL MOTIL CYTOSKEL, V13, P274, DOI 10.1002/cm.970130406; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER K, 1984, EUR J BIOCHEM, V142, P75, DOI 10.1111/j.1432-1033.1984.tb08252.x; SLED VD, 1994, BIOCHEMISTRY-US, V33, P10069, DOI 10.1021/bi00199a034; THOMSON AJ, 1981, BIOCHIM BIOPHYS ACTA, V637, P423, DOI 10.1016/0005-2728(81)90047-5; TRANBETCKE A, 1990, J BACTERIOL, V172, P2920, DOI 10.1128/jb.172.6.2920-2929.1990; UNEMOTO T, 1993, J BIOENERG BIOMEMBR, V25, P385, DOI 10.1007/BF00762464; WALKER JE, 1992, Q REV BIOPHYS, V25, P253, DOI 10.1017/S003358350000425X; WEIDNER U, 1993, J MOL BIOL, V233, P109, DOI 10.1006/jmbi.1993.1488; XU XM, 1992, BIOCHEMISTRY-US, V31, P6925, DOI 10.1021/bi00145a009; XU XM, 1992, ARCH BIOCHEM BIOPHYS, V296, P40, DOI 10.1016/0003-9861(92)90542-5; XU XM, 1993, BIOCHEMISTRY-US, V32, P968, DOI 10.1021/bi00054a030; XU XM, 1991, BIOCHEMISTRY-US, V30, P8678, DOI 10.1021/bi00099a027; XU XM, 1991, BIOCHEMISTRY-US, V30, P6422, DOI 10.1021/bi00240a012; YAGI T, 1990, BIOCHEMISTRY-US, V29, P5515, DOI 10.1021/bi00475a015; YAGI T, 1993, J BIOENERG BIOMEMBR, V25, P339, DOI 10.1007/BF00762459; YAGI T, 1986, ARCH BIOCHEM BIOPHYS, V250, P302, DOI 10.1016/0003-9861(86)90731-9; YAGI T, 1992, BIOCHIM BIOPHYS ACTA, V1101, P181, DOI 10.1016/S0005-2728(05)80014-3; YAGI T, 1993, BIOCHIM BIOPHYS ACTA, V1141, P1, DOI 10.1016/0005-2728(93)90182-F; YAMAGUCHI M, 1993, BIOCHEMISTRY-US, V32, P1935, DOI 10.1021/bi00059a008; YANO T, 1994, FEBS LETT, V354, P160, DOI 10.1016/0014-5793(94)01107-9; YANO T, 1994, BIOCHEMISTRY-US, V33, P494, DOI 10.1021/bi00168a014	58	52	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18264	18270		10.1074/jbc.270.31.18264	http://dx.doi.org/10.1074/jbc.270.31.18264			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629145	hybrid			2022-12-27	WOS:A1995RM64200020
J	BELLIS, SL; MILLER, JT; TURNER, CE				BELLIS, SL; MILLER, JT; TURNER, CE			CHARACTERIZATION OF TYROSINE PHOSPHORYLATION OF PAXILLIN IN-VITRO BY FOCAL ADHESION KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-TRANSFORMED CELLS; SWISS 3T3 CELLS; EXTRACELLULAR-MATRIX; SH3 DOMAINS; PROTEIN; IDENTIFICATION; FIBRONECTIN; VASOPRESSIN; PP125FAK; BOMBESIN	The concomitant tyrosine phosphorylation of the focal adhesion protein, paxillin, and the tyrosine kinase, focal adhesion kinase (FAK), in response to multiple stimuli including integrin-mediated cell adhesion suggests that paxillin phosphorylation is closely coupled to FAK activity. In the present study, we have identified a specific tyrosine residue within paxillin, tyrosine 118 (Tyr-118), that represents the principle site of phospho rylation by FAK in vitro. The identification of this site as a target for FAK phosphorylation was accomplished by immunoprecipitating FAK and performing in vitro kinase assays, using as substrate either glutathione S-transferase (GST)-paxillin fusion proteins containing truncations in paxillin sequence or fusion proteins with phenylalanine substitutions for tyrosine residues. GST-paxillin containing a phenylalanine substitution at Tyr-118 (Y118F) was not phosphorylated by FAK immunoprecipitates; however, this mutant was shown to bind FAK equally as well as the wild type fusion protein. As a first step toward assessing the function of paxillin phosphorylation on Tyr-118, a Y118F paxillin cDNA construct was transiently transfected into NIH 3T3 cells. Similar to wild type paxillin, mutated paxillin localized to focal adhesions, indicating that the phosphorylation of paxillin on Tyr-118 is not essential for the recruitment of paxillin to sites of cell adhesion.	SUNY HLTH SCI CTR, DEPT ANAT & CELL BIOL, SYRACUSE, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047607, R29GM047607] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM047607, GM47607] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BIRGE RB, 1993, MOL CELL BIOL, V13, P4648, DOI 10.1128/MCB.13.8.4648; BOCKHOLT SM, 1993, J BIOL CHEM, V268, P14565; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Damsky CH, 1991, CURR OPIN CELL BIOL, V3, P777, DOI 10.1016/0955-0674(91)90049-5; GAZIT A, 1989, J MED CHEM, V32, P2344, DOI 10.1021/jm00130a020; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; GUAN JL, 1991, CELL REGUL, V2, P951, DOI 10.1091/mbc.2.11.951; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; MUSACCHIO A, 1994, PROG BIOPHYS MOL BIO, V61, P283, DOI 10.1016/0079-6107(94)90003-5; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; RANKIN S, 1994, J BIOL CHEM, V269, P704; ROHRSCHNEIDER LR, 1980, P NATL ACAD SCI-BIOL, V77, P3514, DOI 10.1073/pnas.77.6.3514; ROMER LH, 1994, MOL BIOL CELL, V5, P349, DOI 10.1091/mbc.5.3.349; SALGIA R, 1995, J BIOL CHEM, V270, P5039, DOI 10.1074/jbc.270.10.5039; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schaller Michael D., 1993, Trends in Cell Biology, V3, P258, DOI 10.1016/0962-8924(93)90053-4; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P27610; SEUFFERLEIN T, 1994, J BIOL CHEM, V269, P9345; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOLOWSKA J, 1989, J CELL BIOL, V109, P853, DOI 10.1083/jcb.109.2.853; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURNER CE, 1995, J CELL SCI, V108, P333; TURNER CE, 1993, J CELL SCI, V105, P637; TURNER CE, 1991, J CELL BIOL, V115, P201, DOI 10.1083/jcb.115.1.201; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; TURNER CE, 1994, J CELL SCI, V107, P1583; TURNER CE, 1994, BIOESSAYS, V16, P47, DOI 10.1002/bies.950160107; Turner CE, 1991, CURR OPIN CELL BIOL, V3, P849, DOI 10.1016/0955-0674(91)90059-8; Van Der Geer P., 1993, PROTEIN PHOSPHORYLAT, P31; WENG ZG, 1993, J BIOL CHEM, V268, P14956; ZACHARY I, 1993, J BIOL CHEM, V268, P22060; ZACHARY I, 1992, J BIOL CHEM, V267, P19031; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	43	297	298	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17437	17441		10.1074/jbc.270.29.17437	http://dx.doi.org/10.1074/jbc.270.29.17437			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615549	hybrid			2022-12-27	WOS:A1995RK68900062
J	CALLAHAN, SM; CORNELL, NW; DUNLAP, PV				CALLAHAN, SM; CORNELL, NW; DUNLAP, PV			PURIFICATION AND PROPERTIES OF PERIPLASMIC 3'/5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE - A NOVEL ZINC-CONTAINING ENZYME FROM THE MARINE SYMBIOTIC BACTERIUM VIBRIO-FISCHERI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; DICTYOSTELIUM-DISCOIDEUM; PROTEINS; BINDING; RELEASE	The 3':5'-cyclic nucleotide phosphodiesterase (CNP) of Vibrio fischeri, due to its unusual location in the periplasm, allows this symbiotic bacterium to utilize extracellular 3':5'-cyclic nucleotides (e.g. cAMP) as sole sources of carbon and energy, nitrogen, and phosphorus for growth. The enzyme was purified to apparent homogeneity by a four-step procedure: chloroform shock, ammonium sulfate precipitation, and chromotography on DEAE-Sephacel and Cibacron Blue 3GA-agarose. The active enzyme consists of a single polypeptide with a mass of 34 kDa. At 25 degrees C, it has a pH optimum of 8.25, a K-m for cAMP of 73 mu m, and a V-max of 3700 mu mol of cAMP hydrolyzed/min/mg protein (turnover number of 1.24 x 10(5)/min). The specific activity of the V. fischeri enzyme is approximately 20-fold greater than that of any previously characterized CNP when comparisons of activity are made at the same assay temperature. Activity increases with temperature up to 60 degrees C. The CNP contains 2 atoms of zinc/monomer, and zinc, copper, magnesium, and calcium can restore activity of the apoenzyme 60 varying degrees. The exceptional specific activity of the enzyme and its unusual location in the periplasm support proposals that the enzyme enables the bacterium to scavenge 3':5'-cyclic nucleotides in seawater and that the enzyme plays a role in cAMP-mediated host-symbiont interactions.	WOODS HOLE OCEANOG INST,REDFIELD LAB,DEPT BIOL,WOODS HOLE,MA 02543; MARINE BIOL LAB,WOODS HOLE,MA 02543	Woods Hole Oceanographic Institution; Marine Biological Laboratory - Woods Hole								AMES GF, 1984, J BACTERIOL, V160, P1181, DOI 10.1128/JB.160.3.1181-1183.1984; AMMERMAN JW, 1981, MAR ECOL PROG SER, V5, P85, DOI 10.3354/meps005085; Beavo J., 1990, CYCLIC NUCLEOTIDE PH, P3; Bertini I., 1986, ZINC ENZYMES, P27; BOTSFORD JL, 1992, MICROBIOL REV, V56, P100, DOI 10.1128/MMBR.56.1.100-122.1992; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUTCHER RW, 1962, J BIOL CHEM, V237, P1244; CHASIN M, 1972, METHODS CYCLIC NUCLE, P169; CORNELL NW, 1972, ANAL BIOCHEM, V47, P203, DOI 10.1016/0003-2697(72)90293-X; Dunlap P.V., 1991, MICROBIAL CELL CELL, P219; DUNLAP PV, 1993, J BACTERIOL, V175, P4615, DOI 10.1128/JB.175.15.4615-4624.1993; DUNLAP PV, 1992, J GEN MICROBIOL, V138, P115, DOI 10.1099/00221287-138-1-115; DVORAK HF, 1968, J BIOL CHEM, V243, P2647; FERSHT A, 1984, ENZYME STRUCTURE MEC, P156; FERSHT A, 1984, ENZYME STRUCTURE MEC, P152; FRANCKO DA, 1989, J PHYCOL, V25, P300, DOI 10.1111/j.1529-8817.1989.tb00126.x; HANSEN RS, 1982, P NATL ACAD SCI-BIOL, V79, P2788, DOI 10.1073/pnas.79.9.2788; HOFSTEE BHJ, 1952, SCIENCE, V116, P329, DOI 10.1126/science.116.3013.329; HORECKER BL, 1948, J BIOL CHEM, V175, P385; Jaffe E. K., 1993, COMMENTS INORG CHEM, V15, P67; KESSIN RH, 1979, P NATL ACAD SCI USA, V76, P5450, DOI 10.1073/pnas.76.11.5450; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBIODA L, 1991, BIOCHEMISTRY-US, V30, P2823, DOI 10.1021/bi00225a013; LONDESBOROUGH J, 1983, J BIOL CHEM, V258, P2966; MANNERVIK B, 1986, ZINC ENZYMES, P517; MATIN A, 1982, J BACTERIOL, V149, P801, DOI 10.1128/JB.149.3.801-807.1982; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; OKABAYASHI T, 1970, BIOCHIM BIOPHYS ACTA, V220, P116, DOI 10.1016/0005-2744(70)90235-4; ORLOW SJ, 1981, J BIOL CHEM, V256, P7620; PLOCKE DJ, 1962, BIOCHEMISTRY-US, V1, P373, DOI 10.1021/bi00909a001; REICH KA, 1994, J BACTERIOL, V176, P3085, DOI 10.1128/JB.176.10.3085-3088.1994; RUBY EG, 1992, J BACTERIOL, V174, P4865, DOI 10.1128/JB.174.15.4865-4870.1992; RUBY EG, 1976, BIOL BULL, V151, P574, DOI 10.2307/1540507; SCHAAP P, 1991, MICROBIAL CELL CELL, P147; Sharp GWG, 1971, NATURE, V229, P266, DOI 10.1038/229266a0; ULLMANN A, 1983, ADV CYCL NUCL RES<D>, V15, P1	36	47	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17627	17632		10.1074/jbc.270.29.17627	http://dx.doi.org/10.1074/jbc.270.29.17627			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615571	hybrid			2022-12-27	WOS:A1995RK68900088
J	XING, LP; GOPAL, VK; QUINN, PG				XING, LP; GOPAL, VK; QUINN, PG			CAMP RESPONSE ELEMENT-BINDING PROTEIN (CREB) INTERACTS WITH TRANSCRIPTION FACTOR-IIB AND FACTOR-IID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA POLYMERASE-II; CYCLIC-AMP; FACTOR-TFIIB; PREINITIATION COMPLEX; ACCURATE INITIATION; ACTIVATION DOMAIN; NUCLEAR-PROTEIN; MINIMAL SET; FACTOR ATF; BASAL	cAMP response element-binding protein (CREB) participates in both constitutive and cAMP-induced transcription of cAMP-responsive genes. CREB-mediated constitutive transcription requires only CREB-binding sites and a minimal promoter region (containing the TATA through start sequences), indicating that CREB interacts directly with components of the general transcription machinery. In this study, a coimmunoprecipitation assay was used to test for interaction of CREB with the general transcription factors (TF) TFIIB and TFIID and the core component of TFIID, TATA-binding protein (TBP). Human TFIIB and TBP, tagged with distinct epitopes (eTFIIB and eTBP), were expressed in and purified from Escherichia coli, and holo-eTFIID, containing eTBP, was obtained from the HeLa cell line LTR alpha 3. S-35-Labeled CREB, synthesized in vitro and incubated with eTFIIB, was coimmunoprecipitated with antibody recognizing eTFIIB, indicating that CREB spe cifically binds to TFIIB. S-35-CREB was coimmunoprecipitated with antibody against eTBP, but only when incubated with the holo eTFIID complex, not with eTBP alone. TFIIB interacted with TBP, but CREB was not coprecipitated with the eTBP antibody when incubated with eTBP plus TFIIB, so CREB did not form a stable ternary complex with TFIIB and TBP. Conversely, depletion of TFIIB from the holo-TFIID preparation did not diminish the level of interaction between CBEB and TFIID. Thus, CREB interacts independently with TFIIB and TFIID, but not directly with TBP. A protein kinase A phosphorylation site mutant of CREB and wild-type CREB exhibited equivalent interaction with TFIIB, indicating that this phosphorylation is not required. Consistent with the role of CREB in promoting constitutive or basal transcription, the constitutive activation domain of CREB was sufficient for interaction with both TFIIB and TFIID.	PENN STATE UNIV, COLL MED, DEPT CELLULAR & MOLEC PHYSIOL, HERSHEY, PA 17033 USA; PENN STATE UNIV, COLL MED, PROGRAM CELL & MOLEC BIOL, HERSHEY, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043871] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 43871] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; BRINDLE P, 1993, NATURE, V364, P821, DOI 10.1038/364821a0; BROU C, 1993, EMBO J, V12, P489, DOI 10.1002/j.1460-2075.1993.tb05681.x; BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7; CHOY B, 1993, NATURE, V366, P531, DOI 10.1038/366531a0; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; DAVISON BL, 1983, NATURE, V301, P680, DOI 10.1038/301680a0; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; FERRERI K, 1994, P NATL ACAD SCI USA, V91, P1210, DOI 10.1073/pnas.91.4.1210; FIRE A, 1984, J BIOL CHEM, V259, P2509; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GOODRICH JA, 1993, CELL, V75, P519, DOI 10.1016/0092-8674(93)90386-5; HAI T, 1988, CELL, V54, P1043, DOI 10.1016/0092-8674(88)90119-5; HISATAKE K, 1993, NATURE, V363, P744, DOI 10.1038/363744a0; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; HORIKOSHI M, 1988, CELL, V54, P1033, DOI 10.1016/0092-8674(88)90118-3; HORIKOSHI N, 1991, P NATL ACAD SCI USA, V88, P5124, DOI 10.1073/pnas.88.12.5124; HURST HC, 1990, MOL CELL BIOL, V10, P6192, DOI 10.1128/MCB.10.12.6192; ING NH, 1992, J BIOL CHEM, V267, P17617; KAO CC, 1990, SCIENCE, V248, P1646, DOI 10.1126/science.2194289; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; LEE CQ, 1990, EMBO J, V9, P4455, DOI 10.1002/j.1460-2075.1990.tb07896.x; LEE WS, 1991, CELL, V67, P365, DOI 10.1016/0092-8674(91)90188-5; LIEBERMAN PM, 1991, GENE DEV, V5, P2441, DOI 10.1101/gad.5.12b.2441; LIN YS, 1991, CELL, V64, P971, DOI 10.1016/0092-8674(91)90321-O; LIN YS, 1991, NATURE, V353, P569, DOI 10.1038/353569a0; MALIK S, 1993, MOL CELL BIOL, V13, P6253, DOI 10.1128/MCB.13.10.6253; MATSUI T, 1980, J BIOL CHEM, V255, P1992; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; PUGH BF, 1992, J BIOL CHEM, V267, P679; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; QUINN PG, 1988, MOL CELL BIOL, V8, P3467, DOI 10.1128/MCB.8.8.3467; QUINN PG, 1993, J BIOL CHEM, V268, P16999; RAPOPORT SM, 1986, RETICULOCYTE; ROBERTS SGE, 1993, NATURE, V363, P741, DOI 10.1038/363741a0; RUPPERT S, 1993, NATURE, V362, P15; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; SMITH CA, 1993, J VIROL, V67, P4676, DOI 10.1128/JVI.67.8.4676-4687.1993; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; TYREE CM, 1993, GENE DEV, V7, P1254, DOI 10.1101/gad.7.7a.1254; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; XING LP, 1993, MOL ENDOCRINOL, V7, P1484, DOI 10.1210/me.7.11.1484; XING LP, 1994, J BIOL CHEM, V269, P28732; ZHOU Q, 1992, GENE DEV, V6, P1964, DOI 10.1101/gad.6.10.1964	48	45	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17488	17493		10.1074/jbc.270.29.17488	http://dx.doi.org/10.1074/jbc.270.29.17488			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615553	hybrid			2022-12-27	WOS:A1995RK68900068
J	EMILSSON, V; NILSSON, L				EMILSSON, V; NILSSON, L			FACTOR FOR INVERSION STIMULATION-DEPENDENT GROWTH-RATE REGULATION OF SERINE AND THREONINE TRANSFER-RNA SPECIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA SYNTHESIS; COLI FIS PROTEIN; ESCHERICHIA-COLI; GUANOSINE TETRAPHOSPHATE; FEEDBACK-REGULATION; STRINGENT CONTROL; OPERONS; EXPRESSION; TRANSCRIPTION; ACTIVATION	We have previously shown that the accumulation of 20 tRNA species in Escherichia coli is individually regulated as a function of cellular growth rate. We have also reported that the growth rate regulation of some but not all tRNA species is dependent on the activity of the factor for inversion stimulation (FIS). In present work, we studied the growth rate regulation of the serine- and threonine-accepting tRNA families. We show that the levels of tRNA(3)(Thr), tRNA(3)(Ser), tRNA(2)(Thr), tRNA(3)(Thr), and tRNA(4)(Thr) are reduced in fis cells as the growth rate increases. The accumulation of these tRNA species is reduced 2-5-fold at the fastest bacterial growth rate. The strongest effect is observed for the two minor tRNA species; tRNA(2)(Ser) and tRNA(2)(Thr). In contrast, we find that the accumulation of tRNA(1)(Ser), tRNA(5)(Ser), and tRNA(1)(Ser) is similar in wild type and fis bacteria, The data presented provide further evidence for the suggestion that FIS is a stimulating factor that is involved, directly or indirectly, in the high expression level of some tRNA genes at fast bacterial growth rates.	UPPSALA UNIV, BIOMED CTR, DEPT MOLEC BIOL, S-75124 UPPSALA, SWEDEN	Uppsala University				Emilsson, Valur/0000-0001-9982-0524				BALL CA, 1992, J BACTERIOL, V174, P8043, DOI 10.1128/JB.174.24.8043-8056.1992; BARTLETT MS, 1994, J BACTERIOL, V176, P5560, DOI 10.1128/JB.176.17.5560-5564.1994; BOSCH L, 1990, BIOCHIM BIOPHYS ACTA, V1050, P293, DOI 10.1016/0167-4781(90)90184-4; CASHEL M, 1987, ESCHERICHIA COLI SAL, V2, P1410; COLE JR, 1987, J MOL BIOL, V198, P383, DOI 10.1016/0022-2836(87)90288-9; CONDON C, 1993, EMBO J, V12, P4305, DOI 10.1002/j.1460-2075.1993.tb06115.x; CONDON C, 1992, EMBO J, V11, P4175, DOI 10.1002/j.1460-2075.1992.tb05511.x; EMILSSON V, 1990, EMBO J, V9, P4359, DOI 10.1002/j.1460-2075.1990.tb07885.x; EMILSSON V, 1993, J MOL BIOL, V230, P483, DOI 10.1006/jmbi.1993.1165; FILUTOWICZ M, 1992, J BACTERIOL, V174, P398, DOI 10.1128/jb.174.2.398-407.1992; FINKEL SE, 1992, MOL MICROBIOL, V6, P3257, DOI 10.1111/j.1365-2958.1992.tb02193.x; GAAL T, 1990, P NATL ACAD SCI USA, V87, P5533, DOI 10.1073/pnas.87.14.5533; GILLE H, 1991, NUCLEIC ACIDS RES, V19, P4167, DOI 10.1093/nar/19.15.4167; GOURSE RL, 1984, J BACTERIOL, V160, P1022, DOI 10.1128/JB.160.3.1022-1026.1984; GOURSE RL, 1986, CELL, V44, P197, DOI 10.1016/0092-8674(86)90498-8; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; HERNANDEZ VJ, 1993, J BIOL CHEM, V268, P10851; HERNANDEZ VJ, 1990, J BIOL CHEM, V265, P11605; HIASA H, 1994, J BIOL CHEM, V269, P24999; JINKSROBERTSON S, 1983, CELL, V33, P865, DOI 10.1016/0092-8674(83)90029-6; JOHNSON RC, 1988, P NATL ACAD SCI USA, V85, P3484, DOI 10.1073/pnas.85.10.3484; KOMINE Y, 1990, J MOL BIOL, V96, P69; LAZARUS LR, 1993, EMBO J, V12, P2483, DOI 10.1002/j.1460-2075.1993.tb05903.x; LECLERC G, 1989, J BACTERIOL, V171, P2090, DOI 10.1128/jb.171.4.2090-2095.1989; Maniatis T., 1982, MOL CLONING; MIZUSHIMASUGANO J, 1985, EMBO J, V4, P1053, DOI 10.1002/j.1460-2075.1985.tb03738.x; MULLIN DA, 1984, CELL, V37, P669, DOI 10.1016/0092-8674(84)90399-4; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NILSSON L, 1990, EMBO J, V9, P727, DOI 10.1002/j.1460-2075.1990.tb08166.x; NILSSON L, 1994, J BIOL CHEM, V269, P9460; NILSSON L, 1992, J BACTERIOL, V174, P921, DOI 10.1128/jb.174.3.921-929.1992; NINNEMANN O, 1992, EMBO J, V11, P1075, DOI 10.1002/j.1460-2075.1992.tb05146.x; NOLLER HF, 1981, SCIENCE, V212, P403, DOI 10.1126/science.6163215; ROSS W, 1990, EMBO J, V9, P3733, DOI 10.1002/j.1460-2075.1990.tb07586.x; RYALS J, 1982, J BACTERIOL, V151, P1261, DOI 10.1128/JB.151.3.1261-1268.1982; SARUBBI E, 1988, MOL GEN GENET, V213, P214, DOI 10.1007/BF00339584; SPRINZL M, 1989, NUCLEIC ACIDS RES, V17, pR1, DOI 10.1093/nar/17.1.1; VIND J, 1993, J MOL BIOL, V231, P678, DOI 10.1006/jmbi.1993.1319; ZACHARIAS M, 1990, NUCLEIC ACIDS RES, V18, P6271, DOI 10.1093/nar/18.21.6271	39	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16610	16614		10.1074/jbc.270.28.16610	http://dx.doi.org/10.1074/jbc.270.28.16610			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622468	hybrid			2022-12-27	WOS:A1995RJ34700025
J	SERVETNICK, DA; BRASAEMLE, DL; GRUIAGRAY, J; KIMMEL, AR; WOLFF, J; LONDOS, C				SERVETNICK, DA; BRASAEMLE, DL; GRUIAGRAY, J; KIMMEL, AR; WOLFF, J; LONDOS, C			PERILIPINS ARE ASSOCIATED WITH CHOLESTERYL ESTER DROPLETS IN STEROIDOGENIC ADRENAL-CORTICAL AND LEYDIG-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; ADIPOSE-TISSUE; TUMOR-CELLS; RECEPTORS; ENZYME	Steroidogenic cells store cholesteryl esters, precursors for steroid hormone synthesis, in intracellular lipid droplets. Cholesteryl ester hydrolysis is activated by protein kinase A and catalyzed by cholesteryl esterase. The esterase is similar, if not identical, to hormone-sensitive lipase in adipocytes where an analogous lipolytic mechanism occurs. Perilipins, proteins located exclusively at lipid droplet surfaces in adipocytes, are polyphosphorylated by protein kinase A in response to lipolytic stimuli, suggesting a role for these proteins in mediating lipid metabolism. The present study reveals that perilipins are associated with cholesteryl ester droplets in two steroidogenic cell lines: Y-1 adrenal cortical cells and MA-10 Leydig cells. The relative abundance of perilipin mRNAs and protein is much less in steroidogenic cells than in adipocytes. Like adipocytes, steroidogenic cells express perilipin A; additionally, the latter cells contain relatively abundant amounts of perilipin C, a protein that is not detectable in adipocytes by Western analysis. The data suggest a strong link between perilipins and lipid hydrolysis that is mediated by the hormone sensitive lipase/cholesteryl esterase class of enzymes.	NIDDK,CELLULAR & DEV BIOL LAB,BETHESDA,MD 20892; NIDDK,MEMBRANE REGULAT SECT,BETHESDA,MD 20892; NIDDK,MOLEC MECHANISMS DEV SECT,BETHESDA,MD 20892; NIDDK,ENDOCRINE BIOCHEM SECT,BIOCHEM PHARMACOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)				Brasaemle, Dawn/0000-0002-8553-8285				ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; BUONASSISI V, 1962, P NATL ACAD SCI USA, V48, P1184, DOI 10.1073/pnas.48.7.1184; COOK KG, 1982, EUR J BIOCHEM, V125, P245, DOI 10.1111/j.1432-1033.1982.tb06675.x; DIXON JL, 1993, J LIPID RES, V34, P167; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; GREENBERG AS, 1993, P NATL ACAD SCI USA, V90, P12035, DOI 10.1073/pnas.90.24.12035; HOLM C, 1987, BIOCHEM BIOPH RES CO, V148, P99, DOI 10.1016/0006-291X(87)91081-3; LI WH, 1988, J LIPID RES, V29, P245; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; SACKETT DL, 1986, BIOCHIM BIOPHYS ACTA, V888, P163, DOI 10.1016/0167-4889(86)90017-0; STRALFORS P, 1987, ENZYMES B, V18, P147; TEMPLE R, 1973, J BIOL CHEM, V248, P261; YEAMAN SJ, 1990, BIOCHIM BIOPHYS ACTA, V1052, P128, DOI 10.1016/0167-4889(90)90067-N	13	159	162	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16970	16973		10.1074/jbc.270.28.16970	http://dx.doi.org/10.1074/jbc.270.28.16970			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622516	hybrid			2022-12-27	WOS:A1995RJ34700077
J	DESNOS, C; LARAN, MP; LANGLEY, K; AUNIS, D; HENRY, JP				DESNOS, C; LARAN, MP; LANGLEY, K; AUNIS, D; HENRY, JP			LONG-TERM STIMULATION CHANGES THE VESICULAR MONOAMINE TRANSPORTER CONTENT OF CHROMAFFIN GRANULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINE BETA-HYDROXYLASE; RAT ADRENAL-MEDULLA; IMMATURE SECRETORY GRANULE; AMINE TRANSPORTER; MESSENGER-RNA; TYROSINE-HYDROXYLASE; SECRETOGRANIN-II; CELLS; MEMBRANE; CATECHOLAMINES	Bovine chromaffin cells cultured for 5 days in the presence of depolarizing concentrations of K+ ions show a decreased number of secretory (chromaffin) granules per cell. These cells were still capable of exocytosis, Their contents in catecholamine and chromogranin A, components of the granule matrix, and cytochrome b(561), a major protein of the granule membrane, were decreased to 35, 30, and 50% of control cells, respectively, However, in the same cells, the number of [H-3]dihydrotetrabenazine binding sites, a specific ligand of the vesicular monoamine transporter, was increased to 180% of controls. In situ uptake of noradrenaline in permeabilized cells indicated that [H-3]dihydrotetrabenazinc binding sites were associated with a functional vesicular monoamine transporter, When analyzed by isopycnic centrifugation, these sites cosedimented with catecholamine, chromogranin A, and cytochrome b(561), in a peak with a density lighter than that from controls, The composition of this peak suggests that it contains incompletely matured secretory granules, with a 3-5-fold increase in the vesicular monoamine transporter content of this membrane, This increase might indicate that an adaptative process occurs which allows a faster filling of the granules in continuously secreting cells.	INST BIOL PHYSICOCHIM,SERV NEUROBIOL PHYSICOCHIM,CNRS,UNITE ASSOCIEE 1112,F-75005 PARIS,FRANCE; CTR NEUROCHIM,INSERM,U338,UNITE BIOL COMMUN CELLULAIRE,F-67084 STRASBOURG,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg			Dominique, Aunis/W-1419-2019; Langley, Keith/M-7516-2014					AHNERTHILGER G, 1993, METHOD ENZYMOL, V221, P139, DOI 10.1016/0076-6879(93)21013-X; ANNAERT WG, 1993, J NEUROCHEM, V60, P1746, DOI 10.1111/j.1471-4159.1993.tb13399.x; ANOUAR Y, 1991, J NEUROENDOCRINOL, V3, P233, DOI 10.1111/j.1365-2826.1991.tb00269.x; BADER MF, 1986, J BIOL CHEM, V261, P5777; BANNON MJ, 1992, P NATL ACAD SCI USA, V89, P7095, DOI 10.1073/pnas.89.15.7095; BAUERFEIND R, 1993, NEURON, V11, P105, DOI 10.1016/0896-6273(93)90275-V; CLIFTOGRADY L, 1990, J CELL BIOL, V10, P1693; DARCHEN F, 1990, P NATL ACAD SCI USA, V87, P5692, DOI 10.1073/pnas.87.15.5692; DESNOS C, 1992, J NEUROCHEM, V59, P2105; EIDEN LE, 1984, NATURE, V312, P661, DOI 10.1038/312661a0; ERICKSON JD, 1992, P NATL ACAD SCI USA, V89, P10993, DOI 10.1073/pnas.89.22.10993; GAGNON C, 1977, J NEUROCHEM, V28, P853, DOI 10.1111/j.1471-4159.1977.tb10638.x; GASNIER B, 1994, FEBS LETT, V342, P225, DOI 10.1016/0014-5793(94)80506-7; GRIMES M, 1992, J CELL BIOL, V117, P539, DOI 10.1083/jcb.117.3.539; HENRY JP, 1989, BIOCHEM PHARMACOL, V38, P2395, DOI 10.1016/0006-2952(89)90082-8; HOPWOOD D, 1971, PROGR HISTOCHEM CYTO, V3, P1; HOWELL M, 1994, FEBS LETT, V338, P16, DOI 10.1016/0014-5793(94)80108-8; JOHNSON RG, 1988, PHYSIOL REV, V68, P232, DOI 10.1152/physrev.1988.68.1.232; KACSER H, 1974, CONTROL FLUX, P65; KANAMATSU T, 1986, P NATL ACAD SCI USA, V83, P9245, DOI 10.1073/pnas.83.23.9245; KLEY N, 1986, EMBO J, V5, P967, DOI 10.1002/j.1460-2075.1986.tb04310.x; KREJCI E, 1993, FEBS LETT, V335, P27, DOI 10.1016/0014-5793(93)80432-T; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; MAHATA SK, 1993, MOL BRAIN RES, V19, P83, DOI 10.1016/0169-328X(93)90152-F; MAHATA SK, 1993, NEUROSCI LETT, V156, P70, DOI 10.1016/0304-3940(93)90442-N; MORO MA, 1991, J NEUROCHEM, V57, P363, DOI 10.1111/j.1471-4159.1991.tb03761.x; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; PATRICK RL, 1971, MOL PHARMACOL, V7, P87; PEYRIN L, 1973, ANAL BIOCHEM, V56, P515, DOI 10.1016/0003-2697(73)90218-2; PHILLIPS JH, 1982, NEUROSCIENCE, V7, P1595, DOI 10.1016/0306-4522(82)90017-3; SARAFIAN T, 1991, J CELL BIOL, V114, P1135, DOI 10.1083/jcb.114.6.1135; SCHERMAN D, 1983, BIOCHEMISTRY-US, V22, P2805, DOI 10.1021/bi00281a006; SCHERMAN D, 1983, P NATL ACAD SCI-BIOL, V80, P584, DOI 10.1073/pnas.80.2.584; SIETZEN M, 1987, NEUROSCIENCE, V22, P131, DOI 10.1016/0306-4522(87)90203-X; STACHOWIAK MK, 1990, BRAIN RES, V510, P277, DOI 10.1016/0006-8993(90)91378-T; THOENEN H, 1974, LIFE SCI, V14, P223, DOI 10.1016/0024-3205(74)90052-6; THOENEN H, 1969, J PHARMACOL EXP THER, V160, P249; TOOZE SA, 1991, FEBS LETT, V285, P220, DOI 10.1016/0014-5793(91)80805-D; TOOZE SA, 1991, J CELL BIOL, V115, P1491, DOI 10.1083/jcb.115.6.1491; UNSICKER K, 1983, DEV BRAIN RES, V9, P369, DOI 10.1016/0165-3806(83)90034-2; VONEULER US, 1961, ACTA PHYSL SCAND, V51, P343; VONZASTROW M, 1987, J CELL BIOL, V105, P2675, DOI 10.1083/jcb.105.6.2675; WINKLER H, 1980, NEUROSCIENCE, V5, P1803, DOI 10.1016/0306-4522(80)90031-7	43	21	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16030	16038		10.1074/jbc.270.27.16030	http://dx.doi.org/10.1074/jbc.270.27.16030			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608164	hybrid			2022-12-27	WOS:A1995RH22600025
J	DEVOS, P; SALADIN, R; AUWERX, J; STAELS, B				DEVOS, P; SALADIN, R; AUWERX, J; STAELS, B			INDUCTION OF OB GENE-EXPRESSION BY CORTICOSTEROIDS IS ACCOMPANIED BY BODY-WEIGHT LOSS AND REDUCED FOOD-INTAKE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							OBESE; MICE; ADRENALECTOMY; MOUSE	Genetic studies in mice have identified the ob gene product as a potential signaling factor regulating body weight homeostasis and energy balance. It is suggested that modulation of ob gene expression results in changes in body weight and food intake, Glucocorticoids are shown to have important metabolic effects and to modulate food intake and body weight, In order to test the hypothesis that these metabolic effects of glucocorticoids are linked to changes in the expression of the ob gene, ob mRNA levels were evaluated in rats treated with different glucocorticosteroids at catabolic doses and correlated to the kinetics of changes in body weight gain and food intake, Results from time course experiments demonstrate that adipose tissue ob gene expression is rapidly induced by glucocorticosteroids. This induction is followed by a concordant decrease in body weight gain and food consumption, These data suggest that the catabolic effects of corticosteroids on body weight mass and food intake might be mediated by changes in ob expression, Modulation of ob expression may therefore constitute a mechanism through which hormonal, pharmacological, or other factors control body weight homeostasis.	INST PASTEUR,DEPT ATHEROSCLEROSE,BIOL REG EUCARYOTES LAB,F-59019 LILLE,FRANCE	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille			Auwerx, Johan/ABE-9307-2021; Staels, Bart/N-9497-2016	Staels, Bart/0000-0002-3784-1503; Auwerx, Johan/0000-0002-5065-5393				CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; DEVENPORT L, 1989, LIFE SCI, V45, P1389, DOI 10.1016/0024-3205(89)90026-X; DUBUC PU, 1976, HORM METAB RES, V9, P95; FRIEDMAN JM, 1991, GENOMICS, V11, P1054, DOI 10.1016/0888-7543(91)90032-A; FRIEDMAN JM, 1990, CELL, V69, P217; GRUNDY SM, 1990, DM-DIS MON, V36, P641; HERBERG L, 1975, HORM METAB RES, V7, P410, DOI 10.1055/s-0028-1093695; MCGINNIS R, 1987, LIFE SCI, V40, P1561, DOI 10.1016/0024-3205(87)90121-4; NAESER P, 1974, DIABETOLOGIA, V10, P449, DOI 10.1007/BF01221636; SAITO M, 1984, AM J PHYSIOL, V246, pR20, DOI 10.1152/ajpregu.1984.246.1.R20; SOLOMON J, 1973, ENDOCRINOLOGY, V93, P510, DOI 10.1210/endo-93-2-510; SOLOMON J, 1977, HORM METAB RES, V9, P152, DOI 10.1055/s-0028-1093566; STAELS B, 1992, DEVELOPMENT, V115, P1035; YUKIMURA Y, 1978, P SOC EXP BIOL MED, V159, P364; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	17	447	462	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15958	15961		10.1074/jbc.270.27.15958	http://dx.doi.org/10.1074/jbc.270.27.15958			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608151	hybrid			2022-12-27	WOS:A1995RH22600012
J	DIXON, DA; KOWALCZYKOWSKI, SC				DIXON, DA; KOWALCZYKOWSKI, SC			ROLE OF THE ESCHERICHIA-COLI RECOMBINATION HOTSPOT, CHI, IN RECABCD-DEPENDENT HOMOLOGOUS PAIRING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JOINT MOLECULE FORMATION; HOT SPOT ACTIVITY; MUTANT RECBCD ENZYME; SINGLE-STRANDED-DNA; BACTERIOPHAGE-LAMBDA; HELICASE ACTIVITY; RECD MUTANTS; GENERALIZED RECOMBINATION; RECB(2109)CD ENZYME; PURIFIED SUBUNITS	Genetic recombination occurring in wild type Escherichia coli is stimulated at DNA sequences known as chi sites, 5'-GCTGGTGG-3'. In vitro, homologous pairing between duplex DNA substrates dependent upon the RecA, RecBCD, and SSB proteins is stimulated by the presence of a chi sequence in the donor linear double-stranded DNA. We show that this stimulation is due to two factors: 1) the enhanced production of chi-specific single-stranded DNA fragments and 2) their preferential use in the RecA protein-promoted pairing step. Furthermore, under conditions of limiting Mg2+ concentration, joint molecule formation does not occur, even though DNA unwinding and chi-specific single-stranded DNA fragment production are observed. Also, under these conditions, chi-specific fragments derived from both the upstream and downstream regions of the DNA strand containing chi and from cleavage of the non-chi-containing DNA strand are detected. Finally, the behavior of mutant RecBCD enzymes (RecBC*D and RecBCD double dagger) in this in vitro reaction is shown to parallel their in vivo phenotypes with respect to chi stimulation of recombination. Thus we suggest that, in addition to its ability to regulate the degradative activities of RecBCD enzyme, chi itself may be a preferred site for initiation of homologous pairing in this concerted process.	UNIV CALIF DAVIS,MICROBIOL SECT,DAVIS,CA 95616; UNIV CALIF DAVIS,MOLEC & CELLULAR BIOL SECT,DAVIS,CA 95616	University of California System; University of California Davis; University of California System; University of California Davis					NIGMS NIH HHS [GM-41347] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041347] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMUNDSEN SK, 1986, P NATL ACAD SCI USA, V83, P5558, DOI 10.1073/pnas.83.15.5558; BOEHMER PE, 1991, GENE, V102, P1, DOI 10.1016/0378-1119(91)90529-K; CHAUDHURY AM, 1984, P NATL ACAD SCI-BIOL, V81, P7850, DOI 10.1073/pnas.81.24.7850; CLARK AJ, 1994, CRIT REV MICROBIOL, V20, P125, DOI 10.3109/10408419409113552; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; COX MM, 1993, BIOESSAYS, V15, P617, DOI 10.1002/bies.950150908; COX MM, 1987, ANNU REV BIOCHEM, V56, P229, DOI 10.1146/annurev.bi.56.070187.001305; DIXON DA, 1991, CELL, V66, P361, DOI 10.1016/0092-8674(91)90625-9; DIXON DA, 1993, CELL, V73, P87, DOI 10.1016/0092-8674(93)90162-J; DIXON DA, 1994, P NATL ACAD SCI USA, V91, P2980, DOI 10.1073/pnas.91.8.2980; DIXON DA, 1993, THESIS NW U EVANSTON; EGGLESTON AK, 1993, J MOL BIOL, V231, P621, DOI 10.1006/jmbi.1993.1314; EGGLESTON AK, 1993, J MOL BIOL, V231, P605, DOI 10.1006/jmbi.1993.1313; EICHLER DC, 1977, J BIOL CHEM, V252, P499; EMMERSON PT, 1967, J BACTERIOL, V93, P1729, DOI 10.1128/JB.93.5.1729-1731.1967; GLASSBERG J, 1979, J BACTERIOL, V140, P14, DOI 10.1128/JB.140.1.14-19.1979; GRIFFITH J, 1985, BIOCHEMISTRY-US, V24, P158, DOI 10.1021/bi00322a022; HOWARDFLANDERS P, 1966, GENETICS, V53, P1137; KONFORTI BB, 1987, P NATL ACAD SCI USA, V84, P690, DOI 10.1073/pnas.84.3.690; KONFORTI BB, 1990, J BIOL CHEM, V265, P6916; KORANGY F, 1993, BIOCHEMISTRY-US, V32, P4873, DOI 10.1021/bi00069a024; KOWALCZYKOWSKI SC, 1994, EXPERIENTIA, V50, P204, DOI 10.1007/BF01924003; KOWALCZYKOWSKI SC, 1991, BIOCHIMIE, V73, P289, DOI 10.1016/0300-9084(91)90216-N; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; KOWALCZYKOWSKI SC, 1990, UCLA S MOL CELLULAR, P357; LAM ST, 1974, GENETICS, V77, P425; LEBOWITZ J, 1985, THESIS J HOPKINS U B; LOVETT ST, 1988, GENETICS, V120, P37; LOVETT ST, 1989, P NATL ACAD SCI USA, V86, P2627, DOI 10.1073/pnas.86.8.2627; MACKAY V, 1976, J BIOL CHEM, V251, P3716; MASTERSON C, 1992, J BIOL CHEM, V267, P13564; MCMILIN KD, 1974, GENETICS, V77, P409; PONTICELLI AS, 1985, CELL, V41, P145, DOI 10.1016/0092-8674(85)90069-8; RADDING CM, 1991, J BIOL CHEM, V266, P5355; RINKEN R, 1992, J BACTERIOL, V174, P5424, DOI 10.1128/JB.174.16.5424-5429.1992; ROMAN LJ, 1989, J BIOL CHEM, V264, P18340; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2863, DOI 10.1021/bi00433a018; ROMAN LJ, 1992, J BIOL CHEM, V267, P4207; ROMAN LJ, 1991, P NATL ACAD SCI USA, V88, P3367, DOI 10.1073/pnas.88.8.3367; ROMAN LJ, 1986, BIOCHEMISTRY-US, V25, P7375, DOI 10.1021/bi00371a020; RUYECHAN WT, 1975, BIOCHEMISTRY-US, V14, P5529, DOI 10.1021/bi00696a023; Sambrook J, 1989, MOL CLONING LABORATO; SCHULTZ DW, 1983, J BACTERIOL, V155, P664, DOI 10.1128/JB.155.2.664-680.1983; SHIBATA T, 1982, J BIOL CHEM, V257, P3981; SMITH GR, 1981, CELL, V24, P429, DOI 10.1016/0092-8674(81)90333-0; SMITH GR, 1989, CELL, V58, P807, DOI 10.1016/0092-8674(89)90929-X; SMITH GR, 1994, EXPERIENTIA, V50, P234, DOI 10.1007/BF01924006; SMITH GR, 1988, MICROBIOL REV, V52, P1; SMITH GR, 1983, CELL, V34, P709, DOI 10.1016/0092-8674(83)90525-1; SMITH GR, 1990, NUCL ACIDS MOL BIOL, P78; STAHL FW, 1975, J MOL BIOL, V94, P203, DOI 10.1016/0022-2836(75)90078-9; TAYLOR AF, 1985, CELL, V41, P153, DOI 10.1016/0092-8674(85)90070-4; TAYLOR AF, 1985, J MOL BIOL, V185, P431, DOI 10.1016/0022-2836(85)90414-0; TAYLOR AF, 1988, GENETIC RECOMBINATIO, P231; THALER DS, 1989, GENOME, V31, P53, DOI 10.1139/g89-013; WEST SC, 1992, ANNU REV BIOCHEM, V61, P603, DOI 10.1146/annurev.bi.61.070192.003131	58	50	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16360	16370		10.1074/jbc.270.27.16360	http://dx.doi.org/10.1074/jbc.270.27.16360			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608206	hybrid			2022-12-27	WOS:A1995RH22600073
J	CHANG, ZF; HUANG, DY; LAI, TC				CHANG, ZF; HUANG, DY; LAI, TC			DIFFERENT REGULATION OF THE HUMAN THYMIDINE KINASE PROMOTER IN NORMAL HUMAN-DIPLOID IMR-90 FIBROBLASTS AND HELA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; CYCLIN-A; S-PHASE; CANDIDATE ONCOGENE; PROTEIN-BINDING; GENE PROMOTER; IDENTIFICATION; AMPLIFICATION; OVEREXPRESSION; TRANSCRIPTION	Transcriptional activation of the human thymidine kinase (hTK) promoter plays an important role in the cell cycle control of thymidine kinase expression, Using the luciferase reporter cotransfection assay, we found that the activity of the hTK promoter in IMR-90 normal human diploid fibroblasts was increased by the constitutively: over-expressed cyclin A or cyclin E but not by cyclin D, suggesting that the former two cyclins may act as positive regulators for the hTK promoter. The sequence responsible for the transcriptional activation by cyclin E was identified to be located between -133 and -92 of the hTK promoter, Regulation of the hTK promoter in HeLa cells appeared to be different from that in IMR-90 fibroblasts. Firstly, the hTK promoter in HeLa was already highly activated and could not be further activated by ectopically expressed cyclin A or E, Secondly, the -133 to -92 region of the hTK promoter was important for the promoter strength in HeLa cells but not in IMR-90 cells. The steady-state levels of cyclins A and E were readily detected in HeLa cells but not in normal IMR-90 fibroblasts. Based on these results, we propose. that the cellular environment of the HeLa cell allows the hTK promoter to stay fully activated for transcription regardless of ectopically expressed cyclin A or E and that transcriptional activation of thymidine kinase gene is deregulated in these tumor cells.			CHANG, ZF (corresponding author), CHANG GUNG COLL MED & TECHNOL,DEPT BIOCHEM,259 WEN HWA 1 RD,TAYUAN,TAIWAN.							ARCOT SS, 1989, J BIOL CHEM, V264, P2343; BELLO LJ, 1974, EXP CELL RES, V89, P263, DOI 10.1016/0014-4827(74)90790-3; BRADSHAW HD, 1984, MOL CELL BIOL, V4, P2316, DOI 10.1128/MCB.4.11.2316; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; CHANG ZF, 1988, J BIOL CHEM, V263, P11431; CHANG ZF, 1994, J BIOL CHEM, V269, P17893; CHANG ZF, 1993, CANCER RES, V53, P3253; COPPOCK DL, 1987, MOL CELL BIOL, V7, P2925, DOI 10.1128/MCB.7.8.2925; DAVIES R, 1993, J VIROL, V67, P2521, DOI 10.1128/JVI.67.5.2521-2528.1993; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOU QP, 1991, P NATL ACAD SCI USA, V88, P1157, DOI 10.1073/pnas.88.4.1157; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; GROSS MK, 1989, P NATL ACAD SCI USA, V86, P4987, DOI 10.1073/pnas.86.13.4987; GUDAS JM, 1988, P NATL ACAD SCI USA, V85, P4705, DOI 10.1073/pnas.85.13.4705; GUDAS JM, 1990, MOL CELL BIOL, V10, P5591, DOI 10.1128/MCB.10.10.5591; HALLEK M, 1992, ANN HEMATOL, V65, P1, DOI 10.1007/BF01715117; HENGSTSCHLAGER M, 1994, J BIOL CHEM, V269, P13836; ITO M, 1990, J BIOL CHEM, V265, P6954; JIANG W, 1992, CANCER RES, V52, P2980; JOHNSON LF, 1982, EXP CELL RES, V138, P79, DOI 10.1016/0014-4827(82)90093-3; KEYOMARSI K, 1994, CANCER RES, V54, P380; KIM YK, 1991, MOL CELL BIOL, V11, P2296, DOI 10.1128/MCB.11.4.2296; KIM YK, 1992, J BIOL CHEM, V267, P2723; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; LAM EWF, 1994, EMBO J, V13, P871, DOI 10.1002/j.1460-2075.1994.tb06330.x; LAMMIE GA, 1992, ONCOGENE, V7, P2381; LAMMIE GA, 1991, ONCOGENE, V6, P439; LEACH FS, 1993, CANCER RES, V53, P1986; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; LI LJ, 1993, P NATL ACAD SCI USA, V90, P3554, DOI 10.1073/pnas.90.8.3554; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P6848, DOI 10.1073/pnas.86.18.6848; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Maxam A M, 1980, Methods Enzymol, V65, P499; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; ROEHL HH, 1990, MOL CELL BIOL, V10, P3834, DOI 10.1128/MCB.10.7.3834; ROSENBERG CL, 1991, ONCOGENE, V6, P449; ROSENBLATT J, 1992, P NATL ACAD SCI USA, V89, P2824, DOI 10.1073/pnas.89.7.2824; SCHWARTZ O, 1990, GENE, V88, P197, DOI 10.1016/0378-1119(90)90032-M; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; STEWART CJ, 1987, MOL CELL BIOL, V7, P1156, DOI 10.1128/MCB.7.3.1156; STUART P, 1985, MOL CELL BIOL, V5, P1490, DOI 10.1128/MCB.5.6.1490; WANG J, 1990, NATURE, V343, P555, DOI 10.1038/343555a0	47	21	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27374	27379		10.1074/jbc.270.45.27374	http://dx.doi.org/10.1074/jbc.270.45.27374			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7593001	hybrid			2022-12-27	WOS:A1995TE58300101
J	WATANABE, E; MAEDA, N; MATSUI, F; KUSHIMA, Y; NODA, M; OOHIRA, A				WATANABE, E; MAEDA, N; MATSUI, F; KUSHIMA, Y; NODA, M; OOHIRA, A			NEUROGLYCAN-C, A NOVEL MEMBRANE-SPANNING CHONDROITIN SULFATE PROTEOGLYCAN THAT IS RESTRICTED TO THE BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; NEURITE OUTGROWTH; MOLECULAR-CLONING; CELL-ADHESION; CORE PROTEIN; IDENTIFICATION; ATTACHMENT; INHIBITORS; ACTIVATION; RETRACTION	Monoclonal antibodies were raised to membrane-bound proteoglycans derived from rat brain, and four monoclonal antibodies that recognized a 150-kDa chondroitin sulfate proteoglycan with a core glycoprotein of 120 kDa were obtained. Immunohistological study revealed that the proteoglycan was associated with developing neurons. We screened rat brain cDNA libraries using the four monoclonal antibodies and isolated overlapping cDNA clones that encoded the entire core protein of 514 amino acids plus a 30-residue signal peptide. The deduced amino acid sequence suggested an integral membrane protein divided into five structurally different domains: an N-terminal domain to which chondroitin sulfate chains might be attached, a basic amino acid cluster consisting of seven arginine and two lysine residues, a cysteine-containing domain, a membrane spanning segment, and a C-terminal cytoplasmic domain of 95 amino acids. On Northern blots, the cDNA hybridized with a single mRNA of 3.1 kilobases that was detectable in brains of neonatal and adult rats but not in kidney, liver, lung, and muscle of either. The sequence of the proteoglycan did not exhibit significant homology to any other known protein, indicating that the proteoglycan, designated neuroglycan C, is a novel integral membrane proteoglycan.	GRAD UNIV ADV STUDIES,NATL INST BASIC BIOL,DIV MOLEC NEUROBIOL,OKAZAKI,AICHI 444,JAPAN; GRAD UNIV ADV STUDIES,DEPT MOLEC BIOMECH,OKAZAKI,AICHI 444,JAPAN; SEIKAGAKU CORP,TOKYO RES INST,TOKYO 207,JAPAN	Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Seikagaku Corporation	WATANABE, E (corresponding author), INST DEV RES,DEPT PERINATOL & NEUROGLYCOSCI,KASUGAI,AICHI 48003,JAPAN.		Noda, Masaharu/D-7146-2016	Noda, Masaharu/0000-0002-3796-524X; Watanabe, Eiji/0000-0001-9089-8122				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BOURDON MA, 1987, P NATL ACAD SCI USA, V84, P3194, DOI 10.1073/pnas.84.10.3194; BREUER B, 1991, J BIOL CHEM, V266, P13224; CAREY DJ, 1992, J CELL BIOL, V117, P191, DOI 10.1083/jcb.117.1.191; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLE GJ, 1991, NEURON, V7, P1007, DOI 10.1016/0896-6273(91)90345-Z; CROSSIN KL, 1989, DEV BIOL, V136, P381, DOI 10.1016/0012-1606(89)90264-9; DOEGE K, 1987, J BIOL CHEM, V262, P17757; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; DOU CL, 1994, J NEUROSCI, V14, P7616; GRAFF JM, 1989, J BIOL CHEM, V264, P11912; GRUMET M, 1993, J CELL BIOL, V120, P815, DOI 10.1083/jcb.120.3.815; HAWKINS RL, 1986, BRAIN RES, V398, P63, DOI 10.1016/0006-8993(86)91250-3; HERNDON ME, 1990, NEURON, V4, P949, DOI 10.1016/0896-6273(90)90148-9; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; JALINK K, 1992, J CELL BIOL, V118, P411, DOI 10.1083/jcb.118.2.411; JAWORSKI DM, 1994, J CELL BIOL, V125, P495, DOI 10.1083/jcb.125.2.495; KARTHIKEYAN L, 1992, BIOCHEM BIOPH RES CO, V188, P395, DOI 10.1016/0006-291X(92)92398-H; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KRUEGER RC, 1990, J BIOL CHEM, V265, P12075; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANDER AD, 1985, P NATL ACAD SCI USA, V82, P2183, DOI 10.1073/pnas.82.7.2183; MAEDA N, 1992, DEV BIOL, V151, P564, DOI 10.1016/0012-1606(92)90194-L; MAEDA N, 1994, FEBS LETT, V354, P67, DOI 10.1016/0014-5793(94)01093-5; MATSUI F, 1994, NEUROCHEM INT, V25, P425, DOI 10.1016/0197-0186(94)90018-3; MAUREL P, 1994, P NATL ACAD SCI USA, V91, P2512, DOI 10.1073/pnas.91.7.2512; MONARD D, 1988, TRENDS NEUROSCI, V11, P541, DOI 10.1016/0166-2236(88)90182-8; MONARD D, 1983, PROG BRAIN RES, V58, P359, DOI 10.1016/S0079-6123(08)60037-0; NISHIYAMA A, 1991, J CELL BIOL, V114, P359, DOI 10.1083/jcb.114.2.359; OOHIRA A, 1988, J BIOL CHEM, V263, P10240; OOHIRA A, 1991, J NEUROSCI, V11, P822; OOHIRA A, 1994, NEUROSCIENCE, V60, P145, DOI 10.1016/0306-4522(94)90210-0; PITTMAN RN, 1989, J NEUROSCI, V9, P4269; RAUCH U, 1992, J BIOL CHEM, V267, P19536; RIOPELLE RJ, 1990, BRAIN RES, V525, P92, DOI 10.1016/0006-8993(90)91324-A; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; SABATINI DD, 1982, J CELL BIOL, V92, P1, DOI 10.1083/jcb.92.1.1; Sambrook J, 1989, MOL CLONING LABORATO; SAUNDERS S, 1989, J CELL BIOL, V108, P1547, DOI 10.1083/jcb.108.4.1547; SCOTT MG, 1988, BIOCHEM BIOPH RES CO, V155, P1353, DOI 10.1016/S0006-291X(88)81290-7; Segrest JP, 1972, METHOD ENZYMOL, V28, P54, DOI DOI 10.1016/0076-6879(72)28007-7; STRIPP CS, 1994, J CELL BIOL, V124, P149; SUIDAN HS, 1992, NEURON, V8, P363, DOI 10.1016/0896-6273(92)90302-T; SUR M, 1988, J NEUROSCI, V8, P874; TOMITA M, 1978, BIOCHEMISTRY-US, V17, P4756, DOI 10.1021/bi00615a025; WATANABE E, 1989, NEUROSCIENCE, V29, P645, DOI 10.1016/0306-4522(89)90137-1; WATANABE E, 1995, EUR J NEUROSCI, V7, P547, DOI 10.1111/j.1460-9568.1995.tb00659.x; YAMADA H, 1994, J BIOL CHEM, V269, P10119; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	52	58	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26876	26882		10.1074/jbc.270.45.26876	http://dx.doi.org/10.1074/jbc.270.45.26876			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592931	hybrid			2022-12-27	WOS:A1995TE58300031
J	FROST, V; MORLEY, SJ; MERCEP, L; MEYER, T; FABBRO, D; FERRARI, S				FROST, V; MORLEY, SJ; MERCEP, L; MEYER, T; FABBRO, D; FERRARI, S			THE PHOSPHODIESTERASE INHIBITOR SQ-20006 SELECTIVELY BLOCKS MITOGEN ACTIVATION OF P70(S6K) AND TRANSITION TO S-PHASE OF THE CELL-DIVISION CYCLE WITHOUT AFFECTING THE STEADY-STATE PHOSPHORYLATION OF EIF-4E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; MOUSE 3T3 CELLS; TRANSLATIONAL CONTROL; FACTOR-4F; DOMAINS; GROWTH; SITES; CAMP	In quiescent cells high levels of protein synthesis are required in order to re-enter the cell cycle upon stimulation. Initiation of polypeptide synthesis is the step most often subject to regulation, controlled in part by phosphorylation of 40 S ribosomal protein S6 and a number of initiation factors. The kinase responsible for S6 phosphorylation is p70(S6k). We now show that the p70(S6k) pathway can be selectively blocked by the aminopurine analogue, SQ 20006. This agent is known to raise cAMP levels, resulting in activation of protein kinase A. We present evidence that the increase in cAMP is not responsible for the inhibitory effect observed. We also show that SQ 20006 can prevent the activation of p70(S6k) in a rapid and reversible manner. The compound does not exert its inhibitory activity on p70(S6k) but can inhibit in vitro two protein kinase C isozymes (alpha and gamma). In a B lymphoblastoid cell line, treatment with SQ 20006 results in inhibition of protein synthesis at the initiation stage. In contrast, when tested directly upon the translational machinery in the reticulocyte lysate, inhibition is manifest at both the level of initiation and elongation. The role of protein kinase A in the modulation of p70(S6k) and the rate of translation is discussed.	INST EXPTL CANC RES, CTR TUMOR BIOL, D-79011 FREIBURG, GERMANY; UNIV SUSSEX, SCH BIOL SCI, DEPT BIOCHEM, BRIGHTON BN1 9QG, E SUSSEX, ENGLAND; CIBA GEIGY AG, DIV PHARMA, CH-4002 BASEL, SWITZERLAND	University of Sussex; Novartis			Ferrari, Stefano/I-7357-2016	Ferrari, Stefano/0000-0002-6607-215X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; AZZI L, 1992, EUR J BIOCHEM, V203, P353, DOI 10.1111/j.1432-1033.1992.tb16557.x; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BALLOU LM, 1988, P NATL ACAD SCI USA, V85, P7154, DOI 10.1073/pnas.85.19.7154; BALLOU LM, 1991, NATURE, V349, P348, DOI 10.1038/349348a0; BROOKS RF, 1977, CELL, V12, P311, DOI 10.1016/0092-8674(77)90209-4; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; CHASIN M, 1972, BIOCHEM PHARMACOL, V21, P2443, DOI 10.1016/0006-2952(72)90414-5; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; COOPER JA, 1994, CURR BIOL, V4, P1118, DOI 10.1016/S0960-9822(00)00251-7; DUNCAN R, 1987, J BIOL CHEM, V262, P380; FERRARI S, 1991, METHOD ENZYMOL, V200, P159; FERRARI S, 1993, J BIOL CHEM, V268, P16091; FERRARI S, 1992, P NATL ACAD SCI USA, V89, P7282, DOI 10.1073/pnas.89.15.7282; FERRARI S, 1994, CRIT REV BIOCHEM MOL, V29, P385, DOI 10.3109/10409239409083485; HAN JW, 1995, J BIOL CHEM, V270, P21396, DOI 10.1074/jbc.270.36.21396; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; JACKSON RJ, 1983, METHOD ENZYMOL, V96, P50; JEFFERIES HBJ, 1994, J BIOL CHEM, V269, P4367; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MARTE BM, 1994, CELL GROWTH DIFFER, V5, P239; MARTE BM, 1995, ONCOGENE, V10, P167; MATSUMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P2355, DOI 10.1073/pnas.79.7.2355; MATTEN W, 1994, MOL CELL BIOL, V14, P4419, DOI 10.1128/MCB.14.7.4419; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; MING XF, 1994, NATURE, V371, P426, DOI 10.1038/371426a0; MONFAR M, 1995, MOL CELL BIOL, V15, P326, DOI 10.1128/MCB.15.1.326; MORLEY SJ, 1995, J CELL SCI, V108, P1751; MORLEY SJ, 1989, J BIOL CHEM, V264, P2401; MORLEY SJ, 1994, MOL BIOL REP, V19, P221, DOI 10.1007/BF00986964; MORLEY SJ, 1991, PHARMACOL THERAPEUT, V50, P291, DOI 10.1016/0163-7258(91)90047-P; MORLEY SJ, 1993, EUR J BIOCHEM, V218, P39, DOI 10.1111/j.1432-1033.1993.tb18349.x; OTTEN J, 1972, J BIOL CHEM, V247, P7082; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; PROUD CG, 1994, NATURE, V371, P747, DOI 10.1038/371747a0; PROUD CG, 1992, CURR TOP CELL REGUL, V32, P243; QUILLIAM LA, 1994, P NATL ACAD SCI USA, V91, P8512, DOI 10.1073/pnas.91.18.8512; REDPATH NT, 1993, BIOCHEM J, V293, P31, DOI 10.1042/bj2930031; REINHARD C, 1994, EMBO J, V13, P1557, DOI 10.1002/j.1460-2075.1994.tb06418.x; SONENBERG N, 1994, BIOCHIMIE, V76, P839, DOI 10.1016/0300-9084(94)90185-6; SUSA M, 1989, CELL, V57, P817, DOI 10.1016/0092-8674(89)90796-4; TERADA N, 1993, J BIOL CHEM, V268, P12062; THOMAS G, 1980, CELL, V19, P1015, DOI 10.1016/0092-8674(80)90092-6; VESELY J, 1994, EUR J BIOCHEM, V224, P771, DOI 10.1111/j.1432-1033.1994.00771.x; WENG QP, 1995, MOL CELL BIOL, V15, P2333	56	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	1995	270	44					26698	26706		10.1074/jbc.270.44.26698	http://dx.doi.org/10.1074/jbc.270.44.26698			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TC978	7592897	hybrid			2022-12-27	WOS:A1995TC97800104
J	TUMA, PL; COLLINS, CA				TUMA, PL; COLLINS, CA			DYNAMIN FORMS POLYMERIC COMPLEXES IN THE PRESENCE OF LIPID VESICLES - CHARACTERIZATION OF CHEMICALLY CROSS-LINKED DYNAMIN MOLECULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; SEA-URCHIN EGGS; CYTOPLASMIC DYNEIN; GTPASE; PURIFICATION; ACTIVATION; DOMAINS	Dynamin is a GTP-binding protein that is involved in the release of coated endocytic vesicles from the plasma membrane, We have been characterizing the enzymatic properties of purified rat brain dynamin to better understand how GTP binding and hydrolysis relate to its proposed function, Previously, we have demonstrated that activation of dynamin GTPase results from positive cooperative associations between dynamin molecules as they are bound to a polymeric surface, Our present report has extended these studies and has examined the structural features of dynamin self association. After treatment with the zero length protein cross-linking reagent, 1-ethyl-3-[3-(dimethylamino)propyl]carbo ide, dynamin in solution was found cross linked into dimers, This homodimer likely reflects the native soluble state of the molecule, After binding to brain vesicles, dynamin was cross-linked into higher order oligomers of greater than 800 kDa, Dynamin, copurified on brain membranous organelles, also formed multimeric complexes when cross-linked suggesting dynamin exists in polymeric form in vivo. No cross linked species other than homo-oligomers were observed, providing no evidence for close interactions between dynamin and membrane proteins, From experiments examining the effects of GTP, GDP, guanosine 5'-3-O-(thio)triphosphate, and 5'-guanylyl-beta,gamma-imidodiphosphate on cross-linking, we have determined that both dynamin membrane binding and self-association occur independently from the nucleotide-bound state of the enzyme, An 80-kDa dynamin fragment that is lacking its carboxyl-terminal domain is not cross-linked into higher order oligomers, suggesting that this domain is required for binding of dynamin to membranes and the subsequent enhancement of oligomerization, However, the dynamin fragment was found to form dimers indicating that this domain is not required for dynamin dimerization, Cross linked dynamin was able to cooperatively bind microtubules, but did not exhibit GTPase activation, We propose that intramolecular cross links in the dynamin monomer impart structural constraints that prevent the enhancement of GTP hydrolysis, We describe a model of the dynamin activation process to be considered in further investigations of the role for dynamin in endocytic vesicle formation.	NORTHWESTERN UNIV, SCH MED, DEPT CELL & MOLEC BIOL, CHICAGO, IL 60611 USA	Northwestern University								Collins C A, 1991, Trends Cell Biol, V1, P57, DOI 10.1016/0962-8924(91)90090-V; COLLINS CA, 1986, P NATL ACAD SCI USA, V83, P4799, DOI 10.1073/pnas.83.13.4799; COLLINS CA, 1989, CELL MOTIL CYTOSKEL, V14, P491, DOI 10.1002/cm.970140407; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HERSKOVITS JS, 1993, P NATL ACAD SCI USA, V90, P11468, DOI 10.1073/pnas.90.24.11468; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU JP, 1994, J BIOL CHEM, V269, P21043; MAEDA K, 1992, MOL BIOL CELL, V3, P1181, DOI 10.1091/mbc.3.10.1181; NAKAYAMA M, 1993, J BIOL CHEM, V268, P15033; ROBINSON PJ, 1993, NATURE, V365, P163, DOI 10.1038/365163a0; SCAIFE R, 1990, J CELL BIOL, V111, P3023, DOI 10.1083/jcb.111.6.3023; SHIMIZU T, 1989, BIOCHEMISTRY-US, V28, P7016, DOI 10.1021/bi00443a035; SHPETNER HS, 1992, NATURE, V355, P733, DOI 10.1038/355733a0; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; STACHNIAK MC, 1989, J CELL BIOL, V111, pA291; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; TUMA PL, 1994, J BIOL CHEM, V269, P30842; TUMA PL, 1993, J BIOL CHEM, V268, P17240; VALLEE RB, 1986, METHOD ENZYMOL, V134, P89; VALLEE RB, 1986, METHOD ENZYMOL, V134, P116; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; WARNOCK DE, 1995, EMBO J, V14, P1322, DOI 10.1002/j.1460-2075.1995.tb07118.x; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	28	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	1995	270	44					26707	26714		10.1074/jbc.270.44.26707	http://dx.doi.org/10.1074/jbc.270.44.26707			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TC978	7592898	hybrid			2022-12-27	WOS:A1995TC97800105
J	CHEN, XR; RAAB, G; DEUTSCH, U; ZHANG, JC; EZZELL, RM; KLAGSBRUN, M				CHEN, XR; RAAB, G; DEUTSCH, U; ZHANG, JC; EZZELL, RM; KLAGSBRUN, M			INDUCTION OF HEPARIN-BINDING EGF-LIKE GROWTH-FACTOR EXPRESSION DURING MYOGENESIS - ACTIVATION OF THE GENE BY MYOD AND LOCALIZATION OF THE TRANSMEMBRANE FORM OF THE PROTEIN ON THE MYOTUBE SURFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; DIPHTHERIA-TOXIN RECEPTOR; DNA-BINDING; FIBROBLAST GROWTH; SKELETAL-MUSCLE; MESSENGER-RNA; MYC HOMOLOGY; DIFFERENTIATION; SULFATE; MEMBER	Heparin binding epidermal growth factor-like growth factor (HB-EGF) gene expression and protein localization were analyzed during the process of myogenic differentiation, The mouse HB-EGF gene was isolated, and a 1.8-kilobase genomic fragment flanking the 5' end of the cDNA was cloned, This fragment contains two sequences which match the consensus CANNTG sequence for E-boxes, binding sites for the MyoD family of DNA-binding transcription factors that regulate myogenesis. Accordingly, HB-EGF synthesis was analyzed in 10T1/2 cells and C2C12 cells which are used commonly for the study of myogenesis, HB-EGF gene expression was upregulated in both cell types during myogenesis. In 10T1/2 cells, direct activation of HB-EGF gene expression by MyoD was shown in that: i) transient transfection of these cells with a plasmid expressing MyoD resulted in a 10-20-fold increase in endogenous HB-EGF mRNA levels; ii) co-transfection of MyoD and an HE EGF promoter-reporter plasmid resulted in a 5-10-fold increase in reporter activity, an increase that was abrogated by deletion of a putative HB-EGF proximal E-box sequence; and iii) incubation of MyoD protein with a 25-base pair double stranded oligonucleotide corresponding to the HB-EGF proximal E-box sequence resulted in retarded electrophoretic mobility of the oligonucleotide. In C2C12 cells, differentiation of myoblasts into myotubes resulted in a 40-50 fold increase in HB-EGF promoter activity, In addition, immunostaining and laser confocal microscopy detected HB-EGF protein in C2C12 myotubes but not in myoblasts, The HB-EGF produced was in its transmembrane form and localized to the myotube surface, Taken together, it was concluded that during skeletal muscle cell differentiation, MyoD plays a direct role in activating HB-EGF gene expression and that HB-EGF protein is expressed preferentially in myotubes and in its membrane-anchored form.	CHILDRENS HOSP,DEPT SURG,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,SURG RES LAB,BOSTON,MA 02129	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital				Deutsch, Urban/0000-0003-4265-6262	NATIONAL CANCER INSTITUTE [R01CA037392, R56CA037392, R37CA037392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047397] Funding Source: NIH RePORTER; NCI NIH HHS [CA37392] Funding Source: Medline; NIGMS NIH HHS [GM47397] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM JA, 1993, BIOCHEM BIOPH RES CO, V190, P125, DOI 10.1006/bbrc.1993.1020; BESNER G, 1990, CELL REGUL, V1, P811, DOI 10.1091/mbc.1.11.811; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BLOTNICK S, 1994, P NATL ACAD SCI USA, V91, P2890, DOI 10.1073/pnas.91.8.2890; BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BRENNAN TJ, 1991, P NATL ACAD SCI USA, V88, P3822, DOI 10.1073/pnas.88.9.3822; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V161, P156; CLEGG CH, 1987, J CELL BIOL, V105, P949, DOI 10.1083/jcb.105.2.949; COVAULT J, 1986, J CELL BIOL, V102, P716, DOI 10.1083/jcb.102.3.716; DAS SK, 1994, DEVELOPMENT, V120, P1071; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DLUZ SM, 1993, J BIOL CHEM, V268, P18330; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; FEN Z, 1993, BIOCHEMISTRY-US, V32, P7932, DOI 10.1021/bi00082a014; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; FLORKIEWICZ RZ, 1991, ANN NY ACAD SCI, V638, P109, DOI 10.1111/j.1749-6632.1991.tb49022.x; FOX JC, 1994, MOL CELL BIOL, V14, P4244, DOI 10.1128/MCB.14.6.4244; GHOSH D, 1990, NUCLEIC ACIDS RES, V18, P1749, DOI 10.1093/nar/18.7.1749; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HIGASHIYAMA S, 1993, J CELL BIOL, V122, P933, DOI 10.1083/jcb.122.4.933; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; HIGASHIYAMA S, 1995, J CELL BIOL, V128, P929, DOI 10.1083/jcb.128.5.929; HSU SM, 1981, AM J CLIN PATHOL, V75, P734, DOI 10.1093/ajcp/75.5.734; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; KINGSTON RE, 1992, CURRENT PROTOCOLS MO, P481; KUME N, 1994, J CLIN INVEST, V93, P907, DOI 10.1172/JCI117047; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; MARIKOVSKY M, 1993, P NATL ACAD SCI USA, V90, P3889, DOI 10.1073/pnas.90.9.3889; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; MESRI EA, 1994, J CELL SCI, V107, P2559; MINER JH, 1990, P NATL ACAD SCI USA, V87, P1089, DOI 10.1073/pnas.87.3.1089; MITAMURA T, 1995, J BIOL CHEM, V270, P1015, DOI 10.1074/jbc.270.3.1015; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; NAKANO T, 1993, J BIOL CHEM, V268, P22941; NAKANO T, 1994, P NATL ACAD SCI USA, V268, P22941; OLWIN BB, 1992, J CELL BIOL, V118, P631, DOI 10.1083/jcb.118.3.631; ONO M, 1994, J BIOL CHEM, V269, P31315; POWELL PP, 1993, AM J PATHOL, V147, P784; RAAB G, 1994, BIOCHEM BIOPH RES CO, V204, P592, DOI 10.1006/bbrc.1994.2500; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; TEMIZER DH, 1992, J BIOL CHEM, V267, P24892; THOMPSON SA, 1994, J BIOL CHEM, V269, P2541; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; YOSHIZUMI M, 1992, J BIOL CHEM, V267, P9467; ZUK A, 1989, J CELL BIOL, V108, P903, DOI 10.1083/jcb.108.3.903	53	53	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18285	18294		10.1074/jbc.270.31.18285	http://dx.doi.org/10.1074/jbc.270.31.18285			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629148	hybrid			2022-12-27	WOS:A1995RM64200023
J	BLIN, N; YUN, J; WESS, J				BLIN, N; YUN, J; WESS, J			MAPPING OF SINGLE AMINO-ACID-RESIDUES REQUIRED FOR SELECTIVE ACTIVATION OF G(Q/11) BY THE M3 MUSCARINIC ACETYLCHOLINE-RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; HUMAN BETA-2-ADRENERGIC RECEPTOR; SITE-DIRECTED MUTAGENESIS; PROTEIN-COUPLED RECEPTORS; PHOSPHATIDYLINOSITOL HYDROLYSIS; CYTOPLASMIC DOMAINS; LIGAND-BINDING; SUBTYPES; REGIONS; GENES	Each G protein coupled receptor can interact only with a limited number of the many structurally similar G proteins expressed within a cell. This study was undertaken to identify single amino acids required for selectively coupling the m3 muscarinic acetylcholine receptor to G proteins of the G(q/11) family. To this goal, distinct intracellular segments/amino acids of the m3 receptor were systematically substituted into the structurally closely related m2 muscarinic receptor, which couples to G(i/o) proteins, not G(q/11) proteins. The resultant mutant receptors were expressed in COS-7 cells and studied for their ability to induce agonist-dependent stimulation of phosphatidylinositol hydrolysis, a response known to be mediated by G proteins of the G(q/11) class. Using this approach, we were able to identify four amino acids in the second intracellular loop and four amino acids at the C terminus of the third intracellular loop of the m3 muscarinic receptor that are essential for efficient G(q/11) activation. We could demonstrate that these amino acids, together with a short segment at the N terminus of the third intracellular loop, fully account for the G protein coupling preference of the m3 muscarinic receptor. Taken together, our data strongly suggest that only a limited number of amino acids, located on different intracellular regions, are required to determine the functional profile of a given G protein-coupled receptor.	NIDDK,BIOORGAN CHEM LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)								BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BERSTEIN G, 1992, J BIOL CHEM, V267, P8081; BLUML K, 1994, J BIOL CHEM, V269, P402; BLUML K, 1994, P NATL ACAD SCI USA, V91, P7980, DOI 10.1073/pnas.91.17.7980; BLUML K, 1994, J BIOL CHEM, V269, P11537; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURSTEIN ES, 1995, J BIOL CHEM, V270, P3141, DOI 10.1074/jbc.270.7.3141; CHEUNG AH, 1992, MOL PHARMACOL, V41, P1061; COTECCHIA S, 1992, J BIOL CHEM, V267, P1633; COTECCHIA S, 1990, P NATL ACAD SCI USA, V87, P2896, DOI 10.1073/pnas.87.8.2896; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DELLACQUA ML, 1993, J BIOL CHEM, V268, P5676; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; DORJE F, 1991, J PHARMACOL EXP THER, V256, P727; FRASER CM, 1989, MOL PHARMACOL, V36, P840; HEDIN KE, 1993, CELL SIGNAL, V5, P505, DOI 10.1016/0898-6568(93)90046-O; Higuchi R., 1989, PCR TECHNOLOGY, P61; HOGGER P, 1995, J BIOL CHEM, V270, P7405; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; KUNKEL MT, 1993, EMBO J, V12, P3809, DOI 10.1002/j.1460-2075.1993.tb06059.x; LECHLEITER J, 1990, EMBO J, V9, P4381, DOI 10.1002/j.1460-2075.1990.tb07888.x; LIGGETT SB, 1991, J BIOL CHEM, V266, P4816; MORO O, 1993, J BIOL CHEM, V268, P6862; MORO O, 1993, J BIOL CHEM, V268, P22273; MUNCH G, 1991, EUR J BIOCHEM, V198, P357, DOI 10.1111/j.1432-1033.1991.tb16023.x; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; OFFERMANNS S, 1994, MOL PHARMACOL, V45, P890; OKAMOTO T, 1992, J BIOL CHEM, V267, P8342; PARKER EM, 1991, J BIOL CHEM, V266, P519; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; PERALTA EG, 1988, NATURE, V334, P434, DOI 10.1038/334434a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAVARESE TM, 1992, BIOCHEM J, V283, P1; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; TOBIN AB, 1993, J BIOL CHEM, V268, P9817; WATSON S, 1994, G PROTEIN LINKED REC, P1; WESS J, 1989, FEBS LETT, V258, P133, DOI 10.1016/0014-5793(89)81633-3; WESS J, 1990, MOL PHARMACOL, V38, P517; WESS J, 1990, MOL PHARMACOL, V38, P872; WESS J, 1993, TRENDS PHARMACOL SCI, V14, P308, DOI 10.1016/0165-6147(93)90049-P; WONG SKF, 1990, J BIOL CHEM, V265, P6219; ZHU SZ, 1994, MOL PHARMACOL, V45, P517	48	105	113	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17741	17748		10.1074/jbc.270.30.17741	http://dx.doi.org/10.1074/jbc.270.30.17741			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629074	hybrid			2022-12-27	WOS:A1995RM26600020
J	BROWNAUGSBURGER, P; TISDALE, C; BROEKELMANN, T; SLOAN, C; MECHAM, RP				BROWNAUGSBURGER, P; TISDALE, C; BROEKELMANN, T; SLOAN, C; MECHAM, RP			IDENTIFICATION OF AN ELASTIN CROSS-LINKING DOMAIN THAT JOINS 3 PEPTIDE CHAINS - POSSIBLE ROLE IN NUCLEATED ASSEMBLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODEL	The alignment of elastin molecules in the mature elastic fiber was investigated by purifying and sequencing crosslink-containing peptides generated by proteolytic digestion of incompletely cross-linked insoluble elastin. Peptides of interest were purified by reverse phase and size exclusion high performance liquid chromatography and characterized by amino acid analysis and protein sequencing. One peptide, consisting of the cross-linking domain encoded by exon 10, contained a modified lysine residue that had not condensed to form a polyfunctional cross link. Although this domain contains the characteristic paired lysine residues found in other cross-linking domains of elastin, protein sequence analysis indicated that the first but not the second lysine had been oxidized by lysyl oxidase. This finding suggests that lysine residues in an individual cross-linking domain may not have equal susceptibility to oxidation by lysyl oxidase. In a second peptide, we found that a major cross-linking site in elastin is formed through the association of sequences encoded by exons 10, 19, and 25 and that the three chains are joined together by one desmosine and two lysinonor-leucine cross-links. Past structural studies and computer modeling predict that domains 19 and 25 are linked by a desmosine cross-link, while domain 10 bridges domains 19 and 25 through lysinonorleucine cross-links. These findings, together with the high degree of sequence conservation for these three domains, suggest an important function for these regions of the molecule, possibly nucleating the aggregation and polymerization of tropoelastin monomers in the developing elastic fiber.	WASHINGTON UNIV,SCH MED,DEPT CELL BIOL & PHYSIOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MED,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026499, R37HL053325, R01HL053325] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-26499, HL-53325] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAIG KM, 1980, BIOCHEM J, V185, P611, DOI 10.1042/bj1850611; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; BROWNAUGSBURGER P, 1994, J BIOL CHEM, V269, P28443; FOSTER JA, 1976, BIOPOLYMERS, V15, P833, DOI 10.1002/bip.1976.360150503; FOSTER JA, 1974, J BIOL CHEM, V249, P6191; GALLOP PM, 1972, ANNU REV BIOCHEM, V41, P617, DOI 10.1146/annurev.bi.41.070172.003153; GERBER GE, 1975, BIOCHEM J, V149, P685, DOI 10.1042/bj1490685; GERBER GE, 1974, J BIOL CHEM, V249, P5200; Gray W R, 1977, Adv Exp Med Biol, V79, P285; GRAY WR, 1973, NATURE, V246, P461, DOI 10.1038/246461a0; GRAY WR, 1968, NATURE, V220, P1300, DOI 10.1038/2201300a0; INDIK Z, 1990, GENES EXTRACELLULAR, P221; Mecham R. P., 1994, EXTRACELLULAR MATRIX, P281; MECHAM RP, 1978, BIOCHEM J, V173, P617, DOI 10.1042/bj1730617; MECHAM RP, 1979, BIOCHIM BIOPHYS ACTA, V577, P147, DOI 10.1016/0005-2795(79)90017-5; PARTRIDGE SM, 1964, BIOCHEM J, V93, pC30; PARTRIDGE SM, 1955, BIOCHEM J, V61, P11, DOI 10.1042/bj0610011; PIERCE RA, 1990, BIOCHEMISTRY-US, V29, P9677, DOI 10.1021/bi00493a024; RAJU K, 1987, J BIOL CHEM, V262, P5755; REISER K, 1992, FASEB J, V6, P2439, DOI 10.1096/fasebj.6.7.1348714; Sandberg LB., 1984, PEPTIDES PROTEIN REV, V3, P169	21	122	127	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17778	17783		10.1074/jbc.270.30.17778	http://dx.doi.org/10.1074/jbc.270.30.17778			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629078	hybrid			2022-12-27	WOS:A1995RM26600025
J	BRYANT, SS; BRIGGS, S; SMITHGALL, TE; MARTIN, GA; MCCORMICK, F; CHANG, JH; PARSONS, SJ; JOVE, R				BRYANT, SS; BRIGGS, S; SMITHGALL, TE; MARTIN, GA; MCCORMICK, F; CHANG, JH; PARSONS, SJ; JOVE, R			2 SH2 DOMAINS OF P120 RAS GTPASE-ACTIVATING PROTEIN BIND SYNERGISTICALLY TO TYROSINE-PHOSPHORYLATED P190 RHO-GTPASE-ACTIVATING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTORS; GAP-ASSOCIATED PROTEINS; SRC-TRANSFORMED-CELLS; C-TERMINAL DOMAIN; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; P21 GTPASE; KINASES; P62	p120 GTPase-activating protein (GAP) is a negative regulator of Pas that functions at a key relay point in signal transduction pathways that control cell proliferation. Among other proteins, p120 GAP associates with p190, a GAP for the Pas-related protein, Rho. To characterize the p120 . p190 interaction further, we used bacterially expressed glutathione S-transferase fusion polypeptides to map the regions of p120 necessary for its interactions with p190. Our results show that both the N-terminal and the C-terminal SH2 domains of p120 are individually capable of binding p190 expressed in a baculovirus/insect cell system. Moreover, the two SH2 domains together on one polypeptide bind synergistically to p190, and this interaction is dependent on tyrosine phosphorylation of p190. In addition, mutation of the highly conserved Arg residues in the critical FLVR sequences of both SH2 domains of full-length p120 reduces binding to tyrosine-phosphorylated p190. The dependence on p190 phosphorylation for complex formation with p120 . SH2 domains observed in vitro is consistent with analysis of the native p120 . p190 complexes formed in vivo. These findings suggest that SH2-phosphotyrosine interaction is one mechanism by which the cell regulates p120 p190 association and thus may be a means for coordinating the Ras- and Rho-mediated signaling pathways.	UNIV MICHIGAN,SCH MED,DEPT MICROBIOL & IMMUNOL,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,MOLEC & CELLULAR BIOL PROGRAM,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,CTR COMPREHENS CANC,ANN ARBOR,MI 48109; UNIV NEBRASKA,MED CTR,EPPLEY INST RES CANC,OMAHA,NE 68198; ONYX PHARMACEUT,RICHMOND,CA 94806; UNIV VIRGINIA,HLTH SCI CTR,DEPT MICROBIOL,CHARLOTTESVILLE,VA 22908	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Medical Center; University of Virginia				Briggs, Scott D/0000-0003-2852-3594	NCI NIH HHS [CA58667, CA39438, CA55652] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058667, R01CA055652, R01CA039438] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; BIRGE RB, 1993, SCIENCE, V262, P1522, DOI 10.1126/science.7504323; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BROTT BK, 1991, P NATL ACAD SCI USA, V88, P755, DOI 10.1073/pnas.88.3.755; CHANG JH, 1995, METHOD ENZYMOL, V254, P430; CHANG JH, 1993, ONCOGENE, V8, P959; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; DECLUE JE, 1991, MOL CELL BIOL, V11, P2819, DOI 10.1128/MCB.11.5.2819; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; FOSTER R, 1994, MOL CELL BIOL, V14, P7173, DOI 10.1128/MCB.14.11.7173; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; HEIDECKER G, 1992, ADV CANCER RES, V58, P53, DOI 10.1016/S0065-230X(08)60290-0; HJERMSTAD SJ, 1993, BIOCHEMISTRY-US, V32, P10519, DOI 10.1021/bi00090a031; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAWAI S, 1980, J VIROL, V34, P772, DOI 10.1128/JVI.34.3.772-776.1980; KAZLAUSKAS A, 1990, SCIENCE, V247, P1578, DOI 10.1126/science.2157284; KOCH CA, 1992, MOL CELL BIOL, V12, P1366, DOI 10.1128/MCB.12.3.1366; KUNG HF, 1986, EXP CELL RES, V162, P363, DOI 10.1016/0014-4827(86)90341-1; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MARENGERE LEM, 1992, J BIOL CHEM, V267, P22779; MARENGERE LEM, 1994, NATURE, V369, P502, DOI 10.1038/369502a0; MARSHALL MS, 1989, EMBO J, V8, P1105, DOI 10.1002/j.1460-2075.1989.tb03480.x; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; MCGLADE J, 1993, EMBO J, V12, P3073, DOI 10.1002/j.1460-2075.1993.tb05976.x; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; MORAN MF, 1991, MOL CELL BIOL, V11, P1804, DOI 10.1128/MCB.11.4.1804; MORAN MF, 1990, P NATL ACAD SCI USA, V87, P8622, DOI 10.1073/pnas.87.21.8622; MUSACCHIO A, 1992, NATURE, V359, P851, DOI 10.1038/359851a0; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; PARK S, 1992, J BIOL CHEM, V267, P11612; PARK S, 1992, J BIOL CHEM, V267, P17194; PARK S, 1993, J BIOL CHEM, V268, P25728; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROBERTS TM, 1992, NATURE, V360, P534, DOI 10.1038/360534a0; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; STACEY DW, 1987, EXP CELL RES, V171, P232, DOI 10.1016/0014-4827(87)90266-7; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0	47	41	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17947	17952		10.1074/jbc.270.30.17947	http://dx.doi.org/10.1074/jbc.270.30.17947			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629101	hybrid			2022-12-27	WOS:A1995RM26600051
J	ZHU, ZX; BAO, ZH; LI, JX				ZHU, ZX; BAO, ZH; LI, JX			MACMARCKS MUTATION BLOCKS MACROPHAGE PHAGOCYTOSIS OF ZYMOSAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN-KINASE-C; RECEPTOR-MEDIATED PHAGOCYTOSIS; PLASMA-MEMBRANE; HUMAN-MONOCYTES; MARCKS FAMILY; ACTIVATION; CALMODULIN; SUBSTRATE; PHOSPHORYLATION; ERYTHROCYTES	A major protein kinase C substrate, MacMARCKS (F52, MPR), was examined for its role in phagocytosis. In macrophage-phagocytosing zymosan particles, MacMARCKS was concentrated around nascent phagosomes as detected by immunofluorescent microscopy. The effector domain of MacMARCKS contains the phosphorylation sites, a calmodulin binding site, as well as a putative actin binding site. Stable J774 macrophage cell lines constitutively expressing effector domain deletion mutants of MacMARCKS were generated. When given zymosan particles, these transfectants showed approximately a 90% reduction in their phagocytic capacity. The receptor-mediated endocytosis of acetylated low density lipoproteins, however, was not affected by the mutant. These results strongly suggest the involvement of MacMARCKS in macrophage phagocytosis.	UNIV TENNESSEE,COLL MED,DEPT MICROBIOL & IMMUNOL,MEMPHIS,TN 38163	University of Tennessee System; University of Tennessee Health Science Center								ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; ADEREM AA, 1986, P NATL ACAD SCI USA, V83, P5817, DOI 10.1073/pnas.83.16.5817; ALPUCHEARANDA CM, 1994, J EXP MED, V179, P601, DOI 10.1084/jem.179.2.601; ARAI H, 1989, BIOCHEM BIOPH RES CO, V159, P1375, DOI 10.1016/0006-291X(89)92262-6; BLACKSHEAR PJ, 1992, J BIOL CHEM, V267, P13540; BLACKSHEAR PJ, 1993, J BIOL CHEM, V268, P1501; COSTA TE, 1992, J EXP MED, V175, P1669, DOI 10.1084/jem.175.6.1669; FRANCIS CL, 1993, NATURE, V364, P639, DOI 10.1038/364639a0; GEORGE DJ, 1989, J BIOL CHEM, V267, P24879; GRAFF JM, 1989, SCIENCE, V246, P503, DOI 10.1126/science.2814478; GREENBERG S, 1988, Journal of Cell Biology, V107, p453A; GREENBERG S, 1994, J BIOL CHEM, V269, P3897; GREENBERG S, 1990, J EXP MED, V172, P1853, DOI 10.1084/jem.172.6.1853; GREENBERG S, 1991, J IMMUNOL METHODS, V139, P115, DOI 10.1016/0022-1759(91)90358-M; GRESHAM HD, 1990, J BIOL CHEM, V265, P7819; GRIFFIN FM, 1975, J EXP MED, V142, P1263, DOI 10.1084/jem.142.5.1263; GRIFFIN FM, 1976, J EXP MED, V144, P788, DOI 10.1084/jem.144.3.788; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; HINRICHSEN RD, 1993, P NATL ACAD SCI USA, V90, P1585, DOI 10.1073/pnas.90.4.1585; KIM JY, 1994, BIOPHYS J, V67, P227, DOI 10.1016/S0006-3495(94)80473-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI JX, 1992, CELL, V70, P791, DOI 10.1016/0092-8674(92)90312-Z; LIAO GJ, 1994, BLOOD, V83, P2294; LIU YC, 1990, TRENDS PHARMACOL SCI, V11, P107; MITCHELL MA, 1994, BLOOD, V84, P1753; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; ROSEN A, 1990, J EXP MED, V172, P1211, DOI 10.1084/jem.172.4.1211; ROSS GD, 1985, J IMMUNOL, V134, P3307; SAWAI T, 1993, J BIOL CHEM, V268, P1995; Silverstein SC, 1989, FUNDAMENTAL IMMUNOLO, P703; SPEERT DP, 1985, J LEUKOCYTE BIOL, V38, P665; STACEY KJ, 1993, IMMUNOL CELL BIOL, V71, P75, DOI 10.1038/icb.1993.8; SUZUKI K, 1990, BIOCHIM BIOPHYS ACTA, V1042, P210, DOI 10.1016/0005-2760(90)90010-U; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; UMEKAGE T, 1991, FEBS LETT, V286, P147, DOI 10.1016/0014-5793(91)80961-2; WRIGHT SD, 1982, J EXP MED, V156, P1149, DOI 10.1084/jem.156.4.1149; ZHELEZNYAK A, 1992, J BIOL CHEM, V267, P12042; ZIGMOND SH, 1972, EXP CELL RES, V73, P383, DOI 10.1016/0014-4827(72)90062-6	38	50	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17652	17655		10.1074/jbc.270.30.17652	http://dx.doi.org/10.1074/jbc.270.30.17652			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629059	hybrid			2022-12-27	WOS:A1995RM26600004
J	KRUEGER, JK; PADRE, RC; STULL, JT				KRUEGER, JK; PADRE, RC; STULL, JT			INTRASTERIC REGULATION OF MYOSIN LIGHT-CHAIN KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRACHEAL SMOOTH-MUSCLE; BASIC RESIDUES; CALMODULIN BINDING; PROTEIN-KINASE; PHOSPHORYLATION; AUTOINHIBITION; RECOGNITION; ACTIVATION; SEQUENCE; LOCATION	Ca2+/calmodulin activates myosin light chain kinase by reversal of an autoinhibited state. The effects of substitution mutations on calmodulin activation properties implicate 4 of the 8 basic residues between the catalytic core and the calmodulin-binding domain in maintaining autoinhibition. These residues are further amino-terminal to the basic residues comprising the previously proposed pseudosubstrate sequence and suggest involvement of the connecting region in intrasteric autoinhibition. The pseudosubstrate model for autoinhibition proposes that basic residues within the autoinhibitory region mimic basic residues in the substrate and bind to defined acidic residues within the catalytic core, Charge reversal mutations of these specific acidic residues, however, had little or no effect on the K-m value for regulatory light chain. From a total of 20 acidic residues on the surface of the substrate binding lobe of the catalytic core, 7 are implicated in binding directly or indirectly to the autoinhibitory domain but not to the light chain. Only 2 acidic residues near the catalytic site may bind to the autoinhibitory domain and the arginine at P-3 in the light chain. Exposure of these 2 residues upon calmodulin binding may be necessary and sufficient for light chain phosphorylation.			KRUEGER, JK (corresponding author), UNIV TEXAS,SW MED CTR,DEPT PHYSIOL,5323 HARRY HINES BLVD,DALLAS,TX 75235, USA.		Krueger, Joanna/A-3110-2011		NHLBI NIH HHS [HL26043, T32-HL07360, F32 HL08874] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL026043, R01HL026043, T32HL007360, F32HL008874] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BLUMENTHAL DK, 1980, BIOCHEMISTRY-US, V19, P5608, DOI 10.1021/bi00565a023; FAUX MC, 1993, MOL CELL BIOCHEM, V128, P81, DOI 10.1007/BF01076759; FITZSIMONS DP, 1992, J BIOL CHEM, V267, P23903; GALLAGHER PJ, 1993, J BIOL CHEM, V268, P26578; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23936; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23945; GRIBSKOV M, 1986, NUCLEIC ACIDS RES, V14, P6745, DOI 10.1093/nar/14.16.6745; HERRING BP, 1991, J BIOL CHEM, V266, P11838; HERRING BP, 1992, J BIOL CHEM, V267, P25945; HERRING BP, 1990, J BIOL CHEM, V265, P16588; HU SH, 1994, NATURE, V369, P581, DOI 10.1038/369581a0; IKEBE M, 1989, J BIOL CHEM, V264, P6967; IKEBE M, 1987, J BIOL CHEM, V262, P13828; ITO M, 1991, BIOCHEMISTRY-US, V30, P3498, DOI 10.1021/bi00228a021; KEMP BE, 1983, P NATL ACAD SCI-BIOL, V80, P7471, DOI 10.1073/pnas.80.24.7471; KEMP BE, 1985, J BIOL CHEM, V260, P3355; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KEMP BE, 1994, TRENDS BIOCHEM SCI, V19, P440, DOI 10.1016/0968-0004(94)90126-0; KEMP BE, 1991, BIOCHIM BIOPHYS ACTA, V1094, P67, DOI 10.1016/0167-4889(91)90027-U; KEMP BE, 1987, J BIOL CHEM, V262, P2542; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; MILLER JR, 1983, MOL PHARMACOL, V24, P235; PEARSON RB, 1988, SCIENCE, V241, P970, DOI 10.1126/science.3406746; POTTER JD, 1975, J BIOL CHEM, V250, P4628; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHOEMAKER MO, 1990, J CELL BIOL, V111, P1107, DOI 10.1083/jcb.111.3.1107; Smith T.F., 1981, ADV APPL MATH, V2, P482, DOI DOI 10.1016/0196-8858(81)90046-4; STULL JT, 1990, J BIOL CHEM, V265, P16683; STULL JT, 1995, IN PRESS 1995 INT S; WALSH MP, 1982, BIOCHEMISTRY-US, V21, P1919, DOI 10.1021/bi00537a034; YANO K, 1993, BIOCHEMISTRY-US, V32, P12054, DOI 10.1021/bi00096a016; ZHI G, 1994, J BIOL CHEM, V40, P24723	35	32	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16848	16853		10.1074/jbc.270.28.16848	http://dx.doi.org/10.1074/jbc.270.28.16848			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622500	hybrid			2022-12-27	WOS:A1995RJ34700061
J	MIGEON, JC; THOMAS, SL; NATHANSON, NM				MIGEON, JC; THOMAS, SL; NATHANSON, NM			DIFFERENTIAL COUPLING OF M2 AND M4 MUSCARINIC RECEPTORS TO INHIBITION OF ADENYLYL-CYCLASE BY G(I)ALPHA AND G(O)ALPHA SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SPECIFIC EXPRESSION; ACETYLCHOLINE-RECEPTOR; SIGNAL-TRANSDUCTION; G-PROTEINS; CHICK HEART; ALPHA-SUBUNITS; GENE; SUBTYPES; CLONING; FAMILY	We compared the G-protein requirements for coupling of human and chicken m2 and m4 muscarinic acetylcholine receptors (mAChRs) to inhibition of adenylyl cyclase, using a luciferase reporter gene under the transcriptional control of a cAMP response element as a sensitive monitor of intracellular cAMP levels. Previously, we used this system to demonstrate that the chick m4 receptor preferentially coupled to G(i) alpha-2 and G(o) alpha over G(i) alpha-1 and G(i) alpha-3. We found that both the chick and human m2 mAChRs can couple to G(i) alpha-1, G(i) alpha-2, G(i) alpha-3, and G(o) alpha, while the human m4 mAChR preferentially couples to G(i) alpha-2 and G(o) alpha. Both the G(o1) and G(o2) forms of the G(o) alpha subunit were effective in reconstituting coupling of the m2 and m4 mAChRs to inhibit adenylyl cyclase activity. The m2 and m4 mAChRs thus couple to inhibition of adenylyl cyclase by overlapping but different sets of G-protein alpha subunits.	UNIV WASHINGTON,DEPT PHARMACOL,SEATTLE,WA 98195	University of Washington; University of Washington Seattle					NIGMS NIH HHS [GM07108, GM07750] Funding Source: Medline; NINDS NIH HHS [NS07332] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASHKENAZI A, 1989, NATURE, V340, P146, DOI 10.1038/340146a0; BEALS CR, 1987, P NATL ACAD SCI USA, V84, P7886, DOI 10.1073/pnas.84.22.7886; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; DAY RN, 1989, J BIOL CHEM, V264, P431; DELLACQUA ML, 1993, J BIOL CHEM, V268, P5676; DITTMAN AH, 1994, BIOCHEMISTRY-US, V33, P943, DOI 10.1021/bi00170a013; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; JOCKERS R, 1994, J BIOL CHEM, V269, P32077; JONES DT, 1987, J BIOL CHEM, V262, P14241; JONES SVP, 1991, MOL PHARMACOL, V40, P242; KLEUSS C, 1992, NATURE, V358, P424, DOI 10.1038/358424a0; KLEUSS C, 1991, NATURE, V353, P43, DOI 10.1038/353043a0; KLEUSS C, 1993, SCIENCE, V259, P832, DOI 10.1126/science.8094261; KUBO T, 1986, FEBS LETT, V209, P367, DOI 10.1016/0014-5793(86)81144-9; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; LUETJE CW, 1987, BIOCHEMISTRY-US, V26, P6892, DOI 10.1021/bi00396a003; MIGEON JC, 1994, J BIOL CHEM, V269, P9767; MIGEON JC, 1994, J BIOL CHEM, V269, P29146; MONTMAYEUR JP, 1993, MOL ENDOCRINOL, V7, P161, DOI 10.1210/me.7.2.161; NOVOTNY E, 1989, TRENDS PHARM S, V4; OFFERMANNS S, 1994, MOL PHARMACOL, V45, P890; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; PARKER EM, 1991, J BIOL CHEM, V266, P519; PEI L, 1991, MOL ENDOCRINOL, V5, P521, DOI 10.1210/mend-5-4-521; PERALTA EG, 1988, NATURE, V334, P434, DOI 10.1038/334434a0; PERALTA EG, 1987, SCIENCE, V236, P600, DOI 10.1126/science.3107123; PERALTA EG, 1987, EMBO J, V6, P3923, DOI 10.1002/j.1460-2075.1987.tb02733.x; RICHARDSON RM, 1991, MOL PHARMACOL, V40, P908; SHAPIRO RA, 1988, J BIOL CHEM, V263, P18397; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SPIEGEL AM, 1992, ENDOCR REV, V13, P536, DOI 10.1210/er.13.3.536; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P6477, DOI 10.1073/pnas.87.17.6477; STRATHMANN M, 1989, P NATL ACAD SCI USA, V86, P7407, DOI 10.1073/pnas.86.19.7407; TIETJE KM, 1991, J BIOL CHEM, V266, P17382; TIETJE KM, 1990, J BIOL CHEM, V265, P2828; TOTA MR, 1990, MOL PHARMACOL, V37, P950; YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0	38	51	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16070	16074		10.1074/jbc.270.27.16070	http://dx.doi.org/10.1074/jbc.270.27.16070			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608168	hybrid			2022-12-27	WOS:A1995RH22600031
J	NAGAHARA, N; OKAZAKI, T; NISHINO, T				NAGAHARA, N; OKAZAKI, T; NISHINO, T			CYTOSOLIC MERCAPTOPYRUVATE SULFURTRANSFERASE IS EVOLUTIONARILY RELATED TO MITOCHONDRIAL RHODANESE - STRIKING SIMILARITY IN ACTIVE-SITE AMINO-ACID-SEQUENCE AND THE INCREASE IN THE MERCAPTOPYRUVATE SULFURTRANSFERASE ACTIVITY OF RHODANESE BY SITE-DIRECTED MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE LIVER RHODANESE; THIOSULFATE; SULFUR; MECHANISM; CATALYSIS; PROTEINS; COVALENT; CLONING	Rat liver mercaptopyruvate sulfurtransferase (MST) was purified to homogeneity. MST is very similar to rhodanese in physicochemical properties. Further, rhodanese cross-reacts with anti MST antibody. Both purified authentic MST and expressed rhodanese possess MST and rhodanese activities, although the ratio of rhodanese to MST activity is low in MST and high in rhodanese. In order to compare the active site regions of MST and rhodanese, the primary structure of a possible active site region of MST was determined. The sequence showed 66% homology with that of rat liver rhodanese. An active site cysteine residue (Cys(246); site of formation of persulfide in catalysis) and an arginine residue (Arg(185); substrate binding site) in rhodanese were also conserved in MST. On the other hand, two other active site residues (Arg(247), and Lys(248)) were replaced by Gly and Ser, respectively. Conversion of rhodanese to MST was tried by site-directed mutagenesis. After cloning of rat liver rhodanese, recombinant wild type and three mutants (Arg(247) --> Gly and/or Lys(248) --> Ser) were constructed. The enzymes were expressed in Escherichia coli strain BL21(DE3) with a T7 promoter system. The mutation of these residues decreases rhodanese activity and increases MST activity.	NIPPON MED COLL, DEPT BIOCHEM & MOLEC BIOL, BUNKYO KU, TOKYO 113, JAPAN	Nippon Medical School								DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; FASTH A, 1973, BIOCHEM PHARMACOL, V22, P1337, DOI 10.1016/0006-2952(73)90308-0; FINAZZIAGRO A, 1971, FEBS LETT, V16, P172; HIRANO H, 1989, J PROTEIN CHEM, V8, P115, DOI 10.1007/BF01025083; HOROWITZ P, 1970, J BIOL CHEM, V245, P984; JARABAK R, 1980, BIOCHEMISTRY-US, V19, P900, DOI 10.1021/bi00546a012; JARABAK R, 1978, ARCH BIOCHEM BIOPHYS, V185, P458, DOI 10.1016/0003-9861(78)90189-3; KOHANSKI RA, 1990, J PROTEIN CHEM, V9, P369, DOI 10.1007/BF01024612; KOJ A, 1962, ACTA BIOCHIM POL, V9, P373; KUN E, 1957, BIOCHIM BIOPHYS ACTA, V25, P135, DOI 10.1016/0006-3002(57)90429-8; KUN E, 1959, BIOCHIM BIOPHYS ACTA, V32, P338, DOI 10.1016/0006-3002(59)90605-5; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang K, 1933, BIOCHEM Z, V259, P243; LUDEWIG S, 1950, ARCH BIOCHEM, V29, P441; LUO GX, 1994, J BIOL CHEM, V269, P8220; MEISTER A, 1954, J BIOL CHEM, V206, P561; Meister A., 1953, FED PROC, V12, P245; MILLER DM, 1992, BIOCHIM BIOPHYS ACTA, V1121, P286, DOI 10.1016/0167-4838(92)90158-A; MILLER DM, 1991, J BIOL CHEM, V266, P4686; Nishino T, 1986, Adv Exp Med Biol, V195 Pt B, P259; NISHINO T, 1983, P NATL ACAD SCI-BIOL, V80, P1826, DOI 10.1073/pnas.80.7.1826; PALLINI R, 1991, BIOCHEM BIOPH RES CO, V180, P887, DOI 10.1016/S0006-291X(05)81148-9; PLOEGMAN JH, 1978, J MOL BIOL, V123, P557, DOI 10.1016/0022-2836(78)90207-3; PLOEGMAN JH, 1979, J MOL BIOL, V127, P149, DOI 10.1016/0022-2836(79)90236-5; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; RUSSELL J, 1978, J BIOL CHEM, V253, P8102; SCHLESINGER P, 1974, J BIOL CHEM, V249, P780; SORBO B, 1954, ACTA CHEM SCAND, V8, P694, DOI 10.3891/acta.chem.scand.08-0694; SORBO BH, 1951, ACTA CHEM SCAND, V5, P724, DOI 10.3891/acta.chem.scand.05-0724; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1129, DOI 10.3891/acta.chem.scand.07-1129; VACHEK H, 1972, BIOCHIM BIOPHYS ACTA, V258, P133, DOI 10.1016/0005-2744(72)90973-4; VOLINI M, 1967, J BIOL CHEM, V242, P5220; WANG SF, 1968, J BIOL CHEM, V243, P5465; WASYLEWSKI Z, 1979, B ACAD POL SCI BIOL, V27, P807; WEILAND KL, 1991, BIOCHEM J, V275, P227, DOI 10.1042/bj2750227; WENG L, 1978, J BIOL CHEM, V253, P8109; WESTLEY J, 1962, J BIOL CHEM, V237, P547; WESTLEY J, 1971, J BIOL CHEM, V246, P1468; WOOD JL, 1953, J BIOL CHEM, V205, P231	40	127	133	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16230	16235		10.1074/jbc.270.27.16230	http://dx.doi.org/10.1074/jbc.270.27.16230			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608189	hybrid			2022-12-27	WOS:A1995RH22600054
J	PALLARD, C; GOUILLEUX, F; CHARON, M; GRONER, B; GISSELBRECHT, S; DUSANTERFOURT, I				PALLARD, C; GOUILLEUX, F; CHARON, M; GRONER, B; GISSELBRECHT, S; DUSANTERFOURT, I			INTERLEUKIN-3, ERYTHROPOIETIN, AND PROLACTIN ACTIVATE A STAT5-LIKE FACTOR IN LYMPHOID-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							COLONY-STIMULATING FACTOR; REGULATORY FACTOR-I; TYROSINE PHOSPHORYLATION; GROWTH-HORMONE; RECEPTOR; LINE; KINASE	Interleukin-3 (IL-3)-, erythropoietin (EPO)-, and prolactin (PRL)-induced signal transduction via the JAK/STAT pathway was studied in the IL-3-dependent BAF-3 lymphoid cell Line. Transfected cells expressing either the long form of the PRL receptor or the EPO receptor were used. We demonstrated that IL-3, EPO, and PRL activated a transcription factor related to the mammary transcription factor STATS but not to STAT1, -2, -3, or -4 as opposed to interferon gamma (IFN gamma) which activated STAT1 in the same cells. Similarly, PRL and EPO activated a STAT5-like factor (STAT5-L) in the rat Nb2 and the human UT7 cells expressing endogenous PRL and EPO receptors, respectively. The hematopoietic STAT5-L activated by IL-3, EPO, or PRL was identified as a 97-kDa tyrosine-phosphorylated protein. These results confer to STAT5 a much broader role than previously suggested.	HOP COCHIN,INST COCHIN GENET MOLEC,INSERM,U363,F-75014 PARIS,FRANCE; TUMOR BIOL CTR,INST EXPTL CANC RES,D-79106 FREIBURG,GERMANY	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite			Dusanter-Fourt, Isabelle/P-4558-2017	Dusanter-Fourt, Isabelle/0000-0002-9286-1021; Gouilleux, Fabrice/0000-0001-6047-1718				ALI S, 1991, J BIOL CHEM, V266, P20110; AZAM M, 1995, EMBO J, V14, P1402, DOI 10.1002/j.1460-2075.1995.tb07126.x; BAZANJF, 1989, P NATL ACAD SCI USA, V87, P6934; CAMPBELL GS, 1994, P NATL ACAD SCI USA, V91, P5232, DOI 10.1073/pnas.91.12.5232; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVID M, 1994, P NATL ACAD SCI USA, V91, P7174, DOI 10.1073/pnas.91.15.7174; DUSANTERFOURT I, 1992, J BIOL CHEM, V267, P10670; DUSANTERFOURT I, 1994, EMBO J, V13, P2583, DOI 10.1002/j.1460-2075.1994.tb06548.x; FINBLOOM DS, 1994, MOL CELL BIOL, V14, P2113, DOI 10.1128/MCB.14.3.2113; FUH G, 1993, J BIOL CHEM, V268, P5376; GALA RR, 1991, P SOC EXP BIOL MED, V198, P513; GILMOUR KC, 1994, P NATL ACAD SCI USA, V91, P6850, DOI 10.1073/pnas.91.15.6850; GOUILLEUX F, 1995, EMBO J, V14, P2005, DOI 10.1002/j.1460-2075.1995.tb07192.x; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; HARADA H, 1994, MOL CELL BIOL, V14, P1500, DOI 10.1128/MCB.14.2.1500; HERMINE O, 1992, BLOOD, V80, P3060; HOU JZ, 1994, SCIENCE, V265, P1701, DOI 10.1126/science.8085155; KELLY PA, 1991, ENDOCR REV, V12, P235, DOI 10.1210/edrv-12-3-235; KOMATSU N, 1991, CANCER RES, V51, P341; LARNER AC, 1993, SCIENCE, V261, P1730, DOI 10.1126/science.8378773; MUI ALF, 1995, EMBO J, V14, P1166, DOI 10.1002/j.1460-2075.1995.tb07100.x; ONEAL KD, 1994, J BIOL CHEM, V269, P26076; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; RAZ R, 1994, J BIOL CHEM, V269, P24391; RUI H, 1992, J BIOL CHEM, V267, P24076; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; SHIU RPC, 1983, ENDOCRINOLOGY, V113, P159, DOI 10.1210/endo-113-1-159; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; STANDKE GJR, 1994, MOL ENDOCRINOL, V8, P469, DOI 10.1210/me.8.4.469; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; YULEE LY, 1990, MOL CELL BIOL, V10, P3087, DOI 10.1128/MCB.10.6.3087	33	113	114	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15942	15945		10.1074/jbc.270.27.15942	http://dx.doi.org/10.1074/jbc.270.27.15942			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608147	hybrid, Green Published			2022-12-27	WOS:A1995RH22600008
J	RIFKIN, MR; STROBOS, CAM; FAIRLAMB, AH				RIFKIN, MR; STROBOS, CAM; FAIRLAMB, AH			SPECIFICITY OF ETHANOLAMINE TRANSPORT AND ITS FURTHER METABOLISM IN TRYPANOSOMA-BRUCEI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLINE TRANSPORT; RAT-LIVER; GLUCOSE-TRANSPORT; PHOSPHATIDYLETHANOLAMINE; BIOSYNTHESIS; CELLS; MEMBRANES; PHOSPHATIDYLCHOLINE; KINASE; GENE	Ethanolamine is found in trypanosomes as an integral component of the variant surface glycoprotein (VSG) and the membrane phospholipid phosphatidylethano-lamine (PE). Steps in the utilization of ethanolamine could represent novel targets for the development of chemotherapeutic drugs and were therefore investigated in detail. Transport of [H-3]ethanolamine was studied using structural analogs of ethanolamine. Compounds with substitutions in the amino group or of one of the methylene hydrogens of ethanolamine were the most effective inhibitors, Those analogs studied in detail with respect to their kinetic properties were all found to be competitive inhibitors of ethanolamine transport. Following uptake, ethanolamine is rapidly phosphorylated by an ethanolamine-specific kinase to form phosphoethanolamine. Other acid-soluble intermediates identified by thin layer chromatography were CDP-ethanolamine, dCDP-ethanolamine, and glycero-phosphorylethanolamine. The relative amounts of these metabolites varied between slender (dividing) and stumpy (non-dividing) trypanosomes and may reflect special biosynthetic needs of the different morphological forms, Pulse-chase experiments indicated that the acid-soluble metabolites served as precursors for chloroform/methanol-soluble Lipids. Radioactive lipids included PE, mono-methyl and dimethyl PE, and lysoPE. Further methylation of dimethylPE to phosphatidylcholine was not observed under the experimental conditions described. These results are consistent with the conclusion that trypanosomes are able to synthesize phospholipids via the Kennedy pathway.	ROCKEFELLER UNIV,MED BIOCHEM LAB,NEW YORK,NY 10021	Rockefeller University			Fairlamb, Alan/A-5272-2009	Fairlamb, Alan/0000-0001-5134-0329	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020324, R01AI021429] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-20324, AI-21429] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BABA S, 1984, CLIN CHIM ACTA, V136, P49, DOI 10.1016/0009-8981(84)90246-8; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BISHOP WR, 1988, ANNU REV CELL BIOL, V4, P579, DOI 10.1146/annurev.cb.04.110188.003051; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DIXON H, 1970, COMP BIOCHEM PHYSIOL, V33, P111, DOI 10.1016/0010-406X(70)90487-1; DODIA C, 1992, AM J RESP CELL MOL, V6, P426, DOI 10.1165/ajrcmb/6.4.426; ESKO JD, 1981, J BIOL CHEM, V256, P7388; FOLCH J, 1957, J BIOL CHEM, V226, P497; HIRATA F, 1980, SCIENCE, V209, P1082, DOI 10.1126/science.6157192; HOSAKA K, 1989, J BIOL CHEM, V264, P2053; INFANTE JP, 1984, FEBS LETT, V170, P1, DOI 10.1016/0014-5793(84)81358-7; JENNINGS FW, 1979, INT J PARASITOL, V9, P381, DOI 10.1016/0020-7519(79)90089-4; KANFER JN, 1980, CAN J BIOCHEM CELL B, V58, P1370, DOI 10.1139/o80-186; KANOSUEOKA T, 1983, J CELL PHYSIOL, V117, P109, DOI 10.1002/jcp.1041170115; KANOSUEOKA T, 1993, CELL GROWTH DIFFER, V4, P533; KENNEDY EP, 1959, J BIOL CHEM, V234, P1998; KRUSE T, 1985, J NEUROL SCI, V70, P129, DOI 10.1016/0022-510X(85)90082-6; LEVINE RF, 1981, INFECT IMMUN, V34, P513, DOI 10.1128/IAI.34.2.513-518.1981; LIPTON BA, 1988, J CELL PHYSIOL, V137, P571, DOI 10.1002/jcp.1041370325; MCGEE R, 1980, J NEUROCHEM, V35, P829, DOI 10.1111/j.1471-4159.1980.tb07079.x; MELLORS A, 1989, PARASITOL TODAY, V5, P239, DOI 10.1016/0169-4758(89)90255-X; MENON AK, 1993, EMBO J, V12, P1907, DOI 10.1002/j.1460-2075.1993.tb05839.x; MILLS GORDON C., 1960, TEXAS REPTS BIOL AND MED, V18, P43; NIKAWA J, 1990, J BIOL CHEM, V265, P15996; NIKAWA JI, 1986, J BACTERIOL, V166, P328, DOI 10.1128/jb.166.1.328-330.1986; OPPERDOES FR, 1984, FEBS LETT, V169, P35, DOI 10.1016/0014-5793(84)80284-7; PIERINGER RA, 1983, ENZYMES, V16, P255; PILCH PF, 1980, P NATL ACAD SCI-BIOL, V77, P915, DOI 10.1073/pnas.77.2.915; PLAGEMANN PG, 1969, BIOCHEMISTRY-US, V8, P4782, DOI 10.1021/bi00840a020; PORTER RK, 1992, J BIOL CHEM, V267, P14637; POTTER RL, 1958, J BIOL CHEM, V233, P462; POTTER RL, 1957, J BIOL CHEM, V226, P381; PU GAW, 1984, J NEUROCHEM, V42, P185, DOI 10.1111/j.1471-4159.1984.tb09715.x; RIDGWAY ND, 1988, J BIOL CHEM, V263, P16864; RIFKIN MR, 1985, MOL BIOCHEM PARASIT, V15, P245, DOI 10.1016/0166-6851(85)90088-X; SCHNEIDER WC, 1966, ANAL BIOCHEM, V14, P121, DOI 10.1016/0003-2697(66)90064-9; SCHNEIDER WC, 1958, J BIOL CHEM, V233, P948; SUNDLER R, 1973, BIOCHIM BIOPHYS ACTA, V306, P218, DOI 10.1016/0005-2760(73)90227-0; TIJBURG LBM, 1989, BIOCHIM BIOPHYS ACTA, V1004, P1, DOI 10.1016/0005-2760(89)90206-3; TURNER JD, 1970, ANAL BIOCHEM, V38, P423, DOI 10.1016/0003-2697(70)90467-7; VANCE JE, 1988, J BIOL CHEM, V263, P5898; VOELKER DR, 1984, P NATL ACAD SCI-BIOL, V81, P2669, DOI 10.1073/pnas.81.9.2669; WEINHOLD PA, 1972, BIOCHIM BIOPHYS ACTA, V276, P143, DOI 10.1016/0005-2744(72)90015-0; WEINHOLD PA, 1974, BIOCHEMISTRY-US, V13, P5135, DOI 10.1021/bi00722a013; WEISS SB, 1958, J BIOL CHEM, V231, P53; YOREK MA, 1986, J LIPID RES, V27, P1205; YULI I, 1981, BIOCHEMISTRY-US, V20, P4250, DOI 10.1021/bi00518a003	48	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16160	16166		10.1074/jbc.270.27.16160	http://dx.doi.org/10.1074/jbc.270.27.16160			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608181	hybrid			2022-12-27	WOS:A1995RH22600044
J	ZHAO, Y; NICHOLS, JE; BULUN, SE; MENDELSON, CR; SIMPSON, ER				ZHAO, Y; NICHOLS, JE; BULUN, SE; MENDELSON, CR; SIMPSON, ER			AROMATASE P450 GENE-EXPRESSION IN HUMAN ADIPOSE-TISSUE - ROLE OF A JAK/STAT PATHWAY IN REGULATION OF THE ADIPOSE-SPECIFIC PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RIBONUCLEIC-ACID; POLYMERASE CHAIN-REACTION; BREAST-CANCER CELLS; PLASMA ANDROSTENEDIONE; ESTROGEN BIOSYNTHESIS; MOLECULAR-CLONING; MONOLAYER-CULTURE; SKIN FIBROBLASTS; MENSTRUAL-CYCLE; ALTERNATIVE USE	In the present report we describe a heretofore unrecognized role for a Jak/STAT signaling pathway, namely the stimulation of expression of the aromatase P450 (CYP19) gene, and hence of estrogen biosynthesis, in human adipose tissue. Expression of this gene in adipose tissue as well as in adipose stromal cells maintained in the presence of serum and glucocorticoids is regulated by a distal TATA-less promoter, I.4, which contains a glucocorticoid response element, an Sp1 binding site, and an interferon-gamma activation site (GAS) element, The stimulatory action of serum (in the presence of dexamethasone) can be replaced by interleukin (IL)-11, leukemia inhibitory factor, and oncostatin-M, as web as by IL-6, providing the IL-6 soluble receptor is also present. Stimulation of the cells by these factors led to rapid phosphorylation of Jak1, but not Jak2 or Jab3, on tyrosine residues. STAT3 but not STAT1 was also phosphorylated and bound to the GAS element in the I.4 promoter region. When regions of this promoter were fused upstream of the chloramphenicol acetyltransferase reporter gene and transfected into the cells, mutagenesis or deletion of the GAS element led to complete loss of reporter gene expression. Since adipose tissue is the major site of estrogen biosynthesis in men and in postmenopausal women, this pathway involving a Jak/STAT signaling mechanism acting together with glucocorticoids and Sp1 appears to be the principal means whereby estrogen biosynthesis is regulated in the elderly.	UNIV TEXAS, SW MED CTR, CECIL H & IDA GREEN CTR REPROD BIOL SCI, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT OBSTET GYNECOL, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT BIOCHEM, DALLAS, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas				Mendelson, Carole Ruth/0000-0003-1696-9791	NIA NIH HHS [5-R37-AG08174] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R37AG008174] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ACKERMAN GE, 1981, J CLIN ENDOCR METAB, V53, P412, DOI 10.1210/jcem-53-2-412; BEADLING C, 1994, EMBO J, V13, P5605, DOI 10.1002/j.1460-2075.1994.tb06898.x; BERKOVITZ GD, 1989, J STEROID BIOCHEM, V33, P341, DOI 10.1016/0022-4731(89)90322-1; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; BULUN SE, 1993, J CLIN ENDOCR METAB, V77, P1622, DOI 10.1210/jc.77.6.1622; BULUN SE, 1994, TRENDS ENDOCRIN MET, V5, P113, DOI 10.1016/1043-2760(94)90092-2; BULUN SE, 1994, J CLIN ENDOCR METAB, V78, P428, DOI 10.1210/jc.78.2.428; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DICKSON RB, 1987, ENDOCR REV, V8, P29, DOI 10.1210/edrv-8-1-29; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOODY KJ, 1990, J CLIN ENDOCR METAB, V70, P1041, DOI 10.1210/jcem-70-4-1041; EDMAN CD, 1975, GASTROENTEROLOGY, V69, P819; EDMAN CD, 1978, AM J OBSTET GYNECOL, V130, P456, DOI 10.1016/0002-9378(78)90288-0; FITZPATRICK SL, 1993, MOL ENDOCRINOL, V7, P341, DOI 10.1210/me.7.3.341; GORDON GG, 1975, J CLIN ENDOCR METAB, V40, P1018, DOI 10.1210/jcem-40-6-1018; GRODIN JM, 1973, J CLIN ENDOCR METAB, V36, P207, DOI 10.1210/jcem-36-2-207; HARADA N, 1992, BIOCHEM BIOPH RES CO, V189, P1001, DOI 10.1016/0006-291X(92)92303-F; HARADA N, 1993, P NATL ACAD SCI USA, V90, P11312, DOI 10.1073/pnas.90.23.11312; HARADA N, 1990, BIOCHEM BIOPH RES CO, V166, P365, DOI 10.1016/0006-291X(90)91954-Q; HARLOW E, 1988, ANTIBODIES LABORATOR; HEMSELL DL, 1974, J CLIN ENDOCR METAB, V38, P476, DOI 10.1210/jcem-38-3-476; HILTON DJ, 1994, EMBO J, V13, P4765, DOI 10.1002/j.1460-2075.1994.tb06802.x; HONDA S, 1994, BIOCHEM BIOPH RES CO, V198, P1153, DOI 10.1006/bbrc.1994.1163; JENKINS C, 1993, MOL CELL ENDOCRINOL, V97, pR1, DOI 10.1016/0303-7207(93)90227-B; KELLER DC, 1993, BLOOD, V82, P1428; KELLIS JT, 1987, J BIOL CHEM, V262, P4413; KILGORE MW, 1992, MOL CELL ENDOCRINOL, V83, pR9, DOI 10.1016/0303-7207(92)90202-H; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; LANOUX MJ, 1985, ENDOCRINOLOGY, V117, P361, DOI 10.1210/endo-117-1-361; MACDONALD PC, 1979, J CLIN ENDOCR METAB, V49, P905, DOI 10.1210/jcem-49-6-905; MAHENDROO MS, 1993, J BIOL CHEM, V268, P19463; MAHENDROO MS, 1991, J BIOL CHEM, V266, P11276; MCNATTY KP, 1976, J ENDOCRINOL, V71, P77, DOI 10.1677/joe.0.0710077; MEANS GD, 1991, MOL ENDOCRINOL, V5, P2005, DOI 10.1210/mend-5-12-2005; MEANS GD, 1989, J BIOL CHEM, V264, P19385; MENDELSON CR, 1985, ARCH BIOCHEM BIOPHYS, V243, P480, DOI 10.1016/0003-9861(85)90525-9; Naftolin F, 1975, Recent Prog Horm Res, V31, P295; NAKAJIN S, 1986, BIOCHEM BIOPH RES CO, V134, P704, DOI 10.1016/S0006-291X(86)80477-6; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; ONEILL JS, 1988, BRIT MED J, V296, P741, DOI 10.1136/bmj.296.6624.741; PRICE T, 1992, J CLIN ENDOCR METAB, V74, P1247, DOI 10.1210/jc.74.6.1247; PRICE T, 1992, P SOC GYNECOL INVEST, V39, P179; REED MJ, 1993, J STEROID BIOCHEM, V44, P589, DOI 10.1016/0960-0760(93)90264-W; REED MJ, 1992, J ENDOCRINOL, V132, pR5, DOI 10.1677/joe.0.132R005; ROSELLI CE, 1985, ENDOCRINOLOGY, V117, P2471, DOI 10.1210/endo-117-6-2471; SASANO H, 1994, HUM PATHOL, V25, P530, DOI 10.1016/0046-8177(94)90127-9; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; SCHMIDT M, 1994, EUR J CELL BIOL, V63, P96; SIMPSON ER, 1981, P NATL ACAD SCI-BIOL, V78, P5690, DOI 10.1073/pnas.78.9.5690; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; STAHL N, 1993, CELL, V74, P587, DOI 10.1016/0092-8674(93)90506-L; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; THOMPSON EA, 1974, J BIOL CHEM, V249, P5364; THOMPSON EA, 1974, J BIOL CHEM, V249, P5373; TODA K, 1994, MOL ENDOCRINOL, V8, P210, DOI 10.1210/me.8.2.210; TODA K, 1993, EUR J BIOCHEM, V213, P383, DOI 10.1111/j.1432-1033.1993.tb17772.x; TODA K, 1990, EUR J BIOCHEM, V193, P559, DOI 10.1111/j.1432-1033.1990.tb19372.x; TSAIMORRIS CH, 1985, ENDOCRINOLOGY, V116, P31, DOI 10.1210/endo-116-1-31; ZHAO Y, 1995, MOL ENDOCRINOL, V9, P340, DOI 10.1210/me.9.3.340; ZHONG Z, 1994, P NATL ACAD SCI USA, V91, P4806, DOI 10.1073/pnas.91.11.4806	64	209	214	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16449	16457		10.1074/jbc.270.27.16449	http://dx.doi.org/10.1074/jbc.270.27.16449			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608217	hybrid			2022-12-27	WOS:A1995RH22600085
J	ENGEL, K; SCHULTZ, H; MARTIN, F; KOTLYAROV, A; PLATH, K; HAHN, M; HEINEMANN, U; GAESTEL, M				ENGEL, K; SCHULTZ, H; MARTIN, F; KOTLYAROV, A; PLATH, K; HAHN, M; HEINEMANN, U; GAESTEL, M			CONSTITUTIVE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN-KINASE-2 BY MUTATION OF PHOSPHORYLATION SITES AND AN A-HELIX MOTIF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE; HEAT-SHOCK; IDENTIFICATION; SUBUNIT; CELLS; RAF	A recently described downstream target of mitogen-activated protein kinases (MAPKs) is the MAPK-activated protein (MAPKAP) kinase 2 which has been shown to be responsible for small heat shock protein phosphorylation, We have analyzed the mechanism of MAPKAP kinase 2 activation by MAPK phosphorylation using a recombinant MAPKAP kinase 2-fusion protein, p44(MAPK) and p38/40(MAPK) in vitro and using an epitope-tagged MAPKAP kinase 2 in heat-shocked NIH 3T3 cells. It is demonstrated that, in addition to the known phosphorylation of the threonine residue carboxyl-terminal to the catalytic domain, Thr-317, activation of MAPKAP kinase 2 in vitro and in vivo is dependent on phosphorylation of a second threonine residue, Thr-205, which is located within the catalytic domain and which is highly conserved in several protein kinases. Constitutive activation of MAPKAP kinase 2 is obtained by replacement of both of these threonine residues by glutamic acid, A constitutively active form of MAPKAP kinase 2 is also obtained by deletion of a carboxyl-terminal region containing Thr-317 and the A-helix motif or by replacing the conserved residues of the A-helix, These data suggest a dual mechanism of MAPKAP kinase 2 activation by phosphorylation of Thr-205 inside the catalytic domain and by phosphorylation of Thr-317 outside the catalytic domain involving an autoinhibitory A-helix motif.	MAX DELBRUCK CENTRUM MOLEK MED, D-13122 BERLIN, GERMANY	Helmholtz Association; Max Delbruck Center for Molecular Medicine			Heinemann, Udo/AAH-4766-2019; Heinemann, Udo/S-3379-2016; Gaestel, Matthias/A-6560-2013	Heinemann, Udo/0000-0002-8191-3850; Heinemann, Udo/0000-0002-8191-3850; Gaestel, Matthias/0000-0002-4944-4652; Plath, Kathrin/0000-0001-7796-3372				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; CANO E, 1994, MOL CELL BIOL, V14, P7352, DOI 10.1128/MCB.14.11.7352; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P15180; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DUBOIS MF, 1993, FEBS LETT, V324, P191, DOI 10.1016/0014-5793(93)81391-C; ELION EA, 1995, TRENDS CELL BIOL, V5, P322, DOI 10.1016/S0962-8924(00)89055-8; ENGEL K, 1995, J CELL BIOCHEM, V57, P321, DOI 10.1002/jcb.240570216; ENGEL K, 1993, FEBS LETT, V336, P143, DOI 10.1016/0014-5793(93)81628-D; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FRESHNEY NW, 1994, CELL, V78, P1039, DOI 10.1016/0092-8674(94)90278-X; GAESTEL M, 1989, EUR J BIOCHEM, V179, P209, DOI 10.1111/j.1432-1033.1989.tb14542.x; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KEMP BE, 1991, METHOD ENZYMOL, V201, P287; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL CJ, 1994, NATURE, V367, P686, DOI 10.1038/367686a0; PAGES G, 1994, EMBO J, V13, P3003, DOI 10.1002/j.1460-2075.1994.tb06599.x; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PELECH SL, 1993, MOL CELL BIOCHEM, V128, P157, DOI 10.1007/BF01076767; PLATH K, 1994, BIOCHEM BIOPH RES CO, V203, P1188, DOI 10.1006/bbrc.1994.2308; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SODERLING TR, 1993, BIOTECHNOL APPL BIOC, V18, P185; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; STOKOE D, 1993, BIOCHEM J, V296, P843, DOI 10.1042/bj2960843; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; SUTHERLAND C, 1993, EUR J BIOCHEM, V212, P581, DOI 10.1111/j.1432-1033.1993.tb17696.x; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; VERON M, 1993, P NATL ACAD SCI USA, V90, P10618, DOI 10.1073/pnas.90.22.10618; VERON M, 1994, CELL MOL BIOL, V40, P587; WESTWICK JK, 1994, P NATL ACAD SCI USA, V91, P6030, DOI 10.1073/pnas.91.13.6030; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; ZU YL, 1994, BIOCHEM BIOPH RES CO, V200, P1118, DOI 10.1006/bbrc.1994.1566; ZU YL, 1995, J BIOL CHEM, V270, P202, DOI 10.1074/jbc.270.1.202	47	91	99	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27213	27221		10.1074/jbc.270.45.27213	http://dx.doi.org/10.1074/jbc.270.45.27213			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592979	hybrid			2022-12-27	WOS:A1995TE58300079
J	GORZOWSKI, JJ; ECKERLEY, CA; HALGREN, RG; MANGURTEN, AB; PHILLIPS, B				GORZOWSKI, JJ; ECKERLEY, CA; HALGREN, RG; MANGURTEN, AB; PHILLIPS, B			METHYLATION-ASSOCIATED TRANSCRIPTIONAL SILENCING OF THE MAJOR HISTOCOMPATIBILITY COMPLEX-LINKED HSP70 GENES IN MOUSE-CELL LINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK FACTOR; EMBRYONAL CARCINOMA-CELLS; DNA-BINDING; ERYTHROLEUKEMIA-CELLS; CHROMATIN STRUCTURE; CPG ISLANDS; ACTIVATION; EXPRESSION; PROMOTER; PROTEIN	The MHC-linked hsp70 locus consists of duplicated genes, hsp70.1 and hsp70.3, which in primary mouse embryo cells are highly heat shock-inducible. Several mouse cell lines in which hsp70 expression is not activated by heat shock have been described previously, but the basis for the deficiency has not been identified. In this study, genomic footprinting analysis has identified a common basis for the deficient response of the hsp70.1 gene to heat shock in four such cell lines, viz., the promoter is inaccessible to transcription factors, including heat shock transcription factor. Southern blot analyses reveal extensive CpG methylation of a 1.2-kilobase re region spanning the hsp70.1 transcription start site and hypermethylation of the adjacent hsp70.3 gene, which is presumably also inaccessible to regulatory factors. Of four additional, randomly chosen mouse cell lines, three show no or minimal hsp70.3 heat shock responsiveness and CpG methylation of both hsp70 genes, and two of the three lines exhibit a suboptimal hsp70.1 response to heat shock as well. In all three lines, the accessibility of the hsp70.1 promoter to transcription factors is detectable but clearly diminished (relative to that in primary mouse cells). Our results suggest that the tandem hsp70 genes are concomitantly methylated and transcriptionally repressed with high frequency in cultured mouse cells.	NORTHWESTERN UNIV,SCH MED,DEPT OBSTET & GYNECOL,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,DEPT CELL MOLEC & STRUCT BIOL,CHICAGO,IL 60611	Northwestern University; Northwestern University								ABRAVAYA K, 1991, MOL CELL BIOL, V11, P586, DOI 10.1128/MCB.11.1.586; AMIN J, 1988, MOL CELL BIOL, V8, P3761, DOI 10.1128/MCB.8.9.3761; ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; AUJAME L, 1985, MOL CELL BIOL, V5, P1780, DOI 10.1128/MCB.5.7.1780; AUJAME L, 1987, BIOCH CELL BIOL, V66, P691; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; BECKER PB, 1991, P NATL ACAD SCI USA, V88, P4109, DOI 10.1073/pnas.88.10.4109; BECKER PB, 1988, GENETIC ENG PRINCIPL, P1; BONAL FJ, 1986, J IMMUNOGENET, V13, P179; COSTELLO JF, 1994, J BIOL CHEM, V269, P17228; COSTELLO JF, 1994, MOL CELL BIOL, V14, P6515, DOI 10.1128/MCB.14.10.6515; DAVIDSON S, 1995, MOL CELL BIOL, V15, P1071; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HANSEN RS, 1988, MOL CELL BIOL, V8, P4692, DOI 10.1128/MCB.8.11.4692; HARRINGTON MA, 1988, P NATL ACAD SCI USA, V85, P2066, DOI 10.1073/pnas.85.7.2066; HENSOLD JO, 1990, MOL CELL BIOL, V10, P1600, DOI 10.1128/MCB.10.4.1600; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; HICKEY E, 1989, MOL CELL BIOL, V9, P2615, DOI 10.1128/MCB.9.6.2615; HOLLER M, 1988, GENE DEV, V2, P1127, DOI 10.1101/gad.2.9.1127; HORNSTRA IK, 1994, MOL CELL BIOL, V14, P1419, DOI 10.1128/MCB.14.2.1419; HUNT C, 1990, GENE, V87, P199, DOI 10.1016/0378-1119(90)90302-8; JAKOBSEN BK, 1988, MOL CELL BIOL, V8, P5040, DOI 10.1128/MCB.8.11.5040; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KASS SU, 1993, MOL CELL BIOL, V13, P7372, DOI 10.1128/MCB.13.12.7372; KINGSTON RE, 1987, MOL CELL BIOL, V7, P1530, DOI 10.1128/MCB.7.4.1530; LEE WH, 1994, P NATL ACAD SCI USA, V91, P11733, DOI 10.1073/pnas.91.24.11733; LI BY, 1994, J BIOL CHEM, V269, P7756; LOWE DG, 1986, J BIOL CHEM, V261, P2102; LU Q, 1993, MOL CELL BIOL, V13, P2802, DOI 10.1128/MCB.13.5.2802; MATHUR SK, 1994, P NATL ACAD SCI USA, V91, P8695, DOI 10.1073/pnas.91.18.8695; MERUELO D, 1986, P NATL ACAD SCI USA, V83, P4504, DOI 10.1073/pnas.83.12.4504; MEZGER V, 1987, DEV BIOL, V124, P544, DOI 10.1016/0012-1606(87)90507-0; MILNER CM, 1990, IMMUNOGENETICS, V32, P242; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; MORIMOTO RI, 1992, J BIOL CHEM, V267, P21987; MOSSER DD, 1988, MOL CELL BIOL, V8, P4736, DOI 10.1128/MCB.8.11.4736; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; MURPHY SP, 1988, P NATL ACAD SCI USA, V85, P5587, DOI 10.1073/pnas.85.15.5587; MURPHY SP, 1994, MOL CELL BIOL, V14, P5309, DOI 10.1128/MCB.14.8.5309; PEDERSON DS, 1994, MOL CELL BIOL, V14, P189, DOI 10.1128/MCB.14.1.189; PERRY MD, 1994, GENE, V146, P273, DOI 10.1016/0378-1119(94)90305-0; PFEIFER GP, 1990, GENE DEV, V4, P1277, DOI 10.1101/gad.4.8.1277; PIRITY M, 1993, EUR J BIOCHEM, V210, P793; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SARGE KD, 1991, GENE DEV, V5, P1902, DOI 10.1101/gad.5.10.1902; SARGENT CA, 1989, P NATL ACAD SCI USA, V86, P1968, DOI 10.1073/pnas.86.6.1968; SARGENT CA, 1989, EMBO J, V8, P2305, DOI 10.1002/j.1460-2075.1989.tb08357.x; SISTONEN L, 1992, MOL CELL BIOL, V12, P4104, DOI 10.1128/MCB.12.9.4104; SNOEK M, 1993, GENOMICS, V15, P350, DOI 10.1006/geno.1993.1067; TAYLOR ICA, 1991, GENE DEV, V5, P1285, DOI 10.1101/gad.5.7.1285; TOTH M, 1989, P NATL ACAD SCI USA, V86, P3728, DOI 10.1073/pnas.86.10.3728; TYKOCINSKI ML, 1984, NUCLEIC ACIDS RES, V12, P4385, DOI 10.1093/nar/12.10.4385; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; WU B, 1985, MOL CELL BIOL, V5, P330, DOI 10.1128/MCB.5.2.330; WU BJ, 1986, P NATL ACAD SCI USA, V83, P629, DOI 10.1073/pnas.83.3.629; WU C, 1984, NATURE, V309, P229, DOI 10.1038/309229a0; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; ZION M, 1994, P NATL ACAD SCI USA, V91, P10722, DOI 10.1073/pnas.91.22.10722	62	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26940	26949		10.1074/jbc.270.45.26940	http://dx.doi.org/10.1074/jbc.270.45.26940			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592940	hybrid			2022-12-27	WOS:A1995TE58300040
J	KAUPPINEN, S; CHRISTGAU, S; KOFOD, LV; HALKIER, T; DORREICH, K; DALBOGE, H				KAUPPINEN, S; CHRISTGAU, S; KOFOD, LV; HALKIER, T; DORREICH, K; DALBOGE, H			MOLECULAR-CLONING AND CHARACTERIZATION OF A RHAMNOGALACTURONAN ACETYLESTERASE FROM ASPERGILLUS-ACULEATUS - SYNERGISM BETWEEN RHAMNOGALACTURONAN DEGRADING ENZYMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIRY RAMIFIED REGIONS; LYASE GENE PELA; CELL-WALLS; NIGER; NIDULANS; PECTINS; EXPRESSION; ACID; POLYGALACTURONASES; TRANSFORMATION	A rhamnogalacturonan acetylesterase (RGAE) was purified to homogeneity from the filamentous fungus Aspergillus aculeatus, and the NH2-terminal amino acid sequence was determined, Full-length cDNAs encoding the enzyme were isolated from an A. aculeatus cDNA library using a polymerase chain reaction-generated product as a probe, The 936-base pair rha1 cDNA encodes a 25O-residue precursor protein of 26,350 Da, including a 17-amino acid signal peptide, The rha1 cDNA was overexpressed in Aspergillus oryzae, a filamentous fungus that does not possess RGAE activity, and the recombinant enzyme was purified and characterized, Mass spectrometry of the native and recombinant RGAE revealed that the enzymes are heterogeneously glycosylated, In addition, the observed differences in their molecular masses, lectin binding patterns, and monosaccharide compositions indicate that the glycan moieties on the two enzymes are structurally different, The RGAE was shown to act in synergy with rhamnogalacturonase A as well as rhamnogalacturonase B from A, aculeatus in the degradation of apple pectin rhamnogalacturonan. RNA gel blot analyses indicate that the expression of rhamnogalacturonan degrading enzymes by A, aculeatus is regulated at the level of transcription and is subjected to carbon catabolite repression by glucose.			KAUPPINEN, S (corresponding author), NOVO NORDISK AS,GENESEARCH,NOVO ALLE,BLDG 1B121,DK-2880 BAGSVAERD,DENMARK.							ANDERSON AJ, 1978, PHYTOPATHOLOGY, V68, P1585, DOI 10.1094/Phyto-68-1585; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BENSHALOM N, 1986, J FOOD SCI, V51, P720, DOI 10.1111/j.1365-2621.1986.tb13919.x; BUSSINK HJD, 1991, CURR GENET, V19, P467, DOI 10.1007/BF00312738; BUSSINK HJD, 1992, APPL MICROBIOL BIOT, V37, P324, DOI 10.1007/BF00210987; BUSSINK HJD, 1992, EUR J BIOCHEM, V208, P83, DOI 10.1111/j.1432-1033.1992.tb17161.x; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHRISTENSEN T, 1988, BIO-TECHNOL, V6, P1419, DOI 10.1038/nbt1288-1419; CHRISTGAU S, 1994, BIOCHEM MOL BIOL INT, V33, P917; Cooper RM, 1984, PLANT DIS INFECT DAM, P13; DALBOGE H, 1994, MOL GEN GENET, V243, P253, DOI 10.1007/BF00301060; DEAN RA, 1989, PLANT CELL, V1, P265, DOI 10.1105/tpc.1.3.265; DEAN RA, 1989, PLANT CELL, V1, P275, DOI 10.1105/tpc.1.3.275; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; HARMSEN JAM, 1990, CURR GENET, V18, P161, DOI 10.1007/BF00312604; KOFOD LV, 1994, J BIOL CHEM, V269, P29182; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANKARIOS AT, 1980, PHYSIOL PLANT PATHOL, V17, P93, DOI 10.1016/0048-4059(80)90010-7; MAY GS, 1985, J CELL BIOL, V101, P712, DOI 10.1083/jcb.101.3.712; MUTTER M, 1994, PLANT PHYSIOL, V106, P241, DOI 10.1104/pp.106.1.241; Nirpjit S, 1996, J GEN MICROBIOL, V18, P1435; ONeill M., 1990, METHODS PLANT BIOCH, V2, P415, DOI [DOI 10.1016/B978-0-12-461012-5.50018-5, 10.1016/b978-0-12-461012-5.50018-5]; PILNIK W, 1979, POLYSACCHARIDES FOOD, P109; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOLS HA, 1994, CARBOHYD RES, V256, P97, DOI 10.1016/0008-6215(94)84230-2; SCHOLS HA, 1990, CARBOHYD RES, V206, P105, DOI 10.1016/0008-6215(90)84010-R; SCHOLS HA, 1990, CARBOHYD RES, V206, P117, DOI 10.1016/0008-6215(90)84011-I; SEARLEVANLEEUWE.MJ, 1992, APPL MICROBIOL BIOT, V38, P347; SIESSERE V, 1992, J GEN MICROBIOL, V138, P1801, DOI 10.1099/00221287-138-9-1801; SIGGAARDANDERSE.M, 1991, P NATL ACAD SCI USA, V88, P4114, DOI 10.1073/pnas.88.10.4114; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAHARA T, 1975, J FERMENT TECHNOL, V53, P409; THIBAULT JF, 1993, CARBOHYD RES, V238, P271, DOI 10.1016/0008-6215(93)87019-O; THOMAS PS, 1983, METHOD ENZYMOL, V100, P255; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; YELTON MM, 1984, P NATL ACAD SCI-BIOL, V81, P1470, DOI 10.1073/pnas.81.5.1470	40	56	64	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27172	27178		10.1074/jbc.270.45.27172	http://dx.doi.org/10.1074/jbc.270.45.27172			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592973	hybrid			2022-12-27	WOS:A1995TE58300073
J	WONG, MH; OELKERS, P; DAWSON, PA				WONG, MH; OELKERS, P; DAWSON, PA			IDENTIFICATION OF A MUTATION IN THE ILEAL SODIUM-DEPENDENT BILE-ACID TRANSPORTER GENE THAT ABOLISHES TRANSPORT ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLINE RESIDUES; MEMBRANE; PROTEINS; MALABSORPTION; EXPRESSION; CLONING; VESICLES; DIARRHEA; GLUCOSE; SYSTEM	The ileal Na+/bile acid cotransporter plays a critical role in the reabsorption of bile acids from the small intestine. In the course of cloning and characterizing the human ileal Na+/bile acid cotransporter cDNA, a dysfunctional isoform was identified in a patient diagnosed with Crohn's disease. Expression studies using hamster-human ileal Na+/bile acid cotransporter cDNA chimeras narrowed the location of the defect to the carboxyl-terminal 94 amino acids. Comparison of the sequence of the dysfunctional isoform to that of a wild-type human ileal Na+/bile acid cotransporter genomic clone revealed a single C to T transition resulting in a proline to serine substitution at amino acid position 290. The inheritance of this mutation in the proband's family was confirmed by single-stranded conformation polymorphism analysis and DNA sequencing. In transfected COS-l cells, the single amino acid change abolished taurocholate transport activity but did not alter the transporter's synthesis or subcellular distribution. This dysfunctional mutation represents the first known molecular defect in a human sodium-dependent bile acid transporter.			WONG, MH (corresponding author), WAKE FOREST UNIV, BOWMAN GRAY SCH MED, DEPT INTERNAL MED, DIV GASTROENTEROL, WINSTON SALEM, NC 27157 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047987, R29DK047987, F31DK008718] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK47987, R29 DK047987, DK08718] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BRANDL CJ, 1986, P NATL ACAD SCI USA, V83, P917, DOI 10.1073/pnas.83.4.917; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; DAWSON PA, 1991, J BIOL CHEM, V266, P9128; Dawson Paul A., 1995, Current Opinion in Lipidology, V6, P109, DOI 10.1097/00041433-199504000-00009; DONALDSON RM, 1989, GASTROINTESTINAL DIS, P127; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; HAGENBUCH B, 1994, J CLIN INVEST, V93, P1326, DOI 10.1172/JCI117091; HEUBI JE, 1982, GASTROENTEROLOGY, V83, P804; HOFMANN AF, 1993, GASTROINTESTINAL DIS, P127; KESSLER M, 1978, BIOCHIM BIOPHYS ACTA, V506, P136, DOI 10.1016/0005-2736(78)90440-6; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LACHMANN PJ, 1986, CIBA F SYMP, V119, P25; LANTZ LM, 1995, BIOTECHNIQUES, V18, P56; LODISH HF, 1983, NATURE, V304, P80, DOI 10.1038/304080a0; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; REIZER J, 1994, BBA-REV BIOMEMBRANES, V1197, P133, DOI 10.1016/0304-4157(94)90003-5; Sambrook J, 1989, MOL CLONING LABORATO; SANSOM MSP, 1992, PROTEIN ENG, V5, P53, DOI 10.1093/protein/5.1.53; SHNEIDER BL, 1995, J CLIN INVEST, V95, P745, DOI 10.1172/JCI117722; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; SMALL DM, 1972, ARCH INTERN MED, V130, P552, DOI 10.1001/archinte.130.4.552; STRAUSS WM, 1994, CURRENT PROTOCOLS MO; THAYSEN EH, 1973, DAN MED BULL, V20, P174; THAYSEN EH, 1985, SCAND J GASTROENTERO, V20, P452, DOI 10.3109/00365528509089679; TURK E, 1994, J BIOL CHEM, V269, P15204; TURK E, 1991, NATURE, V350, P354, DOI 10.1038/350354a0; VANTILBURG AJP, 1992, SCAND J GASTROENTERO, V27, P66, DOI 10.3109/00365529209096030; VANTILBURG AJP, 1991, GUT, V32, P500, DOI 10.1136/gut.32.5.500; WEINBERG SL, 1986, J CLIN INVEST, V78, P44, DOI 10.1172/JCI112571; WILSON FA, 1991, HDB PHYSL GASTROINTE, V4, P389; WONG MH, 1994, J BIOL CHEM, V269, P1340; XU SY, 1986, GENE ANAL TECH, V3, P90	35	189	197	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27228	27234		10.1074/jbc.270.45.27228	http://dx.doi.org/10.1074/jbc.270.45.27228			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592981	hybrid			2022-12-27	WOS:A1995TE58300081
J	ZHELKOVSKY, AM; KESSLER, MM; MOORE, CL				ZHELKOVSKY, AM; KESSLER, MM; MOORE, CL			STRUCTURE-FUNCTION-RELATIONSHIPS IN THE SACCHAROMYCES-CEREVISIAE POLY(A) POLYMERASE - IDENTIFICATION OF A NOVEL RNA-BINDING SITE AND A DOMAIN THAT INTERACTS WITH SPECIFICITY FACTOR(S)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; GEL ELECTROPHORESIS; VACCINIA VIRUS; 3' END; POLYADENYLATION; EXPRESSION; GENE; SEPARATION	We have constructed deletions in the nonconserved regions at the amino and carboxyl ends of the poly(A) polymerase (PAP) of Saccharomyces cerevisiae and examined the effects of these truncations on function of the enzyme, PAP synthesizes a poly(A) tail onto the 3'-end of RNA without any primer specificity but, in the presence of cellular factors, is directed specifically to the cleaved ends of mRNA precursors, The last 31 amino acids of PAP are dispensable for both nonspecific and specific activities, Removal of the next 36 amino acids affects an RNA binding domain, which is essential for the activity of the enzyme and for cell viability. This novel RNA binding site was further localized using additional deletions, cyanogen bromide cleavage of PAP cross-linked with RNA or 8-azido-ATP, and a monoclonal antibody against a COOH-terminal PAP epitope, A deletion that partially disrupts this domain has reduced nonspecific activity but functions in specific polyadenylation. In contrast, deletion of the first 18 amino acids of PAP has no effect on nonspecific polyadenylation but completely eliminates specific activity. This region is essential for enzyme function in vivo and is probably involved in the interaction of PAP with other protein(s) of the polyadenylation machinery.	TUFTS UNIV,SCH MED,DEPT MOLEC MICROBIOL,BOSTON,MA 02111	Tufts University					NIGMS NIH HHS [R01 GM41752] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041752] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE A, 1990, EMBO J, V9, P3691, DOI 10.1002/j.1460-2075.1990.tb07581.x; BALLANTYNE S, 1995, RNA, V1, P64; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAO GJ, 1992, P NATL ACAD SCI USA, V89, P10380, DOI 10.1073/pnas.89.21.10380; CHEN J, 1992, MOL CELL BIOL, V12, P3470, DOI 10.1128/MCB.12.8.3470; DAYHUFF TJ, 1992, BIOTECHNIQUES, V13, P499; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; GERSHON PD, 1991, CELL, V66, P1269, DOI 10.1016/0092-8674(91)90048-4; GUNDERSON SI, 1994, CELL, V76, P531, DOI 10.1016/0092-8674(94)90116-3; GUTHRIE C, 1991, METHOD ENZYMOL, V194, P94; GUTHRIE C, 1991, METHOD ENZYMOL, V194, P186; KELLER W, 1995, CELL, V81, P829, DOI 10.1016/0092-8674(95)90001-2; KESSLER MM, 1995, BIOCHEMISTRY-US, V34, P1750, DOI 10.1021/bi00005a032; LINGNER J, 1991, NATURE, V354, P496, DOI 10.1038/354496a0; LINGNER J, 1991, J BIOL CHEM, V266, P8741; LINGNER J, 1993, NUCLEIC ACIDS RES, V21, P2917, DOI 10.1093/nar/21.12.2917; LIU J, 1988, J BACTERIOL, V171, P1254; Maniatis T., 1982, MOL CLONING; MINVIELLESEBAST.L, 1994, SCIENCE, V266, P1702; NEVINS JR, 1977, J BIOL CHEM, V252, P6939; NIKODEM V, 1979, ANAL BIOCHEM, V97, P382, DOI 10.1016/0003-2697(79)90089-7; POTTER RL, 1983, METHOD ENZYMOL, V91, P613; PREKER PJ, 1995, CELL, V81, P379, DOI 10.1016/0092-8674(95)90391-7; RAABE T, 1994, MOL CELL BIOL, V14, P2946, DOI 10.1128/MCB.14.5.2946; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; SADHALE PP, 1991, NUCLEIC ACIDS RES, V19, P3683, DOI 10.1093/nar/19.13.3683; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; THURESSON AC, 1994, P NATL ACAD SCI USA, V91, P979, DOI 10.1073/pnas.91.3.979; WAHLE E, 1991, EMBO J, V10, P4251, DOI 10.1002/j.1460-2075.1991.tb05003.x; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; WAHLE E, 1995, BBA-GENE STRUCT EXPR, V1261, P183, DOI 10.1016/0167-4781(94)00248-2	34	41	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 3	1995	270	44					26715	26720		10.1074/jbc.270.44.26715	http://dx.doi.org/10.1074/jbc.270.44.26715			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TC978	7592899	hybrid			2022-12-27	WOS:A1995TC97800106
J	BERGHOFER, J; KARNAUCHOV, I; HERRMANN, RG; KLOSGEN, RB				BERGHOFER, J; KARNAUCHOV, I; HERRMANN, RG; KLOSGEN, RB			ISOLATION AND CHARACTERIZATION OF A CDNA-ENCODING THE SECA PROTEIN FROM SPINACH-CHLOROPLASTS - EVIDENCE FOR AZIDE RESISTANCE OF SEC-DEPENDENT PROTEIN TRANSLOCATION ACROSS THYLAKOID MEMBRANES IN SPINACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING COMPLEX; ESCHERICHIA-COLI; TRANSIT PEPTIDE; PHOSPHATE TRANSLOCATOR; NUCLEOTIDE-SEQUENCE; PRECURSOR PROTEIN; LUMENAL PROTEINS; PROTON GRADIENT; IMPORT; TRANSPORT	Thylakoid membranes of chloroplasts in higher plants harbor different pathways for the translocation of proteins. One of these routes is related to the prokaryotic Sec pathway, which mediates the secretion of particular proteins into the periplasmic space and involves the SecA protein as an essential component. We have isolated a full size cDNA of 3739 nucleotides encoding the SecA homologue from spinach. It contains an open reading frame of 1036 codons corresponding to a polypeptide with a calculated mass of 117 kDa. The deduced amino acid sequence shows between 45 and 49% identity to SecA proteins from bacteria and lower algae and 62% identity to SecA of the cyanobacterium Synechococcus sp. PCC7942. Compared with the Escherichia coli protein, spinach SecA carries an amino-terminal extension of approximately 80 residues. In organello experiments performed with the protein made in vitro by transcription of the cDNA and cell-free translation of the resulting RNA showed that this extension comprises a transit peptide that mediates the import of the protein into the chloroplast. The processed product of approximately 107 kDa accumulates predominantly in the stroma and to a lower extent associates with the thylakoid membrane. Comparably to E. coli, in which SecA activity can be inhibited by sodium azide, thylakoid translocation of a subset of lumenal proteins is sensitive to sodium azide in pea but not in spinach chloroplasts, suggesting that the latter contain an azide-resistant SecA variant.	UNIV MUNICH, INST BOT, D-80638 MUNICH, GERMANY	University of Munich								CAI D, 1993, PLANT J, V3, P383, DOI 10.1046/j.1365-313X.1993.t01-21-00999.x; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; CLAUSMEYER S, 1993, J BIOL CHEM, V268, P13869; CLINE K, 1992, J BIOL CHEM, V267, P2688; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; FLUGGE UI, 1989, EMBO J, V8, P39, DOI 10.1002/j.1460-2075.1989.tb03346.x; FRANKLIN AE, 1993, J BIOL CHEM, V268, P22175; HAEHNEL W, 1994, EMBO J, V13, P1028, DOI 10.1002/j.1460-2075.1994.tb06351.x; HAGEMAN J, 1990, PLANT CELL, V2, P479, DOI 10.1105/tpc.2.5.479; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HENRY R, 1994, J BIOL CHEM, V269, P10189; HULFORD A, 1994, J BIOL CHEM, V269, P3251; JAMES HE, 1989, J BIOL CHEM, V264, P19573; KARNAUCHOV I, 1994, J BIOL CHEM, V269, P32871; KIM YJ, 1994, CELL, V78, P845; KLOSGEN RB, 1992, PLANT MOL BIOL, V18, P1031, DOI 10.1007/BF00019226; KNOTT TG, 1994, J BIOL CHEM, V269, P7843; KO K, 1989, EMBO J, V8, P3187, DOI 10.1002/j.1460-2075.1989.tb08477.x; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KROLKIEWICZ S, 1994, MOL GEN GENET, V245, P565, DOI 10.1007/BF00282219; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPPA GK, 1988, J BIOL CHEM, V263, P14996; LUTCKE HA, 1987, EMBO J, V6, P43, DOI 10.1002/j.1460-2075.1987.tb04716.x; MANT A, 1994, J BIOL CHEM, V269, P27303; MICHL D, 1994, EMBO J, V13, P1310, DOI 10.1002/j.1460-2075.1994.tb06383.x; MOULD RM, 1991, J BIOL CHEM, V266, P17286; MOULD RM, 1991, J BIOL CHEM, V266, P12189; NAKAI M, 1994, J BIOL CHEM, V269, P31338; NAKAI M, 1994, BIOCHEM BIOPH RES CO, V200, P844, DOI 10.1006/bbrc.1994.1528; NIELSEN VS, 1994, J BIOL CHEM, V269, P3762; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; ROBINSON C, 1994, EMBO J, V13, P279, DOI 10.1002/j.1460-2075.1994.tb06260.x; ROBINSON C, 1994, PLANT MOL BIOL, V26, P15, DOI 10.1007/BF00039516; SADAIE Y, 1991, GENE, V98, P101; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCARAMUZZI CD, 1992, CURR GENET, V22, P421, DOI 10.1007/BF00352444; SCHMIDT MG, 1988, J BACTERIOL, V170, P3404, DOI 10.1128/jb.170.8.3404-3414.1988; SEIDLER A, 1990, EMBO J, V9, P1743, DOI 10.1002/j.1460-2075.1990.tb08298.x; SMEEKENS S, 1986, CELL, V46, P365, DOI 10.1016/0092-8674(86)90657-4; THEG SM, 1989, J BIOL CHEM, V264, P6730; VALENTIN K, 1993, MOL GEN GENET, V236, P245, DOI 10.1007/BF00277119; VIITANEN PV, 1988, J BIOL CHEM, V263, P15000; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; WILLEY DL, 1991, PLANTA, V183, P451, DOI 10.1007/BF00197745; YUAN JG, 1994, SCIENCE, V266, P796, DOI 10.1126/science.7973633	49	30	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18341	18346		10.1074/jbc.270.31.18341	http://dx.doi.org/10.1074/jbc.270.31.18341			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629156	hybrid			2022-12-27	WOS:A1995RM64200032
J	SAVES, I; BURLETSCHILTZ, O; SWAREN, P; LEFEVRE, F; MASSON, JM; PROME, JC; SAMAMA, JP				SAVES, I; BURLETSCHILTZ, O; SWAREN, P; LEFEVRE, F; MASSON, JM; PROME, JC; SAMAMA, JP			THE ASPARAGINE TO ASPARTIC-ACID SUBSTITUTION AT POSITION-276 OF TEM-35 AND TEM-36 IS INVOLVED IN THE BETA-LACTAMASE RESISTANCE TO CLAVULANIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; ACTIVE-SITE; ARGININE-244; INACTIVATION; CONSTRUCTION; RESOLUTION; GENES; TEM1	TEM-35 (inhibitor resistant TEM (IRT)-4) and TEM-36 (IRT-7) clavulanic acid-resistant beta-lactamases have evolved from TEM-1 beta-lactamase by two substitutions: a methionine to a leucine or a valine at position 69 and an asparagine to an aspartic acid at position 276. The substitutions at position 69 have previously been shown to be responsible for the resistance to clavulanic acid, and they are the only mutations encountered in TEM-33 (IRT-5) and TEM-34 (IRT-6). However, the N276D substitution has never been found alone in inhibitor-resistant beta-lactamases, and its role in resistance to clavulanic acid was thus unclear, The N276D mutant was constructed, purified, and kinetically characterized, It was shown that the substitution has a direct effect on substrate affinities and leads to slightly decreased catalytic efficiencies and that clavulanic acid becomes a poor substrate of the enzyme, Electrospray mass spectrometry demonstrated the simultaneous presence of free and inhibited enzymes after incubation with clavulanic acid and showed that a cleaved moiety of clavulanic acid leads to the formation of the major inactive complex, The kinetic properties of the N276D mutant could be linked to a salt-bridge interaction of aspartic acid 276 with arginine 244 that alters the electrostatic properties in the substrate binding area.	CNRS,PHARMACOL & TOXICOL FONDAMENTALES LAB,INGN PROT GRP,F-31077 TOULOUSE,FRANCE; CNRS,PHARMACOL & TOXICOL FONDAMENTALES LAB,CRISTALLOG BIOL GRP,F-31077 TOULOUSE,FRANCE; CNRS,PHARMACOL & TOXICOL FONDAMENTALES LAB,SPECTROMETRIE MASSE GRP,F-31077 TOULOUSE,FRANCE; INST NATL SCI APPL,F-31077 TOULOUSE,FRANCE	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National des Sciences Appliquees de Toulouse				Schiltz, Odile/0000-0002-3606-2356				AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; BELAAOUAJ A, 1994, FEMS MICROBIOL LETT, V120, P75; BLASQUEZ J, 1993, ANTIMICROB AGENTS CH, V37, P2059; BONOMO RA, 1995, BBA-PROTEIN STRUCT M, V1247, P121, DOI 10.1016/0167-4838(94)00188-M; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUN T, 1994, FEMS MICROBIOL LETT, V120, P111, DOI 10.1016/0378-1097(94)00186-3; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; CHARNAS RL, 1978, BIOCHEMISTRY-US, V17, P2185, DOI 10.1021/bi00604a025; CHEN CCH, 1992, J MOL BIOL, V224, P1103, DOI 10.1016/0022-2836(92)90472-V; DELAIRE M, 1992, J BIOL CHEM, V267, P20600; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; GILSON MK, 1987, J COMPUT CHEM, V9, P327; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; HENQUELL C, 1995, ANTIMICROB AGENTS CH, V39, P427, DOI 10.1128/AAC.39.2.427; IMTIAZ U, 1993, J AM CHEM SOC, V115, P4435, DOI 10.1021/ja00064a003; JACOBY GA, 1991, ANTIMICROB AGENTS CH, V35, P1697, DOI 10.1128/AAC.35.9.1697; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KITZ R, 1962, J BIOL CHEM, V237, P3245; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P482; LENFANT F, 1991, J BIOL CHEM, V266, P17187; LENFANT F, 1993, EUR J BIOCHEM, V217, P939, DOI 10.1111/j.1432-1033.1993.tb18324.x; LENFANT F, 1990, BIOCHIMIE, V72, P495, DOI 10.1016/0300-9084(90)90073-P; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; NORMANLY J, 1990, J MOL BIOL, V213, P719, DOI 10.1016/S0022-2836(05)80258-X; NORMANLY J, 1986, P NATL ACAD SCI USA, V83, P6548, DOI 10.1073/pnas.83.17.6548; PAUL GC, 1988, ANTIMICROB AGENTS CH, V33, P1958; SAMUNI A, 1975, ANAL BIOCHEM, V63, P17, DOI 10.1016/0003-2697(75)90185-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sharp K.A., 1989, DELPHI V 3 0 MANUAL; SOUGAKOFF W, 1989, FEMS MICROBIOL LETT, V56, P343; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; THOMSON CJ, 1992, FEMS MICROBIOL LETT, V91, P113; ZAFARALLA G, 1992, BIOCHEMISTRY-US, V31, P3847, DOI 10.1021/bi00130a016; ZHOU XY, 1994, ANTIMICROB AGENTS CH, V38, P1085, DOI 10.1128/AAC.38.5.1085	36	35	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18240	18245		10.1074/jbc.270.31.18240	http://dx.doi.org/10.1074/jbc.270.31.18240			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629142	hybrid			2022-12-27	WOS:A1995RM64200016
J	VOGEL, U; JENSEN, KF				VOGEL, U; JENSEN, KF			EFFECTS OF THE ANTITERMINATOR BOXA ON TRANSCRIPTION ELONGATION KINETICS AND PPGPP INHIBITION OF TRANSCRIPTION ELONGATION IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA TRANSCRIPTION; GUANOSINE TETRAPHOSPHATE; CHAIN ELONGATION; TERMINATION; OPERON; ORGANIZATION; TRANSLATION; EXPRESSION; COMPONENTS; POLYMERASE	It has been Shown previously that two different mRNA chains (lacZ and infB) are elongated at a rate of similar to 40 nucleotides (nt)/s during steady state growth on minimal medium and that the rate of mRNA chain elongation is inhibited by ppGpp in vivo. On the other hand, it was found that a truncated ribosomal RNA chain was elongated at a rate of similar to 80 nt/s, independent of growth condition (Vogel, U., and Jensen, K. F. (1994) J. Biol. Chem. 269, 16236-16241). We reasoned that the different transcriptional behavior of mRNA genes and rRNA operons might be caused by the antiterminator sequences present in the rRNA operons. To test this possibility, we have (a) inserted the minimal anti-terminator boxA sequence between the promoter and the lacZ and infB genes and (b) deleted the antiterminator sequences from the rRNA transcription unit and measured transcription elongation rates in vivo on the resulting hybrid genes. We found that insertion of boxA in front of the coding region of lacZ increased the transcription elongation rate from 42 nt/s to 69 nt/s during steady state growth and that it eliminated the ppGpp-dependent decrease in the transcription elongation rate during the stringent response. On the other hand, deletion of the antiterminator sequences hom the rRNA operon resulted in a reduced transcription elongation rate, but the elongation rate was still insensitive to changes in the ppGpp pool. These results are consistent with the hypothesis that the antiterminator boxA is a primary determinant of the rate of transcription elongation rate.	UNIV COPENHAGEN, INST MOLEC BIOL, CTR ENZYME RES, DK-1307 COPENHAGEN K, DENMARK	University of Copenhagen	VOGEL, U (corresponding author), UNIV COPENHAGEN, DEPT BIOL CHEM, SOLVGADE 83H, DK-1307 COPENHAGEN K, DENMARK.		Vogel, Ulla B/I-5048-2012; Vogel, Ulla/ABC-2212-2020	Vogel, Ulla B/0000-0001-6807-1524; Vogel, Ulla/0000-0001-6807-1524				AKSOY S, 1984, J BACTERIOL, V159, P260, DOI 10.1128/JB.159.1.260-264.1984; BARACCHINI E, 1988, J BIOL CHEM, V263, P2597; BERG KL, 1989, J MOL BIOL, V209, P345, DOI 10.1016/0022-2836(89)90002-8; Bremer H., 1987, ESCHERICHIA COLI SAL, V2, P1527, DOI [10.1046/j.1365-2486.2000.06017.x, DOI 10.1046/J.1365-2486.2000.06017.X]; BROSIUS J, 1981, J MOL BIOL, V148, P107, DOI 10.1016/0022-2836(81)90508-8; Cashel M, 1987, ESCHERICHIA COLI SAL, P1410; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; CONDON C, 1993, EMBO J, V12, P4305, DOI 10.1002/j.1460-2075.1993.tb06115.x; HASELTINE WA, 1973, P NATL ACAD SCI USA, V70, P1564, DOI 10.1073/pnas.70.5.1564; HORWITZ RJ, 1987, CELL, V51, P631, DOI 10.1016/0092-8674(87)90132-2; JENSEN KF, 1990, MICROBIOL REV, V54, P89, DOI 10.1128/MMBR.54.2.89-100.1990; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; KINGSTON RE, 1981, J BIOL CHEM, V256, P2787; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LEAVITT RI, 1962, J BACTERIOL, V83, P624, DOI 10.1128/JB.83.3.624-630.1962; LI SC, 1984, CELL, V38, P851, DOI 10.1016/0092-8674(84)90280-0; LINN T, 1985, PLASMID, V14, P134, DOI 10.1016/0147-619X(85)90073-3; PEDERSEN FS, 1973, NATURE-NEW BIOL, V243, P13; PLUMBRIDGE JA, 1983, J MOL BIOL, V167, P227, DOI 10.1016/S0022-2836(83)80333-7; SCHLEIF R, 1973, J BACTERIOL, V115, P9, DOI 10.1128/JB.115.1.9-14.1973; SORENSEN MA, 1994, J MOL BIOL, V236, P441, DOI 10.1006/jmbi.1994.1156; SORENSEN MA, 1993, ANTON LEEUW INT J G, V63, P323, DOI 10.1007/BF00871227; SQUIRES CL, 1993, P NATL ACAD SCI USA, V90, P970, DOI 10.1073/pnas.90.3.970; STENT GS, 1961, P NATL ACAD SCI USA, V47, P2005, DOI 10.1073/pnas.47.12.2005; SVITIL AL, 1993, J BIOL CHEM, V268, P2307; TEDIN K, 1992, J BIOL CHEM, V267, P2337; VIND J, 1993, J MOL BIOL, V231, P678, DOI 10.1006/jmbi.1993.1319; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994; VOGEL U, 1994, J BIOL CHEM, V269, P16236; VOGEL U, 1992, MOL MICROBIOL, V6, P2191, DOI 10.1111/j.1365-2958.1992.tb01393.x; XIAO H, 1991, J BIOL CHEM, V266, P5980; [No title captured]	33	62	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18335	18340		10.1074/jbc.270.31.18335	http://dx.doi.org/10.1074/jbc.270.31.18335			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629155	hybrid			2022-12-27	WOS:A1995RM64200031
J	JIANG, XC; BRUCE, C				JIANG, XC; BRUCE, C			REGULATION OF MURINE PLASMA PHOSPHOLIPID TRANSFER PROTEIN-ACTIVITY AND MESSENGER-RNA LEVELS BY LIPOPOLYSACCHARIDE AND HIGH CHOLESTEROL DIET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; ESTER TRANSFER PROTEIN; LIPID TRANSFER PROTEINS; ENDOTOXIN; RNA; ACYLTRANSFERASE; CONVERSION; EXCHANGE; LECITHIN; MOUSE	Plasma phospholipid transfer protein mediates the net movement of phospholipids between lipoproteins and between lipid bilayers and high density lipoprotein, In this study, the mouse phospholipid transfer protein cDNA was cloned by reverse transcription polymerase chain reactions based on the cDNA sequence of human phospholipid transfer protein, The predicted amino acid sequence of mouse phospholipid transfer protein shows the protein to be 476 amino acids long and to have a sequence identity of 83% with that of human phospholipid transfer protein, Mouse plasma phospholipid transfer protein activity is 1.5-2 times that of human plasma phospholipid transfer protein activity, As in humans, mouse peripheral tissues displayed a higher abundance of phospholipid transfer protein mRNA than observed in central organs, The order of phospholipid transfer protein mRNA expression was as follows: lung > adipose tissue, placenta, testis > brain > muscle, heart, liver, We examined the regulation of phospholipid transfer protein expression by dietary cholesterol and by bacterial lipopolysaccharide, A high fat, high cholesterol diet caused a significant increase (35%) in plasma phospholipid transfer protein activity and a significant increase (18%) in high density lipoprotein phospholipids. This increased activity was accompanied by similar to 100% increase in phospholipid transfer protein mRNA in lung, After lipopolysaccharide injection, plasma phospholipid transfer protein activity was decreased by similar to 66%, This decrease in activity was associated with a similar decrease in phospholipid transfer protein mRNA in lung, adipose tissue, and liver, The decrease in plasma phospholipid transfer protein activity was also associated with a significant increase (17%) in high density lipoprotein phospholipid concentration, The opposite changes in phospholipids levels with lipopolysaccharide treat ment and dietary cholesterol despite similarly increased high density lipoprotein phospholipids levels indicate that high density lipoprotein phospholipids levels are likely determined both by phospholipid transfer protein levels and by gradients of phospholipids concentration between high density lipoprotein and other phospholipids sources.			JIANG, XC (corresponding author), COLUMBIA UNIV,DEPT MED,DIV MOLEC MED,630 W 168TH ST,NEW YORK,NY 10032, USA.			Bruce, Can/0000-0002-3101-1250	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL054591, R01HL043165] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL54591, HL43165] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGELLON LB, 1990, BIOCHEMISTRY-US, V29, P1372, DOI 10.1021/bi00458a004; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BAGBY GJ, 1980, AM J PHYSIOL, V239, pH325; Brown ML, 1990, CURR OPIN LIPIDOL, V1, P122; DAY JR, 1994, J BIOL CHEM, V269, P9388; DULLAART RPF, 1994, ARTERIOSCLER THROMB, V14, P1581, DOI 10.1161/01.ATV.14.10.1581; DULLAART RPF, 1994, EUR J CLIN INVEST, V24, P188, DOI 10.1111/j.1365-2362.1994.tb00987.x; ETTINGER WH, 1992, BIOCHIM BIOPHYS ACTA, V1128, P186, DOI 10.1016/0005-2760(92)90306-G; GARFINKEL AS, 1987, PLASMA LIPOPROTEINS, P335; HOFFMAN JS, 1982, J BIOL CHEM, V257, P510; JANSEN H, 1992, BIOCHIM BIOPHYS ACTA, V1128, P181, DOI 10.1016/0005-2760(92)90305-F; JAUHIAINEN M, 1993, J BIOL CHEM, V268, P4032; JIANG XC, 1992, J CLIN INVEST, V90, P1290, DOI 10.1172/JCI115993; JIANG XC, 1991, J BIOL CHEM, V266, P4631; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; MARRA MN, 1990, J IMMUNOL, V144, P662; MASUCCIMAGOULAS L, 1995, J CLIN INVEST, V95, P1587, DOI 10.1172/JCI117832; MEIJER GW, 1993, BIOCHEM J, V293, P729, DOI 10.1042/bj2930729; POWNALL HJ, 1991, J LIPID RES, V32, P793; QUINET EM, 1990, J CLIN INVEST, V85, P3357; SPEIJER H, 1991, ATHEROSCLEROSIS, V90, P159, DOI 10.1016/0021-9150(91)90110-O; SU GL, 1994, J IMMUNOL, V153, P743; TALL AR, 1983, J BIOL CHEM, V258, P2174; TALL AR, 1985, J LIPID RES, V26, P842; TALL AR, 1986, J LIPID RES, V27, P361; TALL AR, 1993, J LIPID RES, V34, P1255; TALL AR, 1983, J LIPID RES, V24, P277; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TOBIAS PS, 1986, J EXP MED, V164, P7777; TOLLEFSON JH, 1988, J LIPID RES, V29, P1593; TU AY, 1993, J BIOL CHEM, V268, P23098; TU AY, 1995, BIOCHEM BIOPH RES CO, V207, P552, DOI 10.1006/bbrc.1995.1223; ULEVITCH RJ, 1978, J CLIN INVEST, V62, P1313, DOI 10.1172/JCI109252; VOYNOYASENETSKA.TA, 1993, P NATL ACAD SCI USA, V90, P4256	34	97	101	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17133	17138		10.1074/jbc.270.29.17133	http://dx.doi.org/10.1074/jbc.270.29.17133			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615508	hybrid			2022-12-27	WOS:A1995RK68900015
J	JOHNSON, ES; MA, PCM; OTA, IM; VARSHAVSKY, A				JOHNSON, ES; MA, PCM; OTA, IM; VARSHAVSKY, A			A PROTEOLYTIC PATHWAY THAT RECOGNIZES UBIQUITIN AS A DEGRADATION SIGNAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-END RULE; SHORT-LIVED PROTEIN; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; MULTIUBIQUITIN CHAIN; BETA-GALACTOSIDASE; BINDING-PROTEINS; SHUTTLE VECTORS; E6 ONCOPROTEIN; GENE ENCODES	Previous work has shown that a fusion protein bearing a ''nonremovable'' N-terminal ubiquitin (Uh) moiety is short-lived in vivo, the fusion's Ub functioning as a degradation signal. The proteolytic system involved, termed the UFD pathway (Ub fusion degradation), was dissected in the yeast Saccharomyces cerevisiae by analyzing mutations that perturb the pathway. Two of the five genes thus identified, UFD1 and UFD5, function at post ubiquitination steps in the UFD pathway. UFD3 plays a role in controlling the concentration of Ub in a cell: ufd3 mutants have greatly reduced levels of free Ub, and the degradation of Ub fusions in these mutants can be restored by overexpressing Ub. UFD2 and UFD4 appear to influence the formation and topology of a multi-Ub chain linked to the fusion's Ub moiety. UFD1, UFD2, and UFD4 encode previously undescribed proteins of 40, 110, and 170 kDa, respectively. The sequence of the last similar to 280 residues of Ufd4p is similar to that of E6AP, a human protein that binds to both the E6 protein of oncogenic papilloma viruses and the tumor suppressor protein p53, whose Ub-dependent degradation involves E6AP. UFD5 is identical to the previously identified SON1, isolated as an extragenic suppressor of sec63 alleles that impair the transport of proteins into the nucleus. UFD5 is essential for activity of both the UFD and N-end rule pathways (the latter system degrades proteins that bear certain N-terminal residues). We also show that a Lys --> Arg conversion at either position 29 or position 48 in the fusion's Ub moiety greatly reduces ubliquitination and degradation of Ub fusions to beta-galactosidase. By contrast, the ubiquitination and degradation of Ub fusions to dihydrofolate reductase are inhibited by the Ub(R29) but not by the Ub(R48) moiety. ufd4 mutants are unable to ubiquitinate the fusion's Ub moiety at Lys(29), whereas ufd2 mutants are impaired in the ubiquitination at Lys(48). These and related findings suggest that Ub-Ub isopeptide bonds in substrate-linked multi-Ub chains involve not only the previously identified Lys(48) but also Lys(29) of Ub, and that structurally different multi-Ub chains have distinct functions in Ub-dependent protein degradation.	CALTECH, DIV BIOL, PASADENA, CA 91125 USA	California Institute of Technology					NIDDK NIH HHS [DK39520] Funding Source: Medline; NIGMS NIH HHS [GM31530] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039520, R37DK039520, R56DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARCHAMBAULT J, 1992, J BIOL CHEM, V267, P3282; ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; Ausubel FM, 1988, MOL REPROD DEV; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER R, 1991, NUCLEIC ACIDS RES, V19, P1945, DOI 10.1093/nar/19.8.1945; BAKER RT, 1991, P NATL ACAD SCI USA, V88, P1090, DOI 10.1073/pnas.88.4.1090; BANERJI J, 1990, P NATL ACAD SCI USA, V87, P2374, DOI 10.1073/pnas.87.6.2374; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; BUTT TR, 1988, J BIOL CHEM, V263, P16364; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; COVITZ PA, 1991, GENE DEV, V5, P1982, DOI 10.1101/gad.5.11.1982; DALE RMK, 1985, PLASMID, V13, P31, DOI 10.1016/0147-619X(85)90053-8; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; EUSTICE DC, 1991, BIOTECHNIQUES, V11, P739; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; FINLEY D, 1992, MOL CELLULAR BIOL YE, V2, P539; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; GONDA DK, 1989, J BIOL CHEM, V264, P16700; GREGORI L, 1990, J BIOL CHEM, V265, P8354; GUARENTE L, 1982, P NATL ACAD SCI-BIOL, V79, P7410, DOI 10.1073/pnas.79.23.7410; HAAS AL, 1991, J BIOL CHEM, V266, P5104; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HILL CP, 1993, P NATL ACAD SCI USA, V90, P4136, DOI 10.1073/pnas.90.9.4136; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Hochstrasser Mark, 1992, Current Opinion in Cell Biology, V4, P1024, DOI 10.1016/0955-0674(92)90135-Y; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Jentsch S, 1992, Trends Cell Biol, V2, P98, DOI 10.1016/0962-8924(92)90013-D; JOHNSON ES, 1990, NATURE, V346, P287, DOI 10.1038/346287a0; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; JOHNSON ES, 1992, THESIS MIT CAMBRIDGE; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; LINNEN JM, 1993, GENE, V128, P181, DOI 10.1016/0378-1119(93)90561-G; MADURA K, 1993, J BIOL CHEM, V268, P12046; MANSFIELD E, 1994, DEV BIOL, V165, P507, DOI 10.1006/dbio.1994.1271; MARCK C, 1993, P NATL ACAD SCI USA, V90, P4027, DOI 10.1073/pnas.90.9.4027; MULLER D, 1992, NUCLEIC ACIDS RES, V20, P1471, DOI 10.1093/nar/20.7.1471; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; NELSON MK, 1993, GENETICS, V134, P159; OLSON MV, 1986, P NATL ACAD SCI USA, V83, P7826, DOI 10.1073/pnas.83.20.7826; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P119; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; PARKHURST SM, 1988, GENE DEV, V2, P1205, DOI 10.1101/gad.2.10.1205; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; PASCOLO S, 1992, YEAST, V8, P987, DOI 10.1002/yea.320081109; PICKART CM, 1988, UBIQUITIN, P77; RECHSTEINER M, 1991, CELL, V66, P615, DOI 10.1016/0092-8674(91)90104-7; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; RONNE H, 1991, MOL CELL BIOL, V11, P4876, DOI 10.1128/MCB.11.10.4876; ROSE M, 1981, P NATL ACAD SCI-BIOL, V78, P2460, DOI 10.1073/pnas.78.4.2460; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; SEUFERT W, 1992, EMBO J, V11, P3077, DOI 10.1002/j.1460-2075.1992.tb05379.x; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; SEWELL JL, 1988, P NATL ACAD SCI USA, V85, P4620, DOI 10.1073/pnas.85.13.4620; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sherman F., 1986, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; SMITH SA, 1992, MOL GEN GENET, V235, P285, DOI 10.1007/BF00279372; SNEDDON AA, 1990, EMBO J, V9, P4339, DOI 10.1002/j.1460-2075.1990.tb07883.x; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; STRUHL K, 1979, P NATL ACAD SCI USA, V76, P1035, DOI 10.1073/pnas.76.3.1035; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; VANNOCKER S, 1993, J BIOL CHEM, V268, P24766; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; VIERSTRA RD, 1993, ANNU REV PLANT PHYS, V44, P385, DOI 10.1146/annurev.pp.44.060193.002125; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; WATKINS JF, 1993, MOL CELL BIOL, V13, P7757, DOI 10.1128/MCB.13.12.7757; WOYCHIK NA, 1992, P NATL ACAD SCI USA, V89, P3999, DOI 10.1073/pnas.89.9.3999; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZHONG T, 1993, CELL, V73, P1175, DOI 10.1016/0092-8674(93)90646-8	94	659	679	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17442	17456		10.1074/jbc.270.29.17442	http://dx.doi.org/10.1074/jbc.270.29.17442			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615550	hybrid			2022-12-27	WOS:A1995RK68900063
J	BURRITT, JB; QUINN, MT; JUTILA, MA; BOND, CW; JESAITIS, AJ				BURRITT, JB; QUINN, MT; JUTILA, MA; BOND, CW; JESAITIS, AJ			TOPOLOGICAL MAPPING OF NEUTROPHIL CYTOCHROME-B EPITOPES WITH PHAGE-DISPLAY LIBRARIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; SUPEROXIDE-GENERATING OXIDASE; NADPH-BINDING-COMPONENT; CELL-FREE SYSTEM; HUMAN-GRANULOCYTES; PEPTIDE LIBRARIES; PLASMA-MEMBRANE; NUCLEOTIDE; ACTIVATION; PROTEIN	Cytochrome b of human neutrophils is the central component of the microbicidal NADPH-oxidase system. However, the folding topology of this integral membrane protein remains undetermined. Two random-sequence bacteriophage peptide libraries were used to map structural features of cytochrome b by determining the epitopes of monoclonal antibodies (mAbs) 44.1 and 54.1, specific for the p22(phox) and gp91(phox) cytochrome b chains, respectively. The unique peptides of phage selected by mAb affinity purification were deduced from the phage DNA sequences. Phage selected by mAb 44.1 displayed the consensus peptide sequence GGPQVXPI, which is nearly identical to (181)GGPQVNPI(188) of p22(phox). Phage selected by mAb 54.1 displayed the consensus sequence PKXAVDGP, which resembles (382)pKIAVDGP(389) of gp91(phox). Western blotting demonstrated specific binding of each mAb to the respective cytochrome b subunit and selected phage peptides. In flow cytometric analysis, mAb 44.1 bound only permeabilized neutrophils, while 54.1 did not bind intact or permeabilized cells. However, mAb 54.1 immunosedimented detergent-solubilized cytochrome b in sucrose gradients. These results suggest the (181)GGPQVNPI(188) segment of p22(phox) is accessible on its intracellular surface, but the (382)PKIAVDGP(389) region on gp91(phox) is not accessible to antibody, and probably not on the protein surface.	MONTANA STATE UNIV,DEPT MICROBIOL,BOZEMAN,MT 59717; MONTANA STATE UNIV,DEPT VET MOLEC BIOL,BOZEMAN,MT 59717	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman				Quinn, Mark/0000-0001-8114-5073; Jesaitis, Algirdas/0000-0001-9001-5617	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026711] Funding Source: NIH RePORTER; NIAID NIH HHS [5RO1 AI 26711] Funding Source: Medline; NIAMS NIH HHS [AR 20929] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403; BERENDES H, 1957, Minn Med, V40, P309; BOKOCH GM, 1991, SCIENCE, V254, P1794, DOI 10.1126/science.1763330; BOMMAKANTI RK, 1995, BIOCHEMISTRY-US, V34, P5720; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BROMBERG Y, 1985, J BIOL CHEM, V260, P3539; Burritt J. B., 1994, Molecular Biology of the Cell, V5, p121A; CURNUTTE JT, 1993, CLIN IMMUNOL IMMUNOP, V67, pS2, DOI 10.1006/clin.1993.1078; CURNUTTE JT, 1985, J CLIN INVEST, V75, P1740, DOI 10.1172/JCI111885; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; De Leo F. R., 1994, Molecular Biology of the Cell, V5, p121A; DEMENDEZ I, 1994, J BIOL CHEM, V269, P16326; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; DINAUER MC, 1987, NATURE, V327, P717, DOI 10.1038/327717a0; EBRIGHT R, 1992, GENE, V114, P81, DOI 10.1016/0378-1119(92)90710-7; FELICI F, 1993, GENE, V128, P21, DOI 10.1016/0378-1119(93)90148-V; GINSEL LA, 1990, BLOOD, V76, P2105; GOLDSMITH ME, 1977, BIOCHEMISTRY-US, V16, P2686, DOI 10.1021/bi00631a016; GUILLET V, 1993, STRUCTURE, V1, P165, DOI 10.1016/0969-2126(93)90018-C; HACKETT PB, 1988, INTRO RECOMBINANT DN; HENRY TJ, 1969, P NATL ACAD SCI USA, V62, P800, DOI 10.1073/pnas.62.3.800; IMAJOHOHMI S, 1992, J BIOL CHEM, V267, P180; JAZWINSKI SM, 1973, P NATL ACAD SCI USA, V70, P205, DOI 10.1073/pnas.70.1.205; JESAITIS AJ, 1990, J CLIN INVEST, V85, P821, DOI 10.1172/JCI114509; KOSHKIN V, 1994, FEBS LETT, V338, P285, DOI 10.1016/0014-5793(94)80285-8; LANDING BH, 1957, PEDIATRICS, V20, P431; MICELI RM, 1994, J IMMUNOL METHODS, V167, P279, DOI 10.1016/0022-1759(94)90097-3; Miller J.H., 1972, EXPT MOL GENETICS; MOREL F, 1991, EUR J BIOCHEM, V201, P523, DOI 10.1111/j.1432-1033.1991.tb16312.x; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; PARKOS CA, 1988, BIOCHIM BIOPHYS ACTA, V932, P71, DOI 10.1016/0005-2728(88)90140-5; PARKOS CA, 1988, P NATL ACAD SCI USA, V85, P3319, DOI 10.1073/pnas.85.10.3319; PARKOS CA, 1992, MOL BASIS OXIDATIVE; QUINN MT, 1993, J BIOL CHEM, V268, P20983; QUINN MT, 1989, NATURE, V342, P198, DOI 10.1038/342198a0; QUINN MT, 1992, J BIOL CHEM, V267, P7303; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; ROTROSEN D, 1990, J BIOL CHEM, V265, P8745; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; SMITH RM, 1991, BLOOD, V77, P673; TAYLOR WR, 1993, PROTEIN SCI, V2, P1675, DOI 10.1002/pro.5560021013; TZAGOLOFF H, 1964, VIROLOGY, V24, P372, DOI 10.1016/0042-6822(64)90174-6; UMEI T, 1987, BIOCHEM J, V243, P467, DOI 10.1042/bj2430467; UMEI T, 1991, J BIOL CHEM, V266, P6019; UMEI T, 1986, J BIOL CHEM, V261, P5229; WOOLFORD JL, 1977, BIOCHEMISTRY-US, V12, P2694	49	155	160	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16974	16980		10.1074/jbc.270.28.16974	http://dx.doi.org/10.1074/jbc.270.28.16974			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622517	hybrid, Green Submitted			2022-12-27	WOS:A1995RJ34700078
J	CANDEIAS, LP; HARVEY, PJ				CANDEIAS, LP; HARVEY, PJ			LIFETIME AND REACTIVITY OF THE VERATRYL ALCOHOL RADICAL-CATION - IMPLICATIONS FOR LIGNIN PEROXIDASE CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULSE-RADIOLYSIS; OXIDATION; BIODEGRADATION; CHRYSOSPORIUM; HORSERADISH; ACID	The formation and decay of veratryl alcohol radical cation upon oxidation of veratryl alcohol by thallium (II) ions was studied by pulse radiolysis with spectrophotometric and conductometric detection. In aqueous solution at pH 3 the radical cation decays by a first order process, assigned to the deprotonation from the ru-carbon. On the basis of its Lifetime (59 +/- 8 ms) and of its ability to oxidize a polymeric dye (Poly R-478) we estimate that the radical cation can diffuse about 7 mu m in an aqueous environment to act as a mediator of oxidations over long distances. However, 4-methoxymandelic acid is not oxidized by the veratryl alcohol radical cation in homogeneous solution, and the comparison with previous studies on lignin peroxidase catalysis suggests a second role for veratryl alcohol radical cation in the enzyme action: it may exist as an enzyme-bound species that has either a longer lifetime or a higher reduction potential than the free radical cation in bulk solution.	UNIV GREENWICH,SCH BIOL & CHEM SCI,LONDON SE18 6PF,ENGLAND	University of Greenwich	CANDEIAS, LP (corresponding author), MT VERNON HOSP,GRAY LAB,POB 100,NORTHWOOD HA6 2JR,MIDDX,ENGLAND.		Harvey, Patricia/D-4577-2012	Harvey, Patricia/0000-0001-7193-4570				BANCI L, 1993, BIOCHEMISTRY-US, V32, P5825, DOI 10.1021/bi00073a015; BARR DP, 1994, ARCH BIOCHEM BIOPHYS, V312, P511, DOI 10.1006/abbi.1994.1339; BIELSKI BHJ, 1993, RADIAT PHYS CHEM, V41, P527, DOI 10.1016/0969-806X(93)90015-M; CANDEIAS LP, 1993, FREE RADICAL BIO MED, V15, P385, DOI 10.1016/0891-5849(93)90038-V; CERCEK B, 1966, J CHEM SOC A, P612, DOI 10.1039/j19660000612; DEJONG E, 1994, FEMS MICROBIOL REV, V13, P153, DOI 10.1016/0168-6445(94)90078-7; GILARDI G, 1990, BIOCHIM BIOPHYS ACTA, V1041, P129, DOI 10.1016/0167-4838(90)90055-K; HAMMEL KE, 1991, ENZYME MICROB TECH, V13, P15, DOI 10.1016/0141-0229(91)90182-A; HARVEY PJ, 1986, FEBS LETT, V195, P242, DOI 10.1016/0014-5793(86)80168-5; KERSTEN PJ, 1990, BIOCHEM J, V268, P475, DOI 10.1042/bj2680475; KODURI RS, 1994, BIOCHEMISTRY-US, V33, P4225, DOI 10.1021/bi00180a016; ONEILL P, 1975, J PHYS CHEM-US, V79, P2773, DOI 10.1021/j100592a013; PASCZYNSKI A, 1991, BIOCHEM BIOPH RES CO, V178, P1056; REDDY CA, 1994, FEMS MICROBIOL REV, V13, P137, DOI 10.1016/0168-6445(94)90077-9; SCHOEMAKER HE, 1994, FEMS MICROBIOL REV, V13, P321, DOI 10.1111/j.1574-6976.1994.tb00052.x; SCOTT SL, 1993, J PHYS CHEM-US, V97, P6710, DOI 10.1021/j100127a022; TABATA Y, 1991, HDB RAD CHEM, P79; Tabata Y., 1990, PULSE RADIOLYSIS; TIEN M, 1986, J BIOL CHEM, V261, P1687; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; VALLI K, 1990, BIOCHEMISTRY-US, V29, P8535, DOI 10.1021/bi00489a005; WELLINDER KG, 1995, BIOCHEM SOC T, V23, P257	22	63	63	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16745	16748		10.1074/jbc.270.28.16745	http://dx.doi.org/10.1074/jbc.270.28.16745			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622486	hybrid			2022-12-27	WOS:A1995RJ34700046
J	CORNILLE, F; DELOYE, F; FOURNIEZALUSKI, MC; ROQUES, BP; POULAIN, B				CORNILLE, F; DELOYE, F; FOURNIEZALUSKI, MC; ROQUES, BP; POULAIN, B			INHIBITION OF NEUROTRANSMITTER RELEASE BY SYNTHETIC PROLINE-RICH PEPTIDES SHOWS THAT THE N-TERMINAL DOMAIN OF VESICLE-ASSOCIATED MEMBRANE PROTEIN/SYNAPTOBREVIN IS CRITICAL FOR NEURO-EXOCYTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETANUS TOXIN; ACETYLCHOLINE-RELEASE; PROTEIN; GENES; SYNAPTOBREVIN; NEUROTOXINS; IDENTIFICATION; SYNAPTOTAGMIN; DROSOPHILA; APLYSIA	Tetanus toxin and clostridial neurotoxins type B, D, F, and G inhibit intracellular Ca2+ dependent neurotransmitter release via the specific proteolytic cleavage of vesicle-associated membrane protein (VAMP)/synaptobrevin, a highly conserved 19-kDa integral protein of the small synaptic vesicle membrane. This results in the release of the larger part of the cytosolic domain of this synaptic protein into the cytoplasm. Microinjection of synthetic peptides corresponding to this fragment into identified presynaptic neurons of Aplysia californica led to a potent, long lasting, and dose-dependent inhibition (similar to 50% at 10 mu M) of acetylcholine release, probably by hindering endogenous VAMP/synaptobrevin from interacting with synaptic proteins involved in exocytosis. Structure activity studies showed that this effect is confined to the N-terminal domain of VAMP/synaptobrevin isoform II and is related to the presence of a proline-rich motif (PGGPXGX(3)PP or PAAPXGX(3)PP). At higher concentrations, the inhibitory effect was lower and only transient, suggesting that the N-terminal proline-rich domain of VAMP/synaptobrevin plays opposing roles in neurotransmitter release very likely by interacting with different synaptic proteins. This probably occurs by disruption of the recently reported in vitro VAMP-synaptophysin interaction that involves the N-terminal domain of VAMP II and was proposed to hinder synaptophysin-related formation of a fusion pore. The observed recovery of neurotransmitter release following injection of high concentration of N-terminal fragments of VAMP II brings a strong in vivo support to this hypothesis. The minimum active peptide GPGGPQGGMQPPREQS could be used for rationally designing potent synthetic blockers of neurotransmission.	UNIV PARIS 05,FAC PHARM,FAC SCI PHARMACEUT & BIOL,DEPT PHARMACOCHIM MOLEC & BIOL,CNRS,F-75270 PARIS 06,FRANCE; CNRS,NEUROBIOL CELLULAIRE & MOLEC LAB,F-91198 GIF SUR YVETTE,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay								ARCHER BT, 1990, J BIOL CHEM, V265, P17267; BARK IC, 1994, P NATL ACAD SCI USA, V91, P4621, DOI 10.1073/pnas.91.11.4621; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; CORNILLE F, 1994, EUR J BIOCHEM, V222, P173, DOI 10.1111/j.1432-1033.1994.tb18855.x; DEBELLO WM, 1995, NATURE, V373, P626, DOI 10.1038/373626a0; DIANTONIO A, 1993, J NEUROSCI, V13, P4924; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; ELFERINK LA, 1993, CELL, V72, P153, DOI 10.1016/0092-8674(93)90059-Y; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; GARDNER D, 1971, SCIENCE, V173, P550, DOI 10.1126/science.173.3996.550; GERST JE, 1992, P NATL ACAD SCI USA, V89, P4338, DOI 10.1073/pnas.89.10.4338; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HORIKAWA HPM, 1993, FEBS LETT, V2, P236; HUNT JM, 1994, NEURON, V12, P1269, DOI 10.1016/0896-6273(94)90443-X; JOHN R, 1994, ANNU REV NEUROSCI, V17, P219; LLINAS R, 1994, J PHYSIOL-LONDON, V477, P129, DOI 10.1113/jphysiol.1994.sp020177; MACMAHON HT, 1993, NATURE, V364, P346; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MOCHIDA S, 1989, FEBS LETT, V253, P47, DOI 10.1016/0014-5793(89)80926-3; MOLGO J, 1990, J PHYSIOLOGY PARIS, V84, P152; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; POULAIN B, 1991, J BIOL CHEM, V266, P9580; POULAIN B, 1993, J NEUROCHEM, V61, P1175, DOI 10.1111/j.1471-4159.1993.tb03640.x; POULAIN B, 1995, IN PRESS CURR TOP IM, V195; POULAIN B, 1988, P NATL ACAD SCI USA, V85, P1090; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SCHANTZ EJ, 1992, MICROBIOL REV, V56, P80, DOI 10.1128/MMBR.56.1.80-99.1992; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SOLLNER T, 1994, TRENDS NEUROSCI, V17, P3; SUDHOF TC, 1989, NEURON, V2, P1475, DOI 10.1016/0896-6273(89)90193-1; THOMAS L, 1988, SCIENCE, V242, P1050, DOI 10.1126/science.2461586; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4238; WASHBOURNE P, 1995, BIOCHEM J, V305, P721, DOI 10.1042/bj3050721; YAMASAKI S, 1994, BIOCHEM BIOPH RES CO, V200, P829, DOI 10.1006/bbrc.1994.1526; YAMASAKI S, 1994, P NATL ACAD SCI USA, V981, P4688; [No title captured]	43	47	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16826	16832		10.1074/jbc.270.28.16826	http://dx.doi.org/10.1074/jbc.270.28.16826			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622497	hybrid			2022-12-27	WOS:A1995RJ34700058
J	DILWORTH, FJ; SCOTT, I; GREEN, A; STRUGNELL, S; GUO, YD; ROBERTS, EA; KREMER, R; CALVERLEY, MJ; MAKIN, HLJ; JONES, G				DILWORTH, FJ; SCOTT, I; GREEN, A; STRUGNELL, S; GUO, YD; ROBERTS, EA; KREMER, R; CALVERLEY, MJ; MAKIN, HLJ; JONES, G			DIFFERENT MECHANISMS OF HYDROXYLATION SITE SELECTION BY LIVER AND KIDNEY CYTOCHROME-P450 SPECIES (CYP27 AND CYP24) INVOLVED IN VITAMIN-D METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN; CELL-DIFFERENTIATION; KERATINOCYTE MODEL; MOLECULAR-CLONING; TUMOR PROGRESSION; D ANALOG; 1,25-DIHYDROXYVITAMIN-D3; 25-HYDROXYVITAMIN-D3; MITOCHONDRIA; EXPRESSION	A series of homologated 1 alpha-hydroxyvitamin D-3 and 1,25-dihydroxyvitamin D-3 molecules with one to three extra carbons in the side chain were used to examine the substrate preferences and hydroxylation site selection mechanisms of the liver vitamin D-3-25-hydroxylase (CYP27) and the target cell 25-hydroxyvitamin D-3-24-hydroxylase (CYP24). Cultured and transfected cell models, used as sources of these hydroxylases, gave 23-, 24-, 25-, and 27-hydroxylated metabolites which were identified by their high performance liquid chromatography and GC-MS characteristics. Lengthening the side chain is tolerated by each cytochrome P450 isoform such that 25-hydroxylation or 24-hydroxylation continues to occur at the same rate as in the native side chain, while the site of hydroxylation remains the same for the liver enzyme in that CYP27 continues to hydroxylate at C-25 and C-27 (minor) despite the two-carbon-atom extension. Somewhat surprising is the finding that C-24 and C-23 (minor) hydroxylations also do not change as the side chain is extended by as much as three carbons. We conclude that CYP24 must be directed to its hydroxylation site(s) by the distance of carbon 24 from the vitamin D ring structure and not as in CYP27 by the distance of the hydroxylation site from the end of the side chain.	QUEENS UNIV,DEPT BIOCHEM,KINGSTON,ON K7L 3N6,CANADA; UNIV TORONTO,DEPT PHARMACOL,TORONTO,ON M5G 1X8,CANADA; MCGILL UNIV,DEPT BIOCHEM,MONTREAL,PQ H3A 1A1,CANADA; LEO PHARMACEUT PROD,DEPT CHEM RES,DK-2750 BALLERUP,DENMARK; UNIV LONDON LONDON HOSP,COLL MED,DEPT CHEM PATHOL,LONDON E1 2AD,ENGLAND	Queens University - Canada; University of Toronto; McGill University; University of London; University College London				Dilworth, F. Jeffrey/0000-0002-6265-8102; Kremer, Richard/0000-0002-7053-2139; Scott, Ian/0000-0001-6665-1410				AKIYOSHISHIBATA M, 1994, EUR J BIOCHEM, V224, P335, DOI 10.1111/j.1432-1033.1994.00335.x; AMARNEH B, 1993, MOL ENDOCRINOL, V7, P1617, DOI 10.1210/me.7.12.1617; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BRETTING C, 1991, VITAMIN D, P159; BROWN AJ, 1992, BIOCHEM BIOPH RES CO, V189, P759, DOI 10.1016/0006-291X(92)92266-Z; Calverley M. J., 1992, ANTITUMOR STEROIDS, P193; DILWORTH FJ, 1994, BIOCHEM PHARMACOL, V47, P987; DILWORTH FJ, 1994, VITAMIN D, P131; GUO YD, 1993, P NATL ACAD SCI USA, V90, P8668, DOI 10.1073/pnas.90.18.8668; HENDERSON J, 1991, CANCER RES, V51, P6521; IKEKAWA N, 1993, BIOORG MED CHEM LETT, V3, P1789, DOI 10.1016/S0960-894X(00)80106-7; JONES G, 1993, TRENDS ENDOCRIN MET, V4, P297, DOI 10.1016/1043-2760(93)90049-K; JONES G, 1986, METHOD ENZYMOL, V123, P141; MAKIN G, 1989, BIOCHEM J, V262, P173, DOI 10.1042/bj2620173; MASUDA S, 1994, J BIOL CHEM, V269, P4794; OFTEBRO H, 1981, J LIPID RES, V22, P1254; OHYAMA Y, 1991, FEBS LETT, V278, P195, DOI 10.1016/0014-5793(91)80115-J; OHYAMA Y, 1991, J BIOL CHEM, V266, P8690; OKAMURA T, 1985, P NATL ACAD SCI USA, V82, P5705, DOI 10.1073/pnas.82.17.5705; OSTREM VK, 1987, P NATL ACAD SCI USA, V84, P2610, DOI 10.1073/pnas.84.9.2610; OSTREM VK, 1987, J BIOL CHEM, V262, P14164; PAULSON SK, 1990, J BONE MINER RES, V5, P201, DOI 10.1002/jbmr.5650050214; PERLMAN K, 1990, BIOCHEMISTRY-US, V29, P190, DOI 10.1021/bi00453a026; QAW F, 1993, J BIOL CHEM, V268, P282; REDDY GS, 1993, BIOORG MED CHEM LETT, V3, P1879, DOI 10.1016/S0960-894X(00)80124-9; ROBERTS EA, 1993, DRUG METAB DISPOS, V21, P56; SAMBROOK J, 1985, MOL CLONING LABORATO; SEBAG M, 1992, J BIOL CHEM, V267, P12162; SORENSEN H, 1990, BIOCHEM PHARMACOL, V39, P391, DOI 10.1016/0006-2952(90)90039-N; STRUGNELL S, 1990, BIOCHEM PHARMACOL, V40, P333, DOI 10.1016/0006-2952(90)90696-I; SUDA T, 1990, ANNU REV NUTR, V10, P195, DOI 10.1146/annurev.nu.10.070190.001211; USUI E, 1990, FEBS LETT, V262, P135, DOI 10.1016/0014-5793(90)80172-F; USUI E, 1990, FEBS LETT, V274, P175, DOI 10.1016/0014-5793(90)81357-T	33	35	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16766	16774		10.1074/jbc.270.28.16766	http://dx.doi.org/10.1074/jbc.270.28.16766			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622489	hybrid			2022-12-27	WOS:A1995RJ34700049
J	KARIN, M				KARIN, M			THE REGULATION OF AP-1 ACTIVITY BY MITOGEN-ACTIVATED PROTEIN-KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							C-JUN; PHORBOL ESTER; GENE-PRODUCT; DNA-BINDING; MAP KINASES; PHOSPHORYLATION; DOMAIN; FOS; TRANSCRIPTION; ELEMENT				KARIN, M (corresponding author), UNIV CALIF SAN DIEGO,DEPT PHARMACOL,PROGRAM BIOMED SCI,9500 GILMAN DR,LA JOLLA,CA 92093, USA.							ADLER V, 1992, P NATL ACAD SCI USA, V89, P5341, DOI 10.1073/pnas.89.12.5341; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; ARANY F, 1994, CELL, V97, P799; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BUSCHER M, 1988, ONCOGENE, V3, P301; CHOU SY, 1992, MOL BIOL CELL, V3, P1117, DOI 10.1091/mbc.3.10.1117; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DEIJARD B, 1994, CELL, V76, P1; DENT P, 1992, SCIENCE, V254, P1404; DENT T, 1994, NATURE, V371, P171; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; DEVARY Y, 1992, CELL, V71, P1081, DOI 10.1016/S0092-8674(05)80058-3; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; KIM SJ, 1992, NATURE, V358, P331, DOI 10.1038/358331a0; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LANGECARTER CA, 1994, SCIENCE, V265, P1458, DOI 10.1126/science.8073291; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LEE W, 1987, NATURE, V325, P369; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MINDEN A, 1994, SCIENCE, V226, P1719; MINDEN A, 1994, MOL CELL BIOL, V14, P6688; OFFRINGA R, 1990, CELL, V62, P527, DOI 10.1016/0092-8674(90)90017-9; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; ROBBINS DJ, 1992, P NATL ACAD SCI USA, V89, P6924, DOI 10.1073/pnas.89.15.6924; ROZEK D, 1993, MOL CELL BIOL, V13, P5490, DOI 10.1128/MCB.13.9.5490; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; SHENG ME, 1994, SCIENCE, V252, P1427; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; SMEAL T, 1994, EMBO J, V13, P6006, DOI 10.1002/j.1460-2075.1994.tb06946.x; SMEAL T, 1989, GENE DEV, V3, P2091, DOI 10.1101/gad.3.12b.2091; SMEAL T, 1992, MOL CELL BIOL, V12, P3507, DOI 10.1128/MCB.12.8.3507; SUTHERLAND JA, 1992, GENE DEV, V6, P1810, DOI 10.1101/gad.6.9.1810; SUZUKI T, 1992, NUCLEIC ACIDS RES, V19, P5537; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; VANDAM H, 1993, EMBO J, V12, P479, DOI 10.1002/j.1460-2075.1993.tb05680.x	54	2326	2378	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16483	16486		10.1074/jbc.270.28.16483	http://dx.doi.org/10.1074/jbc.270.28.16483			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622446	hybrid			2022-12-27	WOS:A1995RJ34700001
J	PENG, HB; RAJAVASHISTH, TB; LIBBY, P; LIAO, JK				PENG, HB; RAJAVASHISTH, TB; LIBBY, P; LIAO, JK			NITRIC-OXIDE INHIBITS MACROPHAGE-COLONY-STIMULATING FACTOR GENE-TRANSCRIPTION IN VASCULAR ENDOTHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; LOW-DENSITY LIPOPROTEINS; ATHEROSCLEROTIC LESIONS; MESSENGER-RNA; EXPRESSION; ADHESION; INVITRO; ACTIVATION; INDUCTION	Macrophage-colony stimulating factor (M-CSF) contributes to atherogenesis by regulating macrophage-derived foam cells in atherosclerotic lesions. Here we report that nitric oxide (NO) inhibits the expression of M-CSF in human vascular endothelial cells independent of guanylyl cyclase activation. The induction of M-CSF mRNA expression by either oxidized low density lipoprotein (ox-LDL) or tumor necrosis factor-alpha (TNF alpha) was attenuated by NO donors, S-nitrosoglutathione (GSNO), sodium nitroprusside (SNP), and 3-morpholinosydnonimine, but not by cGMP analogues, glutathione, or nitrite. Inhibition of endogenous NO production by N-monomethyl-L-arginine (L-NMA) also increased M-CSF expression in control and TNF alpha-stimulated cells. Nuclear run-on assays and transfection studies using M-CSF promoter constructs linked to chloramphenicol acetyltransferase reporter gene indicated that NO repressed M-CSF gene transcription through nuclear factor-kappa B (NF-kappa B). Electrophoretic mobility shift assays demonstrated that activation of NF-kappa B by L-NMA, ox-LDL, and TNF alpha was attenuated by GSNO and SNP, but not by glutathione or cGMP analogues. Since the induction of M-CSF expression depends upon NF-kappa B activation, the ability of NO to inhibit NF-kappa B activation and M-CSF expression may contribute to some of NO's antiatherogenic properties.	BRIGHAM & WOMENS HOSP,DEPT MED,DIV CARDIOVASC,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School			Libby, Peter/AAY-6404-2021; Rajavashisth, Tripathi/ABB-6379-2020	Libby, Peter/0000-0002-1502-502X; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL034636, R01HL034636] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL02508, HL34636] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAEUERLE PA, 1991, BIOCHIM BIOPHYS ACTA, V1072, P63, DOI 10.1016/0304-419X(91)90007-8; BATH PMW, 1991, ARTERIOSCLER THROMB, V11, P254, DOI 10.1161/01.ATV.11.2.254; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BOSSALER C, 1987, J CLIN INVEST, V79, P174; CLINTON SK, 1992, AM J PATHOL, V140, P301; COLLINS T, 1993, LAB INVEST, V68, P499; COOKE JP, 1992, J CLIN INVEST, V90, P1168, DOI 10.1172/JCI115937; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; KOWALUK EA, 1990, J PHARMACOL EXP THER, V255, P1256; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; KUNSCH C, 1994, J IMMUNOL, V153, P153; KURUSE L, 1993, CIRC RES, V73, P164; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LIAO JK, 1995, J BIOL CHEM, V270, P319, DOI 10.1074/jbc.270.1.319; LIAO JK, 1994, J BIOL CHEM, V269, P12987; Libby Peter, 1993, Current Opinion in Lipidology, V4, P355, DOI 10.1097/00041433-199310000-00003; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARUI N, 1993, J CLIN INVEST, V92, P1866, DOI 10.1172/JCI116778; MUNN DH, 1993, CANCER RES, V53, P2603; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NEISH AS, 1992, J EXP MED, V176, P1583, DOI 10.1084/jem.176.6.1583; RADOMSKI MW, 1987, BRIT J PHARMACOL, V92, P639, DOI 10.1111/j.1476-5381.1987.tb11367.x; RADOMSKI MW, 1992, BRIT J PHARMACOL, V107, P745, DOI 10.1111/j.1476-5381.1992.tb14517.x; RAJAVASHISTH TB, 1990, NATURE, V344, P254, DOI 10.1038/344254a0; RASBAND W, 1993, NIH IMAGE PROGRAM; ROSENFELD ME, 1992, AM J PATHOL, V140, P291; Sambrook J, 1989, MOL CLONING LABORATO; SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SHU HB, 1993, MOL CELL BIOL, V13, P6283, DOI 10.1128/MCB.13.10.6283; STANLEY ER, 1978, NATURE, V274, P168, DOI 10.1038/274168a0; TANNER FC, 1991, CIRCULATION, V83, P2012, DOI 10.1161/01.CIR.83.6.2012; TIPPING PG, 1993, AM J PATHOL, V142, P1721; YAGI K, 1976, BIOCHEM MED METAB B, V15, P212, DOI 10.1016/0006-2944(76)90049-1; YAMADA H, 1991, BLOOD, V78, P1988; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; YOSHIZUMI M, 1993, CIRC RES, V73, P205, DOI 10.1161/01.RES.73.1.205	44	156	157	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					17050	17055		10.1074/jbc.270.28.17050	http://dx.doi.org/10.1074/jbc.270.28.17050			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622526	hybrid			2022-12-27	WOS:A1995RJ34700089
J	CREUWELS, LAJM; BOER, EH; DEMEL, RA; VANGOLDE, LMG; HAAGSMAN, HP				CREUWELS, LAJM; BOER, EH; DEMEL, RA; VANGOLDE, LMG; HAAGSMAN, HP			NEUTRALIZATION OF THE POSITIVE CHARGES OF SURFACTANT PROTEIN-C - EFFECTS ON STRUCTURE AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCES; LUNG SURFACTANT; SP-B; MONOMOLECULAR LAYERS; ORIENTATION; LIPOPEPTIDE; MEMBRANES; RESIDUES; BILAYER; BOVINE	Pulmonary surfactant protein C (SP-C) is a small, extremely hydrophobic peptide with a highly conservative primary structure. The protein is characterized by two adjacent palmitoylated cysteine residues, two positively charged residues (one arginine residue and one lysine residue) in the N-terminal region, and a long hydrophobic stretch. SP-C enhances the adsorption of phospho lipids into an air-water interface. To determine the importance of the positively charged residues, we carried out experiments with natural porcine SP-C and modified porcine SP-C (SP-C-m) in which the positive charges had been blocked by phenylglyoxal. Circular dichroism experiments showed that SP-C-m had an increased content of alpha-helix. Natural SP-C, but not SP-C-m, catalyzed insertion of phospholipids into a monolayer at the air-water interface. This reduced insertion was due to a strong reduction of binding of phospholipid vesicles to the monolayer. The insertion catalyzed by the natural porcine SP-C was decreased by an increased pH of the subphase. In contrast to natural SP-C, SP-C-m induced lipid mixing between phospholipid vesicles. The extent of lipid mixing was a function of the SP-C content. We conclude that the positively charged residues of SP-C are important for the binding of phospholipid vesicles to the monolayer, a process that precedes the insertion of phospholipids into the monolayer.	UNIV UTRECHT,VET BIOCHEM LAB,3508 TD UTRECHT,NETHERLANDS; UNIV UTRECHT,CTR BIOMEMBRANES & LIPID ENZYMOL,3508 TD UTRECHT,NETHERLANDS	Utrecht University; Utrecht University			Haagsman, Henk P/F-8919-2010					BAATZ JE, 1992, CHEM PHYS LIPIDS, V63, P91, DOI 10.1016/0009-3084(92)90026-L; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BOHLEN P, 1973, ARCH BIOCHEM BIOPHYS, V155, P213, DOI 10.1016/S0003-9861(73)80023-2; CHUNG J, 1989, BIOCHIM BIOPHYS ACTA, V1002, P348, DOI 10.1016/0005-2760(89)90349-4; CRENWELS LAJ, 1993, J BIOL CHEM, V268, P26752; CREUWELS LAJM, 1995, BBA-LIPID LIPID MET, V1254, P326, DOI 10.1016/0005-2760(94)00195-5; CURSTEDT T, 1990, P NATL ACAD SCI USA, V87, P2985, DOI 10.1073/pnas.87.8.2985; HAAGSMAN HP, 1987, J BIOL CHEM, V262, P13877; HAAGSMAN HP, 1991, ANNU REV PHYSIOL, V53, P441, DOI 10.1146/annurev.physiol.53.1.441; HAWGOOD S, 1987, P NATL ACAD SCI USA, V84, P66, DOI 10.1073/pnas.84.1.66; HAWGOOD S, 1985, BIOCHEMISTRY-US, V24, P184, DOI 10.1021/bi00322a026; JOHANSSON J, 1991, FEBS LETT, V281, P119, DOI 10.1016/0014-5793(91)80373-B; KELLER A, 1991, BIOCHEM J, V277, P493, DOI 10.1042/bj2770493; KEOUGH KMW, 1992, PULMONARY SURFACTANT, P110; LIS LJ, 1982, BIOPHYS J, V37, P657; NOGEE LM, 1993, NEW ENGL J MED, V328, P406, DOI 10.1056/NEJM199302113280606; OOSTERLAKENDIJK.MA, 1991, BIOCHEMISTRY-US, V30, P8276; OOSTERLAKENDIJK.MA, 1992, BIOCHIM BIOPHYS ACTA, V1110, P45; OOSTERLAKENDIJK.MA, 1991, BIOCHEMISTRY-US, V30, P10965; PASTRANA B, 1991, BIOCHEMISTRY-US, V30, P10058, DOI 10.1021/bi00105a033; PEREZGIL J, 1992, BIOPHYS J, V63, P197, DOI 10.1016/S0006-3495(92)81582-5; PHIZACKERLEY PJR, 1979, BIOCHEM J, V183, P731, DOI 10.1042/bj1830731; RIORDAN JF, 1979, MOL CELL BIOCHEM, V26, P71; ROBERTSON B, 1991, PEDIATR RES, V30, P239, DOI 10.1203/00006450-199109000-00007; SASAKI T, 1985, BIOCHEMISTRY-US, V24, P1079, DOI 10.1021/bi00326a002; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHIFFER K, 1993, BIOCHEMISTRY-US, V32, P590, DOI 10.1021/bi00053a026; STULTS JT, 1991, AM J PHYSIOL, V261, pL118, DOI 10.1152/ajplung.1991.261.2.L118; TAKAHASHI A, 1986, BIOCHEM BIOPH RES CO, V135, P527, DOI 10.1016/0006-291X(86)90026-4; TAKAHASHI K, 1968, J BIOL CHEM, V243, P6171; TAKAHASHI K, 1977, J BIOCHEM-TOKYO, V81, P395, DOI 10.1093/oxfordjournals.jbchem.a131471; VANDENBUSSCHE G, 1992, EUR J BIOCHEM, V203, P201, DOI 10.1111/j.1432-1033.1992.tb19848.x; WARR RG, 1987, P NATL ACAD SCI USA, V84, P7915, DOI 10.1073/pnas.84.22.7915	33	50	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16225	16229		10.1074/jbc.270.27.16225	http://dx.doi.org/10.1074/jbc.270.27.16225			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608188	hybrid			2022-12-27	WOS:A1995RH22600053
J	LI, CQ; DONG, JF; LANZA, F; SANAN, DA; SAETUNG, G; LOPEZ, JA				LI, CQ; DONG, JF; LANZA, F; SANAN, DA; SAETUNG, G; LOPEZ, JA			EXPRESSION OF PLATELET GLYCOPROTEIN (GP)-V IN HETEROLOGOUS CELLS AND EVIDENCE FOR ITS ASSOCIATION WITH GP IB-ALPHA IN FORMING A GP IB-IX-V COMPLEX ON THE CELL-SURFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH GLYCOPROTEINS; MEMBRANE; GENE	The glycoprotein (GP) Ib-IX-V complex comprises four polypeptides: the subunits of the GP Ib-IX complex (GP Ib alpha, GP Ib beta, GP IX) and GP V, To determine the requirements for cell-surface expression of GP V, we transiently expressed the recombinant polypeptide in wild-type Chinese hamster ovary (CHO) cells by cotransfection with plasmids for the subunits of the GP Ib-IX complex and in CHO cells that stably express different combinations of the GP Ib IX complex subunits. Glycoprotein V expressed alone was detectable on the cell surface, and the level was not augmented by cotransfection with any one of the subunits of the GP Ib-IX complex, However, when GP V was expressed in cells that stably express combinations of GP Ib-IX complex subunits, its expression on the cell surface was greater in an the cell lines that contained GP Ib alpha than in wild-type CHO cells, That GP V associates with GP Ib alpha was also suggested by confocal microscopy studies: GP V colocalized with GP Ib alpha in CHO alpha beta IX (cells that express GP Ib alpha, GP Ib beta, and GP IX), CHO alpha beta, and CHO alpha IX cells, but did not colocalize with GP Ib beta in CHO PIX cells, Similarly, immunoprecipitation of GP V from cells expressing GP Ib alpha led to coprecipitation of the latter polypeptide; neither GP Ib beta nor GP IX coprecipitated with GP V from CHO beta IX cells. Taken together, these data indicate that G;P V associates with the GP Ib-IX complex through a direct interaction with GP Ib alpha and establish the topology of the GP Ib-IX-V subunits on the cell surface.	UNIV CALIF SAN FRANCISCO,GLADSTONE INST CARDIOVASC DIS,SAN FRANCISCO,CA 94110; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94110; CTR REG TRANSFUS SANGUINE,INSERM,F-67085 STRASBOURG,FRANCE	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg			Lanza, Francois/H-9252-2016	Lanza, Francois/0000-0002-5802-4748	NHLBI NIH HHS [HL46416, HL02463] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL002463, R29HL046416] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BUSBY SJ, 1991, J BIOL CHEM, V266, P15286; CLEMETSON JM, 1994, BLOOD, V84, P1124; DELASALLE C, 1995, BRIT J HAEMATOL, V89, P501; DONG JF, 1994, BIOCHEMISTRY-US, V33, P13946, DOI 10.1021/bi00250a050; GEORGE JN, 1994, HEMOSTASIS THROMBOSI, P726; HICKEY MJ, 1993, P NATL ACAD SCI USA, V90, P8327, DOI 10.1073/pnas.90.18.8327; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANZA F, 1993, J BIOL CHEM, V268, P20801; LOPEZ JA, 1994, BLOOD COAGUL FIBRIN, V5, P479; LOPEZ JA, 1994, J BIOL CHEM, V269, P23716; LOPEZ JA, 1992, J BIOL CHEM, V267, P12851; LOPEZ JA, 1994, BLOOD COAGUL FIBRIN, V5, P97; MCMICHAEL AJ, 1981, BRIT J HAEMATOL, V49, P501, DOI 10.1111/j.1365-2141.1981.tb07258.x; MODDERMAN PW, 1992, J BIOL CHEM, V267, P364; ROTH GJ, 1991, BLOOD, V77, P5; WRIGHT SD, 1993, BLOOD, V81, P2339	16	67	67	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16302	16307		10.1074/jbc.270.27.16302	http://dx.doi.org/10.1074/jbc.270.27.16302			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608197	hybrid			2022-12-27	WOS:A1995RH22600064
J	UDDIN, S; YENUSH, L; SUN, XJ; SWEET, ME; WHITE, MF; PLATANIAS, LC				UDDIN, S; YENUSH, L; SUN, XJ; SWEET, ME; WHITE, MF; PLATANIAS, LC			INTERFERON-ALPHA ENGAGES THE INSULIN-RECEPTOR SUBSTRATE-1 TO ASSOCIATE WITH THE PHOSPHATIDYLINOSITOL 3'-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN-TYROSINE KINASE; SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTOR; HEMATOPOIETIC-CELLS; SH3 DOMAINS; PHOSPHORYLATION; IRS-1; STIMULATION; EXPRESSION; JAK	Interferon-alpha (IFN alpha) induces rapid tyrosine phosphorylation of the insulin receptor substrate-1 (IRS-1), a docking protein with multiple tyrosine phosphorylation sites that bind to the Src homology 2 (SH2) domains of various signaling proteins. During IFN alpha stimulation, the p85 regulatory subunit of the phosphatidylinositol 3'-kinase binds via its SH2 domains to tyrosine-phosphorylated IRS-1, and phosphatidylinositol 3'-kinase activity is detected in association with IRS-1. Thus, IFN alpha responses occur by activation of the IRS signaling system, which it shares with insulin, insulin-like growth factor-1, and interleukin-4.	EDWARD HINES VET ADM MED CTR,HINES,IL 60141; HARVARD UNIV,SCH MED,JOSLIN DIABET CTR,DIV RES,BOSTON,MA 02115	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	UDDIN, S (corresponding author), LOYOLA UNIV,DIV HEMATOL ONCOL,BLDG 112,2160 S 1ST AVE,MAYWOOD,IL 60153, USA.		Yenush, Lynne/J-8815-2014	Yenush, Lynne/0000-0001-8589-7002; Uddin, Shahab/0000-0003-1886-6710	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038712, R01DK043808, R01DK038712, R55DK038712] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK38712, DK43808] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BACKER JM, 1992, J BIOL CHEM, V267, P1367; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; COLAMONICI OR, 1994, J BIOL CHEM, V269, P3518; COLAMONICI OR, 1994, J BIOL CHEM, V269, P5660; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; FU XY, 1992, CELL, V70, P323, DOI 10.1016/0092-8674(92)90106-M; GUTCH MJ, 1992, P NATL ACAD SCI USA, V8, P11411; KEEGAN AD, 1994, CELL, V76, P811, DOI 10.1016/0092-8674(94)90356-5; LARNER AC, 1993, J IMMUNOL, V150, P1944; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; MYERS MG, 1994, TRENDS BIOCHEM SCI, V19, P289, DOI 10.1016/0968-0004(94)90007-8; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PETSKA S, 1987, ANNU REV BIOCHEM, V56, P727; PLATANIAS LC, 1994, J BIOL CHEM, V269, P3143; PLATANIAS LC, 1992, J BIOL CHEM, V267, P24053; PLATANIAS LC, 1994, J BIOL CHEM, V269, P17761; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; SOUZA SC, 1994, J BIOL CHEM, V269, P30085; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; UDDIN S, 1995, J BIOL CHEM, V270, P7712, DOI 10.1074/jbc.270.13.7712; UZE G, 1990, CELL, V60, P225, DOI 10.1016/0092-8674(90)90738-Z; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; WANG LM, 1993, P NATL ACAD SCI USA, V90, P4032, DOI 10.1073/pnas.90.9.4032	30	185	188	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15938	15941		10.1074/jbc.270.27.15938	http://dx.doi.org/10.1074/jbc.270.27.15938			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608146	hybrid			2022-12-27	WOS:A1995RH22600007
J	WHITE, TK; ZHU, QA; TANZER, ML				WHITE, TK; ZHU, QA; TANZER, ML			CELL-SURFACE CALRETICULIN IS A PUTATIVE MANNOSIDE LECTIN WHICH TRIGGERS MOUSE MELANOMA CELL SPREADING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							BINDING PROTEIN; LAMININ; PURIFICATION; EXPRESSION; HOMOLOGY; DOMAINS; ANTIGEN; CHAINS	B16 mouse melanoma cells adhere to and spread on laminin. We have previously shown that cell spreading is uncoupled from adhesion when unglycosylated laminin is used as a substratum; spreading was restored by a Pronase digest of laminin which became inactive when it was specifically depleted of its mannoside peptides; spreading was also specifically restored by mannosides such as mannan, Man9, and Man6, but not Man3. The effector mannosides bind to a cell surface receptor, previously shown by direct and indirect methods, We have now identified the receptor as cell surface calreticulin by isolating it via mannan affinity chromatography and showing its sequence identity with mouse calreticulin, Anti-calreticulin antibodies confirm this identity, decorate the B16 cell surface, and block cell spreading, Purified B16 cell calreticulin from whole cell lysates successfully competes with cell surface calreticulin and prevents cell spreading. The composite data implicate cell surface calreticulin as a putative lectin that must be occupied to initiate spreading of laminin-adherent B16 cells.	UNIV CONNECTICUT, CTR HLTH, SCH DENT MED, DEPT BIOSTRUCT & FUNCT, FARMINGTON, CT 06030 USA	University of Connecticut					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007340, R01AR017220] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR17220, T32 AR07340] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AKITA EM, 1992, J FOOD SCI, V57, P629, DOI 10.1111/j.1365-2621.1992.tb08058.x; ARUMUGHAM RG, 1986, BIOCHIM BIOPHYS ACTA, V883, P112, DOI 10.1016/0304-4165(86)90142-X; Burns K, 1994, Trends Cell Biol, V4, P152; CHANDRASEKARAN S, 1994, J BIOL CHEM, V269, P3367; CHANDRASEKARAN S, 1994, J BIOL CHEM, V269, P3356; Damsky CH, 1991, CURR OPIN CELL BIOL, V3, P777, DOI 10.1016/0955-0674(91)90049-5; DEAN JW, 1990, J BIOL CHEM, V265, P12553; DEDHAR S, 1994, TRENDS BIOCHEM SCI, V19, P269, DOI 10.1016/0968-0004(94)90001-9; DIAMOND MS, 1994, CURR BIOL, V4, P506, DOI 10.1016/S0960-9822(00)00111-1; EGGLETON P, 1994, CLIN IMMUNOL IMMUNOP, V72, P405, DOI 10.1006/clin.1994.1160; FUJIWARA S, 1988, BIOCHEM J, V252, P453, DOI 10.1042/bj2520453; GERSTEN DM, 1990, BIOCHIM BIOPHYS ACTA, V1096, P20, DOI 10.1016/0925-4439(90)90007-C; GERSTEN DM, 1992, BIOCHIM BIOPHYS ACTA, V1138, P109, DOI 10.1016/0925-4439(92)90049-S; GINGELL D, 1993, SYM SOC EXP BIOL, V47, P1; HOLMSKOV U, 1993, J BIOL CHEM, V268, P10120; HURLEY WL, 1990, METHOD ENZYMOL, V184, P429; KAWANO T, 1993, INT J CANCER, V53, P91, DOI 10.1002/ijc.2910530118; KNIBBS RN, 1989, BIOCHEMISTRY-US, V28, P6379, DOI 10.1021/bi00441a034; KRAMER RH, 1991, CANCER METAST REV, V10, P49, DOI 10.1007/BF00046843; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEUNGHAGESTEIJN CY, 1994, J CELL SCI, V107, P589; Malhotra R, 1993, Behring Inst Mitt, P254; MICHALAK M, 1992, BIOCHEM J, V285, P681, DOI 10.1042/bj2850681; NASH PD, 1994, MOL CELL BIOCHEM, V135, P71, DOI 10.1007/BF00925962; NAUSEEF WM, 1995, J BIOL CHEM, V270, P4741, DOI 10.1074/jbc.270.9.4741; OPAS M, 1991, J CELL PHYSIOL, V149, P160, DOI 10.1002/jcp.1041490120; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; Schaller Michael D., 1993, Trends in Cell Biology, V3, P258, DOI 10.1016/0962-8924(93)90053-4; Schweighoffer Tamas, 1992, Current Opinion in Cell Biology, V4, P824, DOI 10.1016/0955-0674(92)90106-M; SHATTIL SJ, 1994, J BIOL CHEM, V269, P14738; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697	33	146	147	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15926	15929		10.1074/jbc.270.27.15926	http://dx.doi.org/10.1074/jbc.270.27.15926			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608143	hybrid			2022-12-27	WOS:A1995RH22600004
J	ZHANG, HL; YUNIANTA; MARTIN, ML				ZHANG, HL; YUNIANTA; MARTIN, ML			SITE-SPECIFIC ISOTOPE FRACTIONATION IN THE CHARACTERIZATION OF BIOCHEMICAL-MECHANISMS - THE GLYCOLYTIC PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOGLUCOISOMERASE-CATALYZED INTERCONVERSION; NATURAL ABUNDANCE LEVEL; HEXOSE PHOSPHATES; DEUTERIUM; DISCRIMINATION; HYDROGEN; SUGAR; NMR	For a given biochemical transformation, such as the fermentation reaction, the redistribution coefficients, which relate the natural site specific isotope contents in end products to those of their precursors, are a source of mechanistic information, These coefficients characterize the traceability of specific hydrogens in the products (ethanol and water) to their parent hydrogens in the starting materials (glucose and water). In conditions of complete transformation, they also enable intermolecular exchanges with the water medium to be estimated. Thus it is directly confirmed that hydrogens 1, 2, 6, and 6' of glucose are strongly connected to the methyl site I of ethanol obtained by fermentation by Saccharomyces cerevisiae, However, whereas hydrogens 6 and 6' are transferred to a great extent, transfer is only partial for hydrogen 2, and it is even less for hydrogen 1. Because the two moieties of glucose corresponding to carbons 1-2-3 and 4-5-6 are scrambled by the aldolase and triosephosphate isomerase reactions, additional exchange of hydrogens at positions 1 and 2 must have occurred before these steps. The value of the coefficient that relates site 2 of glucose to site I of ethanol in particular can be used to quantify the contribution of intermolecular exchange occurring in the course of the transfer from site 2 of glucose 6-phosphate to site I of fructose 6-phosphate mediated by phosphoglucoisomerase. The average hydrogen isotope effects associated with the transfer of hydrogen from the water pool to the methyl or methylene site of ethanol are estimated. In contrast to conventional experiments carried out in strongly deuterium-enriched media where metabolic switching may occur, the NMR investigation of site-specific natural isotope fractionation, which operates at tracer isotopic abundance, faithfully describes the unperturbed metabolic pathways.			ZHANG, HL (corresponding author), UNIV NANTES,RESONANCE MAGNET NUCL & REACTIV CHIM LAB,CNRS,URA 472,2 RUE HOUSSINIERE,F-44072 NANTES 03,FRANCE.							COOK PF, 1980, BIOCHEMISTRY-US, V19, P4853, DOI 10.1021/bi00562a023; DENHOLLANDER JA, 1979, P NATL ACAD SCI USA, V76, P6096; DUNBAR J, 1983, VITIS, V22, P375; GUNTHER H, 1973, Z NATURFORSCH C, VC 28, P241; KOZIET J, 1993, ANAL CHIM ACTA, V271, P31, DOI 10.1016/0003-2670(93)80548-Y; LOEWUS FA, 1953, J AM CHEM SOC, V75, P5018, DOI 10.1021/ja01116a039; London R.E., 1992, BIOL MAGN RESON, V11, P277; MAHLER HR, 1957, J AM CHEM SOC, V79, P1159, DOI 10.1021/ja01562a035; MALAISSE WJ, 1990, MOL CELL BIOCHEM, V93, P153; MARTENS L, 1990, MOD AUSTRIAN LIT, V23, P1; MARTIN GJ, 1986, J AM CHEM SOC, V108, P5116, DOI 10.1021/ja00277a013; MARTIN GJ, 1981, TETRAHEDRON LETT, V22, P3525, DOI 10.1016/S0040-4039(01)81948-1; MARTIN GJ, 1991, J SCI FOOD AGR, V56, P419, DOI 10.1002/jsfa.2740560403; MARTIN YL, 1994, J MAGN RESON SER A, V111, P1, DOI 10.1006/jmra.1994.1218; MOUSSA I, 1990, J PHYS CHEM-US, V94, P8303, DOI 10.1021/j100384a056; RABILLER C, 1990, CHIRALITY, V2, P85, DOI 10.1002/chir.530020205; RIEDER SV, 1959, J BIOL CHEM, V234, P1007; ROSE IA, 1961, J BIOL CHEM, V236, P3086; ROSE IA, 1991, BIOCHEMISTRY-US, V30, P722, DOI 10.1021/bi00217a021; SAUR WK, 1968, BIOCHEMISTRY-US, V7, P3529, DOI 10.1021/bi00850a030; SCHMIDT K, 1968, Z NATURFORSCH PT B, VB 23, P64; SIMON H, 1968, Z NATURFORSCH PT B, VB 23, P59, DOI 10.1515/znb-1968-0112; WILLEM R, 1990, BIOCHEM J, V265, P519, DOI 10.1042/bj2650519; ZHANG BL, 1994, PHYTOCHEM ANALYSIS, V5, P105, DOI 10.1002/pca.2800050304	24	37	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16023	16029		10.1074/jbc.270.27.16023	http://dx.doi.org/10.1074/jbc.270.27.16023			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608163				2022-12-27	WOS:A1995RH22600024
J	MOSHER, RH; CAMP, DJ; YANG, KQ; BROWN, MP; SHAW, WV; VINING, LC				MOSHER, RH; CAMP, DJ; YANG, KQ; BROWN, MP; SHAW, WV; VINING, LC			INACTIVATION OF CHLORAMPHENICOL BY O-PHOSPHORYLATION - A NOVEL RESISTANCE MECHANISM IN STREPTOMYCES-VENEZUELAE ISP5230, A CHLORAMPHENICOL PRODUCER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BINDING PROTEINS; TRIPHOSPHATE CONFORMATION; TETRACYCLINE RESISTANCE; NUCLEOTIDE-SEQUENCE; CONFERS RESISTANCE; STRUCTURAL MODEL; GENE-EXPRESSION; CODON USAGE; ATP-BINDING	Plasmid pJV4, containing a 2.4-kilobase pair insert of genomic DNA from the chloramphenicol (Cm) producer Streptomyces venezuelae ISP5230, confers resistance when introduced by transformation into the Cm-sensitive host Streptomyces lividans M252 (Mosher, R. H. Ranade, N. P., Schrempf, H., and Vining, L. C. (1990) J. Gen. Microbiol. 136, 293-301), Transformants rapidly metabolized Cm to one major product, which was isolated and purified by reversed phase chromatography, The metabolite was identified by nuclear magnetic resonance spectroscopy and mass spectrometry as 3'-O-phospho-Cm, and was shown to have negligible inhibitory activity against Cm sensitive Micrococcus luteus, The nucleotide sequence of the S. venezuelae DNA insert in pJV4 contains an open reading frame (ORF) that encodes a polypeptide (19 kDa) with a consensus motif at its NH, terminus corresponding to a nucleotide-binding amino acid sequence (motif A or P-loop; Walker, J. E., Saraste, M., Runswick, M. J., and Gay, N. J. (1982) EMBO J. 1, 945-951). When a recombinant vector containing this ORF as a 1.6-kilobase pair SmaI-SmaI fragment was used to transform S. lividans M252, uniformly Cm-resistant transformants were obtained, A strain of S. lividans transformed by a vector in which the ORF had been disrupted by an internal deletion yielded clones that were unable to phosphorylate Cm, and exhibited normal susceptibility to the antibiotic. The results implicate the product of the ORF from S. venezuelae as an enzymic effector of Cm resistance in the producing organism by 3'-O-phosphorylation. We suggest the trivial name chloramphenicol 3'-O-phosphotransferase for the enzyme.	UNIV LEICESTER, DEPT BIOCHEM, LEICESTER LE1 7RH, LEICS, ENGLAND; DALHOUSIE UNIV, DEPT BIOL, HALIFAX, NS B3H 4J1, CANADA	University of Leicester; Dalhousie University								ALEXEEV D, 1994, STRUCTURE, V2, P1061, DOI 10.1016/S0969-2126(94)00109-X; BIBB MJ, 1982, MOL GEN GENET, V187, P265, DOI 10.1007/BF00331128; BIBB MJ, 1984, GENE, V30, P157, DOI 10.1016/0378-1119(84)90116-1; CUNDLIFFE E, 1992, CIBA F SYMP, V171, P199; DESOMER J, 1992, MOL MICROBIOL, V6, P2377, DOI 10.1111/j.1365-2958.1992.tb01412.x; DEVER TE, 1987, P NATL ACAD SCI USA, V84, P1814, DOI 10.1073/pnas.84.7.1814; DITTRICH W, 1991, MOL MICROBIOL, V5, P2789, DOI 10.1111/j.1365-2958.1991.tb01987.x; DORAN JL, 1990, J IND MICROBIOL, V5, P197, DOI 10.1007/BF01569677; Hopwood D.A., 1985, GENETIC MANIPULATION; HUANG WJ, 1994, STRUCTURE, V2, P407, DOI 10.1016/S0969-2126(00)00042-3; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; JURNAK F, 1985, SCIENCE, V230, P32, DOI 10.1126/science.3898365; LARSON JL, 1986, PLASMID, V15, P199, DOI 10.1016/0147-619X(86)90038-7; LEVY SB, 1992, ANTIMICROB AGENTS CH, V36, P695, DOI 10.1128/AAC.36.4.695; MALIK VS, 1972, CAN J MICROBIOL, V18, P137, DOI 10.1139/m72-023; MALIK VS, 1970, CAN J MICROBIOL, V16, P173, DOI 10.1139/m70-030; MCMURRY LM, 1987, ANTIMICROB AGENTS CH, V31, P1648, DOI 10.1128/AAC.31.10.1648; MILNERWHITE EJ, 1991, J MOL BIOL, V221, P751; MIMURA CS, 1991, P NATL ACAD SCI USA, V88, P84, DOI 10.1073/pnas.88.1.84; MOSHER RH, 1990, J GEN MICROBIOL, V136, P293, DOI 10.1099/00221287-136-2-293; MOSHER RH, 1993, THESIS DALHOUSIE U C; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; MURAKAMI T, 1989, J BACTERIOL, V171, P1459, DOI 10.1128/jb.171.3.1459-1466.1989; NAKANO H, 1977, J ANTIBIOT, V30, P76, DOI 10.7164/antibiotics.30.76; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; PAULSEN IT, 1993, GENE, V124, P1, DOI 10.1016/0378-1119(93)90755-R; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PONGS O, 1979, ANTIBIOTICS MECH ACT, P26; REEDER T, 1991, J BACTERIOL, V173, P7765, DOI 10.1128/jb.173.24.7765-7771.1991; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SCHULZ GE, 1992, CURR OPIN STRUC BIOL, V2, P61; SHAW WV, 1983, CRC CR REV BIOCH MOL, V14, P1, DOI 10.3109/10409238309102789; SHAW WV, 1991, ANNU REV BIOPHYS BIO, V20, P363, DOI 10.1146/annurev.biophys.20.1.363; SHAW WV, 1976, J GEN MICROBIOL, V94, P159, DOI 10.1099/00221287-94-1-159; SONG WJ, 1992, J BACTERIOL, V174, P6411, DOI 10.1128/JB.174.20.6411-6417.1992; STROHL WR, 1992, NUCLEIC ACIDS RES, V20, P961, DOI 10.1093/nar/20.5.961; STURROCK SS, 1993, BIOCOMPUTING UNIT; TINOCO I, 1973, NATURE-NEW BIOL, V246, P40, DOI 10.1038/newbio246040a0; UCHIYAMA H, 1985, GENE, V38, P103, DOI 10.1016/0378-1119(85)90208-2; Vining LC, 1984, BIOTECHNOLOGY IND AN, P387; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WRIGHT F, 1992, GENE, V113, P55, DOI 10.1016/0378-1119(92)90669-G; WU LJ, 1991, J BACTERIOL, V173, P4877, DOI 10.1128/jb.173.15.4877-4888.1991; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YOSHIDA H, 1990, J BACTERIOL, V172, P6942, DOI 10.1128/jb.172.12.6942-6949.1990	49	45	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27000	27006		10.1074/jbc.270.45.27000	http://dx.doi.org/10.1074/jbc.270.45.27000			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592948	hybrid			2022-12-27	WOS:A1995TE58300048
J	PANAYOTOVAHEIERMANN, M; LOO, DDF; WRIGHT, EM				PANAYOTOVAHEIERMANN, M; LOO, DDF; WRIGHT, EM			KINETICS OF STEADY-STATE CURRENTS AND CHARGE MOVEMENTS ASSOCIATED WITH THE RAT NA+/GLUCOSE COTRANSPORTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ GLUCOSE COTRANSPORTER; ELECTROGENIC PROPERTIES; VOLTAGE-CLAMP; CLONING; EXPRESSION; CDNA	The rat Na+/glucose cotransporter (SGLT1) was expressed in Xenopus oocytes and steady-state and transient currents were measured using a two-electrode voltage clamp. The maximal glucose induced Na+-dependent inward current was similar to 300-500 nA, The apparent affinity constants for sugar (alpha-methyl-D-glucopyrano-side; alpha MDG) (K-0.5(alpha MDG)) sodium (K-0.5(Na)) at a membrane potential of -150 mV were 0.2 mM and 4 mM. The (Na)(0.5) increased continuously with depolarizing potentials reaching 40 mM at -30 mV, K-0.5(alpha MDG) was steeply voltage dependent, 0.46 mM at -30 mV and 1 mM at -10 mV. From all tested monovalent cations only Li+ could substitute for Na+ but with lower affinity, The relative substrate specificity was D-glucose > alpha MDG approximate to D-galactose > 3-O-Me-Glc much greater than beta-naphthyl-D-glucoside much greater than uridine, Phlorizin (Pt), the specific blocker of sugar transport, showed an extremely high affinity for the rat cotransporter with an inhibitor constant (K-i(Pz)) of 12 nM. SGLT1 charge movements in the absence of sugar were fitted by the Boltzmann equation with an apparent valence of the movable charge of similar to 1, a potential for 50% maximal charge transfer (V-0.5) of -43 mV, and a maximal charge (Q(max)) of 9 nanocoulombs, The apparent turnover number for the rat SGLT1 was 30 s(-1), Model simulations showed that the kinetics of the rat SGLT1 are described by a six-state ordered nonrapid equilibrium model, and comparison of the kinetics of the rat, rabbit and human cotransporters indicate that they differ mainly in their presteady-state kinetic parameters.			PANAYOTOVAHEIERMANN, M (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT PHYSIOL,10833 LE CONTE AVE,LOS ANGELES,CA 90095, USA.				NIDDK NIH HHS [DK4460] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BIRNIR B, 1991, PFLUG ARCH EUR J PHY, V418, P79, DOI 10.1007/BF00370455; CHARON JP, 1994, AM J PHYSIOL-LUNG C, V267, pL390, DOI 10.1152/ajplung.1994.267.4.L390; DIEDRICH DF, 1990, METHOD ENZYMOL, V191, P755; HAGER K, 1995, J MEMBRANE BIOL, V143, P103; HEDIGER MA, 1989, P NATL ACAD SCI USA, V86, P5748, DOI 10.1073/pnas.86.15.5748; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; Hirayama B. A., 1995, Biophysical Journal, V68, pA439; KWON HM, 1992, J BIOL CHEM, V267, P6297; LEE WS, 1994, J BIOL CHEM, V269, P12032; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; MACKENZIE B, 1994, J BIOL CHEM, V269, P22488; MIZUMA T, 1992, BIOCHEM PHARMACOL, V43, P2037, DOI 10.1016/0006-2952(92)90649-4; MORRISON AI, 1991, BIOCHIM BIOPHYS ACTA, V1089, P121, DOI 10.1016/0167-4781(91)90093-2; OHTA T, 1990, MOL CELL BIOL, V10, P6491, DOI 10.1128/MCB.10.12.6491; PAJOR AM, 1992, J BIOL CHEM, V267, P3557; PANAYOTOVAHEIER.M, 1994, J BIOL CHEM, V269, P21016; PARENT L, 1992, J MEMBRANE BIOL, V125, P63; PARENT L, 1992, J MEMBRANE BIOL, V125, P49; TURK E, 1994, J BIOL CHEM, V269, P15204; WRIGHT E M, 1992, Current Opinion in Cell Biology, V4, P696, DOI 10.1016/0955-0674(92)90091-P; WRIGHT EM, 1994, J EXP BIOL, V196, P197; WRIGHT EM, 1994, BIOCHEM SOC T, V22, P646, DOI 10.1042/bst0220646	22	90	94	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27099	27105		10.1074/jbc.270.45.27099	http://dx.doi.org/10.1074/jbc.270.45.27099			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592962	hybrid			2022-12-27	WOS:A1995TE58300062
J	MCQUENEY, MS; MARKHAM, GD				MCQUENEY, MS; MARKHAM, GD			INVESTIGATION OF MONOVALENT CATION ACTIVATION OF S-ADENOSYLMETHIONINE SYNTHETASE USING MUTAGENESIS AND URANYL INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL ASPECTS; ESCHERICHIA-COLI; ION SPECIFICITY; BINDING-SITES; ACTIVE-SITE; METAL; SALTS; COMPLEXES; ENZYMES; DNA	S-Adenosylmethionine (AdoMet) synthetase catalyzes the formation of AdoMet from ATP and L-methionine with subsequent hydrolysis of the bound tripolyphosphate intermediate. Maximal activity requires the presence of two divalent and one monovalent cation per active site, Recently, the x-ray structure of the Escherichia coli AdoMet synthetase was solved, and the positions of the two Mg2+ binding sites were identified, Based on additional spherical electron density, the K+ binding site was postulated to be a nearby site where the uranyl heavy atom derivative also bound in the crystal, The side chain of glutamate 42 is within ligation distance of the metals. Mutagenesis of glutamate 42 to glutamine (E42QMetK) abolished monovalent cation activation and produced an enzyme that has kinetic properties virtually identical to those of K+-free wild type AdoMet synthetase in both the overall AdoMet synthetase reaction and in the hydrolysis of tripolyphosphate, Thus, there is a similar to 100-fold decrease in the V-max for AdoMet synthesis and large increases in the K-m values for both substrates. In contrast there is only a a-fold decrease in V-max for tripolyphosphate hydrolysis. The uranyl ion, UO22+, is a competitive inhibitor with respect to K+ (K-i = 350 nM) and is the first ion to bind at this site and inhibit the enzyme, The UO22+ inhibition is reversible and tight-binding, and results from UO22+ and not UO22+. ATP. Analogous to K+ activation, UO22+ predominantly inhibits AdoMet formation rather than tripolyphosphate hydrolysis, The kinetic results indicate that UO22+ inhibition is likely to result from interference with productive ATP binding, UO22+ remains a tight-binding inhibitor of the E42Q mutant, which suggests that K+ and UO22+ have different ligation preferences when bound in the monovalent cation binding pocket, The results support the model that glutamate 42 provides ligands to the K+ and has a major role in monovalent cation binding.	FOX CHASE CANC CTR,INST CANC RES,PHILADELPHIA,PA 19111	Fox Chase Cancer Center					NCI NIH HHS [CA-06927] Funding Source: Medline; NIGMS NIH HHS [GM-31186, GM-15790] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM015790, R01GM031186] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balzani V., 1978, TOP CURR CHEM, P1, DOI [10.1007/BFb0048835, DOI 10.1007/BFB0048835]; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BELL JT, 1965, J MOL SPECTROSC, V18, P247, DOI 10.1016/0022-2852(65)90140-2; BLUNDELL TL, 1976, PROTEIN CRYSTALLOGRA, P201; BOYLE SM, 1984, GENE, V30, P129, DOI 10.1016/0378-1119(84)90113-6; BUCHACHENKO AL, 1991, ACCOUNTS CHEM RES, V24, P177, DOI 10.1021/ar00006a004; Bucholtz A., 1805, ANN CHIM PHYS, V56, P142; BURROWS HD, 1974, CHEM SOC REV, V3, P139, DOI 10.1039/cs9740300139; BURROWS HD, 1989, MEM ACAD CIENCIAS LI, V30, P33; CARRELL CJ, 1988, J AM CHEM SOC, V110, P8651, DOI 10.1021/ja00234a011; Cleland W W, 1979, Methods Enzymol, V63, P103; COHN M, 1954, NATURE, V173, P1090, DOI 10.1038/1731090b0; FALKE JJ, 1991, BIOCHEMISTRY-US, V30, P8690, DOI 10.1021/bi00099a029; FELDMAN I, 1967, J AM CHEM SOC, V89, P49, DOI 10.1021/ja00977a010; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; GREENWOOD NN, 1986, CHEM ELEMENTS, P1478; HAMPTON A, 1969, BIOCHEMISTRY-US, V8, P2303, DOI 10.1021/bi00834a011; HUHEEY JE, 1983, INORG CHEM; JENKINS J, 1992, BIOCHEMISTRY-US, V31, P5449, DOI 10.1021/bi00139a005; JUNG WS, 1987, J CHEM SOC CHEM COMM, P372, DOI 10.1039/c39870000372; KE HYD, 1992, APPL SPECTROSC, V46, P1168, DOI 10.1366/0003702924124178; LARSEN TM, 1994, BIOCHEMISTRY-US, V33, P6301, DOI 10.1021/bi00186a033; MARKHAM GD, 1980, J BIOL CHEM, V255, P9082; MARKHAM GD, 1987, J BIOL CHEM, V262, P5609; MARKHAM GD, 1981, J BIOL CHEM, V256, P1903; MARKHAM GD, 1987, J AM CHEM SOC, V109, P599, DOI 10.1021/ja00236a057; MARKHAM GD, 1986, J BIOL CHEM, V261, P1507; Martell A.E., 1976, CRITICAL STABILITY C, V4; MATHEWS FS, 1971, COLD SPRING HARB SYM, V36, P387, DOI 10.1101/SQB.1972.036.01.050; NEEDHAM JV, 1993, BIOCHEMISTRY-US, V32, P3363, DOI 10.1021/bi00064a020; NIELSEN PE, 1988, FEBS LETT, V235, P122, DOI 10.1016/0014-5793(88)81245-6; NIELSEN PE, 1992, J AM CHEM SOC, V114, P4967, DOI 10.1021/ja00039a003; O'Sullivan W J, 1979, Methods Enzymol, V63, P294; Rabinowitch E., 1964, SPECTROSCOPY PHOTOCH; SCHLOSS JV, 1988, ACCOUNTS CHEM RES, V21, P348, DOI 10.1021/ar00153a005; SHANNON RD, 1969, ACTA CRYSTALL B-STRU, VB 25, P925, DOI 10.1107/S0567740869003220; SUELTER CH, 1970, SCIENCE, V168, P789, DOI 10.1126/science.168.3933.789; TANSWELL P, 1974, FEBS LETT, V48, P60, DOI 10.1016/0014-5793(74)81062-8; TONEY MD, 1993, SCIENCE, V261, P756, DOI 10.1126/science.8342040; TOTH LM, 1981, J PHYS CHEM-US, V85, P547, DOI 10.1021/j150605a018; Williams J W, 1979, Methods Enzymol, V63, P437	41	37	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18277	18284		10.1074/jbc.270.31.18277	http://dx.doi.org/10.1074/jbc.270.31.18277			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629147	hybrid			2022-12-27	WOS:A1995RM64200022
J	FAN, JQ; QUESENBERRY, MS; TAKEGAWA, K; IWAHARA, S; KONDO, A; KATO, I; LEE, YC				FAN, JQ; QUESENBERRY, MS; TAKEGAWA, K; IWAHARA, S; KONDO, A; KATO, I; LEE, YC			SYNTHESIS OF NEOGLYCOCONJUGATES BY TRANSGLYCOSYLATION WITH ARTHROBACTER PROTOPHORMIAE ENDO-BETA-N-ACETYLGLUCOSAMINIDASE - DEMONSTRATION OF A MACRO-CLUSTER EFFECT FOR MANNOSE-BINDING PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYMATIC-SYNTHESIS; ANIMAL LECTINS; ALPHA; OLIGOSACCHARIDES; RECOGNITION; GLYCOSIDES; XYLOSIDASE; LIGANDS; SERUM	The transglycosylation activity of endo-beta-N-acetylglucosaminidase from Arthrobacter protophormiae (endo-A) can be enhanced dramatically by inclusion of organic solvent in the reaction mixture (see accompanying article; Fan, J.-Q., Takegawa, K., Iwahara, S., Kondo, A., Kato, I., Abeygunawardana, C., and Lee, Y. C. (1995) J. Biol. Chem. 270, 17723-17729). This finding was extended to synthesis of important intermediates for preparation of neoglycoconjugates. When 0.2 M GlcNAc-O-(CH2)(6)NH2, GlcNAc-O-CH2CH=CH2, GlcNAc-O-(CH2)(3)CH=CH2, GlcNAc-O-(CH2)(3)NHCOCH=CH2, GlcNAc-SCH2CN, GlcNAc-S-(CH2)(3)CH3, or GlcNAc-S-CH2CONHCH2CH(OMe)(2) were used as accepters in 30% acetone-containing media, the transglycosylation was accomplished with about 80% yield. The transglycosylation yields to benzyl beta-GlcNAc (67%), 4-methyl-umbelliferyl beta-GlcNAc (66%), p-nitrophenyl beta-GlcNAc (33%), and (GlcNAc-beta-S-CH2CH2CH2)(2) (43%) were lower, because their poor solubilities allowed only 0.05 M or lower concentrations in the reaction mixture. A micromole-scale synthesis of Man(9)GlcNAc(2)-O-(CH2)NHCOCH=CH2 (Man(9)GlcNAc(2)-NAP) was accomplished with 90% yield, and the structure of the transglycosylation product was confirmed by H-1 NMR. Man(9)GlcNAc(2)NAP was co-polymerized with acrylamide. The ratio of sugar side chain to acrylamide in this glycopolymer was 1:44 and the molecular weight of glycopolymer was estimated to be between 1,500,000 and 2,000,000 by high performance gel filtration chromatography. The glycopolymer was shown to be a much more efficient inhibitor of binding by recombinant rat mannose binding pro tein-carbohydrate recognition domains (MBP-CRD) from serum (I-50 = 3.5 mu M Man(9)GlcNAc(2) sugar chain) and liver (I-50 = 74.5 mu M) than soybean agglutinin.	JOHNS HOPKINS UNIV,DEPT BIOL,BALTIMORE,MD 21218; KAGAWA UNIV,FAC AGR,DEPT BIORESOURCE SCI,KAGAWA,JAPAN; TAKARA SHUZO CO LTD,BIOTECHNOL RES LAB,OTSU,SHIGA 52021,JAPAN	Johns Hopkins University; Kagawa University; Takara Holdings Inc.								BARDALES RM, 1989, J BIOL CHEM, V264, P19893; CANTACUZENE D, 1991, BIOMED BIOCHIM ACTA, V50, pS231; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; FAN JQ, 1994, ANAL BIOCHEM, V219, P224, DOI 10.1006/abio.1994.1261; FAN JQ, 1995, J BIOL CHEM, V270, P17723, DOI 10.1074/jbc.270.30.17723; FUKASE K, 1994, J CARBOHYD CHEM, V13, P715, DOI 10.1080/07328309408011676; GLICK GD, 1991, J BIOL CHEM, V266, P23660; KOBAYASHI K, 1994, J CARBOHYD CHEM, V13, P753, DOI 10.1080/07328309408011678; KOCHETKOV NK, 1984, PURE APPL CHEM, V56, P923, DOI 10.1351/pac198456070923; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; Lee Reiko T., 1994, P23; LEE RT, 1992, ARCH BIOCHEM BIOPHYS, V299, P129, DOI 10.1016/0003-9861(92)90254-T; LEE RT, 1987, METHOD ENZYMOL, V138, P424; Lee Y. C., 1994, P3; Lee Y C, 1988, Adv Exp Med Biol, V228, P105; LEE YC, 1993, BIOCHEM SOC T, V21, P460, DOI 10.1042/bst0210460; LEE YC, 1991, PURE APPL CHEM, V63, P499, DOI 10.1351/pac199163040499; LEE YC, 1992, GLYCOCONJUGATES, P121; MCKELVY JF, 1969, ARCH BIOCHEM BIOPHYS, V132, P99, DOI 10.1016/0003-9861(69)90341-5; NILSSON KGI, 1989, CARBOHYD RES, V188, P9, DOI 10.1016/0008-6215(89)84053-4; NILSSON KGI, 1987, CARBOHYD RES, V167, P95, DOI 10.1016/0008-6215(87)80271-9; NISHIMURA SI, 1994, MACROMOLECULES, V27, P157, DOI 10.1021/ma00079a023; NISHIMURA SI, 1994, MACROMOLECULES, V27, P4876, DOI 10.1021/ma00096a004; NISHIMURA SI, 1991, MACROMOLECULES, V24, P4236, DOI 10.1021/ma00015a002; PATANKAR MS, 1993, J BIOL CHEM, V268, P21770; QUESENBERRY MS, 1992, J BIOL CHEM, V267, P10831; SAKAI K, 1992, J CARBOHYD CHEM, V11, P553, DOI 10.1080/07328309208016148; SHINOYAMA H, 1988, AGR BIOL CHEM TOKYO, V52, P2375; SHINOYAMA H, 1988, AGR BIOL CHEM TOKYO, V52, P2197; TAKEGAWA K, 1991, BIOCHEM INT, V24, P849; TAKEGAWA K, 1989, APPL ENVIRON MICROB, V55, P3107, DOI 10.1128/AEM.55.12.3107-3112.1989; TAKEGAWA K, 1991, BIOCHEM INT, V25, P829; TOOGOOD PL, 1991, J MED CHEM, V34, P3140; TRIMBLE RB, 1986, J BIOL CHEM, V261, P2000; USUI T, 1994, GLYCOCONJUGATE J, V11, P105, DOI 10.1007/BF00731150; USUI T, 1988, J BIOCHEM-TOKYO, V103, P969, DOI 10.1093/oxfordjournals.jbchem.a122395; VLIEGENTHART JFG, 1983, ADV CARBOHYD CHEM BI, V41, P209, DOI 10.1016/S0065-2318(08)60059-1; WASSARMAN PM, 1991, DEVELOPMENT, V108, P1	38	54	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17730	17735		10.1074/jbc.270.30.17730	http://dx.doi.org/10.1074/jbc.270.30.17730			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629072				2022-12-27	WOS:A1995RM26600018
J	HASHIMOTO, R; FUJIWARA, H; HIGASHIHASHI, N; KIMURA, TE; TERASAWA, H; FUJITAYAMAGUCHI, Y; INAGAKI, F; PERDUE, JF; SAKANO, KI				HASHIMOTO, R; FUJIWARA, H; HIGASHIHASHI, N; KIMURA, TE; TERASAWA, H; FUJITAYAMAGUCHI, Y; INAGAKI, F; PERDUE, JF; SAKANO, KI			N-TERMINAL DELETION MUTANTS OF INSULIN-LIKE GROWTH FACTOR-II (IGF-II) SHOW THR(7) AND LEU(8) IMPORTANT FOR BINDING TO INSULIN AND IGF-I RECEPTORS AND LEU(8) CRITICAL FOR ALL IGF-II FUNCTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY BINDING; BIOLOGICAL-ACTIVITIES; IDENTIFICATION; PURIFICATION; EXPRESSION; POTENCY; PROTEIN; BRAIN; FORM	To define the role of the N-terminal region of insulinlike growth factor-II (IGF-II) in its binding to insulin and IGF receptors, deletion mutants des-(1-5)-, des-(1-7)-, and des-(1-8)-recombinant (r) IGF-II, and the Gly(8) for Leu substitution mutant of rIGF-II were prepared by site-directed mutagenesis, expressed in Escherichia coli, and purified. The binding affinity and mitogenic activity of these rIGF-II mutants as well as commercially available des-(1-6)-rIGF-II were analyzed. While the relative affinity of des-(1-5)- and des-(1-6)-rIGF-II for purified human insulin and IGF-I receptors remained at greater than or equal to 50% levels of that of rIGF-II, the affinity of des-(1-7)-rIGF-II decreased to similar to 10% and similar to 3%, respectively, of that of rIGF-II. When the octapeptide including Leu(8) was removed prior to the Cys(9)-Cys(47) intrachain bond, the relative affinity of this deletion mutant, des(1-8)-rIGF-II, for these receptors dramatically decreased to <1% of that of rIGF-II. Substituting Gly(8) for Leu in rIGF-II decreased the affinity of this mutant for the IGF-I and insulin receptors to about the same extent. These results suggest that the side chains of Thr(7) and Leu(8) may play an important role in retaining all of the IGF-II functions. Decreases in the relative affinity for binding of the mutants to these receptors paralleled the decreases in their mitogenic potency for cultured Balb/c 3T3 cells. Although the relative affinity of des-(1-8)- or [Gly(8)]rIGF-II for rat IGF-II/CIM6-P (cation-independent mannose 6-phosphate) receptors was also <1% of that of rIGF-II, the relative affinities of des-(1-5)-, des-(1-6)-, and des-(1-7)-rIGF-II for these receptors was significantly greater than that of rIGF-II. These results clearly demonstrate that Thr(7) and Leu(8) are important for binding to insulin and IGF-I receptors and Leu(8) is critical for expression of all IGF-II functions.	TOKYO METROPOLITAN INST MED SCI, BUNKYO KU, TOKYO 113, JAPAN; CITY HOPE NATL MED CTR, BECKMAN RES INST, DEPT MOLEC GENET, DUARTE, CA 91010 USA; AMER RED CROSS, JEROME H HOLLAND LAB, MOLEC BIOL LAB, ROCKVILLE, MD 20855 USA	Tokyo Metropolitan Institute of Medical Science; City of Hope; Beckman Research Institute of City of Hope; American Red Cross	HASHIMOTO, R (corresponding author), DAIICHI PHARMACEUT CO LTD, MOLEC BIOL RES LAB, EDOGAWA KU, 16-13 KITAKASAI 1-CHOME, TOKYO 134, JAPAN.				NCI NIH HHS [CA47150] Funding Source: Medline; NIDDK NIH HHS [DK34427] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA047150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034427] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BACH LA, 1993, J BIOL CHEM, V268, P9246; BAGLEY CJ, 1989, BIOCHEM J, V259, P665, DOI 10.1042/bj2590665; BAYNE ML, 1990, J BIOL CHEM, V265, P15648; CARLSSONSKWIRUT C, 1986, FEBS LETT, V201, P46, DOI 10.1016/0014-5793(86)80568-3; CASCIERI MA, 1989, J CELL PHYSIOL, V139, P181, DOI 10.1002/jcp.1041390125; CASELLA SJ, 1986, J BIOL CHEM, V261, P9268; FRANCIS GL, 1988, BIOCHEM J, V251, P95, DOI 10.1042/bj2510095; FUJITAYAMAGUCHI Y, 1983, J BIOL CHEM, V258, P5045; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; IWAI M, 1989, J BIOCHEM-TOKYO, V106, P949, DOI 10.1093/oxfordjournals.jbchem.a122978; LEBON TR, 1986, J BIOL CHEM, V261, P7685; LUTHI C, 1992, EUR J BIOCHEM, V205, P483, DOI 10.1111/j.1432-1033.1992.tb16804.x; MARUMOTO Y, 1987, J GEN VIROL, V68, P2599, DOI 10.1099/0022-1317-68-10-2599; NAKAGAWA SH, 1991, J BIOL CHEM, V266, P11502; OGASAWARA M, 1989, BIOCHEMISTRY-US, V28, P2710, DOI 10.1021/bi00432a052; PERDUE JF, 1994, INT CONGR SER, V1056, P67; PERDUE JF, 1983, J BIOL CHEM, V258, P7800; ROSS M, 1989, BIOCHEM J, V258, P267, DOI 10.1042/bj2580267; SAHAGIAN GG, 1982, METHOD ENZYMOL, V83, P392; SAITO Y, 1987, J BIOCHEM-TOKYO, V101, P123, DOI 10.1093/oxfordjournals.jbchem.a121883; SAKANO KI, 1991, J BIOL CHEM, V266, P20626; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARA VR, 1986, P NATL ACAD SCI USA, V83, P4904, DOI 10.1073/pnas.83.13.4904; SMITH MC, 1989, J BIOL CHEM, V264, P9314; TERASAWA H, 1994, EMBO J, V13, P5590, DOI 10.1002/j.1460-2075.1994.tb06896.x	25	10	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18013	18018		10.1074/jbc.270.30.18013	http://dx.doi.org/10.1074/jbc.270.30.18013			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629109	hybrid			2022-12-27	WOS:A1995RM26600060
J	ZULIANELLO, L; VANULSEN, P; VANDEPUTTE, P; GOOSEN, N				ZULIANELLO, L; VANULSEN, P; VANDEPUTTE, P; GOOSEN, N			PARTICIPATION OF THE FLANK REGIONS OF THE INTEGRATION HOST FACTOR PROTEIN IN THE SPECIFICITY AND STABILITY OF DNA-BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE-LIKE PROTEINS; ESCHERICHIA-COLI; FACTOR IHF; SITES; GENE; REPLICATION; EXPRESSION; RESOLUTION; COMPLEXES; MUTANTS	The heterodimeric integration host factor (IHF) protein is a site-specific DNA-binding protein from Escherichia coli that strongly bends the DNA. It has been proposed (Yang, C., and Nash, H. A. (1989) Cell 57, 869-880; Granston, A. E., and Nash, H. A. (1993) J. Mol. Biol 234, 45-59; Lee, E. C., Hales, L. M., Gumport, R. I., and Gardner, J. F. (1992) EMBO J. 11, 305313) that the wrapping of the DNA around the protein is stabilized through interactions between the flanks of the protein and the DNA. In order to elucidate which domains of the IHF protein are involved in these interactions, we have constructed mutant proteins in which the C-terminal part of one of the subunits has been deleted. We observed that the C-terminal alpha 3 helix of HimD is involved in the stability of DNA binding, but not in the specificity. In contrast the corresponding alpha 3 helix of HimA is essential for the sequence specificity, since an IHF mutant lacking this domain only binds to the DNA in a nonspecific way. The possible role of the two C-terminal alpha-helical structures in complex formation will be discussed. We also examined the properties of an IHF mutant that has an amino acid substitution between beta sheets beta 1 and beta 2 of the HimD subunit (R46H). The occupancy of the ihf site by the mutant and wild type proteins differ in the 3' part of the ihf site and as a result the bend introduced in the DNA by the mutant protein is less pronounced. We propose that the arginine 46 in the HimD subunit is in vicinity of the TTR region of the consensus and that through contacts within the minor groove the DNA bend introduced by IHF is stabilized.	LEIDEN UNIV,GORLAEUS LABS,LEIDEN INST CHEM,GENET MOLEC LAB,2300 RA LEIDEN,NETHERLANDS	Leiden University; Leiden University - Excl LUMC				van Ulsen, Peter/0000-0002-2164-1611				BONNEFOY E, 1991, EMBO J, V10, P687, DOI 10.1002/j.1460-2075.1991.tb07998.x; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; CRAIG NL, 1984, CELL, V39, P707, DOI 10.1016/0092-8674(84)90478-1; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; FENG JA, 1994, SCIENCE, V263, P348, DOI 10.1126/science.8278807; FLAMM EL, 1985, J MOL BIOL, V183, P117, DOI 10.1016/0022-2836(85)90206-2; FREUNDLICH M, 1992, MOL MICROBIOL, V6, P2557, DOI 10.1111/j.1365-2958.1992.tb01432.x; FRIEDMAN DI, 1988, CELL, V55, P545, DOI 10.1016/0092-8674(88)90213-9; GAMAS P, 1987, J MOL BIOL, V195, P261, DOI 10.1016/0022-2836(87)90648-6; GEIERSTANGER BH, 1994, BIOCHEMISTRY-US, V33, P5347, DOI 10.1021/bi00183a043; GOLDENBERG D, 1994, BIOCHIMIE, V76, P941, DOI 10.1016/0300-9084(94)90019-1; GOODRICH JA, 1990, NUCLEIC ACIDS RES, V18, P4993, DOI 10.1093/nar/18.17.4993; GOOSEN N, 1995, MOL MICROBIOL, V16, P1, DOI 10.1111/j.1365-2958.1995.tb02386.x; GRANSTON AE, 1993, J MOL BIOL, V234, P45, DOI 10.1006/jmbi.1993.1562; HALES LM, 1994, J BACTERIOL, V176, P2999, DOI 10.1128/JB.176.10.2999-3006.1994; JIA X, 1994, BIOCHEMISTRY-US, V33, P8842, DOI 10.1021/bi00195a028; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; LEE EC, 1992, EMBO J, V11, P305, DOI 10.1002/j.1460-2075.1992.tb05053.x; MENGERITSKY G, 1993, J MOL BIOL, V231, P646, DOI 10.1006/jmbi.1993.1316; MILLER HI, 1984, COLD SPRING HARB SYM, V49, P691, DOI 10.1101/SQB.1984.049.01.078; MILLER HI, 1977, DNA INSERTION ELEMEN, P349; Miller J. H., 1972, EXPT MOL GENETICS, P431; MORISATO D, 1987, CELL, V51, P101, DOI 10.1016/0092-8674(87)90014-6; SAYRE MH, 1988, J VIROL, V62, P3455, DOI 10.1128/JVI.62.9.3455-3462.1988; STENZEL TT, 1987, CELL, V49, P709, DOI 10.1016/0092-8674(87)90547-2; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TANAKA I, 1984, NATURE, V310, P376, DOI 10.1038/310376a0; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; VANRIJN PA, 1989, NUCLEIC ACIDS RES, V17, P10203, DOI 10.1093/nar/17.24.10203; WERNER MH, 1994, CURR BIOL, V4, P477, DOI 10.1016/S0960-9822(00)00108-1; WHITE SW, 1989, PROTEINS, V5, P281, DOI 10.1002/prot.340050405; Williams JGK, 1977, DNA INSERTION ELEMEN, P357; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; YANG CC, 1989, CELL, V57, P869, DOI 10.1016/0092-8674(89)90801-5; YANG SW, 1994, P NATL ACAD SCI USA, V91, P12183, DOI 10.1073/pnas.91.25.12183; ZULIANELLO L, 1994, EMBO J, V13, P1534, DOI 10.1002/j.1460-2075.1994.tb06415.x	36	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17902	17907		10.1074/jbc.270.30.17902	http://dx.doi.org/10.1074/jbc.270.30.17902			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629095	hybrid			2022-12-27	WOS:A1995RM26600043
J	RUVINOV, SB; AHMED, SA; MCPHIE, P; MILES, EW				RUVINOV, SB; AHMED, SA; MCPHIE, P; MILES, EW			MONOVALENT CATIONS PARTIALLY REPAIR A CONFORMATIONAL DEFECT IN A MUTANT TRYPTOPHAN SYNTHASE ALPHA(2)BETA(2) COMPLEX (BETA-E109A)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHENOL-LYASE; AMINO-ACID SWITCH; ESCHERICHIA-COLI; BETA-SUBUNIT; SALMONELLA-TYPHIMURIUM; BIENZYME COMPLEX; ALPHA-SUBUNIT; ALLOSTERIC INTERACTIONS; 3-DIMENSIONAL STRUCTURE; ALPHA-2-BETA-2 COMPLEX	We are using the tryptophan synthase alpha(2) beta(2) complex as a model system to investigate how ligands, protein-protein interaction, and mutations regulate enzyme activity, reaction specificity, and substrate specificity. The rate of conversion of L-serine and indole to L-tryptophan by the beta(2) subunit alone is quite low, but is activated by certain monovalent cations or by association with alpha subunit to form an alpha(2) beta(2) complex. Since monovalent cations and a subunit appear to stabilize an active conformation of the beta(2) subunit, we have investigated the effects of monovalent cations on the activities and spectroscopic properties of a mutant form of alpha(2) beta(2) complex having beta(2) subunit glutamic acid 109 replaced by alanine (E109A). The E109A alpha(2) beta(2) complex is inactive in reactions with L-serine but active in reactions with beta-chloro-L-alanine. Parallel experiments show effects of monovalent cations on the properties of wild type beta(2) subunit and alpha(2) beta(2) complex. We find that CsCl stimulates the activity of the E109A alpha(2) beta(2) complex and of wild type beta(2) subunit with L-serine and indole and alters the equilibrium distribution of L-serine reaction intermediates. The results indicate that CsCl partially repairs the deleterious effects of the E109A mutation on the activity of the alpha(2) beta(2) complex by stabilizing a conformation with catalytic properties more similar to those of the wild type alpha(2) beta(2) complex. This conclusion is consistent with observations that monovalent cations alter the catalytic and spectroscopic properties of several pyridoxal phosphate dependent enzymes by stabilizing alternative conformations.	NIDDK, BIOCHEM PHARMACOL LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)								AASLESTAD HG, 1968, PYRIDOXAL CATALYSIS, P479; AHMED SA, 1991, J BIOL CHEM, V266, P21548; AHMED SA, 1994, J BIOL CHEM, V269, P16486; ANDERSON KS, 1991, J BIOL CHEM, V266, P8020; ANTSON AA, 1993, BIOCHEMISTRY-US, V32, P4195, DOI 10.1021/bi00067a006; BRZOVIC PS, 1992, BIOCHEMISTRY-US, V31, P1180, DOI 10.1021/bi00119a030; BRZOVIC PS, 1992, BIOCHEMISTRY-US, V31, P3831, DOI 10.1021/bi00130a014; CRAWFORD IP, 1964, P NATL ACAD SCI USA, V51, P390, DOI 10.1073/pnas.51.3.390; CRAWFORD IP, 1963, GENETICS, V48, P725; CREIGHTO.TE, 1970, EUR J BIOCHEM, V13, P1, DOI 10.1111/j.1432-1033.1970.tb00892.x; DEMIDKINA TV, 1989, BIOCHIMIE, V71, P565, DOI 10.1016/0300-9084(89)90188-0; DREWE WF, 1985, BIOCHEMISTRY-US, V24, P3977, DOI 10.1021/bi00336a027; DUNN MF, 1987, INDIAN J BIOCHEM BIO, V24, P44; DUNN MF, 1990, BIOCHEMISTRY-US, V29, P8598, DOI 10.1021/bi00489a015; DUNN MF, 1994, ADV LIF SCI-SERIES, P119; GOLDBERG ME, 1968, BIOCHEMISTRY-US, V7, P3662, DOI 10.1021/bi00850a045; HATANAKA M, 1962, ARCH BIOCHEM BIOPHYS, V97, P596, DOI 10.1016/0003-9861(62)90129-7; HOHENESTER E, 1994, BIOCHEMISTRY-US, V33, P13561, DOI 10.1021/bi00250a008; HOUBEN KF, 1990, BIOCHEMISTRY-US, V29, P2421, DOI 10.1021/bi00461a028; HYDE CC, 1988, J BIOL CHEM, V263, P17857; ISUPOV M, 1994, ADV LIF SCI-SERIES, P183; KAWASAKI H, 1987, J BIOL CHEM, V262, P10678; KAYASTHA AM, 1991, INDIAN J BIOCHEM BIO, V28, P352; KAYASTHA AM, 1991, INT UNION B, V199, P265; KAYASTHA AM, 1990, FASEB J, V4, pA2118; KIRSCHNER K, 1991, BIOCHEMISTRY-US, V30, P472, DOI 10.1021/bi00216a024; KUMAGAI H, 1971, BIOCHEM BIOPH RES CO, V44, P1271, DOI 10.1016/S0006-291X(71)80223-1; LANE AN, 1983, EUR J BIOCHEM, V129, P561; LANE AN, 1984, EMBO J, V3, P279, DOI 10.1002/j.1460-2075.1984.tb01797.x; Miles E W, 1995, Subcell Biochem, V24, P207; Miles E W, 1979, Adv Enzymol Relat Areas Mol Biol, V49, P127; Miles E.W., 1986, PYRIDOXAL PHOSPHAT B, V1, P253; Miles Edith Wilson, 1994, P127, DOI 10.1002/9783527615971.ch7; MILES EW, 1991, ADV ENZYMOL RAMB, V64, P93; MILES EW, 1987, METHOD ENZYMOL, V142, P398; MILES EW, 1974, J BIOL CHEM, V249, P2852; MILES EW, 1989, J BIOL CHEM, V264, P6280; MILES EW, 1991, J BIOL CHEM, V266, P10715; MORINO Y, 1967, J BIOL CHEM, V242, P2800; MOZZARELLI A, 1991, INT UNION B, V199, P273; PERACCHI A, 1995, BIOCHEMISTRY-US, V34, P9459, DOI 10.1021/bi00029a022; PERACCHI A, 1994, ADV LIF SCI-SERIES, P125; SUELTER CH, 1977, J BIOL CHEM, V252, P1852; TONEY MD, 1993, SCIENCE, V261, P756, DOI 10.1126/science.8342040; TONEY MD, 1995, J MOL BIOL, V245, P151, DOI 10.1006/jmbi.1994.0014; TORAYA T, 1976, EUR J BIOCHEM, V69, P411, DOI 10.1111/j.1432-1033.1976.tb10925.x; WOEHL EU, 1995, IN PRESS BIOCHEMISTR; WOEHL EU, 1995, IN PRESS COORDINATIO; YANG XJ, 1992, PROTEIN EXPRES PURIF, V3, P347, DOI 10.1016/1046-5928(92)90011-K; YANOFSKY C, 1972, ENZYMES, V7, P1; YORK SS, 1972, BIOCHEMISTRY-US, V11, P2733, DOI 10.1021/bi00764a029; ZHAO GP, 1993, J BIOL CHEM, V268, P14921; ZHAO GP, 1992, J BIOL CHEM, V267, P526	53	34	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17333	17338		10.1074/jbc.270.29.17333	http://dx.doi.org/10.1074/jbc.270.29.17333			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615535	hybrid			2022-12-27	WOS:A1995RK68900046
J	CHUEH, SH; SONG, SL; LIU, TY				CHUEH, SH; SONG, SL; LIU, TY			HETEROLOGOUS DESENSITIZATION OF OPIOID-STIMULATED CA2+ INCREASE BY BRADYKININ OR ATP IN NG108-15 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLIOMA HYBRID NG108-15; NG 108-15 CELLS; INTRACELLULAR CA-2+; ADENYLATE-CYCLASE; CALCIUM CHANNELS; EXTRACELLULAR ATP; RECEPTORS; INHIBITION; MOBILIZATION; ENKEPHALIN	Leucine-enkephalin (Leu-EK) dose-dependently elicited an increase in cytosolic Ca2+ concentration ([Ca2+](i)) with an EC(50) of 1.2 mu M via the phosphoinositide cascade in NG108-15 cells. Chronic treatment of cells with [D-Ala(2),D-Leu(5)]enkephalin caused time-dependent homologous desensitization. In the presence of extracellular Ca2+, ATP as well as bradykinin stimulated significantly higher increases in inositol 1,4,5-trisphosphate (IF3) generation than did Leu-EK; however, the magnitude of intracellular Ca2+ pools increased after ATP stimulation, whereas bradykinin depleted intracellular pools. Hence, cells lost their [Ca2+](i) response to Leu-EK if bradykinin was first added to induce a [Ca2+](i) increase, whereas the response was unchanged if Leu-EK was added after addition of ATP. When Leu-EK was added simultaneously with bradykinin or ATP, an additive response was observed in IF3 generation; however, the rise in [Ca2+](i) reached the same level as that induced by bradykinin or ATP alone. In the absence of extracellular Ca2+ in which the replenishment of intracellular pools was not possible, ATP displayed an inhibitory effect similar to that of bradykinin on the Leu-EK-induced [Ca2+](i) increase. Prior treatment of cells with Leu-EK slightly heterologously desensitized the action of bradykinin, but had no effect on the ATP response. Our results suggest that a shared intracellular Ca2+ pool is sensitive to the opioid, bradykinin and P-2-purinoceptor agonists; however, a defined pool of phosphatidylinositol 4,5-bisphosphate or a specific phospholipase C is responsible for each receptor.	NATL DEF MED CTR,GRAD INST LIFE SCI,TAIPEI 10764,TAIWAN	National Defense Medical Center	CHUEH, SH (corresponding author), NATL DEF MED CTR,DEPT BIOCHEM,TAIPEI 10764,TAIWAN.							BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BORIN ML, 1994, AM J PHYSIOL, V266, pC311, DOI 10.1152/ajpcell.1994.266.1.C311; CARRITHERS MD, 1990, BIOCHEM BIOPH RES CO, V170, P1096, DOI 10.1016/0006-291X(90)90505-H; CHAN J, 1991, J PHARMACOL EXP THER, V258, P524; CHUEH SH, 1994, BRAIN RES, V660, P81, DOI 10.1016/0006-8993(94)90841-9; CHUEH SH, 1994, MOL PHARMACOL, V45, P532; CHUEH SH, 1993, J NEUROCHEM, V61, P1782, DOI 10.1111/j.1471-4159.1993.tb09816.x; CHUEH SH, 1994, AM J PHYSIOL, V266, pC1008; EBERHARD DA, 1988, TRENDS NEUROSCI, V11, P517, DOI 10.1016/0166-2236(88)90174-9; EHRLICH YH, 1988, J NEUROCHEM, V50, P295, DOI 10.1111/j.1471-4159.1988.tb13263.x; GREEN DA, 1982, J NEUROCHEM, V39, P1125, DOI 10.1111/j.1471-4159.1982.tb11505.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hamprecht B, 1977, Int Rev Cytol, V49, P99; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; JIN WZ, 1992, MOL PHARMACOL, V42, P1083; JIN WZ, 1994, J NEUROSCI, V14, P1920; JIN WZ, 1993, BRAIN RES, V607, P17, DOI 10.1016/0006-8993(93)91484-A; KLEE WA, 1974, P NATL ACAD SCI USA, V71, P3474, DOI 10.1073/pnas.71.9.3474; KOSKI G, 1981, P NATL ACAD SCI-BIOL, V78, P4185, DOI 10.1073/pnas.78.7.4185; LAW PY, 1991, J PHARMACOL EXP THER, V256, P710; LOW PY, 1983, MOL PHARMACOL, V23, P26; MIWA N, 1988, J NEUROCHEM, V50, P1418, DOI 10.1111/j.1471-4159.1988.tb03025.x; MONTERO M, 1990, BIOCHEM J, V271, P535, DOI 10.1042/bj2710535; OKAJIMA F, 1993, BIOCHEM J, V290, P241, DOI 10.1042/bj2900241; OKAJIMA F, 1992, FEBS LETT, V301, P223, DOI 10.1016/0014-5793(92)81252-H; PRATHER PL, 1994, MOL PHARMACOL, V45, P997; SABOL SL, 1979, J BIOL CHEM, V254, P1913; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P3092, DOI 10.1073/pnas.72.8.3092; SHIMAHARA T, 1990, BRAIN RES, V524, P219, DOI 10.1016/0006-8993(90)90694-7; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; TSUNOO A, 1986, P NATL ACAD SCI USA, V83, P9832, DOI 10.1073/pnas.83.24.9832; WOJCIKIEWICZ RJH, 1994, J BIOL CHEM, V269, P7963; YANO K, 1984, J BIOL CHEM, V259, P201	33	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16630	16637		10.1074/jbc.270.28.16630	http://dx.doi.org/10.1074/jbc.270.28.16630			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622472	hybrid			2022-12-27	WOS:A1995RJ34700029
J	CROSTON, GE; CAO, ZD; GOEDDEL, DV				CROSTON, GE; CAO, ZD; GOEDDEL, DV			NF-KAPPA-B ACTIVATION BY INTERLEUKIN-1 (IL-1) REQUIRES AN IL-1 RECEPTOR-ASSOCIATED PROTEIN-KINASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TUMOR-NECROSIS-FACTOR; ELAM-1 GENE-TRANSCRIPTION; SIGNAL-TRANSDUCTION; FACTOR-ALPHA; EXPRESSION; CELLS; DROSOPHILA; DISEASE; CLONING; DORSAL	An important function of interleukin-1 (IL-1) is activation of the transcription factor NF-kappa B, which is signaled via the type I IL-1 receptor (IL-1RI), By receptor mutagenesis studies, we have identified a region of the cytoplasmic domain of IL-1RI that is required for both IL-1-mediated NF-kappa B activation and IL-1-dependent activation of a receptor-associated protein kinase activity we term IRAK. No IL-1RI mutants were found that can activate NF-kappa B in the absence of IRAK activity, Therefore, we propose that IRAK activation is a necessary step in the activation of NF-kappa B by IL-1.	TULARIK INC,S SAN FRANCISCO,CA 94080									Ausubel FM, 1994, CURRENT PROTOCOLS MO; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; COLLINS T, 1993, TRENDS CARDIOVAS MED, V3, P92, DOI 10.1016/1050-1738(93)90030-A; COLOTTA F, 1994, IMMUNOL TODAY, V15, P562, DOI 10.1016/0167-5699(94)90217-8; CURTIS BM, 1989, P NATL ACAD SCI USA, V86, P3045, DOI 10.1073/pnas.86.9.3045; DINARELLO CA, 1993, IMMUNOL TODAY, V14, P260, DOI 10.1016/0167-5699(93)90042-J; DINARELLO CA, 1991, BLOOD, V77, P1627; DINARELLO CA, 1993, NEW ENGL J MED, V328, P106; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; HEGUY A, 1992, J BIOL CHEM, V267, P2605; KRASNOW SW, 1991, CYTOKINE, V3, P372, DOI 10.1016/1043-4666(91)90040-K; KUNO K, 1993, J BIOL CHEM, V268, P13510; LEUNG KY, 1994, J BIOL CHEM, V269, P1579; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; MARTIN M, 1994, EUR J IMMUNOL, V24, P1566, DOI 10.1002/eji.1830240717; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; MONTGOMERY KF, 1991, P NATL ACAD SCI USA, V88, P6523, DOI 10.1073/pnas.88.15.6523; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; PITTI RM, 1994, MOL IMMUNOL, V17, P1345; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P2424, DOI 10.1128/MCB.9.6.2424; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; STYLIANOU E, 1992, J BIOL CHEM, V267, P15836; WASSERMAN SA, 1993, MOL BIOL CELL, V4, P767, DOI 10.1091/mbc.4.8.767; WHELAN J, 1991, NUCLEIC ACIDS RES, V19, P2645, DOI 10.1093/nar/19.10.2645	27	146	154	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16514	16517		10.1074/jbc.270.28.16514	http://dx.doi.org/10.1074/jbc.270.28.16514			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622454	hybrid			2022-12-27	WOS:A1995RJ34700009
J	DOMIGAN, NM; CHARLTON, TS; DUNCAN, MW; WINTERBOURN, CC; KETTLE, AJ				DOMIGAN, NM; CHARLTON, TS; DUNCAN, MW; WINTERBOURN, CC; KETTLE, AJ			CHLORINATION OF TYROSYL RESIDUES IN PEPTIDES BY MYELOPEROXIDASE AND HUMAN NEUTROPHILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOCHLOROUS ACID PRODUCTION; HYDROGEN PEROXIDE; OXIDANTS; SUPEROXIDE; CYTOTOXICITY; CHLORAMINES; GENERATION; LEUKOCYTE; MECHANISM; OXIDATION	Hypochlorous acid is the major strong oxidant generated by human neutrophils, and it has the potential to cause much of the tissue damage that these inflammatory cells promote, It is produced from hydrogen peroxide and chloride by the heme enzyme myeloperoxidase. To unequivocally establish that hypochlorous acid contributes to inflammation, a stable and unique marker for its reaction with biomolecules needs to be identified, In this investigation we have found that reagent hypochlorous acid reacts with tyrosyl residues in small peptides and converts them to chlorotyrosine. Purified myeloperoxidase in combination with hydrogen peroxide and chloride, as well as stimulated human neutrophils, chlorinated tyrosine in the peptide Gly-Gly-Tyr-Arg. Rather than reacting directly with the aromatic ring of tyrosine, hypochlorous acid initially reacted with an amine group of the peptide to form a chloramine. The chloramine then underwent an intramolecular reaction with the tyrosyl residue to convert it to chlorotyrosine. This indicates that tyrosyl residues in proteins that are close to amine groups will be susceptible to chlorination. Peroxidases are the only enzymes capable of chlorinating an aromatic ring. Furthermore, myeloperoxidase isthe only human enzyme that produces hypochlorous acid under physiological conditions. Therefore, chlorotyrosine will be a specific marker for the production of hypochlorous acid in vivo and for the involvement of myeloperoxidase in inflammatory tissue damage.	CHRISTCHURCH SCH MED,FREE RADICAL RES GRP,CHRISTCHURCH,NEW ZEALAND; UNIV NEW S WALES,BIOMED MASS SPECT UNIT,SYDNEY,NSW 2052,AUSTRALIA	University of Otago; University of New South Wales Sydney			Kettle, Anthony J/A-8520-2008	Kettle, Anthony J/0000-0002-8218-7766; Duncan, Mark/0000-0001-9256-8274				ALBRICH JM, 1981, P NATL ACAD SCI-BIOL, V78, P210, DOI 10.1073/pnas.78.1.210; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; BEAN MF, 1991, ANAL CHEM, V63, P1473, DOI 10.1021/ac00014a024; BEERS RF, 1952, J BIOL CHEM, V195, P133; BERNOFSKY C, 1991, FASEB J, V5, P295, DOI 10.1096/fasebj.5.3.1848195; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; COHEN SA, 1988, ANAL BIOCHEM, V174, P1, DOI 10.1016/0003-2697(88)90512-X; DELAMARE PBD, 1959, AROMATIC SUBSTITUTIO; FOOTE CS, 1983, NATURE, V301, P715, DOI 10.1038/301715a0; GRISHAM MB, 1994, LANCET, V344, P859, DOI 10.1016/S0140-6736(94)92831-2; GRISHAM MB, 1984, J BIOL CHEM, V259, P404; HAGER LP, 1966, J BIOL CHEM, V241, P1769; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; HEINECKE JW, 1994, CORONARY ARTERY DIS, V5, P205, DOI 10.1097/00019501-199403000-00004; JOHNSON RA, 1975, J ORG CHEM, V40, P2186, DOI 10.1021/jo00903a011; KETTLE AJ, 1990, BIOCHIM BIOPHYS ACTA, V1052, P379, DOI 10.1016/0167-4889(90)90146-5; KETTLE AJ, 1994, J BIOL CHEM, V269, P17146; KETTLE AJ, 1988, BIOCHEM J, V252, P529, DOI 10.1042/bj2520529; KETTLE AJ, 1988, BIOCHIM BIOPHYS ACTA, V957, P185, DOI 10.1016/0167-4838(88)90271-3; KETTLE AJ, 1994, METHOD ENZYMOL, V233, P502; KETTLE AJ, 1993, BIOCHEM PHARMACOL, V45, P2003, DOI 10.1016/0006-2952(93)90010-T; Klebanoff SJ., 1988, INFLAMMATION BASIC P, P391; LAMPERT MB, 1983, BLOOD, V62, P645; Magnussen RP, 1991, PEROXIDASES CHEM BIO, P199; MITCHELL E D JR, 1981, Proceedings of the Oklahoma Academy of Science, V61, P43; MORRISON M, 1976, ANNU REV BIOCHEM, V45, P861, DOI 10.1146/annurev.bi.45.070176.004241; Neidleman S.L., 1986, BIOHALOGENATION PRIN; ODAJIMA T, 1970, BIOCHIM BIOPHYS ACTA, V206, P71, DOI 10.1016/0005-2744(70)90083-5; PEREIRA WE, 1973, BIOCHIM BIOPHYS ACTA, V313, P170, DOI 10.1016/0304-4165(73)90198-0; RUDIE NG, 1980, J BIOL CHEM, V255, P498; SAYO H, 1990, XENOBIOTICA, V20, P957, DOI 10.3109/00498259009046911; SELVARAJ RJ, 1974, INFECT IMMUN, V9, P255, DOI 10.1128/IAI.9.2.255-260.1974; SLUNGAARD A, 1991, J BIOL CHEM, V266, P4903; TAUROG A, 1991, ARCH BIOCHEM BIOPHYS, V287, P288, DOI 10.1016/0003-9861(91)90481-W; TEST ST, 1984, J CLIN INVEST, V74, P1341, DOI 10.1172/JCI111544; Thomas E L, 1986, Methods Enzymol, V132, P569; UETRECHT JP, 1991, CHEM RES TOXICOL, V4, P218, DOI 10.1021/tx00020a015; VISSERS MCM, 1991, ARCH BIOCHEM BIOPHYS, V285, P53, DOI 10.1016/0003-9861(91)90327-F; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WEISS SJ, 1986, SCIENCE, V234, P200, DOI 10.1126/science.3018933; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; WEITZMAN SA, 1990, BLOOD, V76, P655; Winterbourn C.C., 1990, OXYGEN RADICALS SYST, P31; WINTERBOURN CC, 1992, ARCH BIOCHEM BIOPHYS, V296, P547, DOI 10.1016/0003-9861(92)90609-Z; WINTERBOURN CC, 1985, BIOCHIM BIOPHYS ACTA, V840, P204, DOI 10.1016/0304-4165(85)90120-5	45	277	281	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16542	16548		10.1074/jbc.270.28.16542	http://dx.doi.org/10.1074/jbc.270.28.16542			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622459	hybrid			2022-12-27	WOS:A1995RJ34700015
J	MATHUPALA, SP; REMPEL, A; PEDERSEN, PL				MATHUPALA, SP; REMPEL, A; PEDERSEN, PL			GLUCOSE CATABOLISM IN CANCER-CELLS - ISOLATION, SEQUENCE, AND ACTIVITY OF THE PROMOTER FOR TYPE-II HEXOKINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL BOUND HEXOKINASE; NOVIKOFF ASCITES TUMOR; RAT HEPATOMA; AEROBIC GLYCOLYSIS; ENERGY-METABOLISM; GLUCOKINASE GENE; BINDABLE FORM; BINDING-SITES; EXPRESSION; PHOSPHORYLATION	One of the most characteristic phenotypes of rapidly growing cancer cells is their propensity to catabolize glucose at high rates. Type II hexokinase, which is expressed at high levels in such cells and bound to the outer mitochondrial membrane, has been implicated as a major player in this aberrant metabolism. Here we report the isolation and sequence of a 4.3-kilobase pair proximal promoter region of the Type II hexokinase gene from a rapidly growing, highly glycolytic hepatoma cell line (AS-30D). Analysis of the sequence enabled the identification of putative promoter elements, including a TATA box, a CAAT element, several Sp-1 sites, and response elements for glucose, insulin, cAMP, Ap-1, and a number of other factors. Transfection experiments with AS-30D cells showed that promoter activity was enhanced 3.4-, 3.3-, 2.4-, 2.1-, and 1.3-fold, respectively, by glucose, phorbol 12-myristate 13-acetate (a phorbol ester), insulin, cAMP, and glucagon. In transfected hepatocytes, these same agents produced little or no effect. The results emphasize normal versus tumor cell differences in the regulation of Type II hexokinase and indicate that transcription of the Type II tumor gene may occur independent of metabolic state, thus, providing the cancer cell with a selective advantage over its cell of origin.	JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,MOLEC & CELLULAR BIOENERGET LAB,BALTIMORE,MD 21205	Johns Hopkins University					NCI NIH HHS [CA 32742] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA032742] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aisenberg A.C., 1961, GLYCOLYSIS RESPIRATI; ARORA KK, 1990, J BIOL CHEM, V265, P6481; ARORA KK, 1988, J BIOL CHEM, V263, P17422; ARORA KK, 1993, ARCH BIOCHEM BIOPHYS, V304, P515, DOI 10.1006/abbi.1993.1384; BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8; BERRY MN, 1991, LAB TECH BIOCH MOL B, V21, P56; BERRY MN, 1991, LAB TECH BIOCH MOL B, V21, P24; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BUSTAMANTE E, 1981, J BIOL CHEM, V256, P8699; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; FLORIDI A, 1981, J NATL CANCER I, V66, P497; FLORIDI A, 1981, CANCER RES, V41, P4661; FRESHNEY RI, 1987, CULTURE ANIMAL CELLS, P264; GRANGE T, 1991, NUCLEIC ACIDS RES, V19, P131, DOI 10.1093/nar/19.1.131; GRANNER D, 1990, J BIOL CHEM, V265, P10173; GUMAA KA, 1969, BIOCHEM BIOPH RES CO, V36, P771, DOI 10.1016/0006-291X(69)90676-7; GUTMAN A, 1990, EMBO J, V9, P2241, DOI 10.1002/j.1460-2075.1990.tb07394.x; HAMMOND KD, 1978, CANCER RES, V38, P1323; HERZFELD A, 1972, CANCER RES, V32, P1826; INUI M, 1979, J BIOCHEM, V85, P1151; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; JOHANSSON T, 1985, BIOCHEM BIOPH RES CO, V133, P608, DOI 10.1016/0006-291X(85)90948-9; KIKUCHI Y, 1972, CANCER, V30, P444, DOI 10.1002/1097-0142(197208)30:2<444::AID-CNCR2820300222>3.0.CO;2-9; KUROKAWA M, 1981, BIOCHEM INT, V2, P645; LAI E, 1991, TRENDS BIOCHEM SCI, V16, P427, DOI 10.1016/0968-0004(91)90169-V; LEMAIGRE FP, 1994, BIOCHEM J, V303, P1; LOCKER J, 1993, GENE TRANSCRIPTION P, P321; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; MAGNUSON MA, 1989, J BIOL CHEM, V264, P15986; NAKASHIMA RA, 1984, CANCER RES, V44, P5702; NAKASHIMA RA, 1986, BIOCHEMISTRY-US, V25, P1015, DOI 10.1021/bi00353a010; NAKASHIMA RA, 1988, CANCER RES, V48, P913; OBRIEN RM, 1991, BIOCHEM J, V278, P609, DOI 10.1042/bj2780609; PAGGI MG, 1991, BIOCHEM BIOPH RES CO, V178, P648, DOI 10.1016/0006-291X(91)90157-3; PARRY DM, 1983, J BIOL CHEM, V258, P904; Pedersen P L, 1978, Prog Exp Tumor Res, V22, P190; PRINTZ RL, 1993, ANNU REV NUTR, V13, P463, DOI 10.1146/annurev.nu.13.070193.002335; PRINTZ RL, 1993, J BIOL CHEM, V268, P5209; REMPEL A, 1994, BBA-GENE STRUCT EXPR, V1219, P660, DOI 10.1016/0167-4781(94)90225-9; ROSE IA, 1982, ARCH BIOCHEM BIOPHYS, V213, P625, DOI 10.1016/0003-9861(82)90592-6; ROSE IA, 1967, J BIOL CHEM, V242, P1635; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO S, 1972, GANN MONOGR CANCER R, V13, P279; SHINOHARA Y, 1991, FEBS LETT, V291, P55, DOI 10.1016/0014-5793(91)81102-E; SHOWE MK, 1992, NUCLEIC ACIDS RES, V20, P3153, DOI 10.1093/nar/20.12.3153; SINGH M, 1978, J CELL PHYSIOL, V97, P285, DOI 10.1002/jcp.1040970303; TANIZAWA Y, 1992, MOL ENDOCRINOL, V6, P1070, DOI 10.1210/me.6.7.1070; THELEN AP, 1991, ARCH BIOCHEM BIOPHYS, V286, P645, DOI 10.1016/0003-9861(91)90094-Y; VAULONT S, 1994, FASEB J, V8, P28, DOI 10.1096/fasebj.8.1.8299888; WARBURG O, 1980, METABOLISM TUMORS; WEINHOUSE SIDNEY, 1966, GANN MONOGR, V1., P99; [No title captured]; 1991, PROMEGA PROTOCOLS AP	56	136	145	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16918	16925		10.1074/jbc.270.28.16918	http://dx.doi.org/10.1074/jbc.270.28.16918			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622509	hybrid			2022-12-27	WOS:A1995RJ34700070
J	ZHOU, JZ; BAI, YL; WEINER, H				ZHOU, JZ; BAI, YL; WEINER, H			PROTEOLYSIS PREVENTS IN-VIVO CHIMERIC FUSION PROTEIN IMPORT INTO YEAST MITOCHONDRIA - CYTOSOLIC CLEAVAGE AND SUBCELLULAR-DISTRIBUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F1-ATPASE BETA-SUBUNIT; LIVER ALDEHYDE DEHYDROGENASE; ESCHERICHIA-COLI; SIGNAL PEPTIDE; GENE FUSIONS; RAT; PRESEQUENCE; PURIFICATION; SEQUENCES; PRECURSOR	The in vivo import of liver mitochondrial aldehyde dehydrogenase was investigated in yeast by constructing fusion proteins between its leader sequence and beta-galactosidase. Only 7% of the protein was imported. If 21 or 71 amino acids from the mature portion of aldehyde dehydrogenase were included in the construct, 40% was imported. The protein remaining in cytosol was sequenced. When the leader was fused directly to beta-galactosidase, the first 7 residues of the leader were missing. When 21 residues of mature aldehyde dehydrogenase were included, the entire leader plus 6 residues of the mature portion were missing; if 71 residues of mature aldehyde dehydrogenase were included, the first residue found corresponds to the 66th residue of the mature portion. When the leader was fused directly to beta-galactosidase, no processing of the imported protein occurred, and the N-terminal amino acid was blocked, presumably by acetylation. If the 21-amino acid insert was included, processing occurred. A modified leader sequence lacking the three-amino acid linker (RGP) was imported but not processed, just as we found in vitro (Thornton, K., Wang, Y., Weiner, H., and Gorenstein, D.G. (1993) J. Biol. Chem. 268, 19906-19914). The less than 100% import of pre-aldehyde dehydrogenase was due to the action of a post-translational protease attack which prevented import by destroying the leader peptide segment.	PURDUE UNIV, DEPT BIOCHEM, W LAFAYETTE, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus					NIAAA NIH HHS [AA00028, AA05812] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA005812, R37AA005812] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BADARACCO G, 1983, J BIOL CHEM, V258, P2022; BELTZER JP, 1988, J BIOL CHEM, V263, P368; Bergmeyer HU, 1974, METHOD ENZYMAT AN, P452; BRISCO PRG, 1990, J BIOL CHEM, V265, P11667; BRUCH MD, 1992, BIOCHIM BIOPHYS ACTA, V1159, P81, DOI 10.1016/0167-4838(92)90078-R; CASADABAN MJ, 1983, METHOD ENZYMOL, V100, P293; DAUM G, 1982, J BIOL CHEM, V257, P3028; DOUGLAS MG, 1984, P NATL ACAD SCI-BIOL, V81, P3983, DOI 10.1073/pnas.81.13.3983; EMR SD, 1986, J CELL BIOL, V102, P523, DOI 10.1083/jcb.102.2.523; ENDO T, 1989, J BIOCHEM, V106, P396, DOI 10.1093/oxfordjournals.jbchem.a122864; EPAND RM, 1986, J BIOL CHEM, V261, P17; FARRES J, 1989, EUR J BIOCHEM, V180, P67, DOI 10.1111/j.1432-1033.1989.tb14616.x; FUJIKI M, 1993, J BIOL CHEM, V268, P1914; GERMINO J, 1983, P NATL ACAD SCI-BIOL, V80, P6848, DOI 10.1073/pnas.80.22.6848; GHENBOT G, 1992, PROTEIN EXPRES PURIF, V3, P470, DOI 10.1016/1046-5928(92)90064-4; Guthrie C, 1991, GUIDE YEAST GENETICS; HAMMEN PK, 1994, BIOCHEMISTRY-US, V33, P8610, DOI 10.1021/bi00194a028; HEMPEL J, 1985, EUR J BIOCHEM, V153, P13, DOI 10.1111/j.1432-1033.1985.tb09260.x; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JENG JJ, 1991, ARCH BIOCHEM BIOPHYS, V289, P214, DOI 10.1016/0003-9861(91)90464-T; JUST WW, 1987, PEROXISOMES BIOL MED, P402; KARSLAKE C, 1990, BIOCHEMISTRY-US, V29, P9872, DOI 10.1021/bi00494a017; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEMIRE BD, 1989, J BIOL CHEM, V264, P20206; LOHR GW, 1974, METHOD ENZYMAT AN, P636; MAGDOLEN V, 1992, FEBS LETT, V299, P267, DOI 10.1016/0014-5793(92)80129-5; Maniatis T., 1982, MOL CLONING; Miller J.H., 1972, EXPT MOL GENETICS; MULLER M, 1984, P NATL ACAD SCI-BIOL, V81, P7421, DOI 10.1073/pnas.81.23.7421; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEFFIELD WP, 1990, J BIOL CHEM, V265, P11069; THORNTON K, 1993, J BIOL CHEM, V268, P19906; VERNER K, 1992, MOL MICROBIOL, V6, P1723, DOI 10.1111/j.1365-2958.1992.tb01344.x; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WANG TTY, 1991, ALCOHOL CLIN EXP RES, V15, P286, DOI 10.1111/j.1530-0277.1991.tb01870.x; WANG Y, 1993, J BIOL CHEM, V268, P4759; WEINER H, 1991, ADV LIF SCI, P161; WICKNER WT, 1985, SCIENCE, V230, P400, DOI 10.1126/science.4048938	40	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16689	16693		10.1074/jbc.270.28.16689	http://dx.doi.org/10.1074/jbc.270.28.16689			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622479	hybrid			2022-12-27	WOS:A1995RJ34700038
J	ALVAREZ, CV; SHON, KJ; MILOSO, M; BEGUINOT, L				ALVAREZ, CV; SHON, KJ; MILOSO, M; BEGUINOT, L			STRUCTURAL REQUIREMENTS OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR FOR TYROSINE PHOSPHORYLATION OF EPS8 AND EPS15, SUBSTRATES LACKING SRC SH2 HOMOLOGY DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C-GAMMA; PROTO-ONCOGENE; PHOSPHOTYROSINE PHOSPHATASE; AUTOPHOSPHORYLATION SITES; KINASE-ACTIVITY; POINT MUTATION; EGF RECEPTOR; BINDING; IDENTIFICATION; DNA	Phosphorylation of two newly identified epidermal growth factor (EG;F) receptor substrates, eps8 and eps15, which do not possess Src homology (SH2) domains, was investigated using EGF receptor mutants of the autophosphorylation sites and deletion mutants of the carboxyl terminal region. Two mutants, F5, in which all five tyrosine autophosphorylation sites substituted by phenylalanine, and Dc 123F, in which four tyrosines were removed by deletion and the fifth (Tyr-992) was mutated into phenylalanine, phosphorylated eps8 and eps15 as efficiently as the wild-type receptor. In contrast, SH2-containing substrates, phospholipase C gamma, the GTPase-activating protein of Ras, the p85 subunit of phosphatidylinositol 3 kinase, and the Src and collagen homology protein, are not phosphorylated by the FS and Dc 123F mutants. A longer EGF receptor deletion mutant, Dc 214, lacking all five autophosphorylation sites, was unable to phosphorylate eps15 but phosphorylated eps8 13-fold more than the wild type receptor. To determine the EGF receptor region important for phosphorylation of eps8 and eps15, progressive deletion mutants lacking the final 123, 165, 196, and 214 COOH-terminal residues were used. eps8 phosphorylation was progressively increased in Dc 165, Dc 196, and Dc 214 EGF receptor mutants, indicating that removal of the final 214 COOH-terminal residues increases the phosphorylation of this substrate by the EGF receptor. In contrast, eps15 was phosphorylated by Dc 123 and Dc 165 EGF receptor mutants but not by Dc 196 and Dc 214 mutants. This indicates that a region of 30 residues located between Dc 165 and Dc 196 is essential for eps15 phosphorylation. This is the first demonstration of structural requirements in the EGF receptor COOH terminus for efficient phosphorylation of non SH2-containing substrates. In addition, enhanced eps8 phosphorylation correlates well with the increased transforming potential of EGF receptor deletion mutants Dc 196 and Dc 214, suggesting that this substrate may be involved in mitogenic signaling.	HS RAFFAELE,DIPARTIMENTO RIC BIOL & TECNOL,MOLEC BIOL LAB,I-20132 MILAN,ITALY; HS RAFFAELE,DIPARTIMENTO RIC BIOL & TECNOL,MOLEC ONCOL LAB,I-20132 MILAN,ITALY; HS RAFFAELE,CNR,IST NEUROSCI & BIOIMMAGINI,I-20132 MILAN,ITALY	Consiglio Nazionale delle Ricerche (CNR)			Miloso, Mariarosaria/AAC-7373-2021; Alvarez, Clara V/AAN-4173-2020	Alvarez, Clara V/0000-0003-1500-4058				BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; BERTICS PJ, 1988, J BIOL CHEM, V263, P3610; CARPENTER G, 1995, IN PRESS ANN NY ACAD; CARPENTER G, 1993, FORUM, V3, P616; CHANG CP, 1993, J BIOL CHEM, V268, P19312; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; FAZIOLI F, 1992, J BIOL CHEM, V267, P5155; FAZIOLI F, 1992, ONCOGENE, V8, P1335; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; FILHOL O, 1993, J BIOL CHEM, V268, P26978; HELIN K, 1991, ONCOGENE, V6, P3610; HONEGGER AM, 1987, MOL CELL BIOL, V7, P4568, DOI 10.1128/MCB.7.12.4568; MILARSKI KL, 1993, J BIOL CHEM, V268, P23634; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; NISHIMURA R, 1993, MOL CELL BIOL, V13, P6889, DOI 10.1128/MCB.13.11.6889; OBERMEIER A, 1993, EMBO J, V12, P933, DOI 10.1002/j.1460-2075.1993.tb05734.x; OBERMEIER A, 1993, J BIOL CHEM, V268, P22963; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PETERS KG, 1992, NATURE, V358, P678, DOI 10.1038/358678a0; REEDIJK M, 1992, EMBO J, V11, P1365, DOI 10.1002/j.1460-2075.1992.tb05181.x; RONNSTRAND L, 1992, EMBO J, V11, P3911, DOI 10.1002/j.1460-2075.1992.tb05484.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTORO M, 1994, MOL CELL BIOL, V14, P663, DOI 10.1128/MCB.14.1.663; SOLER C, 1994, ONCOGENE, V9, P2207; SOLER C, 1994, J BIOL CHEM, V269, P12320; SOLER C, 1993, J BIOL CHEM, V268, P22010; SORKIN A, 1992, J BIOL CHEM, V267, P8672; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VALIUS M, 1993, MOL CELL BIOL, V13, P133, DOI 10.1128/MCB.13.1.133; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; VELU TJ, 1989, MOL CELL BIOL, V9, P1772, DOI 10.1128/MCB.9.4.1772; VOGEL W, 1993, SCIENCE, V259, P1611, DOI 10.1126/science.7681217	36	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16271	16276		10.1074/jbc.270.27.16271	http://dx.doi.org/10.1074/jbc.270.27.16271			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608194	hybrid			2022-12-27	WOS:A1995RH22600060
J	COLAMONICI, OR; DOMANSKI, P; SWEITZER, SM; LARNER, A; BULLER, RML				COLAMONICI, OR; DOMANSKI, P; SWEITZER, SM; LARNER, A; BULLER, RML			VACCINIA VIRUS B18R GENE ENCODES A TYPE-I INTERFERON-BINDING PROTEIN THAT BLOCKS INTERFERON-ALPHA TRANSMEMBRANE SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA RECEPTOR; MYXOMA VIRUS; CELLS; REPLICATION; SUBUNIT; KINASE; PHOSPHORYLATION; IDENTIFICATION; SUPERFAMILY; INHIBITION	Poxviruses encode a large number of proteins that attenuate the inflammatory and immune responses to infection, In this report we demonstrate that a number of orthopoxviruses express a type I interferon (IFN)-binding protein, which is encoded by the Dish open reading frame in the WR strain of vaccinia virus, The B18R protein has significant regions of homology with the alpha subunits of the mouse, human, and bovine type I IFN receptors, bound human IFN alpha 2 with high affinity, and inhibited transmembrane signaling as demonstrated by inhibition of Fc receptor factor gamma 1/gamma 2 and interferon-stimulated gene factor-3 formation as well as inhibition of the IFN alpha antiviral response, Among viral host response modifiers, the B18R protein is unique inasmuch as it exists as a soluble extracellular as well as a cell surface protein and thus should effectively block both autocrine and paracrine functions of IFN.	US FDA,BETHESDA,MD 20892; ST LOUIS UNIV,DEPT MOLEC MICROBIOL & IMMUNOL,ST LOUIS,MO 63104	US Food & Drug Administration (FDA); Saint Louis University	COLAMONICI, OR (corresponding author), UNIV TENNESSEE,DEPT PATHOL,899 MADISON AVE,M-576,MEMPHIS,TN 38163, USA.				NATIONAL CANCER INSTITUTE [R01CA055079] Funding Source: NIH RePORTER; NCI NIH HHS [CA55079] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BEATTIE E, 1991, VIROLOGY, V183, P419, DOI 10.1016/0042-6822(91)90158-8; BOS JD, 1993, IMMUNOL TODAY, V14, P75, DOI 10.1016/0167-5699(93)90062-P; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; CHEN W, 1992, VIROLOGY, V187, P433, DOI 10.1016/0042-6822(92)90445-U; COLAMONICI OR, 1993, J BIOL CHEM, V268, P10895; COLAMONICI OR, 1995, J BIOL CHEM, V270, P8188, DOI 10.1074/jbc.270.14.8188; COLAMONICI OR, 1994, J BIOL CHEM, V269, P3518; COLAMONICI OR, 1994, J BIOL CHEM, V269, P9598; COLAMONICI OR, 1990, P NATL ACAD SCI USA, V87, P7230, DOI 10.1073/pnas.87.18.7230; COLAMONICI OR, 1992, J IMMUNOL, V148, P2126; DALE TC, 1989, P NATL ACAD SCI USA, V86, P1203, DOI 10.1073/pnas.86.4.1203; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVIES MV, 1992, J VIROL, V66, P1943, DOI 10.1128/JVI.66.4.1943-1950.1992; DIAZGUERRA M, 1993, VIROLOGY, V197, P485, DOI 10.1006/viro.1993.1618; HU FQ, 1994, VIROLOGY, V204, P343, DOI 10.1006/viro.1994.1539; KARUPIAH G, 1990, J EXP MED, V172, P1495, DOI 10.1084/jem.172.5.1495; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; LEVY DE, 1989, GENE DEV, V3, P1203; LIM JK, 1993, BIOCHIM BIOPHYS ACTA, V1173, P314, DOI 10.1016/0167-4781(93)90129-2; MASSUNG RF, 1993, NATURE, V366, P748, DOI 10.1038/366748a0; MOUCHELVIELH E, 1992, FEBS LETT, V313, P255, DOI 10.1016/0014-5793(92)81204-Y; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; PAEZ E, 1984, VIROLOGY, V134, P12, DOI 10.1016/0042-6822(84)90268-X; PEARSE RN, 1993, P NATL ACAD SCI USA, V90, P4314, DOI 10.1073/pnas.90.9.4314; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; RICE AP, 1984, J VIROL, V50, P220, DOI 10.1128/JVI.50.1.220-228.1984; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; SEN GC, 1984, PHARMACOL THERAPEUT, V24, P235, DOI 10.1016/0163-7258(84)90036-6; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; SMITH CA, 1991, BIOCHEM BIOPH RES CO, V176, P335, DOI 10.1016/0006-291X(91)90929-2; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SMITH GL, 1991, J GEN VIROL, V72, P511, DOI 10.1099/0022-1317-72-3-511; SPRIGGS MK, 1992, CELL, V71, P145, DOI 10.1016/0092-8674(92)90273-F; UEDA Y, 1990, VIROLOGY, V177, P588, DOI 10.1016/0042-6822(90)90524-U; UPTON C, 1992, SCIENCE, V258, P1369, DOI 10.1126/science.1455233; UPTON C, 1991, VIROLOGY, V184, P370, DOI 10.1016/0042-6822(91)90853-4; UZE G, 1992, P NATL ACAD SCI USA, V89, P4774, DOI 10.1073/pnas.89.10.4774; UZE G, 1990, CELL, V60, P225, DOI 10.1016/0092-8674(90)90738-Z; WILSON KC, 1992, P NATL ACAD SCI USA, V89, P11964, DOI 10.1073/pnas.89.24.11964	43	257	269	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15974	15978		10.1074/jbc.270.27.15974	http://dx.doi.org/10.1074/jbc.270.27.15974			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608155	hybrid			2022-12-27	WOS:A1995RH22600016
J	DOU, Y; ADMIRAAL, SJ; IKEDASAITO, M; KRZYWDA, S; WILKINSON, AJ; LI, TS; OLSON, JS; PRINCE, RC; PICKERING, IJ; GEORGE, GN				DOU, Y; ADMIRAAL, SJ; IKEDASAITO, M; KRZYWDA, S; WILKINSON, AJ; LI, TS; OLSON, JS; PRINCE, RC; PICKERING, IJ; GEORGE, GN			ALTERATION OF AXIAL COORDINATION BY PROTEIN ENGINEERING IN MYOGLOBIN - BISIMIDAZOLE LIGATION IN THE HIS(64)-]VAL/VAL(68)-]HIS DOUBLE MUTANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERM WHALE MYOGLOBIN; SITE-DIRECTED MUTAGENESIS; ELECTRON-PARAMAGNETIC-RES; ABSORPTION FINE-STRUCTURE; DISTAL HISTIDINE MUTANTS; LIGAND-BINDING; INFRARED-SPECTROSCOPY; ESCHERICHIA-COLI; POCKET POLARITY; CARBON-MONOXIDE	Pig and human myoglobin have been engineered to reverse the positions of the distal histidine and valine (i.e. His(64)(E7) --> Val and Val(68)(E11) --> His). Spectroscopic and ligand binding properties have been measured for human and pig H64V/V68H myoglobin, and the structure of the pig H64V/V68H double mutant has been determined to 2.07-Angstrom resolution by x-ray crystallography. The crystal structure shows that the N-epsilon of His(68) is located 2.3 Angstrom away from the heme iron, resulting in the formation of a hexacoordinate species, The imidazole plane of His(68) is tilted relative to the heme normal; moreover it is not parallel to that of His(93), in agreement with our previous proposal (Qin, J,, La Mar, G. N., Dou, Y,, Admiraal, S. J., and Ikeda-Saito, M. (1994) J. Biol. Chem. 269, 1083-1090). At cryogenic temperatures, the heme iron is in a low spin state, which exhibits a highly anisotropic EPR spectrum (g(1) = 3.34, g(2) = 2.0, and g(3) < 1), quite different from that of the imidazole complex of metmyoglobin. The mean iron-nitrogen distance is 2.01 Angstrom for the low spin ferric state as determined by x-ray spectroscopy, The ferrous form of H64V/V68H myoglobin shows an optical spectrum that is similar to that of b-type cytochromes and consistent with the hexacoordinate bisimidazole hemin structure determined by the x-ray crystallography, The double mutation lowers the ferric/ferrous couple midpoint potential from +54 mV of the wild-type protein to -128 mV. Ferrous H64V/V68H myoglobin binds CO and NO to form stable complexes, but its reaction with O-2 results in a rapid autooxidation to the ferric species. All of these results demonstrate that the three-dimensional positions of His(64) and Val(68) in the wild-type myoglobin are as important as the chemical nature of the side chains in facilitating reversible O-2 binding and inhibiting autooxidation.	UNIV YORK,DEPT CHEM,YORK YO1 5DD,N YORKSHIRE,ENGLAND; ADAM MICKIEWICZ UNIV POZNAN,FAC CHEM,DEPT CRYSTALLOG,PL-60720 POZNAN,POLAND; RICE UNIV,DEPT BIOCHEM & CELL BIOL,HOUSTON,TX 77251; RICE UNIV,WM KECK CTR COMP BIOL,HOUSTON,TX 77251; EXXON RES & ENGN CO,ANNANDALE,NJ 08801; STANFORD UNIV,STANFORD SYNCHROTRON RADIAT LAB,STANFORD,CA	University of York - UK; Adam Mickiewicz University; Rice University; Rice University; Exxon Mobil Corporation; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	DOU, Y (corresponding author), CASE WESTERN RESERVE UNIV,SCH MED,DEPT PHYSIOL & BIOPHYS,CLEVELAND,OH 44106, USA.		Ikeda-Saito, Masao/A-5992-2008; Pickering, Ingrid J/A-4547-2013; George, Graham N/E-3290-2013; Ikeda-Saito, Masao/K-2703-2015	Pickering, Ingrid J/0000-0002-0936-2994; George, Graham/0000-0002-0420-7493; Wilkinson, Anthony/0000-0003-4577-9479; Krzywda, Szymon/0000-0002-1216-3187; Olson, John/0000-0002-0760-5403	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649, R01GM051588] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 47020] Funding Source: Medline; NIGMS NIH HHS [GM 35649, GM 51588] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonini E., 1971, HEMOGLOBIN MYOGLOBIN, V21, P436, DOI 10.1126/science.178.4058.296; BALASUBRAMANIAN S, 1993, P NATL ACAD SCI USA, V90, P4718, DOI 10.1073/pnas.90.10.4718; Blumberg WE, 1971, PROBES STRUCTURE FUN, V2, P215; BRANCACCIO A, 1994, J BIOL CHEM, V269, P13843; CAMERON AD, 1993, BIOCHEMISTRY-US, V32, P13061, DOI 10.1021/bi00211a016; CARVER TE, 1990, J BIOL CHEM, V265, P20007; CHOMA CT, 1994, J AM CHEM SOC, V116, P856, DOI 10.1021/ja00082a005; CRAMER SP, 1988, NUCL INSTRUM METH A, V266, P586, DOI 10.1016/0168-9002(88)90449-4; DAWSON JH, 1988, SCIENCE, V240, P433, DOI 10.1126/science.3358128; DELEON JM, 1991, PHYS REV B, V44, P4146, DOI 10.1103/PhysRevB.44.4146; DEREWENDA ZS, 1989, ACTA CRYSTALLOGR A, V45, P227, DOI 10.1107/S0108767388010700; DICKERSON RE, 1983, HEMOGLOBIN STRUCTURE, P21; DODSON G, 1988, PROTEIN ENG, V2, P233, DOI 10.1093/protein/2.3.233; DURLEY RC, 1994, 1CYO PDB; Eaton W A, 1981, Methods Enzymol, V76, P175; EGEBERG KD, 1990, BIOCHEMISTRY-US, V29, P9783, DOI 10.1021/bi00494a004; EGEBERG KD, 1990, J BIOL CHEM, V265, P11788; GEORGE GN, 1989, BIOCHEMISTRY-US, V28, P5075, DOI 10.1021/bi00438a026; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; HARGROVE MS, 1994, BIOCHEMISTRY-US, V33, P11767, DOI 10.1021/bi00205a012; HORI H, 1971, BIOCHIM BIOPHYS ACTA, V251, P227, DOI 10.1016/0005-2795(71)90106-1; IKEDA M, 1974, BIOCHIM BIOPHYS ACTA, V336, P15, DOI 10.1016/0005-2795(74)90378-X; IKEDASAITO M, 1991, J BIOL CHEM, V266, P23641; IKEDASAITO M, 1985, J BIOL CHEM, V260, P8301; IKEDASAITO M, 1992, J BIOL CHEM, V267, P22843; INNISS D, 1988, J AM CHEM SOC, V110, P5644, DOI 10.1021/ja00225a010; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KITAGAWA T, 1982, NATURE, V298, P869, DOI 10.1038/298869a0; LAMAR GN, 1994, J BIOL CHEM, V269, P29629; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LEE KB, 1990, BIOCHEMISTRY-US, V29, P9623, DOI 10.1021/bi00493a017; LI TS, 1994, BIOCHEMISTRY-US, V33, P1433, DOI 10.1021/bi00172a021; LIONETTI C, 1991, J MOL BIOL, V217, P409, DOI 10.1016/0022-2836(91)90744-Q; MAURUS R, 1994, J BIOL CHEM, V269, P12606; MIKI T, 1992, J BIOL CHEM, V267, P19673; NITSCHKE W, 1989, BIOCHEMISTRY-US, V28, P3161, DOI 10.1021/bi00434a008; OLSON JS, 1988, NATURE, V336, P265, DOI 10.1038/336265a0; PERK KD, 1991, BIOCHEMISTRY-US, V30, P2333; PHILLIPS SEV, 1981, NATURE, V292, P81, DOI 10.1038/292081a0; QIN J, 1994, J BIOL CHEM, V269, P1083; QUILLIN ML, 1995, J MOL BIOL, V245, P416, DOI 10.1006/jmbi.1994.0034; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; REHR JJ, 1991, J AM CHEM SOC, V113, P5135, DOI 10.1021/ja00014a001; ROBERTSON DE, 1994, NATURE, V368, P425, DOI 10.1038/368425a0; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; SAKAN Y, 1993, BIOCHEMISTRY-US, V32, P5815, DOI 10.1021/bi00073a014; SALERNO JC, 1984, J AM CHEM SOC, V106, P2156, DOI 10.1021/ja00319a041; SALERNO JC, 1984, J BIOL CHEM, V259, P2831; SHIRO Y, 1990, J AM CHEM SOC, V112, P2921, DOI 10.1021/ja00164a012; SLIGAR SG, 1987, J AM CHEM SOC, V109, P7896, DOI 10.1021/ja00259a056; SMERDON SJ, 1991, BIOCHEMISTRY-US, V30, P6252, DOI 10.1021/bi00239a025; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; SPRINGER BA, 1989, J BIOL CHEM, V264, P3057; TSAI AL, 1983, BIOCHIM BIOPHYS ACTA, V722, P349, DOI 10.1016/0005-2728(83)90083-X; VARADARAJAN R, 1985, P NATL ACAD SCI USA, V82, P5681, DOI 10.1073/pnas.82.17.5681; WALKER FA, 1986, J AM CHEM SOC, V108, P5288, DOI 10.1021/ja00277a038; 1979, SUITE PROGRAMS PROTE	57	65	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15993	16001		10.1074/jbc.270.27.15993	http://dx.doi.org/10.1074/jbc.270.27.15993			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608158	hybrid			2022-12-27	WOS:A1995RH22600019
J	HOOPER, LV; HINDSGAUL, O; BAENZIGER, JU				HOOPER, LV; HINDSGAUL, O; BAENZIGER, JU			PURIFICATION AND CHARACTERIZATION OF THE GALNAC-4-SULFOTRANSFERASE RESPONSIBLE FOR SULFATION OF GALNAC-BETA-1,4GLCNAC-BEARING OLIGOSACCHARIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; PITUITARY GLYCOPROTEIN HORMONES; CARBONIC-ANHYDRASE ISOENZYME; SIALYLATED OLIGOSACCHARIDES; STRUCTURAL ELUCIDATION; BOVINE LUTROPIN; SULFOTRANSFERASE; RAT; EXPRESSION; RECEPTOR	The pituitary glycoprotein hormone lutropin is characterized by its pulsatile appearance in the bloodstream which is important for the expression of its biological activity in the ovary, We have previously shown that lutropin bears unique Asn-linked oligosaccharides terminating with GalNac-4-SO4 which allow the hormone to be rapidly cleared from the bloodstream via a specific receptor in the liver, thus contributing to its pulsatile appearance in the circulation, Furthermore, we have found that carbonic anhydrase VI, synthesized by the submaxillary gland and secreted into the saliva, also bears Asn-linked oligosaccharides terminating with QalNAc-4-SO4, suggesting that this unique sulfated structure mediates other biological functions in addition to rapid clearance from the circulation, We report here the purification of a GalNAc-4-sulfotransferase which transfers sulfate to terminal beta 1,4-linked GalNAc on Asn-linked oligosaccharides. We show that the purified submaxillary gland enzyme has kinetic parameters identical to the pituitary enzyme, indicating that the same sulfotransferase is responsible for the sulfation of lutropin oligosaccharides in pituitary and carbonic anhydrase VI oligosaccharides in submaxillary gland, This GalNAc-4-sulfotransferase has an apparent molecular mass of 128 kDa and can be specifically photoaffinity radiolabeled with 3',5'-ADP, a competitive inhibitor of sulfotransferase activity. The acceptor specificity of this GalNAc-4-sulfotransferase indicates that it is able to transfer sulfate to terminal GalNAc beta 1,4GlcNAc on both N- and O-glycosidically linked oligosaccharides, suggesting that this enzyme is also responsible for the sulfation of O-linked glycans on proopiomelanocortin.	ST LOUIS UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110; UNIV ALBERTA,DEPT CHEM,EDMONTON,AB T6G 2G2,CANADA	Saint Louis University; University of Alberta			Baenziger, Jacques U/E-9430-2012		NIDDK NIH HHS [R01-DK41738] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041738] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; BRANDAN E, 1988, J BIOL CHEM, V263, P2417; CROWLEY WF, 1985, EPISODIC SECRETION H, P121; DHARMESH SM, 1993, P NATL ACAD SCI USA, V90, P11127, DOI 10.1073/pnas.90.23.11127; DHARMESH SM, 1993, J BIOL CHEM, V268, P17096; EVANS WS, 1992, ENDOCR REV, V13, P81, DOI 10.1210/er.13.1.81; FELDSTEIN JB, 1984, J BIOL CHEM, V259, P5447; FERNLEY RT, 1989, BIOCHEM J, V259, P91, DOI 10.1042/bj2590091; FERNLEY RT, 1988, BIOCHEM J, V249, P201, DOI 10.1042/bj2490201; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; FREEZE HH, 1986, J BIOL CHEM, V261, P127; GREEN ED, 1985, J BIOL CHEM, V260, P5623; GREEN ED, 1988, J BIOL CHEM, V263, P25; GREEN ED, 1988, J BIOL CHEM, V263, P36; GREEN ED, 1986, MOL CELL BIOCHEM, V72, P81; HASHIMOTO Y, 1992, J BIOL CHEM, V267, P15744; HINDSGAUL V, 1987, CAN J CHEM, V65, P1645; HOOPER LV, 1995, J BIOL CHEM, V270, P5985, DOI 10.1074/jbc.270.11.5985; LINCOLN DW, 1985, RECENT PROG HORM RES, V41, P364; MANDON EC, 1994, P NATL ACAD SCI USA, V91, P10707, DOI 10.1073/pnas.91.22.10707; MENGELING BJ, 1995, P NATL ACAD SCI USA, V92, P502, DOI 10.1073/pnas.92.2.502; MURAKAMI H, 1987, J BIOL CHEM, V262, P1382; OGAWA Y, 1992, J HISTOCHEM CYTOCHEM, V40, P807, DOI 10.1177/40.6.1588027; OTTERNESS DM, 1991, MOL PHARMACOL, V39, P34; PALCIC M M, 1991, Glycobiology, V1, P205, DOI 10.1093/glycob/1.2.205; PARKKILA S, 1990, J HISTOCHEM CYTOCHEM, V38, P941, DOI 10.1177/38.7.2113069; ROUX L, 1988, J BIOL CHEM, V263, P8879; SCHWYZER M, 1977, J BIOL CHEM, V252, P2338; SICILIANO RA, 1993, GLYCOBIOLOGY, V3, P225, DOI 10.1093/glycob/3.3.225; SICILIANO RA, 1994, J BIOL CHEM, V269, P910; SKELTON TP, 1991, J BIOL CHEM, V266, P17142; SKELTON TP, 1992, J BIOL CHEM, V267, P12998; SMITH PL, 1993, J BIOL CHEM, V268, P795; SMITH PL, 1992, P NATL ACAD SCI USA, V89, P329, DOI 10.1073/pnas.89.1.329; SPIRO RG, 1988, J BIOL CHEM, V263, P14351; SRIVASTAVA V, 1989, CARBOHYD RES, V185, P163, DOI 10.1016/0008-6215(89)84031-5; VELDHUIS JD, 1987, P NATL ACAD SCI USA, V84, P7686, DOI 10.1073/pnas.84.21.7686; WANG H, 1991, J BIOL CHEM, V266, P780; YAMASHITA K, 1983, J BIOL CHEM, V258, P4144	39	27	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16327	16332		10.1074/jbc.270.27.16327	http://dx.doi.org/10.1074/jbc.270.27.16327			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608201	hybrid			2022-12-27	WOS:A1995RH22600068
J	LI, JM; NICHOLS, MA; CHANDRASEKHARAN, S; XIONG, Y; WANG, XF				LI, JM; NICHOLS, MA; CHANDRASEKHARAN, S; XIONG, Y; WANG, XF			TRANSFORMING GROWTH-FACTOR-BETA ACTIVATES THE PROMOTER OF CYCLIN-DEPENDENT KINASE INHIBITOR P15(INK4B) THROUGH AN SP1 CONSENSUS SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TRANSCRIPTION FACTOR; BINDING FACTOR; TATA BOX; PROTEIN; DNA	Transforming growth factor beta (TGF-beta) causes growth arrest in the G(1) phase in many cell types. One probable pathway for this growth inhibition is through the TGF-beta-mediated up-regulation of the cyclin-dependent kinase (CDK) inhibitor p15(INK4B), which specifically inhibits the enzymatic activities of CDK4 and CDKG6. An active cyclin D-CDK4/6 complex is required for pRb phosphorylation to allow the cell cycle to progress from G(1) to S phase, To study the molecular mechanism of the p15(INK4B) induction by TGF-beta, we isolated a 780-base pair promoter sequence of the human p15 gene and inserted this fragment upstream of a luciferase reporter gene, When this construct was transiently transfected into HaCaT cells, luciferase activity was induced more than 10-fold upon TGF-beta treatment, indicating that the induction of p15(INK4B) expression by TGF-beta is partly exerted at the transcription level, Promoter deletion analysis revealed that the sequence from -110 to -40 relative to the transcription start site is capable of conferring the 10-fold induction by TGF-beta. Within this region there are three Spl consensus sites. Mutation of one of these sites, GGGGCGGAG, substantially reduced both the induction by TGF-beta and the basal promoter activity, whereas mutations in the other two Spl sites and the spacer sequences had Little effect. In addition, gel mobility shift assay indicates that the transcription factors Spl and Sp3 bind to this Spl site. Taken together, these data suggest that a specific Spl consensus site is involved in the mediation of TGF-beta induction as well as the basal promoter activity of the p15 gene and that Sp1 and Sp3 transcription factors might be involved in this regulation.	DUKE UNIV, MED CTR, DEPT PHARMACOL, DURHAM, NC 27708 USA; UNIV N CAROLINA, LINEBERGER COMPREHENS CANC CTR, DEPT BIOCHEM & BIOPHYS, CHAPEL HILL, NC 27599 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill					NATIONAL CANCER INSTITUTE [R01CA065572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045746] Funding Source: NIH RePORTER; NCI NIH HHS [CA 65572] Funding Source: Medline; NIDDK NIH HHS [DK45746] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; DATTO MB, 1995, IN PRESS J BIOL CHEM, V270; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GEISER AG, 1993, GENE, V129, P223, DOI 10.1016/0378-1119(93)90272-5; GILL G, 1994, P NATL ACAD SCI USA, V91, P192, DOI 10.1073/pnas.91.1.192; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HISATAKE K, 1993, NATURE, V362, P179, DOI 10.1038/362179a0; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KAGEYAMA R, 1989, CELL, V59, P815, DOI 10.1016/0092-8674(89)90605-3; KAGEYAMA R, 1989, J BIOL CHEM, V264, P15508; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; KIM SJ, 1992, MOL CELL BIOL, V12, P2455, DOI 10.1128/MCB.12.6.2455; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LAIHO M, 1990, CELL, V62, P175, DOI 10.1016/0092-8674(90)90251-9; LYONS RM, 1990, EUR J BIOCHEM, V187, P467, DOI 10.1111/j.1432-1033.1990.tb15327.x; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; NEVINS JR, 1992, SCIENCE, V258, P424; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P421; Sanger F, 1992, Biotechnology, V24, P104; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; UDVADIA AJ, 1995, P NATL ACAD SCI USA, V92, P3953, DOI 10.1073/pnas.92.9.3953; UDVADIA AJ, 1993, P NATL ACAD SCI USA, V90, P3265, DOI 10.1073/pnas.90.8.3265; VERRIJZER CP, 1995, CELL, V81, P1115, DOI 10.1016/S0092-8674(05)80016-9; WANG EH, 1994, SCIENCE, V263, P811, DOI 10.1126/science.8303298	30	233	237	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26750	26753		10.1074/jbc.270.45.26750	http://dx.doi.org/10.1074/jbc.270.45.26750			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592908	hybrid			2022-12-27	WOS:A1995TE58300008
J	OOHASHI, T; UEKI, Y; SUGIMOTO, M; NINOMIYA, Y				OOHASHI, T; UEKI, Y; SUGIMOTO, M; NINOMIYA, Y			ISOLATION AND STRUCTURE OF THE COL4A6 GENE ENCODING THE HUMAN ALPHA-6(IV) COLLAGEN CHAIN AND COMPARISON WITH OTHER TYPE-IV COLLAGEN GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPORT SYNDROME; LONG ARM; DNA; IDENTIFICATION; POLYMORPHISMS; ORGANIZATION; CHROMOSOME-2; CONSERVATION; ASSIGNMENT; SEQUENCES	The genes COL4A5 and COL4A6, coding for the basement membrane collagen chains, alpha 5(IV) and alpha 6(IV), respectively, are located head-to-head in close proximity on human chromosome Xq22, and COL4A6 is transcribed from two alternative promoters in a tissue-specific fashion (Sugimoto M., Oohashi T., and Ninomiya Y. (1994) Proc. Natl. Acad. Sci. U. S. A, 91, 11679-11683), Immuno fluorescence studies using alpha chain-specific antibodies demonstrated that the two genes are expressed in a tissue-specific manner (Ninomiya, Y., Kagawa, M., Iyama, K., Naito, I., Kishiro, Y., Seyer, J. M., Sugimoto, M,, Oohashi, T,, and Sado, Y. (1995) J. Cell Biol. 130, 1219-1229), We report here for the first time the isolation and the structural organization of the human COL4A6 gene, The entire gene presumably exceeds 200 kilobase pairs and contains 46 exons, Exons 1' and 1 encode the two different 5'-UTRs and the two amino terminal parts of of the signal peptide, The carboxyl part of the signal peptide and the 7 S domain are coded for by the following 6 different exons, 2-7, whereas the exons 7-42 encode the central COL 1 domain, which contains the Gly-X-Y repeats, The last three exons, 43-45, encode the carboxyl-terminal NC1 domain, Sizes of more than a half of the exons of the gene are the same as those of Col4a2 but quite different from those of COL4A5, Within the COL4A6 gene we found three CA repeat markers that can be used for allele detection. The detailed structure of the COL4A6 gene and the high heterozygosity microsatellite markers located within the gene will be useful for linkage analysis and familial diagnosis of diseases caused by mutations of this gene.	OKAYAMA UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOL,OKAYAMA 700,JAPAN; OKAYAMA UNIV,SCH MED,DEPT OPHTHALMOL,OKAYAMA 700,JAPAN	Okayama University; Okayama University			Oohashi, Toshitaka/B-1599-2011	Oohashi, Toshitaka/0000-0002-9302-1913	NEI NIH HHS [EY07334] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007334] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BOYD CD, 1988, AM J HUM GENET, V42, P309; BUTTICE G, 1990, J MOL EVOL, V30, P479, DOI 10.1007/BF02101102; DRICKAMER K, 1987, J BIOL CHEM, V262, P2582; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HEIDET L, 1995, HUM MOL GENET, V4, P99, DOI 10.1093/hmg/4.1.99; HLAING T, 1994, J AM SOC NEPHROL, V5, P625; HOSTIKKA SL, 1987, FEBS LETT, V224, P297, DOI 10.1016/0014-5793(87)80473-8; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Junqueira LCU, 1992, BASIC HISTOLOGY; KALLURI R, 1994, P NATL ACAD SCI USA, V91, P6201, DOI 10.1073/pnas.91.13.6201; KAMAGATA Y, 1992, J BIOL CHEM, V267, P23753; KRAMER JM, 1982, CELL, V30, P599, DOI 10.1016/0092-8674(82)90256-2; LEMMINK HH, 1994, HUM MOL GENET, V3, P1269, DOI 10.1093/hmg/3.8.1269; LOZANO G, 1984, P NATL ACAD SCI USA, V82, P4050; Maniatis T., 1982, MOL CLONING; MARIYAMA M, 1992, GENOMICS, V13, P809, DOI 10.1016/0888-7543(92)90157-N; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; NINOMIYA Y, 1990, EXTRACELLULAR MATRIX, P79; OOHASHI T, 1994, J BIOL CHEM, V269, P7520; REID KBM, 1985, BIOCHEM J, V231, P729, DOI 10.1042/bj2310729; Rohrbach DH, 1993, MOL CELLULAR ASPECTS; SANDELL LJ, 1990, EXTRACELLULAR MATRIX, P1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOININEN R, 1989, J BIOL CHEM, V264, P13565; SOREQ H, 1985, P NATL ACAD SCI USA, V82, P1827, DOI 10.1073/pnas.82.6.1827; SUGIMOTO M, 1993, FEBS LETT, V330, P122, DOI 10.1016/0014-5793(93)80256-T; SUGIMOTO M, 1994, P NATL ACAD SCI USA, V91, P11679, DOI 10.1073/pnas.91.24.11679; TIKKA L, 1991, J BIOL CHEM, V266, P17713; WARMAN ML, 1993, GENOMICS, V17, P694, DOI 10.1006/geno.1993.1391; WEBER JL, 1989, AM J HUM GENET, V44, P388; WHITE RT, 1985, NATURE, V317, P361, DOI 10.1038/317361a0; YAMADA Y, 1984, NATURE, V310, P333, DOI 10.1038/310333a0; ZHOU J, 1993, SCIENCE, V261, P1167, DOI 10.1126/science.8356449; ZHOU J, 1994, J BIOL CHEM, V269, P6608	38	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26863	26867		10.1074/jbc.270.45.26863	http://dx.doi.org/10.1074/jbc.270.45.26863			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592929	hybrid			2022-12-27	WOS:A1995TE58300029
J	HARTLEY, D; MEISNER, H; CORVERA, S				HARTLEY, D; MEISNER, H; CORVERA, S			SPECIFIC ASSOCIATION OF THE BETA-ISOFORM OF THE P85 SUBUNIT OF PHOSPHATIDYLINOSITOL-3 KINASE WITH THE PROTOONCOGENE C-CBL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASES; SH2 DOMAINS; T-CELLS; 3-KINASE; RECEPTOR; BINDING; PI3-KINASE; ACTIVATION; PROTEINS	Phosphatidylinositol-3 kinase (PI-3 kinase) has been implicated in cellular events such as mitogenic signaling, actin organization, and receptor sorting, The p85 subunit of PI-3 kinase contains multiple domains capable of protein-protein interactions that may contribute to mediate the multiple physiological functions of this enzyme, Here, we demonstrate that antibodies raised against the p85 subunit of PI-3 kinase immunoprecipitate a single tyrosine-phosphorylated protein of 120 kDa (pp120) from lysates of activated Jurkat T cells and A20 B cells, This protein is the only significant phosphotyrosine-containing protein in p85 immunoprecipitates from these cells, and it cannot be detected in immunoprecipitates of other signaling proteins such as PLC gamma. Furthermore, antibodies specific for the beta isoform of p85 but not antibodies specific for the alpha isoform immunoprecipitate this tyrosine-phosphorylated protein. pp120 completely comigrates with the proto-oncogene c-cbl, which is a 120 kDa protein product abundant in lymphoid cells, Furthermore, immunoblots of p85 immunoprecipitates using antibodies raised against c-cbl detect a band at exactly the position of pp120, In addition, p85 can be detected in immunoblots of c-cbl immunoprecipitates, Thus, pp120 appears to correspond to c-cbl, A direct association between c-cbl and p85 can be observed in vitro using a fusion protein comprising the Src homology 2 (SH2) domains of p85, and this binding is abolished by phenyl phosphate, suggesting that the interaction is mediated through phosphotyrosine-SH2 domain interactions, Thus, these results show important functional differences between the alpha and beta isoforms of p85 in vivo and point to c-cbl as a potentially important mediator of some of the functions of PI-3 kinase in intact cells.	UNIV MASSACHUSETTS,SCH MED,PROGRAM MOLEC MED,WORCESTER,MA 01655; UNIV MASSACHUSETTS,SCH MED,DEPT CELL BIOL,WORCESTER,MA 01655	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040330] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-40330] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALTENSPERGER K, 1994, J BIOL CHEM, V269, P28937; BLAKE TJ, 1991, ONCOGENE, V6, P653; DONOVAN JA, 1994, J BIOL CHEM, V269, P22921; EGERTON M, 1992, EMBO J, V11, P3533, DOI 10.1002/j.1460-2075.1992.tb05436.x; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; GILLILAND LK, 1992, J BIOL CHEM, V267, P13610; Herman Paul K., 1992, Trends in Cell Biology, V2, P363, DOI 10.1016/0962-8924(92)90048-R; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; KAPELLER R, 1994, J BIOL CHEM, V269, P1927; KAPELLER R, 1994, BIOESSAYS, V16, P565, DOI 10.1002/bies.950160810; LIU XQ, 1993, MOL CELL BIOL, V13, P5225, DOI 10.1128/MCB.13.9.5225; MUSHINSKI JF, 1994, ONCOGENE, V9, P2489; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; PRASAD KVS, 1993, P NATL ACAD SCI USA, V90, P7366, DOI 10.1073/pnas.90.15.7366; PRASAD KVS, 1993, MOL CELL BIOL, V13, P7708, DOI 10.1128/MCB.13.12.7708; REIF K, 1993, J BIOL CHEM, V268, P10780; RIVEROLEZCANO OM, 1994, J BIOL CHEM, V269, P17363; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; TRUITT KE, 1994, J EXP MED, V179, P1071, DOI 10.1084/jem.179.3.1071; TUVESON DA, 1993, SCIENCE, V260, P986, DOI 10.1126/science.7684160; WARD SG, 1992, J BIOL CHEM, V267, P23862	21	92	92	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18260	18263		10.1074/jbc.270.31.18260	http://dx.doi.org/10.1074/jbc.270.31.18260			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629144	hybrid			2022-12-27	WOS:A1995RM64200019
J	KAMBEROV, ES; ATKINSON, MR; NINFA, AJ				KAMBEROV, ES; ATKINSON, MR; NINFA, AJ			THE ESCHERICHIA-COLI PII SIGNAL-TRANSDUCTION PROTEIN IS ACTIVATED UPON BINDING 2-KETOGLUTARATE AND ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMINE-SYNTHETASE ADENYLYLATION; URIDYLYL-REMOVING ENZYME; REGULATOR-II NR(II); ALLOSTERIC REGULATION; NITROGEN-METABOLISM; ENTERIC BACTERIA; CASCADE CONTROL; GLNALG OPERON; URIDYLYLTRANSFERASE; PHOSPHORYLATION	Nitrogen regulation of transcription in Escherichia coli requires sensation of the intracellular nitrogen status and control of the dephosphorylation of the transcriptional activator NRI similar to P. This dephosphorylation is catalyzed by the bifunctional kinase/phosphatase NRII in the presence of the dissociable PII protein. The ability of PII to stimulate the phosphatase activity of NRII is regulated by a signal transducing uridylyltransferase/uridylyl-removing enzyme (UTase/UR), which converts PII to PB-UMP under conditions of nitrogen starvation; this modification prevents PII from stimulating the dephosphorylation of NRI similar to P. We used purified components to examine the binding of small molecules to PII, the effect of small molecules on the stimulation of the NRII phosphatase activity by PII, the retention of PII on immobilized NRII, and the regulation of the uridylylation of PII by the UTase/UR enzyme. Our results indicate that PII is activated upon binding ATP and either 2-ketoglutarate or glutamate, and that the liganded form of PII binds much better to immobilized NRII. We also demonstrate that the concentration of glutamine required to inhibit the uridylyltransferase activity is independent of the concentration of 2-ketoglutarate present. We hypothesize that nitrogen sensation in E. coli involves the separate measurement of glutamine by the UTase/UR protein and 2-ketoglutarate by the PII protein.	UNIV MICHIGAN,SCH MED,DEPT BIOL CHEM,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan					NIGMS NIH HHS [GM47460] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047460] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLER SP, 1975, J BIOL CHEM, V250, P6264; ATKINSON MR, 1992, J BACTERIOL, V174, P4538, DOI 10.1128/JB.174.14.4538-4548.1992; ATKINSON MR, 1994, J BIOL CHEM, V269, P28288; ATKINSON MR, 1993, J BACTERIOL, V175, P7016, DOI 10.1128/jb.175.21.7016-7023.1993; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949; BUENO R, 1985, J BACTERIOL, V164, P816, DOI 10.1128/JB.164.2.816-822.1985; CONTRERAS A, 1991, J BACTERIOL, V173, P7741, DOI 10.1128/jb.173.24.7741-7749.1991; ENGLEMAN EG, 1978, ARCH BIOCHEM BIOPHYS, V191, P602, DOI 10.1016/0003-9861(78)90398-3; FENG JL, 1992, J BACTERIOL, V174, P6061, DOI 10.1128/JB.174.19.6061-6070.1992; FRANCIS SH, 1978, ARCH BIOCHEM BIOPHYS, V191, P590, DOI 10.1016/0003-9861(78)90397-1; FREIFELDER D, 1982, PHYSICAL BIOCH APPLI, P654; GARCIA E, 1983, J BIOL CHEM, V258, P2246; Hulme E. C., 1992, RECEPTOR LIGAND INTE, P63; KAMBEROV ES, 1994, CELL MOL BIOL RES, V40, P175; KAMBEROV ES, 1994, J BIOL CHEM, V269, P28294; KAMBEROV ES, 1994, CELLULAR MOL BIOL PH, P302; KEENER J, 1988, P NATL ACAD SCI USA, V85, P4976, DOI 10.1073/pnas.85.14.4976; KEENER J, 1987, RNA POLYM REGULATION, P159; LIU J, 1995, J BACTERIOL, V177, P926, DOI 10.1128/jb.177.4.926-931.1995; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACNEIL T, 1982, MOL GEN GENET, V188, P325, DOI 10.1007/BF00332696; MACNEIL T, 1982, J BACTERIOL, V150, P1302, DOI 10.1128/JB.150.3.1302-1313.1982; MAGASANIK B, 1988, TRENDS BIOCHEM SCI, V13, P475, DOI 10.1016/0968-0004(88)90234-4; MAGASANIK B, 1987, ESCHERICHIA COLI SAL, P1318; MANGUM JH, 1973, ARCH BIOCHEM BIOPHYS, V158, P514, DOI 10.1016/0003-9861(73)90543-2; MURA U, 1981, J BIOL CHEM, V256, P3022; MURA U, 1981, J BIOL CHEM, V256, P3014; NINFA AJ, 1991, J BIOL CHEM, V266, P6888; NINFA AJ, 1986, P NATL ACAD SCI USA, V83, P5909, DOI 10.1073/pnas.83.16.5909; NINFA EG, 1993, J BACTERIOL, V175, P7024, DOI 10.1128/jb.175.21.7024-7032.1993; PAHEL G, 1978, J BACTERIOL, V133, P139, DOI 10.1128/JB.133.1.139-148.1978; RHEE SG, 1985, METHOD ENZYMOL, V113, P213; RHEE SG, 1985, CURR TOP CELL REGUL, V27, P221; RHEE SG, 1978, P NATL ACAD SCI USA, V75, P3138, DOI 10.1073/pnas.75.7.3138; SENIOR PJ, 1975, J BACTERIOL, V123, P407, DOI 10.1128/JB.123.2.407-418.1975; Stadtman ER, 1980, GLUTAMINE METABOLISM, P41; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; WEISS V, 1988, P NATL ACAD SCI USA, V85, P8919, DOI 10.1073/pnas.85.23.8919	39	148	149	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17797	17807		10.1074/jbc.270.30.17797	http://dx.doi.org/10.1074/jbc.270.30.17797			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629080	hybrid			2022-12-27	WOS:A1995RM26600028
J	PU, RT; XU, G; WU, LP; VIERULA, J; ODONNELL, K; YE, XS; OSMANI, SA				PU, RT; XU, G; WU, LP; VIERULA, J; ODONNELL, K; YE, XS; OSMANI, SA			ISOLATION OF A FUNCTIONAL HOMOLOG OF THE CELL CYCLE-SPECIFIC NIMA PROTEIN-KINASE OF ASPERGILLUS-NIDULANS AND FUNCTIONAL-ANALYSIS OF CONSERVED RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CATALYTIC DOMAINS; NEUROSPORA-CRASSA; CONTROL GENE; ACTIVATION; MUTATION; CLONING; FAMILY; DNA; PHOSPHORYLATION	To investigate the degree of conservation of the cell cycle-specific NIMA protein kinase of Aspergillus nidulans, and to help direct its functional analysis, we cloned a homolog (designated nim-1) from Neurospora crassa. Over the catalytic domain NIM-1 is 75% identical to NIMA, but overall the identity drops to 52%. nim-1 was able to functionally complement nimA5 in A. nidulans. Mutational analysis of potential activating phosphorylation sites found in NIMA, NIM-1, and related protein kinases was performed on NIMA. Mutation of threonine 199 (conserved in all NIMA-related kinases) inhibited NIMA beta-casein kinase activity and abolished its in vivo function. This site conforms to a minimal consensus phosphorylation site for NIMA (FXXT) and is analogous to the autophosphorylation site of cyclic-AMP-dependent protein kinases. However, mutation of a unique cysteine residue found only in the catalytic site of NIMA and NIM-1 had no effect on NIMA kinase activity or function. Three temperature-sensitive alleles of nimA that cause arrest in G(2) were sequenced and shown to generate three different amino acid substitutions. None of the mutations prevented accumulation of NIMA protein during G(2) arrest, but all prevented the p34(cdc2)/cyclin B-dependent phosphorylation of NIMA normally seen during mitotic initiation even though p34(cdc2)/cyclin B H1 kinase activity was fully activated.	WEIS CTR RES,GEISINGER CLIN,DANVILLE,PA 17822; CARLETON UNIV,DEPT BIOL,OTTAWA,ON K1S 5B6,CANADA; USDA,NATL CTR AGR UTILIZAT RES,PEORIA,IL 61604	Carleton University; United States Department of Agriculture (USDA)			Osmani, Stephen A./AAS-3904-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042564] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM42564] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTON AB, 1992, GENE, V117, P137, DOI 10.1016/0378-1119(92)90502-G; BERGEN LG, 1984, J BACTERIOL, V159, P114, DOI 10.1128/JB.159.1.114-119.1984; BOOHER R, 1986, MOL CELL BIOL, V6, P3523, DOI 10.1128/MCB.6.10.3523; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; DOONAN JH, 1991, J BIOL CHEM, V266, P18889; DOONAN JH, 1982, J CELL SCI, V103, P599; DRAETTA G, 1990, TRENDS BIOCHEM SCI, V15, P378, DOI 10.1016/0968-0004(90)90235-4; GALE M, 1993, MOL BIOCHEM PARASIT, V59, P111, DOI 10.1016/0166-6851(93)90012-M; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; JONES DGL, 1990, GENE, V90, P87, DOI 10.1016/0378-1119(90)90442-T; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LETWIN K, 1992, EMBO J, V11, P3521, DOI 10.1002/j.1460-2075.1992.tb05435.x; LEVEDAKOU EN, 1994, ONCOGENE, V9, P1977; LU KP, 1995, CELL, V81, P413, DOI 10.1016/0092-8674(95)90394-1; LU KP, 1994, EMBO J, V13, P2103, DOI 10.1002/j.1460-2075.1994.tb06486.x; LU KP, 1993, J BIOL CHEM, V268, P8769; LU KP, 1994, J BIOL CHEM, V269, P6603; LU KP, 1994, CELL, V13, P2103; MORRIS NR, 1975, GENET RES, V26, P237, DOI 10.1017/S0016672300016049; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441, DOI 10.1146/annurev.bi.61.070192.002301; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OAKLEY BR, 1987, GENE, V61, P385, DOI 10.1016/0378-1119(87)90201-0; OAKLEY BR, 1983, J CELL BIOL, V96, P1155, DOI 10.1083/jcb.96.4.1155; OCONNELL MJ, 1994, EMBO J, V13, P4926, DOI 10.1002/j.1460-2075.1994.tb06820.x; ORBACH MJ, 1986, MOL CELL BIOL, V6, P2452, DOI 10.1128/MCB.6.7.2452; ORBACH MJ, 1990, J BIOL CHEM, V265, P10981; OSMANI AH, 1991, CELL, V67, P283, DOI 10.1016/0092-8674(91)90180-7; OSMANI AH, 1994, J CELL SCI, V107, P1519; OSMANI AH, 1991, EMBO J, V10, P2669, DOI 10.1002/j.1460-2075.1991.tb07810.x; OSMANI SA, 1988, CELL, V53, P237, DOI 10.1016/0092-8674(88)90385-6; OSMANI SA, 1988, CELL, V52, P241, DOI 10.1016/0092-8674(88)90513-2; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PU RT, 1995, EMBO J, V14, P995, DOI 10.1002/j.1460-2075.1995.tb07080.x; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULTZ SJ, 1993, CELL GROWTH DIFFER, V4, P821; SCHULTZ SJ, 1994, CELL GROWTH DIFFER, V5, P1; SCHWEITZER B, 1992, MOL GEN GENET, V234, P164, DOI 10.1007/BF00272358; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; WARING RB, 1989, GENE, V79, P119, DOI 10.1016/0378-1119(89)90097-8; YE XS, 1995, EMBO J, V14, P986, DOI 10.1002/j.1460-2075.1995.tb07079.x	43	51	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18110	18116		10.1074/jbc.270.30.18110	http://dx.doi.org/10.1074/jbc.270.30.18110			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629122	hybrid			2022-12-27	WOS:A1995RM26600073
J	CROSS, AR; RAE, J; CURNUTTE, JT				CROSS, AR; RAE, J; CURNUTTE, JT			CYTOCHROME-B(-245) OF THE NEUTROPHIL SUPEROXIDE-GENERATING SYSTEM CONTAINS 2 NONIDENTICAL HEMES - POTENTIOMETRIC STUDIES OF A MUTANT FORM OF GP91(PHOX)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PHAGOCYTE NADPH OXIDASE; RESPIRATORY BURST; PLASMA-MEMBRANE; PURIFICATION; COMPONENT	Analysis of potentiometric titrations of the cytochrome b(-245) from a X(+) chronic granulomatous disease patient with an Arg(54) --> Ser mutation in gp91(phox) indicates that the mutant form of the cytochrome contains two nonidentical hemes with midpoint potentials of E(m7) = -220 and E(m7) = -300 mV. In the light of this information, reanalysis of redox titrations of wild type cytochrome b(-245) implies that it probably also contains two separate heme centers with midpoint potentials of E(m7) = -225 and E(m7) = -265 mV. The effect of the Arg(54) --> Ser substitution is to reduce the midpoint potential of one of the heme centers by approximately 35 mV and suggests possible interaction between Arg(54) and heme propionate side chain.	GENENTECH INC, DEPT IMMUNOL, S SAN FRANCISCO, CA 94080 USA	Roche Holding; Genentech	CROSS, AR (corresponding author), SCRIPPS RES INST, DEPT MOLEC & EXPTL MED CAL1, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.				NCRR NIH HHS [RR00833] Funding Source: Medline; NIAID NIH HHS [AI24838] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024838] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BELLAVITE P, 1983, BIOCHIM BIOPHYS ACTA, V746, P40, DOI 10.1016/0167-4838(83)90008-0; CROSS AR, 1981, BIOCHEM J, V194, P599, DOI 10.1042/bj1940599; CROSS AR, 1995, J BIOL CHEM, V270, P6543, DOI 10.1074/jbc.270.12.6543; CROSS AR, 1995, J BIOL CHEM, V270, P8194, DOI 10.1074/jbc.270.14.8194; CURNUTTE JT, 1987, J BIOL CHEM, V262, P6450; CUTLER RL, 1989, BIOCHEMISTRY-US, V28, P3188, DOI 10.1021/bi00434a012; DOUSSIERE J, 1995, BIOCHEMISTRY-US, V34, P1760, DOI 10.1021/bi00005a033; HARPER AM, 1984, BIOCHEM J, V219, P519, DOI 10.1042/bj2190519; HURST JK, 1991, J BIOL CHEM, V266, P1627; IIZUKA T, 1985, J BIOL CHEM, V260, P2049; ISOGAI Y, 1993, J BIOL CHEM, V268, P4025; KNIGHT M, 1979, ANAL BIOCHEM, V95, P19, DOI 10.1016/0003-2697(79)90179-9; KOSHKIN V, 1994, FEBS LETT, V338, P285, DOI 10.1016/0014-5793(94)80285-8; MIKI T, 1992, J BIOL CHEM, V267, P19673; PALMER G, 1994, BIOCHEMISTRY-US, V33, P176, DOI 10.1021/bi00167a023; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; QUINN MT, 1992, J BIOL CHEM, V267, P7303; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; SUMIMOTO H, 1992, BIOCHEM BIOPH RES CO, V186, P1368, DOI 10.1016/S0006-291X(05)81557-8; THRASHER AJ, 1994, BBA-MOL BASIS DIS, V1227, P1, DOI 10.1016/0925-4439(94)90100-7; YAMAGUCHI T, 1989, J BIOL CHEM, V264, P112; YOSHIDA LS, 1992, BIOCHIM BIOPHYS ACTA, V1135, P245	23	96	97	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17075	17077		10.1074/jbc.270.29.17075	http://dx.doi.org/10.1074/jbc.270.29.17075			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615499	hybrid			2022-12-27	WOS:A1995RK68900006
J	EBERT, SN; WONG, DL				EBERT, SN; WONG, DL			DIFFERENTIAL ACTIVATION OF THE RAT PHENYLETHANOLAMINE N-METHYLTRANSFERASE GENE BY SP1 AND EGR-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC FINGER PROTEIN; MESSENGER-RNA; TRANSCRIPTION FACTORS; INSITU HYBRIDIZATION; GROWTH-FACTORS; LESS PROMOTER; BINDING-SITE; EXPRESSION; DNA; ZIF268	The rat phenylethanolamine N-methyltransferase (PNMT) gene contains overlapping consensus elements for the Sp1 and Egr-1 transcription factors located at -45 bp and -165 bp in the PNMT promoter. In the present study, we show that Sp1 and Egr-1 can specifically bind to these overlapping elements, that this binding appears to be mutually exclusive, and that binding site occupancy is dependent upon the concentration of each factor and its binding affinity for each site. Egr-1 binds to the -165 bp site with relatively high affinity (IC50 = 14 nM) and to the -45 bp site with relatively low affinity (IC50 = 1360 nM), whereas Sp1 binds to both sites with intermediate affinities (IC50 = 210 and 140 nM, respectively). Consistent with the DNA-binding data, Egr-1 stimulates PNMT promoter activity primarily through interaction with the -165 bp site, while Sp1 stimulates PNMT promoter activity by interacting with both the -45 bp and the -165 bp sites. These results show that Sp1 and Egr-1 are capable of differentially activating PNMT gene expression, thereby suggesting that different stimuli may control the activity of the PNMT gene by selectively regulating Sp1 and/or Egr-1.	STANFORD UNIV,SCH MED,DEPT PSYCHIAT & BEHAV SCI,NANCY PRITZKER LAB DEV & MOLEC NEUROBIOL,STANFORD,CA 94305	Stanford University					NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH010350] Funding Source: NIH RePORTER; NIMH NIH HHS [MH10350] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ACKERMAN SL, 1991, P NATL ACAD SCI USA, V88, P7523, DOI 10.1073/pnas.88.17.7523; BHAT RV, 1992, J PHARMACOL EXP THER, V263, P343; BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; BOISCLAIR YR, 1993, J BIOL CHEM, V268, P24892; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; CAO XM, 1993, J BIOL CHEM, V268, P16949; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; CIARANELLO RD, 1980, CATECHOLAMINES STRES, P317; CIARANELLO RD, 1971, SCIENCE, V175, P789; EBERT SN, 1994, J BIOL CHEM, V269, P20885; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; GASHLER AL, 1993, MOL CELL BIOL, V13, P4556, DOI 10.1128/MCB.13.8.4556; GUPTA MP, 1991, J BIOL CHEM, V266, P12813; IWAKI K, 1990, J BIOL CHEM, V265, P13809; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; JOLIFF K, 1991, NUCLEIC ACIDS RES, V19, P2267; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KATAYAMA N, 1993, J NEUROCHEM, V60, P902, DOI 10.1111/j.1471-4159.1993.tb03235.x; KRIWACKI RW, 1992, P NATL ACAD SCI USA, V89, P9759, DOI 10.1073/pnas.89.20.9759; KVETANSK.R, 1971, AM J PHYSIOL, V220, P928, DOI 10.1152/ajplegacy.1971.220.4.928; LEMAIGRE FP, 1990, MOL CELL BIOL, V10, P1811, DOI 10.1128/MCB.10.4.1811; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LI Y, 1993, J BIOL CHEM, V268, P3563; LIM RW, 1987, ONCOGENE, V1, P263; MAILLEUX P, 1992, NEUROSCI LETT, V147, P182, DOI 10.1016/0304-3940(92)90590-4; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MOLNAR G, 1994, MOL CELL BIOL, V14, P5242, DOI 10.1128/MCB.14.8.5242; MORITA K, 1995, J BIOL CHEM, V270, P11161, DOI 10.1074/jbc.270.19.11161; MULLER MT, 1987, J VIROL, V61, P858, DOI 10.1128/JVI.61.3.858-865.1987; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Sambrook J, 1989, MOL CLONING LABORATO; VISKUPIC E, 1994, J NEUROCHEM, V63, P808; WEISBERG EP, 1989, MOL BRAIN RES, V6, P159, DOI 10.1016/0169-328X(89)90050-8; WONG DL, 1992, FASEB J, V6, P3310, DOI 10.1096/fasebj.6.14.1426768; WONG DL, 1993, MOL BRAIN RES, V18, P107, DOI 10.1016/0169-328X(93)90178-R	36	74	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17299	17305		10.1074/jbc.270.29.17299	http://dx.doi.org/10.1074/jbc.270.29.17299			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615530	hybrid			2022-12-27	WOS:A1995RK68900040
J	JANS, DA; MOLL, T; NASMYTH, K; JANS, P				JANS, DA; MOLL, T; NASMYTH, K; JANS, P			CYCLIN-DEPENDENT KINASE SITE-REGULATED SIGNAL-DEPENDENT NUCLEAR-LOCALIZATION OF THE SWI5 YEAST TRANSCRIPTION FACTOR IN MAMMALIAN-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RETINOBLASTOMA GENE-PRODUCT; RENAL EPITHELIAL-CELLS; SV40 T-ANTIGEN; NF-KAPPA-B; PROTEIN-KINASE; VASOPRESSIN V2-RECEPTOR; LATERAL MOBILITY; PHOSPHORYLATION; TRANSLOCATION; TRANSPORT	Control over the nuclear transport of transcription factors (TFs) represents a level of gene regulation integral to cellular processes such as differentiation, transformation and signal transduction. The Saccharomyces cerevisiae TF SW15 is excluded from the nucleus in a cell cycle-dependent fashion, mediated by phosphorylation by the cyclin-dependent kinase (cdk) CDC28. Nuclear entry occurs in G(1). beta-galactosidase fusion proteins carrying SWI5 amino acids 633-682, including the nuclear localization sequence (NLS: Lys-Lys-Tyr-Glu-Asn-Val-Val-Ile-Lys-Arg-Ser-Pro-Arg-Lys-Arg-Gly-Arg-Pro-Arg-Lys(655)) were analyzed for subcellular localization in appropriate temperature-sensitive yeast strains blocked in G(1) or G(2)/M using indirect immunofluorescence, and for nuclear import kinetics in living rat hepatoma or Vero African green monkey kidney cells microinjected with fluorescently labeled bacterially expressed protein and quantitative confocal laser micros copy, Cell cycle dependent nuclear localization in yeast was both NLS and cdk site-dependent, whereby mutation of the cdk site serines (Ser(646) and Ser(664)) to alanine resulted in constitutive nuclear localization, In mammalian cells, the SWI5 fusion proteins were similarly transported to the nucleus in an NLS dependent fashion, while the mutation to Ala of the cdk site serines increased the maximal level of nuclear accumulation from about 1- to over 8-fold, We suggest that phosphorylation at the cdk sites inhibits nuclear transport of SWI5, consistent with our previous observations for the inhibition of SV40 large tumor antigen nuclear transport by phosphorylation by the cdk cdc2. The results indicate for the first time that a yeast NLS and, fascinatingly, its regulatory mechanisms are functional in higher eukaryotes, implying the universal nature of regulatory signals for protein transport to the nucleus.	MAX PLANCK INST BIOPHYS, W-6000 FRANKFURT, GERMANY; VIENNA INT RES COOPERAT CTR, VIENNA, AUSTRIA; INST MOLEK PATHOL, VIENNA, AUSTRIA	Max Planck Society; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	JANS, DA (corresponding author), AUSTRALIAN NATL UNIV, JOHN CURTIN SCH MED RES, DIV BIOCHEM & MOLEC BIOL, NUCL SIGNALLING LAB, CANBERRA, ACT 2601, AUSTRALIA.			Nasmyth, Kim/0000-0001-7030-4403				CAPOBIANCO AJ, 1990, ONCOGENE, V5, P257; CASADABAN MJ, 1983, METHOD ENZYMOL, V100, P293; CHIDA K, 1992, P NATL ACAD SCI USA, V89, P4290, DOI 10.1073/pnas.89.10.4290; GIRDHAM CH, 1991, GENE DEV, V5, P1786, DOI 10.1101/gad.5.10.1786; GOVIND S, 1991, TRENDS GENET, V7, P119, DOI 10.1016/0168-9525(91)90456-Z; GUSSE M, 1989, MOL CELL BIOL, V9, P5395, DOI 10.1128/MCB.9.12.5395; HENNEKES H, 1993, J CELL BIOL, V120, P1293, DOI 10.1083/jcb.120.6.1293; JANS DA, 1989, EMBO J, V8, P2481, DOI 10.1002/j.1460-2075.1989.tb08384.x; JANS DA, 1990, EMBO J, V9, P2693, DOI 10.1002/j.1460-2075.1990.tb07455.x; JANS DA, 1991, J CELL BIOL, V114, P53, DOI 10.1083/jcb.114.1.53; JANS DA, 1994, ONCOGENE, V9, P2961; JANS DA, 1991, J CELL BIOL, V115, P1203, DOI 10.1083/jcb.115.5.1203; JANS DA, 1992, BIOCHIM BIOPHYS ACTA, V1113, P271, DOI 10.1016/0304-4157(92)90001-Q; JANS DA, 1995, IN PRESS BIOCH J; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; MILLER M, 1991, PHYSIOL REV, V71, P909, DOI 10.1152/physrev.1991.71.3.909; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; NASMYTH K, 1990, CELL, V62, P631, DOI 10.1016/0092-8674(90)90110-Z; NASMYTH K, 1987, SCIENCE, V237, P1162, DOI 10.1126/science.3306917; NISHIDA E, 1987, P NATL ACAD SCI USA, V84, P5262, DOI 10.1073/pnas.84.15.5262; OHTA Y, 1989, J BIOL CHEM, V264, P16143; PICARD D, 1988, CELL, V54, P1073, DOI 10.1016/0092-8674(88)90122-5; PINES J, 1994, EMBO J, V13, P3772, DOI 10.1002/j.1460-2075.1994.tb06688.x; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; RIHS HP, 1989, EMBO J, V8, P1479, DOI 10.1002/j.1460-2075.1989.tb03531.x; RIHS HP, 1991, EMBO J, V10, P633, DOI 10.1002/j.1460-2075.1991.tb07991.x; ROUX P, 1990, CELL, V63, P341, DOI 10.1016/0092-8674(90)90167-D; RYAN JJ, 1994, P NATL ACAD SCI USA, V91, P5878, DOI 10.1073/pnas.91.13.5878; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Schmitz M L, 1991, Trends Cell Biol, V1, P130, DOI 10.1016/0962-8924(91)90118-S; SHAULSKY G, 1991, ONCOGENE, V6, P2055; SHAULSKY G, 1990, MOL CELL BIOL, V10, P6565, DOI 10.1128/MCB.10.12.6565; SHIOZAKI K, 1992, J CELL BIOL, V119, P1023, DOI 10.1083/jcb.119.5.1023; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P2424, DOI 10.1128/MCB.9.6.2424; STILLMAN DJ, 1988, EMBO J, V7, P485, DOI 10.1002/j.1460-2075.1988.tb02836.x; TEMPLETON DJ, 1991, P NATL ACAD SCI USA, V88, P3033, DOI 10.1073/pnas.88.8.3033; TEMPLETON DJ, 1992, MOL CELL BIOL, V12, P435, DOI 10.1128/MCB.12.2.435; TINLAND B, 1992, P NATL ACAD SCI USA, V89, P7442, DOI 10.1073/pnas.89.16.7442; VANCUROVA I, 1995, J CELL SCI, V108, P779; VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5; ZACKSENHAUS E, 1993, MOL CELL BIOL, V13, P4588, DOI 10.1128/MCB.13.8.4588	41	79	80	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17064	17067		10.1074/jbc.270.29.17064	http://dx.doi.org/10.1074/jbc.270.29.17064			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615496	hybrid			2022-12-27	WOS:A1995RK68900003
J	RYAN, TC; CRUIKSHANK, WW; KORNFELD, H; COLLINS, TL; CENTER, DM				RYAN, TC; CRUIKSHANK, WW; KORNFELD, H; COLLINS, TL; CENTER, DM			THE CD4-ASSOCIATED TYROSINE KINASE P56(LCK) IS REQUIRED FOR LYMPHOCYTE CHEMOATTRACTANT FACTOR-INDUCED T-LYMPHOCYTE MIGRATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BEARING MONONUCLEAR-CELLS; PROTEIN-KINASE; SIGNAL TRANSDUCTION; CD4 RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; FUNCTIONAL-CHARACTERISTICS; SURFACE-ANTIGENS; HERBIMYCIN-A; MYOSIN-I; ACTIVATION	Lymphocyte chemoattractant factor (LCF) is a polypeptide cytokine which induces both cell motility and activation of T lymphocytes. These LCF-induced events demonstrate an absolute requirement for the cell surface expression of CD4, Because many CD4-mediated T lymphocyte activation events have been demonstrated to require the association of the src-related tyrosine kinase p56(lck) with the cytoplasmic domain of CD4, we examined the role of p56(lck) in LCF-induced lymphocyte migration in a murine T cell hybridoma line expressing transfected human CD4. LCF induces the catalytic activity of CD4 associated p56(lck) at chemoattractant concentrations of cytokine, Hybridoma cells that express CD4 with cytoplasmic point mutations which uncouple the CD4-lck association lack both lck enzymatic activity and chemotactic responses to LCF. The enzymatic activity of lck however does not appear to be required for CD4-mediated migratory signal, First, the protein tyrosine kinase inhibitor herbimycin A blocked LCF-induced p56(lck) activation but had no effect on the LCF-induced motile response. Second, T cell hybridomas expressing a chimeric receptor combining the extracellular domain of human CD4 and murine p56(lck) which lacked the kinase domain had a normal LCF-induced motile response, We conclude from these observations that CD4-lck coupling is essential for LCF-induced T lymphocyte migration but the motile response is independent of the enzymatic activity of CD4-associated p56(lck).	BOSTON UNIV, SCH MED, CTR PULM, BOSTON, MA 02118 USA; HARVARD UNIV, SCH MED, DEPT PEDIAT, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DIV PEDIAT ONCOL, BOSTON, MA 02115 USA	Boston University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School			Kornfeld, Hardy/AAS-2903-2021	Center, David/0000-0002-5879-7978	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032802] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL32802] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS RJ, 1989, NATURE, V340, P565, DOI 10.1038/340565a0; BERMAN JS, 1990, AM REV RESPIR DIS, V142, P238, DOI 10.1164/ajrccm/142.1.238; BERMAN JS, 1984, J IMMUNOL, V133, P1495; BERMAN JS, 1985, CELL IMMUNOL, V95, P105, DOI 10.1016/0008-8749(85)90299-0; BRAMSON HN, 1991, J BIOL CHEM, V266, P16219; CENTER DM, 1983, J IMMUNOL, V131, P1854; CENTER DM, 1993, CHEST, V103, pS88; COLLINS TL, 1992, J IMMUNOL, V148, P2159; COLLINS TL, 1993, P NATL ACAD SCI USA, V90, P11885, DOI 10.1073/pnas.90.24.11885; CRUIKSHANK WW, 1991, J IMMUNOL, V146, P2928; CRUIKSHANK WW, 1994, P NATL ACAD SCI USA, V91, P5109, DOI 10.1073/pnas.91.11.5109; CRUIKSHANK WW, 1987, J IMMUNOL, V138, P3817; DRUBIN DG, 1990, NATURE, V343, P288, DOI 10.1038/343288a0; GOLDMAN F, 1994, J IMMUNOL, V153, P2905; Herman Paul K., 1992, Trends in Cell Biology, V2, P363, DOI 10.1016/0962-8924(92)90048-R; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; KORNFELD H, 1988, NATURE, V335, P445, DOI 10.1038/335445a0; LEDBETTER JA, 1987, P NATL ACAD SCI USA, V84, P1384, DOI 10.1073/pnas.84.5.1384; LIU XQ, 1993, MOL CELL BIOL, V13, P5225, DOI 10.1128/MCB.13.9.5225; METZGER H, 1992, J IMMUNOL, V149, P1477; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; PLEIMAN CM, 1993, MOL CELL BIOL, V13, P5877, DOI 10.1128/MCB.13.9.5877; PRASAD KVS, 1993, P NATL ACAD SCI USA, V90, P7366, DOI 10.1073/pnas.90.15.7366; RAND TH, 1991, J EXP MED, V173, P1521, DOI 10.1084/jem.173.6.1521; ROITT IM, 1991, ESSENTIAL IMMUNOLOGY; RUDD CE, 1993, BIOCHIM BIOPHYS ACTA, V1155, P239, DOI 10.1016/0304-419X(93)90007-Y; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SHELANSKI ML, 1989, ANN NY ACAD SCI, V568, P121; SLECKMAN BP, 1987, NATURE, V328, P351, DOI 10.1038/328351a0; SLECKMAN BP, 1992, P NATL ACAD SCI USA, V89, P7566, DOI 10.1073/pnas.89.16.7566; TEFLER JC, 1991, SCIENCE, V254, P439; THOMPSON PA, 1991, CELL GROWTH DIFFER, V2, P609; THORP KM, 1994, IMMUNOLOGY, V81, P546; UEHARA Y, 1989, CANCER RES, V49, P780; UEHARA Y, 1989, BIOCHEM BIOPH RES CO, V163, P803, DOI 10.1016/0006-291X(89)92293-6; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1993, J BIOL CHEM, V268, P17547; WEBER JR, 1992, J EXP MED, V176, P373, DOI 10.1084/jem.176.2.373; WENG ZG, 1993, J BIOL CHEM, V268, P14956; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N	41	72	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17081	17086		10.1074/jbc.270.29.17081	http://dx.doi.org/10.1074/jbc.270.29.17081			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615501	hybrid			2022-12-27	WOS:A1995RK68900008
J	TROUSSARD, AA; KHALLOU, J; MANN, CJ; ANDRE, P; STRICKLAND, DK; BIHAIN, BE; YEN, FT				TROUSSARD, AA; KHALLOU, J; MANN, CJ; ANDRE, P; STRICKLAND, DK; BIHAIN, BE; YEN, FT			INHIBITORY EFFECT ON THE LIPOLYSIS-STIMULATED RECEPTOR OF THE 39-KDA RECEPTOR-ASSOCIATED PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							LOW-DENSITY-LIPOPROTEIN; ALPHA-2-MACROGLOBULIN RECEPTOR; HIGH-AFFINITY; MULTIFUNCTIONAL RECEPTOR; BINDING; LIVER	Adenovirus vector-mediated transfer of the receptor-associated protein (RAP) gene into low density lipoprotein (LDL) receptor deficient mice was shown to achieve plasma concentrations ranging between 20 and 200 mu g/ml and to result in the accumulation of remnant lipoproteins (Willnow, T. E., Sheng, Z., Ishibashi, S., and Herz, J. (1994) Science 264, 1471-1474). Both this finding and the observation that in addition to various other members of the LDL receptor gene family, RAP binds to a yet unidentified protein of apparent molecular mass of 105 kDa prompted us to examine the effect of high concentrations of RAP on the lipolysis-stimulated receptor (LSR). LSR is a receptor distinct from the LDL receptor and the LDL receptor-related protein and is capable of binding apoB and apoE when activated by free fatty acids. Data reported here show that in fibroblasts isolated from a subject homozygous for familial hypercholesterolemia, RAP fusion protein inhibited LSR-mediated binding of I-125-LDL and the subsequent internalization and degradation of the particles. Studies on the interaction of RAP with LSR in isolated rat liver membranes revealed that at concentrations greater than or equal to 10 mu g/ml, RAP inhibited in a dose-dependent manner the binding of LDL to LSR; half-maximum inhibition was obtained with 20 mu g/ml RAP. Ligand blotting studies revealed that RAP bound directly to two rat liver membrane proteins of apparent molecular masses identical to those that bind I-125-LDL after preincubation with oleate. However, unlike LDL, binding of I-125-RAP to LSR did not require preincubation with oleate. Preincubation of nitrocellulose membranes with an excess of unlabeled RAP fusion protein decreased oleate-induced binding of I-125-LDL to LSR candidate proteins, whereas preincubation with excess unlabeled LDL was unable to prevent the subsequent binding of I-125-RAP to the LSR proteins. Both the latter data and analysis of the mechanism of inhibition were consistent with the RAP inhibitory effect on LSR being achieved by interference with a site distinct from the oleate induced LDL binding site. In conclusion, this study shows that at concentrations reported to delay chylomicron remnant removal in LDL receptor-deficient mice, RAP exerted a significant inhibitory effect on LSR.	UNIV RENNES 1,FAC SCI PHARMACEUT & BIOL,INSERM,U391,F-35043 RENNES,FRANCE; AMER RED CROSS,ROCKVILLE,MD 20855	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; American Red Cross			André, Patrice/M-8139-2014; Yen, Frances T/G-9175-2014	André, Patrice/0000-0002-5834-7395; Yen, Frances T/0000-0001-8740-4304; Laschet, Jamila/0000-0002-5090-4417				ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; BATTEY FD, 1994, J BIOL CHEM, V269, P23268; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; BELCHER JD, 1987, P NATL ACAD SCI USA, V84, P6785, DOI 10.1073/pnas.84.19.6785; BIHAIN BE, 1992, BIOCHEMISTRY-US, V31, P4628, DOI 10.1021/bi00134a013; BIHAIN BE, 1995, ATHEROSCLEROSIS, V10, P465; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BROWN MS, 1991, CURR OPIN LIPIDOL, V2, P65; FARQUHAR MG, 1994, ANN NY ACAD SCI, V737, P96, DOI 10.1111/j.1749-6632.1994.tb44304.x; GAFVELS ME, 1994, ENDOCRINOLOGY, V1135, P387; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1977, INT CELL BIOL 1976 1, P639; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz Joachim, 1993, Current Opinion in Lipidology, V4, P107, DOI 10.1097/00041433-199304000-00006; JENSEN PH, 1989, FEBS LETT, V255, P275, DOI 10.1016/0014-5793(89)81105-6; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P21162; KOUNNAS MZ, 1994, ANN NY ACAD SCI, V787, P114; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Markwell M A, 1981, Methods Enzymol, V72, P296; MEDH JD, 1995, J BIOL CHEM, V270, P536, DOI 10.1074/jbc.270.2.536; MOESTRUP SK, 1991, J BIOL CHEM, V266, P14011; MOKUNO H, 1994, J BIOL CHEM, V269, P13238; SOUTAR AK, 1989, NATURE, V341, P106, DOI 10.1038/341106a0; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; Van Berkel Theo J. C., 1994, Current Opinion in Lipidology, V5, P331, DOI 10.1097/00041433-199410000-00004; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; WILLNOW TE, 1994, SCIENCE, V264, P1471, DOI 10.1126/science.7515194; YEN FT, 1994, BIOCHEMISTRY-US, V33, P1172, DOI 10.1021/bi00171a017	31	25	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17068	17071		10.1074/jbc.270.29.17068	http://dx.doi.org/10.1074/jbc.270.29.17068			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615497	hybrid			2022-12-27	WOS:A1995RK68900004
J	GALISTEO, ML; GORDON, CL; KING, J				GALISTEO, ML; GORDON, CL; KING, J			STABILITY OF WILD-TYPE AND TEMPERATURE-SENSITIVE PROTEIN SUBUNITS OF THE PHAGE-P22 CAPSID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY FORMATION; TURNIP CRINKLE VIRUS; ESCHERICHIA-COLI; FOLDING MUTANTS; COAT PROTEIN; CONFORMATIONAL-CHANGES; SCANNING CALORIMETRY; SCAFFOLDING SUBUNITS; BACTERIOPHAGE P22; HEAD	Temperature-sensitive folding (tsf) mutants of the phage P22 coat protein prevent newly synthesized polypeptide chains from reaching the conformation competent for capsid assembly in cells, and can be rescued by the GroEL chaperone (Gordon, C., Sather, S., Casjens, S., and King, J. (1994) J. Biol. Chem. 269, 27941-27951). Here we investigate the stabilities of wild-type and four tsf mutant unpolymerized subunits. Wild-type coat protein subunits denatured at 40 degrees C, with a calorimetric enthalpy of approximately 600 kJ/mol. Comparison with coat protein denaturation within the shell lattice (T-m = 87 degrees C, Delta H similar to 1700 kJ/mol) (Galisteo, M. L., and King, J. (1993) Biophys, J. 65, 227-235) indicates that protein-protein interactions within the capsid provide enormous stabilization. The melting temperatures of the subunits carrying tsf substitutions were similar to wildtype. At low temperatures, the tsf mutants, but not the wild-type, formed non-covalent dimers, which were dissociated at temperatures above 30 degrees C. Spectroscopic and calorimetric studies indicated that the mutant proteins have reduced amounts of ordered structure at low temperature, as compared to the wild-type protein. Although complex, the in vitro phenotypes are consistent with the in vivo finding that the mutants are defective in folding, rather than subunit stability. These results suggest a role for incompletely folded subunits as precursors in viral capsid assembly, providing a mechanism of reaching multiple conformations in the polymerized form.	MIT,DEPT BIOL,CAMBRIDGE,MA 02139; UNIV GRANADA,FAC CIENCIAS,DEPT QUIM FIS,E-18071 GRANADA,SPAIN	Massachusetts Institute of Technology (MIT); University of Granada					NIGMS NIH HHS [GM17980] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM017980, R01GM017980] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERTAZZON A, 1989, BIOCHEMISTRY-US, V28, P9784, DOI 10.1021/bi00451a036; BERTAZZON A, 1990, BIOCHEMISTRY-US, V29, P6447, DOI 10.1021/bi00479a016; BRANDTS JF, 1989, BIOCHEMISTRY-US, V28, P8588, DOI 10.1021/bi00447a048; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; CASPAR DLD, 1980, BIOPHYS J, V32, P103, DOI 10.1016/S0006-3495(80)84929-0; CEPKO CL, 1982, CELL, V31, P407, DOI 10.1016/0092-8674(82)90134-9; CHRUNYK BA, 1993, J BIOL CHEM, V268, P18053; COPPO A, 1973, J MOL BIOL, V76, P61, DOI 10.1016/0022-2836(73)90081-8; EARNSHAW W, 1976, J MOL BIOL, V104, P387, DOI 10.1016/0022-2836(76)90278-3; EARNSHAW WC, 1980, CELL, V21, P319, DOI 10.1016/0092-8674(80)90468-7; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; EPPLER K, 1991, VIROLOGY, V183, P519, DOI 10.1016/0042-6822(91)90981-G; FOGUEL D, 1995, BIOCHEMISTRY-US, V34, P1120, DOI 10.1021/bi00004a003; FULLER MT, 1981, VIROLOGY, V112, P529, DOI 10.1016/0042-6822(81)90300-7; FULLER MT, 1982, J MOL BIOL, V156, P633, DOI 10.1016/0022-2836(82)90270-4; GALISTEO ML, 1991, BIOCHEMISTRY-US, V30, P2061, DOI 10.1021/bi00222a009; GALISTEO ML, 1993, BIOPHYS J, V65, P227, DOI 10.1016/S0006-3495(93)81073-7; GOLDBERG ME, 1991, BIOCHEMISTRY-US, V30, P2790, DOI 10.1021/bi00225a008; GOLDENBERG D, 1991, J MOL BIOL, V145, P633; GOLDENBERG DP, 1983, P NATL ACAD SCI-BIOL, V80, P7060, DOI 10.1073/pnas.80.23.7060; GORDON CL, 1994, J BIOL CHEM, V269, P27941; GORDON CL, 1993, J BIOL CHEM, V268, P9358; GORDON CL, 1994, GENETICS, V136, P427; GREENE B, 1994, VIROLOGY, V205, P188, DOI 10.1006/viro.1994.1634; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; HARRISON SC, 1984, TRENDS BIOCHEM SCI, V9, P345, DOI 10.1016/0968-0004(84)90057-4; HENDRIX RW, 1985, VIRUS STRUCTURE ASSE, P169; HORWITZ M S, 1991, P771; JAENICKE R, 1987, PROG BIOPHYS MOL BIO, V49, P117, DOI 10.1016/0079-6107(87)90011-3; KING J, 1974, NATURE, V251, P112, DOI 10.1038/251112a0; KING J, 1973, J MOL BIOL, V80, P697, DOI 10.1016/0022-2836(73)90205-2; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LARSON SB, 1993, J MOL BIOL, V231, P375, DOI 10.1006/jmbi.1993.1289; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; LONDON J, 1974, EUR J BIOCHEM, V47, P409, DOI 10.1111/j.1432-1033.1974.tb03707.x; MARTIN J, 1992, SCIENCE, V258, P995, DOI 10.1126/science.1359644; MITRAKI A, 1989, BIO-TECHNOL, V7, P690, DOI 10.1038/nbt0789-690; NEWCOMB WW, 1991, J VIROL, V65, P613, DOI 10.1128/JVI.65.2.613-620.1991; PRASAD BVV, 1993, J MOL BIOL, V231, P65, DOI 10.1006/jmbi.1993.1257; PREVELIGE PE, 1988, J MOL BIOL, V202, P743, DOI 10.1016/0022-2836(88)90555-4; PREVELIGE PE, 1993, BIOPHYS J, V64, P824, DOI 10.1016/S0006-3495(93)81443-7; PREVELIGE PE, 1994, BIOPHYS J, V66, P1631, DOI 10.1016/S0006-3495(94)80955-5; Privalov P L, 1986, Methods Enzymol, V131, P4; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; ROSS PD, 1985, J MOL BIOL, V183, P353, DOI 10.1016/0022-2836(85)90006-3; RUECKERT R R, 1991, P409; SALUNKE DM, 1986, CELL, V46, P895, DOI 10.1016/0092-8674(86)90071-1; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; SORGER PK, 1986, J MOL BIOL, V191, P639, DOI 10.1016/0022-2836(86)90451-1; STEVEN AC, 1992, J MOL BIOL, V228, P870, DOI 10.1016/0022-2836(92)90871-G; STOCKLEY PG, 1986, J MOL BIOL, V191, P721, DOI 10.1016/0022-2836(86)90456-0; STURTEVANT JM, 1989, J BIOL CHEM, V264, P10693; SUGIHARA J, 1988, BIOCHEMISTRY-US, V27, P2872, DOI 10.1021/bi00408a031; TESCHKE CM, 1993, BIOCHEMISTRY-US, V32, P10839, DOI 10.1021/bi00091a040; TESCHKE CM, 1995, IN PRESS BIOCHEMISTR; THOMAS D, 1991, VIROLOGY, V182, P673, DOI 10.1016/0042-6822(91)90608-E; TRUONG HTN, 1991, BIOCHEMISTRY-US, V30, P10722; VANDERVIES SM, 1994, NATURE, V368, P654, DOI 10.1038/368654a0; WINSTON F, 1979, J BACTERIOL, V137, P433, DOI 10.1128/JB.137.1.433-439.1979	59	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16595	16601		10.1074/jbc.270.28.16595	http://dx.doi.org/10.1074/jbc.270.28.16595			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622466	hybrid			2022-12-27	WOS:A1995RJ34700023
J	KANE, PM				KANE, PM			DISASSEMBLY AND REASSEMBLY OF THE YEAST VACUOLAR H+-ATPASE IN-VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICLE PROTON PUMP; SACCHAROMYCES-CEREVISIAE; ADENOSINE-TRIPHOSPHATASE; SUBUNIT; MUTANTS; TRANSPORT; PATHWAY	The vacuolar H+-ATPase of the yeast Saccharomyces cerevisiae is composed of a complex of peripheral subunits (the V-1 sector) attached to an integral membrane complex (the V-0 sector). In the experiments described here, attachment of the V-1 to the V-0 sector was assessed in wild-type cells under a variety of growth conditions. Depriving the yeast cells of glucose, even for as little as 5 min, caused dissociation of approximately 70% of the assembled enzyme complexes into separate V-1 and V-0 subcomplexes. Restoration of glucose induced rapid and efficient reassembly of the enzyme from the previously synthesized subcomplexes. Indirect immunofluorescence microscopy and subcellular fractionation revealed detachment of the peripheral subunits from the vacuolar membrane in the absence of glucose, followed by reattachment in the presence of glucose. Rapid dissociation of vacuolar H+-ATPases could also be triggered by shifting cells into a variety of other carbon sources, and reassembly could be generated by addition of glucose. Disassembly and reassembly of vacuolar H+-ATPases in vivo may be a means of regulating organelle acidification in response to extracellular conditions, or a mechanism for assembling alternate complexes of vacuolar H+-ATPases in different intracellular compartments.			KANE, PM (corresponding author), SUNY HLTH SCI CTR, DEPT BIOCHEM & MOLEC BIOL, SYRACUSE, NY 13210 USA.				NIGMS NIH HHS [R01-GM50322, R01 GM050322] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050322] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAUERLE C, 1993, J BIOL CHEM, V268, P12749; BOWMAN BJ, 1989, J BIOL CHEM, V264, P15606; CHANG A, 1991, J CELL BIOL, V115, P289, DOI 10.1083/jcb.115.2.289; DOHERTY RD, 1993, J BIOL CHEM, V268, P16845; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; FORGAC M, 1992, J BIOENERG BIOMEMBR, V24, P341, DOI 10.1007/BF00762527; FORGAC M, 1989, PHYSIOL REV, V69, P765, DOI 10.1152/physrev.1989.69.3.765; JOHNSTON M, 1991, MOL CELL BIOL YEAST, V2, P193; KANE PM, 1989, J BIOL CHEM, V264, P19236; KANE PM, 1992, J BIOL CHEM, V267, P447; KANE PM, 1992, J BIOENERG BIOMEMBR, V24, P383, DOI 10.1007/BF00762531; LAI S, 1991, J BIOL CHEM, V266, P16078; LILL H, 1986, EUR J BIOCHEM, V160, P627, DOI 10.1111/j.1432-1033.1986.tb10084.x; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4128, DOI 10.1021/bi00313a018; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; MORIYAMA Y, 1989, J BIOL CHEM, V264, P3577; MYERS M, 1993, J CELL PHYSIOL, V156, P35, DOI 10.1002/jcp.1041560106; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; NELSON N, 1989, TRENDS BIOCHEM SCI, V14, P113, DOI 10.1016/0968-0004(89)90134-5; NOUMI T, 1991, P NATL ACAD SCI USA, V88, P1938, DOI 10.1073/pnas.88.5.1938; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; OHYA Y, 1991, J BIOL CHEM, V266, P13971; PENEFSKY HS, 1991, ADV ENZYMOL, V64, P173; PUOPOLO K, 1990, J BIOL CHEM, V265, P14836; PUOPOLO K, 1992, J BIOL CHEM, V267, P5171; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; SERRANO R, 1991, MOL CELLULAR BIOL YE, V1, P523; SHERMAN F, 1982, METHODS YEAST GENETI, P177; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; SZE H, 1992, J BIOENERG BIOMEMBR, V24, P371, DOI 10.1007/BF00762530; THEVELEIN JM, 1992, ANTON LEEUW INT J G, V62, P109, DOI 10.1007/BF00584466; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; UMEMOTO N, 1990, J BIOL CHEM, V265, P18447; WARD JM, 1992, PLANT PHYSIOL, V99, P170, DOI 10.1104/pp.99.1.170; YAMASHIRO CT, 1990, MOL CELL BIOL, V10, P3737, DOI 10.1128/MCB.10.7.3737; ZHANG JM, 1992, J BIOL CHEM, V267, P9773	38	381	384	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					17025	17032						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622524				2022-12-27	WOS:A1995RJ34700086
J	SRIVASTAVA, SP; DAVIES, MV; KAUFMAN, RJ				SRIVASTAVA, SP; DAVIES, MV; KAUFMAN, RJ			CALCIUM DEPLETION FROM THE ENDOPLASMIC-RETICULUM ACTIVATES THE DOUBLE-STRANDED RNA-DEPENDENT PROTEIN-KINASE (PKR) TO INHIBIT PROTEIN-SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION FACTOR-II; MAMMALIAN-CELLS; TRANSLATIONAL INITIATION; SECRETORY PROTEINS; HELA-CELLS; INTERFERON; PHOSPHORYLATION; VIRUS; EXPRESSION; MECHANISM	Calcium depletion from the endoplasmic reticulum inhibits protein synthesis and correlates with increased phosphorylation of the alpha subunit of eukaryotic initiation factor 2 (eLF-2 alpha) by a mechanism that does not require ongoing protein synthesis, To elucidate whether protein synthesis inhibition requires eIF-2 alpha phosphorylation and whether eIF-2 alpha phosphorylation is mediated by the double-stranded RNA-dependent protein kinase (PKR), we studied protein synthesis in response to calcium depletion mediated by calcium ionophore A23187 in cell lines overexpressing wild-type eIF-2 alpha, a mutant eLF-2 alpha (S51A) that is resistant to phosphorylation, or a dominant negative mutant PKR (K296P in catalytic subdomain II), Expression of either mutant eIF-2 alpha or mutant PKR partially protected NIH3T3 cells from inhibition of protein synthesis upon A23187 treatment. In contrast, overexpression of wild-type PKR increased sensitivity to protein synthesis inhibition mediated by A23187 treatment. In a COS-1 monkey cell transient transfection system, increased eLF-2 alpha phosphorylation in response to A23187 treatment was inhibited by expression of the dominant negative PKR mutant. Overexpression of the PKR regulatory RNA binding domain, independent of the PKR catalytic do main, was sufficient to inhibit increased phosphorylation of eIF-2 alpha upon A23187 treatment. In addition, over expression of the HIV TAR RNA binding protein also inhibited eIF-2 alpha phosphorylation upon A23187 treatment. Taken together, our data show that calcium depletion activates PKR to phosphorylate eIF-2 alpha, and this activation is likely mediated through the PKR RNA binding domain.	UNIV MICHIGAN,MED CTR,DEPT BIOL CHEM,ANN ARBOR,MI 48105; UNIV MICHIGAN,MED CTR,HOWARD HUGHES MED INST,ANN ARBOR,MI 48105; GENET INST INC,CAMBRIDGE,MA 02140	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan					NHLBI NIH HHS [HL5777, HL5273] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMESZ H, 1979, EUR J BIOCHEM, V98, P513, DOI 10.1111/j.1432-1033.1979.tb13212.x; BARBER GN, 1994, P NATL ACAD SCI USA, V91, P4278, DOI 10.1073/pnas.91.10.4278; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROSTROM CO, 1989, J BIOL CHEM, V264, P1644; BROSTROM CO, 1990, ANNU REV PHYSIOL, V52, P577; CHENG TC, 1994, BIOCHEM J, V301, P563, DOI 10.1042/bj3010563; CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x; CRAIG EA, 1985, CRC CR REV BIOCH MOL, V18, P239, DOI 10.3109/10409238509085135; DAVIES MV, 1992, J VIROL, V66, P1943, DOI 10.1128/JVI.66.4.1943-1950.1992; DAVIES MV, 1989, P NATL ACAD SCI USA, V86, P9163, DOI 10.1073/pnas.86.23.9163; DORNER AJ, 1990, METHOD ENZYMOL, V185, P577; DRUMMOND IAS, 1987, J BIOL CHEM, V262, P12801; DUNCAN R, 1985, J BIOL CHEM, V260, P5493; DUNCAN R, 1984, J BIOL CHEM, V259, P1882; GALABRU J, 1989, EUR J BIOCHEM, V178, P581, DOI 10.1111/j.1432-1033.1989.tb14485.x; GREEN SR, 1995, MOL CELL BIOL, V15, P358, DOI 10.1128/MCB.15.1.358; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; HERSHEY JWB, 1993, SEMIN VIROL, V4, P201, DOI 10.1006/smvy.1993.1016; HOVANESSIAN AG, 1993, SEMIN VIROL, V4, P237, DOI 10.1006/smvy.1993.1020; HOVANESSIAN AG, 1982, EUR J BIOCHEM, V167, P467; JACKSON RJ, 1990, TRANSLATION EUKARYOT, P193; JUDWARE R, 1992, J BIOL CHEM, V267, P21685; KATZE MG, 1993, SEMIN VIROL, V4, P259, DOI 10.1006/smvy.1993.1022; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P487, DOI 10.1016/0076-6879(90)85041-L; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; KONIECZNY A, 1983, J BIOL CHEM, V258, P3402; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; LEE A S, 1992, Current Opinion in Cell Biology, V4, P267, DOI 10.1016/0955-0674(92)90042-B; LEE TG, 1994, MOL CELL BIOL, V14, P2331, DOI 10.1128/MCB.14.4.2331; LODISH HF, 1990, J BIOL CHEM, V265, P10893; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; MATHEWS MB, 1993, SEMIN VIROL, V4, P247, DOI 10.1006/smvy.1993.1021; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; MEURS EF, 1993, P NATL ACAD SCI USA, V90, P232, DOI 10.1073/pnas.90.1.232; MUNDSCHAU L, 1992, J BIOL CHEM, V267, P21685; PARK HS, 1994, P NATL ACAD SCI USA, V91, P4713, DOI 10.1073/pnas.91.11.4713; PATHAK VK, 1988, MOL CELL BIOL, V8, P993, DOI 10.1128/MCB.8.2.993; PRESTON SF, 1992, CELL CALCIUM, V13, P303, DOI 10.1016/0143-4160(92)90065-Z; PROSTKO CR, 1992, J BIOL CHEM, V267, P16751; ROMANO PR, 1995, MOL CELL BIOL, V15, P365, DOI 10.1128/MCB.15.1.365; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; SAMBROOK JF, 1990, CELL, V61, P197, DOI 10.1016/0092-8674(90)90798-J; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; SCHNEIDER RJ, 1987, ANNU REV BIOCHEM, V56, P317, DOI 10.1146/annurev.biochem.56.1.317; Singh V K, 1985, Prog Clin Biol Res, V202, P351; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; THOMIS DC, 1993, J VIROL, V67, P7695, DOI 10.1128/JVI.67.12.7695-7700.1993; WEISSMANN G, 1980, P NATL ACAD SCI-BIOL, V77, P1506, DOI 10.1073/pnas.77.3.1506; WHITAKER M, 1990, DEVELOPMENT, V108, P525	52	114	115	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16619	16624		10.1074/jbc.270.28.16619	http://dx.doi.org/10.1074/jbc.270.28.16619			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622470	hybrid			2022-12-27	WOS:A1995RJ34700027
J	YAMAGUCHI, M; HATEFI, Y				YAMAGUCHI, M; HATEFI, Y			PROTON-TRANSLOCATING NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE OF ESCHERICHIA-COLI - INVOLVEMENT OF ASPARTATE-213 IN THE MEMBRANE-INTERCALATING DOMAIN OF THE BETA-SUBUNIT IN ENERGY TRANSDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-ENERGY; SEQUENCE; PROTEIN; ENZYME; GENE; N,N'-DICYCLOHEXYLCARBODIIMIDE; TRANSPORT; FRAGMENTS; CLEAVAGE; SITES	Mutations in the beta subunit of Escherichia coli proton-translocating nicotinamide nucleotide transhydrogenase of the conserved residue beta Asp-213 to Asn (beta D213N) and He (beta D213I) resulted in the loss, respectively, of about 70% and 90% NADPH --> 3-acetylpyridine adenine dinucleotide (AcPyAD) transhydrogenation and coupled proton translocation activities. However, the cyclic NADP(H)-dependent NADH --> AcPyAD transhydrogenase activities of the mutants were only similar to 35% inhibited. The latter transhydrogenation, which is not coupled to proton translocation, occurs apparently via NADP under conditions that enzyme-NADP(H) complex is stabilized. Mutations beta D213N and beta D213I also resulted in decreases in apparent K-m(NADPH) for the NADPH --> AcPyAD and S-0.5(NADPH) (NADPH concentration needed for half-maximal activity) for the cyclic NADH --> AcPyAD transhydrogenation reactions, and in K-d(NADPH), as determined by equilibrium binding studies on the purified wild-type and the beta D213I mutant enzymes. These results point to a structural role of beta Asp-213 in energy transduction and are discussed in relation to our previous suggestion that proton translocation coupled to NADPH --> NAD (or AcPyAD) transhydrogenation is driven mainly by the difference in the binding energies of NADPH and NADP.	SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, DIV BIOCHEM, LA JOLLA, CA 92037 USA	Scripps Research Institute					NCRR NIH HHS [M01 RR0033] Funding Source: Medline; NIGMS NIH HHS [GM24887] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024887] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMAD S, 1992, EUR J BIOCHEM, V207, P733, DOI 10.1111/j.1432-1033.1992.tb17103.x; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CLARKE DM, 1985, J BACTERIOL, V162, P367, DOI 10.1128/JB.162.1.367-373.1985; CLARKE DM, 1986, EUR J BIOCHEM, V158, P647, DOI 10.1111/j.1432-1033.1986.tb09802.x; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; FISHER R. R., 1982, PYRIDINE NUCLEOTIDE, P279; GLAVAS NA, 1994, THESIS U BRIT COLUMB; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; HATEFI Y, 1980, J BIOL CHEM, V255, P9526; HATEFI Y, 1992, MOL MECHANISMS BIOEN, P265; HOLMBERG E, 1994, BIOCHEMISTRY-US, V33, P7691, DOI 10.1021/bi00190a024; HOU C, 1990, BIOCHIM BIOPHYS ACTA, V1018, P61, DOI 10.1016/0005-2728(90)90110-P; HOWLETT GJ, 1978, ARCH BIOCHEM BIOPHYS, V190, P809, DOI 10.1016/0003-9861(78)90341-7; HUTTON M, 1994, EUR J BIOCHEM, V219, P1041, DOI 10.1111/j.1432-1033.1994.tb18587.x; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; JENCKS WP, 1989, METHOD ENZYMOL, V171, P145; KRAMER RA, 1993, MOL BIOCHEM PARASIT, V60, P327, DOI 10.1016/0166-6851(93)90144-M; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CP, 1989, BIOCHIM BIOPHYS ACTA, V1000, P371, DOI 10.1016/S0006-3002(89)80032-0; LEVER TM, 1991, EUR J BIOCHEM, V197, P247, DOI 10.1111/j.1432-1033.1991.tb15905.x; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PHELPS DC, 1984, BIOCHEMISTRY-US, V23, P6340, DOI 10.1021/bi00321a008; PHELPS DC, 1985, BIOCHEMISTRY-US, V24, P3503, DOI 10.1021/bi00335a017; PHELPS DC, 1980, J BIOL CHEM, V255, P9647; ROTHSCHILD KJ, 1992, J BIOENERG BIOMEMBR, V24, P147, DOI 10.1007/BF00762674; Rydstrom J., 1987, PYRIDINE NUCLEOTIDE, P433; Sambrook J, 1989, MOL CLONING LABORATO; SEGEL IH, 1975, ENZYME KINETICS BEHA, P218; SONAR S, 1994, J BIOL CHEM, V269, P28851; SONE N, 1977, J BIOCHEM-TOKYO, V81, P519, DOI 10.1093/oxfordjournals.jbchem.a131485; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VERMEULEN AN, 1993, FEMS MICROBIOL LETT, V110, P223, DOI 10.1111/j.1574-6968.1993.tb06324.x; WAKABAYASHI S, 1987, BIOCHEM INT, V15, P915; WAKABAYASHI S, 1987, BIOCHEM INT, V15, P667; WANG TP, 1954, J BIOL CHEM, V211, P465; WILLIAMS R, 1994, MICROBIOL-UK, V140, P1595, DOI 10.1099/13500872-140-7-1595; WU LNY, 1981, J BIOL CHEM, V256, P7401; YAMAGUCHI M, 1993, J BIOL CHEM, V268, P17871; YAMAGUCHI M, 1991, J BIOL CHEM, V266, P5728; YAMAGUCHI M, 1994, J BIOENERG BIOMEMBR, V26, P435, DOI 10.1007/BF00762784; YAMAGUCHI M, 1988, J BIOL CHEM, V263, P2761; YAMAGUCHI M, 1990, BIOCHEMISTRY-US, V29, P4136, DOI 10.1021/bi00469a017; YAMAGUCHI M, 1989, BIOCHEMISTRY-US, V28, P6050, DOI 10.1021/bi00440a049; YU Y, 1994, MOL BIOCHEM PARASIT, V68, P323, DOI 10.1016/0166-6851(94)90178-3	45	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16653	16659		10.1074/jbc.270.28.16653	http://dx.doi.org/10.1074/jbc.270.28.16653			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622474	hybrid			2022-12-27	WOS:A1995RJ34700032
J	HOUWELING, M; CUI, Z; DENNIS, DE				HOUWELING, M; CUI, Z; DENNIS, DE			EXPRESSION OF PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE-2 CANNOT COMPENSATE FOR AN IMPAIRED CDP-CHOLINE PATHWAY IN MUTANT CHINESE-HAMSTER OVARY CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; PHOSPHOLIPID BIOSYNTHESIS; MEMBRANE-FRACTION; RAT HEPATOCYTES; PHOSPHATIDYLCHOLINE; METHYLTRANSFERASE; PROTEINS; CLONING; YEAST; LIVER	Phosphatidylcholine is a product of the CDP-choline pathway and the pathway that methylates phosphatidylethanolamine, We have asked the question: are the two pathways functionally interchangeable? We addressed this question by investigating the expression of phosphatidylethanolamine N-methyltransferase-2 (PEMT2) of rat liver in mutant Chinese hamster ovary cells (MT-58) (Esko, J. D., Wermuth, M. M., and Raetz, C. R. H. (1981) J, Biol. Chem, 256, 7388-7393) defective in the CDP-choline pathway for phosphatidylcholine biosynthesis. Cell lines stably expressing different amounts of PEMT2 activity (up to 700 pmol/min mg protein) were isolated. A positive correlation between the amount of PEMT2 activity expressed and the incorporation of [H-3]methionine into phosphatidylcholine at both the permissive and restrictive temperatures showed that PEMT2 was functional in the Chinese hamster ovary MT-58 cells. In contrast to mutant cell lines stably expressing transfected CTP:phosphocholine cytidylyltransferase, the cell lines stably expressing PEMT2 did not survive at the restrictive temperature, Determination of the phosphatidylcholine mass in wild type cells, mutant MT-58 cells, and cells with the highest level of PEMT2 expression showed that PEMT2 was functional and synthesized the same amount of phosphatidylcholine as did wild type cells at the restrictive temperature, Indirect immunofluorescence studies showed that localization of the over-expressed cytidylyltransferase in MT-58 cells was largely nuclear, whereas PEMT2 was predominantly located outside the nucleus. Our data show that methylation of phosphatidylethanolamine to phosphatidylcholine cannot substitute for the CDP-choline pathway.	UNIV ALBERTA,LIPID & LIPOPROT RES GRP,EDMONTON,AB T6G 2S2,CANADA; UNIV ALBERTA,DEPT BIOCHEM,EDMONTON,AB T6G 2S2,CANADA	University of Alberta; University of Alberta								ARONDEL V, 1993, J BIOL CHEM, V268, P16002; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; CUI Z, 1994, J BIOL CHEM, V269, P24531; CUI Z, 1993, J BIOL CHEM, V268, P16655; EAGLE H, 1955, J EXP MED, V102, P595, DOI 10.1084/jem.102.5.595; ESKO JD, 1982, P NATL ACAD SCI-BIOL, V79, P1698, DOI 10.1073/pnas.79.6.1698; ESKO JD, 1983, J BIOL CHEM, V258, P3051; ESKO JD, 1981, J BIOL CHEM, V256, P7388; EXTON JH, 1990, J BIOL CHEM, V265, P1; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; JAMIL H, 1992, J BIOL CHEM, V267, P1752; Kennedy E. P., 1986, LIPIDS MEMBRANES PRE, P171; KENT C, 1991, PROG LIPID RES, V29, P87; KODAKI T, 1987, J BIOL CHEM, V262, P15428; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCGEE TP, 1994, J CELL BIOL, V124, P273, DOI 10.1083/jcb.124.3.273; RIDGWAY ND, 1992, METHOD ENZYMOL, V209, P366; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; SKINNER HB, 1995, P NATL ACAD SCI USA, V98, P112; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SUNDLER R, 1974, J BIOL CHEM, V249, P5102; SWEITZER TD, 1994, ARCH BIOCHEM BIOPHYS, V311, P107, DOI 10.1006/abbi.1994.1215; TERCE F, 1994, J LIPID RES, V35, P2130; TIJBURG LBM, 1990, BIOCHIM BIOPHYS ACTA, V1004, P1; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRONCHERE H, 1994, BBA-LIPID LIPID MET, V1212, P137, DOI 10.1016/0005-2760(94)90248-8; VANCE DE, 1990, BIOCHEM CELL BIOL, V68, P1151, DOI 10.1139/o90-172; VANCE DE, 1988, PROG LIPID RES, V22, P61; VANCE DE, 1982, METHOD ENZYMOL, V71, P576; VANCE JE, 1990, J BIOL CHEM, V265, P7248; WALKEY CJ, 1994, J BIOL CHEM, V269, P5742; WANG YL, 1993, J BIOL CHEM, V268, P5899; WATKINS JD, 1992, J BIOL CHEM, V267, P5686; WEINHOLD PA, 1985, J BIOL CHEM, V261, P5104; YAO Z, 1990, J BIOL CHEM, V565, P4326	38	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16277	16282		10.1074/jbc.270.27.16277	http://dx.doi.org/10.1074/jbc.270.27.16277			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608195	hybrid			2022-12-27	WOS:A1995RH22600061
J	HUTCHINSON, LE; MCCLOSKEY, MA				HUTCHINSON, LE; MCCLOSKEY, MA			FC-EPSILON-RI-MEDIATED INDUCTION OF NUCLEAR FACTOR OF ACTIVATED T-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CYCLOSPORINE-A; MAST-CELLS; ANTIGEN RECEPTOR; TRANSCRIPTION; CALCINEURIN; LYMPHOCYTE; FOS; EXPRESSION; SIGNALS	Nuclear factor of activated T-cells (NFAT) is a transcriptional activator that binds to the interleukin-2 promoter and is believed to be responsible for T-cell-specific interleukin-2 gene expression. Here we demonstrate using electrophoretic mobility shift assays that nuclear NFAT can be induced in the rat basophilic leukemia (RBL 2H3) mast cell line and rat bone marrow-derived mast cells upon cross-linkage of the high affinity receptor (Fc epsilon RI) for immunoglobulin E (IgE). Receptor-dependent activation of NFAT was mimicked by the combination of the protein kinase C activator phorbol myristate acetate and the calcium ionophore ionomycin. The induced binding activity was specific for the NFAT recognition motif because competition with nonradioactive NFAT oligonucleotide abolished the DNA binding activity, whereas nonradioactive oligonucleotides recognized by the transcription factors NF kappa B, glucocorticoid receptors, and TFIID did not, An oligonucleotide representing the AP-1 recognition sequence also blocked the NFAT DNA binding activity, as did a combination of anti-Fos and anti-Jun antibodies. Using electrophoretic mobility shift assays, AP-1-binding proteins were found to be induced in RBL-2H3 cells under the same conditions as was the NFAT binding activity. Together these data suggest that the NFAT complex in mast cells contains Fos and dun proteins as does NFAT in T-cells, The appearance of nuclear NFAT binding activity was dependent in part upon calcium mobilization, as buffering the antigen-induced calcium rise with intracellular BAPTA strongly inhibited NFAT activation. Prevention of calcium influx with external EGTA also inhibited NFAT activation, indicating that release of calcium from internal stores was insufficient for sustained activation of mast cell NFAT. Cyclosporin A, a potent inhibitor of the calmodulin-dependent phosphatase calcineurin, blocked the induction of NFAT-DNA binding activity, implicating calcineurin as a key signaling enzyme in this pathway, These results suggest that NFAT is present in the mast cell line RBL-2H3 and in primary bone marrow-derived mast cells, is similar in subunit composition to the T-cell NFAT, and may play a role in calcium-dependent signal transduction in mast cells.	IOWA STATE UNIV SCI & TECHNOL,SIGNAL TRANSDUCT TRAINING GRP,AMES,IA 50011	Iowa State University	HUTCHINSON, LE (corresponding author), IOWA STATE UNIV SCI & TECHNOL,DEPT ZOOL & GENET,AMES,IA 50011, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048144] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM48144] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARANES D, 1991, BLOOD, V78, P2354; BARSUMIAN EL, 1984, EUR J IMMUNOL, V11, P317; BEAVEN MA, 1984, J BIOL CHEM, V259, P7129; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COCKERILL PN, 1993, P NATL ACAD SCI USA, V90, P2466, DOI 10.1073/pnas.90.6.2466; DURAND DB, 1987, J EXP MED, V165, P395, DOI 10.1084/jem.165.2.395; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; HUANG FL, 1989, J BIOL CHEM, V264, P4238; HULTSCH T, 1991, P NATL ACAD SCI USA, V88, P6229, DOI 10.1073/pnas.88.14.6229; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JAIN JN, 1993, J IMMUNOL, V151, P837; KAYE RE, 1992, P NATL ACAD SCI USA, V89, P8542, DOI 10.1073/pnas.89.18.8542; LEWIN I, 1993, BLOOD, V82, P3745; MATTILA PS, 1990, EMBO J, V9, P4425, DOI 10.1002/j.1460-2075.1990.tb07893.x; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.immunol.8.1.421; VERWEIJ CL, 1990, J BIOL CHEM, V265, P15788; WODNARFILIPOWICZ A, 1989, NATURE, V339, P150, DOI 10.1038/339150a0; YASEEN NR, 1993, J BIOL CHEM, V268, P14285	31	74	77	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16333	16338		10.1074/jbc.270.27.16333	http://dx.doi.org/10.1074/jbc.270.27.16333			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608202	hybrid			2022-12-27	WOS:A1995RH22600069
J	SHAPIRO, AB; LING, V				SHAPIRO, AB; LING, V			RECONSTITUTION OF DRUG TRANSPORT BY PURIFIED P-GLYCOPROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSING DIFFERENT LEVELS; MULTIDRUG-RESISTANCE; ADENOSINE-TRIPHOSPHATASE; ATPASE ACTIVITY; CELL-LINES; BINDING; SERIES; PROBE; GENE	P-glycoprotein confers multidrug resistance upon cells in which it is highly expressed, reducing the effectiveness of numerous cytotoxic drugs, including many of those used for chemotherapy of cancer. Although P-glycoprotein is widely believed to function as an ATP-dependent drug efflux pump, the unusually broad substrate specificity of P-glycoprotein has engendered the proposal of other, less direct mechanisms. None of the hypothetical mechanisms has been definitively tested, however, in a purified system where other cellular components and processes are absent. We have used a fluorescent substrate of P-glycoprotein, Hoechst 33342, to measure transport activity in real-time of highly purified P-glycoprotein in a reconstituted liposome system in which the P-glycoprotein has a uniformly inside-out orientation. Using this system, we demonstrated MgATP-dependent, chemosensitizer-inhibitable transport of Hoechst 33342. Transport was prevented by omission of Mg2+, by substitution of nonhydrolyzable adenylyl-beta,gamma-imidodiphosphate for ATP, by inhibition of the ATPase activity of P-glycoprotein with vanadate and N-ethylmaleimide, and by the chemosensitizers verapamil and amiodarone, Measurements of intraliposomal pH during Hoechst 33342 transport detected no large pH changes in P-glycoprotein-containing liposomes. These results are inconsistent with a mechanism in which P-glycoprotein affects drug accumulation by directly altering intracellular pH. The Hoechst 33342 transport assay re suits are consistent with mechanisms in which P-glycoprotein alone is sufficient to transport drugs out of the membrane bilayer.	ONTARIO CANC INST,DIV MOLEC & STRUCT BIOL,TORONTO,ON M4X 1K9,CANADA; UNIV TORONTO,DEPT MED BIOPHYS,TORONTO,ON M4X 1K9,CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto					NCI NIH HHS [CA 37130] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA037130] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; ALSHAWI MK, 1994, J BIOL CHEM, V269, P8986; ALTENBERG GA, 1993, P NATL ACAD SCI USA, V90, P9735, DOI 10.1073/pnas.90.20.9735; ALTENBERG GA, 1994, P NATL ACAD SCI USA, V91, P4654, DOI 10.1073/pnas.91.11.4654; CHEN AY, 1993, CANCER RES, V53, P1332; Childs S, 1994, Important Adv Oncol, P21; CHIN KV, 1993, ADV CANCER RES, V60, P157; DOIGE CA, 1993, ANNU REV MICROBIOL, V47, P291, DOI 10.1146/annurev.micro.47.1.291; DOIGE CA, 1992, BIOCHIM BIOPHYS ACTA, V1109, P149, DOI 10.1016/0005-2736(92)90078-Z; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; FREZARD F, 1991, EUR J BIOCHEM, V196, P483, DOI 10.1111/j.1432-1033.1991.tb15840.x; Gatmaitan Z C, 1993, Adv Pharmacol, V24, P77, DOI 10.1016/S1054-3589(08)60934-5; GEORGES E, 1991, J CELL PHYSIOL, V148, P479, DOI 10.1002/jcp.1041480321; GILL DR, 1992, CELL, V71, P23, DOI 10.1016/0092-8674(92)90263-C; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; KANO K, 1978, BIOCHIM BIOPHYS ACTA, V509, P289, DOI 10.1016/0005-2736(78)90048-2; LALANDE ME, 1981, P NATL ACAD SCI-BIOL, V78, P363, DOI 10.1073/pnas.78.1.363; NIELSEN D, 1992, BIOCHIM BIOPHYS ACTA, V1139, P169, DOI 10.1016/0925-4439(92)90131-6; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; PORUCHYNSKY MS, 1994, BIOCHEMISTRY-US, V33, P4163, DOI 10.1021/bi00180a009; ROEPE PD, 1993, BIOCHEMISTRY-US, V32, P11042, DOI 10.1021/bi00092a014; ROEPE PD, 1992, BIOCHEMISTRY-US, V31, P12555, DOI 10.1021/bi00165a003; RUETZ S, 1993, P NATL ACAD SCI USA, V90, P11588, DOI 10.1073/pnas.90.24.11588; RUETZ S, 1994, J BIOL CHEM, V269, P12277; SCHLEMMER SR, 1994, J BIOL CHEM, V269, P31059; SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745; SHAROM FJ, 1993, J BIOL CHEM, V268, P24197; SIMON S, 1994, P NATL ACAD SCI USA, V91, P1128, DOI 10.1073/pnas.91.3.1128; STEIN WD, 1994, MOL PHARMACOL, V45, P763; VALVERDE MA, 1992, NATURE, V355, P830, DOI 10.1038/355830a0; WEST IC, 1990, TRENDS BIOCHEM SCI, V15, P42, DOI 10.1016/0968-0004(90)90171-7; YOUNG XK, 1992, THESIS CORNELL U	35	186	189	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16167	16175		10.1074/jbc.270.27.16167	http://dx.doi.org/10.1074/jbc.270.27.16167			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608182	hybrid			2022-12-27	WOS:A1995RH22600045
J	STEVENS, A; POOLE, TL				STEVENS, A; POOLE, TL			5'-EXONUCLEASE-2 OF SACCHAROMYCES-CEREVISIAE - PURIFICATION AND FEATURES OF RIBONUCLEASE ACTIVITY WITH COMPARISON TO 5'-EXONUCLEASE-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACKING 5'->3' EXORIBONUCLEASE-1; MESSENGER-RNA; SUBSTRATE-SPECIFICITY; CYTOPLASMIC EXTRACTS; ASCITES-CELLS; YEAST-CELLS; GENE; PROTEIN; CLEAVAGE; XRN1	5'-Exonuclease-2 has been purified 17,000-fold from whole cell extracts of Saccharomyces cerevisiae. A 116-kDa polypeptide parallels the enzyme activity when the purified protein is examined by polyacrylamide gel electrophoresis in sodium dodecyl sulfate. Amino terminal sequencing of the 116-kDa protein shows that the sequence agrees with that encoded by the HKE1 gene, previously reported to encode exonuclease-2. A 45-kDa polypeptide also parallels the enzyme activity upon purification, and Sephacryl S-200 molecular sieve chromatography of the purified enzyme shows a parallel elution of most of the 116- and 45-kDa polypeptides, suggesting a close association of the two. Enzyme instability has precluded a more detailed analysis of their associative properties. The enzyme hydrolyzes RNA substrates to 5'-mononucleotides in a processive manner. Measurements of its substrate specificity and mode of action are compared with 5'-exonuclease-1. Restriction cut single-stranded T7 DNA is hydrolyzed at approximately 5-7% of the rate of 18 S rRNA of yeast by both enzymes. That 5'-exonuclease-2 hydrolyzes in a processive manner and lacks endonuclease activity is shown by the finding that [5'-P-32]GMP is the only product of its hydrolysis of [alpha-P-32]GTP-labeled synthetic RNAs. That 5'-exonuclease-2 hydrolyzes by a 5' --> 3' mode is shown by: 1) its poor hydrolysis of both 5'-capped and triphosphate-ended RNA substrates; 2) the products of its hydrolysis of [5'-P-32,H-3](pA)(4); and 3) the accumulation of 3'-stall fragments when a strong artificial RNA secondary structure is present in synthetic RNAs. 5'-Exonuclease-1 hydrolyzes the synthetic RNAs and (pA)(4) in an identical manner.			STEVENS, A (corresponding author), OAK RIDGE NATL LAB,DIV BIOL,POB 2009,OAK RIDGE,TN 37831, USA.			Poole, Toni/0000-0003-0882-0209				ALDRICH TL, 1993, MOL CELL BIOL, V13, P3434, DOI 10.1128/MCB.13.6.3434; AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173; COUTTS M, 1993, BIOCHIM BIOPHYS ACTA, V1173, P57, DOI 10.1016/0167-4781(93)90242-6; COUTTS M, 1993, BIOCHIM BIOPHYS ACTA, V1173, P49, DOI 10.1016/0167-4781(93)90241-5; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; DISEGNI G, 1993, MOL CELL BIOL, V13, P3424, DOI 10.1128/MCB.13.6.3424; HENRY Y, 1994, EMBO J, V13, P2452, DOI 10.1002/j.1460-2075.1994.tb06530.x; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; JOHNSON AW, 1991, J BIOL CHEM, V266, P14046; Kearsey S, 1991, Trends Cell Biol, V1, P110, DOI 10.1016/0962-8924(91)90101-E; KENNA M, 1993, MOL CELL BIOL, V13, P341, DOI 10.1128/MCB.13.1.341; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARIMER FW, 1992, GENE, V120, P51, DOI 10.1016/0378-1119(92)90008-D; LARIMER FW, 1990, GENE, V95, P85, DOI 10.1016/0378-1119(90)90417-P; LASATER LS, 1984, BIOCHEMISTRY-US, V23, P4367, DOI 10.1021/bi00314a019; LIU ZP, 1994, CELL, V77, P1083, DOI 10.1016/0092-8674(94)90447-2; MATSUDAIRA PT, 1989, PRATICAL GUIDE PROTE; MUHLRADD, 1994, GENE DEV, V8, P855; MURTHY KGK, 1991, NUCLEIC ACIDS RES, V19, P2685, DOI 10.1093/nar/19.10.2685; Sambrook J, 1989, MOL CLONING LABORATO; SEN D, 1992, METHOD ENZYMOL, V211, P191; Sherman F., 1986, METHODS YEAST GENETI; STEVENS A, 1987, NUCLEIC ACIDS RES, V15, P695, DOI 10.1093/nar/15.2.695; STEVENS A, 1988, MOL CELL BIOL, V8, P2005, DOI 10.1128/MCB.8.5.2005; STEVENS A, 1991, J BACTERIOL, V173, P7024, DOI 10.1128/jb.173.21.7024-7028.1991; STEVENS A, 1980, J BIOL CHEM, V255, P3080; STEVENS A, 1987, ARCH BIOCHEM BIOPHYS, V252, P339, DOI 10.1016/0003-9861(87)90040-3; VREKEN P, 1992, MOL CELL BIOL, V12, P2986, DOI 10.1128/MCB.12.7.2986	28	95	98	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16063	16069		10.1074/jbc.270.27.16063	http://dx.doi.org/10.1074/jbc.270.27.16063			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608167	hybrid			2022-12-27	WOS:A1995RH22600030
J	WRUTNIAK, C; CASSARMALEK, I; MARCHAL, S; RASCLE, A; HEUSSER, S; KELLER, JM; FLECHON, J; DAUCA, M; SAMARUT, J; GHYSDAEL, J; CABELLO, G				WRUTNIAK, C; CASSARMALEK, I; MARCHAL, S; RASCLE, A; HEUSSER, S; KELLER, JM; FLECHON, J; DAUCA, M; SAMARUT, J; GHYSDAEL, J; CABELLO, G			A 43-KDA PROTEIN RELATED TO C-ERB-A-ALPHA-1 IS LOCATED IN THE MITOCHONDRIAL MATRIX OF RAT-LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; ADENINE-NUCLEOTIDE TRANSLOCASE; TRANSCRIPTIONAL ACTIVITY; TRIIODOTHYRONINE T3; LIVING CELLS; LOCALIZATION; BINDING; ACID; PHOSPHORYLATION; ACTIVATION	In order to characterize Sterling's triiodothyronine (T-3) mitochondrial receptor using photoaffinity labeling, we observed two specific T-3-binding proteins in the inner membrane (28 kDa) and in the matrix (43 kDa) of rat liver mitochondria. Western blots and immunoprecipitation using antibodies raised against the T-3-binding domain of the T-3 nuclear receptor c-Erb A alpha 1 indicated that at least the 43-kDa protein was c-Erb A alpha 1-related. In addition, gel mobility shift assays demonstrated the occurrence of a c-Erb A alpha 1-related mitochondrial protein that specifically binds to a natural or a palindromic thyroid-responsive element. Moreover, this protein specifically binds to a direct repeat 2 sequence located in the D-loop of the mitochondrial genome. Furthermore, electron microscopy studies allowed the direct observation of a c-Erb A-related protein in mitochondria. Lastly, the relative amounts of the 43-kDa protein related to c-Erb A alpha 1 were in good correlation with the known mitochondrial mass in three typical tissues. Interestingly, expression of a truncated form of the c-Erb A alpha 1 nuclear receptor in CV1 cells was associated with a mitochondrial localization and a stimulation of mitochondrial activity. These results supply evidence of the localization of a member of the nuclear receptor superfamily in the mitochondrial matrix involved in the regulation of mitochondrial activity that could act as a mitochondrial T-3-dependent transcription factor.	INRA,DIFFERENCIAT CELLULAIRE & CROISSANCE LAB,UNITE ENDOCRINOL CELLULAIRE,F-34060 MONTPELLIER 1,FRANCE; ECOLE NORMALE SUPER LYON,INRA,BIOL CELLULAIRE & MOLEC LAB,CNRS,UMR 40,F-69364 LYON 07,FRANCE; UNIV NANCY 1,BIOL CELLULAIRE DEV LAB,F-54506 VANDOEUVRE NANCY,FRANCE; INRA,BIOL CELLULAIRE & MOLEC LAB,F-78352 JOUY EN JOSAS,FRANCE; INST CURIE,ONCOGENESE VIRALE & CELLULAIRE LAB,URA D1443,F-91405 ORSAY,FRANCE	INRAE; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); INRAE; Universite de Lorraine; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie			Samarut, Jacques/AAD-2587-2019; Rascle, Anne/AAC-1904-2019; GHYSDAEL, Jacques/F-3377-2013; , Cassar-Malek/AAW-6386-2020	Rascle, Anne/0000-0001-7464-8545; , Cassar-Malek/0000-0001-7407-1408				BIGLER J, 1992, MOL CELL BIOL, V12, P2406, DOI 10.1128/MCB.12.5.2406; BIGLER J, 1988, MOL CELL BIOL, V8, P4155, DOI 10.1128/MCB.8.10.4155; BOGAZZI F, 1994, J BIOL CHEM, V269, P11683; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cb.04.110188.001103; DELEO T, 1976, PFLUG ARCH EUR J PHY, V366, P73, DOI 10.1007/BF02486563; DISELA C, 1991, GENE DEV, V5, P2033, DOI 10.1101/gad.5.11.2033; Fleischer S, 1974, Methods Enzymol, V31, P6; GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930; GOGLIA F, 1981, PFLUG ARCH EUR J PHY, V390, P120, DOI 10.1007/BF00590193; GOLDBERG Y, 1988, EMBO J, V7, P2425, DOI 10.1002/j.1460-2075.1988.tb03088.x; GRAUPNER G, 1989, NATURE, V340, P653, DOI 10.1038/340653a0; Greenawalt J W, 1974, Methods Enzymol, V31, P310; GUSTAFSS.R, 1965, J CELL BIOL, V26, P555, DOI 10.1083/jcb.26.2.555; HAFNER RP, 1990, BIOCHEM J, V265, P731, DOI 10.1042/bj2650731; HASHIZUME K, 1982, BIOCHEM BIOPH RES CO, V106, P920, DOI 10.1016/0006-291X(82)91798-3; HOGER TH, 1991, EUR J CELL BIOL, V54, P150; HOROWITZ ZD, 1988, AFFINITY LABELING CL, P79; JAKOVCIC S, 1978, J CELL BIOL, V77, P887, DOI 10.1083/jcb.77.3.887; JOHNSON LV, 1980, P NATL ACAD SCI-BIOL, V77, P990, DOI 10.1073/pnas.77.2.990; KADENBACH B, 1986, REGULATION METABOLIC, P508; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN KH, 1992, P NATL ACAD SCI USA, V89, P7737, DOI 10.1073/pnas.89.16.7737; MARTINO G, 1986, MOL BIOL REP, V11, P205, DOI 10.1007/BF00419598; MORRE DJ, 1971, METHOD ENZYMOL, V22, P130; MUTVEI A, 1989, EUR J BIOCHEM, V180, P235, DOI 10.1111/j.1432-1033.1989.tb14638.x; MUTVEI A, 1989, ACTA ENDOCRINOL-COP, V121, P223, DOI 10.1530/acta.0.1210223; Ragan MT, 1987, MITOCHONDRIA PRACTIC, P79; RASMUSSEN UB, 1989, FEBS LETT, V255, P385, DOI 10.1016/0014-5793(89)81128-7; RODD C, 1992, ENDOCRINOLOGY, V131, P2559, DOI 10.1210/en.131.6.2559; Sambrook J, 1989, MOL CLONING LABORATO; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SCHWARTZ HL, 1992, J BIOL CHEM, V267, P11794; SOBOLL S, 1992, BIOCHEM J, V281, P171, DOI 10.1042/bj2810171; STERLING K, 1975, P NATL ACAD SCI USA, V72, P3225, DOI 10.1073/pnas.72.8.3225; STERLING K, 1986, ENDOCRINOLOGY, V119, P292, DOI 10.1210/endo-119-1-292; STERLING K, 1977, SCIENCE, V197, P996, DOI 10.1126/science.196334; STERLING K, 1984, CELL TISSUE RES, V236, P321; STERLING K, 1984, ACTA ENDOCRINOL-COP, V105, P391, DOI 10.1530/acta.0.1050391; STERLING K, 1980, SCIENCE, V210, P340, DOI 10.1126/science.7423197; STERLING K, 1978, SCIENCE, V201, P1126, DOI 10.1126/science.210507; SZCZESNAKACZMAR.A, 1990, INT J BIOCHEM, V22, P617; VANITALLIE CM, 1990, ENDOCRINOLOGY, V127, P55, DOI 10.1210/endo-127-1-55; Wharton DC., 1967, METHOD ENZYMOL, P245; [No title captured]	44	172	182	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16347	16354		10.1074/jbc.270.27.16347	http://dx.doi.org/10.1074/jbc.270.27.16347			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608204	hybrid, Green Submitted			2022-12-27	WOS:A1995RH22600071
J	COWBURN, D; ZHENG, J; XU, QH; BARANY, G				COWBURN, D; ZHENG, J; XU, QH; BARANY, G			ENHANCED AFFINITIES AND SPECIFICITIES OF CONSOLIDATED LIGANDS FOR THE SRC HOMOLOGY (SH)3 AND SH2 DOMAINS OF ABELSON PROTEIN-TYROSINE KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SOLID-PHASE SYNTHESIS; IDENTIFICATION; PEPTIDES; BINDING; DESIGN	The possible interrelationships between multiple domains of proteins involved in intracellular signal transduction are complex and not easily investigated. We have synthesized a series of bivalent consolidated ligands, which interact simultaneously with the SH2 and SH3 domain of Abelson kinase in a SH(32) dual domain construct, a portion of native Abelson kinase. Affinities were measured by quenching of intrinsic tryptophan fluorescence, Consolidated ligands have enhanced affinity and specificity compared to monovalent equivalents. Affinity is also dependent on the length of the linker joining the two parts, with an optimum distance similar to that expected from structural models of Abl (SH(32). These results suggest that consolidated ligands may be generally useful reagents for probing structural and functional activities of multidomain proteins.	UNIV MINNESOTA, DEPT CHEM, MINNEAPOLIS, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	COWBURN, D (corresponding author), ROCKEFELLER UNIV, 1230 YORK AVE, BOX 163, NEW YORK, NY 10021 USA.		Cowburn, David/A-8448-2008	Zheng, Jie/0000-0001-6524-6800; Cowburn, David/0000-0001-6770-7172	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042722, R01GM051628, R01GM047021] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-42722, GM-47021, GM-51628] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERICIO F, 1990, J ORG CHEM, V55, P3730, DOI 10.1021/jo00299a011; BRUGGE JS, 1993, SCIENCE, V260, P918, DOI 10.1126/science.8388123; BYCROFT BW, 1993, J CHEM SOC CHEM COMM, P778, DOI 10.1039/c39930000778; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; ECK MJ, 1994, NATURE, V368, P764, DOI 10.1038/368764a0; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; GIBBS JB, 1994, CELL, V77, P175, DOI 10.1016/0092-8674(94)90308-5; GILMER T, 1994, J BIOL CHEM, V269, P31711; GOSSER YQ, 1995, STRUCTURE, V3, P1075, DOI 10.1016/S0969-2126(01)00243-X; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; KURIYAN J, 1993, CURR OPIN STRUC BIOL, V3, P828, DOI 10.1016/0959-440X(93)90145-B; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; MAIGNAN S, 1995, SCIENCE, V268, P291, DOI 10.1126/science.7716522; MARAGANORE JM, 1990, BIOCHEMISTRY-US, V29, P7095, DOI 10.1021/bi00482a021; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; OTTINGER EA, 1993, BIOCHEMISTRY-US, V32, P4354, DOI 10.1021/bi00067a027; OVERDUIN M, 1992, CELL, V70, P697, DOI 10.1016/0092-8674(92)90437-H; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; TURCK CW, 1992, PEPTIDE RES, V5, P156; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; ZHU GC, 1994, ONCOGENE, V9, P1379	24	34	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26738	26741		10.1074/jbc.270.45.26738	http://dx.doi.org/10.1074/jbc.270.45.26738			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592905	hybrid			2022-12-27	WOS:A1995TE58300005
J	PETERS, JW; FISHER, K; NEWTON, WE; DEAN, DR				PETERS, JW; FISHER, K; NEWTON, WE; DEAN, DR			INVOLVEMENT OF THE P-CLUSTER IN INTRAMOLECULAR ELECTRON-TRANSFER WITHIN THE NITROGENASE MOFE PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-MOLYBDENUM COFACTOR; KLEBSIELLA-PNEUMONIAE NITROGENASE; AZOTOBACTER-VINELANDII; FE-PROTEIN; CRYSTALLOGRAPHIC STRUCTURE; HYDROGEN EVOLUTION; ATP HYDROLYSIS; ALPHA-SUBUNIT; CROSS-LINKING; COMPLEX	Nitrogenase is the catalytic component of biological nitrogen fixation, and it is comprised of two component proteins called the Fe protein and MoFe protein. The Fe protein contains a single Fe4S4 cluster, and the MoFe protein contains two metallocluster types called the P cluster (Fe8S8) and FeMo-cofactor (Fe7S9Mo-homocitrate), During turnover, electrons are delivered one at a time from the Fe protein to the MoFe protein in a reaction coupled to component-protein association dissociation and MgATP hydrolysis, Under conditions of optimum activity, the rate of component-protein dissociation is rate-limiting, The Fe protein's Fe4S4 cluster is the redox entity responsible for intermolecular electron delivery to the MoFe protein, and FeMo-cofactor provides the substrate reduction site, In contrast, the role of the P cluster in catalysis is not well understood although it is believed to be involved in accumulating electrons delivered from the Fe protein and brokering their intramolecular delivery to the substrate reduction site, A nitrogenase component-protein docking model, which is based on the crystallographic structures of the component proteins and which pairs the S-fold symmetric surface of the Fe protein with the exposed surface of the MoFe protein's pseudosymmetric cup interface, is now available, During component-protein interaction, this model places the P cluster between the Fe protein's Fe4S4 cluster and FeMo-cofactor, which implies that the P cluster is involved in mediating intramolecular electron transfer between the clusters, In the present study, evidence supporting this idea was obtained by demonstrating that it is possible to alter the rate of substrate reduction by perturbing the polypeptide environment between the P cluster and FeMo-cofactor without necessarily disrupting the metallocluster polypeptide environments or altering component-protein interaction.	VIRGINIA POLYTECH INST & STATE UNIV, DEPT BIOCHEM & ANAEROB MICROBIOL, BLACKSBURG, VA 24061 USA	Virginia Polytechnic Institute & State University			Fisher, Karl/A-5956-2013	Fisher, Karl/0000-0003-3539-8939; Peters, John/0000-0001-9117-9568	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051962] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK37255] Funding Source: Medline; NIGMS NIH HHS [GM51962] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRIGLE KE, 1985, GENE, V37, P37, DOI 10.1016/0378-1119(85)90255-0; BRIGLE KE, 1987, P NATL ACAD SCI USA, V84, P7066, DOI 10.1073/pnas.84.20.7066; BURGESS BK, 1980, J BIOL CHEM, V255, P353; DEAN DR, 1993, J BACTERIOL, V175, P6737, DOI 10.1128/jb.175.21.6737-6744.1993; DILWORTH MJ, 1966, BIOCHIM BIOPHYS ACTA, V127, P285, DOI 10.1016/0304-4165(66)90383-7; FARID RS, 1993, CURR OPIN STRUC BIOL, V3, P225, DOI 10.1016/S0959-440X(05)80157-5; FISHER K, 1991, BIOCHEM J, V279, P81, DOI 10.1042/bj2790081; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; HAGEMAN RV, 1978, BIOCHEMISTRY-US, V17, P4117, DOI 10.1021/bi00613a002; HAWKES TR, 1984, BIOCHEM J, V217, P317, DOI 10.1042/bj2170317; HOWARD JB, 1993, ACS SYM SER, V535, P271; HOWARD JB, 1994, ANNU REV BIOCHEM, V63, P235, DOI 10.1146/annurev.bi.63.070194.001315; IMAM S, 1980, FEBS LETT, V110, P35, DOI 10.1016/0014-5793(80)80016-0; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; JENG DY, 1970, J BIOL CHEM, V245, P2809; Johnson M. K., 1988, METAL CLUSTERS PROTE, P326; KIM CH, 1995, BIOCHEMISTRY-US, V34, P2798, DOI 10.1021/bi00009a008; KIM CH, 1993, CURR PLANT SCI BIOT, V17, P105; KIM J, 1994, BIOCHEMISTRY-US, V33, P389, DOI 10.1021/bi00168a001; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; KLUGKIST J, 1986, EUR J BIOCHEM, V155, P33, DOI 10.1111/j.1432-1033.1986.tb09455.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDAHL PA, 1985, J BIOL CHEM, V260, P1160; LJONES T, 1972, BIOCHIM BIOPHYS ACTA, V275, P93, DOI 10.1016/0005-2728(72)90027-8; LOWE DJ, 1993, BIOCHEM J, V292, P93, DOI 10.1042/bj2920093; LOWRY OH, 1951, J BIOL CHEM, V193, P265; ORMEJOHNSON WH, 1977, IRON SULFUR PROTEINS, P15; PETERS JW, 1994, J BIOL CHEM, V269, P28076; Rees DC, 1993, ADV INORG CHEM, V40, P89; SCHOLLHORN R, 1967, P NATL ACAD SCI USA, V74, P3249; SCOTT DJ, 1990, NATURE, V343, P188, DOI 10.1038/343188a0; SCOTT DJ, 1992, J BIOL CHEM, V267, P20002; SEEFELDT LC, 1994, PROTEIN SCI, V3, P2073, DOI 10.1002/pro.5560031120; SHAH VK, 1977, P NATL ACAD SCI USA, V74, P3249, DOI 10.1073/pnas.74.8.3249; SMITH BE, 1974, BIOCHEM J, V137, P169, DOI 10.1042/bj1370169; STEPHENS PJ, 1985, MOLYBDENUM ENZYMES, P117; STRANDBERG GW, 1968, CAN J MICROBIOL, V14, P25, DOI 10.1139/m68-005; THORNELEY RNF, 1983, BIOCHEM J, V215, P393, DOI 10.1042/bj2150393; THORNELEY RNF, 1993, ACS SYM SER, V535, P290; THORNELEY RNF, 1975, BIOCHEM J, V145, P391, DOI 10.1042/bj1450391; THORNELEY RNF, 1991, BIOCHEM J, V277, P735, DOI 10.1042/bj2770735; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WATT GD, 1977, BIOCHEMISTRY-US, V16, P264, DOI 10.1021/bi00621a017; WATT GD, 1975, BIOCHEMISTRY-US, V14, P4266, DOI 10.1021/bi00690a019; WILLING A, 1990, J BIOL CHEM, V265, P6596; WILLING AH, 1989, J BIOL CHEM, V264, P8499; WOLLE D, 1992, J BIOL CHEM, V267, P3667	47	70	72	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27007	27013		10.1074/jbc.270.45.27007	http://dx.doi.org/10.1074/jbc.270.45.27007			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592949	hybrid			2022-12-27	WOS:A1995TE58300049
J	STRIETER, RM; POLVERINI, PJ; KUNKEL, SL; ARENBERG, DA; BURDICK, MD; KASPER, J; DZUIBA, J; VANDAMME, J; WALZ, A; MARRIOTT, D; CHAN, SY; ROCZNIAK, S; SHANAFELT, AB				STRIETER, RM; POLVERINI, PJ; KUNKEL, SL; ARENBERG, DA; BURDICK, MD; KASPER, J; DZUIBA, J; VANDAMME, J; WALZ, A; MARRIOTT, D; CHAN, SY; ROCZNIAK, S; SHANAFELT, AB			THE FUNCTIONAL-ROLE OF THE ELR MOTIF IN CXC CHEMOKINE-MEDIATED ANGIOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET FACTOR-IV; NEUTROPHIL CHEMOTACTIC FACTOR; CAPILLARY ENDOTHELIAL-CELLS; TUMOR ANGIOGENESIS; ACTIVATES NEUTROPHILS; GENE-EXPRESSION; GROWTH-FACTOR; INHIBITION; INTERLEUKIN-8; CYTOKINES	In this study, we demonstrate that the CXC family of chemokines displays disparate angiogenic activity depending upon the presence or absence of the ELR motif. CXC chemokines containing the ELR motif (ELR-CXC chemokines) were found to be potent angiogenic factors, inducing both in vitro endothelial chemotaxis and in vivo corneal neovascularization. In contrast, the CXC chemokines lacking the ELR motif, platelet factor 4, interferon gamma-inducible protein 10, and monokine induced by gamma-interferon, not only failed to induce significant in vitro endothelial cell chemotaxis or in vivo corneal neovacularization but were found to be potent angiostatic factors in the presence of either ELR-CXC chemokines or the unrelated angiogenic factor, basic fibroblast growth factor, Additionally, mutant interleukin-g proteins lacking the ELR motif demonstrated potent angiostatic effects in the presence of either ELR-CXC chemokines or basic fibroblast growth factor, In contrast, a mutant of monokine induced by gamma-interferon containing the ELR motif was found to induce in vivo angiogenic activity, These findings suggest a functional role of the ELR motif in determining the angiogenic or angiostatic potential of CXC chemokines, supporting the hypothesis that the net biological balance between angiogenic and angiostatic CXC chemokines may play an important role in regulating overall angiogenesis.	UNIV MICHIGAN, MED CTR, SCH MED, DEPT PATHOL, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, SCH DENT, ORAL PATHOL SECT, ANN ARBOR, MI 48109 USA; UNIV LOUVAIN, REGA INST, B-3000 LOUVAIN, BELGIUM; UNIV BERN, THEODOR KOCHER INST, CH-3000 BERN 9, SWITZERLAND; BAYER CORP, INST RES TECHNOL, W HAVEN, CT 06516 USA; BAYER CORP, DEPT MOLEC & CELLULAR BIOL, BERKELEY, CA 94701 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; KU Leuven; University of Bern; Bayer AG; Bayer AG	STRIETER, RM (corresponding author), UNIV MICHIGAN, MED CTR,SCH MED,DEPT INTERNAL MED, DIV PULM & CRIT CARE MED, BOX 0360, ANN ARBOR, MI 48109 USA.		Arenberg, Douglas/P-7251-2014; Polverini, Peter/AAJ-8392-2020	Arenberg, Douglas/0000-0001-7707-5092; 	NCI NIH HHS [CA66180] Funding Source: Medline; NHLBI NIH HHS [HL50057, 1P50HL46487] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA066180] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050057, P50HL046487] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AUERBACH R, 1981, LYMPHOKINES, V4; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; BOUCK N, 1990, CANCER CELL-MON REV, V2, P179; BREM H, 1975, J EXP MED, V141, P427, DOI 10.1084/jem.141.2.427; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; CLARK RAF, 1993, J DERMATOL SURG ONC, V19, P693, DOI 10.1111/j.1524-4725.1993.tb00413.x; CLARKLEWIS I, 1993, P NATL ACAD SCI USA, V90, P3574, DOI 10.1073/pnas.90.8.3574; CRUM R, 1985, SCIENCE, V230, P1375, DOI 10.1126/science.2416056; DEWALD B, 1992, IMMUNOL LETT, V32, P81, DOI 10.1016/0165-2478(92)90203-Z; ENGERMAN RL, 1967, LAB INVEST, V17, P738; FARBER JM, 1993, BIOCHEM BIOPH RES CO, V192, P223, DOI 10.1006/bbrc.1993.1403; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FOLKMAN J, 1985, ADV CANCER RES, V43, P175, DOI 10.1016/S0065-230X(08)60946-X; FOLKMAN J, 1978, INT REV EXP PATHOL, V16, P207; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; GUSELLA GL, 1993, J IMMUNOL, V151, P2725; HADLEY TJ, 1994, J CLIN INVEST, V94, P985, DOI 10.1172/JCI117465; HEBERT CA, 1991, J BIOL CHEM, V266, P18989; HOMANDBERG GA, 1986, BIOCHIM BIOPHYS ACTA, V874, P61, DOI 10.1016/0167-4838(86)90102-0; HU DE, 1993, INFLAMMATION, V17, P135, DOI 10.1007/BF00916100; INGBER D, 1988, LAB INVEST, V59, P44; INGBER DE, 1986, ENDOCRINOLOGY, V119, P1768, DOI 10.1210/endo-119-4-1768; KAPLAN G, 1987, J EXP MED, V166, P1098, DOI 10.1084/jem.166.4.1098; KLAGSBRUN M, 1991, ANNU REV PHYSIOL, V53, P217, DOI 10.1146/annurev.physiol.53.1.217; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE A, 1983, SCIENCE, V221, P1185, DOI 10.1126/science.6193581; LEE K, 1987, CANCER RES, V47, P5021; Leibovich S J, 1988, Prog Clin Biol Res, V266, P131; MADRI JA, 1988, J CELL BIOL, V106, P1375, DOI 10.1083/jcb.106.4.1375; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; MARAGOUDAKIS ME, 1988, J PHARMACOL EXP THER, V244, P729; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MILLER MD, 1992, CRIT REV IMMUNOL, V12, P17; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; NEOTE K, 1993, J BIOL CHEM, V268, P12247; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; PETERSON HI, 1986, ANTICANCER RES, V6, P251; POBER JS, 1990, PHYSIOL REV, V70, P427, DOI 10.1152/physrev.1990.70.2.427; PROOST P, 1993, J IMMUNOL, V150, P1000; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO N, 1987, J NATL CANCER I, V79, P1383; SCHNYDERCANDRIAN S, 1995, J LEUKOCYTE BIOL, V57, P929, DOI 10.1002/jlb.57.6.929; SCHONBECK U, 1995, J IMMUNOL, V154, P2375; SHAPIRO R, 1987, P NATL ACAD SCI USA, V84, P2238, DOI 10.1073/pnas.84.8.2238; SHARPE RJ, 1990, JNCI-J NATL CANCER I, V82, P848, DOI 10.1093/jnci/82.10.848; SIDKY YA, 1987, CANCER RES, V47, P5155; SMITH DR, 1994, J EXP MED, V179, P1409, DOI 10.1084/jem.179.5.1409; STOUT AJ, 1993, INT J EXP PATHOL, V74, P79; STRIETER RM, 1989, J BIOL CHEM, V264, P10621; STRIETER RM, 1989, SCIENCE, V243, P1467, DOI 10.1126/science.2648570; STRIETER RM, 1992, AM J PATHOL, V141, P1279; TANNOCK IF, 1972, CANCER RES, V32, P77; TAYLOR S, 1982, NATURE, V297, P307, DOI 10.1038/297307a0	57	979	1055	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27348	27357		10.1074/jbc.270.45.27348	http://dx.doi.org/10.1074/jbc.270.45.27348			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592998	hybrid			2022-12-27	WOS:A1995TE58300098
J	TIAN, HC; KLAMBT, D; JONES, AM				TIAN, HC; KLAMBT, D; JONES, AM			AUXIN-BINDING PROTEIN-1 DOES NOT BIND AUXIN WITHIN THE ENDOPLASMIC-RETICULUM DESPITE THIS BEING THE PREDOMINANT SUBCELLULAR LOCATION FOR THIS HORMONE-RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZEA-MAYS-L; HEYMANN NEPHRITIS ANTIGEN; ALPHA-2-MACROGLOBULIN RECEPTOR; MOLECULAR-CLONING; PLASMA-MEMBRANE; IMMUNOLOGICAL METHODS; COLEOPTILE MEMBRANES; MAIZE COLEOPTILES; SECRETORY PATHWAY; CORN COLEOPTILES	Auxin-binding protein 1 (ABP1) is a unique hormone receptor because it resides primarily in the lumen of the endoplasmic reticulum (ER); however, two lines of evidence presented here suggest that ABP1 does not bind auxin within the endoplasmic reticulum, despite its predominant location there, First, ABP1 cannot be photolabeled in intact cells that have accumulated the auxin and photolabeling reagent 5-[7-H-3]azidoindole-3-acetic acid, indicating either that auxin is excluded from the ER and is not available for photolabeling to ABP1 or that binding conditions within the ER lumen are insufficient for photolabeling, Second, at the pH of the ER lumen, auxin binding to ABP1 is not detectable. The pH estimate of the ER lumen is based on an indirect assay, which indicates that the pH is closer to pH 7 than to the binding optimum of pH 5.5. These results indicate that ABP1 does not bind auxin within the ER and point to a site of action that is post-ER, The effect of auxin on its trafficking from the ER was tested in an animal expression system, ABP1 expressed at high levels in COS7 cells is efficiently retained in the ER lumen and is not secreted even in the presence of 190 mu M indole-3-acetic acid, an auxin concentration that is 40 times above the K-d for indole-3-acetic acid binding to ABP1.	UNIV N CAROLINA, DEPT BIOL, CHAPEL HILL, NC 27599 USA; UNIV BONN, INST BOT, W-5300 BONN, GERMANY	University of North Carolina; University of North Carolina Chapel Hill; University of Bonn								ABBATE M, 1993, EUR J CELL BIOL, V61, P139; ANDERSON RGW, 1985, CELL, V40, P635, DOI 10.1016/0092-8674(85)90212-0; Ausubel FA, 1990, CURRENT PROTOCOLS MO; BARBIERBRYGOO H, 1991, PLANT J, V1, P83, DOI 10.1111/j.1365-313X.1991.00083.x; BARRIERBRYGOO H, 1989, P NATL ACAD SCI USA, V86, P891, DOI 10.1073/pnas.86.3.891; BATTEY FD, 1994, J BIOL CHEM, V269, P23268; BLATT MR, 1994, PLANT J, V5, P55, DOI 10.1046/j.1365-313X.1994.5010055.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN JC, 1994, J BIOL CHEM, V269, P21136; CHAUDHARY VK, 1990, P NATL ACAD SCI USA, V87, P308, DOI 10.1073/pnas.87.1.308; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CLELAND RE, 1976, PLANT PHYSIOL, V58, P210, DOI 10.1104/pp.58.2.210; CROSS JW, 1991, NEW BIOL, V3, P813; DIEKMANN W, 1995, P NATL ACAD SCI USA, V92, P3425, DOI 10.1073/pnas.92.8.3425; EDGERTON MD, 1994, PHYTOCHEMISTRY, V35, P1111, DOI 10.1016/S0031-9422(00)94807-6; GOLDSMITH MHM, 1993, P NATL ACAD SCI USA, V90, P11442, DOI 10.1073/pnas.90.24.11442; HERTEL R, 1972, PLANTA, V107, P325, DOI 10.1007/BF00386394; HESSE T, 1989, EMBO J, V8, P2453, DOI 10.1002/j.1460-2075.1989.tb08380.x; HOFFMANN B, 1992, PHYSIOL PLANTARUM, V84, P146, DOI 10.1111/j.1399-3054.1992.tb08777.x; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; INOHARA N, 1989, P NATL ACAD SCI USA, V86, P3564, DOI 10.1073/pnas.86.10.3564; JACOBS M, 1976, PLANT PHYSIOL, V58, P203, DOI 10.1104/pp.58.2.203; JONES AM, 1984, PLANT PHYSIOL, V74, P295, DOI 10.1104/pp.74.2.295; JONES AM, 1993, PLANT PHYSIOL, V101, P595, DOI 10.1104/pp.101.2.595; JONES AM, 1991, PLANT PHYSIOL, V97, P352, DOI 10.1104/pp.97.1.352; JONES AM, 1990, PLANT PHYSIOL, V93, P1154, DOI 10.1104/pp.93.3.1154; JONES AM, 1989, PLANTA, V179, P409, DOI 10.1007/BF00391088; JONES AM, 1989, P NATL ACAD SCI USA, V86, P6153, DOI 10.1073/pnas.86.16.6153; JONES AM, 1994, ANNU REV PLANT PHYS, V45, P393, DOI 10.1146/annurev.pp.45.060194.002141; KLAMBT D, 1990, PLANT MOL BIOL, V14, P1045, DOI 10.1007/BF00019401; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P21162; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; LOBLER M, 1985, J BIOL CHEM, V260, P9848; MACDONALD H, 1994, PLANT PHYSIOL, V105, P1049, DOI 10.1104/pp.105.4.1049; MELHADO LL, 1982, PHYTOCHEMISTRY, V21, P2879, DOI 10.1016/0031-9422(80)85060-6; NAPIER RM, 1988, PLANTA, V176, P519, DOI 10.1007/BF00397659; NAPIER RM, 1990, PLANTA, V182, P313, DOI 10.1007/BF00197128; NAPIER RM, 1992, J CELL SCI, V102, P261; ORLANDO RA, 1992, P NATL ACAD SCI USA, V89, P6698, DOI 10.1073/pnas.89.15.6698; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PIETROMONACO S, 1990, P NATL ACAD SCI USA, V87, P1811, DOI 10.1073/pnas.87.5.1811; PILARSKY C, 1992, EUR J CELL BIOL, V59, P275; RAY PM, 1977, PLANT PHYSIOL, V59, P594, DOI 10.1104/pp.59.4.594; RAY PM, 1977, PLANT PHYSIOL, V60, P585, DOI 10.1104/pp.60.4.585; RITTER JK, 1993, J BIOL CHEM, V268, P23573; RONNE H, 1983, J CELL BIOL, V96, P907, DOI 10.1083/jcb.96.3.907; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; RUCK A, 1993, PLANT J, V4, P41, DOI 10.1046/j.1365-313X.1993.04010041.x; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SHIMOMURA S, 1986, J BIOCHEM-TOKYO, V99, P1513, DOI 10.1093/oxfordjournals.jbchem.a135621; SHIMOMURA S, 1988, PLANTA, V175, P558, DOI 10.1007/BF00393079; STRICKLAND DK, 1994, FIBRINOLYSIS, V8, P204, DOI 10.1016/0268-9499(94)90718-8; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; THIEL G, 1993, P NATL ACAD SCI USA, V90, P11493, DOI 10.1073/pnas.90.24.11493; TILLMANN U, 1989, EMBO J, V8, P2463, DOI 10.1002/j.1460-2075.1989.tb08381.x; WANG XM, 1991, J BIOL CHEM, V266, P19981; WILSON DW, 1993, J BIOL CHEM, V268, P7465; YILLA M, 1993, J BIOL CHEM, V268, P19092; YOO SH, 1992, J BIOL CHEM, V267, P11236; ZIMMERMANN S, 1994, PLANT J, V6, P707, DOI 10.1046/j.1365-313X.1994.6050707.x	61	55	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26962	26969		10.1074/jbc.270.45.26962	http://dx.doi.org/10.1074/jbc.270.45.26962			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592943	Green Published, hybrid			2022-12-27	WOS:A1995TE58300043
J	SUN, SC; MAGGIRWAR, SB; HARHAJ, E				SUN, SC; MAGGIRWAR, SB; HARHAJ, E			ACTIVATION OF NF-KAPPA-B BY PHOSPHATASE INHIBITORS INVOLVES THE PHOSPHORYLATION OF I-KAPPA-B-ALPHA AT PHOSPHATASE 2A-SENSITIVE SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN IMMUNODEFICIENCY VIRUS; DNA-BINDING SUBUNIT; TUMOR-NECROSIS-FACTOR; TRANSCRIPTION FACTOR; PHORBOL ESTER; MESSENGER-RNA; 65-KD SUBUNIT; REL ONCOGENE; PROTEIN; GENE	Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear. In the present study, the role of serine/threonine phosphatases in the regulation of I kappa B alpha phosphorylation was investigated. Our studies demonstrate that incubation of human T cells with low concentrations (similar to 1-5 nM) of calyculin A or okadaic acid, potent inhibitors of protein phosphatase type 1 (PP-1) and type 2A (PP-2A), induces the phosphorylation of I kappa B alpha even in the absence of any cellular stimulus. This action of the phosphatase inhibitors, which is associated with the activation of the RelA . p50 NF-kappa B heterodimer, is not affected by agents that block the induction of I kappa B alpha phosphorylation by tumor necrosis factor alpha (TNF-alpha). Furthermore, the phosphorylated I kappa B alpha from calyculin A-treated cells, but not that from TNF-alpha-stimulated cells, is sensitive to PP-BA in vitro, suggesting the existence of fundamental differences in the phosphorylation of I kappa B alpha induced by the two different NF-kappa B inducers. However, induction of I kappa B alpha phosphorylation by both TNF-alpha and the phosphatase inhibitors is associated with the subse quent degradation of I kappa B alpha. We further demonstrate that TNF-alpha- and calyculin A-induced I kappa B alpha degradation exhibits similar but not identical sensitivities to a proteasome inhibitor, Together, these results suggest that phosphorylation of I kappa B alpha, mediated through both the TMF-alpha-inducible and the PP-2A-opposing kinases, may serve to target I kappa B alpha for proteasome-mediated degradation.			SUN, SC (corresponding author), PENN STATE UNIV,COLL MED,MILTON S HERSHEY MED CTR,DEPT MICROBIOL & IMMUNOL,POB 850,HERSHEY,PA 17033, USA.							ALKALAY I, 1995, MOL CELL BIOL, V15, P1294; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BAEUERLE PA, 1990, MOL ASPECTS CELLULAR, P409; BALLARD D W, 1989, New Biologist, V1, P83; BALLARD DW, 1992, P NATL ACAD SCI USA, V89, P1875, DOI 10.1073/pnas.89.5.1875; BEG AA, 1992, GENE DEV, V6, P1899, DOI 10.1101/gad.6.10.1899; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; BOURS V, 1990, NATURE, V348, P76, DOI 10.1038/348076a0; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; CORDLE SR, 1993, J BIOL CHEM, V268, P11803; DEMARTIN R, 1993, EMBO J, V12, P2773, DOI 10.1002/j.1460-2075.1993.tb05938.x; DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302; FINCO TS, 1994, P NATL ACAD SCI USA, V91, P11884, DOI 10.1073/pnas.91.25.11884; GANCHI PA, 1992, MOL BIOL CELL, V3, P1339, DOI 10.1091/mbc.3.12.1339; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GILMORE TD, 1990, CELL, V62, P841, DOI 10.1016/0092-8674(90)90257-F; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; HENKEL T, 1992, CELL, V68, P1121, DOI 10.1016/0092-8674(92)90083-O; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; KAUFMAN JD, 1987, MOL CELL BIOL, V7, P3759, DOI 10.1128/MCB.7.10.3759; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; LEBAIL O, 1993, EMBO J, V12, P5043, DOI 10.1002/j.1460-2075.1993.tb06197.x; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; MENON SD, 1993, J BIOL CHEM, V268, P26805; MEYER R, 1991, P NATL ACAD SCI USA, V88, P966, DOI 10.1073/pnas.88.3.966; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P12740, DOI 10.1073/pnas.91.26.12740; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; RICE NR, 1993, EMBO J, V12, P4685, DOI 10.1002/j.1460-2075.1993.tb06157.x; RUBEN SM, 1991, SCIENCE, V251, P1490, DOI 10.1126/science.2006423; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; SIEKEVITZ M, 1987, SCIENCE, V238, P1575, DOI 10.1126/science.2825351; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; SUN SC, 1994, MOL CELL BIOL, V14, P7377, DOI 10.1128/MCB.14.11.7377; SUZUKI YJ, 1994, J IMMUNOL, V153, P5008; THEVENIN C, 1991, NEW BIOL, V2, P793; TONGSTARKSEN SE, 1987, P NATL ACAD SCI USA, V84, P6845, DOI 10.1073/pnas.84.19.6845; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; ZABEL U, 1993, EMBO J, V12, P201, DOI 10.1002/j.1460-2075.1993.tb05646.x	49	86	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18347	18351		10.1074/jbc.270.31.18347	http://dx.doi.org/10.1074/jbc.270.31.18347			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629157	hybrid			2022-12-27	WOS:A1995RM64200033
J	TANG, L; GOUNARIS, K; GRIFFITHS, CM; SELKIRK, ME				TANG, L; GOUNARIS, K; GRIFFITHS, CM; SELKIRK, ME			HETEROLOGOUS EXPRESSION AND ENZYMATIC-PROPERTIES OF A SELENIUM-INDEPENDENT GLUTATHIONE-PEROXIDASE FROM THE PARASITIC NEMATODE BRUGIA-PAHANGI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE CUTICULAR GLYCOPROTEIN; I IODOTHYRONINE DEIODINASE; LYMPHATIC FILARIAE; CDNA SEQUENCE; LINOLEIC-ACID; HUMAN-PLASMA; SELENOENZYME; PURIFICATION; HYDROPEROXIDES; IDENTIFICATION	A full-length cDNA from the parasitic nematode Brugia pahangi encoding a secreted homolog of glutathione peroxidase in which the codon for the active site selenocysteine is substituted naturally by a cysteine codon has been expressed in Spodoptera frugiperda (insect) cells via Autographa californica nuclear polyhedrosis virus (baculovirus). The recombinant protein was glycosylated and secreted from the cells in tetrameric form, The purified protein showed glutathione peroxidase activity with a range of organic hydroperoxides, including L-alpha-phosphatidylcholine hydroperoxide, but no significant activity against hydrogen peroxide, Glutathione was the only thiol tested that served as a substrate for the enzyme, which showed no activity with the thioredoxin system (thioredoxin, thioredoxin reductase, and NADPH), No glutathione-conjugating activity was detected against a range of electrophilic compounds that are common substrates for glutathione S-transferases. The apparent (pseudo) K-m for glutathione was determined as 4.9 mM at a fixed concentration of linolenic acid hydroperoxide (3 mu M). The enzyme showed low affinity for hydroperoxide substrates (apparent K-m for linolenic acid hydroperoxide and L-alpha-phosphatidylcholine hydroperoxide of 3.8 and 9.7 mM, respectively at a fixed glutathione concentration of 3 mM).	UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,DEPT BIOCHEM,LONDON SW7 2AY,ENGLAND; WELLCOME CTR PARASIT INFECT,BECKENHAM,KENT,ENGLAND; WELLCOME RES LABS,BECKENHAM BR3 3BS,KENT,ENGLAND	Imperial College London; GlaxoSmithKline; GlaxoSmithKline; Wellcome Research Laboratories				Selkirk, Murray/0000-0002-6274-6014	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON ME, 1980, J BIOL CHEM, V255, P9530; BERRY MJ, 1991, J BIOL CHEM, V266, P14155; BERRY MJ, 1991, NATURE, V349, P438, DOI 10.1038/349438a0; BJORNSTEDT M, 1994, J BIOL CHEM, V269, P29382; CHAUDIERE J, 1984, J BIOL CHEM, V259, P1043; CHU FF, 1993, J BIOL CHEM, V268, P2571; COOKSON E, 1992, P NATL ACAD SCI USA, V89, P5837, DOI 10.1073/pnas.89.13.5837; COOKSON E, 1993, MOL BIOCHEM PARASIT, V58, P155, DOI 10.1016/0166-6851(93)90099-J; CRIQUI MC, 1992, PLANT MOL BIOL, V18, P623, DOI 10.1007/BF00040684; DEAR TN, 1991, BIOCHEMISTRY-US, V30, P10376, DOI 10.1021/bi00107a003; Devaney E., 1991, P46; EPP O, 1983, EUR J BIOCHEM, V133, P51, DOI 10.1111/j.1432-1033.1983.tb07429.x; ESWORTHY RS, 1993, ARCH BIOCHEM BIOPHYS, V307, P29, DOI 10.1006/abbi.1993.1555; FLOHE L, 1972, H-S Z PHYSIOL CHEM, V353, P987, DOI 10.1515/bchm2.1972.353.1.987; FLOHE L, 1973, FEBS LETT, V32, P132, DOI 10.1016/0014-5793(73)80755-0; Flohe L., 1974, GLUTATHIONE, P132; FRIEDRICH MJ, 1986, J BACTERIOL, V167, P928, DOI 10.1128/jb.167.3.928-934.1986; FUNK CD, 1987, BIOCHIM BIOPHYS ACTA, V921, P213, DOI 10.1016/0005-2760(87)90021-X; GANTHER HE, 1984, METHOD ENZYMOL, V107, P593; GARSSEN GJ, 1971, BIOCHEM J, V122, P327, DOI 10.1042/bj1220327; GHYSELINCK NB, 1990, NUCLEIC ACIDS RES, V18, P7144, DOI 10.1093/nar/18.23.7144; GODEAS C, 1994, BBA-BIOMEMBRANES, V1191, P147, DOI 10.1016/0005-2736(94)90242-9; GROSSMANN A, 1983, EUR J BIOCHEM, V135, P549, DOI 10.1111/j.1432-1033.1983.tb07687.x; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HOLLAND D, 1993, PLANT MOL BIOL, V21, P923, DOI 10.1007/BF00027124; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HUBER RE, 1967, ARCH BIOCHEM BIOPHYS, V122, P164, DOI 10.1016/0003-9861(67)90136-1; KRAUS RJ, 1980, BIOCHIM BIOPHYS ACTA, V615, P19, DOI 10.1016/0005-2744(80)90004-2; LADENSTEIN R, 1979, J MOL BIOL, V134, P199, DOI 10.1016/0022-2836(79)90032-9; MADDIPATI KR, 1987, J BIOL CHEM, V262, P17398; MAIORINO M, 1990, METHOD ENZYMOL, V186, P448; MAIZELS RM, 1989, MOL BIOCHEM PARASIT, V32, P213, DOI 10.1016/0166-6851(89)90072-8; MANNERVIK B, 1985, METHOD ENZYMOL, V113, P490; MARTIN H, 1991, BIOCHEM BIOPH RES CO, V175, P123, DOI 10.1016/S0006-291X(05)81209-4; OVERBAUGH JM, 1985, PLANT PHYSIOL, V77, P437, DOI 10.1104/pp.77.2.437; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; PERRY ACF, 1992, BIOCHEM J, V285, P863, DOI 10.1042/bj2850863; ROCHER C, 1992, EUR J BIOCHEM, V205, P955, DOI 10.1111/j.1432-1033.1992.tb16862.x; ROVERI A, 1992, J BIOL CHEM, V267, P6142; SCHALLREUTER KU, 1988, BIOCHIM BIOPHYS ACTA, V967, P103, DOI 10.1016/0304-4165(88)90194-8; SCHUCKELT R, 1991, FREE RADICAL RES COM, V14, P343, DOI 10.3109/10715769109093424; SELKIRK ME, 1990, MOL BIOCHEM PARASIT, V42, P31, DOI 10.1016/0166-6851(90)90110-8; SELKIRK ME, 1989, MOL BIOCHEM PARASIT, V32, P229, DOI 10.1016/0166-6851(89)90073-X; SMITH GE, 1983, MOL CELL BIOL, V3, P2156, DOI 10.1128/MCB.3.12.2156; TAKAHASHI K, 1987, ARCH BIOCHEM BIOPHYS, V256, P677, DOI 10.1016/0003-9861(87)90624-2; THOMAS JP, 1990, J BIOL CHEM, V265, P454; URSINI F, 1982, BIOCHIM BIOPHYS ACTA, V710, P197, DOI 10.1016/0005-2760(82)90150-3; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; URSINI F, 1995, IN PRESS METHODS ENZ; YAMAMOTO Y, 1993, ARCH BIOCHEM BIOPHYS, V305, P541, DOI 10.1006/abbi.1993.1458; ZVELEBIL MJJM, 1993, MOL BIOCHEM PARASIT, V58, P145, DOI 10.1016/0166-6851(93)90098-I	51	43	45	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18313	18318		10.1074/jbc.270.31.18313	http://dx.doi.org/10.1074/jbc.270.31.18313			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629152	hybrid			2022-12-27	WOS:A1995RM64200027
J	CHEN, XS; NAUMANN, TA; KURRE, U; JENKINS, NA; COPELAND, NG; FUNK, CD				CHEN, XS; NAUMANN, TA; KURRE, U; JENKINS, NA; COPELAND, NG; FUNK, CD			CDNA CLONING, EXPRESSION, MUTAGENESIS, INTRACELLULAR-LOCALIZATION, AND GENE CHROMOSOMAL ASSIGNMENT OF MOUSE 5-LIPOXYGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSECT CELL SYSTEM; MAST-CELLS; ARACHIDONIC-ACID; MEMBRANE TRANSLOCATION; LEUKOTRIENE SYNTHESIS; HUMAN-LEUKOCYTES; BONE-MARROW; PROTEIN; ENZYME; BIOSYNTHESIS	5-Lipoxygenase of mouse macrophages and bone marrow derived mast cells (BMMC) was investigated. Indirect immunocytofluorescence combined with confocal microscopy provided evidence for distinct intracellular expression patterns and trafficking of 5-lipoxygenase upon cellular activation. In resting BMMC, 5-lipoxygenase was found within the nucleus co-localizing with the nuclear stain Yo-Pro-1. When BMMC were IgE/antigen-activated the 5-lipoxygenase immunofluorescence pattern was changed from nuclear to perinuclear. The absence of divalent cations in the incubation medium, or calcium ionophore A23187 challenge, altered the predominantly nuclear expression pattern to new sites both cytosolic and intranuclear. The cDNA for murine macrophage 5-lipoxygenase was cloned by the polymerase chain reaction and would predict a 674 amino acid protein. Using control cells obtained from 5-lipoxygenase-deficient mice it was determined that a single isoform accounts for both soluble and membrane bound and nuclear and cytosolic-localized enzyme in macrophages and BMMC. A mutation at amino acid 672 (Val --> Met) introduced serendipitously during the cloning process was found to completely abolish 5-lipoxygenase enzyme activity when the enzyme was expressed in human embryonic kidney 293 cells. This subtle change is proposed to affect the ability of the COOH-terminal isoleucine to coordinate the essential non-heme iron atom. In macrophages and BMMC obtained from 5-lipoxygenase-deficient mice, compensatory changes in expression of genes involved in the biosynthesis of leukotriene B-4 were investigated. 5-Lipoxygenase-activating protein expression was reduced by 50%, while leukotriene A(4) hydrolase expression was unaltered. The 5-lipoxygenase gene was mapped to the central region of mouse chromosome 6 in a region that shares homology with human chromosome 10 by interspecific backcross analysis. These studies provide a global picture of the murine 5-lipoxygenase system and raise questions about the role of 5-lipoxygenase and leukotrienes within the nucleus.	VANDERBILT UNIV,DEPT PHARMACOL,NASHVILLE,TN 37232; NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,MAMMALIAN GENET LAB,FREDERICK,MD 21702	Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick			Funk, Colin D/A-9518-2010	Funk, Colin/0000-0001-7029-4233	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, P50GM015431] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO046000] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-46000] Funding Source: Medline; NHLBI NIH HHS [HL02710] Funding Source: Medline; NIGMS NIH HHS [GM15431] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMOVITZ M, 1993, EUR J BIOCHEM, V215, P105, DOI 10.1111/j.1432-1033.1993.tb18012.x; BALCAREK JM, 1988, J BIOL CHEM, V263, P13937; BOADO RJ, 1992, P NATL ACAD SCI USA, V89, P9044, DOI 10.1073/pnas.89.19.9044; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; BROCK TG, 1994, J BIOL CHEM, V269, P22059; CHEN XS, 1994, J BIOL CHEM, V269, P13979; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; CHEN XS, 1993, EUR J BIOCHEM, V214, P845, DOI 10.1111/j.1432-1033.1993.tb17988.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COFFEY M, 1992, J BIOL CHEM, V267, P570; COHN ZA, 1965, J EXP MED, V121, P153, DOI 10.1084/jem.121.1.153; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; DIXON RAF, 1988, P NATL ACAD SCI USA, V85, P416, DOI 10.1073/pnas.85.2.416; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; FUNK CD, 1992, P NATL ACAD SCI USA, V89, P3962, DOI 10.1073/pnas.89.9.3962; FUNK CD, 1989, P NATL ACAD SCI USA, V86, P2587, DOI 10.1073/pnas.86.8.2587; FUNK CD, 1991, J BIOL CHEM, V266, P12508; FUNK CD, 1989, P NATL ACAD SCI USA, V86, P2592, DOI 10.1073/pnas.86.8.2592; FUNK CD, 1994, ANN NY ACAD SCI, V714, P253, DOI 10.1111/j.1749-6632.1994.tb12051.x; FUNK CD, 1995, ADV PROSTAG THROMB L, V23, P145; GORMAN CM, 1990, DNA PROTEIN ENG TECH, V2, P3; Green EL, 1981, GENETICS PROBABILITY, P77; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; HOGAN A, 1991, DEVELOPMENT, V113, P363; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; KENNEDY BP, 1991, J BIOL CHEM, V266, P8511; LAM BK, 1989, J BIOL CHEM, V264, P12885; LAM BK, 1990, J BIOL CHEM, V265, P13438; LEPLEY RA, 1994, J BIOL CHEM, V269, P24163; MALAVIYA R, 1993, J BIOL CHEM, V268, P4939; MATSUMOTO T, 1988, P NATL ACAD SCI USA, V85, P3406; MATSUMOTO T, 1988, P NATL ACAD SCI USA, V85, P26, DOI 10.1073/pnas.85.1.26; MINOR W, 1993, BIOCHEMISTRY-US, V32, P6320, DOI 10.1021/bi00076a003; PETERSGOLDEN M, 1993, BIOCHEM BIOPH RES CO, V196, P147, DOI 10.1006/bbrc.1993.2227; RAZIN E, 1983, J EXP MED, V157, P189, DOI 10.1084/jem.157.1.189; RAZIN E, 1982, P NATL ACAD SCI-BIOL, V79, P4665, DOI 10.1073/pnas.79.15.4665; ROUZER CA, 1988, J BIOL CHEM, V263, P10980; ROUZER CA, 1982, J EXP MED, V155, P720, DOI 10.1084/jem.155.3.720; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SAMUELSSON B, 1989, J BIOL CHEM, V264, P19469; WONG A, 1992, BIOCHEMISTRY-US, V31, P4046, DOI 10.1021/bi00131a021; WONG A, 1991, BIOCHEMISTRY-US, V30, P9346, DOI 10.1021/bi00102a030; WOODS JW, 1995, J CLIN INVEST, V95, P2035, DOI 10.1172/JCI117889; WOODS JW, 1993, J EXP MED, V178, P1935, DOI 10.1084/jem.178.6.1935; ZHANG YY, 1992, P NATL ACAD SCI USA, V89, P485, DOI 10.1073/pnas.89.2.485; ZHENG YL, 1991, EXP CELL RES, V194, P301, DOI 10.1016/0014-4827(91)90369-6	46	82	86	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17993	17999		10.1074/jbc.270.30.17993	http://dx.doi.org/10.1074/jbc.270.30.17993			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629107	hybrid			2022-12-27	WOS:A1995RM26600057
J	HAUSNER, W; THOMM, M				HAUSNER, W; THOMM, M			THE TRANSLATION PRODUCT OF THE PRESUMPTIVE THERMOCOCCUS-CELER TATA-BINDING PROTEIN-SEQUENCE IS A TRANSCRIPTION FACTOR-RELATED IN STRUCTURE AND FUNCTION TO METHANOCOCCUS TRANSCRIPTION FACTOR-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RNA-POLYMERASE; THERMOLITHOTROPHICUS; EXPRESSION; VANNIELII; SYSTEM; TFIIB; GENES; BOX	A gene for a putative homolog of TATA-binding protein (TBP) from Thermococcus celer has been expressed in Escherichia coli, and the function of the purified recombinant protein was studied in a Methanococcus-derived cell-free transcription system. Thermococcus TBP can replace archaeal transcription factor B (aTFB) in cell-free transcription reactions. This transcriptional activation is TATA box-dependent and occurs both on tRNA(Val) and protein-encoding genes as templates indicating that Thermococcus TBP is a general transcription factor. Antibodies raised against Thermococcus TBP bind to Methanococcus aTFB and inhibit aTFB activity. These findings demonstrate that Thermococcus TBP (like eucaryal TBPs) can direct specific transcription from TATA boxes.	CHRISTIAN ALBRECHTS UNIV KIEL,INST ALLGEMEINE MIKROBIOL,D-24118 KIEL,GERMANY	University of Kiel								CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; CRETI R, 1993, NUCLEIC ACIDS RES, V21, P2942, DOI 10.1093/nar/21.12.2942; FREY G, 1990, NUCLEIC ACIDS RES, V18, P1361, DOI 10.1093/nar/18.6.1361; HAUSNER W, 1991, J MOL BIOL, V222, P495, DOI 10.1016/0022-2836(91)90492-O; HAUSNER W, 1993, J BIOL CHEM, V268, P24047; HUBER H, 1982, ARCH MICROBIOL, V132, P47, DOI 10.1007/BF00690816; MARSH TL, 1994, P NATL ACAD SCI USA, V91, P5788; OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994; OUZOUNIS C, 1992, CELL, V71, P189, DOI 10.1016/0092-8674(92)90347-F; REITER WD, 1990, P NATL ACAD SCI USA, V87, P9509, DOI 10.1073/pnas.87.24.9509; ROWLANDS T, 1994, SCIENCE, V264, P1326, DOI 10.1126/science.8191287; STETTER KO, 1990, FEMS MICROBIOL LETT, V75, P117, DOI 10.1111/j.1574-6968.1990.tb04089.x; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; THOMM M, 1994, SYST APPL MICROBIOL, V16, P648; THOMM M, 1993, J BACTERIOL, V174, P3508; WETTACH J, 1995, P NATL ACAD SCI USA, V92, P472, DOI 10.1073/pnas.92.2.472; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576	17	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17649	17651		10.1074/jbc.270.30.17649	http://dx.doi.org/10.1074/jbc.270.30.17649			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629058	hybrid			2022-12-27	WOS:A1995RM26600003
J	KOWALAK, JA; BRUENGER, E; MCCLOSKEY, JA				KOWALAK, JA; BRUENGER, E; MCCLOSKEY, JA			POSTTRANSCRIPTIONAL MODIFICATION OF THE CENTRAL LOOP OF DOMAIN-V IN ESCHERICHIA-COLI 23-S RIBOSOMAL-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; PERFORMANCE LIQUID-CHROMATOGRAPHY; PEPTIDYL TRANSFERASE; SECONDARY STRUCTURE; MAGNETIC-RESONANCE; NUCLEOTIDES; NUCLEOSIDES; PROTEIN; SITES	Knowledge of the sites, structures, and functional roles of posttranscriptional modification in rRNAs is limited, despite steadily accumulating evidence that rRNA plays a direct role in the peptidyl transferase reaction and that modified nucleotides are concentrated at the functional center of the ribosome. Using methods based on mass spectrometry, modifications have been mapped in Escherichia coli 23 S rRNA in the central loop of domain V, a region of established interaction between 23 S RNA and tRNA. Two segments of RNA were isolated following protection with oligodeoxynucleotides and nuclease digestion: residues 2423-2473 (51-mer) and 2481-2519 (39-mer). Dihydrouridine was located at position 2449, within the RNase T-1 hydrolysis product 2448-ADAACAGp-2454, as evidenced by a molecular mass 2 daltons higher than the gene sequence-predicted mass. This nucleoside, which is nearly ubiquitous in tRNA (where it is involved in maintenance of loop structure), is two bases from A-2551, a previously determined site of interaction between 23 S RNA and the CCA-aminoacyl terminus of tRNA at the ribosomal P-site. The oligonucleotide 2496-CACmCUCGp-2502 was isolated and accurately mass measured, and its nucleoside constituents were characterized by high performance liquid chromatography-mass spectrometry; there was no evidence of modification at position 2501 as implied by earlier work. Using similar techniques, the modified adenosine at position 2503 was unambiguously determined to be 2-methyladenosine in the fragment 2503-m(2)A Psi Gp-2505.	UNIV UTAH,DEPT BIOCHEM,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT MED CHEM,SALT LAKE CITY,UT 84112	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah					NCI NIH HHS [5P30CA42014] Funding Source: Medline; NIGMS NIH HHS [GM29812] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029812] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKIN A, 1993, BIOCHEMISTRY-US, V32, P9754, DOI 10.1021/bi00088a030; BJORK GR, 1987, ANNU REV BIOCHEM, V56, P263, DOI 10.1146/annurev.bi.56.070187.001403; Bjork GR, 1992, TRANSFER RNA PROTEIN, P23; BRANLANT C, 1981, NUCLEIC ACIDS RES, V9, P4303, DOI 10.1093/nar/9.17.4303; BRANLANT C, 1977, J MOL BIOL, V111, P215, DOI 10.1016/S0022-2836(77)80050-8; BRANLANT C, 1975, BIOCHIMIE, V57, P175, DOI 10.1016/S0300-9084(75)80168-4; BRIMACOMBE R, 1993, FASEB J, V7, P161, DOI 10.1096/fasebj.7.1.8422963; BROSIUS J, 1980, P NATL ACAD SCI-BIOL, V77, P201, DOI 10.1073/pnas.77.1.201; BUCK M, 1983, ANAL BIOCHEM, V129, P1, DOI 10.1016/0003-2697(83)90044-1; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; CRAIN PF, 1994, BIOLOGICAL MASS SPECTROMETRY: PRESENT AND FUTURE, P509; CUNDLIFFE E, 1990, RIBOSOME, P479; DESLAURIERS R, 1971, CAN J BIOCHEM CELL B, V49, P1279, DOI 10.1139/o71-185; EDMONDS CG, 1985, NUCLEIC ACIDS RES, V13, P8197, DOI 10.1093/nar/13.22.8197; EMERSON J, 1980, ACTA CRYSTALLOGR B, V36, P537, DOI 10.1107/S0567740880003780; FELLNER P, 1969, EUR J BIOCHEM, V11, P12, DOI 10.1111/j.1432-1033.1969.tb00733.x; GEHRKE CW, 1989, J CHROMATOGR, V471, P3, DOI 10.1016/S0021-9673(00)94152-9; GUTELL RR, 1993, NUCL ACIDS RES S, V20, P2095; JACK A, 1976, J MOL BIOL, V108, P619, DOI 10.1016/S0022-2836(76)80109-X; JOHNSON JD, 1971, BIOCHIM BIOPHYS ACTA, V247, P262, DOI 10.1016/0005-2787(71)90675-7; KOWALAK JA, 1994, BIOCHEMISTRY-US, V33, P7869, DOI 10.1021/bi00191a014; KOWALAK JA, 1993, NUCLEIC ACIDS RES, V21, P4577, DOI 10.1093/nar/21.19.4577; KOWALAK JA, 1993, TRANSLATIONAL APPARATUS, P79; LIMBACH PA, 1994, NUCLEIC ACIDS RES, V22, P2183, DOI 10.1093/nar/22.12.2183; Maden B E, 1990, Prog Nucleic Acid Res Mol Biol, V39, P241, DOI 10.1016/S0079-6603(08)60629-7; MADEN BEH, 1980, NATURE, V288, P293, DOI 10.1038/288293a0; MOAZED D, 1986, J MOL BIOL, V191, P483, DOI 10.1016/0022-2836(86)90143-9; MORAS D, 1980, NATURE, V288, P669, DOI 10.1038/288669a0; NICHOLS JL, 1967, J MOL BIOL, V30, P477, DOI 10.1016/0022-2836(67)90363-4; NOLLER HF, 1984, ANNU REV BIOCHEM, V53, P119, DOI 10.1146/annurev.bi.53.070184.001003; NOLLER HF, 1981, NUCLEIC ACIDS RES, V9, P6167, DOI 10.1093/nar/9.22.6167; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; NOLLER HF, 1991, ANNU REV BIOCHEM, V60, P191, DOI 10.1146/annurev.biochem.60.1.191; NOLLER HF, 1981, SCIENCE, V212, P403, DOI 10.1126/science.6163215; NOLLER HF, 1993, J BACTERIOL, V175, P5297, DOI 10.1128/JB.175.17.5297-5300.1993; POMERANTZ SC, 1993, J AM SOC MASS SPECTR, V4, P204, DOI 10.1016/1044-0305(93)85082-9; POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q; QUIGLEY GJ, 1976, SCIENCE, V194, P794; SMITH JE, 1992, BIOCHEMISTRY-US, V31, P10825, DOI 10.1021/bi00159a025; STAHL DA, 1978, THESIS U ILLINOIS UR; STEINBERG S, 1993, NUCLEIC ACIDS RES, V21, P3011, DOI 10.1093/nar/21.13.3011; STEINER G, 1988, EMBO J, V7, P3949, DOI 10.1002/j.1460-2075.1988.tb03281.x; SUCK D, 1980, ACTA CRYSTALLOGR, V28, P596; SUNDARALINGAM M, 1971, SCIENCE, V172, P725, DOI 10.1126/science.172.3984.725; SUNDARALINGAM M, 1982, CONFORMATION BIOL, P191; TAKEDA N, 1991, J CHROMATOGR-BIOMED, V562, P225, DOI 10.1016/0378-4347(91)80580-6; WOESE CR, 1980, RIBOSOMES STRUCTURE, P3; YOKOYAMA S, 1981, BIOCHEMISTRY-US, V20, P2981, DOI 10.1021/bi00513a041	48	77	80	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17758	17764		10.1074/jbc.270.30.17758	http://dx.doi.org/10.1074/jbc.270.30.17758			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629075				2022-12-27	WOS:A1995RM26600022
J	LESCAR, J; PELLEGRINI, M; SOUCHON, H; TELLO, D; POLJAK, RJ; PETERSON, N; GREENE, M; ALZARI, PM				LESCAR, J; PELLEGRINI, M; SOUCHON, H; TELLO, D; POLJAK, RJ; PETERSON, N; GREENE, M; ALZARI, PM			CRYSTAL-STRUCTURE OF A CROSS-REACTION COMPLEX BETWEEN FAB F9.13.7 AND GUINEA-FOWL LYSOZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ANTIBODY-ANTIGEN COMPLEX; 3-DIMENSIONAL STRUCTURE; HYPERVARIABLE REGIONS; BINDING SPECIFICITY; RECOGNITION; RESOLUTION; MIMICRY; REFINEMENT; GENERATION	The crystal structure of the complex between the cross-reacting antigen Guinea fowl lysozyme and the Fab from monoclonal antibody F9.13.7, raised against hen egg lysozyme, has been determined by x-ray diffraction to 3-Angstrom resolution. The antibody interacts with exposed residues of an alpha-helix and surrounding loops adjacent to the lysozyme active site cleft. The epitope of lysozyme bound by antibody F9.13.7 overlaps almost completely with that bound by antibody HyHEL10; the same 12 residues of the antigen interact with the two antibodies. The antibodies, however, have different combining sites with no sequence homology at any of their complementarity-determining regions and show a dissimilar pattern of cross-reactivity with heterologous antigens. Side chain mobility of epitope residues contributes to confer steric and electrostatic complementarity to differently shaped combining sites, allowing functional mimicry to occur. The capacity of two antibodies that have different fine specificities to bind the same area of the antigen emphasizes the operational character of the definition of an antigenic determinant. This example demonstrates that degenerate binding of the same structural motif does not require the existence of sequence homology or other chemical similarities between the different binding sites.	INST PASTEUR,DEPT IMMUNOL,UNITE IMMUNOL STRUCT,F-75724 PARIS 15,FRANCE; INST PASTEUR,CNRS,URA 359,F-75724 PARIS 15,FRANCE; UNIV PENN,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Pennsylvania				Alzari, Pedro/0000-0002-4233-1903				AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; BENJAMIN DC, 1984, ANNU REV IMMUNOL, V2, P67, DOI 10.1146/annurev.iy.02.040184.000435; BENTLEY GA, 1990, NATURE, V348, P254, DOI 10.1038/348254a0; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BRADEN BC, 1994, J MOL BIOL, V243, P767, DOI 10.1016/0022-2836(94)90046-9; BRICOGNE G, 1976, ACTA CRYSTALLOGR A, V32, P832, DOI 10.1107/S0567739476001691; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CHITARRA V, 1993, P NATL ACAD SCI USA, V90, P7711, DOI 10.1073/pnas.90.16.7711; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; DAVIES D R, 1992, Current Biology, V2, P254, DOI 10.1016/0960-9822(92)90369-L; DAVIS SJ, 1992, NATURE, V358, P76, DOI 10.1038/358076a0; DEVEREUX J, 1991, GCG SEQUENCE ANAL SO; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; FISCHMANN TO, 1991, J BIOL CHEM, V266, P12915; GARCIA KC, 1992, SCIENCE, V257, P502, DOI 10.1126/science.1636085; HARPER M, 1987, MOL IMMUNOL, V24, P97, DOI 10.1016/0161-5890(87)90081-2; HOUDUSSE AA, 1992, THESIS U PARIS SUD F; HUSE WD, 1989, SCIENCE, V246, P1275, DOI 10.1126/science.2531466; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KABAT EA, 1991, NIH913242 PUBL; KAMMORGAN LNW, 1993, P NATL ACAD SCI USA, V90, P3958, DOI 10.1073/pnas.90.9.3958; LASCOMBE MB, 1992, P NATL ACAD SCI USA, V89, P9429, DOI 10.1073/pnas.89.20.9429; LAVOIE TB, 1992, J IMMUNOL, V148, P503; LESCAR J, 1994, PROTEIN SCI, V3, P788; LESCAR J, 1993, PROTEINS, V15, P209, DOI 10.1002/prot.340150211; LESLIE A, 1990, CRYSTALLOGRAPHIC COM, P110; MALBY RL, 1994, STRUCTURE, V2, P733, DOI 10.1016/S0969-2126(00)00074-5; MARIUZZA RA, 1993, CURR OPIN IMMUNOL, V5, P50, DOI 10.1016/0952-7915(93)90080-C; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; PELLEGRINI M, 1993, PROTEINS, V15, P436, DOI 10.1002/prot.340150410; SANZ I, 1987, P NATL ACAD SCI USA, V84, P1085, DOI 10.1073/pnas.84.4.1085; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; SIEKEVITZ M, 1983, EUR J IMMUNOL, V13, P123, DOI 10.1002/eji.1830130207; SMITHGILL SJ, 1984, J IMMUNOL, P384; TAUB R, 1992, BIOCHEMISTRY-US, V31, P7431, DOI 10.1021/bi00148a001; TELLO D, 1993, BIOCHEM SOC T, V21, P943, DOI 10.1042/bst0210943; TELLO D, 1990, BIOCHIMIE, V72, P507, DOI 10.1016/0300-9084(90)90114-V; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; VANREGENMORTEL MHV, 1989, IMMUNOL TODAY, V10, P266, DOI 10.1016/0167-5699(89)90140-0; WILSON IA, 1993, CURR OPIN STRUC BIOL, V3, P113, DOI 10.1016/0959-440X(93)90210-C; 1986, SERC4 DAR LAB COLL C	45	64	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18067	18076		10.1074/jbc.270.30.18067	http://dx.doi.org/10.1074/jbc.270.30.18067			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629116	Green Published, hybrid			2022-12-27	WOS:A1995RM26600067
J	OU, WJ; BERGERON, JJM; LI, Y; KANG, CY; THOMAS, DY				OU, WJ; BERGERON, JJM; LI, Y; KANG, CY; THOMAS, DY			CONFORMATIONAL-CHANGES INDUCED IN THE ENDOPLASMIC-RETICULUM LUMINAL DOMAIN OF CALNEXIN BY MG-ATP AND CA2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN HEAVY-CHAIN; MOLECULAR CHAPERONE; BINDING-PROTEIN; BIP; MEMBRANE; IDENTIFICATION; RELEASE; LIVER; ALPHA; SITE	The type I membrane protein calnexin functions as a molecular chaperone for secretory glycoproteins in the endoplasmic reticulum with ATP and Ca2+ as two of the cofactors involved in substrate binding. Protease protection experiments with intact canine rough microsomes showed that amino acid residues 1-462 of calnexin are located within the lumen of the endoplasmic reticulum. Expression using the baculovirus Sf9 insect cell system of a recombinant truncated calnexin corresponding to residues 1-462 (calnexin Delta TMC) revealed an association in vivo with a coexpressed secretory glycoprotein substrate, human immunodeficiency virus type I gp120. For the in vitro characterization of calnexin Delta TMC, we purified this secreted form to homogeneity from the medium of Sf9 cells. We demonstrate that the properties of the purified calnexin Delta TMC correspond to those of full-length calnexin in canine microsomes with at least one intramolecular disulfide bond and binding to Ca-45(2+). Calnexin Delta TMC underwent a marked and reversible conformational change following Ca2+ binding as measured by its resistance to proteinase K digestion of a 60-kDa fragment and also by the change from an oligomeric form of calnexin Delta TMC to a monomeric form. We also found that calnexin bound Mg-ATP leading to a conformational change from a monomeric to an oligomeric form that coincided as with markedly increased proteinase sensitivity. Our results identify the luminal domain of calnexin as responsible for binding substrates, Ca2+, and Mg-ATP. Because Ca2+ and ATP are required in vivo for the maintenance of calnexin-substrate interactions, conformational changes in the luminal domain of calnexin induced by Ca2+ and Mg-ATP are relevant to the in vivo function of calnexin as a molecular chaperone.	NATL RES COUNCIL CANADA,BIOTECHNOL RES INST,EUKARYOT GENET GRP,MONTREAL,PQ H4P 2R2,CANADA; MCGILL UNIV,DEPT ANAT & CELL BIOL,MONTREAL,PQ H3A 2B2,CANADA; MCGILL UNIV,DEPT BIOL,MONTREAL,PQ H3A 1B1,CANADA; UNIV WESTERN ONTARIO,FAC MED,DEPT ZOOL,LONDON,ON N6A 5B7,CANADA; UNIV WESTERN ONTARIO,FAC MED,DEPT MICROBIOL & IMMUNOL,LONDON,ON N6A 5B7,CANADA	National Research Council Canada; McGill University; McGill University; Western University (University of Western Ontario); Western University (University of Western Ontario)			Bergeron, John/AAW-1893-2021; Thomas, David/M-7661-2017	Thomas, David/0000-0002-8854-762X				BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; BLONDELGUINDI S, 1993, J BIOL CHEM, V268, P12730; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROT N, 1994, P NATL ACAD SCI USA, V91, P12120, DOI 10.1073/pnas.91.25.12120; CALA SE, 1993, J BIOL CHEM, V268, P2969; CAPPS GG, 1994, J BIOL CHEM, V269, P11634; CLAIRMONT CA, 1992, J BIOL CHEM, V267, P3983; CSERMELY P, 1991, J BIOL CHEM, V266, P4943; DAVID V, 1993, J BIOL CHEM, V268, P9585; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; FREIDEN PJ, 1992, EMBO J, V11, P63, DOI 10.1002/j.1460-2075.1992.tb05028.x; GAUT JR, 1993, J BIOL CHEM, V268, P7248; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HAMMOND C, 1994, SCIENCE, V266, P456, DOI 10.1126/science.7939687; KIM PS, 1995, J CELL BIOL, V128, P29, DOI 10.1083/jcb.128.1.29; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LE AQ, 1994, J BIOL CHEM, V269, P7514; LI Y, 1994, VIROLOGY, V204, P266, DOI 10.1006/viro.1994.1531; LOO TW, 1994, J BIOL CHEM, V269, P28683; MARGOLESE L, 1993, J BIOL CHEM, V268, P17959; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; OU WJ, UNPUB; OU WJ, 1993, NATURE, V364, P671; PARODI AJ, 1984, J BIOL CHEM, V259, P6351; RAJAGOPALAN S, 1994, SCIENCE, V263, P387, DOI 10.1126/science.8278814; SIMON WL, 1981, NATURE, V291, P201; SOMLYO AP, 1985, NATURE, V314, P622, DOI 10.1038/314622a0; SUZUKI CK, 1991, J CELL BIOL, V114, P189, DOI 10.1083/jcb.114.2.189; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; VIALARD J, 1990, J VIROL, V64, P37, DOI 10.1128/JVI.64.1.37-50.1990; WADA I, 1994, J BIOL CHEM, V269, P7464; WADA I, 1991, J BIOL CHEM, V266, P19599; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9	35	102	110	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18051	18059		10.1074/jbc.270.30.18051	http://dx.doi.org/10.1074/jbc.270.30.18051			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629114	hybrid			2022-12-27	WOS:A1995RM26600065
J	DURRER, P; GAUDIN, Y; RUIGROK, RWH; GRAF, R; BRUNNER, J				DURRER, P; GAUDIN, Y; RUIGROK, RWH; GRAF, R; BRUNNER, J			PHOTOLABELING IDENTIFIES A PUTATIVE FUSION DOMAIN IN THE ENVELOPE GLYCOPROTEIN OF RABIES AND VESICULAR STOMATITIS VIRUSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM DODECYL-SULFATE; HEMAGGLUTININ MEMBRANE GLYCOPROTEIN; POLYACRYLAMIDE-GEL-ELECTROPHORESIS; INFLUENZA-VIRUS; LOW-PH; CONFORMATIONAL-CHANGES; PROTEINS; PEPTIDE; MECHANISM; CELLS	Vesicular stomatitis and rabies viruses enter cells through receptor-mediated endocytosis, followed by fusion of the viral with the endosomal membrane. The latter step is catalyzed by the viral envelope glycoprotein, which, in the low pH environment of the endosome, undergoes a conformational transition to a fusion com petent state. To investigate whether fusion competence involves the low pH exposure of a hydrophobic fusion region(s), we have applied hydrophobic photolabeling using the recently developed phospholipid analogue 1-O-hexadecanoyl-2-O-[9-[[[2-[I-125]iodo-4-(trifluoro-methyl-3H-diazirin-3-yl)benzyl]oxy]carbonyl]nonanoyl]-sn-glycero-3-phosphocholine ([I-125]TID-PC/16) (Weber, T., and Brunner, J. (1995) J. Am. Chem. Soc. 117, 3084-3095). Rosettes of rabies virus glycoprotein, whole rabies virus, or vesicular stomatitis virus were incubated with large unilamellar vesicles containing [I-125]TID-PC/16. Following reagent activation, the labeled glycoprotein was isolated and analyzed. In all cases, labeling of the glycoprotein strongly increased as the pH was lowered from 7.0 to 6.0, suggesting the exposure at acidic pH of a domain capable of interacting with membranes. To identify the labeled region(s), CNBr fragments were generated and analyzed by SDS-polyacrylamide followed by autoradiography. In rabies glycoprotein, the labeled segment was found to be contained within fragment RCr5 (residues 103-179). Glycoprotein from vesicular stomatitis virus was labeled within fragment VCr1 (residues 59-221). These results demonstrate that rhabdovirus glycoprotein contains a domain that at low pH is capable of interacting with a target membrane in a hydrophobic manner. This domain may play a role similar to that of the fusion peptide found in many other viral fusion proteins.	ETH ZENTRUM, BIOCHEM LAB 2, CH-8092 ZURICH, SWITZERLAND; CNRS, GENET VIRUS LAB, F-91198 GIF SUR YVETTE, FRANCE; INST MAX VON LAUE PAUL LANGEVIN, EMBL, GRENOBLE OUTSTN, F-38042 GRENOBLE 9, FRANCE	Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; European Molecular Biology Laboratory (EMBL); Institut Laue-Langevin (ILL)				Gaudin, Yves/0000-0002-0122-2954				BALL EH, 1986, ANAL BIOCHEM, V155, P23, DOI 10.1016/0003-2697(86)90218-6; BARGE A, 1993, J VIROL, V67, P7246, DOI 10.1128/JVI.67.12.7246-7253.1993; BLOBEL CP, 1992, NATURE, V356, P248, DOI 10.1038/356248a0; BRUNNER J, 1981, BIOCHEMISTRY-US, V20, P7174, DOI 10.1021/bi00528a019; BRUNNER J, 1993, ANNU REV BIOCHEM, V62, P483, DOI 10.1146/annurev.bi.62.070193.002411; BRUNNER J, 1989, METHOD ENZYMOL, V172, P628; CLAGUE MJ, 1990, BIOCHEMISTRY-US, V29, P1303, DOI 10.1021/bi00457a028; CRIMMINS DL, 1983, BIOCHEMISTRY-US, V22, P5790, DOI 10.1021/bi00294a017; DIETZSCHOLD B, 1982, J VIROL, V44, P595, DOI 10.1128/JVI.44.2.595-602.1982; DOMS RW, 1987, J CELL BIOL, V105, P1957, DOI 10.1083/jcb.105.5.1957; FREDERICKSEN BL, 1995, J VIROL, V69, P1435, DOI 10.1128/JVI.69.3.1435-1443.1995; GALLIONE CJ, 1983, J VIROL, V46, P162, DOI 10.1128/JVI.46.1.162-169.1983; GALLIONE CJ, 1985, J VIROL, V54, P374, DOI 10.1128/JVI.54.2.374-382.1985; GAUDIN Y, 1991, J VIROL, V65, P4853, DOI 10.1128/JVI.65.9.4853-4859.1991; GAUDIN Y, 1992, VIROLOGY, V187, P627, DOI 10.1016/0042-6822(92)90465-2; GAUDIN Y, 1993, J VIROL, V67, P1365, DOI 10.1128/JVI.67.3.1365-1372.1993; GETHING MJ, 1986, J CELL BIOL, V102, P11, DOI 10.1083/jcb.102.1.11; HARTER C, 1989, J BIOL CHEM, V264, P6459; KAMP HH, 1974, METHOD ENZYMOL, V22, P140; KONIGSBERG WH, 1983, METHOD ENZYMOL, V91, P254; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURIERE M, 1993, ANAL BIOCHEM, V212, P206, DOI 10.1006/abio.1993.1313; LI Y, 1993, J VIROL, V67, P4070, DOI 10.1128/JVI.67.7.4070-4077.1993; MASTERS PS, 1989, VIROLOGY, V171, P285, DOI 10.1016/0042-6822(89)90540-0; MATLIN KS, 1982, J MOL BIOL, V156, P609, DOI 10.1016/0022-2836(82)90269-8; MORIMOTO K, 1992, VIROLOGY, V189, P203, DOI 10.1016/0042-6822(92)90696-M; MUGA A, 1994, BIOCHEMISTRY-US, V33, P4444, DOI 10.1021/bi00181a002; Ohnishi Shun-Ichi, 1988, Curr Top Membr Transp, V32, P257, DOI 10.1016/S0070-2161(08)60137-9; PURI A, 1988, J BIOL CHEM, V263, P4749; RAMALHOSANTOS J, 1993, BIOCHEMISTRY-US, V32, P2771, DOI 10.1021/bi00062a006; ROSE JK, 1981, J VIROL, V39, P519, DOI 10.1128/JVI.39.2.519-528.1981; ROSE JK, 1982, J VIROL, V43, P361, DOI 10.1128/JVI.43.1.361-364.1982; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHLEGEL R, 1984, J BIOL CHEM, V259, P4691; SCHLEGEL R, 1985, J VIROL, V53, P319, DOI 10.1128/JVI.53.1.319-323.1985; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; STEGMANN T, 1989, ANNU REV BIOPHYS BIO, V18, P187, DOI 10.1146/annurev.bb.18.060189.001155; STEGMANN T, 1991, J BIOL CHEM, V266, P18404; SUPERTI F, 1984, J GEN VIROL, V65, P781, DOI 10.1099/0022-1317-65-4-781; TORDO N, 1993, VIROLOGY, V194, P59, DOI 10.1006/viro.1993.1235; TORDO N, 1986, P NATL ACAD SCI USA, V83, P3914, DOI 10.1073/pnas.83.11.3914; TSURUDOME M, 1992, J BIOL CHEM, V267, P20225; WEBER T, 1994, J BIOL CHEM, V269, P18353; WEBER T, 1995, J AM CHEM SOC, V117, P3084, DOI 10.1021/ja00116a013; WHITE JM, 1987, J CELL BIOL, V105, P2887, DOI 10.1083/jcb.105.6.2887; WHITE JM, 1992, SCIENCE, V258, P917, DOI 10.1126/science.1439803; WHITT MA, 1990, J VIROL, V64, P4907, DOI 10.1128/JVI.64.10.4907-4913.1990; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; ZHANG L, 1994, J VIROL, V68, P2186, DOI 10.1128/JVI.68.4.2186-2193.1994; ZIMMERBERG J, 1993, ANNU REV BIOPH BIOM, V22, P433, DOI 10.1146/annurev.bb.22.060193.002245	51	133	136	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17575	17581		10.1074/jbc.270.29.17575	http://dx.doi.org/10.1074/jbc.270.29.17575			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615563	hybrid			2022-12-27	WOS:A1995RK68900080
J	KUDO, N; BARR, AJ; BARR, RL; DESAI, S; LOPASCHUK, GD				KUDO, N; BARR, AJ; BARR, RL; DESAI, S; LOPASCHUK, GD			HIGH-RATES OF FATTY-ACID OXIDATION DURING REPERFUSION OF ISCHEMIC HEARTS ARE ASSOCIATED WITH A DECREASE IN MALONYL-COA LEVELS DUE TO AN INCREASE IN 5'-AMP-ACTIVATED PROTEIN-KINASE INHIBITION OF ACETYL-COA CARBOXYLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCARDIAL TRIGLYCERIDE TURNOVER; CARNITINE PALMITOYLTRANSFERASE; LIVER-MITOCHONDRIA; GLOBAL-ISCHEMIA; WORKING HEART; COENZYME-A; METABOLISM; GLUCOSE; PHOSPHORYLATION; IDENTIFICATION	We determined whether high fatty acid oxidation rates during aerobic reperfusion of ischemic hearts could be explained by a decrease in malonyl-CoA levels, which would relieve inhibition of carnitine palmitoyltransferase 1, the rate limiting enzyme involved in mitochondrial uptake of fatty acids. Isolated working rat hearts perfused with 1.2 mM palmitate were subjected to 30 min of global ischemia, followed by 60 min of aerobic reperfusion. Fatty acid oxidation rates during reperfusion were 136% higher than rates seen in aerobically perfused control hearts, despite the fact that cardiac work recovered to only 16% of pre-ischemic values. Neither the activity of carnitine palmitoyltransferase 1, or the IC50 value of malonyl-CoA for carnitine palmitoyl transferase 1 were altered in mitochondria isolated from aerobic, ischemic, or reperfused ischemic hearts. Levels of malonyl-CoA were extremely low at the end of reperfusion compared to levels seen in aerobic controls, as was the activity of acetyl-CoA carboxylase, the enzyme which produces malonyl-CoA. The activity of 5'-AMP activated protein kinase, which has been shown to phosphorylate and inactivate acetyl CoA carboxylase in other tissues, was significantly increased at the end of ischemia, and remained elevated throughout reperfusion. These results suggest that accumulation of 5'-AMP during ischemia results in an activation of AMP-activated protein kinase, which phosphorylates and inactivates ACC during reperfusion. The subsequent decrease in malonyl-CoA levels will result in accelerated fatty acid oxidation rates during reperfusion of ischemic hearts.	UNIV ALBERTA, FAC MED,DEPT PEDIAT & PHARMACOL, LIPID & LIPOPROT RES GRP,CARDIOVASC DIS RES GRP, EDMONTON, AB T6G 2S2, CANADA	University of Alberta								AQUAN K, 1994, GENE, V149, P345; AWAN MM, 1993, BIOCHEM J, V295, P61, DOI 10.1042/bj2950061; BENZI RH, 1992, CIRC RES, V71, P567, DOI 10.1161/01.RES.71.3.567; BIANCHI A, 1990, J BIOL CHEM, V265, P1502; BING RJ, 1965, PHYSIOL REV, V45, P171, DOI 10.1152/physrev.1965.45.2.171; BREMER J, 1981, BIOCHIM BIOPHYS ACTA, V665, P628, DOI 10.1016/0005-2760(81)90282-4; BRODERICK TL, 1993, CIRCULATION, V87, P972, DOI 10.1161/01.CIR.87.3.972; BUNGER R, 1989, EUR J BIOCHEM, V180, P221, DOI 10.1111/j.1432-1033.1989.tb14637.x; CARLING D, 1989, J BIOCH, V29, P129; CHALLONE.DR, 1966, AM J PHYSIOL, V210, P280, DOI 10.1152/ajplegacy.1966.210.2.280; CONSTANTINTEODOSIU D, 1991, ANAL BIOCHEM, V198, P347, DOI 10.1016/0003-2697(91)90437-X; COOK GA, 1992, MOL CELL BIOCHEM, V116, P39, DOI 10.1007/BF01270567; FABIATO A, 1978, J PHYSIOL-LONDON, V276, P233, DOI 10.1113/jphysiol.1978.sp012231; GORGE G, 1991, CIRC RES, V68, P1681, DOI 10.1161/01.RES.68.6.1681; HA J, 1994, J BIOL CHEM, V269, P22162; HARDIE DG, 1989, PROG LIPID RES, V28, P117, DOI 10.1016/0163-7827(89)90010-6; HARDIE DG, 1992, BIOCHIM BIOPHYS ACTA, V1123, P231, DOI 10.1016/0005-2760(92)90001-C; HERBIN C, 1987, EUR J BIOCHEM, V165, P201, DOI 10.1111/j.1432-1033.1987.tb11212.x; KIM KH, 1989, FASEB J, V3, P2250, DOI 10.1096/fasebj.3.11.2570725; KIM YS, 1978, ARCH BIOCHEM BIOPHYS, V190, P234, DOI 10.1016/0003-9861(78)90273-4; KING MT, 1988, METHOD ENZYMOL, V166, P70; LIEDTKE AJ, 1988, CIRC RES, V62, P535, DOI 10.1161/01.RES.62.3.535; LOPASCHUK GD, 1992, AM J PHYSIOL, V263, pE1046; LOPASCHUK GD, 1988, CIRC RES, V63, P1036, DOI 10.1161/01.RES.63.6.1036; LOPASCHUK GD, 1994, AM HEART J, V128, P61, DOI 10.1016/0002-8703(94)90010-8; LOPASCHUK GD, 1990, CIRC RES, V66, P546, DOI 10.1161/01.RES.66.2.546; LOPASCHUK GD, 1993, J PHARMACOL EXP THER, V264, P135; LOPASCHUK GD, 1994, BBA-LIPID LIPID MET, V1213, P263, DOI 10.1016/0005-2760(94)00082-4; LOPASCHUK GD, 1994, J BIOL CHEM, V269, P25871; LOPASCHUK GD, 1994, CAN J PHYSIOL PHARM, V72, P1101, DOI 10.1139/y94-156; LOPASCHUK GD, 1991, AM J PHYSIOL, V261, pH1698, DOI 10.1152/ajpheart.1991.261.6.H1698; MALLET RT, 1990, EUR J BIOCHEM, V188, P481, DOI 10.1111/j.1432-1033.1990.tb15426.x; MCGARRY JD, 1989, DIABETES METAB REV, V5, P271, DOI 10.1002/dmr.5610050305; MCVEIGH JJ, 1990, AM J PHYSIOL, V259, pH1079, DOI 10.1152/ajpheart.1990.259.4.H1079; MUELLER HS, 1978, AM J CARDIOL, V42, P363, DOI 10.1016/0002-9149(78)90929-3; NEELY JR, 1976, CIRC RES, V38, P22; NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213; OHGOSHI Y, 1991, CIRC RES, V69, P975, DOI 10.1161/01.RES.69.4.975; OLIVER MF, 1968, LANCET, V1, P710; OPIE LH, 1975, AM J CARDIOL, V36, P938, DOI 10.1016/0002-9149(75)90086-7; PAULY DF, 1991, CIRC RES, V68, P1085, DOI 10.1161/01.RES.68.4.1085; RANDLE PJ, 1986, BIOCHEM SOC T, V14, P799, DOI 10.1042/bst0140799; RENSTROM B, 1989, CIRC RES, V65, P1094, DOI 10.1161/01.RES.65.4.1094; SADDIK M, 1992, J BIOL CHEM, V267, P3825; SADDIK M, 1991, J BIOL CHEM, V266, P8162; SADDIK M, 1993, J BIOL CHEM, V268, P25836; SATO R, 1993, P NATL ACAD SCI USA, V90, P9261, DOI 10.1073/pnas.90.20.9261; SCHULZ H, 1994, J NUTR, V124, P165, DOI 10.1093/jn/124.2.165; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SVENSSON S, 1990, J THORAC CARDIOV SUR, V99, P1063; SVORONOS S, 1988, COMP BIOCHEM PHYS B, V90, P179, DOI 10.1016/0305-0491(88)90058-2; THAMPY KG, 1989, J BIOL CHEM, V264, P17631; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WEEKES J, 1994, EUR J BIOCHEM, V219, P751, DOI 10.1111/j.1432-1033.1994.tb18554.x; WEIS BC, 1994, J BIOL CHEM, V269, P26443; WEIS BC, 1994, J BIOL CHEM, V269, P18712; WINZ R, 1994, J BIOL CHEM, V269, P14438; WITTERS LA, 1992, J BIOL CHEM, V267, P2864	58	490	513	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17513	17520		10.1074/jbc.270.29.17513	http://dx.doi.org/10.1074/jbc.270.29.17513			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615556	hybrid			2022-12-27	WOS:A1995RK68900072
J	LAI, F; DRAKAS, R; NISHIKURA, K				LAI, F; DRAKAS, R; NISHIKURA, K			MUTAGENIC ANALYSIS OF DOUBLE-STRANDED-RNA ADENOSINE-DEAMINASE, A CANDIDATE ENZYME FOR RNA EDITING OF GLUTAMATE-GATED ION-CHANNEL TRANSCRIPTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR CHANNELS; ESCHERICHIA-COLI; CYTIDINE DEAMINASE; UNWINDING ACTIVITY; MODIFYING ACTIVITY; CA2+ PERMEABILITY; MAMMALIAN-CELLS; PROTEIN-KINASE; BINDING DOMAIN; IDENTIFICATION	Mutagenic analysis of the substrate binding and catalytic domains of double-stranded RNA (dsRNA) adenosine deaminase (DRADA) was carried out. This nuclear enzyme is likely to be involved in the RNA editing of glutamate-gated ion channels that are essential for fast excitatory neurotransmission in mammalian brain. The deletion of the first or the third of the three dsRNA binding motifs within the substrate binding domain dramatically decreases enzyme activity, whereas the second motif seems to be dispensable. The results indicate that the three motifs are not functionally equivalent in the catalytic action of DRADA. Mutation of the putative zinc coordinating residues, His(910), Cys(966), and Cys(1036), abolished the DRADA activity. Similarly, the Glu(912) residue, predicted to be involved in the proton transfer functions of the enzyme, was found to be indispensable. Our results reinforce the previous proposal that the hydrolytic deamination mechanism of DRADA may be more similar to that of the cytidine deaminases than of adenosine deaminases.	WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104	The Wistar Institute					NCI NIH HHS [CA09171, CA10815] Funding Source: Medline; NIGMS NIH HHS [GM40536] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009171, P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040536] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON JE, 1987, NATURE, V326, P846, DOI 10.1038/326846a0; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; BASS BL, 1993, RNA WORLD, P383; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; BURK RR, 1983, METHOD ENZYMOL, V91, P247; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CHANG HW, 1993, VIROLOGY, V194, P537, DOI 10.1006/viro.1993.1292; CHANG Z, 1991, BIOCHEMISTRY-US, V30, P2273, DOI 10.1021/bi00222a033; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EGERBJERG J, 1994, P NATL ACAD SCI USA, V91, P10270; FENG GS, 1992, P NATL ACAD SCI USA, V89, P5447, DOI 10.1073/pnas.89.12.5447; GATIGNOL A, 1993, MOL CELL BIOL, V13, P2193, DOI 10.1128/MCB.13.4.2193; GREEN SR, 1992, GENE DEV, V6, P2478, DOI 10.1101/gad.6.12b.2478; GREEN SR, 1995, MOL CELL BIOL, V15, P358, DOI 10.1128/MCB.15.1.358; HARRIS SG, 1993, J BIOL CHEM, V268, P7382; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HOPP TP, 1988, BIOTECHNOLOGY, V6, P1205; Kim U, 1993, Semin Cell Biol, V4, P285, DOI 10.1006/scel.1993.1034; KIM U, 1994, J BIOL CHEM, V269, P13480; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKEY RA, 1993, CELL, V74, P585, DOI 10.1016/0092-8674(93)90505-K; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; MATTAJ IW, 1993, CELL, V73, P837, DOI 10.1016/0092-8674(93)90265-R; MCCORMACK SJ, 1992, VIROLOGY, V188, P47, DOI 10.1016/0042-6822(92)90733-6; MELCHER T, 1995, J BIOL CHEM, V270, P8566, DOI 10.1074/jbc.270.15.8566; NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709; NISHIKURA K, 1991, EMBO J, V10, P3523, DOI 10.1002/j.1460-2075.1991.tb04916.x; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; POLSON AG, 1991, BIOCHEMISTRY-US, V30, P11157; RIGGS AD, 1968, J MOL BIOL, V34, P365, DOI 10.1016/0022-2836(68)90261-1; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; SAMBROOK S, 1989, MOL CLONING LABORATO; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SILVERKLANG M, 1979, METHOD ENZYMOL, V91, P247; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; STEITZ TA, 1993, RNA WORLD, P219; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; WAGNER RW, 1990, MOL CELL BIOL, V10, P5586, DOI 10.1128/MCB.10.10.5586; WAGNER RW, 1989, P NATL ACAD SCI USA, V86, P2647, DOI 10.1073/pnas.86.8.2647; WAGNER RW, 1988, MOL CELL BIOL, V8, P770, DOI 10.1128/MCB.8.2.770; WEINER KXB, 1993, J BIOL CHEM, V268, P12983; WILSON DK, 1991, SCIENCE, V250, P1278; WILSON R, 1994, NATURE, V68, P32; YAMANAKA S, 1994, J BIOL CHEM, V269, P21725; YANG C, 1992, BIOCHEMISTRY-US, V31, P4168, DOI 10.1021/bi00132a003; YANG JH, 1995, NATURE, V374, P77, DOI 10.1038/374077a0	52	135	138	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17098	17105		10.1074/jbc.270.29.17098	http://dx.doi.org/10.1074/jbc.270.29.17098			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615504	hybrid			2022-12-27	WOS:A1995RK68900011
J	YANAGAWA, Y; CHEN, JC; HSU, LC; YOSHIDA, A				YANAGAWA, Y; CHEN, JC; HSU, LC; YOSHIDA, A			THE TRANSCRIPTIONAL REGULATION OF HUMAN ALDEHYDE DEHYDROGENASE-I GENE - THE STRUCTURAL AND FUNCTIONAL-ANALYSIS OF THE PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOCHEMICAL-CHARACTERIZATION; ALBUMIN PROMOTER; BINDING-PROTEIN; EXPRESSION; CLONING; CELLS; MOUSE; CDNA; EXTRACTION; RECEPTORS	Human cytosolic aldehyde dehydrogenase 1 (ALDH1) plays a role in the biosynthesis of retinoic acid that is a modulator for gene expression and cell differentiation. Northern blot analysis showed that liver tissue, pancreas tissue, hepatoma cells, and genital skin fibroblast cells expressed high levels of ALDH1. Sequence analysis showed that the 5'-flanking region contains a number of putative regulatory elements, such as NF-IL6, HNF-5, GATA binding sites, and putative response elements for interleukin-6, phenobarbital and androgen, in addition to a noncanonical TATA box (ATAAA) and a CCAAT box. Functional characterization of the 5'-regulatory region of the human ALDH1 gene was carried out by a fusion to the chloramphenicol acetyltransferase gene. A construct containing 2.6 kilobase pairs of the 5'-flanking region was efficiently expressed in hepatoma Hep3B cells, but not in erythroleukemic K562 cells or in fibroblast LTK(-) cells, which do not express ALDH1. Within this region, we define a minimal promoter (-91 to +53) that contains positive regulatory elements. The study using site directed mutagenesis demonstrated that the CCAAT box region is the major cis-acting element involved in basal ALDH1 promoter activity in Hep3B cells. Gel mobility shift assays showed that NF-Y and other octamer factors bound CCAAT box and an octamer motif sequence, but not GATA site existing in the minimal promoter region. Two additional DNA binding activities associated with the minimal promoter were found in the nuclear extract from Hep3B cells, but not from K562 cells. These results offer the possible molecular mechanism of the cell type-specific expression of ALDH1 gene.			YANAGAWA, Y (corresponding author), CITY HOPE NATL MED CTR, BECKMAN RES INST, DEPT BIOCHEM GENET, DUARTE, CA 91010 USA.				NHLBI NIH HHS [HL-29515] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029515, R37HL029515] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BRUGGEMEIER U, 1991, CELL, V64, P565, DOI 10.1016/0092-8674(91)90240-Y; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DANIEL V, 1988, NUCLEIC ACIDS RES, V16, P351, DOI 10.1093/nar/16.1.351; DE LUCA LM, 1991, FASEB J, V5, P2924; DENT CL, 1991, MOL CELL BIOL, V11, P3925, DOI 10.1128/MCB.11.8.3925; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DUNN TJ, 1989, J BIOL CHEM, V264, P13057; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; FALANY CN, 1987, J BIOL CHEM, V262, P5924; GIL G, 1988, P NATL ACAD SCI USA, V85, P8963, DOI 10.1073/pnas.85.23.8963; GODBOUT R, 1992, EXP EYE RES, V54, P297, DOI 10.1016/S0014-4835(05)80219-2; HARADA S, 1980, LIFE SCI, V26, P1773, DOI 10.1016/0024-3205(80)90577-9; HE JS, 1991, J BIOL CHEM, V266, P7864; HERBOMEL P, 1989, MOL CELL BIOL, V9, P4750, DOI 10.1128/MCB.9.11.4750; HSU LC, 1989, GENOMICS, V5, P857, DOI 10.1016/0888-7543(89)90127-4; HSU LC, 1985, P NATL ACAD SCI USA, V82, P3771, DOI 10.1073/pnas.82.11.3771; HSU LC, 1986, AM J HUM GENET, V38, P641; JANSON L, 1990, P NATL ACAD SCI USA, V87, P4732, DOI 10.1073/pnas.87.12.4732; KOVACS WJ, 1989, ENDOCRINOLOGY, V124, P1270, DOI 10.1210/endo-124-3-1270; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; LIU YH, 1993, MOL CELL BIOL, V13, P1836, DOI 10.1128/MCB.13.3.1836; MAJELLO B, 1990, EMBO J, V9, P457, DOI 10.1002/j.1460-2075.1990.tb08131.x; MANIATIS T, 1989, GENE CLONING LABORAT; MANTOVANI R, 1992, EMBO J, V11, P3315, DOI 10.1002/j.1460-2075.1992.tb05410.x; MARSELOS M, 1987, CHEM-BIOL INTERACT, V62, P75, DOI 10.1016/0009-2797(87)90080-9; MCCAFFERY P, 1993, DEV BIOL, V158, P390, DOI 10.1006/dbio.1993.1197; MCKNIGHT S, 1986, CELL, V46, P795, DOI 10.1016/0092-8674(86)90061-9; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; MILOS PM, 1992, GENE DEV, V6, P991, DOI 10.1101/gad.6.6.991; ONEILL EA, 1988, SCIENCE, V241, P1210, DOI 10.1126/science.3413485; PEREIRA F, 1991, BIOCHEM BIOPH RES CO, V175, P831, DOI 10.1016/0006-291X(91)91640-X; RADIN AI, 1991, BIOCHEM PHARMACOL, V42, P1933, DOI 10.1016/0006-2952(91)90592-S; RAGHUNATHAN L, 1988, Genomics, V2, P267, DOI 10.1016/0888-7543(88)90012-2; RONGNOPARUT P, 1991, GENE, V101, P261, DOI 10.1016/0378-1119(91)90421-7; SALIER JP, 1990, J BIOL CHEM, V265, P7062; SCHOLER HR, 1991, TRENDS GENET, V7, P323, DOI 10.1016/0168-9525(91)90422-M; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; SHERMAN PA, 1989, MOL CELL BIOL, V9, P50, DOI 10.1128/MCB.9.1.50; TAFURI SR, 1990, P NATL ACAD SCI USA, V87, P9028, DOI 10.1073/pnas.87.22.9028; URANO Y, 1986, J BIOL CHEM, V261, P3244; VANHUIJSDUIJNEN RH, 1990, EMBO J, V9, P3119, DOI 10.1002/j.1460-2075.1990.tb07509.x; YOSHIDA A, 1993, ADV EXP MED BIOL, V328, P63; YOSHIDA A, 1990, EXPERIENTIA, V46, P747, DOI 10.1007/BF01939955; YOSHIDA A, 1993, ADV EXP MED BIOL, V328, P37; YOSHIDA A, 1992, ENZYME, V46, P239, DOI 10.1159/000468794; YOSHIDA A, 1991, PROG NUCLEIC ACID RE, V40, P255; ZHAO J, 1990, DNA CELL BIOL, V9, P37, DOI 10.1089/dna.1990.9.37	50	56	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17521	17527		10.1074/jbc.270.29.17521	http://dx.doi.org/10.1074/jbc.270.29.17521			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615557	hybrid			2022-12-27	WOS:A1995RK68900073
J	CONWAY, EM; LIU, LL; NOWAKOWSKI, B; STEINERMOSONYI, M; RIBEIRO, SP; MICHALAK, M				CONWAY, EM; LIU, LL; NOWAKOWSKI, B; STEINERMOSONYI, M; RIBEIRO, SP; MICHALAK, M			HEAT SHOCK-SENSITIVE EXPRESSION OF CALRETICULIN - IN-VITRO AND IN-VIVO UP-REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN; MUSCLE SARCOPLASMIC-RETICULUM; RO/SS-A AUTOANTIGEN; MOLECULAR-CLONING; CELLS; IDENTIFICATION; ANTIGEN; GENES; THROMBOMODULIN; ACTIVATION	Calreticulin (CRT) is an ubiquitous, highly conserved, Ca2+-binding protein of the sarcoplasmic and endoplasmic reticulum. The precise function(s) of CRT is unknown. However, based on sequence analyses and observations that it may bind to steroid receptors and integrins and store Ca2+ within the cell, it has been postulated to play a ''housekeeping'' role. To determine whether the level of expression of CRT is affected by stress, we examined the heat shock response of CRT from a variety of cultured cells, including vascular endothelial, lung epithelial, and lung fibroblasts. Following exposure of the cells to 42 degrees C, CRT mRNA transiently accumulated 2.5-4.2-fold at 1-6 h. Nuclear run-on studies and mRNA stability experiments confirmed that the predominant mechanism of augmentation was transcriptional. Chloramphenieol acetyltransferase assays further indicated that the promoter region, containing a putative heat shock element between -172 and -158 of the human CRT gene, is heat shock-sensitive. Finally, we demonstrated the in vivo significance of these findings by exposing rats to hyperthermia. This resulted in accumulation of CRT mRNA and an augmentation of CRT protein in lung tissue. We hypothesize that this stress-induced up-regulation of CRT contributes to the mechanism(s) by which the vascular endothelium and lung tissue, and possibly other organ systems, maintain homeostasis when exposed to a variety of pathophysiological conditions.	UNIV TORONTO, TORONTO HOSP, DEPT MED, TORONTO, ON M5G 2C4, CANADA; UNIV ALBERTA, DEPT BIOCHEM, CARDIOVASC DIS RES GRP, EDMONTON, AB T6G 2S2, CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Alberta	CONWAY, EM (corresponding author), UNIV TORONTO, TORONTO HOSP, DIV HEMATOL ONCOL, 586 UNIV AVE, MULOCK LARKIN BLDG 2-031A, TORONTO, ON M5G 2C4, CANADA.			Conway, Edward/0000-0003-0081-0305				ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; BAKSH S, 1991, J BIOL CHEM, V266, P21458; BURNS K, 1992, J BIOL CHEM, V267, P19039; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; BURNS K, 1993, FEBS LETT, V318, P181, DOI 10.1016/0014-5793(93)80017-O; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CONWAY EM, 1994, J BIOL CHEM, V269, P22804; CONWAY EM, 1992, J CELL PHYSIOL, V151, P604, DOI 10.1002/jcp.1041510321; CONWAY EM, 1993, BLOOD, V81, P726; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; DUGAICZYK A, 1983, BIOCHEMISTRY-US, V22, P1605, DOI 10.1021/bi00276a013; EGGLETON P, 1994, CLIN IMMUNOL IMMUNOP, V72, P405, DOI 10.1006/clin.1994.1160; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; GERSTEN DM, 1990, BIOCHIM BIOPHYS ACTA, V1096, P20, DOI 10.1016/0925-4439(90)90007-C; GUAN SH, 1991, BIOCHEMISTRY-US, V30, P9892, DOI 10.1021/bi00105a012; HAWN TR, 1993, J BIOL CHEM, V268, P7692; HOOPER WC, 1994, BLOOD, V84, P483, DOI 10.1182/blood.V84.2.483.bloodjournal842483; HOTCHKISS R, 1993, AM J PHYSIOL, V265, pR1447, DOI 10.1152/ajpregu.1993.265.6.R1447; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; JETHMALANI SM, 1994, J BIOL CHEM, V269, P23603; KENNEDY TE, 1992, NEURON, V9, P1013, DOI 10.1016/0896-6273(92)90062-I; KETIS NV, 1988, J CELL BIOL, V106, P893, DOI 10.1083/jcb.106.3.893; KHANNA NC, 1986, J BIOL CHEM, V261, P8883; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LIU N, 1993, BIOCHIM BIOPHYS ACTA, V1202, P70, DOI 10.1016/0167-4838(93)90064-X; MACLENNAN DH, 1973, COLD SPRING HARB SYM, V37, P469, DOI 10.1101/SQB.1973.037.01.058; MCCAULIFFE DP, 1990, J CLIN INVEST, V86, P332, DOI 10.1172/JCI114704; MCCAULIFFE DP, 1992, J BIOL CHEM, V267, P2557; MCCAULIFFE DP, 1990, J CLIN INVEST, V85, P1379, DOI 10.1172/JCI114582; MICHALAK M, 1992, BIOCHEM J, V285, P681, DOI 10.1042/bj2850681; MILNER RE, 1991, J BIOL CHEM, V266, P7155; MIRAULT ME, 1982, EMBO J, V1, P1279, DOI 10.1002/j.1460-2075.1982.tb00025.x; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; MORIMOTO RI, 1992, J BIOL CHEM, V267, P21987; NAKAMURA M, 1992, BIOCHEM BIOPH RES CO, V186, P984, DOI 10.1016/0006-291X(92)90843-A; OBANION MK, 1993, J VIROL, V67, P3427, DOI 10.1128/JVI.67.6.3427-3434.1993; OPAS M, 1991, J CELL PHYSIOL, V149, P160, DOI 10.1002/jcp.1041490120; OSTWALD TJ, 1974, J BIOL CHEM, V249, P974; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; PERISIC O, 1989, CELL, V59, P797, DOI 10.1016/0092-8674(89)90603-X; RIBEIRO SP, 1994, CRIT CARE MED, V22, P922, DOI 10.1097/00003246-199406000-00008; ROJIANI MV, 1991, BIOCHEMISTRY-US, V30, P9859, DOI 10.1021/bi00105a008; ROKEACH LA, 1991, J IMMUNOL, V147, P3031; Sambrook J, 1989, MOL CLONING LABORATO; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; TREVES S, 1992, BIOCHEM J, V287, P579, DOI 10.1042/bj2870579; UDELSMAN R, 1993, J CLIN INVEST, V91, P465, DOI 10.1172/JCI116224; VILLAR J, 1994, CRIT CARE MED, V22, P914; WELCH WJ, 1993, PHILOS T ROY SOC B, V339, P327, DOI 10.1098/rstb.1993.0031; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q	51	71	76	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					17011	17016		10.1074/jbc.270.28.17011	http://dx.doi.org/10.1074/jbc.270.28.17011			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622522	hybrid			2022-12-27	WOS:A1995RJ34700084
J	HANSON, PI; OTTO, H; BARTON, N; JAHN, R				HANSON, PI; OTTO, H; BARTON, N; JAHN, R			THE N-ETHYLMALEIMIDE-SENSITIVE FUSION PROTEIN AND ALPHA-SNAP INDUCE A CONFORMATIONAL CHANGE IN SYNTAXIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR TRANSPORT; NEUROTRANSMITTER RELEASE; SYNAPTIC VESICLES; MEMBRANE-PROTEIN; ESCHERICHIA-COLI; GOLGI MEMBRANES; SYNAPTOBREVIN; PURIFICATION; CLEAVAGE; BINDING	The N-ethylmaleimide-sensitive fusion protein (NSF) plays an essential role in intracellular membrane fusion events and has been implicated in the exocytosis of synaptic vesicles. NSF binds through soluble NSF attachment proteins (SNAPs) to a complex of neuronal membrane proteins comprised of synaptobrevin, syntaxin, and SNAP-25. Disassembly of this complex by NSF is thought to be a critical step in the molecular events which lead to vesicle fusion with the plasma membrane. Here we have studied the interaction of alpha-SNAP and NSF with individual components of this complex and have identified syntaxin as a primary substrate for NSF/alpha-SNAP. We find that alpha-SNAP binds directly to syntaxin 1A as well as weakly to SNAP-25, while it does not bind to synaptobrevin II. NSF binds to syntaxin through alpha-SNAP and in the presence of ATP catalyzes a conformational rearrangement which abolishes binding of itself and alpha-SNAP. This reaction leads to the previously described disassembly of the fusion complex, since synaptobrevin binding to syntaxin is also reduced, alpha-SNAP binds to a carboxyl-terminal syntaxin fragment (residues 194-288) that also binds synaptobrevin and SNAP-25. However, NSF action on this syntaxin fragment has no effect on the binding of alpha-SNAP or synaptobrevin. This suggests that the conformational change normally induced by NSF in syntaxin depends on an interaction between carboxyl- and amino-terminal do mains of syntaxin.	YALE UNIV,SCH MED,DEPT PHARMACOL,NEW HAVEN,CT 06510	Yale University	HANSON, PI (corresponding author), YALE UNIV,SCH MED,BOYER CTR MOLEC MED,HOWARD HUGHES MED INST,RM 247,NEW HAVEN,CT 06510, USA.		Hanson, Phyllis/E-9420-2012	Jahn, Reinhard/0000-0003-1542-3498				BARK IC, 1993, J MOL BIOL, V233, P67, DOI 10.1006/jmbi.1993.1485; BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1994, ANNU REV BIOCHEM, V63, P63, DOI 10.1146/annurev.bi.63.070194.000431; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BINZ T, 1994, J BIOL CHEM, V269, P1617; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; CLARY DO, 1990, J BIOL CHEM, V265, P10109; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; DEBELLO WM, 1995, NATURE, V373, P626, DOI 10.1038/373626a0; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HARLOW E, 1988, ANTIBODIES LABORATOR; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; INOUE A, 1992, J BIOL CHEM, V267, P10613; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINK E, 1992, BIOCHEM BIOPH RES CO, V189, P1017, DOI 10.1016/0006-291X(92)92305-H; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; MCMAHON HT, 1995, J BIOL CHEM, V270, P2213, DOI 10.1074/jbc.270.5.2213; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; MORGAN A, 1994, J BIOL CHEM, V269, P29347; ORCI L, 1989, CELL, V56, P357, DOI 10.1016/0092-8674(89)90239-0; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sambrook J, 1989, MOL CLONING LABORATO; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SHENG ZH, 1994, NEURON, V13, P1303, DOI 10.1016/0896-6273(94)90417-0; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SUMIDA M, 1994, J BIOL CHEM, V269, P20636; TAGAYA M, 1993, J BIOL CHEM, V268, P2662; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; WEIDMAN PJ, 1989, J CELL BIOL, V108, P1589, DOI 10.1083/jcb.108.5.1589; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; WHITEHEART SW, 1995, TRENDS CELL BIOL, V5, P64, DOI 10.1016/S0962-8924(00)88948-5; WHITEHEART SW, 1992, J BIOL CHEM, V267, P12239; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; WILSON DW, 1992, METHOD ENZYMOL, V219, P309; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531; WILSON DW, 1989, NATURE, V339, P355, DOI 10.1038/339355a0	54	195	197	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16955	16961		10.1074/jbc.270.28.16955	http://dx.doi.org/10.1074/jbc.270.28.16955			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622514	hybrid			2022-12-27	WOS:A1995RJ34700075
J	MONK, PN; BARKER, MD; PARTRIDGE, LJ; PEASE, JE				MONK, PN; BARKER, MD; PARTRIDGE, LJ; PEASE, JE			MUTATION OF GLUTAMATE-199 OF THE HUMAN C5A RECEPTOR DEFINES A BINDING-SITE FOR LIGAND DISTINCT FROM THE RECEPTOR N-TERMINUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHYLATOXIN; IDENTIFICATION; EXPRESSION; ANTIBODIES; CLONING	C5a, a potent chemoattractant for monocytes, neutrophils, and other leukocytes, binds to a cell surface receptor of the seven-transmembrane superfamily. Here we report the effects of substituting Gin for Glu(199) of the human C5a receptor (hC5aR) expressed in a model cell system for chemoattractant receptor signaling, the rat basophilic leukemia cell line RBL-2H3. Both the binding affinity for hC5a and the EC(50) for subsequent cellular signals are reduced 5-10-fold by this substitution. A peptide mimic of the C terminus of C5a also binds to, and activates, hC5aR. The response to this peptide is reduced in cells bearing mutated hC5aR, indicating that the mutation affects interactions with the C terminus of hC5a. The C-terminal peptide contains only two basic residues, a Lys and an Arg (assumed to be analogous to Lys(68) and Arg(74) of hC5a), which could act as counter-ions for Glu(199) of the receptor. If the counter-ion on hC5a was Arg(74), then it would be expected that intact hC5a and hC5a des-Arg(74) would have identical affinities and potencies when interacting with mutant hC5aR. It was found, however, that the binding affinity and potency (for receptor signaling events) of hC5a des-Arg(74) was always lower than for intact hC5a. Furthermore, the equivalent C-terminal peptide to hC5a des-Arg(74) (i.e. lacking the C-terminal Arg) could partially activate the wild type but not the mutant receptor, whereas the converse peptide, containing Arg but containing Met instead of Lys, had equal potencies for both wild type and mutant receptors. Taken together these data indicate that Glu(199) of hC5aR is not involved in an interaction with Arg(74) Of hC5a, but may interact with Lys(68) of hC5a. Mutation of Glu(199) defines a second ligand binding site on hC5aR, distinct from the previously characterized site on the receptor N terminus. Unlike the N-terminal binding site, this second site is associated not just with the interaction with hC5a, but also with receptor activation.			MONK, PN (corresponding author), UNIV SHEFFIELD,KREBS INST BIOMOLEC RES,DEPT MOLEC BIOL & BIOTECHNOL,POB 594,SHEFFIELD S10 2UH,S YORKSHIRE,ENGLAND.		Monk, Peter/C-6155-2008; Pease, James/X-4521-2018	Monk, Peter/0000-0003-4637-3059; Pease, James/0000-0003-3749-0341; Partridge, Linda/0000-0001-9615-0094				ALI H, 1993, J BIOL CHEM, V268, P24247; BOULAY F, 1991, BIOCHEMISTRY-US, V30, P2993, DOI 10.1021/bi00226a002; CHENOWETH DE, 1980, MOL IMMUNOL, V17, P151, DOI 10.1016/0161-5890(80)90067-X; DEMARTINO JA, 1994, J BIOL CHEM, V269, P14446; Gallin JI., 1992, INFLAMMATION BASIC P; GERARD C, 1981, P NATL ACAD SCI-BIOL, V78, P1833, DOI 10.1073/pnas.78.3.1833; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; GROTZINGER J, 1991, PROTEIN ENG, V4, P767, DOI 10.1093/protein/4.7.767; KAWAI M, 1992, J MED CHEM, V35, P223; KONTEATIS ZD, 1994, J IMMUNOL, V153, P4200; MERY L, 1994, J BIOL CHEM, V269, P3457; MOLLISON KW, 1989, P NATL ACAD SCI USA, V86, P292, DOI 10.1073/pnas.86.1.292; MONK PN, 1994, EUR J IMMUNOL, V24, P2922, DOI 10.1002/eji.1830241152; MONK PN, 1994, BIOCHEM MOL BIOL INT, V32, P13; MORGAN EL, 1993, J IMMUNOL, V151, P377; OPPERMANN M, 1993, J IMMUNOL, V151, P3785; PEASE JE, 1994, EUR J IMMUNOL, V24, P211, DOI 10.1002/eji.1830240133; PEASE JE, 1993, BIOCHEM MOL BIOL INT, V31, P719; PEASE JE, 1993, BIOCHEM MOL BIOL INT, V29, P339; PEASE JE, 1994, MOL IMMUNOL, V31, P733, DOI 10.1016/0161-5890(94)90147-3; PERRET JJ, 1992, BIOCHEM J, V288, P911, DOI 10.1042/bj2880911; SICILIANO SJ, 1994, P NATL ACAD SCI USA, V91, P1214, DOI 10.1073/pnas.91.4.1214	22	35	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16625	16629		10.1074/jbc.270.28.16625	http://dx.doi.org/10.1074/jbc.270.28.16625			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622471	hybrid			2022-12-27	WOS:A1995RJ34700028
J	KHANANSHVILI, D; SHAULOV, G; WEILMASLANSKY, E; BAAZOV, D				KHANANSHVILI, D; SHAULOV, G; WEILMASLANSKY, E; BAAZOV, D			POSITIVELY CHARGED CYCLIC HEXAPEPTIDES, NOVEL BLOCKERS FOR THE CARDIAC SARCOLEMMA NA+-CA2+ EXCHANGER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; NA-CA EXCHANGE; MEMBRANE-VESICLES; PEPTIDE LIGANDS; SYSTEM; TRANSLOCATION; TRANSPORT; MECHANISM; CYCLIZATION; BINDING	Positively charged cyclic hexapeptides have been synthesized and tested for their effects on the cardiac sarcolemma Na+-Ca2+ exchange activities with a goal to identify a potent blocker, The cyclic hexapeptides, having the different amino acid sequence, contain two arginines (to retain a positive charge), two phenylalanines (to control hydrophobicity), and two cysteines (to form an intramolecular S-S bond). The effect of cyclic hexapeptides were tested on Na+-Ca2+ exchange and its partial reaction, the Ca2+-Ca2+ exchange, by measuring the Ca-45 fluxes in the semi-rapid mixer or monitoring the calcium-sensitive dye Arsenazo III and voltage-sensitive dyes (Oxanol-V or Merocyanine-540). Seven cyclic hexapeptides inhibit Na+-Ca2+ exchange with a different potency (IC50 = 2-300 mu M). Phe-Arg-Cys-Arg-Cys-Phe-CONH2 (FRCRCFa) inhibits the Na-i(+)-dependent Ca-45 uptake (Na+-Ca2+ exchange) and Ca-i(2+)-dependent Ca-45 uptake (Ca2+-Ca2+ exchange) in the isolated cardiac sarcolemma vesicles with IC50 = 10 +/- 2 mu M and IC50 = 7 +/- 3 mu M, respectively. Interaction of FRCRCFa with a putative inhibitory site does not involve a ''slow'' binding (a maximal inhibitory effect is already observed after t = 1 s of mixing). The inside positive potential, generated by Na-o(+)-dependent Ca2+ efflux, was monitored by Oxanol-V (A(635)-A(612)) or Merocyanine-540 (A(570)-A(500)). In both assay systems, FRCRCFa inhibits the Na+-Ca2+ exchange with IC50 = 2-3 mu M, while a complete inhibition occurs at 20 mu M FRCRCFa. The forward (Na-i(+)-dependent Ca2+ influx) and reverse (Na-o(+)-dependent Ca2+ efflux) modes of Na+-Ca2+ exchange, monitored by Arsenazo III (A(600)-A(785)), are also inhibited by FRCRCFa. The L-Arg(4) --> D-Arg(4) substitution in FRCRCFa does not alter the IC50, meaning that this structural change may increase a proteolytic resistance without a loss of inhibitory potency. At fixed [Na+](i) (160 mM) or [Ca2+](i) (250 mu M) and varying Ca-45(o) (2-200 mu M), FRCRCFa decreases V-max without altering the K-m. Therefore, FRCRCFa is a noncompetitive inhibitor in regard to extravesicular Ca2+ either for Na+-Ca2+ or Ca2+-Ca2+ exchange. It is suggested that FRCRCFa prevents the ion movements through the exchanger rather than the ion binding.			KHANANSHVILI, D (corresponding author), TEL AVIV UNIV, SACKLER SCH MED, DEPT PHYSIOL & PHARMACOL, IL-69978 TEL AVIV, ISRAEL.			Khananshvili, Daniel/0000-0002-4202-9966				ALBERICIO F, 1991, INT J PEPT PROT RES, V37, P402; AMBESI A, 1991, ANN NY ACAD SCI, V639, P245, DOI 10.1111/j.1749-6632.1991.tb17311.x; Bashford C L, 1979, Methods Enzymol, V55, P569; BAUER PJ, 1981, ANAL BIOCHEM, V110, P61, DOI 10.1016/0003-2697(81)90112-3; BRIDGE JHB, 1990, SCIENCE, V248, P376, DOI 10.1126/science.2158147; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; DIPOLO R, 1994, AM J PHYSIOL, V267, pC307, DOI 10.1152/ajpcell.1994.267.1.C307; FREIDINGER RM, 1989, TRENDS PHARMACOL SCI, V10, P270, DOI 10.1016/0165-6147(89)90026-6; GARTY H, 1994, FASEB J, V8, P522, DOI 10.1096/fasebj.8.8.8181670; GILON C, 1991, BIOPOLYMERS, V31, P745, DOI 10.1002/bip.360310619; HILGEMANN DW, 1991, NATURE, V352, P715, DOI 10.1038/352715a0; HILGEMANN DW, 1991, ANN NY ACAD SCI, V639, P126, DOI 10.1111/j.1749-6632.1991.tb17296.x; HRUBY VJ, 1990, BIOCHEM J, V268, P249, DOI 10.1042/bj2680249; JONES LR, 1988, METHOD ENZYMOL, V157, P85; KACZOROWSKI GJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P287, DOI 10.1016/0304-4157(89)90022-1; KHANANSHVILI D, 1993, J BIOL CHEM, V268, P200; KHANANSHVILI D, 1994, BIOCHEMISTRY-US, V33, P312, DOI 10.1021/bi00167a041; KHANANSHVILI D, 1990, BIOCHEMISTRY-US, V29, P2437, DOI 10.1021/bi00462a001; KHANANSHVILI D, 1991, J BIOL CHEM, V266, P13764; KHANANSHVILI D, 1991, ANN NY ACAD SCI, V639, P85, DOI 10.1111/j.1749-6632.1991.tb17291.x; Khananshvili D, 1990, CURR OPIN CELL BIOL, V2, P731, DOI 10.1016/0955-0674(90)90117-W; KHANANSHVILI D, 1992, 8TH INT S CALC BIND; KLEIBOEKER SB, 1992, J BIOL CHEM, V267, P17836; LANGER GA, 1994, TRENDS CARDIOVAS MED, V4, P103, DOI 10.1016/1050-1738(94)90061-2; LI JM, 1991, ANN NY ACAD SCI, V639, P48, DOI 10.1111/j.1749-6632.1991.tb17288.x; LI Z, 1990, J BIOL CHEM, V266, P1014; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MATSUOKA S, 1992, J GEN PHYSIOL, V100, P963, DOI 10.1085/jgp.100.6.963; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; NIGGLI E, 1991, NATURE, V349, P621, DOI 10.1038/349621a0; NOBLE D, 1991, ANN NY ACAD SCI, V639, P334, DOI 10.1111/j.1749-6632.1991.tb17323.x; PHILIPSON K D, 1992, Current Opinion in Cell Biology, V4, P678, DOI 10.1016/0955-0674(92)90089-U; Philipson K D, 1993, Int Rev Cytol, V137C, P199; REEVES JP, 1988, METHOD ENZYMOL, V157, P505; Scarpa A, 1979, Methods Enzymol, V56, P301; SLAUGHTER RS, 1988, BIOCHEMISTRY-US, V27, P2403, DOI 10.1021/bi00407a023; STEIN WD, 1986, TRANSPORT DIFFUSION, P326; TONIOLO C, 1990, INT J PEPT PROT RES, V35, P287, DOI 10.1111/j.1399-3011.1990.tb00052.x; ZUKERMANN RN, 1994, CURR OPIN STRUC BIOL, V3, P580	39	35	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16182	16188		10.1074/jbc.270.27.16182	http://dx.doi.org/10.1074/jbc.270.27.16182			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608184	hybrid			2022-12-27	WOS:A1995RH22600047
J	KLENCHIN, VA; CALVERT, PD; BOWNDS, MD				KLENCHIN, VA; CALVERT, PD; BOWNDS, MD			INHIBITION OF RHODOPSIN KINASE BY RECOVERIN - FURTHER EVIDENCE FOR A NEGATIVE FEEDBACK-SYSTEM IN PHOTOTRANSDUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD OUTER SEGMENTS; CYCLIC-GMP PHOSPHODIESTERASE; RETINAL RODS; CALCIUM SENSOR; AUTOPHOSPHORYLATION; PHOTORECEPTORS; TERMINUS; PROTEIN; VISION; CELLS	Recoverin is a 23-kDa Ca2+-binding protein found predominantly in vertebrate photoreceptor cells. Recent electrophysiological and biochemical studies suggest that recoverin may regulate the photoresponse by inhibiting rhodopsin phosphorylation. We find in both cell homogenates and reconstituted systems that the inhibition of rhodopsin phosphorylation by recoverin occurs over a significantly higher free Ca2+ range than previously reported, Half-maximal inhibition occurs at 1.5-3 mu M free Ca2+ and is cooperative with a Hill coefficient of similar to 2. Measurements of transducin activation demonstrate that this inhibition prolongs the lifetime of catalytically active rhodopsin. Ca2+-recoverin directly inhibits rhodopsin kinase activity, and Ca2+-dependent binding of recoverin to rod outer segment membranes is not required for its action, Extrapolation of the in vitro data to in vivo conditions based on simple mass action calculations places the Ca2+-recoverin regulation within the physiological free Ca2+ range in intact rod outer segment. The data are consistent with a model in which the fall in free Ca2+ that accompanies rod excitation exerts negative feedback by relieving inhibition of rhodopsin phosphorylation.	UNIV WISCONSIN,NEUROSCI TRAINING PROGRAM,MADISON,WI 53706; UNIV WISCONSIN,DEPT ZOOL,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	KLENCHIN, VA (corresponding author), UNIV WISCONSIN,MOLEC BIOL LAB 327,1525 LINDEN DR,MADISON,WI 53706, USA.				NEI NIH HHS [EY 00463] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AMES JB, 1995, J BIOL CHEM, V270, P4526, DOI 10.1074/jbc.270.9.4526; BIERNBAUM MS, 1985, J GEN PHYSIOL, V85, P83, DOI 10.1085/jgp.85.1.83; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; BUCZYLKO J, 1991, P NATL ACAD SCI USA, V88, P2568, DOI 10.1073/pnas.88.6.2568; CHEN CK, 1994, INVEST OPHTH VIS SCI, V35, P1485; DIZHOOR AM, 1992, J BIOL CHEM, V267, P16033; DIZHOOR AM, 1993, SCIENCE, V259, P829, DOI 10.1126/science.8430337; DODD RL, 1995, INVEST OPHTH VIS SCI, V36, pS641; DUMKE CL, 1994, J GEN PHYSIOL, V103, P1071, DOI 10.1085/jgp.103.6.1071; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; GORODOVIKOVA EN, 1994, FEBS LETT, V353, P171, DOI 10.1016/0014-5793(94)01030-7; GRAYKELLER MP, 1994, NEURON, V13, P849, DOI 10.1016/0896-6273(94)90251-8; GRAYKELLER MP, 1993, NEURON, V10, P523, DOI 10.1016/0896-6273(93)90339-S; HSU YT, 1993, NATURE, V361, P76, DOI 10.1038/361076a0; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; KAWAMURA S, 1994, BIOCHEM BIOPH RES CO, V203, P121, DOI 10.1006/bbrc.1994.2157; KELLEHER DJ, 1990, J BIOL CHEM, V265, P2632; KLENCHIN VA, 1994, BIOPHYS J, V66, pA48; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KORENBROT JI, 1989, VISION RES, V29, P939, DOI 10.1016/0042-6989(89)90108-9; LAGNADO L, 1992, J PHYSIOL-LONDON, V455, P111, DOI 10.1113/jphysiol.1992.sp019293; LAGNADO L, 1994, NATURE, V367, P273, DOI 10.1038/367273a0; Liebman P.A., 1972, PHOTOCHEMISTRY VISIO, P481; MCCARTHY ST, 1994, BIOPHYS J, V67, P2076, DOI 10.1016/S0006-3495(94)80691-5; McDowell J. H., 1993, PHOTORECEPTOR CELLS, V15, P123; MCGUIGAN JAS, 1990, CAN J PHYSL PHARM, V69, P1733; MCNAUGHTON PA, 1990, PHYSIOL REV, V70, P847, DOI 10.1152/physrev.1990.70.3.847; MILAM AH, 1993, VISUAL NEUROSCI, V10, P1, DOI 10.1017/S0952523800003175; MILLER DJ, 1984, AM J PHYSIOL, V246, pC160, DOI 10.1152/ajpcell.1984.246.1.C160; Miller James L., 1994, Current Opinion in Neurobiology, V4, P488, DOI 10.1016/0959-4388(94)90048-5; PALCZEWSKI K, 1988, BIOCHEMISTRY-US, V27, P2306, DOI 10.1021/bi00407a010; PALCZEWSKI K, 1992, J BIOL CHEM, V267, P18991; POLANS AS, 1993, METH NEUROSCI, V15, P248; RAY S, 1992, P NATL ACAD SCI USA, V89, P5705, DOI 10.1073/pnas.89.13.5705; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569; [No title captured]	37	181	181	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16147	16152		10.1074/jbc.270.27.16147	http://dx.doi.org/10.1074/jbc.270.27.16147			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608179	hybrid			2022-12-27	WOS:A1995RH22600042
J	KUNTZWEILER, TA; WALLICK, ET; JOHNSON, CL; LINGREL, JB				KUNTZWEILER, TA; WALLICK, ET; JOHNSON, CL; LINGREL, JB			AMINO-ACID REPLACEMENT OF ASP(369) IN THE SHEEP ALPHA-1 ISOFORM ELIMINATES ATP AND PHOSPHATE STIMULATION OF [H-3] OUABAIN BINDING TO THE NA+,K+-ATPASE WITHOUT ALTERING THE CATION-BINDING PROPERTIES OF THE ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; (NA+ + K+)-ATPASE; TRANSPORT ADENOSINE-TRIPHOSPHATASE; CARDIAC GLYCOSIDE INTERACTIONS; G-STROPHANTHIN; OX BRAIN; PHOSPHORYLATION; NA,K-ATPASE; OUABAIN; SUBUNIT	Modification of aspartic acid 369 in the sheep alpha 1 Na+,K+-ATPase to asparagine results in a membrane-associated form of Na+,K+-ATPase that can bind [H-3]ouabain with high affinity in the presence of Mg2+ alone (K-D = 20.4 +/- 2.6 nM). Ouabain binding to the D369N mutant is not stimulated by inorganic phosphate, confirming that Asp(369) is both the catalytic phosphorylation site and the only P-i interaction site which stimulates ouabain binding. Cation inhibition of Mg2+-stimulated ouabain binding to the D369N mutant demonstrated that three Na+ and two K+ ions inhibit [H-3]ouabain binding and suggests that this inhibition must occur via a cation-sensitive conformational change which does not directly involve dephosphorylation of the enzyme. In the presence of 10 mM Mg2+, ATP stimulates ouabain binding to the wild type protein, (AC(50) = 21.4 +/- 2.7 mu M) but inhibits the binding to the D369N mutant (IC50 = 2.52 +/- 0.17 mu M) indicating that the mutation does not destroy the high affinity site for MgATP but does change the nature of the protein conformation normally induced by a nucleotide-Na+,K+-ATPase interaction. Increasing the Mg2+ from 1 to 10 mM did not alter the AC(50) or IC50 values for ATP and reveals that the Mg2+ inter-action which stimulates ouabain binding in the absence of nucleotide involves a distinct divalent cation site not associated with the binding of the magnesium-nucleotide complex. Thus, altering the catalytic phosphorylation site of Na+,K+-ATPase does not affect the expression of the ouabain-sensitive protein in the membrane fraction of NIH 3T3 cells and does not disrupt the binding of Na+, K+, Mg2+, ouabain, or ATP to the enzyme. However, the D369N substitution does inhibit the formation of a nucleotide-protein complex with high affinity for ouabain.	UNIV CINCINNATI,COLL MED,DEPT MOLEC GENET BIOCHEM & MICROBIOL,CINCINNATI,OH 45267; UNIV CINCINNATI,COLL MED,DEPT PHARMACOL & CELL BIOPHYS,CINCINNATI,OH 45267	University of Cincinnati; University of Cincinnati					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL008612, R01HL050613, R01HL028573] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 50613, HL 28573, HL 08612-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERS RW, 1968, MOL PHARMACOL, V4, P324; ASKARI A, 1988, J BIOL CHEM, V263, P235; BALL WJ, 1982, BIOCHIM BIOPHYS ACTA, V719, P413, DOI 10.1016/0304-4165(82)90228-8; BALL WJ, 1988, METHOD ENZYMOL, V156, P87; CAVIERES JD, 1977, MEMBRANE TRANSPORT R, P1; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLARKE DM, 1990, J BIOL CHEM, V265, P22223; ERDMANN E, 1973, BIOCHIM BIOPHYS ACTA, V330, P302, DOI 10.1016/0005-2736(73)90235-6; FORBUSH B, 1987, J BIOL CHEM, V262, P11116; GRISHAM CM, 1974, J BIOL CHEM, V249, P3187; HANSEN O, 1973, BIOCHIM BIOPHYS ACTA, V311, P51, DOI 10.1016/0005-2736(73)90254-X; HANSEN O, 1984, PHARMACOL REV, V36, P143; JOHNSON CL, 1995, ARCH BIOCHEM BIOPHYS, V317, P133, DOI 10.1006/abbi.1995.1145; JOHNSON CL, 1995, IN PRESS BIOCH J, V308; KUNTZWEILER TA, 1995, J BIOL CHEM, V270, P2993, DOI 10.1074/jbc.270.7.2993; LANE LK, 1973, J BIOL CHEM, V248, P7197; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MATSUI H, 1968, BIOCHIM BIOPHYS ACTA, V151, P655, DOI 10.1016/0005-2744(68)90013-2; OHTSUBO M, 1990, BIOCHIM BIOPHYS ACTA, V1021, P157, DOI 10.1016/0005-2736(90)90028-M; PLESNER IW, 1981, BIOCHIM BIOPHYS ACTA, V643, P483, DOI 10.1016/0005-2736(81)90090-0; POST RL, 1975, J BIOL CHEM, V250, P691; POST RL, 1969, J GEN PHYSIOL, V54, pS306, DOI 10.1085/jgp.54.1.306; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; PRICE EM, 1990, J BIOL CHEM, V265, P6638; RAO R, 1993, J BIOL CHEM, V268, P6708; SCHULTHEIS PJ, 1993, J BIOL CHEM, V268, P22686; SCHWARTZ A, 1968, SCIENCE, V160, P323, DOI 10.1126/science.160.3825.323; SIEGEL GJ, 1969, J BIOL CHEM, V244, P3264; SKOU JC, 1971, BIOCHIM BIOPHYS ACTA, V241, P443, DOI 10.1016/0005-2736(71)90044-7; SKOU JC, 1960, BIOCHIM BIOPHYS ACTA, V255, P9852; STEKHOVEN FMA, 1980, BIOCHIM BIOPHYS ACTA, V597, P100; SWANN AC, 1978, BIOCHIM BIOPHYS ACTA, V523, P215, DOI 10.1016/0005-2744(78)90024-4; TOBIN T, 1970, BIOCHIM BIOPHYS ACTA, V198, P120, DOI 10.1016/0005-2744(70)90040-9; WALDERHAUG MO, 1985, J BIOL CHEM, V260, P3852; WALLICK ET, 1988, METHOD ENZYMOL, V156, P201; WALLICK ET, 1980, ARCH BIOCHEM BIOPHYS, V202, P442, DOI 10.1016/0003-9861(80)90448-8; YODA A, 1982, MOL PHARMACOL, V22, P700	37	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16206	16212		10.1074/jbc.270.27.16206	http://dx.doi.org/10.1074/jbc.270.27.16206			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608186	hybrid			2022-12-27	WOS:A1995RH22600050
J	LOHRET, TA; KINNALLY, KW				LOHRET, TA; KINNALLY, KW			TARGETING PEPTIDES TRANSIENTLY BLOCK A MITOCHONDRIAL CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN IMPORT; YEAST MITOCHONDRIA; CATIONIC CHANNEL; OUTER-MEMBRANE; PRESEQUENCE; MITOPLASTS; PATHWAY; PORE	The effects of synthetic targeting peptides on the activity of the multiple conductance channel (MCC) of mouse and yeast mitochondria were investigated using patch-clamp techniques. Amino-terminal targeting peptides of two inner membrane proteins reversibly decreased the open probability and mean open time of MCC. One of these targeting peptides had no effect on two other voltage-dependent mitochondrial channels. Furthermore, the effects induced by the two targeting peptides on MCC were not elicited by two peptides of an outer membrane protein. The specific interactions of targeting peptides with MCC suggest that this channel may be involved in protein import across the inner mitochondrial membrane.	WADSWORTH CTR,DIV MOLEC MED,ALBANY,NY 12201; SUNY ALBANY,DEPT BIOMED SCI,ALBANY,NY 12222; SUNY ALBANY,DEPT BIOL SCI,ALBANY,NY 12222	Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany								BAKER KP, 1991, NATURE, V349, P205, DOI 10.1038/349205a0; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; CAMPO ML, 1992, J BIOL CHEM, V267, P8123; CHICH JF, 1991, EUR J BIOCHEM, V196, P29, DOI 10.1111/j.1432-1033.1991.tb15781.x; CRIADO M, 1987, FEBS LETT, V224, P172, DOI 10.1016/0014-5793(87)80442-8; DAUM G, 1982, J BIOL CHEM, V257, P3028; DECKER GL, 1977, J ULTRA MOL STRUCT R, V59, P44, DOI 10.1016/S0022-5320(77)80027-0; EMTAGE JLT, 1993, J CELL BIOL, V122, P1003, DOI 10.1083/jcb.122.5.1003; FEVRE F, 1994, BIOPHYS J, V66, P1887, DOI 10.1016/S0006-3495(94)80982-8; FEVRE F, 1990, FEBS LETT, V262, P201, DOI 10.1016/0014-5793(90)80189-P; FONT B, 1991, FEBS LETT, V279, P105, DOI 10.1016/0014-5793(91)80262-2; GIAKWAD AS, 1994, J BIOL CHEM, V269, P6437; GLASER SM, 1990, J BIOL CHEM, V265, P8808; GUO XW, 1995, J STRUCT BIOL, V114, P41, DOI 10.1006/jsbi.1995.1004; HENRY JP, 1989, J MEMBRANE BIOL, V112, P139, DOI 10.1007/BF01871275; HUGOSSON M, 1994, EUR J BIOCHEM, V223, P1027, DOI 10.1111/j.1432-1033.1994.tb19081.x; KINNALLY KW, 1989, J BIOENERG BIOMEMBR, V21, P497, DOI 10.1007/BF00762521; KINNALLY KW, 1992, J BIOENERG BIOMEMBR, V24, P99, DOI 10.1007/BF00769536; KINNALLY KW, 1993, P NATL ACAD SCI USA, V90, P1374, DOI 10.1073/pnas.90.4.1374; KINNALLY KW, 1994, MOL BIOL MITOCHONDRI, P169; KUBRICH M, 1994, FEBS LETT, V349, P222, DOI 10.1016/0014-5793(94)00670-9; LOHRET TA, 1995, BIOPHYS J, V68, P2299, DOI 10.1016/S0006-3495(95)80412-1; MANNELLA CA, 1982, J CELL BIOL, V94, P680, DOI 10.1083/jcb.94.3.680; PFANNER N, 1994, TRENDS BIOCHEM SCI, V19, P368, DOI 10.1016/0968-0004(94)90113-9; RYAN KR, 1993, J BIOL CHEM, V268, P23743; SCHNELL DJ, 1993, J CELL BIOL, V120, P103, DOI 10.1083/jcb.120.1.103; SIMON SM, 1992, CELL, V69, P677, DOI 10.1016/0092-8674(92)90231-Z; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; SINGER SJ, 1987, P NATL ACAD SCI USA, V84, P1960, DOI 10.1073/pnas.84.7.1960; SZABO I, 1992, J BIOENERG BIOMEMBR, V24, P111, DOI 10.1007/BF00769537; SZABO I, 1995, IN PRESS BIOCH BIOPH; THIEFFRY M, 1992, BIOPHYS J, V63, P333, DOI 10.1016/S0006-3495(92)81626-0; VALLETTE FM, 1994, J BIOL CHEM, V269, P13367; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; ZORATTI M, 1994, J BIOENERG BIOMEMBR, V26, P543, DOI 10.1007/BF00762739	35	54	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15950	15953		10.1074/jbc.270.27.15950	http://dx.doi.org/10.1074/jbc.270.27.15950			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608149	hybrid			2022-12-27	WOS:A1995RH22600010
J	DAVEY, JC; BECKER, KB; SCHNEIDER, MJ; STGERMAIN, DL; GALTON, VA				DAVEY, JC; BECKER, KB; SCHNEIDER, MJ; STGERMAIN, DL; GALTON, VA			CLONING OF A CDNA FOR THE TYPE-II IODOTHYRONINE DEIODINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RANA-CATESBEIANA TADPOLES; THYROID-HORMONE; LIFE-CYCLE; EXPRESSION; GENE; ENZYME	Three types of iodothyronine deiodinase have been identified in vertebrate tissues. cDNAs for the types I and III have been cloned and shown to contain an in-frame TGA that codes for selenocysteine at the active site of the enzyme. We now report the cloning of a cDNA for a type II deiodinase using a reverse transcription/polymerase chain reaction strategy and RNA obtained from Rana catesbeiana tissues. This cDNA (RC5'DII) manifests limited but significant homology with other deiodinase cDNAs and contains a conserved in-frame TGA codon. Injection of capped in vitro synthesized transcripts of the cDNA into Xenopus laevis oocytes results in the induction of deiodinase activity with characteristics typical of a type II deiodinase. The levels of RC5'DII transcripts in R. catesbeiana tadpole tail and liver mRNA at stages XII and XXIII correspond well with that of type II deiodinase activity but not that of the type III activity in these tissues. These findings indicate that the amphibian type II 5'-deiodinase is a structurally unique member of the family of selenocysteine-containing deiodinases.	DARTMOUTH COLL SCH MED,DEPT PHYSIOL,LEBANON,NH 03756; DARTMOUTH COLL SCH MED,DEPT MED,LEBANON,NH 03756	Dartmouth College; Dartmouth College					NICHD NIH HHS [HD 27706, HD 09020] Funding Source: Medline; NIDDK NIH HHS [DK 07508] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027706, R01HD009020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007508] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BECKER KB, 1995, ENDOCRINOLOGY, V136, P4424, DOI 10.1210/en.136.10.4424; BERRY MJ, 1991, NATURE, V349, P438, DOI 10.1038/349438a0; BERRY MJ, 1992, ENDOCR REV, V13, P207, DOI 10.1210/er.13.2.207; BERRY MJ, 1992, J BIOL CHEM, V267, P18055; CROTEAU W, 1995, J BIOL CHEM, V270, P16569, DOI 10.1074/jbc.270.28.16569; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; GALTON VA, 1987, ENDOCRINOLOGY, V121, P42, DOI 10.1210/endo-121-1-42; GALTON VA, 1988, ENDOCRINOLOGY, V122, P640; GALTON VA, 1991, ENDOCRINOLOGY, V129, P2298, DOI 10.1210/endo-129-5-2298; GALTON VA, 1988, ENDOCRINOLOGY, V122, P1746; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Kaplan MM, 1986, THYROID HORMONE META, P231; Leonard JL, 1986, THYROID HORMONE META, P189; MANDEL SJ, 1992, J CLIN ENDOCR METAB, V75, P1133, DOI 10.1210/jc.75.4.1133; MORENO M, 1994, FEBS LETT, V344, P143, DOI 10.1016/0014-5793(94)00365-3; SCHNEIDER MJ, 1993, ENDOCRINOLOGY, V133, P2488, DOI 10.1210/en.133.6.2488; SHARIFI J, 1992, J BIOL CHEM, V267, P12539; STGERMAIN DL, 1994, P NATL ACAD SCI USA, V91, P7767, DOI 10.1073/pnas.91.16.7767; STGERMAIN DL, 1994, P NATL ACAD SCI USA, V91, P11282; STGERMAIN DL, 1989, MOL ENDOCRINOL, V3, P2049; TAYLOR AC, 1946, ANAT REC, V94, P7, DOI 10.1002/ar.1090940103; TOYODA N, 1994, J BIOL CHEM, V269, P20329; WANG Z, 1993, J BIOL CHEM, V268, P16270	23	176	185	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26786	26789		10.1074/jbc.270.45.26786	http://dx.doi.org/10.1074/jbc.270.45.26786			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592917	hybrid			2022-12-27	WOS:A1995TE58300017
J	LIU, JQ; KURIHARA, T; MIYAGI, M; ESAKI, N; SODA, K				LIU, JQ; KURIHARA, T; MIYAGI, M; ESAKI, N; SODA, K			REACTION-MECHANISM OF L-2-HALOACID DEHALOGENASE OF PSEUDOMONAS SP. YL - IDENTIFICATION OF ASP(10) AS THE ACTIVE-SITE NUCLEOPHILE BY O-18 INCORPORATION EXPERIMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-HALOALKANOIC ACID DEHALOGENASE; 2-HALOACID HALIDOHYDROLASE IVA; SP STRAIN CBS3; CEPACIA MBA4; PURIFICATION; GENE; MUTAGENESIS; PROTEIN; PUTIDA	L-2-Haloacid dehalogenase (EC 3.8.1.2) catalyzes the hydrolytic dehalogenation of L-2-haloacids to produce the corresponding D-2-hydroxy acids, We have analyzed the reaction mechanism of the enzyme from Pseudomonas sp, YL and found that Asp(10) is the active site nucleophile, When the multiple turnover enzyme reaction was carried out in (H2O)-O-18 with L-2-chloropropionate as a substrate, lactate produced was labeled with O-18. However, when the single turnover enzyme reaction was carried out by use of a large excess of the enzyme, the product was not labeled, This suggests that an oxygen atom of the solvent water is first incorporated into the enzyme and then transferred to the product, After the multiple turnover reaction in (H2O)-O-18, the enzyme was digested with lysyl endopeptidase, and the molecular masses of the peptide fragments formed were measured by an ionspray mass spectrometer, Two O-18 atoms were shown to be incorporated into a hexapeptide, Gly(6)-Lys(11). Tandem mass spectrometric analysis of this peptide revealed that Asp(10) was labeled with two O-18 atoms, Our previous site-directed mutagenesis experiment showed that the replacement of Asp(10) led to a significant loss in the enzyme activity. These results indicate that Asp(10) acts as a nucleophile on the alpha-carbon of the substrate leading to the formation of an ester intermediate, which is hydrolyzed by nucleophilic attack of a water molecule on the carbonyl carbon atom.	TAKARA SHUZO CO LTD, BIOTECHNOL RES LABS, OTSU, SHIGA 52021, JAPAN; KYOTO UNIV, INST CHEM RES, MICROBIAL BIOCHEM LAB, UJI, KYOTO 611, JAPAN	Takara Holdings Inc.; Kyoto University								ASMARA W, 1993, BIOCHEM J, V292, P69, DOI 10.1042/bj2920069; GOLDMAN P, 1968, J BIOL CHEM, V243, P428; HASAN AKMQ, 1994, BIOSCI BIOTECH BIOCH, V58, P1599, DOI 10.1271/bbb.58.1599; IWASAKI I, 1956, B CHEM SOC JPN, V29, P860, DOI 10.1246/bcsj.29.860; JONES DHA, 1992, J GEN MICROBIOL, V138, P675, DOI 10.1099/00221287-138-4-675; KAWASAKI H, 1992, J GEN MICROBIOL, V138, P1317, DOI 10.1099/00221287-138-7-1317; KAWASAKI H, 1994, BIOSCI BIOTECH BIOCH, V58, P160, DOI 10.1271/bbb.58.160; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KURIHARA T, 1995, J BIOCHEM, V117, P1317, DOI 10.1093/oxfordjournals.jbchem.a124861; LACOURCIERE GM, 1993, J AM CHEM SOC, V115, P10466, DOI 10.1021/ja00075a115; LITTLE M, 1971, EUR J BIOCHEM, V21, P99, DOI 10.1111/j.1432-1033.1971.tb01445.x; LIU JQ, 1994, APPL ENVIRON MICROB, V60, P2389, DOI 10.1128/AEM.60.7.2389-2393.1994; LIU JQ, 1994, J BIOCHEM-TOKYO, V116, P248, DOI 10.1093/oxfordjournals.jbchem.a124514; LIU JQ, 1995, IN PRESS BIODEGRADAT; MOTOSUGI K, 1982, AGR BIOL CHEM TOKYO, V46, P837, DOI 10.1080/00021369.1982.10865158; MURDIYATMO U, 1992, BIOCHEM J, V284, P87, DOI 10.1042/bj2840087; NARDIDEI V, 1994, APPL ENVIRON MICROB, V60, P3375, DOI 10.1128/AEM.60.9.3375-3380.1994; PRIES F, 1994, BIOCHEMISTRY-US, V33, P1242, DOI 10.1021/bi00171a026; SCHNEIDER B, 1993, BIOL CHEM H-S, V374, P489, DOI 10.1515/bchm3.1993.374.7-12.489; SCHNEIDER B, 1991, J BACTERIOL, V173, P1530, DOI 10.1128/jb.173.4.1530-1535.1991; TSANG JSH, 1988, ARCH MICROBIOL, V150, P441, DOI 10.1007/BF00422284; VANDERPLOEG J, 1991, J BACTERIOL, V173, P7925, DOI 10.1128/jb.173.24.7925-7933.1991; YANG G, 1994, BIOCHEMISTRY-US, V33, P8527, DOI 10.1021/bi00194a018	24	79	81	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18309	18312		10.1074/jbc.270.31.18309	http://dx.doi.org/10.1074/jbc.270.31.18309			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629151	hybrid			2022-12-27	WOS:A1995RM64200026
J	DOHMEN, RJ; STAPPEN, R; MCGRATH, JP; FORROVA, H; KOLAROV, J; GOFFEAU, A; VARSHAVSKY, A				DOHMEN, RJ; STAPPEN, R; MCGRATH, JP; FORROVA, H; KOLAROV, J; GOFFEAU, A; VARSHAVSKY, A			AN ESSENTIAL YEAST GENE ENCODING A HOMOLOG OF UBIQUITIN-ACTIVATING ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE Y-CHROMOSOME; N-END RULE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; PROTEIN-DEGRADATION; CONJUGATING ENZYME; TAGGED UBIQUITIN; EXPRESSION; PURIFICATION; CLONING	Ubiquitin (Ub) activation by the Ub-activating (E1) enzyme is the initial and essential step common to all of the known processes that involve post-translational conjugation of Ub to itself or other proteins. The ''activated'' Ub, linked via a thioester bond to a specific cysteine residue of E1 enzyme, can be transferred to a cysteine residue in one of several Ub-conjugating (E2) enzymes, which catalyze the formation of isopeptide bonds between the C-terminal glycine of Ub and lysine residues of acceptor proteins. In the yeast Saccharomyces cerevisiae, a 114-kDa E1 enzyme is encoded by an essential gene termed UBA1 (McGrath, J. P., Jentsch, S., and Varshavsky, A. (1991) EMBO J. 10, 227-236). We describe the isolation and analysis of another essential gene, termed UBA2, that encodes a 71-kDa protein with extensive sequence similarities to both the UBA1-encoded yeast E1 and E1 enzymes of other organisms. The regions of similarities between Uba1p and Uba2p encompass a putative ATP-binding site as well as a sequence that is highly conserved between the known E1 enzymes and contains the active-site cysteine of E1. This cysteine is shown to be required for an essential function of Uba2p, suggesting that Uba2p-catalyzed reactions involve a transient thioester bond between Uba2p and either Ub or another protein. Uba2p is located largely in the nucleus. The putative nuclear localization signal of Uba2p is near its C terminus. The Uba1p (E1 enzyme) and Uba2p cannot complement each others essential functions even if their subcellular localization is altered by mutagenesis. Uba2p appears to interact with itself and several other S. cerevisiae proteins with apparent molecular masses of 52, 63, 87, and 120 kDa. Uba2p is multiubiquitinated in vivo, suggesting that at least a fraction of Uba2p is metabolically unstable. Uba2p is likely to be a component of the Ub system that functions as either an E2 or E1/E2 enzyme.	ALKERMES INC,CAMBRIDGE,MA 02139; COMENIUS UNIV BRATISLAVA,DEPT BIOCHEM,BRATISLAVA 84215,SLOVAKIA; UNIV CATHOLIQUE LOUVAIN,UNITE BIOCHEM PHYSIOL,B-1348 LOUVAIN,BELGIUM; CALTECH,DIV BIOL,PASADENA,CA 91125; UNIV DUSSELDORF,INST MIKROBIOL,D-40225 DUSSELDORF,GERMANY	Alkermes; Comenius University Bratislava; Universite Catholique Louvain; California Institute of Technology; Heinrich Heine University Dusseldorf			Dohmen, R. Jürgen/AAD-6649-2022; kolarov, jordan/R-5382-2019; Kolarov, Jordan/O-3768-2014	Dohmen, R. Jürgen/0000-0002-5756-6780; 	NIGMS NIH HHS [GM31530] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel FM, 1992, CURRENT PROTOCOLS MO; AYSAWA D, 1992, CELL STRUCT FUNCT, V17, P113; BEERS EP, 1993, J BIOL CHEM, V268, P21645; BRIZZARD BL, 1994, BIOTECHNIQUES, V16, P730; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHEN J, 1992, MOL CELL BIOL, V12, P3470, DOI 10.1128/MCB.12.8.3470; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; CIECHANOVER A, 1984, CELL, V37, P43; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; DOHMEN RJ, 1991, YEAST, V7, P691, DOI 10.1002/yea.320070704; DUNN TM, 1990, MOL CELL BIOL, V10, P2308, DOI 10.1128/MCB.10.5.2308; ECKER DJ, 1987, J BIOL CHEM, V262, P3524; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1983, BIOCHEMISTRY-US, V22, P4388, DOI 10.1021/bi00288a007; HANDLEY PM, 1991, P NATL ACAD SCI USA, V88, P258, DOI 10.1073/pnas.88.1.258; HATFIELD PM, 1990, J BIOL CHEM, V265, P15813; HATFIELD PM, 1992, J BIOL CHEM, V267, P14799; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HERSKOWITZ I, 1986, METHOD ENZYMOL, V194, P132; Hochstrasser Mark, 1992, Current Opinion in Cell Biology, V4, P1024, DOI 10.1016/0955-0674(92)90135-Y; HOFFMANN A, 1991, NUCLEIC ACIDS RES, V19, P6337, DOI 10.1093/nar/19.22.6337; HOVLAND P, 1989, GENE, V83, P57, DOI 10.1016/0378-1119(89)90403-4; IMAI N, 1992, GENE, V118, P279, DOI 10.1016/0378-1119(92)90200-9; JENTSCH S, 1992, ANNU REV GENET, V26, P177; JOHNSON ME, 1987, J BACTERIOL, V169, P117, DOI 10.1128/jb.169.1.117-125.1987; KAY GF, 1991, NATURE, V354, P486, DOI 10.1038/354486a0; KOK K, 1993, P NATL ACAD SCI USA, V90, P6071, DOI 10.1073/pnas.90.13.6071; KULKA RG, 1988, J BIOL CHEM, V263, P15726; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEYSER HMO, 1993, NATURE, V364, P161, DOI 10.1038/364161a0; LINGNER J, 1991, NATURE, V354, P496, DOI 10.1038/354496a0; MADURA K, 1993, J BIOL CHEM, V268, P12046; MCGRATH JP, 1991, EMBO J, V10, P27; MENDENHALL MD, 1988, NUCLEIC ACIDS RES, V16, P8713, DOI 10.1093/nar/16.17.8713; MINVIELLESEBAST.L, 1994, SCIENCE, V266, P1702; MITCHELL MJ, 1991, NATURE, V354, P483, DOI 10.1038/354483a0; NISHITANI H, 1992, BIOCHEM BIOPH RES CO, V184, P1015, DOI 10.1016/0006-291X(92)90692-E; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; PICKART CM, 1994, J BIOL CHEM, V269, P7115; PICKART CM, 1988, UBIQUITIN, P77; RECHSTEINER M, 1991, CELL, V66, P615, DOI 10.1016/0092-8674(91)90104-7; ROTHSTEIN R, 1993, METHOD ENZYMOL, V194, P281; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sherman F., 1986, METHODS YEAST GENETI; SIKORSKI RS, 1986, GENETICS, V122, P19; STRUHL K, 1979, P NATL ACAD SCI USA, V76, P1035, DOI 10.1073/pnas.76.3.1035; SUNG P, 1991, EMBO J, V10, P2187, DOI 10.1002/j.1460-2075.1991.tb07754.x; VARSHAVSKY A, 1991, CELL, V69, P725; VIERSTRA RD, 1993, ANNU REV PLANT PHYS, V44, P385, DOI 10.1146/annurev.pp.44.060193.002125; WIERENGA RK, 1983, NATURE, V302, P842, DOI 10.1038/302842a0; WINSTON F, 1986, NUCLEIC ACIDS RES, V14, P6885, DOI 10.1093/nar/14.17.6885; YOUNG RA, 1983, SCIENCE, V222, P778, DOI 10.1126/science.6356359	63	165	169	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18099	18109		10.1074/jbc.270.30.18099	http://dx.doi.org/10.1074/jbc.270.30.18099			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629121	hybrid, Green Accepted			2022-12-27	WOS:A1995RM26600072
J	WITCHER, DR; DEWAARD, M; LIU, HY; PRAGNELL, M; CAMPBELL, KP				WITCHER, DR; DEWAARD, M; LIU, HY; PRAGNELL, M; CAMPBELL, KP			ASSOCIATION OF NATIVE CA2+ CHANNEL BETA-SUBUNITS WITH THE ALPHA(1) SUBUNIT INTERACTION DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICK SENSORY NEURONS; CALCIUM-CHANNEL; SKELETAL-MUSCLE; 1,4-DIHYDROPYRIDINE RECEPTOR; BRAIN; EXPRESSION; CLONING; IDENTIFICATION; RELEASE; BINDING	beta Subunits of voltage-dependent Ca2+ channels play an important role in regulating Ca2+ channel function. The sites of alpha(1)-beta subunit interaction have been localized recently to cytoplasmic domains of both subunits. The alpha(1) subunit interaction domain (AID) is an 18-amino-acid conserved motif located between repeats I and II on all alpha(1) subunits which is essential for the binding of beta subunits. In order to further study the interaction of beta subunits with AID, we have expressed a 50-amino-acid glutathione S-transferase (GST) fusion protein from the alpha(1A) subunit that contains the AID. Mutant GST fusion proteins that contain a single amino acid change (Y392S, Y392F, and Y392W) in the AID(A) along with control GST were coupled to glutathione-Sepharose beads to form affinity beads. Binding assays using these affinity beads with in vitro synthesized S-35-labeled beta(2) and beta(3) subunits demonstrate that the hydroxyl group on tyrosine 392 of AID(A) is critical for binding to beta subunits. The affinity bead assay was also used to identify and characterize native beta subunits from detergent extracts of different tissues. The AID(A) affinity beads, but not the control or Y392S beads, specifically bind beta subunits from detergent extracts of skeletal muscle, cardiac muscle, and brain. Immunoblot analyses demonstrate the presence of beta(1a) in skeletal muscle, beta(2) and beta(3) in cardiac muscle, and beta(1b), beta(3), and beta(4) in brain. The assays also demonstrate the AID(A) beads bind to beta subunits from tissue homogenates extracted with low salt and no detergent suggesting the existence of a pool of beta subunits which is not always associated with alpha(1) subunits. Also, beta subunits from solubilized skeletal muscle triads can be affinity-purified using AID(A) CNBr-Sepharose. Our data demonstrate that the AID binds to native beta subunits from detergent and non-detergent tissue extracts illustrating that this domain on the alpha(1) subunit is the major anchoring site for the beta subunit.	UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242; UNIV IOWA,COLL MED,PROGRAM NEUROSCI,IOWA CITY,IA 52242	Howard Hughes Medical Institute; University of Iowa; University of Iowa			De Waard, Michel/G-7406-2014	De Waard, Michel/0000-0002-2782-9615; Campbell, Kevin/0000-0003-2066-5889	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007343] Funding Source: NIH RePORTER; NIAID NIH HHS [T32-AI07343] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BIRNBAUMER L, 1994, NEURON, V13, P503; CASTELLANO A, 1993, J BIOL CHEM, V268, P12359; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; De Waard M., 1995, Biophysical Journal, V68, pA13; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; JAHN H, 1988, EUR J BIOCHEM, V178, P535, DOI 10.1111/j.1432-1033.1988.tb14480.x; KOMURO H, 1992, SCIENCE, V257, P806, DOI 10.1126/science.1323145; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEUNG AT, 1987, J BIOL CHEM, V262, P7943; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; MILLER RJ, 1992, J BIOL CHEM, V267, P1403; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; NISHIMURA S, 1993, FEBS LETT, V324, P283, DOI 10.1016/0014-5793(93)80135-H; OLCESE R, 1994, NEURON, V13, P1433, DOI 10.1016/0896-6273(94)90428-6; PEREZREYES E, 1990, J BIOL CHEM, V265, P20430; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; POWERS PA, 1992, J BIOL CHEM, V267, P22967; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; PRAGNELL M, 1991, FEBS LETT, V291, P253, DOI 10.1016/0014-5793(91)81296-K; RUTH P, 1989, SCIENCE, V245, P1115, DOI 10.1126/science.2549640; SHARP AH, 1987, J BIOL CHEM, V262, P12309; SHARP AH, 1989, J BIOL CHEM, V264, P2816; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; WITCHER DR, 1994, J BIOL CHEM, V269, P13076; WITCHER DR, 1993, SCIENCE, V261, P486, DOI 10.1126/science.8392754; WITCHER DR, 1993, NEUROPHARMACOLOGY, V32, P1127, DOI 10.1016/0028-3908(93)90007-P	34	78	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18088	18093		10.1074/jbc.270.30.18088	http://dx.doi.org/10.1074/jbc.270.30.18088			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629119	hybrid			2022-12-27	WOS:A1995RM26600070
J	KISHIGAMI, S; KANAYA, E; KIKUCHI, M; ITO, K				KISHIGAMI, S; KANAYA, E; KIKUCHI, M; ITO, K			DSBA-DSBB INTERACTION THROUGH THEIR ACTIVE-SITE CYSTEINES - EVIDENCE FROM AN ODD CYSTEINE MUTANT OF DSBA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							DISULFIDE BOND FORMATION; FORMATION INVIVO; ALKALINE-PHOSPHATASE; PERIPLASMIC ENZYME; IN-VIVO; IDENTIFICATION; PRODUCT; INVITRO	Formation of disulfide bonds in Escherichia coli envelope proteins is facilitated by the Dsb system, which is thought to consist of at least two components, a periplasmic soluble enzyme (DsbA) and a membrane-bound factor (DsbB), Although it is believed that DsbA directly oxidizes substrate cysteines and DsbB reoxidizes DsbA to allow multiple rounds of reactions, direct evidence for the DsbA-DsbB interaction has been lacking, We examined intracellular activities of mutant forms of DsbA, DsbA30S and DsbA33S, in which one of its active site cysteines (Cys(30) or Cys(33), respectively) has been replaced by serine, The DsbA33S protein was found to dominantly interfere with the disulfide bond formation and to form intermolecular disulfide bonds with numerous other proteins when cells were grown in media containing low molecular weight disulfides such as GSSG. In the absence of added GSSG, DsbA33S protein remained specifically disulfide-bonded with DsbB, These in vivo results not only confirm the previous findings that Cys(30) of DsbA is hyper-reactive in vitro but provide evidence that DsbA indeed interacts selectively with DsbB. We propose that the Cys(30)-mediated DsbA-DsbB complex represents an intermediate state of DsbA-DsbB recycling reaction that has been fixed because of the absence of Cys(33) on DsbA.	KYOTO UNIV,INST VIRUS RES,DEPT CELL BIOL,SAKYO KU,KYOTO 60601,JAPAN; PROT ENGN RES INST,SUITA,OSAKA 565,JAPAN	Kyoto University				Kishigami, Satoshi/0000-0001-9447-5100				AKIYAMA Y, 1992, J BIOL CHEM, V267, P22440; AKIYAMA Y, 1994, J BIOL CHEM, V269, P5218; AKIYAMA Y, 1993, J BIOL CHEM, V268, P8146; BARDWELL JCA, 1993, CELL, V74, P769, DOI 10.1016/0092-8674(93)90455-Y; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; BARDWELL JCA, 1994, MOL MICROBIOL, V14, P199, DOI 10.1111/j.1365-2958.1994.tb01281.x; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; ITO K, 1993, CELL, V32, P789; JANDER G, 1994, EMBO J, V13, P5121, DOI 10.1002/j.1460-2075.1994.tb06841.x; KAMITANI S, 1992, EMBO J, V11, P57, DOI 10.1002/j.1460-2075.1992.tb05027.x; KANAYA E, 1994, J BIOL CHEM, V269, P4273; KISHIGAMI S, 1995, FEBS LETT, V364, P55, DOI 10.1016/0014-5793(95)00354-C; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; MISSIAKAS D, 1994, EMBO J, V13, P2013, DOI 10.1002/j.1460-2075.1994.tb06471.x; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; WUNDERLICH M, 1993, J MOL BIOL, V233, P559, DOI 10.1006/jmbi.1993.1535; YU J, 1993, J BIOL CHEM, V268, P4326; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016; ZAPUN A, 1994, BIOCHEMISTRY-US, V33, P1907, DOI 10.1021/bi00173a038	21	99	101	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17072	17074		10.1074/jbc.270.29.17072	http://dx.doi.org/10.1074/jbc.270.29.17072			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615498	hybrid			2022-12-27	WOS:A1995RK68900005
J	MCGWIRE, GB; SKIDGEL, RA				MCGWIRE, GB; SKIDGEL, RA			EXTRACELLULAR CONVERSION OF EPIDERMAL GROWTH-FACTOR (EGF) TO DES-ARG(53)-EGF BY CARBOXYPEPTIDASE-M	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-BOUND CARBOXYPEPTIDASE; CANINE KIDNEY-CELLS; UROGASTRONE; PURIFICATION; TRANSCYTOSIS; ENDOSOMES; TRANSPORT; NERVE	Epidermal growth factor (EGF) is a 53-amino-acid mitogenic polypeptide present in a variety of tissues and fluids including kidney, urine, and amniotic fluid, An EGF isoform, des-Arg(53)-EGF, has been identified in urine and is the earliest metabolite generated in target cells upon EGF binding, In this study, purified carboxypeptidase M efficiently released the COOH-terminal arginine residue from EGF with a K-m = 56 mu M, k(cat) = 388 min(-1), and k(cat)/K-m = 6.9 mu M(-1) min(-1), When EGF was incubated with urine or amniotic fluid, des-Arg(53)-EGF was the only metabolite detected, This conversion was blocked by immunoprecipitation with specific antiserum to carboxypeptidase M or by 10 mu M DL-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid (a carboxypeptidase M inhibitor), indicating that the major EGF metabolizing enzyme in these fluids is carboxypeptidase M. When incubated on a confluent monolayer of Madin-Darby canine kidney (MDCK) cells, EGF was readily converted to a single metabolite, des-Arg(53)-EGF, by carboxypeptidase M, To investigate one possible functional consequence of this conversion, mitogenic activities of EGF and des-Arg(53)-EGF were tested, Both peptides were equipotent in stimulating [H-3]thymidine incorporation in MDCK cells at all doses tested, In addition, inhibition of the conversion of EGF to des-Arg(53)-EGF by the carboxypeptidase M inhibitor did not affect the mitogenic potency of EGF. These data indicate that carboxypeptidase M, present in a variety of cells and biological fluids, can convert EGF to des-Arg(53)-EGF, However, in contrast to many other peptide hormones whose activity depends on a final carboxypeptidase processing step, removal of Arg(53) of EGF is not required for its mitogenic activity.	UNIV ILLINOIS, COLL MED, DEPT PHARMACOL MC 868, CHICAGO, IL 60612 USA; UNIV ILLINOIS, COLL MED, DEPT ANESTHESIOL, PEPTIDE RES LAB, CHICAGO, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital			McGwire, Gerd/E-3638-2011		NIDDK NIH HHS [DK41431] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK041431, R01DK041431, R56DK041431] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRANDLI AW, 1991, J BIOL CHEM, V266, P8560; BURGESS AW, 1988, BIOCHEMISTRY-US, V27, P4977, DOI 10.1021/bi00414a005; CARPENTER G, 1990, HDB EXPT PHARM, V95, P69; DEDDISH PA, 1990, J BIOL CHEM, V265, P15083; FAHNESTOCK M, 1991, CURR TOP MICROBIOL, V165, P1; FISHER DA, 1989, ANNU REV PHYSIOL, V51, P67, DOI 10.1146/annurev.physiol.51.1.67; GOODYER PR, 1988, AM J PHYSIOL, V255, pF1191, DOI 10.1152/ajprenal.1988.255.6.F1191; GREGORY H, 1988, REGUL PEPTIDES, V22, P217, DOI 10.1016/0167-0115(88)90034-1; GREGORY H, 1975, NATURE, V257, P325, DOI 10.1038/257325a0; HAUGUELDEMOUZON S, 1992, J CELL PHYSIOL, V150, P180, DOI 10.1002/jcp.1041500124; HOLLENBERG MD, 1980, MOL PHARMACOL, V17, P314; JAHNKE GD, 1994, ENDOCRINOLOGY, V135, P2022, DOI 10.1210/en.135.5.2022; JORGENSEN PE, 1994, GROWTH FACTORS, V11, P113, DOI 10.3109/08977199409001053; MARATOSFLIER E, 1987, J CELL BIOL, V105, P1595, DOI 10.1083/jcb.105.4.1595; MCGWIRE GB, 1995, FASEB J, V9, pA692; NAGAE A, 1993, AM J RESP CELL MOL, V9, P221, DOI 10.1165/ajrcmb/9.2.221; NAGAE A, 1992, J NEUROCHEM, V59, P2201; NICHOLS RA, 1985, DEV NEUROSCI-BASEL, V7, P216, DOI 10.1159/000112290; OLSEN PS, 1984, REGUL PEPTIDES, V10, P37, DOI 10.1016/0167-0115(84)90051-X; PLANCK SR, 1984, J BIOL CHEM, V259, P3053; RAO RK, 1990, PEPTIDES, V11, P1093, DOI 10.1016/0196-9781(90)90136-S; RENFREW CA, 1991, J BIOL CHEM, V266, P4348; SCHAUDIES RP, 1986, ENDOCRINOLOGY, V118, P875, DOI 10.1210/endo-118-2-875; SCHAUDIES RP, 1987, BIOCHEM BIOPH RES CO, V143, P710, DOI 10.1016/0006-291X(87)91412-4; SERVER AC, 1976, J BIOL CHEM, V251, P1188; SKIDGEL RA, 1989, J BIOL CHEM, V264, P2236; SKIDGEL RA, 1988, TRENDS PHARMACOL SCI, V9, P299, DOI 10.1016/0165-6147(88)90015-6; SKIDGEL RA, 1984, ANAL BIOCHEM, V140, P520, DOI 10.1016/0003-2697(84)90203-3; SKIDGEL RA, 1984, BIOCHEM PHARMACOL, V33, P3471, DOI 10.1016/0006-2952(84)90122-9; STEINER DF, 1992, J BIOL CHEM, V267, P23435; TAN F, 1995, IN PRESS METHODS ENZ, V248; TAN FL, 1989, J BIOL CHEM, V264, P13165; VEHASKARI VM, 1991, AM J PHYSIOL, V261, pF896, DOI 10.1152/ajprenal.1991.261.5.F896; WARDEN DH, 1993, AM J PHYSIOL, V264, pF670, DOI 10.1152/ajprenal.1993.264.4.F670	34	37	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17154	17158		10.1074/jbc.270.29.17154	http://dx.doi.org/10.1074/jbc.270.29.17154			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615511	hybrid			2022-12-27	WOS:A1995RK68900018
J	FISCHER, WN; KWART, M; HUMMEL, S; FROMMER, WB				FISCHER, WN; KWART, M; HUMMEL, S; FROMMER, WB			SUBSTRATE-SPECIFICITY AND EXPRESSION PROFILE OF AMINO-ACID TRANSPORTERS (AAPS) IN ARABIDOPSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; PERMEASE; THALIANA; MUTANTS; CLONING; COMPLEMENTATION; PLANTS; LEAVES; SUGAR	Three amino acid transporter genes (AAP3-5) were isolated from Arabidopsis by complementation of a yeast mutant defective in histidine uptake. Transport is driven against a concentration gradient and sensitive to protonophores. Analysis of the substrate specificity demonstrates that the carriers have a broad substrate specificity covering the major transport forms of reduced nitrogen, i.e. glutamine and glutamate. The transporters have similar affinities for glutamate, glutamine, and alanine but differ with respect to valine, phenylalanine, histidine, arginine, and lysine. AAP3 and AAP5 efficiently transport arginine and lysine and are involved in basic amino acid transport. The predicted polypeptides of 53 kDa are highly hydrophobic with 12 putative membrane-spanning regions and show significant homologies to Arabidopsis amino acid transporters AAP1 and AAP2. Each of the genes has a different organ-specific expression in the plant, AAP3 is exclusively expressed in roots and AAP4 mainly in source leaves, stems, and flowers, whereas AAP5 is found in all tissues. The specific distribution in the plant and the different substrate specificities of AAP transporters may indicate that tissues differ both qualitatively and quantitatively regarding import or export of amino acids.	INST GENBIOL FORSCH,D-14195 BERLIN,GERMANY				Frommer, Wolf B/K-5042-2017; Frommer, Wolf B/A-8256-2008	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115				BORSTLAP AC, 1985, PLANTA, V166, P141, DOI 10.1007/BF00397397; BRIGHT SWJ, 1983, PLANT PHYSIOL, V72, P821, DOI 10.1104/pp.72.3.821; BUSH DR, 1993, ANNU REV PLANT PHYS, V44, P513, DOI 10.1146/annurev.pp.44.060193.002501; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOHMEN RJ, 1991, YEAST, V7, P691, DOI 10.1002/yea.320070704; Feller U, 1991, RECENT ADV PHLOEM TR, P91; FROMMER WB, 1994, FEBS LETT, V347, P185, DOI 10.1016/0014-5793(94)00533-8; FROMMER WB, 1994, PLANT MOL BIOL, V26, P1651, DOI 10.1007/BF00016495; FROMMER WB, 1993, P NATL ACAD SCI USA, V90, P5944, DOI 10.1073/pnas.90.13.5944; HSU LC, 1993, P NATL ACAD SCI USA, V90, P7441, DOI 10.1073/pnas.90.16.7441; JAUNIAUX JC, 1987, EUR J BIOCHEM, V164, P601, DOI 10.1111/j.1432-1033.1987.tb11169.x; JESCHKE WD, 1991, RECENT ADV PHLOEM TR, P96; KWART M, 1993, PLANT J, V4, P993, DOI 10.1046/j.1365-313X.1993.04060993.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LI ZC, 1990, PLANT PHYSIOL, V94, P268, DOI 10.1104/pp.94.1.268; MARIONPOLL A, 1988, THEOR APPL GENET, V75, P272, DOI 10.1007/BF00303963; MINET M, 1992, PLANT J, V2, P417; Pate J.S., 1975, TRANSPORT PLANTS, P451, DOI 10.1007/978-3-642-66161-7_19; PEOPLES MB, 1990, PLANT PHYSL BIOCH MO, P442; RIENS B, 1991, PLANT PHYSIOL, V97, P227, DOI 10.1104/pp.97.1.227; RIESMEIER JW, 1991, EMBO J, V13, P1; TANAKA J, 1985, GENE, V38, P205, DOI 10.1016/0378-1119(85)90219-7; VONSCHAEWEN A, 1990, EMBO J, V9, P3033, DOI 10.1002/j.1460-2075.1990.tb07499.x	23	172	193	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16315	16320		10.1074/jbc.270.27.16315	http://dx.doi.org/10.1074/jbc.270.27.16315			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608199	hybrid			2022-12-27	WOS:A1995RH22600066
J	NELSON, TR; CHARONIS, AS; MCIVOR, RS; BUTKOWSKI, RJ				NELSON, TR; CHARONIS, AS; MCIVOR, RS; BUTKOWSKI, RJ			IDENTIFICATION OF A CDNA-ENCODING TUBULOINTERSTITIAL NEPHRITIS ANTIGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE ANTIBODIES; PROTEINS; DISEASE; KIDNEY	Tubulointerstitial nephritis antigen (TIN-ag) is a 58-kDa basement membrane glycoprotein that is recognized by human autoantibodies in certain forms of tubulointerstitial nephritis. To further characterize this macromolecule and isolate cDNAs encoding TIN-ag, amino acid sequences from tryptic peptides were used to design and synthesize primers in order to amplify a probe for screening a rabbit kidney cortex cDNA library, A cDNA encoding TIN-ag was cloned and sequenced. The predicted amino acid sequence deduced from this cDNA includes the chemically determined sequences of peptides derived from TIN-ag, supporting its authenticity. The predicted amino acid sequence also shows that the carboxyl-terminal region of the molecule exhibits a 30% homology with human preprocathepsin B, a member of the cysteine proteinase family of proteins, A domain in the amino-terminal region of TIN-ag contains an epidermal growth factor-like motif that shares homology with laminin A and S chains, alpha 1 chain of type I collagen, von Willebrand's factor, and mucin, suggesting structural and perhaps functional similarities among these molecules, Immunoprecipitation of in vitro generated recombinant protein using a TIN-ag-specific monoclonal antibody (AS), confirms the identity of the isolated TIN-ag cDNA, In this report the cDNA and predicted amino acid sequences of TIN-ag are presented, Knowledge of the primary structure of TIN-ag will facilitate our understanding of the molecular structure of this novel basement membrane component and may provide clues toward understanding its functional role.	UNIV MINNESOTA,SCH MED,DEPT PATHOL & LAB MED,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,SCH MED,DEPT PEDIAT,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,SCH MED,INST HUMAN GENET,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities				Charonis, Aristidis/0000-0001-9956-732X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043569, R01DK036007] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 43569, DK 36007] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDRES GA, 1987, RENAL BASEMENT MEMBR, P431; BUTKOWSKI RJ, 1990, J BIOL CHEM, V265, P21091; BUTKOWSKI RJ, 1991, KIDNEY INT, V40, P838, DOI 10.1038/ki.1991.283; CLAYMAN MD, 1985, J EXP MED, V161, P290, DOI 10.1084/jem.161.2.290; COLVIN RB, 1994, RENAL PATHOLOGY, P728; COOPER AA, 1993, BIOESSAYS, V15, P667, DOI 10.1002/bies.950151006; DUFOUR E, 1988, BIOCHIMIE, V70, P1335, DOI 10.1016/0300-9084(88)90004-1; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; GRAINDORGE PP, 1978, KIDNEY INT, V14, P594, DOI 10.1038/ki.1978.168; HEIJNE G, 1985, J MOL BIOL, V184, P99; KALFA TA, 1994, J BIOL CHEM, V269, P1654; KAMPHUIS IG, 1985, J MOL BIOL, V262, P14448; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maniatis T., 1982, MOL CLONING; NEVINS JR, 1983, ANNU REV BIOCHEM, V52, P441, DOI 10.1146/annurev.bi.52.070183.002301; NIELSON EG, 1991, P NATL ACAD SCI USA, V88, P2006; OHNO S, 1984, NATURE, V312, P566, DOI 10.1038/312566a0; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAKASHIN Y, 1981, CLIN IMMUNOL IMMUNOP, V19, P360, DOI 10.1016/0090-1229(81)90079-9; YOSHIOKA K, 1992, CLIN EXP IMMUNOL, V90, P319; YOSHIOKA K, 1986, J IMMUNOL, V136, P1654; ZANETTI M, 1983, J IMMUNOL, V130, P2173	24	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16265	16270		10.1074/jbc.270.27.16265	http://dx.doi.org/10.1074/jbc.270.27.16265			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608193	hybrid			2022-12-27	WOS:A1995RH22600059
J	VALENZANO, KJ; REMMLER, J; LOBEL, P				VALENZANO, KJ; REMMLER, J; LOBEL, P			SOLUBLE INSULIN-LIKE GROWTH-FACTOR-II MANNOSE 6-PHOSPHATE RECEPTOR CARRIES MULTIPLE HIGH-MOLECULAR-WEIGHT FORMS OF INSULIN-LIKE GROWTH-FACTOR II IN FETAL BOVINE SERUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IGF-II; POLYACRYLAMIDE GELS; BINDING-PROTEINS; RAT; PURIFICATION; ARGININE; RESIDUES; SEQUENCE; VARIANT	We have characterized a soluble form of the insulinlike growth factor II/mannose 6-phosphate receptor (sIGF-II/MPR) and bound ligands from bovine serum. Fetal serum contained 2-8 mg/liter sIGF-II/MPR. Affinity-purified receptor isolated by adsorption to phosphomannan-agarose and elution with mannose 6-phosphate contained nearly stoichiometric amounts of bound 7.5-kDa IGF-II. In addition, at least 12 distinct 12-20-kDa proteins immunologically related to IGF-II also copurified with receptor. Receptor was separated from its associated ligands by acidification and gel filtration chromatography. Sequence analysis revealed that the 12-20-kDa proteins have the same amino termini as mature 7.5-kDa IGF-II. Protease and glycosidase treatments revealed that the different high molecular weight IGF-II species contain an identical COOH-terminal extension that is differentially glycosylated with O-linked sugars. Radiolabeled tracer experiments demonstrated that the sIGF-II/MPR carries similar to 1/4 of the IGF-II in fetal bovine serum. These results support a significant role for sIGF-II/MPR in the transport of circulating IGF-II isoforms during development.	CTR ADV BIOTECHNOL & MED,PISCATAWAY,NJ 08854; UNIV MED & DENT NEW JERSEY,DEPT PHARMACOL,PISCATAWAY,NJ 08854	Rutgers State University New Brunswick; Rutgers State University Medical Center					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008339] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM08339] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNER P, 1989, DIABETOLOGIA, V32, P753, DOI 10.1007/BF00274537; BANKER GA, 1972, J BIOL CHEM, V247, P5856; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAUSIN C, 1988, BIOCHEM J, V252, P795, DOI 10.1042/bj2520795; CHEN HJ, 1993, J BIOL CHEM, V268, P22338; CLEMMONS DR, 1993, MOL REPROD DEV, V35, P368, DOI 10.1002/mrd.1080350409; DAHMS NM, 1993, J BIOL CHEM, V268, P5457; DAHMS NM, 1994, J BIOL CHEM, V269, P3802; DAUGHADAY WH, 1993, P NATL ACAD SCI USA, V90, P5823, DOI 10.1073/pnas.90.12.5823; DAUGHADAY WH, 1987, METHOD ENZYMOL, V146, P248; DEIBLER GE, 1975, J BIOL CHEM, V250, P7931; FIELDER K, 1994, CELL, V77, P625; FILSON AJ, 1993, DEVELOPMENT, V118, P761; FROST AA, 1953, KINETICS MECHANISM, P178; GARMROUDI F, 1994, J BIOL CHEM, V269, P26944; GELATO MC, 1989, ENDOCRINOLOGY, V124, P2935, DOI 10.1210/endo-124-6-2935; GELATO MC, 1988, J CLIN ENDOCR METAB, V67, P669, DOI 10.1210/jcem-67-4-669; HAMPTON B, 1989, J BIOL CHEM, V264, P19155; HOFLACK B, 1993, ADV CELL MOL BIOL M, V1, P51; HONEGGER A, 1986, J BIOL CHEM, V261, P569; HUDGINS WR, 1992, J BIOL CHEM, V267, P8153; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; KIESS W, 1987, J BIOL CHEM, V262, P12745; KIESS W, 1987, P NATL ACAD SCI USA, V84, P7720, DOI 10.1073/pnas.84.21.7720; KIESS W, 1989, J BIOL CHEM, V264, P4710; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamson G, 1991, Growth Factors, V5, P19, DOI 10.3109/08977199109000268; Lentner C, 1984, GEIGY SCI TABLES, V3, P78; LI M, 1991, Glycobiology, V1, P511, DOI 10.1093/glycob/1.5.511; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; LOBEL P, 1988, J BIOL CHEM, V263, P2563; MCCUMBER LJ, 1976, BIOCHIM BIOPHYS ACTA, V446, P536, DOI 10.1016/0005-2795(76)90020-9; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; NISHIMOTO I, 1991, MODERN CONCEPTS INSU, P517; OKA Y, 1985, J BIOL CHEM, V260, P9435; RECHLER MM, 1991, INSULIN LIKE GROWTH, P87; SAHAGIAN GG, 1982, METHOD ENZYMOL, V83, P392; SAIRAM MR, 1989, FASEB J, V3, P1915, DOI 10.1096/fasebj.3.8.2542111; TONG PY, 1988, J BIOL CHEM, V263, P2585; TONG PY, 1989, J BIOL CHEM, V264, P7962; VALENZANO KJ, 1993, ANAL BIOCHEM, V209, P156, DOI 10.1006/abio.1993.1096; WHITE RM, 1982, J CLIN INVEST, V69, P1239, DOI 10.1172/JCI110563; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; YANG YWH, 1991, ENDOCRINOLOGY, V128, P1177, DOI 10.1210/endo-128-2-1177; ZUMSTEIN PP, 1985, P NATL ACAD SCI USA, V82, P3169, DOI 10.1073/pnas.82.10.3169	47	48	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16441	16448		10.1074/jbc.270.27.16441	http://dx.doi.org/10.1074/jbc.270.27.16441			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608216	hybrid			2022-12-27	WOS:A1995RH22600084
J	BROWN, LS; SASAKI, J; KANDORI, H; MAEDA, A; NEEDLEMAN, R; LANYI, JK				BROWN, LS; SASAKI, J; KANDORI, H; MAEDA, A; NEEDLEMAN, R; LANYI, JK			GLUTAMIC-ACID-204 IS THE TERMINAL PROTON RELEASE GROUP AT THE EXTRACELLULAR SURFACE OF BACTERIORHODOPSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE C-13; SCHIFF-BASE; VIBRATIONAL SPECTROSCOPY; STRUCTURAL-CHANGES; PHOTOCYCLE; TRANSLOCATION; MUTANTS; MECHANISM; ASP-96; ARG-82	We have measured proton release into the medium after proton transfer from the retinal Schiff base to Asp(85) in the photocycle and the C=O stretch bands of carboxylic acids in wild type bacteriorhodopsin and the E204Q and E204D mutants. In E204Q, but not in E204D, the normal proton release is absent. Consistent with this, a negative band in the Fourier transform infrared difference spectra at 1700 cm(-1) in the wild type, which we now attribute to depletion of the protonated E204, is also absent in E204Q, In E204D, this band is shifted to 1714 cm(-1), as expected from the higher frequency for a protonated aspartic than for a glutamic acid. Consistent with their origin from protonated carboxyls, the depletion bands in the wild type and E204D shift in D2O to 1690 and 1703 cm(-1), respectively. In the protein structure, Glu(204) seems to be connected to the Schiff base region by a chain of hydrogen-bonded water. As with other residues closer to the Schiff base, replacement of Glu(204) with glutamine changes the O-H stretch frequency of the bound water molecule near Asp(85) that undergoes hydrogen-bonding change in the photocycle. The results therefore identify Glu(204) as XH, the earlier postulated residue that is the source of the released proton during the transport, and suggest that its deprotonation is triggered by the protonation of Asp(85) through a network that contains water dipoles.	UNIV CALIF IRVINE, DEPT PHYSIOL & BIOPHYS, IRVINE, CA 92717 USA; KYOTO UNIV, FAC SCI, DEPT BIOPHYS, KYOTO 60601, JAPAN; WAYNE STATE UNIV, SCH MED, DEPT BIOCHEM, DETROIT, MI 48201 USA	University of California System; University of California Irvine; Kyoto University; Wayne State University			Brown, Leonid/A-1050-2008; Brown, Leonid/X-7445-2019; Lanyi, Janos/C-3808-2011	Brown, Leonid/0000-0002-5614-8317; Brown, Leonid/0000-0002-5614-8317; 	NIGMS NIH HHS [GM 29498] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029498, R01GM029498] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMES JB, 1990, J AM CHEM SOC, V112, P9007, DOI 10.1021/ja00180a071; BALASHOV SP, 1993, BIOCHEMISTRY-US, V32, P10331, DOI 10.1021/bi00090a008; BALASHOV SP, 1992, COLLOQ INSE, V221, P111; BOUSCHE O, 1991, J BIOL CHEM, V266, P11063; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; BRAIMAN MS, 1994, BIOCHEMISTRY-US, V33, P1629, DOI 10.1021/bi00173a003; BROWN LS, 1994, BIOCHEMISTRY-US, V33, P12001, DOI 10.1021/bi00206a001; BROWN LS, 1993, BIOPHYS J, V65, P124, DOI 10.1016/S0006-3495(93)81064-6; BROWN LS, 1995, IN PRESS BIOPHYS J; CAO Y, 1993, BIOCHEMISTRY-US, V32, P10239, DOI 10.1021/bi00089a046; CAO Y, 1993, BIOCHEMISTRY-US, V32, P1981, DOI 10.1021/bi00059a015; DEGROOT HJM, 1990, BIOCHEMISTRY-US, V29, P6873, DOI 10.1021/bi00481a017; DEGROOT HJM, 1989, BIOCHEMISTRY-US, V28, P3346, DOI 10.1021/bi00434a033; DER A, 1991, P NATL ACAD SCI USA, V88, P4751, DOI 10.1073/pnas.88.11.4751; Ebrey T.G., 1993, THERMODYNAMICS MEMBR, P353; EISENSTEIN L, 1987, J AM CHEM SOC, V109, P6860, DOI 10.1021/ja00256a055; FAHMY K, 1992, PHOTOCHEM PHOTOBIOL, V56, P1073, DOI 10.1111/j.1751-1097.1992.tb09731.x; FISCHER WB, 1994, BIOCHEMISTRY-US, V33, P12757, DOI 10.1021/bi00209a005; HEBERLE J, 1992, P NATL ACAD SCI USA, V89, P5996, DOI 10.1073/pnas.89.13.5996; HERZFELD J, 1990, BIOCHEMISTRY-US, V29, P5567, DOI 10.1021/bi00475a022; HUMPHREY W, 1994, BIOCHEMISTRY-US, V33, P3668, DOI 10.1021/bi00178a025; KANDORI H, 1995, J AM CHEM SOC, V117, P2118, DOI 10.1021/ja00112a036; KATAOKA M, 1994, J MOL BIOL, V243, P621, DOI 10.1016/0022-2836(94)90037-X; KONO M, 1993, FEBS LETT, V331, P31, DOI 10.1016/0014-5793(93)80291-2; KREBS MP, 1993, J BACTERIOL, V175, P1555, DOI 10.1128/JB.175.6.1555-1560.1993; LANYI JK, 1993, BIOCHIM BIOPHYS ACTA, V1183, P241, DOI 10.1016/0005-2728(93)90226-6; LOZIER RH, 1975, BIOPHYS J, V15, P955, DOI 10.1016/S0006-3495(75)85875-9; MAEDA A, 1994, BIOCHEMISTRY-US, V33, P1713, DOI 10.1021/bi00173a013; MAEDA A, 1992, BIOCHEMISTRY-US, V31, P462, DOI 10.1021/bi00117a023; MARTI T, 1992, J BIOL CHEM, V267, P16922; MATHIES RA, 1991, ANNU REV BIOPHYS BIO, V20, P491, DOI 10.1146/annurev.bb.20.060191.002423; MCDERMOTT AE, 1991, BIOCHEMISTRY-US, V30, P8366, DOI 10.1021/bi00098a013; NEEDLEMAN R, 1991, J BIOL CHEM, V266, P11478; Oesterhelt D, 1974, Methods Enzymol, V31, P667; OTTO H, 1990, P NATL ACAD SCI USA, V87, P1018, DOI 10.1073/pnas.87.3.1018; SASAKI J, 1994, BIOCHEMISTRY-US, V33, P3178, DOI 10.1021/bi00177a006; SCHARNAGL C, 1995, J PHYS CHEM-US, V99, P7787, DOI 10.1021/j100019a068; SUBRAMANIAM S, 1990, P NATL ACAD SCI USA, V87, P1013, DOI 10.1073/pnas.87.3.1013; SUBRAMANIAM S, 1993, EMBO J, V12, P1; THORGEIRSSON TE, 1991, BIOCHEMISTRY-US, V30, P9133, DOI 10.1021/bi00102a003; TITTOR J, 1994, BIOPHYS J, V67, P1682, DOI 10.1016/S0006-3495(94)80642-3; Tittor J, 1991, CURR OPIN STRUC BIOL, V1, P534, DOI 10.1016/S0959-440X(05)80074-0; VARO G, 1995, IN PRESS BIOCHEMISTR; YAMAZAKI Y, 1995, BIOCHEMISTRY-US, V34, P7088, DOI 10.1021/bi00021a021; ZIMANYI L, 1992, BIOCHEMISTRY-US, V31, P8535, DOI 10.1021/bi00151a022; ZIMANYI L, 1993, BIOCHEMISTRY-US, V32, P7669, DOI 10.1021/bi00081a010	47	279	281	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27122	27126		10.1074/jbc.270.45.27122	http://dx.doi.org/10.1074/jbc.270.45.27122			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592966	hybrid			2022-12-27	WOS:A1995TE58300066
J	COLASANTI, M; PERSICHINI, T; MENEGAZZI, M; MARIOTTO, S; GIORDANO, E; CALDARERA, CM; SOGOS, V; LAURO, GM; SUZUKI, H				COLASANTI, M; PERSICHINI, T; MENEGAZZI, M; MARIOTTO, S; GIORDANO, E; CALDARERA, CM; SOGOS, V; LAURO, GM; SUZUKI, H			INDUCTION OF NITRIC-OXIDE SYNTHASE MESSENGER-RNA EXPRESSION - SUPPRESSION BY EXOGENOUS NITRIC-OXIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MECHANISMS; BINDING; RNA	The reactive nitrogen species, nitric oxide (NO), plays an important role in the pathogenesis of neurodegenerative diseases, The suppression of NO production may be fundamental for survival of neurons. Here, we report that pretreatment of human ramified microglial cells with nearly physiological levels of exogenous NO prevents lipopolysaccharide (LPS)/tumor necrosis factor alpha (TNF alpha)-inducible NO synthesis, because by affecting NF-kappa B activation it inhibits inducible Ca2+-independent NO synthase isoform (iNOS) mRNA expression. Using reverse transcriptase polymerase chain reaction, we have found that both NO donor sodium nitroprusside (SNP) and authentic NO solution are able to inhibit LPS/TNF alpha-inducible iNOS gene expression; this effect was reversed by reduced hemoglobin, a trapping agent for NO. The early presence of SNP during LPS/TNF alpha induction is essential for inhibition of iNOS mRNA expression. Furthermore, SNP is capable of inhibiting LPS/TNF alpha-inducible nitrite release, as determined by Griess reaction, Finally, using electrophoretic mobility shift assay, we have shown that SNP inhibits LPS/TNF alpha-elicited NF-kappa B activation, This suggests that inhibition of iNOS gene expression by exogenous NO may be ascribed to a decreased NF-kappa B availability.	UNIV ROME 3, DEPT BIOL, I-00154 ROME, ITALY; UNIV BOLOGNA, DEPT BIOCHEM, I-40126 BOLOGNA, ITALY; UNIV CAGLIARI, DEPT CYTOMORPHOL, I-09124 CAGLIARI, ITALY; UNIV VERONA, INST BIOL CHEM, I-37134 VERONA, ITALY	Roma Tre University; University of Bologna; University of Cagliari; University of Verona			mariotto, sofia/AAH-5473-2019; Giordano, Emanuele/AAH-6448-2021; Sogos, Valeria/B-5471-2012; COLASANTI, MARCO/A-5616-2010; Menegazzi, Marta/AAE-7079-2019	Giordano, Emanuele/0000-0002-8054-2875; Sogos, Valeria/0000-0002-4021-1043; COLASANTI, MARCO/0000-0002-5752-4943; Menegazzi, Marta/0000-0003-1310-9227; PERSICHINI, TIZIANA/0000-0001-8291-6706				BOGDAN C, 1994, J LEUKOCYTE BIOL, V55, P227, DOI 10.1002/jlb.55.2.227; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; CHAO CC, 1992, J IMMUNOL, V149, P2736; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLASANTI M, 1995, NEUROSCI LETT, V195, P45, DOI 10.1016/0304-3940(95)11778-U; COLASANTI M, 1995, IN PRESS NEUROSCI LE; DAWSON VL, 1993, J NEUROSCI, V13, P2651; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; GOLDRING CEP, 1995, BIOCHEM BIOPH RES CO, V209, P73, DOI 10.1006/bbrc.1995.1472; GRISCAVAGE JM, 1993, J IMMUNOL, V151, P6329; MARIOTTO S, 1995, BRIT J PHARMACOL, V114, P1105, DOI 10.1111/j.1476-5381.1995.tb13320.x; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; MONCADA S, 1991, PHARMACOL REV, V43, P109; NUNOKAWA Y, 1994, BIOCHEM BIOPH RES CO, V200, P802, DOI 10.1006/bbrc.1994.1522; PARK SK, 1994, BIOCHEM BIOPH RES CO, V201, P762, DOI 10.1006/bbrc.1994.1766; PENG HB, 1995, J BIOL CHEM, V270, P14214, DOI 10.1074/jbc.270.23.14214; REILING N, 1994, EUR J IMMUNOL, V24, P1941, DOI 10.1002/eji.1830240836; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SUZUKI H, 1995, IN PRESS ADV NEUROIM; VODOVOTZ Y, 1993, J EXP MED, V178, P605, DOI 10.1084/jem.178.2.605; YOSHIZUMI M, 1993, CIRC RES, V73, P205, DOI 10.1161/01.RES.73.1.205	23	200	208	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26731	26733		10.1074/jbc.270.45.26731	http://dx.doi.org/10.1074/jbc.270.45.26731			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592903	hybrid			2022-12-27	WOS:A1995TE58300003
J	YETTER, A; UDDIN, S; KROLEWSKI, JJ; JIAO, HY; YI, TL; PLATANIAS, LC				YETTER, A; UDDIN, S; KROLEWSKI, JJ; JIAO, HY; YI, TL; PLATANIAS, LC			ASSOCIATION OF THE INTERFERON-DEPENDENT TYROSINE KINASE TYK-2 WITH THE HEMATOPOIETIC-CELL PHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MOTH-EATEN MICE; TRANSCRIPTION FACTOR; SH2 DOMAIN; PHOSPHORYLATION; ALPHA; EXPRESSION; MUTATIONS; RECEPTOR; GENE; JAK	The tyrosine kinase Tyk-2 is physically associated with the Type I interferon (IFN) receptor complex and is rapidly activated during IFN alpha stimulation. We report that Tyk-2 forms stable complexes with the SH2-containing hematopoietic cell phosphatase (HCP) in several hematopoietic cell lines in vivo, and that the IFN alpha-induced tyrosine-phosphorylated form of Tyk-2 is a substrate for the phosphatase activity of HCP in in vitro assays. Furthermore, treatment of cells with the phosphatase inhibitor sodium orthovanadate induces tyrosine phosphorylation of Tyk-2 and an associated 115-kDa protein. Altogether, these data suggest that HCP regulates tyrosine phosphorylation of the Tyk-2 kinase, and thus its function may be important in the transmission of signals generated at the Type I IFN receptor level.	LOYOLA UNIV,DIV HEMATOL ONCOL,MAYWOOD,IL 60153; EDWARD HINES VET ADM MED CTR,HINES,IL 60141; COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,COLUMBIA PRESBYTERIAN CANC CTR,NEW YORK,NY 10032; CLEVELAND CLIN FDN,RES INST,DEPT CANC BIOL,CLEVELAND,OH 44195	Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Columbia University; Columbia University; Cleveland Clinic Foundation				Uddin, Shahab/0000-0003-1886-6710	NATIONAL CANCER INSTITUTE [R01CA056862] Funding Source: NIH RePORTER; NCI NIH HHS [CA56862] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		COLAMONICI O, 1994, MOL CELL BIOL, V14, P8133, DOI 10.1128/MCB.14.12.8133; COLAMONICI OR, 1994, J BIOL CHEM, V269, P3518; COLAMONICI OR, 1994, J BIOL CHEM, V269, P5660; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVID M, 1993, J BIOL CHEM, V268, P6593; FU XY, 1992, CELL, V70, P323, DOI 10.1016/0092-8674(92)90106-M; GUTCH MJ, 1992, P NATL ACAD SCI USA, V8, P11411; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; KOZLOWSKI M, 1993, J EXP MED, V178, P2157, DOI 10.1084/jem.178.6.2157; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6; PETSKA S, 1987, ANNU REV BIOCHEM, V56, P727; PLATANIAS LC, 1994, J BIOL CHEM, V269, P3143; PLATANIAS LC, 1992, J BIOL CHEM, V267, P24053; PLATANIAS LC, 1994, J BIOL CHEM, V269, P17761; PLUTZKY J, 1992, P NATL ACAD SCI USA, V89, P1123, DOI 10.1073/pnas.89.3.1123; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; UCHIDA T, 1994, J BIOL CHEM, V269, P12220; UDDIN S, 1995, J BIOL CHEM, V270, P15938, DOI 10.1074/jbc.270.27.15938; UDDIN S, 1995, J BIOL CHEM, V270, P7712, DOI 10.1074/jbc.270.13.7712; YI TL, 1995, BLOOD, V85, P87, DOI 10.1182/blood.V85.1.87.bloodjournal85187; YI TL, 1992, MOL CELL BIOL, V12, P836, DOI 10.1128/MCB.12.2.836; YI TL, 1993, MOL CELL BIOL, V13, P7577, DOI 10.1128/MCB.13.12.7577; YI TL, 1993, MOL CELL BIOL, V13, P3350, DOI 10.1128/MCB.13.6.3350	31	96	105	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18179	18182		10.1074/jbc.270.31.18179	http://dx.doi.org/10.1074/jbc.270.31.18179			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629131	hybrid			2022-12-27	WOS:A1995RM64200002
J	CAO, YW; CRAWFORD, NM; SCHROEDER, JI				CAO, YW; CRAWFORD, NM; SCHROEDER, JI			AMINO-TERMINUS AND THE FIRST 4 MEMBRANE-SPANNING SEGMENTS OF THE ARABIDOPSIS K+ CHANNEL KAT1 CONFER INWARD-RECTIFICATION PROPERTY OF PLANT-ANIMAL CHIMERIC CHANNELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING POTASSIUM CHANNEL; FUNCTIONAL EXPRESSION; DROSOPHILA; GENE; CLONING; PROTEIN; FAMILY; MOUSE	The Arabidopsis hyperpolarization-activated (inward-rectifying) K+ channel KAT1 is structurally more similar to animal depolarization-activated (outward-rectifying) K+ channels than to animal hyperpolarization-activated K+ channels. To gain insight into the structural basis for the opposite voltage dependences of plant inward-rectifying and animal outward-rectifying K+ channels, we constructed recombinant chimeric channels between the hyperpolarization-activated K+ channel KAT1 and a Xenopus depolarization-activated K+ channel. We report here that two of the chimeric constructs, which contain the first third of the KAT1 sequence, including the first four membrane-spanning segments (S1-S4) and the linker sequence between the fourth and fifth membrane-spanning segments, express functional channels that retain activation by hyperpolarization, but not depolarization. These two chimeric channels are no longer selective for K+. The chimeras are selective for cations over anions and are permeable to Ca2+. Therefore, unlike animal hyperpolarization-activated K+ channels, in which the carboxyl terminus is important for inward rectification induced by Mg2+ and polyamine block, the plant KAT1 channel has its major determinants for inward rectification in the amino-terminal region, which ends at the end of the S4-S5 linker.	UNIV CALIF SAN DIEGO, DEPT BIOL 0116, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, CTR MOLEC GENET, LA JOLLA, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM040672, R01GM040672] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM40672] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; BEZANILLA F, 1994, ANNU REV BIOPH BIOM, V23, P819, DOI 10.1146/annurev.bb.23.060194.004131; BROWN AM, 1993, ANNU REV BIOPH BIOM, V22, P173, DOI 10.1146/annurev.bb.22.060193.001133; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; CAO Y, 1995, IN PRESS PLANT PHYSL; CAO YW, 1992, PLANT CELL, V4, P961, DOI 10.1105/tpc.4.8.961; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; JAN LY, 1992, ANNU REV PHYSIOL, V54, P535, DOI 10.1146/annurev.physiol.54.1.535; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; MATSUDA H, 1991, ANNU REV PHYSIOL, V53, P289, DOI 10.1146/annurev.ph.53.030191.001445; RIBERA AB, 1990, NEURON, V5, P691, DOI 10.1016/0896-6273(90)90223-3; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; SCHROEDER JI, 1994, ANNU REV BIOPH BIOM, V23, P441, DOI 10.1146/annurev.bb.23.060194.002301; SCHROEDER JI, 1987, P NATL ACAD SCI USA, V84, P4108, DOI 10.1073/pnas.84.12.4108; SCHROEDER JI, 1995, FEBS LETT, V363, P157, DOI 10.1016/0014-5793(95)00306-T; Schroeder Julian I., 1994, Methods (Orlando), V6, P70, DOI 10.1006/meth.1994.1009; SENTENAC H, 1992, SCIENCE, V256, P663, DOI 10.1126/science.1585180; SLESINGER PA, 1993, NEURON, V11, P739, DOI 10.1016/0896-6273(93)90083-4; SOREQ H, 1992, METHOD ENZYMOL, V207, P225; TAGLIALATELA M, 1994, SCIENCE, V264, P844, DOI 10.1126/science.8171340; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; VANDONGEN AM, 1990, NEURON, V5, P691; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0	32	43	45	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17697	17701		10.1074/jbc.270.30.17697	http://dx.doi.org/10.1074/jbc.270.30.17697			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629068	hybrid			2022-12-27	WOS:A1995RM26600013
J	TSENG, MJ; COON, S; STUENKEL, E; STRUK, V; LOGSDON, CD				TSENG, MJ; COON, S; STUENKEL, E; STRUK, V; LOGSDON, CD			INFLUENCE OF 2ND AND 3RD CYTOPLASMIC LOOPS ON BINDING, INTERNALIZATION, AND COUPLING OF CHIMERIC BOMBESIN/M3 MUSCARINIC RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; HUMAN BETA-2-ADRENERGIC RECEPTOR; SWISS 3T3 CELLS; SIGNAL TRANSDUCTION; DOWN-REGULATION; LIGAND-BINDING; CARBOXYL-TERMINUS; PEPTIDE RECEPTOR; AGONIST BINDING; G-PROTEINS	In order to investigate the molecular basis for differences in the characteristics of bombesin (Bn) and m3 muscarinic cholinergic (m3 ACh) receptors, chimeric Bn receptors possessing cytoplasmic domains from the m3 ACh receptor were produced. The receptors were expressed in CHO-KI cells and binding, structural, and signal transduction characteristics were analyzed. Cell lines bearing chimeric Bn receptors possessing m3 ACh receptor domains in place of either the second cytoplasmic loop (BM2L), the third cytoplasmic loop (BM3L), or both loops (BM23L) each bound I-125-bombesin with a single affinity that was approximately the same as that of the Bn receptor (5-10 nM). However, Bn receptors possessing the m3 ACh third cytoplasmic loop were severely affected in other respects, Internalization of ligand in Bn and BM2L cells was rapid and extensive (>80% of bound I-125-bombesin was acid-resistant). In contrast, internalization was dramatically reduced in BM3L and BM23L cells (similar to 20% of bound I-125-bombesin was acid-resistant). In Bn or BM2L cells 10 nM bombesin stimulated similar to 10-fold increases in phosphatidylinositol hydrolysis. Activation of Bn receptors also induced an increase in arachidonic acid release (478 +/- 32% of control, n = 3) and large increases in intracellular Ca2+. In contrast, in BM3L or BM23L cells, bombesin had no significant effect on phosphatidylinositol hydrolysis. Furthermore, BM3L receptor activation did not increase arachidonic acid release. However, BM3L and BM23L cells showed a small increase in intracellular Ca2+ at high concentrations of bombesin. These data indicate that the third cytoplasmic loop alone, or together with the second cytoplasmic loop, was not sufficient to transfer the characteristics of G protein interaction between m3 ACh and bombesin receptors. Furthermore, for the Bn receptor, ligand internalization does, whereas formation of the high affinity binding state does not, appear to require activation of G proteins.	UNIV MICHIGAN,DEPT PHYSIOL,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan				Stuenkel, Edward/0000-0001-8225-5725	NIDDK NIH HHS [DK41350] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041350] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARAK LS, 1994, J BIOL CHEM, V269, P2790; BATTEY JF, 1991, P NATL ACAD SCI USA, V88, P395, DOI 10.1073/pnas.88.2.395; BENYA RV, 1994, MOL PHARMACOL, V46, P495; BENYA RV, 1993, J BIOL CHEM, V268, P20285; BERRIDGE MJ, 1983, BIOCHEM J, V212, P849, DOI 10.1042/bj2120849; BLUML K, 1994, J BIOL CHEM, V269, P402; CAMPBELL PT, 1991, MOL PHARMACOL, V39, P192; CHABRY J, 1995, J BIOL CHEM, V270, P2439, DOI 10.1074/jbc.270.6.2439; CHEUNG AH, 1989, MOL PHARMACOL, V35, P132; CHEUNG AH, 1990, MOL PHARMACOL, V37, P775; COOK SJ, 1990, BIOCHEM J, V265, P617, DOI 10.1042/bj2650617; CURRIE S, 1992, J BIOL CHEM, V267, P6056; DUZIC E, 1992, J BIOL CHEM, V267, P9844; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; Gardner Jerry D., 1993, P151; GOLDMAN PS, 1994, J BIOL CHEM, V269, P15640; HAIGLER HT, 1980, J BIOL CHEM, V255, P1239; HAUSDORFF WP, 1990, J BIOL CHEM, V265, P1388; HERTEL C, 1990, J BIOL CHEM, V265, P17988; JOHANSEN TE, 1990, FEBS LETT, V267, P289, DOI 10.1016/0014-5793(90)80947-H; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; LAMEH J, 1992, J BIOL CHEM, V267, P13406; LECHLEITER J, 1990, EMBO J, V9, P4381, DOI 10.1002/j.1460-2075.1990.tb07888.x; MAHAN LC, 1985, P NATL ACAD SCI USA, V82, P129, DOI 10.1073/pnas.82.1.129; MANTEY S, 1993, MOL PHARMACOL, V43, P762; MORO O, 1994, J BIOL CHEM, V269, P6651; MORO O, 1993, J BIOL CHEM, V268, P6862; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; PERALTA EG, 1987, EMBO J, V6, P3923, DOI 10.1002/j.1460-2075.1987.tb02733.x; RODRIGUEZ MC, 1992, MOL ENDOCRINOL, V6, P327, DOI 10.1210/me.6.3.327; SPIEGEL AM, 1992, ENDOCR REV, V13, P536, DOI 10.1210/er.13.3.536; STEFAN CJ, 1994, MOL CELL BIOL, V14, P3339, DOI 10.1128/MCB.14.5.3339; STRADER CD, 1987, J BIOL CHEM, V262, P16439; STRADER CD, 1987, CELL, V49, P855, DOI 10.1016/0092-8674(87)90623-4; THOMPSON AK, 1990, J PHARMACOL EXP THER, V252, P744; VALIQUETTE M, 1990, P NATL ACAD SCI USA, V87, P5089, DOI 10.1073/pnas.87.13.5089; WESS J, 1990, MOL PHARMACOL, V38, P872; WONG SKF, 1990, J BIOL CHEM, V265, P6219; YANG J, 1993, MOL PHARMACOL, V44, P1158; YULE DI, 1993, AM J PHYSIOL, V265, pG999, DOI 10.1152/ajpgi.1993.265.5.G999; YULE DI, 1992, J BIOL CHEM, V267, P13830; ZANOLARI B, 1992, CELL, V71, P755, DOI 10.1016/0092-8674(92)90552-N	43	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17884	17891		10.1074/jbc.270.30.17884	http://dx.doi.org/10.1074/jbc.270.30.17884			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629092	hybrid			2022-12-27	WOS:A1995RM26600040
J	ALTMANN, F; SCHWIHLA, H; STAUDACHER, E; GLOSSL, J; MARZ, L				ALTMANN, F; SCHWIHLA, H; STAUDACHER, E; GLOSSL, J; MARZ, L			INSECT CELLS CONTAIN AN UNUSUAL, MEMBRANE-BOUND BETA-N-ACETYLGLUCOSAMINIDASE PROBABLY INVOLVED IN THE PROCESSING OF PROTEIN N-GLYCANS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHESIS; ENZYME; LIVER	The beta-N-acetylglucosaminidase activity in the lepidopteran insect cell line Sf21 has been studied using pyridylaminated oligosaccharides and chromogenic synthetic glycosides as substrates. Ultracentrifugation experiments indicated that the insect cell beta-N-acetylglucosaminidase exists in a soluble and a membrane-bound form. This latter form accounted for two-thirds of the total activity and was associated with vesicles of the same density as those containing GlcNAc transferase I. Partial membrane association of the enzyme was observed with all substrates tested, i.e. 4-nitrophenyl beta-N-acetylglucosaminide, tri-N-acetylchitotriose, and an N-linked biantennary agalactooligosaccharide. Inhibition studies indicated a single enzyme to be responsible for the hydrolysis of all these substrates. With the biantennary substrate, the beta-N-acetylglucosaminidase exclusively removed beta-N-acetylglucosamine from the alpha 1,3-antenna. GlcNAcMan(5)GlcNAc(2), the primary product of GlcNAc-transferase I, was not perceptibly hydrolyzed. beta-N-Acetylglucosaminidases with the same branch specificity were also found in the lepidopteran cell lines Bm-N and Mb-0503. In contrast, beta-N-acetylglucosaminidase activities from rat or frog (Xenopus laevis) liver and from mung bean seedlings were not membrane-bound, and they did not exhibit a strict branch specificity. An involvement of this unusual beta-N-acetylglucosaminidase in the processing of asparagine-linked oligosaccharides in insects is suggested.	UNIV BODENKULTUR WIEN,ZENTRUM ANGEW GENET,A-1180 VIENNA,AUSTRIA	University of Natural Resources & Life Sciences, Vienna	ALTMANN, F (corresponding author), UNIV BODENKULTUR WIEN,INST CHEM,GREGOR MENDELSTR 33,A-1180 VIENNA,AUSTRIA.		Glössl, Josef/H-8208-2013	Glössl, Josef/0000-0002-5042-8828; Altmann, Friedrich/0000-0002-0112-7877; Staudacher, Erika/0000-0001-8282-1424				ALTMANN F, 1992, ANAL BIOCHEM, V204, P215, DOI 10.1016/0003-2697(92)90164-3; ALTMANN F, 1993, GLYCOBIOLOGY, V3, P619, DOI 10.1093/glycob/3.6.619; ALTMANN F, 1995, GLYCOCONJUGATE J, V12, P150, DOI 10.1007/BF00731359; EISENTHAL R, 1974, BIOCHEM J, V139, P715, DOI 10.1042/bj1390715; IWAMOTO T, 1993, BIOSCI BIOTECH BIOCH, V57, P841, DOI 10.1271/bbb.57.841; JOZIASSE DH, 1992, GLYCOBIOLOGY, V2, P271, DOI 10.1093/glycob/2.4.271; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KUBELKA V, 1994, ARCH BIOCHEM BIOPHYS, V308, P148, DOI 10.1006/abbi.1994.1021; KUBELKA V, 1993, EUR J BIOCHEM, V213, P1193, DOI 10.1111/j.1432-1033.1993.tb17870.x; LONGMORE GD, 1982, CARBOHYD RES, V100, P365, DOI 10.1016/S0008-6215(00)81049-6; MARZ L, 1995, IN PRESS PROTEIN GLY; MOREMEN KW, 1994, GLYCOBIOLOGY, V4, P113, DOI 10.1093/glycob/4.2.113; STAUDACHER E, 1992, EUR J BIOCHEM, V207, P987, DOI 10.1111/j.1432-1033.1992.tb17134.x; TULSIANI DRP, 1982, J BIOL CHEM, V257, P3660; VELARDO MA, 1993, J BIOL CHEM, V268, P17902; VITALE A, 1984, J CELL BIOL, V99, P133, DOI 10.1083/jcb.99.1.133	16	177	181	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17344	17349		10.1074/jbc.270.29.17344	http://dx.doi.org/10.1074/jbc.270.29.17344			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615537	hybrid			2022-12-27	WOS:A1995RK68900048
J	BARBER, GN; JAGUS, R; MEURS, EF; HOVANESSIAN, AG; KATZE, MG				BARBER, GN; JAGUS, R; MEURS, EF; HOVANESSIAN, AG; KATZE, MG			MOLECULAR MECHANISMS RESPONSIBLE FOR MALIGNANT TRANSFORMATION BY REGULATORY AND CATALYTIC DOMAIN VARIANTS OF THE INTERFERON-INDUCED ENZYME RNA-DEPENDENT PROTEIN-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; INITIATION FACTOR-2-ALPHA; FUNCTIONAL EXPRESSION; P68 KINASE; PHOSPHORYLATION; YEAST; GCN2; AUTOPHOSPHORYLATION; TRANSLATION; HOMOLOGY	Double-stranded RNA-dependent protein kinase (PKR) is suggested to play an important role in both the antiviral and antiproliferative arms of the interferon response. To gain insights into the molecular mechanisms underlying PKR's growth regulatory properties, we examined the biological and biochemical properties of PKR variants containing either a mutation in catalytic domain II (PKR-M1) or a deletion of RNA binding domain I (PKR-M7) in both reticulocyte translation extracts and in vitro kinase assays with purified reagents and compared these results with those using the same mutants stably expressed in vivo. While wild-type PKR (PKR-WT) efficiently inhibited mRNA translation in a reticulocyte extract, the inactive PKR-M1 had no effect. The PKR-M7 mutant was modestly inhibitory in this assay. The PKR-M1 variant was able to reverse the translational inhibitory effects and increased eukaryotic initiation factor (eLF)-2 alpha phosphorylation levels caused by addition of double stranded RNA to reticulocyte extract, whereas PKR-M7 could not. Both PKR-M1 and PKR-M7 functioned as transdominant inhibitors of PKR-WT in our in vitro kinase assays. While the inhibition by PKR-M1 required a vast excess of mutant to shut down PKR function, PKR-M7 inhibited PKR-WT at approximately stoichiometric levels. To complement these experiments, we compared growth rates and alpha phosphorylation levels in transformed cell lines overexpressing either PKR-M1 or PKR-M7. Levels of endogenous eIF-2 alpha phosphorylation were significantly more diminished in PKR-M7 overexpressing cells compared with PKR-M1. These paradoxical data will be discussed in terms of the potential molecular mechanisms underlying malignant transformation caused by the PKR variants.	UNIV WASHINGTON,SCH MED,DEPT MICROBIOL,SEATTLE,WA 98195; UNIV MARYLAND,INST BIOTECHNOL,CTR MARINE BIOTECHNOL,BALTIMORE,MD 21202; INST PASTEUR,VIROL & CELLULAR IMMUNOL UNIT,F-75724 PARIS,FRANCE	University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland Baltimore; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris					NCRR NIH HHS [RR 00166] Funding Source: Medline; NIAID NIH HHS [AI-22646] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022646] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARBER GN, 1993, P NATL ACAD SCI USA, V90, P4621, DOI 10.1073/pnas.90.10.4621; BARBER GN, 1991, BIOCHEMISTRY-US, V30, P10356, DOI 10.1021/bi00106a038; BARBER GN, 1995, MOL CELL BIOL, V15, P3138; BARBER GN, 1992, VIROLOGY, V191, P670, DOI 10.1016/0042-6822(92)90242-H; BARBER GN, 1994, P NATL ACAD SCI USA, V91, P4278, DOI 10.1073/pnas.91.10.4278; CARROLL K, 1993, J BIOL CHEM, V268, P12837; CHEN JJ, 1991, P NATL ACAD SCI USA, V88, P7729, DOI 10.1073/pnas.88.17.7729; CHONG KL, 1992, EMBO J, V11, P1553, DOI 10.1002/j.1460-2075.1992.tb05200.x; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; DEVER TE, 1993, P NATL ACAD SCI USA, V90, P466; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; GALABRU J, 1987, J BIOL CHEM, V262, P15538; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; HOVANESSIAN AG, 1989, J INTERFERON RES, V9, P641, DOI 10.1089/jir.1989.9.641; JAGUS R, 1987, METHOD ENZYMOL, V152, P267; KATZE MG, 1993, SEMIN VIROL, V4, P259, DOI 10.1006/smvy.1993.1022; KATZE MG, 1991, MOL CELL BIOL, V11, P5497, DOI 10.1128/MCB.11.11.5497; KATZE MG, 1992, J INTERFERON RES, V12, P241, DOI 10.1089/jir.1992.12.241; Katze Michael G., 1995, Trends in Microbiology, V3, P75, DOI 10.1016/S0966-842X(00)88880-0; KOROMILAS AE, 1992, SCIENCE, V257, P1685, DOI 10.1126/science.1382315; KUMAR A, 1994, P NATL ACAD SCI USA, V91, P6288, DOI 10.1073/pnas.91.14.6288; LANGLAND JO, 1994, J VIROL, V68, P3821, DOI 10.1128/JVI.68.6.3821-3829.1994; LAURENT AG, 1985, P NATL ACAD SCI USA, V82, P4341, DOI 10.1073/pnas.82.13.4341; LEE TG, 1994, MOL CELL BIOL, V14, P2331, DOI 10.1128/MCB.14.4.2331; LENGYEL P, 1993, P NATL ACAD SCI USA, V90, P5893, DOI 10.1073/pnas.90.13.5893; MARAN A, 1994, SCIENCE, V265, P789, DOI 10.1126/science.7914032; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; MEURS EF, 1992, J VIROL, V66, P5805, DOI 10.1128/JVI.66.10.5805-5814.1992; MEURS EF, 1993, P NATL ACAD SCI USA, V90, P232, DOI 10.1073/pnas.90.1.232; RHOADS RE, 1993, J BIOL CHEM, V268, P3017; ROMANO PR, 1995, MOL CELL BIOL, V15, P365, DOI 10.1128/MCB.15.1.365; SAMUEL CE, 1991, VIROLOGY, V183, P1, DOI 10.1016/0042-6822(91)90112-O; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; SHARP TV, 1993, EUR J BIOCHEM, V214, P945, DOI 10.1111/j.1432-1033.1993.tb17998.x; THOMIS DC, 1993, J VIROL, V67, P7695, DOI 10.1128/JVI.67.12.7695-7700.1993	36	71	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17423	17428		10.1074/jbc.270.29.17423	http://dx.doi.org/10.1074/jbc.270.29.17423			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615547	hybrid			2022-12-27	WOS:A1995RK68900060
J	MERLE, PL; FEIGE, JJ; VERDETTI, J				MERLE, PL; FEIGE, JJ; VERDETTI, J			BASIC FIBROBLAST GROWTH-FACTOR ACTIVATES CALCIUM CHANNELS IN NEONATAL RAT CARDIOMYOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE-ACTIVITY; FACTOR RECEPTOR; SIGNAL TRANSDUCTION; ENDOTHELIAL-CELLS; HEART MYOCYTES; DNA-SYNTHESIS; LOCALIZATION; STIMULATION; BINDING; IDENTIFICATION	Basic fibroblast growth factor (bFGF) is a potent mitogen for many cell lineages including fetal cardiomyocytes. Furthermore, bFGF has been shown to modify gene expression, in vitro, in adult nonproliferative ventricular myocytes. This effect is suspected to be partly responsible for the genetic modifications that occur in vivo under pathophysiological conditions such as ischemia or pressure overload and that lead to myocardial hypertrophy. However, little is known about the first steps of the molecular mechanisms that take place soon after cell activation by bFGF. In this study, using bio chemical and electrophysiological approaches, we have established, on cardiomyocytes cultured from neonatal rat ventricles, that (i) differentiated beating cells express at least two classes of bFGF-receptors having high and low affinity (K-d = 10 +/- 2 pM and 1 +/- 0.5 nM); (ii) the stimulation of these bFGF receptors promotes an increase in the beating frequencies of cultured cardiomyocytes (40 +/- 10%); (iii) bFGF provokes the activation of poorly specific and voltage-independent calcium channels (12pS); (iv) inositol 1,4,5-trisphosphate enhances similar bFGF-induced Ca2+ currents and is therefore suspected to be a second messenger triggering this activation. These results support the presence, in cultured cardiomyocytes, of new calcium channels whose activation after bFGF binding may be partly responsible for the cell response to this growth factor.	CEN, DEPT BIOL MOLEC & STRUCT, INSERM, U244, CEA, F-38054 GRENOBLE 9, FRANCE	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm)	MERLE, PL (corresponding author), UNIV GRENOBLE 1, CTR PHYSIOL & PHYSIOPHATHOL, ELECTROPHYSIOL MOLEC GRP, BP 53X, F-38041 GRENOBLE, FRANCE.		Feige, Jean-Jacques/M-8905-2017	Feige, Jean-Jacques/0000-0002-1354-7692				ATGHIAS P, 1979, PATHOL BIOL, V27, P13; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; BERRIDGE MJ, NATURE, V341, P197; BOGOYEVITCH MA, 1994, J BIOL CHEM, V269, P1110; BURGESS W, 1988, ANNR EV BIOCH, V58, P575; CASSCELLS W, 1990, J CLIN INVEST, V85, P433, DOI 10.1172/JCI114456; CHAPRON Y, 1989, BIOCHEM BIOPH RES CO, V158, P527, DOI 10.1016/S0006-291X(89)80081-6; COHEN NM, 1987, J PHYSIOL-LONDON, V391, P169, DOI 10.1113/jphysiol.1987.sp016732; COUGHLIN SR, 1988, J BIOL CHEM, V263, P988; CUMMINS P, 1993, CARDIOVASC RES, V27, P1150, DOI 10.1093/cvr/27.7.1150; ESTACION M, 1993, CELL CALCIUM, V14, P439, DOI 10.1016/0143-4160(93)90003-O; FEIGE JJ, 1988, J BIOL CHEM, V263, P14023; FERHAT L, 1993, J NEUROCHEM, V61, P1105, DOI 10.1111/j.1471-4159.1993.tb03626.x; GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95, DOI 10.1210/edrv-8-2-95; IWAKI K, 1990, J BIOL CHEM, V265, P13809; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; JIN Y, 1994, J MOL CELL CARDIOL, V26, P1449, DOI 10.1006/jmcc.1994.1164; KAN M, 1991, METHOD ENZYMOL, V198, P158; KARDAMI E, 1989, J CELL BIOL, V109, P1865, DOI 10.1083/jcb.109.4.1865; KATZBERG AA, 1977, AM J ANAT, V149, P489, DOI 10.1002/aja.1001490406; KUNO M, 1987, NATURE, V326, P301, DOI 10.1038/326301a0; MOGAMI H, 1993, BIOCHEM BIOPH RES CO, V196, P650, DOI 10.1006/bbrc.1993.2299; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; MOOLENAAR WH, 1986, J EXP BIOL, V124, P359; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; NEUFELD G, 1988, J CELL PHYSIOL, V136, P537, DOI 10.1002/jcp.1041360321; PARKER TG, 1991, ANNU REV PHYSIOL, V53, P179; PEPPELENBOSCH MP, 1991, J BIOL CHEM, V266, P19938; PINSON A, 1973, BIOCHIMIE, V55, P1261; RABKIN SW, 1987, BIOCHEM BIOPH RES CO, V146, P889, DOI 10.1016/0006-291X(87)90614-0; ROBERTS AB, 1992, MOL ENDOCRINOL, V6, P1921, DOI 10.1210/me.6.11.1921; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; Savona C, 1991, GROWTH FACTORS, V5, DOI 10.3109/08977199109000291; SAWYER ST, 1981, BIOCHEMISTRY-US, V20, P6280, DOI 10.1021/bi00524a057; SCHANNE OF, 1990, J APPL PHYSIOL, V29, P892; SCHNEIDER MD, 1992, BASIC RES CARDIOL, V87, P33; SOLTOFF SP, 1988, ANNU REV PHYSIOL, V50, P207; SPEIR E, 1992, CIRC RES, V71, P251, DOI 10.1161/01.RES.71.2.251; SPIRITO P, 1991, CIRCULATION, V84, P322, DOI 10.1161/01.CIR.84.1.322; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VETTER U, 1988, BASIC RES CARDIOL, V83, P647, DOI 10.1007/BF01906959; WALICKE PA, 1989, J BIOL CHEM, V264, P4120	42	34	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17361	17367		10.1074/jbc.270.29.17361	http://dx.doi.org/10.1074/jbc.270.29.17361			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615540	hybrid			2022-12-27	WOS:A1995RK68900051
J	RAMAMOORTHY, JD; RAMAMOORTHY, S; PAPAPETROPOULOS, A; CATRAVAS, JD; LEIBACH, FH; GANAPATHY, V				RAMAMOORTHY, JD; RAMAMOORTHY, S; PAPAPETROPOULOS, A; CATRAVAS, JD; LEIBACH, FH; GANAPATHY, V			CYCLIC AMP-INDEPENDENT UP-REGULATION OF THE HUMAN SEROTONIN TRANSPORTER BY STAUROSPORINE IN CHORIOCARCINOMA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; INDUCED NEURITE OUTGROWTH; HIGH-AFFINITY BINDING; NOREPINEPHRINE TRANSPORTER; HUMAN PLATELETS; RAT-BRAIN; EXPRESSION; INHIBITION; STIMULATION; DOPAMINE	Treatment of confluent cultures of JAR human placental choriocarcinoma cells with staurosporine caused a marked stimulation of serotonin transport activity in these cells, The stimulatory effect was noticeable at nanomolar concentrations of staurosporine, and a treatment time of >4 h was required for staurosporine to elicit the effect, At 40 nM and with a treatment time of 16 h, the stimulation of the transport activity was 3.5-6.0-fold, None of the several other protein kinase inhibitors tested had similar effect except KT 5720, a protein kinase A inhibitor, which showed a small but significant (similar to 1.4-fold) stimulatory effect at a concentration of 5 mu M. Blockade of RNA synthesis and protein synthesis in the cells prevented completely the stimulation of the trans port activity induced by staurosporine. The stimulation was observed not only in intact cells but also in plasma membrane vesicles prepared from staurosporine-treated cells, The stimulation was accompanied by a 5-7-fold increase in the steady state levels of the trans porter specific mRNAs, by a 7-fold increase in the maximal velocity of the transport process, and by a 6-fold increase in the transporter density in the plasma membrane, Even though both staurosporine and cholera toxin had similar effects on the serotonin transport activity in these cells, the effect was not additive when the cells were treated with both reagents together. While treatment of the cells with cholera toxin markedly elevated intracellular levels of cAMP, staurosporine did not have any effect on the cellular levels of this cyclic nucleotide. It is concluded that staurosporine up-regulates the serotonin transport activity in JAR cells by increasing the steady state levels of the serotonin transporter mRNA and by the consequent increase in the transporter density in the plasma membrane and that the process involves a cAMP-independent signaling pathway.	MED COLL GEORGIA,DEPT BIOCHEM & MOLEC BIOL,AUGUSTA,GA 30912; MED COLL GEORGIA,DEPT PHARMACOL & TOXICOL,AUGUSTA,GA 30912	University System of Georgia; Augusta University; University System of Georgia; Augusta University			Andreas, Papapetropoulos/AAJ-3089-2020	Papapetropoulos, Andreas/0000-0002-4253-5930	NICHD NIH HHS [HD 27487] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027487] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSON GM, 1992, BIOCHIM BIOPHYS ACTA, V1137, P331, DOI 10.1016/0167-4889(92)90154-4; BALKOVETZ DF, 1989, J BIOL CHEM, V264, P2195; BOJA JW, 1992, SYNAPSE, V12, P27, DOI 10.1002/syn.890120104; BOSIN TR, 1990, BIOCHEM PHARMACOL, V40, P723, DOI 10.1016/0006-2952(90)90307-7; BRANDSCH M, 1994, BBA-BIOMEMBRANES, V1192, P177, DOI 10.1016/0005-2736(94)90116-3; COOL DR, 1991, J BIOL CHEM, V266, P15750; COOL DR, 1990, BIOCHEMISTRY-US, V29, P1818, DOI 10.1021/bi00459a022; FOGUET M, 1993, EMBO J, V12, P903, DOI 10.1002/j.1460-2075.1993.tb05731.x; GANAPATHY V, 1994, PLACENTA, V15, P785, DOI 10.1016/S0143-4004(05)80181-X; GANAPATHY V, 1995, PLACENTAL TOXICOLOGY, P161; GANAPATHY V, 1993, TROPHOBLAST RES, V7, P35; HABENER JF, 1990, MOL ENDOCRINOL, V4, P1087, DOI 10.1210/mend-4-8-1087; HASHIMOTO S, 1989, EXP CELL RES, V184, P351, DOI 10.1016/0014-4827(89)90334-0; JAYANTHI LD, 1993, BIOCHEMISTRY-US, V32, P12178, DOI 10.1021/bi00096a030; JAYYANATHI LD, 1994, J BIOL CHEM, V269, P14424; KULANTHAIVEL P, 1991, BIOCHEM J, V277, P53, DOI 10.1042/bj2770053; LAUNAY JM, 1994, AM J PHYSIOL, V266, pR526, DOI 10.1152/ajpregu.1994.266.2.R526; Lee KAW, 1991, CURR OPIN CELL BIOL, V3, P953, DOI 10.1016/0955-0674(91)90113-D; LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434; LESCH KP, 1993, J NEUROCHEM, V60, P2319, DOI 10.1111/j.1471-4159.1993.tb03522.x; LESCH KP, 1993, J NEURAL TRANSM-GEN, V91, P67, DOI 10.1007/BF01244919; MARCZIN N, 1992, CIRC RES, V70, P326, DOI 10.1161/01.RES.70.2.326; MILLER KJ, 1994, J BIOL CHEM, V269, P27351; MYERS CL, 1989, AM J PHYSIOL, V257, pL253, DOI 10.1152/ajplung.1989.257.4.L253; NISHIO H, 1995, EUR J PHARM-MOLEC PH, V288, P149, DOI 10.1016/0922-4106(95)90189-2; PRASAD PD, 1994, PLACENTA, V15, P267, DOI 10.1016/0143-4004(94)90018-3; RAFFIONI S, 1995, J BIOL CHEM, V270, P7568, DOI 10.1074/jbc.270.13.7568; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; RAMAMOORTHY S, 1993, J BIOL CHEM, V268, P21626; RAMAMOORTHY S, 1993, BIOCHEMISTRY-US, V32, P1346, DOI 10.1021/bi00056a021; RAMAMOORTHY S, 1992, AM J PHYSIOL, V262, pC1119; RASOULY D, 1992, MOL PHARMACOL, V42, P35; TISCHLER AS, 1990, J NEUROCHEM, V55, P1159, DOI 10.1111/j.1471-4159.1990.tb03120.x; WALL SC, 1993, MOL PHARMACOL, V43, P264; ZHANG L, 1994, J BIOL CHEM, V269, P10270	35	58	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17189	17195		10.1074/jbc.270.29.17189	http://dx.doi.org/10.1074/jbc.270.29.17189			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615516	hybrid			2022-12-27	WOS:A1995RK68900023
J	SANCHEZ, MA; ZEOLI, D; KLAMO, EM; KAVANAUGH, MP; LANDFEAR, SM				SANCHEZ, MA; ZEOLI, D; KLAMO, EM; KAVANAUGH, MP; LANDFEAR, SM			A FAMILY OF PUTATIVE RECEPTOR-ADENYLATE CYCLASES FROM LEISHMANIA-DONOVANI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-BRUCEI; GUANYLATE-CYCLASE; CYCLIC-AMP; EXPRESSION; GENE; DIFFERENTIATION; ACID; IDENTIFICATION; CRUZI; PROMASTIGOTES	Leishmania parasites are exposed to pronounced changes in their environment during their life cycle as they migrate from the sandfly midgut to the insect proboscis and then into the phagolysosomes of the vertebrate macrophages. The developmental transformations that produce each life cycle stage of the parasite may be signaled in part by binding of environmental ligands to receptors which mediate transduction of extracellular signals. We have identified a family of five clustered genes in Leishmania donovani which may encode signal transduction receptors. The coding regions of two of these genes, designated rac-A and rac-B, have been sequenced and shown to code for proteins with an NH2-terminal hydrophilic domain, an intervening putative transmembrane segment, and a COOH-terminal domain that has high sequence identity to the catalytic domain from adenylate cyclases in other eukaryotes. We have expressed the receptor-adenylate cyclase protein (RAC)-A protein in Xenopus oocytes and demonstrated that it functions as an adenylate cyclase. Although RAC-B exhibits no catalytic activity when expressed in oocytes, co-expression of RAC-A and RAC-B negatively regulates the adenylate cyclase activity of RAC-A, suggesting that these two proteins interact in the membrane. Furthermore, a truncated version of RAC-A functions as a dominant negative mutant that inhibits the catalytic activity of the wild type receptor. The rac-A and rac-B genes encode developmentally regulated mRNAs which are expressed in the insect stage but not in the mammalian host stage of the parasite life cycle.	OREGON HLTH SCI UNIV,DEPT MOLEC MICROBIOL & IMMUNOL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,VOLLUM INST,PORTLAND,OR 97201	Oregon Health & Science University; Oregon Health & Science University				Landfear, Scott/0000-0002-1643-6664	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048709] Funding Source: NIH RePORTER; NIAID NIH HHS [AI25920, AI01162] Funding Source: Medline; NIGMS NIH HHS [GM48709] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDRE S, 1990, MOL BIOCHEM PARASIT, V43, P279, DOI 10.1016/0166-6851(90)90152-C; ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; CAIRNS BR, 1989, P NATL ACAD SCI USA, V85, P2130; Chang K.-P., 1990, P79; CHANG KP, 1980, SCIENCE, V209, P1240, DOI 10.1126/science.7403880; CHANG M, 1989, NATURE, V341, P68, DOI 10.1038/341068a0; CHINKERS M, 1992, J BIOL CHEM, V267, P18589; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHU G, 1987, SCIENCE, V234, P1582; CLAYTON C, 1992, PROG NUCLEIC ACID RE, V43, P37, DOI 10.1016/S0079-6603(08)61043-0; COMEAU AM, 1986, MOL BIOCHEM PARASIT, V21, P161, DOI 10.1016/0166-6851(86)90019-8; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; CURRIE MG, 1992, P NATL ACAD SCI USA, V89, P947, DOI 10.1073/pnas.89.3.947; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRAIDENRAICH D, 1993, P NATL ACAD SCI USA, V90, P10140, DOI 10.1073/pnas.90.21.10140; GARBERS DL, 1994, MOL BIOL CELL, V5, P1; GONZALESPERDOMO M, 1988, EXP PARASITOL, V66, P205, DOI 10.1016/0014-4894(88)90092-6; GOY MF, 1987, J NEUROCHEM, V48, P954, DOI 10.1111/j.1471-4159.1987.tb05610.x; IOVANNISCI DM, 1983, J PARASITOL, V69, P633, DOI 10.2307/3281131; KAVANAUGH MP, 1992, J BIOL CHEM, V267, P22007; LANGFORD CK, 1994, J BIOL CHEM, V269, P17939; LANGFORD CK, 1992, EXP PARASITOL, V74, P360, DOI 10.1016/0014-4894(92)90161-3; LEMMON MA, 1994, TRENDS BIOCHEM SCI, V19, P459, DOI 10.1016/0968-0004(94)90130-9; MANCINI PE, 1981, MOL BIOCHEM PARASIT, V3, P19, DOI 10.1016/0166-6851(81)90074-8; PAINDAVOINE P, 1992, MOL CELL BIOL, V12, P1218, DOI 10.1128/MCB.12.3.1218; PAVLOFF MS, 1990, J NEUROCHEM, V55, P788, DOI 10.1111/j.1471-4159.1990.tb04561.x; RANGELALDAO R, 1987, MOL BIOCHEM PARASIT, V22, P39, DOI 10.1016/0166-6851(87)90067-3; REED SL, 1985, INFECT IMMUN, V49, P844, DOI 10.1128/IAI.49.3.844-847.1985; ROSS DT, 1991, EMBO J, V10, P2047, DOI 10.1002/j.1460-2075.1991.tb07735.x; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1987, P NATL ACAD SCI USA, V74, P5463; SCHULZ S, 1990, CELL, V63, P941, DOI 10.1016/0092-8674(90)90497-3; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; TILLY BC, 1992, J BIOL CHEM, V267, P9470; VIERA J, 1987, METHOD ENZYMOL, V153, P3; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WALTER RD, 1982, MOL BIOCHEM PARASIT, V6, P287, DOI 10.1016/0166-6851(82)90061-5; WALTER RD, 1981, BIOCH PARASITES, P152	44	58	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17551	17558		10.1074/jbc.270.29.17551	http://dx.doi.org/10.1074/jbc.270.29.17551			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615561	Green Published, hybrid			2022-12-27	WOS:A1995RK68900077
J	HUNYADY, L; BOR, M; BAUKAL, AJ; BALLA, T; CATT, KJ				HUNYADY, L; BOR, M; BAUKAL, AJ; BALLA, T; CATT, KJ			A CONSERVED NPLFY SEQUENCE CONTRIBUTES TO AGONIST BINDING AND SIGNAL-TRANSDUCTION BUT IS NOT AN INTERNALIZATION SIGNAL FOR THE TYPE-1 ANGIOTENSIN-II RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ADRENAL GLOMERULOSA CELLS; POTENTIAL MECHANISM; CARBOXYL-TERMINUS; LIGAND-BINDING; MUTAGENESIS; SEQUESTRATION; GENERATION; RESIDUES	A conserved NPX(2-3)Y sequence that is located in the seventh transmembrane helix of many G protein-coupled receptors has been predicted to participate in receptor signaling and endocytosis, The role of this sequence (NPLFY) in angiotensin II receptor function was studied in mutant and wild-type rat type la angiotensin II receptors transiently expressed in COS-7 cells. The ability of the receptor to interact with G proteins and to stimulate inositol phosphate responses was markedly impaired by alanine replacement of Asn(298) and was reduced by replacement of Pro(299) or Tyr(302). The F301A mutant receptor exhibited normal G protein coupling and inositol phosphate responses, and the binding of the peptide antagonist, [Sar(1),Ile(8)]angiotensin II, was only slightly affected, However, its affinity for angiotensin II and the nonpeptide antagonist losartan was reduced by an order of a magnitude, suggesting that angiotensin II and losartan share an intramembrane binding site, possibly through their aromatic moieties. None of the agonist-occupied mutant receptors, including Y302A and triple alanine replacements of Phe(301), Tyr(302), and Phe(304), showed substantial changes in their internalization kinetics, These findings demonstrate that the NPLFY sequence of the type 1a angiotensin II receptor is not an important determinant of agonist-induced internalization, However, the Phe(301) residue contributes significantly to agonist binding, and Asn(298) is required for normal receptor activation and signal transduction.	NICHHD,ENDOCRINOL & REPROD RES BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)				Balla, Tamas/0000-0002-9077-3335				BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BALLA T, 1991, J BIOL CHEM, V266, P24719; BARAK LS, 1994, J BIOL CHEM, V269, P2790; BENYA RV, 1993, J BIOL CHEM, V268, P20285; BERNSTEIN KE, 1993, AM J KIDNEY DIS, V22, P745, DOI 10.1016/S0272-6386(12)80441-0; BIHOREAU C, 1993, P NATL ACAD SCI USA, V90, P5133, DOI 10.1073/pnas.90.11.5133; BUMPUS FM, 1977, FED PROC, V36, P2128; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; CATT KJ, 1991, J BIOENERG BIOMEMBR, V23, P7; Catt KJ, 1993, CELLULAR MOL BIOL RE, P307; DONNELLY D, 1994, RECEPTOR CHANNEL, V2, P61; FINDLAY JBC, 1993, BIOCHEM SOC T, V21, P869, DOI 10.1042/bst0210869; GRIENDLING KK, 1987, J BIOL CHEM, V262, P14555; HJORTH SA, 1994, J BIOL CHEM, V269, P30953; HUANG ZM, 1995, J BIOL CHEM, V270, P151, DOI 10.1074/jbc.270.1.151; HUNYADY L, 1994, J BIOL CHEM, V269, P31378; HUNYADY L, 1994, J BIOL CHEM, V269, P24798; HUNYADY L, 1991, J BIOL CHEM, V266, P2783; JI H, 1994, J BIOL CHEM, V269, P16583; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MARIE J, 1994, J BIOL CHEM, V269, P20815; MORO O, 1993, J BIOL CHEM, V268, P6862; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; NUSSENZVEIG DR, 1993, J BIOL CHEM, V268, P2389; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; SALTMAN S, 1975, ENDOCRINOLOGY, V97, P275, DOI 10.1210/endo-97-2-275; SAVARESE TM, 1992, BIOCHEM J, V283, P1; SCHAMBYE HT, 1994, P NATL ACAD SCI USA, V91, P7046, DOI 10.1073/pnas.91.15.7046; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; SCHULTZ G, 1993, ARZNEIMITTELFORSCUNG, V42, P229; SLICE LW, 1994, J BIOL CHEM, V269, P21755; SPAT A, 1991, EXP PHYSIOL, V76, P859, DOI 10.1113/expphysiol.1991.sp003550; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; TRUMPPKALLMEYER S, 1992, J MED CHEM, V35, P3448, DOI 10.1021/jm00097a002; WESS J, 1993, EMBO J, V12, P331, DOI 10.1002/j.1460-2075.1993.tb05661.x; YAMANO Y, 1992, BIOCHEM BIOPH RES CO, V187, P1426, DOI 10.1016/0006-291X(92)90461-S; YU SS, 1993, J BIOL CHEM, V268, P337; ZHOU W, 1994, MOL PHARMACOL, V45, P165	40	106	107	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16602	16609		10.1074/jbc.270.28.16602	http://dx.doi.org/10.1074/jbc.270.28.16602			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622467	hybrid			2022-12-27	WOS:A1995RJ34700024
J	KIS, K; BACHER, A				KIS, K; BACHER, A			SUBSTRATE CHANNELING IN THE LUMAZINE SYNTHASE RIBOFLAVIN SYNTHASE COMPLEX OF BACILLUS-SUBTILIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOGLYCERATE KINASE; TRYPTOPHAN SYNTHASE; MECHANISM; PURIFICATION; SYNTHETASE; SUBUNIT	The lumazine synthase/riboflavin synthase complex of Bacillus subtilis consists of an icosahedral capsid of 60 beta subunits surrounding a core of three alpha subunits. The beta subunits catalyze the condensation of 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione (PYR) with 3,4-dihydroxy-2-butanone 4-phosphate (DHB) yielding 6,7-dimethyl-8-ribityllumazine. This intermediate is converted to riboflavin by the alpha subunits via an unusual dismutation. The second product of this reaction is PYR, which is also a substrate of the beta subunits and can be recycled in the catalytic process. Sigmoidal kinetics would be expected for the formation of riboflavin from PYR and DHB and are indeed observed with mixtures of artifactual beta(60) capsids and alpha subunit trimers. In contrast, the formation of riboflavin from PYR and DHB by the native alpha(3) beta(60) is characterized by a finite initial rate, which is similar to the rate of lumazine formation. Most notably, the rate of riboflavin formation has its maximum value at t = 0 and decreases dramatically after the consumption of PYR and DHB despite the presence of transiently formed lumazine. These data suggest that a significant fraction of DHB is converted to riboflavin by substrate channeling, which is conducive to an improved overall catalytic rate of riboflavin formation at low substrate concentrations. The channel is leaky, and the intermediate lumazine is therefore transiently accumulated in the bulk solution. The partitioning factor relating the direct formation of riboflavin via substrate channeling and the formation of transient 6,7-dimethyl-8-ribityllumazine increases at low concentrations of the substrates PYR and DHB and has a maximum value at pH 7.5. Channeling appears to result from the compartmentalization of the alpha subunits inside the icosahedral beta subunit capsid whose catalytic sites are located close to the inner capsid surface.			KIS, K (corresponding author), TECH UNIV MUNICH,DEPT ORGAN CHEM & BIOCHEM,LICHTENBERGSTR 4,D-85747 GARCHING,GERMANY.							ANDERSON KS, 1991, J BIOL CHEM, V266, P8020; BACHER A, 1986, METHOD ENZYMOL, V122, P192; BACHER A, 1980, J BIOL CHEM, V255, P632; BACHER A, 1986, J MOL BIOL, V187, P75, DOI 10.1016/0022-2836(86)90407-9; BACHER A, 1978, J BACTERIOL, V134, P476, DOI 10.1128/JB.134.2.476-482.1978; BACHER A, 1990, CHEM BIOCH FLAVOENZY, V1, P215; BRESLER SE, 1976, GENETIKA+, V12, P83; CREIGHTO.TE, 1970, EUR J BIOCHEM, V13, P1, DOI 10.1111/j.1432-1033.1970.tb00892.x; CRESSWELL RM, 1960, J CHEM SOC, P4776, DOI 10.1039/jr9600004776; DUNN MF, 1990, BIOCHEMISTRY-US, V29, P8598, DOI 10.1021/bi00489a015; HARVEY RA, 1966, J BIOL CHEM, V241, P2120; KIS K, 1995, BIOCHEMISTRY-US, V34, P2883, DOI 10.1021/bi00009a019; KVASSMAN J, 1989, EUR J BIOCHEM, V186, P261, DOI 10.1111/j.1432-1033.1989.tb15204.x; KVASSMAN J, 1989, EUR J BIOCHEM, V186, P265, DOI 10.1111/j.1432-1033.1989.tb15205.x; LADENSTEIN R, 1994, EUR J BIOCHEM, V223, P1007, DOI 10.1111/j.1432-1033.1994.tb19079.x; LADENSTEIN R, 1988, J MOL BIOL, V203, P1045, DOI 10.1016/0022-2836(88)90128-3; LADENSTEIN R, 1986, J MOL BIOL, V187, P87, DOI 10.1016/0022-2836(86)90408-0; NEUBERGER G, 1986, BIOCHEM BIOPH RES CO, V127, P175; OVADI J, 1991, J THEOR BIOL, V152, P1, DOI 10.1016/S0022-5193(05)80500-4; Plaut G. W., 1975, CHEM BIOL PTERIDINES, P101; PLAUT GWE, 1970, BIOCHEMISTRY-US, V9, P771, DOI 10.1021/bi00806a010; Plaut GWE, 1971, METHODS ENZYMOL B, V18, P515; RITSERT K, 1995, IN PRESS J MOL BIOL; SCHOTT K, 1990, J BIOL CHEM, V265, P4204; SCHOTT K, 1990, J BIOL CHEM, V265, P12686; SEDLMAIER H, 1987, Z NATURFORSCH C, V42, P425; VOLK R, 1990, J BIOL CHEM, V265, P19479	27	77	78	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16788	16795		10.1074/jbc.270.28.16788	http://dx.doi.org/10.1074/jbc.270.28.16788			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622491	hybrid			2022-12-27	WOS:A1995RJ34700052
J	SEPPLORENZINO, L; MA, ZP; LEBWOHL, DE; VINITSKY, A; ROSEN, N				SEPPLORENZINO, L; MA, ZP; LEBWOHL, DE; VINITSKY, A; ROSEN, N			HERBIMYCIN-A INDUCES THE 20S PROTEASOME-DEPENDENT AND UBIQUITIN-DEPENDENT DEGRADATION OF RECEPTOR TYROSINE KINASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST-CANCER; ROUS-SARCOMA VIRUS; MULTICATALYTIC PROTEINASE COMPLEX; RAT-KIDNEY CELLS; TRANSFORMING ACTIVITY; CONSERVED FEATURES; INSULIN-RECEPTOR; INHIBITION; GROWTH; IDENTIFICATION	Herbimycin A is an ansamycin antibiotic isolated as an agent that reverses morphological transformation induced by v-src. Although herbimycin A is widely used as a tool for inhibiting multiple tyrosine protein kinases and tyrosine kinase-activated signal transduction, its mechanism of action is not well defined and includes a decrease in both tyrosine kinase protein levels and activity (Uehara, Y., Murakami, Y., Sugimoto, Y., and Mizuno, S, (1989) Cancer Res. 49, 780-785). We now show that herbimycin A induces a profound decrease in the total cellular activity of transmembrane tyrosine kinase receptors, such as insulin-like growth factor, insulin, and epidermal growth factor receptors. A substantial proportion of the in vivo inhibition could be explained by an increase in the rate of degradation, The enhanced degradation of insulin-like growth factor-insulin receptor was prevented by inhibitors of the 20S proteasome, whereas neither lysosomotropic agents nor general serine- and cysteine-protease inhibitors were active in preventing receptor degradation induced by herbimycin A. Moreover, in a temperature-sensitive mutant cell line defective in the E1-catalyzed activation of ubiquitin, herbimycin A treatment at the restrictive temperature did not result in the degradation of insulin receptor, These results suggest that herbimycin A represents a novel class of drug that targets the degradation of tyrosine kinases by the 20S proteasome. The ubiquitin dependence of this process indicates that this degradation of tyrosine kinases might involve the 20S proteasome as the proteolytic core of the ubiquitin-dependent 26S protease.	MEM SLOAN KETTERING CANC CTR, CELL BIOL & GENET PROGRAM, NEW YORK, NY 10021 USA; MEM SLOAN KETTERING CANC CTR, DEPT MED, NEW YORK, NY 10021 USA; CUNY MT SINAI SCH MED, DEPT PHARMACOL, NEW YORK, NY 10029 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai			Rosen, Neal/ABF-2677-2020		NCI NIH HHS [CA 58706-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA058706] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARTEAGA CL, 1988, MOL ENDOCRINOL, V2, P1064, DOI 10.1210/mend-2-11-1064; ARTEAGA CL, 1989, J CLIN INVEST, V84, P1418, DOI 10.1172/JCI114315; BOLEN JB, 1993, ONCOGENE, V8, P2025; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; DICKSON RB, 1986, CANCER RES, V46, P1707; ENNIS BW, 1989, MOL ENDOCRINOL, V3, P1830, DOI 10.1210/mend-3-11-1830; FUKAZAWA H, 1990, BIOCHEM BIOPH RES CO, V173, P276, DOI 10.1016/S0006-291X(05)81053-8; FUKAZAWA H, 1991, BIOCHEM PHARMACOL, V42, P1661; GRUENBERG J, 1989, ANNU REV CELL BIOL, V5, P453; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HERRERA R, 1988, J BIOL CHEM, V263, P5560; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; KAZLAUSKAS A, 1994, CURR OPIN GENET DEV, V4, P5, DOI 10.1016/0959-437X(94)90085-X; Knop M, 1993, CURR OPIN CELL BIOL, V5, P990, DOI 10.1016/0955-0674(93)90082-2; KULKA RG, 1988, J BIOL CHEM, V263, P15726; MILLER P, 1994, CANCER RES, V54, P2724; MURAKAMI Y, 1994, BIOCHEM J, V301, P63, DOI 10.1042/bj3010063; ORLOWSKI M, 1990, BIOCHEMISTRY-US, V29, P10289, DOI 10.1021/bi00497a001; ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022; PAPA V, 1993, CANCER RES, V53, P3736; PFITZNER KE, 1965, J AM CHEM SOC, V87, P5661, DOI 10.1021/ja00952a026; RECHSTEINER M, 1993, J BIOL CHEM, V268, P6065; RIVETT AJ, 1993, BIOCHEM J, V291, P1; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; RUSSELL DS, 1987, J BIOL CHEM, V262, P11833; SEPPLORENZINO L, 1994, CELL GROWTH DIFFER, V5, P1077; UEHARA Y, 1989, CANCER RES, V49, P780; UEHARA Y, 1988, VIROLOGY, V164, P294, DOI 10.1016/0042-6822(88)90649-6; UEHARA Y, 1986, MOL CELL BIOL, V6, P2198, DOI 10.1128/MCB.6.6.2198; UEHARA Y, 1985, JPN J CANCER RES, V76, P672; UEHARA Y, 1989, BIOCHEM BIOPH RES CO, V163, P803, DOI 10.1016/0006-291X(89)92293-6; VANDEVIJVER MJ, 1991, BIOCHIM BIOPHYS ACTA, V1072, P33, DOI 10.1016/0304-419X(91)90005-6; VEILLETTE A, 1993, J BIOL CHEM, V268, P17547; VINITSKY A, 1994, J BIOL CHEM, V269, P29860; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; WILK S, 1983, J NEUROCHEM, V41, P69, DOI 10.1111/j.1471-4159.1983.tb11815.x; WILKS AF, 1993, ADV CANCER RES, V60, P43	39	177	183	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16580	16587		10.1074/jbc.270.28.16580	http://dx.doi.org/10.1074/jbc.270.28.16580			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622464	hybrid			2022-12-27	WOS:A1995RJ34700021
J	FORNE, T; ROSSI, F; LABOURIER, E; ANTOINE, E; CATHALA, G; BRUNEL, C; TAZI, J				FORNE, T; ROSSI, F; LABOURIER, E; ANTOINE, E; CATHALA, G; BRUNEL, C; TAZI, J			DISRUPTION OF BASE-PAIRED U4-CENTER-DOT-U6 SMALL NUCLEAR RNAS INDUCED BY MAMMALIAN HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN-C PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							U6 SNRNA; 3' END; ACTIVE-SITE; SPLICEOSOME; BINDING; U2; PURIFICATION; PARTICLES; U5; U4	Due to 3' end modifications, mammalian U6 small nuclear RNA (snRNA) is heterogeneous in size. The major form terminates with five U residues and a 2',3'-cyclic phosphate, but multiple RNAs containing up to 12 U residues have a 3'-OH end. They are labeled in the presence of [alpha-P-32]UTP by the terminal uridylyl transferase activity present in HeLa cell nuclear extracts. That these forms all enter the U6 snRNA-containing particles, U4 . U6, U4 . U5 . U6, and the spliceosome, has been demonstrated previously. Here, we report an interaction between the heterogeneous nuclear ribonucleoprotein (hnRNP) C protein, an abundant nuclear pre-mRNA binding protein, and the U6 snRNAs that have the longest uridylate stretches. This U6 snRNA subset is free of any one of the other snRNPs, since anti-Sm antibodies failed to immunoprecipitate hnRNP C protein. Furthermore, isolated U4 . U6 snRNPs containing U6 snRNAs with long oligouridylate stretches are disrupted upon binding of hnRNP C protein either purified from HeLa cells or produced as recombinant protein from Escherichia coli. In view of these data and our previous proposal that the U6 snRNA active in splicing has 3'-OH end, we discuss a model where the hnRNP C protein has a decisive function in the catalytic activation of the spliceosome by allowing the release of U4 snRNP.	UNIV MONTPELLIER 1,INST GENET MOLEC,CNRS,UMR 9942,F-34033 MONTPELLIER 1,FRANCE; UNIV MONTPELLIER 2,CNRS,F-34033 MONTPELLIER 1,FRANCE	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier			Forne, Thierry/D-3718-2013	Forne, Thierry/0000-0002-9179-1551; Labourier, Emmanuel/0000-0001-8010-0674; Tazi, Jamal/0000-0002-1949-8748				BEHRENS SE, 1991, GENE DEV, V5, P1439, DOI 10.1101/gad.5.8.1439; BLENCOWE BJ, 1989, CELL, V59, P531, DOI 10.1016/0092-8674(89)90036-6; BROW DA, 1988, NATURE, V334, P213, DOI 10.1038/334213a0; CHOI YD, 1986, SCIENCE, V231, P1534, DOI 10.1126/science.3952495; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DAUGERON MC, 1992, NUCLEIC ACIDS RES, V14, P3625; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; GORLACH M, 1992, EMBO J, V11, P3289, DOI 10.1002/j.1460-2075.1992.tb05407.x; GORLACH M, 1994, J BIOL CHEM, V269, P23074; GRABOWSKI PJ, 1986, SCIENCE, V223, P1294; HINTERBERGER M, 1983, J BIOL CHEM, V258, P2604; HIRAI H, 1988, J BIOCHEM-TOKYO, V104, P991, DOI 10.1093/oxfordjournals.jbchem.a122597; HUANG M, 1994, MOL CELL BIOL, V14, P518, DOI 10.1128/MCB.14.1.518; KANDELSLEWIS S, 1993, SCIENCE, V262, P2035, DOI 10.1126/science.8266100; KHELLIL S, 1991, NUCLEIC ACIDS RES, V19, P877, DOI 10.1093/nar/19.4.877; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; LAMOND AI, 1988, P NATL ACAD SCI USA, V85, P411, DOI 10.1073/pnas.85.2.411; LELAYTAHA MN, 1986, J MOL BIOL, V189, P519, DOI 10.1016/0022-2836(86)90321-9; LESSER CF, 1993, SCIENCE, V262, P1982, DOI 10.1126/science.8266093; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; LUND E, 1992, SCIENCE, V255, P327, DOI 10.1126/science.1549778; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Moore M., 1993, RNA WORLD, P303; PINOLROMA S, 1993, MOL CELL BIOL, V13, P5762, DOI 10.1128/MCB.13.9.5762; PORTMAN DS, 1994, EMBO J, V13, P213, DOI 10.1002/j.1460-2075.1994.tb06251.x; REDDY R, 1987, J BIOL CHEM, V262, P75; RINKE J, 1985, NUCLEIC ACIDS RES, V13, P2617, DOI 10.1093/nar/13.7.2617; SHANNON KW, 1991, GENE DEV, V5, P773, DOI 10.1101/gad.5.5.773; SONTHEIMER EJ, 1993, SCIENCE, V262, P1989, DOI 10.1126/science.8266094; STEPHANO JE, 1984, CELL, V36, P145; STRAUSS EJ, 1991, GENE DEV, V5, P773; SWANSON MS, 1988, EMBO J, V7, P3519, DOI 10.1002/j.1460-2075.1988.tb03228.x; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; TAZI J, 1993, MOL CELL BIOL, V13, P1641, DOI 10.1128/MCB.13.3.1641; TERNS MP, 1992, MOL CELL BIOL, V12, P3032, DOI 10.1128/MCB.12.7.3032; WASSARMAN DA, 1992, SCIENCE, V257, P1918, DOI 10.1126/science.1411506; WASSARMAN DA, 1991, NATURE, V249, P463; WILUSZ J, 1990, MOL CELL BIOL, V10, P6397, DOI 10.1128/MCB.10.12.6397; WILUSZ J, 1988, MOL CELL BIOL, V8, P4477, DOI 10.1128/MCB.8.10.4477; WISE JA, 1993, SCIENCE, V262, P1978, DOI 10.1126/science.8266091; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243	42	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16476	16481		10.1074/jbc.270.27.16476	http://dx.doi.org/10.1074/jbc.270.27.16476			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608220	Green Published, hybrid			2022-12-27	WOS:A1995RH22600089
J	OKADA, N; KOIZUMI, S				OKADA, N; KOIZUMI, S			A NEUROPROTECTIVE COMPOUND, AURIN TRICARBOXYLIC-ACID, STIMULATES THE TYROSINE PHOSPHORYLATION CASCADE IN PC12 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; AURINTRICARBOXYLIC ACID; PROTEIN-KINASE; EGF RECEPTOR; SIGNAL TRANSDUCTION; PHOSPHATIDYLINOSITOL-3 KINASE; MOLECULAR-WEIGHT; SH2 DOMAINS; ACTIVATION; RAS	Aurin tricarboxylic acid (ATA), a general nuclease inhibitor, was reported to prevent PC12 cells from cell death caused by serum starvation (1). In our study, ATA also protected PC12 cells, but not NIH3T3 cells, from serum-starved cell death. When we investigated the mechanism of action of ATA on these cells, ATA was found to increase tyrosine phosphorylation in PC12 cells, but not in NIH3T3 cells. Further investigation on tyrosine-phosphorylated proteins revealed that ATA, similar to nerve growth factor and epidermal growth factor, induced tyrosine phosphorylation of mitogen-activated protein kinases. Since the tyrosine phosphorylation of mitogen-activated protein kinases is thought to play an important role in growth factor-dependent signal pathways, this finding suggests that the action of ATA on PC12 cells is mediated by tyrosine phosphorylation cascade, similar 60 growth factor signaling. In addition, we found that She proteins, phosphatidylinositol 3-kinase, and phospholipase C-gamma were also phosphorylated in ATA-treated PC12 cells. These key proteins in signal transduction pathways are known to associate with ligand-activated growth factor receptors and are phosphorylated on tyrosine. Thus, the phosphorylation of these three proteins by ATA stimulation supports the speculation that ATA activates a certain receptor tyrosine kinase.	CIBA GEIGY JAPAN LTD, INT RES LABS, BIOORGAN RES DEPT, TAKARAZUKA, HYOGO 665, JAPAN									AHN NG, 1990, J BIOL CHEM, V265, P11495; ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; BATISTATOU A, 1993, J CELL BIOL, V122, P523, DOI 10.1083/jcb.122.3.523; BATISTATOU A, 1991, J CELL BIOL, V115, P461, DOI 10.1083/jcb.115.2.461; BINASTEIN M, 1976, MOL PHARMACOL, V12, P191; BJORGE JD, 1990, P NATL ACAD SCI USA, V87, P3816, DOI 10.1073/pnas.87.10.3816; BLUMENTHAL T, 1973, BIOCHEM BIOPH RES CO, V55, P680, DOI 10.1016/0006-291X(73)91198-4; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; COUGHLIN SR, 1989, SCIENCE, V243, P1191; CUSHMAN M, 1991, J MED CHEM, V34, P329, DOI 10.1021/jm00105a052; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; ESCOBEDO JA, 1991, MOL CELL BIOL, V11, P1125, DOI 10.1128/MCB.11.2.1125; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GAN YX, 1990, BIOCHEM BIOPH RES CO, V172, P1298, DOI 10.1016/0006-291X(90)91590-O; GILBERTOGONZALEZ R, 1980, BIOCHEMISTRY-US, V19, P4299, DOI 10.1021/bi00559a023; GIVENS JF, 1976, NUCLEIC ACIDS RES, V3, P405, DOI 10.1093/nar/3.2.405; GROLLMAN AP, 1968, P NATL ACAD SCI USA, V61, P719, DOI 10.1073/pnas.61.2.719; HOSHI M, 1988, J BIOL CHEM, V263, P5396; JOSEPH R, 1993, BRAIN RES, V625, P244, DOI 10.1016/0006-8993(93)91065-Z; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LIAO LL, 1975, J MED CHEM, V18, P117, DOI 10.1021/jm00235a029; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MARGOLIS B, 1990, EMBO J, V9, P4375, DOI 10.1002/j.1460-2075.1990.tb07887.x; MCCUNE SA, 1989, BIOCHEM J, V259, P925, DOI 10.1042/bj2590925; MIYASAKA T, 1990, J BIOL CHEM, V265, P4730; MOGIL RJ, 1994, J IMMUNOL, V152, P1674; OHMICHI M, 1994, J BIOL CHEM, V269, P1143; OHMICHI M, 1992, NEURON, V9, P769, DOI 10.1016/0896-6273(92)90039-G; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; PRONK GJ, 1994, MOL CELL BIOL, V14, P1575, DOI 10.1128/MCB.14.3.1575; ROBERTSLEWIS JM, 1993, J NEUROCHEM, V61, P378, DOI 10.1111/j.1471-4159.1993.tb03583.x; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; SOLTOFF SP, 1992, J BIOL CHEM, V267, P17472; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; TSAO H, 1990, J BIOL CHEM, V265, P15471; TSUKAHARA T, 1994, NEUROSURGERY, V34, P323, DOI 10.1227/00006123-199402000-00016; WAHL MI, 1988, SCIENCE, V241, P968, DOI 10.1126/science.2457254; WAHL MI, 1989, MOL CELL BIOL, V9, P2934, DOI 10.1128/MCB.9.7.2934; WEAVER JL, 1990, AIDS RES HUM RETROV, V6, P1125, DOI 10.1089/aid.1990.6.1125; ZEEVALK GD, 1993, J NEUROCHEM, V61, P386, DOI 10.1111/j.1471-4159.1993.tb03585.x	45	49	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16464	16469		10.1074/jbc.270.27.16464	http://dx.doi.org/10.1074/jbc.270.27.16464			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608219	hybrid			2022-12-27	WOS:A1995RH22600087
J	ROTMAN, EI; MURPHY, BJ; CATTERALL, WA				ROTMAN, EI; MURPHY, BJ; CATTERALL, WA			SITES OF SELECTIVE CAMP-DEPENDENT PHOSPHORYLATION OF THE L-TYPE CALCIUM-CHANNEL ALPHA-1 SUBUNIT FROM INTACT RABBIT SKELETAL-MUSCLE MYOTUBES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 SIZE FORMS; PROTEIN-KINASE; DIHYDROPYRIDINE RECEPTOR; CYCLIC-AMP; 1,4-DIHYDROPYRIDINE RECEPTOR; ANTAGONIST RECEPTOR; BINDING POLYPEPTIDE; CA-2+ CHANNEL; IDENTIFICATION; ALPHA-1-SUBUNIT	The principal (alpha 1) subunit of purified skeletal muscle dihydropyridine-sensitive (L-type) calcium channels is present in full-length (212 kDa) and COOH-terminal truncated (190 kDa) forms, which are both phosphorylated by cAMP-dependent protein kinase (cA-PK) in vitro. Immunoprecipitation of the calcium channel from rabbit muscle myotubes in primary cell culture followed by phosphorylation with cA-PK, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and two-dimensional phosphopeptide mapping revealed comparable phosphorylation of three COOH-terminal phosphopeptides found in the purified full-length alpha 1 subunit. Stimulation of muscle myotubes with a permeant cAMP analogue, 8-(4-chlorophenylthio) adenosine 3',5'-cyclic monophosphate, prior to immunoprecipitation of alpha 1 results in a 60-80% reduction of cA-PK catalyzed ''back'' phosphorylation of each of these sites in vitro in calcium channels purified from the cells, indicating that these sites are phosphorylated in vivo in response to increased intracellular cAMP. Serine 687, the most rapidly phosphorylated site in the truncated 190-kDa alpha 1 subunit, was observed as a minor phosphopeptide whose level of phosphorylation was not significantly affected by stimulation of endogenous cA-PK in the myotubes. The COOH-terminal sites, designated tryptic phosphopeptides 4, 5, and 6, were identified as serine 1757 (phosphopeptides 4 and 6) and 1854 (phosphopeptide 5) by a combination of protease cleavage, phosphorylation of synthetic peptides and fusion proteins, specific immunoprecipitation, and phosphopeptide mapping. Phosphorylation of serines 1757 and 1854 in the COOH-terminal region of the 212-kDa alpha 1 subunit in intact skeletal muscle cells may play a pivotal role in the regulation of calcium channel function by cA-PK.			ROTMAN, EI (corresponding author), UNIV WASHINGTON, DEPT PHARMACOL, SEATTLE, WA 98195 USA.				NINDS NIH HHS [NS22625] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARREOLA J, 1987, J PHYSIOL-LONDON, V393, P307, DOI 10.1113/jphysiol.1987.sp016825; BEAM KG, 1992, NATURE, V360, P169, DOI 10.1038/360169a0; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; BORSOTTO M, 1985, J BIOL CHEM, V260, P4255; CURTIS BM, 1984, BIOCHEMISTRY-US, V23, P2113, DOI 10.1021/bi00305a001; CURTIS BM, 1985, P NATL ACAD SCI USA, V82, P2528, DOI 10.1073/pnas.82.8.2528; DEJONGH KS, 1989, P NATL ACAD SCI USA, V86, P8585; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; DEJONGH KS, 1991, P NATL ACAD SCI USA, V88, P10778, DOI 10.1073/pnas.88.23.10778; DOUCET JP, 1990, ANAL BIOCHEM, V190, P209, DOI 10.1016/0003-2697(90)90182-9; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; FLOCKERZI V, 1986, NATURE, V323, P66, DOI 10.1038/323066a0; FLUCHER BE, 1990, NEURON, V5, P339, DOI 10.1016/0896-6273(90)90170-K; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOSEY MM, 1988, J MEMBRANE BIOL, V104, P81, DOI 10.1007/BF01870922; HUTTNER WB, 1979, P NATL ACAD SCI USA, V76, P5402, DOI 10.1073/pnas.76.10.5402; HYMEL L, 1988, P NATL ACAD SCI USA, V85, P4290, DOI 10.1073/pnas.85.12.4290; JAHN H, 1988, EUR J BIOCHEM, V178, P535, DOI 10.1111/j.1432-1033.1988.tb14480.x; KACZMAREK LK, 1980, P NATL ACAD SCI-BIOL, V77, P7487, DOI 10.1073/pnas.77.12.7487; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI Y, 1990, J BIOL CHEM, V265, P20839; LEUNG AT, 1987, J BIOL CHEM, V262, P7943; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MURPHY BJ, 1993, J BIOL CHEM, V268, P27355; NUNOKI K, 1989, P NATL ACAD SCI USA, V86, P6816, DOI 10.1073/pnas.86.17.6816; OCALLAHAN CM, 1988, BIOCHEMISTRY-US, V27, P6071, DOI 10.1021/bi00416a036; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; REUTER H, 1983, NATURE, V301, P569, DOI 10.1038/301569a0; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; ROHRKASTEN A, 1988, J BIOL CHEM, V263, P15325; ROTMAN EI, 1992, J BIOL CHEM, V267, P16100; SCHAFFNER AE, 1982, J NEUROSCI, V2, P623; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMID A, 1985, J BIOL CHEM, V260, P3041; SCULPTOREANU A, 1993, NATURE, V364, P240, DOI 10.1038/364240a0; SHARP AH, 1987, J BIOL CHEM, V262, P12309; STRIESSNIG J, 1990, J BIOL CHEM, V265, P363; STRIESSNIG J, 1987, FEBS LETT, V212, P247, DOI 10.1016/0014-5793(87)81354-6; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; TSIEN RW, 1986, J MOL CELL CARDIOL, V18, P691, DOI 10.1016/S0022-2828(86)80941-5; TSIEN RW, 1983, ANNU REV PHYSIOL, V45, P341, DOI 10.1146/annurev.ph.45.030183.002013; VAGHY PL, 1987, J BIOL CHEM, V262, P14337	46	44	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16371	16377		10.1074/jbc.270.27.16371	http://dx.doi.org/10.1074/jbc.270.27.16371			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608207	hybrid			2022-12-27	WOS:A1995RH22600074
J	SIDERS, WM; MIZEL, SB				SIDERS, WM; MIZEL, SB			INTERLEUKIN-1-BETA SECRETION - A POSSIBLE MULTISTEP PROCESS THAT IS REGULATED IN A CELL-TYPE-SPECIFIC MANNER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; MURINE INTERLEUKIN-1; ESCHERICHIA-COLI; PROTEASE; IDENTIFICATION; PRECURSOR; MONOCYTES; 1-BETA; PURIFICATION; IL-1-ALPHA	In a prior study, we found that the processed-form of human interleukin-1 beta (mature IL-1 beta) is secreted to a significantly greater extent than the precursor form of the protein, indicating that the precursor domain acts in some manner to reduce the secretory potential of the protein, In view of this observation, we sought to define the sequence(s) in the IL-1 beta precursor that limit the secretion of the protein as well as the sequences in the mature protein that promote secretion, The P388D1 murine macrophage cell line and the Jurkat human T cell line were transiently transfected with cDNA expression vectors encoding truncated forms of human precursor IL-1 beta proteins, lacking either the first 76, 94, 99, or 104 amino acids, The removal of increasing numbers of precursor amino acid residues resulted in a graded increase in the secretion of the truncated precursor IL 1 beta proteins from both cell lines, The minimal region of the precursor sequence required to inhibit the optimal secretion of IL-1 beta occurs between amino acids 100 and 104 for P388D1 cells and 95-99 for Jurkat cells, Deletion of the amino acids within these regions increased the secretion level of the truncated proteins to that of mature IL-1 beta, Mutagenesis of the mature IL-1 beta sequence revealed that a region of basic amino acids may play an important role in the optimal secretion of mature IL-1 beta in P388D1 cells, but not in Jurkat cells. Based on the differences in the structural requirements for IL-1 beta secretion in P388D1 and Jurkat cell lines, it is likely that the secretion of IL-1 beta may be subject to multiple levels of regulation that are differentially operative in different cell types.	WAKE FOREST UNIV, MED CTR, DEPT MICROBIOL & IMMUNOL, WINSTON SALEM, NC 27157 USA	Wake Forest University					NIAID NIH HHS [AI25836, AI07401] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007401, R01AI025836] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AIYAR A, 1993, BIOTECHNIQUES, V14, P366; BLACK RA, 1989, J BIOL CHEM, V264, P5323; CARRUTH LM, 1991, J BIOL CHEM, V266, P12162; CLORE GM, 1991, BIOCHEMISTRY-US, V30, P2315, DOI 10.1021/bi00223a005; CREIGHTON AM, 1995, J BIOL CHEM, V270, P1663, DOI 10.1074/jbc.270.4.1663; DINARELLO CA, 1992, CHEM IMMUNOL, V51, P1; DORNER AJ, 1988, MOL CELL BIOL, V8, P4063, DOI 10.1128/MCB.8.10.4063; GIRI JG, 1985, J IMMUNOL, V134, P343; HABAZETTL J, 1992, NATURE, V359, P855, DOI 10.1038/359855a0; HAZUDA DJ, 1988, J BIOL CHEM, V263, P8473; HAZUDA DJ, 1991, J BIOL CHEM, V266, P7081; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; KESSLER E, 1994, J BIOL CHEM, V269, P22726; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; KOSTURA MJ, 1989, P NATL ACAD SCI USA, V86, P5227, DOI 10.1073/pnas.86.14.5227; LABRIOLATOMPKINS E, 1991, P NATL ACAD SCI USA, V88, P11182, DOI 10.1073/pnas.88.24.11182; LOMEDICO PT, 1984, NATURE, V312, P458, DOI 10.1038/312458a0; MILLER DK, 1993, J BIOL CHEM, V268, P18062; MINNICHCARRUTH LL, 1989, J IMMUNOL, V142, P526; MIZEL SB, 1981, J IMMUNOL, V126, P834; MOSLEY B, 1987, P NATL ACAD SCI USA, V84, P4572, DOI 10.1073/pnas.84.13.4572; MOSLEY B, 1987, J BIOL CHEM, V262, P2941; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PUGSLEY AP, 1991, MOL MICROBIOL, V5, P865, DOI 10.1111/j.1365-2958.1991.tb00760.x; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; SIDERS WM, 1993, J BIOL CHEM, V268, P22170; SINGER II, 1988, J EXP MED, V167, P389, DOI 10.1084/jem.167.2.389; STEVENSON FT, 1992, J CELL PHYSIOL, V152, P223, DOI 10.1002/jcp.1041520202; SUTTLES J, 1990, J IMMUNOL, V144, P175; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; VEERAPANDIAN B, 1992, PROTEINS, V12, P10, DOI 10.1002/prot.340120103; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	33	39	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16258	16264		10.1074/jbc.270.27.16258	http://dx.doi.org/10.1074/jbc.270.27.16258			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608192	hybrid			2022-12-27	WOS:A1995RH22600058
J	ZHANG, SS; MAACKE, H; GROSSE, F				ZHANG, SS; MAACKE, H; GROSSE, F			MOLECULAR-CLONING OF THE GENE ENCODING NUCLEAR-DNA HELICASE-II - A BOVINE HOMOLOG OF HUMAN RNA HELICASE-A AND DROSOPHILA MLE-PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; MALELESS PROTEIN; X-CHROMOSOME; CALF THYMUS; BINDING; FAMILY; BOX; PURIFICATION; SEQUENCES	Nuclear DNA helicase II (NDH II) unwinds both DNA and RNA (Zhang, S., and Grosse, F. (1994) Biochemistry 33, 3906-3912). Here, we report on the molecular cloning and sequence determination of the complementary DNA (cDNA) coding for this DNA and RNA helicase. The full-length cDNA sequence was derived from overlapping clones that were detected by immunoscreening of a calf thymus cDNA library in bacteriophage lambda gt11. This cDNA was 4,528 bases in length, which corresponded well with a 4.5-4.7-kilobase-long mRNA as detected by Northern blot analysis. The open reading frame of NDH II cDNA predicts a polypeptide of 1287 amino acids and a calculated molecular mass of 141,854 daltons. NDH II is related to a group of nucleic acid helicases from the DEAD/H box family II, with the signature motif DEIH in domain II. Two further proteins of this family, i.e. human RNA helicase A and Drosophila Maleless (Mle) protein, were found to be highly homologous to NDH II. With RNA helicase A, there was 91.5% identity and 95.5% similarity between the amino acid residues; with Mle protein, we observed a 50% identity and an 85% similarity. Antibodies against human RNA helicase A crossreacted with NDH II, further supporting that NDH II is the bovine homologue of human RNA helicase A. Immunofluorescence studies revealed a mainly nuclear localization of NDH II. A role for NDH II in nuclear DNA and RNA metabolism is suggested.	UNIV HAMBURG, HEINRICH PETTE INST EXPTL VIROL & IMMUNOL, D-20251 HAMBURG, GERMANY	Heinrich Pette Institute; University of Hamburg								BORK P, 1993, NUCLEIC ACIDS RES, V21, P751, DOI 10.1093/nar/21.3.751; CHEN JH, 1990, NUCLEIC ACIDS RES, V18, P6447, DOI 10.1093/nar/18.21.6447; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COBIANCHI F, 1986, J BIOL CHEM, V261, P3536; COMPANY M, 1991, NATURE, V349, P487, DOI 10.1038/349487a0; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; GHISOLFI L, 1992, J BIOL CHEM, V267, P2955; GIBSON TJ, 1994, NUCLEIC ACIDS RES, V22, P2552, DOI 10.1093/nar/22.13.2552; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; GORMAN M, 1994, TRENDS GENET, V10, P376, DOI 10.1016/0168-9525(94)90135-X; Grosse Frank, 1993, V16, P95; HERRICK G, 1976, J BIOL CHEM, V251, P2124; KERNAN MJ, 1991, CELL, V66, P949, DOI 10.1016/0092-8674(91)90440-A; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; KORNBERG A, 1991, DNA REPLICATION, P373; KURODA MI, 1991, CELL, V66, P935, DOI 10.1016/0092-8674(91)90439-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CG, 1993, J BIOL CHEM, V268, P16822; LEE CG, 1992, J BIOL CHEM, V267, P4398; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; LOH EY, 1989, SCIENCE, V243, P217, DOI 10.1126/science.2463672; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; MATSON SW, 1991, PROG NUCLEIC ACID RE, V40, P289; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; Ochman H., 1990, PCR PROTOCOLS GUIDE, P219; PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789; RIVA S, 1986, EMBO J, V5, P2267, DOI 10.1002/j.1460-2075.1986.tb04494.x; Sambrook J, 1989, MOL CLONING LABORATO; SHURMAN S, 1992, P NATL ACAD SCI USA, V89, P10935; SNUDDEN DK, 1994, EMBO J, V13, P4840, DOI 10.1002/j.1460-2075.1994.tb06810.x; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; STRAUSS EJ, 1991, GENE DEV, V5, P629, DOI 10.1101/gad.5.4.629; THOMMES P, 1990, FEBS LETT, V268, P325, DOI 10.1016/0014-5793(90)81279-W; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WASSARMAN DA, 1991, NATURE, V349, P463, DOI 10.1038/349463a0; ZHANG SS, 1994, BIOCHEMISTRY-US, V33, P3906, DOI 10.1021/bi00179a016; ZHANG SS, 1991, J BIOL CHEM, V266, P20483	38	61	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16422	16427		10.1074/jbc.270.27.16422	http://dx.doi.org/10.1074/jbc.270.27.16422			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608213	hybrid			2022-12-27	WOS:A1995RH22600081
J	EPIFANO, O; LIANG, LF; DEAN, J				EPIFANO, O; LIANG, LF; DEAN, J			MOUSE ZP1 ENCODES A ZONA-PELLUCIDA PROTEIN HOMOLOGOUS TO EGG ENVELOPE PROTEINS IN MAMMALS AND FISH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OOCYTE-SPECIFIC EXPRESSION; SPERM RECEPTOR; DEVELOPMENTAL REGULATION; GENOMIC ORGANIZATION; BINDING-PROTEIN; GENES; DNA; SEQUENCE; ZP-2	Zp1 encodes one of the three major glycoproteins of the zona pellucida, an extracellular matrix that surrounds growing oocytes, ovulated eggs, and preimplantation embryos. The mouse gene is composed of 12 exons ranging in size from 82 to 364 base pairs and spans 6.5 kilobase pairs on chromosome 19 (2.13 +/- 1.5 centimorgans distal to D19Bir1), The Zp1 exon map is similar to ZPB, a human orthologue, and an E-box (CANNTG), implicated in oocyte-specific gene expression of mouse Zp2 and Zp3, is similarly located upstream of the transcription start site, The single copy Zp1 gene encodes a 623-amino acid protein, the carboxyl-terminal half of which is significantly similar to a corresponding region of mouse ZP2, The conservation of this same region in a fish egg;envelope protein suggests that not only has this protein domain been duplicated in mammals but that it has been conserved and used as an egg envelope protein in species that diverged 650 million years ago.			EPIFANO, O (corresponding author), NIDDK,CELLULAR & DEV BIOL LAB,BLDG 6,RM B1-26,6 CTR DR MSC 2715,BETHESDA,MD 20892, USA.							AMANZE D, 1990, DEVELOPMENT, V109, P495; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CHAMBERLIN ME, 1990, P NATL ACAD SCI USA, V87, P6014, DOI 10.1073/pnas.87.16.6014; CHAMBERLIN ME, 1989, DEV BIOL, V131, P207, DOI 10.1016/S0012-1606(89)80052-1; DOOLITTLE RF, 1993, SCI AM, V269, P50, DOI 10.1038/scientificamerican1093-50; EPIFANO O, 1995, DEVELOPMENT, V121, P1947; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; GREENE JM, 1993, CURRENT PROTOCOLS MO; HARRIS JD, 1994, DNA SEQUENCE, V4, P361, DOI 10.3109/10425179409010186; HOLLAND SK, 1990, INTERVENING SEQUENCE, P10; KINLOCH RA, 1990, DEV BIOL, V142, P414, DOI 10.1016/0012-1606(90)90363-N; KINLOCH RA, 1988, P NATL ACAD SCI USA, V85, P6409, DOI 10.1073/pnas.85.17.6409; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LIANG LF, 1990, MOL CELL BIOL, V10, P1507, DOI 10.1128/MCB.10.4.1507; LIANG LF, 1993, DEV BIOL, V156, P399, DOI 10.1006/dbio.1993.1087; LUNSFORD RD, 1990, GENOMICS, V6, P184, DOI 10.1016/0888-7543(90)90465-7; LYONS CE, 1993, J BIOL CHEM, V268, P21351; MILLAR SE, 1993, DEV BIOL, V158, P410, DOI 10.1006/dbio.1993.1199; MILLAR SE, 1991, MOL CELL BIOL, V12, P6197; MURATA K, 1995, DEV BIOL, V167, P9, DOI 10.1006/dbio.1995.1002; Patthy L, 1991, CURR OPIN STRUC BIOL, V1, P351, DOI 10.1016/0959-440X(91)90033-P; PHILPOTT CC, 1987, DEV BIOL, V121, P568, DOI 10.1016/0012-1606(87)90192-8; RINGUETTE MJ, 1988, DEV BIOL, V127, P287, DOI 10.1016/0012-1606(88)90315-6; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; Sambrook J, 1989, MOL CLONING LABORATO; SCHWOEBEL E, 1991, J BIOL CHEM, V266, P7214; SETO D, 1990, NUCLEIC ACIDS RES, V18, P5905, DOI 10.1093/nar/18.19.5905; TAYA T, 1995, BIOCHEM BIOPH RES CO, V207, P790, DOI 10.1006/bbrc.1995.1256; YAMAGAMI K, 1992, INT REV CYTOL, V136, P51, DOI 10.1016/S0074-7696(08)62050-1; Yanagimachi R., 1994, P189; YUREWICZ EC, 1993, BIOCHIM BIOPHYS ACTA, V1174, P211, DOI 10.1016/0167-4781(93)90119-X	31	83	91	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27254	27258		10.1074/jbc.270.45.27254	http://dx.doi.org/10.1074/jbc.270.45.27254			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592984	hybrid			2022-12-27	WOS:A1995TE58300084
J	HAWLEY, SA; SELBERT, MA; GOLDSTEIN, EG; EDELMAN, AM; CARLING, D; HARDIE, DG				HAWLEY, SA; SELBERT, MA; GOLDSTEIN, EG; EDELMAN, AM; CARLING, D; HARDIE, DG			5'-AMP ACTIVATES THE AMP-ACTIVATED PROTEIN-KINASE CASCADE AND CA2+/CALMODULIN ACTIVATES THE CALMODULIN-DEPENDENT PROTEIN-KINASE-I CASCADE, VIA 3 INDEPENDENT MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT; RAT-BRAIN; PHOSPHORYLATION; IDENTIFICATION; PURIFICATION; P34(CDC2); P40(MO15)	ARIP-activated protein kinase (AMPK) and Ca2+/calmodulin (CaM) dependent protein kinase I (CaMKI) are protein kinases that are regulated both by allosteric activation (AMP and Ca2+/CaM, respectively) and by phosphorylation by upstream protein kinases (AMPK kinase (AMPKK) and CaMKI kinase (CaMKIK), respectively). We now report that AMPKK can activate CaMKI and that, conversely, CaMKIK can activate AMPK. CaMKIK is 68-fold more effective at activating CaMKI than AMPK, while AMPKK is 17-fold more effective at activating AMPK than CaMKI. Our results suggest that CaMKIK and AMPKK are distinct enzymes dedicated to their respective kinase targets but with some overlap in their substrate specificities. The availability of alternative substrates for AMPKK and CaMKIK allowed the unequivocal demonstration that AMP and Ca2+/calmodulin promote the activation of AMPK and CaMKI, respectively, via three independent mechanisms: 1) direct activation of AMPK and CaMKI, 2) activation of AMPKK and CaMKIK, and 3) by binding to AMPK and CaMKI, inducing exposure of their phosphorylation sites. Since AMP and Ca2+/calmodulin each has a triple effect in its respective system, in vivo, the two systems would be expected to be exquisitely sensitive to changes in concentration of their respective activating ligands.	SUNY BUFFALO,DEPT PHARMACOL & TOXICOL,BUFFALO,NY 14214; UNIV DUNDEE,DEPT BIOCHEM,DUNDEE DD1 4HN,SCOTLAND; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,MRC,MOLEC MED GRP,LONDON W12 0NN,ENGLAND	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Dundee; Imperial College London			Carling, David/F-1943-2014; Hardie, David/Z-1979-2019	Carling, David/0000-0002-2316-1830; Hardie, Grahame/0000-0002-8373-7379	NIGMS NIH HHS [GM07145-20] Funding Source: Medline; NINDS NIH HHS [NS24738] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS024738, R01NS024738] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CARLING D, 1994, J BIOL CHEM, V269, P11442; CARLING D, 1989, EUR J BIOCHEM, V185, P129; CLARKE PR, 1991, ADV PROT PHOSPHATASE, V6, P187; COHEN P, 1988, METHOD ENZYMOL, V159, P390; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; DALE S, 1994, FEBS LETT, V361, P191; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; DEREMER MF, 1992, J BIOL CHEM, V267, P13460; DEREMER MF, 1992, J BIOL CHEM, V267, P13466; DESAI D, 1995, MOL CELL BIOL, V15, P345, DOI 10.1128/MCB.15.1.345; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; FERRER A, 1985, BIOCHEM BIOPH RES CO, V132, P497, DOI 10.1016/0006-291X(85)91161-1; FESQUET D, 1993, EMBO J, V12, P3111, DOI 10.1002/j.1460-2075.1993.tb05980.x; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; HANKS SK, 1995, PROTEIN KINASE FACTS, P7; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; Hardie D. Grahame, 1994, Seminars in Cell Biology, V5, P409, DOI 10.1006/scel.1994.1048; HARDIE DG, 1992, BIOESSAYS, V14, P699, DOI 10.1002/bies.950141011; HARIBABU B, 1995, EMBO J, V15, P3679; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBBE JC, 1994, EMBO J, V13, P5155; LEE JC, 1995, BIOCHEM BIOPH RES CO, V210, P631, DOI 10.1006/bbrc.1995.1705; LEE JC, 1994, P NATL ACAD SCI USA, V91, P6413, DOI 10.1073/pnas.91.14.6413; LEE JSC, 1994, J BIOL CHEM, V269, P2158; MAKELA TP, 1994, NATURE, V371, P254, DOI 10.1038/371254a0; MOORE F, 1991, EUR J BIOCHEM, V199, P691, DOI 10.1111/j.1432-1033.1991.tb16172.x; MOORE SK, 1990, DNA CELL BIOL, V9, P387, DOI 10.1089/dna.1990.9.387; NAIRN AC, 1987, J BIOL CHEM, V262, P7273; OKUNO S, 1994, J BIOCHEM, V116, P923, DOI 10.1093/oxfordjournals.jbchem.a124617; PICCIOTTO MR, 1993, J BIOL CHEM, V268, P26512; POON RYC, 1993, EMBO J, V12, P3123, DOI 10.1002/j.1460-2075.1993.tb05981.x; SELBERT MA, 1995, J BIOL CHEM, V270, P17616, DOI 10.1074/jbc.270.29.17616; SOLOMON MJ, 1993, EMBO J, V12, P3133, DOI 10.1002/j.1460-2075.1993.tb05982.x; TOKUMITSU H, 1994, J BIOL CHEM, V269, P28640; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; WEEKES J, 1993, FEBS LETT, V334, P335, DOI 10.1016/0014-5793(93)80706-Z; WEEKES J, 1994, EUR J BIOCHEM, V219, P751, DOI 10.1111/j.1432-1033.1994.tb18554.x	38	347	361	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27186	27191		10.1074/jbc.270.45.27186	http://dx.doi.org/10.1074/jbc.270.45.27186			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592975	hybrid			2022-12-27	WOS:A1995TE58300075
J	KWAK, JY; LOPEZ, I; UHLINGER, DJ; RYU, SH; LAMBETH, JD				KWAK, JY; LOPEZ, I; UHLINGER, DJ; RYU, SH; LAMBETH, JD			RHOA AND A CYTOSOLIC 50-KDA FACTOR RECONSTITUTE GTP-GAMMA-S-DEPENDENT PHOSPHOLIPASE-D ACTIVITY IN HUMAN NEUTROPHIL SUBCELLULAR-FRACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP-DISSOCIATION INHIBITOR; BINDING PROTEIN; REGULATORY PROTEIN; D ACTIVATION; RAS; PHOSPHOHYDROLASE; GRANULOCYTES; HYDROLYSIS; MEMBRANE; CALCIUM	Receptor activation of phospholipase D has been implicated in signal transduction in a variety of cells, Reconstitution of cell free guanosine 5'-O-(3-thiotriphosphate)(GTP gamma S)-dependent phospholipase D activity from human neutrophils requires protein factors in both the plasma membrane and the cytosol, We previously proposed that one of the factors is a Ras-family small molecular weight GTPase of the Rho subtype (Bowman, E.P., Uhlinger, D.J., and Lambeth, J.D. (1993) J, Biol, Chem. 268, 21509-21512), Herein, we have used RhoGDI (GDP dissociation inhibitor), an inhibitory Rho-binding protein, to selectively extract Rho-type GTPases from the plasma membrane, and have used immunoprecipitation as well as chromatographic methods to remove cytosolic Rho, Depletion of RhoA from either the plasma membrane or the cytosol re suited in a partial loss in GTP gamma S dependent activity, while removal of RhoA from both fractions resulted in a nearly complete loss in activity, Activity was nearly completely restored by adding purified recombinant RhoA, which showed an EC(50) of 52 nM, while Rad showed little activity, Cytosol fractionated using DEAE- cellulose chromatography separated ADP-ribosylation factor and Rho from the major activating fraction, Gel exclusion chromatography of this fraction revealed an activating factor of 50 KDa apparent molecular-mass, Using RhoA-depleted membranes, reconstitution of phospholipase D activity required both RhoA and the 50-kDa factor, Thus, RhoA along with a non-Rho, non-ADP-ribosylation factor 50-kDa cytosolic factor are both required to reconstitute GTP gamma S dependent phospholipase D activity by neutrophil plasma membranes.	EMORY UNIV, SCH MED, ATLANTA, GA 30322 USA	Emory University				Ryu, Sung Ho/0000-0003-0913-3048	NATIONAL CANCER INSTITUTE [R01CA046508] Funding Source: NIH RePORTER; NCI NIH HHS [CA46508] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANTHES JC, 1989, BIOCHEM BIOPH RES CO, V163, P657, DOI 10.1016/0006-291X(89)92187-6; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; BOCCKINO SB, 1987, FEBS LETT, V225, P201, DOI 10.1016/0014-5793(87)81157-2; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOURGOIN S, 1995, J BIOL CHEM, V270, P3172, DOI 10.1074/jbc.270.7.3172; BOWMAN EP, 1993, J BIOL CHEM, V268, P21509; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; CHONG LD, 1994, CELL, V79, P507, DOI 10.1016/0092-8674(94)90259-3; CHUANG TH, 1993, J BIOL CHEM, V268, P775; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; EGAN SE, 1993, NATURE, V365, P781, DOI 10.1038/365781a0; FREEMAN JLR, 1994, BIOCHEMISTRY-US, V33, P13431, DOI 10.1021/bi00249a031; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; HORWITZ J, 1992, J NEUROCHEM, V59, P1474, DOI 10.1111/j.1471-4159.1992.tb08463.x; KRECK ML, 1994, J BIOL CHEM, V269, P4161; KUSNER DJ, 1994, BIOCHEM J, V304, P485, DOI 10.1042/bj3040485; LAMBETH JD, 1995, J BIOL CHEM, V270, P2431, DOI 10.1074/jbc.270.6.2431; LAMBETH JD, 1994, PROTEIN KINASE C, P121; LEONARD D, 1992, J BIOL CHEM, V267, P22860; LISCOVITCH M, 1994, J BIOL CHEM, V269, P21403; MALCOLM KC, 1994, J BIOL CHEM, V269, P25951; MOOLENAAR WH, 1991, ADV CANCER RES, V57, P87; OLSON SC, 1991, J BIOL CHEM, V266, P17236; PEMBER SO, 1983, ARCH BIOCHEM BIOPHYS, V221, P391, DOI 10.1016/0003-9861(83)90158-3; PERRY DK, 1992, J IMMUNOL, V149, P2749; PERTILE P, 1995, J BIOL CHEM, V270, P5130, DOI 10.1074/jbc.270.10.5130; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6; UEDA T, 1990, J BIOL CHEM, V265, P9373	31	68	68	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27093	27098		10.1074/jbc.270.45.27093	http://dx.doi.org/10.1074/jbc.270.45.27093			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592961	hybrid			2022-12-27	WOS:A1995TE58300061
J	ROY, K; MITSUGI, K; SIRLIN, S; SHANE, B; SIROTNAK, FM				ROY, K; MITSUGI, K; SIRLIN, S; SHANE, B; SIROTNAK, FM			DIFFERENT ANTIFOLATE-RESISTANT L1210 CELL VARIANTS WITH EITHER INCREASED OR DECREASED FOLYLPOLYGLUTAMATE SYNTHETASE GENE-EXPRESSION AT THE LEVEL OF MESSENGER-RNA TRANSCRIPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANALOG TRANSPORT INWARD; METHOTREXATE RESISTANCE; FOLATE TRANSPORT; CYTO-TOXICITY; TUMOR-CELLS; BETA-ACTIN; MOUSE; POLYGLUTAMYLATION; POLYGLUTAMATES; NITROCELLULOSE	L1210 cell variants selected in the presence of the lipophilic dihydrofolate reductase inhibitor, metoprine, expressed increased levels of one-carbon, reduced folate transport inward (Sirotnak, F. M., Moccio, D. M., and Yang, C.-H, (1984) J. Biol. Chem, 259, 13139-13144), Growth of one of these variants (L1210/R69), with metoprine in the presence of decreasing concentrations of 1,L5-CHO-folateH(4) (natural diastereoisomer of B-formyltetrahydrofolate), resulted in the selection of other variants (L1210/R82, R83, and R84) with further reduction in one-carbon, reduced folate transport and in two cases (L1210/R83 and R84) with 3-8-fold increased folylpolyglutamate synthetase (FPGS) activity and folate compound polyglutamate formation in situ, Metoprine resistance was further increased, and the requirement for exogenous folate during growth was decreased as well in these variants, The increase in FPGS activity observed in L1210/R83 and R84 was characterized by 3-and 8-fold increases in value for V-max with no change in K-m and the same increase in a 60-61-kDa protein as shown by immunoblotting, Northern blotting revealed the same increases in these two variants in the level of a 2.3-kilobase FPGS mRNA when compared with control, while Southern blotting of genomic DNA did not reveal any increase in FPGS gene copy number or restriction polymorphisms. Also, no difference in stability of FPGS mRNA was found between parental and variant cells, In contrast, nuclear run-on assays revealed differences among these cell types in the rate of FPGS mRNA transcription that correlated with increased FPGS activity, protein, and mRNA level in the variants, Similar studies with a transport-defective, methotrexate resistant L1210 cell variant (L1210/R25) documented a 2-3-fold decrease in FPGS activity, protein, and mRNA levels that was accounted for by a decrease in FPGS mRNA transcription, These results provide the first examples of constituitively altered transcriptional regulation of FPGS activity associated with acquired resistance to antifolates.	MEM SLOAN KETTERING CANC CTR, MOLEC THERAPEUT LAB, PROGRAM MOLEC PHARMACOL & THERAPEUT, NEW YORK, NY 10021 USA; CORNELL UNIV, GRAD SCH MED SCI, NEW YORK, NY 10021 USA; UNIV CALIF BERKELEY, DEPT NUTR SCI, BERKELEY, CA 94720 USA	Memorial Sloan Kettering Cancer Center; Cornell University; University of California System; University of California Berkeley					NCI NIH HHS [CA08748, CA56517] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748, R35CA056517] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BADLEY JE, 1988, BIOTECHNIQUES, V6, P114; BARREDO J, 1992, MOL PHARMACOL, V42, P687; BARRUECO JR, 1992, J BIOL CHEM, V267, P15356; CHELLO PL, 1982, BIOCHEM PHARMACOL, V31, P1527, DOI 10.1016/0006-2952(82)90376-8; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; CUATRECA.P, 1968, P NATL ACAD SCI USA, V61, P636, DOI 10.1073/pnas.61.2.636; DICKER AP, 1993, P NATL ACAD SCI USA, V90, P11797, DOI 10.1073/pnas.90.24.11797; Egan M. G., 1993, Proceedings of the American Association for Cancer Research Annual Meeting, V34, P275; EGAN MG, 1995, J BIOL CHEM, V270, P5462, DOI 10.1074/jbc.270.10.5462; FABRE I, 1984, CANCER RES, V44, P3190; GARROW TA, 1992, P NATL ACAD SCI USA, V89, P9151, DOI 10.1073/pnas.89.19.9151; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; Harlow E, 1988, ANTIBODIES LABORATOR, P471; HENDRICK SM, 1984, NATURE, V308, P149; HENGEN PN, 1992, BIOTECHNIQUES, V13, P56; JACKSON RC, 1984, FOLATE ANTAGONISTS T, V1, P290; KISLIUK RL, 1981, MOL CELL BIOCHEM, V39, P331, DOI 10.1007/BF00232583; KISLIUK RL, 1984, FOLATE ANTAGONISTS T, V1, P2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; MCBURNEY MW, 1974, CELL, V2, P173, DOI 10.1016/0092-8674(74)90091-9; MCCLOSKEY DE, 1991, J BIOL CHEM, V266, P6181; MCGUIRE JJ, 1980, J BIOL CHEM, V255, P5776; MCGUIRE JJ, 1984, FOLATES PTERINS, V1, P135; MORAN RG, 1985, MOL PHARMACOL, V27, P156; MORAN RG, 1984, BIOCHEMISTRY-US, V23, P4580, DOI 10.1021/bi00315a011; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; POSER RG, 1981, CANCER RES, V41, P4441; RHEE MS, 1993, CANCER RES, V53, P2227; RUMBERGER BG, 1990, CANCER COMMUN, V2, P305; RUMBERGER BG, 1990, CANCER RES, V50, P4639; SAMUELS LL, 1986, CANCER RES, V46, P2230; SAMUELS LL, 1985, CANCER RES, V45, P1488; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHANE B, 1989, VITAM HORM, V45, P263; SHEEHAN JC, 1965, J AM CHEM SOC, V87, P2492, DOI 10.1021/ja01089a034; SIROTNAK FM, 1988, BIOCHEM PHARMACOL, V37, P4239, DOI 10.1016/0006-2952(88)90122-0; SIROTNAK FM, 1985, CANCER RES, V45, P4732; SIROTNAK FM, 1985, CANCER RES, V45, P3992; SIROTNAK FM, 1980, PHARMACOL THERAPEUT, V8, P71, DOI 10.1016/0163-7258(80)90060-1; SIROTNAK FM, 1984, J BIOL CHEM, V259, P3139; SIROTNAK FM, 1984, FOLATE ANTAGONISTS T, V2, P43; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; YANG CH, 1988, J BIOL CHEM, V263, P9703	49	18	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26918	26922		10.1074/jbc.270.45.26918	http://dx.doi.org/10.1074/jbc.270.45.26918			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592937	hybrid			2022-12-27	WOS:A1995TE58300037
J	YU, W; SCHUSTER, W				YU, W; SCHUSTER, W			EVIDENCE FOR A SITE-SPECIFIC CYTIDINE DEAMINATION REACTION INVOLVED IN C TO U RNA EDITING OF PLANT-MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; MOLECULES; INSERTION; ENZYME	Transcripts of higher plant mitochondria are modified post-transcriptionally by RNA editing. To distinguish between the mechanisms by which the cytidine to uridine transition could occur a combined transcription/RNA editing assay and an in vitro RNA editing system were investigated. Mitochondria isolated from etiolated pea seedlings and potato tubers were supplied with [alpha-P-32]CTP to radiolabel the mitochondrial run-on transcripts. High molecular weight run-on transcripts were isolated and hydrolyzed, and nucleotide identities were analyzed by one- and two dimensional thin layer chromatography. The amount of label comigrating with UMP nucleotides increases with extended incubation times. Analogous products were obtained by incubation of [alpha-P-32]CTP or, [5-H-3]CTP radiolabeled in vitro transcripts with a mitochondrial lysate from pea mitochondria. 5-H-3 label of the cytosine base was detected in the UMP spot after incubation of in vitro transcripts with mitochondrial lysate. These results are consistent with a deamination reaction involved in this post-transcriptional C to U modification process. To prove that cytidines are deaminated specifically in vitro transcripts were reisolated after incubation and analyzed by reverse transcription-polymerase chain reaction. Sequence analysis clearly shows that only cytidines at editing sites are edited while residual cytidines are not modified and suggests that site specific factors are involved in RNA editing of plant mitochondria.	INST GENBIOL FORSCH BERLIN GMBH,D-14195 BERLIN,GERMANY									ARAYA A, 1992, P NATL ACAD SCI USA, V89, P1040, DOI 10.1073/pnas.89.3.1040; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; BENNE R, 1986, CELL, V46, P519; BLUM B, 1991, CELL, V65, P543, DOI 10.1016/0092-8674(91)90087-F; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; COVELLO PS, 1989, NATURE, V341, P662, DOI 10.1038/341662a0; COVELLO PS, 1990, FEBS LETT, V268, P5, DOI 10.1016/0014-5793(90)80958-L; COVELLO PS, 1990, NUCLEIC ACIDS RES, V18, P5189, DOI 10.1093/nar/18.17.5189; ELLIOTT MS, 1984, J BIOL CHEM, V259, P2407; FINNEGAN PM, 1987, PLANT PHYSIOL, V85, P304, DOI 10.1104/pp.85.1.304; GUALBERTO JM, 1989, NATURE, V341, P660, DOI 10.1038/341660a0; HIESEL R, 1989, SCIENCE, V246, P1632, DOI 10.1126/science.2480644; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; HODGES PE, 1991, NUCLEIC ACIDS RES, V19, P1197, DOI 10.1093/nar/19.6.1197; MULLIGAN RM, 1991, MOL CELL BIOL, V11, P533, DOI 10.1128/MCB.11.1.533; NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709; Nishimura S, 1972, Prog Nucleic Acid Res Mol Biol, V12, P49; OKADA N, 1979, J BIOL CHEM, V254, P3061; RAJASEKHAR VK, 1993, PLANT CELL, V5, P1843, DOI 10.2307/3869699; SCHUSTER W, 1994, PLANT MOL BIOL, V25, P33, DOI 10.1007/BF00024196; SCHUSTER W, 1990, MOL CELL BIOL, V10, P2428, DOI 10.1128/MCB.10.5.2428; SCHUSTER W, 1991, CURR GENET, V20, P397, DOI 10.1007/BF00317068; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J	24	97	103	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18227	18233		10.1074/jbc.270.31.18227	http://dx.doi.org/10.1074/jbc.270.31.18227			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629140	hybrid			2022-12-27	WOS:A1995RM64200014
J	BUSCH, S; WIELAND, T; ESCHE, H; JAKOBS, KH; SIFFERT, W				BUSCH, S; WIELAND, T; ESCHE, H; JAKOBS, KH; SIFFERT, W			G-PROTEIN REGULATION OF THE NA+/H+ ANTIPORTER IN XENOPUS-LAEVIS OOCYTES - INVOLVEMENT OF PROTEIN-KINASE-A AND PROTEIN-KINASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; PHOSPHOLIPASE-C; CYCLIC-AMP; ACTIVATION; INHIBITOR; EXCHANGE; RECEPTOR; CLONING; CELLS	We have characterized the regulation of the endogenous Na+/H+ exchanger in Xenopus laevis oocytes by G proteins and protein kinases by measuring the ethylisopropylamiloride-sensitive Li+ uptake. Injection of oocytes with the stable GTP analog GTP gamma S stimulated Li+ uptake up to almost 4-fold, an effect blocked by coinjection with the GDP analog guanyl-5'-yl thiophosphate. Injection into oocytes of beta gamma subunits of the heterotrimeric G protein transducin enhanced Li+ uptake by about 3-fold. This stimulation was blocked by transducin alpha subunits, which by themselves did not influence Li+ uptake. Using various activators and inhibitors of protein kinases, it is demonstrated that the X. laevis oocyte Na+/H+ antiporter can be stimulated by activation of both protein kinase A and C. Stimulation of Na+/H+ exchanger activity by GTP gamma S but not that induced by transducin beta gamma subunits was blocked by the protein kinase A inhibitor H-89. On the other hand, transducin beta gamma subunit-stimulated activity was prevented by the protein kinase C inhibitor, calphostin C. The non-selective protein kinase inhibitor H-7 blocked both GTP gamma S- and transducin beta gamma subunit-stimulated Na+/H+ exchanger activity. The results suggest that the Na+/H+ exchanger of X. laevis oocytes can be activated by G proteins and that this activation is not direct but mediated by protein kinase A- and/or protein kinase C-dependent pathways.	UNIV ESSEN GESAMTHSCH, INST PHARMAKOL, D-45122 ESSEN, GERMANY; UNIV ESSEN GESAMTHSCH, INST MOLEK BIOL, D-45122 ESSEN, GERMANY	University of Duisburg Essen; University of Duisburg Essen			Wieland, Thomas/Q-1506-2019; Wieland, Thomas/G-1772-2012	Wieland, Thomas/0000-0001-8262-8261; Wieland, Thomas/0000-0001-8262-8261				BERTRAND B, 1994, J BIOL CHEM, V269, P13703; BLITZER RD, 1993, J BIOL CHEM, V268, P7532; BORGESE F, 1992, P NATL ACAD SCI USA, V89, P6765, DOI 10.1073/pnas.89.15.6765; BORGESE F, 1994, P NATL ACAD SCI USA, V91, P5431, DOI 10.1073/pnas.91.12.5431; BURCKHARDT BC, 1992, PFLUG ARCH EUR J PHY, V420, P78, DOI 10.1007/BF00378644; BUSCH S, 1995, PFLUG ARCH EUR J PHY, V429, P859, DOI 10.1007/BF00374811; CAMPS M, 1992, EUR J BIOCHEM, V206, P821, DOI 10.1111/j.1432-1033.1992.tb16990.x; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; COUNILLON L, 1993, SOC GEN PHY, V48, P169; COUNILLON L, 1992, Cellular Physiology and Biochemistry, V2, P138, DOI 10.1159/000154636; DHANASEKARAN N, 1994, J BIOL CHEM, V269, P11802; GREEN J, 1992, AM J PHYSIOL, V262, pC111, DOI 10.1152/ajpcell.1992.262.1.C111; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; GUIZOUARN H, 1993, J BIOL CHEM, V268, P8632; GUPTA A, 1994, AM J PHYSIOL, V266, pC1083, DOI 10.1152/ajpcell.1994.266.4.C1083; HELMLEKOLB C, 1990, PFLUG ARCH EUR J PHY, V415, P461, DOI 10.1007/BF00373624; HIDAKA H, 1992, ANNU REV PHARMACOL, V32, P377, DOI 10.1146/annurev.pharmtox.32.1.377; KOBAYASHI E, 1989, BIOCHEM BIOPH RES CO, V159, P548, DOI 10.1016/0006-291X(89)90028-4; LEVINE SA, 1993, J BIOL CHEM, V268, P25527; MA HW, 1993, J BIOL CHEM, V268, P19915; PARK DG, 1993, J BIOL CHEM, V268, P4573; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; SAKUTA H, 1991, EUR J PHARM-MOLEC PH, V208, P31, DOI 10.1016/0922-4106(91)90048-M; TOWLE DW, 1991, J EXP BIOL, V159, P359; TSE M, 1994, J AM SOC NEPHROL, V4, P969; VANWEZENBEEK LACM, 1988, EUR J PHARMACOL, V151, P497, DOI 10.1016/0014-2999(88)90551-1; VOYNOYASENETSKAYA T, 1994, J BIOL CHEM, V269, P4721; WAKABAYASHI S, 1992, REV PHYSIOL BIOCH P, V119, P157; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P13710; WIELAND T, 1991, EUR J BIOCHEM, V196, P707, DOI 10.1111/j.1432-1033.1991.tb15869.x	30	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17898	17901		10.1074/jbc.270.30.17898	http://dx.doi.org/10.1074/jbc.270.30.17898			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629094	hybrid			2022-12-27	WOS:A1995RM26600042
J	PAYNE, JA; XU, JC; HAAS, M; LYTLE, CY; WARD, D; FORBUSH, B				PAYNE, JA; XU, JC; HAAS, M; LYTLE, CY; WARD, D; FORBUSH, B			PRIMARY STRUCTURE, FUNCTIONAL EXPRESSION, AND CHROMOSOMAL LOCALIZATION OF THE BUMETANIDE-SENSITIVE NA-K-CL COTRANSPORTER IN HUMAN COLON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHARK RECTAL GLAND; CO-TRANSPORT SYSTEM; CELL LINE; NA+/K+/CL COTRANSPORT; SQUALUS-ACANTHIAS; DOG KIDNEY; PROTEIN; GENES; PHOSPHORYLATION; IDENTIFICATION	By moving chloride into epithelial cells, the Na-K-CI cotransporter aids transcellular movement of chloride across both secretory and absorptive epithelia. Using cDNA probes from the recently identified elasmobranch secretory Na-K-Cl cotransporter (sNKCC1) (Xu, J. C., Lytle, C. Zhu, T. T., Payne, J. A., Bent, E., and Forbush, B., III (1994) Proc. Natl. Acad. Sci. 91, 2201-2205), we have identified the human homologue. By screening cDNA libraries of a human colonic carcinoma line, T84 cell, we identified a sequence of 4115 bases from overlapping clones. The deduced protein is 1212 amino acids in length, and analysis of the primary structure indicates 12 transmembrane segments. The primary structure is 74% identical to sNKCC1, 91% identical to a mouse Na-K-Cl cotransporter (mNKCC1), 58% identical to rabbit and rat renal Na-K-Cl cotransporters (NKCC2), and 43% identical to the thiazide-sensitive Na-Cl cotransporters from flounder urinary bladder and rat kidney. Similar to sNKCC1 and mNKCC1, the 5'-end of the human colonic cotransporter is rich in G+C content. Interestingly, a triple repeat (GCG)(7) occurs within the 5'-coding region and contributes to a large alanine repeat (Ala(15)). Two sites for N-linked glycosylation are predicted on an extracellular loop between putative transmembrane segments 7 and 8. A single potential site for phosphorylation by protein kinase A is present in the predicted cytoplasmic C-terminal domain. Northern blot analysis revealed a 7.4-7.5-kilobase transcript in T84 cells and shark rectal gland and a similar to 7.2-kilobase transcript in mammalian colon, kidney, lung, and stomach. Metaphase spreads from lymphocytes were probed with biotin-labeled cDNA and avidin fluorescein (the cotransporter gene was localized to human chromosome 5 at position 5q23.3). Human embryonic kidney cells stably transfected with the full-length cDNA expressed a similar to 170-kDa protein recognized by anti-cotransporter antibodies. Following treatment with N-glycosidase F, the molecular mass of the expressed protein was similar to that predicted for the core protein from the cDNA sequence (132-kDa) and identical to that of deglycosylated T84 cotransporter (similar to 135-kDa). The stably transfected cells exhibited a similar to 15-fold greater bumetanide-sensitive Rb-86 influx than control cells, and this flux required external sodium and chloride. Flux kinetics were consistent with an electroneutral cotransport of 1Na:1K:2Cl. Preincubation in chloride-free media was necessary to activate fully the expressed cotransporter, suggesting a [Cl]-dependent regulatory mechanism.	YALE UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510	Yale University; Yale University			Lytle, Christian/X-2836-2019	Lytle, Christian/0000-0001-5442-1546	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047661, P01DK017433] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK17433, DK47661] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARNOLD N, 1993, TECHNIQUES METHODS M, P324; BECK PJ, 1990, MOL CELL BIOL, V10, P4612, DOI 10.1128/MCB.10.9.4612; CANTRELL A, 1987, PLANT MOL BIOL, V9, P453, DOI 10.1007/BF00015877; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DELPIRE E, 1994, J BIOL CHEM, V269, P25677; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; DHARMSATHAPHORN K, 1985, J CLIN INVEST, V75, P462, DOI 10.1172/JCI111721; FONG P, 1991, AM J PHYSIOL, V261, pL290, DOI 10.1152/ajplung.1991.261.4.L290; FORBUSH B, 1992, AM J PHYSIOL, V262, pC1000, DOI 10.1152/ajpcell.1992.262.4.C1000; FORBUSH B, 1983, J BIOL CHEM, V258, P1787; FORBUSH B, 1989, BIOPHYS J, V55, P422; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; GAMBA G, 1994, J BIOL CHEM, V269, P17713; GREGER R, 1981, PFLUG ARCH EUR J PHY, V392, P92, DOI 10.1007/BF00584588; HAAS M, 1994, AM J PHYSIOL, V266, pC1440, DOI 10.1152/ajpcell.1994.266.5.C1440; HAAS M, 1994, AM J PHYSIOL-CELL PH, V267, pC869, DOI 10.1152/ajpcell.1994.267.4.C869; HAAS M, 1989, ANNU REV PHYSIOL, V51, P443, DOI 10.1146/annurev.physiol.51.1.443; HAAS M, 1993, MAMM GENOME, V4, P711, DOI 10.1007/BF00357794; HAAS M, 1991, AM J PHYSIOL, V260, pC791, DOI 10.1152/ajpcell.1991.260.4.C791; HAAS M, 1988, BIOCHIM BIOPHYS ACTA, V939, P131, DOI 10.1016/0005-2736(88)90054-5; HAAS M, 1987, AM J PHYSIOL, V253, pC243, DOI 10.1152/ajpcell.1987.253.2.C243; HALM DR, 1990, TXB SECRETORY DIARRH, P47; HANNAFIN J, 1983, J MEMBRANE BIOL, V75, P73, DOI 10.1007/BF01870801; KIM HD, 1988, BIOCHIM BIOPHYS ACTA, V946, P397, DOI 10.1016/0005-2736(88)90415-4; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LTLE C, 1992, AM J PHYSIOL, V262, pC1009; LYTLE C, 1992, J BIOL CHEM, V267, P25428; LYTLE C, 1992, J BIOL CHEM, V267, P25438; LYTLE C, 1992, J GEN PHYSIOL, V100, P39; MCROBERTS JA, 1982, J BIOL CHEM, V257, P2260; MORELL V, 1993, SCIENCE, V260, P1422, DOI 10.1126/science.8502986; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; OGRADY SM, 1987, AM J PHYSIOL, V253, pC177, DOI 10.1152/ajpcell.1987.253.2.C177; PAYNE JA, 1994, P NATL ACAD SCI USA, V91, P4544, DOI 10.1073/pnas.91.10.4544; PUDDINGTON L, 1987, P NATL ACAD SCI USA, V84, P2756; QUAGGIN SE, 1995, IN PRESS MAMM GENOME; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; ROST B, 1995, IN PRESS PROTEIN SCI; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SILVA P, 1986, AM J PHYSIOL, V250, pF516, DOI 10.1152/ajprenal.1986.250.3.F516; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; TORCHIA J, 1992, J BIOL CHEM, V267, P25444; TURNER RJ, 1986, J MEMBRANE BIOL, V94, P143, DOI 10.1007/BF01871194; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201	47	224	237	0	84	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17977	17985		10.1074/jbc.270.30.17977	http://dx.doi.org/10.1074/jbc.270.30.17977			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629105	hybrid			2022-12-27	WOS:A1995RM26600055
J	WISE, A; LEE, TW; MACEWAN, DJ; MILLIGAN, G				WISE, A; LEE, TW; MACEWAN, DJ; MILLIGAN, G			DEGRADATION OF G(11)ALPHA/G(Q)ALPHA IS ACCELERATED BY AGONIST OCCUPANCY OF ALPHA(1A/D), ALPHA(1B), AND ALPHA(1C) ADRENERGIC-RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING PROTEIN; ALPHA-1-ADRENERGIC RECEPTOR; MOLECULAR-CLONING; DOWN-REGULATION; FUNCTIONAL IMPLICATIONS; ACETYLCHOLINE-RECEPTOR; MEDIATED PATHWAYS; ADENYLYL CYCLASE; CROSS-REGULATION; RAT-BRAIN	Cells of clones of rat 1 fibroblasts transfected to express the molecularly defined alpha(1A/D), alpha(1B), or alpha(1C) adrenoreceptors and prelabeled with myo-[H-3]inositol were each shown to generate high levels of inositol phosphates when exposed to the alpha(1) adrenoreceptor agonist phenylephrine, Maintained exposure of each of these cells to phenylephrine resulted in a large down-regulation of the receptors and also a marked down-regulation of cellular levels of both of the phosphoinositidase C-linked G-proteins G(q) alpha and G(11)alpha. To examine the mechanism of phenylephrine-induced down-regulation of G(q) alpha and G(11)alpha, pulse-chase S-35-amino acid labeling experiments were performed with each of the alpha(1A/D), alpha(1B), and alpha(1C) adrenoreceptor-expressing cell lines. The rate of degradation of G(11)alpha/G(q) alpha, which was adequately modeled by a monoexponential with half-life between 33 and 40 h in each of the cell lines in the absence of agonist, was accelerated substantially (some 4 fold) in the presence of phenylephrine. By contrast, the rate of degradation of the G-protein G(i)2 alpha, which would not be anticipated to be activated by members of the alpha(1) adrenoreceptor family, was unaltered by the presence of phenylephrine, Levels of mRNA encoding G(q) alpha and G(11)alpha were not substantially altered by exposure of the cells to phenylephrine in any of the cell lines studied.	UNIV GLASGOW,INST BIOMED & LIFE SCI,DIV BIOCHEM & MOLEC BIOL,MOLEC PHARMACOL GRP,GLASGOW G12 8QQ,LANARK,SCOTLAND	University of Glasgow			Milligan, Graeme/F-9426-2011; MacEwan, David/F-7044-2011	Milligan, Graeme/0000-0002-6946-3519; MacEwan, David/0000-0002-2879-0935				ADIE EJ, 1994, BIOCHEM J, V300, P709, DOI 10.1042/bj3000709; ADIE EJ, 1992, BIOCHEM J, V285, P529, DOI 10.1042/bj2850529; COTECCHIA S, 1988, P NATL ACAD SCI USA, V85, P7159, DOI 10.1073/pnas.85.19.7159; DEGTYAREV MY, 1993, J BIOL CHEM, V268, P23769; EASON MG, 1992, J BIOL CHEM, V267, P25473; EASON MG, 1991, P NATL ACAD SCI USA, V91, P11178; FINAN PM, 1994, PLANT MOL BIOL, V25, P59, DOI 10.1007/BF00024198; FORD APDW, 1994, TRENDS PHARMACOL SCI, V15, P167, DOI 10.1016/0165-6147(94)90136-8; GREEN A, 1990, J BIOL CHEM, V265, P5206; HADCOCK JR, 1991, J BIOL CHEM, V266, P11915; HADCOCK JR, 1990, J BIOL CHEM, V265, P14784; KENNEDY ME, 1993, J BIOL CHEM, V268, P8003; KIM GD, 1994, J BIOL CHEM, V269, P19933; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; LOMASNEY JW, 1991, J BIOL CHEM, V266, P6365; MACNULTY EE, 1992, J BIOL CHEM, V267, P2149; MCKENZIE FR, 1990, J BIOL CHEM, V265, P17084; MCKENZIE FR, 1990, BIOCHEM J, V267, P391, DOI 10.1042/bj2670391; MILLIGAN G, 1994, BIOCHEM PHARMACOL, V48, P1059; MILLIGAN G, 1993, TRENDS PHARMACOL SCI, V14, P413, DOI 10.1016/0165-6147(93)90064-Q; MITCHELL FM, 1991, FEBS LETT, V287, P171, DOI 10.1016/0014-5793(91)80043-3; MITCHELL FM, 1993, BIOCHEM J, V293, P495, DOI 10.1042/bj2930495; MORROW AL, 1985, EUR J PHARMACOL, V109, P285, DOI 10.1016/0014-2999(85)90432-7; MORROW AL, 1986, MOL PHARMACOL, V29, P321; MULLANEY I, 1993, FEBS LETT, V324, P241, DOI 10.1016/0014-5793(93)81401-K; MULLANEY I, 1994, FEBS LETT, V353, P231, DOI 10.1016/0014-5793(94)01043-9; MUMBY SM, 1994, P NATL ACAD SCI USA, V91, P2800, DOI 10.1073/pnas.91.7.2800; PEREZ DM, 1991, MOL PHARMACOL, V40, P876; PLEVIN R, 1990, BIOCHEM J, V268, P605, DOI 10.1042/bj2680605; SCHWINN DA, 1990, J BIOL CHEM, V265, P8183; SHAH BH, 1994, MOL PHARMACOL, V46, P1; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; STEEL MC, 1993, MOL PHARMACOL, V43, P694; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; SVOBODA P, 1994, EUR J BIOCHEM, V224, P455, DOI 10.1111/j.1432-1033.1994.00455.x; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; WU DQ, 1992, J BIOL CHEM, V267, P25798	38	52	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17196	17203		10.1074/jbc.270.29.17196	http://dx.doi.org/10.1074/jbc.270.29.17196			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615517	hybrid			2022-12-27	WOS:A1995RK68900024
J	ENENKEL, C; BLOBEL, G; REXACH, M				ENENKEL, C; BLOBEL, G; REXACH, M			IDENTIFICATION OF A YEAST KARYOPHERIN HETERODIMER THAT TARGETS IMPORT SUBSTRATE TO MAMMALIAN NUCLEAR-PORE COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SACCHAROMYCES-CEREVISIAE; KARYOPHILIC PROTEINS; TRANSLOCATION; TRANSPORT; ENVELOPE; INVITRO	Targeting of import substrate to nuclear pore complexes of permeabilized vertebrate cells was previously shown to require a protein complex composed of two subunits, termed karyopherin. Yeast contain a homologue of karyopherin alpha named Srp1p, which was initially identified as a genetic Suppressor of mutations in a subunit of RNA polymerase I. To determine whether yeast contain a karyopherin complex that includes Srp1p as the karyopherin alpha homologue, we genetically replaced Srp1p with a Srp1-Protein A chimera, Cytosol from this strain contained a complex, composed of the chimera and a protein of 95 kDa, that was purified using affinity chromatography on IgG Sepharose, Microsequence analysis showed that the 95-kDa protein was identical with a yeast protein encoded by gene L8300.15 on chromosome XII. Sequence comparison revealed that the L8300.15 gene product is the closest structural homologue of vertebrate karyopherin beta. The yeast alpha and beta karyopherin subunits were expressed in Escherichia coli and were purified, When combined, they formed a heterodimeric complex and were active in targeting import substrate to nuclear envelopes of mammalian cells. We propose that all karyopherins function as alpha/beta heterodimers.	ROCKEFELLER UNIV, HOWARD HUGHES MED INST, CELL BIOL LAB, NEW YORK, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University								ADAM EJH, 1994, J CELL BIOL, V125, P547, DOI 10.1083/jcb.125.3.547; ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; [Anonymous], 1991, Methods Enzymol, V194, P1; BELANGER KD, 1994, J CELL BIOL, V126, P619, DOI 10.1083/jcb.126.3.619; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; FERNANDEZ J, 1994, ANAL BIOCHEM, V218, P112, DOI 10.1006/abio.1994.1148; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; IMAMOTO N, 1992, J CELL BIOL, V119, P1047, DOI 10.1083/jcb.119.5.1047; IMAMOTO N, 1995, J BIOL CHEM, V270, P8559, DOI 10.1074/jbc.270.15.8559; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; KALINICH JF, 1989, J BIOL CHEM, V264, P17979; MELCHIOR F, 1993, J CELL BIOL, V123, P1649, DOI 10.1083/jcb.123.6.1649; MOORE MS, 1994, TRENDS BIOCHEM SCI, V19, P211, DOI 10.1016/0968-0004(94)90024-8; MOORE MS, 1992, CELL, V69, P939, DOI 10.1016/0092-8674(92)90613-H; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; MOORE MS, 1994, P NATL ACAD SCI USA, V91, P10212, DOI 10.1073/pnas.91.21.10212; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P2008, DOI 10.1073/pnas.92.6.2008; MOROIANU J, 1995, IN PRESS P NATL ACAD; OKUNO Y, 1993, EXP CELL RES, V206, P134, DOI 10.1006/excr.1993.1129; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; SCHLENSTEDT G, 1993, J CELL BIOL, V123, P785, DOI 10.1083/jcb.123.4.785; SCHNELL DJ, 1993, J CELL BIOL, V120, P103, DOI 10.1083/jcb.120.1.103; SIKORSKI RS, 1989, GENETICS, V122, P19; TACHIBANA T, 1994, J BIOL CHEM, V269, P24542; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; YANO R, 1994, P NATL ACAD SCI USA, V91, P6880, DOI 10.1073/pnas.91.15.6880; YANO R, 1992, MOL CELL BIOL, V12, P5640, DOI 10.1128/MCB.12.12.5640	30	194	196	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16499	16502		10.1074/jbc.270.28.16499	http://dx.doi.org/10.1074/jbc.270.28.16499			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622450	hybrid			2022-12-27	WOS:A1995RJ34700005
J	ROWLINSON, SW; BARNARD, R; BASTIRAS, S; ROBINS, AJ; BRINKWORTH, R; WATERS, MJ				ROWLINSON, SW; BARNARD, R; BASTIRAS, S; ROBINS, AJ; BRINKWORTH, R; WATERS, MJ			A GROWTH-HORMONE AGONIST PRODUCED BY TARGETED MUTAGENESIS AT BINDING-SITE-1 - EVIDENCE THAT SITE-1 REGULATES BIOACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR DOMAIN; SCANNING MUTAGENESIS; RABBIT LIVER; RECEPTOR; PURIFICATION; PROTEIN; SERUM	Growth hormone (GH) is believed to signal by dimerizing its receptor through two binding sites on the hormone, Previous attempts to increase the biopotency of GH by increasing its site 1 affinity have been unsuccessful, which has led to a bias toward engineering site 2 interactions in the quest for creation of super agonists, Here we report that increasing site 1 affinity can markedly increase proliferative bioactivity in FDC-P1 cells expressing full-length GHR, In contrast, we find three site 1 mutants with affinities for site one similar to or greater than wild type GH, which have markedly decreased bioactivity. Through crystal structure analysis of the receptor interactive regions of these GH analogues, we are able to suggest why previous mutagenesis on human GH failed to improve biopotency, and thus provide a new avenue for GH and cytokine agonist design.	UNIV QUEENSLAND,CTR MOLEC BIOL & BIOTECHNOL,BRISBANE,QLD 4072,AUSTRALIA; BRESATEC LTD,ADELAIDE,SA 5001,AUSTRALIA; UNIV QUEENSLAND,CTR DRUG DESIGN & DEV,BRISBANE,QLD 4072,AUSTRALIA	University of Queensland; University of Queensland	ROWLINSON, SW (corresponding author), UNIV QUEENSLAND,DEPT PHYSIOL & PHARMACOL,BRISBANE,QLD 4072,AUSTRALIA.		waters, michael j/C-9582-2014; Barnard, Ross/AAR-9852-2020	Barnard, Ross/0000-0002-5685-4828				ABDELMEGUID SS, 1987, P NATL ACAD SCI USA, V84, P6434, DOI 10.1073/pnas.84.18.6434; BARNARD R, 1988, BIOCHEM J, V250, P533, DOI 10.1042/bj2500533; BARNARD R, 1986, BIOCHEM J, V237, P885, DOI 10.1042/bj2370885; BASTIRAS S, 1992, BIOCHEMISTRY-US, V31, P9304, DOI 10.1021/bi00153a025; BAUMGARTNER JW, 1994, J BIOL CHEM, V269, P29094; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; BELLEAU B, 1964, J MED CHEM, V7, P776, DOI 10.1021/jm00336a022; CAMPBELL RG, 1988, J ANIM SCI, V66, P1643; CLARK AJ, 1937, HDB EXPERIMENTELLEN, V4, P4; CUNNINGHAM BC, 1990, SCIENCE, V250, P1709, DOI 10.1126/science.2270485; CUNNINGHAM BC, 1989, SCIENCE, V243, P1330, DOI 10.1126/science.2466339; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; FUKUNAGA R, 1991, EMBO J, V10, P2855, DOI 10.1002/j.1460-2075.1991.tb07835.x; GOBIUS KS, 1992, J MOL ENDOCRINOL, V9, P213, DOI 10.1677/jme.0.0090213; HAPEL AJ, 1984, BLOOD, V64, P786; ILONDO MM, 1994, ENDOCRINOLOGY, V134, P2397, DOI 10.1210/en.134.6.2397; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; Mossmann T., 1983, J IMMUNOL METHODS, V65, P55; ROWLINSON SW, 1994, BIOCHEMISTRY-US, V33, P11724, DOI 10.1021/bi00205a008; SEELY JE, 1992, 74TH ANN M END SOC S; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; SPENCER SA, 1988, J BIOL CHEM, V263, P7862; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; WATERS MJ, 1979, J BIOL CHEM, V254, P6815; WELLS JA, 1993, RECENT PROG HORM RES, V48, P253; [No title captured]	29	43	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16833	16839		10.1074/jbc.270.28.16833	http://dx.doi.org/10.1074/jbc.270.28.16833			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622498	hybrid			2022-12-27	WOS:A1995RJ34700059
J	TIPPING, AJ; MCPHERSON, MJ				TIPPING, AJ; MCPHERSON, MJ			CLONING AND MOLECULAR ANALYSIS OF THE PEA SEEDLING COPPER AMINE OXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-METHYLPUTRESCINE OXIDASE; DIAMINE-OXIDASE; FUNCTIONAL EXPRESSION; PEROXIDASE-ACTIVITIES; STRUCTURAL GENE; TOBACCO ROOTS; TOPA QUINONE; ACTIVE-SITE; SEQUENCE; PURIFICATION	A pea seedling amine oxidase cDNA has been isolated and sequenced. A single long open reading frame has amino acid sequences corresponding to those determined from active site peptide (Janes, S. M., Palcic, M. M., Scaman, C. H., Smith, A. J., Brown, D. E., Dooley, D. M., Mure, M., and Klinman, J.P. (1992) Biochemistry 31, 12147-12154) and N-terminal sequencing experiments, The latter reveals the protein to have a 25-amino acid leader sequence with characteristics of a secretion signal peptide, as expected for this extracellular enzyme. Comparisons of the amino acid sequence of the mature pea enzyme (649 amino acids) with that of the mature lentil enzyme (569 amino acids; Rossi, A., Petruzzelli, R., and Finazzi-Agro, A. (1992) FEBS Lett. 301, 253-257) reveal important and unexpected differences particularly with regard to protein length. Sequencing of part of the lentil gene identified several frameshift differences within the coding region resulting in a mature lentil protein of exactly the same length, 649 amino acids, as the pea enzyme. Multiple alignments of 10 copper amine oxidase sequences reveal 33 completely conserved residues of which 10 are found within 41 aligned residues at the C-terminal tails, the region missing from the original lentil sequence. One of only four conserved histidines is found in this region and may represent the third ligand to the copper, The pea enzyme contains around 3-4% carbohydrate as judged by deglycosylation experiments. We have also demonstrated by hybridization analysis that copper amine oxidase genes are present in a range of mono- and dicotyledonous plants.	UNIV LEEDS, DEPT BIOCHEM & MOLEC BIOL, LEEDS LS2 9JT, W YORKSHIRE, ENGLAND; UNIV LEEDS, CTR PLANT BIOCHEM & BIOTECHNOL, LEEDS LS2 9JT, W YORKSHIRE, ENGLAND	University of Leeds; University of Leeds				McPherson, Michael/0000-0002-0719-6427				ANGELINI R, 1993, J PLANT PHYSIOL, V142, P704, DOI 10.1016/S0176-1617(11)80906-5; ANGELINI R, 1990, PLANTA, V182, P89, DOI 10.1007/BF00239989; ANGELINI R, 1989, J PLANT PHYSIOL, V135, P212, DOI 10.1016/S0176-1617(89)80179-8; ANGELINI R, 1985, BIOCH STUDIES NATURA, P183; AZAKAMI H, 1994, J FERMENT BIOENG, V77, P315, DOI 10.1016/0922-338X(94)90241-0; BARBRY P, 1990, P NATL ACAD SCI USA, V87, P7347, DOI 10.1073/pnas.87.19.7347; BARKER GJ, 1986, BIOCHEM J, V237, P609; BRUINENBERG PG, 1989, BIOCHIM BIOPHYS ACTA, V1008, P157, DOI 10.1016/0167-4781(80)90003-2; CAI DY, 1994, J BIOL CHEM, V269, P32039; CAI DY, 1994, BIOCHEMISTRY-US, V33, P7647, DOI 10.1021/bi00190a019; CHOI YH, 1995, J BIOL CHEM, V270, P4712, DOI 10.1074/jbc.270.9.4712; COOPER RA, 1992, BIOCHEM J, V288, P337, DOI 10.1042/bj2880337; DAVIES HM, 1989, PHYTOCHEMISTRY, V28, P1573, DOI 10.1016/S0031-9422(00)97802-6; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; FARNUM M, 1986, BIOCHEMISTRY-US, V25, P1898, DOI 10.1021/bi00356a010; FEDERICO R, 1988, PLANTA, V173, P317, DOI 10.1007/BF00401018; FEDERICO R, 1985, CELL MOL BIOL, V31, P171; FEDERICO R, 1986, PLANTA, V167, P300, DOI 10.1007/BF00391430; FEDERICO R, 1988, PLASMA MEMBRANE OXID, P333; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FETH F, 1986, PLANTA, V168, P402, DOI 10.1007/BF00392368; GURR SJ, 1992, MOL PLANT PATHOL, V1, P109; HAINES BD, 1981, GEL ELECTROPHORESIS, P1; HASHIMOTO T, 1990, PLANT PHYSIOL, V93, P216, DOI 10.1104/pp.93.1.216; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; HOOPES BC, 1981, NUCLEIC ACIDS RES, V9, P5493, DOI 10.1093/nar/9.20.5493; HUNT AG, 1994, ANNU REV PLANT PHYS, V45, P47, DOI 10.1146/annurev.pp.45.060194.000403; JANES SM, 1990, SCIENCE, V248, P981, DOI 10.1126/science.2111581; JANES SM, 1992, BIOCHEMISTRY-US, V31, P12147, DOI 10.1021/bi00163a025; JOSHI CP, 1987, NUCLEIC ACIDS RES, V15, P6643, DOI 10.1093/nar/15.16.6643; KLINMAN JP, 1994, ANNU REV BIOCHEM, V63, P299, DOI 10.1146/annurev.bi.63.070194.001503; KNOWLES PF, 1994, MET IONS BIOL SYST, V30, P361; Large P. J., 1986, YEAST, V2, P1; LINGUEGLIA E, 1993, EUR J BIOCHEM, V216, P679, DOI 10.1111/j.1432-1033.1993.tb18188.x; MATSUZAKI R, 1994, FEBS LETT, V351, P360, DOI 10.1016/0014-5793(94)00884-1; MCCRACKEN J, 1987, J AM CHEM SOC, V109, P4064, DOI 10.1021/ja00247a037; MCGOWAN RE, 1971, PLANT PHYSIOL, V47, P644, DOI 10.1104/pp.47.5.644; MCGUIRL MA, 1994, PLANT PHYSIOL, V106, P1205, DOI 10.1104/pp.106.3.1205; McIntire W. S., 1993, COPPER CONTAINING AM, P97; MIZUSAKI S, 1972, PHYTOCHEMISTRY, V11, P2757, DOI 10.1016/S0031-9422(00)86509-7; MU D, 1994, J BIOL CHEM, V269, P9926; MU D, 1992, J BIOL CHEM, V267, P7979; PARRYSMITH DJ, 1991, COMPUT APPL BIOSCI, V7, P233; PEDERSEN JZ, 1992, BIOCHEMISTRY-US, V31, P8, DOI 10.1021/bi00116a002; PERCIVAL FW, 1974, PLANT PHYSIOL, V54, P601, DOI 10.1104/pp.54.4.601; RINALDI A, 1982, EUR J BIOCHEM, V127, P417, DOI 10.1111/j.1432-1033.1982.tb06888.x; ROB JH, 1994, J MOL BIOL, V238, P635, DOI 10.1006/jmbi.1994.1321; ROSSI A, 1992, FEBS LETT, V301, P253, DOI 10.1016/0014-5793(92)80251-B; Sambrook J, 1989, MOL CLONING LABORATO; SCALET M, 1991, J PLANT PHYSIOL, V137, P571, DOI 10.1016/S0176-1617(11)80701-7; SCOTT RA, 1985, J AM CHEM SOC, V107, P4348, DOI 10.1021/ja00300a055; SLOCUM RD, 1991, PLANTA, V183, P443; SMITH TA, 1985, BIOCHEM SOC T, V13, P319, DOI 10.1042/bst0130319; SRIVASTAVA SK, 1977, PHYTOCHEMISTRY, V16, P185, DOI 10.1016/S0031-9422(00)86781-3; STADEN R, 1986, NUCLEIC ACIDS RES, V14, P217, DOI 10.1093/nar/14.1.217; SUGINO H, 1992, J BACTERIOL, V174, P2485, DOI 10.1128/jb.174.8.2485-2492.1992; SUZUKI Y, 1993, PHYTOCHEMISTRY, V33, P995, DOI 10.1016/0031-9422(93)85010-O; TANIZAWA K, 1994, BIOCHEM BIOPH RES CO, V199, P1096, DOI 10.1006/bbrc.1994.1343; TORRIGIANI P, 1989, PLANT PHYSIOL, V89, P69, DOI 10.1104/pp.89.1.69; TSUSHIDA T, 1985, AGR BIOL CHEM TOKYO, V49, P319, DOI 10.1080/00021369.1985.10866725; VIGNEVICH V, 1993, J MOL BIOL, V229, P243, DOI 10.1006/jmbi.1993.1022; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; ZHANG XP, 1993, J BACTERIOL, V175, P5617, DOI 10.1128/JB.175.17.5617-5627.1993	63	109	112	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16939	16946		10.1074/jbc.270.28.16939	http://dx.doi.org/10.1074/jbc.270.28.16939			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622512	hybrid			2022-12-27	WOS:A1995RJ34700073
J	VALDIZAN, EM; LOUKIANOV, EV; OLSNES, S				VALDIZAN, EM; LOUKIANOV, EV; OLSNES, S			INDUCTION OF TOXIN SENSITIVITY IN INSECT CELLS BY INFECTION WITH BACULOVIRUS ENCODING DIPHTHERIA-TOXIN RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERO CELLS; LOW PH; GROWTH-FACTOR; MOUSE CELLS; CD9 ANTIGEN; MEMBRANE; EXPRESSION; BINDING; PROTEIN; ENTRY	The diphtheria toxin receptor (DTR) has been identified as the precursor of heparin-binding epidermal growth factor-like growth factor, which may interact with other membrane proteins to form the functional receptor. To test if mammalian DTR is able to confer toxin sensitivity onto phylogenetically distant cells, we expressed monkey DTR in the baculovirus system and tested infected insect cells for toxin sensitivity. cDNA encoding an epitope-tagged heparin-binding epidermal growth factor-like growth factor precursor (DTR(B3)) was inserted into the virus genome by allelic replacement to construct the recombinant virus VAc-DTR(B3). SF9 cells infected with vAc-DTR(B3), expressed functional DTR, which could be precipitated from the solubilized membrane fraction of infected cells with Sepharose-immobilized diphtheria toxin. The highest level of expression (about 5 x 10(6) receptors/cell) was observed 48 h after infection, at which time the infected cells were highly sensitive to diphtheria toxin. Uninfected SF9 cells and cells infected with the wild type virus were resistant to the toxin. The presence of heparin increased both the binding and the toxin sensitivity of vAc-DTR(B3)-infected SF9 cells. Translocation of toxin A fragment was induced when cells with surface bound toxin were exposed to low pH, and the translocation was optimal at pH less than or equal to 5.5. It was similar to 100 times more efficient at 24 degrees C than at 4 degrees C. The data indicate that monkey DTR is fully functional when expressed in insect cells.	NORWEGIAN RADIUM HOSP,CANC RES INST,DEPT BIOCHEM,N-0310 OSLO,NORWAY	University of Oslo				Valdizan, Elsa/0000-0001-8898-8217				BLEWITT MG, 1985, BIOCHEMISTRY-US, V24, P5458, DOI 10.1021/bi00341a027; BROWN JG, 1993, P NATL ACAD SCI USA, V90, P8184, DOI 10.1073/pnas.90.17.8184; CHRISTOPHE S, 1993, BIOCHEM BIOPH RES CO, V196, P402, DOI 10.1006/bbrc.1993.2263; CIEPLAK W, 1987, J BIOL CHEM, V262, P13246; COLLIER RJ, 1975, BACTERIOL REV, V39, P54, DOI 10.1128/MMBR.39.1.54-85.1975; DRAPER RK, 1980, J CELL BIOL, V87, P849, DOI 10.1083/jcb.87.3.849; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GEORGE ST, 1989, BIOCHEM BIOPH RES CO, V163, P1265, DOI 10.1016/0006-291X(89)91114-5; GREENFIELD L, 1983, P NATL ACAD SCI-BIOL, V80, P6853, DOI 10.1073/pnas.80.22.6853; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; IWAMOTO R, 1991, J BIOL CHEM, V266, P20463; KOHNO K, 1987, EXP CELL RES, V172, P54, DOI 10.1016/0014-4827(87)90092-9; MCGILL S, 1989, EMBO J, V8, P2843, DOI 10.1002/j.1460-2075.1989.tb08431.x; MEKADA E, 1988, J CELL BIOL, V107, P511, DOI 10.1083/jcb.107.2.511; MEKADA E, 1982, BIOCHEM BIOPH RES CO, V109, P792, DOI 10.1016/0006-291X(82)92009-5; MIDDLEBROOK JL, 1978, J BIOL CHEM, V253, P7325; MIDDLEBROOK JL, 1977, CAN J MICROBIOL, V23, P183, DOI 10.1139/m77-026; MILLER LK, 1988, ANNU REV MICROBIOL, V42, P147; MITAMURA T, 1992, J CELL BIOL, V118, P1389, DOI 10.1083/jcb.118.6.1389; MORRIS RE, 1985, INFECT IMMUN, V50, P721, DOI 10.1128/IAI.50.3.721-727.1985; MORRISON DK, 1990, MOL CELL BIOL, V10, P2359, DOI 10.1128/MCB.10.5.2359; MOSKAUG JO, 1988, J BIOL CHEM, V263, P2518; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; NAGLICH JG, 1992, P NATL ACAD SCI USA, V89, P2170, DOI 10.1073/pnas.89.6.2170; ONO M, 1994, J BIOL CHEM, V269, P31315; OREILLY DR, 1992, BACULOVIRUS EXPRESSI, P216; PAPINI E, 1988, EMBO J, V7, P3353, DOI 10.1002/j.1460-2075.1988.tb03207.x; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; PARKER EM, 1991, J BIOL CHEM, V266, P519; REILANDER H, 1991, FEBS LETT, V282, P441, DOI 10.1016/0014-5793(91)80532-8; SANDVIG K, 1981, J BIOL CHEM, V256, P9068; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; SANDVIG K, 1980, J CELL BIOL, V87, P828, DOI 10.1083/jcb.87.3.828; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SMITH GE, 1993, J VIROL, V46, P584; SUMMERS MD, 1987, TEX AGR EXP STN B, V1555	37	5	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16879	16885		10.1074/jbc.270.28.16879	http://dx.doi.org/10.1074/jbc.270.28.16879			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622504	hybrid			2022-12-27	WOS:A1995RJ34700065
J	ABRAMSON, SR; CONNER, GE; NAGASE, H; NEUHAUS, I; WOESSNER, JF				ABRAMSON, SR; CONNER, GE; NAGASE, H; NEUHAUS, I; WOESSNER, JF			CHARACTERIZATION OF RAT UTERINE MATRILYSIN AND ITS CDNA - RELATIONSHIP TO HUMAN PUMP-1 AND ACTIVATION OF PROCOLLAGENASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHEUMATOID SYNOVIAL FIBROBLASTS; MATRIX METALLOPROTEINASE; DEGRADING METALLOPROTEINASE; HUMAN-SKIN; PURIFICATION; COLLAGENASE; TISSUE; EXPRESSION; PROTEOGLYCAN; CELLS	A small uterine metalloproteinase of the rat has been shown by amino acid and cDNA sequencing to be orthologous to human pump-1. Both proteinases are now designated as matrilysin or matrix metalloproteinase 7. The properties of purified uterine metalloproteinase and recombinant pump-1 were compared. Their specificities on substrates (gelatins, fibronectin, transferrin, elastin, Azocoll, and (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3,[2, 4-dinitrophenyl]-L-2, 3-diaminopropionyl)-Ala-Arg-NH2) are similar and distinct from those of the stromelysins and gelatinases. The two matrilysins have similar sensitivity to hydroxamate and pseudopeptide inhibitors. Rat matrilysin selectively cleaves the alpha 2(I) chain of rat gelatin, producing major cuts at Gly(713)- down arrow - Ile(714), Gly(775)- down arrow - Leu(776), and Gly(809)- down arrow -Ile(810). Rat matrilysin produces maximum activation of latent human interstitial collagenase 1 (pro-matrix metalloproteinase 1) when added in the presence of 4-aminophenylmercuric acetate (APMA) by cleaving the Gln(80)- down arrow -Phe(81) bond. Rat and human matrilysin do not directly activate latent rat collagenase 3 (matrix metalloproteinase 13) and do not enhance its activation when added together with APMA. Autoactivation of collagenase 3 in the presence of APMA results in cleavage at Val(81)- down arrow -Tyr(82) corresponding to the Gln(80)- down arrow -Phe(81) cleavage in collagenase 1. Thus collagenase 3 is capable of maximal autoactivation, whereas collagenase 1 is dependent upon another matrix metalloproteinase in order to be activated to its full potential.	UNIV MIAMI, SCH MED, DEPT BIOCHEM & MOLEC BIOL, MIAMI, FL 33136 USA; UNIV MIAMI, SCH MED, DEPT CELL BIOL & ANAT, MIAMI, FL 33136 USA; UNIV MIAMI, SCH MED, DEPT MED, MIAMI, FL 33136 USA; UNIV KANSAS, MED CTR, DEPT BIOCHEM & MOLEC BIOL, KANSAS CITY, KS 66160 USA	University of Miami; University of Miami; University of Miami; University of Kansas; University of Kansas Medical Center	ABRAMSON, SR (corresponding author), CLEVELAND CLIN FLORIDA, DIV RES, 3000 W CYPRESS CREEK RD, FT LAUDERDALE, FL 33809 USA.		Conner, Gregory/AAI-1285-2021	Conner, Gregory/0000-0003-2217-2252	NIAMS NIH HHS [AR-39189] Funding Source: Medline; NICHD NIH HHS [HD-06773] Funding Source: Medline; NIGMS NIH HHS [GM-35812] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035812] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUSIEK DF, 1992, J BIOL CHEM, V267, P9087; CRABBE T, 1992, BIOCHEMISTRY-US, V31, P8500, DOI 10.1021/bi00151a017; CRABBE T, 1994, BIOCHEMISTRY-US, V33, P14419, DOI 10.1021/bi00252a007; DEAN DD, 1985, ANAL BIOCHEM, V148, P174, DOI 10.1016/0003-2697(85)90642-6; DOCHERTY AJP, 1990, ANN RHEUM DIS, P469; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; GAIRE M, 1994, J BIOL CHEM, V269, P2032; GALLOWAY WA, 1983, BIOCHEM J, V209, P741, DOI 10.1042/bj2090741; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; GUNJASMITH Z, 1989, BIOCHEM J, V258, P115, DOI 10.1042/bj2580115; HARRIS ED, 1972, BIOCHIM BIOPHYS ACTA, V258, P566, DOI 10.1016/0005-2744(72)90249-5; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOVEJOY B, 1994, SCIENCE, V263, P375, DOI 10.1126/science.8278810; MARCOTTE PA, 1992, J BIOL CHEM, V267, P13803; MARTI HP, 1992, BIOCHEM J, V285, P899, DOI 10.1042/bj2850899; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; MAYER U, 1993, EUR J BIOCHEM, V217, P877, DOI 10.1111/j.1432-1033.1993.tb18316.x; MCDONNELL S, 1991, MOL CARCINOGEN, V4, P527, DOI 10.1002/mc.2940040617; MIYAZAKI K, 1990, CANCER RES, V50, P7758; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; MULLER D, 1988, BIOCHEM J, V253, P187, DOI 10.1042/bj2530187; MULLER D, 1991, INT J CANCER, V48, P550, DOI 10.1002/ijc.2910480412; MURPHY G, 1992, J BIOL CHEM, V267, P9612; MURPHY G, 1991, BIOCHEM J, V277, P277, DOI 10.1042/bj2770277; OKADA Y, 1988, BIOCHEM J, V254, P731, DOI 10.1042/bj2540731; OKADA Y, 1990, EUR J BIOCHEM, V194, P721, DOI 10.1111/j.1432-1033.1990.tb19462.x; OKADA Y, 1986, J BIOL CHEM, V261, P14245; PAJOUH MS, 1991, J CANCER RES CLIN, V117, P144, DOI 10.1007/BF01613138; PHILLIPS CL, 1992, GENOMICS, V13, P1345, DOI 10.1016/0888-7543(92)90065-Z; PIEZ KA, 1963, BIOCHEMISTRY-US, V2, P58, DOI 10.1021/bi00901a012; POWELL WC, 1993, CANCER RES, V53, P417; QUANTIN B, 1989, BIOCHEMISTRY-US, V28, P5327, DOI 10.1021/bi00439a004; QUINN CO, 1990, J BIOL CHEM, V265, P22342; REINEMER P, 1994, FEBS LETT, V338, P227, DOI 10.1016/0014-5793(94)80370-6; RODGERS WH, 1993, AM J OBSTET GYNECOL, V168, P253, DOI 10.1016/S0002-9378(12)90922-9; Sambrook J, 1989, MOL CLONING LABORATO; SELLERS A, 1980, BIOCHEM J, V189, P521, DOI 10.1042/bj1890521; SELTZER JL, 1981, J BIOL CHEM, V256, P4662; SHAPIRO SD, 1992, J BIOL CHEM, V267, P4664; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; TYREE B, 1981, ARCH BIOCHEM BIOPHYS, V208, P440, DOI 10.1016/0003-9861(81)90530-0; WEBB EC, 1992, ENZYME NOMENCLATURE, P412; WILHELM SM, 1993, J BIOL CHEM, V268, P21906; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; WOESSNER JF, 1988, J BIOL CHEM, V263, P16918	48	34	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16016	16022		10.1074/jbc.270.27.16016	http://dx.doi.org/10.1074/jbc.270.27.16016			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608162	hybrid			2022-12-27	WOS:A1995RH22600023
J	LEONE, TC; CRESCI, S; CARTER, ME; ZHANG, ZF; LALA, DS; STRAUSS, AW; KELLY, DP				LEONE, TC; CRESCI, S; CARTER, ME; ZHANG, ZF; LALA, DS; STRAUSS, AW; KELLY, DP			THE HUMAN MEDIUM-CHAIN ACYL-COA DEHYDROGENASE GENE PROMOTER CONSISTS OF A COMPLEX ARRANGEMENT OF NUCLEAR RECEPTOR RESPONSE ELEMENTS AND SP1 BINDING-SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC EXPRESSION; TRANSCRIPTION FACTOR; ALPHA-SUBUNIT; MOUSE; PROTEINS; CLONING; HORMONE; FAMILY; SUPERFAMILY; DEFICIENCY	Expression of the gene encoding the mitochondrial fatty acid beta-oxidation enzyme, medium-chain acyl-CoA dehydrogenase (MCAD), is regulated among tissues during development and in response to alterations in substrate availability. To identify and characterize cis-acting MCAD gene promoter regulatory elements and corresponding transcription factors, DNA-protein binding studies and mammalian cell transfection analyses were performed with human MCAD gene promoter fragments, DNA:protein binding studies with nuclear protein extracts prepared from hepatoma G2 cells, 3T3 fibroblasts, or Y-1 adrenal tumor cells identified three sequences (nuclear receptor response element 1 or NRRE-1, NRRE-2, and NRRE-3) that bind orphan mem members of the steroid/thyroid nuclear receptor superfamily including chicken ovalbumin upstream promoter transcription factor and steroidogenic factor 1, Sp1 binding sites (A-C) were identified in close proximity to each of the NRREs. NRRE-3 conferred cell line-specific transcriptional repression by interacting with chicken ovalbumin upstream promoter transcription factor or activation via steroidogenic factor 1. In contrast, the Sp1 binding site A behaved as a transcriptional activator in all cell lines examined, Ne propose that multiple nuclear receptor transcription factors interact with MCAD gene promoter elements to differentially regulate transcription among a variety of cell types.	WASHINGTON UNIV,SCH MED,DEPT MED,DIV CARDIOVASC,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT PEDIAT,ST LOUIS,MO 63110; DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Duke University			Kelly, Daniel/ABG-2056-2021		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045416, R29DK045416] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK45416-03] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUSUBEL FM, 1994, CURRENT PROTOCOLS MO, V2; BASSELDUBY R, 1994, MOL CELL BIOL, V14, P4596, DOI 10.1128/MCB.14.7.4596; BEINERT H, 1963, ENZYMES, P447; BESSEREAU JL, 1993, EMBO J, V12, P443, DOI 10.1002/j.1460-2075.1993.tb05676.x; BROWN CJ, 1992, GENE, V121, P313, DOI 10.1016/0378-1119(92)90136-D; CARTER ME, 1993, J BIOL CHEM, V268, P13805; CARTER ME, 1994, MOL CELL BIOL, V14, P4360, DOI 10.1128/MCB.14.7.4360; CHAN CA, 1992, J BIOL CHEM, V267, P6999; DESAIYAJNIK V, 1993, MOL CELL BIOL, V13, P5057, DOI 10.1128/MCB.13.8.5057; DITTMER J, 1994, J BIOL CHEM, V269, P21428; DURAN M, 1986, PEDIATRICS, V78, P1052; FISCHER KD, 1993, J BIOL CHEM, V268, P23915; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; HEBERLEIN U, 1988, NATURE, V331, P410, DOI 10.1038/331410a0; IKEDA Y, 1993, MOL ENDOCRINOL, V7, P852, DOI 10.1210/me.7.7.852; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KELLY DP, 1987, P NATL ACAD SCI USA, V84, P4068, DOI 10.1073/pnas.84.12.4068; KELLY DP, 1989, J BIOL CHEM, V264, P18921; KIMURA A, 1993, J BIOL CHEM, V268, P11125; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; KREY G, 1995, MOL ENDOCRINOL, V9, P219, DOI 10.1210/me.9.2.219; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; LEE JS, 1993, P NATL ACAD SCI USA, V90, P6145, DOI 10.1073/pnas.90.13.6145; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; NAGAO M, 1993, J BIOL CHEM, V268, P24114; RAISHER BD, 1992, J BIOL CHEM, V267, P20264; REVZIN A, 1989, BIOTECHNIQUES, V7, P346; ROBIDOUX S, 1992, MOL CELL BIOL, V12, P3796, DOI 10.1128/MCB.12.9.3796; SETO E, 1993, NATURE, V365, P462, DOI 10.1038/365462a0; STANLEY CA, 1983, PEDIATR RES, V17, P877, DOI 10.1203/00006450-198311000-00008; SU W, 1991, GENE DEV, V5, P820, DOI 10.1101/gad.5.5.820; SYLVESTER I, 1994, NUCLEIC ACIDS RES, V22, P901, DOI 10.1093/nar/22.6.901; TANSEY WP, 1991, J BIOL CHEM, V266, P9805; TENG CT, 1992, MOL ENDOCRINOL, V6, P1969, DOI 10.1210/me.6.11.1969; TRAN P, 1992, MOL CELL BIOL, V12, P4666, DOI 10.1128/MCB.12.10.4666; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; WEHRENBERG U, 1994, P NATL ACAD SCI USA, V91, P1440, DOI 10.1073/pnas.91.4.1440; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; XU J, 1993, J BIOL CHEM, V268, P16065; ZHANG ZF, 1992, BIOCHEMISTRY-US, V31, P81, DOI 10.1021/bi00116a013	42	39	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16308	16314		10.1074/jbc.270.27.16308	http://dx.doi.org/10.1074/jbc.270.27.16308			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608198	hybrid			2022-12-27	WOS:A1995RH22600065
J	NISIMOTO, Y; OTSUKAMURAKAMI, H; LAMBETH, DJ				NISIMOTO, Y; OTSUKAMURAKAMI, H; LAMBETH, DJ			RECONSTITUTION OF FLAVIN-DEPLETED NEUTROPHIL FLAVOCYTOCHROME B(558) WITH 8-MERCAPTO-FAD AND CHARACTERIZATION OF THE FLAVIN-RECONSTITUTED ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY BURST OXIDASE; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; CHRONIC GRANULOMATOUS-DISEASE; PHAGOCYTE NADPH-OXIDASE; ACTIVE-SITE PROBES; CELL-FREE SYSTEM; FLAVOPROTEIN COMPONENT; SUPEROXIDE GENERATION; CYTOSOLIC COMPONENT; PORCINE NEUTROPHILS	Cytochrome b(558) isolated from human neutrophils was inactive and contained no detectable FAD, However, high NADPH oxidase activity was seen upon reconstitution of the cytochrome with either native FAD or 8-mercapto-FAD in the presence of phospholipids (phosphatidylcholine/phosphatidylethanolamine/phosphatidylinositol/sphingomyelin/cholesterol, 4:2:1:3:3 (w/w)). Their cell-free superoxide-generating activities were 40.5 and 35.5 mol/s/mol of heme, respectively, which corresponded to 70 and 61% of the original activity of the plasma membranes, Both flavins co-eluted with heme and protein on gel exclusion chromatography. The respective specific flavin content was 6.45 and 7.93 nmol/mg of protein and corresponded to a flavin:heme molar ratio of 0.41 and 0.51 consistent with a 2:1 ratio of heme to flavin. Mixing of 8-mercapto-FAD with flavin-depleted cytochrome b(558) caused a red-shift of the flavin absorption maximum from 520 nm to around 560 nn, as has been seen when a variety of other apoflavoprotein dehydrogenases bind this analog. The 8-mercapto-FAD reconstituted into the cytochrome reacted readily with either iodoacetamide (k = 38.8 M(-1). min(-1)) or iodoacetic acid (k = 12.1 M(-1). min(-1)) to give a fluorescence spectrum characteristic of a 8-mercaptoflavin derivative, 8-SCH2CONH2 FAD or 8-SCH2COOH FAD. These results indicate that position 8 of FAD bound to the protein is freely accessible to solvent. These studies support the idea that cytochrome b(558) is a flavocytochrome.	EMORY UNIV,SCH MED,DEPT BIOCHEM,ATLANTA,GA 30322	Emory University	NISIMOTO, Y (corresponding author), AICHI MED UNIV,DEPT BIOCHEM,NAGAKUTE,AICHI 48011,JAPAN.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022809] Funding Source: NIH RePORTER; NIAID NIH HHS [AI22809] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABO A, 1991, J BIOL CHEM, V266, P23577; ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; BABIOR BM, 1977, BLOOD, V50, P517; BORREGAARD N, 1984, J BIOL CHEM, V259, P47; BURNHAM DN, 1990, J BIOL CHEM, V265, P17550; CROSS AR, 1982, BIOCHEM J, V208, P759, DOI 10.1042/bj2080759; GABIG TG, 1983, J BIOL CHEM, V258, P6352; HALEY EE, 1954, J AM CHEM SOC, V76, P5093, DOI 10.1021/ja01649a025; IMAJOHOHMI S, 1992, J BIOL CHEM, V267, P180; KAKINUMA K, 1986, J BIOL CHEM, V261, P9426; KARPLUS PA, 1991, SCIENCE, V251, P60, DOI 10.1126/science.1986412; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; KNOLLER S, 1991, J BIOL CHEM, V266, P2795; KOSHKIN V, 1993, FEBS LETT, V327, P57, DOI 10.1016/0014-5793(93)81039-3; KOSHKIN V, 1994, FEBS LETT, V338, P285, DOI 10.1016/0014-5793(94)80285-8; LETO TL, 1990, SCIENCE, V248, P727, DOI 10.1126/science.1692159; LIGHT DR, 1981, BIOCHEMISTRY-US, V20, P1468, DOI 10.1021/bi00509a010; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTTER R, 1985, J BIOL CHEM, V260, P2237; MANSTEIN DJ, 1986, J BIOL CHEM, V261, P6169; MARKERT M, 1985, P NATL ACAD SCI USA, V82, P3144, DOI 10.1073/pnas.82.10.3144; MASSEY V, 1979, J BIOL CHEM, V254, P9640; MIKI T, 1992, J BIOL CHEM, V267, P18695; MOORE EG, 1978, J BIOL CHEM, V254, P8173; NAKAMURA M, 1988, BLOOD, V72, P1550; NISIMOTO Y, 1994, BIOCHEM J, V297, P585, DOI 10.1042/bj2970585; NISIMOTO Y, 1993, ARCH BIOCHEM BIOPHYS, V302, P215; NISIMOTO Y, 1990, BIOCHIM BIOPHYS ACTA, V1010, P260; PARKINSON JF, 1988, J BIOENERG BIOMEMBR, V20, P653, DOI 10.1007/BF00762547; PARKINSON JF, 1988, J BIOL CHEM, V263, P8859; PARKOS CA, 1988, P NATL ACAD SCI USA, V85, P3319, DOI 10.1073/pnas.85.10.3319; PEMBER SO, 1983, BLOOD, V61, P1105; ROTROSEN D, 1993, J BIOL CHEM, V268, P14256; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; ROTROSEN D, 1990, J BIOL CHEM, V265, P8745; Rudolph S A, 1979, Adv Cyclic Nucleotide Res, V10, P107; SCHOPFER LM, 1981, J BIOL CHEM, V256, P7329; SEGAL AW, 1987, NATURE, V326, P88, DOI 10.1038/326088a0; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; SEGAL AW, 1989, J CLIN INVEST, V326, P88; SMITH RM, 1989, J BIOL CHEM, V264, P1958; SWAIN CG, 1968, J AM CHEM SOC, V90, P4328, DOI 10.1021/ja01018a024; TAKASUGI S, 1989, J BIOCHEM-TOKYO, V105, P155, DOI 10.1093/oxfordjournals.jbchem.a122630; TANAKA T, 1990, J BIOL CHEM, V265, P18717; TAUBER AI, 1979, BIOCHEMISTRY-US, V18, P5576, DOI 10.1021/bi00592a009; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UMEI T, 1991, J BIOL CHEM, V266, P6019; VOLPP BD, 1989, P NATL ACAD SCI USA, V86, P7195, DOI 10.1073/pnas.86.18.7195	49	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16428	16434		10.1074/jbc.270.27.16428	http://dx.doi.org/10.1074/jbc.270.27.16428			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608214	hybrid			2022-12-27	WOS:A1995RH22600082
J	REZAIE, AR; ESMON, CT				REZAIE, AR; ESMON, CT			CONTRIBUTION OF RESIDUE-192 IN FACTOR-XA TO ENZYME SPECIFICITY AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION FACTOR-XA; PROTEIN-C ACTIVATION; ACTIVE-SITE; FACTOR-VA; CONFORMATIONAL SENSITIVITY; PROTHROMBINASE COMPLEX; PHOSPHOLIPID SURFACE; BLOOD-COAGULATION; ANTITHROMBIN-III; THROMBIN	Mutation of residue 192 (chymotrypsin numbering) from Glu to Gin in thrombin and activated protein C has been shown to dramatically alter substrate and inhibitor specificity, in large part by allowing these enzymes to accept substrates with acidic residues in the P3 and/or P3' positions. In factor Xa, residue 192 is already a Gln. We now compare the properties of a Q192E mutant of Gla-domainless factor X (GDFX). Kinetic analysis of prothrombin activation indicates similar affinity of factor Va for GDFXa and GDFXa Q192E (K-d(app) = 3.6 and 3.7 mu M, respectively). Prothrombin activation rates are similar for both enzymes with factor Va, but are similar to 10-fold slower for the Q192E mutant without factor Va. This defect is in the activation of prethrombin 2 and is corrected by factor Va only in the presence of fragment 2. Without factor Va, fragment 2 has no influence on bovine prethrombin 2 activation by GDFXa, but fragment 2 enhances prethrombin 2 activation by the Q192E mutant at least 10-fold. These results indicate that the fragment 2 domain of prothrombin probably alters the conformation of the prethrombin 2 domain, selectively improving its presentation to GDFXa Q192E. With respect to inhibition, tissue factor pathway inhibitor and bovine pancreatic trypsin inhibitor are greater than or equal to 30 times poorer inhibitors of GDFXa Q192E than of GDFXa, but these enzymes are inhibited at comparable rates by antithrombin. These results indicate that Gln-192 in factor Xa is a key determinant of substrate/inhibitor specificity.	UNIV OKLAHOMA,HLTH SCI CTR,DEPT PATHOL,OKLAHOMA CITY,OK 73104; UNIV OKLAHOMA,HLTH SCI CTR,DEPT BIOCHEM & MOLEC BIOL,OKLAHOMA CITY,OK 73104; HOWARD HUGHES MED INST,OKLAHOMA CITY,OK 73104	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Howard Hughes Medical Institute	REZAIE, AR (corresponding author), OKLAHOMA MED RES FDN,CARDIOVASC BIOL RES PROGRAM,835 NE 13TH ST,OKLAHOMA CITY,OK 73104, USA.				NHLBI NIH HHS [R01 HL 29807, R37 HL30340] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL030340, R01HL029807] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARMSTRONG SA, 1990, J BIOL CHEM, V265, P6210; BROZE GJ, 1990, BIOCHEMISTRY-US, V29, P7539, DOI 10.1021/bi00485a001; ESMON CT, 1979, J BIOL CHEM, V254, P964; ESMON CT, 1974, J BIOL CHEM, V249, P7791; ESMON CT, 1973, THESIS WASHINGTON U; FRANZA BR, 1975, J BIOL CHEM, V250, P7057; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; GUINTO ER, 1994, J BIOL CHEM, V269, P18395; GUINTO ER, 1984, J BIOL CHEM, V259, P3986; HUANG ZF, 1993, J BIOL CHEM, V268, P26950; HUSTEN EJ, 1987, J BIOL CHEM, V262, P12953; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBONNIEC BF, 1992, J BIOL CHEM, V267, P6970; LEBONNIEC BF, 1991, J BIOL CHEM, V266, P13796; LEBONNIEC BF, 1991, P NATL ACAD SCI USA, V88, P7371, DOI 10.1073/pnas.88.16.7371; LIU LW, 1994, J BIOL CHEM, V269, P11807; MANN KG, 1990, BLOOD, V76, P1; MANN KG, 1990, BLOOD, V76, P755; OWEN WG, 1974, J BIOL CHEM, V249, P594; REZAIE AR, 1993, J BIOL CHEM, V268, P19943; REZAIE AR, 1993, J BIOL CHEM, V268, P8176; REZAIE AR, 1992, J BIOL CHEM, V267, P26104; ROSING J, 1986, J BIOL CHEM, V261, P4224; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOEN P, 1987, J BIOL CHEM, V262, P11268; SKOGEN WF, 1984, J BIOL CHEM, V259, P2306; STUBBS MT, 1992, EUR J BIOCHEM, V206, P187, DOI 10.1111/j.1432-1033.1992.tb16916.x; WALKER FJ, 1979, J BIOL CHEM, V254, P5618; WALKER RK, 1993, J BIOL CHEM, V268, P13920; WALKER RK, 1994, J BIOL CHEM, V269, P27441; YE J, 1991, J BIOL CHEM, V266, P23016	33	32	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16176	16181		10.1074/jbc.270.27.16176	http://dx.doi.org/10.1074/jbc.270.27.16176			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608183	hybrid			2022-12-27	WOS:A1995RH22600046
J	WOLF, A; SHAW, EW; OH, BH; DEBONDT, H; JOSHI, AK; AMES, GFL				WOLF, A; SHAW, EW; OH, BH; DEBONDT, H; JOSHI, AK; AMES, GFL			STRUCTURE-FUNCTION ANALYSIS OF THE PERIPLASMIC HISTIDINE-BINDING PROTEIN - MUTATIONS DECREASING LIGAND BINDING ALTER THE PROPERTIES OF THE CONFORMATIONAL CHANGE AND OF THE CLOSED FORM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURE; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; TRANSPORT-SYSTEMS; MALTOSE TRANSPORT; RHODOBACTER-CAPSULATUS; DEPENDENT TRANSPORT; MEMBRANE-VESICLES; ARGININE-BINDING; ACTIVE-TRANSPORT	The periplasmic histidine-binding protein, HisJ, is a receptor for the histidine permease of Salmonella typhimurium. Receptors of this type are composed of two lobes that are far apart in the unliganded structure (open conformation) and drawn close together in the liganded structure (closed conformation), The binding of the ligand, in a cleft between the lobes, stabilizes the closed conformation. Such receptors have several functions in transport: interaction with the membrane-bound complex, transmission of a transmembrane signal to hydrolyze ATP, and receiving a signal to open the lobes and release the ligand. In this study the mechanism of action of HisJ was further investigated using mutant proteins defective in ligand binding activity and closed form-specific monoclonal antibodies (Wolf, A., Shaw, E. W., Nikaido, K., and Ames G. F.-L. (1994) J. Biol. Chem. 269, 23051-23058). Y14H is defective in stabilization of the closed form, does not assume the closed empty form, and assumes an altered closed liganded form. T121A and G119R are similar to Y14H, but assume a normal closed Liganded form. S72P binds the ligand to the open form, but does not assume a recognizable closed form. S92F is defective in the ability to undergo conformational change and to stabilize the closed form. Ad other mutant proteins appear to fall within one of these four categories. The biochemical characterization of these mutant proteins agrees with the structural analysis of the protein. We suggest that mutant proteins that do not assume the normal closed form, in addition to their defect in ligand binding, fail to interact with the membrane-bound complex and/or to transmit transmembrane signals.	UNIV CALIF BERKELEY,LAWRENCE BERKELEY LAB,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720; UNIV CALIF BERKELEY,LAWRENCE BERKELEY LAB,DEPT CHEM & STRUCT BIOL,BERKELEY,CA 94720; POHANG UNIV SCI & TECHNOL,DEPT LIFE SCI,KYUNGBUK 790784,SOUTH KOREA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Pohang University of Science & Technology (POSTECH)			Oh, Byung-Ha/C-2061-2011		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK012121, R01DK012121] Funding Source: NIH RePORTER; NIAID NIH HHS [AI30725] Funding Source: Medline; NIDDK NIH HHS [DK12121] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAMS MD, 1989, J BIOL CHEM, V264, P15739; ADAMS MD, 1991, J BIOL CHEM, V266, P6209; AMES BN, 1952, J AM CHEM SOC, V74, P252; AMES GF, 1989, J BIOL CHEM, V264, P3998; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; AMES GFL, 1977, J BACTERIOL, V129, P1289, DOI 10.1128/JB.129.3.1289-1297.1977; BENNETT WS, 1984, CRIT REV BIOCH, V15, P290; BISHOP L, 1989, P NATL ACAD SCI USA, V86, P6953, DOI 10.1073/pnas.86.18.6953; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; DEAN DA, 1990, RES MICROBIOL, V141, P348, DOI 10.1016/0923-2508(90)90010-N; DEAN DA, 1992, MOL MICROBIOL, V6, P2033, DOI 10.1111/j.1365-2958.1992.tb01376.x; DOIGE CA, 1993, ANNU REV MICROBIOL, V47, P291, DOI 10.1146/annurev.micro.47.1.291; FLOCCO MM, 1994, J BIOL CHEM, V269, P8931; FRIGUET B, 1990, IMMUNOCHEMICAL ANAL, P287; FURLONG CE, 1987, ESCHERICHIA COLI SAL, P768; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HOR LI, 1993, J MOL BIOL, V233, P659, DOI 10.1006/jmbi.1993.1543; HOSHINO T, 1992, J BIOL CHEM, V267, P21313; JOSHI AK, 1989, J BIOL CHEM, V264, P2126; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KANG CH, 1991, J BIOL CHEM, V266, P23893; KERPPOLA RE, 1991, J BIOL CHEM, V266, P9857; KUSTU SG, 1974, J BIOL CHEM, V249, P6976; LEVER JE, 1972, J BIOL CHEM, V247, P4317; LEVER JE, 1972, ANAL BIOCHEM, V50, P73, DOI 10.1016/0003-2697(72)90487-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTINEAU P, 1990, J MOL BIOL, V214, P337, DOI 10.1016/0022-2836(90)90165-I; MILLER DM, 1983, J BIOL CHEM, V258, P3665; MOWBRAY SL, 1992, J MOL BIOL, V225, P155, DOI 10.1016/0022-2836(92)91033-L; NIKAIDO K, 1992, J BIOL CHEM, V267, P20706; NOEL D, 1979, BIOCHEMISTRY-US, V18, P4159, DOI 10.1021/bi00586a017; OH BH, 1993, J BIOL CHEM, V268, P11348; OH BH, 1994, J BIOL CHEM, V269, P4135; OH BH, 1994, J BIOL CHEM, V269, P26323; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; PETRONILLI V, 1991, J BIOL CHEM, V266, P16293; POST JFM, 1984, J MOL BIOL, V179, P729, DOI 10.1016/0022-2836(84)90164-5; PROSSNITZ E, 1988, J BIOL CHEM, V263, P17917; PROSSNITZ E, 1989, J BIOL CHEM, V264, P5006; PROSSNITZ E, 1989, THESIS U CALIFORNIA; QUIOCHO FA, 1990, PHILOS T R SOC B, V326, P341, DOI 10.1098/rstb.1990.0016; RICHARME G, 1992, BIOCHIM BIOPHYS ACTA, V1104, P201, DOI 10.1016/0005-2736(92)90151-B; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; SHARFF AJ, 1993, BIOCHEMISTRY-US, V32, P10553, DOI 10.1021/bi00091a004; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; SHUMAN HA, 1993, J BIOENERG BIOMEMBR, V25, P613; TAME JRH, 1994, SCIENCE, V264, P1578, DOI 10.1126/science.8202710; TREPTOW NA, 1988, J MOL BIOL, V202, P809, DOI 10.1016/0022-2836(88)90560-8; WALMSLEY AR, 1992, BIOCHEMISTRY-US, V31, P11175, DOI 10.1021/bi00160a031; WALMSLEY AR, 1992, J BIOL CHEM, V267, P8064; WOLF A, 1994, J BIOL CHEM, V269, P23051; YAO NH, 1994, BIOCHEMISTRY-US, V33, P4769, DOI 10.1021/bi00182a004; ZHANG YH, 1992, J BIOL CHEM, V267, P22813; ZOU JY, 1993, J MOL BIOL, V233, P739, DOI 10.1006/jmbi.1993.1549; ZUKIN RS, 1986, BIOPHYS J, V49, P1229, DOI 10.1016/S0006-3495(86)83752-3	58	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16097	16106		10.1074/jbc.270.27.16097	http://dx.doi.org/10.1074/jbc.270.27.16097			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608172	hybrid			2022-12-27	WOS:A1995RH22600035
J	ALLEN, RM; CHATTERJEE, R; LUDDEN, PW; SHAH, VK				ALLEN, RM; CHATTERJEE, R; LUDDEN, PW; SHAH, VK			INCORPORATION OF IRON AND SULFUR FROM NIFB COFACTOR INTO THE IRON-MOLYBDENUM COFACTOR OF DINITROGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AZOTOBACTER-VINELANDII; KLEBSIELLA-PNEUMONIAE; INVITRO SYNTHESIS; NITROGENASE; PROTEIN; REDUCTASE; GENE; APODINITROGENASE; BIOSYNTHESIS; HOMOCITRATE	NifB-co is an iron- and sulfur-containing precursor to the iron-molybdenum cofactor (FeMo-co) of dinitrogenase. The synthesis of NifB-co requires at least the product of the nifB gene. Incorporation of Fe-55 and S-35 from NifB-co into FeMo-co was observed only when all components of the in vitro FeMo-co synthesis system were present. Incorporation of iron and sulfur from NifB-co into dinitrogenase was not observed in control experiments in which the apodinitrogenase (lacking FeMo-co) was initially activated with purified, unlabeled FeMo-co or in assays where NifB-co was oxygen-inactivated prior to addition to the synthesis system. These data clearly demonstrate that iron and sulfur from active NifB-co are specifically incorporated into FeMo-co of dinitrogenase and provide direct biochemical identification of an iron-sulfur precursor of FeMo-co. Under different in vitro FeMo-co synthesis conditions, iron and sulfur from NifB-co were associated with at least two other proteins (NIFNE and gamma) that are involved in the formation of active dinitrogenase. The results presented here suggest that multiple FeMo-co processing steps might occur on NIFNE and that FeMo-co synthesis is most likely completed prior to the association of FeMo-co with gamma.	UNIV WISCONSIN,COLL AGR & LIFE SCI,DEPT BIOCHEM,MADISON,WI 53706; UNIV WISCONSIN,COLL AGR & LIFE SCI,CTR STUDY NITROGEN FIXAT,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison					NIGMS NIH HHS [GM35332] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035332, R01GM035332] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN RM, 1993, J BIOL CHEM, V268, P23670; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BOLIN JT, 1990, NITROGEN FIXATION : ACHIEVEMENTS AND OBJECTIVES, P117; BRANDNER JP, 1989, J BACTERIOL, V171, P360, DOI 10.1128/jb.171.1.360-368.1989; BRIGLE KE, 1987, J BACTERIOL, V169, P1547, DOI 10.1128/jb.169.4.1547-1553.1987; BRUMBY PE, 1965, J BIOL CHEM, V240, P2222; BULEN WA, 1966, P NATL ACAD SCI USA, V56, P979, DOI 10.1073/pnas.56.3.979; DEAN DR, 1993, J BACTERIOL, V175, P6737, DOI 10.1128/jb.175.21.6737-6744.1993; FILLER WA, 1986, EUR J BIOCHEM, V160, P371, DOI 10.1111/j.1432-1033.1986.tb09981.x; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; HAGEMAN RV, 1978, P NATL ACAD SCI USA, V75, P2699, DOI 10.1073/pnas.75.6.2699; HOMER MJ, 1995, J BIOL CHEM, V270, P24755; HOOVER TR, 1988, BIOCHEMISTRY-US, V27, P3647, DOI 10.1021/bi00410a019; HOOVER TR, 1989, BIOCHEMISTRY-US, V28, P2768, DOI 10.1021/bi00433a004; IMPERIAL J, 1987, J BACTERIOL, V169, P1784, DOI 10.1128/jb.169.4.1784-1786.1987; JACOBSON MR, 1989, J BACTERIOL, V171, P1017, DOI 10.1128/jb.171.2.1017-1027.1989; JOERGER RD, 1988, J BACTERIOL, V170, P1475, DOI 10.1128/jb.170.4.1475-1487.1988; KIM JS, 1992, SCIENCE, V257, P1677, DOI 10.1126/science.1529354; MACNEIL T, 1978, J BACTERIOL, V136, P253, DOI 10.1128/JB.136.1.253-266.1978; PAUSTIAN TD, 1990, BIOCHEMISTRY-US, V29, P3515, DOI 10.1021/bi00466a014; ROBINSON AC, 1987, J BIOL CHEM, V262, P14327; ROLL JT, 1995, J BIOL CHEM, V270, P4432, DOI 10.1074/jbc.270.9.4432; SHAH VK, 1994, J BIOL CHEM, V269, P1154; SHAH VK, 1986, P NATL ACAD SCI USA, V83, P1636, DOI 10.1073/pnas.83.6.1636; SHAH VK, 1977, P NATL ACAD SCI USA, V74, P3249, DOI 10.1073/pnas.74.8.3249; UGALDE RA, 1984, J BACTERIOL, V159, P888, DOI 10.1128/JB.159.3.888-893.1984; WAUGH SI, 1995, J BACTERIOL, V177, P1505, DOI 10.1128/jb.177.6.1505-1510.1995; YOCH DC, 1966, J BACTERIOL, V168, P618; ZHENG LM, 1994, J BIOL CHEM, V269, P18723	29	79	80	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26890	26896		10.1074/jbc.270.45.26890	http://dx.doi.org/10.1074/jbc.270.45.26890			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592933	hybrid			2022-12-27	WOS:A1995TE58300033
J	BALL, HJ; SHINE, J; HERZOG, H				BALL, HJ; SHINE, J; HERZOG, H			MULTIPLE PROMOTERS REGULATE TISSUE-SPECIFIC EXPRESSION OF THE HUMAN NPY-Y1 RECEPTOR GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROPEPTIDE-Y; TRANSCRIPTION; BRAIN; ELEMENTS; BINDING	Several cDNA clones encoding the human neuropeptide Y-Y1 receptor have been isolated that contain differing sequences at their 5'-ends. The divergence occurs at a splice junction in the 5'-untranslated region, suggesting that at least three forms of the neuropeptide Y-Y1 receptor transcript are generated by alternative splicing at this site, Genomic clones have been isolated that encompass the alternatively spliced 5'-exons. The exons are found 6.4, 18.4, and 23.9 kilobases upstream of exon 2, In the corresponding promoter regions of the various exons, possible response elements for the glucocorticoid receptor, as well as potential binding sites for the AP-1, AP-2, and NF-KB transcription factors are found.;Analysis of NPY-Y1 transcripts in various cell types demonstrates the tissue-specific activation of the three promoters.	ST VINCENTS HOSP, GARVAN INST MED RES, DARLINGHURST, NSW 2010, AUSTRALIA	Garvan Institute of Medical Research; St Vincents Hospital Sydney			Ball, Helen J/A-4242-2010; Herzog, Herbert/B-8294-2008	Ball, Helen J/0000-0003-3733-9748; 				AHUJA SK, 1994, J BIOL CHEM, V269, P26381; BLOMQVIST AG, 1995, BBA-GENE STRUCT EXPR, V1261, P439, DOI 10.1016/0167-4781(95)00051-H; CHENG HF, 1993, MOL PHARMACOL, V44, P533; DUMONT Y, 1992, PROG NEUROBIOL, V38, P125, DOI 10.1016/0301-0082(92)90038-G; EVA C, 1992, FEBS LETT, V314, P285, DOI 10.1016/0014-5793(92)81490-D; EVA C, 1990, FEBS LETT, V271, P81, DOI 10.1016/0014-5793(90)80377-U; FUHLENDORFF J, 1990, P NATL ACAD SCI USA, V87, P182, DOI 10.1073/pnas.87.1.182; HERZOG H, 1993, J BIOL CHEM, V268, P6703; HERZOG H, 1992, P NATL ACAD SCI USA, V89, P5794, DOI 10.1073/pnas.89.13.5794; JI RR, 1994, J NEUROSCI, V14, P6423; KALRA SP, 1992, ENDOCRINOLOGY, V130, P3323, DOI 10.1210/en.130.6.3323; LARSEN PJ, 1994, J NEUROENDOCRINOL, V6, P153, DOI 10.1111/j.1365-2826.1994.tb00566.x; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; NUSING RM, 1993, J BIOL CHEM, V268, P25253; PERALTA EG, 1987, SCIENCE, V236, P600, DOI 10.1126/science.3107123; PESQUERO JB, 1994, J BIOL CHEM, V269, P26920; PETITTO JM, 1994, J NEUROIMMUNOL, V54, P81, DOI 10.1016/0165-5728(94)90234-8; QUIRION R, 1990, ANN NY ACAD SCI, V611, P58; REN HZ, 1994, P NATL ACAD SCI USA, V91, P4864, DOI 10.1073/pnas.91.11.4864; REN HZ, 1994, J BIOL CHEM, V269, P3104; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; Sambrook J, 1989, MOL CLONING LABORATO; SHEIKH SP, 1989, J BIOL CHEM, V264, P6648; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; STANLEY BG, 1984, LIFE SCI, V35, P2635, DOI 10.1016/0024-3205(84)90032-8; VALDENAIRE O, 1994, EUR J BIOCHEM, V220, P577, DOI 10.1111/j.1432-1033.1994.tb18658.x; VONDERAHE D, 1985, NATURE, V313, P706, DOI 10.1038/313706a0; WAHLESTEDT C, 1985, J PHARMACOL EXP THER, V234, P735; WAHLESTEDT C, 1986, REGUL PEPTIDES, V13, P307, DOI 10.1016/0167-0115(86)90048-0; WHARTON J, 1993, P NATL ACAD SCI USA, V90, P687, DOI 10.1073/pnas.90.2.687	33	52	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27272	27276		10.1074/jbc.270.45.27272	http://dx.doi.org/10.1074/jbc.270.45.27272			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592987	hybrid			2022-12-27	WOS:A1995TE58300087
J	GAMM, DM; FRANCIS, SH; ANGELOTTI, TP; CORBIN, JD; UHLER, MD				GAMM, DM; FRANCIS, SH; ANGELOTTI, TP; CORBIN, JD; UHLER, MD			THE TYPE-II ISOFORM OF CGMP-DEPENDENT PROTEIN-KINASE IS DIMERIC AND POSSESSES REGULATORY AND CATALYTIC PROPERTIES DISTINCT FROM THE TYPE-I ISOFORMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIG CORONARY-ARTERIES; CYCLIC-GMP; BOVINE AORTA; SMOOTH-MUSCLE; RAT-TISSUES; BINDING; ACTIVATION; CAMP; PHOSPHORYLATION; ANALOGS	The type I cGMP-dependent protein kinases (cGK I alpha and I beta) form homodimers (subunit M(r) similar to 76,000), presumably through conserved, amino-terminal leucine zipper motifs, Type II cGMP-dependent protein kinase (cGK II) has been reported to be monomeric (M(r) similar to 86,000), but recent cloning and sequencing of mouse brain cGK II cDNA revealed a leucine zipper motif near its amino terminus, In the present study, recombinant mouse brain cGK II was expressed, purified, and characterized, Sucrose gradient centrifugation and gel filtration chromatography were used to determine M(r) values for holoenzymes of cGK I alpha (168,000) and cGK II (152,500), which suggest that both are dimers. Native cGK I alpha possessed significantly lower K-a values for cGMP (8-fold) and beta-phenyl-1,N-2-etheno-cGMP (300-fold) than did recombinant cGK II, Conversely, the Sp- and Rp-isomers of 8-(4-chloro-phenylthio)-guanosine-3',5'-cyclic monophosphorothioate demonstrated selectivity toward cGK II in assays of kinase activation or inhibition, respectively, A peptide substrate derived from histone f(2B) had a 20-fold:greater V-max/K-m ratio for cGK I alpha than for cGK II, whereas a peptide based upon a cAMP response element binding protein phosphorylation site exhibited a greater V-max/K-m ratio for cGK II, Finally, gel filtration of extracts of mouse intestine partially resolved two cGK activities, one of which had properties similar to those demonstrated by recombinant cGK II, The combined results show that both cGK I and cGK II form homodimers but possess distinct cyclic nucleotide and substrate specificities.	UNIV MICHIGAN, NEUROSCI PROGRAM, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, MENTAL HLTH RES INST, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT BIOL CHEM, ANN ARBOR, MI 48109 USA; VANDERBILT UNIV, SCH MED, DEPT MOLEC PHYSIOL & BIOPHYS, NASHVILLE, TN 37232 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vanderbilt University			Angelotti, Timothy/AAD-3714-2022	Angelotti, Timothy/0000-0002-0100-2011	NIDDK NIH HHS [DK 40029] Funding Source: Medline; NIGMS NIH HHS [GM 38788] Funding Source: Medline; NIMH NIH HHS [MH 42652] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038788, R29GM038788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH042652] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ATKINSON RA, 1991, BIOCHEMISTRY-US, V30, P9387, DOI 10.1021/bi00103a001; BEAVO JA, 1988, ADV SEC MESS PHOSPH, V22, P1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUTT E, 1992, BIOCHEM PHARMACOL, V43, P2591, DOI 10.1016/0006-2952(92)90148-C; BUTT E, 1994, EUR J PHARM-MOLEC PH, V269, P265, DOI 10.1016/0922-4106(94)90095-7; BUTT E, 1990, FEBS LETT, V263, P47, DOI 10.1016/0014-5793(90)80702-K; COLBRAN JL, 1992, BIOCHEM CELL BIOL, V70, P1277, DOI 10.1139/o92-174; COLBRAN JL, 1992, J BIOL CHEM, V267, P9589; CORBIN JD, 1983, J BIOL CHEM, V258, P1391; DEJONGE HR, 1981, ADV CYCLIC NUCL PROT, V14, P315; Eadie GS, 1942, J BIOL CHEM, V146, P85; ELHUSSEINI AED, 1995, J NEUROCHEM, V64, P2814; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FORTE LR, 1992, AM J PHYSIOL, V263, pC607, DOI 10.1152/ajpcell.1992.263.3.C607; FOSTER JL, 1981, J BIOL CHEM, V256, P5029; Francis S H, 1994, Adv Pharmacol, V26, P115, DOI 10.1016/S1054-3589(08)60053-8; Francis S H, 1988, Second Messengers Phosphoproteins, V12, P301; FRANCIS SH, 1980, J BIOL CHEM, V255, P620; FRANCIS SH, 1991, METHOD ENZYMOL, V200, P332; FRANCIS SH, 1988, MOL PHARMACOL, V34, P506; GAMM DM, 1995, J BIOL CHEM, V270, P7227, DOI 10.1074/jbc.270.13.7227; GLASS DB, 1982, J BIOL CHEM, V257, P1196; GLASS DB, 1990, PEPT PROT PHOSPH, P209; GOTTLIEB M, 1987, ANAL BIOCHEM, V165, P33, DOI 10.1016/0003-2697(87)90197-7; HASLAM RJ, 1987, THROMB DIATH HAEMO, P147; HOFSTEE BHJ, 1959, NATURE, V184, P1296, DOI 10.1038/1841296b0; JARCHAU T, 1994, P NATL ACAD SCI USA, V91, P9426, DOI 10.1073/pnas.91.20.9426; JIANG H, 1992, J BIOL CHEM, V267, P1015; KEMP BE, 1977, J BIOL CHEM, V252, P4888; KOBAYASHI S, 1985, SCIENCE, V229, P553, DOI 10.1126/science.3927484; KOMALAVILAS P, 1994, J BIOL CHEM, V269, P8701; KUO JF, 1975, P NATL ACAD SCI USA, V72, P2256, DOI 10.1073/pnas.72.6.2256; KUO JF, 1970, J BIOL CHEM, V245, P2493; LANDGRAF W, 1986, EUR J BIOCHEM, V154, P113, DOI 10.1111/j.1432-1033.1986.tb09365.x; LANDGRAF W, 1989, EUR J BIOCHEM, V181, P643, DOI 10.1111/j.1432-1033.1989.tb14771.x; LINCOLN TM, 1976, P NATL ACAD SCI USA, V73, P2559, DOI 10.1073/pnas.73.8.2559; LINCOLN TM, 1989, PHARMACOL THERAPEUT, V41, P479, DOI 10.1016/0163-7258(89)90127-7; LOHMANN SM, 1981, P NATL ACAD SCI-BIOL, V78, P653, DOI 10.1073/pnas.78.1.653; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; ORSTAVIK S, 1992, CYTOGENET CELL GENET, V59, P270, DOI 10.1159/000133267; ROGERS J, 1988, J BIOL CHEM, V263, P3713; RUTH P, 1991, EUR J BIOCHEM, V202, P1339, DOI 10.1111/j.1432-1033.1991.tb16509.x; SCHMIDT HHHW, 1992, SCIENCE, V255, P721, DOI 10.1126/science.1371193; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SEKHAR KR, 1992, MOL PHARMACOL, V42, P103; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TAKIO K, 1984, BIOCHEMISTRY-US, V23, P4207, DOI 10.1021/bi00313a030; THOMAS MK, 1990, J BIOL CHEM, V265, P14971; TREMBLAY J, 1988, ADV SEC MESS PHOSPH, V22, P319; UHLER MD, 1993, J BIOL CHEM, V268, P13586; Vaandrager A B, 1994, Adv Pharmacol, V26, P253, DOI 10.1016/S1054-3589(08)60057-5; WALDMAN SA, 1984, J BIOL CHEM, V259, P4332; Walter U, 1989, REV PHYSL BIOCH PHAR, V113, P41; WANG X, 1995, J NEUROCHEM, V65, P595; WERNET W, 1989, FEBS LETT, V251, P191, DOI 10.1016/0014-5793(89)81453-X; WOLFE L, 1987, J BIOL CHEM, V262, P16906; WOLFE L, 1989, J BIOL CHEM, V264, P7734; WOLFE L, 1989, J BIOL CHEM, V264, P4157	59	92	95	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27380	27388		10.1074/jbc.270.45.27380	http://dx.doi.org/10.1074/jbc.270.45.27380			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7593002	hybrid			2022-12-27	WOS:A1995TE58300102
J	GRILLI, M; RIBOLA, M; ALBERICI, A; VALERIO, A; MEMO, M; SPANO, PF				GRILLI, M; RIBOLA, M; ALBERICI, A; VALERIO, A; MEMO, M; SPANO, PF			IDENTIFICATION AND CHARACTERIZATION OF A KAPPA-B/REL BINDING-SITE IN THE REGULATORY REGION OF THE AMYLOID PRECURSOR PROTEIN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MESSENGER-RNA; ALZHEIMERS-DISEASE; BRAIN; EXPRESSION; PROMOTER; CELLS; APP; INTERLEUKIN-1; NEURONS; DAMAGE	Several observations support the hypothesis that pathogenetic mechanisms of beta amyloid formation in Alzheimer's disease may involve alterations in amyloid precursor protein (APP) gene expression, In this regard, molecular dissection of the APP gene transcriptional regulation is of primary importance. We report evidence that members of the family of transcription factors NF kappa B/Rel can specifically recognize two identical sequences located in the 5'-regulatory region of APP, These sequences, which we refer to as APP kappa B sites, interact preferentially with p50-containing members of the family, In particular, p50 homodimers and p50/p65 and p50/c-Rel heterodimers act as transcriptional activators at the APP kappa B site, Finally, the nuclear complex specifically binding to the APP kappa B sites proves to be an integral part of neurons and lymphocytes.			GRILLI, M (corresponding author), UNIV BRESCIA, SCH MED, DEPT BIOMED SCI & BIOTECHNOL, DIV PHARMACOL, VIA VALSBBINA 19, I-25124 BRESCIA, ITALY.		Spano, Pier Franco A/E-7621-2010; Memo, Maurizio/AAK-7197-2020; Valerio, Alessandra/B-3413-2009; Spano, Pier Franco F/J-9944-2016; Memo, Maurizio/C-2555-2011; grilli, mariagrazia/ABF-1542-2020	Valerio, Alessandra/0000-0001-5844-2256; Spano, Pier Franco F/0000-0002-9906-0964; grilli, mariagrazia/0000-0001-9165-5827; MEMO, Maurizio/0000-0002-7543-0289				ABE K, 1991, NEUROSCI LETT, V125, P169, DOI 10.1016/0304-3940(91)90019-P; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; COHEN ML, 1988, P NATL ACAD SCI USA, V85, P1227, DOI 10.1073/pnas.85.4.1227; CRENON I, 1993, ONCOGENE, V8, P867; FORLONI G, 1992, MOL BRAIN RES, V16, P128, DOI 10.1016/0169-328X(92)90202-M; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; GRILLI M, 1993, INT REV CYTOL, V143, P1; HIGGINS GA, 1988, P NATL ACAD SCI USA, V85, P1297, DOI 10.1073/pnas.85.4.1297; INOUE J, 1991, P NATL ACAD SCI USA, V88, P3715, DOI 10.1073/pnas.88.9.3715; JOHNSON SA, 1990, SCIENCE, V248, P854, DOI 10.1126/science.2111579; KALTSCHMIDT C, 1993, MECH DEVELOP, V43, P135, DOI 10.1016/0925-4773(93)90031-R; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; KANG SM, 1992, SCIENCE, V256, P1452, DOI 10.1126/science.1604322; KAWARABAYASHI T, 1991, BRAIN RES, V563, P334, DOI 10.1016/0006-8993(91)91558-I; LAFAUCI G, 1989, BIOCHEM BIOPH RES CO, V159, P297, DOI 10.1016/0006-291X(89)92437-6; LAHIRI DK, 1991, MOL BRAIN RES, V9, P253, DOI 10.1016/0169-328X(91)90009-M; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MONNING U, 1992, J BIOL CHEM, V267, P23950; NEVE RL, 1988, NEURON, V1, P669, DOI 10.1016/0896-6273(88)90166-3; OHLSSON H, 1986, CELL, V45, P35, DOI 10.1016/0092-8674(86)90535-0; POLLWEIN P, 1992, NUCLEIC ACIDS RES, V20, P63, DOI 10.1093/nar/20.1.63; QUITSCHKE WW, 1994, J BIOL CHEM, V269, P21229; QUITSCHKE WW, 1992, J BIOL CHEM, V267, P17362; RATTNER A, 1993, EMBO J, V12, P4261, DOI 10.1002/j.1460-2075.1993.tb06110.x; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; SALBAUM JM, 1988, EMBO J, V7, P2807, DOI 10.1002/j.1460-2075.1988.tb03136.x; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; SOLA C, 1993, MOL BRAIN RES, V17, P41, DOI 10.1016/0169-328X(93)90071-V; TREJO J, 1994, J BIOL CHEM, V269, P21682; VANDENABEELE P, 1991, IMMUNOL TODAY, V12, P217, DOI 10.1016/0167-5699(91)90032-O; YOSHIKAI S, 1990, GENE, V87, P257, DOI 10.1016/0378-1119(90)90310-N; YOSHIKAWA K, 1992, NATURE, V359, P64, DOI 10.1038/359064a0	35	85	86	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26774	26777		10.1074/jbc.270.45.26774	http://dx.doi.org/10.1074/jbc.270.45.26774			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592914	hybrid			2022-12-27	WOS:A1995TE58300014
J	LIN, K; HWANG, PK; FLETTERICK, RJ				LIN, K; HWANG, PK; FLETTERICK, RJ			MECHANISM OF REGULATION IN YEAST GLYCOGEN-PHOSPHORYLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; T-STATE; PURIFICATION; ACTIVATION; EVOLUTION; BINDING; GLUCOSE; SITES	The mechanism of yeast glycogen phosphorylase activation by covalent phosphorylation involves structural elements distinct from the mammalian homologs, To understand the role of the amino-terminal 39-residue extension in the phosphorylation control mechanism, mutants with 22 and 42 amino-terminal residues removed mere expressed in Escherichia coli, and their properties were compared with the wild-type (WT) enzyme. The unphosphorylated WT enzyme had a specific activity of 0.1 unit/mg and was not activated significantly by the substrate, glucose l-phosphate. Phosphorylation by protein kinase resulted in a 1300-fold activation, Glucose B-phosphate inhibited the unphosphorylated enzyme more effectively than the phosphorylated form, and inhibition of the latter was cooperative, Glucose was a poor inhibitor for both the unphosphorylated and phosphorylated WT enzyme with K-i > 300 mM. The rate of phosphorylation by protein kinase depended on substrates and interactions of the amino terminus. Maltoheptaose increased the rate of phosphorylation of the WT enzyme by yeast phosphorylase kinase 5-fold. The 22-residue deletion mutant (Nd22) had overall kinetic properties similar to the WT enzyme, except that Nd22 was a better substrate for the protein kinase and the rate of phosphorylation was unaffected by maltoheptaose. The 42-residue deletion mutant (Nd42), which lacks the phosphorylation site, was measurably active, although much less active than phosphorylated WT. Sedimentation equilibrium analysis indicated that the WT, Nd22, and Nd42 exist as tetramer, partially dissociated tetramer, and dimer, respectively, Phosphorylation of the WT and Nd22 converted both to dimer, The results indicated that the amino terminus affects quaternary structure and mediates activity regulation through conformational transition.	UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032822] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK32822] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMES BN, 1966, METHOD ENZYMOL, V8, P116; BECKER JU, 1983, ARCH BIOCHEM BIOPHYS, V225, P667, DOI 10.1016/0003-9861(83)90078-4; BROWNER MF, 1992, TRENDS BIOCHEM SCI, V17, P66, DOI 10.1016/0968-0004(92)90504-3; CARNEY IT, 1978, ANAL BIOCHEM, V85, P321, DOI 10.1016/0003-2697(78)90309-3; FOSSET M, 1971, BIOCHEMISTRY-US, V10, P4105, DOI 10.1021/bi00798a015; GOLDSMITH EJ, 1987, J BIOL CHEM, V262, P1449; HUDSON JW, 1993, J MOL BIOL, V234, P700, DOI 10.1006/jmbi.1993.1621; HWANG PK, 1989, MOL CELL BIOL, V9, P1659, DOI 10.1128/MCB.9.4.1659; HWANG PK, 1986, NATURE, V324, P80, DOI 10.1038/324080a0; ITAYA K, 1966, CLIN CHIM ACTA, V14, P361, DOI 10.1016/0009-8981(66)90114-8; Johnson L. N., 1989, ALLOSTERIC ENZYMES, P81; JOHNSON LN, 1993, J MOL BIOL, V232, P253, DOI 10.1006/jmbi.1993.1380; JOHNSON LN, 1992, FASEB J, V6, P2274, DOI 10.1096/fasebj.6.6.1544539; KASVINSKY PJ, 1978, J BIOL CHEM, V253, P1290; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LERCH K, 1975, BIOCHEMISTRY-US, V14, P2009, DOI 10.1021/bi00680a031; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NEWGARD CB, 1989, CRIT REV BIOCHEM MOL, V24, P69, DOI 10.3109/10409238909082552; RATH VL, 1992, J MOL BIOL, V225, P1027, DOI 10.1016/0022-2836(92)90102-P; RATH VL, 1994, NAT STRUCT BIOL, V1, P681, DOI 10.1038/nsb1094-681; ROBERTSON JG, 1989, KINETASYST, V2; SAGARDIA F, 1971, BIOCHEM BIOPH RES CO, V42, P829, DOI 10.1016/0006-291X(71)90505-5; SPRANG S, 1987, SCIENCE, V237, P1012, DOI 10.1126/science.3616621; SPRANG SR, 1982, BIOCHEMISTRY-US, V21, P5364, DOI 10.1021/bi00264a038; SPRANG SR, 1988, NATURE, V336, P215, DOI 10.1038/336215a0; STALMANS W, 1970, EUR J BIOCHEM, V15, P9, DOI 10.1111/j.1432-1033.1970.tb00968.x; STULL JT, 1977, J BIOL CHEM, V252, P851; TANABE S, 1987, AGR BIOL CHEM TOKYO, V51, P2465; WINGENDERDRISSE.R, 1983, FEBS LETT, V163, P33	29	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26833	26839		10.1074/jbc.270.45.26833	http://dx.doi.org/10.1074/jbc.270.45.26833			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592925	hybrid			2022-12-27	WOS:A1995TE58300025
J	MINTZ, E; MATA, AM; FORGE, V; PASSAFIUME, M; GUILLAIN, F				MINTZ, E; MATA, AM; FORGE, V; PASSAFIUME, M; GUILLAIN, F			THE MODULATION OF CA2+ BINDING TO SARCOPLASMIC-RETICULUM ATPASE BY ATP ANALOGS IS PH-DEPENDENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE-TRIPHOSPHATASE; CALCIUM-BINDING; FLUORESCEIN ISOTHIOCYANATE; CONFORMATIONAL TRANSITION; RAPID-FILTRATION; KINETIC EVIDENCE; CATALYTIC SITE; CA-2+; MECHANISM; PHOSPHORYLATION	Excess ATP is known to enhance Ca2+-ATPase activity and, among other effects, to accelerate the Ca2+ binding reaction, In previous work, we studied the pH dependence of this reaction and proposed a 3H(+)/2Ca(2+) exchange at the transport sites, in agreement with the H+/Ca2+ counter transport, Here we studied the effect of ADP and nonhydrolyzable ATP analogues on the Ca2+ binding reaction at various pH values. At pH 6, where Ca2+ binding is monophasic and slow, ADP, adenosine 5'-(beta,gamma-methylene)triphosphate (AMP-PCP), or adenyl-5'-yl imidodiphosphate (AMPPNP) increased the Ca2+ binding rate constant 20-fold, At pH 7 and 8, where Ca2+ binding is biphasic, the nucleotides induce fast and monophasic Ca2+ binding. At pH 7, AMP-PCP accelerated Ca2+ binding with an apparent dissociation constant of 10 mu M. At acidic pH, ADP, AMPPCP, or AMPPNP increased the equilibrium affinity of Ca2+ for ATPase, whereas at alkaline pH, these nucleotides had no effect, At pH 5.5, AMPPCP increased equilibrium Ca2+ binding with an apparent dissociation constant of 1 mu M.	CTR ETUDES SACLAY,DEPT BIOL CELLULAIRE & MOLEC,BIOPHYS PROT & MEMBRANES SECT,CNRS,F-91191 GIF SUR YVETTE,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	MINTZ, E (corresponding author), CTR ETUDES SACLAY,DEPT BIOL CELLULAIRE & MOLEC,BIOPHYS PROT & MEMBRANES SECT,F-91191 GIF SUR YVETTE,FRANCE.		Mata, Ana M./J-8460-2014	Mata, Ana M./0000-0002-2887-7854				BISHOP JE, 1987, J BIOL CHEM, V262, P4658; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; CHAMPEIL P, 1986, BIOCHEMISTRY-US, V25, P7623, DOI 10.1021/bi00371a053; CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288; COLL RJ, 1991, BIOCHEMISTRY-US, V30, P1456, DOI 10.1021/bi00220a002; CUENDA A, 1994, BBA-BIOMEMBRANES, V1194, P35, DOI 10.1016/0005-2736(94)90200-3; DUPONT Y, 1984, ANAL BIOCHEM, V142, P504, DOI 10.1016/0003-2697(84)90496-2; DUPONT Y, 1977, EUR J BIOCHEM, V72, P185, DOI 10.1111/j.1432-1033.1977.tb11238.x; DUPONT Y, 1978, NATURE, V273, P396, DOI 10.1038/273396a0; FERNANDEZBELDA F, 1988, ARCH BIOCHEM BIOPHYS, V260, P118, DOI 10.1016/0003-9861(88)90431-6; FERNANDEZBELDA F, 1984, J BIOL CHEM, V259, P9687; FORGE V, 1993, J BIOL CHEM, V268, P10953; FORGE V, 1993, J BIOL CHEM, V268, P10961; GUILLAIN F, 1980, J BIOL CHEM, V255, P2072; GUILLAIN F, 1981, J BIOL CHEM, V256, P6140; LACAPERE JJ, 1990, J BIOL CHEM, V265, P348; LACAPERE JJ, 1993, EUR J BIOCHEM, V211, P117, DOI 10.1111/j.1432-1033.1993.tb19877.x; MCINTOSH DB, 1983, BIOCHEMISTRY-US, V22, P2867, DOI 10.1021/bi00281a015; MINTZ E, 1990, J BIOL CHEM, V265, P18762; MITCHINSON C, 1982, FEBS LETT, V146, P87, DOI 10.1016/0014-5793(82)80710-2; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; NAKAMURA J, 1994, J BIOL CHEM, V269, P30822; NAKAMURA Y, 1982, J BIOENERG BIOMEMBR, V14, P307, DOI 10.1007/BF00743060; NEET KE, 1977, ARCH BIOCHEM BIOPHYS, V178, P588, DOI 10.1016/0003-9861(77)90230-2; OGAWA Y, 1986, J BIOCHEM-TOKYO, V100, P1305, DOI 10.1093/oxfordjournals.jbchem.a121837; PICK U, 1980, BIOCHIM BIOPHYS ACTA, V626, P255, DOI 10.1016/0005-2795(80)90216-0; PICK U, 1981, FEBS LETT, V123, P127, DOI 10.1016/0014-5793(81)80035-X; PICK U, 1982, J BIOL CHEM, V257, P6120; SCOFANO HM, 1979, J BIOL CHEM, V254, P227; STAHL N, 1984, BIOCHEMISTRY-US, V23, P5389, DOI 10.1021/bi00318a002; VIANNA AL, 1975, BIOCHIM BIOPHYS ACTA, V410, P389, DOI 10.1016/0005-2744(75)90241-7; WAKABAYASHI S, 1990, BIOCHEMISTRY-US, V29, P7309, DOI 10.1021/bi00483a022; WAKABAYASHI S, 1990, BIOCHEMISTRY-US, V29, P10613, DOI 10.1021/bi00499a006; WAKABAYASHI S, 1986, J BIOL CHEM, V261, P9762; WATANABE T, 1981, BIOCHEMISTRY-US, V20, P6617, DOI 10.1021/bi00526a015; YAMAGUCHI M, 1985, J BIOL CHEM, V260, P4896; YAMAGUCHI M, 1984, J BIOL CHEM, V259, P9526; YATES DW, 1976, BIOCHEM J, V159, P719, DOI 10.1042/bj1590719	38	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27160	27164		10.1074/jbc.270.45.27160	http://dx.doi.org/10.1074/jbc.270.45.27160			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592971	hybrid			2022-12-27	WOS:A1995TE58300071
J	SERRANO, AA; SCHENKMAN, S; YOSHIDA, N; MEHLERT, A; RICHARDSON, JM; FERGUSON, MAJ				SERRANO, AA; SCHENKMAN, S; YOSHIDA, N; MEHLERT, A; RICHARDSON, JM; FERGUSON, MAJ			THE LIPID STRUCTURE OF THE GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED MUCIN-LIKE SIALIC-ACID ACCEPTORS OF TRYPANOSOMA-CRUZI CHANGES DURING PARASITE DIFFERENTIATION FROM EPIMASTIGOTES TO INFECTIVE METACYCLIC TRYPOMASTIGOTE FORMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-SIALIDASE; GLYCOSYLATED PHOSPHATIDYLINOSITOLS; LEISHMANIA-DONOVANI; MEMBRANE; LIPOPEPTIDOPHOSPHOGLYCAN; LIPOPHOSPHOGLYCAN; 35-KILODALTON; GLYCOPROTEINS; GLYCOLIPIDS; GLYCAN	The major accepters of sialic acid on the surface of metacyclic trypomastigotes, which are the infective forms of Trypanosoma cruzi found in the insect vector, are mucin-like glycoproteins linked to the parasite membrane via glycosylphosphatidylinositol anchors. Here we have compared the lipid and the carbohydrate structure of the glycosylphosphatidylinositol anchors and the O-linked oligosaccharides of the mucins isolated from metacyclic trypomastigotes and noninfective epimastigote forms obtained in culture. The single difference found was in the lipid structure. While the phosphatidylinositol moiety of the epimastigote mucins contains mainly 1-O-hexadecyl-2-O-hexadecanoylphos phatidylinositol, the phosphatidylinositol moiety of the metacyclic trypomastigote mucins contains mostly (similar to 70%) inositol phosphoceramides, consisting of a C-18:0 sphinganine long chain base and mainly C-24:0 and C-16:0 fatty acids. The remaining 30% of the metacyclic phosphatidylinositol moieties are the same alkylacylphosphatidylinositol species found in epimastigotes. In contrast, the glycosylphosphatidylinositol glycan cores of both molecules are very similar, mainly Man alpha 1-2Man alpha 1-2Man alpha 1-6Man alpha 1-4GlcN. The glycans are substituted at the GlcN residue and at the third alpha Man distal to the GlcN residue by ethanolamine phosphate or 2-aminoethylphosphonate groups. The structures of the desialylated O-linked oligosaccharides of the metacyclic trypomastigote mucin-like molecules, released by beta-elimination with concomitant reduction, are identical to the structures reported for the epimastigote mucins (Previato, J. O., Jones, C., Goncalves, L. P. B., Wait, R., Travassos, L, R., and Mendoca-Previato, L, (1994) Biochem. J. 301, 151-159), In addition, a significant amount of nonsubstituted N-acetylglucosaminitol was released from the mucins of both forms of the parasite, Taken together, these results indicate that when epimastigotes transform into infective metacyclic trypomastigotes, the phosphatidylinositol moiety of the glycosylphosphatidylinositol anchor of the major acceptor of sialic acid is modified, while the glycosylphosphatidylinositol anchor and O-linked sugar chains remain essentially unchanged.	UNIV DUNDEE, DEPT BIOCHEM, DUNDEE DD1 4HN, SCOTLAND	University of Dundee	SERRANO, AA (corresponding author), UNIV FED SAO PAULO, ESCOLA PAULISTA MED, DEPT MICROBIOL IMMUNOL & PARASITOL, BR-04023062 SAO PAULO, BRAZIL.		Acosta-Serrano, Alvaro/L-5503-2015; Ferguson, Michael A. J./F-7829-2010; Richardson, Julia/D-1808-2013; Schenkman, Sergio/A-9227-2013	Acosta-Serrano, Alvaro/0000-0002-2576-7959; Ferguson, Michael A. J./0000-0003-1321-8714; Richardson, Julia/0000-0002-1547-3009; Schenkman, Sergio/0000-0001-9353-8480	FIC NIH HHS [RTW00227-03] Funding Source: Medline; Wellcome Trust Funding Source: Medline	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust(Wellcome TrustEuropean Commission)		ACOSTA A, 1994, BRAZ J MED BIOL RES, V27, P439; ALMEIDA IC, 1994, BIOCHEM J, V304, P793, DOI 10.1042/bj3040793; ALVES MJM, 1975, FEBS LETT, V52, P188, DOI 10.1016/0014-5793(75)80803-9; ANDREWS NW, 1987, EXP PARASITOL, V64, P474, DOI 10.1016/0014-4894(87)90062-2; BRIONES MRS, 1994, EXP PARASITOL, V79, P211, DOI 10.1006/expr.1994.1083; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; COLLI W, 1993, FASEB J, V7, P1257, DOI 10.1096/fasebj.7.13.8405811; CONZELMANN A, 1992, EMBO J, V11, P457, DOI 10.1002/j.1460-2075.1992.tb05075.x; COUTO AS, 1993, EUR J BIOCHEM, V217, P597, DOI 10.1111/j.1432-1033.1993.tb18282.x; CROSS GAM, 1993, ANNU REV MICROBIOL, V47, P385, DOI 10.1146/annurev.mi.47.100193.002125; DELEDERKREMER RM, 1991, J BIOL CHEM, V266, P23670; Ferguson M. A. J., 1993, GLYCOBIOLOGY, P349; FERGUSON MAJ, 1985, BIOCHIM BIOPHYS ACTA, V842, P39, DOI 10.1016/0304-4165(85)90290-9; FERREROGARCIA MA, 1993, EUR J BIOCHEM, V213, P765, DOI 10.1111/j.1432-1033.1993.tb17818.x; GOLGHER DB, 1993, MOL BIOCHEM PARASIT, V60, P249, DOI 10.1016/0166-6851(93)90136-L; GUTHER MLS, 1992, J BIOL CHEM, V267, P6820; HEISE N, 1995, MOL BIOCHEM PARASIT, V70, P71, DOI 10.1016/0166-6851(95)00009-P; HEISE N, 1994, MEM I OSWALDO CRUZ, V89, P98; KOBATA A, 1993, GLYCOBIOLOGY PRACTIC, P79; LEDERKREMER RM, 1990, EUR J BIOCHEM, V192, P337; Lederkremer RM, 1993, EUR J BIOCHEM, V218, P929, DOI [DOI 10.1111/J.1432-1033.1993.TB18449.X, 10.1111/j.1432-1033.1993.tb18449.x]; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; MCCONVILLE MJ, 1991, J BIOL CHEM, V266, P15170; MCCONVILLE MJ, 1992, EMBO J, V11, P3593, DOI 10.1002/j.1460-2075.1992.tb05443.x; MORTARA RA, 1992, INFECT IMMUN, V60, P4673, DOI 10.1128/IAI.60.11.4673-4678.1992; PREVIATO JO, 1985, MOL BIOCHEM PARASIT, V16, P85, DOI 10.1016/0166-6851(85)90051-9; PREVIATO JO, 1995, J BIOL CHEM, V270, P7241, DOI 10.1074/jbc.270.13.7241; PREVIATO JO, 1994, BIOCHEM J, V301, P151, DOI 10.1042/bj3010151; PREVIATO JO, 1990, J BIOL CHEM, V265, P2518; RUIZ RD, 1993, PARASITE IMMUNOL, V15, P121, DOI 10.1111/j.1365-3024.1993.tb00591.x; SACKS DL, 1995, J EXP MED, V181, P685, DOI 10.1084/jem.181.2.685; SCHENKMAN S, 1991, CELL, V65, P1117, DOI 10.1016/0092-8674(91)90008-M; SCHENKMAN S, 1993, MOL BIOCHEM PARASIT, V59, P293, DOI 10.1016/0166-6851(93)90227-O; SCHENKMAN S, 1994, J BIOL CHEM, V269, P7970; SCHENKMAN S, 1994, ANNU REV MICROBIOL, V48, P499, DOI 10.1146/annurev.mi.48.100194.002435; SCHNEIDER P, 1995, METHOD ENZYMOL, V250, P614; SINGH BN, 1994, J BIOL CHEM, V269, P21972; SIPOS G, 1994, EMBO J, V13, P2789, DOI 10.1002/j.1460-2075.1994.tb06572.x; TURCO SJ, 1989, J BIOL CHEM, V264, P6711; VANDEKERCKHOVE F, 1992, GLYCOBIOLOGY, V2, P541, DOI 10.1093/glycob/2.6.541; YOSHIDA N, 1983, INFECT IMMUN, V40, P836, DOI 10.1128/IAI.40.2.836-839.1983; YOSHIDA N, 1989, INFECT IMMUN, V57, P1663, DOI 10.1128/IAI.57.6.1663-1667.1989	42	132	132	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27244	27253		10.1074/jbc.270.45.27244	http://dx.doi.org/10.1074/jbc.270.45.27244			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592983	hybrid, Green Published			2022-12-27	WOS:A1995TE58300083
J	YANG, SS; VANAELST, L; BARSAGI, D				YANG, SS; VANAELST, L; BARSAGI, D			DIFFERENTIAL INTERACTIONS OF HUMAN SOS1 AND SOS2 WITH GRB2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GUANINE-NUCLEOTIDE EXCHANGE; RECEPTOR TYROSINE KINASES; POLYACRYLAMIDE GELS; EGF RECEPTOR; SH3 DOMAINS; RAS; PROTEIN; IDENTIFICATION; ACTIVATION; BINDING	The guanine nucleotide exchange factor Son of sevenless (Sos) performs a crucial step in the coupling of receptor tyrosine kinases to Ras activation, Mammalian cells contain two related but distinct Sos proteins, Sos1 and Sos2. Although they share a high degree of overall similarity, it is not known to what extent their biological and biochemical properties overlap, In the present study, we have compared the interactions of the two human homologues of Sos, hSos1 and hSos2, with the adaptor protein Grb2. We show that hSos2 interacts with Grb2 via its proline-rich COOH-terminal domain and that this interaction is dependent on the SH3 domains of Grb2. In general, these characteristics are similar to the ones reported previously for the interaction of hSos1 with Grb2. However, the apparent binding affinity of hSos2 for Grb2 is significantly higher relative to that of hSos1 both in vitro and in vivo. The region conferring this higher binding affinity has been mapped to residues 1126-1242 of the hSos2 COOH-terminal domain, These results suggest that Sos1 and Sos2 may differentially contribute to receptor-mediated Ras activation.	SUNY STONY BROOK, SCH MED, DEPT MOLEC GENET & MICROBIOL, STONY BROOK, NY 11794 USA; COLD SPRING HARBOR LAB, COLD SPRING HARBOR, NY 11724 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Cold Spring Harbor Laboratory				Bar-Sagi, Dafna/0000-0003-2597-8948	NATIONAL CANCER INSTITUTE [R56CA055360, P01CA028146, R01CA055360, R37CA055360] Funding Source: NIH RePORTER; NCI NIH HHS [CA28146, CA55360] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; BLATTLER DP, 1972, J CHROMATOGR, V64, P147, DOI 10.1016/S0021-9673(00)92958-3; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOWTELL D, 1992, P NATL ACAD SCI USA, V89, P6511, DOI 10.1073/pnas.89.14.6511; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; FEIG LA, 1994, CURR OPIN CELL BIOL, V6, P204, DOI 10.1016/0955-0674(94)90137-6; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GOUDREAU N, 1994, STRUCT BIOL, V1, P898; HARLOW E, 1988, ANTIBODIES LAB MANUA, P522; KOHDA D, 1994, STRUCTURE, V2, P1029, DOI 10.1016/S0969-2126(94)00106-5; LI B, 1993, FASEB J, V7, P957, DOI 10.1096/fasebj.7.10.8344494; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; QUILLIAM LA, 1994, P NATL ACAD SCI USA, V91, P8512, DOI 10.1073/pnas.91.18.8512; ROSE MD, 1990, METHODS YEAST GENETI, P93; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Sambrook J, 1989, MOL CLONING LABORATO; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; TERASAWA H, 1994, STRUCT BIOL, V1, P891; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	31	42	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18212	18215		10.1074/jbc.270.31.18212	http://dx.doi.org/10.1074/jbc.270.31.18212			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629138	hybrid			2022-12-27	WOS:A1995RM64200011
J	BOURGUIGNON, LYW; CHU, A; JIN, H; BRANDT, NR				BOURGUIGNON, LYW; CHU, A; JIN, H; BRANDT, NR			RYANODINE RECEPTOR-ANKYRIN INTERACTION REGULATES INTERNAL CA2+ RELEASE IN MOUSE T-LYMPHOMA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; CALCIUM RELEASE; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; TRANSMEMBRANE GLYCOPROTEIN; INOSITOL TRISPHOSPHATE; BINDING-SITES; CHANNEL; CHARGE; PURIFICATION	In this study, we have identified and partially characterized a mouse T-lymphoma ryanodine receptor on a unique type of internal vesicle which bands at the relatively light density of 1.07 g/ml. Analysis of the binding of [H-3]ryanodine to these internal vesicles reveals the presence of a single, low affinity binding site with a dissociation constant (K-d) of 200 nM. The second messenger, cyclic ADP-ribose, was found to increase the binding affinity of [H-3]ryanodine to its vesicle receptor at least 5-fold (K-d approximate to 40 nM). In addition, cADP-ribose appears to be a potent activator of internal Ca2+ release in T-lymphoma cells and is capable of overriding ryanodine-mediated inhibition of internal Ca2+ release. Immunoblot analyses using a monoclonal mouse anti-ryanodine receptor antibody indicate that mouse T-lymphoma cells contain a 500-kDa polypeptide similar to the ryanodine receptor found in skeletal muscle, cardiac muscle, and brain tissues. Double immunofluorescence staining and laser confocal microscopic analysis show that the ryanodine receptor is preferentially accumulated underneath surface receptor-capped structures. T-lymphoma ryanodine receptor was isolated (with an apparent sedimentation coefficient of 30 S) by extraction of the light density vesicles with 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid (CHAPS) in 1 M NaCl followed by sucrose gradient centrifugation. Further analysis indicates that specific, high affinity binding occurs between ankyrin and this 30 S lymphoma ryanodine receptor (K-d = 0.075 nM). Most importantly, the binding of ankyrin to the light density vesicles significantly blocks ryanodine binding and ryanodine-mediated inhibition of internal Ca2+ release. These findings suggest that the cytoskeleton plays a pivotal role in the regulation of ryanodine receptor-mediated internal Ca2+ release during lymphocyte activation.	UNIV MIAMI,SCH MED,DEPT MOLEC PHARMACOL,MIAMI,FL 33101	University of Miami	BOURGUIGNON, LYW (corresponding author), UNIV MIAMI,SCH MED,DEPT CELL BIOL & ANAT,1600 NW 10TH AVE,MIAMI,FL 33101, USA.				NATIONAL CANCER INSTITUTE [R01CA066163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036353] Funding Source: NIH RePORTER; NCI NIH HHS [CA 66163] Funding Source: Medline; NIGMS NIH HHS [GM 36353] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENNETT V, 1980, J BIOL CHEM, V255, P2540; BENNETT V, 1990, PHYSIOL REV, V70, P1029, DOI 10.1152/physrev.1990.70.4.1029; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BOURGUIGNON GJ, 1981, BIOCHIM BIOPHYS ACTA, V646, P109, DOI 10.1016/0005-2736(81)90277-7; BOURGUIGNON LYW, 1984, INT REV CYTOL, V87, P195, DOI 10.1016/S0074-7696(08)62443-2; BOURGUIGNON LYW, 1986, J CELL PHYSIOL, V127, P146, DOI 10.1002/jcp.1041270118; BOURGUIGNON LYW, 1992, MOL CELL BIOL, V12, P4464, DOI 10.1128/MCB.12.10.4464; BOURGUIGNON LYW, 1995, J BIOL CHEM, V270, P7257, DOI 10.1074/jbc.270.13.7257; BOURGUIGNON LYW, 1993, J BIOL CHEM, V268, P7290; BOURGUIGNON LYW, 1993, J IMMUNOL, V151, P6634; BOURGUIGNON LYW, 1988, J CELL BIOCHEM, V37, P131, DOI 10.1002/jcb.240370202; BOURGUIGNON LYW, 1992, ENCY IMMUNOLOGY, P1044; CARROLL S, 1991, ARCH BIOCHEM BIOPHYS, V290, P239, DOI 10.1016/0003-9861(91)90615-P; CORONADO R, 1994, AM J PHYSIOL, V266, pC1485, DOI 10.1152/ajpcell.1994.266.6.C1485; FABIATO A, 1989, MOL CELL BIOCHEM, V89, P135; Fleischer S., 1967, METHOD ENZYMOL, V10, P406; FRUEN BR, 1994, FEBS LETT, V352, P123, DOI 10.1016/0014-5793(94)00931-7; GALIONE A, 1993, NATURE, V365, P456, DOI 10.1038/365456a0; GIANNINI G, 1992, SCIENCE, V257, P91, DOI 10.1126/science.1320290; GOLDBERG DE, 1983, J BIOL CHEM, V258, P3159; HAKAMATA Y, 1994, FEBS LETT, V352, P206, DOI 10.1016/0014-5793(94)00955-4; HAKAMATA Y, 1992, FEBS LETT, V312, P229, DOI 10.1016/0014-5793(92)80941-9; HUBBARD AL, 1983, J CELL BIOL, V96, P217, DOI 10.1083/jcb.96.1.217; JOSEPH SK, 1993, J BIOL CHEM, V268, P6477; KALOMIRIS EL, 1989, J BIOL CHEM, V264, P8113; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LEE HC, 1994, NATURE, V370, P307, DOI 10.1038/370307a0; LEE HC, 1993, J BIOL CHEM, V268, P293; LOKESHWAR VB, 1992, J BIOL CHEM, V267, P22073; LOKESHWAR VB, 1994, J CELL BIOL, V126, P1099, DOI 10.1083/jcb.126.4.1099; MCGREW SG, 1989, BIOCHEMISTRY-US, V28, P1686, DOI 10.1021/bi00430a039; MESZAROS LG, 1993, NATURE, V364, P76, DOI 10.1038/364076a0; MONNERON A, 1978, J CELL BIOL, V27, P211; NABAUER M, 1989, SCIENCE, V244, P800, DOI 10.1126/science.2543067; OGAWA Y, 1994, CRIT REV BIOCHEM MOL, V29, P229, DOI 10.3109/10409239409083482; OTSU K, 1990, J BIOL CHEM, V265, P13472; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; ROSSIER MF, 1989, J BIOL CHEM, V264, P14078; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; SITSAPESAN R, 1994, CIRC RES, V75, P596, DOI 10.1161/01.RES.75.3.596; STATES DJ, 1992, TRENDS BIOCHEM SCI, V17, P495, DOI 10.1016/0968-0004(92)90337-9; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; WANG JP, 1993, J BIOL CHEM, V268, P20974	44	94	96	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17917	17922		10.1074/jbc.270.30.17917	http://dx.doi.org/10.1074/jbc.270.30.17917			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629097	hybrid			2022-12-27	WOS:A1995RM26600046
J	CHELSTOWSKA, A; BUTOW, RA				CHELSTOWSKA, A; BUTOW, RA			RTG GENES IS YEAST THAT FUNCTION IN COMMUNICATION BETWEEN MITOCHONDRIA AND THE NUCLEUS ARE ALSO REQUIRED FOR EXPRESSION OF GENES ENCODING PEROXISOMAL PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE SELECTION PROCEDURE; SACCHAROMYCES-CEREVISIAE; CITRATE SYNTHASE; TRANSCRIPTIONAL CONTROL; MALATE-DEHYDROGENASE; ASSEMBLY MUTANTS; BETA-OXIDATION; FATTY-ACIDS; CATALASE-A; PROLIFERATION	In Saccharomyces cerevisiae cells with dysfunctional mitochondria, such as in petites, the CIT2 gene encoding the peroxisomal glyoxylate cycle enzyme, citrate synthase 2 (CS2), is transcriptionally activated by as much as 30-fold, a phenomenon we call retrograde regulation. Two genes, RTG1 and RTG2, are required for both basal and elevated expression of CIT2 (Liao, X, and Butow, R. A. (1993) Cell 72, 61-71). Different blocks in the tricarboxylic acid cycle also elicit an increase in CIT2 expression, but not to the extent observed in petites. We have examined whether other genes of the glyoxylate cycle exhibit retrograde regulation and the role of RTG1 and RTG2 in their expression. Of the glyoxylate cycle genes tested, CIT2 is the only one that shows retrograde regulation, suggesting that CS2 may be an important control point for metabolic cross-feeding from the glyoxylate cycle to mitochondria. Surprisingly, RTG1 and RTG2 are required for efficient growth of cells on medium containing oleic acid, a condition which induces peroxisome biogenesis; these genes are also required together for oleic acid induction of three peroxisomal protein genes tested, POX1 and CTA1 involved beta-oxidation of long chain fatty acids and PMP27, which encodes the most abundant protein of peroxisomal membranes. These data indicate that, in addition to their role in retrograde regulation of CIT2, the RTG genes are important for expression of genes encoding peroxisomal proteins and are thus key components in a novel, three-way path of communication between mitochondria, the nucleus, and peroxisomes.	UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas				Chelstowska, Anna/0000-0002-2431-7921	PHS HHS [22525] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ATOMI H, 1993, FEMS MICROBIOL LETT, V112, P31, DOI 10.1016/0378-1097(93)90533-8; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; COHEN G, 1988, EUR J BIOCHEM, V176, P159; CONRADWEBB H, 1995, MOL CELL BIOL, V15, P2420; DMOCHOWSKA A, 1990, GENE, V88, P247, DOI 10.1016/0378-1119(90)90038-S; EINERHAND AWC, 1993, EUR J BIOCHEM, V214, P323, DOI 10.1111/j.1432-1033.1993.tb17927.x; ELGERSMA Y, 1993, GENETICS, V135, P731; ERDMANN R, 1995, J CELL BIOL, V128, P509, DOI 10.1083/jcb.128.4.509; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; FEARON K, 1988, MOL CELL BIOL, V8, P3636, DOI 10.1128/MCB.8.9.3636; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERNANDEZ E, 1992, EUR J BIOCHEM, V204, P983, DOI 10.1111/j.1432-1033.1992.tb16720.x; FILIPITS M, 1993, GENE, V132, P49, DOI 10.1016/0378-1119(93)90513-3; HARTIG A, 1992, NUCLEIC ACIDS RES, V20, P5677, DOI 10.1093/nar/20.21.5677; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; KOONIN EV, 1994, TRENDS BIOCHEM SCI, V19, P156, DOI 10.1016/0968-0004(94)90275-5; KUNAU WH, 1988, BIOCHEM SOC T, V16, P418, DOI 10.1042/bst0160418; LEWIN AS, 1990, MOL CELL BIOL, V10, P1399, DOI 10.1128/MCB.10.4.1399; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; LIAO XS, 1991, MOL CELL BIOL, V11, P38, DOI 10.1128/MCB.11.1.38; LUNARDI J, 1991, J BIOL CHEM, V266, P16534; MARSHALL PA, 1995, J CELL BIOL, V129, P345, DOI 10.1083/jcb.129.2.345; Mayfield SP, 1990, CURR OPIN CELL BIOL, V2, P509, DOI 10.1016/0955-0674(90)90135-2; MCCAMMON MT, 1990, J BACTERIOL, V172, P5816, DOI 10.1128/jb.172.10.5816-5827.1990; NG R, 1980, P NATL ACAD SCI-BIOL, V77, P3912, DOI 10.1073/pnas.77.7.3912; PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892; ROSE MD, 1988, METHODS YEAST GENETI; ROSENKRANTZ M, 1986, MOL CELL BIOL, V6, P4509, DOI 10.1128/MCB.6.12.4509; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SHYJAN AW, 1993, CURR BIOL, V3, P398, DOI 10.1016/0960-9822(93)90212-7; SIMON M, 1992, YEAST, V8, P303, DOI 10.1002/yea.320080407; SKONECZNY M, 1988, EUR J BIOCHEM, V174, P297, DOI 10.1111/j.1432-1033.1988.tb14097.x; SMALL WC, 1995, BIOCHEMISTRY-US, V34, P5569, DOI 10.1021/bi00016a031; SRERE P, 1994, TRENDS BIOCHEM SCI, V19, P519, DOI 10.1016/0968-0004(94)90048-5; STEFFAN JS, 1992, J BIOL CHEM, V267, P24708; SUISSA M, 1984, EMBO J, V3, P1773, DOI 10.1002/j.1460-2075.1984.tb02045.x; SUSEK RE, 1992, AUST J PLANT PHYSIOL, V19, P387, DOI 10.1071/PP9920387; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; THOMPSON LM, 1988, BIOCHEMISTRY-US, V27, P8393, DOI 10.1021/bi00422a015; TOLBERT NE, 1981, ANNU REV BIOCHEM, V50, P133, DOI 10.1146/annurev.bi.50.070181.001025; VANDERLEIJ I, 1992, J CELL BIOL, V119, P153, DOI 10.1083/jcb.119.1.153; VEENHUIS M, 1987, YEAST, V3, P77, DOI 10.1002/yea.320030204	42	102	102	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18141	18146		10.1074/jbc.270.30.18141	http://dx.doi.org/10.1074/jbc.270.30.18141			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629125	hybrid			2022-12-27	WOS:A1995RM26600077
J	SCHNEIKERT, J; HERSCOVICS, A				SCHNEIKERT, J; HERSCOVICS, A			2 NATURALLY-OCCURRING MOUSE ALPHA-1,2-MANNOSIDASE IB CDNA CLONES DIFFER IN 3 POINT MUTATIONS - MUTATION OF PHE(592) TO SER(592) IS SUFFICIENT TO ABOLISH ENZYME-ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; LIVER GOLGI MEMBRANES; GLYCOPROTEIN-BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; ALPHA-MANNOSIDASE; PURIFICATION; GENE; IA	In mammalian cells, alpha-1,2-mannosidases play an essential role in the early steps of N-linked oligosaccharide maturation. We previously reported (Herscovics, A., Schneikert, J., Athanassiadis, A., and Moremen, K. W. (1994) J. Biol. Chem. 269, 9864-9871) the isolation of mouse cy-mannosidase IB cDNA clones from a Balb/c 3T3 cDNA library. Clone 4 encodes a type II membrane protein of 641 amino acids with a cytoplasmic tail of 35 amino acids, followed by a transmembrane domain and a large C-terminal catalytic domain, whereas clone 16 encodes only the last 471 amino acids. Their overlapping sequences (from amino acid 152) are identical, except for three point mutations that result in three amino acid differences in the catalytic domain of the enzyme (Thr(411), Leu(468), and Ser(592) in clone 4 to Met(411), Phe(468), and Phe(592) in clone 16, respectively). Both sequences could be amplified by polymerase chain reaction using templates of cDNAs derived from colon and brain of CD1 mice and from L cells derived from the C3H/An mouse, indicating that both are natural isoforms found in two inbred and one outbred mouse strains. When expressed in COS7 cells as a secreted protein A fusion protein, the catalytic domain of clone 16 displays alpha-1,2-mannosidase activity using [H-3]mannose-labeled Man(9)GlcNAc as substrate, but the corresponding region of clone 4 is poorly secreted under identical conditions. The contribution of each point mutation to this differential secretion and enzyme activity of the two fusion proteins was assessed by testing the six recombinants corresponding to all the possible sequence permutations. Mutation of Phe(592) to Ser(592), as found in clone 4, is sufficient to abolish alpha-1,2-mannosidase activity, whereas mutation of Met(411) to Thr(411) or of Phe(468) to Leu(468) affects secretion with relatively little effect on enzyme activity. Phe(592) is part of a highly conserved region that seems important for enzyme activity of class 1 alpha-1,2-mannosidases.	MCGILL UNIV,MCGILL CANC CTR,MONTREAL,PQ H3G 1Y6,CANADA	McGill University								BANERJEE P, 1994, J BIOL CHEM, V269, P4819; BAUSE E, 1993, EUR J BIOCHEM, V217, P535, DOI 10.1111/j.1432-1033.1993.tb18274.x; CAMIRAND A, 1991, J BIOL CHEM, V266, P15120; FORSEE WT, 1989, J BIOL CHEM, V264, P3869; HERSCOVICS A, 1987, ANAL BIOCHEM, V166, P85, DOI 10.1016/0003-2697(87)90550-1; HERSCOVICS A, 1994, J BIOL CHEM, V269, P9864; JELINEKKELLY S, 1988, J BIOL CHEM, V263, P14757; JELINEKKELLY S, 1985, J BIOL CHEM, V260, P2253; KERSCHER S, 1995, DEV BIOL, V168, P613, DOI 10.1006/dbio.1995.1106; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LAL A, 1994, J BIOL CHEM, V269, P9872; MOLLICONE R, 1994, J BIOL CHEM, V269, P20987; MOREMEN KW, 1994, GLYCOBIOLOGY, V4, P113, DOI 10.1093/glycob/4.2.113; PONDER BAJ, 1985, J EMBRYOL EXP MORPH, V87, P229; SANCHEZLOPEZ R, 1988, J BIOL CHEM, V263, P11892; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIKERT J, 1994, GLYCOBIOLOGY, V4, P445, DOI 10.1093/glycob/4.4.445; SCHWEDEN J, 1986, EUR J BIOCHEM, V157, P563, DOI 10.1111/j.1432-1033.1986.tb09703.x; TULSIANI DRP, 1988, J BIOL CHEM, V263, P5408; TULSIANI DRP, 1982, J BIOL CHEM, V257, P3660; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; YANG MH, 1992, BIOCHEM BIOPH RES CO, V189, P1063, DOI 10.1016/0006-291X(92)92312-L; ZIEGLER F D, 1991, Glycobiology, V1, P605, DOI 10.1093/glycob/1.6.605	23	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17736	17740		10.1074/jbc.270.30.17736	http://dx.doi.org/10.1074/jbc.270.30.17736			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629073	hybrid			2022-12-27	WOS:A1995RM26600019
J	HARRISON, KA; MURPHY, RC				HARRISON, KA; MURPHY, RC			ISOLEUKOTRIENES ARE BIOLOGICALLY-ACTIVE FREE-RADICAL PRODUCTS OF LIPID-PEROXIDATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-NEUTROPHILS; LEUKOTRIENE-B4 RECEPTORS; ACTIVATION; MECHANISM; ANALOGS; BINDING; ACID; 8-EPI-PROSTAGLANDIN-F2-ALPHA; PHOSPHOLIPIDS; STIMULATION	The free radical oxidation of arachidonic acid esterified to glycerophospholipids is known to generate complex metabolites, termed isoprostanes, that share structural features of prostaglandins derived from prostaglandin H-2 synthase. Furthermore, certain isoprostanes have been found to exert biological activity through endogenous receptors on cell surfaces. Using mass spectrometry and ancillary techniques, the free radical oxidation of 1-hexadecanoyl-2-arachidonoyl-glycerophosphocholine was studied in the search for products of arachidonic acid isomeric to the leukotrienes that are derived from 5-lipoxygenase-catalyzed metabolism of arachidonic acid. Several conjugated triene metabolites were chromatographically separated from known 5-lipoxygenase products and structures characterized as 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid esterified to the glycerophosphocholine backbone. We have termed these products as B-4-isoleukotrienes. Following saponification some, but not all, B-4-isoleukotrienes were found to exert biological activity in elevating intracellular calcium in Indo-1-loaded human polymorphonuclear leukocytes. This activity could be blocked by a leukotriene B-4 receptor antagonist. An EC(50) of approximately 30 nM was determined for one unique B-4-isoleukotriene with a relative retention index of 2.54. We have shown that free radical processes can lead to the formation of biologically active isoleukotrienes in glycerophosphocholine liposomes, and we propose that B-4-isoleukotrienes may also be formed in membrane glycerophospholipids as a result of lipid peroxidation during tissue injury. Such B-4-isoleukotrienes could then mediate events of tissue damage through activation of leukotriene B-4 receptors on target cells.	NATL JEWISH CTR IMMUNOL & RESP MED,DENVER,CO 80206	National Jewish Health			Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034303] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL34303] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BASU AK, 1984, CARCINOGENESIS LOND, V4, P331; BOMALASKI JS, 1987, PROSTAGLANDINS, V33, P855, DOI 10.1016/0090-6980(87)90114-6; BRITTON RS, 1994, HEPATO-GASTROENTEROL, V41, P343; DAHINDEN CA, 1984, J IMMUNOL, V133, P1477; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FLOYD RA, 1992, ANN NEUROL, V32, pS22, DOI 10.1002/ana.410320706; GOLDMAN DW, 1985, J IMMUNOL, V135, P525; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Halliwell B., 1989, FREE RADICAL BIO MED, V2nd; Halliwell B, 1989, FREE RADICAL BIO MED, P416; JACKSON WT, 1992, J PHARMACOL EXP THER, V263, P1009; JAESCHKE H, 1991, CHEM-BIOL INTERACT, V79, P115, DOI 10.1016/0009-2797(91)90077-K; KANG KH, 1993, J APPL PHYSIOL, V74, P460, DOI 10.1152/jappl.1993.74.1.460; KAYGANICHHARRIS.KA, 1993, J LIPID RES, V34, P1229; KERWIN JL, 1994, J LIPID RES, V35, P1102; KNEEPKENS CMF, 1994, FREE RADICAL BIO MED, V17, P127; KOBAYASHI Y, 1994, BBA-LIPID LIPID MET, V1215, P280, DOI 10.1016/0005-2760(94)90054-X; LAZZARI KG, 1986, J BIOL CHEM, V261, P9710; LEBLANC Y, 1987, PROSTAGLANDINS, V33, P617, DOI 10.1016/0090-6980(87)90029-3; LEE TH, 1984, J BIOL CHEM, V259, P2383; LEWIS RA, 1981, J EXP MED, V154, P1243, DOI 10.1084/jem.154.4.1243; MCLEAN LR, 1993, LIPIDS, V28, P505, DOI 10.1007/BF02536081; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; MORROW JD, 1994, J BIOL CHEM, V269, P4317; MORROW JD, 1992, PROSTAGLANDINS, V44, P155, DOI 10.1016/0090-6980(92)90077-7; MURPHY RC, 1993, HDB LIPID RES MASS S, P106; OMANN GM, 1987, J IMMUNOL, V138, P2626; PALMBLAD J, 1981, BLOOD, V58, P658; POWELL WS, 1993, J BIOL CHEM, V268, P9280; PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657, DOI 10.1146/annurev.ph.48.030186.003301; SEYA A, 1988, FATTY ACIDS, V34, P37; SHIMIZU T, 1981, ARCH BIOCHEM BIOPHYS, V206, P271, DOI 10.1016/0003-9861(81)90091-6; SOYOMBO O, 1993, EUR J BIOCHEM, V218, P59, DOI 10.1111/j.1432-1033.1993.tb18351.x; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; TARR M, 1993, OXYGEN FREE RADICAL; WHEELAN P, 1995, J AM SOC MASS SPECTR, V6, P40, DOI 10.1016/1044-0305(94)00090-M; WHITE JR, 1983, BIOCHEM BIOPH RES CO, V113, P44, DOI 10.1016/0006-291X(83)90429-1	38	86	90	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17273	17278		10.1074/jbc.270.29.17273	http://dx.doi.org/10.1074/jbc.270.29.17273			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615527	hybrid			2022-12-27	WOS:A1995RK68900036
J	LEE, HJ; MASUDA, ES; ARAI, N; ARAI, K; YOKOTA, T				LEE, HJ; MASUDA, ES; ARAI, N; ARAI, K; YOKOTA, T			DEFINITION OF CIS-REGULATORY ELEMENTS OF THE MOUSE INTERLEUKIN-5 GENE PROMOTER - INVOLVEMENT OF NUCLEAR FACTOR OF ACTIVATED T-CELL-RELATED FACTORS IN INTERLEUKIN-5 EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; DNA-BINDING PROTEIN; TRANSCRIPTION FACTOR; MEDIATES INDUCTION; LYMPHOKINE GENES; CYCLOSPORINE-A; GM-CSF; IL-5; RECEPTOR; CAMP	We have previously reported that the promoter region of the mouse interleukin-5 (IL-5) gene, extending from a nucleotide position about -1,200 to +33 relative to the transcription initiation site, can mediate transcriptional stimulation by phorbol 12-myristate 13-acetate and dibutyryl cAMP (Bt(2)cAMP) in mouse thymoma EL-4 cells. Here, we describe identification of four cis-regulatory elements necessary for full activity of the IL-5 promoter, using deletion and mutation analyses. We designated these elements as IL-5A (-948 similar to -933), IL-5P (-117 similar to -92), IL-5C (-74 similar to -56), and IL-5CLEO (-55 similar to -38). We found that IL-5P bears homology to the binding site for the nuclear factor of activated T cells (NF-AT) and interacted with protein factors in nuclear extracts prepared from EL-4 cells stimulated with phorbol 12-myristate 13-acetate and Bt(2)cAMP (designated NFIL-5P). NFIL-5P complex was inhibited in the presence of an excess NF-AT and AP1 oligonucleotides and supershifted by antisera raised against NF-ATp, c-Fos, and c-Jun. It thus seems likely that an NF-AT-related factor is involved in the regulation of IL-5 gene transcription.	UNIV TOKYO, INST MED SCI, DEPT MOLEC & DEV BIOL, MINATO KU, TOKYO 108, JAPAN; DNAX RES INST MOLEC & CELLULAR BIOL INC, DEPT CELL SIGNALING, PALO ALTO, CA 94304 USA	University of Tokyo; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.			Yokota, Takashi/J-8483-2015	Masuda, Esteban/0000-0002-3175-2868				ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; ARAI N, 1992, PHARMACOL THERAPEUT, V55, P303, DOI 10.1016/0163-7258(92)90054-4; ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Ausubel FM, 1991, CURRENT PROTOCOLS MO; BETZ M, 1991, J IMMUNOL, V146, P108; BOISE LH, 1993, MOL CELL BIOL, V13, P1911, DOI 10.1128/MCB.13.3.1911; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BRUHN KW, 1993, P NATL ACAD SCI USA, V90, P9707, DOI 10.1073/pnas.90.20.9707; CAMPBELL HD, 1988, EUR J BIOCHEM, V174, P345, DOI 10.1111/j.1432-1033.1988.tb14104.x; CHANG TC, 1990, J BIOL CHEM, V265, P8176; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, J IMMUNOL, V151, P837; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KARIN M, 1992, TRENDS BIOCHEM SCI, V17, P418, DOI 10.1016/0968-0004(92)90012-X; KO LJ, 1991, MOL CELL BIOL, V11, P2778, DOI 10.1128/MCB.11.5.2778; KRUSEMEIER M, 1988, J IMMUNOL, V140, P367; LEE HJ, 1993, J IMMUNOL, V151, P6135; LEE JS, 1989, SOMAT CELL MOLEC GEN, V15, P143, DOI 10.1007/BF01535075; Lee KAW, 1991, CURR OPIN CELL BIOL, V3, P953, DOI 10.1016/0955-0674(91)90113-D; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LEIDEN JM, 1993, ANNU REV IMMUNOL, V11, P539, DOI 10.1146/annurev.iy.11.040193.002543; LI TK, 1993, J IMMUNOL, V150, P1680; MASUDA ES, 1993, MOL CELL BIOL, V13, P7399, DOI 10.1128/MCB.13.12.7399; MASUDA ES, 1995, MOL CELL BIOL, V15, P2697; MASUDA ES, 1993, IMMUNOLOGIST, V1, P198; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; MCCAFFREY PG, 1992, J BIOL CHEM, V267, P1864; MIYATAKE S, 1991, MOL CELL BIOL, V11, P5894, DOI 10.1128/MCB.11.12.5894; Mizuta TR, 1988, GROWTH FACTORS, V1, P51, DOI 10.3109/08977198809000246; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; MORGAN JG, 1992, NUCLEIC ACIDS RES, V20, P5173, DOI 10.1093/nar/20.19.5173; MORI A, 1994, INT ARCH ALLERGY IMM, V104, P32, DOI 10.1159/000236745; MOSMANN TR, 1991, IMMUNOL RES, V10, P183, DOI 10.1007/BF02919690; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MUNOZ E, 1990, J EXP MED, V172, P95, DOI 10.1084/jem.172.1.95; NAORA H, 1994, J IMMUNOL, V153, P3466; NAORA H, 1994, BLOOD, V83, P3620; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; ORKIN SH, 1992, BLOOD, V80, P575; RAO A, 1994, IMMUNOL TODAY, V15, P274, DOI 10.1016/0167-5699(94)90007-8; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; SANDERSON CJ, 1992, BLOOD, V79, P3101, DOI 10.1182/blood.V79.12.3101.3101; SCHMIDT J, 1994, EUR J PHARMACOL, V260, P247, DOI 10.1016/0014-2999(94)90345-X; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SCOTT P, 1991, IMMUNOL TODAY, V12, P346, DOI 10.1016/0167-5699(91)90063-Y; SERFLING E, 1989, EMBO J, V8, P465, DOI 10.1002/j.1460-2075.1989.tb03399.x; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; SZABO SJ, 1993, MOL CELL BIOL, V13, P4793, DOI 10.1128/MCB.13.8.4793; TAKATSU K, 1988, IMMUNOL REV, V102, P107, DOI 10.1111/j.1600-065X.1988.tb00743.x; TANABE T, 1987, J BIOL CHEM, V262, P16580; TSURUTA L, 1995, J IMMUNOL, V154, P5255; ULLMAN KS, 1990, ANNU REV IMMUNOL, V8, P421, DOI 10.1146/annurev.immunol.8.1.421; VANLEEUWEN BH, 1989, BLOOD, V73, P1142; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; YOKOTA T, 1987, P NATL ACAD SCI USA, V84, P7388, DOI 10.1073/pnas.84.21.7388	62	84	84	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17541	17550		10.1074/jbc.270.29.17541	http://dx.doi.org/10.1074/jbc.270.29.17541			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615560	hybrid			2022-12-27	WOS:A1995RK68900076
J	ROBERTS, JR; NARASIMHAN, C; MIZIORKO, HM				ROBERTS, JR; NARASIMHAN, C; MIZIORKO, HM			EVALUATION OF CYSTEINE-266 OF HUMAN 3-HYDROXY-3-METHYLGLUTARYL-COA LYASE AS A CATALYTIC RESIDUE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A LYASE; PSEUDOMONAS-MEVALONII; ESCHERICHIA-COLI; ENZYME; SYNTHASE; LIVER; PROTEIN; ISOZYME; BINDING; SITE	The role of cysteine 266 in human 3-hydroxy-3-methylglutaryl-CoA (HMG CoA) lyase, a residue that is homologous to a cysteine mapped to the active site of prokaryotic HMG-CoA lyase by protein chemistry approaches, has been investigated by site-directed mutagenesis. Both the wild-type human enzyme and a C323S variant, in which a regulatory sulfhydryl has been eliminated without any negative effect on catalytic activity (Roberts, J. R., Narasimhan, C., Hruz, P. W., Mitchell, G. A. and Miziorko, H. M. (1994) J. Biol. Chem. 269, 17841-17846), were used as models. Mutant enzymes C266A, C266A/C323S, C266S, and C266S/C323S were overexpressed in Escherichia coli and purified to homo geneity. In all cases, kinetic characterization indicated that the K-m value for HMG-CoA was not substantially different from the value measured using wild-type human lyase, suggesting that no serious structural perturbation occurs upon replacing Cys-266. A dissociable divalent cation (Mn2+ or Mg2+), which is required for activity in both native and C323S enzymes, is also an essential component for activity in each of the Cys-266 mutants. The structural integrity of the human mutants was further indicated by Mn2+ binding studies, which demonstrate similarities not only in the activator cation binding stoichiometries, but also in the K-D values for Mn2+ as determined for wild-type and mutant C266A or C266S proteins. Purified C266A and C266A/C323S mutants both displayed approximate to 1.3 x 10(4)-fold diminution in specific activity, while the k(cat) value was diminished in both C266S and C266S/C323S by approximate to 9.9 x 10(2) fold. This large diminution in catalytic efficiency in enzyme variants that display no substantial structural perturbations is in accord with an active site assignment to Cys-266 and qualifies its sulfhydryl group for consideration as a component of the catalytic apparatus.	MED COLL WISCONSIN,DEPT BIOCHEM,MILWAUKEE,WI 53226	Medical College of Wisconsin					NCRR NIH HHS [RR-01008] Funding Source: Medline; NIDDK NIH HHS [DK21491, DK09018] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK021491, F32DK009018, R01DK021491] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON DH, 1989, J BACTERIOL, V171, P6468, DOI 10.1128/jb.171.12.6468-6472.1989; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLINKENBEARD KD, 1975, J BIOL CHEM, V250, P3108; Coon M. J., 1955, S AMINO ACID METABOL, P431; DIXON M, 1958, ENZYMES, P456; GIBSON KM, 1988, EUR J PEDIATR, V148, P180, DOI 10.1007/BF00441397; GOLDFARB S, 1971, J LIPID RES, V12, P512; HANSON KR, 1975, ACCOUNTS CHEM RES, V8, P1, DOI 10.1021/ar50085a001; HRUZ PW, 1993, BIOCHIM BIOPHYS ACTA, V1162, P149, DOI 10.1016/0167-4838(93)90141-D; HRUZ PW, 1992, BIOCHEMISTRY-US, V31, P6842, DOI 10.1021/bi00144a026; HRUZ PW, 1992, PROTEIN SCI, V1, P1144, DOI 10.1002/pro.5560010908; KRAMER PR, 1980, J BIOL CHEM, V255, P1023; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Marquardt D. W., 1963, J SOC IND APPL MATH, V2, P431; MILDVAN AS, 1965, J BIOL CHEM, V240, P238; MISRA I, 1993, J BIOL CHEM, V268, P12129; MITCHELL GA, 1993, J BIOL CHEM, V368, P4376; MORRIS AJ, 1994, BIOCHEMISTRY-US, V33, P12291, DOI 10.1021/bi00206a036; NARASIMHAN C, 1994, ARCH BIOCHEM BIOPHYS, V312, P467, DOI 10.1006/abbi.1994.1333; NARASIMHAN C, 1992, BIOCHEMISTRY-US, V31, P11224, DOI 10.1021/bi00160a037; OZAND PT, 1992, J CHILD NEUROL S, V7, pS4; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; ROBERTS JR, 1994, J BIOL CHEM, V269, P17841; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHER DS, 1989, BIOCHIM BIOPHYS ACTA, V1003, P321, DOI 10.1016/0005-2760(89)90239-7; SIMON EJ, 1953, J AM CHEM SOC, V75, P2520, DOI 10.1021/ja01106a522; STEGINK LD, 1968, J BIOL CHEM, V243, P5272; STEPHENS CM, 1992, J BIOL CHEM, V267, P5762; WANG SP, 1993, MAMM GENOME, V4, P382, DOI 10.1007/BF00360589; WEIDMAN SW, 1973, BIOCHEMISTRY-US, V12, P1874, DOI 10.1021/bi00734a006	31	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17311	17316		10.1074/jbc.270.29.17311	http://dx.doi.org/10.1074/jbc.270.29.17311			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615532	hybrid			2022-12-27	WOS:A1995RK68900042
J	ZAIDI, SHE; MALTER, JS				ZAIDI, SHE; MALTER, JS			NUCLEOLIN AND HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN-C PROTEINS SPECIFICALLY INTERACT WITH THE 3'-UNTRANSLATED REGION OF AMYLOID PROTEIN-PRECURSOR MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; BINDING-PROTEINS; ALZHEIMERS-DISEASE; SEQUENCE; CELLS; CDNA; IDENTIFICATION; ACTIVATION; CYTOPLASM; RECEPTOR	The central nervous system deposition by neurons and glia of beta A4 amyloid protein is an important contributing factor to the development of Alzheimer's disease. Amyloidogenic cells overexpress amyloid precursor protein (APP) mRNAs suggesting a transcriptional or posttranscriptional defect may contribute to this process. We have previously shown that APP mRNAs display regulated stability which is dependent on a 29-base element within the 3'-untranslated region (UTR). This domain specifically interacted with several cytoplasmic RNA-binding proteins. We have purified these APP RNA-binding proteins from a human T-cell leukemia and demonstrate that five cytoplasmic proteins of 70, 48, 47, 39, and 38 kDa form the previously observed APP RNA protein complexes. Amino acid sequence analyses showed that the 70-, 48-, and 47-kDa proteins were fragments of nucleolin and that the 39- and 38-kDa proteins were heterogeneous nuclear ribonucleoprotein (hnRNP) C protein. Northwestern and Western blot analyses of purified material further confirmed these data. Nucleolin protein is known to shuttle between the nucleus and cytoplasm but hnRNP C has not been reported within the cytoplasm. This report of sequence specific, mRNA binding by nucleolin Emd hnRNP C suggests that these proteins participate in the post-transcriptional regulation of APP mRNA through 3'-UTR, site-specific interactions.	UNIV WISCONSIN, SCH MED, DEPT PATHOL & LAB MED, MADISON, WI 53792 USA; UNIV WISCONSIN, SCH MED, NEUROSCI PROGRAM, MADISON, WI 53792 USA; UNIV WISCONSIN, SCH MED, INST AGING, MADISON, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison					NIA NIH HHS [R01-AG 10675] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG010675] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ATWATER JA, 1990, ANNU REV GENET, V24, P519; BARNETT SF, 1990, METHOD ENZYMOL, V181, P293; BARRIJAL S, 1992, NUCLEIC ACIDS RES, V20, P5053, DOI 10.1093/nar/20.19.5053; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; BUGLER B, 1987, J BIOL CHEM, V262, P10922; BURD CG, 1989, P NATL ACAD SCI USA, V86, P9788, DOI 10.1073/pnas.86.24.9788; CAIZERGUESFERRER M, 1987, BIOCHEMISTRY-US, V26, P7876, DOI 10.1021/bi00398a051; CHEN CM, 1991, J BIOL CHEM, V266, P7754; CHOI YD, 1986, SCIENCE, V231, P1534, DOI 10.1126/science.3952495; ERARD MS, 1988, EUR J BIOCHEM, V175, P525, DOI 10.1111/j.1432-1033.1988.tb14224.x; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GEGONNE A, 1993, EMBO J, V12, P1169, DOI 10.1002/j.1460-2075.1993.tb05758.x; GORLACH M, 1994, J BIOL CHEM, V269, P23074; HAMILTON BJ, 1993, J BIOL CHEM, V268, P8881; HARFORD JB, 1990, ENZYME, V44, P28, DOI 10.1159/000468745; HENSON J, 1992, ANN NEUROL, V32, P72, DOI 10.1002/ana.410320112; ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301; JOHNSON SA, 1990, SCIENCE, V248, P854, DOI 10.1126/science.2111579; JORDAN G, 1987, NATURE, V329, P489, DOI 10.1038/329489a0; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; LAPEYRE B, 1986, J BIOL CHEM, V261, P9167; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; PETER M, 1990, CELL, V60, P791, DOI 10.1016/0092-8674(90)90093-T; PINOLROMA S, 1990, METHOD ENZYMOL, V181, P317; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; RAJAGOPALAN LE, 1994, J BIOL CHEM, V269, P23882; ROYER HD, 1991, NUCLEIC ACIDS RES, V19, P2363, DOI 10.1093/nar/19.9.2363; SAPP M, 1989, EUR J BIOCHEM, V179, P541, DOI 10.1111/j.1432-1033.1989.tb14581.x; SELKOE DJ, 1991, SCI AM, V11, P68; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SMITH C, 1994, NEUROPATH APPL NEURO, V20, P322, DOI 10.1111/j.1365-2990.1994.tb00977.x; SRIVASTAVA M, 1989, FEBS LETT, V250, P99, DOI 10.1016/0014-5793(89)80692-1; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TREJO J, 1994, J BIOL CHEM, V269, P21682; VOELKERDING KV, 1995, ONCOGENE, V10, P515; WILUSZ J, 1988, MOL CELL BIOL, V8, P4477, DOI 10.1128/MCB.8.10.4477; YANG TH, 1994, MOL CELL BIOL, V14, P6068, DOI 10.1128/MCB.14.9.6068; ZAIDI SHE, 1994, J BIOL CHEM, V269, P24000; ZAIDI SHE, 1994, J BIOL CHEM, V269, P24007	41	97	106	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17292	17298		10.1074/jbc.270.29.17292	http://dx.doi.org/10.1074/jbc.270.29.17292			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615529	hybrid			2022-12-27	WOS:A1995RK68900039
J	CHOI, H; TANG, CK; TU, SC				CHOI, H; TANG, CK; TU, SC			CATALYTICALLY ACTIVE FORMS OF THE INDIVIDUAL SUBUNITS OF VIBRIO-HARVEYI LUCIFERASE AND THEIR KINETIC AND BINDING-PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL BIOLUMINESCENT REACTION; SITE-DIRECTED MUTATION; ALPHA-SUBUNIT; BETA-SUBUNIT; ALDEHYDE	Contradictory findings have recently been reported regarding the (in)abilities of individual subunits of the Vibrio harveyi alpha beta dimeric luciferase to catalyze bioluminescence. We have produced individual alpha and beta subunits separately in Escherichia coli JM109 cells by recombinant DNA techniques. Both subunits were purified to more than 90% homogeneity and found to be catalytically active, with their general catalytic properties and the specific activities similar to those reported earlier (Sinclair, J. F., Waddle, J. J., Waddill, E. F., and Baldwin, T. O. (1993) Biochemistry 32, 5038-5044). Individual subunits were significantly distinct from the native luciferase with respect to inactivations by trypsin and N-ethylmaleimide, and the stability of the flavin 4a-hydroperoxide intermediate. The active species in isolated alpha and beta samples were each the predominant protein species, corresponding to a 42,000 M(r) alpha monomer and a 67,000 M(r) beta dimer, respectively. These findings clearly indicate that the activities of the individual subunits are not due to trace contaminations of the respective counter subunits. The much reduced specific activities of the individual subunits are, in part, a consequence of diminished abilities to oxidize the aldehyde substrate. Kinetic and equilibrium measurements indicate that alpha and beta(2) each contained a reduced flavin site, an aldehyde substrate site, and an aldehyde inhib itor site. The on and off rates of the decanal inhibitor binding were substantially slower than the bindings of decanal and reduced riboflavin 5'-phosphate substrates. These findings are consistent with a scheme that the aldehyde inhibitor blocks the binding of the reduced flavin substrate.	UNIV HOUSTON,DEPT BIOCHEM & BIOPHYS SCI,HOUSTON,TX 77204; UNIV HOUSTON,DEPT CHEM,HOUSTON,TX 77204	University of Houston System; University of Houston; University of Houston System; University of Houston					NIGMS NIH HHS [GM25953] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025953] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALDWIN TO, 1978, J BIOL CHEM, V253, P5551; BECVAR JE, 1975, P NATL ACAD SCI USA, V72, P3374, DOI 10.1073/pnas.72.9.3374; CLINE TW, 1972, BIOCHEMISTRY-US, V11, P3359, DOI 10.1021/bi00768a008; DUNN DK, 1973, BIOCHEMISTRY-US, V12, P4911, DOI 10.1021/bi00748a016; FLYNN GC, 1993, P NATL ACAD SCI USA, V90, P10826, DOI 10.1073/pnas.90.22.10826; FRIEDLAND J, 1967, P NATL ACAD SCI USA, V58, P2336, DOI 10.1073/pnas.58.6.2336; GHISLA S, 1974, BIOCHEMISTRY-US, V13, P589, DOI 10.1021/bi00700a029; GUNSALUSMIGUEL A, 1972, J BIOL CHEM, V247, P398; HASTINGS JW, 1969, BIOCHEMISTRY-US, V8, P4681, DOI 10.1021/bi00840a004; HUMMEL JP, 1962, BIOCHIM BIOPHYS ACTA, V63, P532; Job P, 1928, ANN CHIM FRANCE, V9, P113; LEI BF, 1991, PHOTOCHEM PHOTOBIOL, V54, P473, DOI 10.1111/j.1751-1097.1991.tb02043.x; LEI BF, 1993, J BIOL CHEM, V269, P5612; LI Z, 1993, BIOCHIM BIOPHYS ACTA, V1158, P137, DOI 10.1016/0304-4165(93)90007-U; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEIGHEN EA, 1971, J BIOL CHEM, V246, P7666; MEIGHEN EA, 1973, BIOCHEMISTRY-US, V12, P1482, DOI 10.1021/bi00732a003; MEIGHEN EA, 1971, BIOCHEMISTRY-US, V10, P4069, DOI 10.1021/bi00798a009; MEIGHEN EA, 1980, J BIOL CHEM, V255, P1181; NICOLI MZ, 1974, J BIOL CHEM, V249, P2385; SINCLAIR JF, 1993, BIOCHEMISTRY-US, V32, P5036, DOI 10.1021/bi00070a010; TU S, 1975, BIOCHEMISTRY-US, V14, P4310, DOI 10.1021/bi00690a027; TU SC, 1983, BIOCHEMISTRY-US, V22, P519, DOI 10.1021/bi00271a040; WADDLE J, 1991, BIOCHEM BIOPH RES CO, V178, P1188, DOI 10.1016/0006-291X(91)91018-8; WATANABE H, 1982, ARCH BIOCHEM BIOPHYS, V215, P405, DOI 10.1016/0003-9861(82)90100-X; XI L, 1990, J BIOL CHEM, V265, P4200; XIN X, 1994, BIOCHEMISTRY-US, V33, P12194, DOI 10.1021/bi00206a023; XIN X, 1991, BIOCHEMISTRY-US, V30, P11255, DOI 10.1021/bi00111a010	28	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16813	16819		10.1074/jbc.270.28.16813	http://dx.doi.org/10.1074/jbc.270.28.16813			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622495	hybrid			2022-12-27	WOS:A1995RJ34700056
J	LIN, KT; XUE, JY; NOMEN, M; SPUR, B; WONG, PYK				LIN, KT; XUE, JY; NOMEN, M; SPUR, B; WONG, PYK			PEROXYNITRITE-INDUCED APOPTOSIS IN HL-60 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							NITRIC-OXIDE; DNA FRAGMENTATION; L-ARGININE; SUPEROXIDE; OXIDATION	Peroxynitrite (ONOO-), an anion and a potent oxidant, generated by the interaction of nitric oxide (NO) and superoxide is able to induce apoptosis in HL-60 human leukemia cells in a time- and concentration-dependent manner. Characteristic morphology of apoptosis can be observed 3 h after HL-60 cells are exposed to 10 mu M ONOO-. Treatment of HL-60 cells with increasing concentrations of ONOO- from 1 to 100 mu M confirms the concentration dependence of apoptosis as evidenced by: 1) degradation of nuclear DNA of these cells into integer multiples of approximately 200 base pairs; 2) colorimetric DNA fragmentation assay; and 3) evidence of condensation of chromatin and nuclear fragmentation shown by propidium iodide staining, Under the same conditions, peroxynitrite causes apoptosis in another transformed cell line, U-937 cells, but is ineffective at inducing apoptosis in normal endothelial cells derived from human umbilical cord and normal human peripheral blood mononuclear cells, This direct evidence of peroxynitrite inducing apoptosis implicated a new function of this potent oxidant.	UNIV MED & DENT NEW JERSEY, SCH OSTEOPATH MED, DEPT CELL BIOL, STRATFORD, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center				Spur, Bernd/0000-0002-7581-4741	PHS HHS [P01-43203, 41747, R01-25316-15] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALBINA JE, 1993, J IMMUNOL, V150, P5080; ALLAN DJ, 1992, J PATHOL, V167, P25, DOI 10.1002/path.1711670106; BECKER H, 1977, ORGANICUM, P657; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; CASTRO L, 1994, J BIOL CHEM, V269, P29409; CUI SJ, 1994, CANCER RES, V54, P2462; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; HADDAD IY, 1994, AM J PHYSIOL, V267, pL242, DOI 10.1152/ajplung.1994.267.3.L242; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; HIBBS JB, 1991, RES IMMUNOL, V142, P565, DOI 10.1016/0923-2494(91)90103-P; IGNARRO LJ, 1993, THROMB HAEMOSTASIS, V70, P148; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; KERR KM, 1984, J PATHOL, V107, P41; KOOY NW, 1994, ARCH BIOCHEM BIOPHYS, V310, P352, DOI 10.1006/abbi.1994.1178; LEIS JR, 1993, J CHEM SOC CHEM COMM, P1298, DOI 10.1039/c39930001298; MARTIN BL, 1990, J BIOL CHEM, V265, P7108; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; RACHMILEWITZ D, 1993, GASTROENTEROLOGY, V105, P1681, DOI 10.1016/0016-5085(93)91063-N; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; RADI R, 1991, J BIOL CHEM, V266, P4244; RADI R, 1994, ARCH BIOCHEM BIOPHYS, V308, P89, DOI 10.1006/abbi.1994.1013; RUBBO H, 1994, J BIOL CHEM, V269, P26066; SEAGO ND, 1995, MEDIAT INFLAMM, V4, P19, DOI 10.1155/S0962935195000044; SELLINS KS, 1987, J IMMUNOL, V139, P3199; SKAPER SD, 1995, J NEUROCHEM, V64, P266; WHITE CR, 1994, P NATL ACAD SCI USA, V91, P1044, DOI 10.1073/pnas.91.3.1044; WIZEMANN TM, 1994, J LEUKOCYTE BIOL, V56, P759, DOI 10.1002/jlb.56.6.759; WONG YPK, 1993, ATHEROSCLER REV, V25, P101; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	33	289	299	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16487	16490		10.1074/jbc.270.28.16487	http://dx.doi.org/10.1074/jbc.270.28.16487			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622447	hybrid			2022-12-27	WOS:A1995RJ34700002
J	MCINTOSH, JM; HASSON, A; SPIRA, ME; GRAY, WR; LI, WQ; MARSH, M; HILLYARD, DR; OLIVERA, BM				MCINTOSH, JM; HASSON, A; SPIRA, ME; GRAY, WR; LI, WQ; MARSH, M; HILLYARD, DR; OLIVERA, BM			A NEW FAMILY OF CONOTOXINS THAT BLOCKS VOLTAGE-GATED SODIUM-CHANNELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONUS-GEOGRAPHUS; OMEGA-CONOTOXIN; PEPTIDE LIGAND; VENOM; SNAIL; NEUROTOXINS; SUBTYPES; TOXINS; CELLS	Conus peptides, including omega-conotoxins and alpha-conotoxins (targeting calcium channels and nicotinic acetylcholine receptors, respectively) have been useful ligands in neuroscience. In this report, we describe a new family of sodium channel ligands, the mu O-conotoxins. The two peptides characterized, mu O-conotoxins MrVIA and MrVIB from Conus marmoreus potently block the sodium conductance in Aplysia neurons. This is in marked contrast to standard sodium channel blockers that are relatively ineffective in this system. The sequences of the peptides are as follows. mu O-conotoxin MrVIA: ACRKKWEYCIVPIIGFIYCCPGLICGPFVCV mu O-conotoxin MrVIB: ACSKKWEYCIVPILGFVYCCPGLICGPFVCV mu O-conotoxin MrVIA was chemically synthesized and proved indistinguishable from the natural product. Surprisingly, the mu O-conotoxins show no sequence similarity to the mu-conotoxins. However, ananalysis of cDNA clones encoding the mu O-conotoxin MrVIB demonstrated striking sequence similarity to omega- and delta-conotoxin pre cursors. Together, the omega-, delta-, and mu O-conotoxins define the O-superfamily of Conus peptides. The probable bio logical role and evolutionary affinities of these peptides are discussed.	UNIV UTAH,DEPT PATHOL,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT PSYCHIAT,SALT LAKE CITY,UT 84112; HEBREW UNIV JERUSALEM,INST LIFE SCI,DEPT NEUROBIOL,IL-91904 JERUSALEM,ISRAEL; INTERUNIV INST MARINE SCI,IL-88103 ELAT,ISRAEL	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Hebrew University of Jerusalem	MCINTOSH, JM (corresponding author), UNIV UTAH,DEPT BIOL,201 SO BIOL,SALT LAKE CITY,UT 84112, USA.		Spira, Micha/B-6470-2012		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K20MH000929] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM28677] Funding Source: Medline; NIMH NIH HHS [K20 MH 00929] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BENBASSAT D, 1993, EXP NEUROL, V122, P295, DOI 10.1006/exnr.1993.1129; CATTERALL WA, 1980, ANNU REV PHARMACOL, V20, P15, DOI 10.1146/annurev.pa.20.040180.000311; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; CLARK C, 1981, TOXICON, V19, P691, DOI 10.1016/0041-0101(81)90106-9; COLLEDGE CJ, 1992, TOXICON, V30, P1111, DOI 10.1016/0041-0101(92)90056-B; CRUZ LJ, 1989, BIOCHEMISTRY-US, V28, P3437, DOI 10.1021/bi00434a043; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; FAINZILBER M, 1995, IN PRESS J NAT TOXIN; Fox AP, 1987, J PHYSIOL-LONDON, V394, P49; GEDULDIG D, 1968, J PHYSIOL-LONDON, V199, P347, DOI 10.1113/jphysiol.1968.sp008657; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HASSON A, 1995, J NEUROPHYSIOL, V73, P1295, DOI 10.1152/jn.1995.73.3.1295; HASSON A, 1993, EUR J NEUROSCI, V5, P56, DOI 10.1111/j.1460-9568.1993.tb00205.x; MCINTOSH JM, 1994, J BIOL CHEM, V269, P16733; MCINTOSH JM, 1993, TOXICON, V32, P1561; MONJE VD, 1993, NEUROPHARMACOLOGY, V32, P1141, DOI 10.1016/0028-3908(93)90008-Q; OHIZUMI Y, 1986, J PHARMACOL EXP THER, V239, P243; OLIVERA BM, 1994, ANNU REV BIOCHEM, V63, P823, DOI 10.1146/annurev.bi.63.070194.004135; OLIVERA BM, 1987, BIOCHEMISTRY-US, V26, P2086, DOI 10.1021/bi00382a004; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; SHON KJ, 1994, BIOCHEMISTRY-US, V33, P11420, DOI 10.1021/bi00204a003; SPIRA ME, 1993, J NEUROBIOL, V24, P300, DOI 10.1002/neu.480240304; SPIRA ME, 1993, ISRAEL J MED SCI, V29, P530; STRICHARTZ G, 1987, ANNU REV NEUROSCI, V10, P237; Walls J.G., 1979, CONE SHELLS SYNOPSIS; WOODWARD SR, 1990, EMBO J, V1, P1015; ZIV NE, 1993, EUR J NEUROSCI, V5, P657, DOI 10.1111/j.1460-9568.1993.tb00531.x	29	139	147	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16796	16802		10.1074/jbc.270.28.16796	http://dx.doi.org/10.1074/jbc.270.28.16796			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622492	hybrid			2022-12-27	WOS:A1995RJ34700053
J	NELSON, CC; HENDY, SC; ROMANIUK, PJ				NELSON, CC; HENDY, SC; ROMANIUK, PJ			RELATIONSHIP BETWEEN P-BOX AMINO-ACID-SEQUENCE AND DNA-BINDING SPECIFICITY OF THE THYROID-HORMONE RECEPTOR - THE EFFECTS OF HALF-SITE SEQUENCE IN EVERTED REPEATS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER DOMAIN; GLUCOCORTICOID RECEPTOR; ESTROGEN-RECEPTOR; RESPONSE ELEMENTS; NUCLEAR RECEPTORS; RETINOIC ACID; WILD-TYPE; DETERMINANTS; HETERODIMERS; SUPERFAMILY	The three P-box amino acids in the DNA recognition alpha-helix of steroid/thyroid hormone receptors participate in the discrimination of the central base pairs of the hexameric half-sites of receptor response elements in DNA. A series of 57 variants of the beta isoform of the human thyroid hormone receptor were constructed in which the 19 possible amino acid substitutions were incorporated at each of the three P-box positions. The effects of these substitutions on the sequence specificity of the DNA binding activity of the receptor were analyzed using 16 everted repeat elements which differed in sequence in the two central base pairs of the hexameric half-sites. Only receptors with glutamate or aspartate as the first P-box amino acid had detectable DNA binding affinity on everted repeats with AGGNCA half-sites. Only those receptors with alanine, glycine, serine, or proline in the second P-box position were able to bind to this same group of everted repeat elements. In contrast, many of the variant receptors with substitutions at the third P-box position were capable of binding to the AGGNCA group of repeat elements. The actual substitutions at the third P-box position that were compatible with binding depended upon the identity of the fourth base pair of the AGGNCA half-sites. Of the remaining 12 everted repeat sequences, only those with AGTTCA or AGTCCA half-sites were able to bind any of the receptors. In addition to wild type receptor, several variant receptors with amino acid substitutions in either the first or third P-box position were able to bind to the everted repeat with AGTTCA half-sites. The everted repeat with AGTCCA half-sites was bound by receptors with a DGG, NGG, or EGQ P-box sequence, but not the wild type receptor which has an EGG P-box sequence. These data demonstrate that all three P-box positions of the thyroid hormone receptor function to discriminate between half sites that differ in sequence at the third and fourth base pairs.	UNIV VICTORIA,DEPT BIOCHEM & MICROBIOL,VICTORIA,BC V8W 3P6,CANADA	University of Victoria				Romaniuk, Paul/0000-0002-5931-8879				CHEN HW, 1993, MOL CELL BIOL, V13, P2366, DOI 10.1128/MCB.13.4.2366; DANIELSEN M, 1989, CELL, V57, P1131, DOI 10.1016/0092-8674(89)90050-0; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; KATZ RW, 1993, J BIOL CHEM, V268, P19392; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; LANDET V, 1992, EMBO J, V11, P1003; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MADER S, 1993, EMBO J, V12, P5029, DOI 10.1002/j.1460-2075.1993.tb06196.x; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; NELSON CC, 1995, J BIOL CHEM, V270, P16988, DOI 10.1074/jbc.270.28.16988; NELSON CC, 1994, MOL ENDOCRINOL, V8, P829, DOI 10.1210/me.8.7.829; NELSON CC, 1993, MOL ENDOCRINOL, V7, P1185, DOI 10.1210/me.7.9.1185; NISHIKAWA J, 1993, J BIOL CHEM, V268, P19739; SCHRADER M, 1994, J BIOL CHEM, V269, P6444; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; SCHWABE JWR, 1990, NATURE, V348, P458, DOI 10.1038/348458a0; SMITMCBRIDE Z, 1994, MOL ENDOCRINOL, V8, P819, DOI 10.1210/me.8.7.819; TRUSS M, 1991, MOL CELL BIOL, V11, P3247, DOI 10.1128/MCB.11.6.3247; UEDA H, 1992, MOL CELL BIOL, V12, P5667, DOI 10.1128/MCB.12.12.5667; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WAHLI W, 1991, FASEB J, V5, P2243, DOI 10.1096/fasebj.5.9.1860615; WILLIAMS GR, 1992, MOL ENDOCRINOL, V6, P1527, DOI 10.1210/me.6.10.1527; WILSON TE, 1992, SCIENCE, V256, P107, DOI 10.1126/science.1314418; ZILLIACUS J, 1994, P NATL ACAD SCI USA, V91, P4175, DOI 10.1073/pnas.91.10.4175; ZILLIACUS J, 1992, J BIOL CHEM, V267, P24941	29	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16981	16987		10.1074/jbc.270.28.16981	http://dx.doi.org/10.1074/jbc.270.28.16981			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622518	hybrid			2022-12-27	WOS:A1995RJ34700079
J	WOLFF, J; KNIPLING, L				WOLFF, J; KNIPLING, L			COLCHICINE BINDING BY THE ISOLATED BETA-MONOMER OF TUBULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE ANISOTROPY; DIMER DISSOCIATION; BRAIN TUBULIN; LACTOPEROXIDASE; KINETICS; IDENTIFICATION; PURIFICATION	At mole ratios of lactoperoxidase to tubulin monomers of 3-4, bovine lactoperoxidase forms 1:1 adducts with both alpha- and beta-tubulin from rat brain, thereby separating the tubulin heterodimer into its monomers. This mixture binds colchicine normally, and we show here by direct photoaffinity labeling that the bulk of the [H-3]colchicine becomes attached to beta-tubulin under these conditions. When the alpha-tubulin has been displaced by lactoperoxidase, the ratio of label in beta-tubulin to alpha-tubulin is increased. The amount of label in alpha-tubulin decreases with a corresponding appearance of label in lactoperoxidase. The rate of labeling of beta-tubulin remains slow. We conclude that alpha-tubulin is not necessary for colchicine binding and propose a model wherein the A and C rings of colchicine bind to beta-tubulin, while the B ring faces alpha-tubulin in the dimer.			WOLFF, J (corresponding author), NIDDK,BIOCHEM PHARMACOL LAB,BETHESDA,MD 20892, USA.			Knipling, Leslie/0000-0002-2636-6460				ANDREU JM, 1982, BIOCHEMISTRY-US, V21, P534, DOI 10.1021/bi00532a019; BANE S, 1984, J BIOL CHEM, V259, P7391; BHATTACHARYYA B, 1986, P NATL ACAD SCI USA, V83, P2052, DOI 10.1073/pnas.83.7.2052; DETRICH HW, 1982, BIOCHEMISTRY-US, V21, P2392, DOI 10.1021/bi00539a018; DUMONTET C, 1983, J BIOL CHEM, V258, P4166; ENGELBORGHS Y, 1987, J BIOL CHEM, V262, P5204; GARLAND DL, 1978, BIOCHEMISTRY-US, V17, P4266, DOI 10.1021/bi00613a024; HASTIE SB, 1991, PHARMACOL THERAPEUT, V51, P377, DOI 10.1016/0163-7258(91)90067-V; HESSE J, 1987, J BIOL CHEM, V262, P15472; JAYARAM B, 1994, J BIOL CHEM, V269, P3233; MEJILLANO MR, 1989, BIOCHEMISTRY-US, V28, P6518, DOI 10.1021/bi00441a053; PANDA D, 1992, BIOCHEMISTRY-US, V31, P9709, DOI 10.1021/bi00155a026; RIGHETTI PG, 1976, J CHROMATOGR, V127, P1, DOI 10.1016/S0021-9673(00)98537-6; ROUSSET B, 1980, J BIOL CHEM, V255, P2514; ROUSSET B, 1980, J BIOL CHEM, V255, P1677; ROUSSET B, 1980, FEBS LETT, V115, P235, DOI 10.1016/0014-5793(80)81176-8; SACKETT DL, 1991, BIOCHEMISTRY-US, V30, P3511, DOI 10.1021/bi00228a023; SACKETT DL, 1994, BIOCHEMISTRY-US, V33, P12868, DOI 10.1021/bi00209a019; SHEARWIN KE, 1994, BIOCHEMISTRY-US, V33, P894, DOI 10.1021/bi00170a007; SHIVANNA BD, 1993, J BIOL CHEM, V268, P127; SUZUKI T, 1984, BIOCHEM MED METAB B, V31, P211, DOI 10.1016/0006-2944(84)90025-5; UPPULURI S, 1993, P NATL ACAD SCI USA, V890, P11598; WOLFF J, 1992, BIOCHEMISTRY-US, V31, P3935, DOI 10.1021/bi00131a007; WOLFF J, 1991, P NATL ACAD SCI USA, V88, P2820, DOI 10.1073/pnas.88.7.2820	24	25	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16809	16812		10.1074/jbc.270.28.16809	http://dx.doi.org/10.1074/jbc.270.28.16809			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622494	hybrid			2022-12-27	WOS:A1995RJ34700055
J	WRAGG, S; HAGEN, FK; TABAK, LA				WRAGG, S; HAGEN, FK; TABAK, LA			KINETIC-ANALYSIS OF A RECOMBINANT UDP-N-ACETYL-D-GALACTOSAMINE - POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLYCOSYLATION; PURIFICATION; PROTEINS; GALNAC; TRANSFERASE; INVITRO	A mammalian expression vector was designed to express a secreted soluble form of the UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase (polypeptide GalNAc transferase) with a metal binding site (HHWHHH) at the NH2 terminus. The recombinant enzyme was purified to homogeneity from COS-7 cell media by sequential chromatography on columns of NiCl2-chelating Sepharose, Affi-Gel blue, and Sephacryl S-100. Kinetic parameters of recombinant and native polypeptide GalNAc transferase were comparable for the donor UDP-GalNAc and for the peptide accepters Ac (T) under bar PPP, EPO-T (PPDAA (T) under bar AAPLR), and HVF (PHMAQV (T) under bar VGPGL). Initial velocity and product inhibition studies were carried out with purified recombinant polypeptide GalNAc transferase and the substrates UDP-GalNAc and peptide EPO-T. Initial velocity data was consistent with a sequential type mechanism in which binding of both substrates precedes product release. Product inhibition analysis using UDP showed competitive inhibition against UDP-GalNAc and a noncompetitive inhibition against peptide EPO-T. The dead end peptide analogue EPO-G (PPDAAGAAPLR) was a noncompetitive inhibitor of UDP-GalNAc and a competitive inhibitor of peptide EPO-T. Collectively, the results suggest that the most probable kinetic mechanism for the enzyme is one in which both substrates must bind in a random order prior to catalysis. Interestingly, the K-m for EPO-T is similar to the K-i for EPO-G, suggesting that peptide interaction with the polypeptide GalNAc transferase does not require a hydroxyamino acid.	UNIV ROCHESTER, SCH MED & DENT, DEPT DENT RES, ROCHESTER, NY 14642 USA; UNIV ROCHESTER, SCH MED & DENT, DEPT BIOCHEM, ROCHESTER, NY 14642 USA	University of Rochester; University of Rochester					NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE008108, R01DE008108] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE-08108] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		[Anonymous], 1989, SAS STAT USERS GUIDE, V2; BRIAND JP, 1981, J BIOL CHEM, V256, P2205; Cleland W W, 1979, Methods Enzymol, V63, P103; Cleland W W, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P273; ELHAMMER A, 1986, J BIOL CHEM, V261, P5249; ELHAMMER AP, 1993, J BIOL CHEM, V268, P10029; HAGEN FK, 1993, J BIOL CHEM, V268, P18960; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; HSUEH EC, 1986, J BIOL CHEM, V261, P4940; KASHER MS, 1993, BIOTECHNIQUES, V14, P630; KEARNS AE, 1991, BIOCHEMISTRY-US, V30, P7477, DOI 10.1021/bi00244a016; MCGUIRE EJ, 1967, J BIOL CHEM, V242, P3745; NISHIMORI I, 1994, J BIOL CHEM, V269, P16123; OCONNELL BC, 1992, J BIOL CHEM, V267, P25010; OCONNELL BC, 1993, J DENT RES, V72, P1554, DOI 10.1177/00220345930720120401; Sadler J. E., 1984, BIOL CARBOHYDRATES, V2, P199; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Segel I.H., 1975, ENZYME KINETICS; SUGIURA M, 1982, J BIOL CHEM, V257, P9501; TABAK LA, 1985, ARCH BIOCHEM BIOPHYS, V242, P383, DOI 10.1016/0003-9861(85)90222-X; WANG YC, 1992, J BIOL CHEM, V267, P2728	21	32	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16947	16954		10.1074/jbc.270.28.16947	http://dx.doi.org/10.1074/jbc.270.28.16947			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622513	hybrid			2022-12-27	WOS:A1995RJ34700074
J	XU, Q; HOPPE, D; CHITNIS, VP; ODOM, WR; GUIKEMA, JA; CHITNIS, PR				XU, Q; HOPPE, D; CHITNIS, VP; ODOM, WR; GUIKEMA, JA; CHITNIS, PR			MUTATIONAL ANALYSIS OF PHOTOSYSTEM-I POLYPEPTIDES IN THE CYANOBACTERIUM SYNECHOCYSTIS SP, PCC-6803 - TARGETED INACTIVATION OF PSAI REVEALS THE FUNCTION OF PSAI IN THE STRUCTURAL ORGANIZATION OF PSAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANABAENA-VARIABILIS ATCC-29413; CHEMICAL CROSS-LINKING; ENCODING SUBUNIT-II; SP PCC-6803; ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; CHLOROPLAST GENOME; MOLECULAR-CLONING; GENE ORGANIZATION; SYNECHOCOCCUS-SP	We cloned, characterized, and inactivated the psaI gene encoding a 4-kDa hydrophobic subunit of photosystem I from the cyanobacterium Synechocystis sp. PCC 6803, The peal gene is located 90 base pairs downstream from psaL, and is transcribed on 0,94- and 0,SB-kilobase transcripts, To identify the function of psaI, we generated a cyanobacterial strain in which psaI has been interrupted by a gene for chloramphenicol resistance. The wild-type and the mutant cells showed comparable rates of photoautotrophic growth at 25 degrees C, However, the mutant cells grew slower and contained less chlorophyll than the wild-type cells, when grown at 40 degrees C. The PsaI-less membranes from cells grown at either temperature showed a small decrease in NADP(+) photoreduction rate when compared to the wild-type membranes. Inactivation of psaI led to an 80% decrease in the PsaL level in the photosynthetic membranes and to a complete loss of PsaL in the purified photosystem I preparations, but had little effect on the accumulation of other photosystem I subunits, Upon solubilization with nonionic detergents, photosystem I trimers could be obtained from the wild-type, but not from the PsaI-less membranes, The PsaI-less photosystem I monomers did not contain detectable levels of PsaL. Therefore, a structural interaction between PsaL and PsaI may stabilize the association of PsaL with the photosystem I core. PsaL in the mild-type and PsaI-less membranes showed equal resistance to removal by chaotropic agents. However, PsaL in the PsaI-less strain exhibited an increased susceptibility to proteolysis. From these data, we conclude that PsaI has a crucial role in aiding normal structural organization of PsaL within the photosystem I complex and the absence of PsaI alters PsaL organization, leading to a small, but physiologically significant, defect in photosystem I function.	KANSAS STATE UNIV AGR & APPL SCI, DIV BIOL, MANHATTAN, KS 66506 USA	Kansas State University								ANDERSON SL, 1991, PLANT MOL BIOL, V16, P487, DOI 10.1007/BF00023416; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BRYANT DA, 1992, PHOTOSYSTEMS STRUCTU, P501; CHITNIS PR, 1991, J BIOL CHEM, V266, P20146; CHITNIS PR, 1989, J BIOL CHEM, V264, P18374; CHITNIS PR, 1989, J BIOL CHEM, V264, P18381; CHITNIS PR, 1992, PLANT PHYSIOL, V99, P239, DOI 10.1104/pp.99.1.239; CHITNIS PR, 1991, PHOTOSYNTHETIC APPAR, P178; CHITNIS PR, 1995, IN PRESS PHOTOSYNTH; CHITNIS VP, 1993, FEBS LETT, V336, P330, DOI 10.1016/0014-5793(93)80831-E; CHITNIS VP, 1993, J BIOL CHEM, V268, P11678; COOPER CE, 1991, BIOCHEM CELL BIOL, V69, P586, DOI 10.1139/o91-089; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; FROMME P, 1994, BBA-BIOENERGETICS, V1187, P99, DOI 10.1016/0005-2728(94)90092-2; GOLBECK JH, 1993, P NATL ACAD SCI USA, V90, P1642, DOI 10.1073/pnas.90.5.1642; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HENIKOFF S, 1987, METHOD ENZYMOL, V155, P156; HENRY RL, 1992, PLANT PHYSIOL BIOCH, V30, P357; HIPPLER M, 1989, FEBS LETT, V250, P280, DOI 10.1016/0014-5793(89)80738-0; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; IKEUCHI M, 1992, PLANT CELL PHYSIOL, V33, P1057; IKEUCHI M, 1991, FEBS LETT, V287, P5, DOI 10.1016/0014-5793(91)80003-L; Kok B., 1980, METHODS ENZYMOLOGY C, V69, P280; KRAUSS N, 1993, NATURE, V361, P326, DOI 10.1038/361326a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEMMON MA, 1994, Q REV BIOPHYS, V27, P157, DOI 10.1017/S0033583500004522; LI N, 1991, BIOCHEMISTRY-US, V30, P7863, DOI 10.1021/bi00245a028; MENGINLECREULX D, 1990, NUCLEIC ACIDS RES, V18, P2810, DOI 10.1093/nar/18.9.2810; MENGINLECREULX D, 1991, J BACTERIOL, V173, P4625, DOI 10.1128/jb.173.15.4625-4636.1991; MUHLENHOFF U, 1993, GENE, V127, P71, DOI 10.1016/0378-1119(93)90618-D; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; PIERRE Y, 1993, CR ACAD SCI III-VIE, V316, P1404; REILLY P, 1988, J BIOL CHEM, V263, P17658; ROUSSEAU F, 1993, EMBO J, V12, P1755, DOI 10.1002/j.1460-2075.1993.tb05823.x; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHELLER HV, 1989, J BIOL CHEM, V264, P18402; SHEN GZ, 1994, BIOCHEMISTRY-US, V33, P7379, DOI 10.1021/bi00189a044; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; SMART LB, 1991, PLANT MOL BIOL, V17, P959, DOI 10.1007/BF00037136; SONOIKE K, 1992, PLANT MOL BIOL, V20, P987, DOI 10.1007/BF00027168; STEINMULLER K, 1992, PLANT MOL BIOL, V20, P997, DOI 10.1007/BF00027170; VERMAAS WFJ, 1991, PHOTOSYNTHETIC APPAR, P26; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; WEBER N, 1993, BIOCHIM BIOPHYS ACTA, V1143, P204, DOI 10.1016/0005-2728(93)90144-5; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; WYNN RM, 1988, BIOCHEMISTRY-US, V27, P5863, DOI 10.1021/bi00416a007; WYNN RM, 1989, BIOCHEMISTRY-US, V28, P5554, DOI 10.1021/bi00439a032; XU Q, 1994, PLANT PHYSIOL, V106, P1057, DOI 10.1104/pp.106.3.1057; XU Q, 1994, PLANT MOL BIOL, V26, P291, DOI 10.1007/BF00039540; XU Q, 1994, J BIOL CHEM, V269, P21512; XU QA, 1994, J BIOL CHEM, V269, P3205; YU L, 1993, PLANT PHYSIOL, V103, P171, DOI 10.1104/pp.103.1.171; ZANETTI G, 1987, EUR J BIOCHEM, V169, P143, DOI 10.1111/j.1432-1033.1987.tb13591.x; ZILBER AL, 1988, PLANT PHYSIOL, V88, P810, DOI 10.1104/pp.88.3.810; ZILBER AL, 1992, PLANT PHYSIOL, V99, P901, DOI 10.1104/pp.99.3.901	56	74	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16243	16250		10.1074/jbc.270.27.16243	http://dx.doi.org/10.1074/jbc.270.27.16243			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608190	hybrid			2022-12-27	WOS:A1995RH22600056
J	CONSTAM, DB; TOBLER, AR; RENSINGEHL, A; KEMLER, I; HERSH, LB; FONTANA, A				CONSTAM, DB; TOBLER, AR; RENSINGEHL, A; KEMLER, I; HERSH, LB; FONTANA, A			PUROMYCIN-SENSITIVE AMINOPEPTIDASE - SEQUENCE-ANALYSIS, EXPRESSION, AND FUNCTIONAL-CHARACTERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; ENKEPHALIN-DEGRADING AMINOPEPTIDASES; MATURATION-PROMOTING FACTOR; EPIDERMAL GROWTH-FACTOR; AMINO-ACID SEQUENCE; MULTICATALYTIC PROTEINASE; TAU-PROTEIN; NUCLEAR TRANSLOCATION; EMBRYONIC-DEVELOPMENT; MITOTIC-ARREST	Among the molecular mechanisms that control the cell division cycle, proteolysis has emerged as a key regulatory process enabling cells to pass critical check points. Such proteolysis involves a cascade of enzymes including a multisubunit complex termed 26S proteasome. Here we report on the analysis of a novel mouse cDNA encoding the puromycin-sensitive aminopeptidase (PSA) and on its expression in COS cells and 3T3 fibroblasts. PSA is 27-40% homologous to several known Zn2+-binding aminopeptidases including aminopeptidase N. Immunohistochemical analysis revealed that PSA is localized to the cytoplasm and to the nucleus and associates with microtubules of the spindle apparatus during mitosis. Furthermore, puromycin and bestatin both arrested the cell cycle, leading to an accumulation of cells in G(2)/M phase, and ultimately induced cells to undergo apoptosis at concentrations that inhibit PSA. Control experiments including cycloheximide further suggested that the induction of apoptosis by puromycin was not attributable to inhibition of protein synthesis. Taken together, these data favor the novel idea that PSA participates in proteolytic events essential for cell growth and viability.	UNIV ZURICH HOSP,DEPT INTERNAL MED,CLIN IMMUNOL SECT,CH-8044 ZURICH,SWITZERLAND; UNIV KENTUCKY,ALBERT B CHANDLER MED CTR,DEPT BIOCHEM,LEXINGTON,KY 40536	University of Zurich; University Zurich Hospital; University of Kentucky				Constam, Daniel B./0000-0002-6256-3891	NIDA NIH HHS [DA 02243] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002243] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AIZAWA H, 1989, J BIOL CHEM, V264, P5885; AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; AMSTERDAM A, 1993, P NATL ACAD SCI USA, V90, P99, DOI 10.1073/pnas.90.1.99; BARRY MA, 1993, CANCER RES, V53, P2349; BROWNLEES J, 1993, J NEUROCHEM, V60, P793, DOI 10.1111/j.1471-4159.1993.tb03223.x; CHAILLET P, 1983, EUR J PHARMACOL, V86, P329, DOI 10.1016/0014-2999(83)90181-4; DAVIDOFF AN, 1992, LEUKEMIA RES, V16, P1077, DOI 10.1016/0145-2126(92)90046-A; DAVIDOFF AN, 1993, EXP HEMATOL, V21, P456; DEERY WJ, 1984, J CELL BIOL, V98, P904, DOI 10.1083/jcb.98.3.904; DRAETTA G, 1989, CELL, V56, P829, DOI 10.1016/0092-8674(89)90687-9; DRISCOLL J, 1989, P NATL ACAD SCI USA, V86, P787, DOI 10.1073/pnas.86.3.787; DYER SH, 1990, J NEUROCHEM, V54, P547, DOI 10.1111/j.1471-4159.1990.tb01906.x; GALLANT P, 1992, J CELL BIOL, V117, P213, DOI 10.1083/jcb.117.1.213; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; HAMBROOK JM, 1976, NATURE, V262, P782, DOI 10.1038/262782a0; HERSH LB, 1980, NATURE, V286, P160, DOI 10.1038/286160a0; HERSH LB, 1981, J NEUROCHEM, V36, P171, DOI 10.1111/j.1471-4159.1981.tb02392.x; HERSHKO A, 1991, J BIOL CHEM, V266, P16376; HERSHKO A, 1994, J BIOL CHEM, V269, P4940; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; HOUGH R, 1986, J BIOL CHEM, V261, P2400; HOUGH R, 1987, J BIOL CHEM, V262, P8303; HUI KS, 1983, BIOCHEMISTRY-US, V22, P1062, DOI 10.1021/bi00274a010; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; KAWAHARA H, 1992, DEV BIOL, V151, P27, DOI 10.1016/0012-1606(92)90210-8; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; Loewe Jan, 1995, Science (Washington D C), V268, P533; LUCA FC, 1989, J CELL BIOL, V109, P1895, DOI 10.1083/jcb.109.5.1895; MCLELLAN S, 1988, J NEUROCHEM, V51, P1552, DOI 10.1111/j.1471-4159.1988.tb01124.x; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; ORLOWSKI M, 1993, BIOCHEMISTRY-US, V32, P1563, DOI 10.1021/bi00057a022; PACKHAM G, 1994, MOL CELL BIOL, V14, P5741, DOI 10.1128/MCB.14.9.5741; PAL JK, 1988, J CELL SCI, V90, P555; PETERS JM, 1994, J BIOL CHEM, V269, P7709; RIVETT AJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1165, DOI 10.1177/40.8.1619280; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; SHANNON JD, 1989, J BIOL CHEM, V264, P11575; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; SOLHONNE B, 1987, NEUROSCIENCE, V22, P225, DOI 10.1016/0306-4522(87)90212-0; TAKAHASHI SI, 1985, J ANTIBIOT, V38, P1767, DOI 10.7164/antibiotics.38.1767; TAKAHASHI SI, 1989, EXP CELL RES, V183, P399, DOI 10.1016/0014-4827(89)90400-X; TANAKA K, 1990, FEBS LETT, V271, P41, DOI 10.1016/0014-5793(90)80367-R; TANAKA K, 1989, J CELL PHYSIOL, V139, P34, DOI 10.1002/jcp.1041390107; TAYLOR A, 1993, TRENDS BIOCHEM SCI, V18, P167; WELLER M, 1994, EUR J IMMUNOL, V24, P1293, DOI 10.1002/eji.1830240608; ZWICKL P, 1992, BIOCHEMISTRY-US, V31, P964, DOI 10.1021/bi00119a004	53	165	171	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26931	26939		10.1074/jbc.270.45.26931	http://dx.doi.org/10.1074/jbc.270.45.26931			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592939	hybrid			2022-12-27	WOS:A1995TE58300039
J	KOBAYASHI, K; MORITA, S; SAWADA, H; MIZUGUCHI, T; YAMADA, K; NAGATSU, I; HATA, T; WATANABE, Y; FUJITA, K; NAGATSU, T				KOBAYASHI, K; MORITA, S; SAWADA, H; MIZUGUCHI, T; YAMADA, K; NAGATSU, I; HATA, T; WATANABE, Y; FUJITA, K; NAGATSU, T			TARGETED DISRUPTION OF THE TYROSINE-HYDROXYLASE LOCUS RESULTS IN SEVERE CATECHOLAMINE DEPLETION AND PERINATAL LETHALITY IN MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID DECARBOXYLASE; IMMUNO-CYTOCHEMICAL LOCALIZATION; DEPENDENT PROTEIN-KINASE; PRENATAL RAT-BRAIN; MANIC-DEPRESSION; MESSENGER-RNA; NORADRENERGIC PHENOTYPE; TRANSIENT EXPRESSION; TRANSGENIC MICE; ENTERIC NEURONS	Tyrosine 3-hydroxylase (TH, EC 1.14.16.2) catalyzes the first and rate-limiting step of the catecholamine biosynthetic pathway in the nervous and endocrine systems. The TH locus was disrupted in mouse embryonic stem cells by homologous recombination, Mice heterozygous for the TH mutation were apparently normal, In these mice, TH activity in the embryos and adult tissues was less than 50% of the wild-type values, but the catecholamine level was decreased only moderately in the developing animals and was maintained normally at adulthood, suggesting the presence of a regulatory mechanism for ensuring the proper catecholamine level during animal development, In contrast, the homozygous mutant mice died at a late stage of embryonic development or shortly after birth. Both TH mRNA and enzyme activity were lacking in the homozygous mutants, which thus explained the severe depletion of catecholamines. These changes, however, did not affect gross morphological development of the cells that normally express high catecholamine levels, Analysis of electrocardiograms of surviving newborn mutants showed bradycardia, suggesting an alteration of cardiac functions in the homozygous mice that may lead to the lethality of this mutation. In addition, transfer of a human TH transgene into the homozygous mice corrected the mutant phenotype, showing recovery of TH activity by expression of the human enzyme, These results indicate that TH is essential for survival of the animals during the late gestational development and after birth.	FUJITA HLTH UNIV, SCH MED, INST COMPREHENS MED SCI, TOYOAKE, AICHI 47011, JAPAN; FUJITA HLTH UNIV, SCH MED, DEPT ANAT, TOYOAKE, AICHI 47011, JAPAN; FUJITA HLTH UNIV, SCH MED, INST CARDIOVASC, TOYOAKE, AICHI 47011, JAPAN; CHUBU NATL HOSP, DEPT CLIN RES, AICHI 474, JAPAN	Fujita Health University; Fujita Health University; Fujita Health University				Kobayashi, Kazuto/0000-0002-7617-2939				ALBERT KA, 1984, P NATL ACAD SCI-BIOL, V81, P7713, DOI 10.1073/pnas.81.24.7713; ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; AXELROD J, 1966, PHARMACOL REV, V18, P95; AXELROD J, 1963, SCIENCE, V140, P499, DOI 10.1126/science.140.3566.499; BAETGE G, 1989, DEV BIOL, V132, P189, DOI 10.1016/0012-1606(89)90217-0; BAETGE G, 1990, DEV BIOL, V141, P353, DOI 10.1016/0012-1606(90)90391-U; BOHN MC, 1986, DEV BIOL, V114, P180, DOI 10.1016/0012-1606(86)90394-5; BOHN MC, 1982, DEV BIOL, V89, P299, DOI 10.1016/0012-1606(82)90319-0; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; BUDNIK V, 1987, J NEUROGENET, V4, P309, DOI 10.3109/01677068709102351; Buijs R.M., 1992, HDB CHEM NEUROANATOM, P63; BYERLEY W, 1992, HUM HERED, V42, P259, DOI 10.1159/000154079; CHRISTENSON JG, 1970, ARCH BIOCHEM BIOPHYS, V141, P356, DOI 10.1016/0003-9861(70)90144-X; COCHARD P, 1979, DEV BIOL, V71, P100, DOI 10.1016/0012-1606(79)90085-X; DETERAWADLEIGH SD, 1987, NATURE, V325, P806, DOI 10.1038/325806a0; DUMAS S, 1990, J NEUROSCI RES, V25, P569, DOI 10.1002/jnr.490250415; EISENHOFER G, 1989, J CLIN ENDOCR METAB, V68, P247, DOI 10.1210/jcem-68-2-247; FAXELIUS G, 1983, ARCH DIS CHILD, V58, P262, DOI 10.1136/adc.58.4.262; GILL M, 1988, J MED GENET, V25, P634, DOI 10.1136/jmg.25.9.634; GIZANGGINSBERG E, 1990, GENE DEV, V4, P477, DOI 10.1101/gad.4.4.477; HODGKINSON S, 1987, NATURE, V325, P805, DOI 10.1038/325805a0; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; ICARDLIEPKALNS C, 1992, J NEUROSCI RES, V32, P290, DOI 10.1002/jnr.490320219; IWATA N, 1992, BIOCHEM BIOPH RES CO, V182, P348, DOI 10.1016/S0006-291X(05)80151-2; JAVOYAGID F, 1990, NEUROSCIENCE, V38, P245, DOI 10.1016/0306-4522(90)90389-L; JONAKAIT GM, 1984, DEV BIOL, V101, P51, DOI 10.1016/0012-1606(84)90116-7; Jones CT., 1980, BIOGENIC AMINES DEV, P63; KANEDA N, 1991, NEURON, V6, P583, DOI 10.1016/0896-6273(91)90061-4; KOBAYASHI K, 1992, P NATL ACAD SCI USA, V89, P1631, DOI 10.1073/pnas.89.5.1631; KOBAYASHI K, 1988, J BIOCHEM, V103, P907, DOI 10.1093/oxfordjournals.jbchem.a122386; KOBAYASHI K, 1994, J BIOL CHEM, V269, P29725; KOBAYASHI K, 1988, FEBS LETT, V238, P431, DOI 10.1016/0014-5793(88)80526-X; LAUWERYNS JM, 1988, J HISTOCHEM CYTOCHEM, V36, P1181, DOI 10.1177/36.9.2900264; LEBLANC GG, 1989, DEV BIOL, V131, P44, DOI 10.1016/S0012-1606(89)80037-5; LEBOYER M, 1990, LANCET, V335, P1219, DOI 10.1016/0140-6736(90)92738-4; LEVITT M, 1965, J PHARMACOL EXP THER, V148, P1; LEWIS EJ, 1987, MOL CELL BIOL, V7, P3332, DOI 10.1128/MCB.7.9.3332; LEWIS EJ, 1987, P NATL ACAD SCI USA, V84, P3550, DOI 10.1073/pnas.84.11.3550; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MELIGENI JA, 1982, J BIOL CHEM, V257, P2632; MILLS E, 1986, AM J PHYSIOL, V250, pR188, DOI 10.1152/ajpregu.1986.250.2.R188; NAGATSU I, 1993, TEC BEHAV N 1, V11, P151; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Nagatsu T, 1984, Adv Neurol, V40, P467; NECKAMEYER WS, 1993, J NEUROGENET, V8, P189, DOI 10.3109/01677069309083448; OLIVER RE, 1981, ARCH DIS CHILD, V56, P659, DOI 10.1136/adc.56.9.659; PATTERSON PH, 1990, CELL, V62, P1035, DOI 10.1016/0092-8674(90)90379-S; PEARSE AGE, 1969, J HISTOCHEM CYTOCHEM, V17, P303, DOI 10.1177/17.5.303; RAHMAN MK, 1981, BIOCHEM PHARMACOL, V30, P645, DOI 10.1016/0006-2952(81)90139-8; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; SEIDLER FJ, 1985, J PHYSIOL-LONDON, V358, P1; SILVER M, 1980, BIOGENIC AMINES DEV, P147; SPECHT LA, 1981, J COMP NEUROL, V199, P255, DOI 10.1002/cne.901990208; SPECHT LA, 1981, J COMP NEUROL, V199, P233, DOI 10.1002/cne.901990207; TEITELMAN G, 1978, BRAIN RES, V158, P229, DOI 10.1016/0006-8993(78)90021-5; TEITELMAN G, 1983, J NEUROSCI, V3, P1379; TEITELMAN G, 1987, CELL TISSUE RES, V250, P435; VULLIET PR, 1985, FEBS LETT, V182, P335, DOI 10.1016/0014-5793(85)80328-8; VYAS S, 1990, EMBO J, V9, P3707, DOI 10.1002/j.1460-2075.1990.tb07583.x; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215; ZIMLICHMAN R, 1988, CLIN SCI, V75, P515, DOI 10.1042/cs0750515	63	178	184	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27235	27243		10.1074/jbc.270.45.27235	http://dx.doi.org/10.1074/jbc.270.45.27235			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592982	hybrid			2022-12-27	WOS:A1995TE58300082
J	MARTIN, BL; SCHRADERFISCHER, G; BUSCIGLIO, J; DUKE, M; PAGANETTI, P; YANKNER, BA				MARTIN, BL; SCHRADERFISCHER, G; BUSCIGLIO, J; DUKE, M; PAGANETTI, P; YANKNER, BA			INTRACELLULAR ACCUMULATION OF BETA-AMYLOID IN CELLS EXPRESSING THE SWEDISH MUTANT AMYLOID PRECURSOR PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ALZHEIMERS-DISEASE; MUTATION; PEPTIDE	beta-Amyloid (beta A) is a normal metabolic product of the amyloid precursor protein (APP) that accumulates in senile plaques in Alzheimer's disease. Cells that express the Swedish mutant APP (Sw-APP) associated with early onset Alzheimer's disease overproduce beta A, In this report, we show that expression of Sw-APP gives rise to cell-associated beta A, which is not detected in cells that express wild-type APP, Cell-associated beta A is rapidly generated, is trypsin-resistant, and is not derived from beta A uptake, indicating that it is generated from intracellular processing of Sw-APP, Intracellular and secreted beta A are produced with different kinetics, The generation of intracellular beta A is partially resistant to monensin and a 20 degrees C temperature block but is completely inhibited by brefeldin A, suggesting that it occurs in the Golgi complex, Monensin, brefeldin A, and a 20 degrees C temperature block almost completely inhibit beta A secretion without causing increased cellular retention of beta A, suggesting that secreted beta A is generated in a post-Golgi compartment, These results suggest that the metabolism of Sw-APP gives rise to intracellular and secreted forms of beta A through distinct processing pathways, Pathological conditions may therefore alter both the level and sites of accumulation of beta A It remains to be determined whether the intracellular form of beta A plays a role in the formation of amyloid plaques.	CHILDRENS HOSP,DEPT NEUROL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115; SANDOZ RES INST,CH-3001 BERN,SWITZERLAND	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Novartis; Sandoz			Paganetti, Paolo/AAF-8039-2020	Paganetti, Paolo/0000-0003-1896-6324	NIA NIH HHS [AG09229] Funding Source: Medline; NINDS NIH HHS [NS30352] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R29AG009229] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; GABUZDA D, 1994, J BIOL CHEM, V269, P13623; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAASS C, 1992, NATURE, V359, P325; HIGAKI J, 1995, NEURON, V14, P651, DOI 10.1016/0896-6273(95)90322-4; LO ACY, 1994, J BIOL CHEM, V269, P30966; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; PAGANETTI P, 1994, BRAIN RES, V633, P53, DOI 10.1016/0006-8993(94)91521-0; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; TARTAKOFF AM, 1983, CELL, V32, P1026, DOI 10.1016/0092-8674(83)90286-6; WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513; YAMAZAKI T, 1995, J CELL BIOL, V129, P431, DOI 10.1083/jcb.129.2.431; ZHONG ZY, 1994, J BIOL CHEM, V269, P12179	20	88	93	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26727	26730		10.1074/jbc.270.45.26727	http://dx.doi.org/10.1074/jbc.270.45.26727			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592902	hybrid			2022-12-27	WOS:A1995TE58300002
J	OBRIEN, LM; MEDVED, LV; FAY, PJ				OBRIEN, LM; MEDVED, LV; FAY, PJ			LOCALIZATION OF FACTOR IXA AND FACTOR VIIIA INTERACTIVE SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE FACTOR-VIII; GAMMA-CARBOXYGLUTAMIC ACID; ACTIVATED PROTEIN-C; FACTOR-X ACTIVATION; A1/A3-C1-C2 DIMER; MONOCLONAL-ANTIBODIES; DOMAIN INTERACTIONS; A2 SUBUNIT; THROMBIN; BINDING	The contribution of the catalytic and noncatalytic domains of factor Ma to the interaction with its cofactor, factor VIIIa, was evaluated, Two proteolytic fragments of factor Ma, lacking some or all of the serine protease domain, failed to mimic the ability of factor Ma to enhance the reconstitution of factor VIIIa from isolated A1/A3-C1-C2 dimer and A2 subunit. Both fragments, however, inhibited this factor Ma-dependent activity, Selective thermal denaturation of the factor Ma serine protease domain eliminated its effect on factor Villa reconstitution, Modification of factor IXa with dansyl-Glu-Gly-Arg chloromethyl ketone (DEGR-IXa) stabilized this domain, and heat-treated DEGR-IXa retained its ability to enhance factor VIIIa reconstitution. These results indicate the importance of the serine protease do main as well as structures residing in the factor Ma light chain (gamma-carboxyglutamic acid and/or epidermal growth factor domains) for cofactor stabilizing activity, In the presence of phospholipid, the A1/A3-C1-C2 dimer produced a saturable increase in the fluorescence anisotropy of fluorescein-Phe-Phe-Arg chloromethyl ketone-modified factor IXa (F1-FFR-IXa), This effect was inhibited by a factor Ma fragment comprised of the gamma-carboxyglutamic acid and epidermal growth factor domains, The difference in F1-FFR-IXa anisotropy in the presence of A1/A3-C1-C2 dimer (Delta r = 0.043) compared with factor VIIIa (Delta r = 0.069) represented the contribution of the A2 subunit, A peptide corresponding to factor VIII A2 domain residues 558-565 decreased the factor Villa dependent anisotropy of F1-FFR-IXa to a value similar to that observed with the A1/A3-C1-C2 dimer, These results support a model of multiple interactive sites in the association of the enzyme-cofactor complex and localize sites for the A1/A3-C1-C2 dimer and the A2 subunit to the factor Ma light chain and serine protease domain, respectively.	UNIV ROCHESTER,SCH MED & DENT,MED CTR,DEPT MED,HEMATOL UNIT,ROCHESTER,NY 14642; UNIV ROCHESTER,SCH MED & DENT,DEPT BIOCHEM,ROCHESTER,NY 14642; AMER RED CROSS,HOLLAND LAB,ROCKVILLE,MD 20855	University of Rochester; University of Rochester; American Red Cross				Medved, Leonid/0000-0002-3665-9849	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038199, P01HL030616] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 38199, HL 30616, HL-07152-20] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSSON LO, 1986, P NATL ACAD SCI USA, V83, P2979, DOI 10.1073/pnas.83.9.2979; ASTERMARK J, 1992, J BIOL CHEM, V267, P3249; BAJAJ SP, 1993, METHOD ENZYMOL, V222, P96; BAJAJ SP, 1985, J BIOL CHEM, V260, P1574; CASILLAS G, 1971, COAGULATION, V4, P107; CURTIS JE, 1994, J BIOL CHEM, V269, P6246; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DUFFY EJ, 1992, J BIOL CHEM, V267, P17006; EATON D, 1986, BIOCHEMISTRY-US, V25, P505, DOI 10.1021/bi00350a035; FASS DN, 1982, BLOOD, V59, P594; FAY PJ, 1993, J BIOL CHEM, V268, P17861; FAY PJ, 1994, J BIOL CHEM, V269, P20522; FAY PJ, 1991, J BIOL CHEM, V266, P20139; FAY PJ, 1992, J BIOL CHEM, V267, P13246; FAY PJ, 1991, J BIOL CHEM, V266, P8957; FAY PJ, 1986, BIOCHIM BIOPHYS ACTA, V871, P268, DOI 10.1016/0167-4838(86)90208-6; FOSTER PA, 1990, BLOOD, V75, P1999; FRAZIER D, 1989, BLOOD, V74, P971; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; HAMAGUCHI N, 1994, BLOOD, V84, P1837, DOI 10.1182/blood.V84.6.1837.bloodjournal8461837; HUGHES PE, 1993, J BIOL CHEM, V268, P17727; LAMPHEAR BJ, 1992, BLOOD, V80, P3120; LAMPHEAR BJ, 1992, J BIOL CHEM, V267, P3725; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; LIN SW, 1990, J BIOL CHEM, V265, P144; LOLLAR P, 1990, J BIOL CHEM, V265, P1688; LOLLAR P, 1984, ARCH BIOCHEM BIOPHYS, V233, P438, DOI 10.1016/0003-9861(84)90465-X; LOLLAR P, 1984, BLOOD, V63, P1303; LOLLAR P, 1991, J BIOL CHEM, V266, P12481; LOLLAR P, 1992, J BIOL CHEM, V267, P23652; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; MUTUCUMARANA VP, 1992, J BIOL CHEM, V267, P17012; NOVOKHATNY VV, 1993, J BIOL CHEM, V268, P17211; OBRIEN DP, 1992, BIOCHEMISTRY-US, V31, P2805, DOI 10.1021/bi00125a022; REGAN LM, 1995, J BIOL CHEM, V270, P8546, DOI 10.1074/jbc.270.15.8546; SCHWALBE RA, 1989, J BIOL CHEM, V264, P20288; THARAKAN J, 1990, VOX SANG, V58, P21, DOI 10.1111/j.1423-0410.1990.tb02050.x; TOOLE JJ, 1984, NATURE, V312, P330; TOOMEY JR, 1992, BIOCHEMISTRY-US, V31, P1806, DOI 10.1021/bi00121a031; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0; VYSOTCHIN A, 1993, J BIOL CHEM, V268, P8436; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0	43	52	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27087	27092		10.1074/jbc.270.45.27087	http://dx.doi.org/10.1074/jbc.270.45.27087			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592960	hybrid			2022-12-27	WOS:A1995TE58300060
J	PRASAD, ARK; DAILEY, HA				PRASAD, ARK; DAILEY, HA			EFFECT OF CELLULAR LOCATION ON THE FUNCTION OF FERROCHELATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTOPORPHYRINOGEN OXIDASE; SACCHAROMYCES-CEREVISIAE; PRECURSOR; MITOCHONDRIA; ORIENTATION; PROTEINS; SYNTHASE; SEQUENCE; LIVER; HEME	Ferrochelatase, the terminal enzyme of the heme biosynthetic pathway, is a nuclear encoded protein that is synthesized in the cytoplasm in a precursor form and then is translocated to the matrix side of the inner mitochondrial membrane, Since the product of the enzymatic reaction, protoheme IX, is utilized almost exclusively in the cytoplasmic compartment or on the cytoplasmic side of the inner mitochondrial membrane, it was of interest to determine if the intracellular location of ferrochelatase is crucial for its effective functioning, In a ferrochelatase-deficient strain of the yeast Saccharomyces cerevisiae vectors that coded for full-length ferrochelatase and a truncated form of the enzyme that lacked the mitochondrial targeting sequence were expressed, Both of these transformed cells produce approximately equal total amounts of ferrochelatase, as determined by enzyme assays and Western blot analysis, but only with the full-length construct was ferrochelatase properly localized. In cells containing the truncated construct, ferrochelatase activity was found in all membrane fractions but was not located on the matrix side of the inner mitochondrial membrane, Cells containing either construct produced heme, although the amount of heme synthesized by cells with the truncated construct was significantly less, Interestingly in cells with improperly localized ferrochelatase the amount of b-type cytochrome decreased by 80% as opposed to c- and a-type cytochromes where the decreases were only 60 and 40%, respectively.	UNIV GEORGIA,DEPT MICROBIOL,ATHENS,GA 30602; UNIV GEORGIA,CTR METALLOENZYME STUDIES,ATHENS,GA 30602	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK032303, R01DK035898, R01DK032303] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 32303, R56 DK032303, DK 35898] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADES IZ, 1981, J BIOL CHEM, V256, P9329; BORTHWICK IA, 1985, EUR J BIOCHEM, V150, P481, DOI 10.1111/j.1432-1033.1985.tb09047.x; CAMADRO JM, 1988, J BIOL CHEM, V263, P11675; Dailey H. A., 1990, BIOSYNTHESIS HEME CH, P123; DAILEY HA, 1983, J BIOL CHEM, V258, P1453; DAUM G, 1982, J BIOL CHEM, V257, P3028; DEYBACH JC, 1985, EUR J BIOCHEM, V149, P431, DOI 10.1111/j.1432-1033.1985.tb08943.x; FERREIRA GC, 1988, J BIOL CHEM, V263, P3835; Greenawalt J W, 1974, Methods Enzymol, V31, P310; HARBIN BM, 1985, BIOCHEMISTRY-US, V24, P366, DOI 10.1021/bi00323a019; Jordan PM, 1990, BIOSYNTHESIS HEME CH, P55; KARR SR, 1988, BIOCHEM J, V254, P799, DOI 10.1042/bj2540799; Labbe-Bois R, 1990, BIOSYNTHESIS HEME CH, P235; LABBEBOIS R, 1990, J BIOL CHEM, V265, P7278; ROISE D, 1988, J BIOL CHEM, V263, P4509; Towbin H, 1979, 10 1073 PNAS 76 9 43, V76, P4350, DOI [10.1073/pnas.76.9.4350, DOI 10.1073/PNAS.76.9.4350]; YAMAUCHI K, 1980, FEBS LETT, V115, P15, DOI 10.1016/0014-5793(80)80716-2	17	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18198	18200		10.1074/jbc.270.31.18198	http://dx.doi.org/10.1074/jbc.270.31.18198			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629135	hybrid			2022-12-27	WOS:A1995RM64200007
J	SMITH, T; FERREIRA, LR; HEBERT, C; NORRIS, K; SAUK, JJ				SMITH, T; FERREIRA, LR; HEBERT, C; NORRIS, K; SAUK, JJ			HSP47 AND CYCLOPHILIN-B TRAVERSE THE ENDOPLASMIC-RETICULUM WITH PROCOLLAGEN INTO PRE-GOLGI INTERMEDIATE VESICLES - A ROLE FOR HSP47 AND CYCLOPHILIN-B IN THE EXPORT OF PROCOLLAGEN FROM THE ENDOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS-ISOMERASE; SIGNAL RECOGNITION PARTICLE; COLLAGEN TRIPLE-HELIX; PROTEIN TRANSLOCATION; I PROCOLLAGEN; OSTEOGENESIS IMPERFECTA; THERMAL-STABILITY; SECRETORY PATHWAY; PEPTIDE-BONDS; ALPHA-CHAINS	Hsp47 and cyclophilin B (CyPB) are residents of the endoplasmic reticulum (ER), Both of these proteins are closely associated with polysome-associated alpha 1(I) procollagen chains, Hsp47 possesses chaperone properties early during the translation of procollagen while the cis/trans-isomerase properties of CyPB facilitate procollagen folding. In this report, we further investigate the interaction of these proteins with procollagen I during export from the ER. To inhibit vesicular budding and retain procollagen within the ER, cells were treated with the heterotrimeric G protein inhibitor mastoparan or calphostin C, a specific inhibitor of diacylglycerol/phorbol ester binding proteins. To arrest procollagen in pre Golgi intermediate vesicles, cells were treated with guanosine 5'-3-O-(thio)triphosphate. Pulse chase experiments of cells labeled with [S-35]methionine followed by immunoprecipitation during the chase period with anti-procollagen, anti-Hsp47, and anti-CyPB antibodies were performed to reveal the relationship between Hsp47/CyPB/procollagen I. The distribution of procollagen, Hsp47, and CS PB to the ER and/or pre-Golgi vesicles was verified by immunofluorescence. Hsp47 and CyPB remained associated with procollagen retained within the ER, Hsp47 and CyPB were also associated with procollagen exported from the ER into pre-Golgi intermediate vesicles. Treatment of cells with cyclosporin A diminished the levels of CyPB bound to procollagen and diminished the rate of Hsp47 released from procollagen and the rate of procollagen secretion, suggesting that Hsp47 release from procollagen may be driven by helix formation. Also, these studies suggest that Hsp47 may resemble protein disulfide isomerase and possess both chaperone and anti-chaperone properties. During translation, high levels of Hsp47 are seen to limit protein aggregation and facilitate chain registration, Later, Hsp47 and/or CS PB and protein disulfide isomerase act as anti-chaperones and provide the basis for concentration of procollagen for ER export.	UNIV MARYLAND, SCH DENT, DEPT PATHOL, BALTIMORE, MD 21201 USA	University System of Maryland; University of Maryland Baltimore				Sauk, John/0000-0002-9208-5739	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008648] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR41572] Funding Source: Medline; NIDCR NIH HHS [DE08648] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; BALCH W E, 1992, Current Biology, V2, P157, DOI 10.1016/0960-9822(92)90276-G; BALCH WE, 1994, CELL, V76, P841, DOI 10.1016/0092-8674(94)90359-X; BECKERS CJM, 1989, J CELL BIOL, V108, P1245, DOI 10.1083/jcb.108.4.1245; BERGMAN LW, 1977, BIOCHEMISTRY-US, V16, P4490, DOI 10.1021/bi00639a025; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BOREL JF, 1976, IMMUNOLOGY, V31, P631; BOSE S, 1994, BIOCHEM J, V300, P871, DOI 10.1042/bj3000871; CARONI P, 1991, J BIOL CHEM, V266, P10739; CHESSLER SD, 1992, J BIOL CHEM, V267, P7751; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; CONNERN CP, 1992, BIOCHEM J, V284, P381, DOI 10.1042/bj2840381; DAVIS JM, 1989, J BIOL CHEM, V264, P8956; FABBRI M, 1994, J BIOL CHEM, V269, P26848; FERREIRA LR, 1994, J CELL BIOCHEM, V56, P518, DOI 10.1002/jcb.240560412; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; HASEL KW, 1991, MOL CELL BIOL, V11, P3484, DOI 10.1128/MCB.11.7.3484; HIGH S, 1991, J CELL BIOL, V113, P35, DOI 10.1083/jcb.113.1.35; HOHMAN R J, 1990, New Biologist, V2, P663; KELLARIS KV, 1991, J CELL BIOL, V114, P21, DOI 10.1083/jcb.114.1.21; KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P3053, DOI 10.1021/bi00464a023; KIRK TZ, 1987, J BIOL CHEM, V262, P5540; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Mayne R., 1987, STRUCTURE FUNCTION C; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; MEYER DI, 1982, NATURE, V297, P647, DOI 10.1038/297647a0; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; PLUNTER H, 1992, J CELL BIOL, V119, P1097; PRICE ER, 1994, P NATL ACAD SCI USA, V91, P3931, DOI 10.1073/pnas.91.9.3931; PUIG A, 1994, J BIOL CHEM, V269, P7764; QUESNIAUX VFJ, 1987, EUR J IMMUNOL, V17, P1359, DOI 10.1002/eji.1830170921; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SARKAR SK, 1984, P NATL ACAD SCI-BIOL, V81, P4800, DOI 10.1073/pnas.81.15.4800; SAUK JJ, 1994, J BIOL CHEM, V269, P3941; SAUK JJ, 1990, BIOCHEM BIOPH RES CO, V172, P135, DOI 10.1016/S0006-291X(05)80183-4; Schmid Sandra L., 1993, Trends in Cell Biology, V3, P145, DOI 10.1016/0962-8924(93)90129-O; SCHONBRUNNER ER, 1992, P NATL ACAD SCI USA, V89, P4510, DOI 10.1073/pnas.89.10.4510; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; SCHWANINGER R, 1992, J CELL BIOL, V119, P1077, DOI 10.1083/jcb.119.5.1077; SHROFF B, 1993, CONNECT TISSUE RES, V29, P273, DOI 10.3109/03008209309016833; SIEKIERKA JJ, 1989, J IMMUNOL, V143, P1580; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; SPIK G, 1991, J BIOL CHEM, V266, P10735; Stamnes MA, 1990, CURR OPIN CELL BIOL, V2, P1104, DOI 10.1016/0955-0674(90)90163-9; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557; YOKOI H, 1993, BIOCHEM BIOPH RES CO, V195, P769, DOI 10.1006/bbrc.1993.2112	54	107	109	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18323	18328		10.1074/jbc.270.31.18323	http://dx.doi.org/10.1074/jbc.270.31.18323			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629154	hybrid			2022-12-27	WOS:A1995RM64200029
J	TRINKLEMULCAHY, L; ICHIKAWA, K; HARTSHORNE, DJ; SIEGMAN, MJ; BUTLER, TM				TRINKLEMULCAHY, L; ICHIKAWA, K; HARTSHORNE, DJ; SIEGMAN, MJ; BUTLER, TM			THIOPHOSPHORYLATION OF THE 130-KDA SUBUNIT IS ASSOCIATED WITH A DECREASED ACTIVITY OF MYOSIN LIGHT-CHAIN PHOSPHATASE IN ALPHA-TOXIN-PERMEABILIZED SMOOTH-MUSCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CA-2+ SENSITIVITY; PROTEIN; PHOSPHORYLATION; CALCIUM; CONTRACTION; MODULATION; INHIBITION; GIZZARD; ARTERY	Pretreatment of alpha-toxin-permeabilized smooth muscle with ATP gamma S (adenosine 5'-O-(thiotriphosphate)) under conditions resulting in minimal (<1%) thiophosphorylation of the myosin light chain increases the subsequent calcium sensitivity of force output and myosin light chain phosphorylation, The change in calcium sensitivity results at least in part from a 5-fold decrease in myosin light chain phosphatase activity, One of the few proteins thiophosphorylated under these conditions is the 130-kDa subunit of myosin light chain phosphatase. These results suggest that thiophosphorylation of this subunit leads to a decrease in the activity of the phosphatase, and that phosphorylation and dephosphorylation of the subunit may play a role in regulating myosin light chain phosphatase activity.	THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT PHYSIOL,PHILADELPHIA,PA 19107; UNIV ARIZONA,MUSCLE BIOL GRP,TUCSON,AZ 85721	Jefferson University; University of Arizona					NHLBI NIH HHS [HL-50586, HL-23615, HL-20984] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050586, R01HL023615, P01HL020984] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; BOLLEN M, 1992, CRIT REV BIOCHEM MOL, V27, P227, DOI 10.3109/10409239209082564; BUTLER TM, 1983, AM J PHYSIOL, V244, pC234, DOI 10.1152/ajpcell.1983.244.3.C234; CHEN YH, 1994, FEBS LETT, V356, P51, DOI 10.1016/0014-5793(94)01231-8; CRICHTON CA, 1990, J PHYSL, V437, P543; FUJIWARA T, 1989, J PHYSIOL-LONDON, V408, P535, DOI 10.1113/jphysiol.1989.sp017474; GONG MC, 1992, J BIOL CHEM, V267, P21492; GRATECOS D, 1974, BIOCHEM BIOPH RES CO, V58, P960, DOI 10.1016/S0006-291X(74)80237-8; HIMPENS B, 1990, PFLUG ARCH EUR J PHY, V417, P21, DOI 10.1007/BF00370764; HOAR PE, 1979, SCIENCE, V204, P503, DOI 10.1126/science.432654; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; ITO M, 1989, BIOCHEMISTRY-US, V28, P5567, DOI 10.1021/bi00439a034; KITAZAWA T, 1991, P NATL ACAD SCI USA, V88, P9307, DOI 10.1073/pnas.88.20.9307; KITAZAWA T, 1991, J BIOL CHEM, V266, P1708; KITAZAWA T, 1989, J BIOL CHEM, V264, P5339; KOBAYASHI S, 1989, J BIOL CHEM, V264, P17997; KUBOTA Y, 1992, AM J PHYSIOL, V262, pC405, DOI 10.1152/ajpcell.1992.262.2.C405; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MASUO M, 1994, J GEN PHYSIOL, V104, P265, DOI 10.1085/jgp.104.2.265; MORGAN JP, 1984, J PHYSIOL-LONDON, V351, P155, DOI 10.1113/jphysiol.1984.sp015239; NISHIMURA J, 1988, BIOCHEM BIOPH RES CO, V157, P677, DOI 10.1016/S0006-291X(88)80303-6; SAITOH M, 1987, J BIOL CHEM, V262, P7796; SHERRY JMF, 1978, BIOCHEMISTRY-US, V17, P4411, DOI 10.1021/bi00614a009; SHIMIZU H, 1994, J BIOL CHEM, V269, P30407; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; TRINKLEMULCAHY L, 1994, AM J PHYSIOL, V266, pC1673, DOI 10.1152/ajpcell.1994.266.6.C1673; VINCENT M, 1991, J MOL CELL CARDIOL, V23, P873, DOI 10.1016/0022-2828(91)90220-G	28	92	93	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18191	18194		10.1074/jbc.270.31.18191	http://dx.doi.org/10.1074/jbc.270.31.18191			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629133	hybrid			2022-12-27	WOS:A1995RM64200005
J	CHEN, CG; XUE, JC; ZHU, JM; CHEN, YW; KUNAPULI, S; DERIEL, JK; LIUCHEN, LY				CHEN, CG; XUE, JC; ZHU, JM; CHEN, YW; KUNAPULI, S; DERIEL, JK; LIUCHEN, LY			CHARACTERIZATION OF IRREVERSIBLE BINDING OF BETA-FUNALTREXAMINE TO THE CLONED RAT MU-OPIOID RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUINEA-PIG BRAIN; OPIATE RECEPTOR; MOLECULAR-CLONING; HUMAN-PLATELET; EXPRESSION; SITE; MEMBRANES; COMPLEX; CELLS; ACID	Binding of beta-funaltrexamine (beta-FNA) to the cloned rat mu opioid receptor expressed in COS-1 cells or Chinese hamster ovary cells was examined. beta-FNA bound to the mu receptor with high affinity. Irreversible binding of [H-3]beta-FNA was defined as the binding that could not be dissociated by trichloroacetic acid. Na+ greatly enhanced the specific irreversible binding of [H-3]beta-FNA to the mu receptor, which was concentration- and time-dependent. Specific irreversible binding of [H-3]beta-FNA was potently inhibited by CTAP (a mu ligand), but not by ICI174,864 (a delta ligand) or U50,488H (a kappa ligand). These results indicate that [H-3]beta-FNA binds irreversibly to the cloned mu opioid receptor. SDS-polyacrylamide gel electrophoresis and fluorography showed that [H-3]beta-FNA-labeled receptors migrated as one broad and diffuse band with a mass of 80 kDa in Chinese hamster ovary or COS cells and as one band with a mass of 67 kDa in the rat brain preparation. Upon removal of N-linked carbohydrates, labeled receptors became a sharper band with a mass of similar to 40 kDa, [H-3]beta-FNA did not bind irreversibly to the cloned rat kappa receptor. [H-3]beta-FNA binding to four chimeric mu/kappa receptors was examined, The region from the middle of the third intracellular loop to the C terminus of the mu receptor is necessary for irreversible binding of beta-FNA.	TEMPLE UNIV,SCH MED,DEPT PHARMACOL,PHILADELPHIA,PA 19140; TEMPLE UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,PHILADELPHIA,PA 19140; TEMPLE UNIV,SCH MED,FELS INST MOLEC BIOL & CANC RES,PHILADELPHIA,PA 19140; INDIANA UNIV,SCH MED,DEPT MED & MOLEC GENET,INDIANAPOLIS,IN 46202	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Indiana University System; Indiana University-Purdue University Indianapolis					NIDA NIH HHS [DA 04745] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R29DA004745, R01DA004745] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ACKERS GK, 1985, ANNU REV BIOCHEM, V54, P597, DOI 10.1146/annurev.bi.54.070185.003121; BARE LA, 1994, FEBS LETT, V354, P213, DOI 10.1016/0014-5793(94)01129-X; BUNZOW JR, 1995, J NEUROCHEM, V64, P14; CHEN Y, 1993, MOL PHARMACOL, V44, P8; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FRANKLIN TG, 1991, BRIT J PHARMACOL, V102, P718, DOI 10.1111/j.1476-5381.1991.tb12239.x; FUKUDA K, 1993, FEBS LETT, V327, P311, DOI 10.1016/0014-5793(93)81011-N; KONG HY, 1994, P NATL ACAD SCI USA, V91, P8042, DOI 10.1073/pnas.91.17.8042; LAW PY, 1985, BIOCHEM PHARMACOL, V34, P9, DOI 10.1016/0006-2952(85)90093-0; LI SX, 1993, BIOCHEM J, V295, P629, DOI 10.1042/bj2950629; LIUCHEN LY, 1993, MOL PHARMACOL, V44, P749; LIUCHEN LY, 1990, MOL PHARMACOL, V37, P243; LIUCHEN LY, 1987, MOL PHARMACOL, V32, P321; LIUCHEN LY, 1991, BRAIN RES, V544, P235, DOI 10.1016/0006-8993(91)90059-5; MATSUI H, 1989, BIOCHEMISTRY-US, V28, P4125, DOI 10.1021/bi00435a075; ONOGI T, 1995, FEBS LETT, V357, P93, DOI 10.1016/0014-5793(94)01341-W; PASTERNAK GW, 1974, MOL PHARMACOL, V10, P183; PASTERNAK GW, 1988, OPIATE RECEPTORS; PORTOGHESE PS, 1980, J MED CHEM, V23, P233, DOI 10.1021/jm00177a002; RECHT LD, 1987, EUR J PHARMACOL, V140, P209, DOI 10.1016/0014-2999(87)90807-7; REGAN JW, 1986, BIOCHEM BIOPH RES CO, V137, P606, DOI 10.1016/0006-291X(86)91121-6; ROTHMAN RB, 1988, J PHARMACOL EXP THER, V247, P405; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SURRATT CK, 1994, J BIOL CHEM, V269, P20548; TAKEMORI AE, 1985, ANNU REV PHARMACOL, V25, P193; TAM SW, 1986, J PHARMACOL EXP THER, V239, P351; THOMPSON RC, 1993, NEURON, V11, P903, DOI 10.1016/0896-6273(93)90120-G; TOLL L, 1992, J PHARMACOL EXP THER, V260, P9; WANG JB, 1993, P NATL ACAD SCI USA, V90, P10230, DOI 10.1073/pnas.90.21.10230; WANG JB, 1994, FEBS LETT, V338, P217, DOI 10.1016/0014-5793(94)80368-4; WANG JB, 1994, J BIOL CHEM, V269, P25966; XUE JC, 1995, J BIOL CHEM, V270, P12977; XUE JC, 1994, J BIOL CHEM, V269, P30195	33	58	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17866	17870		10.1074/jbc.270.30.17866	http://dx.doi.org/10.1074/jbc.270.30.17866			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629089	hybrid			2022-12-27	WOS:A1995RM26600037
J	JAGIELLO, I; BEULLENS, M; STALMANS, W; BOLLEN, M				JAGIELLO, I; BEULLENS, M; STALMANS, W; BOLLEN, M			SUBUNIT STRUCTURE AND REGULATION OF PROTEIN PHOSPHATASE-1 IN RAT-LIVER NUCLEI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; INHIBITORY POLYPEPTIDES; KINASE-A	The activity of protein phosphatase-1 in rat liver nuclei (PP-1N) was decreased by up to 97% by associated inhibitory polypeptides, depending on the assay and extraction conditions. These inhibitors were rapidly degraded by endogenous proteases, resulting in the accumulation of active heat stable intermediates. Two major species of PP-1N could be differentiated by fractionation of a nuclear extract. PP-1N(R111) contained, besides the delta-isoform of the catalytic subunit, an inhibitory polypeptide of 111 kDa, PP-1N(R41) was found to be an inactive heterodimer between the delta-isoform of the catalytic subunit and NIPP-1, a nuclear inhibitor of PP-1, which in its undegraded form is heat labile and migrates during SDS-polyacrylamide gel electrophoresis as a polypeptide of 41 kDa. Native hepatic NIPP-1 displayed a reduced affinity for the catalytic subunit after phosphorylation by protein kinase A in vitro and after glucagon-induced phosphorylation in vivo.	CATHOLIC UNIV LEUVEN,FAC GENEESHUNDE,AFDELING BIOCHEM,B-3000 LOUVAIN,BELGIUM	KU Leuven								AGOSTINIS P, 1992, EUR J BIOCHEM, V205, P241, DOI 10.1111/j.1432-1033.1992.tb16774.x; ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; ANTONIW JF, 1977, BIOCHEM J, V162, P423, DOI 10.1042/bj1620423; BEULLENS M, 1993, J BIOL CHEM, V268, P13172; BEULLENS M, 1992, J BIOL CHEM, V267, P16538; BLOBEL G, 1966, SCIENCE, V154, P1662, DOI 10.1126/science.154.3757.1662; BOLLEN M, 1992, CRIT REV BIOCHEM MOL, V27, P227, DOI 10.3109/10409239209082564; BOLLEN M, 1993, ADV PROTEIN PHOSPHAT, V7, P31; BRAUTIGAN DL, 1990, NATURE, V344, P74, DOI 10.1038/344074a0; CARDINALI B, 1994, FEBS LETT, V352, P276, DOI 10.1016/0014-5793(94)00973-2; CRESSMAN DE, 1994, J BIOL CHEM, V269, P26594; DEGUZMAN A, 1988, METHOD ENZYMOL, V159, P356; DEPAOLIROACH AA, 1994, ADV ENZYME REGUL, V34, P199, DOI 10.1016/0065-2571(94)90017-5; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; FISCHER EDMOND H., 1958, JOUR BIOL CHEM, V231, P65; GOODWIN GH, 1973, EUR J BIOCHEM, V38, P14, DOI 10.1111/j.1432-1033.1973.tb03026.x; JAKES S, 1986, BIOCHIM BIOPHYS ACTA, V888, P135, DOI 10.1016/0167-4889(86)90079-0; JESSUS C, 1989, BIOCHEM J, V260, P45, DOI 10.1042/bj2600045; KURET J, 1986, FEBS LETT, V230, P197; MERCIER JC, 1968, B SOC CHIM BIOL, V50, P521; MERMOUD JE, 1994, EMBO J, V13, P5679, DOI 10.1002/j.1460-2075.1994.tb06906.x; OHKURA H, 1991, CELL, V64, P149, DOI 10.1016/0092-8674(91)90216-L; RIVETT AJ, 1993, BIOCHEM J, V291, P1; SOLA MM, 1991, BIOCHIM BIOPHYS ACTA, V1094, P211, DOI 10.1016/0167-4889(91)90011-L; STONE EM, 1993, CURR BIOL, V3, P13, DOI 10.1016/0960-9822(93)90140-J; VAN EYNDE A, 1994, BIOCHEM J, V297, P447, DOI 10.1042/bj2970447; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; WAELKENS E, 1987, J BIOL CHEM, V262, P1049; WALTER G, 1993, BIOCHIM BIOPHYS ACTA, V1155, P207, DOI 10.1016/0304-419X(93)90005-W; YANG SD, 1981, FEBS LETT, V132, P289; ZHANG ZJ, 1993, ARCH BIOCHEM BIOPHYS, V303, P402, DOI 10.1006/abbi.1993.1301	31	91	92	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17257	17263		10.1074/jbc.270.29.17257	http://dx.doi.org/10.1074/jbc.270.29.17257			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615525	hybrid			2022-12-27	WOS:A1995RK68900033
J	KIKUCHI, K; YAMASHITA, M; WATABE, S; AIDA, K				KIKUCHI, K; YAMASHITA, M; WATABE, S; AIDA, K			THE WARM TEMPERATURE ACCLIMATION-RELATED 65-KDA PROTEIN, WAP65, IN GOLDFISH AND ITS GENE-EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEMOPEXIN; MYOFIBRILLAR ATPASE; SEQUENCE; CARP; MECHANISMS	cDNAs encoding a warm temperature acclimation-related protein (Wap65) were cloned from the muscle and hepatopancreas cDNA libraries of the warm temperature-acclimated goldfish Carassius auratus, and their nucleotide sequences containing 5'- and 3'-noncoding regions together with their polyadenylation signal were determined, The deduced amino acid sequence of Wap65 was 31% homologous to rat hemopexin, However, goldfish Wap65 lacked a few possible glycosylation sites and presumed functional histidine residues, implying that it may have different functions from hemopexin, Wap65 contained a leader peptide of 30 amino acids and a mature protein region of 415 amino acids, Southern blot analysis demonstrated that the protein is expressed by a single copy gene in the goldfish haploid genome, In RNA blot analysis using isolated cDNA clones, a single transcript of about 2.0 kilobases was detected in the hepatopancreas but not in brain, muscle, or hemocytes, The abundancy of this transcript markedly increased in the hepatopancreas as a result of warm temperature acclimation, Electrophoretic analysis of plasma proteins revealed a good correlation of plasma Wap65 levels to those of the corresponding transcript in the hepatopancreas, suggesting that serum Wap65 concentrations are regulated mainly by transcript levels in the hepato pancreas via the secretion process.	UNIV TOKYO, FAC AGR, MARINE BIOCHEM LAB, BUNKYO KU, TOKYO 113, JAPAN; UNIV TOKYO, FAC AGR, FISH PHYSIOL LAB, BUNKYO KU, TOKYO 113, JAPAN; NATL RES INST FISHERIES SCI, YOKOHAMA, KANAGAWA 236, JAPAN	University of Tokyo; University of Tokyo; Japan Fisheries Research & Education Agency (FRA)								ALTRUDA F, 1985, NUCLEIC ACIDS RES, V13, P3841, DOI 10.1093/nar/13.11.3841; BARNES WM, 1983, METHOD ENZYMOL, V101, P98; GERLACH GF, 1990, AM J PHYSIOL, V259, pR237, DOI 10.1152/ajpregu.1990.259.2.R237; GROSS-BELLARD MM, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x; GUO XF, 1994, J BIOCHEM-TOKYO, V116, P728, DOI 10.1093/oxfordjournals.jbchem.a124588; HAZEL JR, 1974, PHYSIOL REV, V54, P620, DOI 10.1152/physrev.1974.54.3.620; HEAP SP, 1985, J FISH BIOL, V26, P733, DOI 10.1111/j.1095-8649.1985.tb04313.x; HWANG GC, 1990, J COMP PHYSIOL B, V160, P233, DOI 10.1007/BF00302588; JENNE D, 1987, BIOCHEMISTRY-US, V26, P6735, DOI 10.1021/bi00395a024; JOHNSTON IA, 1975, FEBS LETT, V50, P293, DOI 10.1016/0014-5793(75)80512-6; KIKUCHI K, 1993, J COMP PHYSIOL B, V163, P349; KOJ A, 1974, STRUCTURE FUNCTION P, V1, P73; KUSHNER I, 1988, METHOD ENZYMOL, V163, P373; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Morimoto RI, 1990, STRESS PROTEINS BIOL; Muller- Eberhard U, 1974, STRUCTURE FUNCTION P, V1, ppp; MULLEREBERHARD M, 1983, METHOD ENZYMOL, V101, P536; NIKKILA H, 1991, BIOCHEMISTRY-US, V30, P823, DOI 10.1021/bi00217a036; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; POLI V, 1989, P NATL ACAD SCI USA, V86, P8202, DOI 10.1073/pnas.86.21.8202; Sambrook J, 1989, MOL CLONING LABORATO; SATOH T, 1994, P NATL ACAD SCI USA, V91, P8423, DOI 10.1073/pnas.91.18.8423; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P73, DOI 10.1073/pnas.82.1.73; TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P2021, DOI 10.1073/pnas.81.7.2021; WATABE S, 1993, NIPPON SUISAN GAKK, V59, P151; WATABE S, 1995, BIOCHEM BIOPH RES CO, V208, P118, DOI 10.1006/bbrc.1995.1313; WATABE S, 1992, J BIOCHEM-TOKYO, V111, P113, DOI 10.1093/oxfordjournals.jbchem.a123706	27	69	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17087	17092		10.1074/jbc.270.29.17087	http://dx.doi.org/10.1074/jbc.270.29.17087			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615502	hybrid			2022-12-27	WOS:A1995RK68900009
J	LOHI, J; KESKIOJA, J				LOHI, J; KESKIOJA, J			CALCIUM IONOPHORES DECREASE PERICELLULAR GELATINOLYTIC ACTIVITY VIA INHIBITION OF 92-KDA GELATINASE EXPRESSION AND DECREASE OF 72-KDA GELATINASE ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORMING GROWTH FACTOR-BETA-1; SKIN FIBROBLAST PROCOLLAGENASE; PHORBOL-MYRISTATE ACETATE; IV COLLAGENASE GENE; SYNOVIAL FIBROBLASTS; MATRIX METALLOPROTEINASES; INTERSTITIAL COLLAGENASE; CULTURED FIBROBLASTS; ENDOGENOUS ACTIVATION; RIBONUCLEIC-ACID	To understand the roles of intracellular calcium levels on gelatinase/type IV collagenase expression, we analyzed the effects of calcium ionophores on the expression of 92- and 72-kDa gelatinases (MMP-9 and MMP-2) in human fibrosarcoma cells (HT-1080). Calcium ionophores ionomycin and A23187 reduced the levels of pericellular gelatinolytic activity in both untreated and phorbol 12-myristate 13-acetate (PMA) or tumor necrosis factor-alpha (TNF alpha)-stimulated cells as determined by degradation of radiolabeled gelatin. Gelatin zymography and immunoblotting revealed a dose-dependent decrease in the levels of secreted 92-kDa gelatinase, which was paralleled by a decrease of its mRNA. Treatment of cells with thapsigargin caused similar decreases of 92-kDa gelatinase mRNA and protein. The decrease of 99-kDa gelatinase expression was due to lower transcription rate as determined by transfection assays with 92-kDa gelatinase/luciferase construct. The expression of 72-kDa gelatinase was only slightly decreased by ionophores. Treatment of HT-1080 cells with PMA, TNF alpha, or concanavalin A resulted in the conversion of 72-kDa gelatinase proenzyme to its presumed 64- and 62-kDa active forms as determined by gelatin zymography and immunoblotting. Simultaneous treatment with the ionophores or thapsigarin resulted in inhibition of PMA-induced gelatinase activation. The expression of membrane-type matrix metalloproteinase, a potential activator of 72-kDa gelatinase, was not affected by ionophores. The results indicate that calcium ionophores decrease gelatinolysis by repressing both the expression of 92-kDa gelatinase and the activation of the 72-kDa gelatinase.	UNIV HELSINKI,DEPT VIROL,SF-00290 HELSINKI,FINLAND; UNIV HELSINKI,DEPT DERMATOL & VENEROL,SF-00290 HELSINKI,FINLAND	University of Helsinki; University of Helsinki								BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; BRINCKERHOFF CE, 1982, BIOCHEMISTRY-US, V21, P2674, DOI 10.1021/bi00540a015; BRINCKERHOFF CE, 1981, BIOCHIM BIOPHYS ACTA, V677, P424, DOI 10.1016/0304-4165(81)90256-7; BROWN PD, 1990, CANCER RES, V50, P6184; BROWN PD, 1993, KIDNEY INT, V43, P163, DOI 10.1038/ki.1993.27; CAO J, 1995, J BIOL CHEM, V270, P801, DOI 10.1074/jbc.270.2.801; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; CONCA W, 1989, J CLIN INVEST, V83, P1753, DOI 10.1172/JCI114077; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GAIRE M, 1994, J BIOL CHEM, V269, P2032; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; GRANT GA, 1987, J BIOL CHEM, V262, P5886; HE CS, 1989, P NATL ACAD SCI USA, V86, P2632, DOI 10.1073/pnas.86.8.2632; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; HUHTALA P, 1990, J BIOL CHEM, V265, P11077; HUHTALA P, 1991, J BIOL CHEM, V266, P16485; KESKIOJA J, 1992, EXP CELL RES, V202, P471, DOI 10.1016/0014-4827(92)90101-D; Kleiner DE, 1993, CURR OPIN CELL BIOL, V5, P891, DOI 10.1016/0955-0674(93)90040-W; KOHN EC, 1994, J BIOL CHEM, V269, P21505; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOHI J, 1992, J CELL BIOCHEM, V50, P337, DOI 10.1002/jcb.240500402; Lohi Jouko, 1994, Matrix Biology, V14, P421, DOI 10.1016/0945-053X(94)90171-6; MACNAUL KL, 1990, J BIOL CHEM, V265, P17238; MAINARDI CL, 1984, COLLAGEN REL RES, V4, P479; MATRISIAN LM, 1986, MOL CELL BIOL, V5, P1679; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; OKADA Y, 1990, EUR J BIOCHEM, V194, P721, DOI 10.1111/j.1432-1033.1990.tb19462.x; OVERALL CM, 1990, J BIOL CHEM, V265, P21141; POSTLETHWAITE AE, 1983, J EXP MED, V157, P801, DOI 10.1084/jem.157.2.801; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; REPONEN P, 1994, J CELL BIOL, V124, P1091, DOI 10.1083/jcb.124.6.1091; REPONEN P, 1995, DEV DYNAM, V202, P388, DOI 10.1002/aja.1002020408; RODLAND KD, 1992, J INVEST DERMATOL, V98, pS12, DOI 10.1111/1523-1747.ep12462100; SAARIALHOKERE UK, 1993, J BIOL CHEM, V268, P17354; SAARINEN J, 1994, J BIOL CHEM, V268, P18134; SALO T, 1991, J BIOL CHEM, V266, P11436; Sambrook J, 1989, MOL CLONING LABORATO; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; SATO H, 1993, ONCOGENE, V8, P395; STRICKLIN GP, 1983, BIOCHEMISTRY-US, V22, P61, DOI 10.1021/bi00270a009; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; STRONGIN AY, 1993, J BIOL CHEM, V268, P14033; TAIPALE J, 1992, J BIOL CHEM, V267, P25378; TRYGGVASON K, 1990, CELL DIFFER DEV, V32, P307, DOI 10.1016/0922-3371(90)90044-W; UNEMORI EN, 1988, J BIOL CHEM, V263, P16252; WHITFIELD J F, 1992, Critical Reviews in Oncogenesis, V3, P55; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; XU D, 1994, CELL, V78, P473, DOI 10.1016/0092-8674(94)90425-1	53	55	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17602	17609		10.1074/jbc.270.29.17602	http://dx.doi.org/10.1074/jbc.270.29.17602			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615567	hybrid			2022-12-27	WOS:A1995RK68900084
J	PINES, G; ZHANG, YM; KANNER, BI				PINES, G; ZHANG, YM; KANNER, BI			GLUTAMATE-404 IS INVOLVED IN THE SUBSTRATE DISCRIMINATION OF GLT-1, A (NA++K+)-COUPLED GLUTAMATE TRANSPORTER FROM RAT-BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; ESCHERICHIA-COLI; LACTOSE PERMEASE; HIGH-AFFINITY; EXPRESSION; PROTEIN; ASPARTATE; CLONING; CARRIER; GENE	Sodium coupled glutamate transporters, located in the plasma membrane of nerve terminals and glial processes, serve to keep its extracellular glutamate concentration below extracellular levels. Moreover, they help in conjunction with diffusion to terminate the transmitter's action in synaptic transmission. We have investigated the role of negatively charged amino acid residues of GLT-1, a cloned (Na+ + K+)-coupled glutamate transporter from rat brain. Using site-directed mutagenesis we modified these negative residues, which are located in hydrophobic surroundings and are highly conserved within the glutamate transporter family. Out of five residues meeting these criteria, three, aspartate 398, glutamate 404, and aspartate 470, are critical for heterologously expressed glutamate transport, This defective transport cannot be attributed to the mere requirement of a negative charge at these positions. After prelabeling of the proteins with [S-35]methionine, immunoprecipitation of all mutant transporters indicates that their expression levels are similar to that of wild type. No cryptic activity was revealed by reconstitution experiments aimed to monitor the activity of transporter molecules not located in the plasma membrane, Significantly, whereas all of the mutants at the glutamate 404 position exhibit impaired transport of glutamate, they possess considerable transport of D- and L-aspartate, up to 80% of wild type values. Binding of glutamate is not impaired in these mutants, Our observations indicate that the glutamate 404 residue may be located in the vicinity of the glutamate-aspartate permeation pathway.	HEBREW UNIV JERUSALEM, HADASSAH MED SCH, DEPT BIOCHEM, IL-91120 JERUSALEM, ISRAEL	Hebrew University of Jerusalem								Amara S G, 1993, Curr Opin Neurobiol, V3, P337, DOI 10.1016/0959-4388(93)90126-J; ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; BARBOUR B, 1991, J PHYSIOL-LONDON, V436, P169, DOI 10.1113/jphysiol.1991.sp018545; BOUVIER M, 1992, NATURE, V360, P471, DOI 10.1038/360471a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASADO M, 1993, J BIOL CHEM, V268, P27313; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; DANBOLT NC, 1990, BIOCHEMISTRY-US, V29, P6734, DOI 10.1021/bi00480a025; DUNTEN RL, 1993, BIOCHEMISTRY-US, V22, P3138; FOLCH J, 1957, J BIOL CHEM, V226, P497; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GRUNEWALD M, 1995, J BIOL CHEM, V270, P17017, DOI 10.1074/jbc.270.28.17017; IGO RP, 1995, BBA-BIOMEMBRANES, V1233, P153, DOI 10.1016/0005-2736(94)00246-L; JIANG J, 1989, J BACTERIOL, V171, P5244, DOI 10.1128/jb.171.10.5244-5253.1989; KANAI Y, 1993, TRENDS NEUROSCI, V16, P365, DOI 10.1016/0166-2236(93)90094-3; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1987, CRIT REV BIOCHEM MOL, V22, P1, DOI 10.3109/10409238709082546; KANNER BI, 1993, FEBS LETT, V325, P95, DOI 10.1016/0014-5793(93)81421-U; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KING SC, 1991, BIOCHIM BIOPHYS ACTA, V1062, P177, DOI 10.1016/0005-2736(91)90390-T; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; POCOCK JM, 1988, J NEUROCHEM, V50, P745, DOI 10.1111/j.1471-4159.1988.tb02977.x; SAHINTOTH M, 1993, BIOCHEMISTRY-US, V32, P10027, DOI 10.1021/bi00089a019; SAHINTOTH M, 1992, P NATL ACAD SCI USA, V89, P10547, DOI 10.1073/pnas.89.21.10547; SHAFQAT S, 1993, J BIOL CHEM, V268, P15351; STALLCUP WB, 1979, J NEUROCHEM, V32, P57, DOI 10.1111/j.1471-4159.1979.tb04509.x; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; TOLNER B, 1992, J BACTERIOL, V174, P2391, DOI 10.1128/JB.174.7.2391-2393.1992; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; WADICHE JI, 1995, IN PRESS NEURON; ZHANG YM, 1994, J BIOL CHEM, V269, P19573	41	74	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17093	17097		10.1074/jbc.270.29.17093	http://dx.doi.org/10.1074/jbc.270.29.17093			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615503	hybrid			2022-12-27	WOS:A1995RK68900010
J	WONG, SC; PROEFKE, SA; BHUSHAN, A; MATHERLY, LH				WONG, SC; PROEFKE, SA; BHUSHAN, A; MATHERLY, LH			ISOLATION OF HUMAN CDNAS THAT RESTORE METHOTREXATE SENSITIVITY AND REDUCED FOLATE CARRIER ACTIVITY IN METHOTREXATE TRANSPORT-DEFECTIVE CHINESE-HAMSTER OVARY CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE CARRIER; ANALOG TRANSPORT; BINDING-PROTEINS; TUMOR-CELLS; L1210 CELLS; LEUKEMIA; LINES; IDENTIFICATION; RESISTANCE; PLACENTA	This report describes the isolation, nucleotide sequencing, and functional expression of human cDNAs that restore reduced folate carrier activity in transport-defective cells. Based on homology to a partial murine cDNA probe, two functional cDNAs were isolated from a lambda gt11 library prepared from methotrexate transport upregulated K562 cells (K562.4CF). A 2.8-kilobase (kb) clone, KS43, contained a 1776-base pair open reading frame. The 2.5-kb clone, KS32, contained an internal deletion (626 base pairs) resulting a shortened open reading frame and 3'-untranslated region. KS43 and KS32 encoded proteins with multiple hydrophobic domains, one consensus N-glycosylation site, and predicted molecular masses of 65 and 58 kDa, respectively. The deduced amino acid sequence of KS43 is 79% and 80% homologous to the mouse and hamster sequences, respectively (Dixon, K. H., Lanpher, B. C., Chiu, J., Kelley, R., and Cowan, K. H. (1994) J. Biol. Chem. 269, 17-20; Williams, F. M. R., Murray, R. C., Underhill, T. M., and Flintoff, W. F. (1994) J. Biol. Chem. 269, 5810-5816). Northern blots identified one primary transcript at 3.1 kb in parental K562, R562.4CF, and transport-impaired K500E cells; transcript levels varied by 7-fold. The expression of both KS43 and KS32 in methotrexate transport-defective Chinese hamster ovary cells restored methotrexate sensitivity and transport. Certain transport characteristics of the transfected cells resembled both the wild type human (K562) and hamster ''classical'' reduced folate carriers, suggesting the expression of a hybrid system. For instance, based on K-i values, up to a 4-fold increased affinity for 1843U89 over wild type hamster cells (typical of human cells), and a 19-fold increased affinity for methotrexate over K562 cells (typical of hamster cells) was observed. Farther, a photoaffinity probe with high specificity for the reduced folate carrier labeled 94-kDa proteins in K562 cells and the transfectant containing the full length KS43, and a 85-kDa protein in the transfectant containing the 3'-truncated KS32. No specifically labeled proteins were de tected in wild type or mock-transfected hamster cells. Collectively, our results suggest that the KS43/KS32 cDNAs encode the human reduced folate carrier; however, additional modulatory/regulatory factors may be required to manifest the full spectrum of transport substrate activities typical of this system.	MICHIGAN CANC FDN, DEV THERAPEUT PROGRAM, DETROIT, MI 48201 USA; WAYNE STATE UNIV, SCH MED, DEPT PHARMACOL, DETROIT, MI 48201 USA; UNIV VERMONT, DEPT PHARMACOL, BURLINGTON, VT 05405 USA; UNIV VERMONT, VERMONT CANC CTR, BURLINGTON, VT 05405 USA	Wayne State University; University of Vermont; University of Vermont					NCI NIH HHS [CA 53535] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANTONY AC, 1992, BLOOD, V79, P2807; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P151; CHUNG KN, 1993, J CLIN INVEST, V91, P1289, DOI 10.1172/JCI116327; DIXON KH, 1994, J BIOL CHEM, V269, P17; DUCH DS, 1993, CANCER RES, V53, P810; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; ELWOOD PC, 1989, J BIOL CHEM, V264, P14893; FLINTOFF WF, 1983, ARCH BIOCHEM BIOPHYS, V223, P433, DOI 10.1016/0003-9861(83)90607-0; FREISHEIM JH, 1992, ADV ENZYME REGUL, V32, P17; FRY DW, 1982, J BIOL CHEM, V257, P1890; GOLDMAN ID, 1985, PHARMACOL THERAPEUT, V28, P77, DOI 10.1016/0163-7258(85)90083-X; GOLDMAN ID, 1971, ANN NY ACAD SCI, V186, P400; HENDERSON GB, 1990, ANNU REV NUTR, V10, P319, DOI [10.1146/annurev.nutr.10.1.319, 10.1146/annurev.nu.10.070190.001535]; KESSEL D, 1965, SCIENCE, V150, P752, DOI 10.1126/science.150.3697.752; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T, 1989, MOL CLONING; MATHERLY LH, 1992, J BIOL CHEM, V267, P23253; MATHERLY LH, 1991, CANCER RES, V51, P3420; OVERVOORDE PJ, 1994, J BIOL CHEM, V269, P15154; PORTIN P, 1993, Q REV BIOL, V68, P173, DOI 10.1086/418039; PRASAD PD, 1995, BIOCHEM BIOPH RES CO, V206, P681, DOI 10.1006/bbrc.1995.1096; PRICE EM, 1987, BIOCHEMISTRY-US, V26, P4757, DOI 10.1021/bi00389a024; RATNAM M, 1989, BIOCHEMISTRY-US, V28, P8249, DOI 10.1021/bi00446a042; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUETZ JD, 1988, J BIOL CHEM, V263, P9840; SIROTNAK FM, 1981, CANCER RES, V41, P4447; SIROTNAK FM, 1985, CANCER RES, V45, P3992; SIROTNAK FM, 1980, PHARMACOL THERAPEUT, V8, P71, DOI 10.1016/0163-7258(80)90060-1; SIROTNAK FM, 1987, BIOCHEM PHARMACOL, V36, P1659, DOI 10.1016/0006-2952(87)90051-7; TRIPPETT T, 1992, BLOOD, V80, P1158; UNDERHILL TM, 1989, SOMAT CELL MOLEC GEN, V15, P49, DOI 10.1007/BF01534669; WEITMAN SD, 1992, CANCER RES, V52, P3396; WILLIAMS FMR, 1994, J BIOL CHEM, V269, P5810; WILLIAMS FMR, 1995, J BIOL CHEM, V270, P2987, DOI 10.1074/jbc.270.7.2987; YANG CH, 1988, J BIOL CHEM, V263, P9703	37	173	177	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17468	17475		10.1074/jbc.270.29.17468	http://dx.doi.org/10.1074/jbc.270.29.17468			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615551	hybrid			2022-12-27	WOS:A1995RK68900065
J	BEGER, RD; BALASUBRAMANIAN, S; BENNETT, SE; MOSBAUGH, DW; BOLTON, PH				BEGER, RD; BALASUBRAMANIAN, S; BENNETT, SE; MOSBAUGH, DW; BOLTON, PH			TERTIARY STRUCTURE OF URACIL-DNA GLYCOSYLASE INHIBITOR PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-PBS2; PURIFICATION; ASSOCIATION; GENE	The Bacillus subtilis bacteriophage PBS2 uracil-DNA glycosylase inhibitor (Ugi) is an acidic protein of 84 amino acids that inactivates uracil-DNA glycosylase from diverse organisms. The secondary structure of Ugi consists of five anti-parallel beta-strands and two alpha-helices (Balasubramanian, S., Beger, R. D., Bennett, S. E., Mosbaugh, D. W., and Bolton, P. H. (1995) J. Biol. Chem. 270, 296-303). The tertiary structure of Ugi has been deter mined by solution state multidimensional nuclear magnetic resonance. The Ugi structure contains an area of highly negative electrostatic potential produced by the close proximity of a number of acidic residues. The unfavorable interactions between these acidic residues are apparently accommodated by the stability of the beta-strands. This negatively charged region is likely to play an important role in the binding of Ugi to uracil-DNA glycosylase.	WESLEYAN UNIV,DEPT CHEM,MIDDLETOWN,CT 06459; OREGON STATE UNIV,DEPT AGR CHEM,CORVALLIS,OR 97331; OREGON STATE UNIV,DEPT BIOCHEM & BIOPHYS,CORVALLIS,OR 97331; OREGON STATE UNIV,CTR ENVIRONM HLTH SCI,CORVALLIS,OR 97331	Wesleyan University; Oregon State University; Oregon State University; Oregon State University				Balasubramanian, Suganthi/0000-0003-2243-5948	NIEHS NIH HHS [ES 00210] Funding Source: Medline; NIGMS NIH HHS [GM 32823] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032823] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALASUBRAMANIAN S, 1994, J MAGN RESON SER B, V104, P240, DOI 10.1006/jmrb.1994.1081; BALASUBRAMANIAN S, 1995, J BIOL CHEM, V270, P296, DOI 10.1074/jbc.270.1.296; BENNETT SE, 1993, J BIOL CHEM, V268, P26879; BENNETT SE, 1992, J BIOL CHEM, V267, P22512; BENNETT SE, 1994, J BIOL CHEM, V269, P21870; BRUNGER AT, 1993, SCIENCE, V261, P328, DOI 10.1126/science.8332897; CONE R, 1980, J BIOL CHEM, V255, P354; DYSON HJ, 1994, 2 DIMENSIONAL NMR SP, P655; Hull W., 1994, 2 DIMENSIONAL NMR SP, P67; KARRAN P, 1981, BIOCHEMISTRY-US, V20, P6092, DOI 10.1021/bi00524a027; KESSLER H, 1994, 2 DIMENSIONAL NMR SP; LEMASTER DM, 1994, PROG NUCL MAG RES SP, V26, P371, DOI 10.1016/0079-6565(94)80010-3; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; UPTON C, 1993, P NATL ACAD SCI USA, V90, P4518, DOI 10.1073/pnas.90.10.4518; WANG Z, 1989, J BIOL CHEM, V264, P1163; WANG ZG, 1988, J BACTERIOL, V170, P1082, DOI 10.1128/jb.170.3.1082-1091.1988; WANG ZG, 1991, GENE, V99, P31; WILLIAMS MV, 1990, J BACTERIOL, V172, P2979, DOI 10.1128/jb.172.6.2979-2985.1990; WINTERS TA, 1993, VIROLOGY, V195, P315, DOI 10.1006/viro.1993.1382	19	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16840	16847		10.1074/jbc.270.28.16840	http://dx.doi.org/10.1074/jbc.270.28.16840			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622499	hybrid			2022-12-27	WOS:A1995RJ34700060
J	CHUNG, SH; TAKAI, Y; HOLZ, RW				CHUNG, SH; TAKAI, Y; HOLZ, RW			EVIDENCE THAT THE RAB3A-BINDING PROTEIN, RABPHILIN3A, ENHANCES REGULATED SECRETION - STUDIES IN ADRENAL CHROMAFFIN CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; PUTATIVE TARGET PROTEIN; ENDOCYTIC PATHWAY; KINASE-C; RAB3A; DOMAIN; SYNAPTOTAGMIN; EXOCYTOSIS; RECEPTORS; TRANSPORT	Rabphilin3a had been identified in brain as a Rab3a-binding protein and may serve as an effector for Rab3a function. We have cloned a splice variant of brain-Rabphilin3a from a bovine adrenal chromaffin cell cDNA library and investigated the function of the protein in regulated exocytosis in bovine chromaffin cells. The predicted amino acid sequence of chromaffin cell (c-) Rabphilin3a was identical with that of brain (b-) Rabphilin3a except for a 6-amino-acid insert VFSLSA in the amino-terminal half of the protein. An antibody directed against a carboxyl-terminal peptide recognized an 85-kDa protein in COS7 cells transfected with the cDNA in a mammalian expression vector. A band of similar mobility was enriched in a fraction of highly purified chromaffin granule membranes, consistent with the Rabphilin3a being associated with chromaffin granule membranes. Overexpression of either chromaffin cell or brain Rabphilin3a by transfection with the corresponding cDNAs in mammalian expression vectors enhanced DMPP-induced secretion of co-expressed human growth hormone (GH) approximately 30%. Chromaffin cells transfected with a plasmid with the entire coding sequence of c-Rabphilin3a inserted in the antisense orientation inhibited secretion of co-expressed GH by approximately 30%. Rabphilin3a mutants lacking one or both of the carboxyl-terminal C2 domains strongly inhibited DMPP-stimulated exocytosis. The single C2 domain deletion also strongly inhibited Ca2+-dependent secretion from digitonin-permeabilized cells. These data indicate that Rabphilin3a is a positive regulator of exocytosis. Because the C2 deletion mutants contain the aminoterminal Rab3a-GTP binding domain, they may inhibit secretion by competing with endogenous Rabphilin3a for interaction with Rab3a-GTP without being able to mimic the functional effects of full-length Rabphilin3a.	UNIV MICHIGAN,SCH MED,DEPT PHARMACOL,ANN ARBOR,MI 48109; OSAKA UNIV,SCH MED,DEPT MOLEC BIOL & BIOCHEM,SUITA,OSAKA 565,JAPAN	University of Michigan System; University of Michigan; Osaka University					NIDDK NIH HHS [R01 DK27959] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027959] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAJJALIEH SM, 1995, J BIOL CHEM, V270, P1971, DOI 10.1074/jbc.270.5.1971; BARBIERI MA, 1994, J BIOL CHEM, V269, P18720; BITTNER MA, 1992, J BIOL CHEM, V267, P16226; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; BRONDYK WH, 1995, MOL CELL BIOL, V15, P1137; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; ELAZAR Z, 1994, J BIOL CHEM, V269, P794; FERRONOVICK S, 1994, NATURE, V370, P191, DOI 10.1038/370191a0; FUJITA Y, 1994, FEBS LETT, V353, P67, DOI 10.1016/0014-5793(94)01015-3; GARDNER K, 1987, NATURE, V328, P359, DOI 10.1038/328359a0; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; HOLZ RW, 1994, J BIOL CHEM, V269, P10229; HOLZ RW, 1982, J NEUROCHEM, V39, P635, DOI 10.1111/j.1471-4159.1982.tb07940.x; INAGAKI N, 1994, J BIOCHEM-TOKYO, V116, P239, DOI 10.1093/oxfordjournals.jbchem.a124512; JOHANNES L, 1994, EMBO J, V13, P2029, DOI 10.1002/j.1460-2075.1994.tb06476.x; KAIBUCHI K, 1989, J BIOL CHEM, V264, P13489; KISHIDA S, 1993, J BIOL CHEM, V268, P22259; LI C, 1994, NEURON, V13, P885, DOI 10.1016/0896-6273(94)90254-2; LIAN JP, 1994, NATURE, V372, P698, DOI 10.1038/372698a0; LLEDO PM, 1993, NATURE, V364, P540, DOI 10.1038/364540a0; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; LU B, 1992, NEURON, V8, P521, DOI 10.1016/0896-6273(92)90280-Q; MCKIERNAN CJ, 1993, J BIOL CHEM, V268, P24449; MIYAZAKI M, 1994, BIOCHEM BIOPH RES CO, V205, P460, DOI 10.1006/bbrc.1994.2688; MIZOGUCHI A, 1994, BIOCHEM BIOPH RES CO, V202, P1235, DOI 10.1006/bbrc.1994.2063; MOCHLYROSEN D, 1992, BIOCHEMISTRY-US, V31, P8120, DOI 10.1021/bi00150a003; MOLLARD GFV, 1990, P NATL ACAD SCI USA, V87, P1988; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; PFEFFER SR, 1994, CURR OPIN CELL BIOL, V6, P522, DOI 10.1016/0955-0674(94)90071-X; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; SHIRATAKI H, 1994, J BIOL CHEM, V269, P32717; SHIRATAKI H, 1992, J BIOL CHEM, V267, P10946; SMITH AD, 1967, BIOCHEM J, V103, P480, DOI 10.1042/bj1030480; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; VANDERSLUIJS P, 1991, P NATL ACAD SCI USA, V88, P6313, DOI 10.1073/pnas.88.14.6313; WADA K, 1994, BIOCHEM BIOPH RES CO, V198, P158, DOI 10.1006/bbrc.1994.1023; WICK PF, 1993, J BIOL CHEM, V268, P10983; YAMAGUCHI T, 1993, J BIOL CHEM, V268, P27164	47	127	129	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16714	16718		10.1074/jbc.270.28.16714	http://dx.doi.org/10.1074/jbc.270.28.16714			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622481	hybrid			2022-12-27	WOS:A1995RJ34700041
J	COLIGE, A; BESCHIN, A; SAMYN, B; GOEBELS, Y; VANBEEUMEN, J; NUSGENS, BV; LAPIERE, CM				COLIGE, A; BESCHIN, A; SAMYN, B; GOEBELS, Y; VANBEEUMEN, J; NUSGENS, BV; LAPIERE, CM			CHARACTERIZATION AND PARTIAL AMINO-ACID SEQUENCING OF A 107-KDA PROCOLLAGEN-I N-PROTEINASE PURIFIED BY AFFINITY-CHROMATOGRAPHY ON IMMOBILIZED TYPE-XIV COLLAGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICK-EMBRYO TENDONS; PURIFICATION; ENZYME; DERMATOSPARAXIS; PEPTIDASE; BINDING; FORM	Procollagen I N-proteinase (EC 3.4.24.14), the enzyme that specifically processes type I and type II procollagens to collagen, was isolated from extracts of fetal calf skin. After two chromatographic steps on concanavalin A-Sepharose and heparin-Sepharose, the semi-purified preparation was used to produce monoclonal antibodies. One reacting antibody was found to recognize not the enzyme itself but type XIV collagen on which the enzyme was bound. This binding, highly sensitive to ionic conditions (pH, salt concentrations) but not affected by non-ionic detergents, was used for affinity chromatography that strongly improved the purification procedure. The enzyme is extensively characterized: 1) it has a molecular mass of 107 kDa as determined by polyacrylamide gel electrophoresis in presence of SDS and of about 130 kDa when estimated by gel filtration on a Sephacryl-S300; 2) in standard assay (pH 7.5, 0.2 M NaCl, 35 degrees C), the activation energy for reaction with amino procollagen type I was 17,000 calories per mole. In the same conditions, K-m and V-max values were, respectively, 435 and 39 nM per hour but varied strongly with pH and salt concentration; 3) the enzyme cleaved the NH2-terminal propeptide of type I procollagen at the specific site, the Pro-Gin bond in the alpha 1 type I procollagen chain; 4) the enzyme contained a high proportion of Gly, Asx, and Glx residues but no Hyp or Hyl; 5) partial amino acid sequences obtained from internal peptides of the enzyme displayed no significant homology with known sequences. The association of procollagen I N-proteinase with a FACIT (fibril associated colla gens with interrupted triple helices) collagen as found here might be of physiological significance.	UNIV LIEGE,CHU SART TILMAN,EXPTL DERMATOL LAB,B-4000 SART,BELGIUM; FREE UNIV BRUSSELS,INST MOLEC BIOL,CELLULAR IMMUNOL LAB,B-1640 RHODE ST GENESE,BELGIUM; VAKGRP BIOCHEM FYSIOL & MICROBIOL,B-9000 GHENT,BELGIUM	University of Liege			Beschin, Alain/L-2154-2014	Beschin, Alain/0000-0001-8478-6941				AUBERTFOUCHER E, 1992, J BIOL CHEM, V267, P15759; BROWN JC, 1993, J CELL BIOL, V120, P557, DOI 10.1083/jcb.120.2.557; EISENTHAL R, 1974, BIOCHEM J, V139, P715, DOI 10.1042/bj1390715; FERNANDEZ J, 1992, ANAL BIOCHEM, V201, P255, DOI 10.1016/0003-2697(92)90336-6; FONT B, 1993, J BIOL CHEM, V268, P25015; GOFFIN C, 1992, MOL BIOL, V11, P203; HALIA R, 1992, AM J HUM GENET, V51, P128; HANSET R, 1967, ANN MED VET, V7, P451; HOJIMA Y, 1989, J BIOL CHEM, V264, P11336; HOJIMA Y, 1985, J BIOL CHEM, V260, P5996; HOJIMA Y, 1994, J BIOL CHEM, V269, P11389; HOJIMA Y, 1989, J BIOL CHEM, V264, P11389; HORLEIN D, 1978, FEBS LETT, V89, P279, DOI 10.1016/0014-5793(78)80236-1; LAPIERE CM, 1971, P NATL ACAD SCI USA, V68, P3054, DOI 10.1073/pnas.68.12.3054; LENAERS A, 1971, EUR J BIOCHEM, V23, P533, DOI 10.1111/j.1432-1033.1971.tb01651.x; MORADIAMELI M, 1994, MATRIX BIOL, V14, P233, DOI 10.1016/0945-053X(94)90187-2; NUSGENS B, 1979, ANAL BIOCHEM, V95, P406, DOI 10.1016/0003-2697(79)90747-4; NUSGENS BV, 1980, BIOCHEM J, V191, P699, DOI 10.1042/bj1910699; NUSGENS BV, 1992, NAT GENET, V1, P214, DOI 10.1038/ng0692-214; SMITH LT, 1992, AM J HUM GENET, V51, P235; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; WALCHLI C, 1994, J CELL SCI, V107, P669	22	65	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16724	16730		10.1074/jbc.270.28.16724	http://dx.doi.org/10.1074/jbc.270.28.16724			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622483	hybrid			2022-12-27	WOS:A1995RJ34700043
J	COVER, CM; WANG, JM; STLEZIN, E; KURTZ, TW; MELLON, SH				COVER, CM; WANG, JM; STLEZIN, E; KURTZ, TW; MELLON, SH			MOLECULAR VARIANTS IN THE P450C11AS GENE AS DETERMINANTS OF ALDOSTERONE SYNTHASE ACTIVITY IN THE DAHL RAT MODEL OF HYPERTENSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-RESISTANT RATS; ADRENAL-CORTEX; CYTOCHROME-P-450; BIOSYNTHESIS; EXPRESSION; SEQUENCE; CDNA; MINERALOCORTICOIDS; MUTATIONS; CYP11B2	Dahl salt-sensitive (S) and salt-resistant (R) rats are widely used to study genetic determinants of salt sensitive hypertension. Differences in blood pressure under a high sodium diet in these two strains may be due to differences in the synthesis of 18-OH-11-deoxycorticosterone (18-OH DOC). This difference in 18-OH-DOC synthesis is due to mutations in the Dahl R rat's gene for P450c11 beta (11 beta-hydroxylase), an adrenal enzyme involved in the synthesis of both corticosterone and 18-OH DOC from 11-deoxycorticosterone. Aldosterone/renin ratios in plasma and in the adrenals are greater in Dahl S than R rats, suggesting an altered physiologic relationship between the renin-angiotensin and aldosterone systems between these strains. We demonstrate that the mRNA for P450c11AS, (aldosterone synthase), an enzyme required for aldosterone synthesis, is identical in the Dahl S rat and in normotensive Sprague-Dawley rats, but that P450c11AS mRNA from the Dahl R rat contains 7 mutations that result in two amino acid substitutions, These two changes result in a form of P450c11AS that has a greater apparent V-max and lower apparent K-m, resulting in an enzyme that catalyzes the conversion of 11-deoxycorticosterone to aldosterone at a greater rate in Dahl R rats than the P450c11AS in Dahl S rats or Sprague Dawley rats, Although plasma and adrenal renin are lower in Dahl S versus R rats, the regulation of P450c11AS mRNA expression in rats fed a low and high salt diet are identical in these strains, The current findings may explain both the reduced aldosterone concentrations and increased aldosterone/renin ratios previously reported in the Dahl S versus Dahl R rat.	UNIV CALIF SAN FRANCISCO,DEPT OBSTET GYNECOL & REPROD SCI,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,METAB RES UNIT,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD011979, R01HD027970] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-11979, HD 27970] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADLER GK, 1993, ENDOCRINOLOGY, V133, P2235, DOI 10.1210/en.133.5.2235; CICILA GT, 1993, NAT GENET, V3, P346, DOI 10.1038/ng0493-346; CONNELL JMC, 1991, J HYPERTENS, V9, P97, DOI 10.1097/00004872-199102000-00001; CURNOW KM, 1991, MOL ENDOCRINOL, V5, P1513, DOI 10.1210/mend-5-10-1513; DAHL LK, 1962, J EXP MED, V115, P1173, DOI 10.1084/jem.115.6.1173; DOMALIK LJ, 1991, MOL ENDOCRINOL, V5, P1853, DOI 10.1210/mend-5-12-1853; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; FARDELLA CE, 1995, J CLIN ENDOCR METAB, V80, P1040, DOI 10.1210/jc.80.3.1040; FRASER R, 1985, P158; IMAI M, 1990, FEBS LETT, V263, P299, DOI 10.1016/0014-5793(90)81398-8; KUSANO E, 1986, J HYPERTENS       S5, V4, P20; LAUBER M, 1989, ARCH BIOCHEM BIOPHYS, V274, P109, DOI 10.1016/0003-9861(89)90421-9; LIFTON RP, 1992, NAT GENET, V2, P66, DOI 10.1038/ng0992-66; MALEE MP, 1991, P NATL ACAD SCI USA, V88, P4731, DOI 10.1073/pnas.88.11.4731; MATSUKAWA N, 1993, J BIOL CHEM, V268, P9117; MELLON SH, 1995, STEROIDS, V60, P59, DOI 10.1016/0039-128X(94)00020-D; MELLON SH, 1991, DNA CELL BIOL, V10, P339, DOI 10.1089/dna.1991.10.339; MELLON SH, 1989, J CLIN INVEST, V84, P1497, DOI 10.1172/JCI114325; MELLON SH, 1995, J BIOL CHEM, V270, P1643, DOI 10.1074/jbc.270.4.1643; MORNET E, 1989, J BIOL CHEM, V264, P20961; MUKAI K, 1993, J BIOL CHEM, V268, P9130; NONAKA Y, 1989, FEBS LETT, V255, P21, DOI 10.1016/0014-5793(89)81053-1; NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759; OGISHIMA T, 1992, ENDOCRINOLOGY, V130, P2971, DOI 10.1210/en.130.5.2971; OONK RB, 1989, J BIOL CHEM, V264, P21934; PASCOE L, 1992, P NATL ACAD SCI USA, V89, P8327, DOI 10.1073/pnas.89.17.8327; RAPP JP, 1982, HYPERTENSION, V4, P753, DOI 10.1161/01.HYP.4.6.753; RAPP JP, 1973, ENDOCRINOLOGY, V92, P1286, DOI 10.1210/endo-92-4-1286; RAPP JP, 1972, NATURE, V237, P338, DOI 10.1038/237338a0; RAPP JP, 1978, ENDOCR RES COMMUN, V5, P35, DOI 10.3109/07435807809073634; RAPP JP, 1976, BIOCHEMISTRY-US, V15, P1235, DOI 10.1021/bi00651a010; SANDER M, 1994, P NATL ACAD SCI USA, V91, P148, DOI 10.1073/pnas.91.1.148; STLEZIN EM, 1994, HYPERTENSION, V23, P786, DOI 10.1161/01.HYP.23.6.786; TREMBLAY A, 1992, ENDOCRINOLOGY, V130, P3152, DOI 10.1210/en.130.6.3152	34	42	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16555	16560		10.1074/jbc.270.28.16555	http://dx.doi.org/10.1074/jbc.270.28.16555			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622461	hybrid			2022-12-27	WOS:A1995RJ34700017
J	KINLAW, WB; CHURCH, JL; HARMON, J; MARIASH, CN				KINLAW, WB; CHURCH, JL; HARMON, J; MARIASH, CN			DIRECT EVIDENCE FOR A ROLE OF THE SPOT-14 PROTEIN IN THE REGULATION OF LIPID-SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S14 GENE-TRANSCRIPTION; RIBONUCLEIC-ACID S14; THYROID-HORMONE; MESSENGER-RNA; RAT-LIVER; MOLECULAR-CLONING; HEPATIC ZONATION; MALIC ENZYME; CARBOHYDRATE; EXPRESSION	''Spot 14'' is a nuclear protein that is rapidly induced by thyroid hormone (T-3) and dietary carbohydrate in liver, We used an antisense oligonucleotide to inhibit induction of spot 14 protein by T-3 and glucose in primary cultures of rat hepatocytes to test the hypothesis that the protein could function in the regulation of lipid synthesis. Spot 14 protein was undetectable in hepatocytes maintained in 5.5 mM glucose without T-3, and was induced within 4 h after addition of 27.5 mM glucose and 50 nM T-3 to the culture medium, reaching a maximal level within 24 h. Accumulation of spot 14 protein was markedly inhibited in hepatocytes transfected with a spot 14 antisense oligonucleotide, but not in those treated with a control oligonucleotide. Transfection of the antisense, but not control, oligonucleotide also abrogated the increase in lipogenesis induced by T-3 and glucose. Reduced triglyceride formation accounted for the diminished net lipid synthesis, In contrast to lipogenesis, glucose uptake was not significantly affected by the transfections. Antisense transfection inhibited the induction of both ATP citrate lyase and fatty acid synthase immunoreactivities, as well as malic enzyme activity, indicating that the observed reduction in lipogenesis could be explained by diminished cellular content of lipogenic enzymes. Reduced malic enzyme activity in antisense-transfected hepatocytes was accompanied by lowered relative abundance of malic enzyme mRNA, suggesting that the antisense effects on lipogenic enzymes were mediated at the pretranslational level. The oligonucleotides did not significantly affect lipogenesis in a rat hepatoma cell line that does not express detectable spot 14 mRNA or protein. These data directly implicate the spot 14 protein in the transduction of hormonal and dietary signals for increased lipid metabolism in hepatocytes.	DARTMOUTH COLL,SCH MED,DEPT MED,DIV ENDOCRINOL & METAB,LEBANON,NH 03750; UNIV MINNESOTA,SCH MED,DEPT MED,DIV ENDOCRINOL & METAB,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,SCH MED,DEPT CELL BIOL & NEUROANAT,MINNEAPOLIS,MN 55455	Dartmouth College; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043142] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-32855, DK-43142] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BLIGH EG, 1989, CAN J BIOCH PHYSL, V37, P911; CAMPBELL JM, 1990, J BIOCHEM BIOPH METH, V20, P259, DOI 10.1016/0165-022X(90)90084-P; CARR FE, 1984, P NATL ACAD SCI-BIOL, V81, P974, DOI 10.1073/pnas.81.3.974; ELSHOURBAGY NA, 1990, J BIOL CHEM, V265, P1430; FREAKE HC, 1987, P NATL ACAD SCI USA, V84, P3070, DOI 10.1073/pnas.84.9.3070; GOTO Y, 1992, DIABETES, V41, P339, DOI 10.2337/diabetes.41.3.339; HSU RY, 1967, J BIOL CHEM, V242, P520; JUMP DB, 1990, J BIOL CHEM, V265, P3474; JUMP DB, 1993, P NATL ACAD SCI USA, V90, P8454, DOI 10.1073/pnas.90.18.8454; JUMP DB, 1985, ENDOCRINOLOGY, V117, P2259, DOI 10.1210/endo-117-6-2259; JUMP DB, 1984, J BIOL CHEM, V259, P2789; KINLAW WB, 1989, J BIOL CHEM, V264, P19779; KINLAW WB, 1988, ENDOCRINOLOGY, V123, P2255, DOI 10.1210/endo-123-5-2255; KINLAW WB, 1992, ENDOCRINOLOGY, V131, P3120, DOI 10.1210/en.131.6.3120; KINLAW WB, 1986, J CLIN INVEST, V78, P1091, DOI 10.1172/JCI112665; KINLAW WB, 1993, ENDOCRINOLOGY, V133, P645, DOI 10.1210/en.133.2.645; KINLAW WB, 1987, ENDOCRINOLOGY, V120, P1563, DOI 10.1210/endo-120-4-1563; LIAW CW, 1984, J BIOL CHEM, V259, P7253; MAGNUSON MA, 1983, J BIOL CHEM, V258, P2712; MARIASH CN, 1986, J BIOL CHEM, V261, P9583; MARIASH CN, 1984, BIOCHEM BIOPH RES CO, V123, P1122; MARIASH CN, 1981, J CLIN INVEST, V65, P1126; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; PEREZCASTILLO A, 1987, AM J PHYSIOL, V253, pE536, DOI 10.1152/ajpendo.1987.253.5.E536; SEELIG S, 1981, P NATL ACAD SCI-BIOL, V78, P4733, DOI 10.1073/pnas.78.8.4733; SHIH HM, 1992, J BIOL CHEM, V267, P13222; STRAIT KA, 1989, J BIOL CHEM, V264, P19784; WADDELL WJ, 1956, J LAB CLIN MED, V48, P311; YU K, BIOCHEM J, V268, P539; ZILZ ND, 1990, J BIOL CHEM, V265, P8136; [No title captured]	31	124	128	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16615	16618		10.1074/jbc.270.28.16615	http://dx.doi.org/10.1074/jbc.270.28.16615			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622469	hybrid			2022-12-27	WOS:A1995RJ34700026
J	LIU, DH; POSTBEITTENMILLER, D				LIU, DH; POSTBEITTENMILLER, D			DISCOVERY OF AN EPIDERMAL STEAROYL-ACYL CARRIER PROTEIN THIOESTERASE - ITS POTENTIAL ROLE IN WAX BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UMBELLULARIA-CALIFORNICA; IMMATURE COTYLEDONS; ACP THIOESTERASE; PURIFICATION; EXPRESSION; PLANTS; SEEDS; DESATURASE; INDUCTION; SPINACH	Plant epicuticular, or surface, waxes are synthesized primarily, if not exclusively, by epidermal cells. The epicuticular wax constitutes almost 20% of the chloroformextractable lipids in developing leek leaf and is derived predominantly from saturated fatty acids. The significant requirement for saturated fatty acids in epidermal tissues led us to investigate whether or not epidermal extracts have thioesterase activities that prefer saturated acyl-acyl carrier protein (ACP) substrates, rather than the 18:1-ACP more commonly hydrolyzed by total leaf extracts. Epidermal extracts from Brassica, pea, and leek exhibited higher activities toward saturated acyl-ACPs relative to 18:1-ACP when compared to total leaf or leaf parenchymal extracts. We identified and purified a stearoyl-ACP (18:0-ACP)-specific thioesterase from leek epidermal extracts which could be separated from 18:1-ACP thioesterase using hydroxyapatite chromatography. The stearoyl-ACP thioesterase exhibited a high preference for 18:0-ACP, having less than 10% of the 18:0-ACP hydrolyzing activity when presented with 18:1-ACP, 16:0-ACP, or 18:0-CoA substrates. The stearoyl-ACP thioesterase was predominantly, if not exclusively, expressed in epidermis and may play a role in generating the saturated fatty acid pool required for wax production.	SAMUEL ROBERTS NOBLE FDN INC,DIV PLANT BIOL,ARDMORE,OK 73402	Noble Research Institute								CLOUGH RC, 1992, J BIOL CHEM, V267, P20992; DAVIES HM, 1991, ARCH BIOCHEM BIOPHYS, V290, P37, DOI 10.1016/0003-9861(91)90588-A; DORMANN P, 1994, PLANT PHYSIOL, V104, P839, DOI 10.1104/pp.104.3.839; DORMANN P, 1993, PLANTA, V189, P425, DOI 10.1007/BF00194441; ELHUSSEIN SA, 1988, BIOCHEM J, V251, P39; HELLYER A, 1992, PLANT MOL BIOL, V20, P763, DOI 10.1007/BF00027148; IMAI H, 1992, PLANT MOL BIOL, V20, P199, DOI 10.1007/BF00014488; JONES A, 1995, PLANT CELL, V7, P359, DOI 10.1105/tpc.7.3.359; KNUDSEN J, 1975, BIOCHEM BIOPH RES CO, V65, P921, DOI 10.1016/S0006-291X(75)80473-6; KNUTZON DS, 1992, P NATL ACAD SCI USA, V89, P2624, DOI 10.1073/pnas.89.7.2624; KOLATTUKUDY PE, 1985, J BIOL CHEM, V260, P789; KOLATTUKUDY PE, 1991, ARCH BIOCHEM BIOPHYS, V284, P201, DOI 10.1016/0003-9861(91)90284-P; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIBERTINI LJ, 1978, J BIOL CHEM, V253, P1393; MCKEON TA, 1982, J BIOL CHEM, V257, P2141; OHLROGGE JB, 1978, ARCH BIOCHEM BIOPHYS, V189, P382, DOI 10.1016/0003-9861(78)90225-4; POLLARD MR, 1991, ARCH BIOCHEM BIOPHYS, V284, P306, DOI 10.1016/0003-9861(91)90300-8; POSTBEITTENMILL.MA, 1989, PLANT CELL, V1, P889; TAYLOR DC, 1990, ANAL BIOCHEM, V184, P311, DOI 10.1016/0003-2697(90)90686-4; VOELKER TA, 1992, SCIENCE, V257, P72, DOI 10.1126/science.1621095	20	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16962	16969		10.1074/jbc.270.28.16962	http://dx.doi.org/10.1074/jbc.270.28.16962			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622515	hybrid			2022-12-27	WOS:A1995RJ34700076
J	WANG, CL; JAYADEV, S; ESCOBEDO, JA				WANG, CL; JAYADEV, S; ESCOBEDO, JA			IDENTIFICATION OF A DOMAIN IN THE ANGIOTENSIN-II TYPE-1 RECEPTOR DETERMINING G(Q) COUPLING BY THE USE OF RECEPTOR CHIMERAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; SIGNAL-TRANSDUCTION PATHWAYS; SITE-DIRECTED MUTAGENESIS; SMOOTH-MUSCLE CELLS; PHOSPHOLIPASE-C; PHOSPHATIDYLINOSITOL HYDROLYSIS; 2ND MESSENGERS; WASP VENOM; G-PROTEINS; EXPRESSION	The angiotensin II type 1 (AT1R) and type 2 (AT2R) receptors belong to the seven transmembrane receptor superfamily. Previous studies have suggested that the AT1R couples to a G(q) signaling pathway, whereas the AT2R does not associate with G(q). To identify the role that individual intracellular domains play in AT1R function, AT1R/AT2R chimeric receptors were prepared by substitution of intracellular loops. CHO cells expressing these chimeras were used to test angiotensin II-induced c-fos expression and Ca2+ mobilization which are involved in the AT1R signaling pathway through G(q) coupling. Substitution of the second intracellular loop (IC2) and the cytoplasmic tail between the two receptors did not affect AT1R function. However, exchange of the third intracellular loop (IC3) resulted in the loss of function in the AT1R and conferred to the AT2R the ability to constitutively activate the fos promoter. These findings suggest that the third intracellular loop of the AT1R is critical for G(q) coupling. Substitution of discrete amino acid sequences of the third intracellular loop indicate that its N-terminal and C-terminal portions, especially the seven amino acids 219-225 in the N-terminal portion, are important for AT1R function, and that the intermediate portion of this loop is not required for G(q) coupling.	UNIV CALIF SAN FRANCISCO, CARDIOVASC RES INST, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DAIICHI RES CTR, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco								BERRIDGE MJ, 1989, PROC R SOC SER B-BIO, V238, P235, DOI 10.1098/rspb.1989.0079; BIHOREAU C, 1993, P NATL ACAD SCI USA, V90, P5133, DOI 10.1073/pnas.90.11.5133; BLUML K, 1994, P NATL ACAD SCI USA, V91, P7980, DOI 10.1073/pnas.91.17.7980; BOTTARI SP, 1992, BIOCHEM BIOPH RES CO, V183, P206, DOI 10.1016/0006-291X(92)91629-5; BRECHLER V, 1994, RECEPTOR CHANNEL, V2, P89; CHANG RSL, 1990, MOL PHARMACOL, V37, P347; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; COTECCHIA S, 1992, J BIOL CHEM, V267, P1633; COTECCHIA S, 1990, P NATL ACAD SCI USA, V87, P2896, DOI 10.1073/pnas.87.8.2896; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; HAWES BE, 1994, J BIOL CHEM, V269, P15776; HIGASHIJIMA T, 1983, FEBS LETT, V152, P227, DOI 10.1016/0014-5793(83)80385-8; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUNYADY L, 1994, J BIOL CHEM, V269, P24798; KAMBAYASHI Y, 1993, J BIOL CHEM, V268, P24543; KANG J, 1994, AM J PHYSIOL-CELL PH, V267, pC1389, DOI 10.1152/ajpcell.1994.267.5.C1389; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; KOSUGI S, 1994, MOL ENDOCRINOL, V8, P498, DOI 10.1210/me.8.4.498; KUNKEL MT, 1993, EMBO J, V12, P3809, DOI 10.1002/j.1460-2075.1993.tb06059.x; LANDAU EM, 1994, METHOD ENZYMOL, V238, P140; LECHLEITER J, 1990, EMBO J, V9, P4381, DOI 10.1002/j.1460-2075.1990.tb07888.x; LOKUTA AJ, 1994, J BIOL CHEM, V269, P4832; LUTTRELL LM, 1993, SCIENCE, V259, P1453, DOI 10.1126/science.8383880; MARIE J, 1994, J BIOL CHEM, V269, P20815; MOLLOY CJ, 1993, J BIOL CHEM, V268, P7338; MUKOYAMA M, 1993, J BIOL CHEM, V268, P24539; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; OHNISHI J, 1992, BIOCHEM BIOPH RES CO, V186, P1094, DOI 10.1016/0006-291X(92)90859-J; OHYAMA K, 1992, BIOCHEM BIOPH RES CO, V189, P677, DOI 10.1016/0006-291X(92)92254-U; OKAMOTO T, 1990, CELL, V62, P709, DOI 10.1016/0092-8674(90)90116-V; OKAMOTO T, 1992, J BIOL CHEM, V267, P8342; OPPI C, 1992, P NATL ACAD SCI USA, V89, P8268, DOI 10.1073/pnas.89.17.8268; REN Q, 1993, J BIOL CHEM, V268, P16483; SADOSHIMA J, 1993, CIRC RES, V73, P424, DOI 10.1161/01.RES.73.3.424; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SONG KF, 1992, LIFE SCI, V51, pPL165, DOI 10.1016/0024-3205(92)90542-W; TAKAHASI K, 1994, BIOCHEM BIOPH RES CO, V198, P60, DOI 10.1006/bbrc.1994.1009; TAYLOR JM, 1994, J BIOL CHEM, V269, P27618; TAYLOR JM, 1994, PEPTIDES, V15, P829, DOI 10.1016/0196-9781(94)90038-8; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; TSUDA T, 1990, J BIOL CHEM, V265, P1165; WESS J, 1989, FEBS LETT, V258, P133, DOI 10.1016/0014-5793(89)81633-3; WESS J, 1990, MOL PHARMACOL, V38, P517; WONG SKF, 1990, J BIOL CHEM, V265, P6219	51	90	98	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16677	16682		10.1074/jbc.270.28.16677	http://dx.doi.org/10.1074/jbc.270.28.16677			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622477	hybrid			2022-12-27	WOS:A1995RJ34700036
J	MERCURE, C; THIBAULT, G; LUSSIERCACAN, S; DAVIGNON, J; SCHIFFRIN, EL; REUDELHUBER, TL				MERCURE, C; THIBAULT, G; LUSSIERCACAN, S; DAVIGNON, J; SCHIFFRIN, EL; REUDELHUBER, TL			MOLECULAR ANALYSIS OF HUMAN PRORENIN PROSEGMENT VARIANTS IN-VITRO AND IN-VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; RENIN-ANGIOTENSIN SYSTEM; BLOOD-PRESSURE; ESSENTIAL-HYPERTENSION; GENE; ASSOCIATION; CELLS; INHIBITORS; BIOLOGY; PEPTIDE	The aspartyl protease renin, an important modulator of blood pressure in humans, is present in the circulation not only in its active form, but also as an inactive precursor, prorenin, in which a 43-amino acid prosegment blocks access of the substrate to the active site of the enzyme, Site-directed mutagenesis of the prosegment has led to the following conclusions. 1) Maintenance of the enzymatically inactive state of prorenin requires a short peptide sequence between positions 10P and 20P (where P denotes prosegment and numbering is relative to amino terminus) of the prosegment; and 2) there is an inverse relationship between the ability of prosegment mutations to activate and their effect on the secretion of the various prorenins, suggesting that this same region of the prosegment plays a critical role in the biosynthesis of human prorenin, Since these results demonstrated that single amino acid mutations could activate human prorenin to varying degrees, mutations in this region of the renin gene could be clinically important in humans. To test this hypothesis, genomic screening was carried out on the corresponding region of the human renin gene (exon 2) in a cohort of patients selected for a likely familial component to their hypertension. While this study identified a novel polymorphism in exon 2 of the human renin gene, evidence was not obtained for either the presence of prosegment mutations or the association of the novel polymorphism with hypertension in the patient population studied. In conclusion, both structure-function studies and genetic screening suggest that mutation of the prorenin prosegment is an unlikely factor in activation of the renin-angiotensin system in humans.	CLIN RES INST MONTREAL, MRC, MULTIDISCIPLINARY RES GRP HYPERTENS, MONTREAL, PQ H2W 1R7, CANADA; CLIN RES INST MONTREAL, JA DESEVE LAB HYPERLIPIDEMIA & ATHEROSCLEROSIS, MONTREAL, PQ H2W 1R7, CANADA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal			Schiffrin, Ernesto L/AAB-9061-2019	Schiffrin, Ernesto L/0000-0002-4502-2823				ALDERMAN MH, 1991, NEW ENGL J MED, V324, P1098, DOI 10.1056/NEJM199104183241605; Baker D, 1993, CURR OPIN CELL BIOL, V5, P966, DOI 10.1016/0955-0674(93)90078-5; BARLEY J, 1991, J HYPERTENS, V9, P993, DOI 10.1097/00004872-199111000-00003; BAXTER JD, 1991, RECENT PROG HORM RES, V47, P211; CHU WN, 1990, MOL ENDOCRINOL, V4, P1905, DOI 10.1210/mend-4-12-1905; CHU WN, 1992, HYPERTENSION, V20, P782, DOI 10.1161/01.HYP.20.6.782; CREAGER MA, 1991, HYPERTENSION, V17, P989, DOI 10.1161/01.HYP.17.6.989; DAHL LK, 1962, NATURE, V194, P480, DOI 10.1038/194480b0; DANSER AHJ, 1989, J CLIN ENDOCR METAB, V68, P160, DOI 10.1210/jcem-68-1-160; DERKX FHM, 1987, J BIOL CHEM, V262, P2472; DERKX FHM, 1992, J BIOL CHEM, V267, P22837; FRITZ LC, 1987, J BIOL CHEM, V262, P12409; FROHLICH ED, 1990, AM J MED S6B, V87; GRIENDLING KK, 1993, CIRCULATION, V87, P1816, DOI 10.1161/01.CIR.87.6.1816; HARDMAN JA, 1984, DNA-J MOLEC CELL BIO, V3, P457, DOI 10.1089/dna.1.1984.3.457; HARRISON TM, 1989, PROTEINS, V5, P259, DOI 10.1002/prot.340050402; HEINRIKSON RL, 1989, AM J HYPERTENS, V2, P367, DOI 10.1093/ajh/2.5.367; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; HSUEH WA, 1991, HYPERTENSION, V17, P469, DOI 10.1161/01.HYP.17.4.469; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; JEUNEMAITRE X, 1992, HUM GENET, V88, P301; LINDPAINTNER K, 1991, CARDIOLOGY, V79, P32, DOI 10.1159/000174905; NAGAHAMA M, 1989, FEBS LETT, V259, P202, DOI 10.1016/0014-5793(89)81528-5; NEURINGER JR, 1993, AM J KIDNEY DIS, V22, P98, DOI 10.1016/S0272-6386(12)70174-9; OKURA T, 1993, J HUM HYPERTENS, V7, P457; PITARRESI TM, 1992, J BIOL CHEM, V267, P11753; RAPP JP, 1989, SCIENCE, V243, P542, DOI 10.1126/science.2563177; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; SCHALEKAMP MADH, 1992, J HYPERTENS, V10, pS157; SEALEY JE, 1989, AM J HYPERTENS, V2, P358, DOI 10.1093/ajh/2.5.358; VILLARD E, 1994, J BIOL CHEM, V269, P30307; WARD R, 1990, HYPERTENSION PATHOPH, P81; WILLIAMS RR, 1989, HYPERTENSION, V14, P610, DOI 10.1161/01.HYP.14.6.610; XHIGNESSE M, 1991, ARTERIOSCLER THROMB, V11, P1100, DOI 10.1161/01.ATV.11.4.1100	35	47	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16355	16359		10.1074/jbc.270.27.16355	http://dx.doi.org/10.1074/jbc.270.27.16355			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608205	Green Submitted, hybrid			2022-12-27	WOS:A1995RH22600072
J	ADACHI, K; SABNEKAR, P; ADACHI, M; REDDY, LR; PANG, JA; REDDY, KS; SURREY, S				ADACHI, K; SABNEKAR, P; ADACHI, M; REDDY, LR; PANG, JA; REDDY, KS; SURREY, S			POLYMERIZATION OF RECOMBINANT HB S-KEMPSEY (DEOXY-R STATE) AND HB S-KANSAS (OXY-T STATE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOGLOBIN-KANSAS; AFFINITY VARIANT; GLOBIN STRUCTURE; GELATION; DEOXYHEMOGLOBIN; CRYSTALLIZATION; AGGREGATION; BINDING; HEME	In order to investigate the role of the R (relaxed) to T (tense) structural transition in facilitating polymerization of deoxy-Hb S, we have engineered and expressed two Hb S variants which destabilize either T state (Hb S-Kempsey, alpha(2) beta(2)(Val-6, Asn-99)). R State structures (Hb S-Kansas, alpha(2) beta(2)(Val-6, Thr-102)), Polymerization of deoxy-Hb S-Kempsey, which shows high oxygen affinity and increased dimer dissociation, required about 2- and Ci fold higher hemoglobin concentrations than deoxy-fm S for polymerization in low and high phosphate concentrations, and its kinetic pattern of polymerization was biphasic, In contrast, oxy- or CO Hb S-Kansas, which shows low oxygen affinity and increased dimer dissociation, polymerized at a slightly higher critical concentration than that required for polymerization of deoxy-Hb S in both low and high phosphate buffers, Polymerization of oxy- and CO Kb S Kansas was linear and showed no delay time, which is similar to oversaturated oxy- or CO Hb S, These results suggest that nuclei formation, which occurs during the delay time prior to deoxy-Hb S polymerization, does not occur in T state oxy-Hb S-Kansas, even though the critical concentration for polymerization of T state oxy-Hb S-Kansas is similar to that of T state deoxy Hb S.	UNIV PENN, DEPT BIOPHYS, PHILADELPHIA, PA 19104 USA	University of Pennsylvania	ADACHI, K (corresponding author), UNIV PENN, CHILDRENS HOSP, SCH MED, DIV HEMATOL, 34TH ST & CIVIC CTR BLVD, PHILADELPHIA, PA 19104 USA.		Adachi, Megumi/M-7746-2017	Adachi, Megumi/0000-0003-3404-6640	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P60HL038632] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL38632] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADACHI K, 1979, J BIOL CHEM, V254, P2273; ADACHI K, 1981, J BIOL CHEM, V256, P1824; ADACHI K, 1992, PROTEIN ENG, V5, P807, DOI 10.1093/protein/5.8.807; ANDERSON L, 1975, J MOL BIOL, V94, P33, DOI 10.1016/0022-2836(75)90403-9; AROUS N, 1981, FEBS LETT, V126, P114, DOI 10.1016/0014-5793(81)81046-0; ATHA DH, 1979, J BIOL CHEM, V254, P2390; ATHA DH, 1976, J BIOL CHEM, V251, P5537; BLOUQUIT Y, 1981, HEMOGLOBIN, V5, P19, DOI 10.3109/03630268108996908; BONAVENTURA J, 1968, J BIOL CHEM, V243, P980; BUNN HF, 1974, J BIOL CHEM, V249, P7402; BUNN HF, 1986, HEMOGLOBIN MOL GENET, P452; DICKERSON RE, 1983, HEMOGLOBIN STRUCTURE, P125; GIBSON QH, 1973, J BIOL CHEM, V248, P5976; GREER J, 1971, J MOL BIOL, V59, P99, DOI 10.1016/0022-2836(71)90415-3; HARRIS JW, 1950, P SOC EXP BIOL MED, V75, P197, DOI 10.3181/00379727-75-18144; HOFRICHTER J, 1976, P NATL ACAD SCI USA, V73, P3035, DOI 10.1073/pnas.73.9.3035; JONES RT, 1967, J CLIN INVEST, V46, P1840, DOI 10.1172/JCI105674; KIM HW, 1994, P NATL ACAD SCI USA, V91, P11547, DOI 10.1073/pnas.91.24.11547; LINDSTROM TR, 1973, BIOCHEMISTRY-US, V12, P4212, DOI 10.1021/bi00745a027; NAGAI K, 1982, BIOCHEMISTRY-US, V21, P842, DOI 10.1021/bi00534a005; NAGEL RL, 1976, NEW ENGL J MED, V295, P125, DOI 10.1056/NEJM197607152950302; OGAWA S, 1972, BIOCHEM BIOPH RES CO, V49, P1485, DOI 10.1016/0006-291X(72)90507-4; PERUTZ MF, 1971, COLD SPRING HARB SYM, V36, P295; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; PERUTZ MF, 1974, BIOCHEMISTRY-US, V13, P2174, DOI 10.1021/bi00707a027; PERUTZ MF, 1974, BIOCHEMISTRY-US, V13, P2163, DOI 10.1021/bi00707a026; REED CS, 1968, BLOOD, V31, P523, DOI 10.1182/blood.V31.5.623.623; RICHARD AJ, 1991, HEMOGLOBIN, V15, P125, DOI 10.3109/03630269109072493; ROCHETTE J, 1984, FEBS LETT, V32, P6411; RUCKNAGEL DL, 1967, CLIN RES, V15, P270; Shackleton CHL, 1994, MASS SPECTROMETRY CL, V2, P135; TAMAGNINI GP, 1991, HEMOGLOBIN, V15, P487, DOI 10.3109/03630269109027896; TORREBLANCO A, 1992, J BIOL CHEM, V267, P2650; WAGENBACH M, 1991, BIO-TECHNOL, V9, P57, DOI 10.1038/nbt0191-57; WAJCMAN H, 1991, BLOOD, V78, P206; WEATHERALL DJ, 1977, BRIT J HAEMATOL, V35, P177, DOI 10.1111/j.1365-2141.1977.tb00575.x; YANASE H, 1995, PROTEIN SCI, V4, P21; YANASE H, 1994, PROTEIN SCI, V3, P1213, DOI 10.1002/pro.5560030807	38	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26857	26862		10.1074/jbc.270.45.26857	http://dx.doi.org/10.1074/jbc.270.45.26857			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592928	hybrid			2022-12-27	WOS:A1995TE58300028
J	TANG, DM; YEUNG, J; LEE, KY; MATSUSHITA, M; MATSUI, H; TOMIZAWA, K; HATASE, O; WANG, JH				TANG, DM; YEUNG, J; LEE, KY; MATSUSHITA, M; MATSUI, H; TOMIZAWA, K; HATASE, O; WANG, JH			AN ISOFORM OF THE NEURONAL CYCLIN-DEPENDENT KINASE-5 (CDK5) ACTIVATOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECTED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNIT; BOVINE BRAIN; P34(CDC2); YEAST; PHASE; G1; PURIFICATION; P40(MO15)	Neuronal Cdc2-like kinase is a heterodimer of Cdk5 and a 25-kDa subunit that is derived from a 35-kDa brain- and neuron-specific protein called the neuronal Cdk5 activator (p35/p25(nck5a)) (Lew, J., Huang, Q.-Q., Qi, Z., Winkfein, R. J., Aebersold, R., Hunt, T., and Wang, J. H. (1994) Nature 371, 423-426; Tsai, L. H., Delalle, I., Caviness, V. S., Jr., Chae, T., and Harlow, E. (1994) Nature 371, 419-423). Upon screening of a human hippocampus library with a bovine Nck5a cDNA, we uncovered a distinct clone encoding a 39-kDa isoform of Nck5a. The isoform, designated the neuronal Cdk5 activator isoform (p39(nck5ai)), showed a high degree of sequence similarity to p35(nck5a) with 57% amino acid identity. Northern blot analysis detected its mRNA transcript in bovine and rat cerebrum and cerebellum, but not in any other rat tissues examined. In situ hybridization showed that Nck5ai was enriched in CA1 to CA3 of the hippocampus, but absent in the fimbria of hippocampal formation. Among seven cell lines in proliferating cultures, only PC12 and N2A, two cell lines capable of differentiating into neuron-like cells, were found to contain Nck5ai mRNA. A 30-kDa truncated form of Nck5ai expressed as a glutathione S-transferase fusion protein in Escherichia coli] was found to associate with Cdk5 to form an active Cdk5 kinase. Thus, the isoform shares many common characteristics with p35(nck5a), including Ckd5 activating activity and brain- and neuron-specific expression. Both proteins show limited sequence homology to cyclins, suggesting that they define a new family of cyclin-dependent kinase-activating proteins.	HONG KONG UNIV SCI & TECHNOL, DEPT BIOCHEM, KOWLOON, HONG KONG; UNIV CALGARY, DEPT MED BIOCHEM, MRC, SIGNAL TRANSDUCT GRP, CALGARY, AB T2N 4N1, CANADA; KAGAWA MED SCH, DEPT PHYSIOL, MIKI, KAGAWA 76107, JAPAN; OKAYAMA UNIV, SCH MED, DEPT PHYSIOL, OKAYAMA 700, JAPAN	Hong Kong University of Science & Technology; University of Calgary; Kagawa University; Okayama University			Tang, Damu/AAQ-1786-2021	Tang, Damu/0000-0002-3282-9521				AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BEAUDETTE KN, 1993, J BIOL CHEM, V268, P20825; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Fantes P, 1989, CURR OPIN CELL BIOL, V1, P250, DOI 10.1016/0955-0674(89)90096-3; FESQUET D, 1993, EMBO J, V12, P3111, DOI 10.1002/j.1460-2075.1993.tb05980.x; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; GHIARA JB, 1991, CELL, V65, P163, DOI 10.1016/0092-8674(91)90417-W; HADWIGER JA, 1989, P NATL ACAD SCI USA, V86, P6255, DOI 10.1073/pnas.86.16.6255; Hay R, 1992, AM TYPE CULTURE COLL; HELLMICH MR, 1992, P NATL ACAD SCI USA, V89, P10867, DOI 10.1073/pnas.89.22.10867; HIROTA S, 1992, MOL BRAIN RES, V15, P47, DOI 10.1016/0169-328X(92)90150-A; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; ISHIGURO K, 1994, FEBS LETT, V342, P203, DOI 10.1016/0014-5793(94)80501-6; KOZAK M, 1983, MICROBIOL REV, V47, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEW J, 1992, J BIOL CHEM, V267, P25922; LEW J, 1992, J BIOL CHEM, V267, P13383; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MORGAN DO, 1994, CURR OPIN CELL BIOL, V6, P239, DOI 10.1016/0955-0674(94)90142-2; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Nasmyth K, 1993, CURR OPIN CELL BIOL, V5, P166, DOI 10.1016/0955-0674(93)90099-C; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PINES J, 1992, Current Opinion in Cell Biology, V4, P144, DOI 10.1016/0955-0674(92)90024-7; PINES J, 1993, CURR BIOL, V3, P544, DOI 10.1016/0960-9822(93)90053-Q; POON RYC, 1993, EMBO J, V12, P3123, DOI 10.1002/j.1460-2075.1993.tb05981.x; QI Z, 1995, J BIOL CHEM, V270, P10847, DOI 10.1074/jbc.270.18.10847; REED SI, 1992, ANNU REV CELL BIOL, V8, P529, DOI 10.1146/annurev.cb.08.110192.002525; RICHARDSON HE, 1989, CELL, V59, P1127, DOI 10.1016/0092-8674(89)90768-X; Sambrook J, 1989, MOL CLONING LABORATO; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOLOMON MJ, 1993, EMBO J, V12, P3133, DOI 10.1002/j.1460-2075.1993.tb05982.x; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; WITTENBERG C, 1990, CELL, V62, P225, DOI 10.1016/0092-8674(90)90361-H; YUE X, 1991, CELL, V65, P691, DOI 10.1016/0092-8674(91)90100-D	40	282	297	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26897	26903		10.1074/jbc.270.45.26897	http://dx.doi.org/10.1074/jbc.270.45.26897			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592934	hybrid			2022-12-27	WOS:A1995TE58300034
J	TSUTAKAWA, SE; MEDZIHRADSZKY, KF; FLINT, AJ; BURLINGAME, AL; KOSHLAND, DE				TSUTAKAWA, SE; MEDZIHRADSZKY, KF; FLINT, AJ; BURLINGAME, AL; KOSHLAND, DE			DETERMINATION OF IN-VIVO PHOSPHORYLATION SITES IN PROTEIN-KINASE-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; IDENTIFICATION; ACTIVATION; BOVINE; AUTOPHOSPHORYLATION; MULTIPLE; SEQUENCE; PEPTIDES; FAMILY; IONS	The primary structure of rat protein kinase C beta II was probed by high pressure liquid chromatography directly coupled to an electrospray ionization mass spectrometer and by high energy collision-induced dissociation analysis to identify in vivo phosphorylation sites, The N-terminal methionine was found to be cleaved post-translationally and replaced with an acetyl group, Four phosphopeptides were identified, Two peptides, Thr(500)-Lys(520) and Glu(490)-Lys(520), are phosphorylated at Thr(500) greater than 90%. Peptide His(636)-Arg(649) is phosphorylated about 75% at Thr(641). It is the only site that was previously identified during the in vitro autophosphorylation studies (Flint, A. J., Paladini, R. D., and Koshland, D. E., Jr. (1990) Science 249, 408-411). The fourth peptide Asn(650)-Lys(672) is phosphorylated at Thr(660). A discussion of the potential implication of these results follows.	UNIV CALIF BERKELEY,DEPT BIOCHEM & MOLEC BIOL,BERKELEY,CA 94720; UNIV CALIF SAN FRANCISCO,SCH PHARM,DEPT PHARMACEUT CHEM,SAN FRANCISCO,CA 94143; COLD SPRING HARBOR LAB,COLD SPRING HARBOR,NY 11724	University of California System; University of California Berkeley; University of California System; University of California San Francisco; Cold Spring Harbor Laboratory				Tsutakawa, Susan/0000-0002-4918-4571	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK009765, R37DK009765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705] Funding Source: NIH RePORTER; NCRR NIH HHS [RR01614] Funding Source: Medline; NIDDK NIH HHS [DK09765] Funding Source: Medline; NIEHS NIH HHS [ES04705] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AZZI A, 1992, EUR J BIOCHEM, V208, P547, DOI 10.1111/j.1432-1033.1992.tb17219.x; BIEMANN K, 1990, METHOD ENZYMOL, V193, P886, DOI 10.1016/0076-6879(90)93460-3; CAZAUBON S, 1994, BIOCHEM J, V301, P443, DOI 10.1042/bj3010443; CAZAUBON SM, 1993, J BIOL CHEM, V268, P17559; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; DRAPEAU GR, 1980, J BIOL CHEM, V255, P839; DUTIL EM, 1994, J BIOL CHEM, V269, P29359; ERICKSON AK, 1990, J BIOL CHEM, V265, P19728; FALICK AM, 1990, RAPID COMMUN MASS SP, V4, P318, DOI 10.1002/rcm.1290040905; FALICK AM, 1995, ANAL CHEM, V58, P1308; Fisher E.H., 1955, J BIOL CHEM, V216, P121; FLINT AJ, 1990, SCIENCE, V249, P408, DOI 10.1126/science.2377895; GIBSON BW, 1990, METHOD ENZYMOL, V193, P480, DOI 10.1016/0076-6879(90)93434-M; GRIFFIN PR, 1991, INT J MASS SPECTROM, V111, P131, DOI 10.1016/0168-1176(91)85052-N; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HEMLING ME, 1990, BIOMED ENVIRON MASS, V19, P677, DOI 10.1002/bms.1200191107; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; JOHNSON RS, 1988, INT J MASS SPECTROM, V86, P137, DOI 10.1016/0168-1176(88)80060-0; KIKKAWA U, 1982, J BIOL CHEM, V257, P13341; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNOPF JL, 1986, CELL, V46, P491, DOI 10.1016/0092-8674(86)90874-3; Medzihradszky Katalin F., 1994, Methods (Orlando), V6, P284, DOI 10.1006/meth.1994.1030; MITCHELL FE, 1989, BIOCHEM J, V261, P131, DOI 10.1042/bj2610131; MOCHLYROSEN D, 1987, J BIOL CHEM, V262, P2291; NEWTON AC, 1987, J BIOL CHEM, V262, P10185; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; ORR JW, 1994, J BIOL CHEM, V269, P27715; ORR JW, 1994, J BIOL CHEM, V269, P8383; PAPAC DI, 1993, BIOCHEMISTRY-US, V32, P5930, DOI 10.1021/bi00074a002; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PEARS C, 1992, BIOCHEM J, V283, P515, DOI 10.1042/bj2830515; PELECH SL, 1991, BIOCH CELL BIOL, V68, P1297; SANDERS DA, 1992, J BACTERIOL, V174, P5117, DOI 10.1128/JB.174.15.5117-5122.1992; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; SU LH, 1993, RECEPTOR CHANNEL, V1, P1; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; WALLS FC, 1993, 41ST P ASMS C MASS S; ZHANG J, 1994, J BIOL CHEM, V269, P19578; ZHANG J, 1993, P NATL ACAD SCI USA, V90, P6130, DOI 10.1073/pnas.90.13.6130	42	82	83	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26807	26812		10.1074/jbc.270.45.26807	http://dx.doi.org/10.1074/jbc.270.45.26807			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592921	hybrid			2022-12-27	WOS:A1995TE58300021
J	URBATSCH, IL; SANKARAN, B; BHAGAT, S; SENIOR, AE				URBATSCH, IL; SANKARAN, B; BHAGAT, S; SENIOR, AE			BOTH P-GLYCOPROTEIN NUCLEOTIDE-BINDING SITES ARE CATALYTICALLY ACTIVE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE; ADENOSINE-TRIPHOSPHATASE; VANADATE ION; MYOSIN; ATPASE; INHIBITION; RECONSTITUTION; GENE	The technique of vanadate trapping of nucleotide was used to study catalytic sites of P-glycoprotein (Pgp) in plasma membranes from multidrug-resistant Chinese hamster ovary cells. Vanadate trapping of Mg- or Co-8-azido-nucleotide (1 mol/mol of Pgp) caused complete inhibition of Pgp ATPase activity, with reactivation rates at 37 degrees C of 1.4 x 10(-3) s(-1) (t(1/2) = 8 min) or 3.3 x 10(-4) s(-1) (t(1/2) = 35 min), respectively. UV irradiation of the inhibited Pgp yielded permanent inactivation of ATPase activity and specific photolabeling of Pgp, Mild trypsin digestion showed that the two nucleotide sites were labeled in equal proportion. The results show that both nucleotide sites in Pgp are capable of nucleotide hydrolysis, that vanadate trapping of nucleotide at either site completely prevents hydrolysis at both sites, and that vanadate trapping of nucleotide in the N- or C-terminal nucleotide sites occurs non-selectively. A minimal scheme is presented to explain inhibition by vanadate trapping of nucleotide and to describe the normal catalytic pathway, The inhibited Pgp Mg-nucleotide vanadate complex is probably an analog of the catalytic transition state, implying that when one nucleotide site assumes the catalytic transition state conformation the other site cannot do so and suggesting that the two sites may alternate in catalysis.			URBATSCH, IL (corresponding author), UNIV ROCHESTER,MED CTR,DEPT BIOCHEM,ROCHESTER,NY 14642, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050156] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM50156] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; ALSHAWI MK, 1994, J BIOL CHEM, V269, P8986; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; GEORGES E, 1991, J CELL PHYSIOL, V148, P479, DOI 10.1002/jcp.1041480321; GOODNO CC, 1982, P NATL ACAD SCI-BIOL, V79, P21, DOI 10.1073/pnas.79.1.21; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; GOODNO CC, 1979, P NATL ACAD SCI USA, V76, P2620, DOI 10.1073/pnas.76.6.2620; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Gros P, 1993, Int Rev Cytol, V137C, P169; LOO TW, 1994, J BIOL CHEM, V269, P7750; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; RONINSON IB, 1992, BIOCHEM PHARMACOL, V43, P95, DOI 10.1016/0006-2952(92)90666-7; RUETZ S, 1994, J BIOL CHEM, V269, P12277; SARKADI B, 1992, J BIOL CHEM, V267, P4854; SHAPIRO AB, 1995, J BIOENERG BIOMEMBR, V27, P7, DOI 10.1007/BF02110325; SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745; SHAROM FJ, 1995, BIOCHEM J, V308, P381, DOI 10.1042/bj3080381; SHAROM FJ, 1993, J BIOL CHEM, V268, P24197; SHAROM FJ, 1995, J BIOENERG BIOMEMBR, V27, P15, DOI 10.1007/BF02110326; SHIMIZU T, 1983, J BIOL CHEM, V258, P3833; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1994, BIOCHEMISTRY-US, V33, P7069, DOI 10.1021/bi00189a008; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WERBER MM, 1992, BIOCHEMISTRY-US, V31, P7190, DOI 10.1021/bi00146a023; WOLODKO WT, 1983, J BIOL CHEM, V258, P4116; YOUNT RG, 1992, PHILOS T ROY SOC B, V336, P55, DOI 10.1098/rstb.1992.0044	28	225	226	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26956	26961		10.1074/jbc.270.45.26956	http://dx.doi.org/10.1074/jbc.270.45.26956			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592942	hybrid			2022-12-27	WOS:A1995TE58300042
J	TACHIAS, K; MADISON, EL				TACHIAS, K; MADISON, EL			VARIANTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR WHICH DISPLAY SUBSTANTIALLY ENHANCED STIMULATION BY FIBRIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ONE-CHAIN; PROTEOLYTIC-ENZYMES; STREPTOKINASE; CLEAVAGE; STAPHYLOKINASE; RESISTANT; INHIBITOR; MECHANISM; MUTANTS	Unlike most proteases, tissue-type plasminogen activator (t-PA) is secreted from cells as an active, single chain ''proenzyme'' whose catalytic efficiency is comparable with that of the corresponding mature, two-chain enzyme. We have previously suggested that the absence of the ''zymogen triad'' (Asp(194) His(40)-Ser(32); chymotrypsin numbering) contributes to this unusually high enzymatic activity of single chain t-PA. Consistent with this prediction, the single chain form of a variant of t-PA containing the zymogen triad displayed dramatically reduced activity toward synthetic substrates. Activation cleavage of this variant, however, resulted in a mature, two chain enzyme with full catalytic activity. To further examine the functional significance of the zymogen triad, we used site specific mutagenesis to construct a variant of t-PA, t-PA/R275E,A292S,P305H, that contained this triad but could not be converted into its two-chain form by plasmin. Characterization of this variant demonstrated that the presence of the zymogen triad specifically suppressed plasminogen activation by single chain t-PA in the absence of fibrin. In addition, these studies indicated that, like wild type t-PA, zymogen activation of this variant could be accomplished by binding to the cc-factor fibrin. The combination of full activity in the presence of fibrin and reduced activity in its absence resulted in novel variants of t-PA that displayed dramatically enhanced stimulation by fibrin, While the presence of fibrin increased the catalytic efficiency of t-PA toward plasminogen by a factor of approximately 520, this stimulation factor increased to 130,000 for t-PA/R275E,A292S,F305H. Plasmin-resistant, zymogen-like variants of t-PA, therefore, may represent thrombolytic enzymes with enhanced ''clot selectivity.''	Scripps Res Inst, DEPT VASC BIOL, LA JOLLA, CA 92037 USA	Scripps Research Institute					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031950] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL31950, R01 HL52476] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEATTY K, 1980, J BIOL CHEM, V255, P3931; BERGUM PW, 1992, J BIOL CHEM, V267, P17726; BOOSE JA, 1989, BIOCHEMISTRY-US, V28, P635, DOI 10.1021/bi00428a033; COLLEN D, 1991, BLOOD, V78, P3114; COLLEN D, 1993, J BIOL CHEM, V268, P8284; DAVIDSON DJ, 1990, BIOCHEMISTRY-US, V29, P3585, DOI 10.1021/bi00466a023; GARDELL SJ, 1989, J BIOL CHEM, V264, P17947; HEMKER HC, 1975, BIOCHIM BIOPHYS ACTA, V379, P180, DOI 10.1016/0005-2795(75)90020-3; HENDRIX H, 1983, J BIOL CHEM, V258, P3637; HIGGINS DL, 1990, THROMB RES, V57, P527, DOI 10.1016/0049-3848(90)90070-S; HIGH K, 1995, MOL BASIS THROMBOSIS; HOLMES WE, 1987, BIOCHEMISTRY-US, V26, P5133, DOI 10.1021/bi00390a036; KRATZSCHMAR J, 1991, GENE, V105, P229, DOI 10.1016/0378-1119(91)90155-5; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LIJNEN HR, 1992, FIBRINOLYSIS, V6, P33, DOI 10.1016/0268-9499(92)90045-J; LIJNEN HR, 1991, THROMB HAEMOSTASIS, V66, P88; MADISON EL, 1990, J BIOL CHEM, V265, P21423; MADISON EL, 1990, P NATL ACAD SCI USA, V87, P3530, DOI 10.1073/pnas.87.9.3530; MADISON EL, 1989, NATURE, V339, P721, DOI 10.1038/339721a0; MADISON EL, 1993, SCIENCE, V262, P419, DOI 10.1126/science.8211162; MADISON EL, 1994, FIBRINOLYSIS, V8, P221, DOI 10.1016/0268-9499(94)90720-X; MANN KG, 1993, METHOD ENZYMOL, V223, P1; NEURATH H, 1989, TRENDS BIOCHEM SCI, V14, P268, DOI 10.1016/0968-0004(89)90061-3; NEURATH H, 1986, J CELL BIOCHEM, V32, P35, DOI 10.1002/jcb.240320105; NEURATH H, 1984, SCIENCE, V224, P350, DOI 10.1126/science.6369538; PETERSEN LC, 1988, BIOCHIM BIOPHYS ACTA, V952, P245, DOI 10.1016/0167-4838(88)90123-9; RANBY M, 1982, THROMB RES, V27, P175, DOI 10.1016/0049-3848(82)90197-9; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; SCHICK LA, 1973, BIOCHEMISTRY-US, V12, P4315, DOI 10.1021/bi00746a003; SUMMARIA L, 1969, P SOC EXP BIOL MED, V130, P737; TATE KM, 1987, BIOCHEMISTRY-US, V26, P338, DOI 10.1021/bi00376a002; URANO T, 1989, ARCH BIOCHEM BIOPHYS, V270, P356, DOI 10.1016/0003-9861(89)90038-6; ZOLLER MJ, 1984, DNA-J MOLEC CELL BIO, V3, P479, DOI 10.1089/dna.1.1984.3.479	33	22	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18319	18322		10.1074/jbc.270.31.18319	http://dx.doi.org/10.1074/jbc.270.31.18319			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629153	hybrid			2022-12-27	WOS:A1995RM64200028
J	WANG, QM; GUAN, KL; ROACH, PJ; DEPAOLIROACH, AA				WANG, QM; GUAN, KL; ROACH, PJ; DEPAOLIROACH, AA			PHOSPHORYLATION AND ACTIVATION OF THE ATP-MG-DEPENDENT PROTEIN PHOSPHATASE BY THE MITOGEN-ACTIVATED PROTEIN-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; GLYCOGEN-SYNTHASE KINASE-3; SIGNAL-REGULATED KINASES; PHOSPHOPROTEIN PHOSPHATASE; MOLECULAR-CLONING; SUBUNIT STRUCTURE; INSULIN; TRANSDUCTION; CELLS; INHIBITOR-2	Inhibitor-2 (I-2) is the regulatory subunit of the cytosolic ATP-Mg-dependent form of type 1 serine/threonine protein phosphatase and its phosphorylation at Thr-72 by glycogen synthase kinase-3 results in phosphatase activation. Activation of cytosolic type 1 phosphatase has been observed in cells treated with growth factors. Reported here is the phosphorylation and activation of the ATP-Mg-dependent phosphatase by mitogen-activated protein kinase (MAPR). Recombinant I-2 was phosphorylated by activated MAPK to an extent (similar to 0.3 mol of phosphate/mol of polypeptide) similar to that reported for phosphorylation by the alpha isoform of glycogen synthase kinase-3. The phosphorylation of I-2 by MAPK was exclusively at Thr-72, the site involved in the activation of phosphatase. Incubation of MAPK with purified ATP Mg-dependent phosphatase resulted in phosphorylation of the I-2 component and activation of the phosphatase. Ribosomal S6 protein kinase II (p9O(rsh)) was also able to phosphorylate the recombinant I-2; however, this phosphorylation occurred on serines and had no effect on phosphatase activation. Our data may explain growth factor-induced activation of the ATP-Mg-dependent phosphatase and suggest that MAPK may be the physiological kinase responsible for the activation of cytosolic type 1 phosphatase in response to insulin and/or other growth factors.	INDIANA UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOL,INDIANAPOLIS,IN 46202; UNIV MICHIGAN,SCH MED,DEPT BIOL CHEM,ANN ARBOR,MI 48109	Indiana University System; Indiana University-Purdue University Indianapolis; University of Michigan System; University of Michigan					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027221, R56DK027221, R01DK036569, R37DK027221] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK27221, DK36569] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGOSTINIS P, 1992, FEBS LETT, V305, P121, DOI 10.1016/0014-5793(92)80877-J; BALLOU LM, 1983, BIOCHEMISTRY-US, V22, P3393, DOI 10.1021/bi00283a014; BEULLENS M, 1992, J BIOL CHEM, V267, P16538; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDT H, 1975, J BIOL CHEM, V250, P8038; CHAN CP, 1988, P NATL ACAD SCI USA, V85, P6257, DOI 10.1073/pnas.85.17.6257; CHAREST DL, 1993, MOL CELL BIOL, V13, P4679, DOI 10.1128/MCB.13.8.4679; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; COBB MH, 1994, SEMIN CANCER BIOL, V5, P261; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DENT P, 1990, NATURE, V348, P302, DOI 10.1038/348302a0; DEPAOLIROACH AA, 1984, J BIOL CHEM, V259, P2144; DEPAOLIROACH AA, 1994, ADV ENZYME REGUL, V34, P199, DOI 10.1016/0065-2571(94)90017-5; ERIKSON E, 1988, 2ND MESSENGERS PHOSP, V12, P135; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; HAYSTEAD TAJ, 1994, J BIOL CHEM, V269, P23185; HEMMINGS BA, 1982, FEBS LETT, V150, P319, DOI 10.1016/0014-5793(82)80760-6; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; KLARLUND JK, 1988, J BIOL CHEM, V263, P15872; KOVACINA KS, 1990, J BIOL CHEM, V265, P12115; LAWRENCE JC, 1988, BIOCHEM BIOPH RES CO, V150, P197, DOI 10.1016/0006-291X(88)90505-0; Lin Tai-An, 1994, Journal of Biological Chemistry, V269, P21255; LITCHFIELD DW, 1990, J BIOL CHEM, V265, P7638; NEIMAN AM, 1993, TRENDS GENET, V3, P390; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; OLIVIER AR, 1988, P NATL ACAD SCI USA, V85, P4720, DOI 10.1073/pnas.85.13.4720; PARK IK, 1994, J BIOL CHEM, V269, P28919; PARK IK, 1994, J BIOL CHEM, V269, P944; POSADA J, 1992, MOL BIOL CELL, V3, P583, DOI 10.1091/mbc.3.6.583; RAMAKRISHNA S, 1988, J BIOL CHEM, V263, P12677; ROBINSON LJ, 1993, J BIOL CHEM, V268, P26422; SETH A, 1992, J BIOL CHEM, V267, P24796; SOMMERCORN J, 1987, P NATL ACAD SCI USA, V84, P8834, DOI 10.1073/pnas.84.24.8834; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; TANG PM, 1991, J BIOL CHEM, V266, P15782; VIK TA, 1990, P NATL ACAD SCI USA, V87, P2685, DOI 10.1073/pnas.87.7.2685; VILLAMORUZZI E, 1989, FEBS LETT, V258, P208, DOI 10.1016/0014-5793(89)81654-0; WANG QM, 1994, BIOCHEMISTRY-US, V33, P143, DOI 10.1021/bi00167a018; WANG QM, 1994, J BIOL CHEM, V269, P14566; WELSH GI, 1993, BIOCHEM J, V294, P625, DOI 10.1042/bj2940625; WELSH GI, 1994, BIOCHEM J, V303, P15, DOI 10.1042/bj3030015; WU J, 1991, P NATL ACAD SCI USA, V88, P9508, DOI 10.1073/pnas.88.21.9508; YANG SD, 1989, J BIOL CHEM, V264, P5407; YANG SD, 1981, J BIOL CHEM, V256, P231; ZHENG CF, 1993, J BIOL CHEM, V268, P23933; ZHENG CF, 1993, J BIOL CHEM, V268, P11435	52	47	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18352	18358		10.1074/jbc.270.31.18352	http://dx.doi.org/10.1074/jbc.270.31.18352			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629158	hybrid			2022-12-27	WOS:A1995RM64200034
J	LAMANDE, SR; BATEMAN, JF				LAMANDE, SR; BATEMAN, JF			THE TYPE-I COLLAGEN PRO-ALPHA-1(I) COOH-TEMMINAL PROPEPTIDE N-LINKED OLIGOSACCHARIDE - FUNCTIONAL-ANALYSIS BY SITE-DIRECTED MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL ELECTROPHORESIS; EXTRACELLULAR-MATRIX ACCUMULATION; PERINATAL OSTEOGENESIS IMPERFECTA; CARBOXYL-TERMINAL PROPEPTIDE; EMBRYONIC LETHAL MUTATION; PROCOLLAGEN TYPE-I; ENDOPLASMIC-RETICULUM; INTRACELLULAR-TRANSPORT; INFLUENZA HEMAGGLUTININ; HUMAN-FIBROBLASTS	The C-propeptides of the pro alpha 1(I) and pro alpha 2(I) chains of type I collagen are each substituted with a single high-mannose N-linked oligosaccharide. Conservation of this motif among the fibrillar collagens has led to the proposal that the oligosaccharide has structural or functional importance, but a role in collagen biosynthesis has not been unambiguously defined. To examine directly the function of the pro alpha 1(I) C-propeptide N-linked oligosaccharide, the acceptor Asn residue was changed to Gin by site-directed mutagenesis. In transfected mouse Mov13 and 3T6 cells, unglycosylated mutant pro alpha 1(I) folded and assembled normally into trimeric molecules with pro alpha 2(I). In biosynthetic pulse-chase experiments mutant pro alpha 1(I) were secreted at the same rate as wild-type chains; however, following secretion, the chains were partitioned differently between the cell layer and medium, with a greater proportion of the mutant pro alpha 1(I) being released into the medium. This distribution difference was not eliminated by the inclusion of yeast mannan indicating that the high-mannose oligosaccharide itself was not binding to the matrix or the fibroblast surface after secretion. Subtle alterations in the tertiary structure of unglycosylated C-propeptides may have decreased their affinity for a cell-surface component. Further support for a small conformational change in the mutant C-propeptides came hom experiments suggesting that unglycosylated pro alpha 1(I) chains were cleaved in vitro by the purified C-proteinase slightly less efficiently than wild-type chains. Mutant and normal pro alpha 1(I) were deposited with equal efficiency into the 3T6 cell accumulated matrix, thus the reduced cleavage by C-proteinase and altered distribution in the short pulse-chase experiments were not functionally significant in this in vitro extracellular matrix model system.	UNIV MELBOURNE,ROYAL CHILDRENS HOSP,DEPT PAEDIAT,ORTHOPAED MOLEC BIOL RES UNIT,PARKVILLE,VIC 3052,AUSTRALIA	Royal Children's Hospital Melbourne; University of Melbourne				Bateman, John/0000-0001-8542-0730; Lamande, Shireen/0000-0003-2938-2711				BASSUK JA, 1989, MATRIX, V9, P244, DOI 10.1016/S0934-8832(89)80057-5; BATEMAN JF, 1986, BIOCHEM J, V240, P699, DOI 10.1042/bj2400699; BATEMAN JF, 1988, ANAL BIOCHEM, V168, P171, DOI 10.1016/0003-2697(88)90025-5; BATEMAN JF, 1984, BIOCHEM J, V217, P103, DOI 10.1042/bj2170103; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P1139, DOI 10.1021/bi00274a023; BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P5213, DOI 10.1021/bi00291a023; BIRK DE, 1990, ANN NY ACAD SCI, V580, P176, DOI 10.1111/j.1749-6632.1990.tb17928.x; CHAN D, 1990, BIOCHEM J, V269, P175, DOI 10.1042/bj2690175; CHESSLER SD, 1993, J BIOL CHEM, V268, P18218; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; CHOGLAY AA, 1993, J BIOL CHEM, V268, P6107; CLARK CC, 1979, J BIOL CHEM, V254, P798; DION AS, 1987, J MOL BIOL, V193, P127, DOI 10.1016/0022-2836(87)90632-2; DOEGE KJ, 1986, J BIOL CHEM, V261, P8924; DUBE S, 1988, J BIOL CHEM, V263, P17516; DUKSIN D, 1977, J BIOL CHEM, V252, P955; DUKSIN D, 1978, ARCH BIOCHEM BIOPHYS, V185, P326, DOI 10.1016/0003-9861(78)90174-1; DUKSIN D, 1982, J BIOL CHEM, V257, P3105; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; FENTON SP, 1993, BIOCHIM BIOPHYS ACTA, V1216, P469, DOI 10.1016/0167-4781(93)90016-7; FESSLER LI, 1974, J BIOL CHEM, V249, P7637; Fisher L. W., 1989, CONNECT TISSUE RES, V21, P43; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; HARBERS K, 1984, P NATL ACAD SCI-BIOL, V81, P1504, DOI 10.1073/pnas.81.5.1504; HASELBECK A, 1990, ANAL BIOCHEM, V191, P25, DOI 10.1016/0003-2697(90)90381-I; HOUSLEY TJ, 1980, J BIOL CHEM, V255, P121; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; KADLER KE, 1987, J BIOL CHEM, V262, P15696; KAPLAN HA, 1987, BIOCHIM BIOPHYS ACTA, V906, P161, DOI 10.1016/0304-4157(87)90010-4; KESSLER E, 1990, BIOCHEM BIOPH RES CO, V173, P81, DOI 10.1016/S0006-291X(05)81024-1; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LAMANDE SR, 1995, J BIOL CHEM, V270, P8642, DOI 10.1074/jbc.270.15.8642; LAMANDE SR, 1993, MATRIX, V13, P323, DOI 10.1016/S0934-8832(11)80028-4; LAMANDE SR, 1993, BIOCHEM J, V293, P387, DOI 10.1042/bj2930387; LEUNG MKK, 1979, J BIOL CHEM, V254, P224; LIPPINCOTTSCHWA.J, 1988, CELL, V54, P209; LODISH HF, 1988, J BIOL CHEM, V263, P2107; MAHONEY WC, 1979, J BIOL CHEM, V254, P6572; MATZUK MM, 1988, J CELL BIOL, V106, P1049, DOI 10.1083/jcb.106.4.1049; NG DTW, 1990, MOL CELL BIOL, V10, P1989, DOI 10.1128/MCB.10.5.1989; OLDEN K, 1982, BIOCHIM BIOPHYS ACTA, V650, P209, DOI 10.1016/0304-4157(82)90017-X; OLSEN BR, 1977, BIOCHEMISTRY-US, V16, P3030, DOI 10.1021/bi00632a034; PAULSON JC, 1989, TRENDS BIOCHEM SCI, V14, P272, DOI 10.1016/0968-0004(89)90062-5; PHELPS RG, 1985, COLLAGEN REL RES, V5, P405; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; SCHNIEKE A, 1983, NATURE, V304, P315, DOI 10.1038/304315a0; SCOTT PG, 1976, CONNECT TISSUE RES, V4, P107, DOI 10.3109/03008207609152206; SEILBERG M, 1983, CANCER RES, V43, P845; SINGH I, 1990, EMBO J, V9, P631, DOI 10.1002/j.1460-2075.1990.tb08155.x; SMEDSROD B, 1990, BIOCHEM J, V271, P345, DOI 10.1042/bj2710345; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TANZER ML, 1977, BIOCHIM BIOPHYS ACTA, V500, P187, DOI 10.1016/0304-4165(77)90058-7; TAYLOR AK, 1988, MOL CELL BIOL, V8, P4197, DOI 10.1128/MCB.8.10.4197; TIFFT CJ, 1992, J BIOL CHEM, V267, P3268; TRELSTAD RL, 1979, DEV BIOL, V71, P228, DOI 10.1016/0012-1606(79)90166-0; WESTON SA, 1994, J BIOL CHEM, V269, P20982; WU CH, 1991, J BIOL CHEM, V266, P2983	59	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17858	17865		10.1074/jbc.270.30.17858	http://dx.doi.org/10.1074/jbc.270.30.17858			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629088	hybrid			2022-12-27	WOS:A1995RM26600036
J	TARLAP, A; KAPLAN, H; SYTWU, II; VLATTAS, I; BOHACEK, R; KNAP, AK; HIRAMA, T; HUBER, CP; HASNAIN, S				TARLAP, A; KAPLAN, H; SYTWU, II; VLATTAS, I; BOHACEK, R; KNAP, AK; HIRAMA, T; HUBER, CP; HASNAIN, S			CHARACTERIZATION OF THE S-3 SUBSITE SPECIFICITY OF CATHEPSIN-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEINASES; RAT-LIVER; CATALYZED HYDROLYZES; PH; INHIBITORS; INACTIVATORS; STABILITY; PROTEASE; ARGININE; CALPAIN	Five synthetic substrates containing different amino acid residues at the P-3 position (acetyl-X-Arg-Arg-AMC, where X is Gly, Glu, Arg, Val, and Tyr and where AMC represents 7-amido-4-methylcoumarin) were used to investigate the S-3 subsite specificity of cathepsin B. At pH 6.0, the specificity constant, k(cat)/K-m, for tripeptide substrate hydrolysis was observed to increase in the order Glu < Gly < Arg < Val < Tyr. Molecular modeling studies of substrates containing a P-3 Glu, Arg, or Tyr covalently bound as the tetrahedral intermediate to the enzyme suggest that the specificity for a P-3 Tyr is because of a favorable aromatic-aromatic interaction with Tyr(75) on the enzyme as well as a possible H bond between the P-3 Tyr hydroxyl and the side chain carboxyl of Asp(69).	UNIV OTTAWA,DEPT CHEM,OTTAWA,ON K1N 6N5,CANADA; CIBA GEIGY CORP,DIV PHARMACEUT,RES DEPT,SUMMIT,NJ 07901; NATL RES COUNCIL CANADA,INST BIOL SCI,OTTAWA,ON K1A 0R6,CANADA	University of Ottawa; Novartis; National Research Council Canada								ACHER R, 1952, BIOCHIM BIOPHYS ACTA, V9, P704, DOI 10.1016/0006-3002(52)90236-9; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BROMME D, 1989, BIOCHEM J, V264, P475; BROMME D, 1987, BIOCHEM J, V245, P381; BURLEY SK, 1989, TRENDS BIOTECHNOL, V7, P354, DOI 10.1016/0167-7799(89)90036-X; CRAWFORD C, 1988, BIOCHEM J, V253, P751, DOI 10.1042/bj2530751; ERNST JF, 1986, DNA-J MOLEC CELL BIO, V5, P483, DOI 10.1089/dna.1.1986.5.483; FERSHT AR, 1985, ENZYME STRUCTURE MEC, P156; GOPALAN P, 1987, CAN J PHYSIOL PHARM, V65, P124, DOI 10.1139/y87-025; HASNAIN S, 1992, J BIOL CHEM, V267, P4713; HASNAIN S, 1993, J BIOL CHEM, V268, P235; JIA ZC, 1995, J BIOL CHEM, V270, P5527, DOI 10.1074/jbc.270.10.5527; KATUNUMA N, 1987, REV PHYSL BIOCH PHAR, V108, P2; KHOURI HE, 1991, BIOCHEM J, V275, P751, DOI 10.1042/bj2750751; KOGA H, 1991, J BIOCHEM-TOKYO, V110, P179, DOI 10.1093/oxfordjournals.jbchem.a123554; KRANTZ A, 1991, BIOCHEMISTRY-US, V30, P4678, DOI 10.1021/bi00233a007; LAH TT, 1989, CLIN EXP METASTAS, V7, P461, DOI 10.1007/BF01753666; LEE X, 1990, J BIOL CHEM, V265, P5950; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; MORT JS, 1984, ARTHRITIS RHEUM, V27, P509, DOI 10.1002/art.1780270505; PLIURA DH, 1992, BIOCHEM J, V288, P759, DOI 10.1042/bj2880759; POHL J, 1987, ANAL BIOCHEM, V165, P96, DOI 10.1016/0003-2697(87)90205-3; ROWAN AD, 1992, J BIOL CHEM, V267, P15993; SERRANO L, 1991, J MOL BIOL, V218, P465, DOI 10.1016/0022-2836(91)90725-L; Sloane B F, 1990, Semin Cancer Biol, V1, P137; SLOANE BF, 1990, CANCER METAST REV, V9, P333, DOI 10.1007/BF00049523; VANNOORDEN CJF, 1989, J RHEUMATOL, V15, P1525; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; WIKSTROM P, 1989, ARCH BIOCHEM BIOPHYS, V270, P286, DOI 10.1016/0003-9861(89)90030-1; WILLENBROCK F, 1985, BIOCHEM J, V227, P521, DOI 10.1042/bj2270521	30	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18036	18043		10.1074/jbc.270.30.18036	http://dx.doi.org/10.1074/jbc.270.30.18036			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629112	hybrid			2022-12-27	WOS:A1995RM26600063
J	VIITANEN, PV; SCHMIDT, M; BUCHNER, J; SUZUKI, T; VIERLING, E; DICKSON, R; LORIMER, GH; GATENBY, A; SOLL, J				VIITANEN, PV; SCHMIDT, M; BUCHNER, J; SUZUKI, T; VIERLING, E; DICKSON, R; LORIMER, GH; GATENBY, A; SOLL, J			FUNCTIONAL-CHARACTERIZATION OF THE HIGHER-PLANT CHLOROPLAST CHAPERONINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE BISPHOSPHATE CARBOXYLASE; SYNTHESIZED LARGE SUBUNITS; HEAT-SHOCK PROTEINS; ESCHERICHIA-COLI; RIBULOSEBISPHOSPHATE-CARBOXYLASE; BINDING-PROTEIN; MOLECULAR CHAPERONE; PEA-CHLOROPLASTS; ATP HYDROLYSIS; GROEL	The higher plant chloroplast chaperonins (ch-cpn60 and ch-cpn10) have been purified and their structural/functional properties examined. In all plants surveyed, both proteins were constitutively expressed, and only modest increases in their levels were detected upon heat shock. Like GroEL and GroES of Escherichia coli, the chloroplast chaperonins can physically interact with each other. The asymmetric complexes that form in the presence of ADP are ''bullet-shaped'' particles that likely consist of 1 mol each of ch-cpn60 and ch-cpn10. The purified ch-cpn60 is a functional molecular chaperone. Under ''nonpermissive'' conditions, where spontaneous folding was not observed, it was able to assist in the refolding of two different target proteins. In both cases, successful partitioning to the native state also required ATP hydrolysis and chaperonin 10. Surprisingly, how ever, the ''double-domain'' ch-cpn10, comprised of unique 21-kDa subunits, was not an obligatory co-chaperonin. Both GroES and a mammalian mitochondrial homolog were equally compatible with the ch-cpn60. Finally, the assisted-folding reaction mediated by the chloroplast chaperonins does not require K+ ions. Thus, the K+-dependent ATPase activity that is observed with other known groEL homologs is not a universal property of all chaperonin 60s.	UNIV REGENSBURG,INST BIOPHYS & PHYS BIOCHEM,D-93040 REGENSBURG,GERMANY; UNIV ARIZONA,DEPT MOLEC & CELLULAR BIOL,TUCSON,AZ 85721; INST BOT,D-24098 KIEL,GERMANY	University of Regensburg; University of Arizona	VIITANEN, PV (corresponding author), DUPONT CO INC,DEPT CENT RES & DEV,DIV MOLEC BIOL,EXPTL STN,WILMINGTON,DE 19880, USA.		Buchner, Johannes/A-2651-2010	Buchner, Johannes/0000-0003-1282-7737; Vierling, Elizabeth/0000-0002-0066-4881				AZEM A, 1994, SCIENCE, V265, P653, DOI 10.1126/science.7913553; BANEYX F, 1995, J BIOL CHEM, V270, P10695, DOI 10.1074/jbc.270.18.10695; BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P19, DOI 10.1016/0005-2787(80)90129-X; BERTSCH U, 1992, P NATL ACAD SCI USA, V89, P8696, DOI 10.1073/pnas.89.18.8696; BLOOM MV, 1983, P NATL ACAD SCI-BIOL, V80, P1013, DOI 10.1073/pnas.80.4.1013; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRUNSCHIER R, 1993, J BIOL CHEM, V268, P2767; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; CANNON S, 1986, J CELL BIOL, V103, P1327, DOI 10.1083/jcb.103.4.1327; CHANDRASEKHAR GN, 1986, J BIOL CHEM, V261, P2414; CHEN GG, 1994, P NATL ACAD SCI USA, V91, P11497, DOI 10.1073/pnas.91.24.11497; CHEN Q, 1990, J CELL BIOL, V110, P1873, DOI 10.1083/jcb.110.6.1873; CLONEY LP, 1992, J BIOL CHEM, V267, P23327; CLONEY LP, 1992, J BIOL CHEM, V32, P23333; DICKSON R, 1994, J BIOL CHEM, V269, P26858; FISHER MT, 1992, BIOCHEMISTRY-US, V31, P3955, DOI 10.1021/bi00131a010; GATENBY AA, 1994, ANNU REV PLANT PHYS, V45, P469; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GHOSH S, 1988, ANAL BIOCHEM, V169, P227, DOI 10.1016/0003-2697(88)90278-3; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GRAY TE, 1991, FEBS LETT, V292, P254, DOI 10.1016/0014-5793(91)80878-7; HARTMAN DJ, 1992, FEBS LETT, V305, P147, DOI 10.1016/0014-5793(92)80883-I; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; HEMMINGSEN SM, 1986, PLANT PHYSIOL, V80, P269, DOI 10.1104/pp.80.1.269; HENDRIX RW, 1979, J MOL BIOL, V129, P375, DOI 10.1016/0022-2836(79)90502-3; HUBBS A, 1992, PLANT PHYSIOL, V100, P272, DOI 10.1104/pp.100.1.272; HUBBS AE, 1993, PLANT PHYSIOL, V101, P523, DOI 10.1104/pp.101.2.523; ISHII N, 1992, FEBS LETT, V299, P169, DOI 10.1016/0014-5793(92)80240-H; JACKSON GS, 1993, BIOCHEMISTRY-US, V32, P2554, DOI 10.1021/bi00061a013; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMINET AA, 1990, EMBO J, V9, P2315, DOI 10.1002/j.1460-2075.1990.tb07403.x; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; LISSIN NM, 1995, FEBS LETT, V361, P55, DOI 10.1016/0014-5793(95)00151-X; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUBBEN TH, 1989, PLANT CELL, V1, P1223, DOI 10.1105/tpc.1.12.1223; MARTEL R, 1990, GENE, V94, P181, DOI 10.1016/0378-1119(90)90385-5; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MIZOBATA T, 1992, J BIOL CHEM, V267, P17773; MUSGROVE JE, 1987, EUR J BIOCHEM, V163, P529, DOI 10.1111/j.1432-1033.1987.tb10900.x; PUSHKIN AV, 1982, BIOCHIM BIOPHYS ACTA, V704, P379, DOI 10.1016/0167-4838(82)90169-8; ROSPERT S, 1993, P NATL ACAD SCI USA, V90, P10967, DOI 10.1073/pnas.90.23.10967; ROY H, 1982, J CELL BIOL, V94, P20, DOI 10.1083/jcb.94.1.20; SAIBIL HR, 1993, CURR BIOL, V3, P265, DOI 10.1016/0960-9822(93)90176-O; SAXTON WO, 1973, ULTRAMICROSCOPY, V4, P343; SCHINDLER C, 1987, Z NATURFORSCH C, V42, P103; SCHMIDT M, 1994, J BIOL CHEM, V269, P27964; SCHMIDT M, 1994, J BIOL CHEM, V269, P10304; SCHMIDT M, 1994, SCIENCE, V265, P656, DOI 10.1126/science.7913554; STANIFORTH RA, 1994, FEBS LETT, V344, P129, DOI 10.1016/0014-5793(94)00348-3; Suelter C., 1974, METAL IONS BIOL SYST, V3, P201; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; TODD MJ, 1993, BIOCHEMISTRY-US, V32, P8560, DOI 10.1021/bi00084a024; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; VIITANEN PV, 1992, PROTEIN SCI, V1, P363; VIITANEN PV, 1992, J BIOL CHEM, V267, P695; VIITANEN PV, 1991, BIOCHEMISTRY-US, V30, P9716, DOI 10.1021/bi00104a021; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; YUAN JG, 1993, P NATL ACAD SCI USA, V90, P8552, DOI 10.1073/pnas.90.18.8552; ZABALETA E, 1994, PLANT J, V6, P425, DOI 10.1046/j.1365-313X.1994.06030425.x; ZAHN R, 1994, NATURE, V368, P261, DOI 10.1038/368261a0; ZHENG XX, 1993, J BIOL CHEM, V268, P7489	61	76	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18158	18164		10.1074/jbc.270.30.18158	http://dx.doi.org/10.1074/jbc.270.30.18158			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629128	Green Published, hybrid			2022-12-27	WOS:A1995RM26600080
J	KYRPIDES, N; TAVERNARAKIS, N; PAPAMATHEAKIS, J; THIREOS, G				KYRPIDES, N; TAVERNARAKIS, N; PAPAMATHEAKIS, J; THIREOS, G			A TRANSIENT GCN4 MESSENGER-RNA DESTABILIZATION FOLLOWS GCN4 TRANSLATIONAL DEREPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA DEGRADATION; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATOR; YEAST; GENE; STABILITY; TURNOVER; ELEMENTS; PROTEIN; REGION	Studies based on experimental strategies that utilized either inhibitors or structural alterations point to the existence of an inverse relationship between translation and stability of a given mRNA. In this study we have investigated the potential link between translation and stability of the yeast GCN4 mRNA whose translational rates change with respect to amino acid availability. We observed that under conditions favoring its translation, the steady state levels of the GCN4 mRNA were decreased, but this was not due to a measurable alternation in its decay rate. We have demonstrated that an extensive destabilization of this message is intimately coupled with its increased access to heavy polysomes, which occurs transiently in the process of translational derepression. This transient change in the stability is what readjusts the steady state levels of the GCN4 mRNA. This study demonstrates in vivo the existence of a mechanism of mRNA degradation that is coupled with the process of translation.	UNIV CRETE,DEPT BIOL,GR-71409 IRAKLION,GREECE	University of Crete	KYRPIDES, N (corresponding author), FDN RES & TECHNOL HELLAS,INST MOLEC BIOL & BIOTECHNOL,POB 1527,GR-71110 IRAKLION,GREECE.		Tavernarakis, Nektarios/B-9684-2013; Kyrpides, Nikos C./A-6305-2014	Tavernarakis, Nektarios/0000-0002-5253-1466; Kyrpides, Nikos C./0000-0002-6131-0462				AHARON T, 1993, MOL CELL BIOL, V13, P1971, DOI 10.1128/MCB.13.3.1971; ATWATER JA, 1990, ANNU REV GENET, V24, P519; BEELMAN CA, 1994, J BIOL CHEM, V269, P9687; DEALDANA CRV, 1994, MOL CELL BIOL, V14, P7920; DRISCOLLPENN M, 1984, MOL CELL BIOL, V4, P520; GRAVES RA, 1987, CELL, V48, P615, DOI 10.1016/0092-8674(87)90240-6; HE F, 1993, P NATL ACAD SCI USA, V90, P7034, DOI 10.1073/pnas.90.15.7034; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; HERRICK DJ, 1994, MOL CELL BIOL, V14, P2119, DOI 10.1128/MCB.14.3.2119; HINNEBUSCH AG, 1984, P NATL ACAD SCI-BIOL, V81, P6442, DOI 10.1073/pnas.81.20.6442; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; HOPE IA, 1986, CELL, V46, P885, DOI 10.1016/0092-8674(86)90070-X; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; KOELLER DM, 1991, P NATL ACAD SCI USA, V88, P7778, DOI 10.1073/pnas.88.17.7778; KORNITZER D, 1994, EMBO J, V13, P6021, DOI 10.1002/j.1460-2075.1994.tb06948.x; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; PACHTER JS, 1987, CELL, V51, P283, DOI 10.1016/0092-8674(87)90155-3; PARKER R, 1990, P NATL ACAD SCI USA, V87, P2780, DOI 10.1073/pnas.87.7.2780; PELTZ SW, 1994, PROG NUCLEIC ACID RE, V47, P271, DOI 10.1016/S0079-6603(08)60254-8; PELTZ SW, 1993, GENE DEV, V7, P1737, DOI 10.1101/gad.7.9.1737; PELTZ SW, 1993, CONTROL MRNA STABILI, P231; ROUSSOU I, 1988, MOL CELL BIOL, V8, P2132, DOI 10.1128/MCB.8.5.2132; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; SCHIAVI SC, 1994, J BIOL CHEM, V269, P3441; TAVERNARAKIS N, 1995, IN PRESS MOL GEN GEN; THIREOS G, 1984, P NATL ACAD SCI-BIOL, V81, P5096, DOI 10.1073/pnas.81.16.5096; TZAMARIAS D, 1986, P NATL ACAD SCI USA, V83, P4849, DOI 10.1073/pnas.83.13.4849; TZAMARIAS D, 1989, CELL, V57, P947, DOI 10.1016/0092-8674(89)90333-4	30	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17317	17320		10.1074/jbc.270.29.17317	http://dx.doi.org/10.1074/jbc.270.29.17317			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615533	hybrid			2022-12-27	WOS:A1995RK68900043
J	PORCHER, C; PICAT, C; DAEGELEN, D; BEAUMONT, C; GRANDCHAMP, B				PORCHER, C; PICAT, C; DAEGELEN, D; BEAUMONT, C; GRANDCHAMP, B			FUNCTIONAL-ANALYSIS OF DNASE-I HYPERSENSITIVE SITES AT THE MOUSE PORPHOBILINOGEN DEAMINASE GENE LOCUS - DIFFERENT REQUIREMENTS FOR POSITION-INDEPENDENT EXPRESSION FROM ITS 2 PROMOTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT CONTROL REGION; BETA-GLOBIN GENE; NUCLEAR PROTEINS; TRANSCRIPTION FACTOR; ERYTHROID-CELLS; INVIVO PROTEIN; BINDING; ELEMENTS; ENHANCER; INVITRO	Porphobilinogen deaminase (EC 4.3.1.8; PBG-D) is the third enzyme of the heme biosynthetic pathway. In both human and mouse, the gene encoding PBG-D posseses two promoters, lying in close proximi ty. We have previously reported the mapping of six nuclear DNase-I hypersensitive sites at the PBG-D locus which could contribute to the regulation of the gene. In the present study, and in order to define all the elements necessary for a high level of expression and an integration site independence, we studied the pattern and the level of expression of a cloned PBG-D gene following integration into a host genome. The longest construct that we tested (12.5 kilobases) contained sufficient regulatory elements to promote expression levels similar to that of the endogenous gene, both in transgenic mice and in transfected cells. The overall contribution of individual DNase-I hypersensitive sites to the expression of the gene was then studied using a series of mutants that were stably transfected into mouse erythroleukemia cells. Two regions seem to play a critical role in the erythroid-specific expression of the PBG-D gene: the proximal promoter and a region situated at -1000 relative to the initiation site. Study of individual clones of mouse erythroleukemia cells revealed that the erythroid-specific expression of the gene was submitted to position effects in the absence of the upstream region, although the housekeeping transcription is not sensitive to such effects. The tandem arrangement of the housekeeping and tissue-specific promoters of the PBG-D gene raises some questions about the functioning of these two overlapping transcriptional units in erythroid cells. Previous data have suggested that in erythroid cells most of the transcripts initiated at the upstream promoter stop downstream of the first ubiquitous exon, between the two promoters. Here, we show that the deletion of a constitutive DNase-I hypersensitive site that is located in the region of the elongation block results in opposite effects on the steady state levels of housekeeping and tissue-specific RNA. This finding is consistent with the hypothesis that this region promotes premature termination of the housekeeping transcripts therefore preventing promoter interference.	UNIV PARIS 07,INSERM,U409,F-75018 PARIS,FRANCE; HOP COCHIN,INSERM,U129,F-75014 PARIS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite			Porcher, Catherine/D-7026-2016					BEAUMONT C, 1989, J BIOL CHEM, V264, P14829; CHRETIEN S, 1988, P NATL ACAD SCI USA, V85, P6, DOI 10.1073/pnas.85.1.6; CONCORDET JP, 1993, MOL CELL BIOL, V13, P9, DOI 10.1128/MCB.13.1.9; DYNAN WS, 1983, TRENDS GENET, V2, P196; ELLIS J, 1993, EMBO J, V12, P127, DOI 10.1002/j.1460-2075.1993.tb05638.x; FRASER P, 1990, NUCLEIC ACIDS RES, V18, P3503, DOI 10.1093/nar/18.12.3503; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; HOGAN B, 1986, MANIPULATING MOUSE E; Kawasaki E.S., 1990, PCR PROTOCOLS GUIDE, P146; LACRONIQUE V, 1992, NUCLEIC ACIDS RES, V20, P5669, DOI 10.1093/nar/20.21.5669; MANTOVANI R, 1988, NUCLEIC ACIDS RES, V16, P4299, DOI 10.1093/nar/16.10.4299; MIGNOTTE V, 1989, P NATL ACAD SCI USA, V86, P6548, DOI 10.1073/pnas.86.17.6548; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; OPREY J, 1993, MOL CELL BIOL, V13, P6290, DOI 10.1128/MCB.13.10.6290; Orkin SH, 1990, CURR OPIN CELL BIOL, V2, P1003, DOI 10.1016/0955-0674(90)90149-9; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; PORCHER C, 1992, BIOTECHNIQUES, V13, P106; PORCHER C, 1995, GENOMICS, V25, P312, DOI 10.1016/0888-7543(95)80145-C; PORCHER C, 1991, J BIOL CHEM, V266, P10562; PROUDFOOT NJ, 1986, NATURE, V322, P562, DOI 10.1038/322562a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMON MC, 1992, NAT GENET, V1, P92, DOI 10.1038/ng0592-92; STRAUSS EC, 1992, P NATL ACAD SCI USA, V89, P5809, DOI 10.1073/pnas.89.13.5809; SUN JM, 1992, NUCLEIC ACIDS RES, V20, P6385, DOI 10.1093/nar/20.23.6385; TALBOT D, 1990, EMBO J, V9, P2169, DOI 10.1002/j.1460-2075.1990.tb07386.x; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; XIAO JH, 1987, GENE DEV, V1, P794, DOI 10.1101/gad.1.8.794	27	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17368	17374		10.1074/jbc.270.29.17368	http://dx.doi.org/10.1074/jbc.270.29.17368			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615541	hybrid			2022-12-27	WOS:A1995RK68900052
J	SELBERT, MA; ANDERSON, KA; HUANG, QH; GOLDSTEIN, EG; MEANS, AR; EDELMAN, AM				SELBERT, MA; ANDERSON, KA; HUANG, QH; GOLDSTEIN, EG; MEANS, AR; EDELMAN, AM			PHOSPHORYLATION AND ACTIVATION OF CA2+-CALMODULIN-DEPENDENT PROTEIN-KINASE-IV BY CA2+-CALMODULIN-DEPENDENT PROTEIN-KINASE-IA KINASE - PHOSPHORYLATION OF THREONINE-196 IS ESSENTIAL FOR ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT CHAIN KINASE; CALMODULIN BINDING DOMAIN; CAM KINASE; CA-2+-INDEPENDENT ACTIVITY; AUTOPHOSPHORYLATION SITES; RABBIT RETICULOCYTES; CATALYTIC DOMAINS; MOLECULAR-CLONING; ALPHA-SUBUNIT; RAT-BRAIN	Purified pig brain Ca2+-calmodulin (CaM)-dependent protein kinase Ia kinase (Lee, J. C., and Edelman, A. M. (1994) J. Biol. Chem. 269, 2158-2164) enhances, by up to 24-fold, the activity of recombinant CaM kinase IV in a reaction also requiring Ca2+-CaM and MgATP. The addition of brain extract, although capable of activating CaM kinase IV by itself, provides no further activation beyond that induced by purified CaM kinase Ia kinase, consistent with the lack of a requirement of additional components for activation. Activation is accompanied by the development of significant (38%) Ca2+-CaM-independent CaM kinase IV activity. In parallel fashion to its activation, CaM kinase IV is phosphorylated in a CaM kinase Ia kinase-, Ca2+-CaM-, and MgATP-dependent manner. Phosphorylation occurs on multiple serine and threonine residues with a Ser-P:Thr-P ratio of similar to 3:1. The identical requirements for phosphorylation and activation and a linear relationship between extent of phosphorylation of CaM kinase IV and its activation state indicate that CaM kinase IV activation is induced by its phosphorylation. Replacement of Thr-196 of CaM kinase IV with a nonphosphorylatable alanine by site directed mutagenesis abolishes both the phosphorylation and activation of CaM kinase IV, demonstrating that Thr-196 phosphorylation is essential for activation.	SUNY BUFFALO,DEPT PHARMACOL & TOXICOL,BUFFALO,NY 14214; DUKE UNIV,MED CTR,DEPT PHARMACOL,DURHAM,NC 27710	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Duke University					NICHD NIH HHS [HD07503] Funding Source: Medline; NIGMS NIH HHS [GM07145-20] Funding Source: Medline; NINDS NIH HHS [NS24738] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS024738, R01NS024738] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; BENNETT MK, 1987, P NATL ACAD SCI USA, V84, P1794, DOI 10.1073/pnas.84.7.1794; BLAND MM, 1994, GENE, V142, P191, DOI 10.1016/0378-1119(94)90260-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAZAUBON S, 1994, BIOCHEM J, V301, P443, DOI 10.1042/bj3010443; CRUZALEGUI FH, 1993, J BIOL CHEM, V268, P26171; CRUZALEGUI FH, 1992, P NATL ACAD SCI USA, V89, P12127, DOI 10.1073/pnas.89.24.12127; DEREMER MF, 1992, J BIOL CHEM, V267, P13460; DEREMER MF, 1992, J BIOL CHEM, V267, P13466; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; EDELMAN AM, 1985, J BIOL CHEM, V260, P1275; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FRANGAKIS MV, 1991, J BIOL CHEM, V266, P17592; FRANGAKIS MV, 1991, J BIOL CHEM, V266, P11309; GOULD KL, 1991, EMBO J, V10, P3297, DOI 10.1002/j.1460-2075.1991.tb04894.x; GU Y, 1991, EMBO J, V11, P3995; GUERRIERO V, 1986, BIOCHEMISTRY-US, V25, P8372, DOI 10.1021/bi00374a007; HANISSIAN SH, 1993, J BIOL CHEM, V268, P20055; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANLEY RM, 1987, SCIENCE, V237, P293, DOI 10.1126/science.3037704; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; ITO T, 1994, BIOCHEM BIOPH RES CO, V201, P1561, DOI 10.1006/bbrc.1994.1882; JONES DA, 1991, FEBS LETT, V289, P105, DOI 10.1016/0014-5793(91)80919-T; KAMESHITA I, 1993, J BIOCHEM-TOKYO, V113, P583, DOI 10.1093/oxfordjournals.jbchem.a124087; KATO JY, 1994, MOL CELL BIOL, V14, P2713, DOI 10.1128/MCB.14.4.2713; KEMP BE, 1987, J BIOL CHEM, V262, P2542; KENNELLY PJ, 1987, J BIOL CHEM, V262, P11958; KITANI T, 1994, J BIOCHEM-TOKYO, V115, P637, DOI 10.1093/oxfordjournals.jbchem.a124387; KNIGHTON DR, 1992, SCIENCE, V258, P130, DOI 10.1126/science.1439761; LEE JC, 1995, BIOCHEM BIOPH RES CO, V210, P631, DOI 10.1006/bbrc.1995.1705; LEE JC, 1994, P NATL ACAD SCI USA, V91, P6413, DOI 10.1073/pnas.91.14.6413; LEE JSC, 1994, J BIOL CHEM, V269, P2158; LIN CR, 1987, P NATL ACAD SCI USA, V84, P5962, DOI 10.1073/pnas.84.16.5962; LOU LL, 1989, J NEUROSCI, V9, P2020; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCDONALD OB, 1993, J BIOL CHEM, V268, P10054; MEANS AR, 1991, MOL CELL BIOL, V11, P3960, DOI 10.1128/MCB.11.8.3960; MEANS AR, 1994, ADV 2 MESSENGER PHOS, V30, P1; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; MITSUI K, 1993, J BIOL CHEM, V268, P13422; MIYANO O, 1992, J BIOL CHEM, V267, P1198; MOCHIZUKI H, 1993, J BIOL CHEM, V268, P9143; MOCHIZUKI H, 1993, BIOCHEM BIOPH RES CO, V197, P1595, DOI 10.1006/bbrc.1993.2661; NAIRN AC, 1987, J BIOL CHEM, V262, P7273; OHMSTEDE CA, 1991, P NATL ACAD SCI USA, V88, P5784, DOI 10.1073/pnas.88.13.5784; OHMSTEDE CA, 1989, J BIOL CHEM, V264, P5866; OKUNO S, 1993, J BIOCHEM-TOKYO, V114, P167, DOI 10.1093/oxfordjournals.jbchem.a124149; OKUNO S, 1994, J BIOCHEM, V116, P923, DOI 10.1093/oxfordjournals.jbchem.a124617; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; PEARSON RB, 1988, SCIENCE, V241, P970, DOI 10.1126/science.3406746; PICCIOTTO MR, 1993, J BIOL CHEM, V268, P26512; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; REDPATH NT, 1993, EUR J BIOCHEM, V212, P511, DOI 10.1111/j.1432-1033.1993.tb17688.x; Sambrook J, 1989, MOL CLONING LABORATO; SCHWORER CM, 1988, J BIOL CHEM, V263, P13486; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; SUGITA R, 1994, BIOCHEM BIOPH RES CO, V203, P694, DOI 10.1006/bbrc.1994.2238; TAKIO K, 1985, BIOCHEMISTRY-US, V24, P6028, DOI 10.1021/bi00343a002; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; TOKUMITSU H, 1994, J BIOL CHEM, V269, P28640; YONEMOTO W, 1993, J BIOL CHEM, V268, P18626; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x	63	132	134	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17616	17621		10.1074/jbc.270.29.17616	http://dx.doi.org/10.1074/jbc.270.29.17616			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615569	hybrid			2022-12-27	WOS:A1995RK68900086
J	ONO, H; GRUHLER, A; STUART, RA; GUIARD, B; SCHWARZ, E; NEUPERT, W				ONO, H; GRUHLER, A; STUART, RA; GUIARD, B; SCHWARZ, E; NEUPERT, W			SORTING OF CYTOCHROME B(2) TO THE INTERMEMBRANE SPACE OF MITOCHONDRIA - KINETIC-ANALYSIS OF INTERMEDIATES DEMONSTRATES PASSAGE THROUGH THE MATRIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST MITOCHONDRIA; PROTEIN IMPORT; NUCLEAR GENE; SIGNAL; PRESEQUENCE; PEPTIDASE; TRANSPORT; PRECURSOR; CLEAVAGE; ATP	Precytochrome b(2) is targeted to the mitochondrial intermembrane space by a dual targeting sequence comprising 80 amino acids. A kinetic analysis of intramitochondrial sorting was performed. The intermediate-size form accumulated transiently in the matrix. When import was performed in the presence of metal chelators to prevent the first processing by the matrix processing peptidase, >40% of the imported precursor was localized in the matrix. A deletion of 13 amino acids in the intermembrane space sorting sequence caused partial inhibition of the first processing, and a transient accumulation of the precursor form in the matrix was also observed. The decrease in this matrix-localized precursor form paralleled an increase in the mature-size form in the intermembrane space. A point mutation in the mitochondrial targeting sequence (N-terminal to the sorting sequence) resulted in missorting to the matrix space. Furthermore, a chimeric protein consisting of the initial 85 residues of cytochrome b(2) fused to dihydrofolate reductase was partially targeted to the matrix at 15 degrees C, but not at 25 degrees C. Together, the results presented here indicate that cytochrome b(2) passes through the matrix on its sorting pathway to the intermembrane space.	UNIV MUNICH,INST PHYSIOL CHEM,D-80336 MUNICH,GERMANY; UNIV PARIS 06,CTR MOLEC GENET,CNRS,F-91190 GIF SUR YVETTE,FRANCE	University of Munich; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay								ARRETZ M, 1994, J BIOL CHEM, V269, P4959; BEASLEY EM, 1993, EMBO J, V12, P2303, DOI 10.1002/j.1460-2075.1993.tb05884.x; BEHRENS M, 1991, MOL GEN GENET, V228, P167, DOI 10.1007/BF00282462; DAUM G, 1982, J BIOL CHEM, V257, P3028; GLICK BS, 1993, PROTEIN SCI, V2, P1901, DOI 10.1002/pro.5560021112; GLICK BS, 1992, TRENDS BIOCHEM SCI, V17, P453, DOI 10.1016/0968-0004(92)90487-T; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; GRUHLER A, 1995, EMBO J, V14, P1349, DOI 10.1002/j.1460-2075.1995.tb07121.x; GUIARD B, 1985, EMBO J, V4, P3265, DOI 10.1002/j.1460-2075.1985.tb04076.x; HARTL FU, 1987, CELL, V51, P1027, DOI 10.1016/0092-8674(87)90589-7; HARTL FU, 1990, SCIENCE, V247, P930, DOI 10.1126/science.2406905; HARTL FU, 1986, CELL, V47, P939, DOI 10.1016/0092-8674(86)90809-3; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; JENSEN RE, 1992, MOL CELL BIOL, V12, P4677, DOI 10.1128/MCB.12.10.4677; KOLL H, 1992, CELL, V68, P1163, DOI 10.1016/0092-8674(92)90086-R; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAHLKE K, 1990, EUR J BIOCHEM, V192, P551, DOI 10.1111/j.1432-1033.1990.tb19260.x; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; OHASHI A, 1982, J BIOL CHEM, V257, P3042; RASSOW J, 1990, FEBS LETT, V275, P190, DOI 10.1016/0014-5793(90)81469-5; ROJO EE, 1995, IN PRESS EMBO J; ROMISCH J, 1987, EUR J BIOCHEM, V164, P111, DOI 10.1111/j.1432-1033.1987.tb11000.x; SADLER I, 1984, EMBO J, V3, P2137, DOI 10.1002/j.1460-2075.1984.tb02103.x; Sambrook J, 1989, MOL CLONING LABORATO; SCHLEYER M, 1985, CELL, V43, P339, DOI 10.1016/0092-8674(85)90039-X; SCHMIDT B, 1984, EUR J BIOCHEM, V144, P581, DOI 10.1111/j.1432-1033.1984.tb08505.x; SCHNEIDER A, 1991, EMBO J, V10, P247, DOI 10.1002/j.1460-2075.1991.tb07944.x; SCHWARZ E, 1993, EMBO J, V12, P2295, DOI 10.1002/j.1460-2075.1993.tb05883.x; STUART RA, 1994, EUR J BIOCHEM, V220, P9, DOI 10.1111/j.1432-1033.1994.tb18593.x; WACHTER C, 1992, EMBO J, V11, P4787, DOI 10.1002/j.1460-2075.1992.tb05584.x	30	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16932	16938		10.1074/jbc.270.28.16932	http://dx.doi.org/10.1074/jbc.270.28.16932			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622511	hybrid			2022-12-27	WOS:A1995RJ34700072
J	YE, JJ; SAIER, MH				YE, JJ; SAIER, MH			PURIFICATION AND CHARACTERIZATION OF A SMALL MEMBRANE-ASSOCIATED SUGAR-PHOSPHATE PHOSPHATASE THAT IS ALLOSTERICALLY ACTIVATED BY HPR(SER(P)) OF THE PHOSPHOTRANSFERASE SYSTEM IN LACTOCOCCUS-LACTIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOCARRIER PROTEIN HPR; BACILLUS-SUBTILIS; STREPTOCOCCUS-PYOGENES; ESCHERICHIA-COLI; ENZYME-II; PHOSPHOENOLPYRUVATE; PHOSPHORYLATION; EXPULSION; ATP; TRANSPORT	In the Gram-positive bacterium, Lactococcus lactis, nonmetabolizable cytoplasmic sugar phosphates, accumulated by the phosphoenolpyluvate:sugar phosphotransferase system, are rapidly dephosphorylated and expelled from the cell upon addition of glucose (inducer expulsion). Our recent studies have established that a metabolite-activated, ATP-dependent protein kinase that phosphorylates serine-46 in HPr of the phosphoenolpyruvate:sugar phosphotransferase system activates a sugar phosphate phosphatase, thus initiating the inducer expulsion process. A membrane associated, HPr(Ser(P))-dependent phosphatase has been identified, solubilized from the membrane, separated from other cellular phosphatases, and purified to near homogeneity. It exhibits a low subunit molecular mass (10 kDa) and behaves on gel filtration columns like a monomeric enzyme. It has broad substrate specificity, optimal activity between pH 7.0 and 8.0, is dependent on a divalent cation for activity, and is not inhibited by fluoride. It is stimulated more than 10-fold by HPr(Ser(P)) or a mutant derivative of HPr, S46D HPr, in which the regulatory serine is changed to aspartate, which bears a permanently negative charge as does phosphate. Stimulation is due both to an increase in the maximal velocity (V-max) and a decrease in the Michaelis-Menten kinetic constant (K-m) for sugar phosphate. The enzyme exhibits a K-a for S46D HPr of 15 mu M. Although the enzyme is thermally stable, activation by HPr(Ser(P)) is heat sensitive.	UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093	University of California System; University of California San Diego					NIAID NIH HHS [5RO1AI21702, 2RO1AI14176] Funding Source: Medline; NIGMS NIH HHS [1F33GM16907] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021702, R01AI014176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM016907] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELOGRUDOV GI, 1995, J BIOL CHEM, V270, P2053, DOI 10.1074/jbc.270.5.2053; CHEN Y, 1993, BIOCHEMISTRY-US, V32, P32, DOI 10.1021/bi00052a006; DEUTSCHER J, 1994, J BACTERIOL, V176, P3336, DOI 10.1128/jb.176.11.3336-3344.1994; DEUTSCHER J, 1986, BIOCHEMISTRY-US, V25, P6543, DOI 10.1021/bi00369a031; DEUTSCHER J, 1983, P NATL ACAD SCI-BIOL, V80, P6790, DOI 10.1073/pnas.80.22.6790; DEUTSCHER J, 1995, MOL MICROBIOL, V15, P1049, DOI 10.1111/j.1365-2958.1995.tb02280.x; DIEZEL W, 1972, ANAL BIOCHEM, V48, P617, DOI 10.1016/0003-2697(72)90117-0; HAGUENAUER R, 1971, BIOCHIMIE, V53, P99, DOI 10.1016/S0300-9084(71)80087-1; HERZBERG O, 1992, P NATL ACAD SCI USA, V89, P2499, DOI 10.1073/pnas.89.6.2499; HUECK CJ, 1994, RES MICROBIOL, V145, P503, DOI 10.1016/0923-2508(94)90028-0; KUNDIG W, 1971, J BIOL CHEM, V246, P1407; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MITCHELL WJ, 1993, J BACTERIOL, V175, P2758, DOI 10.1128/JB.175.9.2758-2761.1993; PARVIN R, 1969, ANAL BIOCHEM, V27, P65, DOI 10.1016/0003-2697(69)90219-X; REIZER J, 1992, J BIOL CHEM, V267, P9158; REIZER J, 1989, EMBO J, V8, P2111, DOI 10.1002/j.1460-2075.1989.tb03620.x; REIZER J, 1980, P NATL ACAD SCI-BIOL, V77, P5497, DOI 10.1073/pnas.77.9.5497; REIZER J, 1983, J BACTERIOL, V156, P354, DOI 10.1128/JB.156.1.354-361.1983; REIZER J, 1983, J BACTERIOL, V156, P236, DOI 10.1128/JB.156.1.236-242.1983; SAIER MH, 1977, J BIOL CHEM, V252, P8899; SAIER MH, 1985, MECHANISMS REGULATIO; SUTRINA SL, 1988, J BACTERIOL, V170, P1874, DOI 10.1128/jb.170.4.1874-1877.1988; THOMPSON J, 1981, J BACTERIOL, V146, P885, DOI 10.1128/JB.146.3.885-894.1981; THOMPSON J, 1983, J BACTERIOL, V156, P70, DOI 10.1128/JB.156.1.70-80.1983; WINKLER HH, 1971, J BACTERIOL, V106, P362, DOI 10.1128/JB.106.2.362-368.1971; WITTEKIND M, 1990, BIOCHEMISTRY-US, V29, P7191, DOI 10.1021/bi00483a006; WITTEKIND M, 1992, PROTEIN SCI, V1, P1363, DOI 10.1002/pro.5560011016; WITTEKIND M, 1989, BIOCHEMISTRY-US, V28, P9908, DOI 10.1021/bi00452a005; YE JJ, 1994, P NATL ACAD SCI USA, V91, P3102, DOI 10.1073/pnas.91.8.3102; YE JJ, 1995, P NATL ACAD SCI USA, V92, P417, DOI 10.1073/pnas.92.2.417; YE JJ, 1995, J BACTERIOL, V177, P1900, DOI 10.1128/jb.177.7.1900-1902.1995; YE JJ, 1994, J BIOL CHEM, V269, P11837; YE JJ, 1994, J BACTERIOL, V176, P3484, DOI 10.1128/JB.176.12.3484-3492.1994; YE JJ, 1994, MICROBIOL-UK, V140, P3421, DOI 10.1099/13500872-140-12-3421	34	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16740	16744		10.1074/jbc.270.28.16740	http://dx.doi.org/10.1074/jbc.270.28.16740			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622485	hybrid			2022-12-27	WOS:A1995RJ34700045
J	BHATIA, M; KIRKLAND, JB; MECKLINGGILL, KA				BHATIA, M; KIRKLAND, JB; MECKLINGGILL, KA			MONOCYTIC DIFFERENTIATION OF ACUTE PROMYELOCYTIC LEUKEMIA-CELLS IN RESPONSE TO 1,25-DIHYDROXYVITAMIN D-3 IS INDEPENDENT OF NUCLEAR RECEPTOR-BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GENOMIC BIOLOGICAL RESPONSES; D ENDOCRINE SYSTEM; VITAMIN-D; CALCIUM-METABOLISM; MESSENGER-RNA; RETINOIC ACID; HL-60; PROLIFERATION; ANALOG; 1-ALPHA,25-DIHYDROXYVITAMIN-D3	We have shown that 1,25-dihydroxyvitamin D-3 (1,25 (OH)(2)D-3) primes NB4 cells, the only available acute promyelocytic leukemia cell line, for 12-O-tetradecanoylphorbol-13-acetate-induced monocytic differentiation. Here, we have used isomers of 1,25(OH)(2)D-3 to investigate the role of 1,25(OH)(2)D-3 and its putative nuclear receptor (VDR) in NB4 cell monocytic differentiation. 1 beta,25-dihydroxyvitamin D-3 (HL), a specific antagonist of only the nongenomic signals of 1,25(OH)(2)D-3 attenuated the priming effect of 1,25(OH)(2)D-3. The 6-cis conformer of 1,25(OH)(2)D-3 (HF), which is unable to bind to VDR, was 20 times more potent than 1,25(OH)(2)D-3 as a priming agent for monocytic differentiation. This response was also blocked by the HL antagonist, Unlike myelocytic HL-60 cells, which respond to 1,25(OH)(2)D-3 with increases in VDR expression and monocytic differentiation, neither HF nor 1,25(OH)(2)D-3 regulated VDR expression in NB4 cells. In the monocytic differentiation of acute promyelocytic leukemia cells, 1,25(OH)(2)D-3 appears to signal through a pathway independent of VDR/VDRE action.	UNIV GUELPH,DEPT NUTR SCI,GUELPH,ON N1G 2W1,CANADA	University of Guelph								BHATIA M, 1994, LEUKEMIA, V8, P1744; BINDERUP L, 1993, AACR M MECHANISM ACT; BLACKMORE PF, 1991, BIOCHEM BIOPH RES CO, V181, P331, DOI 10.1016/S0006-291X(05)81422-6; BROWN TA, 1990, J BIOL CHEM, V265, P10025; CHEN TC, 1993, J NUTR BIOCHEM, V4, P49, DOI 10.1016/0955-2863(93)90020-W; CHOMIENNE C, 1991, J CLIN INVEST, V88, P2150, DOI 10.1172/JCI115547; DELUCA HF, 1988, FASEB J, V2, P224, DOI 10.1096/fasebj.2.3.3280376; Desai S S, 1986, J Bone Miner Res, V1, P497; DORMANEN MC, 1994, BIOCHEM BIOPH RES CO, V201, P394, DOI 10.1006/bbrc.1994.1714; FRAMPTON RJ, 1983, CANCER RES, V43, P4443; FREEDOM J, 1993, LEUKEMIA RES, V17, P97; HOEK JB, 1988, TRENDS BIOCHEM SCI, V13, P269, DOI 10.1016/0968-0004(88)90161-2; HOFFMAN PL, 1990, FASEB J, V4, P2612, DOI 10.1096/fasebj.4.9.2161371; JANSSEN JWG, 1985, CANCER RES, V45, P3262; KERNER SA, 1989, P NATL ACAD SCI USA, V86, P4455, DOI 10.1073/pnas.86.12.4455; KOEFFLER HP, 1985, CANCER TREAT REP, V69, P1399; LEE YS, 1989, J BIOL CHEM, V264, P13701; MACFARLANE DE, 1994, J BIOL CHEM, V269, P4327; MANGASARIAN K, 1993, BIOCHIM BIOPHYS ACTA, V1172, P55, DOI 10.1016/0167-4781(93)90269-J; MATHIASEN IS, 1993, J STEROID BIOCHEM, V46, P365, DOI 10.1016/0960-0760(93)90226-M; MCCARTHY DM, 1983, LEUKEMIA RES, V7, P51, DOI 10.1016/0145-2126(83)90057-7; MORELLI S, 1993, BIOCHEM J, V289, P675, DOI 10.1042/bj2890675; MUNKER R, 1986, J CLIN INVEST, V78, P424, DOI 10.1172/JCI112593; NORMAN AW, 1993, J BIOL CHEM, V268, P20022; NORMAN AW, 1993, J BIOL CHEM, V268, P13811; NORMAN AW, 1992, J STEROID BIOCHEM, V41, P231, DOI 10.1016/0960-0760(92)90349-N; OLSSON I, 1983, CANCER RES, V43, P5862; PAN P, 1991, CELL PROLIFERAT, V24, P159, DOI 10.1111/j.1365-2184.1991.tb01146.x; RACHAUD S, 1995, P NATL ACAD SCI USA, V91, P8428; REICHEL H, 1989, NEW ENGL J MED, V320, P980, DOI 10.1056/NEJM198904133201506; ROSEN ED, 1993, J BIOL CHEM, V268, P11534; SELLES J, 1991, MOL CELL ENDOCRINOL, V82, P229, DOI 10.1016/0303-7207(91)90036-R; SUDA T, 1989, P SOC EXP BIOL MED, V191, P214; TAOKA T, 1993, MOL CELL ENDORINOL, V304, P51; VANHAM G, 1988, J STEROID BIOCHEM, V29, P381, DOI 10.1016/0022-4731(88)90246-4; WEHLING M, 1987, AM J PHYSIOL, V252, P505; WIESE RJ, 1992, J BIOL CHEM, V267, P20082; ZHOU JY, 1991, BLOOD, V78, P75	38	61	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15962	15965		10.1074/jbc.270.27.15962	http://dx.doi.org/10.1074/jbc.270.27.15962			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608152	hybrid			2022-12-27	WOS:A1995RH22600013
J	JUNEMANN, S; WRIGGLESWORTH, JM				JUNEMANN, S; WRIGGLESWORTH, JM			CYTOCHROME BD OXIDASE FROM AZOTOBACTER-VINELANDII - PURIFICATION AND QUANTITATION OF LIGAND-BINDING TO THE OXYGEN REDUCTION SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D TERMINAL OXIDASE; ELECTRON-PARAMAGNETIC-RESONANCE; AEROBIC RESPIRATORY-CHAIN; ESCHERICHIA-COLI; D COMPLEX; NITRIC-OXIDE; C OXIDASE; RAMAN-SPECTROSCOPY; UBIQUINOL OXIDASE; CYANIDE	Cytochrome bd has been purified from Azotobacter vinelandii by a new simplified procedure. The heme and total iron content has been measured, as has the number of high affinity CO and NO binding sites. Spectral changes indicate high affinity binding of CO and NO to heme d only, with a stoichiometry of 1 molecule of gas per 2 molecules of heme b or per 3 atoms of iron. The results clearly define a stoichiometry of one heme d per complex. Low affinity binding of CO and NO to heme b595 also occurs at higher ligand concentrations. EPR heme-nitrosyl signals are seen with NO bound to both hemes b595 and d but with no indication of spin exchange coupling. Exposure of the air-oxidized complex to alkaline pH results in removal of molecular oxygen from heme d and a change in line shape of the high spin region of the EPR spectrum. Cyanide binds to both heme d and heme b595 in the air-oxidized complex, displacing molecular oxygen from heme d. The rate of cyanide binding to heme d as assessed by spectral changes at 650 nm does not correlate with the rate of binding to heme b595 as assessed by the loss of the high spin EPR signal. In addition, the cyanide binding rate in the presence of reductant is only 3 times that of the rate of binding to the air-oxidases where strong redox cooperativity makes these two rates differ by a factor of at least 10(6). The results do not support the idea of the presence of two strongly interacting hemes in a binuclear center.	UNIV LONDON KINGS COLL, DIV LIFE SCI, CTR MET BIOL & MED, LONDON W8 7AH, ENGLAND	University of London; King's College London								BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BONNER FT, 1991, BIOCHIM BIOPHYS ACTA, V1056, P133, DOI 10.1016/S0005-2728(05)80279-8; BRUDVIG GW, 1980, BIOCHEMISTRY-US, V19, P5275, DOI 10.1021/bi00564a020; DMELLO R, 1994, FEMS MICROBIOL LETT, V121, P115, DOI 10.1111/j.1574-6968.1994.tb07084.x; DMELLO R, 1994, MICROBIOL-UK, V140, P1395, DOI 10.1099/00221287-140-6-1395; EDWARDS C, 1981, FEBS LETT, V128, P205, DOI 10.1016/0014-5793(81)80081-6; Fuhrhop J. H., 1975, PORPHYRINS METALLOPO, P804; GREEN GN, 1986, BIOCHEMISTRY-US, V25, P2309, DOI 10.1021/bi00357a002; HENRY Y, 1991, EUR BIOPHYS J, V20, P1; HILL JJ, 1993, P NATL ACAD SCI USA, V90, P5863, DOI 10.1073/pnas.90.12.5863; INGLEDEW WJ, 1992, BIOCHEM J, V282, P255, DOI 10.1042/bj2820255; JONES MG, 1984, BIOCHEM J, V220, P57, DOI 10.1042/bj2200057; JUNEMANN S, 1994, FEBS LETT, V345, P198, DOI 10.1016/0014-5793(94)00372-6; Junemann Susanne, 1993, Biochemical Society Transactions, V21, p345S; KAHLOW MA, 1991, BIOCHEMISTRY-US, V30, P11485, DOI 10.1021/bi00113a001; KAHLOW MA, 1993, J AM CHEM SOC, V115, P5845, DOI 10.1021/ja00066a071; KAUFFMAN HF, 1974, BIOCHIM BIOPHYS ACTA, V333, P218, DOI 10.1016/0005-2728(74)90006-1; KAUFFMAN HF, 1975, J BIOENERG, V7, P215, DOI 10.1007/BF01558549; KELLY MJS, 1990, J BACTERIOL, V172, P6010, DOI 10.1128/jb.172.10.6010-6019.1990; KITA K, 1984, J BIOL CHEM, V259, P3375; KOLAND JG, 1984, BIOCHEMISTRY-US, V23, P1051, DOI 10.1021/bi00301a003; KOLONAY JF, 1994, J BACTERIOL, V176, P4177, DOI 10.1128/JB.176.13.4177-4181.1994; KONISHI K, 1986, J BIOCHEM, V99, P1227, DOI 10.1093/oxfordjournals.jbchem.a135586; KRANZ RG, 1985, J BACTERIOL, V161, P709, DOI 10.1128/JB.161.2.709-713.1985; KRASNOSELSKAYA I, 1993, FEBS LETT, V327, P279, DOI 10.1016/0014-5793(93)81004-J; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LORENCE RM, 1986, BIOCHEMISTRY-US, V25, P2314, DOI 10.1021/bi00357a003; LORENCE RM, 1989, J BIOL CHEM, V264, P7135; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MEINHARDT SW, 1989, BIOCHIM BIOPHYS ACTA, V975, P175, DOI 10.1016/S0005-2728(89)80216-6; MILLER MJ, 1983, J BIOL CHEM, V258, P9159; MITCHELL P, 1987, FEBS LETT, V222, P235, DOI 10.1016/0014-5793(87)80378-2; MOSHIRI F, 1991, J BACTERIOL, V173, P6230, DOI 10.1128/jb.173.19.6230-6241.1991; NEESE F, 1993, THESIS U KONSTANZ GE; ORII Y, 1988, ANN NY ACAD SCI, V550, P105, DOI 10.1111/j.1749-6632.1988.tb35327.x; POOLE RK, 1988, FEBS LETT, V231, P243, DOI 10.1016/0014-5793(88)80740-3; POOLE RK, 1982, FEBS LETT, V141, P237, DOI 10.1016/0014-5793(82)80056-2; PUDEK MR, 1974, ARCH BIOCHEM BIOPHYS, V164, P682, DOI 10.1016/0003-9861(74)90081-2; ROTHERY RA, 1989, BIOCHEM J, V261, P437, DOI 10.1042/bj2610437; SMITH A, 1990, J GEN MICROBIOL, V136, P171, DOI 10.1099/00221287-136-1-171; WIKSTROM M, 1994, BBA-BIOENERGETICS, V1187, P106, DOI 10.1016/0005-2728(94)90093-0; WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0; YONETANI T, 1972, J BIOL CHEM, V247, P2447	44	62	63	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16213	16220		10.1074/jbc.270.27.16213	http://dx.doi.org/10.1074/jbc.270.27.16213			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608187	hybrid			2022-12-27	WOS:A1995RH22600051
J	SANCAR, A				SANCAR, A			EXCISION-REPAIR IN MAMMALIAN-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							COMPLEMENTATION GROUP-E; DNA-BINDING PROTEIN; IONIZING-RADIATION; DAMAGED DNA; REPLICATION; CISPLATIN; NUCLEASE				SANCAR, A (corresponding author), UNIV N CAROLINA,SCH MED,DEPT BIOCHEM & BIOPHYS,CB 7260,CHAPEL HILL,NC 27599, USA.							ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; BOYER JC, 1990, CANCER RES, V50, P2593; BRUHN SL, 1992, P NATL ACAD SCI USA, V89, P2307, DOI 10.1073/pnas.89.6.2307; BUDD ME, 1995, MOL CELL BIOL, V15, P2173; CARTY MP, 1994, EMBO J, V13, P2114, DOI 10.1002/j.1460-2075.1994.tb06487.x; CHU G, 1994, J BIOL CHEM, V269, P787; Cleaver J. E., 1989, METABOLIC BASIS INHE, V2, P2949; COLLINS AR, 1993, MUTAT RES, V293, P99, DOI 10.1016/0921-8777(93)90062-L; COVERLEY D, 1991, NATURE, V349, P538, DOI 10.1038/349538a0; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P3502; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; DRAPKIN R, 1994, TRENDS BIOCHEM SCI, V19, P504, DOI 10.1016/0968-0004(94)90139-2; DUTTA A, 1993, NATURE, V365, P79, DOI 10.1038/365079a0; FORNACE AJ, 1992, ANNU REV GENET, V26, P505; FRIEDBERG EC, 1995, DNA REPAIR; HABRAKEN Y, 1994, NUCLEIC ACIDS RES, V22, P3312, DOI 10.1093/nar/22.16.3312; HABRAKEN Y, 1994, J BIOL CHEM, V269, P31342; HANAWALT PC, 1994, SCIENCE, V266, P1457; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P24203; HSU DS, 1995, J BIOL CHEM, V270, P8319, DOI 10.1074/jbc.270.14.8319; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P10394, DOI 10.1073/pnas.91.22.10394; HUANG JC, 1994, J BIOL CHEM, V269, P19034; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P12213, DOI 10.1073/pnas.91.25.12213; HURWITZ J, 1990, J BIOL CHEM, V265, P18043; ISHIZAKI K, 1994, INT J CANCER, V58, P254, DOI 10.1002/ijc.2910580218; KATAOKA H, 1991, BIOCHEM BIOPH RES CO, V175, P1139, DOI 10.1016/0006-291X(91)91684-5; KEENEY S, 1992, MUTAT RES, V273, P49, DOI 10.1016/0921-8777(92)90049-9; LI L, 1994, P NATL ACAD SCI USA, V91, P5012, DOI 10.1073/pnas.91.11.5012; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; LIU VF, 1993, MOL CELL BIOL, V13, P7222, DOI 10.1128/MCB.13.12.7222; LOMMEL L, 1995, MUTAT RES-DNA REPAIR, V336, P181, DOI 10.1016/0921-8777(94)00055-B; MASUTANI C, 1994, EMBO J, V13, P1831, DOI 10.1002/j.1460-2075.1994.tb06452.x; MATSUNAGA T, 1995, IN PRESS J BIOL CHEM, V270; MODRICH P, 1994, SCIENCE, V266, P1959, DOI 10.1126/science.7801122; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; MU D, 1994, NUCLEIC ACIDS RES, V22, P4869, DOI 10.1093/nar/22.23.4869; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; NICHOLS AF, 1992, NUCLEIC ACIDS RES, V20, P2441, DOI 10.1093/nar/20.10.2441; ODONOVAN A, 1994, J BIOL CHEM, V269, P15965; PAN ZQ, 1995, P NATL ACAD SCI USA, V91, P4636; PARK CH, 1995, J BIOL CHEM, V270, P4896, DOI 10.1074/jbc.270.9.4896; PARK CH, 1994, P NATL ACAD SCI USA, V91, P5017, DOI 10.1073/pnas.91.11.5017; PARK HW, 1995, IN PRESS SCIENCE; PIL PM, 1992, SCIENCE, V256, P234, DOI 10.1126/science.1566071; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; REARDON JT, 1993, COLD SPRING HARB SYM, V58, P605, DOI 10.1101/SQB.1993.058.01.067; REARDON JT, 1993, J BIOL CHEM, V268, P21301; ROBINS P, 1991, EMBO J, V10, P3913, DOI 10.1002/j.1460-2075.1991.tb04961.x; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; SANCAR A, 1994, SCIENCE, V266, P1954, DOI 10.1126/science.7801120; SANCAR A, 1995, IN PRESS ANN REV GEN, V29; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SHIKHATTAR R, 1995, NATURE, V374, P283; SHIVJI MKK, 1992, CELL, V69, P367, DOI 10.1016/0092-8674(92)90416-A; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; SVOBODA DL, 1993, J BIOL CHEM, V268, P1931; THOMPSON LH, 1981, P NATL ACAD SCI-BIOL, V78, P3734, DOI 10.1073/pnas.78.6.3734; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; WANG XW, 1994, P NATL ACAD SCI USA, V91, P2230, DOI 10.1073/pnas.91.6.2230; ZENG XR, 1994, J BIOL CHEM, V269, P13748	67	154	156	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15915	15918		10.1074/jbc.270.27.15915	http://dx.doi.org/10.1074/jbc.270.27.15915			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608140	hybrid, Green Published			2022-12-27	WOS:A1995RH22600001
J	TAKUMI, T; ISHII, T; HORIO, Y; MORISHIGE, K; TAKAHASHI, N; YAMADA, M; YAMASHITA, T; KIYAMA, H; SOHMIYA, K; NAKANISHI, S; KURACHI, Y				TAKUMI, T; ISHII, T; HORIO, Y; MORISHIGE, K; TAKAHASHI, N; YAMADA, M; YAMASHITA, T; KIYAMA, H; SOHMIYA, K; NAKANISHI, S; KURACHI, Y			A NOVEL ATP-DEPENDENT INWARD RECTIFIER POTASSIUM CHANNEL EXPRESSED PREDOMINANTLY IN GLIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUINEA-PIG HEART; ION CHANNELS; FUNCTIONAL EXPRESSION; SEQUENCES; RECEPTOR; PROTEIN; OLIGODENDROCYTES; SUBUNITS; MEMBRANE; CURRENTS	We have isolated a novel inward rectifier K+ channel predominantly expressed in glial cells of the central nervous system. Its amino acid sequence exhibited 53% identity with ROMK1 and approximately 40% identity with other inward rectifier K+ channels. Xenopus oocytes injected with cRNA derived from this clone expressed a K+ current, which showed classical inward rectifier K+ channel characteristics. Intracenular Mg . ATP was required to sustain channel activity in excised membrane patches, which is consistent with a Walker type-ii ATP-binding domain on this clone. We designate this new clone as K-AB-2 (the second type of inward rectifying K+ channel with an ATP-binding domain). In situ hybridization showed K-AB-2 mRNA to be expressed predominantly in glial cells of the cerebellum and forebrain. This is the first description of the cloning of a glial cell inward rectifier potassium channel, which may be responsible for K+ buffering action of glial cells in the brain.	OSAKA UNIV, FAC MED, BIOMED RES CTR, DEPT PHARMACOL 2, SUITA, OSAKA 565, JAPAN; OSAKA UNIV, FAC MED, BIOMED RES CTR, DEPT OBSTET & GYNECOL, SUITA, OSAKA 565, JAPAN; OSAKA UNIV, FAC MED, BIOMED RES CTR, DEPT NEUROANAT, SUITA, OSAKA 565, JAPAN; KYOTO UNIV, FAC MED, INST IMMUNOL, KYOTO 60601, JAPAN	Osaka University; Osaka University; Osaka University; Kyoto University			Kiyama, Hiroshi/M-8867-2014	Kiyama, Hiroshi/0000-0001-5963-046X; Horio, Yoshiyuki/0000-0002-5021-5929				ASHFORD MLJ, 1994, NATURE, V370, P456, DOI 10.1038/370456a0; Barres B A, 1991, Curr Opin Neurobiol, V1, P354, DOI 10.1016/0959-4388(91)90052-9; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; BARRES BA, 1988, GLIA, V1, P10, DOI 10.1002/glia.440010104; BREW H, 1986, NATURE, V324, P466, DOI 10.1038/324466a0; BRISMAR T, 1989, BRAIN RES, V480, P249, DOI 10.1016/0006-8993(89)90190-X; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P11235; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; ISHII T, 1993, J BIOL CHEM, V268, P2836; KARSCHIN C, 1994, FEBS LETT, V348, P139, DOI 10.1016/0014-5793(94)00590-7; KENNA S, 1994, MOL BRAIN RES, V24, P353, DOI 10.1016/0169-328X(94)90150-3; KOYAMA H, 1994, FEBS LETT, V341, P303, DOI 10.1016/0014-5793(94)80478-8; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KURACHI Y, 1985, J PHYSIOL-LONDON, V366, P365, DOI 10.1113/jphysiol.1985.sp015803; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; MAKHINA EN, 1994, J BIOL CHEM, V269, P20468; MCLARNON JG, 1989, GLIA, V2, P298, DOI 10.1002/glia.440020503; MORISHIGE K, 1993, FEBS LETT, V336, P375, DOI 10.1016/0014-5793(93)80840-Q; MORISHIGE KI, 1994, FEBS LETT, V346, P251, DOI 10.1016/0014-5793(94)00483-8; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; NEWMAN EA, 1993, J NEUROSCI, V13, P3333; NEWMAN EA, 1984, SCIENCE, V225, P1174, DOI 10.1126/science.6474173; NILIUS B, 1988, PFLUG ARCH EUR J PHY, V411, P654, DOI 10.1007/BF00580862; ORKAND RK, 1966, J NEUROPHYSIOL, V29, P788, DOI 10.1152/jn.1966.29.4.788; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; PERIER F, 1994, P NATL ACAD SCI USA, V91, P6240, DOI 10.1073/pnas.91.13.6240; SAKMANN B, 1984, J PHYSIOL-LONDON, V347, P659, DOI 10.1113/jphysiol.1984.sp015089; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SONTHEIMER H, 1994, GLIA, V11, P156, DOI 10.1002/glia.440110210; STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; SUZUKI M, 1994, NATURE, V367, P642, DOI 10.1038/367642a0; TAKAHASHI N, 1994, J BIOL CHEM, V269, P23274; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WIHLE BA, 1994, NATURE, V371, P246; YOSHIMURA R, 1993, ENDOCRINOLOGY, V133, P1239, DOI 10.1210/en.133.3.1239	42	215	224	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16339	16346		10.1074/jbc.270.27.16339	http://dx.doi.org/10.1074/jbc.270.27.16339			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608203	hybrid			2022-12-27	WOS:A1995RH22600070
J	EDISON, AM; BARKER, SC; KASSEL, DB; LUTHER, MA; KNIGHT, WB				EDISON, AM; BARKER, SC; KASSEL, DB; LUTHER, MA; KNIGHT, WB			EXPLORATION OF THE SEQUENCE SPECIFICITY OF PP60(C-SRC) TYROSINE KINASE - MINIMAL, PEPTIDE SEQUENCE REQUIRED FOR MAXIMAL ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHETIC PEPTIDES; PROTEIN-KINASE; PHOSPHORYLATION; PP60V-SRC; PURIFICATION; INVITRO	The minimum length required for phosphorylation of a peptide by pp60(c-src) tyrosine kinase (srcTK) was delineated in this work, Budde (M. D, Anderson University of Texas, personal communication) suggested that the peptide (FGE)(3)Y(GEF)(2)GD (peptide I) was a ''good'' srcTK substrate. Peptide I yielded a 251-fold higher k(cat)/K-m than RRLIEDAEYAARRG, a peptide substrate based upon the autophosphorylation site of srcTK, This was due to a 38-fold lower K-m and a 6.6-fold increase in k(cat). N-terminal truncation of up to 8 residues in a series of peptides yielded only a 3-fold decrease in activity, Removal of the final N-terminal residue resulted in a 10-fold loss in substrate activity, primarily as a result of an increase in the K-m. C-terminal truncations ending in the amide yielded no significant loss in activity until the Y+3 residue was removed, which resulted in a 73-fold decrease in k(cat)/K-m relative to peptide I. The latter was due primarily to an increase in K-m. The results from peptides truncated on both termini suggest that subsite recognition N- and C-terminal relative to the site of phosphorylation can be examined independently, In addition, the observation that only 5 residues are required for significant substrate activity suggests that small molecule inhibitors based upon interactions with the phosphoacceptor site may be developed.	GLAXO RES INST,DIV MOLEC SCI,RES TRIANGLE PK,NC 27709	GlaxoSmithKline								BUDDE RJA, 1993, PREP BIOCHEM, V23, P493, DOI 10.1080/10826069308544572; CASNELLIE JE, 1982, P NATL ACAD SCI-BIOL, V79, P282, DOI 10.1073/pnas.79.2.282; COLA C, 1989, BIOCHIM BIOPHYS ACTA, V1012, P191, DOI 10.1016/0167-4889(89)90095-5; ELLIS B, 1994, J CELL BIOCH B S, V18, P276; FERSHT A, 1977, ENZYME STRUCTURE MEC, P109; GARCIA P, 1993, J BIOL CHEM, V268, P25146; HUNTER T, 1982, J BIOL CHEM, V257, P4843; Leatherbarrow R. J., 1992, GRAFIT VERSION 3 0; OGAWA W, 1994, J BIOL CHEM, V269, P29602; PIMENTEL E, 1989, ONCOGENES, V2; PIMENTEL E, 1989, ONCOGENES, V1; RADZIEJEWSKI C, 1989, BIOCHEMISTRY-US, V28, P9047, DOI 10.1021/bi00449a013; SAYA H, 1993, FEBS LETT, V327, P224, DOI 10.1016/0014-5793(93)80174-S; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; TILL JH, 1994, J BIOL CHEM, V269, P7423; TINKER DA, 1992, ANTICANCER RES, V12, P123; TINKER DA, 1988, J BIOL CHEM, V263, P5024; WONG TW, 1983, J BIOL CHEM, V258, P1022; ZHANG S, 1991, Cellular Physiology and Biochemistry, V1, P24, DOI 10.1159/000154590	19	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27112	27115		10.1074/jbc.270.45.27112	http://dx.doi.org/10.1074/jbc.270.45.27112			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592964	hybrid			2022-12-27	WOS:A1995TE58300064
J	ELOUAGARI, K; TEISSIE, J; BENOIST, H				ELOUAGARI, K; TEISSIE, J; BENOIST, H			GLYCOPHORIN A PROTECTS K562 CELLS FROM NATURAL-KILLER-CELL ATTACK - ROLE OF OLIGOSACCHARIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED CYTO-TOXICITY; TRANSFERRIN RECEPTOR; SIALIC-ACID; NK SUSCEPTIBILITY; TARGET STRUCTURES; TUMOR-CELLS; LYSIS; GLYCOPROTEINS; EXPRESSION; RESISTANCE	Glycophorin A is a protein with an abundant glycosylation (60% carbohydrate by weight), and studies have suggested that resistance of target cells to natural killing may be correlated with the level of glycophorin A expression, To assess the role of glycophorin A and of its carbohydrates in sensitivity to lysis by natural killer (NK) cells, the glycoprotein was inserted into the membrane of K562 target cells using electropulsation. Peripheral blood lymphocytes were used as effector cells. When glycophorin A was inserted into the membrane, the level of resistance to NK cell attack increased with the number of glycophorin A molecules electroinserted. The resistance to lysis was not due to a defect in target cell effector cell binding, Electroassociation of glycophorin A did not cause a decrease in the expression of either ''positive signals'' for NK cells (such as CD71, CD15, and CD32 antigens) or cellular adhesion molecules (CD18, CD29, CD54, and CD58), Furthermore, electroinsertion of glycophorin A did not trigger any ''negative signals,'' such as class I HLA antigen expression. Finally, it was shown that the sialic acid and O-linked oligosaccharides of glycophorin A did not play any role in its effect against NK cells. Conversely, the unique N-linked oligosaccharide was shown to be essential for resistance to occur.	UNIV TOULOUSE 3,INSERM,U395,F-31024 TOULOUSE,FRANCE; DEPT GLYCOCONJUGUES & BIOMEMBRANES,CNRS,UPR 8221,F-31062 TOULOUSE,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)			Teissie, Justin/AAA-5697-2019; Benoist, Hervé/P-2927-2014	Teissie, Justin/0000-0002-7588-8062; 				AHRENS PB, 1993, J BIOL CHEM, V268, P385; ALARCON B, 1985, J IMMUNOL, V134, P1286; ANDO I, 1987, INT J CANCER, V40, P12, DOI 10.1002/ijc.2910400104; ARORA DJS, 1984, J VIROL, V52, P839, DOI 10.1128/JVI.52.3.839-845.1984; BENOIST H, 1992, IMMUNOL LETT, V34, P45, DOI 10.1016/0165-2478(92)90026-K; BENOIST H, 1988, INT J CANCER, V42, P299, DOI 10.1002/ijc.2910420227; BEZOUSKA K, 1995, NATURE, V372, P150; DILL K, 1990, J PROTEIN CHEM, V9, P129, DOI 10.1007/BF01025303; DLUHY RA, 1983, BIOCHEMISTRY-US, V22, P1170, DOI 10.1021/bi00274a028; ELDER JH, 1982, P NATL ACAD SCI-BIOL, V79, P4540, DOI 10.1073/pnas.79.15.4540; ELOUAGARI K, 1993, BIOCHIM BIOPHYS ACTA, V1151, P105, DOI 10.1016/0005-2736(93)90077-D; ELOUAGARI K, 1994, EUR J BIOCHEM, V219, P1031; GIORDA R, 1990, SCIENCE, V249, P1298, DOI 10.1126/science.2399464; GRIMM E, 1979, J IMMUNOL, V123, P2861; HARRIS DT, 1994, SCAND J IMMUNOL, V39, P73, DOI 10.1111/j.1365-3083.1994.tb03342.x; KAPITZA HG, 1984, BIOPHYS J, V45, P577, DOI 10.1016/S0006-3495(84)84195-8; KARRE K, 1995, SCIENCE, V267, P978, DOI 10.1126/science.7863341; KOBATA A, 1992, EUR J BIOCHEM, V209, P483, DOI 10.1111/j.1432-1033.1992.tb17313.x; LAZARUS AH, 1985, CELL IMMUNOL, V96, P255, DOI 10.1016/0008-8749(85)90358-2; MCCOY J P JR, 1991, Glycobiology, V1, P321, DOI 10.1093/glycob/1.4.321; MORETTA L, 1992, IMMUNOL TODAY, V13, P300, DOI 10.1016/0167-5699(92)90042-6; PATARROYO M, 1991, CLIN IMMUNOL IMMUNOP, V60, P333, DOI 10.1016/0090-1229(91)90091-N; PERL A, 1986, J IMMUNOL, V136, P4714; QUILLET A, 1988, J IMMUNOL, V141, P17; QUILLETMARY A, 1991, INT J CANCER, V47, P473, DOI 10.1002/ijc.2910470328; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; STORKUS WJ, 1989, J IMMUNOL, V143, P3853; TRINCHIERI G, 1992, NATURAL KILLER CELL, P42; UMEMOTO J, 1977, J BIOL CHEM, V252, P8609; WERKMEISTER JA, 1983, INT J CANCER, V32, P71, DOI 10.1002/ijc.2910320112; YOGEESWARAN G, 1981, INT J CANCER, V28, P517, DOI 10.1002/ijc.2910280419; YOKOYAMA WM, 1995, CURR OPIN IMMUNOL, V7, P110, DOI 10.1016/0952-7915(95)80036-0; ZARCONE D, 1987, CANCER RES, V47, P2674; ZEIRA M, 1991, P NATL ACAD SCI USA, V88, P4409, DOI 10.1073/pnas.88.10.4409	34	38	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26970	26975						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592944				2022-12-27	WOS:A1995TE58300044
J	OSTRANDER, DB; GORMAN, JA; CARMAN, GM				OSTRANDER, DB; GORMAN, JA; CARMAN, GM			REGULATION OF PROFILIN LOCALIZATION IN SACCHAROMYCES-CEREVISIAE BY PHOSPHOINOSITIDE METABOLISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; PLASMA-MEMBRANE; MYO-INOSITOL-1-PHOSPHATE SYNTHASE; PHOSPHATIDYLINOSITOL SYNTHASE; PHOSPHOLIPASE-C; STRUCTURAL GENE; YEAST PROFILIN; HUMAN PLATELET; PURIFICATION; INOSITOL	Profilin is an actin- and phosphatidylinositol 4,5-bisphosphate binding protein that plays a role in the organization of the cytoskeleton and may be involved in growth factor signaling pathways. The subcellular localization of profilin was examined in the yeast Saccharomyces cerevisiae, Immunoblot analysis showed that profilin was localized in both the plasma membrane and cytosolic fractions of the cell. Actin was bound to the profilin localized in the cytosol. The association of profilin with the membrane was peripheral and mediated through interaction with phospholipid. The phospholipid dependence of profilin for membrane binding was examined in vitro using pure profilin and defined unilamellar phospholipid vesicles. The presence of phosphatidylinositol 4,5-bisphosphate in phospholipid vesicles was required for maximum profilin binding. Moreover, the binding of profilin to phospholipid vesicles was dependent on the surface concentration of phosphatidylinositol 4,5-bisphosphate. The subcellular localization of profilin was examined in vivo under growth conditions (i.e. inositol starvation of ino1 cells and glucose starvation of respiratory deficient cells) where plasma membrane levels of phosphatidylinositol 4,5-bisphosphate were depleted. Depletion of plasma membrane phosphatidylinositol 4,5-bisphosphate levels resulted in a translocation of profilin from the plasma membrane to the cytosolic fraction. Profilin translocated back to the membrane fraction from the cytosol under growth conditions where plasma membrane levels of phosphatidylinositol 4,5-bisphosphate were replenished. These results suggested that phosphoinositide metabolism played a role in the localization of profilin.	RUTGERS STATE UNIV, COOK COLL, NEW JERSEY AGR EXPT STN, DEPT FOOD SCI, NEW BRUNSWICK, NJ 08903 USA; BRISTOL MYERS SQUIBB PHARMACEUT RES INST, DEPT MICROBIAL MOLEC BIOL, PRINCETON, NJ 08543 USA	Rutgers State University New Brunswick; Bristol-Myers Squibb					NIGMS NIH HHS [GM-28140] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R37GM028140] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BECKER GW, 1977, J BIOL CHEM, V252, P8684; BELENDIUK G, 1978, J BIOL CHEM, V253, P4555; BERRIDGE MJ, 1987, BIOCHIM BIOPHYS ACTA, V907, P33, DOI 10.1016/0304-419X(87)90017-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUXEDA RJ, 1993, J BIOL CHEM, V268, P6248; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; CULBERTSON MR, 1975, GENETICS, V80, P23; DEANJOHNSON M, 1989, J BIOL CHEM, V264, P1274; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; FEDORCHAIKEN M, 1990, CELL, V61, P329, DOI 10.1016/0092-8674(90)90813-T; FISCHL AS, 1986, J BIOL CHEM, V261, P3178; FISCHL AS, 1983, J BACTERIOL, V154, P304, DOI 10.1128/JB.154.1.304-311.1983; GOLDSCHMIDTCLERMONT PJ, 1991, J CELL BIOL, V113, P1081, DOI 10.1083/jcb.113.5.1081; GOLDSCHMIDTCLERMONT PJ, 1990, SCIENCE, V247, P1575, DOI 10.1126/science.2157283; GOLDSCHMIDTCLERMONT PJ, 1991, SCIENCE, V251, P1231, DOI 10.1126/science.1848725; GREEN PR, 1984, J BIOL CHEM, V259, P4688; HAARER BK, 1990, J CELL BIOL, V110, P105, DOI 10.1083/jcb.110.1.105; HAARER BK, 1993, MOL CELL BIOL, V13, P7864, DOI 10.1128/MCB.13.12.7864; HAFFEY ML, 1988, J VIROL, V62, P4493, DOI 10.1128/JVI.62.12.4493-4498.1988; HAID A, 1983, METHOD ENZYMOL, V96, P192; HARLOW E, 1988, ANTIBODIES LABORATOR; HENRY SA, 1977, J BACTERIOL, V130, P472, DOI 10.1128/JB.130.1.472-484.1977; KILMARTIN JV, 1984, J CELL BIOL, V98, P933; KOLAND JG, 1986, J BIOL CHEM, V261, P5936; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Machesky Laura M., 1993, Trends in Cell Biology, V3, P381, DOI 10.1016/0962-8924(93)90087-H; MACHESKY LM, 1990, CELL REGUL, V1, P937, DOI 10.1091/mbc.1.12.937; MAGDOLEN V, 1988, MOL CELL BIOL, V8, P5108, DOI 10.1128/MCB.8.12.5108; METZLER WJ, 1994, J BIOL CHEM, V269, P4620; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; MONK BC, 1991, J BACTERIOL, V173, P6826, DOI 10.1128/jb.173.21.6826-6836.1991; NICKELS JT, 1994, J BIOL CHEM, V269, P11018; OLMSTED JB, 1981, J BIOL CHEM, V256, P1955; PALTAUF F, 1992, MOL CELLULAR BIOL YE, P415; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; PATTON JL, 1992, ARCH BIOCHEM BIOPHYS, V292, P70, DOI 10.1016/0003-9861(92)90052-X; Rose MD., 1990, METHODS YEAST GENETI; SCHAAP AP, 1989, CLIN CHEM, V35, P1863; SERRANO R, 1988, METHOD ENZYMOL, V157, P533; TALWALKAR RT, 1973, BIOCHIM BIOPHYS ACTA, V306, P412, DOI 10.1016/0005-2760(73)90180-X; THERIOT JA, 1993, CELL, V75, P835, DOI 10.1016/0092-8674(93)90527-W; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	46	46	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27045	27050		10.1074/jbc.270.45.27045	http://dx.doi.org/10.1074/jbc.270.45.27045			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592954	hybrid			2022-12-27	WOS:A1995TE58300054
J	HAYWARD, CPM; HASSELL, JA; DENOMME, GA; RACHUBINSKI, RA; BROWN, C; KELTON, JG				HAYWARD, CPM; HASSELL, JA; DENOMME, GA; RACHUBINSKI, RA; BROWN, C; KELTON, JG			THE CDNA SEQUENCE OF HUMAN ENDOTHELIAL-CELL MULTIMERIN - A UNIQUE PROTEIN WITH RGDS, COILED-COIL, AND EPIDERMAL GROWTH FACTOR-LIKE DOMAINS AND A CARBOXYL-TERMINUS SIMILAR TO THE GLOBULAR DOMAIN OF COMPLEMENT C1Q AND COLLAGENS TYPE-VIII AND TYPE-X	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCES; MYOSIN HEAVY-CHAIN; BETA-HYDROXYASPARTIC ACID; HEMOPHILIC FACTOR-IX; COAGULATION FACTOR-X; SUBCOMPONENT C1Q; B-CHAIN; VONWILLEBRAND-FACTOR; TYROSINE SULFATION; MOLECULAR-CLONING	Multimerin is a massive, soluble protein found in platelets and in the endothelium of blood vessels. Multimerin is composed of varying sized, disulfide-linked multimers, the smallest of which is a homotrimer. Multimerin is a factor V/Va-binding protein and may function as a carrier protein for platelet factor V. The cDNA for human multimerin was isolated from lambda gt11 endothelial cell libraries using antibodies, and the isolated cDNA clones were used to obtain the full sequence. The full-length multimerin cDNA was 4.2 kilobase pairs. Northern analyses identified a 4.7-kilobase transcript in cultured endothelial cells, a megakaryocytic cell line, platelets, and highly vascular tissues. The multimerin cDNA can encode a protein of 1228 amino acids with the probable signal peptide cleavage site between amino acids 19 and 20. The protein is predicted to be hydrophilic and to contain 23 N-glycosylation sites. The adhesive motif RGDS (Arg-Gly-Asp-Ser) and an epidermal growth factor-like domain were identified. Sequence searches indicated that multimerin is a unique protein. Analyses identified probable coiled-coil structures in the central portion of the multimerin sequence. Additionally, the carboxyl-terminal region of multimerin resembles the globular, non-collagen-like, carboxyl-terminal domains of several other trimeric proteins, including complement Clq and collagens type VIII and X.	MCMASTER UNIV,DEPT MED,HAMILTON,ON L8N 3Z5,CANADA; MCMASTER UNIV,DEPT BIOCHEM,HAMILTON,ON L8N 3Z5,CANADA; MCMASTER UNIV,INST MOLEC BIOL & BIOTECHNOL,HAMILTON,ON L8N 3Z5,CANADA; CANADIAN RED CROSS BLOOD TRANSFUS SERV,HAMILTON CTR,HAMILTON,ON L8N 3Z5,CANADA	McMaster University; McMaster University; McMaster University	HAYWARD, CPM (corresponding author), MCMASTER UNIV,DEPT PATHOL,HSC 2N32,1200 MAIN ST W,HAMILTON,ON L8N 3Z5,CANADA.		Denomme, Gregory A./T-5397-2019	Denomme, Gregory A./0000-0001-8727-1679; Hayward, Catherine/0000-0002-2843-0817				APTE S, 1991, FEBS LETT, V282, P393, DOI 10.1016/0014-5793(91)80521-4; APTE SS, 1992, EUR J BIOCHEM, V206, P217, DOI 10.1111/j.1432-1033.1992.tb16919.x; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; CHOO KH, 1982, NATURE, V299, P178, DOI 10.1038/299178a0; COFFMAN C, 1990, SCIENCE, V249, P1438, DOI 10.1126/science.2402639; DAVIS C G, 1990, New Biologist, V2, P410; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; FEGHALI R, 1989, J CELL BIOL, V108, P1791, DOI 10.1083/jcb.108.5.1791; Fourney R.M., 1988, FOCUS, V10, P5; FUNG MR, 1985, P NATL ACAD SCI USA, V82, P3591, DOI 10.1073/pnas.82.11.3591; GALAS DJ, 1980, J MOL BIOL, V144, P19, DOI 10.1016/0022-2836(80)90213-2; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; HAYWARD CPM, 1991, J BIOL CHEM, V266, P7114; HAYWARD CPM, 1995, PLATELETS, V6, P1, DOI 10.3109/09537109509013255; HAYWARD CPM, 1993, J CLIN INVEST, V91, P2630, DOI 10.1172/JCI116502; HAYWARD CPM, 1991, BLOOD, V77, P2556; HOURNET AM, 1993, EUR J CELL BIOL, V60, P31; HUNH TV, 1985, DNA CLONING PRACTICA, V1, P49; HUTTNER WB, 1987, TRENDS BIOCHEM SCI, V12, P361, DOI 10.1016/0968-0004(87)90166-6; JAGADEESWARAN P, 1984, SOMAT CELL MOLEC GEN, V10, P465, DOI 10.1007/BF01534851; JAYE M, 1983, NUCLEIC ACIDS RES, V11, P2325, DOI 10.1093/nar/11.8.2325; KIMURA H, 1990, NATURE, V348, P257, DOI 10.1038/348257a0; KNOBEL HR, 1975, EUR J IMMUNOL, V5, P78, DOI 10.1002/eji.1830050119; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KRUSIUS T, 1987, J BIOL CHEM, V262, P13120; KWAN APL, 1991, J CELL BIOL, V114, P597, DOI 10.1083/jcb.114.3.597; LEYTUS SP, 1984, P NATL ACAD SCI-BIOL, V81, P3699, DOI 10.1073/pnas.81.12.3699; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; MCMULLEN BA, 1983, BIOCHEMISTRY-US, V22, P2875, DOI 10.1021/bi00281a016; MITCHELL PJ, 1992, ONCOGENE, V7, P2329; MURAGAKI Y, 1991, EUR J BIOCHEM, V197, P615, DOI 10.1111/j.1432-1033.1991.tb15951.x; PETRY F, 1991, J IMMUNOL, V147, P3988; PETRY F, 1992, EUR J BIOCHEM, V209, P129, DOI 10.1111/j.1432-1033.1992.tb17269.x; PLESS DD, 1977, P NATL ACAD SCI USA, V74, P134, DOI 10.1073/pnas.74.1.134; REICHENBERGER E, 1992, FEBS LETT, V311, P305, DOI 10.1016/0014-5793(92)81126-7; REID KBM, 1979, BIOCHEM J, V179, P367, DOI 10.1042/bj1790367; REID KBM, 1985, BIOCHEM J, V231, P729, DOI 10.1042/bj2310729; REID KBM, 1982, BIOCHEM J, V203, P559, DOI 10.1042/bj2030559; REID KBM, 1986, ESSAYS BIOCHEM, V22, P27; ROSENQUIST GL, 1993, PROTEIN SCI, V2, P215; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; SAEZ CG, 1990, P NATL ACAD SCI USA, V87, P1164, DOI 10.1073/pnas.87.3.1164; SAEZ L, 1986, NUCLEIC ACIDS RES, V14, P2951, DOI 10.1093/nar/14.7.2951; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAMBROOK J, 1989, MOL CLONING LABORATO, P2118; SAWADA H, 1990, J CELL BIOL, V110, P219, DOI 10.1083/jcb.110.1.219; SEELIG HP, 1994, J AUTOIMMUN, V7, P67, DOI 10.1006/jaut.1994.1006; SELLAR GC, 1991, BIOCHEM J, V274, P481, DOI 10.1042/bj2740481; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; STENFLO J, 1988, J BIOL CHEM, V263, P21; THOMAS JT, 1991, BIOCHEM J, V280, P617, DOI 10.1042/bj2800617; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; WAGNER DD, 1991, CELL, V64, P403, DOI 10.1016/0092-8674(91)90648-I; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; YE RD, 1987, J BIOL CHEM, V262, P3718; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	58	63	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18246	18251		10.1074/jbc.270.31.18246	http://dx.doi.org/10.1074/jbc.270.31.18246			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629143	hybrid			2022-12-27	WOS:A1995RM64200017
J	FUKUHARA, T; MORIYAMA, H; NITTA, T				FUKUHARA, T; MORIYAMA, H; NITTA, T			THE UNUSUAL STRUCTURE OF A NOVEL RNA REPLICON IN RICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; NUCLEOTIDE-SEQUENCE; PHASEOLUS-VULGARIS; VIRUS	A linear, plasmid-like, double-stranded RNA (dsRNA) was isolated from rice, and its entire sequence of 13,952 nucleotides (nt) was determined. The dsRNA encodes a single, unusually long, open reading frame (13,716 nt, 4,572 amino acid residues), which includes an RNA he licase-like domain and an RNA-dependent RNA po lymerase-like domain. A series of Northern hybridization and primer extension experiments revealed that the coding (sense) strand of the dsRNA contains a discontinuity (nick) at a position 1,211 nt (or 1, 256 nt) from the 5' end. This discontinuity divides not only the coding strand of dsRNA molecule into a 1,211-nt fragment and a 12,741-nt fragment (or a 1, 256-nt fragment and a 12, 696-nt fragment) but also divides the long open reading frame into a 5' part of 1,045 nt (348 amino acid residues) and a 3' part of 12,671 nt (4,224 amino acid residues) or a 5' part of 1,090 nt (363 amino acid residues) and a 3' part of 12,626 nt (4,209 amino acid residues). It seems likely that almost all dsRNA molecules in rice plants contain such a discontinuity. This rice dsRNA appears to be a novel and unique RNA replicon.			FUKUHARA, T (corresponding author), TOKYO UNIV AGR & TECHNOL, FAC AGR, MOLEC CELL BIOL LAB, FUCHU, TOKYO 183, JAPAN.		Moriyama, Hiromitsu/F-9256-2013; Fukuhara, T./C-3208-2013					ALLISON R, 1986, VIROLOGY, V154, P9, DOI 10.1016/0042-6822(86)90425-3; BOCCARDO G, 1987, ADV VIRUS RES, V32, P171, DOI 10.1016/S0065-3527(08)60477-7; BROWN GG, 1989, INT REV CYTOL, V117, P1; DODDS JA, 1984, ANNU REV PHYTOPATHOL, V22, P151, DOI 10.1146/annurev.py.22.090184.001055; FUKUHARA T, 1993, PLANT MOL BIOL, V21, P1121, DOI 10.1007/BF00023608; GHABRIAL SA, 1994, ADV VIRUS RES, V43, P303, DOI 10.1016/S0065-3527(08)60052-4; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HILLMAN BI, 1994, 6TH REP INT COMM TAX; ISHIHARA J, 1992, PLANTA, V187, P475, DOI 10.1007/BF00199965; Joklik W.K., 1983, REOVIRIDAE; MACKENZIE SA, 1988, THEOR APPL GENET, V76, P59, DOI 10.1007/BF00288832; MINDICH L, 1988, ADV VIRUS RES, V35, P137; MORIYAMA H, 1995, IN PRESS MOL GEN GEN, V248; Nuss D L, 1990, Adv Virus Res, V38, P249, DOI 10.1016/S0065-3527(08)60864-7; PFEIFFER P, 1993, J GEN VIROL, V74, P1167, DOI 10.1099/0022-1317-74-6-1167; SHAPIRA R, 1991, EMBO J, V10, P731, DOI 10.1002/j.1460-2075.1991.tb08004.x; VALVERDE RA, 1990, PLANT SCI, V67, P195, DOI 10.1016/0168-9452(90)90243-H; WAKARCHUK DA, 1990, PLANT MOL BIOL, V14, P637, DOI 10.1007/BF00027512; WAKARCHUK DA, 1985, PLANT MOL BIOL, V5, P55, DOI 10.1007/BF00017873; WANG AL, 1991, ANNU REV MICROBIOL, V45, P251, DOI 10.1146/annurev.mi.45.100191.001343; ZABALGOGEAZCOA IA, 1992, PLANT SCI, V83, P187, DOI 10.1016/0168-9452(92)90078-Z; [No title captured]	22	19	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18147	18149		10.1074/jbc.270.30.18147	http://dx.doi.org/10.1074/jbc.270.30.18147			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629126				2022-12-27	WOS:A1995RM26600078
J	IWASAKI, T; WAKAGI, T; OSHIMA, T				IWASAKI, T; WAKAGI, T; OSHIMA, T			FERREDOXIN-DEPENDENT REDOX SYSTEM OF A THERMOACIDOPHILIC ARCHAEON, SULFOLOBUS SP STRAIN-7 - PURIFICATION AND CHARACTERIZATION OF A NOVEL REDUCED FERREDOXIN-REOXIDIZING IRON-SULFUR FLAVOPROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYROCOCCUS-FURIOSUS; HYPERTHERMOPHILIC ARCHAEON; ELECTRON-TRANSPORT; 2-OXOACID-FERREDOXIN OXIDOREDUCTASES; HALOBACTERIUM-HALOBIUM; PYRUVATE; PROTEINS; ARCHAEBACTERIUM; ACIDOCALDARIUS; REDUCTASE	To elucidate the ferredoxin-dependent redox system of the thermoacidophilic, aerobic archaeon Sulfolobus sp. strain 7, a novel FeS flavoprotein, which can reoxidize the reduced 7Fe ferredoxin in vitro, has been purified and characterized (designated as IFP) using the cognate 7Fe ferredoxin and 2-oxoacid:ferredoxin oxidoreductase, a key enzyme of the archaeal tricarboxylic acid cycle. IFP consists of three non-identical subunits with apparent molecular masses of 87, 32, and 22 kDa, respectively, and contains at least two FMN (E(m),6.8 = -57 mV) and two plant-ferredoxin-type [2Fe-2S](2+,1+) clusters (E(m),6.8 -260 mV)/alpha(2) beta(2) gamma(2) structure. Both FeS and flavin centers of IFP are slowly but fully reduced by the enzymatically reduced cognate ferredoxin under anaerobic conditions at 50 degrees C, but not by NAD(P)H. Thus, the ferredoxin-dependent redox system of Sulfolobus sp. strain 7 is tentatively proposed as follows: 2-oxoacid:ferredoxin oxidoreductase (thiamine pyrophosphate and [4Fe-4S] cluster) --> ferredoxin --> IFP ([2Fe-2S] cluster --> FMN).			IWASAKI, T (corresponding author), TOKYO INST TECHNOL,DEPT LIFE SCI,MIDORI KU,YOKOHAMA,KANAGAWA 226,JAPAN.		Wakagi, Takayoshi/AAJ-4145-2021	Iwasaki, Toshio/0000-0001-9562-4649				ADAMS MWW, 1993, ANNU REV MICROBIOL, V47, P627, DOI 10.1146/annurev.micro.47.1.627; BATIE CJ, 1987, J BIOL CHEM, V262, P1510; BLAMEY JM, 1993, BIOCHIM BIOPHYS ACTA, V1161, P19, DOI 10.1016/0167-4838(93)90190-3; BLAMEY JM, 1994, BIOCHEMISTRY-US, V33, P1000, DOI 10.1021/bi00170a019; BRYANT FO, 1989, J BIOL CHEM, V264, P5070; CORRELL CC, 1992, SCIENCE, V258, P1604, DOI 10.1126/science.1280857; DANSON MJ, 1989, CAN J MICROBIOL, V35, P58, DOI 10.1139/m89-009; Dutton P L, 1978, Methods Enzymol, V54, P411; FAEDER EJ, 1973, ANAL BIOCHEM, V64, P136; FUJII T, 1991, J BIOCHEM, V110, P472, DOI 10.1093/oxfordjournals.jbchem.a123605; GEHRING U, 1972, J BIOL CHEM, V247, P6963; HILLE R, 1992, CHEM BIOCH FLAVOENZY, V3, P21; HUNT J, 1993, J BIOL CHEM, V268, P18685; IWASAKI T, 1994, J BIOL CHEM, V269, P29444; Iwasaki T, 1994, FLAVINS AND FLAVOPROTEINS 1993, P755; IWASAKI T, 1993, INT WORKSH MOL BIOL, P69; KERSCHER L, 1982, EUR J BIOCHEM, V128, P223; KERSCHER L, 1981, EUR J BIOCHEM, V116, P595, DOI 10.1111/j.1432-1033.1981.tb05377.x; KERSCHER L, 1982, TRENDS BIOCHEM SCI, V7, P371, DOI 10.1016/0968-0004(82)90118-9; KERSCHER L, 1981, EUR J BIOCHEM, V116, P587, DOI 10.1111/j.1432-1033.1981.tb05376.x; KNAFF DB, 1991, BIOCHIM BIOPHYS ACTA, V1056, P93, DOI 10.1016/S0005-2728(05)80277-4; Koike M, 1976, Adv Biophys, P187; KOMAI H, 1969, J BIOL CHEM, V244, P1692; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MA K, 1993, P NATL ACAD SCI USA, V90, P5341, DOI 10.1073/pnas.90.11.5341; MALIN R, 1973, IRON SULFUR PROTEINS, V2, P1; MASON JR, 1992, ANNU REV MICROBIOL, V46, P277, DOI 10.1146/annurev.mi.46.100192.001425; MEINECKE B, 1989, ARCH MICROBIOL, V152, P244, DOI 10.1007/BF00409658; MOLL R, 1988, FEBS LETT, V232, P359, DOI 10.1016/0014-5793(88)80769-5; MUKUND S, 1991, J BIOL CHEM, V266, P14208; MUKUND S, 1993, J BIOL CHEM, V268, P13592; MULLER M, 1988, ANNU REV MICROBIOL, V42, P465, DOI 10.1146/annurev.mi.42.100188.002341; ORTIZ ML, 1992, FEBS LETT, V296, P300, DOI 10.1016/0014-5793(92)80309-5; PALMER G, 1969, J BIOL CHEM, V244, P2614; PLAGA W, 1992, EUR J BIOCHEM, V205, P391, DOI 10.1111/j.1432-1033.1992.tb16792.x; PORRAS AG, 1982, J BIOL CHEM, V257, P1617; SCHAFER T, 1993, ARCH MICROBIOL, V159, P354, DOI 10.1007/BF00290918; SCHICHO RN, 1993, J BACTERIOL, V175, P1823, DOI 10.1128/JB.175.6.1823-1830.1993; SHAH VK, 1983, J BIOL CHEM, V258, P2064; STEPHENS PJ, 1978, BIOCHEMISTRY-US, V17, P4770, DOI 10.1021/bi00615a026; TSHISUAKA B, 1993, BIOCHEMISTRY-US, V32, P12928, DOI 10.1021/bi00210a047; UYEDA K, 1971, J BIOL CHEM, V246, P3111; WAHL RC, 1987, J BIOL CHEM, V262, P10489; WAKAGI T, 1986, SYST APPL MICROBIOL, V7, P342; WAKAO H, 1987, J BIOCHEM, V102, P255, DOI 10.1093/oxfordjournals.jbchem.a122049; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; WILLIAMS K, 1987, BIOCHEM J, V246, P529, DOI 10.1042/bj2460529	47	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17878	17883		10.1074/jbc.270.30.17878	http://dx.doi.org/10.1074/jbc.270.30.17878			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629091	hybrid			2022-12-27	WOS:A1995RM26600039
J	LI, XJ; SNYDER, SH				LI, XJ; SNYDER, SH			MOLECULAR-CLONING OF EBNERIN, A VON EBNERS GLAND PROTEIN ASSOCIATED WITH TASTE-BUDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VONEBNERS GLANDS; MEMBRANE-PROTEIN; LINGUAL LIPASE; GROWTH-FACTOR; RECEPTOR; GLYCOPROTEIN; LIGAND; UROMODULIN; EXPRESSION; COMPONENT	Salivary secretions modulate taste perception. Taste buds in the circumvallate and foliate papillae are bathed in secretions of unique lingual salivary glands, von Ebner's glands (VEG). We have identified a rat cDNA encoding a novel protein of 1290 amino acids, Ebnerin, that is specifically expressed in VEG and released onto the tongue surface along the apical region of taste buds in the clefts of circumvallate papillae. Ebnerin possesses a putative single transmembrane domain at the C terminus with 17 amino acids in the cytoplasmic area. The extracellular region of Ebnerin contains a number of repeated domains with homology to the scavenger receptor cysteine-rich domain and to a repeated domain of bone morphogenetic protein-I and other related proteins. Western blot analysis reveals that Ebnerin exists in particulate and soluble forms in VEG and is present in secretions from VEG. In situ hybridization and immunohistochemistry demonstrate that Ebnerin is located in secretory duct epithelial cells of VEG and is released onto the tongue surface along the apical region of taste buds in the clefts of circumvallate papillae. The unique structure and localization of Ebnerin suggest that it may function as a binding protein in saliva for the regulation of taste sensation.			LI, XJ (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205, USA.							AMANO O, 1993, CELL TISSUE RES, V273, P467, DOI 10.1007/BF00333701; ARUFFO A, 1991, J EXP MED, V174, P949, DOI 10.1084/jem.174.4.949; BLEIL JD, 1980, CELL, V20, P873, DOI 10.1016/0092-8674(80)90334-7; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; ELAROUSSI MA, 1994, BBA-GENE STRUCT EXPR, V1217, P1, DOI 10.1016/0167-4781(94)90116-3; FENG P, 1993, J BIOL CHEM, V268, P21453; FIELD RB, 1987, AM J PHYSIOL, V253, pG217, DOI 10.1152/ajpgi.1987.253.2.G217; FRIEDMAN J, 1993, P NATL ACAD SCI USA, V90, P6815, DOI 10.1073/pnas.90.14.6815; FUKAGAWA M, 1994, DEV BIOL, V163, P175, DOI 10.1006/dbio.1994.1133; FUKUOKA SI, 1991, P NATL ACAD SCI USA, V88, P2898, DOI 10.1073/pnas.88.7.2898; GURKAN S, 1988, CHEM SENSES, V13, P655, DOI 10.1093/chemse/13.4.655; HAMOSH M, 1973, J CLIN INVEST, V52, P88, DOI 10.1172/JCI107177; HARLOW E, 1988, ANTIBODIES LABORATOR, P313; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; HOOPS TC, 1991, J BIOL CHEM, V266, P4257; HUMPHREYSBEHER MG, 1994, ENDOCRINOLOGY, V134, P963, DOI 10.1210/en.134.2.963; HWANG PM, 1990, P NATL ACAD SCI USA, V87, P7395, DOI 10.1073/pnas.87.19.7395; JOURNET A, 1986, BIOCHEM J, V240, P783, DOI 10.1042/bj2400783; KINLOCH RA, 1992, P NATL ACAD SCI USA, V85, P6409; KOCK K, 1992, CELL TISSUE RES, V267, P313, DOI 10.1007/BF00302970; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; KOTHS K, 1993, J BIOL CHEM, V268, P14245; LEPAGE T, 1992, DEVELOPMENT, V114, P147; LI XJ, 1994, P NATL ACAD SCI USA, V91, P1814, DOI 10.1073/pnas.91.5.1814; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; MACKINNON CM, 1987, EUR J BIOCHEM, V169, P547, DOI 10.1111/j.1432-1033.1987.tb13644.x; MATSUSHIMA M, 1994, J BIOL CHEM, V269, P19976; MOREN A, 1992, BIOCHEM BIOPH RES CO, V189, P356, DOI 10.1016/0006-291X(92)91566-9; PENNICA D, 1987, SCIENCE, V236, P83, DOI 10.1126/science.3453112; PEVSNER J, 1988, SCIENCE, V241, P336, DOI 10.1126/science.3388043; RINDLER MJ, 1990, J BIOL CHEM, V265, P20784; ROHRER L, 1990, NATURE, V343, P570, DOI 10.1038/343570a0; SCHIFFMAN SS, 1983, P NATL ACAD SCI-BIOL, V80, P6136, DOI 10.1073/pnas.80.19.6136; SCHMALE H, 1990, NATURE, V343, P366, DOI 10.1038/343366a0; SHIMELL MJ, 1991, CELL, V67, P469, DOI 10.1016/0092-8674(91)90522-Z; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; WIJNGAARD PLJ, 1992, J IMMUNOL, V149, P3273; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241	38	90	96	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17674	17679		10.1074/jbc.270.30.17674	http://dx.doi.org/10.1074/jbc.270.30.17674			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629065	hybrid			2022-12-27	WOS:A1995RM26600010
J	PETERSON, GL; TOUMADJE, A; JOHNSON, WC; SCHIMERLIK, MI				PETERSON, GL; TOUMADJE, A; JOHNSON, WC; SCHIMERLIK, MI			PURIFICATION OF RECOMBINANT PORCINE M2 MUSCARINIC ACETYLCHOLINE-RECEPTOR FROM CHINESE-HAMSTER OVARY CELLS - CIRCULAR-DICHROISM SPECTRA AND LIGAND-BINDING PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC RECEPTORS; MAMMALIAN BETA-2-ADRENERGIC RECEPTOR; PROTEIN SECONDARY STRUCTURE; GUANINE-NUCLEOTIDES; HIGH-AFFINITY; ALPHA-1-ADRENERGIC RECEPTOR; AGONIST INTERACTIONS; ANTAGONIST BINDING; RAT FOREBRAIN; MEMBRANE	The recombinant porcine m2 muscarinic acetylcholine receptor (rPm2R) from Chinese hamster ovary cells has been purified to homogeneity. Two mg of purified rPm2R, with a specific activity of 12 nmol of R-(-)-quinuclidinyl benzilate/mg of protein, were obtained from 30 mi of packed Chinese hamster ovary cells. The apparent molecular mass (78.5 kDa) and specific activity for the rPm2R preparation were the same as that for the Pm2R purified from atrial tissue, but the yield was 100 times greater. Purified rPm2R bound agonist and antagonist with the same affinities and coupled to the inhibitory guanine nucleotide-binding protein with the same efficiency as the purified native atrial Pm2R. Ligand binding studies were consistant with a single class of antagonist binding sites but two subclasses of agonist binding sites. The fraction of rPm2R having high affinity for agonists was increased by mM Mg2+, low detergent concentration, and low temperature. Circular dichroism spectra obtained for the purified rPm2R with and without agonists were indistinguishable, but spectra for the antagonist-occupied receptor showed reproducibly deeper characteristic negative deflections at 208 and 220 nm. Secondary structure analysis of the CD spectra predicted 53% alpha-helix for the free receptor and 49% alpha-helix for the R-(-)-quinuclidinyl benzilate-receptor complex.	OREGON STATE UNIV, DEPT BIOCHEM & BIOPHYS, CORVALLIS, OR 97331 USA; OREGON STATE UNIV, CTR ENVIRONM HLTH SCI, CORVALLIS, OR 97331 USA	Oregon State University; Oregon State University					NHLBI NIH HHS [HL23632] Funding Source: Medline; NIEHS NIH HHS [ES00210] Funding Source: Medline; NIGMS NIH HHS [GM21479] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL023632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021479] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartfai T, 1979, Adv Cyclic Nucleotide Res, V10, P219; BENOVIC JL, 1984, BIOCHEMISTRY-US, V23, P4510, DOI 10.1021/bi00315a002; BERRIE CP, 1985, BIOCHEM SOC T, V13, P1101, DOI 10.1042/bst0131101; BERSTEIN G, 1988, J NEUROCHEM, V50, P1687, DOI 10.1111/j.1471-4159.1988.tb02464.x; BIRDSALL NJM, 1980, PROC R SOC SER B-BIO, V207, P1, DOI 10.1098/rspb.1980.0011; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; CREMO CR, 1981, ANAL BIOCHEM, V115, P331, DOI 10.1016/0003-2697(81)90014-2; DORNER AJ, 1989, J BIOL CHEM, V264, P20602; GILLARD M, 1987, MOL PHARMACOL, V32, P100; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HAGA K, 1985, J BIOL CHEM, V260, P7927; HAGA K, 1983, J BIOL CHEM, V258, P3575; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; HOMCY CJ, 1983, BIOCHEMISTRY-US, V22, P660, DOI 10.1021/bi00272a021; HULME EC, 1983, EUR J PHARMACOL, V94, P59, DOI 10.1016/0014-2999(83)90442-9; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; KAHANE I, 1976, BIOCHIM BIOPHYS ACTA, V426, P464, DOI 10.1016/0005-2736(76)90391-6; KRUH J, 1982, MOL CELL BIOCHEM, V42, P65; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBIN P, 1978, ANAL BIOCHEM, V85, P114, DOI 10.1016/0003-2697(78)90281-6; LIU TY, 1989, ANAL BIOCHEM, V182, P383, DOI 10.1016/0003-2697(89)90612-X; LOMASNEY JW, 1986, J BIOL CHEM, V261, P7710; LYNCH CJ, 1988, FEBS LETT, V229, P54, DOI 10.1016/0014-5793(88)80796-8; LYNCH CJ, 1985, J BIOL CHEM, V260, P1593; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; MARTIN MW, 1984, J PHARMACOL EXP THER, V230, P424; MCMAHON KK, 1985, MOL PHARMACOL, V28, P400; NAKATA H, 1989, J BIOL CHEM, V264, P16545; NEUFELD G, 1983, P NATL ACAD SCI-BIOL, V80, P6441, DOI 10.1073/pnas.80.21.6441; PARK K, 1992, PROTEIN SCI, V1, P1032, DOI 10.1002/pro.5560010809; PARKER EM, 1991, J BIOL CHEM, V266, P519; PERALTA EG, 1987, SCIENCE, V236, P600, DOI 10.1126/science.3107123; PERALTA EG, 1987, EMBO J, V6, P3923, DOI 10.1002/j.1460-2075.1987.tb02733.x; PETERSON GL, 1984, PREP BIOCHEM, V14, P33, DOI 10.1080/10826068408070612; PETERSON GL, 1984, P NATL ACAD SCI-BIOL, V81, P4993, DOI 10.1073/pnas.81.15.4993; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; PHAN NT, 1980, EUR J PHARMACOL, V67, P497, DOI 10.1016/0014-2999(80)90195-8; PIKE LJ, 1978, MOL PHARMACOL, V14, P370; QUINTANA DG, 1993, J BIOL CHEM, V268, P2403; REGAN JW, 1986, J BIOL CHEM, V261, P3894; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3090; RUPLEY JA, 1964, BIOCHIM BIOPHYS ACTA, V83, P245, DOI 10.1016/0926-6526(64)90001-1; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHWARZ KR, 1986, BIOCHEMISTRY-US, V25, P7782, DOI 10.1021/bi00371a074; SENOGLES SE, 1988, J BIOL CHEM, V263, P18996; SHIOZAKI K, 1992, BIOCHEMISTRY-US, V31, P10634, DOI 10.1021/bi00158a028; TOEWS ML, 1983, P NATL ACAD SCI-BIOL, V80, P3553, DOI 10.1073/pnas.80.12.3553; TOTA MR, 1987, BIOCHEMISTRY-US, V26, P8175, DOI 10.1021/bi00399a023; TOUMADJE A, 1993, ANAL BIOCHEM, V211, P258, DOI 10.1006/abio.1993.1266; VOGEL WK, 1995, J BIOL CHEM, V270, P15485, DOI 10.1074/jbc.270.26.15485; WAELBROECK M, 1985, BIOCHEM J, V231, P469, DOI 10.1042/bj2310469; WEILAND GA, 1979, NATURE, V281, P114, DOI 10.1038/281114a0; WHEATLEY M, 1987, BIOCHEM SOC T, V15, P113, DOI 10.1042/bst0150113; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; ZAHNISER NR, 1983, MOL PHARMACOL, V23, P303	56	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17808	17814		10.1074/jbc.270.30.17808	http://dx.doi.org/10.1074/jbc.270.30.17808			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629081				2022-12-27	WOS:A1995RM26600029
J	POPIELARZ, M; CAVALOC, Y; MATTEI, MG; GATTONI, R; STEVENIN, J				POPIELARZ, M; CAVALOC, Y; MATTEI, MG; GATTONI, R; STEVENIN, J			THE GENE ENCODING HUMAN SPLICING FACTOR 9G8 - STRUCTURE, CHROMOSOMAL LOCALIZATION, AND EXPRESSION OF ALTERNATIVELY PROCESSED TRANSCRIPTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SR-PROTEINS; CONSERVED FAMILY; NUCLEAR PHOSPHOPROTEINS; FUNCTIONAL-ANALYSIS; SITE SELECTION; FACTOR ASF/SF2; BINDING; INVITRO; SIMILARITIES; REGULATORS	The 9G8 factor is a 30-kDa member of the SR splicing factor family. We report here the isolation and characterization of the human 9G8 gene. This gene spans 7745 nucleotides and consists of 8 exons and 7 introns within the coding sequence, thus contrasting with the organization of the SC35/PR264 or RBP1 SR genes. We have located the human 9G8 gene in the p22-21 region of chromosome 2. The 5'-flanking region is GC-rich and contains basal promoter sequences and potential regulatory elements. Transfection experiments show that the 400-base pair flanking sequence has a promoter activity. Northern blot analysis of poly(A)(+) RNA isolated from human fetal tissues has allowed us to identify five different species, generated by alternative splicing of intron 3, which may be retained or excised as a shorter version, as well as the use of two polyadenylation sites. We also show that the different isoforms are differentially expressed in the fetal tissues. The persistence of sequences between exon 3 and 4 results in the synthesis of a 9G8 protein lacking the SR domain which is expected to be inactive in constitutive splicing. Thus, our results raise the possibility that alternative splicing of intron 3 provides a mechanism for modulation of the 9G8 function.	UNIV STRASBOURG 1,INSERM,CNRS,INST GENET & BIOL MOLEC & CELLULAIRE,F-67404 ILLKIRCH GRAFFENS,FRANCE; FAC MED TIMONE,INSERM,U406,UNITE GENET MED & DEV,F-13385 MARSEILLE,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille				CAVALOC, Yvon/0000-0002-2837-8801				AYANE M, 1991, NUCLEIC ACIDS RES, V19, P1273, DOI 10.1093/nar/19.6.1273; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; BLOOMFIELD CD, 1987, SEMIN ONCOL, V14, P372; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CACERES JF, 1993, EMBO J, V12, P4715, DOI 10.1002/j.1460-2075.1993.tb06160.x; CACERES JF, 1994, NATURE, V265, P1706; CAPUTI M, 1994, NUCLEIC ACIDS RES, V22, P1018, DOI 10.1093/nar/22.6.1018; CAVALOC Y, 1994, EMBO J, V13, P2639, DOI 10.1002/j.1460-2075.1994.tb06554.x; DIRKSEN WP, 1994, J BIOL CHEM, V269, P6431; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; FU XD, 1992, P NATL ACAD SCI USA, V89, P11224, DOI 10.1073/pnas.89.23.11224; FU XD, 1993, NATURE, V365, P82, DOI 10.1038/365082a0; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; FU XD, 1992, SCIENCE, V256, P535, DOI 10.1126/science.1373910; GE H, 1991, CELL, V66, P373, DOI 10.1016/0092-8674(91)90626-A; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; HEDLEY ML, 1991, CELL, V65, P579, DOI 10.1016/0092-8674(91)90090-L; KIM YJ, 1992, GENE DEV, V6, P2569, DOI 10.1101/gad.6.12b.2569; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; KRAINER AR, 1990, GENE DEV, V4, P1158, DOI 10.1101/gad.4.7.1158; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; LAVIGUEUR A, 1993, GENE DEV, V7, P2405, DOI 10.1101/gad.7.12a.2405; LEFF T, 1984, P NATL ACAD SCI-BIOL, V81, P4381, DOI 10.1073/pnas.81.14.4381; LI C, 1992, GENOMICS, V13, P658, DOI 10.1016/0888-7543(92)90138-I; Locker J, 1990, DNA Seq, V1, P3, DOI 10.3109/10425179009041342; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MATTEI MG, 1993, GENOMICS, V16, P786, DOI 10.1006/geno.1993.1270; MAYEDA A, 1992, P NATL ACAD SCI USA, V89, P1301, DOI 10.1073/pnas.89.4.1301; Moore M., 1993, RNA WORLD, P303; ROTH MB, 1991, J CELL BIOL, V115, P587, DOI 10.1083/jcb.115.3.587; RYNER LC, 1991, GENE DEV, V5, P2071, DOI 10.1101/gad.5.11.2071; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Sambrook J, 1989, MOL CLONING LABORATO; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; SUREAU A, 1994, P NATL ACAD SCI USA, V91, P932, DOI 10.1073/pnas.91.3.932; SUREAU A, 1992, P NATL ACAD SCI USA, V89, P11683, DOI 10.1073/pnas.89.24.11683; TANAKA K, 1994, MOL CELL BIOL, V14, P1347, DOI 10.1128/MCB.14.2.1347; VELLARD M, 1992, P NATL ACAD SCI USA, V89, P2511, DOI 10.1073/pnas.89.7.2511; XU RS, 1993, MOL CELL BIOL, V13, P3660, DOI 10.1128/MCB.13.6.3660; ZAHLER AM, 1993, MOL CELL BIOL, V13, P4023, DOI 10.1128/MCB.13.7.4023; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZAHLER AM, 1993, SCIENCE, V260, P219, DOI 10.1126/science.8385799; ZUO P, 1994, P NATL ACAD SCI USA, V91, P3363, DOI 10.1073/pnas.91.8.3363; ZUO P, 1993, EMBO J, V12, P4727, DOI 10.1002/j.1460-2075.1993.tb06161.x	48	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17830	17835		10.1074/jbc.270.30.17830	http://dx.doi.org/10.1074/jbc.270.30.17830			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629084	hybrid			2022-12-27	WOS:A1995RM26600032
J	WANG, XD; PAI, JT; WIEDENFELD, EA; MEDINA, JC; SLAUGHTER, CA; GOLDSTEIN, JL; BROWN, MS				WANG, XD; PAI, JT; WIEDENFELD, EA; MEDINA, JC; SLAUGHTER, CA; GOLDSTEIN, JL; BROWN, MS			PURIFICATION OF AN INTERLEUKIN-1-BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEASE THAT CLEAVES STEROL REGULATORY ELEMENT-BINDING PROTEINS BETWEEN THE LEUCINE-ZIPPER AND TRANSMEMBRANE DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPROTEIN RECEPTOR PROMOTER; NUCLEAR-PROTEIN; CDNA CLONING; GENE; TRANSCRIPTION; EXPRESSION; SEQUENCE	We describe the characterization and purification of a protease that cleaves sterol regulatory element-binding protein-1 (SREBP-1) and SREBP-2 in vitro. Cleavage occurs between the basic helix-loop-helix-leucine zipper and the first transmembrane domain of each SREBP. This is the region in which the SREBPs are cleaved physiologically by a sterol-regulated protease that releases an NH2-terminal fragment that activates transcription of the genes for the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl CoA synthase. The cleavage enzyme, designated SREBP cleavage activity (SCA), belongs to a new class of cysteine proteases of the interleukin-1 beta-converting enzyme (ICE) family, all of which cleave at aspartic acid residues. Like ICE, SCA was inactive in cytosol, and it was activated in vitro by incubation at 30 degrees C. SCA was resistant to inhibitors of serine, aspartyl, and metalloproteases, but it was sensitive to N-ethylmaleimide. The enzyme cleaved SREBP-1 and SREBP-2 between the Asp and Ser of a conserved sequence (S/DEPDSP). The activity was blocked by a tetrapeptide aldehyde, Ac-Asp-Glu-Ala-Asp-aldehyde (Ac-DEAD-CHO). A purified preparation of SCA from hamster liver contained a prominent 20-kDa polypeptide that could be labeled with [C-14]iodoacetic acid. Labeling was blocked by Ac-DEAD-CHO. Partial amino acid sequence of this polypeptide revealed that it was the hamster equivalent of human CPP32, a putative protease whose cDNA was recently identified by virtue of sequence homology to ICE. CPP32 and ICE have been implicated in apoptosis in animal cells, Whether SCA/CPP32 participates in vivo in the sterol-regulated activation of SREBP, or whether it activates SREBPs during apoptosis, remains to be determined.	UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235; TULARIK INC,S SAN FRANCISCO,CA 94080	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	WANG, XD (corresponding author), UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235, USA.			Wang, Xiaodong/0000-0001-9885-356X	NHLBI NIH HHS [HL20948] Funding Source: Medline; NIGMS NIH HHS [GM08014] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AYALA JM, 1994, J IMMUNOL, V153, P2592; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; FERNANDEZ J, 1992, ANAL BIOCHEM, V201, P255, DOI 10.1016/0003-2697(92)90336-6; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUNZ D, 1992, J BIOL CHEM, V267, P9101; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; SATO R, 1994, J BIOL CHEM, V269, P17267; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; STANFIELD CF, 1981, J ORG CHEM, V46, P4797, DOI 10.1021/jo00336a039; THHORNBERRY NA, 1995, PROTEIN SCI, V4, P3; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; WANG XD, 1993, J BIOL CHEM, V268, P14497; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; YANG JX, 1994, GENE DEV, V8, P1910, DOI 10.1101/gad.8.16.1910; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	25	124	128	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18044	18050		10.1074/jbc.270.30.18044	http://dx.doi.org/10.1074/jbc.270.30.18044			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629113				2022-12-27	WOS:A1995RM26600064
J	KLOCKNER, U; MIKALA, G; VARADI, M; VARADI, G; SCHWARTZ, A				KLOCKNER, U; MIKALA, G; VARADI, M; VARADI, G; SCHWARTZ, A			INVOLVEMENT OF THE CARBOXYL-TERMINAL REGION OF THE ALPHA(1) SUBUNIT IN VOLTAGE-DEPENDENT INACTIVATION OF CARDIAC CALCIUM CHANNELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROPYRIDINE RECEPTOR; SODIUM-CHANNEL; BETA-SUBUNIT; ACTIVATION; PHOSPHORYLATION; EXPRESSION; TRYPSIN; HEART; CELLS; RNA	Intracellular application of proteases increases cardiac calcium current to a level similar to beta-adrenergic stimulation. Using transiently transfected HEK 293 cells, we studied the molecular mechanism underlying calcium channel stimulation by proteolytic treatment. Perfusion of HEK cells, coexpressing the human cardiac (hHT) alpha(1), alpha(2), and beta(3) subunits, with 1 mg/ml of trypsin or carboxypeptidase A, increased the peak amplitude of the calcium channel current 3-4-fold without affecting the voltage dependence. Similar results were obtained in HEK cells cotransfected with hHT alpha(1) and alpha(2) or with alpha(1) alone, suggesting that modification of the alpha(1) subunit itself is responsible for the current enhancement by proteolysis. To further characterize the modification of the alpha(1) subunit by trypsin, we expressed a deletion mutant in which part of the carboxyl-terminal tail up to amino acid 1673 was removed. The expressed calcium channel currents no longer responded to intracellular application of the proteases; however, a 3-fold higher current density as well as faster inactivation compared with the wild type was observed. The results provide evidence that a specific region of the carboxyl-terminal tail of the cardiac alpha(1) subunit is an important regulatory segment that may serve as a critical component of the gating machinery that influences both inactivation properties as well as channel availability.	UNIV CINCINNATI,COLL MED,INST PHARMACOL MOLEC & BIOPHYS,CINCINNATI,OH 45267; UNIV COLOGNE,DEPT PHYSIOL,D-50931 COLOGNE,GERMANY	University System of Ohio; University of Cincinnati; University of Cologne					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041496, P01HL022619, R37HL043231] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL 22619-17, P01 HL 41496-06, R37HL 43231-06] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BABITCH J, 1990, NATURE, V346, P321, DOI 10.1038/346321b0; BEAM KG, 1992, NATURE, V360, P169, DOI 10.1038/360169a0; BOURINET E, 1994, EMBO J, V13, P5032, DOI 10.1002/j.1460-2075.1994.tb06832.x; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLIN T, 1994, EUR J BIOCHEM, V220, P257, DOI 10.1111/j.1432-1033.1994.tb18621.x; GONOI T, 1987, J GEN PHYSIOL, V89, P253, DOI 10.1085/jgp.89.2.253; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HELL JW, 1993, J BIOL CHEM, V268, P19451; HESCHELER J, 1988, J PHYSIOL-LONDON, V404, P259, DOI 10.1113/jphysiol.1988.sp017289; HOFMANN F, 1994, ANNU REV NEUROSCI, V17, P399, DOI 10.1146/annurev.neuro.17.1.399; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; KLEPPISCH T, 1994, EMBO J, V13, P2502, DOI 10.1002/j.1460-2075.1994.tb06538.x; KLOCKNER U, 1988, PFLUGERS ARCH, V412, P82; KUNIYASU A, 1992, J BIOCHEM, V112, P235, DOI 10.1093/oxfordjournals.jbchem.a123883; LEON M, 1995, BIOPHYS J, V68, P13; LORY P, 1992, BIOPHYS J, V63, P1421, DOI 10.1016/S0006-3495(92)81705-8; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; MIYAZAKI J, 1989, GENE, V79, P269; NAKAI J, 1994, P NATL ACAD SCI USA, V91, P1014, DOI 10.1073/pnas.91.3.1014; NORMAN RI, 1994, BIOCHEM SOC T, V22, P492, DOI 10.1042/bst0220492; OBEJEROPAZ CA, 1991, J GEN PHYSIOL, V98, P1127, DOI 10.1085/jgp.98.6.1127; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; SCHULTZ D, 1993, P NATL ACAD SCI USA, V90, P6228, DOI 10.1073/pnas.90.13.6228; STIMERS JR, 1985, J GEN PHYSIOL, V85, P65, DOI 10.1085/jgp.85.1.65; STRYER L, 1988, BIOCHEMISTRY-US, P226; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; TANABE T, 1991, NATURE, V352, P800, DOI 10.1038/352800a0; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; WEI XY, 1994, J BIOL CHEM, V269, P1635; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10905; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; YOSHIDA A, 1992, FEBS LETT, V309, P343, DOI 10.1016/0014-5793(92)80804-P; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0	36	58	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17306	17310		10.1074/jbc.270.29.17306	http://dx.doi.org/10.1074/jbc.270.29.17306			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615531	hybrid			2022-12-27	WOS:A1995RK68900041
J	KANAI, Y; NUSSBERGER, S; ROMERO, MF; BORON, WF; HEBERT, SC; HEDIGER, MA				KANAI, Y; NUSSBERGER, S; ROMERO, MF; BORON, WF; HEBERT, SC; HEDIGER, MA			ELECTROGENIC PROPERTIES OF THE EPITHELIAL AND NEURONAL HIGH-AFFINITY GLUTAMATE TRANSPORTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-GLUCOSE COTRANSPORTER; BRUSH-BORDER MEMBRANES; INTRACELLULAR PH; XENOPUS-OOCYTES; RAT-BRAIN; EXPRESSION; RELEASE; NEUROTRANSMITTER; CLONING; SODIUM	Active ion coupled glutamate transport is of critical importance for excitatory synaptic transmission, normal cellular function, and epithelial amino acid metabolism, We previously reported the cloning of the rabbit intestinal high affinity glutamate transporter EAAC1 (Kanai, Y., and Hediger, M. A. (1992) Nature 360, 467-471), which is expressed in numerous tissues including intestine, kidney, liver, heart, and brain. Here, we re port a detailed stoichiometric and kinetic analysis of EAAC1 expressed in Xenopus laevis oocytes. Uptake studies of Na-22(+) and [C-14]glutamate, in combination with measurements of intracellular pH with pH microelectrodes gave a glutamate to charge ratio of 1:1, a glutamate to Na+ ratio of 1:2, and a OH-/H+ to charge ratio of 1:1. Since transport is K+ dependent it can be concluded that EAAC1-mediated glutamate transport is coupled to the cotransport of 2 Na+ ions, the countertransport of one Kf ion and either the countertransport of one OH- ion or the cotransport of 1 H+ ion, We further demonstrate that under conditions where the electro chemical gradients for these ions are disrupted, EAAC1 runs in reverse, a transport mode which is of pathologic importance, Na-22(+) uptake studies revealed that there is a low level of Na+ uptake in the absence of extracellular glutamate which appears to be analogous to the Na+ leak observed for the intestinal. Na+/glucose cotransporter SGLT1. In voltage clamp studies, reducing extracellular Na+ from 100 to 10 mM strongly increased K-0.5(L-glutamate) and decreased I-max. The data indicate that Na+ binding at the extracellular transporter surface be comes rate-limiting. Studies addressing the cooperativity of the substrate-binding sites indicate that there are two distinct Na+-binding sites with different affinities and that Na+ binding is modulated by extracellular glutamate. A hypothetical ordered kinetic transport model for EAAC1 is discussed.	BRIGHAM & WOMENS HOSP,DEPT MED,DIV RENAL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,DIV RENAL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115; YALE UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,NEW HAVEN,CT 06510	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Yale University			Boron, Walter/ABI-1564-2020	Boron, Walter/0000-0003-4741-7287; Hediger, Matthias/0000-0003-1946-027X; Nussberger, Stephan/0000-0003-3619-4452	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043171, R37DK030344, R01DK030344] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-43171, DK-30344] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMATO A, 1994, J PHYSIOL-LONDON, V479, P371, DOI 10.1113/jphysiol.1994.sp020302; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; BENNETT E, 1992, AM J PHYSIOL, V262, pC510, DOI 10.1152/ajpcell.1992.262.2.C510; BOUVIER M, 1992, NATURE, V360, P471, DOI 10.1038/360471a0; DANBOLT NC, 1992, NEUROSCIENCE, V51, P259; DAVIS BA, 1992, AM J PHYSIOL, V263, pC246, DOI 10.1152/ajpcell.1992.263.1.C246; Fairman W. A., 1994, Society for Neuroscience Abstracts, V20, P925; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; HEDIGER MA, 1987, P NATL ACAD SCI USA, V84, P2634, DOI 10.1073/pnas.84.9.2634; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HEDIGER MA, 1994, PHYSIOL REV, V74, P993, DOI 10.1152/physrev.1994.74.4.993; HEINZ E, 1988, BIOCHIM BIOPHYS ACTA, V937, P300, DOI 10.1016/0005-2736(88)90252-0; Hille B., 1992, IONIC CHANNELS EXCIT; KANAI Y, 1993, FASEB J, V7, P1450, DOI 10.1096/fasebj.7.15.7903261; KANAI Y, 1994, J BIOL CHEM, V269, P20599; KANAI Y, 1994, J CLIN INVEST, V93, P397, DOI 10.1172/JCI116972; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KIMELBERG HK, 1989, J NEUROSCI, V9, P1141; Kloeckner Udo, 1993, Journal of Biological Chemistry, V268, P14594; KOEPSELL H, 1984, J BIOL CHEM, V259, P6548; LEE WS, 1994, J BIOL CHEM, V269, P12032; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; PARENT L, 1992, J MEMBRANE BIOL, V125, P49; POW DV, 1994, NEUROSCIENCE, V60, P355, DOI 10.1016/0306-4522(94)90249-6; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SIEBENS AW, 1987, J GEN PHYSIOL, V90, P799, DOI 10.1085/jgp.90.6.799; STALLCUP WB, 1979, J NEUROCHEM, V32, P57, DOI 10.1111/j.1471-4159.1979.tb04509.x; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; SZATKOWSKI M, 1994, TRENDS NEUROSCI, V17, P359, DOI 10.1016/0166-2236(94)90040-X; UMBACH JA, 1990, BIOPHYS J, V57, P1217, DOI 10.1016/S0006-3495(90)82640-0; VANDENPOL AN, 1990, SCIENCE, V250, P1276, DOI 10.1126/science.1978759; YOU GF, 1993, NATURE, V365, P844, DOI 10.1038/365844a0	38	159	164	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16561	16568		10.1074/jbc.270.28.16561	http://dx.doi.org/10.1074/jbc.270.28.16561			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622462	hybrid			2022-12-27	WOS:A1995RJ34700018
J	ZIONCHECK, TF; RICHARDSON, L; LIU, J; CHANG, L; KING, KL; BENNETT, GL; FUGEDI, P; CHAMOW, SM; SCHWALL, RH; STACK, RJ				ZIONCHECK, TF; RICHARDSON, L; LIU, J; CHANG, L; KING, KL; BENNETT, GL; FUGEDI, P; CHAMOW, SM; SCHWALL, RH; STACK, RJ			SULFATED OLIGOSACCHARIDES PROMOTE HEPATOCYTE GROWTH-FACTOR ASSOCIATION AND GOVERN ITS MITOGENIC ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY RECEPTOR; HEPARIN-LIKE MOLECULES; CELL-SURFACE; PROTEOLYTIC CLEAVAGE; EXTRACELLULAR DOMAIN; LIGAND-BINDING; SCATTER FACTOR; RAT PLATELETS; PURIFICATION; EXPRESSION	Hepatocyte growth factor (HGF) is a potent mitogen, motogen, and morphogen for various epithelial cell types. The pleiotropic effects of HGF are mediated by its binding to a specific high affinity receptor, c-Met. In addition, HGF binds to heparan sulfate proteoglycans on cell surfaces and within the extracellular matrix. Incubation of HGF with 0.1, 1.0, and 10 mu g/ml of heparin, heparan sulfate, or dextran sulfate resulted in a concentration-dependent increase in mitogenic potency in a primary rat hepatocyte bioassay, whereas sodium sulfate or fucoidan did not. Although co-incubation of HGF with sulfated compounds that enhanced HGF-dependent mitogenesis did not alter the binding isotherm of HGF for the c-Met receptor in a solid phase assay, an increase in autophosphorylation of the c-Met receptor in intact A549 cells was observed upon their addition. A series of chemically sulfated malto oligosaccharides varying in unit size and charge was tested in the bioassay in order to provide additional insights into the nature of the HGF-heparin interaction. While sulfated di-, tri-, tetra-, and pentasaccharides did not significantly potentiate HGF-dependent mitogenesis, larger oligosaccharides such as the sulfated hexa-, hepta-, or a sulfated oligosaccharide mixture containing decasaccharides resulted in an approximate 2-, 4-, and 7-fold enhancement, respectively. We observed a correlation between the sulfated oligosaccharide preparations that enhanced mitogenic potency and those that promoted HGF oligomerization in vitro, as measured by gel filtration and analytical ultracentrifugation. These findings indicate that heparin-like molecules can stabilize HGF oligomers, which may facilitate c-Met receptor dimerization and activation.	GLYCOMED INC,ALAMEDA,CA 94501		ZIONCHECK, TF (corresponding author), GENENTECH INC,460 POINT SAN BRUNO BLVD,S SAN FRANCISCO,CA 94080, USA.							BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CHAMOW SM, 1994, J IMMUNOL, V153, P4268; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; FRANSSON LA, 1989, HEPARIN, P115; FUGEDI P, 1992, 16TH INT CARB S PAR; FUGEDI P, 1994, 17TH INT C S OTT; Gallagher JT, 1989, CURR OPIN CELL BIOL, V1, P1201, DOI 10.1016/S0955-0674(89)80072-9; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; ILONDO MM, 1994, ENDOCRINOLOGY, V134, P2397, DOI 10.1210/en.134.6.2397; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; JOHNSON ML, 1981, BIOPHYS J, V36, P578; KATO S, 1994, EXP CELL RES, V211, P553; LIU KX, 1992, HEPATOLOGY, V17, P651; LOKKER NA, 1992, EMBO J, V11, P2503, DOI 10.1002/j.1460-2075.1992.tb05315.x; LOKKER NA, 1994, PROTEIN ENG, V7, P895, DOI 10.1093/protein/7.7.895; LON M, 1994, J BIOL CHEM, V269, P11216; LYON M, 1994, J BIOL CHEM, V269, P11208; MARK MR, 1992, J BIOL CHEM, V267, P26166; MASUMOTO A, 1991, BIOCHEM BIOPH RES CO, V174, P90, DOI 10.1016/0006-291X(91)90489-T; MICHALOPOULOS GK, 1992, HEPATOLOGY, V15, P149, DOI 10.1002/hep.1840150125; MIZUNO K, 1994, J BIOL CHEM, V269, P1131; MIZUNO K, 1993, HEPATOCYTE GROWTH FA, P1; NAKA D, 1993, EXP CELL RES, V209, P317, DOI 10.1006/excr.1993.1316; NAKA D, 1992, J BIOL CHEM, V267, P20114; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NAKAMURA T, 1986, P NATL ACAD SCI USA, V83, P6489, DOI 10.1073/pnas.83.17.6489; NAKAMURA T, 1987, FEBS LETT, V224, P311, DOI 10.1016/0014-5793(87)80475-1; NALDINI L, 1992, EMBO J, V11, P4825, DOI 10.1002/j.1460-2075.1992.tb05588.x; NALDINI L, 1989, ONCOGENE, V6, P501; ROSEN EM, 1989, IN VITRO CELL DEV B, V25, P163; RUBIN JS, 1991, P NATL ACAD SCI USA, V88, P415, DOI 10.1073/pnas.88.2.415; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; STRAIN AJ, 1991, J CLIN INVEST, V87, P1853, DOI 10.1172/JCI115207; TAJIMA H, 1992, EXP CELL RES, V202, P423, DOI 10.1016/0014-4827(92)90095-P; TESSLER S, 1994, J BIOL CHEM, V269, P12456; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9451; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; YPHANTIS DA, 1964, BIOCHEMISTRY-US, V3, P397; ZARNEGAR R, 1989, CANCER RES, V49, P3314	43	146	154	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16871	16878		10.1074/jbc.270.28.16871	http://dx.doi.org/10.1074/jbc.270.28.16871			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622503	hybrid			2022-12-27	WOS:A1995RJ34700064
J	GARCIARUIZ, C; MORALES, A; COLELL, A; RODES, J; YI, JR; KAPLOWITZ, N; FERNANDEZCHECA, JC				GARCIARUIZ, C; MORALES, A; COLELL, A; RODES, J; YI, JR; KAPLOWITZ, N; FERNANDEZCHECA, JC			EVIDENCE THAT THE RAT HEPATIC MITOCHONDRIAL CARRIER IS DISTINCT FROM THE SINUSOIDAL AND CANALICULAR TRANSPORTERS FOR REDUCED GLUTATHIONE - EXPRESSION STUDIES IN XENOPUS-LAEVIS OOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MEMBRANE; SYSTEM	Mitochondrial GSH derives hom a mitochondrial transport system (RmGshT), which translocates cytosol GSH into the mitochondrial matrix. Mitochondria of oocytes, isolated 3-4 days after microinjection of total liver mRNA, expressed a RmGshT compared with water-injected oocytes, The expressed RmGshT exhibited similar functional features as reported in isolated mitochondria of rat liver such as ATP stimulation, inhibition by glutamate, and insensitivity to inhibition by sulfobromophthalein-glutathione (BSP-GSH) and S-(2,4-dinitrophenyl)glutathione (DNP-GSH). The expressed RmGshT is localized in the inner mitochondrial membrane since expression is still observed in mitoplasts prepared from total liver mRNA-injected oocytes. Fractionation of poly(A)(+) RNA identified a single mRNA species of similar to 3-3.5 kilobases encoding for the RmGshT, which was stimulated by ATP and inhibited by glutamate but not by BSP-GSH or DNP-GSH, Microinjection of this fraction did not lead to expression of plasma membrane GSH transport in intact oocytes, and conversely, oocytes microinjected with cRNA for rat liver sinusoidal GSH transporter (RsGshT) or rat liver canalicular GSH transporter (RcGshT) did not express mitochondrial GSH transport activity. Thus, our results show the successful expression of the rat hepatic mitochondrial GSH carrier, which is different from RsGshT and RcGshT, and provide the strategic basis for the cloning of this important carrier.	UNIV BARCELONA,HOSP CLIN & PROV,DEPT MED,SERV BIOQUIM,LIVER UNIT,E-08036 BARCELONA,SPAIN; UNIV BARCELONA,CSIC,INST MIXTO INVEST BIOMED AUGUST PI & SUNER,E-08036 BARCELONA,SPAIN; UNIV SO CALIF,DEPT MED,DIV GASTROINTESTINAL & LIVER DIS,LOS ANGELES,CA 90033; UNIV SO CALIF,SCH MED,CTR LIVER DIS,LOS ANGELES,CA 90033	University of Barcelona; Hospital Clinic de Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Southern California; University of Southern California			Fernández-Checa, José Carlos/L-8342-2014; Garcia-Ruiz, Carmen/L-8211-2014; Morales, Albert/E-2988-2013; Colell, Anna/N-8710-2014	Fernández-Checa, José Carlos/0000-0003-3422-2990; Garcia-Ruiz, Carmen/0000-0002-2652-6102; Morales, Albert/0000-0001-8702-2269; Colell, Anna/0000-0001-5236-1834	NIAAA NIH HHS [AA09526] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009526] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BALLATORI N, 1994, J BIOL CHEM, V269, P19731; CHASE JW, 1972, DEV BIOL, V27, P504, DOI 10.1016/0012-1606(72)90189-3; COLMAN A, 1986, TRANSCRIPTION TRANSL, P271; DUTCZAK WJ, 1994, J BIOL CHEM, V269, P9746; FARISS MW, 1987, METHOD ENZYMOL, V143, P101; FERNANDEZCHECA JC, 1993, J BIOL CHEM, V268, P2324; FERNANDEZCHECA JC, 1991, J CLIN INVEST, V87, P397, DOI 10.1172/JCI115010; FERNANDEZCHECA JC, 1992, J BIOL CHEM, V267, P1667; FERNANDEZCHECA JC, 1993, HEPATIC TRANSPORT BI, P345; GARCIARUIZ C, 1994, J CLIN INVEST, V94, P193, DOI 10.1172/JCI117306; GARCIARUIZ C, 1992, J BIOL CHEM, V267, P22256; GRIFFITH OW, 1985, P NATL ACAD SCI USA, V82, P4668, DOI 10.1073/pnas.82.14.4668; ISHIKAWA T, 1990, J BIOL CHEM, V265, P19279; KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pa.25.040185.003435; KUROSAWA K, 1991, BIOCHEM BIOPH RES CO, V167, P367; MANIATIS T, 1982, MOL CLONING LABORATO, P461; MARTENSSON J, 1989, P NATL ACAD SCI USA, V86, P471, DOI 10.1073/pnas.86.2.471; MARTENSSON J, 1989, P NATL ACAD SCI USA, V86, P5296, DOI 10.1073/pnas.86.14.5296; MARTENSSON J, 1990, P NATL ACAD SCI USA, V87, P7185, DOI 10.1073/pnas.87.18.7185; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MEREDITH M, 1988, BIOCHEM PHARMACOL, V32, P1383; SCHNAITMAN C, 1967, J CELL BIOL, V32, P719, DOI 10.1083/jcb.32.3.719; SCHNAITMAN CA, 1968, J CELL BIOL, V33, P158; YI JR, 1995, P NATL ACAD SCI USA, V92, P1495, DOI 10.1073/pnas.92.5.1495; YI JR, 1994, J CLIN INVEST, V93, P1841, DOI 10.1172/JCI117170; ZEHAVIWILLNER T, 1977, CELL, V9, P683	26	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15946	15949		10.1074/jbc.270.27.15946	http://dx.doi.org/10.1074/jbc.270.27.15946			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608148	hybrid			2022-12-27	WOS:A1995RH22600009
J	JI, IH; JI, TH				JI, IH; JI, TH			DIFFERENTIAL ROLES OF EXOLOOP-1 OF THE HUMAN FOLLICLE-STIMULATING-HORMONE RECEPTOR IN HORMONE-BINDING AND RECEPTOR ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							LUTROPIN CHORIOGONADOTROPIN RECEPTOR; HIGH-AFFINITY; FSH RECEPTOR; EXTRACELLULAR DOMAIN; SIGNAL TRANSDUCTION; TSH RECEPTOR; AMINO-ACIDS; EXPRESSION; CLONING; IDENTIFICATION	The follicle-stimulating hormone (FSH) receptor is a member of the glycoprotein hormone receptor subfamily of the seven-transmembrane receptor superfamily, These receptors have an extracellular N-terminal half of similar to 350 amino acids and a membrane-associated C-terminal half of similar to 350 amino acids. The N-terminal halves have the high affinity hormone binding site, On the other hand, the C-terminal half of the lutropin/choriogonadotropin receptor has the receptor activation site. However, little is known about the activation site and mechanism of the FSH receptor, although the existing evidence indicates crucial differences in the activation of the FSH receptor and the lutropin/choriogonadotropin receptor, As a first step to resolve this issue, we examined the upstream juxtamembrane five amino acids, Asp(405)-Ile(406)-His(407)-Thr(408)-Lys(409), of the exoloop 1, Ala scan and multi-substitutions show that the five amino acid sequence is important for both hormone binding and receptor activation to induce cAMP synthesis, despite its short length, Specifically, His(407) is important for high affinity hormone binding, whereas Asp(405) Thr(408), and Lys(409) are crucial for receptor activation, The data suggest that the five amino acids may form a turn of helix that is an extension of the transmembrane helix 2. In this helical arrangement, Asp(405), Thr(408), and Lys(409) are grouped to form a hydrophilic face of the helix, suggesting a correlation between this arrange ment and receptor activation, In addition, the diverse and differential roles of the five amino acids indicate that high affinity hormone binding and receptor activation are discernible functions, These novel observations will be helpful for understanding the activation mechanism of the FSH receptor.	UNIV WYOMING,DEPT MOLEC BIOL,LARAMIE,WY 82071	University of Wyoming					NICHD NIH HHS [HD 18702] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018702] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ATASSI MZ, 1991, P NATL ACAD SCI USA, V88, P3613, DOI 10.1073/pnas.88.9.3613; BOOTHBY M, 1981, J BIOL CHEM, V256, P5121; BRANDEN C, 1991, INTRO PROTEIN STRUCT, P14; DALLAS JS, 1994, ENDOCRINOLOGY, V134, P1437, DOI 10.1210/en.134.3.1437; DATTATREYAMURTY B, 1993, MOL CELL ENDOCRINOL, V93, P39, DOI 10.1016/0303-7207(93)90137-9; DAVIS D, 1995, MOL ENDOCRINOL, V9, P159, DOI 10.1210/me.9.2.159; FRAZIER AL, 1990, MOL ENDOCRINOL, V4, P1264, DOI 10.1210/mend-4-8-1264; GHARIB SD, 1990, ENDOCR REV, V11, P177, DOI 10.1210/edrv-11-1-177; HUNZICKERDUNN M, 1985, INVOLVEMENT ADENYLYL, P57; JAEMSON JL, 1993, ENDOCR REV, V14, P203; JI I, 1993, J BIOL CHEM, V268, P20851; JI I, 1991, J BIOL CHEM, V266, P13076; JI I, 1981, P NATL ACAD SCI-BIOL, V78, P5465, DOI 10.1073/pnas.78.9.5465; JI IH, 1993, J BIOL CHEM, V268, P22971; JI IH, 1991, ENDOCRINOLOGY, V128, P2648, DOI 10.1210/endo-128-5-2648; JI TH, 1995, ENDOCRINE, V3, P187, DOI 10.1007/BF02994442; KELTON CA, 1992, MOL CELL ENDOCRINOL, V89, P141, DOI 10.1016/0303-7207(92)90220-Z; LIBERT F, 1989, BIOCHEM BIOPH RES CO, V165, P1250, DOI 10.1016/0006-291X(89)92736-8; LIU XX, 1994, ENDOCRINOLOGY, V135, P682, DOI 10.1210/en.135.2.682; LOOSFELT H, 1989, SCIENCE, V245, P525, DOI 10.1126/science.2502844; MACFARLAND KC, 1989, SCIENCE, V245, P494; MINEGISH T, 1991, BIOCHEM BIOPH RES CO, V175, P1125, DOI 10.1016/0006-291X(91)91682-3; MISRAHI M, 1990, BIOCHEM BIOPH RES CO, V166, P394, DOI 10.1016/0006-291X(90)91958-U; NAGAYAMA Y, 1990, BIOCHEM BIOPH RES CO, V173, P1150, DOI 10.1016/S0006-291X(05)80906-4; REICHERT LE, 1989, BIOL REPROD, V40, P13, DOI 10.1095/biolreprod40.1.13; REMY JJ, 1993, BIOCHEM BIOPH RES CO, V193, P1023, DOI 10.1006/bbrc.1993.1727; ROCHE PC, 1992, ENDOCRINOLOGY, V131, P268, DOI 10.1210/en.131.1.268; SEETHARAMAIAH GS, 1994, ENDOCRINOLOGY, V134, P549, DOI 10.1210/en.134.2.549; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; TILLY JL, 1992, ENDOCRINOLOGY, V131, P799, DOI 10.1210/en.131.2.799; TSAIMORRIS CH, 1990, J BIOL CHEM, V265, P19385; XIE YB, 1990, J BIOL CHEM, V265, P21411; YOO JK, 1993, J BIOL CHEM, V268, P13034; ZENG HW, 1995, ENDOCRINOLOGY, V136, P2948, DOI 10.1210/en.136.7.2948	34	47	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15970	15973		10.1074/jbc.270.27.15970	http://dx.doi.org/10.1074/jbc.270.27.15970			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608154	hybrid			2022-12-27	WOS:A1995RH22600015
J	BORHAN, B; JONES, AD; PINOT, F; GRANT, DF; KURTH, MJ; HAMMOCK, BD				BORHAN, B; JONES, AD; PINOT, F; GRANT, DF; KURTH, MJ; HAMMOCK, BD			MECHANISM OF SOLUBLE EPOXIDE HYDROLASE - FORMATION OF AN ALPHA-HYDROXY ESTER-ENZYME INTERMEDIATE THROUGH ASP-333	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYZED-HYDROLYSIS; MOUSE-LIVER; INHIBITION; HYDRATION; OXIDES; ACID; TRANS-3-PHENYLGLYCIDOLS; METABOLISM; HYDRASE	O-18-labeled epoxides of trans-1,3-diphenylpropene oxide (tDPPO) and cis-9,10-epoxystearic acid were synthesized and used to determine the regioselectivity of sEH. The nucleophilic nature of sEH catalysis was demonstrated by comparing the enzymatic and nonenzymatic hydrolysis products of tDPPO. The results from single turnover experiments with greater or equal molar equivalents of sEH:substrate were consistent with the existence of a stable intermediate formed by a nucleophilic amino acid attacking the epoxide group. Tryptic digestion of sEH previously subjected to multiple turnovers with tDPPO in (H2O)-O-18 resulted in the isolation and purification of a tryptic fragment containing Asp-333. Electrospray mass spectrometry of this fragment conclusively illustrated the incorporation of O-18. After complete digestion of the latter peptide it was shown that Asp-333 of sEH exhibited an increased mass. The attach by Asp-333 initiates enzymatic activity, leading to the formation of an alpha-hydroxyacyl-enzyme intermediate. Hydrolysis of the acyl enzyme occurs by the addition of an activated water to the carbonyl carbon of the ester bond, after which the resultant tetrahedral intermediate collapses, yielding the active enzyme and the diol product.	UNIV CALIF DAVIS,DEPT ENTOMOL,DAVIS,CA 95616; UNIV CALIF DAVIS,DEPT CHEM,DAVIS,CA 95616; UNIV CALIF DAVIS,DEPT ENVIRONM TOXICOL,DAVIS,CA 95616; UNIV CALIF DAVIS,FACIL ADV INSTRUMENTAT,DAVIS,CA 95616	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis			Jones, Arthur D/C-2670-2013	Jones, A. Daniel/0000-0002-7408-6690	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699, R01ES002710, P30ES005707] Funding Source: NIH RePORTER; NIEHS NIH HHS [P42 ES04699, R01 ES02710, P30 ES05707] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ARAND M, 1994, FEBS LETT, V338, P251, DOI 10.1016/0014-5793(94)80278-5; ARMSTRONG RN, 1980, MICROSOMES DRUG OXID, P1119; BEETHAM JK, 1995, DNA CELL BIOL, V14, P61, DOI 10.1089/dna.1995.14.61; BELLUCCI G, 1989, J ORG CHEM, V54, P968, DOI 10.1021/jo00265a044; BELLUCCI G, 1982, J ORG CHEM, V47, P3105, DOI 10.1021/jo00137a015; BELLUCCI G, 1981, J ORG CHEM, V46, P5148, DOI 10.1021/jo00338a016; BORHAN B, 1994, J ORG CHEM, V59, P4316, DOI 10.1021/jo00094a054; CAPDEVILA JH, 1992, FASEB J, V6, P731, DOI 10.1096/fasebj.6.2.1537463; DANSETTE PM, 1978, ARCH BIOCHEM BIOPHYS, V187, P290, DOI 10.1016/0003-9861(78)90037-1; DIETZE EC, 1993, COMP BIOCHEM PHYS B, V104, P309, DOI 10.1016/0305-0491(93)90373-D; DIETZE EC, 1991, BIOCHEM PHARMACOL, V42, P1163, DOI 10.1016/0006-2952(91)90250-9; GILL SS, 1979, BIOCHEM BIOPH RES CO, V89, P965, DOI 10.1016/0006-291X(79)91872-2; HALARNKAR PP, 1992, ARCH BIOCHEM BIOPHYS, V294, P586, DOI 10.1016/0003-9861(92)90729-G; HAMMOCK BD, 1980, LIFE SCI, V27, P1635, DOI 10.1016/0024-3205(80)90636-0; HAMMOCK BD, 1994, BIOCHEM BIOPH RES CO, V198, P850, DOI 10.1006/bbrc.1994.1121; IWASAWA N, 1988, CHEM LETT, P1721, DOI 10.1246/cl.1988.1721; JANSSEN DB, 1989, J BACTERIOL, V171, P6791, DOI 10.1128/jb.171.12.6791-6799.1989; JERINA DM, 1974, SCIENCE, V185, P573, DOI 10.1126/science.185.4151.573; KARARA A, 1992, BIOCHEM BIOPH RES CO, V182, P1320, DOI 10.1016/0006-291X(92)91877-S; LACOURCIERE GM, 1993, J AM CHEM SOC, V115, P10466, DOI 10.1021/ja00075a115; LEVIN W, 1977, ORIGINS HUMAN CANCER, P668; MEIJER J, 1988, CHEM-BIOL INTERACT, V64, P207, DOI 10.1016/0009-2797(88)90100-7; MIYAMOTO T, 1987, ARCH BIOCHEM BIOPHYS, V254, P203, DOI 10.1016/0003-9861(87)90096-8; MUMBY SM, 1979, PESTIC BIOCHEM PHYS, V11, P275, DOI 10.1016/0048-3575(79)90067-1; OESCH F, 1973, XENOBIOTICA, V3, P305, DOI 10.3109/00498257309151525; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; PARKER RE, 1959, CHEM REV, P737; PINOT F, 1995, J BIOL CHEM, V270, P7968, DOI 10.1074/jbc.270.14.7968; PRESTWICH GD, 1985, ARCH BIOCHEM BIOPHYS, V242, P11, DOI 10.1016/0003-9861(85)90473-4; PRIES F, 1994, BIOCHEMISTRY-US, V33, P1242, DOI 10.1021/bi00171a026; PRITCHAR.JG, 1973, J CHEM SOC PERK T 2, P452, DOI 10.1039/p29730000452; RIZEY JS, 1974, SYNTHETIC REAGENTS, V2, P65; Sims P, 1974, Adv Cancer Res, V20, P165, DOI 10.1016/S0065-230X(08)60111-6; VERSCHUEREN KHG, 1993, NATURE, V363, P693, DOI 10.1038/363693a0; WATABE T, 1971, BIOCHEM BIOPH RES CO, V44, P199, DOI 10.1016/S0006-291X(71)80178-X; WATABE T, 1971, BIOCHEM PHARMACOL, V20, P912; WIXTROM RN, 1988, ANAL BIOCHEM, V169, P71, DOI 10.1016/0003-2697(88)90256-4; WIXTROM RN, 1985, BIOCH PHARM TOXICOLO, V1, P1; ZELDIN DC, 1993, J BIOL CHEM, V268, P6402	39	84	85	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26923	26930		10.1074/jbc.270.45.26923	http://dx.doi.org/10.1074/jbc.270.45.26923			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592938	hybrid			2022-12-27	WOS:A1995TE58300038
J	GREEN, BN; SUZUKI, T; GOTOH, T; KUCHUMOV, AR; VINOGRADOV, SN				GREEN, BN; SUZUKI, T; GOTOH, T; KUCHUMOV, AR; VINOGRADOV, SN			ELECTROSPRAY-IONIZATION MASS-SPECTROMETRIC DETERMINATION OF THE COMPLETE POLYPEPTIDE-CHAIN COMPOSITION OF TYLORRHYNCHUS-HETEROCHAETUS HEMOGLOBIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							AMINO-ACID-SEQUENCE; EXTRACELLULAR HEMOGLOBIN; GIANT HEMOGLOBIN; MAXIMUM-ENTROPY; MYOGLOBIN; SPECTRA; PEPTIDE; HEME	Electrospray ionization mass spectrometry (ESI-MS) of the native, reduced, and carbamidomethylated forms of the extracellular, 3.38-MDa hemoglobin from the marine polychaete Tylorrhynchus heterochaetus, when combined with a maximum entropy (MaxEnt) analysis, provided a complete description of the polypeptide chain composition. This hemoglobin, a hetero-multimeric complex of approximately 180 polypeptide chains, consisting of globin and linker subunits in an similar to 3:1 mass ratio, is among the largest protein complexes investigated by ESI-MS. The globin subunits consist of a monomer subunit (chain I, 15575.4 La) and a disulfide-bonded trimer subunit, 50068.4 Da, consisting of globin chains IIA (16601.9 Da), IIB (16680.4 Da), and IIC (16,794.0 La). Linker subunits L1-L5, 23233.8, 24835.4, 25326.9, 28202.2, and 26317.2 La, respectively, were found together with a disulfide bonded dimer of L2, 52609.4 Da. Using the exact masses of the subunits, a plausible model of the hemoglobin consisting of 144 globin chains (36 monomers and 36 trimers) and 36 linker chains provides a calculated mass of 3.42 MDa.	WAYNE STATE UNIV,SCH MED,DEPT BIOCHEM,DETROIT,MI 48201; VG ORGAN,ALTRINCHAM WA14 5RZ,CHESHIRE,ENGLAND; KOCHI UNIV,DEPT BIOL,KOCHI 780,JAPAN; UNIV TOKUSHIMA,DEPT BIOL,TOKUSHIMA 770,JAPAN	Wayne State University; Kochi University; Tokushima University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038674] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK38674] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHOWDHURY SK, 1990, J AM SOC MASS SPECTR, V1, P382, DOI 10.1016/1044-0305(90)85018-H; CRESTFIELD AM, 1963, J BIOL CHEM, V239, P622; FERRIGE AG, 1991, RAPID COMMUN MASS SP, V5, P374, DOI 10.1002/rcm.1290050810; FERRIGE AG, 1992, RAPID COMMUN MASS SP, V6, P707, DOI 10.1002/rcm.1290061115; GOTOH T, 1990, ZOOL SCI, V7, P1; KIM JS, 1994, EUR J BIOCHEM, V224, P109, DOI 10.1111/j.1432-1033.1994.tb20001.x; Landon, 1977, Methods Enzymol, V47, P145; LOO JA, 1993, RAPID COMMUN MASS SP, V7, P186, DOI 10.1002/rcm.1290070304; PILZ I, 1988, INT J BIOL MACROMOL, V10, P356, DOI 10.1016/0141-8130(88)90029-3; SENKO MW, 1994, ANNU REV BIOPH BIOM, V23, P763, DOI 10.1146/annurev.bb.23.060194.003555; SUZUKI T, 1985, J BIOL CHEM, V260, P3145; SUZUKI T, 1985, J BIOL CHEM, V260, P1481; SUZUKI T, 1982, BIOCHIM BIOPHYS ACTA, V708, P253, DOI 10.1016/0167-4838(82)90434-4; SUZUKI T, 1988, J BIOL CHEM, V263, P18524; SUZUKI T, 1986, J MOL BIOL, V190, P119, DOI 10.1016/0022-2836(86)90081-1; SUZUKI T, 1990, J BIOL CHEM, V265, P12168; SUZUKI T, 1986, J BIOL CHEM, V261, P257; Vinogradov S.N., 1985, P9; Vinogradov S. N., 1982, ELECTRON MICROS, P135; YU W, 1993, ANAL CHEM, V65, P3015, DOI 10.1021/ac00069a014; ZAIA J, 1992, RAPID COMMUN MASS SP, V6, P32, DOI 10.1002/rcm.1290060108; 1993, J PHYS CHEM REF DATA, V22, P1571	22	34	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18209	18211		10.1074/jbc.270.31.18209	http://dx.doi.org/10.1074/jbc.270.31.18209			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629137	hybrid			2022-12-27	WOS:A1995RM64200010
J	HSUEH, YP; LAI, MZ				HSUEH, YP; LAI, MZ			C-JUN N-TERMINAL KINASE BUT NOT MITOGEN-ACTIVATED PROTEIN-KINASE IS SENSITIVE TO CAMP INHIBITION IN T-LYMPHOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; CELLS; PHOSPHORYLATION; SIGNAL; ONCOPROTEIN; ANTI-CD3; RECEPTOR; MODULATE; PATHWAY; CALCIUM	The molecular mechanism underlying the cAMP inhibition of nuclear activation events in T lymphocytes is unknown. Recently, the activation of fibroblasts and muscle cells are shown to be antagonized by cAMP through the inhibition of mitogen-activated protein (MAP) kinases signaling pathway. Whether a similar antagonism may account for the late inhibitory effect of cAMP in T cell was examined. Surprisingly, extracellular signal regulated kinase 2 (ERK2) activation was resistant to cAMP inhibition in all the T lymphocytes tested. Different isoforms (ERK1, ERK2, and ERK3) of MAP kinase were poorly inhibited by cAMP. High concentration of cAMP also only weakly antagonized Raf-1 in T cells. The resistance of ERK and Raf-1 to cAMP clearly distinguishes T cells from fibroblasts. In contrast, another MAP kinase homologue c-Jun N-terminal kinase (JNK) was inhibited by cAMP in good correlation with that of IL-2 suppression. Moreover, JNK was antagonized by a delayed kinetics which is characteristic of cAMP inhibition. Despite that both ERK and JNK are essential for T cell activation, selective inhibition by cAMP further supports the specific role of JNK in T cell activation.	ACAD SINICA, INST MOL BIOL, TAIPEI 11529, TAIWAN; NATL YANG MING UNIV, GRAD INST MICROBIOL & IMMUNOL, TAIPEI 11221, TAIWAN	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University			Hsueh, Yi-Ping/ABH-5052-2020; Lai, Ming-Zong/AAA-4408-2021	Hsueh, Yi-Ping/0000-0002-0866-6275; Lai, Ming-Zong/0000-0002-3237-4803				ANASTASSIOU ED, 1992, J IMMUNOL, V148, P2845; BURGERING BMT, 1993, EMBO J, V12, P4211, DOI 10.1002/j.1460-2075.1993.tb06105.x; CHEN D, 1994, J EXP MED, V179, P931, DOI 10.1084/jem.179.3.931; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; DOWNWARD J, 1992, IMMUNOL TODAY, V13, P89, DOI 10.1016/0167-5699(92)90148-Z; FORCE T, 1994, P NATL ACAD SCI USA, V91, P1270, DOI 10.1073/pnas.91.4.1270; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; HAFNER S, 1994, MOL CELL BIOL, V14, P6696; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HORDIJK PL, 1994, J BIOL CHEM, V269, P3534; IZQUIERDO M, 1994, J EXP MED, V180, P401, DOI 10.1084/jem.180.1.401; JOHNSON GL, 1994, CURR OPIN CELL BIOL, V6, P230, DOI 10.1016/0955-0674(94)90141-4; KAMMER GM, 1988, IMMUNOL TODAY, V9, P222, DOI 10.1016/0167-5699(88)91220-0; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; LAI MZ, 1988, J EXP MED, V168, P1081, DOI 10.1084/jem.168.3.1081; LAI MZ, 1987, J IMMUNOL, V139, P3973; LEE MR, 1993, J IMMUNOL, V151, P5208; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; LERNER A, 1988, J IMMUNOL, V140, P936; MANSOUR SJ, 1994, J BIOCHEM-TOKYO, V116, P304, DOI 10.1093/oxfordjournals.jbchem.a124524; MARY D, 1987, J IMMUNOL, V139, P1179; MEIER KE, 1991, J BIOL CHEM, V266, P1914; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; NEL AE, 1990, J IMMUNOL, V144, P2683; OSHEA JJ, 1987, J IMMUNOL, V139, P3463; OWAKI H, 1993, EMBO J, V12, P4367, DOI 10.1002/j.1460-2075.1993.tb06121.x; PARK JH, 1993, BLOOD, V82, P2470; SEVETSON BR, 1993, P NATL ACAD SCI USA, V90, P10305, DOI 10.1073/pnas.90.21.10305; SIEGEL JN, 1990, J BIOL CHEM, V265, P18472; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; VAILLANCOURT RR, 1994, MOL CELL BIOL, V14, P6522, DOI 10.1128/MCB.14.10.6522; WARTMANN M, 1994, J BIOL CHEM, V269, P6695; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WHITEHURST CE, 1992, J IMMUNOL, V148, P3230; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; YAN MH, 1994, NATURE, V372, P798; ZMUIDZINAS A, 1991, MOL CELL BIOL, V11, P2794, DOI 10.1128/MCB.11.5.2794	40	97	97	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					18094	18098		10.1074/jbc.270.30.18094	http://dx.doi.org/10.1074/jbc.270.30.18094			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629120	hybrid			2022-12-27	WOS:A1995RM26600071
J	PRYZDIAL, ELG; BAJZAR, L; NESHEIM, ME				PRYZDIAL, ELG; BAJZAR, L; NESHEIM, ME			PROTHROMBINASE COMPONENTS CAN ACCELERATE TISSUE-PLASMINOGEN ACTIVATOR-CATALYZED PLASMINOGEN ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION FACTOR-X; FACTOR-VA; ENDOTHELIAL-CELLS; LYS-PLASMINOGEN; HUMAN PLATELETS; BINDING; SURFACE; RECEPTOR; INACTIVATION; TRANSITION	The enzymatic and cofactor subunits of human prothrombinase, factor Xa (FXa) and factor Va (FVa), respectively, were evaluated as modulators of Glu- and Lys-plasminogen (Pg) activation by tissue plasminogen activator (tPA). The data revealed that both FXa and FVa could accelerate tPA activity by as much as 60-fold for Lys-Pg and >150-fold for Glu-Pg. This function of FVa depended on pretreatment with plasmin (Pn), whereas the FXa fibrinolytic cofactor activity was endogenous. In the native state, FVa was observed to inhibit the acceleration of Pn generation by FXa. These effects were dependent on Ca2+ and procoagulant phospholipid. Interactions between plasminogen and prothrombinase components were quantified. The apparent K-d for binding to FXa was 35 nM. Strikingly, the affinity between FVa and Pg was increased by approximately 2 orders of magnitude when the FVa was Pn-pretreated (K-d = 0.1 mu M). These data cumulatively suggest a mechanism by which Pn production is coordinated with coagulation and localized to sites where procoagulant phospholipid is exposed on a cell surface.	UNIV OTTAWA, DEPT BIOCHEM, OTTAWA, ON K1G 4J5, CANADA; QUEENS UNIV, DEPT BIOCHEM, KINGSTON, ON K7L 3N6, CANADA	University of Ottawa; Queens University - Canada	PRYZDIAL, ELG (corresponding author), CANADIAN RED CROSS SOC, RES DEPT, 1800 ALTA VISTA DR, OTTAWA, ON K1G 4J5, CANADA.							ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; BAJAJ SP, 1981, PREP BIOCHEM, V11, P397, DOI 10.1080/00327488108065531; BAJZAR L, 1995, J BIOL CHEM, V270, P14477, DOI 10.1074/jbc.270.24.14477; BEVERS EM, 1982, EUR J BIOCHEM, V122, P429, DOI 10.1111/j.1432-1033.1982.tb05898.x; BEVERS EM, 1983, BIOCHIM BIOPHYS ACTA, V736, P57, DOI 10.1016/0005-2736(83)90169-4; CESARMAN GM, 1994, J BIOL CHEM, V269, P21198; CHURCH WR, 1989, J BIOL CHEM, V264, P17882; DAHLBACK B, 1978, BIOCHEMISTRY-US, V17, P4938, DOI 10.1021/bi00616a013; DUDANI AK, 1993, THROMB RES, V69, P185, DOI 10.1016/0049-3848(93)90044-O; DUDANI AK, 1994, BIOCHEM CELL BIOL, V72, P126, DOI 10.1139/o94-019; ELDERING JA, 1993, FEBS LETT, V318, P231, DOI 10.1016/0014-5793(93)80518-Y; ESMON CT, 1979, J BIOL CHEM, V254, P964; FAIR DS, 1975, BIOCHEMISTRY-US, V14, P5561, DOI 10.1021/bi00697a004; FUNG MR, 1985, P NATL ACAD SCI USA, V82, P3591, DOI 10.1073/pnas.82.11.3591; GONZ PR, 1991, BIOCH CELL BIOL, V69, P554; GONZALEZGRONOW M, 1991, ARCH BIOCHEM BIOPHYS, V286, P625, DOI 10.1016/0003-9861(91)90090-6; GUINTO ER, 1984, J BIOL CHEM, V259, P3986; HAJJAR KA, 1988, J CLIN INVEST, V82, P1769, DOI 10.1172/JCI113790; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; Jesty J, 1976, Methods Enzymol, V45, P95; KALAFATIS M, 1994, BIOCHEMISTRY-US, V33, P6538, DOI 10.1021/bi00187a022; KATZMANN JA, 1981, P NATL ACAD SCI-BIOL, V78, P162, DOI 10.1073/pnas.78.1.162; KELM RJ, 1994, J BIOL CHEM, V269, P30147; KRISHNASWAMY S, 1992, J BIOL CHEM, V267, P26110; KRISHNASWAMY S, 1993, METHOD ENZYMOL, V222, P260; KRISHNASWAMY S, 1989, J BIOL CHEM, V264, P3160; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; KWAAN HC, 1991, SEMIN THROMB HEMOST, V17, P175, DOI 10.1055/s-2007-1002607; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CD, 1989, BLOOD, V73, P185; LIJNEN HR, 1993, METHOD ENZYMOL, V223, P197; LIM TK, 1977, BIOCHEMISTRY-US, V16, P4177, DOI 10.1021/bi00638a007; MANN KG, 1990, BLOOD, V76, P1; MANN KG, 1987, THROMBOSIS HAEMOSTAS; MANN KG, 1987, PROTEASES BIOL CONTR; MCGEE MP, 1991, J BIOL CHEM, V266, P8079; MEERS P, 1991, BIOCHEMISTRY-US, V30, P2903, DOI 10.1021/bi00225a025; MESSIER TL, 1991, GENE, V99, P291, DOI 10.1016/0378-1119(91)90141-W; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; MILETICH JP, 1978, J BIOL CHEM, V253, P6908; NELSESTUEN GL, 1976, J BIOL CHEM, V251, P5648; NESHEIM M, 1990, J BIOL CHEM, V265, P21541; NESHEIM ME, 1981, J BIOL CHEM, V256, P6537; NESHEIM ME, 1992, METHOD ENZYMOL, V215, P316; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; OMAR MN, 1987, J BIOL CHEM, V262, P9750; PACKHAM MA, 1984, BLOOD PLATELET FUNCT; PRYZDIAL ELG, 1991, J BIOL CHEM, V266, P8969; RADCLIFFE RD, 1972, J BIOL CHEM, V247, P7735; REINARTZ J, 1995, J IMMUNOL, V154, P844; ROBBINS KC, 1982, HEMOSTASIS THROMBOSI, P623; RODGERS GM, 1985, BIOCHIM BIOPHYS ACTA, V844, P320, DOI 10.1016/0167-4889(85)90133-8; SAKAI T, 1990, HAEMOSTASIS, V20, P125; TAIT JF, 1989, J BIOL CHEM, V264, P7944; TRACY PB, 1981, J BIOL CHEM, V256, P743; TRACY PB, 1985, J BIOL CHEM, V260, P2119; TRACY PB, 1992, METHOD ENZYMOL, V215, P329; ZWAAL RFA, 1993, BIOCHEM SOC T, V21, P248, DOI 10.1042/bst0210248	59	21	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17871	17877		10.1074/jbc.270.30.17871	http://dx.doi.org/10.1074/jbc.270.30.17871			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629090	hybrid			2022-12-27	WOS:A1995RM26600038
J	CASTANO, EM; PRELLI, F; PRAS, M; FRANGIONE, B				CASTANO, EM; PRELLI, F; PRAS, M; FRANGIONE, B			APOLIPOPROTEIN-E CARBOXYL-TERMINAL FRAGMENTS ARE COMPLEXED TO AMYLOID-A AND AMYLOID-L - IMPLICATIONS FOR AMYLOIDOGENESIS AND ALZHEIMERS-DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLASMA-LIPOPROTEINS; RAT SCIATIC-NERVE; P-COMPONENT; CHOLESTEROL TRANSPORT; DENSITY LIPOPROTEIN; PROTEIN SAA; A-I; CONSTITUENT; BINDING; GLYCOSAMINOGLYCANS	Apolipoprotein E (ApoE) immunoreactivity is consistently present in the senile plaques and neurofibrillary tangles of Alzheimer's disease (AD) brain. In vitro, apoE, and in particular its apoE4 isoform, can bind to and promote fibrillogenesis of the amyloid A beta peptide, the main constituent of senile plaques. These findings, together with the strong genetic association between late onset AD and the E4 allele of apoE, have strengthened the hypothesis that apoE may have a central role in the pathogenesis of AD by modulating A beta cerebral accumulation. However, apoE immunoreactivity is present in all cerebral and systemic amyloidoses tested, and tryptic apoE fragments have been identified in association with amyloid A (AA). In order to further elucidate the interaction between apoE and amyloids, we purified AA and amyloid L (AL) fibrils from patients with familial Mediterranean fever and primary amyloidosis, respectively, and studied the association of apoE with AA and AL proteins. In each case, apoE fragments, detected by Western blot, co-purified with the amyloid fibrils. Microsequencing analysis identified COOH-terminal fragments of apoE, similar to the 10-kDa fragment produced by thrombin digestion that contains the purported binding region to A beta. In vitro co-incubation of AA with purified human apoE resulted in the formation of an SDS-resistant AA-apoE complex and a higher degree of polymerization of the AA peptide. These findings and similar results obtained from AD senile plaques suggest that 1) the carboxyl-terminal fragment of apoE is complexed to amyloid fibrils and resists proteolysis in vivo and 2) apoE may promote amyloidogenesis through a conformation-dependent interaction regardless of the primary structure of the amyloid precursors.	CHAIM SHEBA MED CTR,HELLER INST MED RES,IL-52621 TEL HASHOMER,ISRAEL	Chaim Sheba Medical Center	CASTANO, EM (corresponding author), NYU,MED CTR,DEPT PATHOL,550 1ST AVE,TH427,NEW YORK,NY 10016, USA.				NIAMS NIH HHS [AR02594] Funding Source: Medline; NIA NIH HHS [AG05891, AG10953] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR002594, R01AR002594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R35AG010953, R37AG005891, R01AG005891] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BENDITT EP, 1979, P NATL ACAD SCI USA, V76, P4092, DOI 10.1073/pnas.76.8.4092; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; BUGIANI O, 1994, NEUROBIOL AGING, V15, pS156, DOI 10.1016/0197-4580(94)93095-3; CASTANO EM, 1995, BIOCHEM J, V306, P599, DOI 10.1042/bj3060599; CHOIMIURA NH, 1992, ACTA NEUROPATHOL, V83, P260, DOI 10.1007/BF00296787; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CORIA F, 1988, LAB INVEST, V58, P454; DUONG T, 1989, ACTA NEUROPATHOL, V78, P429, DOI 10.1007/BF00688180; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; GALLO G, 1994, AM J PATHOL, V145, P526; GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GREGG RE, 1986, J CLIN INVEST, V78, P815, DOI 10.1172/JCI112645; LADU MJ, 1994, J BIOL CHEM, V269, P23403; LEBLANC AC, 1990, J NEUROSCI RES, V25, P162, DOI 10.1002/jnr.490250203; MA J, 1995, NATURE, V372, P92; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCADAM KPWJ, 1976, J EXP MED, V144, P1121, DOI 10.1084/jem.144.4.1121; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NICHOLS WC, 1988, BIOCHEM BIOPH RES CO, V156, P762, DOI 10.1016/S0006-291X(88)80909-4; POIRIER J, 1993, NEUROSCIENCE, V55, P81, DOI 10.1016/0306-4522(93)90456-P; PRAS M, 1968, J CLIN INVEST, V47, P924; PRELLI F, 1991, SCAND J IMMUNOL, V33, P783, DOI 10.1111/j.1365-3083.1991.tb02553.x; SANAN DA, 1994, J CLIN INVEST, V94, P860, DOI 10.1172/JCI117407; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SEGREST JP, 1992, J LIPID RES, V33, P141; SELKOE DJ, 1986, J NEUROCHEM, V146, P1820; SNIPES JG, 1986, P NATL ACAD SCI USA, V83, P1130; SNOW AD, 1987, LAB INVEST, V56, P120; SNOW AD, 1988, ALZ DIS ASSOC DIS, V2, P232; SOUTAR AK, 1992, P NATL ACAD SCI USA, V89, P7389, DOI 10.1073/pnas.89.16.7389; STEINMETZ A, 1989, ARTERIOSCLEROSIS, V9, P405, DOI 10.1161/01.ATV.9.3.405; STENSTAD T, 1993, CLIN EXP IMMUNOL, V94, P189; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V20, P1977; WEISGRABER KH, 1986, J BIOL CHEM, V261, P2068; WEISGRABER KH, 1990, J LIPID RES, V31, P1503; WETTERAU JR, 1988, J BIOL CHEM, V263, P6240; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; WISNIEWSKI T, 1995, LANCET, V345, P956, DOI 10.1016/S0140-6736(95)90701-7; WISNIEWSKI T, 1994, AM J PATHOL, V145, P1030; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; WISNIEWSKI T, 1994, ANN NEUROL, V35, P245, DOI 10.1002/ana.410350223; WONG CW, 1985, P NATL ACAD SCI USA, V82, P8729, DOI 10.1073/pnas.82.24.8729; YOUNG ID, 1989, ACTA NEUROPATHOL, V78, P202, DOI 10.1007/BF00688210	47	55	57	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17610	17615		10.1074/jbc.270.29.17610	http://dx.doi.org/10.1074/jbc.270.29.17610			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615568	hybrid			2022-12-27	WOS:A1995RK68900085
J	HOHL, RJ; LEWIS, K				HOHL, RJ; LEWIS, K			DIFFERENTIAL-EFFECTS OF MONOTERPENES AND LOVASTATIN ON RAS PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-LIMONENE; SELECTIVE-INHIBITION; PROTEIN TRANSFERASE; CARCINOGENESIS; ISOPRENYLATION; FARNESYLTRANSFERASE; PEPTIDOMIMETICS; TRANSFORMATION; FARNESYLATION; CELLS	Limonene and related monoterpenes have been shown to impair the incorporation of mevalonic acid-derived isoprene compounds, that is farnesyl pyrophosphate, into RAS and RAS-related proteins. As farnesylation is critical for RAS's membrane localization and function, the isoprenylation pathways have received attention as potential targets of anti-RAS pharmacologic maneuvers. We have expanded on these prior studies and demonstrate that one of limonene's metabolic derivatives, perillyl alcohol, decreases the levels of antigenic RAS in the human-derived myeloid THP-1 and lymphoid RPMI-8402 cell lines. Both limonene and perillyl alcohol decrease levels of [S-35]methionine-labeled RAS proteins in cells that have been pulsed with radiolabeled methionine for 4 h. In contrast, lovastatin, which inhibits hydroxymethylglutaryl coenzyme A reductase and thus depletes cells of farnesyl pyrophosphate, does not diminish levels of total antigenic RAS but rather results in a shift in the RAS protein; levels of farnesylated RAS decrease whereas levels of unmodified/unfarnesylated RAS increase. As limonene and perillyl alcohol do not induce such a shift, we conclude that these monoterpenes decrease farnesylated RAS protein levels by a mechanism that is clearly distinct from that of either depleting cells of farnesyl pyrophosphate or inhibiting the enzyme farnesyl protein transferase that catalyzes the post-translational farnesylation of RAS. Perillyl alcohol decreases antigenic RAS levels but does not decrease levels of another membrane-tethered protein, the alpha subunit of the heterotrimeric G protein. Furthermore, perillyl alcohol decreases the levels of radiolabeled methionine incorporated into immunoprecipitable RAS to a greater extent than it decreases radiolabeled methionine incorporated into total cellular protein. Thus there is some degree of specificity for the activity of perillyl alcohol to depress RAS levels.	UNIV IOWA,DEPT PHARMACOL,IOWA CITY,IA 52242	University of Iowa	HOHL, RJ (corresponding author), UNIV IOWA,DEPT INTERNAL MED,C32-I GH,IOWA CITY,IA 52242, USA.							BUSS JE, 1987, P NATL ACAD SCI USA, V84, P7493, DOI 10.1073/pnas.84.21.7493; CROWELL PL, 1991, J BIOL CHEM, V266, P17679; CROWELL PL, 1994, BIOCHEM PHARMACOL, V47, P1405, DOI 10.1016/0006-2952(94)90341-7; ELEGBEDE JA, 1984, CARCINOGENESIS, V5, P661, DOI 10.1093/carcin/5.5.661; ELSON CE, 1988, CARCINOGENESIS, V9, P331, DOI 10.1093/carcin/9.2.331; GARCIA AM, 1993, J BIOL CHEM, V268, P18415; GIBBS JB, 1993, J BIOL CHEM, V268, P7617; HAAG JD, 1992, CANCER RES, V52, P4021; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; JACKSON JH, 1990, P NATL ACAD SCI USA, V87, P3042, DOI 10.1073/pnas.87.8.3042; JAMES GL, 1993, SCIENCE, V260, P1937, DOI 10.1126/science.8316834; JONES TLZ, 1990, J BIOL CHEM, V265, P19389; KANAI T, 1987, JPN J CANCER RES, V78, P1314; KAWATA S, 1994, BRIT J CANCER, V69, P1015, DOI 10.1038/bjc.1994.199; KOHL NE, 1993, SCIENCE, V260, P1934, DOI 10.1126/science.8316833; LEONARD S, 1990, J BIOL CHEM, V265, P5157; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALTZMAN TH, 1989, CARCINOGENESIS, V10, P781, DOI 10.1093/carcin/10.4.781; NIGAM M, 1993, J BIOL CHEM, V268, P20695; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; SCHAFER WR, 1989, SCIENCE, V245, P379, DOI 10.1126/science.2569235; SCHMIDT RA, 1984, J BIOL CHEM, V259, P175; SINENSKY M, 1990, J BIOL CHEM, V265, P19937; ULSH LS, 1984, MOL CELL BIOL, V4, P1647, DOI 10.1128/MCB.4.8.1647; WATTENBERG LW, 1989, CANCER RES, V49, P2689; WATTENBERG LW, 1991, CARCINOGENESIS, V12, P115, DOI 10.1093/carcin/12.1.115	26	86	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17508	17512		10.1074/jbc.270.29.17508	http://dx.doi.org/10.1074/jbc.270.29.17508			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615555	hybrid			2022-12-27	WOS:A1995RK68900071
J	NAKANISHI, M; ROBETORYE, RS; PEREIRASMITH, OM; SMITH, JR				NAKANISHI, M; ROBETORYE, RS; PEREIRASMITH, OM; SMITH, JR			THE C-TERMINAL REGION OF P21(SDI1/WAF1/CIP1) IS INVOLVED IN PROLIFERATING CELL NUCLEAR ANTIGEN-BINDING BUT DOES NOT APPEAR TO BE REQUIRED FOR GROWTH-INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HUMAN-DIPLOID FIBROBLASTS; KINASES; DNA; P21	The cyclin-dependent kinase (Cdk) inhibitor p21(SDI1/WAF1/CIP1) has been found to be involved in cell senescence, cell cycle arrest, and differentiation. p21(SD11) inhibits the activity of several Cdks, in contrast to other inhibitors such as p15(INK4B) and p16(INK4A), which act on specific cyclin-Cdk complexes, Of interest were reports that p21(SD11) also bound proliferating cell nuclear antigen (PCNA), an auxiliary protein for DNA polymerase delta, and inhibited DNA replication but not DNA repair in vitro, To better understand the function of this interaction in vivo, we first determined the region of p21(SD11) that was needed for PCNA binding. Analysis of deletion mutants of p21(SD11), which covered the majority of the protein, revealed that deletion of either amino acids 142-147 or 149-154 resulted in loss of ability to bind a glutathione S-transferase-PCNA fusion protein. Site-directed mutagenesis in this region led to the identification of the PCNA binding motif RQXXMTXFYXXXR and demonstrated that mutation of either amino acid Met-147 or Phe-150 resulted in almost complete ablation of PCNA binding. Interestingly, when we determined DNA synthesis inhibitory activity of deletion mutants or point mutants that were unable to bind Cdk2 and/or PCNA, we found that loss of binding to PCNA did not affect inhibitory activity, whereas lack of Cdk2 binding greatly reduced the same. This result suggests that the primary mechanism for inhibition of DNA synthesis by p21(SD11) occurs via inhibition of Cdk activity.	BAYLOR COLL MED,DIV MOLEC VIROL,ROY M & PHYLLIS GOUGH HUFFINGTON CTR AGING,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine					NIA NIH HHS [AG05333, AG07123, AG11066] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG005333, R01AG011066, P01AG007123, R37AG005333] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; HARPER JW, 1993, CELL, V75, P805; HUPPI K, 1994, ONCOGENE, V9, P3017; Jiang Hongping, 1993, Molecular and Cellular Differentiation, V1, P285; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; LUMPKIN CK, 1986, SCIENCE, V232, P393, DOI 10.1126/science.2421407; MATSUOKA S, 1994, J BIOL CHEM, V269, P11030; NAKANISHI M, 1995, EMBO J, V14, P555, DOI 10.1002/j.1460-2075.1995.tb07031.x; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; PEREIRASMITH OM, 1982, SOMAT CELL GENET, V8, P731, DOI 10.1007/BF01543015; ROSENBLATT J, 1993, J MOL BIOL, V230, P1317, DOI 10.1006/jmbi.1993.1248; SMITH JR, 1992, EXP GERONTOL, V27, P409, DOI 10.1016/0531-5565(92)90073-9; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7	19	102	107	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17060	17063		10.1074/jbc.270.29.17060	http://dx.doi.org/10.1074/jbc.270.29.17060			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615495	hybrid			2022-12-27	WOS:A1995RK68900002
J	NELSON, RW; BATES, PA; RUTISHAUSER, U				NELSON, RW; BATES, PA; RUTISHAUSER, U			PROTEIN DETERMINANTS FOR SPECIFIC POLYSIALYLATION OF THE NEURAL CELL-ADHESION MOLECULE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE DOMAINS; MONOCLONAL-ANTIBODY EPITOPES; FIBRONECTIN TYPE-III; POLYSIALIC ACID; N-CAM; ELECTROPHORETIC TRANSFER; FUNCTIONAL DETERMINANTS; POLYACRYLAMIDE GELS; SIALYLATION STATE; NCAM	Expression of polysialic acid (PSA) involves its specific attachment to the neural cell adhesion molecule (NCAM), Here we identify the amino acid residues within NCAM that are polysialylated and structural domains of the NCAM polypeptide that are required for addition of PSA in cells, Chicken NCAM cDNAs containing amino acid mutations, domain deletions, and domain substitutions were expressed in the F11 rat/mouse hybrid cell line, which can produce polysialylated NCAM, Polysialylation of the chicken NCAM was evaluated by immunopurification and electrophoresis, Mutation of all three potential N-glycosylation sites within the fifth immunoglobulin domain (Ig5) abrogated polysialylation, Analysis of paired mutations revealed that Asn-459 is heavily polysialylated, Asn-430 has a lower level of substitution, and Asn-404 receives little or no PSA, Analysis of domain deletions established that the intracellular domain, Ig domains 1-3, and the COOH terminal fibronectin-type III (FNIII) repeat are not required for polysialylation, but that deletion of either the adjacent Ig4 or FNIII-type domain prevented addition of PSA, Accordingly, a minimal polypeptide for polysialylation was found to contain Ig domains 4 and 5, the adjacent FNIII repeat, plus a membrane attachment, These results suggest that although all PSA is located within Ig5, regions outside Ig5 also play a role in PSA addition to NCAM, Furthermore, molecular modeling indicates spatial proximity of Asn-430 and Asn-459 and a tight-locking arrangement between Ig4, Ig5, and FMIII#1 that would be consistent with their formation of a spatially discrete enzyme recognition site for polysialylation.	CASE WESTERN RESERVE UNIV, SCH MED, DEPT GENET, CLEVELAND, OH 44106 USA; CASE WESTERN RESERVE UNIV, SCH MED, DEPT MOLEC BIOL & MICROBIOL, CLEVELAND, OH 44106 USA; IMPERIAL CANC RES FUND, BIOMOLEC MODELING LAB, LONDON WC2A 3PX, ENGLAND	Case Western Reserve University; Case Western Reserve University; Cancer Research UK			Bates, Paul A/AAF-8561-2020	Bates, Paul A/0000-0003-0621-0925	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018369, R37HD018369, T32HD007104] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY006107] Funding Source: NIH RePORTER; NEI NIH HHS [EY06107] Funding Source: Medline; NICHD NIH HHS [HD07104, HD18369] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ACHESON A, 1991, J CELL BIOL, V114, P143, DOI 10.1083/jcb.114.1.143; ALCARAZ G, 1991, EUR J CELL BIOL, V55, P165; BATES PA, 1992, FEBS LETT, V301, P207, DOI 10.1016/0014-5793(92)81249-L; BREEN KC, 1988, DEVELOPMENT, V104, P147; BRISSON JR, 1992, BIOCHEMISTRY-US, V31, P4996, DOI 10.1021/bi00136a012; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; CROSSIN KL, 1984, J CELL BIOL, V99, P1848, DOI 10.1083/jcb.99.5.1848; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DIESENHOFER J, 1981, BIOCHEMISTRY-US, V31, P4996; DOHERTY P, 1990, NEURON, V5, P209, DOI 10.1016/0896-6273(90)90310-C; DOHERTY P, 1992, DEVELOPMENT, V115, P885; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; EPP O, 1975, BIOCHEMISTRY-US, V14, P4943, DOI 10.1021/bi00693a025; FINNE J, 1985, J BIOL CHEM, V260, P1265; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; FREDETTE B, 1993, J CELL BIOL, V123, P1867, DOI 10.1083/jcb.123.6.1867; FRELINGER AL, 1986, J CELL BIOL, V103, P1729, DOI 10.1083/jcb.103.5.1729; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; HE HT, 1987, J CELL BIOL, V105, P2489, DOI 10.1083/jcb.105.6.2489; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; HOFFMAN S, 1982, J BIOL CHEM, V257, P7720; HOLDEN HM, 1992, J MOL BIOL, V227, P840, DOI 10.1016/0022-2836(92)90226-A; Johnson D. A., 1984, Gene Analysis Techniques, V1, P3, DOI 10.1016/0735-0651(84)90049-9; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KROG L, 1992, APMIS, V100, P53; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; PLATIKA D, 1985, P NATL ACAD SCI USA, V82, P3499, DOI 10.1073/pnas.82.10.3499; REGAN CM, 1991, INT J BIOCHEM, V23, P513; REGLERO A, 1993, INT J BIOCHEM, V25, P1517, DOI 10.1016/0020-711X(93)90507-B; ROUGON G, 1993, EUR J CELL BIOL, V61, P197; ROUGON G, 1986, J CELL BIOL, V103, P2429, DOI 10.1083/jcb.103.6.2429; RUTISHAUSER U, 1992, DEVELOPMENT, P99; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTONI MJ, 1988, J NEUROSCI RES, V20, P304, DOI 10.1002/jnr.490200304; SCHACHNER M, 1989, CIBA F SYMP, V145, P156; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; SEKI T, 1991, ANAT EMBRYOL, V184, P395, DOI 10.1007/BF00957900; SUNSHINE J, 1987, P NATL ACAD SCI USA, V84, P5986, DOI 10.1073/pnas.84.16.5986; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIMR ER, 1984, P NATL ACAD SCI-BIOL, V81, P1971, DOI 10.1073/pnas.81.7.1971; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; WATANABE M, 1986, J CELL BIOL, V103, P1721, DOI 10.1083/jcb.103.5.1721; WILLIAMS AF, 1987, IMMUNOL TODAY, V8, P298, DOI 10.1016/0167-5699(87)90016-8; ZHANG H, 1992, J NEUROSCI, V12, P3107, DOI 10.1523/JNEUROSCI.12-08-03107.1992	52	112	113	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17171	17179		10.1074/jbc.270.29.17171	http://dx.doi.org/10.1074/jbc.270.29.17171			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615513	hybrid			2022-12-27	WOS:A1995RK68900020
J	VIAL, D; SENORALEPOSE, M; HAVET, N; MOLIO, L; VARGAFTIG, BB; TOUQUI, L				VIAL, D; SENORALEPOSE, M; HAVET, N; MOLIO, L; VARGAFTIG, BB; TOUQUI, L			EXPRESSION OF THE TYPE-II PHOSPHOLIPASE A(2) IN ALVEOLAR MACROPHAGES - DOWN-REGULATION BY AN INFLAMMATORY SIGNAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUINEA-PIG; CELLS; INHIBITION; SECRETION; ENZYMES; CLONING	We have shown previously that guinea pig alveolar macrophages (AM) synthesize a secretory phospholipase A(2) (PLA(2)) during in vitro incubation. Here, we report the molecular cloning of this enzyme and show that it has structural features closely related to all known mammalian type-II PLA(2). The mRNA and PLA(2) activity were undetectable in freshly collected AM, but their levels increased dramatically to reach maximal values after 16 h of culture. Thereafter, the PLA(2) activity remained constant with a parallel secretion in the medium, in contrast to mRNA level which returned to near basal values after 32 h. Incubation of AM for 16 h with the inflammatory secretagogue peptide f-Met-Leu-Phe (fMLP) markedly reduced the PLA(2) activity and mRNA levels. This inhibition was prevented by preexposure of AM to pertussis toxin, an inhibitor of G-protein. In contrast, when AM were first cultured for 16 h and then incubated with fMLP, no significant change was observed in their PLA(2) activity. In conditions where the type-II PLA(2) was completely abrogated by fMLP, the latter did not alter the lipopolysaccharide-induced accumulation of tumor necrosis factor ru mRNA or the release of arachidonic acid induced by the subsequent addition of the calcium ionophore A23187. These studies show that the inflammatory peptide fMLP down-regulates the expression of the type-II PLA(2) by AM through a process mediated by G-protein. A possible negative control of the type-II PLA(2) expression during AM activation is suggested.	CNRS,URA 361,UNITE GENET BIOCHIM DEV,UNITE ASSOCIEE PASTEUR,F-75015 PARIS,FRANCE; INST PASTEUR,F-75015 PARIS,FRANCE	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	VIAL, D (corresponding author), INSERM,U285,UNITE PHARMACOL CELLULAIRE,UNITE ASSOCIEE PASTEUR,25 RUE DR ROUX,F-75015 PARIS,FRANCE.		Vargaftig, Bernardo Boris B.B.J./C-3323-2013					BARBOUR SE, 1993, J BIOL CHEM, V268, P21875; BOUKILI MA, 1989, BRIT J PHARMACOL, V98, P61, DOI 10.1111/j.1476-5381.1989.tb16863.x; BRAQUET P, 1987, PHARMACOL REV, V39, P97; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DENNIS EA, 1989, J BIOL CHEM, V269, P3057; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GLASER KB, 1993, TRENDS PHARMACOL SCI, V14, P92, DOI 10.1016/0165-6147(93)90071-Q; HIDI R, 1989, J IMMUNOL, V151, P5613; KISHINO J, 1994, J BIOL CHEM, V269, P5092; KOMADA M, 1989, J BIOCHEM-TOKYO, V106, P545, DOI 10.1093/oxfordjournals.jbchem.a122890; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; MAYER RJ, 1993, FASEB J, V7, P339, DOI 10.1096/fasebj.7.2.8440410; MOUNIER C, 1993, EUR J BIOCHEM, V216, P169, DOI 10.1111/j.1432-1033.1993.tb18129.x; MOUNIER C, 1994, BBA-LIPID LIPID MET, V1214, P88, DOI 10.1016/0005-2760(94)90013-2; MURAKAMI M, 1993, J BIOL CHEM, V268, P839; PFEILSCHIFTER J, 1993, J CLIN INVEST, V92, P2516, DOI 10.1172/JCI116860; PRETOLANI M, 1993, BIOCHEM PHARMACOL, V45, P791, DOI 10.1016/0006-2952(93)90161-O; RADVANYI F, 1989, ANAL BIOCHEM, V177, P103, DOI 10.1016/0003-2697(89)90022-5; ROSHAK A, 1994, J BIOL CHEM, V269, P25999; Sambrook J, 1989, MOL CLONING LABORATO; SEILHAMER JJ, 1989, J BIOL CHEM, V264, P5335; VADAS P, 1993, J LIPID MEDIATOR, V8, P1; VANDENBOSCH H, 1980, BIOCHIM BIOPHYS ACTA, V604, P191; YING Z, 1993, EUR J BIOCHEM, V215, P91, DOI 10.1111/j.1432-1033.1993.tb18010.x	25	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17327	17332		10.1074/jbc.270.29.17327	http://dx.doi.org/10.1074/jbc.270.29.17327			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615534	hybrid			2022-12-27	WOS:A1995RK68900045
J	COMBADIERE, C; AHUJA, SK; MURPHY, PM				COMBADIERE, C; AHUJA, SK; MURPHY, PM			CLONING AND FUNCTIONAL EXPRESSION OF A HUMAN EOSINOPHIL CC-CHEMOKINE RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HUMAN INTERLEUKIN-8 RECEPTOR; MOLECULAR-CLONING; RANTES; IDENTIFICATION; NEUTROPHILS; BINDING	Eosinophils undergo chemotaxis, degranulate, and exhibit [Ca2+](i) changes in response to the human CC chemokines macrophage inflammatory protein (MLP)-1 alpha, regulated on activation, normal T expressed and secreted (RANTES), and monocyte chemoattractant protein-3 (MCP-3), but the receptors involved have not been defined. We have isolated a human cDNA encoding the first eosinophil-selective chemokine receptor, designated GC chemokine receptor 3 (CC CKR3). CC CKR3 is a seven-transmembrane domain G protein-coupled receptor most closely related to the previously reported monocyte- and neutrophil-selective receptor CC CKR1 (also known as the MIP-1 alpha/RANTES receptor). When [Ca2+](i) changes were monitored in stably transfected human embryonic kidney 293 cells, MIP-1 alpha and RANTES were both potent agonists for CC CKR3 and CC CKR1. However, MIP-1 beta was also an agonist for CC CKR3 but not CC CKR1; MCP-3 was an agonist for CC CKR1 but not CC CKR3, CC CKR3 may be one of the host factors responsible for selective recruitment of eosinophils to sites of inflammation.	NIAID,HOST DEF LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)			Combadiere, Christophe/I-5639-2013	Combadiere, Christophe/0000-0002-1755-4531				AHUJA SK, 1994, J BIOL CHEM, V269, P26381; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; COMBADIERE C, 1995, IN PRESS DNA CELL BI; DAHINDEN CA, 1994, J EXP MED, V179, P751, DOI 10.1084/jem.179.2.751; GAO JL, 1993, J EXP MED, V177, P1421, DOI 10.1084/jem.177.5.1421; GAO JL, 1994, J BIOL CHEM, V269, P28539; GAO JL, 1995, IN PRESS J BIOL CHEM, V270; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; JOSE PJ, 1994, J EXP MED, V179, P881, DOI 10.1084/jem.179.3.881; KAMEYOSHI Y, 1992, J EXP MED, V176, P587, DOI 10.1084/jem.176.2.587; KERNEN P, 1991, J CLIN INVEST, V87, P2012, DOI 10.1172/JCI115230; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; MCCOLL SR, 1993, J IMMUNOL, V150, P4550; MIKI T, 1989, GENE, V83, P137, DOI 10.1016/0378-1119(89)90411-3; MOSER B, 1991, J BIOL CHEM, V266, P10666; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; NOMURA H, 1993, INT IMMUNOL, V5, P1239, DOI 10.1093/intimm/5.10.1239; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; ROT A, 1992, J EXP MED, V176, P1489, DOI 10.1084/jem.176.6.1489; SCHRAUFSTATTER IU, 1993, J IMMUNOL, V151, P6418; VANDAMME J, 1992, J EXP MED, V176, P59, DOI 10.1084/jem.176.1.59; VANRIPER G, 1994, J IMMUNOL, V152, P4055; WANG JM, 1993, J EXP MED, V177, P699, DOI 10.1084/jem.177.3.699	26	209	288	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16491	16494		10.1074/jbc.270.28.16491	http://dx.doi.org/10.1074/jbc.270.28.16491			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622448	hybrid			2022-12-27	WOS:A1995RJ34700003
J	CROTEAU, W; WHITTEMORE, SL; SCHNEIDER, MJ; STGERMAIN, D				CROTEAU, W; WHITTEMORE, SL; SCHNEIDER, MJ; STGERMAIN, D			CLONING AND EXPRESSION OF A CDNA FOR A MAMMALIAN TYPE-III IODOTHYRONINE DEIODINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS-OOCYTES; THYROID-HORMONES; RAT; 5'-DEIODINASE; SELENIUM; SELENOCYSTEINE; THYROXINE; PROPYLTHIOURACIL; SELENOPROTEIN; DEFICIENCY	The type III iodothyronine deiodinase metabolizes the active thyroid hormones thyroxine and 3,5,3'-triiodothyronine to inactive compounds. Recently, we have characterized a Xenopus laevis cDNA (XL-15) that encodes a selenoprotein with type III deiodinase activity (St. Germain, D. L., Schwartzman, R., Croteau, W., Kanamori, A., Wang, Z., Brown, D. D., and Galton, V. A. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 7767-7771). Using the XL-15 as a probe, we screened a rat neonatal skin cDNA library. Among the clones isolated was one (rNS43-1) which contained a 2.1-kilobase pair cDNA insert that manifested significant homology to both the XL-15 and the G21 rat type I deiodinase cDNAs, including the presence of an in-frame TGA codon. Expression studies demonstrated that the rNS43-1 cDNA encodes a protein with 5-, but not 5'-, deiodinase activity that is resistant to inhibition by propylthiouracil and aurothioglucose. Northern analysis demonstrated a pattern of tissue expression in the rat consistent with that of the type III deiodinase and site directed mutagenesis confirmed that the TGA triplet codes for selenocysteine. We conclude that the rNS43-1 cDNA encodes the rat type III deiodinase and that the types I and III deiodinases present in amphibians and mammals constitute a family of conserved selenoproteins important in the metabolism of thyroid hormones.	DARTMOUTH COLL, SCH MED, DEPT MED, LEBANON, NH 03756 USA; DARTMOUTH COLL, SCH MED, DEPT PHYSIOL, LEBANON, NH 03756 USA	Dartmouth College; Dartmouth College					NICHD NIH HHS [HD-27706] Funding Source: Medline; NIDDK NIH HHS [DK42271, DK-08671] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042271, F32DK008671] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEHNE D, 1988, BIOCHIM BIOPHYS ACTA, V966, P12, DOI 10.1016/0304-4165(88)90123-7; BERRY MJ, 1992, ENDOCRINOLOGY, V131, P1848, DOI 10.1210/en.131.4.1848; BERRY MJ, 1991, J BIOL CHEM, V266, P14155; BERRY MJ, 1991, NATURE, V349, P438, DOI 10.1038/349438a0; BERRY MJ, 1992, J BIOL CHEM, V267, P18055; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCKMAN TD, 1993, BIOCHIM BIOPHYS ACTA, V1163, P176, DOI 10.1016/0167-4838(93)90179-U; CHANOINE JP, 1993, J CLIN INVEST, V91, P2709, DOI 10.1172/JCI116510; CHANOINE JP, 1993, PEDIATR RES, V34, P288, DOI 10.1203/00006450-199309000-00009; DAVEY JC, 1994, DEV GENET, V15, P339, DOI 10.1002/dvg.1020150405; GOSWAMI A, 1986, ENDOCRINOLOGY, V119, P916, DOI 10.1210/endo-119-2-916; HUANG TS, 1988, PEDIATR RES, V23, P196, DOI 10.1203/00006450-198802000-00014; HUANG TS, 1985, ENDOCRINOLOGY, V117, P2106, DOI 10.1210/endo-117-5-2106; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; LEONARD JL, 1978, ENDOCRINOLOGY, V103, P2137, DOI 10.1210/endo-103-6-2137; MANDEL SJ, 1992, J CLIN ENDOCR METAB, V75, P1133, DOI 10.1210/jc.75.4.1133; MEINHOLD H, 1993, EXP CLIN ENDOCRINOL, V101, P87, DOI 10.1055/s-0029-1211212; MORENO M, 1994, FEBS LETT, V344, P143, DOI 10.1016/0014-5793(94)00365-3; OMARA BA, 1993, ENDOCRINOLOGY, V133, P1715, DOI 10.1210/en.133.4.1715; SANTINI F, 1992, ENDOCRINOLOGY, V130, P2325, DOI 10.1210/en.130.4.2325; SHARIFI J, 1992, J BIOL CHEM, V267, P12539; SILVA JE, 1984, J CLIN INVEST, V74, P1035, DOI 10.1172/JCI111471; STGERMAIN DL, 1989, J BIOL CHEM, V264, P3054; STGERMAIN DL, 1994, P NATL ACAD SCI USA, V91, P7767, DOI 10.1073/pnas.91.16.7767; STGERMAIN DL, 1994, THYROID HORMONE METABOLISM, P45; STGERMAIN DL, 1989, MOL ENDOCRINOL, V3, P2049; TOYODA N, 1994, J BIOL CHEM, V269, P20329; TOYODA N, 1994, 76TH ANN M END SOC A; VERONIKIS IE, 1994, 68TH M AM THYR ASS C, P69; VISSER TJ, 1992, ACTA MED AUST, V19, P18; WANG Z, 1991, P NATL ACAD SCI USA, V88, P11505, DOI 10.1073/pnas.88.24.11505; WU SY, 1991, THYROID HORMONE META, P293	32	170	177	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16569	16575		10.1074/jbc.270.28.16569	http://dx.doi.org/10.1074/jbc.270.28.16569			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622463	hybrid			2022-12-27	WOS:A1995RJ34700019
J	SHIKATA, Y; WATANABE, T; TERAMOTO, T; INOUE, A; KAWAKAMI, Y; NISHIZAWA, Y; KATAYAMA, K; KUWADA, M				SHIKATA, Y; WATANABE, T; TERAMOTO, T; INOUE, A; KAWAKAMI, Y; NISHIZAWA, Y; KATAYAMA, K; KUWADA, M			ISOLATION AND CHARACTERIZATION OF A PEPTIDE ISOMERASE FROM FUNNEL-WEB SPIDER VENOM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; CALCIUM CHANNELS; IVB	A novel peptide isomerase was purified from the venom of funnel web spider, Agelenopsis aperta. The complete primary structure of the isomerase has been established by sequence analyses of polypeptide chains, assignments of disulfide bridges, carbohydrate analyses, and mass spectrometry of sugar chains. The isomerase was found to be a 29-kDa polypeptide that consists of an 18-residue light chain and a 243-residue heavy chain connected by a single disulfide bridge. The heavy chain contains three intramolecular disulfide bridges and one N-linked oligosaccharide chain with a simple trimannosyl core structure. A sequence homology search showed a significant similarity of the enzyme with serine proteases, particularly around a putative catalytic triad of the isomerase. The isomerase specifically interconverts the configuration of Ser(46) of a 48-amino-acid peptide, omega-agatoxin-TK, and the conversion rate from L-Ser to D-Ser was approximately two times faster than the reverse reaction.	EISAI TSUKUBA RES LABS, DEPT PHYS & ANALYT CHEM, TSUKUBA, IBARAKI 30026, JAPAN	Eisai Co Ltd								ADAMS ME, 1993, MOL PHARMACOL, V44, P681; Bornstein P, 1977, Methods Enzymol, V47, P132; BRANDEN C, 1991, INTRO PROTEIN STRUCT, P4; FUJIKAWA K, 1986, BIOCHEMISTRY-US, V25, P2417, DOI 10.1021/bi00357a018; GALLO KA, 1993, BIOCHEMISTRY-US, V32, P3991, DOI 10.1021/bi00066a020; HECK SD, 1994, J AM CHEM SOC, V116, P10426, DOI 10.1021/ja00102a009; HECK SD, 1994, SCIENCE, V266, P1065, DOI 10.1126/science.7973665; HUANG HV, 1983, METHOD ENZYMOL, V91, P318; ITOH N, 1988, J BIOL CHEM, V263, P7628; JACOBSON J, 1984, J PHYS CHEM-US, V88, P4536, DOI 10.1021/j150664a018; KIMURA M, 1995, NEUROSCIENCE, V66, P609, DOI 10.1016/0306-4522(95)00023-C; KREIL G, 1994, J BIOL CHEM, V269, P10967; KUWADA M, 1994, MOL PHARMACOL, V46, P587; LOWENSON JD, 1992, J BIOL CHEM, V267, P5985; MAGNUSSON S, 1975, PROTEASES BIOL CONTR, P123; SHIEH JC, 1988, J BIOCHEM-TOKYO, V103, P596; STEINMAN HM, 1974, J BIOL CHEM, V249, P7326; TERAMOTO T, 1993, BIOCHEM BIOPH RES CO, V196, P134, DOI 10.1006/bbrc.1993.2225; WATANABE T, 1995, PEPTIDE CH, P253; YU HT, 1993, BIOCHEMISTRY-US, V32, P13123, DOI 10.1021/bi00211a022	20	79	86	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16719	16723		10.1074/jbc.270.28.16719	http://dx.doi.org/10.1074/jbc.270.28.16719			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622482	hybrid			2022-12-27	WOS:A1995RJ34700042
J	DEMARTINO, JA; KONTEATIS, ZD; SICILIANO, SJ; VANRIPER, G; UNDERWOOD, DJ; FISCHER, PA; SPRINGER, MS				DEMARTINO, JA; KONTEATIS, ZD; SICILIANO, SJ; VANRIPER, G; UNDERWOOD, DJ; FISCHER, PA; SPRINGER, MS			ARGININE-206 OF THE C5A RECEPTOR IS CRITICAL FOR LIGAND RECOGNITION AND RECEPTOR ACTIVATION BY C-TERMINAL HEXAPEPTIDE ANALOGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SITE-DIRECTED MUTAGENESIS; COMPLEMENT ACTIVATION; SYNOVIAL-FLUIDS; ANAPHYLATOXIN; IDENTIFICATION; RESIDUES; BINDING; DISEASE; PLASMA	C5a is a 74-amino-acid glycoprotein whose receptor is a member of the rhodopsin superfamily, While antagonists have been generated to many of these receptors, similar efforts directed at family members whose natural ligands are proteins have met with little success, The recent development of hexapeptide analogs of C5a has allowed us to begin elucidation of the molecular events that lead to activation by combining a structure/activity study of the ligand with receptor mutagenesis, Removal of the hexapeptide's C-terminal arginine reduces affinity by 100-fold and eliminates the ability of the ligand to activate the receptor, Both the guanidino side chain and the free carboxyl of the arginine participate in the interaction. The guanidino group makes the energy-yielding contact with the receptor, while the free carboxylate negates ''electrostatic'' interference with Arg-206 of the receptor, It is the apparent movement Arg-206 induced by this set of interactions that is responsible for activation, since conversion of Arg-206 to alanine eliminates the agonist activity of the hexapeptides. Surprisingly, activation is a nearly energy-neutral event and may reflect the binding process rather than the final resting site of the ligand.	MERCK & CO INC,RES LABS,DEPT IMMUNOL RES,RAHWAY,NJ 07065; MERCK & CO INC,RES LABS,DEPT BIOCHEM & MOLEC PATHOL,RAHWAY,NJ 07065; MERCK & CO INC,RES LABS,DEPT ANALYT BIOCHEM,RAHWAY,NJ 07065; MERCK & CO INC,RES LABS,DEPT MOLEC SYST,RAHWAY,NJ 07065; UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT MOLEC GENET & MICROBIOL,PISCATAWAY,NJ 08854	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Rutgers State University New Brunswick; Rutgers State University Medical Center								BERGH K, 1993, ARCH DERMATOL RES, V285, P131, DOI 10.1007/BF01112914; BOULAY F, 1991, BIOCHEMISTRY-US, V30, P2993, DOI 10.1021/bi00226a002; DEMARTINO JA, 1994, J BIOL CHEM, V269, P14446; DRAPEAU G, 1993, BIOCHEM PHARMACOL, V45, P1289, DOI 10.1016/0006-2952(93)90282-2; EMBER JA, 1992, J IMMUNOL, V148, P3165; GARDINALI M, 1992, ARCH SURG-CHICAGO, V127, P1219; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; GOLDSTEIN IM, 1988, INFLAMMATION BASIC P, P55; HOPKINS P, 1988, ARTHRITIS RHEUM, V31, P632, DOI 10.1002/art.1780310508; HUGLI TE, 1984, SPRINGER SEMIN IMMUN, V7, P193; JOSE PJ, 1990, ANN RHEUM DIS, V49, P747, DOI 10.1136/ard.49.10.747; KAWAI M, 1990, Patent No. 09162; KONTEATIS ZD, 1994, J IMMUNOL, V153, P4200; LANGLOIS PF, 1989, HEART LUNG, V18, P71; MOLLISON KW, 1989, P NATL ACAD SCI USA, V86, P292, DOI 10.1073/pnas.86.1.292; MONTZ H, 1991, IMMUNOLOGY, V74, P373; OR YS, 1992, J MED CHEM, V35, P402, DOI 10.1021/jm00080a030; ROLLINS TE, 1988, J BIOL CHEM, V263, P520; ROLLINS TE, 1985, J BIOL CHEM, V260, P7157; SICILIANO SJ, 1990, J BIOL CHEM, V265, P19568; SICILIANO SJ, 1994, P NATL ACAD SCI USA, V91, P1214, DOI 10.1073/pnas.91.4.1214; STRADER CD, 1989, J BIOL CHEM, V264, P13572; TAKEMATSU H, 1993, ARCH DERMATOL, V129, P74, DOI 10.1001/archderm.129.1.74; Underwood D J, 1994, Chem Biol, V1, P211, DOI 10.1016/1074-5521(94)90013-2; WARD PA, 1971, J CLIN INVEST, V50, P606, DOI 10.1172/JCI106531; YAMANO Y, 1992, BIOCHEM BIOPH RES CO, V187, P1426, DOI 10.1016/0006-291X(92)90461-S	26	56	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15966	15969		10.1074/jbc.270.27.15966	http://dx.doi.org/10.1074/jbc.270.27.15966			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608153	hybrid			2022-12-27	WOS:A1995RH22600014
J	SRIVASTAVA, DK; RAWSON, TY; SHOWALTER, SD; WILSON, SH				SRIVASTAVA, DK; RAWSON, TY; SHOWALTER, SD; WILSON, SH			PHORBOL ESTER ABROGATES UP-REGULATION OF DNA-POLYMERASE-BETA BY DNA-ALKYLATING AGENTS IN CHINESE-HAMSTER OVARY CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; REPAIR SYNTHESIS; MESSENGER-RNA; DEOXYRIBONUCLEIC-ACID; MONOCLONAL-ANTIBODIES; DAMAGING AGENTS; BINDING-PROTEIN; CDNA CLONING; C-JUN; PROMOTER	Mammalian DNA polymerase beta (beta-pol), a DNA repair polymerase, is known to be constitutively expressed in cultured cells, but treatment of cells with the DNA-alkylating agents MNNG or methyl methanesulfonate has been shown to up-regulate beta-pol mRNA level. To further characterize this response, we prepared a panel of monoclonal antibodies and used one of them to quantify beta-pol in whole cell extracts by immunoblotting. We found that treatment of Chinese hamster ovary cells with either DNA-alkylating agent up-regulated the beta-pol protein level 5-10-fold. This induction appeared to be secondary to DNA alkylation, as induction was not observed with a genetically altered cell line overexpressing the DNA repair enzyme O-6-methylguanine-methyltransferase We also found that 12-O-tetradecanoylphorbol-13-acetate (TPA) treatment of wild type Chinese hamster ovary cells increased expression of beta-pol protein (similar to 10-fold). Any interrelationship between this TPA response and the DNA-alkylation response was studied by treatment with combinations of MNNG and TPA. The beta-pol up-regulation observed with MNNG treatment was abrogated by TPA, and conversely the up-regulation observed with TPA treatment was abrogated by MNNG.	UNIV TEXAS,MED BRANCH,SEALY CTR MOLEC SCI,GALVESTON,TX 77555; BIOMOLEC TECHNOL INC,FREDERICK,MD 21701	University of Texas System; University of Texas Medical Branch Galveston			Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293	NIEHS NIH HHS [ESO6839, ESO6492] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006839, R01ES006492] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ARTEAGA CL, 1994, CANCER RES, V54, P3758; BENBROOK DM, 1990, ONCOGENE, V5, P295; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BUCKBINDER L, 1989, EMBO J, V8, P4239, DOI 10.1002/j.1460-2075.1989.tb08609.x; BUSCHER M, 1988, ONCOGENE, V3, P301; CHANG LMS, 1972, BIOCHEMISTRY-US, V11, P1264, DOI 10.1021/bi00757a023; CHEN KH, IN PRESS GENE AMST; DENG WP, 1994, MOL CELL BIOL, V14, P391, DOI 10.1128/MCB.14.1.391; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; DIANOV G, 1992, MOL CELL BIOL, V12, P1605, DOI 10.1128/MCB.12.4.1605; DIGIUSEPPE JA, 1989, BIOCHEMISTRY-US, V28, P9515, DOI 10.1021/bi00450a040; DRESLER SL, 1987, BIOCHEMISTRY-US, V26, P2664, DOI 10.1021/bi00384a002; DUNN WC, 1991, CARCINOGENESIS, V12, P83, DOI 10.1093/carcin/12.1.83; ENGLANDER EW, 1992, NUCLEIC ACIDS RES, V20, P5527, DOI 10.1093/nar/20.21.5527; ENGLANDER EW, 1992, DNA CELL BIOL, V11, P61, DOI 10.1089/dna.1992.11.61; FORNACE AJ, 1989, MOL CELL BIOL, V9, P851, DOI 10.1128/MCB.9.2.851; GRAVES LM, 1993, P NATL ACAD SCI USA, V90, P10300, DOI 10.1073/pnas.90.21.10300; HIROSE F, 1989, EXP CELL RES, V181, P169, DOI 10.1016/0014-4827(89)90191-2; KEDAR PS, 1990, MOL CELL BIOL, V10, P3852, DOI 10.1128/MCB.10.7.3852; KEDAR PS, 1991, P NATL ACAD SCI USA, V88, P3729, DOI 10.1073/pnas.88.9.3729; KOHLER G, 1976, EUR J IMMUNOL, V6, P292, DOI 10.1002/eji.1830060411; KUMAR A, 1990, J BIOL CHEM, V265, P2124; MACFARLANE DE, 1994, J BIOL CHEM, V269, P4327; MILLER MR, 1982, J BIOL CHEM, V257, P204; MOSBAUGH DW, 1983, J BIOL CHEM, V258, P108; NARAYAN S, 1995, BIOCHEMISTRY-US, V34, P73, DOI 10.1021/bi00001a009; NELSON WG, 1994, MOL CELL BIOL, V16, P1815; NOWAK R, 1989, BIOCHIM BIOPHYS ACTA, V1008, P203, DOI 10.1016/0167-4781(80)90010-X; RANDAHL H, 1988, J BIOL CHEM, V263, P12228; RECUPERO AJ, 1992, BIOCHEMISTRY-US, V31, P7989, DOI 10.1021/bi00149a033; SAKURAI A, 1991, BIOCHEM BIOPH RES CO, V181, P629, DOI 10.1016/0006-291X(91)91237-7; SENGUPTA DN, 1986, BIOCHEM BIOPH RES CO, V136, P341, DOI 10.1016/0006-291X(86)90916-2; SEVETSON BR, 1993, P NATL ACAD SCI USA, V90, P10305, DOI 10.1073/pnas.90.21.10305; SHOWALTER SD, 1981, INFECT IMMUNOL, V43, P684; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; SMITH CA, 1984, BIOCHEMISTRY-US, V23, P1383, DOI 10.1021/bi00302a008; STEVENSON MA, 1994, CANCER RES, V54, P12; SWACK JA, 1985, ANAL BIOCHEM, V147, P10, DOI 10.1016/0003-2697(85)90003-X; WANG TSF, 1980, BIOCHEMISTRY-US, V19, P1782, DOI 10.1021/bi00550a009; WIDEN SG, 1988, J BIOL CHEM, V263, P16992; WIDEN SG, 1991, BIOCHEMISTRY-US, V30, P6296, DOI 10.1021/bi00239a031; WIEBAUER K, 1990, P NATL ACAD SCI USA, V87, P5842, DOI 10.1073/pnas.87.15.5842; Wilson SH, 1990, EUKARYOTIC NUCLEUS, V1, P199; XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23; ZMUDZKA BZ, 1988, NUCLEIC ACIDS RES, V16, P9587, DOI 10.1093/nar/16.20.9587; ZMUDZKA BZ, 1986, P NATL ACAD SCI USA, V83, P5106, DOI 10.1073/pnas.83.14.5106; ZU YL, 1993, ONCOGENE, V8, P2749	48	37	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16402	16408		10.1074/jbc.270.27.16402	http://dx.doi.org/10.1074/jbc.270.27.16402			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608211	hybrid			2022-12-27	WOS:A1995RH22600078
J	WU, ZN; JOHNSON, KW; GOLDSTEIN, B; CHOI, Y; EATON, SF; LAUE, TM; CIARDELLI, TL				WU, ZN; JOHNSON, KW; GOLDSTEIN, B; CHOI, Y; EATON, SF; LAUE, TM; CIARDELLI, TL			SOLUTION ASSEMBLY OF A SOLUBLE, HETEROMERIC, HIGH-AFFINITY INTERLEUKIN-2 RECEPTOR COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICAL COILED-COILS; GAMMA-CHAIN; FUNCTIONAL CONSEQUENCES; LEUCINE ZIPPERS; AMINO-ACIDS; EXPRESSION; STABILITY; PROTEINS; ANTIBODY; BINDING	In this study, we report the use of coiled-coil (leucine zipper) molecular recognition for the solution assembly of stable, high affinity, heteromeric interleukin-2 receptor complexes, Co-expression of interleukin-2 receptor alpha and beta extracellular domains (ectodomains), each fused to seven coiled-coil heptad repeats, resulted in the formation of heteromeric complexes that bound interleukin-2 in a cooperative fashion and with much higher affinity than similar homomeric complexes, The dissociation constants for these solution complexes are within the range of values reported for the comparable cell surface ''pseudo high affinity'' interleukin-2 receptor. Ligand-induced cross-linking of homomeric or heteromeric receptor subunits is the common signal transmission mechanism employed by hematopoietin receptors. Individual receptor ectodomains, however, often do not bind ligand with measurable affinity, This is the first study to demonstrate the feasibility of coiled coil mediated preassembly of cytokine receptor complexes.	DARTMOUTH COLL,SCH MED,DEPT PHARMACOL & TOXICOL,HANOVER,NH 03755; VET ADM MED CTR,WHITE RIVER JCT,VT 05009; CHIRON CORP,EMERYVILLE,CA 94608; LOS ALAMOS NATL LAB,LOS ALAMOS,NM 87545; UNIV NEW HAMPSHIRE,DEPT BIOCHEM,DURHAM,NH 03824	Dartmouth College; US Department of Veterans Affairs; Veterans Health Administration (VHA); Novartis; United States Department of Energy (DOE); Los Alamos National Laboratory; University System Of New Hampshire; University of New Hampshire			Laue, Tom/AAI-5136-2020	Laue, Tom/0000-0003-3571-9368	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035556, R01GM035556] Funding Source: NIH RePORTER; NIAID NIH HHS [AI34331] Funding Source: Medline; NIGMS NIH HHS [GM35556] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alber T, 1992, CURR OPIN GENET DEV, V2, P205, DOI 10.1016/S0959-437X(05)80275-8; CALIGIURI MA, 1990, J EXP MED, V171, P1509, DOI 10.1084/jem.171.5.1509; COSMAN D, 1993, CYTOKINE, V5, P95, DOI 10.1016/1043-4666(93)90047-9; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Efron B., 1986, STAT SCI, V1, P54, DOI [10.1214/ss/1177013815, DOI 10.1214/SS/1177013815]; GILLIS S, 1978, J IMMUNOL, V121, P2077; GOLDSTEIN B, 1992, INT IMMUNOL, V4, P23, DOI 10.1093/intimm/4.1.23; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; GRADDIS TJ, 1993, BIOCHEMISTRY-US, V32, P12664, DOI 10.1021/bi00210a015; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hodges R. S., 1972, COLD SPRING HARB SYM, V37, P299; JOHNSON K, 1994, EUR CYTOKINE NETW, V5, P23; KOSTELNY SA, 1992, J IMMUNOL, V148, P1547; LANDGRAF BE, 1992, J BIOL CHEM, V267, P18511; LAUE TM, 1994, PROG COLL POL SCI S, V94, P74; LEONARD WJ, 1982, NATURE, V300, P267, DOI 10.1038/300267a0; LOVEJOY B, 1993, SCIENCE, V259, P1288, DOI 10.1126/science.8446897; MATSUOKA M, 1993, EUR J IMMUNOL, V23, P2472, DOI 10.1002/eji.1830231014; MINAMI Y, 1994, J IMMUNOL, V152, P5680; NAKAMURA Y, 1994, NATURE, V369, P330, DOI 10.1038/369330a0; NAKARAI T, 1994, J EXP MED, V180, P241, DOI 10.1084/jem.180.1.241; ONIEL KT, 1990, SCIENCE, V250, P646; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; ROBB RJ, 1987, J IMMUNOL, V137, P142; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SANA TR, 1994, BIOCHEMISTRY-US, V33, P5838, DOI 10.1021/bi00185a023; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223; VANHOLDE KE, 1985, PHYSICAL BIOCH, P118; WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055; WU ZN, 1994, PROTEIN ENG, V7, P1137, DOI 10.1093/protein/7.9.1137; WU ZN, 1995, J BIOL CHEM, V270, P16045, DOI 10.1074/jbc.270.27.16045; ZHOU NE, 1993, BIOCHEMISTRY-US, V32, P6190, DOI 10.1021/bi00075a011; ZHOU NE, 1992, J BIOL CHEM, V267, P2664; ZHU BY, 1993, PROTEIN SCI, V2, P383	35	25	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16039	16044		10.1074/jbc.270.27.16039	http://dx.doi.org/10.1074/jbc.270.27.16039			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608165	Green Published, hybrid			2022-12-27	WOS:A1995RH22600026
J	DELCOMMENNE, M; STREULI, CH				DELCOMMENNE, M; STREULI, CH			CONTROL OF INTEGRIN EXPRESSION BY EXTRACELLULAR-MATRIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; MESSENGER-RNA; KERATINOCYTE ACTIVATION; FIBRONECTIN RECEPTOR; EPITHELIAL-CELLS; MELANOMA-CELLS; BETA-SUBUNIT; GROWTH; PROTEIN; TISSUE	Integrin-mediated interactions between cells and the extracellular matrix play a fundamental role in the development and function of a variety of tissues by triggering intracellular signals that regulate gene expression. In this study, mouse mammary epithelial cells plated on tissue culture plastic were shown to dramatically up-regulate the steady state levels of mRNA encoding the alpha(1), alpha(2), alpha(3), alpha(5), alpha(6), alpha(7), alpha(v), and beta(1) integrin subunits, in contrast to cells cultured on a basement membrane matrix or cells in vivo. This pattern of expression was also observed in a mouse mammary epithelial strain, CID-9 and in other mouse cell lines such as MMTE cells and K1735-M2 melanoma cells. The control of integrin expression was mediated at different levels in different cell types, In K1735-M2 cells, transcription of the beta(1) integrin gene was influenced by the substratum, although the levels of integrin protein remained similar. In mammary epithelial cells, the rates of beta(1) integrin gene transcription were similar, but mRNA and protein levels were higher in cells cultured on plastic than those on basement membrane. For both cell types, the rate of integrin protein turnover was nearly identical in cells cultured on either substratum. Our results demonstrate that extracellular matrix controls the expression of beta(1) integrin subunits and that this regulation is exerted at both transcriptional and post-transcriptional levels.	UNIV MANCHESTER,SCH BIOL SCI,MANCHESTER M13 9PT,LANCS,ENGLAND	University of Manchester					Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AGGELER J, 1991, J CELL SCI, V99, P407; Ausubel FM., 2006, ENZYMATIC MANIPULATI; BENZEEV A, 1991, BIOESSAYS, V13, P207, DOI 10.1002/bies.950130502; BIRKENMEIER TM, 1991, J BIOL CHEM, V266, P20544; BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5; CERVELLA P, 1993, J BIOL CHEM, V268, P5148; CHEN D, 1992, J BIOL CHEM, V267, P23502; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DARDENNE AJ, 1991, J PATHOL, V165, P213, DOI 10.1002/path.1711650304; ERLE DJ, 1991, AM J RESP CELL MOL, V5, P170, DOI 10.1165/ajrcmb/5.2.170; FALCIONI R, 1988, CANCER RES, V48, P816; FONG AM, 1994, J BIOL CHEM, V269, P18441; FULTON AB, 1993, J CELL SCI, V105, P867; GAILIT J, 1994, CURR OPIN CELL BIOL, V6, P717, DOI 10.1016/0955-0674(94)90099-X; GRINNELL F, 1992, J CELL SCI, V101, P1; HODIVALA KJ, 1994, J CELL BIOL, V124, P589, DOI 10.1083/jcb.124.4.589; HOTCHIN NA, 1992, J BIOL CHEM, V267, P14852; IGNOTZ RA, 1987, CELL, V51, P189, DOI 10.1016/0092-8674(87)90146-2; INGBER DE, 1993, CELL, V75, P1249, DOI 10.1016/0092-8674(93)90612-T; KIM LT, 1992, J CELL SCI, V103, P743; KLEIN CE, 1991, J CELL BIOL, V115, P1427, DOI 10.1083/jcb.115.5.1427; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; MARCANTONIO EE, 1988, J CELL BIOL, V106, P1765, DOI 10.1083/jcb.106.5.1765; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MOORADIAN DL, 1990, CANCER RES, V50, P273; NICOLSON GL, 1991, BIOESSAYS, V13, P337, DOI 10.1002/bies.950130706; ROBERTS CJ, 1988, J BIOL CHEM, V263, P4586; RODAWAY ARF, 1990, MOL CELL BIOL, V10, P5388, DOI 10.1128/MCB.10.10.5388; RUCSLAHTI E, 1994, CELL, V77, P477; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; SCHMIDHAUSER C, 1990, P NATL ACAD SCI USA, V87, P9118, DOI 10.1073/pnas.87.23.9118; SCHMIDHAUSER C, 1994, MOL CARCINOGEN, V10, P66, DOI 10.1002/mc.2940100203; SCHMIDHAUSER C, 1992, MOL BIOL CELL, V3, P699, DOI 10.1091/mbc.3.6.699; SONNENBERG A, 1988, NATURE, V367, P487; STREULI CH, 1990, J CELL BIOL, V110, P1405; STREULI CH, 1995, J BIOL CHEM, V270, P21639, DOI 10.1074/jbc.270.37.21639; STREULI CH, 1993, J CELL BIOL, V120, P253, DOI 10.1083/jcb.120.1.253; STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383; TOMINAGA S, 1988, FEBS LETT, V238, P315, DOI 10.1016/0014-5793(88)80503-9; TSUJI T, 1990, J BIOL CHEM, V265, P7016; VUKICEVIC S, 1992, EXP CELL RES, V202, P1, DOI 10.1016/0014-4827(92)90397-Q	42	139	140	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26794	26801		10.1074/jbc.270.45.26794	http://dx.doi.org/10.1074/jbc.270.45.26794			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592919	hybrid			2022-12-27	WOS:A1995TE58300019
J	DELUCA, M; DUNLOP, LC; ANDREWS, RK; FLANNERY, JV; ETTLING, R; CUMMING, DA; VELDMAN, M; BERNDT, MC				DELUCA, M; DUNLOP, LC; ANDREWS, RK; FLANNERY, JV; ETTLING, R; CUMMING, DA; VELDMAN, M; BERNDT, MC			A NOVEL COBRA VENOM METALLOPROTEINASE, MOCARHAGIN, CLEAVES A 10-AMINO ACID PEPTIDE FROM THE MATURE N-TERMINUS OF P-SELECTIN GLYCOPROTEIN LIGAND-RECEPTOR, PSGL-1, AND ABOLISHES P-SELECTIN BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MYELOID CELLS; LINKED OLIGOSACCHARIDES; MEMBRANE-GLYCOPROTEINS; CARBOHYDRATE LIGAND; SECRETORY PATHWAY; RECOGNITION; IDENTIFICATION; NEUTROPHILS; ADHESION; CLONING	Initial rolling of circulating neutrophils on a blood vessel wall prior to adhesion and transmigration to damaged tissue is dependent upon P-selectin expressed on endothelial cells and its specific neutrophil receptor, the P-selectin glycoprotein ligand-l (PSGL-1). Pretreatment of neutrophils, HL60 cells, or a recombinant fucosylated soluble form of PSGL-1 (sPSGL-1,T7) with the cobra venom metalloproteinase, mocarhagin, completely abolished binding to purified P-selectin in a time-dependent and EDTA- and diisopropyl fluorophosphate-inhibitable manner consistent with mocarhagin selectively cleaving PSGL-1. A polyclonal antibody against the N-terminal peptide Gln-1-Glu-15 of mature PSGL-1 immunoprecipitated sPSGL-1.T7 but not sPSGL-1.T7 treated with mocarhagin, indicating that the mocarhagin cleavage site was near the N terminus. A single mocarhagin cleavage site between Tyr-10 and Asp-ll of mature PSGL-1 was determined by N-terminal sequencing of mocarhagin fragments of sPSGL-1.T7 and is within a highly negatively charged amino acid sequence 1-QATEYEYLDY down arrow DFLPETEPPE, containing three tyrosine residues that are consensus sulfation sites. Consistent with a functional role of this region of PSGL-1 in binding P-selectin, an affinity-purified polyclonal antibody against residues Gln-1-Glu-15 of PSGL-1 strongly inhibited P-selectin binding to neutrophils, whereas an antibody against residues Asp-9-Arg-23 was noninhibitory, These combined data strongly suggest that the N-terminal anionic/sulfated tyrosine motif of PSGL-1 as well as downstream sialylated carbohydrate is essential for binding of P-selectin by neutrophils.	BAKER MED RES INST,VASC BIOL LAB,PRAHRAN,VIC 3181,AUSTRALIA; GENET INST INC,SMALL MOLEC DRUG DISCOVERY GRP,CAMBRIDGE,MA 02140	Baker Heart and Diabetes Institute			Berndt, Michael C/D-5580-2012					ARUFFO A, 1991, CELL, V67, P35, DOI 10.1016/0092-8674(91)90570-O; ASA D, 1995, J BIOL CHEM, V270, P11662, DOI 10.1074/jbc.270.19.11662; BERNDT MC, 1981, J BIOL CHEM, V256, P59; BOOTH WJ, 1984, J CLIN INVEST, V73, P291, DOI 10.1172/JCI111213; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; CHONG BH, 1994, BLOOD, V83, P1535; DONG JF, 1994, BIOCHEMISTRY-US, V38, P13946; FUKUDA M, 1984, J BIOL CHEM, V259, P925; HUTTNER WB, 1988, ANNU REV PHYSIOL, V50, P363, DOI 10.1146/annurev.ph.50.030188.002051; KANSAS GS, 1994, J CELL BIOL, V124, P609, DOI 10.1083/jcb.124.4.609; LARSEN GR, 1992, J BIOL CHEM, V267, P11104; LEE N, 1990, J BIOL CHEM, V265, P20476; LEVINOVITZ A, 1993, J CELL BIOL, V121, P449, DOI 10.1083/jcb.121.2.449; LOPEZ JA, 1987, P NATL ACAD SCI USA, V84, P5615, DOI 10.1073/pnas.84.16.5615; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; MOORE KL, 1991, J CELL BIOL, V112, P491, DOI 10.1083/jcb.112.3.491; MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445; MOORE KL, 1994, J BIOL CHEM, V269, P23318; NELSON RM, 1993, J CLIN INVEST, V91, P1157, DOI 10.1172/JCI116275; NORGARD KE, 1993, J BIOL CHEM, V268, P12764; PHILLIPS DR, 1977, J BIOL CHEM, V252, P2121; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; POLLEY MJ, 1991, P NATL ACAD SCI USA, V88, P6224, DOI 10.1073/pnas.88.14.6224; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; SKINNER MP, 1991, J BIOL CHEM, V266, P5371; TITANI K, 1987, P NATL ACAD SCI USA, V84, P5610, DOI 10.1073/pnas.84.16.5610; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; WASLEY LC, 1993, J BIOL CHEM, V268, P8458	28	96	101	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26734	26737		10.1074/jbc.270.45.26734	http://dx.doi.org/10.1074/jbc.270.45.26734			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592904	hybrid			2022-12-27	WOS:A1995TE58300004
J	EARNEST, JP; SANTOS, GF; ZUERBIG, S; FOX, JEB				EARNEST, JP; SANTOS, GF; ZUERBIG, S; FOX, JEB			DYSTROPHIN-RELATED PROTEIN IN THE PLATELET MEMBRANE SKELETON - INTEGRIN-INDUCED CHANGE IN DETERGENT-INSOLUBILITY AND CLEAVAGE BY CALPAIN IN AGGREGATING PLATELETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB-IIIA; DUCHENNE MUSCULAR-DYSTROPHY; THROMBIN-STIMULATED PLATELETS; MUSCLE-CELLS; CA-2+-DEPENDENT PROTEASE; SUBCELLULAR-DISTRIBUTION; TERMINAL DOMAIN; ACTIN-FILAMENTS; PLASMA-MEMBRANE; CALCIUM-CHANNEL	The platelet membrane is lined with a membrane skeleton that associates with transmembrane adhesion receptors and is thought to play a role in regulating the stability of the membrane, distribution and function of adhesive receptors, and adhesive receptor-induced transmembrane signaling, When platelets are lysed with Triton X-100, cytoplasmic actin filaments can be sedimented by centrifugation at low g-forces (15,600 x g) but the membrane skeleton requires 100,000 x g. The present study shows that DRP (dystrophin-related protein) sediments from lysed platelets along with membrane skeleton proteins, Sedimentation results from association with the membrane skeleton because DRP was released into the detergent-soluble fraction when actin filaments were depolymerized, Interaction of fibrinogen with the integrin alpha(IIb)beta(3) induces platelet aggregation, transmembrane signaling, and the formation of integrin-rich cytoskeletal complexes that can be sedimented from detergent lysates at low g-forces. Like other membrane skeleton proteins, DRP redistributed from the high-speed pellet to the integrin-rich low-speed pellet of aggregating platelets, One of the signaling enzymes that is activated following alpha(IIb)beta(3)-ligand interactions in a platelet aggregate is calpain; DRP was cleaved by calpain to generate a similar to 140-kDa fragment that remained associated with the low-speed detergent-insoluble fraction. These studies show that DRP is part of the platelet membrane skeleton and indicate that DRP participates in the cytoskeletal reorganizations resulting from signal transmission between extracellular adhesive ligand and the interior of the cell.	CHILDRENS HOSP,OAKLAND RES INST,OAKLAND,CA 94609; UNIV CALIF SAN FRANCISCO,DEPT PATHOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,INST CARDIOVASC RES,SAN FRANCISCO,CA 94143	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco					NHLBI NIH HHS [HL30657] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R23HL030657, R01HL030657, R37HL030657] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON MS, 1992, TRENDS BIOCHEM SCI, V17, P289, DOI 10.1016/0968-0004(92)90437-E; ANDRE B, 1994, BIOCHEM BIOPH RES CO, V205, P1201, DOI 10.1006/bbrc.1994.2793; BECKERLE MC, 1987, CELL, V51, P569, DOI 10.1016/0092-8674(87)90126-7; BODENSTEINER JB, 1978, NEUROLOGY, V28, P439, DOI 10.1212/WNL.28.5.439; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; BYERS TJ, 1991, J CELL BIOL, V115, P411, DOI 10.1083/jcb.115.2.411; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CLARK EA, 1993, MOL CELL BIOL, V13, P1863, DOI 10.1128/MCB.13.3.1863; COTTIN P, 1992, BIOCHIMIE, V74, P565, DOI 10.1016/0300-9084(92)90156-9; CULLEN MJ, 1990, PROC R SOC SER B-BIO, V240, P197, DOI 10.1098/rspb.1990.0034; DJAFFAR I, 1991, THROMB RES, V62, P127, DOI 10.1016/0049-3848(91)90187-2; Ervasti JM, 1993, CURR OPIN CELL BIOL, V5, P82, DOI 10.1016/S0955-0674(05)80012-2; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FABBRIZIO E, 1994, J MUSCLE RES CELL M, V15, P595, DOI 10.1007/BF00121067; FOX JEB, 1982, J BIOL CHEM, V257, P4120; FOX JEB, 1987, BLOOD, V69, P537; FOX JEB, 1985, J BIOL CHEM, V260, P1060; FOX JEB, 1993, J CELL BIOL, V120, P1501, DOI 10.1083/jcb.120.6.1501; FOX JEB, 1988, J CELL BIOL, V106, P1525, DOI 10.1083/jcb.106.5.1525; FOX JEB, 1985, J CLIN INVEST, V76, P1673, DOI 10.1172/JCI112153; FOX JEB, 1993, THROMB HAEMOSTASIS, V70, P884; FOX JEB, 1993, J BIOL CHEM, V268, P25973; FOX JEB, 1990, J CELL BIOL, V111, P483, DOI 10.1083/jcb.111.2.483; FOX JEB, 1987, THROMB DIATH HAEMO, P175; FOX JEB, 1995, J CELL BIOCH B S, V19, pA136; FRANCO A, 1990, NATURE, V344, P670, DOI 10.1038/344670a0; FRANCO A, 1990, J PHYSIOL-LONDON, V427, P361, DOI 10.1113/jphysiol.1990.sp018176; FUJIMOTO T, 1991, J BIOL CHEM, V266, P16370; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; GEORGE JN, 1984, NEW ENGL J MED, V311, P1084, DOI 10.1056/NEJM198410253111705; GRONDIN P, 1991, J BIOL CHEM, V266, P15705; HARTWIG JH, 1991, J CELL BIOL, V112, P407, DOI 10.1083/jcb.112.3.407; HEMMINGS L, 1992, J CELL BIOL, V116, P1369, DOI 10.1083/jcb.116.6.1369; HOFFMAN EP, 1989, NEURON, V2, P1019, DOI 10.1016/0896-6273(89)90226-2; HORVATH AR, 1992, EMBO J, V11, P855, DOI 10.1002/j.1460-2075.1992.tb05123.x; IBRAGHINOVBESKR, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; JACKSON MJ, 1985, CLIN CHIM ACTA, V147, P215, DOI 10.1016/0009-8981(85)90202-5; JACKSON SP, 1994, J BIOL CHEM, V269, P27093; KHURANA TS, 1992, J CELL BIOL, V119, P357, DOI 10.1083/jcb.119.2.357; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOUNS WC, 1991, J BIOL CHEM, V266, P13891; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKONISHOK M, 1992, DEV BIOL, V152, P209, DOI 10.1016/0012-1606(92)90129-5; LANSMAN JB, 1991, J MUSCLE RES CELL M, V12, P409, DOI 10.1007/BF01738325; LIDOV HGW, 1990, NATURE, V348, P725, DOI 10.1038/348725a0; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; LOVE DR, 1991, P NATL ACAD SCI USA, V88, P3243, DOI 10.1073/pnas.88.8.3243; MAN NT, 1991, J CELL BIOL, V115, P1695; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; MATSUMURA K, 1994, MUSCLE NERVE, V17, P2, DOI 10.1002/mus.880170103; MEHDI S, 1988, BIOCHEM BIOPH RES CO, V157, P1117, DOI 10.1016/S0006-291X(88)80989-6; MENKE A, 1991, NATURE, V349, P69, DOI 10.1038/349069a0; MONGINI T, 1988, NEUROLOGY, V38, P476, DOI 10.1212/WNL.38.3.476; RYBAK ME, 1988, BLOOD, V72, P714; SULTAN C, 1991, J BIOL CHEM, V266, P23554; SUZUKI A, 1992, FEBS LETT, V308, P154, DOI 10.1016/0014-5793(92)81265-N; TAMAI M, 1986, J PHARMACOBIO-DYNAM, V9, P672, DOI 10.1248/bpb1978.9.672; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; TORTI M, 1994, P NATL ACAD SCI USA, V91, P4239, DOI 10.1073/pnas.91.10.4239; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; WAY M, 1992, FEBS LETT, V301, P243, DOI 10.1016/0014-5793(92)80249-G; YOSHIDA M, 1992, J BIOCHEM-TOKYO, V112, P433, DOI 10.1093/oxfordjournals.jbchem.a123918; ZHANG J, 1992, J BIOL CHEM, V267, P4686; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	71	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27259	27265		10.1074/jbc.270.45.27259	http://dx.doi.org/10.1074/jbc.270.45.27259			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592985	hybrid			2022-12-27	WOS:A1995TE58300085
J	HARLOCKER, SL; BERGSTROM, L; INOUYE, M				HARLOCKER, SL; BERGSTROM, L; INOUYE, M			TANDEM BINDING OF 6 OMPR PROTEINS TO THE OMPF UPSTREAM REGULATORY SEQUENCE OF ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL ACTIVATOR PROTEIN; PORIN GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; 2-COMPONENT REGULATORS; TRANSMEMBRANE RECEPTOR; PHOSPHATASE-ACTIVITIES; SIGNAL-TRANSDUCTION; MYXOCOCCUS-XANTHUS; CANONICAL PROMOTER; POSITIVE REGULATOR	OmpR is a transcription factor in Escherichia coli whose function is modulated by phosphorylation in the presence of phosphorylated EnvZ, a transmembrane protein histidine kinase involved in osmosensing. Using a protein S-OmpR hybrid protein, we demonstrated that six OmpR molecules bind tandemly to the -100 to -39 sequence of ompF. This sequence consists of three 20-base pair units: F1, F2, and F3, each of which is bound by two OmpR proteins. Polymerase chain reaction selection of nine randomized base pairs within the F1 sequence revealed highly conserved C residues spaced 10 base pairs apart. Further mutational analysis of conserved bases indicated that two OmpR molecules bind tandemly to two direct repeats. Mobility shift assays showed that cooperative interactions play a role in enhancing binding of OmpR to lower affinity F2 and F3 sites. Activation and repression of ompF expression are thus regulated by a total of eight OmpR molecules, including two molecules that bind to a distal site (-380 to -361).	RUTGERS STATE UNIV,ROBERT WOOD JOHNSON MED SCH,DEPT BIOCHEM,PISCATAWAY,NJ 08854	Rutgers State University New Brunswick; Rutgers State University Medical Center					NIGMS NIH HHS [GM19043] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019043, R01GM019043] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIBA H, 1989, J BIOL CHEM, V264, P8563; AIBA H, 1989, J BIOCHEM-TOKYO, V106, P5, DOI 10.1093/oxfordjournals.jbchem.a122817; AIBA H, 1990, FEBS LETT, V261, P19, DOI 10.1016/0014-5793(90)80626-T; BAGBY S, 1994, P NATL ACAD SCI USA, V91, P4308, DOI 10.1073/pnas.91.10.4308; CARRA JH, 1993, EMBO J, V12, P35, DOI 10.1002/j.1460-2075.1993.tb05629.x; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; COLLADOVIDES J, 1991, MICROBIOL REV, V55, P371, DOI 10.1128/MMBR.55.3.371-394.1991; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; DELGADO J, 1993, MOL MICROBIOL, V10, P1037, DOI 10.1111/j.1365-2958.1993.tb00974.x; FORST S, 1990, J BACTERIOL, V172, P3473, DOI 10.1128/jb.172.6.3473-3477.1990; FORST S, 1989, P NATL ACAD SCI USA, V86, P6052, DOI 10.1073/pnas.86.16.6052; FORST SA, 1989, J BACTERIOL, V171, P2949, DOI 10.1128/jb.171.6.2949-2955.1989; HALL MN, 1981, J MOL BIOL, V151, P1, DOI 10.1016/0022-2836(81)90218-7; HALL MN, 1981, J MOL BIOL, V146, P23, DOI 10.1016/0022-2836(81)90364-8; HUANG KJ, 1994, J BACTERIOL, V176, P1309, DOI 10.1128/jb.176.5.1309-1315.1994; IGO MM, 1988, J BACTERIOL, V170, P5971, DOI 10.1128/jb.170.12.5971-5973.1988; IGO MM, 1989, GENE DEV, V3, P1725, DOI 10.1101/gad.3.11.1725; INOUYE M, 1979, DEV BIOL, V68, P579, DOI 10.1016/0012-1606(79)90228-8; INOUYE S, 1981, J BACTERIOL, V148, P678, DOI 10.1128/JB.148.2.678-683.1981; JIN T, 1993, J MOL BIOL, V232, P484, DOI 10.1006/jmbi.1993.1404; KANAMARU K, 1990, J BIOCHEM-TOKYO, V108, P483, DOI 10.1093/oxfordjournals.jbchem.a123225; KASAHARA M, 1991, J BACTERIOL, V173, P549, DOI 10.1128/jb.173.2.549-558.1991; KAWAJI H, 1979, J BACTERIOL, V140, P843, DOI 10.1128/JB.140.3.843-847.1979; KIMURA S, 1989, MOL GEN GENET, V215, P374, DOI 10.1007/BF00427032; MAEDA S, 1988, J MOL BIOL, V202, P433, DOI 10.1016/0022-2836(88)90276-8; MAEDA S, 1988, J BIOL CHEM, V263, P14629; MAEDA S, 1991, J BIOCHEM-TOKYO, V110, P324, DOI 10.1093/oxfordjournals.jbchem.a123579; MAEDA S, 1990, J BACTERIOL, V172, P501, DOI 10.1128/JB.172.1.501-503.1990; MAKINO K, 1986, J MOL BIOL, V203, P85; MIZUNO T, 1988, J BIOL CHEM, V263, P1008; MIZUNO T, 1987, J BIOCHEM-TOKYO, V101, P387, DOI 10.1093/oxfordjournals.jbchem.a121923; MIZUNO T, 1986, J BACTERIOL, V168, P86, DOI 10.1128/jb.168.1.86-95.1986; MIZUNO T, 1987, GENE, V54, P57, DOI 10.1016/0378-1119(87)90347-7; NIKAIDO H, 1987, ESCHERICHIA COLI SAL, P7; NIXON BT, 1986, P NATL ACAD SCI USA, V83, P7850, DOI 10.1073/pnas.83.20.7850; NORIOKA S, 1986, J BIOL CHEM, V261, P7113; OLIPHANT AR, 1987, NUCLEIC ACIDS RES, V16, P7673; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; RAMPERSAUD A, 1989, J BIOL CHEM, V264, P18693; RAMPERSAUD A, 1994, J BIOL CHEM, V269, P12559; RUSSO FD, 1991, J MOL BIOL, V222, P567, DOI 10.1016/0022-2836(91)90497-T; SARMA V, 1977, J BACTERIOL, V132, P23, DOI 10.1128/JB.132.1.23-27.1977; SLAUCH JM, 1991, J BACTERIOL, V173, P4039, DOI 10.1128/jb.173.13.4039-4048.1991; SLAUCH JM, 1988, J BACTERIOL, V170, P439, DOI 10.1128/jb.170.1.439-441.1988; SLAUCH JM, 1989, J MOL BIOL, V210, P281, DOI 10.1016/0022-2836(89)90330-6; SMITH DL, 1992, CELL, V68, P133, DOI 10.1016/0092-8674(92)90212-U; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; TSUNG K, 1989, J BIOL CHEM, V264, P10104; YANG Y, 1993, J MOL BIOL, V231, P335, DOI 10.1006/jmbi.1993.1286; YANG Y, 1991, P NATL ACAD SCI USA, V88, P11057, DOI 10.1073/pnas.88.24.11057	52	103	105	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26849	26856		10.1074/jbc.270.45.26849	http://dx.doi.org/10.1074/jbc.270.45.26849			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592927	hybrid			2022-12-27	WOS:A1995TE58300027
J	MCGREGOR, WG; MAH, MCM; CHEN, RH; MAHER, VM; MCCORMICK, JJ				MCGREGOR, WG; MAH, MCM; CHEN, RH; MAHER, VM; MCCORMICK, JJ			LACK OF CORRELATION BETWEEN DEGREE OF INTERFERENCE WITH TRANSCRIPTION AND RATE OF STRAND-SPECIFIC REPAIR IN THE HPRT GENE OF DIPLOID HUMAN FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UV-INDUCED MUTATIONS; EXCISION REPAIR; DIOL EPOXIDE; DNA ADDUCTS; PREFERENTIAL REPAIR; MAMMALIAN-CELLS; BENZO<A>PYRENE; INVITRO; RNA; 1-NITROSOPYRENE	The model that transcription coupled excision repair reflects the interference of DNA damage with the transcription process predicts that the rate of such excision repair will be related to the degree to which a particular type of lesion blocks transcription, We tested this by measuring the rate of excision repair of guanine adducts formed in the HPRT gene of diploid human fibroblasts and in the overall genome by two structurally related polycyclic carcinogens, l-nitrosopyrene (1-NOP) and N-acetoxy-2-acetylaminofluorene (N-AcO-AAF) and comparing the results with those we found previously using benzo[a]pyrene diol epoxide (BPDE). We also measured the degree of interference with in vitro transcription by these adducts. Our results showed that, although BPDE adducts are four times more effective than 1-NOP adducts in blocking transcription, the preferential and strand-specific repair of 1-NOP adducts was twice as fast as that of BPDE adducts. Excision repair of N-AcO-AAF adducts was significantly slower than that of BPDE adducts and was not strand-specific. The efficiency of blocking of transcription by deacetylated N-AcO-AAF adducts was similar to 1-NOP adducts. Therefore, the extent to which a particular lesion blocks transcription in vitro does not predict its rate of preferential or transcription-coupled excision repair.	MICHIGAN STATE UNIV,CTR CANC,DEPT BIOCHEM,E LANSING,MI 48824	Michigan State University	MCGREGOR, WG (corresponding author), MICHIGAN STATE UNIV,DEPT MICROBIOL,CARCINOGENESIS LAB,FEE HALL,E LANSING,MI 48824, USA.				NATIONAL CANCER INSTITUTE [R01CA021253, K08CA001747, R01CA056796] Funding Source: NIH RePORTER; NCI NIH HHS [CA56796, K08 CA01747, CA21253] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUST AE, 1984, MUTAT RES, V125, P95, DOI 10.1016/0027-5107(84)90036-8; BELAND FA, 1979, J CHROMATOGR, V174, P177, DOI 10.1016/S0021-9673(00)87048-X; BELAND FA, 1986, CARCINOGENESIS, V7, P1279, DOI 10.1093/carcin/7.8.1279; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Bohr VA, 1988, DNA REPAIR LABORATOR, V3, P347; BROYDE S, 1983, BIOPOLYMERS, V22, P2423, DOI 10.1002/bip.360221109; CHEN RH, 1992, P NATL ACAD SCI USA, V89, P5413, DOI 10.1073/pnas.89.12.5413; CHEN YH, 1993, J BIOL CHEM, V268, P5849; CHEN YH, 1991, P NATL ACAD SCI USA, V88, P9583, DOI 10.1073/pnas.88.21.9583; CHINAULT AC, 1984, PROG NUCLEIC ACID RE, V31, P295, DOI 10.1016/S0079-6603(08)60381-5; CHO BP, 1994, BIOCHEMISTRY-US, V33, P1373, DOI 10.1021/bi00172a013; CHOI DJ, 1994, BIOCHEMISTRY-US, V33, P780, DOI 10.1021/bi00169a020; COSMAN M, 1992, P NATL ACAD SCI USA, V89, P1914, DOI 10.1073/pnas.89.5.1914; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; HEFLICH RH, 1980, CHEM-BIOL INTERACT, V29, P43, DOI 10.1016/0009-2797(80)90085-X; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; HINGERTY BE, 1986, J BIOMOL STRUCT DYN, V4, P365, DOI 10.1080/07391102.1986.10506355; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P12213, DOI 10.1073/pnas.91.25.12213; LIN D, 1988, SOMAT CELL MOLEC GEN, V14, P261, DOI 10.1007/BF01534587; MAH MCM, 1989, CARCINOGENESIS, V10, P2321, DOI 10.1093/carcin/10.12.2321; MCCORMICK JJ, 1988, CARCINOGENESIS, V9, P2073, DOI 10.1093/carcin/9.11.2073; MCCORMICK JJ, 1981, DNA REPAIR LABORAT B, V1, P501; MCGREGOR WG, 1991, MOL CELL BIOL, V11, P1927, DOI 10.1128/MCB.11.4.1927; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; NOLAN SJ, 1995, IN PRESS CARCINOGENE; PATTON JD, 1986, CARCINOGENESIS, V7, P89, DOI 10.1093/carcin/7.1.89; POIRIER MC, 1980, MOL PHARMACOL, V18, P581; ROSENKRANZ HS, 1982, MUTAT RES, V101, P1, DOI 10.1016/0165-1218(82)90159-8; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P11574, DOI 10.1073/pnas.88.24.11574; SINGH SB, 1991, CANCER RES, V51, P3482; SOSCHER DH, 1994, CARCINOGENESIS, V15, P1093; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; TUNG BS, 1995, IN PRESS MUTATION RE; VRIELING H, 1989, MOL CELL BIOL, V9, P1277, DOI 10.1128/MCB.9.3.1277; WANG YY, 1986, MUTAT RES, V175, P107, DOI 10.1016/0165-7992(86)90133-8; WATANABE M, 1985, MUTAT RES, V146, P285, DOI 10.1016/0167-8817(85)90070-7; WEINSTEIN IB, 1976, SCIENCE, V193, P592, DOI 10.1126/science.959820; YANG JL, 1988, MOL CELL BIOL, V8, P196; YANG LL, 1982, MUTAT RES, V94, P435, DOI 10.1016/0027-5107(82)90306-2	40	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27222	27227		10.1074/jbc.270.45.27222	http://dx.doi.org/10.1074/jbc.270.45.27222			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592980	hybrid			2022-12-27	WOS:A1995TE58300080
J	KNIGHT, PJK; KNOWLES, BH; ELLAR, DJ				KNIGHT, PJK; KNOWLES, BH; ELLAR, DJ			MOLECULAR-CLONING OF AN INSECT AMINOPEPTIDASE-N THAT SERVES AS A RECEPTOR FOR BACILLUS-THURINGIENSIS CRYIA(C) TOXIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER MEMBRANE; KIDNEY MICROVILLAR MEMBRANE; AMINO-ACID SEQUENCE; LARVAL MIDGUT; DELTA-ENDOTOXINS; ECTO-ENZYMES; BOMBYX-MORI; PROTEINS; ANTIGEN; METALLOPEPTIDASE	The Bacillus thuringiensis CryIA(c) insecticidal delta-endotoxin binds to a 120 kDa glycoprotein receptor in the larval midgut epithelia of the susceptible insect Manduca sexta. This glycoprotein has recently been purified and identified as aminopeptidase N. We now report the cloning of aminopeptidase N from a M. sexta midgut cDNA library. Two overlapping clones were isolated, and their combined 3095-nucleotide sequence contains an open reading frame encoding a 990-residue prepro-protein. The N-terminal amino acid sequence derived from the glycoprotein is present in the open reading frame, immediately following a predicted cleavable signal peptide and a pro-peptide. There are four potential N-linked glycosylation sites. The C-terminal sequence contains a possible glycosylphosphatidylinositol (GPI) anchor signal peptide, which suggests that, unlike most other characterized aminopeptidases, the lepidopteran enzyme is anchored in the membrane by a GPI anchor. This was confirmed by partial release of aminopeptidase N activity from M. sexta midgut brush border membranes by phosphatidylinositol-specific phospholipase C. The deduced amino acid sequence shows significant similarity to the zinc-dependent aminopeptidase gene family, particularly in the region surrounding the consensus zinc-binding motif characteristic of these enzymes.	UNIV CAMBRIDGE, DEPT BIOCHEM, CAMBRIDGE CB2 1QW, ENGLAND; UNIV CAMBRIDGE, DEPT ZOOL, CAMBRIDGE CB2 3EJ, ENGLAND	University of Cambridge; University of Cambridge								ANGSUTHANASOMBAT C, 1993, FEMS MICROBIOL LETT, V111, P255; BIETLOT H, 1989, BIOCHEM J, V260, P87, DOI 10.1042/bj2600087; BRAVO A, 1992, J INVERTEBR PATHOL, V60, P237, DOI 10.1016/0022-2011(92)90004-N; CARAS IW, 1989, J CELL BIOL, V108, P1387, DOI 10.1083/jcb.108.4.1387; DELMAS B, 1994, J VIROL, V68, P5216, DOI 10.1128/JVI.68.8.5216-5224.1994; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; FROHMAN MA, 1994, PCR METH APPL, V4, pS40; GARCIAALVAREZ N, 1991, EUR J BIOCHEM, V202, P993, DOI 10.1111/j.1432-1033.1991.tb16461.x; GARCZYNSKI SF, 1991, APPL ENVIRON MICROB, V57, P2816, DOI 10.1128/AEM.57.10.2816-2820.1991; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; HIGH S, 1992, BIOESSAYS, V14, P535, DOI 10.1002/bies.950140807; HOOPER NM, 1988, FEBS LETT, V229, P340, DOI 10.1016/0014-5793(88)81152-9; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; HOOPER NM, 1988, BIOCHEM J, V250, P865, DOI 10.1042/bj2500865; Hooper NM, 1992, LIPID MODIFICATION P, P89; ISRAEL DI, 1993, NUCLEIC ACIDS RES, V21, P2627, DOI 10.1093/nar/21.11.2627; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; KENNY AJ, 1987, MAMMALIAN ECTOENZYME, V14, P169; KLEIN JR, 1993, EUR J BIOCHEM, V217, P105, DOI 10.1111/j.1432-1033.1993.tb18224.x; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; KNOWLES BH, 1991, P ROY SOC B-BIOL SCI, V245, P31, DOI 10.1098/rspb.1991.0084; KNOWLES BH, 1987, BIOCHIM BIOPHYS ACTA, V924, P509, DOI 10.1016/0304-4165(87)90167-X; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LECADET MM, 1967, J INVERTEBR PATHOL, V9, P322, DOI 10.1016/0022-2011(67)90066-3; NANUS DM, 1993, P NATL ACAD SCI USA, V90, P7069, DOI 10.1073/pnas.90.15.7069; NEURATH H, 1989, TRENDS BIOCHEM SCI, V14, P268, DOI 10.1016/0968-0004(89)90061-3; NISHIZAWA M, 1994, J BIOL CHEM, V269, P13651; NOREN O, 1989, FEBS LETT, V259, P107, DOI 10.1016/0014-5793(89)81506-6; OLSEN J, 1988, FEBS LETT, V238, P307, DOI 10.1016/0014-5793(88)80502-7; OWENS GC, 1987, P NATL ACAD SCI USA, V84, P294, DOI 10.1073/pnas.84.1.294; Sambrook J, 1989, MOL CLONING LABORATO; SANGADALA S, 1994, J BIOL CHEM, V269, P10088; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cellbio.2.1.255; SIPOS L, 1993, EUR J BIOCHEM, V213, P1333, DOI 10.1111/j.1432-1033.1993.tb17885.x; SODERBERG C, 1993, J VIROL, V67, P6576; TAKESUE S, 1992, COMP BIOCHEM PHYS B, V102, P7, DOI 10.1016/0305-0491(92)90263-Q; TAKESUE Y, 1989, J BIOCHEM, V105, P998, DOI 10.1093/oxfordjournals.jbchem.a122794; TURNER AJ, 1994, BRAZ J MED BIOL RES, V27, P389; VADLAMUDI RK, 1993, J BIOL CHEM, V268, P12334; VADLAMUDI RK, 1995, J BIOL CHEM, V270, P5490, DOI 10.1074/jbc.270.10.5490; VANRIE J, 1989, EUR J BIOCHEM, V186, P239, DOI 10.1111/j.1432-1033.1989.tb15201.x; VONHEIJNE G, 1988, BIOCHIM BIOPHYS ACTA, V947, P307, DOI 10.1016/0304-4157(88)90013-5; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WATT VM, 1989, J BIOL CHEM, V264, P5480; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; WU Q, 1990, P NATL ACAD SCI USA, V87, P993, DOI 10.1073/pnas.87.3.993; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0	51	159	190	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17765	17770		10.1074/jbc.270.30.17765	http://dx.doi.org/10.1074/jbc.270.30.17765			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629076	hybrid			2022-12-27	WOS:A1995RM26600023
J	XIN, H; WORIAX, V; BURKHART, W; SPREMULLI, LL				XIN, H; WORIAX, V; BURKHART, W; SPREMULLI, LL			CLONING AND EXPRESSION OF MITOCHONDRIAL TRANSLATIONAL ELONGATION-FACTOR TS FROM BOVINE AND HUMAN LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST EF-TS; EUKARYOTIC RIBOSOMES; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; ESCHERICHIA-COLI; FACTOR-TU; PROTEIN; ORGANIZATION; GENES; INITIATION	The sequences of the cDNAs for the mitochondrial translational elongation factor Ts (EF-Ts(mt)) from bovine and human liver have been obtained. The deduced amino acid sequence of bovine liver EF-Ts(mt) is 338 residues in length and includes a 55-amino acid signal peptide and a mature protein of 283 residues. The sequence of the mature form of bovine EF-Ts(mt) is 91% identical to that of human EF-Ts(mt) and 29% identical to Escherichia coli EF-Ts. Southern analysis indicates that there are two genes for EF-Ts(mt) in bovine liver chromosomal DNA. A 224-base pair intron is located near the 5'-end of at least one of these genes. Northern analysis using a human multiple tissue blot indicates that EF-Ts(mt) is expressed in all tissues, with the highest levels of expression in skeletal muscle, liver, and kidney. Both the mature and precursor forms of bovine liver EF-Ts(mt) have been expressed in E. coli as histidine-tagged pro teins, The mature form of EF-Ts(mt) forms a complex with E. coli elongation factor Tu. This complex is active in poly(U) directed polymerization of phenylalanine. The precursor form is expressed as a 42-kDa protein, which is rapidly degraded in the cell.	UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,DEPT BIOCHEM CB 3290,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT CHEM,CHAPEL HILL,NC 27599; GLAXO INC,RES INST,DEPT BIOANALYT & STRUCT CHEM,RES TRIANGLE PK,NC 27709	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; GlaxoSmithKline					NIGMS NIH HHS [GM32734] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032734] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AN G, 1981, NUCLEIC ACIDS RES, V9, P4163, DOI 10.1093/nar/9.16.4163; ARAI KI, 1978, EUR J BIOCHEM, V92, P521, DOI 10.1111/j.1432-1033.1978.tb12774.x; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; Carmichael G G, 1980, Methods Enzymol, V65, P380; CHEVALIER C, 1990, J BACTERIOL, V172, P2693, DOI 10.1128/jb.172.5.2693-2703.1990; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CORMIER P, 1993, NUCLEIC ACIDS RES, V21, P743, DOI 10.1093/nar/21.3.743; FOX L, 1980, J BIOL CHEM, V255, P6018; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GOTTESMAN MM, 1987, METHOD ENZYMOL, V151, P363; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; JACOBSON A, 1987, METHOD ENZYMOL, V152, P254; KOZAK M, 1991, GENE EXPRESSION, V1, P117; KOZAK M, 1991, GENE EXPRESSION, V1, P111; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; MILLER DL, 1970, BIOCHEM BIOPH RES CO, V38, P1016, DOI 10.1016/0006-291X(70)90341-4; MORALES J, 1992, NUCLEIC ACIDS RES, V20, P4091, DOI 10.1093/nar/20.15.4091; REINBOLT J, 1993, TRANSLATIONAL APPARATUS, P285; SANANGELANTONI AM, 1990, FEMS MICROBIOL LETT, V66, P141, DOI 10.1016/0378-1097(90)90272-R; SCHWARTZBACH CJ, 1991, J BIOL CHEM, V266, P16324; SCHWARTZBACH CJ, 1989, J BIOL CHEM, V264, P19125; SPREMULLI GH, 1987, BIOCHEM BIOPH RES CO, V148, P1490, DOI 10.1016/S0006-291X(87)80300-5; SPRINZL M, 1994, TRENDS BIOCHEM SCI, V19, P245, DOI 10.1016/0968-0004(94)90149-X; WAHLE E, 1992, ANNU REV BIOCHEM, V61, P419; WITTINGHOFER A, 1983, J BACTERIOL, V153, P1266, DOI 10.1128/JB.153.3.1266-1271.1983	27	55	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17243	17249		10.1074/jbc.270.29.17243	http://dx.doi.org/10.1074/jbc.270.29.17243			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615523	Green Published, hybrid			2022-12-27	WOS:A1995RK68900031
J	CHEN, HC; APPEDDU, PA; PARSONS, JT; HILDEBRAND, JD; SCHALLER, MD; GUAN, JL				CHEN, HC; APPEDDU, PA; PARSONS, JT; HILDEBRAND, JD; SCHALLER, MD; GUAN, JL			INTERACTION OF FOCAL ADHESION KINASE WITH CYTOSKELETAL PROTEIN TALIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS 3T3 CELLS; STIMULATE TYROSINE PHOSPHORYLATION; LYSOPHOSPHATIDIC ACID; EXTRACELLULAR-MATRIX; SIGNAL TRANSDUCTION; BOMBESIN; FIBRONECTIN; VASOPRESSIN; ENDOTHELIN; IDENTIFICATION	The interaction of cells with extracellular matrix proteins plays a critical role in a variety of biological processes. Recent studies suggest that cell-matrix interactions mediated by integrins can transduce biochemical signals to the cell interior that regulate cell proliferation and differentiation. These studies have placed the focal adhesion kinase (FAR), an intracellular protein tyrosine kinase, in a central position in integrin-initiated signal transduction pathways (Zachary, I., and Rozengurt, E. (1992) Cell 71, 891-894; Schaller, M., and Parsons, J. T. (1993) Trends Cell Biol. 3, 258-262). Here, we report data suggesting a possible association of FAK with the cytoskeletal protein talin in NIH 3T3 cells. We have identified a 48-amino acid sequence in the carboxyl-terminal domain of FAK necessary for talin binding in vitro. Furthermore, we have correlated the ability of integrin to induce FAR phosphorylation with its ability to bind talin using a mutant integrin lacking the carboxyl-terminal 13 amino acids. These studies suggest talin may be a mediator for FAK activation in signaling initiated by integrins and may provide an explanation for the dependence on the integrity of actin-cytoskeleton of multiple intracellular signaling pathways converging to FAK activation and autophosphorylation.	CORNELL UNIV, COLL VET MED, DEPT PATHOL, CANC BIOL LABS, ITHACA, NY 14853 USA; UNIV VIRGINIA, SCH MED, DEPT MICROBIOL, CHARLOTTESVILLE, VA 22908 USA; UNIV VIRGINIA, SCH MED, CTR CANC, CHARLOTTESVILLE, VA 22908 USA	Cornell University; University of Virginia; University of Virginia								AKIYAMA SK, 1994, J BIOL CHEM, V269, P15961; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; FORCE T, 1991, J BIOL CHEM, V266, P6650; GUAN JL, 1991, CELL REGUL, V2, P951, DOI 10.1091/mbc.2.11.951; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; HORWITZ A, 1985, J CELL BIOL, V101, P2134, DOI 10.1083/jcb.101.6.2134; HUCKLE WR, 1990, MOL CELL BIOL, V10, P6290, DOI 10.1128/MCB.10.12.6290; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; KANNER SB, 1990, P NATL ACAD SCI USA, V87, P3328, DOI 10.1073/pnas.87.9.3328; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; KUMAGAI N, 1993, J BIOL CHEM, V268, P24535; LEEBLUNDBERG LMF, 1991, J BIOL CHEM, V266, P7746; LEWIS JM, 1995, MOL BIOL CELL, V6, P151, DOI 10.1091/mbc.6.2.151; LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905; MARCANTONIO EE, 1990, CELL REGUL, V1, P597, DOI 10.1091/mbc.1.8.597; MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531; MOOLENAAR WH, 1991, ADV CANCER RES, V57, P87; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; RANKIN S, 1994, FEBS LETT, V354, P315, DOI 10.1016/0014-5793(94)01148-6; RANKIN S, 1994, J BIOL CHEM, V269, P704; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schaller Michael D., 1993, Trends in Cell Biology, V3, P258, DOI 10.1016/0962-8924(93)90053-4; SINNETTSMITH J, 1993, J BIOL CHEM, V268, P14261; TAPLEY P, 1989, ONCOGENE, V4, P325; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; TURNER CE, 1994, J CELL SCI, V107, P1583; VANDERBEND RL, 1992, EMBO J, V11, P2495, DOI 10.1002/j.1460-2075.1992.tb05314.x; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; ZACHARY I, 1991, P NATL ACAD SCI USA, V88, P4577, DOI 10.1073/pnas.88.11.4577; ZACHARY I, 1991, J BIOL CHEM, V266, P24126; ZACHARY I, 1992, CELL, V71, P891, DOI 10.1016/0092-8674(92)90385-P; ZACHARY I, 1992, J BIOL CHEM, V267, P19031	37	320	324	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16995	16999		10.1074/jbc.270.28.16995	http://dx.doi.org/10.1074/jbc.270.28.16995			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622520	hybrid			2022-12-27	WOS:A1995RJ34700081
J	KLESS, H; VERMAAS, W				KLESS, H; VERMAAS, W			TANDEM SEQUENCE DUPLICATIONS FUNCTIONALLY COMPLEMENT DELETIONS IN THE D1 PROTEIN OF PHOTOSYSTEM-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC REACTION CENTER; DNA; MUTATIONS; BINDING; SYNECHOCYSTIS-6803; INTEGRITY; DONOR	Obligate photoheterotrophic mutants of the cyanobacterium Synechocystis sp. PCC 6803 that carry deletions of conserved residues in the plastoquinone-binding niche of the D1 protein were used to select for spontaneous mutations that restore photoautotrophic growth. Spontaneous pseudorevertants emerged from two deletion mutants, Delta YNIV246-9 and Delta NN266-7, when the cultures were maintained long after the carbon source (glucose) had been depleted from the medium and cells had reached stationary phase. Most pseudorevertants were found to contain tandem duplications of 6-45-base pair DNA sequences located close to the domain carrying the deletion; none of them restored the wild-type sequence. Three pseudorevertants isolated from the Delta YNIV246-9 mutant contained a duplication (7-15 codons) of the DNA sequence immediately downstream of the deletion; the protein region encoded by this DNA may include part of the putative de helix, an important constituent of the plastoquinone-binding niche. Three pseudorevertants isolated from the Delta NN266-7 mutant contained duplications corresponding to 2-8 amino acid residues adjacent to the site of the deletion, In all six pseudorevertants carrying duplications, the length of the D1 protein in the modified regions was restored to at least the length present in wild type, suggesting that a minimal length of these protein domains may be required for functional integrity, In another photoautotrophic strain isolated from Delta NN266-7, no secondary mutations could be identified in the gene coding for the D1 protein; such mutations apparently reside on another protein subunit of the photosystem II complex, Photosystem II function in the pseudorevertants was altered as compared with wild type in terms of growth and oxygen evolution rates, photosystem II concentration, the semiquinone equilibrium at the acceptor side, and thermostability. A mechanism leading to tandem sequence duplication may involve DNA damage followed by DNA synthesis, strand displacement, and ligation.	ARIZONA STATE UNIV, CTR STUDY EARLY EVENTS PHOTOSYNTHESIS, TEMPE, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	KLESS, H (corresponding author), ARIZONA STATE UNIV, DEPT BOT, TEMPE, AZ 85287 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051556] Funding Source: NIH RePORTER; NIGMS NIH HHS [1R01GM51556] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; CLEAVER JE, 1994, CELL, V76, P1, DOI 10.1016/0092-8674(94)90165-1; DEBUS RJ, 1988, BIOCHEMISTRY-US, V27, P9071, DOI 10.1021/bi00426a001; ETIENNE AL, 1993, PHOTOSYNTH RES, V38, P387, DOI 10.1007/BF00046765; FOSTER PL, 1993, ANNU REV MICROBIOL, V47, P467; KLESS H, 1992, BIOCHEMISTRY-US, V31, P11065, DOI 10.1021/bi00160a016; KLESS H, 1994, BIOCHEMISTRY-US, V33, P10501, DOI 10.1021/bi00200a035; KLESS H, 1995, J MOL BIOL, V246, P120, DOI 10.1006/jmbi.1994.0071; KUNKEL TA, 1990, BIOCHEMISTRY-US, V29, P8003, DOI 10.1021/bi00487a001; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; MAENPAA P, 1993, PLANT MOL BIOL, V22, P1, DOI 10.1007/BF00038991; MATTOO AK, 1989, CELL, V56, P241, DOI 10.1016/0092-8674(89)90897-0; MICHEL H, 1988, BIOCHEMISTRY-US, V27, P1, DOI 10.1021/bi00401a001; NIXON PJ, 1992, PLANT PROTEIN ENG, P93; OHAD N, 1992, PLANT CELL, V4, P273, DOI 10.1105/tpc.4.3.273; RAO BJ, 1994, P NATL ACAD SCI USA, V91, P6161, DOI 10.1073/pnas.91.13.6161; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; RUFFLE SV, 1992, PHOTOSYNTH RES, V34, P287, DOI 10.1007/BF00033446; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; STARK GR, 1984, ANNU REV BIOCHEM, V53, P447, DOI 10.1146/annurev.bi.53.070184.002311; STEPHAN W, 1989, MOL BIOL EVOL, V6, P198, DOI 10.1093/oxfordjournals.molbev.a040542; SVENSSON B, 1991, Z NATURFORSCH C, V46, P765; SVENSSON B, 1990, EMBO J, V9, P2051, DOI 10.1002/j.1460-2075.1990.tb07372.x; TREBST A, 1987, Z NATURFORSCH C, V42, P742; TRINH TQ, 1993, GENETICS, V134, P409; VERMAAS W, 1990, Z NATURFORSCH C, V45, P359; VERMAAS W, 1993, ANNU REV PLANT PHYS, V44, P457, DOI 10.1146/annurev.pp.44.060193.002325; Vermaas W.F.J., 1991, PHOTOSYNTHETIC APPAR, P25; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; YOON K, 1992, P NATL ACAD SCI USA, V89, P3840, DOI 10.1073/pnas.89.9.3840	31	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16536	16541		10.1074/jbc.270.28.16536	http://dx.doi.org/10.1074/jbc.270.28.16536			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622458	hybrid			2022-12-27	WOS:A1995RJ34700014
J	WAN, JX; BLAKELEY, SD; DENNIS, DT; KO, K				WAN, JX; BLAKELEY, SD; DENNIS, DT; KO, K			IMPORT CHARACTERISTICS OF A LEUKOPLASTID PYRUVATE-KINASE ARE INFLUENCED BY A 19-AMINO-ACID DOMAIN WITHIN THE PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER ENVELOPE MEMBRANE; CHLOROPHYLL-A/B PROTEIN; TRANSIT PEPTIDE; CHLOROPLAST ENVELOPE; SPINACH-CHLOROPLASTS; THYLAKOID MEMBRANE; RICINUS-COMMUNIS; BINDING PROTEIN; PRECURSORS; TRANSPORT	Two cDNA clones encoding distinct forms of plastid pyruvate kinase (designated Pka and Pkg) have recently been characterized. Pkg is found in both leucoplasts and chloroplasts, whereas Pka is present only in leucoplasts. The precursors of these proteins have different in vitro import characteristics. The Pkg precursor behaves like a typical stromal protein precursor with both types of plastid. In contrast, Pka precursors accumulate on the outer envelope membrane of leucoplasts under the same assay conditions and require a higher level of ATP for import into the organelle. Interestingly, the binding of Pka precursors to chloroplasts cannot be detected at any tested level of ATP even though the precursors are imported into the organelle at higher concentrations of ATP. Various N-terminal deletions and chimeric fusions were used to examine the translocation signaling mechanism of the Pka precursor. The N-terminal 83-amino-acid segment of Pka contains a transit peptide that is capable of directing dihydrofolate reductase and the mature body of Pkg into both types of plastid. Unlike the complete Pka precursor, these fusion proteins behave like typical stromal protein precursors. The behavior of the Pka transit peptide is influenced by a 19-amino-acid domain (-P-S-S-I-E-V-D-A-V-T-E-T-E-L-K-E-N-G-F-) located immediately downstream of the N-terminal 83-residue segment. Deletion of this domain from Pka alters its import properties such that it resembles a typical stromal protein precursor. Re-introduction of the 19-residue domain into the Dhfr fusion protein alters its import characteristics to resemble that of the complete Pka precursor. This Is-amino-acid domain can also influence the function of transit sequences from other precursors when it is placed immediately behind the transit peptide. These results suggest that this 19-amino-acid domain plays an important role in governing the import characteristics of the Pka precursor. We have named this 19-residue segment the ''import modifying domain.''	QUEENS UNIV, DEPT BIOL, KINGSTON, ON K7L 3N6, CANADA	Queens University - Canada								BARTLETT SG, 1982, METHODS CHLOROPLAST, P1081; BLAKELEY S, 1995, PLANT MOL BIOL, V27, P79, DOI 10.1007/BF00019180; BLAKELEY SD, 1991, PLANT PHYSIOL, V96, P1283, DOI 10.1104/pp.96.4.1283; BOYLE SA, 1986, PLANT PHYSIOL, V81, P817, DOI 10.1104/pp.81.3.817; CLINE K, 1988, PLANT PHYSIOL, V86, P1120, DOI 10.1104/pp.86.4.1120; CLINE K, 1985, J BIOL CHEM, V260, P3691; CLINE K, 1984, PLANT PHYSIOL, V75, P675, DOI 10.1104/pp.75.3.675; DAHLIN C, 1991, PLANT CELL, V3, P1131, DOI 10.1105/tpc.3.10.1131; DRESESWERRINGLOER U, 1991, EUR J BIOCHEM, V195, P361, DOI 10.1111/j.1432-1033.1991.tb15714.x; FISCHER K, 1994, PLANT MOL BIOL, V25, P167, DOI 10.1007/BF00023235; GREENWOOD JS, 1982, CAN J BOT, V60, P1751, DOI 10.1139/b82-222; HALPIN C, 1989, FEBS LETT, V258, P32, DOI 10.1016/0014-5793(89)81608-4; HAND JM, 1989, EMBO J, V8, P3195, DOI 10.1002/j.1460-2075.1989.tb08478.x; HOFFMAN NE, 1987, P NATL ACAD SCI USA, V84, P8844, DOI 10.1073/pnas.84.24.8844; JOYARD J, 1983, J BIOL CHEM, V258, P1; KEEGSTRA K, 1989, CELL, V56, P247, DOI 10.1016/0092-8674(89)90898-2; KEEGSTRA K, 1989, ANNU REV PLANT PHYS, V40, P471, DOI 10.1146/annurev.pp.40.060189.002351; KEEGSTRA K, 1986, METHOD ENZYMOL, V118, P316; KLOSGEN RB, 1991, MOL GEN GENET, V225, P297, DOI 10.1007/BF00269862; KLOSGEN RB, 1989, MOL GEN GENET, V217, P155, DOI 10.1007/BF00330955; KO K, 1992, J BIOL CHEM, V267, P13910; KO K, 1992, J BIOL CHEM, V267, P2986; KO K, 1989, EMBO J, V8, P3187, DOI 10.1002/j.1460-2075.1989.tb08477.x; KOHORN BD, 1989, PLANT CELL, V1, P159; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPPA GK, 1988, J BIOL CHEM, V263, P14996; LI HM, 1991, PLANT CELL, V3, P709, DOI 10.1105/tpc.3.7.709; LI HM, 1992, J BIOL CHEM, V267, P18999; PLAXTON WC, 1989, EUR J BIOCHEM, V181, P443, DOI 10.1111/j.1432-1033.1989.tb14745.x; SALOMON M, 1990, P NATL ACAD SCI USA, V87, P5778, DOI 10.1073/pnas.87.15.5778; SIMCOX PD, 1979, CAN J BOT, V57, P1008, DOI 10.1139/b79-125; SMEEKENS S, 1986, CELL, V46, P365, DOI 10.1016/0092-8674(86)90657-4; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDENBROECK G, 1988, PLANT SCI, V58, P171, DOI 10.1016/0168-9452(88)90006-4; VIITANEN PV, 1988, J BIOL CHEM, V263, P15000; WU CB, 1993, J BIOL CHEM, V268, P19384; WU CB, 1994, J BIOL CHEM, V269, P32264	37	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16731	16739		10.1074/jbc.270.28.16731	http://dx.doi.org/10.1074/jbc.270.28.16731			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622484	hybrid			2022-12-27	WOS:A1995RJ34700044
J	GEORGE, KM; YUAN, Y; SHERMAN, DR; BARRY, CE				GEORGE, KM; YUAN, Y; SHERMAN, DR; BARRY, CE			THE BIOSYNTHESIS OF CYCLOPROPANATED MYCOLIC ACIDS IN MYCOBACTERIUM-TUBERCULOSIS - IDENTIFICATION AND FUNCTIONAL-ANALYSIS OF CMAS-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; HOMOLOGOUS SERIES; SMEGMATIS; SYNTHASE; ENZYME; CHROMATOGRAPHY; ORGANIZATION; MEMBRANES; CLONING; LIPIDS	The major mycolic acid produced by Mycobacterium tuberculosis contains two cis-cyclopropanes in the meromycolate chain. The gene whose product cyclopropanates the proximal double bond was cloned by homology to a putative cyclopropane synthase identified from the Mycobacterium leprae genome sequencing project. This gene, named cma2, was sequenced and found to be 52% identical to cma1 (which cyclopropanates the distal double bond) and 73% identical to the gene from M. leprae. Both cma genes were found to be restricted in distribution to pathogenic species of mycobacteria. Expression of cma2 in Mycobacterium smegmatis resulted in the cyclopropanation of the proximal double bond in the alpha(1), series of mycolic acids. Coexpression of both cyclopropane synthases resulted in cyclopropanation of both centers, producing a molecule structurally similar to the M; tuberculosis alpha-dicyclopropyl mycolates. Differential scanning calorimetry of purified cell walls and mycolic acids demonstrated that cyclopropanation of the proximal position raised the observed transition temperature by 3 degrees C. These results suggest that cyclepropanation contributes to the structural integrity of the cell wall complex.	NIAID,ROCKY MT LABS,INTRACELLULAR PARASITES LAB,TB RES UNIT,HAMILTON,MT 59840; PATHOGENESIS CORP,TB & MOLEC MICROBIOL LAB,SEATTLE,WA 98119	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)			Barry, III, Clifton/H-3839-2012; Barry, Clifton E/ABE-7992-2020	Barry, III, Clifton/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X	Intramural NIH HHS [Z01 AI000783-11] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BAESS I, 1978, ACTA PATH MICRO IM B, V86, P309; BIBB MJ, 1984, GENE, V30, P157, DOI 10.1016/0378-1119(84)90116-1; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; DANIELSON SJ, 1982, J BIOL CHEM, V257, P2196; DAVIS EO, 1994, EMBO J, V13, P699, DOI 10.1002/j.1460-2075.1994.tb06309.x; DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213; DUFOURC EJ, 1983, CHEM PHYS LIPIDS, V33, P153, DOI 10.1016/0009-3084(83)90019-1; DUFOURC EJ, 1984, BIOCHEMISTRY-US, V23, P2300, DOI 10.1021/bi00305a033; EIGLMEIER K, 1993, MOL MICROBIOL, V7, P197, DOI 10.1111/j.1365-2958.1993.tb01111.x; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; GROGAN DW, 1984, J BACTERIOL, V158, P286, DOI 10.1128/JB.158.1.286-295.1984; GROGAN DW, 1986, J BACTERIOL, V166, P872, DOI 10.1128/jb.166.3.872-877.1986; HARLEY JB, 1978, J BACTERIOL, V134, P808, DOI 10.1128/JB.134.3.808-820.1978; Hopewell Philip C., 1994, P25; INGROSSO D, 1989, NIKAOL CHEM, V264, P20131; KANEDA K, 1986, J CLIN MICROBIOL, V24, P1060, DOI 10.1128/JCM.24.6.1060-1070.1986; KENNERLY DA, 1986, J CHROMATOGR, V363, P462, DOI 10.1016/S0021-9673(01)83775-4; LIU J, 1995, IN PRESS P NATL ACAD; MATHUR M, 1992, J BIOL CHEM, V267, P19388; Minnikin D.E., 1967, J CHEM SOC CHEM COMM, V33, P1172; Minnikin D. E., 1982, BIOL MYCOBACTERIA, P95; NIKAIDO H, 1993, MOL MICROBIOL, V8, P1025, DOI 10.1111/j.1365-2958.1993.tb01647.x; QURESHI N, 1978, J BIOL CHEM, V253, P5411; SARMIENTOS P, 1983, CELL, V32, P1337, DOI 10.1016/0092-8674(83)90314-8; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; SILVIUS JR, 1979, CHEM PHYS LIPIDS, V25, P125, DOI 10.1016/0009-3084(79)90062-8; SNAPPER SB, 1988, P NATL ACAD SCI USA, V85, P6987, DOI 10.1073/pnas.85.18.6987; TAKAYAMA K, 1984, MYCOBACTERIA SOURCEB, V15, P315; WANG AY, 1994, MOL MICROBIOL, V11, P1009, DOI 10.1111/j.1365-2958.1994.tb00379.x; WANG AY, 1992, BIOCHEMISTRY-US, V31, P11020, DOI 10.1021/bi00160a011; WINDER FG, 1982, BIOL MYCOBACTERIA, P353; WONG MYH, 1979, J BIOL CHEM, V254, P5741; WONG MYH, 1979, J BIOL CHEM, V254, P5734; YING Y, 1995, P NATL ACAD SCI USA, V92, P6630	34	145	152	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27292	27298		10.1074/jbc.270.45.27292	http://dx.doi.org/10.1074/jbc.270.45.27292			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592990	hybrid			2022-12-27	WOS:A1995TE58300090
J	KANG, SM; OHSHIMA, K; SHIMIZU, M; AMIRHAERI, S; WELLS, RD				KANG, SM; OHSHIMA, K; SHIMIZU, M; AMIRHAERI, S; WELLS, RD			PAUSING OF DNA-SYNTHESIS IN-VITRO AT SPECIFIC LOCI IN CTG AND CGG TRIPLET REPEATS FROM HUMAN HEREDITARY-DISEASE GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOPURINE-HOMOPYRIMIDINE SEQUENCES; FRAGILE-X SYNDROME; MYOTONIC-DYSTROPHY; ESCHERICHIA-COLI; REPLICATION; TRACTS; TRANSCRIPTION; EXPANSION; MUTATIONS; PLASMIDS	Several human hereditary neuromuscular disease genes are associated with the expansion of CTG or CGG triplet repeats. The DNA syntheses of CTG triplets ranging from 17 to 180 and CGG repeats from 9 to 160 repeats in length were studied in vitro. Primer extensions using the Klenow fragment of DNA polymerase I, the modified T7 DNA polymerase (Sequenase), or the human DNA polymerase beta paused strongly at specific loci in the CTG repeats. The pausings were abolished by heating at 70 degrees C. As the length of the triplet repeats in duplex DNA, but not in single-stranded DNA, was increased, the magnitude of pausings increased. The location of the pause sites was determined by the distance between the site of primer hybridization and the beginning of the triplet repeats. CGG triplet repeats also showed similar, but not identical, patterns of pausings. These results indicate that appropriate lengths of the triplets adopt a non-B conformation(s) that blocks DNA polymerase progression; the resultant idling polymerase may catalyze slippages to give expanded sequences and hence provide the molecular basis for this non-Mendelian genetic process. These mechanisms, if present in human cells, may be related to the etiology of certain neuromuscular diseases such as myotonic dystrophy and Fragile X syndrome.	TEXAS A&M UNIV,TEXAS MED CTR,INST BIOSCI & TECHNOL,HOUSTON,TX 77030	Baylor College of Medicine; Texas A&M University System			Shimizu, Miho/Q-8522-2017; Shimizu, Miho/O-9903-2019	Shimizu, Miho/0000-0003-4070-8209; Shimizu, Miho/0000-0003-4070-8209	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM052982] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM52982] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARAN N, 1991, P NATL ACAD SCI USA, V88, P507, DOI 10.1073/pnas.88.2.507; BERNUES J, 1989, EMBO J, V8, P2087, DOI 10.1002/j.1460-2075.1989.tb03617.x; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BURKE JR, 1994, NAT GENET, V7, P521, DOI 10.1038/ng0894-521; DAYN A, 1992, P NATL ACAD SCI USA, V89, P11406, DOI 10.1073/pnas.89.23.11406; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; HANVEY JC, 1988, J BIOL CHEM, V263, P7386; KANG S, 1995, NAT GENET, V10, P213, DOI 10.1038/ng0695-213; KANG S, 1992, J BIOL CHEM, V267, P1259; KANG S, 1992, J BIOL CHEM, V267, P20889; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KOHWI Y, 1988, P NATL ACAD SCI USA, V85, P3781, DOI 10.1073/pnas.85.11.3781; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LAPIDOT A, 1989, NUCLEIC ACIDS RES, V17, P883, DOI 10.1093/nar/17.3.883; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LEVINSON G, 1987, NUCLEIC ACIDS RES, V15, P5323, DOI 10.1093/nar/15.13.5323; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NELSON DL, 1993, GENOME ANAL, V7, P1; OHSHIMA A, 1992, P NATL ACAD SCI USA, V89, P1016, DOI 10.1073/pnas.89.3.1016; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PALECEK E, 1991, CRIT REV BIOCHEM MOL, V26, P151, DOI 10.3109/10409239109081126; PANYUTIN IG, 1992, J BIOL CHEM, V267, P5495; RAHMOUNI AR, 1992, J MOL BIOL, V223, P131, DOI 10.1016/0022-2836(92)90721-U; RICHARDS RI, 1994, NAT GENET, V6, P114, DOI 10.1038/ng0294-114; RIPLEY LS, 1990, ANNU REV GENET, V24, P189, DOI 10.1146/annurev.ge.24.120190.001201; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; SINGHAL RK, 1993, J BIOL CHEM, V268, P15906; SINGLETON CK, 1982, ANAL BIOCHEM, V122, P253, DOI 10.1016/0003-2697(82)90277-9; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WANG YH, 1995, GENOMICS, V25, P570, DOI 10.1016/0888-7543(95)80061-P; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; WELLS RD, 1988, J BIOL CHEM, V263, P1095; WELLS RD, 1993, GENOME ANAL, V7, P107; WELLS RD, 1988, FASEB J, V2, P2939, DOI 10.1096/fasebj.2.14.3053307; WIERINGA B, 1994, HUM MOL GENET, V3, P1, DOI 10.1093/hmg/3.1.1-a; ZHENG GX, 1991, J MOL BIOL, V221, P107, DOI 10.1016/0022-2836(91)80208-C; 1993, CELL, V72, P971	44	158	160	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27014	27021		10.1074/jbc.270.45.27014	http://dx.doi.org/10.1074/jbc.270.45.27014			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592950	hybrid			2022-12-27	WOS:A1995TE58300050
J	NEILANDS, JB				NEILANDS, JB			SIDEROPHORES - STRUCTURE AND FUNCTION OF MICROBIAL IRON TRANSPORT COMPOUNDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ESCHERICHIA-COLI; OUTER-MEMBRANE; UPTAKE SYSTEM; PROTEIN; GENE; FUR; AEROBACTIN; EXPRESSION; PCOLV-K30; VIRULENCE				NEILANDS, JB (corresponding author), UNIV CALIF BERKELEY, DIV BIOCHEM & MOLEC BIOL, BERKELEY, CA 94720 USA.		Johnson, Michael D. L./B-4352-2012					BAGG A, 1987, MICROBIOL REV, V51, P509, DOI 10.1128/MMBR.51.4.509-518.1987; Barton LL, 1993, IRON CHELATION PLANT; Bergeron RJ, 1993, DEV IRON CHELATORS C; BERISH SA, 1993, INFECT IMMUN, V61, P4599, DOI 10.1128/IAI.61.11.4599-4606.1993; BOYD J, 1990, P NATL ACAD SCI USA, V87, P5968, DOI 10.1073/pnas.87.15.5968; COY M, 1991, BIOCHEMISTRY-US, V30, P8201, DOI 10.1021/bi00247a016; COY M, 1995, BIOCHEM BIOPH RES CO, V212, P784, DOI 10.1006/bbrc.1995.2037; DELORENZO V, 1988, EUR J BIOCHEM, V173, P537; DELORENZO V, 1988, J MOL BIOL, V203, P875, DOI 10.1016/0022-2836(88)90113-1; ERNST JF, 1978, J BACTERIOL, V135, P928, DOI 10.1128/JB.135.3.928-934.1978; FEKETE FA, 1989, APPL ENVIRON MICROB, V55, P2720, DOI 10.1128/AEM.55.10.2720-2722.1989; FRANZA T, 1991, J BACTERIOL, V173, P6874, DOI 10.1128/jb.173.21.6874-6881.1991; GIBSON F, 1969, BIOCHIM BIOPHYS ACTA, V192, P175, DOI 10.1016/0304-4165(69)90353-5; GRIFFITHS E, 1991, BIOL MET, V4, P7, DOI 10.1007/BF01135551; HEESEMANN J, 1993, MOL MICROBIOL, V8, P397, DOI 10.1111/j.1365-2958.1993.tb01583.x; HERRERO M, 1988, J BACTERIOL, V170, P56, DOI 10.1128/jb.170.1.56-64.1988; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; KILLMANN H, 1993, EMBO J, V12, P3007, DOI 10.1002/j.1460-2075.1993.tb05969.x; LECAM E, 1994, P NATL ACAD SCI USA, V91, P11816, DOI 10.1073/pnas.91.25.11816; MACHEROUX P, 1993, EUR J BIOCHEM, V213, P995, DOI 10.1111/j.1432-1033.1993.tb17846.x; MATZANKE BF, 1991, HDB MICROBIAL IRON C, P14; MEI BG, 1993, P NATL ACAD SCI USA, V90, P903, DOI 10.1073/pnas.90.3.903; Neilands J.B., 1987, IRON TRANSPORT MICRO, P3; NEILANDS JB, 1992, CAN J MICROBIOL, V38, P728, DOI 10.1139/m92-119; NIKAIDO H, 1994, J BIOL CHEM, V269, P3905; RAYMOND KN, 1979, ACCOUNTS CHEM RES, V12, P183, DOI 10.1021/ar50137a004; RIECHARD P, 1994, J BIOL CHEM, V268, P8383; ROMBEL IT, 1995, MOL GEN GENET, V246, P519, DOI 10.1007/BF00290456; RUTZ JM, 1992, SCIENCE, V258, P471, DOI 10.1126/science.1411544; SCHWARZENBACH G, 1963, HELV CHIM ACTA, V46, P1390, DOI 10.1002/hlca.19630460434; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; STOJILJKOVIC I, 1994, J MOL BIOL, V236, P531, DOI 10.1006/jmbi.1994.1163; TARDAT B, 1993, MOL MICROBIOL, V9, P53, DOI 10.1111/j.1365-2958.1993.tb01668.x; THARIATH A, 1993, J BACTERIOL, V175, P589, DOI 10.1128/JB.175.3.589-596.1993; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; VANDERHELM D, 1987, IRON TRANSPORT MICRO, P135; WATANABE NA, 1987, ANTIMICROB AGENTS CH, V31, P497, DOI 10.1128/AAC.31.4.497; WAYNE R, 1975, J BACTERIOL, V121, P497, DOI 10.1128/JB.121.2.497-503.1975; WEINBERG ED, 1990, DRUG METAB REV, V22, P531, DOI 10.3109/03602539008991450; WINKELMANN G, 1991, HDB MICROBIAL IRON C; Winkelmann G, 1987, IRON TRANSPORT MICRO; WOOLDRIDGE KG, 1993, FEMS MICROBIOL REV, V12, P325, DOI 10.1016/0168-6445(93)90011-W; [No title captured]	43	1091	1148	8	209	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26723	26726		10.1074/jbc.270.45.26723	http://dx.doi.org/10.1074/jbc.270.45.26723			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592901	hybrid			2022-12-27	WOS:A1995TE58300001
J	SEIDENBECHER, CI; RICHTER, K; RAUCH, U; FASSLER, R; GARNER, CC; GUNDELFINGER, ED				SEIDENBECHER, CI; RICHTER, K; RAUCH, U; FASSLER, R; GARNER, CC; GUNDELFINGER, ED			BREVICAN, A CHONDROITIN SULFATE PROTEOGLYCAN OF RAT-BRAIN, OCCURS AS SECRETED AND CELL-SURFACE GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED ISOFORMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE AGGREGATING PROTEOGLYCAN; GLYCOSYL-PHOSPHATIDYLINOSITOL; EXTRACELLULAR-MATRIX; MOLECULAR-CLONING; CORE PROTEIN; CARTILAGE; EXPRESSION; AGGRECAN; DOMAINS; BINDING	cDNA clones encoding proteins related to the aggrecan/versican family of proteoglycan core proteins have been isolated with antisera against rat brain synaptic junctions, Two sets of overlapping cDNAs have been characterized that differ in their 3'-terminal regions. Northern analyses with probes derived from unique regions of each set were found to hybridize with two brain-specific transcripts of 3.3 and 3.6 kilobases (kb), The 3.6-kb transcript encodes a polypeptide that exhibits 82% sequence identity with bovine brevican and is thought to be the rat ortholog of brevican, Interestingly, the polypeptide deduced from the open reading frame of the 3.3-kb transcript is truncated just carboxyl-terminal of the central domain of brevican and instead contains a putative glypiation signal, Antibodies raised against a bacterially expressed glutathione S-transferase-brevi can fusion protein have been used to show that both soluble:and membrane-bound brevican isoforms exist, Treatment of the crude membrane fraction and purified synaptic plasma membranes with phosphatidylinositol-specific phospholipase C revealed that isoforms of brevican are indeed glycosylphosphatidylinositol-anchored to the plasma membrane, Moreover, digestions with chondroitinase ABC have indicated that rat brevican, like its bovine ortholog, is a conditional chondroitin sulfate proteoglycan. Immunohistochemical studies have shown that brevican is widely distributed in the brain and is localized extracellularly, During postnatal development, amounts of both soluble and phosphatidylinositol:specific phospholipase C-sensitive isoforms increase, suggesting a role for brevican in the terminally differentiating and the adult nervous system.	FED INST NEUROBIOL, D-39778 MAGDEBURG, GERMANY; MAX PLANCK INST BIOCHEM, D-82752 MARTINSRIED, GERMANY; UNIV ALABAMA, NEUROBIOL RES CTR, BIRMINGHAM, AL 35294 USA	Max Planck Society; University of Alabama System; University of Alabama Birmingham				Garner, Craig/0000-0003-1970-5417; Seidenbecher, Constanze/0000-0002-7433-2716				BALDWIN CT, 1989, J BIOL CHEM, V264, P15747; BIGNAMI A, 1993, ANAT EMBRYOL, V188, P419; Brown Deborah A., 1992, Trends in Cell Biology, V2, P338; CAREY DJ, 1992, J CELL BIOL, V117, P191, DOI 10.1083/jcb.117.1.191; CHANDRASEKARAN L, 1992, BIOCHEM J, V288, P903, DOI 10.1042/bj2880903; DOEGE K, 1987, J BIOL CHEM, V262, P17757; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; DOEGE KJ, 1994, J BIOL CHEM, V269, P29232; DOURSZIMMERMANN MT, 1994, J BIOL CHEM, V269, P32992; ENGLUND PT, 1993, ANNU REV BIOCHEM, V62, P121, DOI 10.1146/annurev.bi.62.070193.001005; FRYER HJL, 1992, J BIOL CHEM, V267, P9874; FULOP C, 1993, J BIOL CHEM, V268, P17377; GARNER CC, 1993, TANIG SYMP BRAIN SCI, P317; GORDONWEEKS PR, 1987, NEUROCHEMISTRY PRACT; HERNDON ME, 1990, NEURON, V4, P949, DOI 10.1016/0896-6273(90)90148-9; IWATA M, 1993, J NEUROSCI, V13, P195; JAWORSKI DM, 1995, J NEUROSCI, V15, P1352; JAWORSKI DM, 1994, J CELL BIOL, V125, P495, DOI 10.1083/jcb.125.2.495; KARTHIKEYAN L, 1992, BIOCHEM BIOPH RES CO, V188, P385; KISTNER U, 1993, J BIOL CHEM, V268, P4580; LECLERC N, 1989, J COMP NEUROL, V280, P197, DOI 10.1002/cne.902800204; LITWACK ED, 1994, J NEUROSCI, V14, P3713; LOW MG, 1988, SCIENCE, V239, P268, DOI 10.1126/science.3276003; MAYER U, 1993, EMBO J, V12, P1879, DOI 10.1002/j.1460-2075.1993.tb05836.x; NASO MF, 1994, J BIOL CHEM, V269, P32999; NISHIYAMA A, 1991, J CELL BIOL, V114, P359, DOI 10.1083/jcb.114.2.359; OHSHIMA Y, 1987, J MOL BIOL, V195, P247, DOI 10.1016/0022-2836(87)90647-4; OOHIRA A, 1994, NEUROSCI RES, V20, P195, DOI 10.1016/0168-0102(94)90088-4; PERKINS SJ, 1989, J MOL BIOL, V206, P737, DOI 10.1016/0022-2836(89)90580-9; PURVES D, 1985, PRINCIPLES NEURAL DE; RAUCH U, 1992, J BIOL CHEM, V267, P19536; RODRIGUEZBOULAN E, 1992, ANNU REV CELL BIOL, V8, P395, DOI 10.1146/annurev.cb.08.110192.002143; ROSEN CL, 1992, J CELL BIOL, V117, P617, DOI 10.1083/jcb.117.3.617; Sambrook J, 1989, MOL CLONING LABORATO; STEWARD O, 1991, J COMP NEUROL, V314, P545, DOI 10.1002/cne.903140311; Steward O, 1987, PROG BRAIN RES <D>, V71, P267; STREBEL K, 1986, J VIROL, V57, P983, DOI 10.1128/JVI.57.3.983-991.1986; STRIPP CS, 1994, J CELL BIOL, V124, P149; WATANABE H, 1995, BIOCHEM J, V308, P433, DOI 10.1042/bj3080433; WILLMOTT T, 1992, J NEUROCHEM, V58, P2037, DOI 10.1111/j.1471-4159.1992.tb10944.x; YAMADA H, 1994, J BIOL CHEM, V269, P10119; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x; ZYSKIND JW, 1992, RECOMBINANT DNA LABO	43	118	121	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27206	27212		10.1074/jbc.270.45.27206	http://dx.doi.org/10.1074/jbc.270.45.27206			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592978	hybrid			2022-12-27	WOS:A1995TE58300078
J	ZHANG, LJ; DAVID, G; ESKO, JD				ZHANG, LJ; DAVID, G; ESKO, JD			REPETITIVE SER-GLY SEQUENCES ENHANCE HEPARAN-SULFATE ASSEMBLY IN PROTEOGLYCANS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; MOLECULAR-CLONING; N-SULFOTRANSFERASE; LUNG FIBROBLASTS; GROWTH-FACTOR; MUTANT; BIOSYNTHESIS; EXPRESSION; GLYCOSYLATION; SYNDECAN	We showed previously that the synthesis of heparan sulfate on betaglycan occurs at a Ser-Gly dipeptide flanked by a cluster of acidic residues and an adjacent tryptophan (Zhang, L,, and Esko, J, D, (1994) J. Biol, Chem. 269, 19295-19299), A survey of the protein data base revealed that most heparan sulfate proteoglycans contain repetitive (Ser-Gly), segments (n 2) and a nearby cluster of acidic residues. To study the role of these amino acid sequences in controlling heparan sulfate synthesis, we have examined the assembly of glycosaminoglycans on Chinese hamster ovary (CHO) cell syndecan-1, The glycosylation sites were mapped by making chimeric proteoglycans containing segments of CHO syndecan-1 cDNA fused to Protein A, Two sites near the transmembrane domain (-EG (S) under bar(205)GEQ- and -ET (S) under bar(215)GEN-) were used solely for chondroitin sulfate synthesis, whereas three sites near the N terminus (-DG (S) under bar(35)GDDSDNF (S) under bar(45)G (S) under bar(47)GTG-) supported both heparan sulfate and chondroitin sulfate synthesis, The strongest sites for heparan sulfate synthesis consisted of the repeat unit, -(S) under bar(45)G (S) under bar(47)G-. A, unusual coupling phe nomenon occurred across the adjacent SG dipeptides, leading to a greater proportion of heparan sulfate than predicted by the behavior of each site acting independently. The clusters of acidic residues adjacent to the heparan sulfate sites play important roles as well, These sequence motifs suggest a set of rules for predicting whether heparan sulfate assembles at glycosylation sites in proteoglycan core proteins.	UNIV ALABAMA,SCH MED,DEPT BIOCHEM & MOLEC GENET,BIRMINGHAM,AL 35294; UNIV ALABAMA,SCH DENT,DEPT BIOCHEM & MOLEC GENET,BIRMINGHAM,AL 35294; CATHOLIC UNIV LEUVEN,CTR HUMAN GENET,B-3000 LOUVAIN,BELGIUM	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; KU Leuven				NOIRI, Eisei/0000-0002-9515-7582				BAME KJ, 1994, BIOCHEM J, V303, P81, DOI 10.1042/bj3030081; BAME KJ, 1989, J BIOL CHEM, V264, P8059; BAME KJ, 1991, J BIOL CHEM, V266, P12461; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; DAVID G, 1990, J CELL BIOL, V111, P3165, DOI 10.1083/jcb.111.6.3165; DULBECCO R, 1995, J EXP MED, V99, P167; DUSTIN ML, 1995, J BIOL CHEM, V270, P170, DOI 10.1074/jbc.270.1.170; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; ESKO JD, 1988, SCIENCE, V241, P1092, DOI 10.1126/science.3137658; FRITZ TA, 1994, J BIOL CHEM, V269, P28809; FRITZ TA, 1994, J BIOL CHEM, V269, P300; HAM RG, 1965, P NATL ACAD SCI USA, V53, P288, DOI 10.1073/pnas.53.2.288; KATO M, 1994, J BIOL CHEM, V269, P18881; KIEFER MC, 1990, P NATL ACAD SCI USA, V87, P6985, DOI 10.1073/pnas.87.18.6985; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; KOJIMA T, 1992, J BIOL CHEM, V267, P4870; KOKENYESI R, 1994, J BIOL CHEM, V269, P12304; KOLSET SO, 1990, BIOCHIM BIOPHYS ACTA, V1032, P191, DOI 10.1016/0304-419X(90)90004-K; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; LOPEZCASILLAS F, 1992, CELL, V67, P785; LORIES V, 1992, J BIOL CHEM, V267, P1116; LUGEMWA FN, 1991, J BIOL CHEM, V266, P6674; MANN DM, 1990, J BIOL CHEM, V265, P5317; MENGELING BJ, 1995, P NATL ACAD SCI USA, V92, P502, DOI 10.1073/pnas.92.2.502; RAPRAEGER A, 1989, J CELL BIOL, V109, P2509, DOI 10.1083/jcb.109.5.2509; SANCHEZLOPEZ R, 1988, J BIOL CHEM, V263, P11892; SANGER F, 1981, SCIENCE, V214, P1205, DOI 10.1126/science.7302589; SANT AJ, 1985, J EXP MED, V162, P1916, DOI 10.1084/jem.162.6.1916; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SAUNDERS S, 1989, J CELL BIOL, V108, P1547, DOI 10.1083/jcb.108.4.1547; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; SHWORAK NW, 1994, J BIOL CHEM, V269, P21204; SHWORAK NW, 1994, J BIOL CHEM, V269, P24941; TSEN G, 1995, J BIOL CHEM, V270, P3392, DOI 10.1074/jbc.270.7.3392; ZHANG L, 1995, J BIOL CHEM, V270, P12557, DOI 10.1074/jbc.270.21.12557; ZHANG LJ, 1994, J BIOL CHEM, V269, P19295	38	113	115	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27127	27135		10.1074/jbc.270.45.27127	http://dx.doi.org/10.1074/jbc.270.45.27127			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592967	hybrid			2022-12-27	WOS:A1995TE58300067
J	JEOUNG, DI; TANG, BQ; SONENBERG, M				JEOUNG, DI; TANG, BQ; SONENBERG, M			EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA ON ANTIMITOGENICITY AND CELL CYCLE-RELATED PROTEINS IN MCF-7 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA GENE-PRODUCT; BREAST-CANCER CELLS; TYROSINE PHOSPHORYLATION; RAPID PHOSPHORYLATION; SUSCEPTIBILITY GENE; CARCINOMA-CELLS; MESSENGER-RNA; GROWTH; FIBROBLASTS; EXPRESSION	Tumor necrosis factor-alpha (TNF-alpha) demonstrated antimitogenic activity in MCF-7 cells (estrogen receptor-positive human breast cancer cells) in a dose- and time-dependent manner (EC-50 of 2.5 ng/ml). This antimitogenic effect of TNF-alpha was accompanied by a decreased number of cells in S phase in a dose- and time dependent manner. Based on growth arrest experiments using aphidicolin, it is apparent that TNF-alpha acted in early G(1) phase. It did not show antimitogenic effects once cells reentered the S phase based on [H-3]thymidine incorporation into DNA and cell cycle analysis. Specificity of TNF-alpha was established by using monoclonal anti-human TNF-alpha antibody. On the basis of Western immunoblot analysis of Rb, p53 and cell cycle inhibitory protein (Cip1) (p21) proteins, TNF-alpha decreased Rb protein expression in a dose- and time-dependent manner whereas it increased the expression level of tumor suppressor p53 protein, TNF-alpha also increased the expression level of Cip1 (p21) protein in a dose-dependent manner. This induction of Cip1 (p21) protein was preceded by the induction of p53 protein in MCF-7 cells, Cip1 (p21) protein associated with cyclin D was also increased, Tumor suppressor Rb protein expression was increased during G(1) to S phase progression. Cyclin D protein expression levels were not changed in response to TNF-alpha treatment, although serine/threonine kinase inhibitors such as H7 and the protein kinase C inhibitor staurosporine decreased cyclin D expression levels in MCF-7 cells. Based on experiments with staurosporine, it appears that TNF-alpha does not utilize a protein kinase C pathway in MCF-7 cells. Other cell cycle-related proteins such as Cdk2, CdcB, and Cdk4 did not show any change in response to TNF-alpha. TNF-alpha did not affect complexes between cyclin D and Cdk2, Cdk4, and Rb proteins in RICF-7 cells. Taken together these results suggest that Rb, p53, and Cip1 (p21) proteins mediate TNF-alpha antimitogenic activity, and TNF-alpha induces growth arrest in the G(1) phase in MCB-7 cells.	MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021; CORNELL UNIV,COLL MED,DEPT MED,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center; Cornell University					NATIONAL CANCER INSTITUTE [T32CA009512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041931] Funding Source: NIH RePORTER; NCI NIH HHS [CA09512] Funding Source: Medline; NIDDK NIH HHS [DK 41931] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKIYAMA T, 1992, P NATL ACAD SCI USA, V89, P7900, DOI 10.1073/pnas.89.17.7900; ALBERTS AS, 1993, P NATL ACAD SCI USA, V90, P388, DOI 10.1073/pnas.90.2.388; ARRIGO AP, 1990, MOL CELL BIOL, V10, P1276, DOI 10.1128/MCB.10.3.1276; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; BAUD L, 1989, FEBS LETT, V239, P50; BIRD TA, 1990, J BIOL CHEM, V265, P235; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; CHRETIEN P, 1988, J CELL PHYSIOL, V137, P157, DOI 10.1002/jcp.1041370119; DANFORTH DN, 1993, J ENDOCRINOL, V138, P517, DOI 10.1677/joe.0.1380517; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DONATO NJ, 1992, CELL GROWTH DIFFER, V3, P259; DONATO NJ, 1989, J BIOL CHEM, V264, P20474; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; EVA YH, 1988, SCIENCE, V241, P218; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; GREEN MR, 1989, CELL, V56, P1, DOI 10.1016/0092-8674(89)90975-6; HALL FL, 1993, ONCOGENE, V8, P1377; HARPER JW, 1993, CELL, V75, P805; HEPBURN A, 1988, FEBS LETT, V227, P175, DOI 10.1016/0014-5793(88)80892-5; HU QJ, 1992, MOL CELL BIOL, V2, P971; JAATTELA M, 1993, EMBO J, V11, P3507; KASTAN MB, 1991, CANCER RES, V51, P6304; KATO J, 1993, GENE DEV, V7, P331; KAUR P, 1988, FEBS LETT, V241, P6, DOI 10.1016/0014-5793(88)81019-6; KUMAR R, 1992, P NATL ACAD SCI USA, V89, P6599, DOI 10.1073/pnas.89.14.6599; LANCASTER JR, 1989, FEBS LETT, V248, P169, DOI 10.1016/0014-5793(89)80454-5; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; LEES JA, 1991, EMBO J, V10, P4279, DOI 10.1002/j.1460-2075.1991.tb05006.x; LUDLOW JW, 1989, CELL, V56, P57, DOI 10.1016/0092-8674(89)90983-5; MARINO MW, 1989, P NATL ACAD SCI USA, V86, P8417, DOI 10.1073/pnas.86.21.8417; MARINO MW, 1991, J BIOL CHEM, V266, P2685; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; MIHARA K, 1989, SCIENCE, V246, P1300, DOI 10.1126/science.2588006; MINSHULL J, 1990, EMBO J, V9, P2865, DOI 10.1002/j.1460-2075.1990.tb07476.x; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; PINES J, 1990, NATURE, V34, P760; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; ROSEN OM, 1981, COLD SPRING HARBOR C, V8, P715; RUGGIERO V, 1987, J IMMUNOL, V138, P2711; SCHUTZE S, 1989, J BIOL CHEM, V264, P3562; SGAGIAS MK, 1991, MOL ENDOCRINOL, V5, P1740, DOI 10.1210/mend-5-11-1740; STEIN GH, 1990, SCIENCE, V249, P666, DOI 10.1126/science.2166342; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; TAM SW, 1994, ONCOGENE, V9, P2663; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; WON KA, 1992, P NATL ACAD SCI USA, V89, P9910, DOI 10.1073/pnas.89.20.9910	52	76	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 4	1995	270	31					18367	18373		10.1074/jbc.270.31.18367	http://dx.doi.org/10.1074/jbc.270.31.18367			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM642	7629160	hybrid			2022-12-27	WOS:A1995RM64200036
J	ATHERTON, JC; CAO, P; PEEK, RM; TUMMURU, MKR; BLASER, MJ; COVER, TL				ATHERTON, JC; CAO, P; PEEK, RM; TUMMURU, MKR; BLASER, MJ; COVER, TL			MOSAICISM IN VACUOLATING CYTOTOXIN ALLELES OF HELICOBACTER-PYLORI - ASSOCIATION OF SPECIFIC VACA TYPES WITH CYTOTOXIN PRODUCTION AND PEPTIC-ULCERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-LAYER PROTEIN; RICKETTSIA-RICKETTSII; CAMPYLOBACTER-PYLORI; GASTRIC-CARCINOMA; DUODENAL-ULCER; ANTIGEN; BINDING; GENE; METRONIDAZOLE; RESISTANCE	Approximately 50% of Helicobacter pylori strains produce a cytotoxin, encoded by vacA, that induces vacuolation of eukaryotic cells. Analysis of a clinically isolated tox(-) strain (Tx30a) indicated secretion of a 93-kDa product from a 3933 base pair vacA open reading frame. Characterization of 59 different H. pylori isolates indicated the existence of three different families of vacA signal sequences (s1a, s1b, and s2) and two different families of middle-region alleles (m1 and m2). All possible combinations of these vacA regions were identified, with the exception of s2/m1 (p < 0.001); this mosaic organization implies that recombination has occurred in vivo between vacA alleles. Type s1/m1 strains produced a higher level of cytotoxin activity in vitro than type s1/m2 strains; none of 19 type s2/m2 strains produced detectable cytotoxin activity. The presence of cagA (cytotoxin-associated gene A) was closely associated with the presence of vacA signal sequence type s1 (p < 0.001). Among patients with past or present peptic ulceration, 21 (91%) of 23 harbored type s1 strains compared with 16 (48%) of 33 patients without peptic ulcers; only 2 (10%) of 19 subjects harboring type s2 strains had past or present peptic ulcers (p < 0.005). Thus, specific vacA genotypes of H. pylori strains are associated with the level of in vitro cytotoxin activity as well as clinical consequences.	VANDERBILT UNIV,SCH MED,DEPT MED,DIV INFECT DIS,NASHVILLE,TN 37232; VANDERBILT UNIV,SCH MED,DEPT MED,DIV GASTROENTEROL,NASHVILLE,TN 37232; VET AFFAIRS MED CTR,NASHVILLE,TN 37232	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System			Cover, Timothy/I-3814-2015	Cover, Timothy/0000-0001-8503-002X; /0000-0001-6180-0042	NATIONAL CANCER INSTITUTE [R01CA058834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045293] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA58834] Funding Source: Medline; NIDDK NIH HHS [R29 DK45293] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON BE, 1990, INFECT IMMUN, V58, P2760, DOI 10.1128/IAI.58.9.2760-2769.1990; BLASER MJ, 1992, CLIN INFECT DIS, V15, P386, DOI 10.1093/clind/15.3.386; BUKANOV NO, 1994, MOL MICROBIOL, V11, P509, DOI 10.1111/j.1365-2958.1994.tb00332.x; CARL M, 1990, P NATL ACAD SCI USA, V87, P8237, DOI 10.1073/pnas.87.21.8237; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; COVER TL, 1993, INFECT IMMUN, V61, P5008, DOI 10.1128/IAI.61.12.5008-5012.1993; COVER TL, 1992, J BIOL CHEM, V267, P10570; COVER TL, 1994, J BIOL CHEM, V269, P10566; COVER TL, 1992, J CLIN INVEST, V90, P913, DOI 10.1172/JCI115967; COVER TL, 1995, IN PRESS ADV INTERN, V41; DOWSON CG, 1989, P NATL ACAD SCI USA, V86, P8842, DOI 10.1073/pnas.86.22.8842; FERRERO RL, 1992, J BACTERIOL, V174, P4212, DOI 10.1128/JB.174.13.4212-4217.1992; FIGURA N, 1989, J CLIN MICROBIOL, V27, P225, DOI 10.1128/JCM.27.1.225-226.1989; FUJIMOTO S, 1994, J CLIN MICROBIOL, V32, P331, DOI 10.1128/JCM.32.2.331-334.1994; GARNER JA, 1995, IN PRESS J INFECT DI, V172; GILMORE RD, 1991, MOL MICROBIOL, V5, P2361, DOI 10.1111/j.1365-2958.1991.tb02082.x; GOOSSENS H, 1992, MED MICROBIOL LETT, V1, P153; HAHN MJ, 1993, GENE, V133, P129, DOI 10.1016/0378-1119(93)90237-W; HALTER R, 1989, EMBO J, V8, P2737, DOI 10.1002/j.1460-2075.1989.tb08415.x; HAWRYLIK SJ, 1994, J CLIN MICROBIOL, V32, P790, DOI 10.1128/JCM.32.3.790-792.1994; HENTSCHEL E, 1993, NEW ENGL J MED, V328, P308, DOI 10.1056/NEJM199302043280503; HODGMAN TC, 1988, NATURE, V333, P22, DOI 10.1038/333022b0; IZARD JW, 1994, MOL MICROBIOL, V13, P765, DOI 10.1111/j.1365-2958.1994.tb00469.x; LEUNK RD, 1988, J MED MICROBIOL, V26, P93, DOI 10.1099/00222615-26-2-93; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; OTOOLE PW, 1994, MOL MICROBIOL, V11, P849; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; PHADNIS SH, 1994, INFECT IMMUN, V62, P1557, DOI 10.1128/IAI.62.5.1557-1565.1994; POULSEN K, 1992, J BACTERIOL, V174, P2913, DOI 10.1128/JB.174.9.2913-2921.1992; PREWETT EJ, 1992, GASTROENTEROLOGY, V102, P829, DOI 10.1016/0016-5085(92)90165-U; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; RAUTELIN H, 1994, SCAND J GASTROENTERO, V29, P128, DOI 10.3109/00365529409090450; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SCHMITT W, 1994, MOL MICROBIOL, V12, P307, DOI 10.1111/j.1365-2958.1994.tb01019.x; SMITH JM, 1991, NATURE, V349, P29, DOI 10.1038/349029a0; SPRATT BG, 1989, P NATL ACAD SCI USA, V86, P8988, DOI 10.1073/pnas.86.22.8988; TEE W, 1995, J CLIN MICROBIOL, V33, P1203, DOI 10.1128/JCM.33.5.1203-1205.1995; TELFORD JL, 1994, J EXP MED, V179, P1653, DOI 10.1084/jem.179.5.1653; TUMMURU MKR, 1993, INFECT IMMUN, V61, P1799, DOI 10.1128/IAI.61.5.1799-1809.1993; TUMMURU MKR, 1992, J BACTERIOL, V174, P5916, DOI 10.1128/jb.174.18.5916-5922.1992; TUMMURU MKR, 1994, INFECT IMMUN, V62, P2609, DOI 10.1128/IAI.62.6.2609-2613.1994; WALKER JE, 1982, EMBO J, V8, P945; WANG Y, 1993, J GEN MICROBIOL, V139, P2485, DOI 10.1099/00221287-139-10-2485	43	1263	1331	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17771	17777		10.1074/jbc.270.30.17771	http://dx.doi.org/10.1074/jbc.270.30.17771			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629077				2022-12-27	WOS:A1995RM26600024
J	BENDIXEN, E; HARPEL, PC; SOTTRUPJENSEN, L				BENDIXEN, E; HARPEL, PC; SOTTRUPJENSEN, L			LOCATION OF THE MAJOR EPSILON-(GAMMA-GLUTAMYL)LYSYL CROSS-LINKING SITE IN TRANSGLUTAMINASE-MODIFIED HUMAN PLASMINOGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ENDOTHELIAL-CELLS; AMINO-ACID-SEQUENCE; ALPHA-2-PLASMIN INHIBITOR; GLU-PLASMINOGEN; ACCEPTOR SITES; FACTOR-XIIIA; FIBRIN; ACTIVATOR; BINDING; FIBRONECTIN	Tissue and plasma transglutaminases cross-link human plasminogen into high molecular weight complexes (Bendixen, E., Borth, W., and Harpel, P. C. (1993) J. Biol. Chem. 268, 21962-21967). A major cross-linking site in plasminogen involved in the tissue transglutaminase-mediated polymerization process has been identified. The epsilon-(gamma-glutamyl)lysyl bridges of the polymer are formed between Lys-298 and Gln-322. Both the acyl donor Gin residue and the acyl acceptor Lys residue are located in the kringle 3 domain of plasminogen, i.e. cross-linking of plasminogen by tissue transglutaminase involves neither the catalytic domain nor the lysine dependent binding sites of plasminogen. This study documents that kringle 3 contains a novel functional site with the potential to participate in transglutaminase-mediated cross-linking interactions with plasma, cell-surface, and extracellular proteins.	AARHUS UNIV,DEPT MOLEC BIOL,DK-8000 AARHUS C,DENMARK; MT SINAI MED CTR,DIV HEMATOL,NEW YORK,NY 10029	Aarhus University; Icahn School of Medicine at Mount Sinai					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL018828] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-18828] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AESCHLIMANN D, 1992, J BIOL CHEM, V267, P11316; ALPERT AJ, 1988, J CHROMATOGR, V443, P819; BANYAI L, 1984, J BIOL CHEM, V259, P6466; BENDIXEN E, 1993, J BIOL CHEM, V268, P21962; CHEN R, 1970, P NATL ACAD SCI USA, V66, P472, DOI 10.1073/pnas.66.2.472; CHIN CCQ, 1993, ANAL BIOCHEM, V214, P128, DOI 10.1006/abio.1993.1466; COTTRELL BA, 1979, BIOCHEMISTRY-US, V18, P5405, DOI 10.1021/bi00591a023; CRIMMINS DL, 1989, ANAL BIOCHEM, V176, P255, DOI 10.1016/0003-2697(89)90305-9; DEGEN SJF, 1990, GENOMICS, V8, P49, DOI 10.1016/0888-7543(90)90225-J; FORSGREN M, 1987, FEBS LETT, V213, P254, DOI 10.1016/0014-5793(87)81501-6; GORMAN JJ, 1984, J BIOL CHEM, V259, P9007; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; GRIFFIN M, 1982, ANAL BIOCHEM, V124, P406, DOI 10.1016/0003-2697(82)90057-4; HAJJAR KA, 1986, J BIOL CHEM, V261, P1656; HARPEL PC, 1985, J BIOL CHEM, V260, P4432; HOHL D, 1991, J BIOL CHEM, V266, P6626; KIMURA S, 1986, J BIOL CHEM, V261, P5591; KINSELLA MG, 1990, J BIOL CHEM, V265, P17891; KNUDSEN BS, 1986, J BIOL CHEM, V261, P765; KOJIMA S, 1991, J CELL BIOL, V113, P1439, DOI 10.1083/jcb.113.6.1439; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LORAND L, 1991, P NATL ACAD SCI USA, V88, P82, DOI 10.1073/pnas.88.1.82; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; LORAND L, 1980, PROG HEMOSTASIS THRO, V52, P245; LUCAS MA, 1983, J BIOL CHEM, V258, P4249; MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500; MARTINEZ J, 1989, J BIOL CHEM, V264, P20502; MATSUKA YV, 1990, EUR J BIOCHEM, V190, P93, DOI 10.1111/j.1432-1033.1990.tb15550.x; MAYER M, 1990, CLIN BIOCHEM, V23, P197, DOI 10.1016/0009-9120(90)90601-P; MCDONAGH RP, 1981, FEBS LETT, V127, P174, DOI 10.1016/0014-5793(81)80198-6; MILES LA, 1988, BLOOD, V72, P628; MULICHAK AM, 1991, BIOCHEMISTRY-US, V30, P10576, DOI 10.1021/bi00107a029; NACHMAN RL, 1992, BLOOD, V79, P1897, DOI 10.1182/blood.V79.8.1897.bloodjournal7981897; OSSOWSKI L, 1983, CELL, V35, P611, DOI 10.1016/0092-8674(83)90093-4; PONTING CP, 1992, BIOCHIM BIOPHYS ACTA, V1159, P155, DOI 10.1016/0167-4838(92)90020-E; PUCCI P, 1988, BIOCHEM BIOPH RES CO, V154, P735, DOI 10.1016/0006-291X(88)90201-X; PURVES L, 1987, BIOCHEMISTRY-US, V26, P4640, DOI 10.1021/bi00389a008; REICH R, 1988, CANCER RES, V48, P3307; SAKATA Y, 1980, J CLIN INVEST, V65, P290, DOI 10.1172/JCI109671; SALONEN EM, 1985, J BIOL CHEM, V260, P2302; SANE DC, 1991, BIOCHEM BIOPH RES CO, V174, P465, DOI 10.1016/0006-291X(91)91439-J; SCHALLER J, 1985, EUR J BIOCHEM, V149, P267, DOI 10.1111/j.1432-1033.1985.tb08921.x; SCHALLER J, 1987, Fibrinolysis, V1, P91, DOI 10.1016/0268-9499(87)90015-4; SILVERSTEIN RL, 1984, J CLIN INVEST, V74, P1625, DOI 10.1172/JCI111578; SOTTRUPJENSEN L, 1993, BIOCHEM MOL BIOL INT, V30, P789; SOTTRUPJENSEN L, 1990, J BIOL CHEM, V265, P17727; SOTTRUPJENSEN L, 1978, PROGR CHEM FIBRINOLY, V3, P191; SUENSON E, 1984, EUR J BIOCHEM, V140, P513, DOI 10.1111/j.1432-1033.1984.tb08132.x; THORSEN S, 1981, BIOCHIM BIOPHYS ACTA, V668, P377, DOI 10.1016/0005-2795(81)90171-9; TOMLINSON JE, 1989, J BIOL CHEM, V264, P5957; TOYOOKA T, 1984, ANAL CHEM, V56, P2461, DOI 10.1021/ac00277a044; WU HL, 1990, J BIOL CHEM, V265, P19658	52	10	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17929	17933		10.1074/jbc.270.30.17929	http://dx.doi.org/10.1074/jbc.270.30.17929			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629099	hybrid			2022-12-27	WOS:A1995RM26600048
J	FREEDMAN, NJ; LIGGETT, SB; DRACHMAN, DE; PEI, G; CARON, MG; LEFKOWITZ, RJ				FREEDMAN, NJ; LIGGETT, SB; DRACHMAN, DE; PEI, G; CARON, MG; LEFKOWITZ, RJ			PHOSPHORYLATION AND DESENSITIZATION OF THE HUMAN BETA(1)-ADRENERGIC RECEPTOR - INVOLVEMENT OF G-PROTEIN-COUPLED RECEPTOR KINASES AND CAMP-DEPENDENT PROTEIN-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC RECEPTORS; HUMAN BETA-1-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; CYCLIC-AMP; HOMOLOGOUS DESENSITIZATION; ADENYLATE-CYCLASE; RHODOPSIN KINASE; EXPRESSION; FAMILY; CLONING	Persistent stimulation of the beta(1)-adrenergic receptor (beta(1)AR) engenders, within minutes, diminished responsiveness of the beta(1)AR/adenylyl cyclase signal transduction system. This desensitization remains incompletely defined mechanistically, however. We therefore tested the hypothesis that agonist-induced desensitization of the beta(1)AR (like that of the related beta(2)AR) involves phosphorylation of the receptor itself, by cAMP-dependent protein kinase (PKA) and the beta adrenergic receptor kinase (beta ARK1) or other G protein-coupled receptor kinases (GRKs). Both Chinese hamster fibroblast and 293 cells demonstrate receptor-specific desensitization of the beta(1)AR within 3-5 min. Both cell types also express beta(1)AR and the associated inhibitory proteins beta-arrestin-1 and beta-arrestin-2, as assessed by immunoblotting. Agonist-induced beta(1)AR desensitization in 293 cells correlates with a 2 +/- 0.3-fold increase in phosphorylation of the beta(1)AR, determined by immunoprecipitation of the beta(1)AR from cells metabolically labeled with P-32(i). This agonist induced beta(1)AR phosphorylation derives approximately equally from PKA and GRK activity, as judged by intact cell studies with kinase inhibitors or dominant negative beta ARK1 (K220R) mutant overexpression. Desensitization, likewise, is reduced by only similar to 50% when PKA is inhibited in the intact cells. Overexpression of rho dopsin kinase, beta ARK1, beta ARK2, or GRK5 significantly increases agonist-induced beta(1)AR phosphorylation and concomitantly decreases agonist-stimulated cellular cAMP production (p < 0.05). Furthermore, purified beta ARK1, beta ARK2, and GRK5 all demonstrate agonist-dependent phosphorylation of the beta(1)AR. Consistent with a GRK mechanism, receptor-specific desensitization of the beta(1)AR was enhanced by overexpression of beta-arrestin-1 and -2 in transfected 293 cells. We conclude that rapid agonist-induced desensitization of the beta(1)AR involves phosphorylation of the receptor by both PKA and at least beta ARK1 in intact cells. Like the beta(2)AR, the beta(1)AR appears to bind either beta-arrestin-1 or beta-arrestin-2 and to react with rhodopsin kinase, beta ARK1, beta ARK2, and GRK5.	DUKE UNIV, MED CTR, HOWARD HUGHES MED INST, DEPT MED CARDIOL, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, HOWARD HUGHES MED INST, DEPT BIOCHEM, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, HOWARD HUGHES MED INST, DEPT CELL BIOL, DURHAM, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute			Lefkowitz, Robert/AAW-2649-2021; liggett, stephen b/E-7453-2012	Liggett, Stephen B./0000-0002-0128-3669	NHLBI NIH HHS [HL-16037, HL03008-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARNER P, 1991, J PHARMACOL EXP THER, V259, P317; ARRIZA JL, 1992, J NEUROSCI, V12, P4045; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; BARAK LS, 1994, J BIOL CHEM, V269, P2790; BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BRISTOW MR, 1989, MOL PHARMACOL, V35, P295; BRODDE OE, 1993, PHARMACOL THERAPEUT, V60, P405, DOI 10.1016/0163-7258(93)90030-H; BURGERMEISTER W, 1983, BIOCHIM BIOPHYS ACTA, V729, P219, DOI 10.1016/0005-2736(83)90488-1; CHEN CY, 1993, J BIOL CHEM, V268, P7825; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Colton T., 1974, STAT MED, V1; DEARRY A, 1990, NATURE, V347, P72, DOI 10.1038/347072a0; DIDSBURY JR, 1991, P NATL ACAD SCI USA, V88, P11564, DOI 10.1073/pnas.88.24.11564; ESBENSHADE TA, 1992, MOL PHARMACOL, V42, P753; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; GREEN SA, 1994, J BIOL CHEM, V269, P26215; GREEN SA, 1992, MOL PHARMACOL, V41, P889; HAMMOND HK, 1992, CIRCULATION, V85, P269, DOI 10.1161/01.CIR.85.1.269; HARLOW E, 1988, ANTIBODIES LABORATOR; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; INGLESE J, 1993, J BIOL CHEM, V268, P23735; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; KONG GH, 1994, J BIOL CHEM, V269, P13084; KOPP U, 1983, AM J PHYSIOL, V244, pF418, DOI 10.1152/ajprenal.1983.244.4.F418; KUNAPULI P, 1994, J BIOL CHEM, V269, P1099; LEVY FO, 1993, P NATL ACAD SCI USA, V90, P10798, DOI 10.1073/pnas.90.22.10798; LIGGETT SB, 1993, P NATL ACAD SCI USA, V90, P3665, DOI 10.1073/pnas.90.8.3665; LOHSE MJ, 1993, BIOCHIM BIOPHYS ACTA, V1179, P171, DOI 10.1016/0167-4889(93)90139-G; LOHSE MJ, 1992, J BIOL CHEM, V267, P8558; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; LOHSE MJ, 1989, P NATL ACAD SCI USA, V86, P3011, DOI 10.1073/pnas.86.9.3011; LORENZ W, 1991, P NATL ACAD SCI USA, V88, P8715, DOI 10.1073/pnas.88.19.8715; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; PEI G, 1994, P NATL ACAD SCI USA, V91, P3633, DOI 10.1073/pnas.91.9.3633; PING PP, 1994, CIRCULATION, V90, P358; PREMONT RT, 1994, J BIOL CHEM, V269, P6832; ROTH NS, 1991, P NATL ACAD SCI USA, V88, P6201, DOI 10.1073/pnas.88.14.6201; SALOMON Y, 1991, METHOD ENZYMOL, V195, P22; Sambrook J, 1989, MOL CLONING LABORATO; SEFTON BM, 1991, METHOD ENZYMOL, V201, P245; SHIH ML, 1994, P NATL ACAD SCI USA, V91, P12193, DOI 10.1073/pnas.91.25.12193; STRASSER RH, 1986, BIOCHEMISTRY-US, V25, P1371, DOI 10.1021/bi00354a027; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; ZHOU XM, 1991, J BIOL CHEM, V266, P7462; ZHOU XM, 1995, CELL SIGNAL, V7, P207, DOI 10.1016/0898-6568(94)00091-O	48	300	307	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17953	17961		10.1074/jbc.270.30.17953	http://dx.doi.org/10.1074/jbc.270.30.17953			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629102	hybrid			2022-12-27	WOS:A1995RM26600052
J	AZIM, AC; KNOLL, JHM; BEGGS, AH; CHISHTI, AH				AZIM, AC; KNOLL, JHM; BEGGS, AH; CHISHTI, AH			ISOFORM CLONING, ACTIN-BINDING, AND CHROMOSOMAL LOCALIZATION OF HUMAN ERYTHROID DEMATIN, A MEMBER OF THE VILLIN SUPERFAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHEROCYTOSIS; PROTEINS; GENE; PURIFICATION; GLUTATHIONE; SEQUENCE; DELETION	Dematin is an actin-bundling protein of the erythroid membrane skeleton and is abundantly expressed in human brain, heart, skeletal muscle, kidney, and lung. The 48-kDa subunit of dematin contains a headpiece domain which was originally identified in villin, an actin-binding protein of the brush-border cytoskeleton. The headpiece domain of villin is essential for its morphogenic function in vivo. Here we report the primary structure of 52-kDa subunit of dematin which differs from the 48-kDa subunit by a 22-amino-acid insertion within its headpiece domain. A unique feature of the insertion sequence of the 52-kDa subunit is its homology to erythrocyte protein 4.2. The insertion sequence also includes a cysteine residue which may explain the formation of sulfhydryl-linked trimers of dematin. Actin binding measurements using recombinant fusion proteins re vealed that each monomer of dematin contains two Factin binding sites: one in the headpiece domain and the other in the undefined N-terminal domain. Although the actin bundling activity of intact dematin was abolished by phosphorylation, no effect of phosphorylation was observed on the actin binding activity of fusion proteins. Using somatic cell hybrid panels and fluorescence in situ hybridization, the dematin gene was localized on the short arm of chromosome 8. The dematin locus, 8p21.1, is distal to the known locus of human erythroid ankyrin (8p11.2) and may contribute to the etiology of hemolytic anemia in a subset of patients with severe hereditary spherocytosis.	TUFTS UNIV,ST ELIZABETHS MED CTR,SCH MED,DEPT BIOMED RES,BOSTON,MA 02135; HARVARD UNIV,CHILDRENS HOSP,SCH MED,DIV GENET,BOSTON,MA 02115; HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DEPT PATHOL,BOSTON,MA 02115	St. Elizabeth's Medical Center; Tufts University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School			AZIM, ANSER/U-3483-2019	Beggs, Alan/0000-0001-8818-0568; Knoll, Joan/0000-0001-6691-1710	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL051445, P01HL037462, R01HL051445] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL51445, HL37462] Funding Source: Medline; NICHD NIH HHS [HD18568] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARPIN M, 1988, J CELL BIOL, V107, P1759, DOI 10.1083/jcb.107.5.1759; BAZARI WL, 1988, P NATL ACAD SCI USA, V85, P4986, DOI 10.1073/pnas.85.14.4986; BECK JS, 1993, A J HUM ENET S, V53, pA974; BENNETT V, 1989, BIOCHIM BIOPHYS ACTA, V988, P107, DOI 10.1016/0304-4157(89)90006-3; BRUNS G, 1987, HUM GENET, V76, P58; CHILCOTE RR, 1987, BLOOD, V69, P156; CHISHTI AH, 1989, J BIOL CHEM, V264, P8985; CHISHTI AH, 1988, NATURE, V334, P718; DUBOIS BL, 1993, GENOMICS, V16, P315, DOI 10.1006/geno.1993.1191; FENNER C, 1975, ANAL BIOCHEM, V63, P595, DOI 10.1016/0003-2697(75)90386-3; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; FRIEDERICH E, 1992, CELL, V70, P81, DOI 10.1016/0092-8674(92)90535-K; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; KIDD GH, 1978, NATURE, V276, P733, DOI 10.1038/276733a0; KITATANI M, 1988, HUM GENET, V78, P94, DOI 10.1007/BF00291244; KNOLL JHM, 1994, CURRENT PROTOCOLS HU, V1; KORSGREN C, 1991, P NATL ACAD SCI USA, V88, P4840, DOI 10.1073/pnas.88.11.4840; KORSGREN C, 1994, GENOMICS, V21, P478, DOI 10.1006/geno.1994.1304; KOURY ST, 1989, J CELL BIOL, V109, P3005, DOI 10.1083/jcb.109.6.3005; LUX SE, 1990, NATURE, V345, P736, DOI 10.1038/345736a0; MAHAJANMIKLOS S, 1994, CELL, V78, P291, DOI 10.1016/0092-8674(94)90298-4; OTTO JJ, 1994, CURR OPIN CELL BIOL, V6, P105, DOI 10.1016/0955-0674(94)90123-6; RANA AP, 1993, P NATL ACAD SCI USA, V90, P6651, DOI 10.1073/pnas.90.14.6651; ROOF D, 1991, INVEST OPHTH VIS SCI, V32, P582; SIEGEL DL, 1985, J CELL BIOL, V100, P775, DOI 10.1083/jcb.100.3.775; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866	26	46	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17407	17413		10.1074/jbc.270.29.17407	http://dx.doi.org/10.1074/jbc.270.29.17407			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615546	hybrid			2022-12-27	WOS:A1995RK68900058
J	RAINES, RT; TOSCANO, MP; NIERENGARTEN, DM; HA, JH; AUERBACH, R				RAINES, RT; TOSCANO, MP; NIERENGARTEN, DM; HA, JH; AUERBACH, R			REPLACING A SURFACE LOOP ENDOWS RIBONUCLEASE-A WITH ANGIOGENIC ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; AMINO-ACID SEQUENCE; BINDING-PROTEIN; TUMOR-GROWTH; INHIBITION; NEOVASCULARIZATION; SPECIFICITY; DELETION; PEPTIDES; HYBRID	Angiogenin (ANG) promotes the formation of blood vessels in animals. This hormone is a small, monomeric protein that is homologous to bovine pancreatic ribonuclease A (RNase). ANG is a poor ribonuclease but its ribonucleolytic activity is essential for its angiogenic activity. RNase is not angiogenic. A hybrid protein was produced in which 13 residues of a divergent surface loop of ANG were substituted for the analogous 15 residues of RNase. The value of k(cat)/K-m for the cleavage of uridylyl(3'-->5')adenosine by this hybrid protein was 20-fold less than that of RNase but 10(5)-fold greater than that of ANG. The thermal stability of the hybrid protein was also less than that of RNase. Nevertheless, the RNase/ANG hybrid protein promotes angiogenesis in mice at least as extensively as does authentic ANG. Thus we present a protein endowed with st noncognate biological activity simply by replacing a single element of secondary structure. In addition, a 13 residue peptide corresponding to the surface loop of ANG inhibits endogenous angiogenesis in mice. These results support a model in which both a surface loop and a catalytic site are necessary for the promotion of blood vessel formation by ANG or RNase. The dissection of structure/function elements in ANG reveals a unique opportunity to develop new molecules that modulate neovascularization.	UNIV WISCONSIN,CTR DEV BIOL,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison	RAINES, RT (corresponding author), UNIV WISCONSIN,DEPT BIOCHEM,420 HENRY MALL,MADISON,WI 53706, USA.		Raines, Ronald T./A-5009-2013	Raines, Ronald T./0000-0001-7164-1719	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044783] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM44783] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACHARYA KR, 1994, P NATL ACAD SCI USA, V91, P2915, DOI 10.1073/pnas.91.8.2915; ALLEMANN RK, 1991, PROTEIN ENG, V4, P831, DOI 10.1093/protein/4.7.831; AUERBACH W, 1994, PHARMACOL THERAPEUT, V63, P265, DOI 10.1016/0163-7258(94)90027-2; Ausubel FM, 1988, MOL REPROD DEV; BALDISSERI DM, 1991, BIOCHEMISTRY-US, V30, P3628, DOI 10.1021/bi00229a006; BEAUCAGE SL, 1981, TETRAHEDRON LETT, V22, P1859, DOI 10.1016/S0040-4039(01)90461-7; BEINTEMA JJ, 1987, LIFE CHEM REPORTS, V4, P333; BOND MD, 1993, BIOCHIM BIOPHYS ACTA, V1162, P177, DOI 10.1016/0167-4838(93)90145-H; BRAXTON S, 1992, BIOCHEMISTRY-US, V31, P7796, DOI 10.1021/bi00149a008; BRUNET AP, 1993, NATURE, V364, P355, DOI 10.1038/364355a0; Cleland W W, 1979, Methods Enzymol, V63, P103; DELCARDAYRE SB, 1994, BIOCHEMISTRY-US, V33, P6031, DOI 10.1021/bi00186a001; DELCARDAYRE SB, 1995, PROTEIN ENG, V8, P261, DOI 10.1093/protein/8.3.261; DELCARDAYRE SB, 1995, IN PRESS J MOL BIOL; EIJSINK VG, 1993, PROTEIN ENG, V5, P157; ELZINGA M, 1973, P NATL ACAD SCI USA, V70, P2687, DOI 10.1073/pnas.70.9.2687; FAJARDO LF, 1988, LAB INVEST, V58, P718; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GILL SC, 1989, ANAL BIOCHEM, V189, P283; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; HALLAHAN TW, 1991, P NATL ACAD SCI USA, V88, P2222, DOI 10.1073/pnas.88.6.2222; HARPER JW, 1989, BIOCHEMISTRY-US, V28, P1875, DOI 10.1021/bi00430a067; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; HERMANS J, 1961, J AM CHEM SOC, V83, P3283, DOI 10.1021/ja01476a025; HU GF, 1993, P NATL ACAD SCI USA, V90, P1217, DOI 10.1073/pnas.90.4.1217; HU GF, 1991, P NATL ACAD SCI USA, V88, P2227, DOI 10.1073/pnas.88.6.2227; HYNES TR, 1989, NATURE, V339, P73, DOI 10.1038/339073a0; INGBER D, 1988, LAB INVEST, V59, P44; Ipata P L., 1968, FEBS Lett, V1, P29, DOI 10.1016/0014-5793(68)80010-9; KIM JS, 1995, J BIOL CHEM, V270, P10525, DOI 10.1074/jbc.270.18.10525; KNIGHTON D, 1977, BRIT J CANCER, V35, P347, DOI 10.1038/bjc.1977.49; KNOWLES JR, 1987, SCIENCE, V236, P1252; KUIPERS OP, 1989, SCIENCE, V244, P82, DOI 10.1126/science.2704992; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEE FS, 1989, BIOCHEMISTRY-US, V28, P225, DOI 10.1021/bi00427a031; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; MARAGOUDAKIS ME, 1992, ANGIOGENESIS HLTH DI; MESSMORE JM, 1995, IN PRESS J AM CHEM S; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; MOSES MA, 1990, SCIENCE, V248, P1408, DOI 10.1126/science.1694043; MUTHUKKARUPPAN V, 1979, SCIENCE, V205, P1416, DOI 10.1126/science.472760; OGILVIE KK, 1978, CAN J CHEM, V56, P2768, DOI 10.1139/v78-457; PCE CN, 1989, PROTEIN STRUCTURE, P311; POLAKOWSKI IJ, 1993, AM J PATHOL, V143, P507; POMPLIANO DL, 1990, BIOCHEMISTRY-US, V29, P3186, DOI 10.1021/bi00465a005; RAINES RT, 1989, STRUCTURE CHEM RIBON, P95; REYNOLDS LP, 1992, FASEB J, V6, P886, DOI 10.1096/fasebj.6.3.1371260; RYBAK SM, 1989, BIOCHEM BIOPH RES CO, V162, P535, DOI 10.1016/0006-291X(89)92030-5; SELA M, 1957, BIOCHIM BIOPHYS ACTA, V26, P502, DOI 10.1016/0006-3002(57)90096-3; SHAPIRO R, 1989, BIOCHEMISTRY-US, V28, P7401, DOI 10.1021/bi00444a038; SHAPIRO R, 1989, BIOCHEMISTRY-US, V28, P1726, DOI 10.1021/bi00430a045; SINHA ND, 1984, NUCLEIC ACIDS RES, V12, P4539, DOI 10.1093/nar/12.11.4539; THOMPSON JE, 1994, J AM CHEM SOC, V116, P5467, DOI 10.1021/ja00091a060; TOMA S, 1991, BIOCHEMISTRY-US, V30, P97, DOI 10.1021/bi00215a015; UI N, 1971, BIOCHIM BIOPHYS ACTA, V229, P567; UNGER EF, 1994, AM J PHYSIOL, V266, pH1588, DOI 10.1152/ajpheart.1994.266.4.H1588; VUILLEUMIER S, 1994, EUR J BIOCHEM, V221, P1003, DOI 10.1111/j.1432-1033.1994.tb18817.x; WARSHAW MM, 1966, J MOL BIOL, V20, P29, DOI 10.1016/0022-2836(66)90115-X; WEINSTATSASLOW D, 1994, FASEB J, V8, P401, DOI 10.1096/fasebj.8.6.7513289; WLODAWER A, 1983, BIOCHEMISTRY-US, V22, P2720, DOI 10.1021/bi00280a021; WOLFSON AJ, 1991, PROTEIN ENG, V4, P313, DOI 10.1093/protein/4.3.313; [No title captured]	68	45	48	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17180	17184		10.1074/jbc.270.29.17180	http://dx.doi.org/10.1074/jbc.270.29.17180			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615514	hybrid			2022-12-27	WOS:A1995RK68900021
J	ZUBIAUR, M; SANCHO, J; TERHORST, C; FALLER, DV				ZUBIAUR, M; SANCHO, J; TERHORST, C; FALLER, DV			A SMALL GTP-BINDING PROTEIN, RHO, ASSOCIATES WITH THE PLATELET-DERIVED GROWTH-FACTOR TYPE-BETA RECEPTOR UPON LIGAND-BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; POLYACRYLAMIDE-GEL ELECTROPHORESIS; PHOSPHOLIPASE-C-GAMMA; T-CELL ACTIVATION; PDGF RECEPTOR; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; ADAPTER PROTEIN; TERMINAL REGION; GENE-PRODUCT	Ligand binding to the platelet-derived growth factor (PDGF) receptor initiates a complex and diverging cascade of signaling pathways. GTP-binding proteins with intrinsic GTPase activity (G-proteins) frequently link cell surface receptors to intracellular signaling pathways, but no close associations of the PDGF receptor and any small G-proteins, nor any such associations activated by ligand binding to the receptor have been previously reported. We demonstrate that a small GTP-binding protein binds specifically to the murine and human PDGF type-beta receptor. In response to PDGF-BB stimulation, there is an increase in the amount of labeled small G-protein associated with the PDGF type-beta receptor. The GTP-binding protein did not undergo ligand-induced association with a mutant receptor protein that was unable to bind ATP. Proteolytic cleavage analysis, together with two dimensional separation techniques, identified the small G-protein specifically associating with the PDGF type-beta receptor after ligand binding as a member of the Rho family. This was confirmed by demonstration that the small G-protein coimmunoprecipitated by the anti-PDGF receptor antibody was a substrate for the ADP-ribosyltransferase C3 exoenzyme. Thus, the PDGF type-beta receptor may form a complex with one or more small G-proteins upon binding PDGF-BB, and the Rho small G-protein is likely to be an important component of the proteins making up the multimeric signaling complex of the PDGF type-beta receptor.	BOSTON UNIV,SCH MED,CANC RES CTR,BOSTON,MA 02118; CSIC,INST BIOMED & PARASITOL,E-18001 GRANADA,SPAIN; HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DIV IMMUNOL,BOSTON,MA 02115	Boston University; Consejo Superior de Investigaciones Cientificas (CSIC); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School			Zubiaur, Mercedes/AAC-5792-2021; Zubiaur, Mercedes/K-9390-2014; Sancho, Jaime/O-3228-2013; Sancho, Jaime/K-5989-2019	Zubiaur, Mercedes/0000-0002-4127-3027; Zubiaur, Mercedes/0000-0002-4127-3027; Sancho, Jaime/0000-0003-3852-7951; Sancho, Jaime/0000-0003-3852-7951	NCI NIH HHS [R01-CA50459] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050459] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn Natalie G., 1992, Current Opinion in Cell Biology, V4, P992, DOI 10.1016/0955-0674(92)90131-U; AHN NG, 1990, J BIOL CHEM, V265, P11487; AKTORIES K, 1989, BIOCHEM BIOPH RES CO, V158, P209, DOI 10.1016/S0006-291X(89)80199-8; BALTENSPERGER K, 1993, SCIENCE, V260, P1950, DOI 10.1126/science.8391166; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOURNE HR, 1990, NATURE, V348, P678, DOI 10.1038/348678a0; BOWENPOPE DF, 1989, J BIOL CHEM, V264, P2502; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CAI H, 1993, MOL CELL BIOL, V13, P7645, DOI 10.1128/MCB.13.12.7645; CASE RD, 1994, J BIOL CHEM, V269, P10467; CLAESSONWELSH L, 1988, MOL CELL BIOL, V8, P3476, DOI 10.1128/MCB.8.8.3476; CUI Z, 1991, J BIOL CHEM, V266, P20276; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; EGAN SE, 1993, NATURE, V363, P15; ESCOBEDO JA, 1988, J BIOL CHEM, V263, P1482; GULBINS E, 1993, SCIENCE, V260, P822, DOI 10.1126/science.8484124; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; HALLBERG B, 1994, J BIOL CHEM, V269, P3913; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HOMMA Y, 1995, EMBO J, V14, P286, DOI 10.1002/j.1460-2075.1995.tb07002.x; HUBER LA, 1994, ELECTROPHORESIS, V15, P283, DOI 10.1002/elps.1150150148; JONES PP, 1984, METHOD ENZYMOL, V108, P452; KAHN RA, 1992, FASEB J, V6, P2512, DOI 10.1096/fasebj.6.8.1592203; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; KIKUCHI A, 1992, J BIOL CHEM, V267, P14611; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; KUMAGAI N, 1993, J BIOL CHEM, V268, P24536; KUMJIAN DA, 1989, P NATL ACAD SCI USA, V89, P8232; Lacal JC, 1993, RAS SUPERFAMILY GTPA; LI BQ, 1993, P NATL ACAD SCI USA, V90, P8504, DOI 10.1073/pnas.90.18.8504; LI W, 1994, MOL CELL BIOL, V14, P509, DOI 10.1128/MCB.14.1.509; LOW A, 1993, EUR J BIOCHEM, V215, P473, DOI 10.1111/j.1432-1033.1993.tb18056.x; MALCOLM KC, 1994, J BIOL CHEM, V269, P25951; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MATSUI TG, 1989, P NATL ACAD SCI USA, V89, P8314; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; MCGLADE J, 1993, EMBO J, V12, P3073, DOI 10.1002/j.1460-2075.1993.tb05976.x; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MENARD L, 1992, EUR J BIOCHEM, V206, P537, DOI 10.1111/j.1432-1033.1992.tb16957.x; MOODIE SA, 1994, TRENDS GENET, V10, P44, DOI 10.1016/0168-9525(94)90147-3; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MUNDSCHAU LJ, 1994, J BIOL CHEM, V269, P16137; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; PATTERSON SD, 1992, ANAL BIOCHEM, V202, P193, DOI 10.1016/0003-2697(92)90227-X; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PETER ME, 1992, EMBO J, V11, P933, DOI 10.1002/j.1460-2075.1992.tb05132.x; PETER ME, 1993, ANAL BIOCHEM, V210, P77, DOI 10.1006/abio.1993.1153; PETER ME, 1993, EUR J IMMUNOL, V23, P461, DOI 10.1002/eji.1830230224; QUINONES MA, 1991, J BIOL CHEM, V266, P14055; RAKE JB, 1991, J BIOL CHEM, V266, P5348; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; SEKINE A, 1989, J BIOL CHEM, V264, P8602; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; TSAI MH, 1989, MOL CELL BIOL, V9, P5260, DOI 10.1128/MCB.9.11.5260; UEDA T, 1990, J BIOL CHEM, V265, P9373; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WAHL MI, 1989, MOL CELL BIOL, V9, P2934, DOI 10.1128/MCB.9.7.2934; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WIELAND T, 1990, FEBS LETT, V263, P195, DOI 10.1016/0014-5793(90)81372-U; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; ZHANG J, 1993, J BIOL CHEM, V268, P22251; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0; ZULLO JN, 1988, MOL CELL BIOL, V8, P5080, DOI 10.1128/MCB.8.12.5080	75	26	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17221	17228		10.1074/jbc.270.29.17221	http://dx.doi.org/10.1074/jbc.270.29.17221			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615521	hybrid			2022-12-27	WOS:A1995RK68900028
J	KEMPF, B; BREMER, E				KEMPF, B; BREMER, E			OPUA, AN OSMOTICALLY REGULATED BINDING PROTEIN-DEPENDENT TRANSPORT-SYSTEM FOR THE OSMOPROTECTANT GLYCINE BETAINE IN BACILLUS-SUBTILIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; STAPHYLOCOCCUS-AUREUS; NUCLEOTIDE-SEQUENCE; GENE-EXPRESSION; RNA-POLYMERASE; PROU OPERON; TRANSCRIPTION; BACTERIA; PROMOTER	Exogenously provided glycine betaine can efficiently protect Bacillus subtilis from the detrimental effects of high osmolarity environments. Through functional complementation of an Escherichia coli mutant deficient in glycine betaine uptake with a gene library from B. subtilis, we have identified a multicomponent glycine betaine transport system, OpuA. Uptake of radiolabeled glycine betaine in B. subtilis was found to be osmotically stimulated and was strongly decreased in a mutant strain lacking the OpuA transport system. DNA sequence analysis revealed that the components of the OpuA system are encoded by an operon (opuA) comprising three structural genes: opuAA, opuAB, and opuAC. The products of these genes exhibit features characteristic for binding protein dependent transport systems and in particular show homology to the glycine betaine uptake system ProU from E. coli. Expression of the opuA operon is under osmotic control. The transcriptional initiation sites of opuA were mapped by high resolution primer extension analysis, and two opuA mRNAs were detected that differed by 38 base pairs at their 5' ends. Synthesis of the shorter transcript was strongly increased in cells grown at high osmolarity, whereas the amount of the longer transcript did not vary in response to medium osmolarity. Physical and genetic mapping experiments allowed the positioning the opuA operon at 25 degrees on the genetic map of B. subtilis.	MAX PLANCK INST TERR MIKROBIOL,D-35043 MARBURG,GERMANY	Max Planck Society								ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANAGNOSTOPOULOS C, 1994, BACILLUS SUBTILIS OT, P425; AUBLE DT, 1988, J MOL BIOL, V202, P471, DOI 10.1016/0022-2836(88)90279-3; BAE JH, 1993, APPL ENVIRON MICROB, V59, P2734, DOI 10.1128/AEM.59.8.2734-2736.1993; BARRON A, 1987, J BIOL CHEM, V262, P11841; BENSON AK, 1992, J BACTERIOL, V174, P749, DOI 10.1128/jb.174.3.749-757.1992; BOCH J, 1994, J BACTERIOL, V176, P5364; BOYLAN SA, 1993, J BACTERIOL, V175, P7931, DOI 10.1128/JB.175.24.7931-7937.1993; BRAUN V, 1994, N COMP BIOC, V27, P319, DOI DOI 10.1016/S0167-7306(08)60417-2; BRUCKNER R, 1992, GENE, V122, P187, DOI 10.1016/0378-1119(92)90048-T; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; CULHAM DE, 1993, J MOL BIOL, V229, P268, DOI 10.1006/jmbi.1993.1030; Cutting S., 1990, MOL BIOL METHODS BAC; DERSCH P, 1994, FEMS MICROBIOL LETT, V123, P19, DOI 10.1016/0378-1097(94)90268-2; DOIGE CA, 1993, ANNU REV MICROBIOL, V47, P291, DOI 10.1146/annurev.micro.47.1.291; FAATZ E, 1988, MOL MICROBIOL, V2, P265, DOI 10.1111/j.1365-2958.1988.tb00028.x; FURUSATO T, 1986, J BACTERIOL, V165, P549, DOI 10.1128/jb.165.2.549-556.1986; GONZYTREBOUL G, 1992, J MOL BIOL, V224, P967, DOI 10.1016/0022-2836(92)90463-T; GOWRISHANKAR J, 1989, J BACTERIOL, V171, P1923, DOI 10.1128/jb.171.4.1923-1931.1989; GRAHAM JE, 1992, J BACTERIOL, V174, P2711, DOI 10.1128/jb.174.8.2711-2716.1992; HAARDT M, 1995, MOL GEN GENET, V246, P783, DOI 10.1007/BF00290728; HANSON AD, 1994, P NATL ACAD SCI USA, V91, P306, DOI 10.1073/pnas.91.1.306; Harwood C., 1990, MOL BIOL METHODS BAC, P1; HASHIGUCHI K, 1986, MOL GEN GENET, V204, P36, DOI 10.1007/BF00330184; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; HECKER M, 1990, FEMS MICROBIOL ECOL, V74, P197, DOI 10.1111/j.1574-6968.1990.tb04065.x; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HIGGINS CF, 1987, J GEN MICROBIOL, V133, P305; HIGGINS CF, 1988, CELL, V52, P569, DOI 10.1016/0092-8674(88)90470-9; HUTKINS RW, 1987, APPL ENVIRON MICROB, V53, P2275, DOI 10.1128/AEM.53.10.2275-2281.1987; IMHOFF JF, 1984, J BACTERIOL, V160, P478, DOI 10.1128/JB.160.1.478-479.1984; INUKAI M, 1978, J ANTIBIOT, V31, P421, DOI 10.7164/antibiotics.31.421; ITAYA M, 1991, J MOL BIOL, V220, P631, DOI 10.1016/0022-2836(91)90106-G; ITAYA M, 1992, BIOSCI BIOTECH BIOCH, V56, P685, DOI 10.1271/bbb.56.685; KUMAR A, 1993, J MOL BIOL, V232, P406, DOI 10.1006/jmbi.1993.1400; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUCHT JM, 1994, FEMS MICROBIOL REV, V14, P3, DOI 10.1016/0168-6445(94)90008-6; LUCHT JM, 1994, J BIOL CHEM, V269, P6578; MANNA D, 1994, J BACTERIOL, V176, P5378, DOI 10.1128/JB.176.17.5378-5384.1994; MAY G, 1986, MOL GEN GENET, V205, P225, DOI 10.1007/BF00430432; MAY G, 1989, MOL MICROBIOL, V3, P1521, DOI 10.1111/j.1365-2958.1989.tb00138.x; MELLIES J, 1994, J BACTERIOL, V176, P3638, DOI 10.1128/JB.176.12.3638-3645.1994; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MORAN CP, 1982, MOL GEN GENET, V186, P339, DOI 10.1007/BF00729452; OVERDIER DG, 1992, P NATL ACAD SCI USA, V89, P3140, DOI 10.1073/pnas.89.7.3140; OWENHUGHES TA, 1992, CELL, V71, P255, DOI 10.1016/0092-8674(92)90354-F; PLATT T, 1981, CELL, V24, P10, DOI 10.1016/0092-8674(81)90496-7; POURKOMAILIAN B, 1992, J GEN MICROBIOL, V138, P2515, DOI 10.1099/00221287-138-12-2515; Sambrook J, 1989, MOL CLONING LABORATO; SAURIN W, 1994, MOL MICROBIOL, V12, P993, DOI 10.1111/j.1365-2958.1994.tb01087.x; SCHNEIDER R, 1993, MOL MICROBIOL, V8, P111, DOI 10.1111/j.1365-2958.1993.tb01208.x; STIRLING DA, 1989, MOL MICROBIOL, V3, P1025, DOI 10.1111/j.1365-2958.1989.tb00253.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUTCLIFFE IC, 1995, J BACTERIOL, V177, P1123, DOI 10.1128/jb.177.5.1123-1128.1995; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; TRIEUCUOT P, 1983, GENE, V23, P331, DOI 10.1016/0378-1119(83)90022-7; UEGUCHI C, 1993, EMBO J, V12, P1039, DOI 10.1002/j.1460-2075.1993.tb05745.x; VOLKER U, 1994, MICROBIOL-UK, V140, P741, DOI 10.1099/00221287-140-4-741; WANG JY, 1992, MOL MICROBIOL, V6, P1861, DOI 10.1111/j.1365-2958.1992.tb01358.x; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2521, DOI 10.1099/00221287-136-12-2521; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2527, DOI 10.1099/00221287-136-12-2527; WHITLEY P, 1994, EMBO J, V13, P4653, DOI 10.1002/j.1460-2075.1994.tb06788.x	65	152	157	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16701	16713		10.1074/jbc.270.28.16701	http://dx.doi.org/10.1074/jbc.270.28.16701			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622480	hybrid			2022-12-27	WOS:A1995RJ34700040
J	NEGISHI, M; IRIE, A; SUGIMOTO, Y; NAMBA, T; ICHIKAWA, A				NEGISHI, M; IRIE, A; SUGIMOTO, Y; NAMBA, T; ICHIKAWA, A			SELECTIVE COUPLING OF PROSTAGLANDIN-E RECEPTOR EP3D TO G(I) AND G(S) THROUGH INTERACTION OF ALPHA-CARBOXYLIC ACID OF AGONIST AND ARGININE RESIDUE OF 7TH TRANSMEMBRANE DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL TAIL; ADENYLATE-CYCLASE; G-PROTEINS; SUBTYPE; EXPRESSION; CLONING; BINDING; CDNA; STIMULATION; INHIBITION	Prostaglandin (PG) E receptor EP3D is coupled to both G(i) and G(s). To examine the roles of the interaction of alpha-carboxylic acid of PGE(2) and its putative binding site, the arginine residue in the seventh transmembrane domain of EP3D, in receptor-G protein coupling, we have mutated the arginine residue to the noncharged glutamine. PGE(2) with a negatively charged alpha-carboxylic acid and sulprostone, an EP3 agonist with a noncharged modified alpha-carboxylic acid, inhibited the forskolin-stimulated adenylate cyclase activity via G(i) activation in the EP3D receptor in the same concentration-dependent manner, In contrast, the adenylate cyclase stimulation via G(s) activation by sulprostone was much lower than that by PGE(2). On the other hand, both PGE(2) and sulprostone showed potent G(i) activity but failed to show G(s) activity in the mutant receptor. EP3D receptor showed a high affinity binding for PGE(2) in the form coupled to either G(i) or G(s). Although the mutant receptor showed high affinity binding when coupled to G(i), it lost high affinity binding in the condition of G(s) coupling. Furthermore, sulprostone bound to the G(i)-coupled EP3D receptor with higher affinity than the G(s)-coupled receptor. Among various EP3 agonists, ly-carboxylic acid-unmodified agonists showed both G(i) and G(s) activities, but the modified agonists showed only G(i) activity. These findings suggest that the interaction between the alpha-carboxylic acid of PGE(2) and the arginine residue of the receptor regulates the selectivity of the G protein coupling.	KYOTO UNIV,FAC MED,DEPT PHARMACOL,KYOTO 606,JAPAN	Kyoto University	NEGISHI, M (corresponding author), KYOTO UNIV,FAC PHARMACEUT SCI,DEPT PHYSIOL CHEM,KYOTO 606,JAPAN.		Sugimoto, Yukihiko/AAV-6470-2021	Sugimoto, Yukihiko/0000-0001-6973-932X				ALLGEIER A, 1994, J BIOL CHEM, V269, P13733; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BUNCE KT, 1990, ADV PROSTAGLANDIN TH, V21, P379; Coleman R A, 1987, Adv Prostaglandin Thromboxane Leukot Res, V17A, P467; COLEMAN RA, 1994, PROSTAGLANDINS, V47, P151, DOI 10.1016/0090-6980(94)90084-1; COLEMAN RA, 1990, COMPREHENSIVE MED CH, V3, P643; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; EASON MG, 1992, J BIOL CHEM, V267, P15795; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FINDLAY JBC, 1986, BIOCHEM J, V238, P625, DOI 10.1042/bj2380625; FUNK CD, 1993, MOL PHARMACOL, V44, P934; HALUSHKA PV, 1989, ANN REV PHARM TOXICO, V10, P213; HARRISON JK, 1991, TRENDS PHARMACOL SCI, V12, P62, DOI 10.1016/0165-6147(91)90499-I; HONDA A, 1993, J BIOL CHEM, V268, P7759; HUNG DT, 1992, J BIOL CHEM, V267, P20831; IRIE A, 1993, EUR J BIOCHEM, V217, P313, DOI 10.1111/j.1432-1033.1993.tb18248.x; ITO W, 1991, GENE, V102, P67, DOI 10.1016/0378-1119(91)90539-N; KUBO T, 1988, FEBS LETT, V241, P119, DOI 10.1016/0014-5793(88)81043-3; LAWRENCE RA, 1992, BRIT J PHARMACOL, V105, P271, DOI 10.1111/j.1476-5381.1992.tb14245.x; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; MILLIGAN G, 1993, TRENDS PHARMACOL SCI, V14, P239, DOI 10.1016/0165-6147(93)90019-G; NAKAJIMA Y, 1992, J BIOL CHEM, V267, P2437; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; NEGISHI M, 1993, PROG LIPID RES, V32, P417, DOI 10.1016/0163-7827(93)90017-Q; NEGISHI M, 1994, PROSTAGLANDINS, V48, P275, DOI 10.1016/0090-6980(94)90028-0; OIKAWA S, 1989, BIOCHEM BIOPH RES CO, V164, P39, DOI 10.1016/0006-291X(89)91679-3; ROBB S, 1994, EMBO J, V13, P1325, DOI 10.1002/j.1460-2075.1994.tb06385.x; SONNENBURG WK, 1988, J BIOL CHEM, V263, P6155; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; STEIN R, 1988, EMBO J, V7, P3031, DOI 10.1002/j.1460-2075.1988.tb03167.x; SUGIMOTO Y, 1992, J BIOL CHEM, V267, P6463; SUGIMOTO Y, 1994, AM J PHYSIOL, V266, pF823, DOI 10.1152/ajprenal.1994.266.5.F823; SUGIMOTO Y, 1993, J BIOL CHEM, V268, P2712; TAKEUCHI K, 1994, BIOCHEM BIOPH RES CO, V199, P834, DOI 10.1006/bbrc.1994.1304; WATABE A, 1993, J BIOL CHEM, V268, P20175; WESS J, 1992, J BIOL CHEM, V267, P19313	37	77	81	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16122	16127		10.1074/jbc.270.27.16122	http://dx.doi.org/10.1074/jbc.270.27.16122			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608175	hybrid			2022-12-27	WOS:A1995RH22600038
J	RODRIGUEZ, C; CHEN, F; WEINBERG, RA; LODISH, HF				RODRIGUEZ, C; CHEN, F; WEINBERG, RA; LODISH, HF			COOPERATIVE BINDING OF TRANSFORMING GROWTH-FACTOR (TGF)-BETA-2 TO THE TYPE-I AND TYPE-II TGF-BETA RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							EXPRESSION CLONING; 2 FORMS; KINASE; CELLS; RESPONSIVENESS; BETAGLYCAN; COMPLEXES; ISOFORMS; ACTIVIN; PROTEIN	TGF-beta 1 binds with high affinity (K-D = 25-50 pM) directly to the TGF-beta type II receptor serine-threonine kinase (T beta-RII) in the absence of expression of the TGF-beta type I or III receptors (T beta-RI and T beta-RIII). The serine-threonine kinase T beta-RI is essential for TGF-beta 1 signaling but not for binding to T beta-RII. TGF-beta 2, in contrast, does not bind directly to T beta-RII, although coexpression of T beta-RIII does allow binding and cross-linking of TGF-beta 2 to T beta-RII. Here we show that in transfected COS cells binding and cross-linking of I-125-TGF-beta 2 to T beta-RI or T beta-RII requires expression of both receptors. In cells transfected with the c-myc-tagged human T beta-RII cDNA, only low amounts of I-125-TGF-beta 2 cross-linked to T beta-RI and T beta-RII were detected even with high concentrations (700 pM) of ligand. Cotransfection of the influenza-hemagglutinin-tagged human T beta-RI cDNA dramatically increased the binding of TGF-beta 2 to T beta-RII; the concentration of I-125-TGF-beta 2 required for half-maximal binding and cross-linking to T beta-RI and T beta-RII was similar to 40 pM. Coimmunoprecipitation studies showed that the high affinity receptor for TGF-beta 2 is composed of a hetero-oligomer of T beta-RI and T beta-RII. Thus TGF-beta 1 and -beta 2 bind to TGF-beta receptors in different ways; TGB-beta 1 binds directly to T beta-RII, while binding of TGF-beta 2 to T beta-RII requires coexpression of T beta-RI T beta-RIII.	WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)				rodriguez, carlos/0000-0001-9593-8680	NATIONAL CANCER INSTITUTE [R35CA039826, R01CA063260] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA-63260, 5R35 CA-39826] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; BASSING CH, 1994, SCIENCE, V263, P87, DOI 10.1126/science.8272871; CHEIFETZ S, 1988, J BIOL CHEM, V263, P10783; CHEIFETZ S, 1990, J BIOL CHEM, V265, P20533; CHEIFETZ S, 1987, CELL, V48, P409, DOI 10.1016/0092-8674(87)90192-9; CHEN F, 1995, P NATL ACAD SCI USA, V92, P1565, DOI 10.1073/pnas.92.5.1565; CHEN RH, 1994, J BIOL CHEM, V269, P22868; EBNER R, 1993, SCIENCE, V262, P900, DOI 10.1126/science.8235612; EBNER R, 1993, SCIENCE, V260, P1344, DOI 10.1126/science.8388127; EVAN GI, 1984, MOL CELL BIOL, V4, P2843, DOI 10.1128/MCB.4.12.2843; HENIS YI, 1994, J CELL BIOL, V126, P139, DOI 10.1083/jcb.126.1.139; INAGAKI M, 1993, P NATL ACAD SCI USA, V90, P5359, DOI 10.1073/pnas.90.11.5359; LAIHO M, 1990, J BIOL CHEM, V265, P18518; LAIHO M, 1991, J BIOL CHEM, V266, P9108; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LIN HY, 1995, J BIOL CHEM, V270, P2747, DOI 10.1074/jbc.270.6.2747; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; MASSAGUE J, 1992, MOL REPROD DEV, V32, P99, DOI 10.1002/mrd.1080320204; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MITCHELL EJ, 1992, J CELL PHYSIOL, V150, P334, DOI 10.1002/jcp.1041500217; MITCHELL EJ, 1991, BIOCHEMISTRY-US, V30, P4350, DOI 10.1021/bi00231a034; MOUSTAKAS A, 1993, J BIOL CHEM, V268, P22215; OGAWA Y, 1992, J BIOL CHEM, V267, P2325; OHTA M, 1987, NATURE, V329, P539, DOI 10.1038/329539a0; ROBERTS AB, 1992, MOL REPROD DEV, V32, P91, DOI 10.1002/mrd.1080320203; SEGARINI PR, 1987, J BIOL CHEM, V262, P14655; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; VENTURA F, 1994, EMBO J, V13, P5581, DOI 10.1002/j.1460-2075.1994.tb06895.x; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; WIESER R, 1993, MOL CELL BIOL, V13, P7239, DOI 10.1128/MCB.13.12.7239; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0	36	76	78	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15919	15922		10.1074/jbc.270.27.15919	http://dx.doi.org/10.1074/jbc.270.27.15919			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608141	hybrid			2022-12-27	WOS:A1995RH22600002
J	SCHERER, PE; TANG, ZL; CHUN, MY; SARGIACOMO, M; LODISH, HF; LISANTI, MP				SCHERER, PE; TANG, ZL; CHUN, MY; SARGIACOMO, M; LODISH, HF; LISANTI, MP			CAVEOLIN ISOFORMS DIFFER IN THEIR N-TERMINAL PROTEIN-SEQUENCE AND SUBCELLULAR-DISTRIBUTION - IDENTIFICATION AND EPITOPE MAPPING OF AN ISOFORM-SPECIFIC MONOCLONAL-ANTIBODY PROBE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROUS-SARCOMA VIRUS; TRANS-GOLGI-NETWORK; PLASMA-MEMBRANE; EPITHELIAL-CELLS; MESSENGER-RNA; COMPONENT; INITIATION; VESICLES; RECEPTOR; TYROSINE	Caveolin, an integral membrane protein, is a principal component of caveolae membranes in vivo. Two isoforms of caveolin have been identified: a slower migrating 24-kDa species (alpha-isoform) and a faster migrating 21-kDa species (beta-isoform). Little is known about how these isoforms differ, either structurally or functionally. Here we have begun to study the differences between these two isoforms. Microsequencing of caveolin reveals that both isoforms contain internal caveolin residues 47-77. In a second independent approach, we recombinantly expressed caveolin in a caveolin-negative cell line (FRT cells). Stable transfection of FRT cells with the full-length caveolin cDNA resulted in the expression of both caveolin isoforms, indicating that they can be derived from a single cDNA. Using extracts from caveolin-expressing FRT cells, we fortuitously identified a monoclonal antibody that recognizes only the alpha-isoform of caveolin. Epitope mapping of this monoclonal antibody reveals that it recognizes an epitope within the extreme N terminus of caveolin, specifically residues 1-21. These results suggest that alpha- and beta-isoforms of caveolin differ in their N-terminal protein sequences. To independently evaluate this possibility, we placed an epitope tag at either the extreme N or C terminus of full-length caveolin. Results of these ''tagging'' experiments clearly demonstrate that (i) both isoforms of caveolin contain a complete C terminus and (ii) that the alpha-isoform contains a complete N terminus while the beta-isoform lacks N-terminal-specific protein sequences. Mutational analysis reveals that these two isoforms apparently derive from the use of two alternate start sites: methionine at position 1 and an internal methionine at position 32. This would explain the similar to 3-kDa difference in their apparent migration in SDS-polyacrylamide electrophoresis gels. In addition, using isoform-specific antibody probes we show that caveolin isoforms may assume a distinct but overlapping subcellular distribution by confocal immunofluorescence microscopy. We discuss the possible implications of these differences between alpha- and beta-caveolin.	WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)			Lisanti, Michael P/C-6866-2013; Lisanti, Michael/B-6131-2018; Scherer, Philipp E/K-7819-2012	Lisanti, Michael/0000-0003-2034-1382; Scherer, Philipp E/0000-0003-0680-3392; Sargiacomo, Massimo/0000-0003-4040-706X	NIDDK NIH HHS [DK-47618] Funding Source: Medline; NIGMS NIH HHS [GM-49516, GM-50443] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK047618, R01DK047618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM050443] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson RGW, 1993, CURR OPIN CELL BIOL, V5, P647, DOI 10.1016/0955-0674(93)90135-D; CHANG WJ, 1994, J CELL BIOL, V126, P127, DOI 10.1083/jcb.126.1.127; CHUN MY, 1994, P NATL ACAD SCI USA, V91, P11728, DOI 10.1073/pnas.91.24.11728; CONNEELY OM, 1987, BIOCHEM BIOPH RES CO, V149, P493, DOI 10.1016/0006-291X(87)90395-0; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; FUJIMOTO T, 1992, J CELL BIOL, V119, P1507, DOI 10.1083/jcb.119.6.1507; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; GLENNEY JR, 1992, P NATL ACAD SCI USA, V89, P10517, DOI 10.1073/pnas.89.21.10517; GLENNEY JR, 1989, J BIOL CHEM, V264, P20163; GLENNEY JR, 1992, FEBS LETT, V314, P45, DOI 10.1016/0014-5793(92)81458-X; KAMEN BA, 1991, J CLIN INVEST, V87, P1442, DOI 10.1172/JCI115150; KOLESKE AJ, 1995, P NATL ACAD SCI USA, V92, P1381, DOI 10.1073/pnas.92.5.1381; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; KOZAK M, 1991, J BIOL CHEM, V266, P19867; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Lisanti Michael P., 1995, Seminars in Developmental Biology, V6, P47, DOI 10.1016/S1044-5781(06)80084-8; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; LISANTI MP, 1995, METHOD ENZYMOL, V250, P655; LISANTI MP, 1993, J CELL BIOL, V123, P595, DOI 10.1083/jcb.123.3.595; LISANTI MP, 1989, J CELL BIOL, V109, P2117, DOI 10.1083/jcb.109.5.2117; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; SARGIACOMO M, 1994, ONCOGENE, V9, P2589; SAWIN KE, 1992, J CELL SCI, V101, P303; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SEVERS NJ, 1988, J CELL SCI, V90, P341; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; SLUSHER LB, 1991, P NATL ACAD SCI USA, V88, P9789, DOI 10.1073/pnas.88.21.9789; SMART EJ, 1994, J CELL BIOL, V127, P1185, DOI 10.1083/jcb.127.5.1185; SMART EJ, 1994, J CELL BIOL, V124, P307, DOI 10.1083/jcb.124.3.307; SNELTINGHAVINGA I, 1989, EUR J CELL BIOL, V48, P27; TANG ZL, 1994, GENE, V147, P299, DOI 10.1016/0378-1119(94)90087-6; VASILE E, 1983, J CELL BIOL, V96, P1677, DOI 10.1083/jcb.96.6.1677; ZURZOLO C, 1994, EMBO J, V13, P42, DOI 10.1002/j.1460-2075.1994.tb06233.x	41	323	331	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					16395	16401		10.1074/jbc.270.27.16395	http://dx.doi.org/10.1074/jbc.270.27.16395			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608210	hybrid			2022-12-27	WOS:A1995RH22600077
J	HILAIRE, N; SALVAYRE, R; THIERS, JC; BONNAFE, MJ; NEGRESALVAYRE, A				HILAIRE, N; SALVAYRE, R; THIERS, JC; BONNAFE, MJ; NEGRESALVAYRE, A			THE TURNOVER OF CYTOPLASMIC TRIACYLGLYCEROLS IN HUMAN FIBROBLASTS INVOLVES 2 SEPARATE ACYL-CHAIN LENGTH-DEPENDENT DEGRADATION PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID STORAGE MYOPATHY; LYMPHOID-CELL LINES; FATTY-ACIDS; CULTURED FIBROBLASTS; WOLMANS DISEASE; LYSOSOMAL STORAGE; METABOLISM; CARBOXYLESTERASES; PROTEINS; PATIENT	Cultured fibroblasts from patients affected with the genetic metabolic disorder named neutral Lipid storage disease (NLSD) exhibit a dramatic accumulation of cytoplasmic triacylglycerols (Radom, J., Salvayre, R., Negre, A., Maret, A., and Douste-Blazy, L. (1987) Eur. J. Biochem, 164, 703-708), We compared here the metabolism of radiolabeled short-, medium- and long-chain fatty acids in these cells, Short/medium-chain fatty acids (C4-C10) were incorporated into polar lipids (60-80%) and triacylglycerols (20-40%) at a lower rate (5-10 times lower) than long-chain fatty acids, Pulse chase experiments allowed to evaluate the degradation rate of cytoplasmic triacylglycerols in normal and NLSD fibroblasts and to discriminate between two catabolic pathways of cytoplasmic triacylglycerols, Short/medium-chain (C4-C10) triacylglycerols were degraded at a normal rate in NLSD fibroblasts, whereas long-chain (C12 and longer) triacylglycerols remained undegraded, These data are confirmed by mass analysis, The use of diethylparanitrophenyl phosphate (E600) and parachloromercuribenzoate (PCMB) inhibitors allows to discriminate between the two triacylglycerol degradation pathways, E600 inhibited selectively the in situ degradation of short/medium-chain triacylglycerols without inhibition of the degradation of long-chain triacylglycerols, whereas PCMB inhibited selectively the in situ hydrolysis of long-chain triacylglycerols without affecting the degradation of long-chain triacylglycerols, This was correlated with the in vitro properties of cellular triacylglycerol-hydrolyzing enzymes characterized by their susbtrate specificity and their susceptibility to inhibitors; the neutral lipase specific to long-chain triacylglycerols is inhibited by PCMB, but not by E600, in contrast to short/medium-chain lipase, which is inhibited by E600 but not by PCMB. The data of in vitro and in situ experiments suggest the existence in fibroblasts of two separate acyl chain length-dependent pathways involved in the degradation of cytoplasmic triacylglycerols, one mediated by a neutral long chain lipase and another one mediated by a short/medium-chain lipase.	UNIV TOULOUSE 3,FAC MED,DEPT BIOCHEM,F-31054 TOULOUSE,FRANCE; UNIV TOULOUSE 3,FAC MED,INSERM,CJF9206,F-31054 TOULOUSE,FRANCE	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier				Negre-Salvayre, Anne/0000-0003-2136-5706				BECKER A, 1994, ARTERIOSCLER THROMB, V14, P1346, DOI 10.1161/01.ATV.14.8.1346; BELFRAGE P, 1969, J LIPID RES, V10, P341; BREMER J, 1982, J LIPID RES, V23, P243; BROCKERHOFF H, 1974, LIPOLYTIC ENZYMES, P83; CHANARIN I, 1975, BRIT MED J, V1, P553, DOI 10.1136/bmj.1.5957.553; CHEN PS, 1956, ANAL CHEM, V18, P1756; COHEN JA, 1967, METHOD ENZYMOL, V11, P687; DEGRELLA RF, 1980, J BIOL CHEM, V255, P9731; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; DIDONATO S, 1988, NEUROLOGY, V38, P1107; DIXON M, 1962, ENZYMES, P315; DOLE VP, 1956, J CLIN INVEST, V35, P150, DOI 10.1172/JCI103259; DORFMAN ML, 1974, ARCH DERMATOL, V110, P261, DOI 10.1001/archderm.110.2.261; ESCARGUEILBLANC I, 1994, FASEB J, V8, P1075, DOI 10.1096/fasebj.8.13.7926374; FOLCH J, 1957, J BIOL CHEM, V226, P497; FURST W, 1992, BIOCHIM BIOPHYS ACTA, V1126, P1, DOI 10.1016/0005-2760(92)90210-M; GATT S, 1988, BIOCHIM BIOPHYS ACTA, V958, P130, DOI 10.1016/0005-2760(88)90254-8; GOLDSTEIN JL, 1979, ANN REV BIOCH, V46, P897; HILAIRE N, 1993, FEBS LETT, V328, P230, DOI 10.1016/0014-5793(93)80933-L; HILAIRE N, 1994, BIOCHEM J, V297, P467, DOI 10.1042/bj2970467; JEFFERSON JR, 1990, J BIOL CHEM, V265, P11062; KASURINEN J, 1992, J BIOL CHEM, V267, P6563; LENGLE E, 1973, BIOCHIM BIOPHYS ACTA, V296, P411, DOI 10.1016/0005-2760(73)90099-4; LEVY E, 1981, BIOCHIM BIOPHYS ACTA, V664, P316, DOI 10.1016/0005-2760(81)90054-0; LONG RM, 1988, BIOCHEM BIOPH RES CO, V156, P866, DOI 10.1016/S0006-291X(88)80924-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MORAND O, 1982, BIOCHIM BIOPHYS ACTA, V711, P539, DOI 10.1016/0005-2760(82)90070-4; MOSKOWITZ MS, 1967, LIPID METABOLISM TIS, P49; MUNGER JS, 1991, J BIOL CHEM, V266, P18832; MYERS DK, 1960, ENZYMES, P475; NEGRE A, 1988, BIOCHIM BIOPHYS ACTA, V963, P340, DOI 10.1016/0005-2760(88)90300-1; NEGRE A, 1984, ENZYME, V31, P241, DOI 10.1159/000469533; NEGRE A, 1986, J INHERIT METAB DIS, V9, P193, DOI 10.1007/BF01799458; NEGRE A, 1986, ANAL BIOCHEM, V145, P398; NEGRE A, 1988, COMP BIOCH PHYSL, V91, P78; OBRIEN JS, 1991, FASEB J, V5, P301, DOI 10.1096/fasebj.5.3.2001789; PATRICK AD, 1973, LYSOSOMES STORAGE DI, P453; POWNALL HJ, 1989, CHEM PHYS LIPIDS, V50, P191, DOI 10.1016/0009-3084(89)90050-9; RADOM J, 1989, BIOCHIM BIOPHYS ACTA, V1005, P130, DOI 10.1016/0005-2760(89)90178-1; RADOM J, 1988, BIOL CELL, V62, P39; RADOM J, 1987, BIOCHIM BIOPHYS ACTA, V920, P131, DOI 10.1016/0005-2760(87)90252-9; RADOM J, 1990, BIOCHEM J, V269, P107, DOI 10.1042/bj2690107; RADOM J, 1987, EUR J BIOCHEM, V164, P703, DOI 10.1111/j.1432-1033.1987.tb11183.x; SALVAYRE R, 1989, FEBS LETT, V250, P35, DOI 10.1016/0014-5793(89)80679-9; SALVAYRE R, 1987, EUR J BIOCHEM, V170, P453, DOI 10.1111/j.1432-1033.1987.tb13721.x; SCHNEEBERGER EE, 1971, EXP CELL RES, V69, P193, DOI 10.1016/0014-4827(71)90325-9; WILLIAMS ML, 1991, BIOCHIM BIOPHYS ACTA, V1096, P162, DOI 10.1016/0925-4439(91)90055-E; YAN BF, 1994, J BIOL CHEM, V269, P29688	48	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27027	27034		10.1074/jbc.270.45.27027	http://dx.doi.org/10.1074/jbc.270.45.27027			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592952	hybrid			2022-12-27	WOS:A1995TE58300052
J	LIU, JS; KUO, SR; BROKER, TR; CHOW, LT				LIU, JS; KUO, SR; BROKER, TR; CHOW, LT			THE FUNCTIONS OF HUMAN PAPILLOMAVIRUS TYPE-11 E1, E2, AND E2C PROTEINS IN CELL-FREE DNA-REPLICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE PAPILLOMAVIRUS; TRANSCRIPTIONAL ACTIVATOR; BINDING-SITES; TRANSIENT REPLICATION; T-ANTIGEN; ORIGIN; REQUIRES; ENHANCER; SEQUENCE; INVITRO	We examined the functions of human papillomavirus type 11 (HPV-11) El and E2 proteins purified from Sf9 cells infected with recombinant baculoviruses in cell-free HPV-11 origin (ori) replication. The El protein binds specifically to a wild type but not tb a mutated sequence in the ori spanning nucleotide position 1. It also has a relatively strong affinity for nonspecific DNA, A neutralizing antiserum directed against the amino-terminal one-third of the El protein totally abolishes initiation and elongation, suggesting that it functions as an initiator and a helicase at the replication fork. An antiserum against the carboxyl-terminal portion of El protein abolished replication only when added prior to initiation, Thus this portion of El is hidden in the replication complexes. The HPV-11 E2 protein appears not to be essential for elongation, but it must be present in the preinitiation complex for the El protein to recruit host DNA replication machinery to the ori. E2 antiserum added after preincubation in the absence of the cell extracts totally abolished replication, An identical conclusion is also reached for the bovine papillomavirus type 1 E2 protein. Finally, the HPV-11 E2C protein lacking the transacting domain of the full-length E2 protein partially inhibits E2-dependent ori replication.	UNIV ALABAMA,SCH MED,DEPT BIOCHEM & MOLEC GENET,BIRMINGHAM,AL 35294; UNIV ALABAMA,SCH DENT,DEPT BIOCHEM & MOLEC GENET,BIRMINGHAM,AL 35294; UNIV ROCHESTER,SCH MED & DENT,DEPT BIOCHEM,ROCHESTER,NY 14642	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Rochester					NATIONAL CANCER INSTITUTE [R01CA036200] Funding Source: NIH RePORTER; NCI NIH HHS [CA36200] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDROPHY EJ, 1987, NATURE, V325, P70, DOI 10.1038/325070a0; BEDROSIAN CL, 1990, VIROLOGY, V174, P557, DOI 10.1016/0042-6822(90)90109-5; BLITZ IL, 1991, J VIROL, V65, P649, DOI 10.1128/JVI.65.2.649-656.1991; BONNEANDREA C, 1995, J VIROL, V69, P2341, DOI 10.1128/JVI.69.4.2341-2350.1995; BONNEANDREA C, 1995, J VIROL, V69, P3201, DOI 10.1128/JVI.69.5.3201-3205.1995; BREAM GL, 1993, J VIROL, V67, P2655, DOI 10.1128/JVI.67.5.2655-2663.1993; CHIANG CM, 1992, P NATL ACAD SCI USA, V89, P5799, DOI 10.1073/pnas.89.13.5799; CHIANG CM, 1992, J VIROL, V66, P5224, DOI 10.1128/JVI.66.9.5224-5231.1992; CHIANG CM, 1991, J VIROL, V65, P3317, DOI 10.1128/JVI.65.6.3317-3329.1991; CHIN MT, 1988, J VIROL, V62, P2994, DOI 10.1128/JVI.62.8.2994-3002.1988; CHOW LT, 1994, INTERVIROLOGY, V37, P150, DOI 10.1159/000150373; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P16, DOI 10.1073/pnas.84.1.16; DELVECCHIO AM, 1992, J VIROL, V66, P5949, DOI 10.1128/JVI.66.10.5949-5958.1992; DEPAMPHILIS ML, 1986, PAPOVAVIRIDAE, P99; DEVILLIERS EM, 1989, J VIROL, V63, P4898, DOI 10.1128/JVI.63.11.4898-4903.1989; DONG G, 1994, J VIROL, V68, P1115, DOI 10.1128/JVI.68.2.1115-1127.1994; FRATTINI MG, 1994, VIROLOGY, V204, P799, DOI 10.1006/viro.1994.1596; GILLETTE TG, 1994, P NATL ACAD SCI USA, V91, P8846, DOI 10.1073/pnas.91.19.8846; GOPALAKRISHNAN V, 1994, P NATL ACAD SCI USA, V91, P9597, DOI 10.1073/pnas.91.20.9597; GRUSSENMEYER T, 1985, P NATL ACAD SCI USA, V82, P7952, DOI 10.1073/pnas.82.23.7952; HEDGE RS, 1992, NATURE, V359, P505; HIROCHIKA H, 1988, GENE DEV, V2, P54, DOI 10.1101/gad.2.1.54; HOLT SE, 1994, J VIROL, V68, P1094, DOI 10.1128/JVI.68.2.1094-1102.1994; HUGHES FJ, 1993, NUCLEIC ACIDS RES, V21, P5817, DOI 10.1093/nar/21.25.5817; KUO SR, 1994, J BIOL CHEM, V269, P24058; LI R, 1989, GENE DEV, V3, P510, DOI 10.1101/gad.3.4.510; LI R, 1993, CELL, V73, P1207, DOI 10.1016/0092-8674(93)90649-B; LU JZJ, 1993, J VIROL, V67, P7131, DOI 10.1128/JVI.67.12.7131-7139.1993; LUSKY M, 1994, P NATL ACAD SCI USA, V91, P8895, DOI 10.1073/pnas.91.19.8895; LUSKY M, 1991, P NATL ACAD SCI USA, V88, P6363, DOI 10.1073/pnas.88.14.6363; LUSKY M, 1993, J BIOL CHEM, V268, P15795; MACPHERSON P, 1994, VIROLOGY, V204, P403, DOI 10.1006/viro.1994.1544; MCBRIDE AA, 1989, P NATL ACAD SCI USA, V86, P510, DOI 10.1073/pnas.86.2.510; MCBRIDE AA, 1989, J BIOL CHEM, V266, P18411; MCKAY RDG, 1981, J MOL BIOL, V145, P471, DOI 10.1016/0022-2836(81)90540-4; MOHR IJ, 1990, SCIENCE, V250, P1694, DOI 10.1126/science.2176744; MOSKALUK CA, 1989, VIROLOGY, V169, P236, DOI 10.1016/0042-6822(89)90062-7; MULLER F, 1994, J BIOL CHEM, V269, P17086; PARK P, 1994, P NATL ACAD SCI USA, V91, P8700, DOI 10.1073/pnas.91.18.8700; REMM M, 1992, NUCLEIC ACIDS RES, V20, P6015, DOI 10.1093/nar/20.22.6015; ROTENBERG MO, 1989, VIROLOGY, V172, P468, DOI 10.1016/0042-6822(89)90189-X; RUSSELL J, 1995, J VIROL, V69, P651, DOI 10.1128/JVI.69.2.651-660.1995; SEO YS, 1993, P NATL ACAD SCI USA, V90, P2865, DOI 10.1073/pnas.90.7.2865; SEO YS, 1993, P NATL ACAD SCI USA, V90, P702, DOI 10.1073/pnas.90.2.702; SPALHOLZ BA, 1993, VIROLOGY, V193, P201, DOI 10.1006/viro.1993.1116; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; STOLER MH, 1989, VIROLOGY, V172, P331, DOI 10.1016/0042-6822(89)90135-9; SVERDRUP F, 1995, J VIROL, V69, P1319, DOI 10.1128/JVI.69.2.1319-1323.1995; THORNER LK, 1993, J VIROL, V67, P6000, DOI 10.1128/JVI.67.10.6000-6014.1993; USTAV E, 1993, P NATL ACAD SCI USA, V90, P898, DOI 10.1073/pnas.90.3.898; USTAV M, 1991, EMBO J, V10, P4321, DOI 10.1002/j.1460-2075.1991.tb05010.x; USTAV M, 1991, EMBO J, V10, P449, DOI 10.1002/j.1460-2075.1991.tb07967.x; WILSON VG, 1991, J VIROL, V65, P5314, DOI 10.1128/JVI.65.10.5314-5322.1991; YANG L, 1993, P NATL ACAD SCI USA, V90, P5086, DOI 10.1073/pnas.90.11.5086; YANG L, 1991, NATURE, V353, P628, DOI 10.1038/353628a0	55	59	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27283	27291		10.1074/jbc.270.45.27283	http://dx.doi.org/10.1074/jbc.270.45.27283			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592989	hybrid			2022-12-27	WOS:A1995TE58300089
J	MIURA, Y; TAM, T; IDO, A; MORINAGA, T; MIKI, T; HASHIMOTO, T; TAMAOKI, T				MIURA, Y; TAM, T; IDO, A; MORINAGA, T; MIKI, T; HASHIMOTO, T; TAMAOKI, T			CLONING AND CHARACTERIZATION OF AN ATBF1 ISOFORM THAT EXPRESSES IN A NEURONAL DIFFERENTIATION-DEPENDENT MANNER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENHANCER-BINDING PROTEIN; ZINC-FINGER; GENE-EXPRESSION; HOMEODOMAIN; DROSOPHILA; ZFH-2; REPLICATION; GENOMES; MOTIFS; BOX	The human ATBF1 cDNA reported previously, now termed ATBF1-B, encodes a 306-kDa protein containing 4 homeodomains and 18 zinc fingers including one pseudo zinc finger motif, Here, we report the isolation of a second ATBF1 cDNA, 12 kilobase pairs long, termed ATBF1-A. The deduced ATBF1-A protein is 404 kDa in size and differs from ATBF1-B by a 920-amino acid extention at the N terminus, Analysis of 5'-genomic sequences showed that the 5'-noneoding sequences specific to ATBF1-A and ATBF1-B transcripts were contained in distinct exons that could splice to a downstream exon common to the ATBF1-A and ATBF1-B mRNAs. The expression of ATBF1-A transcripts increased to high levels when P19 and NT2/D1 cells were treated with retinoic acid to induce neuronal. differentiation, Preferential expression of ATBF1-A transcripts was also observed in developing mouse brain. Transient transfection assays showed that the 5,5-kilobase pair sequence upstream of the ATBF1-A-specific exon (exon 2) supported expression of the linked chloramphenicol acetyltransferase gene in neuronal cells derived from P19 cells but not in undifferentiated P19 or in F9 cells, which do not differentiate into neurons. These results showed that ATBF1-A and ATBF1-B transcripts are generated by alternative promoter usage combined with alternative splicing and that the ATBF1-A-specific promoter is activated during neuronal differentiation.	UNIV CALGARY, FAC MED, DEPT MED BIOCHEM, CALGARY, AB T2N 4N1, CANADA; NAGASAKI UNIV, SCH MED, DEPT INTERNAL MED 1, NAGASAKI 852, JAPAN; SNOW BRAND MILK PROD CO LTD, LIFE SCI RES INST, ISHIBASHI, TOCHIGI 32905, JAPAN; NCI, CELLULAR & MOLEC BIOL LAB, BETHESDA, MD 20892 USA; HYOGO MED UNIV, DEPT GENET, NISHINOMIYA, HYOGO 659, JAPAN	University of Calgary; Nagasaki University; Snow Brand Milk Products Co., Ltd.; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hyogo College of Medicine; University of Hyogo								ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; DEMARTIN R, 1993, GENE, V124, P137, DOI 10.1016/0378-1119(93)90776-Y; FORTINI ME, 1991, MECH DEVELOP, V34, P113, DOI 10.1016/0925-4773(91)90048-B; FUNAHASHI J, 1993, DEVELOPMENT, V119, P433; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HASHIMOTO T, 1992, MECH DEVELOP, V39, P125, DOI 10.1016/0925-4773(92)90031-E; HENIKOFF S, 1991, NUCLEIC ACIDS RES, V19, P6565, DOI 10.1093/nar/19.23.6565; HOGAN BLM, 1981, NATURE, V291, P235, DOI 10.1038/291235a0; IDO A, 1994, DEV BIOL, V163, P184, DOI 10.1006/dbio.1994.1134; ISHIBASHI T, 1992, P NATL ACAD SCI USA, V89, P12170, DOI 10.1073/pnas.89.24.12170; KAMACHI Y, 1993, MOL CELL BIOL, V13, P5206, DOI 10.1128/MCB.13.9.5206; KAMPS MP, 1984, NATURE, V310, P589, DOI 10.1038/310589a0; LAI ZC, 1993, P NATL ACAD SCI USA, V90, P4122, DOI 10.1073/pnas.90.9.4122; LAI ZC, 1991, MECH DEVELOP, V34, P123, DOI 10.1016/0925-4773(91)90049-C; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; LUNDELL MJ, 1992, DEV BIOL, V154, P84, DOI 10.1016/0012-1606(92)90050-Q; MIKI T, 1989, GENE, V83, P137, DOI 10.1016/0378-1119(89)90411-3; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; NORTON PA, 1985, MOL CELL BIOL, V5, P281, DOI 10.1128/MCB.5.2.281; PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; Sambrook J, 1989, MOL CLONING LABORATO; SEKIDO R, 1994, MOL CELL BIOL, V14, P5692, DOI 10.1128/MCB.14.9.5692; YASUDA H, 1994, MOL CELL BIOL, V14, P1395, DOI 10.1128/MCB.14.2.1395	26	75	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26840	26848		10.1074/jbc.270.45.26840	http://dx.doi.org/10.1074/jbc.270.45.26840			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592926	hybrid			2022-12-27	WOS:A1995TE58300026
J	PAGES, G; STANLEY, ER; LE GALL, M; BRUNET, A; POUYSSEGUR, J				PAGES, G; STANLEY, ER; LE GALL, M; BRUNET, A; POUYSSEGUR, J			THE MOUSE P44 MITOGEN-ACTIVATED PROTEIN-KINASE (EXTRACELLULAR SIGNAL-REGULATED KINASE-1) GENE - GENOMIC ORGANIZATION AND STRUCTURE OF THE 5'-FLANKING REGULATORY REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR GENE; INDUCED TYROSINE PHOSPHORYLATION; TRANSCRIPTION FACTOR; PROMOTER REGION; BINDING ACTIVITY; MAP KINASES; 5' TERMINI; EXPRESSION; SEQUENCE; INSULIN	Mitogen-activated protein kinase (MAPK) or extracellular signal-regulated kinase are ubiquitous kinases conserved from fungi to mammals. Their activity is regulated by phosphorylation on both threonine and tyrosine, and they play a crucial role in the regulation of proliferation and differentiation. We report here the cloning of the murine p44 MAP kinase (extracellular signal-regulated kinase 1) gene, the determination of its intron/exon boundaries, and the characterization of its promoter. The gene spans approximately eight kilo-bases promoter. bases (kb) and can be divided into nine exons and eight introns, each coding region exon containing from one to three of the highly conserved protein kinase domains. Primer extension analysis reveals the existence of two major start sites of transcription located at -183 and -186 base pairs (bp) as well as four discrete start sites for transcription located at -178, -192, -273, and -292 bp of the initiation of translation. However, the start site region lacks TATA-like sequences but does contain initiator-like sequences proximal to the major start sites obtained by primer extension. 1 kb of the promoter region has been sequenced. It contains three putative TATA boxes far upstream of the main start sites region, one AP-1 box, one AP-2 box, one Malt box, one GAGA box, one half serum-responsive element, and putative binding sites for Spl (five), GC-rich binding factor (five), CTF-NF1 (one), Myb (one), p53 (two), Ets-1 (one), NF-IL6 (two), MyoD (two), Zeste (one), and hepatocyte nuclear factor-5 (one). To determine the sites critical for the function of the p44 MAPK promoter, we constructed a series of chimeric genes containing variable regions of the 5'-flanking sequence of p44 MAPK gene and the coding region for luciferase. Activity of the promoter, measured by its capacity to direct expression of a luciferase reporter gene, is strong, being comparable with the activity of the Rous sarcoma virus promoter. Progressive deletions of the similar to 1 kb (-1200/-78) promoter region allowed us to define a minimal region of 186 bp (-284/ -78) that has maximal promoter activity. Within this context, deletion of the AP-2 binding site reduces by 30-40% the activity of the promoter. Further deletion of this minimal promoter that removes the major start sites (-167/-78) surprisingly preserves promoter activity, This result implicates a major role of this region that contains the Spl sites. Finally, removal of the major start sites of transcription as well as the Spl sites reveals additional promoter activity at the upstream transcription minor start sites (-240/-167), an activity that is enhanced by the upstream cis-acting elements, In summary, our findings reveal a complex pattern of transcriptional of the mouse p44 MAPK promoter.			PAGES, G (corresponding author), CTR BIOCHIM, CNRS, UMR 134, PARC VALROSE, F-06108 NICE 2, FRANCE.		Stanley, Evan R/J-9154-2013; Pages, Gilles/N-7135-2017; Le Gall, Maude/W-2593-2019; Le Gall, Maude/C-3917-2017	Stanley, Evan R/0000-0002-2910-2065; Le Gall, Maude/0000-0002-5372-4585; Le Gall, Maude/0000-0002-5372-4585	NCI NIH HHS [CA 32551, CA 26504] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA026504, R01CA032551, R01CA026504] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BIGGIN MD, 1989, TRENDS GENET, V5, P377, DOI 10.1016/0168-9525(89)90173-X; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BLENIS J, 1991, CANCER CELL-MON REV, V3, P445; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BRUNET A, 1994, ONCOGENE, V9, P3379; COOPER JA, 1984, MOL CELL BIOL, V4, P30, DOI 10.1128/MCB.4.1.30; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DALTON S, 1992, EMBO J, V11, P1797, DOI 10.1002/j.1460-2075.1992.tb05231.x; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DYNAN WS, 1986, NATURE, V319, P246, DOI 10.1038/319246a0; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; GONZALEZ FA, 1992, FEBS LETT, V304, P170, DOI 10.1016/0014-5793(92)80612-K; GONZALEZ FA, 1993, J CELL BIOL, V122, P1089, DOI 10.1083/jcb.122.5.1089; GRANGE T, 1991, NUCLEIC ACIDS RES, V19, P131, DOI 10.1093/nar/19.1.131; GROSSCHEDL R, 1980, P NATL ACAD SCI-BIOL, V77, P1432, DOI 10.1073/pnas.77.3.1432; HAGEN G, 1992, NUCLEIC ACIDS RES, V20, P5519, DOI 10.1093/nar/20.21.5519; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HUDSON LG, 1990, P NATL ACAD SCI USA, V87, P7536, DOI 10.1073/pnas.87.19.7536; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; ISHII S, 1985, P NATL ACAD SCI USA, V82, P4920, DOI 10.1073/pnas.82.15.4920; ISHII S, 1985, SCIENCE, V230, P1378, DOI 10.1126/science.2999983; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; JOHNSON AC, 1988, J BIOL CHEM, V263, P5693; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KAGEYAMA R, 1989, CELL, V59, P815, DOI 10.1016/0092-8674(89)90605-3; KOHNO M, 1986, BIOCHEM J, V238, P451, DOI 10.1042/bj2380451; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; L'Allemain Gilles, 1994, Progress in Growth Factor Research, V5, P291, DOI 10.1016/0955-2235(94)90011-6; LI L, 1994, ONCOGENE, V9, P647; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MATHIS DJ, 1981, NATURE, V290, P310, DOI 10.1038/290310a0; MCGROGAN M, 1985, J BIOL CHEM, V260, P2307; MELOCHE S, 1992, MOL BIOL CELL, V3, P63, DOI 10.1091/mbc.3.1.63; MELTON DW, 1986, CELL, V44, P319, DOI 10.1016/0092-8674(86)90766-X; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; PAPKOFF J, 1994, MOL CELL BIOL, V14, P463, DOI 10.1128/MCB.14.1.463; PECORINO LT, 1991, MOL CELL BIOL, V11, P3139, DOI 10.1128/MCB.11.6.3139; PERKINS KK, 1990, GENE DEV, V4, P822, DOI 10.1101/gad.4.5.822; RAY LB, 1988, P NATL ACAD SCI USA, V85, P3753, DOI 10.1073/pnas.85.11.3753; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; RICHET E, 1989, EMBO J, V8, P981, DOI 10.1002/j.1460-2075.1989.tb03461.x; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; SAZER S, 1986, J BIOL CHEM, V261, P4685; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; VILA J, 1988, J CELL PHYSIOL, V135, P285, DOI 10.1002/jcp.1041350216; WATT R, 1983, P NATL ACAD SCI-BIOL, V80, P6307, DOI 10.1073/pnas.80.20.6307; WEIS L, 1992, FASEB J, V6, P3300, DOI 10.1096/fasebj.6.14.1426767; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; YANG XD, 1995, J BIOL CHEM, V270, P8514, DOI 10.1074/jbc.270.15.8514	61	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					26986	26992		10.1074/jbc.270.45.26986	http://dx.doi.org/10.1074/jbc.270.45.26986			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592946	hybrid			2022-12-27	WOS:A1995TE58300046
J	PIXLEY, FJ; LEE, PSW; DOMINGUEZ, MG; EINSTEIN, DB; STANLEY, ER				PIXLEY, FJ; LEE, PSW; DOMINGUEZ, MG; EINSTEIN, DB; STANLEY, ER			A HETEROMORPHIC PROTEIN-TYROSINE-PHOSPHATASE, PTP-PHI, IS REGULATED BY CSF-1 IN MACROPHAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; HUMAN-PLACENTA; SH2 DOMAIN; EXPRESSION; CLONING; CELL; RNA; PURIFICATION; DROSOPHILA; SEQUENCE	A novel protein-tyrosine phosphatase, PTP phi, was cloned from a murine macrophage cDNA library, As a result of alternative splicing, macrophage PTP phi mRNAs are predicted to encode two membrane-spanning molecules and a cytosolic enzyme with identical catalytic domains, The membrane spanning forms differ in the juxtamembrane region, while a start codon downstream of this region is utilized in the translation of the putative cytosolic form. Expression of PTP phi, mRNA is low and restricted to macrophage cell lines, macrophage-rich tissues, and brain, kidney, and heart. The mRNA in macrophages and heart is similar to 2.8 kilobases (kb), However, a similar to 5.5-kb transcript in brain and kidney indicates a fourth isoform encoding a large extracellular domain. The similar to 5.5-kb PTP phi brain mRNA encodes the mouse homolog of GLEPP1, a recently reported glomerular epithelial protein. The level of expression of the mRNA encoding the cytosolic form was very low, and only the membrane-spanning proteins (43 and 47 kDa) could be detected in macrophages. Following addition of colony stimulating factor-1 to quiescent BAC1.2F5 macrophages, PTP phi mRNA and protein were down-regulated. The restricted expression of the shorter isoforms of PTP phi and their regulation by colony stimulating factor-1 in macrophages suggest that PTP phi may play a role in mononuclear phagocyte survival, proliferation, and/or differentiation.	ALBERT EINSTEIN COLL MED,DEPT DEV & MOLEC BIOL,BRONX,NY 10461	Yeshiva University; Albert Einstein College of Medicine			Stanley, Evan R/J-9154-2013; Pixley, Fiona/ABD-5567-2020	Stanley, Evan R/0000-0002-2910-2065; Pixley, Fiona/0000-0002-1571-2532	NATIONAL CANCER INSTITUTE [R01CA026504, R37CA026504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NCI NIH HHS [CA 26504] Funding Source: Medline; NIGMS NIH HHS [T32-GM07288] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel FM, 1989, CURRENT PROTOCOLS MO, V1-3; BOOCOCK CA, 1992, J LEUKOCYTE BIOL, V51, P535, DOI 10.1002/jlb.51.6.535; BRAUTIGAN DL, 1988, METHOD ENZYMOL, V159, P339; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; CHARBONNEAU H, 1992, ANNU REV CELL BIOL, V8, P463, DOI 10.1146/annurev.cellbio.8.1.463; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; GEBBINK MFBG, 1993, J BIOL CHEM, V268, P16101; GU MX, 1992, P NATL ACAD SCI USA, V89, P2980, DOI 10.1073/pnas.89.7.2980; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; HUME DA, 1984, ANAT REC, V210, P503, DOI 10.1002/ar.1092100311; ICHIKAWA Y, 1969, J CELL PHYSIOL, V74, P223, DOI 10.1002/jcp.1040740303; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; LACHMAN HM, 1984, NATURE, V310, P592, DOI 10.1038/310592a0; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; LEVY JB, 1993, J BIOL CHEM, V268, P10573; MATTHEWS RJ, 1990, P NATL ACAD SCI USA, V87, P4444, DOI 10.1073/pnas.87.12.4444; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; MEI L, 1994, J BIOL CHEM, V269, P12254; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; OUN SH, 1993, J BIOL CHEM, V268, P23964; PAN MG, 1993, J BIOL CHEM, V268, P19284; PELECH S, 1985, EUR J BIOCHEM, V148, P245, DOI 10.1111/j.1432-1033.1985.tb08832.x; PLUTZKY J, 1992, P NATL ACAD SCI USA, V89, P1123, DOI 10.1073/pnas.89.3.1123; POT DA, 1991, J BIOL CHEM, V266, P19688; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAP J, 1994, MOL CELL BIOL, V14, P1; SHEN SH, 1991, NATURE, V352, P736, DOI 10.1038/352736a0; STREULI M, 1987, J EXP MED, V166, P1548, DOI 10.1084/jem.166.5.1548; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; STREULI M, 1988, J EXP MED, V168, P1553; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; THOMAS PE, 1994, J BIOL CHEM, V269, P19953; TIAN SS, 1991, CELL, V67, P675, DOI 10.1016/0092-8674(91)90063-5; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TONKS NK, 1988, J BIOL CHEM, V263, P6722; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WANG Y, 1991, EMBO J, V10, P3231, DOI 10.1002/j.1460-2075.1991.tb04886.x; YANG Q, 1991, P NATL ACAD SCI USA, V88, P5949, DOI 10.1073/pnas.88.14.5949; YANG XH, 1991, CELL, V67, P661, DOI 10.1016/0092-8674(91)90062-4; YEUNG YG, 1992, J BIOL CHEM, V267, P23447; YI TL, 1992, MOL CELL BIOL, V12, P836, DOI 10.1128/MCB.12.2.836	47	46	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 10	1995	270	45					27339	27347		10.1074/jbc.270.45.27339	http://dx.doi.org/10.1074/jbc.270.45.27339			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TE583	7592997	hybrid			2022-12-27	WOS:A1995TE58300097
J	GUZDER, SN; SUNG, P; PRAKASH, S; PRAKASH, L				GUZDER, SN; SUNG, P; PRAKASH, S; PRAKASH, L			LETHALITY IN YEAST OF TRICHOTHIODYSTROPHY (TTD) MUTATIONS IN THE HUMAN XERODERMA-PIGMENTOSUM GROUP-D GENE - IMPLICATIONS FOR TRANSCRIPTIONAL DEFECT IN TTD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SACCHAROMYCES-CEREVISIAE; DNA HELICASE; RAD3 PROTEIN; MUTAGENESIS; SELECTION; ENCODES; REPAIR; ATPASE	Mutations in the human XPD gene result in a defect in nucleotide excision repair of ultraviolet damaged DNA and cause the cancer-prone syndrome xeroderma pigmentosum (XP). Resides XP, mutations in XPD can cause another seemingly unrelated syndrome, trichothiodystrophy (TTD), characterized by sulfur-deficient brittle hair, ichthyosis, and physical and mental retardation. To ascertain the underlying defect responsible for TTD, we have expressed the TTD mutant proteins in the yeast Saccharomyces cerevisiae and determined if these mutations can rescue the inviability of a rad3 null mutation. RAD3, the S. cerevisiae counterpart of XPD, is required for nucleotide excision repair and also has an essential role in RNA polymerase II transcription. Expression of the wild type XPD protein or the XPD Arg-48 protein carrying a mutation in the DNA helicase domain restores viability to the rad3 null mutation. Interestingly, the XPD variants containing TTD mutations fail to complement the lethality of the rad3 null mutation, strongly suggesting that TTD mutations impair the ability of XPD protein to function normally in RNA polymerase II transcription. From our studies, we conclude that XPD DNA helicase activity is not essential for transcription and infer that TTD mutations in XPD result in a defect in transcription.	UNIV TEXAS,MED BRANCH,SEALY CTR MOLEC SCI,GALVESTON,TX 77555	University of Texas System; University of Texas Medical Branch Galveston			Prakash, Louise/C-7891-2012; Prakash, Satya/C-6420-2013	Prakash, Louise/0000-0001-9143-6261; Prakash, Satya/0000-0001-7228-1444	NCI NIH HHS [CA35035] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA035035, R01CA035035] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BROUGHTON BC, 1994, NAT GENET, V7, P189, DOI 10.1038/ng0694-189; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; GEISSELSODER J, 1987, BIOTECHNIQUES, V5, P786; GUZDER S, 1994, NATURE, V369, P579; GUZDER SN, 1994, NATURE, V367, P91, DOI 10.1038/367091a0; JOHNSON RT, 1992, MUTAT RES, V273, P97, DOI 10.1016/0921-8777(92)90072-B; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEHMANN A R, 1987, Cancer Reviews, V7, P82; MA LB, 1994, NUCLEIC ACIDS RES, V22, P4095, DOI 10.1093/nar/22.20.4095; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; QIU HF, 1993, GENE DEV, V7, P2161, DOI 10.1101/gad.7.11.2161; REYNOLDS PR, 1992, NUCLEIC ACIDS RES, V20, P2327, DOI 10.1093/nar/20.9.2327; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; SUNG P, 1987, P NATL ACAD SCI USA, V84, P6045, DOI 10.1073/pnas.84.17.6045; SUNG P, 1987, P NATL ACAD SCI USA, V84, P8951, DOI 10.1073/pnas.84.24.8951; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; SUNG P, 1994, J BIOL CHEM, V269, P8303; XIAO H, 1994, MOL CELL BIOL, V14, P7013, DOI 10.1128/MCB.14.10.7013	22	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 28	1995	270	30					17660	17663		10.1074/jbc.270.30.17660	http://dx.doi.org/10.1074/jbc.270.30.17660			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RM266	7629061	hybrid			2022-12-27	WOS:A1995RM26600006
J	FRERE, V; SOURGEN, F; MONNOT, M; TROALEN, F; FERMANDJIAN, S				FRERE, V; SOURGEN, F; MONNOT, M; TROALEN, F; FERMANDJIAN, S			A PEPTIDE FRAGMENT OF HUMAN DNA TOPOISOMERASE-II-ALPHA FORMS A STABLE COILED-COIL STRUCTURE IN SOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GCN4 LEUCINE-ZIPPER; SECONDARY STRUCTURE; PROTEINS; DESIGN; PURIFICATION; SPECTROSCOPY; DIMERIZATION; PREDICTION; BINDING; MOTIF	Results are presented on a peptide fragment (1013-1056) from human DNA topoisomerase II alpha. This was selected using the procedure of Lupas et al. (Lupas, A., Van Dyke, M., and Stock, J. (1991) Science 252, 1162-1164) for its potential to adopt a stable coiled-coil structure. The same theoretical treatment rejected the segment 994-1021 proposed by Zwelling and Perry (Zwelling, L. A., and Perry, W. M. (1989) Mol. Endocrinol. 3, 603-604) as a possible core for leucine-zipper formation. Our experimental studies combine cross-linking and CD analysis. Cross-linking establishes that the 1013-1056 fragment forms a stable hormodimer in solution. Effects of increasing peptide concentration on CD spectra confirm that only the 1013-1056 fragment can undergo a coiled-coil stabilization from an isolated alpha-helix. Unfolding experiments further show that the coiled-coil is more stable in guanidium chloride than in urea. Values of -6.8 and -7.4 kcal/mol for the dimerization free energy are determined by thermal and urea unfolding, respectively. These are strikingly similar to the value recently found for the dissociation/reassociation of the entire yeast topoisomerase II from sedimentation equilibrium experiments (Lamhasni, S., Larsen, A. K., Barray, M., Monnot, M., Delain, E., and Fermandjian, S. (1995) Biochemistry 34, 3632-3639), although their significance relatively to topoisomerase II undoubtedly requires further analysis.	INST GUSTAVE ROUSSY,DEPT BIOL & PHARMACOL STRUCT,CNRS,URA 147,F-94805 VILLEJUIF,FRANCE; INST GUSTAVE ROUSSY,SERV IMMUNOL MOLEC,F-94805 VILLEJUIF,FRANCE	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy								BALDWIN RL, 1986, TRENDS BIOCHEM SCI, V11, P6, DOI 10.1016/0968-0004(86)90219-7; BIOU V, 1988, PROTEIN ENG, V2, P185, DOI 10.1093/protein/2.3.185; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; CARON PR, 1994, MOL CELL BIOL, V14, P3197, DOI 10.1128/MCB.14.5.3197; CARON PR, 1993, MOLECULAR BIOLOGY OF DNA TOPOISOMERASES AND ITS APPLICATION CHEMOTHERAPY, P1; COHEN C, 1986, TRENDS BIOCHEM SCI, V11, P245, DOI 10.1016/0968-0004(86)90186-6; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; CONEJEROLARA F, 1994, FEBS LETT, V344, P154, DOI 10.1016/0014-5793(94)00358-0; COOPER TM, 1990, BIOPOLYMERS, V30, P657, DOI 10.1002/bip.360300703; CORBETT AH, 1993, CHEM RES TOXICOL, V6, P585, DOI 10.1021/tx00035a001; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; CURRAN T, 1992, TRANSCRIPTIONAL REGU, P797; ENGEL M, 1991, BIOCHEMISTRY-US, V30, P3161, DOI 10.1021/bi00227a002; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GOTO T, 1984, CELL, V36, P1073, DOI 10.1016/0092-8674(84)90057-6; HALLIGAN BD, 1985, J BIOL CHEM, V260, P2475; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hodges R. S., 1972, COLD SPRING HARB SYM, V37, P299; HOLMES MA, 1982, J MOL BIOL, V160, P623, DOI 10.1016/0022-2836(82)90319-9; JAENICKE R, 1987, PROG BIOPHYS MOL BIO, V49, P117, DOI 10.1016/0079-6107(87)90011-3; Jaenicke R, 1986, Methods Enzymol, V131, P218; Kerppola TK, 1991, CURR OPIN STRUC BIOL, V1, P71, DOI 10.1016/0959-440X(91)90014-K; KRYLOV D, 1994, EMBO J, V13, P2849, DOI 10.1002/j.1460-2075.1994.tb06579.x; LAMHASNI S, 1995, BIOCHEMISTRY-US, V34, P3632, DOI 10.1021/bi00011a018; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAU SYM, 1984, J BIOL CHEM, V259, P3253; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; MONERA OD, 1993, J BIOL CHEM, V268, P19218; OAS TG, 1990, BIOCHEMISTRY-US, V29, P2891, DOI 10.1021/bi00464a001; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; OSHEROFF N, 1989, PHARMACOL THERAPEUT, V41, P223, DOI 10.1016/0163-7258(89)90108-3; Pace C N, 1986, Methods Enzymol, V131, P266; RICO M, 1994, BIOCHEMISTRY-US, V33, P14834, DOI 10.1021/bi00253a023; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHELTON ER, 1983, J BIOL CHEM, V258, P9530; VINSON CR, 1993, GENE DEV, V7, P1047, DOI 10.1101/gad.7.6.1047; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; Woody RW, 1985, PEPTIDES ANAL SYNTHE, P15; YOO SH, 1993, BIOCHEMISTRY-US, V32, P8816, DOI 10.1021/bi00085a012; ZHONG LX, 1992, P NATL ACAD SCI USA, V89, P4462, DOI 10.1073/pnas.89.10.4462; ZWELLING LA, 1989, MOL ENDOCRINOL, V3, P603, DOI 10.1210/mend-3-3-603	46	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17502	17507		10.1074/jbc.270.29.17502	http://dx.doi.org/10.1074/jbc.270.29.17502			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615554	hybrid			2022-12-27	WOS:A1995RK68900070
J	WEBB, HK; MATTHEWS, RG				WEBB, HK; MATTHEWS, RG			4-CHLOROTHREONINE IS SUBSTRATE, MECHANISTIC PROBE, AND MECHANISM-BASED INACTIVATOR OF SERINE HYDROXYMETHYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSHYDROXYMETHYLASE; BENZALDEHYDES	Serine hydroxymethyltransferase catalyzes the cleavage of a variety of beta-hydroxy-L-amino acids to form glycine and aldehyde products. 4-chloro-L-threonine has been synthesized and shown to be both a substrate and a mechanism-based inactivator of serine hydroxymethyltransferase. k(cat) values for the formation of glycine in the absence of tetrahydrofolate were determined for 4-chloro-L-threonine and other beta-hydroxyamino acid substrates; an inverse relationship between the rate of cleavage of the amino acid and the electrophilicity of the product aldehyde was demonstrated. 4-Chloro-L-threonine inactivates serine hydroxymethyltransferase in a time- and concentration-dependent manner and exhibits saturation of the rate of inactivation at high concentrations. Our evidence suggests that 4-chlorothreonine undergoes aldol cleavage, and generation of chloroacetaldehyde at the active site of the enzyme results in inactivation. Serine or glycine protect the enzyme against inactivation by chlorothreonine, while tetrahydrofolate does not. The enzyme is also protected from inactivation by 2-mercaptoethanol or by alcohol dehydrogenase and NADH. These studies suggest that halothreonine derivatives that generate electrophilic aldehyde products will be effective inhibitors of serine hydroxymethyltransferase and might be potentially useful chemotherapeutic agents.	UNIV MICHIGAN,DIV BIOPHYS RES,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT BIOL CHEM,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan					NIGMS NIH HHS [R37 GM24908] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024908] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKHTAR M, 1975, BIOCHEM J, V145, P159, DOI 10.1042/bj1450159; BOIT HG, 1963, BEILSTEIN HDB O 2 S3, V4, P1623; BRADFORD MM, 1976, ANAL BIOCHEM, V22, P248; CHEN MS, 1973, J BIOL CHEM, V248, P3631; CHEN MS, 1973, J BIOL CHEM, V248, P7979; CIACCIO JA, 1986, TETRAHEDRON LETT, V27, P3697, DOI 10.1016/S0040-4039(00)83856-3; EICHLER HG, 1981, BIOSCIENCE REP, V1, P101, DOI 10.1007/BF01117006; FIESER LF, 1967, REAGENTS ORGANIC SYN, V1, P135; Finkelstein H, 1910, BER DTSCH CHEM GES, V43, P1528, DOI 10.1002/cber.19100430257; GREENZAID P, 1967, J AM CHEM SOC, V89, P749, DOI 10.1021/ja00980a004; GREENZAID P, 1973, J ORG CHEM, V38, P3164, DOI 10.1021/jo00958a019; GUTHRIE JP, 1975, CAN J CHEM, V53, P898, DOI 10.1139/v75-125; HANESSIAN S, 1984, TETRAHEDRON LETT, V14, P1425; KITZ RJ, 1965, BIOCHEM PHARMACOL, V14, P1471, DOI 10.1016/0006-2952(65)90180-2; LEHENAFF P, 1968, B SOC CHIM FR, V11, P4687; MATTHEWS RG, 1982, BIOCHEMISTRY-US, V21, P1230, DOI 10.1021/bi00535a019; MCCLELLAND RA, 1983, J AM CHEM SOC, V105, P2718, DOI 10.1021/ja00347a033; MUSCATE A, 1995, BURGERS MED CHEM DRU, V1, P733; SCHIRCH L, 1968, J BIOL CHEM, V243, P5651; SCHIRCH L, 1984, FOLATES PTERINS, P399; SCHIRCH LV, 1971, J BIOL CHEM, V246, P3961; SHAW KJ, 1985, J ORG CHEM, V50, P4515, DOI 10.1021/jo00223a019; SHIVELY JE, 1986, METHODS PROTEIN MICR, P155; SNELL K, 1989, CANCER LETT, V44, P217, DOI 10.1016/0304-3835(89)90064-5; STOVER P, 1992, J BIOL CHEM, V267, P17679; ULEVITCH RJ, 1977, BIOCHEMISTRY-US, V16, P5355, DOI 10.1021/bi00643a029; ULEVITCH RJ, 1977, BIOCHEMISTRY-US, V16, P5342, DOI 10.1021/bi00643a027; WEBB H, 1995, THESIS U MICHIGAN; WILSON EM, 1962, J BIOL CHEM, V237, P3180	29	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 21	1995	270	29					17204	17209		10.1074/jbc.270.29.17204	http://dx.doi.org/10.1074/jbc.270.29.17204			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RK689	7615518	hybrid			2022-12-27	WOS:A1995RK68900025
J	BUGGE, TH; SUH, TT; FLICK, MJ; DAUGHERTY, CC; ROMER, J; SOLBERG, H; ELLIS, V; DANO, K; DEGEN, JL				BUGGE, TH; SUH, TT; FLICK, MJ; DAUGHERTY, CC; ROMER, J; SOLBERG, H; ELLIS, V; DANO, K; DEGEN, JL			THE RECEPTOR FOR UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IS NOT ESSENTIAL FOR MOUSE DEVELOPMENT OR FERTILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; CELL-SURFACE RECEPTOR; ENDOTHELIAL-CELLS; HUMAN-TUMOR; GENE-EXPRESSION; STEM-CELLS; MEMBRANE; INVASION; LOCALIZATION; PROTEIN	The urokinase-type plasminogen activator receptor (uPAR) gene was disrupted in mice in order to explore the role of cell surface-associated plasminogen activation in development and hemostasis. Homozygous, uPAR(-/-) mice were born and survived to adulthood with no overt phenotypic abnormalities. There was no indication of loss of fetal animals based on the Mendelian pattern of transmission of the mutant uPAR gene. uPAR(-/-) mice carried no detectable uPAR in lung, spleen, and other tissues when measured both immunologically by Western blot analysis and functionally by ligand cross-linking analyses. In addition, activated peritoneal macrophages collected from uPAR(-/-) mice failed to promote plasminogen activation in vitro. The loss of the receptor also resulted in a redistribution of uPA in some tissues but had no impact on pro-uPA activation in the urogenital tract. Thus, in the absence of other challenging factors such as infection, injury, or other functional deficits, uPAR deficiency does not compromise fertility, development, or hemostasis. These mice provide a means to test the proposed function of uPA/uPAR in wound repair, atherogenesis, and tumor cell invasion in vivo.	CHILDRENS HOSP RES FDN,DIV PATHOL,CINCINNATI,OH 45229; THROMBOSIS RES INST,LONDON SW3 6LR,ENGLAND; RIGSHOSP,FINSEN LAB,DK-2100 COPENHAGEN O,DENMARK	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Thrombosis Research Institute; Rigshospitalet	BUGGE, TH (corresponding author), CHILDRENS HOSP RES FDN,DIV BASIC SCI,TCHRF 2025,3333 BURNET AVE,CINCINNATI,OH 45229, USA.		Ellis, Vincent/D-1860-2009	Ellis, Vincent/0000-0003-1956-073X	NHLBI NIH HHS [HL47826] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047826] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBRECHT JC, 1992, VIROLOGY, V190, P527, DOI 10.1016/0042-6822(92)91247-R; APPELLA E, 1987, J BIOL CHEM, V262, P4437; BARNATHAN ES, 1990, J BIOL CHEM, V265, P2865; BEHRENDT N, 1991, J BIOL CHEM, V266, P7842; BELL SM, 1990, J BIOL CHEM, V265, P1333; BOND JS, 1987, ANNU REV BIOCHEM, V56, P333, DOI 10.1146/annurev.bi.56.070187.002001; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; COLLEN D, 1994, MOL BASIS BLOOD DIS, P725; CROWLEY CW, 1993, P NATL ACAD SCI USA, V90, P5021, DOI 10.1073/pnas.90.11.5021; DANO K, 1980, BIOCHIM BIOPHYS ACTA, V613, P542, DOI 10.1016/0005-2744(80)90110-2; DANO K, 1994, FIBRINOLYSIS, V8, P189, DOI 10.1016/0268-9499(94)90717-X; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DAVIES A, 1989, J EXP MED, V170, P637, DOI 10.1084/jem.170.3.637; DEGEN JL, 1985, J BIOL CHEM, V260, P2426; DUMLER I, 1993, FEBS LETT, V322, P37, DOI 10.1016/0014-5793(93)81106-A; DVORAK HF, 1992, ANN NY ACAD SCI, V667, P101, DOI 10.1111/j.1749-6632.1992.tb51603.x; ELLIS V, 1989, J BIOL CHEM, V264, P2185; ELLIS V, 1992, FIBRINOLYSIS, V6, P27; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; FRIEDMAN GC, 1994, DEV BRAIN RES, V81, P41, DOI 10.1016/0165-3806(94)90066-3; FRIEDMAN S, 1990, IMMUNOGENETICS, V31, P104, DOI 10.1007/BF00661220; GRAINGER DJ, 1994, NATURE, V370, P460, DOI 10.1038/370460a0; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; GYETKO MR, 1994, J CLIN INVEST, V93, P1380, DOI 10.1172/JCI117114; HECKEL JL, 1990, CELL, V62, P447, DOI 10.1016/0092-8674(90)90010-C; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; KIELBERG V, 1985, FEBS LETT, V182, P441, DOI 10.1016/0014-5793(85)80350-1; KOOK YH, 1994, EMBO J, V13, P3983, DOI 10.1002/j.1460-2075.1994.tb06714.x; KRISTENSEN P, 1991, J CELL BIOL, V115, P1763, DOI 10.1083/jcb.115.6.1763; LARSSON LI, 1984, J CELL BIOL, V98, P896; LI H, 1994, EMBO J, V13, P2876, DOI 10.1002/j.1460-2075.1994.tb06582.x; MAGNATTI P, 1993, PHYSIOL REV, V73, P161; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705; MIGNATTI P, 1986, CELL, V47, P487, DOI 10.1016/0092-8674(86)90613-6; MOLLER LB, 1993, J BIOL CHEM, V268, P11152; MORIOKA S, 1987, J INVEST DERMATOL, V88, P418, DOI 10.1111/1523-1747.ep12469754; MOSCATELLI D, 1988, BIOCHIM BIOPHYS ACTA, V948, P67, DOI 10.1016/0304-419X(88)90005-4; NIELSEN LS, 1988, J BIOL CHEM, V263, P2358; OSSOWSKI L, 1991, CANCER RES, V51, P274; OSSOWSKI L, 1988, CELL, V52, P321, DOI 10.1016/S0092-8674(88)80025-4; OSSOWSKI L, 1991, J CELL BIOL, V115, P1107, DOI 10.1083/jcb.115.4.1107; PALFREE RGE, 1991, IMMUNOL TODAY, V12, P170, DOI 10.1016/0167-5699(91)90086-9; PEPPER MS, 1993, J CELL BIOL, V122, P673, DOI 10.1083/jcb.122.3.673; PEPPER MS, 1990, CELL DIFFER DEV, V32, P319, DOI 10.1016/0922-3371(90)90046-Y; PEPPER MS, 1987, J CELL BIOL, V105, P2535, DOI 10.1083/jcb.105.6.2535; PLOUG M, 1993, J BIOL CHEM, V268, P17539; PLOUG M, 1991, J BIOL CHEM, V266, P1926; RABBANI SA, 1990, BIOCHEM BIOPH RES CO, V173, P1058, DOI 10.1016/S0006-291X(05)80893-9; REID LH, 1990, P NATL ACAD SCI USA, V87, P4299, DOI 10.1073/pnas.87.11.4299; RENNUNG U, 1992, ARTERIOSCLER THROMB, V12, P1161; ROMER J, 1994, J INVEST DERMATOL, V102, P519, DOI 10.1111/1523-1747.ep12373187; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; SAPPINO AP, 1989, J CELL BIOL, V109, P2471, DOI 10.1083/jcb.109.5.2471; SKRIVER L, 1982, EUR J BIOCHEM, V124, P409; SOLBERG H, 1992, EUR J BIOCHEM, V205, P451, DOI 10.1111/j.1432-1033.1992.tb16799.x; SOLBERG H, 1994, INT J CANCER, V58, P877, DOI 10.1002/ijc.2910580622; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; STETLERSTEVENSO.WG, 1993, ANNU REV CELL BIOL, V9, P541; STRICKLAND DK, 1994, FIBRINOLYSIS, V8, P204, DOI 10.1016/0268-9499(94)90718-8; SUH TT, 1994, J BIOL CHEM, V269, P25992; Vassalli J D, 1992, Curr Top Microbiol Immunol, V181, P65; VASSALLI JD, 1977, CELL, V11, P695, DOI 10.1016/0092-8674(77)90086-1; WEI Y, 1994, J BIOL CHEM, V269, P32380; WERB Z, 1977, NEW ENGL J MED, V296, P1017, DOI 10.1056/NEJM197705052961801; WILLIAMS AF, 1988, IMMUNOGENETICS, V27, P265, DOI 10.1007/BF00376121; ZINI JM, 1992, BLOOD, V79, P2917	68	189	196	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16886	16894		10.1074/jbc.270.28.16886	http://dx.doi.org/10.1074/jbc.270.28.16886			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622505	hybrid			2022-12-27	WOS:A1995RJ34700066
J	NELSON, CC; HENDY, SC; ROMANIUK, PJ				NELSON, CC; HENDY, SC; ROMANIUK, PJ			RELATIONSHIP BETWEEN P-BOX AMINO-ACID-SEQUENCE AND DNA-BINDING SPECIFICITY OF THE THYROID-HORMONE RECEPTOR - THE EFFECTS OF SEQUENCES FLANKING HALF-SITES IN THYROID-HORMONE RESPONSE ELEMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID; GLUCOCORTICOID RECEPTOR; ESTROGEN-RECEPTOR; HIGH-AFFINITY; DOMAIN; ALPHA; SUPERFAMILY; ALTERS	The three P-box amino acids in the DNA recognition alpha-helix of steroid/thyroid hormone receptors participate in the discrimination of the central base pairs of the hexameric half-sites of receptor response elements in DNA. Using a series of variant receptors incorporating all 19 possible substitutions for each individual P-box amino acid of the human thyroid hormone receptor (hT3R beta), we demonstrated that the first P-box position must have a glutamate, and the second P-box position must have either an alanine or a glycine for high affinity binding to everted repeat elements with half-site sequences of AGGNCA. In the present study, the influence of half-site flanking sequence on the compatibility of P-box amino acids in hT3R beta with DNA binding was investigated. When a 5' sequence of CTG flanked AGGNCA half-sites in an everted repeat, several additional P-box variant receptors were able to bind to the DNA that were not able to bind when the half-sites were flanked with the 5' sequence GAG. Flanking sequence had the most dramatic effects on amino acid substitutions at the first P-box position, with smaller effects observed at the second P-box position and only subtle effects observed at the third P-box position. Expansion of the number of P-box sequences compatible with binding of hT3R beta to thyroid hormone response elements required the thymidine in the CTG flanking sequence, an everted repeat of the AGGNCA half-sites, and an intermolecular interaction in the C terminus of the receptor.	UNIV VICTORIA,DEPT BIOCHEM & MICROBIOL,VICTORIA,BC V8W 3P6,CANADA	University of Victoria				Romaniuk, Paul/0000-0002-5931-8879				ANDERSSON ML, 1992, NUCLEIC ACIDS RES, V20, P4803, DOI 10.1093/nar/20.18.4803; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; DANIELSEN M, 1989, CELL, V57, P1131, DOI 10.1016/0092-8674(89)90050-0; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FREEDMAN LP, 1991, MOL ENDOCRINOL, V5, P1815, DOI 10.1210/mend-5-12-1815; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; KATZ RW, 1993, J BIOL CHEM, V268, P19392; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; LAUDET V, 1992, EMBO J, V11, P1003, DOI 10.1002/j.1460-2075.1992.tb05139.x; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; MIYAMOTO T, 1993, MOL ENDOCRINOL, V7, P224, DOI 10.1210/me.7.2.224; NAAR AM, 1991, CELL, V65, P1267, DOI 10.1016/0092-8674(91)90021-P; NELSON CC, 1995, J BIOL CHEM, V270, P16981, DOI 10.1074/jbc.270.28.16981; NELSON CC, 1994, MOL ENDOCRINOL, V8, P829, DOI 10.1210/me.8.7.829; NELSON CC, 1993, MOL ENDOCRINOL, V7, P1185, DOI 10.1210/me.7.9.1185; RIBEIRO RC, 1992, MOL ENDOCRINOL, V6, P1142, DOI 10.1210/me.6.7.1142; SCHRADER M, 1994, J BIOL CHEM, V269, P6444; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; UEDA H, 1992, MOL CELL BIOL, V12, P5667, DOI 10.1128/MCB.12.12.5667; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WILLIAMS GR, 1992, MOL ENDOCRINOL, V6, P1527, DOI 10.1210/me.6.10.1527; WILSON TE, 1992, SCIENCE, V256, P107, DOI 10.1126/science.1314418; YEN PM, 1992, J BIOL CHEM, V267, P23248; ZILLIACUS J, 1994, P NATL ACAD SCI USA, V91, P4175, DOI 10.1073/pnas.91.10.4175	27	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16988	16994		10.1074/jbc.270.28.16988	http://dx.doi.org/10.1074/jbc.270.28.16988			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622519	hybrid			2022-12-27	WOS:A1995RJ34700080
J	PENG, SB				PENG, SB			NUCLEOTIDE LABELING AND RECONSTITUTION OF THE RECOMBINANT 58-KDA SUBUNIT OF THE VACUOLAR PROTON-TRANSLOCATING ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H+-ATPASE; B-SUBUNIT; ADENOSINE-TRIPHOSPHATASE; PUMP; BINDING; INHIBITORS; EXPRESSION; COMPLEX; PROTEIN; ISOFORM	Evidence suggests that ATP hydrolysis catalyzed by the clathrin-coated vesicle proton-translocating ATPase requires at least four polypeptides of molecular masses of 70, 58, 40, and 33 kDa (Xie, X.-S., and Stone, D.K. (1988) J. Biol. Chem. 263, 9859-9867). To further investigate the subunit requirements for ATP hydrolysis, histidine-tagged, 58-kDa polypeptide was expressed in insect Sf9 (Spodoptera frugiperda) cells. After purification by Ni2+-nitrolotriacetic acid chromatography, the 58-kDa protein was found to lack significant ATPase activity. However, the subunit was photoaffinity labeled with [alpha-P-32]ATP, [C-14]ADP, or S-35-labeled ADP and UV irradiation in a divalent cation-dependent manner. The labeling was saturable with an apparent K-d of 4 mu M for both ATP and ADP. ATP and ADP competition labeling experiments indicate that the two nucleotides share the same binding site. When reconstituted with recombinant 70-kDa subunit and a biochemically prepared catalytic sector (V-c) depleted of the 70- and 58-kDa subunits, the 58-kDa component restores Ca2+-activated ATP hydrolysis to a specific activity of 0.19 mu mol P-i x mg protein(-1) x min(-1), thus demonstrating that ATP hydrolysis in vacuolar type proton pumps is dependent upon the 58-kDa subunit as well as multi-subunit interactions.			PENG, SB (corresponding author), UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DIV MOLEC TRANSPORT,DALLAS,TX 75235, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033627] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-33627] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ALAWQATI Q, 1986, ANNU REV CELL BIOL, V2, P179, DOI 10.1146/annurev.cellbio.2.1.179; ALPERN RA, 1990, KIDNEY, P318; ARAI H, 1989, BIOCHEMISTRY-US, V26, P6632; BERNASCONI P, 1990, J BIOL CHEM, V265, P17428; BOWMAN BJ, 1988, J BIOL CHEM, V263, P14002; BOWMAN EJ, 1986, P NATL ACAD SCI USA, V83, P48, DOI 10.1073/pnas.83.1.48; CRIDER BP, 1994, J BIOL CHEM, V269, P17379; FORGAC M, 1989, PHYSIOL REV, V69, P765, DOI 10.1152/physrev.1989.69.3.765; KEILY B, 1968, J BIOL CHEM, V243, P2273; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAITALA T, 1994, J CLIN INVEST, V93, P2311, DOI 10.1172/JCI117235; MANOLSON MF, 1985, J BIOL CHEM, V260, P2273; MANOLSON MF, 1988, J BIOL CHEM, V263, P17987; MARQUARDT D, 1991, JNCI-J NATL CANCER I, V83, P1098, DOI 10.1093/jnci/83.15.1098; MATTSSON JP, 1994, J BIOL CHEM, V269, P24979; MATTSSON JP, 1991, BIOCHIM BIOPHYS ACTA, V1065, P261, DOI 10.1016/0005-2736(91)90238-4; MCCARTY RE, 1985, ENZYMES BIOL MEMBR, P383; MORIYAMA Y, 1987, J BIOL CHEM, V262, P9175; MORIYAMA Y, 1987, J BIOL CHEM, V262, P14723; NELSON H, 1989, J BIOL CHEM, V264, P1775; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; NOVAK FJS, 1992, BIOCHIM BIOPHYS ACTA, V1132, P67, DOI 10.1016/0167-4781(92)90053-3; PENG SB, 1994, J BIOL CHEM, V269, P27778; PENG SB, 1994, J BIOL CHEM, V269, P11356; PENG SB, 1993, J BIOL CHEM, V268, P23519; PERLIN DS, 1984, BIOCHEMISTRY-US, V23, P4998, DOI 10.1021/bi00316a026; PUOPOLO K, 1992, J BIOL CHEM, V267, P3696; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; STONE DK, 1984, J BIOL CHEM, V259, P2701; STONE DK, 1988, KIDNEY INT, V33, P403; STUDIER FW, 1989, METHOD ENZYMOL, V185, P60; SUDHOF TC, 1989, P NATL ACAD SCI USA, V86, P6067, DOI 10.1073/pnas.86.16.6067; SUN SZ, 1987, J BIOL CHEM, V262, P14790; SUUMMERS MD, 1987, TEXAS AGR EXPT STATI, V1555; TAKASE K, 1993, J BIOL CHEM, V268, P11610; WAGNER MC, 1989, CELL MOTIL CYTOSKEL, V12, P195, DOI 10.1002/cm.970120403; WEBER J, 1994, J BIOL CHEM, V269, P11261; XIE XS, 1986, J BIOL CHEM, V261, P2492; XIE XS, 1994, J BIOL CHEM, V269, P25809; XIE XS, 1988, J BIOL CHEM, V263, P9859; XIE XS, 1993, J BIOL CHEM, V268, P25063; XIE XS, 1989, J BIOL CHEM, V264, P1710; YU F, 1985, ARCH BIOCHEM BIOPHYS, V238, P61, DOI 10.1016/0003-9861(85)90140-7; 1992, QIA EXPRESSIONIST	47	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16926	16931						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622510				2022-12-27	WOS:A1995RJ34700071
J	VAUGHAN, A; HEMINGWAY, J				VAUGHAN, A; HEMINGWAY, J			MOSQUITO CARBOXYLESTERASE EST-ALPHA-2(1)(A(2)) - CLONING AND SEQUENCE OF THE FULL-LENGTH CDNA FOR A MAJOR INSECTICIDE RESISTANCE GENE WORLDWIDE IN THE MOSQUITO CULEX-QUINQUEFASCIATUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANO-PHOSPHATE RESISTANCE; APHIDS MYZUS-PERSICAE; PEACH-POTATO APHID; SRI-LANKA; ESTERASE GENE; CULICIDAE; DIPTERA; ORGANOPHOSPHATE; AMPLIFICATION; CARBAMATE	Organophosphorus insecticide resistance in Culex mosquitoes is commonly caused by increased activity of one or more esterases. The commonest phenotype involves elevation of the esterases Est alpha 2 (A(2)) and Est beta 2 (B-2). A cDNA encoding the Est alpha 2 esterase has now been isolated from a Sri Lankan insecticide-resistant mosquito (Culex quinquefasciatus, Say) expression library. In line with a recently suggested nomenclature system (Karunaratne, S. H. P. P. (1994) Characterization of Multiple Variants of Carboxylesterases Which Are Involved in Insecticide Resistance in the Mosquito Culex quinquefasciatus. Ph.D. thesis, University of London), as the first sequenced variant of this esterase, it is now referred to as Est alpha 2(1). The full-length cDNA of est alpha 2(1) codes for a 540-amino acid protein, which has high homology with other esterases and lipases and belongs to the serine or B-esterase enzyme family. The predicted secondary structure of Est alpha 2(1) is similar to the consensus secondary structure of proteins within the esterase/lipase family where the secondary and tertiary structures have been resolved. The level of identity (similar to 47% at the amino acid level) between the est alpha 2(1) and the various Culex est beta (B-1 and B-2) cDNA alleles that have been cloned and sequenced suggests that the two esterase loci are closely related and arose originally from duplication of a common ancestral gene. The lack of a distinct hydrophobic signal sequence for Est alpha 2(1) and two possible N-linked glycosylation sites, both situated close to the active site serine, suggest that it is a nonglycosylated protein that is not exported from the cell. Southern and dot blot analysis of genomic DNA from various insecticide-resistant and susceptible mosquito strains show that the est alpha 2(1) gene, like est beta 2(1), is amplified in resistant strains. The restriction fragment length polymorphism patterns, after probing Southern blots of EcoRI-digested genomic DNA with est alpha 2(1) cDNA, show that the amplified and nonamplified est alpha alleles differ in the resistant and susceptible Sri Lankan mosquitoes.	UNIV WALES COLL CARDIFF,SCH PURE & APPL BIOL,CARDIFF CF1 3TL,S GLAM,WALES	Cardiff University				Hemingway, Janet/0000-0002-3200-7173	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALDRIDGE WN, 1953, BIOCHEM J, V53, P110, DOI 10.1042/bj0530110; AMIN AM, 1990, MED VET ENTOMOL, V4, P269, DOI 10.1111/j.1365-2915.1990.tb00439.x; CALLAGHAN A, 1993, BIOCHEM GENET, V31, P459, DOI 10.1007/BF02426878; CHANG CK, 1983, PESTIC BIOCHEM PHYS, V19, P190, DOI 10.1016/0048-3575(83)90139-6; CYGLER M, 1993, PROTEIN SCI, V2, P366; DEVONSHIRE AL, 1977, BIOCHEM J, V167, P675, DOI 10.1042/bj1670675; DEVONSHIRE AL, 1982, PESTIC BIOCHEM PHYS, V18, P235, DOI 10.1016/0048-3575(82)90110-9; DEVONSHIRE AL, 1986, INSECT BIOCHEM, V16, P659, DOI 10.1016/0020-1790(86)90009-0; DEVONSHIRE AL, 1989, ENZYMES HYDROLYSING, P181; FIELD LM, 1993, BIOCHEM J, V294, P569, DOI 10.1042/bj2940569; FIELD LM, 1988, BIOCHEM J, V251, P309, DOI 10.1042/bj2510309; FOURNIER D, 1987, PESTIC BIOCHEM PHYS, V27, P211, DOI 10.1016/0048-3575(87)90048-4; GEORGHIOU GP, 1978, J ECON ENTOMOL, V71, P201, DOI 10.1093/jee/71.2.201; HERATH PRJ, 1987, PESTIC BIOCHEM PHYS, V29, P157, DOI 10.1016/0048-3575(87)90074-5; JAYAWARDENA KGI, 1994, B ENTOMOL RES, V84, P39, DOI 10.1017/S000748530003220X; JAYAWARDENA KGI, 1995, MED VET ENTOMOL, V9; JAYAWARDENA KGI, 1992, THESIS U LONDON; KAO LR, 1985, PESTIC BIOCHEM PHYS, V23, P228, DOI 10.1016/0048-3575(85)90010-0; KARUNARATNE SHP, 1995, IN PRESS PESTIC BIOC, V51; KARUNARATNE SHP, 1993, BIOCHEM SOC T, V22, pS127; KARUNARATNE SHPP, 1993, BIOCHEM J, V294, P575, DOI 10.1042/bj2940575; Karunaratne SHPP, 1994, THESIS U LONDON; KETTERMAN AJ, 1992, BIOCHEM J, V287, P355, DOI 10.1042/bj2870355; KETTERMAN AJ, 1993, PESTIC BIOCHEM PHYS, V47, P142, DOI 10.1006/pest.1993.1072; KROETZ DL, 1993, BIOCHEMISTRY-US, V32, P11606, DOI 10.1021/bi00094a018; MALKENSON NCD, 1984, INS BIOCH, V4, P481; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MATSUMURA F, 1968, J ECON ENTOMOL, V61, P598, DOI 10.1093/jee/61.3.598; MOTOYAMA N, 1984, PESTIC BIOCHEM PHYS, V21, P139, DOI 10.1016/0048-3575(84)90049-X; MOUCHES C, 1990, P NATL ACAD SCI USA, V87, P2574, DOI 10.1073/pnas.87.7.2574; MOUCHES C, 1986, SCIENCE, V233, P778, DOI 10.1126/science.3755546; MOUCHES C, 1987, P NATL ACAD SCI USA, V84, P2113, DOI 10.1073/pnas.84.8.2113; PARKER AG, 1991, PESTIC BIOCHEM PHYS, V41, P305, DOI 10.1016/0048-3575(91)90085-Z; PEIRIS HTR, 1990, B ENTOMOL RES, V80, P49, DOI 10.1017/S0007485300045910; PEIRIS HTR, 1990, B ENTOMOL RES, V80, P453, DOI 10.1017/S0007485300050719; PEIRIS HTR, 1993, B ENTOMOL RES, V83, P127, DOI 10.1017/S0007485300041869; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; POIRIE M, 1992, BIOCHEM GENET, V30, P13, DOI 10.1007/BF00554424; RAYMOND M, 1987, J MED ENTOMOL, V24, P24, DOI 10.1093/jmedent/24.1.24; RAYMOND M, 1989, BIOCHEM GENET, V27, P417, DOI 10.1007/BF02399670; ROBBI M, 1992, BIOCHEM BIOPH RES CO, V183, P836, DOI 10.1016/0006-291X(92)90559-4; ROST B, 1993, P NATL ACAD SCI USA, V90, P7558, DOI 10.1073/pnas.90.16.7558; VAUGHAN A, 1995, BIOCHEM J, V305, P651, DOI 10.1042/bj3050651; WIRTH MC, 1990, J MED ENTOMOL, V27, P202, DOI 10.1093/jmedent/27.2.202	44	89	105	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					17044	17049		10.1074/jbc.270.28.17044	http://dx.doi.org/10.1074/jbc.270.28.17044			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622525	hybrid			2022-12-27	WOS:A1995RJ34700088
J	VERNET, T; TESSIER, DC; CHATELLIER, J; PLOUFFE, C; LEE, TS; THOMAS, DY; STORER, AC; MENARD, R				VERNET, T; TESSIER, DC; CHATELLIER, J; PLOUFFE, C; LEE, TS; THOMAS, DY; STORER, AC; MENARD, R			STRUCTURAL AND FUNCTIONAL ROLES OF ASPARAGINE-175 IN THE CYSTEINE PROTEASE PAPAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE; CATALYTIC TRIAD; ION-PAIR; SERINE PROTEASES; TRANSITION-STATE; ALPHA-HELIX; SIDE-CHAIN; MECHANISM; PRECURSOR; STABILIZATION	The role of the asparagine residue in the Cys-His-Asn ''catalytic triad'' of cysteine proteases has been investigated by replacing Asn(175) in papain by alanine and glutamine using site-directed mutagenesis. The mutants were expressed in yeast and kinetic parameters determined against the substrate carbobenzoxy-L-phenylalanyl-(7-amino-4-methylcoumarinyl)-L-arginine. At the optimal pH of 6.5, the specificity constant (k(cat)/K-M)(obs) was reduced by factors of 3.4 and 150 for the Asn(175) --> Gln and Asn(175) --> Ala mutants, respectively. Most of this effect was the result of a decrease in k(cat), as neither mutation significantly affected K-M. Substrate hydrolysis by these mutants is still much faster than the non-catalytic rate, and therefore Asn(175) cannot be considered as an essential catalytic residue in the cysteine protease papain. Detailed analyses of the pH activity profiles for both mutants allow the evaluation of the role of the Asn(175) side chain on the stability of the active site ion pair and on the intrinsic activity of the enzyme. Alteration of the side chain at position 175 was also found to increase aggregation and proteolytic susceptibility of the proenzyme and to affect the thermal stability of the mature enzyme, reflecting a contribution of the asparagine residue to the structural integrity of papain. The strict conservation of Asn(175) in cysteine proteases might therefore result from a combination of functional and structural constraints.	NATL RES COUNCIL CANADA,BIOTECHNOL RES INST,MONTREAL,PQ H4P 2R2,CANADA	National Research Council Canada			Vernet, Thierry/G-1118-2012; Thomas, David/M-7661-2017	Thomas, David/0000-0002-8854-762X				BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; COREY DR, 1992, J AM CHEM SOC, V114, P1784, DOI 10.1021/ja00031a037; COREY DR, 1992, J AM CHEM SOC, V114, P4905, DOI 10.1021/ja00038a067; DIJKMAN JP, 1989, INT J QUANTUM CHEM, V35, P241, DOI 10.1002/qua.560350116; DIJKMAN JP, 1991, INT J QUANT CHEM QUA, V18, P49; DRENTH J, 1976, BIOCHEMISTRY-US, V15, P3731, DOI 10.1021/bi00662a014; DRENTH J, 1968, NATURE, V218, P929, DOI 10.1038/218929a0; Drenth J, 1971, Adv Protein Chem, V25, P79, DOI 10.1016/S0065-3233(08)60279-X; DRENTH J, 1975, P K NED AKAD C BIOL, V78, P104; FERSHT AR, 1985, ENZYME STRUCTURE MEC, P156; GARAVITO RM, 1977, BIOCHEMISTRY-US, V16, P5065, DOI 10.1021/bi00642a019; Glazer A., 1971, ENZYMES, P501; GORDON CL, 1993, J BIOL CHEM, V268, P9358; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; HUSAIN SS, 1968, BIOCHEM J, V108, P855, DOI 10.1042/bj1080855; KAMPHUIS IG, 1984, J MOL BIOL, V179, P233, DOI 10.1016/0022-2836(84)90467-4; LAVERY R, 1983, INT J QUANTUM CHEM, V24, P353, DOI 10.1002/qua.560240404; LEWIS SD, 1976, BIOCHEMISTRY-US, V15, P5009, DOI 10.1021/bi00668a010; LEWIS SD, 1981, BIOCHEMISTRY-US, V20, P48, DOI 10.1021/bi00504a009; LI YS, 1993, J AM CHEM SOC, V115, P8523, DOI 10.1021/ja00072a001; LOWE G, 1965, BIOCHEM J, V96, P194, DOI 10.1042/bj0960194; MELLOR GW, 1993, BIOCHEM J, V294, P201, DOI 10.1042/bj2940201; MENARD R, 1990, BIOCHEMISTRY-US, V29, P6706, DOI 10.1021/bi00480a021; MENARD R, 1991, BIOCHEMISTRY-US, V30, P8924, DOI 10.1021/bi00101a002; MENARD R, 1991, BIOCHEMISTRY-US, V30, P5531, DOI 10.1021/bi00236a028; MITRAKI A, 1992, FEBS LETT, V307, P20, DOI 10.1016/0014-5793(92)80894-M; POLGAR L, 1974, FEBS LETT, V47, P15, DOI 10.1016/0014-5793(74)80415-1; POLGAR L, 1986, J THEOR BIOL, V121, P323, DOI 10.1016/S0022-5193(86)80111-4; RULLMANN JAC, 1989, J MOL BIOL, V206, P101, DOI 10.1016/0022-2836(89)90527-5; SLUYTERMAN LAA, 1976, EUR J BIOCHEM, V71, P383, DOI 10.1111/j.1432-1033.1976.tb11125.x; SPRANG S, 1987, SCIENCE, V237, P905, DOI 10.1126/science.3112942; VANDUIJNEN PT, 1979, BIOPHYS CHEM, V9, P273, DOI 10.1016/0301-4622(79)85010-3; VANDUIJNEN PT, 1980, INT J QUANTUM CHEM, V17, P651, DOI 10.1002/qua.560170407; VERNET T, 1992, J MOL BIOL, V224, P501, DOI 10.1016/0022-2836(92)91011-D; VERNET T, 1991, J BIOL CHEM, V266, P21451; VERNET T, 1993, PROTEIN ENG, V6, P213, DOI 10.1093/protein/6.2.213; VERNET T, 1989, GENE, V77, P229, DOI 10.1016/0378-1119(89)90071-1; WARSHEL A, 1989, BIOCHEMISTRY-US, V28, P3629, DOI 10.1021/bi00435a001	40	126	131	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 14	1995	270	28					16645	16652		10.1074/jbc.270.28.16645	http://dx.doi.org/10.1074/jbc.270.28.16645			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RJ347	7622473	hybrid			2022-12-27	WOS:A1995RJ34700031
J	TAGAYA, M; TOYONAGA, S; TAKAHASHI, M; YAMAMOTO, A; FUJIWARA, T; AKAGAWA, K; MORIYAMA, Y; MIZUSHIMA, S				TAGAYA, M; TOYONAGA, S; TAKAHASHI, M; YAMAMOTO, A; FUJIWARA, T; AKAGAWA, K; MORIYAMA, Y; MIZUSHIMA, S			SYNTAXIN-1 (HPC-1) IS ASSOCIATED WITH CHROMAFFIN GRANULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							INTEGRAL MEMBRANE-PROTEIN; VESICULAR TRANSPORT; SYNAPTIC VESICLES; ANTIGEN; BRAIN; IDENTIFICATION; RECEPTORS; COMPLEX; FAMILY	Syntaxin 1 (HPC-1), a component of the receptor for SNAPs (soluble N-ethylmaleimide-sensitive factor attachment proteins), has been implicated in the docking and fusion of synaptic vesicles with the plasma membrane. It was reported that syntaxin 1 in rat brain and chromaffin cells (PC12) is exclusively located on the plasma membrane (Bennett, M. K., Calakos, N., and Scheller, R. R. (1992) Science 257, 255-259; Sollner, T., Bennett, M. K., Whiteheart, S. W., Scheller, R. H., and Rothman, J. E. (1993) Cell 75, 409-418). By means of biochemical and morphological analyses, we now show that syntaxin 1 is associated with chromaffin granules in the adrenal medulla. This finding raises the possibility that syntaxin 1 in chromaffin cells is a component of vesicle-SNAP receptor as well as one of target SNAP receptor on the plasma membrane.	MITSUBISHI KASEI INST LIFE SCI, MACHIDA 194, TOKYO, JAPAN; KANSAI MED UNIV, DEPT PHYSIOL, MORIGUCHI, OSAKA 570, JAPAN; KYORIN UNIV, SCH MED, DEPT PHYSIOL, MITAKA 181, TOKYO, JAPAN; HIROSHIMA UNIV, FAC SCI, GRAD SCH GENE SCI, MARINE BIOL LAB, HIROSHIMA 722, JAPAN	Kansai Medical University; Kyorin University; Hiroshima University	TAGAYA, M (corresponding author), TOKYO UNIV PHARM & LIFE SCI, SCH LIFE SCI, 1422-1 HORINOUCHI, HACHIOJI, TOKYO 19203, JAPAN.			Fujiwara, Tomonori/0000-0003-1369-7305				AKAGAWA K, 1986, BRAIN RES, V383, P110, DOI 10.1016/0006-8993(86)90012-0; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; DASCHER C, 1994, J BIOL CHEM, V269, P29363; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; HODEL A, 1994, J BIOL CHEM, V269, P8623; HONG RM, 1994, FEBS LETT, V350, P253, DOI 10.1016/0014-5793(94)00778-0; HORIKAWA HPM, 1993, FEBS LETT, V330, P236, DOI 10.1016/0014-5793(93)80281-X; INOUE A, 1992, BIOCHEM BIOPH RES CO, V187, P1144, DOI 10.1016/0006-291X(92)91316-I; INOUE A, 1992, J BIOL CHEM, V267, P10613; KOH S, 1993, J NEUROCYTOL, V22, P995, DOI 10.1007/BF01218356; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MEYER DI, 1979, J BIOL CHEM, V254, P9854; MORGAN A, 1995, EMBO J, V14, P232, DOI 10.1002/j.1460-2075.1995.tb06996.x; NELSON N, 1988, METHOD ENZYMOL, V157, P619; OYER GA, 1989, J CELL BIOL, V109, P3039; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; ROTH D, 1994, FEBS LETT, V351, P207, DOI 10.1016/0014-5793(94)00833-7; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925	26	79	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 7	1995	270	27					15930	15933		10.1074/jbc.270.27.15930	http://dx.doi.org/10.1074/jbc.270.27.15930			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	RH226	7608144	hybrid			2022-12-27	WOS:A1995RH22600005
